<SEC-DOCUMENT>0001932393-25-000014.txt : 20250430
<SEC-HEADER>0001932393-25-000014.hdr.sgml : 20250430
<ACCEPTANCE-DATETIME>20250430062615
ACCESSION NUMBER:		0001932393-25-000014
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		115
CONFORMED PERIOD OF REPORT:	20250331
FILED AS OF DATE:		20250430
DATE AS OF CHANGE:		20250430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GE HealthCare Technologies Inc.
		CENTRAL INDEX KEY:			0001932393
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				882515116
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41528
		FILM NUMBER:		25890735

	BUSINESS ADDRESS:	
		STREET 1:		500 WEST MONROE STREET
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60661
		BUSINESS PHONE:		833-735-1139

	MAIL ADDRESS:	
		STREET 1:		500 WEST MONROE STREET
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60661

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GE Healthcare Holding LLC
		DATE OF NAME CHANGE:	20220603
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>gehc-20250331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:d0a8a86e-df0d-464c-9ff8-447ea6f21cea,g:ade862ec-33b2-4b8a-bb85-176c06a683fa,d:96f768675eb442d1b7b31e27beba1a3b-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:gehc="http://www.gehealthcare.com/20250331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>gehc-20250331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-25">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-26">0001932393</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-27">Q1</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-28">2025</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-29">12/31</ix:nonNumeric><ix:nonNumeric contextRef="c-8" name="us-gaap:HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration" id="f-857">http://fasb.org/us-gaap/2024#LongTermDebtNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-9" name="us-gaap:HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration" id="f-858">http://fasb.org/us-gaap/2024#LongTermDebtNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-7" name="us-gaap:RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="f-1056">http://fasb.org/us-gaap/2024#CostOfRevenue http://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpense</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="f-1057">http://fasb.org/us-gaap/2024#CostOfRevenue http://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpense</ix:nonNumeric><ix:nonNumeric contextRef="c-8" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-1193">http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-9" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-1194">http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-8" name="us-gaap:SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration" id="f-1206">http://fasb.org/us-gaap/2024#AccountsPayableCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-9" name="us-gaap:SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration" id="f-1207">http://fasb.org/us-gaap/2024#AccountsPayableCurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="gehc-20250331.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>gehc:segment</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="series"><xbrli:measure>gehc:series</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-04-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:ImagingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:ImagingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:AVSSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">gehc:ProceduralGuidanceSubsegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:AVSSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">gehc:ProceduralGuidanceSubsegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:AVSSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">gehc:SpecializedUltrasoundSubsegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:AVSSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">gehc:SpecializedUltrasoundSubsegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:AVSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:AVSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PCSSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">gehc:MonitoringSolutionsSubsegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PCSSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">gehc:MonitoringSolutionsSubsegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PCSSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">gehc:LifeSupportSolutionsSubsegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PCSSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">gehc:LifeSupportSolutionsSubsegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PCSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PCSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PDxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PDxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">gehc:FinanceLeaseReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">gehc:FinanceLeaseReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">gehc:FinancialAssetGreaterThan30DaysPastDueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">gehc:FinancialAssetGreaterThan30DaysPastDueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gehc:NihonMediPhysicsCo.LtdNMPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gehc:NihonMediPhysicsCo.LtdNMPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-31</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gehc:NihonMediPhysicsCo.LtdNMPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-31</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">gehc:NihonMediPhysicsCo.LtdNMPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gehc:MIMSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gehc:MIMSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gehc:MIMSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">gehc:ContingentConsiderationPurchasePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gehc:MIMSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">gehc:ContingentConsiderationServiceRequirementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gehc:MIMSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gehc:MIMSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:ImagingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:AVSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PCSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PDxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:ImagingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:AVSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PCSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PDxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:ImagingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:AVSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PCSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PDxSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">gehc:TrademarksAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">gehc:TrademarksAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:SeniorUnsecuredNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5YearRevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A364DayRevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5YearRevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A364DayRevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:FloatingRateTermLoanFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:FloatingRateTermLoanFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5YearRevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A364DayRevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:FloatingRateTermLoanFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:FloatingRateTermLoanFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:FloatingRateTermLoanFacilityDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5600SeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5600SeniorNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5650SeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5650SeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A4.800SeniorNotesDue2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A4.800SeniorNotesDue2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5857SeniorNotesDue2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5857SeniorNotesDue2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5905SeniorNotesDue2032Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5905SeniorNotesDue2032Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A6377SeniorNotesDue2052Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A6377SeniorNotesDue2052Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">gehc:OtherLongTermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">gehc:OtherLongTermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">gehc:CommercialContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">gehc:CommercialContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">gehc:EquipmentResidualValueObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">gehc:EquipmentResidualValueObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">gehc:GEHealthCareSupplementalPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">us-gaap:RetirementPlanNameOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:DebtBasisAdjustmentLongTermBorrowingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:DebtBasisAdjustmentLongTermBorrowingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:DebtBasisAdjustmentLongTermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:DebtBasisAdjustmentLongTermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:DebtBasisAdjustmentLongTermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:DebtBasisAdjustmentLongTermBorrowingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:DebtBasisAdjustmentLongTermBorrowingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:DebtBasisAdjustmentLongTermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:DebtBasisAdjustmentLongTermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:DebtBasisAdjustmentLongTermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">gehc:OtherCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">gehc:OtherCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">gehc:BuildingsStructuresAndRelatedEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">gehc:BuildingsStructuresAndRelatedEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">gehc:LeaseholdImprovementsAndManufacturingPlantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">gehc:LeaseholdImprovementsAndManufacturingPlantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001932393</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-30</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i96f768675eb442d1b7b31e27beba1a3b_238"></div><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:139%">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:162%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:125%">FORM&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(Mark One)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9745;</ix:nonNumeric>&#160;QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the quarterly period ended&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">March 31, 2025</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">or</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric>&#160;TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from ____ to ____</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission file number&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-41528</ix:nonNumeric></span></div><div style="text-align:center"><img src="gehc-20250331_g1.jpg" alt="GE-HLTHCR_Standard_RGB-CompPrpl.jpg" style="height:85px;margin-bottom:5pt;vertical-align:text-bottom;width:250px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">GE HEALTHCARE TECHNOLOGIES INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:0.08pt;text-align:center"><span><br/></span></div><div style="margin-bottom:0.08pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">88-2515116</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">500 W. Monroe Street</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Chicago</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-11">IL</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">60661</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(Zip Code)</span></td></tr></table></div><div style="margin-top:6pt;padding-left:8.01pt;padding-right:8.01pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">(Registrant&#8217;s telephone number, including area code)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:139%"> (<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">833</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">735-1139</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:139%">Securities Registered Pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:36.591%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.592%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #00000a;border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-15">Common stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #00000a;border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-16">GEHC</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #00000a;border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-17">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric>&#160;&#9745; No&#160;&#9744;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405&#160;of&#160;Regulation S-T&#160;(&#167;232.405&#160;of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric>&#160;&#9745;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No&#160;&#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2&#160;of the&#160;Exchange Act.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-21">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#9744;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2&#160;of the&#160;Exchange Act). Yes&#160;&#9744;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-23">No</ix:nonNumeric>&#160;&#9745;</span></div><div style="margin-bottom:3pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-24">457,884,998</ix:nonFraction>&#160;sh</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ares of common stock with a par value of $0.01 per share outstanding as of April&#160;23, 2025.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div></div></div><div id="i96f768675eb442d1b7b31e27beba1a3b_1099511629104"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.177%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.651%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Table of Contents</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Page</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_19">Forward-Looking Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_19">3</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Part I.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Financial Information</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#160;&#160;&#160;&#160;&#160;<a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_244">Item 1.</a> </span></div></td><td colspan="3" style="border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_244">Financial Statements</a><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_244"> (</a><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_244">Unaudited)</a></span></div></td><td colspan="3" style="border-top:1pt solid #6022a6;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_115">Condensed Consolidated Statements of Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_115">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_118">Condensed Consolidated Statements of Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_118">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_121">Condensed Consolidated Statements of Financial Position</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_121">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_124">Condensed Consolidated Statements of Changes in Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_124">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_127">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_127">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_130">Notes to the Condensed Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_130">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_130">Note 1.     Organization and Basis of Presentation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_130">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_136">Note 2.     Revenue Recognition</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_136">10</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_139">Note 3.     Segment Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_139">10</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_142">Note 4.     Receivables</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_142">12</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_145">Note 5.     Financing Receivables</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_145">13</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_148">Note 6.     Leases</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_148">13</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_151">Note 7.     Acquisitions, Goodwill, and Other Intangible Assets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_151">13</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_154">Note 8.     Borrowings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_154">15</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_259">Note 9.     Postretirement Benefit Plans </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_259">16</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_262">Note 10.   Income Taxes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_262">17</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_283">Note 11.   Accumulated Other Comprehensive Income (Loss) &#8211; Net</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_283">17</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_166">Note 12.   Financial Instruments and Fair Value Measurements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_166">18</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_169">Note 13.   Commitments, Guarantees, Product Warranties, and Other Loss Contingencies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_169">21</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_172">Note 14.   Restructuring Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_172">22</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_181">Note 15.   Earnings Per Share</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_181">23</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_184">Note 16.   Supplemental Financial Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_184">23</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_190">Note 17.   Subsequent Events</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_190">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#160;&#160;&#160;&#160;&#160;<a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_70">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_70">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_70">27</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_79">Trends and Factors Impacting Our Performance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_79">27</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_82">Summary of Key Performance Measures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_82">28</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_85">Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_85">29</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_88">Results of Operations &#8211; Segments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_88">31</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_91">Non-GAAP Financial Measures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_91">32</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_94">Liquidity and Capital Resources</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_94">36</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_97">Recently Issued Accounting Pronouncements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_97">37</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_268">Critical Accounting Estimates</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_268">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#160;&#160;&#160;&#160;&#160;<a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_247">Item 3.</a> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_247">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_247">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#160;&#160;&#160;&#160;&#160;<a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_196">Item 4.</a> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_196">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_196">38</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Part II.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Other Information</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#160;&#160;&#160;&#160;&#160;<a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_58">Item 1.</a></span></div></td><td colspan="3" style="border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_58">Legal Proceedings</a></span></div></td><td colspan="3" style="border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_58">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#160;&#160;&#160;&#160;&#160;<a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_277">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_277">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_277">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_271">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_271">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_271">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_274">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_274">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_274">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_61">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_61">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_61">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_199">Item 5.</a> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_199">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_199">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#160;&#160;&#160;&#160;&#160;<a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_292">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_292">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_292">39</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_295">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_295">40</a></span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</span></div></div></div><div id="i96f768675eb442d1b7b31e27beba1a3b_19"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORWARD-LOOKING STATEMENTS </span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains forward-looking statements. These forward-looking statements might be identified by words, and variations of words, such as &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;may,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;potential,&#8221; &#8220;position,&#8221; &#8220;forecast,&#8221; &#8220;target,&#8221; &#8220;guidance,&#8221; &#8220;outlook,&#8221; and similar expressions. These forward-looking statements may include, but are not limited to, statements about our business; financial performance, financial condition, and results of operations, including revenue, revenue growth, profit, taxes, earnings per share, and cash flows; the impacts of macroeconomic and market conditions, including the impact of tariffs and other trade restrictions, and volatility on our business operations, financial results, and financial position and on supply chains and the world economy; our cost structure; our funding and liquidity; the impacts on our business of manufacturing, sourcing, and supply chain management; the Russia and Ukraine conflict; and risks related to foreign currency exchange, interest rates, and commodity price volatility. These forward-looking statements involve risks and uncertainties, many of which are beyond our control. Factors that could cause our actual results to differ materially from those described in our forward-looking statements include, but are not limited to, operating in highly competitive markets; global geopolitical and economic instability, including as a result of changes in trade and tariff policy, the conflict between Ukraine and Russia, and tensions in the Middle East; public health crises, epidemics, and pandemics, and their effects on our business; changes in third-party and government reimbursement processes, rates, and contractual relationships, including related to government shutdowns, and changes in the mix of public and private payers; demand for our products, services, or solutions and factors that affect that demand; developments in the market in China; our ability to control increases in healthcare costs and any subsequent effect on demand for our products, services, or solutions; our ability to successfully complete strategic transactions; the impacts related to our increasing focus on and investment in cloud, edge computing, artificial intelligence (&#8220;AI&#8221;), and software offerings; management of our supply chain and our ability to cost-effectively secure the materials we need to operate our business; disruptions in our operations; the actions or inactions of third parties with whom we partner and the various collaboration, licensing, and other partnerships and alliances we have with third parties; the impact of potential information technology, cybersecurity, or data security breaches; maintenance and protection of our intellectual property rights, as well as maintenance of successful research and development efforts with respect to commercially successful products and technologies; our ability to attract and/or retain key personnel and qualified employees; environmental, social, and governance matters; compliance with the various legal, regulatory, tax, privacy, and other laws to which we are subject, such as the Foreign Corrupt Practices Act and similar anti-corruption and anti-bribery laws globally, and related changes, claims, inquiries, investigations, or actions; the impact of potential product liability claims; and our level of indebtedness, as well as our general ability to comply with covenants under our debt instruments, and any related effect on our business. Please also see Item 1A, &#8220;Risk Factors&#8221; of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the United States Securities and Exchange Commission (&#8220;SEC&#8221;) and any updates or amendments we make in future filings. There may be other factors not presently known to us or which we currently consider to be immaterial that could cause our actual results to differ materially from those projected in any forward-looking statements we make. We do not undertake any obligation to update or revise our forward-looking statements except as required by applicable law or regulation.</span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3</span></div></div></div><div id="i96f768675eb442d1b7b31e27beba1a3b_244"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">PART I. FINANCIAL INFORMATION</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">ITEM 1. FINANCIAL STATEMENTS</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_115"></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:69.094%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.804%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Income (Unaudited)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">(In millions, except per share amounts)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">2024</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Sales of products</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-30">3,117</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-31">3,045</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Sales of services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-32">1,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-33">1,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Total revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-34">4,777</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-35">4,650</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Cost of products</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-36">1,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-37">1,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Cost of services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:CostOfRevenue" scale="6" id="f-38">802</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-6" name="us-gaap:CostOfRevenue" scale="6" id="f-39">782</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Gross profit</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-40">2,012</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-41">1,902</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Selling, general, and administrative</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-42">1,040</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-43">1,038</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Research and development</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-44">344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-45">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Total operating expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="f-46">1,383</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="f-47">1,362</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Operating income</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-48">629</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-49">540</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest and other financial charges &#8211; net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="f-50">110</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="f-51">122</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Non-operating benefit (income) costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="f-52">74</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="f-53">102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other (income) expense &#8211; net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-54">99</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-55">8</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Income before income taxes</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-56">692</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-57">512</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Benefit (provision) for income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-58">104</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-59">124</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Net income</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="f-60">588</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="f-61">388</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Net (income) loss attributable to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="f-62">24</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="f-63">14</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Net income attributable to GE HealthCare</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-64">564</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-65">374</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Earnings per share attributable to GE HealthCare:</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-66">1.23</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-67">0.82</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-68">1.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-69">0.81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Weighted-average number of shares outstanding:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-70">457</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-71">456</ix:nonFraction></span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-72">459</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-73">459</ix:nonFraction></span></td><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:6.75pt;padding-right:6.75pt;text-align:center;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:6.75pt;padding-right:6.75pt;text-align:center;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">4</span></div></div></div><div id="i96f768675eb442d1b7b31e27beba1a3b_118"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:0.08pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:73.237%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.731%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.732%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)</span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">(In millions, net of tax)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">2024</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Net income attributable to GE HealthCare</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-74">564</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-75">374</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Net income (loss) attributable to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="f-76">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="f-77">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Net income</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="f-78">588</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="f-79">388</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Other comprehensive income (loss):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Currency translation adjustments &#8211; net of taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-80">257</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-81">76</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Pension and Other Postretirement Plans &#8211; net of taxes</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-82">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-83">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Cash flow hedges &#8211; net of taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="f-84">8</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="f-85">16</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Other comprehensive income (loss)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-86">180</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-87">95</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Comprehensive income (loss)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-88">768</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-89">292</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Less: Comprehensive income (loss) attributable to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="f-90">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="f-91">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Comprehensive income attributable to GE HealthCare</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-92">744</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-93">278</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="padding-left:6.75pt;padding-right:6.75pt;text-align:center;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">5</span></div></div></div><div id="i96f768675eb442d1b7b31e27beba1a3b_121"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:69.136%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.781%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.783%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:174%">Condensed Consolidated Statements of Financial Position (Unaudited)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:125%">(In millions, except share and per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cash, cash equivalents, and restricted cash</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-94">2,473</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-95">2,889</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Receivables &#8211; net of allowances of $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="f-96">106</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="f-97">103</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="f-98">3,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="f-99">3,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Inventories</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="f-100">2,158</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="f-101">1,939</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Contract and other deferred assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent" scale="6" id="f-102">931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent" scale="6" id="f-103">974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">All other current assets</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-104">601</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-105">532</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-106">9,735</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-107">9,901</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Property, plant, and equipment &#8211; net</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="gehc:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-108">2,851</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="gehc:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-109">2,550</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-110">13,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-111">13,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other intangible assets &#8211; net</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-112">1,238</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-113">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-114">4,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-115">4,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">All other non-current assets</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-116">1,926</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-117">1,950</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-118">33,586</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-119">33,089</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Short-term borrowings</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-120">2,002</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-121">1,502</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="f-122">3,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="f-123">3,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Contract liabilities</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="f-124">1,889</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="f-125">1,943</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Current compensation and benefits</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-126">1,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-127">1,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">All other current liabilities</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-128">1,583</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-129">1,552</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-130">9,969</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-131">9,553</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Long-term borrowings</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-132">6,757</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-133">7,449</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-current compensation and benefits</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-134">5,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-135">5,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Deferred income taxes</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-136">159</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-137">56</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">All other non-current liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-138">1,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-139">1,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total liabilities</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-140">24,168</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-141">24,437</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:125%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-8" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-142"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-9" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-143"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="f-144">211</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="f-145">188</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-146"><ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-147">0.01</ix:nonFraction></ix:nonFraction> per share, <ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-148"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-149">1,000,000,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-150">458,134,263</ix:nonFraction> shares issued as of March 31, 2025; <ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-151">457,246,971</ix:nonFraction> shares issued as of December 31, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="f-152">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="f-153">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Treasury stock, at cost, <ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-154"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-155">291,053</ix:nonFraction></ix:nonFraction> shares as of March 31, 2025 and December 31, 2024</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:TreasuryStockCommonValue" scale="6" id="f-156">25</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:TreasuryStockCommonValue" scale="6" id="f-157">25</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="f-158">6,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="f-159">6,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Retained earnings</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-160">3,810</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-161">3,262</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Accumulated other comprehensive income (loss) &#8211; net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="f-162">1,199</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="f-163">1,379</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total equity attributable to GE HealthCare</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-164">9,187</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-165">8,446</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="f-166">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="f-167">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total equity</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-168">9,207</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-169">8,464</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total liabilities, redeemable noncontrolling interests, and equity</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-170">33,586</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-171">33,089</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements. </span></div><div style="margin-bottom:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;text-align:center"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">6</span></div></div></div><div id="i96f768675eb442d1b7b31e27beba1a3b_124"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:28.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.688%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.132%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.470%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.138%"/><td style="width:0.1%"/></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:174%">Condensed Consolidated Statements of Changes in Equity (Unaudited)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Common stock</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Treasury stock</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">(In millions, except per share amounts)</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Shares</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Amount</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Shares</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Amount</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Additional paid-in capital</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Retained earnings</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Accumulated other comprehensive income (loss) &#8211; net</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Equity attributable to noncontrolling interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Total equity</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Balances as of December 31, 2024</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-172">457</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-173">5</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="-6" name="us-gaap:TreasuryStockCommonShares" format="ixt:fixed-zero" scale="6" id="f-174">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-175">25</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-176">6,583</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-177">3,262</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-178">1,379</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-179">18</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-180">8,464</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Issuance of shares under equity awards, net of shares withheld for taxes and other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-181">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-182">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-183">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net income attributable to GE HealthCare</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-184">564</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-185">564</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="3" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-186">0.035</ix:nonFraction> per common share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-6" name="us-gaap:Dividends" scale="6" id="f-187">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:Dividends" scale="6" id="f-188">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other comprehensive income (loss) attributable to GE HealthCare</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-189">180</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-190">180</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Changes in equity attributable to noncontrolling interests&#160;&#160;&#160;&#160;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="f-191">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="f-192">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Share-based compensation</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-193">22</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-194">22</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balances as of March 31, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-195">458</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-196">5</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="-6" name="us-gaap:TreasuryStockCommonShares" format="ixt:fixed-zero" scale="6" id="f-197">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-198">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-199">6,597</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-200">3,810</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-201">1,199</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-202">20</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-203">9,207</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:0.08pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:28.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.774%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.304%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.887%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Common stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">(In millions, except per share amounts)</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Shares</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Amount</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Additional paid-in capital</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Retained earnings</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Accumulated other comprehensive income (loss) &#8211; net</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Equity attributable to noncontrolling interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Total equity</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Balances as of December 31, 2023</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-204">455</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-205">5</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-206">6,493</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-207">1,326</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-208">691</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-209">12</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-210">7,145</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Issuance of shares under equity awards, net of shares withheld for taxes and other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="shares" contextRef="c-33" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-211">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-212">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-213">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net income attributable to GE HealthCare</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-214">374</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-215">374</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-216">0.03</ix:nonFraction> per common share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-6" name="us-gaap:Dividends" scale="6" id="f-217">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:Dividends" scale="6" id="f-218">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other comprehensive income (loss) attributable to GE HealthCare</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-219">95</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-220">95</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Changes in equity attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="f-221">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="f-222">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Share-based compensation</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-223">34</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-224">34</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balances as of March 31, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="shares" contextRef="c-38" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-225">456</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-226">5</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-227">6,504</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-228">1,687</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-229">787</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-230">14</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-231">7,423</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">The accompanying notes are an integral part of these condensed consolidated financial statements. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">7</span></div></div></div><div id="i96f768675eb442d1b7b31e27beba1a3b_127"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:71.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.848%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:174%">Condensed Consolidated Statements of Cash Flows (Unaudited)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(In millions) </span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Net income</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="f-232">588</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="f-233">388</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Adjustments to reconcile Net income to Cash from (used for) operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Depreciation of property, plant, and equipment</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:Depreciation" scale="6" id="f-234">66</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:Depreciation" scale="6" id="f-235">68</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-236">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-237">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Gain on remeasurement of Nihon Medi-Physics equity method investment</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="f-238">97</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" format="ixt:fixed-zero" scale="6" id="f-239">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net periodic postretirement benefit plan (income) expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" scale="6" id="f-240">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" scale="6" id="f-241">90</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Postretirement plan contributions</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="gehc:PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost" scale="6" id="f-242">98</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="gehc:PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost" scale="6" id="f-243">87</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="f-244">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="f-245">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Provision for income taxes</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-246">104</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-247">124</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cash paid during the year for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="f-248">91</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="f-249">86</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Changes in operating assets and liabilities, excluding the effects of acquisitions:</span></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" scale="6" id="f-250">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" scale="6" id="f-251">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Inventories</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-252">154</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-253">59</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Contract and other deferred assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="gehc:IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts" scale="6" id="f-254">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="gehc:IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts" scale="6" id="f-255">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Accounts payable</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="f-256">146</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="f-257">31</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="f-258">68</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="f-259">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Current compensation and benefits</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="f-260">200</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="f-261">34</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">All other operating activities &#8211; net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="f-262">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="f-263">129</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cash from (used for) operating activities</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-264">250</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-265">419</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cash flows &#8211; investing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Additions to property, plant and equipment and internal-use software</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="f-266">152</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="f-267">145</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Purchases of businesses, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="f-268">269</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="6" id="f-269">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Purchases of investments</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="f-270">20</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="f-271">19</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">All other investing activities &#8211; net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-272">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-273">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cash from (used for) investing activities</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-274">407</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-275">188</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cash flows &#8211; financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net increase (decrease) in borrowings (maturities of 90 days or less)</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" scale="6" id="f-276">1</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" scale="6" id="f-277">1</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Newly issued debt, net of debt issuance costs (maturities longer than 90 days)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromDebtMaturingInMoreThanThreeMonths" format="ixt:fixed-zero" scale="6" id="f-278">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ProceedsFromDebtMaturingInMoreThanThreeMonths" scale="6" id="f-279">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Repayments and other reductions (maturities longer than 90 days)</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RepaymentsOfDebtMaturingInMoreThanThreeMonths" scale="6" id="f-280">257</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:RepaymentsOfDebtMaturingInMoreThanThreeMonths" scale="6" id="f-281">153</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Dividends paid to stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="f-282">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="f-283">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Proceeds from stock issued under employee benefit plans</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="f-284">20</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="f-285">16</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-286">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-287">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">All other financing activities &#8211; net</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="f-288">6</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="f-289">7</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cash from (used for) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-290">286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-291">153</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Effect of foreign currency rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-292">27</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-293">19</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Increase (decrease) in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-294">416</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-295">59</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cash, cash equivalents, and restricted cash at beginning of year</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-296">2,893</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-297">2,506</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cash, cash equivalents, and restricted cash at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-298">2,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-299">2,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Supplemental disclosure of cash flows information</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cash paid during the year for interest</span></td><td style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="f-300">78</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="f-301">55</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Non-cash investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Acquired but unpaid property, plant, and equipment</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="f-302">86</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="f-303">53</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:0.08pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">8</span></div></div></div><div id="i96f768675eb442d1b7b31e27beba1a3b_130"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1. <ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-304" continuedAt="f-304-1" escape="true">ORGANIZATION AND BASIS OF PRESENTATION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-304-1"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">GE HealthCare Technologies Inc. is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services, and data analytics.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-305" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The condensed consolidated financial statements (the &#8220;financial statements&#8221;) of GE HealthCare Technologies Inc. and its subsidiaries (&#8220;GE HealthCare,&#8221; the &#8220;Company,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; or &#8220;we&#8221;) have been prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, the financial statements do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments, including normal recurring adjustments, considered necessary for a fair presentation of the Company&#8217;s financial position and operating results have been included. All intercompany balances and transactions within the Company have been eliminated in the financial statements. Operating results for the three months ended March 31, 2025 and 2024 are not necessarily indicative of the results that may be expected for the fiscal year as a whole. The December 31, 2024 period presented on the Condensed Consolidated Statement of Financial Position was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Tables throughout this document are presented in millions of U.S. dollars unless otherwise stated and certain columns and rows may not sum due to the use of rounded numbers. Percentages presented are calculated from the underlying whole-dollar amounts.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The financial statements and notes should be read in conjunction with the Company&#8217;s audited consolidated and combined financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 3, 2023, the General Electric Company, which now operates as GE Aerospace (&#8220;GE&#8221;), completed the spin-off of GE HealthCare Technologies Inc. (the &#8220;Spin-Off&#8221;). Following this transaction, GE continues to be considered a related party due to the nature of our relationship and board member affiliation. Net costs incurred with GE were not significant for the three months ended March 31, 2025. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="f-306" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain prior year amounts in the financial statements and notes thereto have been reclassified to conform to the current year presentation. On the Condensed Consolidated Statements of Cash Flows, new line items were added and amounts were reclassified accordingly for the following items: amounts related to current compensation and benefits that were previously reported within All other operating activities &#8211; net, amounts related to purchases of investments previously reported within All other investing activities &#8211; net, and amounts related to equity award activity previously reported within All other financing activities &#8211; net. Additionally, amounts due from related parties and due to related parties which were previously shown on separate lines on the Condensed Consolidated Statements of Cash Flows and Condensed Consolidated Statements of Financial Position were reclassified to Receivables, All other current assets, Accounts Payable, All other current liabilities, and All other operating activities - net as applicable.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-307" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><br/>ESTIMATES AND ASSUMPTIONS. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions, which affect the reported amounts and related disclosures in the financial statements. We base our estimates and judgments on historical experience and on various other assumptions and information that we believe to be reasonable under the circumstances. Although our estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations, financial position, and cash flows.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-308" escape="true"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">RECENT ACCOUNTING PRONOUNCEMENTS.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-09 (&#8220;ASU 2023-09&#8221;), </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. ASU 2023-09 addresses investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This update also includes certain other amendments to improve the effectiveness of income tax disclosures. The provisions of ASU 2023-09 are effective for annual periods beginning after December 15, 2024, with early adoption permitted. We expect the adoption to impact disclosures in our notes to the financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU No. 2024-03 (&#8220;ASU 2024-03&#8221;), </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. ASU 2024-03 addresses investor requests for more transparency about expense information through the disaggregation of relevant expense captions in the notes to the financial statements. The provisions of ASU 2024-03 are effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. We expect the adoption to impact disclosures in our notes to the financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">9</span></div></div></div><div id="i96f768675eb442d1b7b31e27beba1a3b_136"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2. <ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-309" continuedAt="f-309-1" escape="true">REVENUE RECOGNITION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-309-1"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Our revenues primarily consist of sales of products and services to customers. Products include equipment, imaging agents, software-related offerings, and upgrades. Services include contractual and stand-by preventative maintenance and corrective services, as well as related parts and labor, extended warranties, training, and other service-type offerings. The Company recognizes revenue from contracts with customers when the customer obtains control of the underlying products or services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:118%">CONTRACT AND OTHER DEFERRED ASSETS.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Contract assets reflect revenue recognized on contracts with customers in excess of billings based on contractual terms. Contract assets are classified as current or non-current based on the amount of time expected to lapse until the Company&#8217;s right to consideration becomes unconditional. Other deferred assets consist of costs to obtain contracts, primarily commissions, other cost deferrals for shipped products, and deferred service, labor, and direct overhead costs.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="f-310" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.955%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.873%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Contract assets</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="f-311">572</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="f-312">589</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other deferred assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:DeferredCostsCurrent" scale="6" id="f-313">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:DeferredCostsCurrent" scale="6" id="f-314">385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Contract and other deferred assets</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent" scale="6" id="f-315">931</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent" scale="6" id="f-316">974</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-current contract assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetNoncurrent" scale="6" id="f-317">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetNoncurrent" scale="6" id="f-318">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-current other deferred assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:DeferredCosts" scale="6" id="f-319">113</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:DeferredCosts" scale="6" id="f-320">105</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total contract and other deferred assets</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts" format="ixt:num-dot-decimal" scale="6" id="f-321">1,144</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts" format="ixt:num-dot-decimal" scale="6" id="f-322">1,183</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%;padding-left:2.52pt">Non-current contract and other deferred assets are recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:118%">CONTRACT LIABILITIES.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Contract liabilities include customer advances and deposits received when orders are placed and billed in advance of completion of performance obligations. Contract liabilities are classified as current or non-current based on the periods over which these remaining performance obligations are expected to be satisfied with our customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">As of March 31, 2025 and December 31, 2024, contract liabilities were approximately $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="f-323">2,613</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="f-324">2,629</ix:nonFraction> million, respectively, of which the non-current portion of $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="f-325">724</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="f-326">686</ix:nonFraction> million, respectively, was recognized in All other non-current liabilities in the Condensed Consolidated Statements of Financial Position. Revenue recognized related to the contract liabilities balance at the beginning of the year was approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-327">752</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-328">741</ix:nonFraction> million for the three months ended March 31, 2025 and 2024, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:118%">REMAINING PERFORMANCE OBLIGATIONS.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Remaining performance obligations (&#8220;RPO&#8221;) represents the estimated revenue expected from customer contracts that are partially or fully unperformed inclusive of amounts deferred in contract liabilities, excluding contracts, or portions thereof, that provide the customer with the right to cancel or terminate without incurring a substantive penalty. RPO also excludes estimated revenue from arrangements where we lease equipment manufactured by the Company to customers.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" id="f-329" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.650%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Products</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-6" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="f-330">4,599</ix:nonFraction></span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-6" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="f-331">4,755</ix:nonFraction></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Services&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-6" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="f-332">10,280</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-6" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="f-333">9,737</ix:nonFraction></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Total RPO</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="f-334">14,879</ix:nonFraction></span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="f-335">14,491</ix:nonFraction></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">We expect to recognize substantially all of the revenue for our product-related RPO within <ix:nonNumeric contextRef="c-48" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durwordsen" id="f-336">two years</ix:nonNumeric> and services-related RPO within <ix:nonNumeric contextRef="c-49" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durwordsen" id="f-337">five years</ix:nonNumeric>.</span></div></ix:continuation><div><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_139"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3. <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-338" continuedAt="f-338-1" escape="true">SEGMENT INFORMATION</ix:nonNumeric></span></div><ix:continuation id="f-338-1" continuedAt="f-338-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Effective July 1, 2024, Image Guided Therapies, previously part of the Imaging segment, was realigned to the Ultrasound segment. The Ultrasound segment was subsequently renamed Advanced Visualization Solutions (&#8220;AVS&#8221;). Following this realignment, the Company continues to have <ix:nonFraction unitRef="segment" contextRef="c-50" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-339"><ix:nonFraction unitRef="segment" contextRef="c-50" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-340">four</ix:nonFraction></ix:nonFraction> reportable segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions (&#8220;PCS&#8221;), and Pharmaceutical Diagnostics (&#8220;PDx&#8221;). These segments have been identified based on the nature of the products sold and how the Company manages its operations. We have not aggregated any of our operating segments to form reportable segments. A description of our reportable segments has been provided in Item 1, &#8220;Business&#8221; of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Historical segment financial information presented within this report has been recast to conform to the new reportable segments structure.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="f-338-2" continuedAt="f-338-3"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s organizational structure is based upon the availability of separate financial information that is evaluated regularly by the Company&#8217;s Chief Operating Decision Maker (&#8220;CODM&#8221;) for the purpose of assessing performance and allocating resources. The Company&#8217;s CODM is its Chief Executive Officer. The CODM assesses segment performance using Total revenues and an earnings metric defined as &#8220;Segment EBIT.&#8221; Segment EBIT is calculated as income before income taxes in our Condensed Consolidated Statements of Income excluding the impact of the following: Interest and other financial charges &#8211; net, Non-operating benefit (income) costs, restructuring costs, acquisition and disposition-related benefits (charges), gain (loss) on business and asset dispositions, Spin-Off and separation costs, amortization of acquisition-related intangible assets, and investment revaluation gain (loss). Segment EBIT is also used in the annual budget and periodic forecasting processes and informs the CODM in decision making regarding the allocation of resources to the segments.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-341" continuedAt="f-341-1" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total Revenues by Segment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total Imaging</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-342">2,140</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-343">2,062</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">AVS:</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Procedural Guidance</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-344">641</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-345">651</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Specialized Ultrasound</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-346">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-347">576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total AVS</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-348">1,239</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-349">1,227</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PCS:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Monitoring Solutions</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-350">556</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-351">527</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Life Support Solutions</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-352">197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-353">220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total PCS</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-354">753</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-355">747</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total PDx</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-356">632</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-357">599</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-358">13</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-359">15</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-360">4,777</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-361">4,650</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Financial information not presented within the reportable segments, shown within the Other category, represents Hea</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">lthCar</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">e Financial Services (&#8220;HFS&#8221;) which does not meet the definition of an operating segment.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Significant Expenses by Segment</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Imaging:</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cost of sales</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-362">1,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="f-363">1,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other segment items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-6" name="us-gaap:SegmentReportingOtherItemAmount" scale="6" id="f-364">588</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-6" name="us-gaap:SegmentReportingOtherItemAmount" scale="6" id="f-365">559</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total Imaging</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="f-366">1,941</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="f-367">1,897</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">AVS:</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cost of sales</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-6" name="us-gaap:CostOfRevenue" scale="6" id="f-368">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-6" name="us-gaap:CostOfRevenue" scale="6" id="f-369">599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other segment items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-6" name="us-gaap:SegmentReportingOtherItemAmount" scale="6" id="f-370">380</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-6" name="us-gaap:SegmentReportingOtherItemAmount" scale="6" id="f-371">371</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total AVS</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-6" name="us-gaap:CostsAndExpenses" scale="6" id="f-372">978</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-6" name="us-gaap:CostsAndExpenses" scale="6" id="f-373">970</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PCS:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cost of sales</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-6" name="us-gaap:CostOfRevenue" scale="6" id="f-374">481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-6" name="us-gaap:CostOfRevenue" scale="6" id="f-375">460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other segment items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-6" name="us-gaap:SegmentReportingOtherItemAmount" scale="6" id="f-376">224</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-6" name="us-gaap:SegmentReportingOtherItemAmount" scale="6" id="f-377">206</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total PCS</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-6" name="us-gaap:CostsAndExpenses" scale="6" id="f-378">705</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-6" name="us-gaap:CostsAndExpenses" scale="6" id="f-379">666</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PDx:</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cost of sales</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-6" name="us-gaap:CostOfRevenue" scale="6" id="f-380">294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-6" name="us-gaap:CostOfRevenue" scale="6" id="f-381">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other segment items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-6" name="us-gaap:SegmentReportingOtherItemAmount" scale="6" id="f-382">133</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-6" name="us-gaap:SegmentReportingOtherItemAmount" scale="6" id="f-383">126</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total PDx</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-6" name="us-gaap:CostsAndExpenses" scale="6" id="f-384">428</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-6" name="us-gaap:CostsAndExpenses" scale="6" id="f-385">421</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:0.08pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1) Other segment items for each segment includes selling, general, administrative, research, and development related expenses, as well as other segment income and expenses.</span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="f-338-3"><ix:continuation id="f-341-1"><div style="margin-bottom:0.08pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Segment EBIT</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Segment EBIT</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Imaging</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-6" name="gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges" scale="6" id="f-386">199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-6" name="gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges" scale="6" id="f-387">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">AVS</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-6" name="gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges" scale="6" id="f-388">261</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-6" name="gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges" scale="6" id="f-389">257</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PCS </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-6" name="gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges" scale="6" id="f-390">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-6" name="gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges" scale="6" id="f-391">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PDx </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-6" name="gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges" scale="6" id="f-392">205</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-6" name="gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges" scale="6" id="f-393">178</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-6" name="gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges" scale="6" id="f-394">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-6" sign="-" name="gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges" scale="6" id="f-395">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges" scale="6" id="f-396">715</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges" scale="6" id="f-397">681</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Restructuring costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="f-398">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="f-399">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Acquisition and disposition-related benefits (charges)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="gehc:AcquisitionAndDispositionRelatedBenefitsCosts" scale="6" id="f-400">8</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="gehc:AcquisitionAndDispositionRelatedBenefitsCosts" format="ixt:fixed-zero" scale="6" id="f-401">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Gain (loss) on business and asset dispositions</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GainLossOnDispositionOfAssets1" scale="6" id="f-402">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:GainLossOnDispositionOfAssets1" format="ixt:fixed-zero" scale="6" id="f-403">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Spin-Off and separation costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="gehc:SpinOffAndSeparationCosts" scale="6" id="f-404">24</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="gehc:SpinOffAndSeparationCosts" scale="6" id="f-405">60</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Amortization of acquisition-related intangible assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="gehc:AmortizationOfIntangibleAssetsAcquired" scale="6" id="f-406">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="gehc:AmortizationOfIntangibleAssetsAcquired" scale="6" id="f-407">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Investment revaluation gain (loss)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GainLossOnInvestments" scale="6" id="f-408">92</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="f-409">20</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Interest and other financial charges &#8211; net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="f-410">110</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="f-411">122</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-operating benefit income (costs)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="f-412">74</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="f-413">102</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Income before income taxes</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-414">692</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-415">512</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:0.08pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Financial information not presented within the reportable segments, shown within the Other category, primarily represents HFS which does not meet the definition of an operating segment.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">The following table represents the depreciation and amortization amounts reported within the Segment EBIT metric for our reportable segments. Depreciation and amortization expense related to shared property, plant, and equipment and intangibles, exclusive of acquisition-related intangible assets, has been fully allocated to our segments and those allocations are reflected in the amounts presented in the table below. These amounts are included within Cost of sales and Other segment items disclosed in the Significant Expenses by Segment table above.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Depreciation and Amortization by Segment</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Imaging</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-416">57</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-417">65</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">AVS</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-418">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-419">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PCS </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-420">13</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-421">15</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PDx </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-422">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-423">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">The Company does not report total assets by segment as the Company&#8217;s CODM does not assess performance, make strategic decisions, or allocate resources based on assets.</span></div></ix:continuation><div style="margin-bottom:0.08pt"><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_142"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4. <ix:nonNumeric contextRef="c-1" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" id="f-424" continuedAt="f-424-1" escape="true">RECEIVABLES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="f-425" continuedAt="f-425-1" escape="true"><ix:continuation id="f-424-1" continuedAt="f-424-2"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.177%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Current Receivables</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Current customer receivables</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="f-426">3,379</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="f-427">3,382</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-income based tax receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:ValueAddedTaxReceivableCurrent" scale="6" id="f-428">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ValueAddedTaxReceivableCurrent" scale="6" id="f-429">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other sundry receivables</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="gehc:OtherNontradeReceivablesCurrent" scale="6" id="f-430">144</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="gehc:OtherNontradeReceivablesCurrent" scale="6" id="f-431">133</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Current sundry receivables</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:NontradeReceivablesCurrent" scale="6" id="f-432">299</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:NontradeReceivablesCurrent" scale="6" id="f-433">287</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="f-434">106</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="f-435">103</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total current receivables &#8211; net</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="f-436">3,572</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="f-437">3,566</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Chargebacks, which are primarily related to our PDx business, are generally settled through issuance of credits, typically within one month of initial recognition, and are recorded as a reduction to current customer receivables. Balances related to chargebacks were $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" scale="6" id="f-438">151</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" scale="6" id="f-439">153</ix:nonFraction> million as of March 31, 2025 and December 31, 2024, respectively.</span></div></ix:continuation></ix:nonNumeric><div style="padding-left:0.36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="f-424-2"><ix:continuation id="f-425-1" continuedAt="f-425-2"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.177%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.262%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Long-Term Receivables</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Long-term customer receivables</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AccountsReceivableGrossNoncurrent" scale="6" id="f-440">68</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AccountsReceivableGrossNoncurrent" scale="6" id="f-441">59</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-income based tax receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:ValueAddedTaxReceivableNoncurrent" scale="6" id="f-442">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ValueAddedTaxReceivableNoncurrent" scale="6" id="f-443">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other sundry receivables</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="gehc:OtherNontradeReceivablesNoncurrent" scale="6" id="f-444">76</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="gehc:OtherNontradeReceivablesNoncurrent" scale="6" id="f-445">68</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Long-term sundry receivables</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:NontradeReceivablesNoncurrent" scale="6" id="f-446">99</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:NontradeReceivablesNoncurrent" scale="6" id="f-447">88</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Allowance for credit losses</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableNoncurrent" scale="6" id="f-448">6</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableNoncurrent" scale="6" id="f-449">5</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total long-term receivables &#8211; net</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="gehc:ReceivablesNetNoncurrent" scale="6" id="f-450">161</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="gehc:ReceivablesNetNoncurrent" scale="6" id="f-451">142</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><br/>Long-term receivables are recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position.</span></div></ix:continuation><div><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_145"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5. <ix:nonNumeric contextRef="c-1" name="us-gaap:FinancingReceivablesTextBlock" id="f-452" continuedAt="f-452-1" escape="true">FINANCING RECEIVABLES</ix:nonNumeric></span></div><ix:continuation id="f-452-1"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><br/>Current financing receivables and non-current financing receivables are recognized within All other current assets and All other non-current assets, respectively, in the Condensed Consolidated Statements of Financial Position.</span></div><ix:continuation id="f-425-2"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.177%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.262%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Loans receivable, at amortized cost</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-6" name="us-gaap:NotesAndLoansReceivableGrossCurrent" scale="6" id="f-453">23</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-6" name="us-gaap:NotesAndLoansReceivableGrossCurrent" scale="6" id="f-454">23</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Investment in finance leases, net of deferred income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-6" name="us-gaap:NotesAndLoansReceivableGrossCurrent" scale="6" id="f-455">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-6" name="us-gaap:NotesAndLoansReceivableGrossCurrent" scale="6" id="f-456">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AllowanceForNotesAndLoansReceivableCurrent" scale="6" id="f-457">3</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AllowanceForNotesAndLoansReceivableCurrent" scale="6" id="f-458">2</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Current financing receivables &#8211; net</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="6" id="f-459">90</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="6" id="f-460">90</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Loans receivable, at amortized cost</span></div></td><td style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-6" name="us-gaap:NotesAndLoansReceivableGrossNoncurrent" scale="6" id="f-461">35</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-6" name="us-gaap:NotesAndLoansReceivableGrossNoncurrent" scale="6" id="f-462">35</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Investment in finance leases, net of deferred income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-6" name="us-gaap:NotesAndLoansReceivableGrossNoncurrent" scale="6" id="f-463">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-6" name="us-gaap:NotesAndLoansReceivableGrossNoncurrent" scale="6" id="f-464">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AllowanceForNotesAndLoansReceivableNoncurrent" scale="6" id="f-465">4</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AllowanceForNotesAndLoansReceivableNoncurrent" scale="6" id="f-466">4</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Non-current financing receivables &#8211; net</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" scale="6" id="f-467">186</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" scale="6" id="f-468">183</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="padding-left:0.36pt"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">March 31, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-73" decimals="2" name="us-gaap:FinancingReceivablePercentPastDue1" scale="-2" id="f-469">3</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-74" decimals="2" name="us-gaap:FinancingReceivablePercentPastDue1" scale="-2" id="f-470">3</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="c-8" decimals="2" name="us-gaap:FinancingReceivableNonaccrualPercentPastDue1" scale="-2" id="f-471">3</ix:nonFraction>% </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of financing receivables were over 30 days past due, over 90 days past due, and on nonaccrual, respectively, with the majority of nonaccrual financing receivables secured by collateral. As of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December 31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-75" decimals="2" name="us-gaap:FinancingReceivablePercentPastDue1" scale="-2" id="f-472">4</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-76" decimals="2" name="us-gaap:FinancingReceivablePercentPastDue1" scale="-2" id="f-473">4</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="c-9" decimals="2" name="us-gaap:FinancingReceivableNonaccrualPercentPastDue1" scale="-2" id="f-474">3</ix:nonFraction>% of financing receivables were over 30 days past due, over 90 days past due, and on nonaccrual, respectively, with the majority of nonaccrual financing receivables secured by collateral.</span></div></ix:continuation><div style="margin-bottom:0.08pt"><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_148"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6. <ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-475" continuedAt="f-475-1" escape="true">LEASES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-475-1"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities recognized within All other current liabilities and All other non-current liabilities in the Condensed Consolidated Statements of Financial Position were $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="f-476">386</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="f-477">385</ix:nonFraction>&#160;million as of March 31, 2025 and December 31, 2024, respectively. The total lease expense related to our operating lease portfolio was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-478">62</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-479">60</ix:nonFraction>&#160;million for the three months ended March 31, 2025 and 2024, respectively.</span></div></ix:continuation><div style="margin-bottom:0.08pt"><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_151"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7. <ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="f-481" continuedAt="f-481-1" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="f-480" continuedAt="f-480-1" escape="true">ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS</ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-top:0.02pt"><span><br/></span></div><ix:continuation id="f-481-1" continuedAt="f-481-2"><ix:continuation id="f-480-1" continuedAt="f-480-2"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">ACQUISITIONS.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:118%">Nihon Medi-Physics</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">On March 31, 2025, the Company acquired the remaining <ix:nonFraction unitRef="number" contextRef="c-77" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-482">50</ix:nonFraction>% interest in Nihon Medi-Physics Co., Ltd (&#8220;NMP&#8221;) from joint venture partner Sumitomo Chemical for net cash consideration of $<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="f-483">269</ix:nonFraction> million. The acquisition was funded with cash on hand. NMP is a leading pharmaceutical manufacturer in Japan, focused on radiopharmaceuticals, which are used to enable clinical images across neurology, cardiology, and oncology procedures, as well as nonclinical and clinical development of radiotracers and theranostics research. Their product portfolio includes several GE HealthCare radiopharmaceuticals. NMP is included in the Company&#8217;s PDx segment.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">On March 31, 2025, the fair value of the Company&#8217;s existing <ix:nonFraction unitRef="number" contextRef="c-77" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="f-484">50</ix:nonFraction>% interest in NMP was determined to be $<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" scale="6" id="f-485">301</ix:nonFraction> million based on the cash consideration exchanged for acquiring the remaining <ix:nonFraction unitRef="number" contextRef="c-77" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-486">50</ix:nonFraction>% equity interest. The carrying value of our <ix:nonFraction unitRef="number" contextRef="c-77" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="f-487">50</ix:nonFraction>% interest was $<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-6" name="gehc:BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue" scale="6" id="f-488">204</ix:nonFraction> million. The Company recognized a net gain of $<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="f-489">97</ix:nonFraction> million resulting from this remeasurement to fair value. This gain included the reclassification of certain amounts related to the Company&#8217;s <ix:nonFraction unitRef="number" contextRef="c-77" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="f-490">50</ix:nonFraction>% interest out of Accumulated other comprehensive income (loss) &#8211; net (&#8220;AOCI&#8221;) including foreign currency translation gains of $<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-6" name="gehc:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax" scale="6" id="f-491">63</ix:nonFraction> million and losses related to a defined benefit pension plan of $<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="f-492">8</ix:nonFraction> million. The net gain from this remeasurement was recorded in Other (income) expense &#8211; net in the Company&#8217;s Condensed Consolidated Statements of Income for the three months ended March 31, 2025.</span></div></ix:continuation></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="f-481-2" continuedAt="f-481-3"><ix:continuation id="f-480-2" continuedAt="f-480-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="f-493" continuedAt="f-493-1" escape="true"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">The following table provides a summary of the purchase price consideration transferred for the acquisition of NMP.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.595%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Purchase consideration</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cash consideration, net of cash acquired</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="f-494">269</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Fair value of previously held interest in NMP</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" scale="6" id="f-495">301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Fair value of contingent consideration</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="6" id="f-496">5</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total allocable purchase price</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="f-497">575</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><br/><br/>The estimated fair values of the assets and liabilities assumed in connection with the acquisition of NMP are as follows.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.595%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Initial allocation</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Receivables</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="f-498">53</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Inventories</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="f-499">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Property, plant, and equipment</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="f-500">243</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Goodwill</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-6" name="us-gaap:Goodwill" scale="6" id="f-501">216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other intangible assets</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="f-502">223</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">All other non-current assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="f-503">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Deferred income taxes</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="f-504">87</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">All other non-current liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="f-505">107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="6" id="f-506">28</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total net assets post acquisition</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="f-507">575</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) All other non-current assets includes $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-6" name="gehc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets" scale="6" id="f-508">12</ix:nonFraction> million of indemnification assets, with the underlying indemnified liabilities recorded in All other non-current liabilities.</span></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-493-1">(2) Other includes Accounts payable, All other current liabilities, and Current compensation and benefits.</ix:continuation><br/><br/>The initial allocation of purchase price of NMP to the tangible and intangible assets acquired and liabilities assumed, as reflected in the table above, is based on the Company&#8217;s preliminary allocations of their fair values. The valuation of assets acquired and liabilities assumed has not yet been finalized as of March 31, 2025. While all amounts remain subject to adjustments, the areas subject to the most significant potential adjustments are property, plant, and equipment, intangible assets, decommissioning liabilities, and deferred income taxes. The preliminary valuation required estimates and assumptions including, but not limited to, estimating future cash flows and direct costs in addition to developing the appropriate discount rates. Accordingly, the purchase price adjustments are preliminary and are subject to further adjustments as additional information becomes available and as additional analyses are performed, and such further adjustments may be material. The Company&#8217;s management believes the fair values recognized for the assets acquired and the liabilities assumed are based on reasonable estimates and assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant, and equipment is mostly comprised of land, buildings, equipment (including machinery, furniture, and fixtures) and construction in process. The fair value of property, plant, and equipment was determined using a market participant approach.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other intangibles relate to $<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-6" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="f-509">200</ix:nonFraction> million of definite-lived intangible assets and $<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-6" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" scale="6" id="f-510">23</ix:nonFraction> million of acquired in-process research and development. Definite-lived intangible assets consist primarily of developed product market authorization rights and customer relationships. The acquired definite-lived intangibles are being amortized over a weighted-average estimated useful life of approximately <ix:nonNumeric contextRef="c-78" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-511">12</ix:nonNumeric> years. The estimated fair value of intangibles was determined using the income approach, which is a valuation technique that provides an estimate of the fair value of an asset based on market participant expectations of cash flows an asset would generate over its useful life.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The goodwill associated with NMP, recorded within the PDx segment, is non-deductible for tax purposes and is attributed to expected synergies with NMP&#8217;s existing assets and workforce that are expected to allow the Company greater access and growth in the Japan market.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in All other non-current liabilities are asset retirement obligations and decommissioning liabilities of $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-6" name="gehc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities" scale="6" id="f-512">96</ix:nonFraction> million, which were assumed in the transaction. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NMP has a defined benefit pension plan which has pension assets of $<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="f-513">73</ix:nonFraction> million and pension liabilities of $<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" scale="6" id="f-514">34</ix:nonFraction> million, a net asset of $<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="f-515">39</ix:nonFraction> million, which we acquired in the transaction and is included in All other non-current assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred income tax liabilities include the expected U.S. federal, state, and foreign tax consequences associated with temporary differences between the preliminary fair values of the assets acquired and liabilities assumed and the respective tax basis. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to the proximity of the acquisition date to the end of the Company&#8217;s first quarter, the revenues and earnings of NMP are not significant to our consolidated results. If the acquisition of NMP had taken place as of the beginning of 2024, consolidated revenues and earnings would not have been significantly different than reported amounts.</span></div></ix:continuation></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="f-481-3"><ix:continuation id="f-480-3"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">MIM Software</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 1, 2024, the Company acquired <ix:nonFraction unitRef="number" contextRef="c-81" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-516">100</ix:nonFraction>% of the stock of MIM Software Inc. (&#8220;MIM Software&#8221;) for approximately $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="f-517">259</ix:nonFraction> million, net of cash acquired of $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="f-518">11</ix:nonFraction> million, and potential contingent payments valued at $<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-519">13</ix:nonFraction>&#160;million pertaining to achievement of certain milestones, for a total preliminary purchase price of $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="f-520">283</ix:nonFraction> million. The acquisition included up to $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-521">23</ix:nonFraction>&#160;million of other contingent payments based on service requirements. The acquisition was funded with cash on hand. This transaction was accounted for as a business combination. The final purchase price allocation resulted in goodwill of $<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-6" name="us-gaap:Goodwill" scale="6" id="f-522">189</ix:nonFraction> million, customer-related intangible assets of $<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-523">52</ix:nonFraction>&#160;million, developed technology intangible assets of $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-524">48</ix:nonFraction>&#160;million, net deferred tax liabilities of $<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="f-525">13</ix:nonFraction> million, and other net assets of $<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-6" name="gehc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets" scale="6" id="f-526">7</ix:nonFraction> million. The goodwill associated with the acquired business, recorded within the Imaging segment, is non-deductible for tax purposes and is attributed to expected synergies and commercial benefits from use of the MIM Software technology in our existing GE HealthCare portfolio. MIM Software is a global provider of medical imaging analysis and artificial intelligence (&#8220;AI&#8221;) solutions for the practice of radiation oncology, molecular radiotherapy, diagnostic imaging, and urology at imaging centers, hospitals, specialty clinics, and research organizations worldwide. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue and earnings of MIM Software included in the Company&#8217;s financial statements since the acquisition date are not material to our consolidated revenue and earnings. If the acquisition of MIM Software had taken place as of the beginning of 2023, consolidated revenues and earnings would not have been significantly different from reported amounts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">GOODWILL.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfGoodwillTextBlock" id="f-527" escape="true"><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Imaging</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">AVS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">PCS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">PDx</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at December 31, 2024</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-528">3,581</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-529">4,987</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-530">2,035</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-531">2,533</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-532">13,136</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Acquisitions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="f-533">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="f-534">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="f-535">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="f-536">216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="f-537">216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency exchange and other</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="f-538">5</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="f-539">12</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="f-540">2</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="f-541">1</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="f-542">20</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at March 31, 2025</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-543">3,587</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-544">4,999</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-545">2,037</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-546">2,750</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-547">13,373</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We assess the possibility that a reporting unit&#8217;s fair value has been reduced below its carrying amount due to the occurrence of events or circumstances between annual impairment testing dates. We did not identify any reporting units that required an interim impairment test since the last annual impairment testing date.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">OTHER INTANGIBLE ASSETS.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="f-549" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="f-548" escape="true"><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.594%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.151%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of March 31, 2025</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of December 31, 2024</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Net</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Definite-lived assets</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Customer-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-550">230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-551">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-552">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-553">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-554">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-555">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Patents and technology</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-556">2,668</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-557">2,021</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-558">647</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-559">2,593</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-560">1,987</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-561">606</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Capitalized software </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-562">1,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-563">1,479</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-564">272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-565">1,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-566">1,437</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-567">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Trademarks and other</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-568">47</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-569">29</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-570">17</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-571">33</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-572">29</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-573">4</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total definite-lived assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-574">4,696</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-575">3,555</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-576">1,141</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="f-577">4,481</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-578">3,477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="f-579">1,004</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Indefinite-lived assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="f-580">97</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="f-581">97</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="f-582">74</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="f-583">74</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total other intangible assets</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-584">4,793</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-585">3,555</ix:nonFraction>)</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-586">1,238</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-587">4,555</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-588">3,477</ix:nonFraction>)</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-589">1,078</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Indefinite-lived intangible assets relate to acquired in-process research and development prior to project completion and are not amortized.</span></div></ix:nonNumeric></ix:nonNumeric><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization expense was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-590">70</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-591">80</ix:nonFraction> million for the three months ended March 31, 2025 and 2024, respectively.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:0.08pt"><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_154"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8. <ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-592" continuedAt="f-592-1" escape="true">BORROWINGS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-592-1" continuedAt="f-592-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings include the following senior unsecured notes and credit agreements:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Unsecured Notes</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings include $<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-593">8,250</ix:nonFraction>&#160;million aggregate principal amount of senior unsecured notes in <ix:nonFraction unitRef="series" contextRef="c-107" decimals="INF" name="gehc:NumberOfDebtSeries" format="ixt-sec:numwordsen" scale="0" id="f-594">six</ix:nonFraction> series with maturity dates ranging from 2025 through 2052 (collectively, the &#8220;Notes&#8221;).</span></div><div><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:125%">Credit Facilities</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the first quarter of 2025, the Company terminated its existing <ix:nonNumeric contextRef="c-108" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-595">five-year</ix:nonNumeric> and <ix:nonNumeric contextRef="c-109" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-596">364-day</ix:nonNumeric> senior unsecured revolving credit facilities. These were replaced with new <ix:nonNumeric contextRef="c-108" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-597">five-year</ix:nonNumeric> and <ix:nonNumeric contextRef="c-109" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-598">364-day</ix:nonNumeric> senior unsecured revolving credit facilities in aggregate committed amounts of $<ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-599">3,000</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-600">500</ix:nonFraction>&#160;million, respectively. The terms of the new facilities are substantially similar to those of the terminated facilities. </span></div></ix:continuation><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="f-592-2"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">The Company has credit agreements providing for:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a <ix:nonNumeric contextRef="c-108" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-601">five-year</ix:nonNumeric> senior unsecured revolving credit facility in an aggregate committed amount of $<ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-602">3,000</ix:nonFraction>&#160;million, maturing on March 27, 2030; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a <ix:nonNumeric contextRef="c-109" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-603">364-day</ix:nonNumeric> senior unsecured revolving credit facility in an aggregate committed amount of $<ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-604">500</ix:nonFraction>&#160;million, maturing on March 26, 2026; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a <ix:nonNumeric contextRef="c-112" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-605">three-year</ix:nonNumeric> senior unsecured term loan credit facility in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-606">2,000</ix:nonFraction>&#160;million, maturing on January 2, 2026 (the &#8220;Term Loan Facility&#8221; and, together with the <ix:nonNumeric contextRef="c-108" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-607">five-year</ix:nonNumeric> revolving credit facility and the <ix:nonNumeric contextRef="c-109" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-608">364-day</ix:nonNumeric> revolving credit facility, the &#8220;Credit Facilities&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="c-114" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="9" id="f-609"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="9" id="f-610">no</ix:nonFraction></ix:nonFraction> outstanding amounts under the <ix:nonNumeric contextRef="c-108" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-611"><ix:nonNumeric contextRef="c-116" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-612">five-year</ix:nonNumeric></ix:nonNumeric> revolving credit facility and <ix:nonNumeric contextRef="c-109" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-613"><ix:nonNumeric contextRef="c-117" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-614">364-day</ix:nonNumeric></ix:nonNumeric> revolving credit facility, and there was $<ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="f-615">500</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="f-616">750</ix:nonFraction>&#160;million outstanding on the Term Loan Facility as of March 31, 2025 and December 31, 2024, respectively. In the first quarter of 2025, we repaid $<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-617">250</ix:nonFraction>&#160;million of the Term Loan Facility.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="f-618" escape="true"><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.177%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.179%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Borrowings Composition</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="number" contextRef="c-121" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-619">5.600</ix:nonFraction>% senior notes due November 15, 2025</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="f-620">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="f-621">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="number" contextRef="c-123" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-622">5.650</ix:nonFraction>% senior notes due November 15, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="f-623">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="f-624">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="number" contextRef="c-125" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-625">4.800</ix:nonFraction>% senior notes due August 14, 2029</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="f-626">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="f-627">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="number" contextRef="c-127" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-628">5.857</ix:nonFraction>% senior notes due March 15, 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="f-629">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="f-630">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="number" contextRef="c-129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-631">5.905</ix:nonFraction>% senior notes due November 22, 2032</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="f-632">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="f-633">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="number" contextRef="c-131" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-634">6.377</ix:nonFraction>% senior notes due November 22, 2052</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="f-635">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="f-636">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Floating rate Term Loan Facility due January 2, 2026</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-637">500</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-638">750</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-639">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-640">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total principal debt issued</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="f-641">8,780</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="f-642">9,036</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Less: Unamortized debt issuance costs and discounts</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="f-643">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="f-644">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Add: Cumulative basis adjustment for fair value hedges</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="f-645">9</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="f-646">51</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total borrowings</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-647">8,759</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-648">8,951</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Less: Short-term borrowings</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-649">2,002</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="f-650">1,502</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Long-term borrowings</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-651">6,757</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-652">7,449</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(1) Short-term borrowings </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">as of March 31, 2025 </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December 31, 2024 i</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ncludes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="f-653">2,000</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="f-654">1,500</ix:nonFraction>&#160;million, respectively,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> related to the current portion of our long-term borrowings, net of unamortized debt issuance costs and discounts.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See Note 12, &#8220;Financial Instruments and Fair Value Measurements&#8221; for further information about borrowings and associated derivatives contracts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">LETTERS OF CREDIT, GUARANTEES, AND OTHER COMMITMENTS.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of March 31, 2025 and December 31, 2024, the Company had bank guarantees and surety bonds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-6" name="us-gaap:GuaranteeObligationsMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="f-655">786</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-6" name="us-gaap:GuaranteeObligationsMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="f-656">784</ix:nonFraction>&#160;million, respectively, related to certain commercial contracts. Additionally, we have issued approximately $<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-6" name="us-gaap:GuaranteeObligationsMaximumExposure" scale="6" id="f-657">24</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-6" name="us-gaap:GuaranteeObligationsMaximumExposure" scale="6" id="f-658">25</ix:nonFraction> million of guarantees as of March 31, 2025 and December 31, 2024, respectively, primarily related to residual value and credit guarantees on equipment sold to third-party finance companies. Our Condensed Consolidated Statements of Financial Position reflect a liability of $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" scale="6" id="f-659">2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" scale="6" id="f-660">3</ix:nonFraction> million as of March 31, 2025 and December 31, 2024, respectively, related to these guarantees. For credit-related guarantees, we estimate our expected credit losses related to off-balance sheet credit exposure consistent with the method used to estimate the allowance for credit losses on financial assets held at amortized cost.</span></div></ix:continuation><div><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_259"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9. <ix:nonNumeric contextRef="c-1" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="f-661" continuedAt="f-661-1" escape="true">POSTRETIREMENT BENEFIT PLANS</ix:nonNumeric></span></div><div style="margin-top:0.02pt"><span><br/></span></div><ix:continuation id="f-661-1" continuedAt="f-661-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We sponsor a number of pension and retiree health and life insurance benefit plans that we present in three categories: U.S. Plans, International Plans, and Other Postretirement Plans (&#8220;OPEB Plans&#8221;). Please refer to Note 10, &#8220;Postretirement Benefit Plans&#8221; in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 for further information. Pension plans with pension assets or obligations less than $<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-6" name="gehc:DefinedBenefitPlanPlanAssetOrObligationReportingThreshold" format="ixt:num-dot-decimal" scale="6" id="f-662"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="gehc:DefinedBenefitPlanPlanAssetOrObligationReportingThreshold" format="ixt:num-dot-decimal" scale="6" id="f-663">50</ix:nonFraction></ix:nonFraction>&#160;million are not included in the results below.</span></div></ix:continuation><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="f-661-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="f-664" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.483%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.483%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.487%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Components of Expense (Income)</span></div></td><td colspan="24" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">U.S. Plans</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">International Plans</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">OPEB Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31,</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Service cost &#8211; Operating</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-665">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-666">8</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-667">5</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-668">5</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-669">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="f-670">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-671">249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-672">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-673">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-674">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-675">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="f-676">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="f-677">287</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="f-678">298</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="f-679">36</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="f-680">48</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="f-681">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:fixed-zero" scale="6" id="f-682">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Amortization of net loss (gain)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="f-683">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="f-684">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="f-685">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="f-686">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="f-687">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="f-688">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Amortization of prior service cost (credit)</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="f-689">3</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="f-690">2</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="f-691">1</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" format="ixt:fixed-zero" scale="6" id="f-692">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="f-693">20</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="f-694">22</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Special termination cost</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-6" name="us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" scale="6" id="f-695">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-6" name="us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" format="ixt:fixed-zero" scale="6" id="f-696">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-6" name="us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" format="ixt:fixed-zero" scale="6" id="f-697">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-6" name="us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" format="ixt:fixed-zero" scale="6" id="f-698">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-6" name="us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" format="ixt:fixed-zero" scale="6" id="f-699">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-6" name="us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" format="ixt:fixed-zero" scale="6" id="f-700">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Non-operating</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="f-701">60</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="f-702">71</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="f-703">4</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="f-704">10</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="f-705">21</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="f-706">24</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Net periodic expense (income)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-707">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-708">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-709">9</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-710">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-711">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="f-712">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">three months ended</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> March 31, 2025, the Company made cash payments totaling $<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="f-713">43</ix:nonFraction> million to its U.S. Plans, $<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="f-714">10</ix:nonFraction> million to its International Plans, and $<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="f-715">45</ix:nonFraction>&#160;million to its OPEB Plans. In 2025, the Company expects to make total cash contributions of approximately $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" format="ixt:num-dot-decimal" scale="6" id="f-716">327</ix:nonFraction>&#160;million to these plans. The Company funds annually, at a minimum, the statutorily required minimum amount for our qualified plans. Non-qualified plans are unfunded and we pay benefits from our cash on hand.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Defined Contribution Plan</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">GE HealthCare sponsors a defined contribution plan for its eligible U.S. employees. Expenses associated with our employees&#8217; participation in GE HealthCare&#8217;s defined contribution plan were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="f-717">45</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="f-718">32</ix:nonFraction> million for the </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">three months ended</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> March 31, 2025 and 2024, respectively.</span></div></ix:continuation><div><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_262"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10. <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-719" continuedAt="f-719-1" escape="true">INCOME TAXES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-719-1"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Our effective income tax rate was <ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-720">15.0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-721">24.2</ix:nonFraction>% for the three months ended March 31, 2025 and 2024, respectively. The tax rate for the three months ended March 31, 2025 is lower than the U.S. statutory rate primarily due to the release of income tax reserves in a foreign jurisdiction for tax years which are no longer subject to an assessment from the local taxing authorities, the remeasurement gain that was recorded due to the NMP acquisition which is not taxable, and research and development (&#8220;R&amp;D&#8221;) benefits, partially offset by geographic earnings mix, withholding taxes, and state taxes. The tax rate for the three months ended March 31, 2024 is higher than the U.S. statutory rate primarily due to geographic earnings mix, withholding taxes, and state taxes, partially offset by R&amp;D benefits.<br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is currently being audited in a number of jurisdictions for tax years 2004-2023, including China, France, Germany, India, Japan, Norway, the United Kingdom, and the United States.</span></div></ix:continuation><div style="margin-bottom:0.08pt"><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_283"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11. <ix:nonNumeric contextRef="c-1" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="f-722" continuedAt="f-722-1" escape="true">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) &#8211; NET</ix:nonNumeric></span></div><div style="margin-top:0.02pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="f-723" continuedAt="f-723-1" escape="true"><ix:continuation id="f-722-1" continuedAt="f-722-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in Accumulated other comprehensive income (loss) - net by component were as follows.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="margin-top:0.02pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">For the three months ended March 31, 2025</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Currency translation adjustments</span><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-right:-1.31pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Pension and Other Postretirement  Plans</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cash flow hedges</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total AOCI</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-724">1,973</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-725">576</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-726">18</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-727">1,379</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other comprehensive income (loss) before reclassifications &#8211; net of taxes of $<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="f-728">15</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="f-729">5</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="f-730">3</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="f-731">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="f-732">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="f-733">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="f-734">163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Reclassifications from AOCI &#8211; net of taxes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(2)(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"> of $<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="6" id="f-735">&#8212;</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="f-736">16</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="6" id="f-737">&#8212;</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="f-738">63</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="f-739">49</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="f-740">3</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="f-741">17</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Other comprehensive income (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-742">257</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-743">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-744">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-745">180</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Less: Other comprehensive income (loss) attributable to noncontrolling interests</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-746">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-747">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-748">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-749">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-750">1,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-751">507</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-752">10</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-753">1,199</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="f-723-1"><ix:continuation id="f-722-2"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31, 2024</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Currency translation adjustments</span><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-right:-1.31pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Pension and Other Postretirement Plans</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cash flow hedges</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total AOCI</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2023</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-754">1,706</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-755">1,033</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-756">18</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-757">691</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other comprehensive income (loss) before reclassifications &#8211; net of taxes of $(<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="f-758">7</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="f-759">1</ix:nonFraction>), and $(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="f-760">4</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="f-761">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="f-762">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="f-763">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="f-764">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Reclassifications from AOCI &#8211; net of taxes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"> of $<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="6" id="f-765">&#8212;</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="f-766">12</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="6" id="f-767">&#8212;</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="f-768">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="f-769">38</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="f-770">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="f-771">37</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Other comprehensive income (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-772">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-773">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-774">16</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-775">95</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Less: Other comprehensive income (loss) attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-776">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-777">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-778">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-779">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2024</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-780">1,781</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-781">997</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-782">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-783">787</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) The amount of Currency translation adjustments recognized in Other comprehensive income (loss) (&#8220;OCI&#8221;) during the three months ended March 31, 2025 and 2024 included net gains (losses) relating to net investment hedges, as further discussed in Note 12, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial Instruments and Fair Value Measurements.&#8221;</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Reclassifications from AOCI into earnings for Pension and Other Postretirement Plans are recognized within Non-operating benefit (income) costs, while Cash flow hedges are recognized within Cost of products and Cost of services in our Condensed Consolidated Statements of Income.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) Includes net of tax impact of $<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-6" name="gehc:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax" scale="6" id="f-784">63</ix:nonFraction> million to Currency translation adjustments and $<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="f-785">8</ix:nonFraction> million to Pension and Other Postretirement Plans related to the derecognition of the prior NMP equity method investment. Refer to Note 7, &#8220;Acquisitions, Goodwill, and Other Intangible Assets&#8221; for additional information on the NMP acquisition.</span></div></ix:continuation></ix:continuation><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_166"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12. <ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativesAndFairValueTextBlock" id="f-786" continuedAt="f-786-1" escape="true">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><div style="margin-top:0.02pt"><span><br/></span></div><ix:continuation id="f-786-1" continuedAt="f-786-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">DERIVATIVES AND HEDGING.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our primary objective in executing and holding derivative contracts is to reduce the volatility of earnings and cash flows associated with risks related to foreign currency exchange rates, interest rates, equity prices, and commodity prices. These derivative contracts reduce, but do not entirely eliminate, the aforementioned risks. Our policy is to use derivative contracts solely for managing risks and not for speculative purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For derivative instruments designated as cash</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">flow hedges, changes in the fair value of designated hedging instruments are initially recorded as a component of AOCI and subsequently reclassified to earnings in the period in which the hedged transaction affects earnings and to the same financial statement line item impacted by the hedged transaction. As of March 31, 2025, we expect to reclassify $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="f-787">14</ix:nonFraction>&#160;million of pre-tax net deferred gains associated with designated cash flow hedges to earnings in the next 12 months, contemporaneously with the impact on earnings of the related hedged transactions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cash flows associated with derivatives designated as cash flow hedges are recorded in All other operating activities &#8211; net in the Condensed Consolidated Statements of Cash Flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Hedges</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We use cross-currency interest rate swaps and foreign currency forward contracts in combination with foreign currency option contracts to hedge the foreign currency risk associated with our net investment in foreign operations. As of March 31, 2025, these contracts were designated as hedges of our net investment in foreign operations, primarily in Euro and Chinese Renminbi currencies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cash flows associated with derivatives designated as net investment hedges are recorded in All other investing activities &#8211; net in the Condensed Consolidated Statements of Cash Flows. Cash flows from the periodic interest settlements on the cross-currency swaps are recorded in All other operating activities &#8211; net in the Condensed Consolidated and Statements of Cash Flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedges</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We use interest rate swaps to hedge the interest rate risk on our fixed rate borrowings. These derivatives are designated as fair value hedges to hedge the changes in fair value due to benchmark interest rate risk of specific designated cash flows of our senior unsecured notes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We record the changes in fair value on these swap contracts in Interest and other financial charges &#8211; net in our Condensed Consolidated Statements of Income, the same line item where the offsetting change in the fair value of the designated cash flows of the senior unsecured note is recorded as a basis adjustment.</span></div></ix:continuation><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="f-786-2" continuedAt="f-786-3"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash flows for the periodic interest settlements on the interest rate swaps are recorded in All other operating activities &#8211; net in the Condensed Consolidated Statements of Cash Flows.</span></div><div><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:125%">Derivatives Not Designated as Hedging Instrument</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">s</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also execute derivative instruments, such as foreign currency forward contracts and equity-linked total return swaps, which are not designated as qualifying hedges. These derivatives serve as economic hedges of foreign currency exchange rate and equity price risks. We also identify and record foreign currency-related features in our purchase or sales contracts where the currency is not the local or functional currency of any substantive party to the contract as embedded derivatives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The changes in fair value of derivatives not designated in qualifying hedge transactions are recorded in Cost of products, Cost of services, Selling, general, and administrative (&#8220;SG&amp;A&#8221;), and Other (income) expense &#8211; net in the Condensed Consolidated Statements of Income based on the nature of the underlying hedged transaction. Changes in fair value of embedded derivatives are recognized in Other (income) expense &#8211; net in the Condensed Consolidated Statements of Income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cash flows associated with derivatives not designated but used as economic hedges are recorded, based on the nature of the underlying hedged transaction, in All other operating activities &#8211; net and All other investing activities &#8211; net in the Condensed Consolidated Statements of Cash Flows. The cash flows related to embedded derivatives are included in All other operating activities &#8211; net in the Condensed Consolidated Statements of Cash Flows.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" id="f-789" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" id="f-788" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the gross fair values of our outstanding derivative instruments.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.177%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.933%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value of Derivatives</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Gross Notional</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value &#8211; Assets</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value &#8211; Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Gross Notional</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value &#8211; Assets</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value &#8211; Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward contracts</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-790">1,474</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-791">25</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-792">15</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-793">1,210</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-794">43</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-795">11</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Derivatives accounted for as cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-796">1,474</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-797">25</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-798">15</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-799">1,210</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-800">43</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-801">11</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cross-currency swaps</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-802">2,075</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-803">12</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-804">97</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-805">1,995</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-806">15</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-807">46</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward and options contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-808">1,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-809">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-810">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-811">1,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-812">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-813">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Derivatives accounted for as net investment hedges</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-814">3,835</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-815">41</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-816">114</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-817">3,726</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-818">45</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-819">64</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Interest rate swaps</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-820">2,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-821">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-822">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-823">2,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="f-824">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-825">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Derivatives accounted for as fair value hedges</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-826">2,700</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-827">17</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-828">14</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-829">2,700</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="f-830">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-831">51</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-832">4,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-833">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-834">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-835">3,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-836">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-837">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other derivatives</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-838">384</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-839">31</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-840">2</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-841">370</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-842">47</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="f-843">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Derivatives not designated as hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-844">4,779</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-845">53</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-846">16</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-847">4,294</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-848">57</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-849">29</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total derivatives</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-850">12,788</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-851">136</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-852">160</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-853">11,930</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-854">145</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-855">155</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) As of March 31, 2025, accrued interest is included in the above fair value and is not considered material. As of December 31, 2024, accrued interest is excluded from the above fair value and is not considered material. </span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Other derivatives are comprised of embedded derivatives and derivatives related to equity contracts.</span></div></ix:nonNumeric></ix:nonNumeric><div style="padding-left:13.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="f-856" continuedAt="f-856-1" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents amounts recorded in Long-term borrowings in the Condensed Consolidated Statements of Financial Position related to cumulative basis adjustment for fair value hedges.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.597%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Carrying amount</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Cumulative basis adjustment included in the carrying amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Carrying amount</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Cumulative basis adjustment included in the carrying amount</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><span style="-sec-ix-hidden:f-857"><span style="-sec-ix-hidden:f-858">Long-term borrowings designated in fair value hedges</span></span></span></div></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedge" format="ixt:num-dot-decimal" scale="6" id="f-859">2,704</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="f-860">9</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:0 1pt"/><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedge" format="ixt:num-dot-decimal" scale="6" id="f-861">2,644</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="f-862">51</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the master arrangements with the respective counterparties to our derivative contracts, in certain circumstances and subject to applicable requirements, we are allowed to net settle transactions with a single net amount payable by one party to the other. However, we have elected to present the derivative assets and derivative liabilities on a gross basis in our Condensed Consolidated Statements of Financial Position and in the table above. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of March 31, 2025 and December 31, 2024, the potential effect of rights of offset associated with the derivative contracts would be an offset to both assets and liabilities by $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="gehc:DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability" format="ixt:num-dot-decimal" scale="6" id="f-863">55</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="gehc:DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability" format="ixt:num-dot-decimal" scale="6" id="f-864">77</ix:nonFraction>&#160;million, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="f-865" continuedAt="f-865-1" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The table below presents the pre-tax gains (losses) recognized in OCI associated with the Company&#8217;s cash flow and net investment hedges.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="f-786-3" continuedAt="f-786-4"><ix:continuation id="f-865-1"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.955%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.873%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Pre-tax Gains (Losses) Recognized in OCI Related to Cash Flow and Net Investment Hedges</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cash flow hedges</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-866">14</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-867">20</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net investment hedges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-868">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-869">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Amounts recognized in OCI for excluded components for the periods presented were immaterial.</span></div></ix:continuation><div style="margin-bottom:0.08pt"><span><br/></span></div><ix:continuation id="f-856-1"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The tables below present the gains (losses) on our derivative financial instruments and hedging activity in the Condensed Consolidated Statements of Income.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.874%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Derivative Financial Instruments and Hedging Activity</span></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31, 2025</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cost of products</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cost of services</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">SG&amp;A</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Interest and other financial charges </span><span style="color:#454545;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8211;</span><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"> net</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Other</span><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward contracts</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-870">2</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-871">1</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-872">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-873">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-874">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-875">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-876">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-877">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-878">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-879">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-880">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-881">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-882">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="f-883">8</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-884">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward and options contracts</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-885">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-886">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-887">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="f-888">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-889">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of net investment hedges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-890">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-891">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-892">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="f-893">11</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-894">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Interest rate swaps</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-895">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-896">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-897">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" scale="6" id="f-898">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-899">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Debt basis adjustment on Long-term borrowings</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-900">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-901">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-902">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-6" sign="-" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" scale="6" id="f-903">61</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-904">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of fair value hedges</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-905">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-906">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-907">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-6" sign="-" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" scale="6" id="f-908">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-909">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward contracts</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-910">15</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-911">4</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:fixed-zero" scale="6" id="f-912">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:fixed-zero" scale="6" id="f-913">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-914">1</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other derivatives</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:fixed-zero" scale="6" id="f-915">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:fixed-zero" scale="6" id="f-916">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-917">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:fixed-zero" scale="6" id="f-918">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-919">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of derivatives not designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-920">15</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-921">4</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-922">3</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:fixed-zero" scale="6" id="f-923">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-924">15</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.874%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31, 2024</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cost of products</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cost of services</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">SG&amp;A</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Interest and other financial charges </span><span style="color:#454545;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8211;</span><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"> net</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Other</span><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward contracts</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-925">1</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-926">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-927">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-928">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-929">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-930">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-931">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-932">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-933">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-934">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-935">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-936">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-937">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="f-938">8</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-939">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward and option contracts</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-940">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-941">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-942">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="f-943">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-944">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of net investment hedges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-945">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-946">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-947">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="f-948">10</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-949">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Interest rate swaps</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-950">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-951">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-952">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-6" sign="-" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" scale="6" id="f-953">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-954">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Debt basis adjustment on Long-term borrowings</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-955">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-956">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-957">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" scale="6" id="f-958">38</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-959">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of fair value hedges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-960">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-961">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-962">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-6" sign="-" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" scale="6" id="f-963">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-6" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="f-964">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-965">12</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-966">3</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:fixed-zero" scale="6" id="f-967">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:fixed-zero" scale="6" id="f-968">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:fixed-zero" scale="6" id="f-969">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other derivatives</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:fixed-zero" scale="6" id="f-970">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:fixed-zero" scale="6" id="f-971">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-972">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:fixed-zero" scale="6" id="f-973">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-974">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of derivatives not designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-975">12</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-976">3</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-977">5</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:fixed-zero" scale="6" id="f-978">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="f-979">20</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Changes in fair value related to components other than the spot rate are excluded from effectiveness testing for the three months ended March 31, 2025 and 2024.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Amount includes $(<ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-6" sign="-" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-980">4</ix:nonFraction>)&#160;million and $(<ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-6" sign="-" name="gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-981">6</ix:nonFraction>)&#160;million of interest expense on interest rate derivatives for the three months ended March 31, 2025 and 2024, respectively.</span></div><div style="margin-bottom:0.08pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) Other derivatives are comprised of embedded derivatives and derivatives related to equity contracts.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4) Amounts are inclusive of gains (losses) in Other (income) expense &#8211; net in the Condensed Consolidated Statements of Income.</span></div></ix:continuation><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FAIR VALUE MEASUREMENTS.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="f-982" continuedAt="f-982-1" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table represents assets and liabilities that are recorded and measured at fair value on a recurring basis.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="f-786-4"><ix:continuation id="f-982-1"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value of Assets and Liabilities Measured on a Recurring Basis</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of March 31, 2025</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of December 31, 2024</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Assets:</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Money market funds</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-6" name="gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" format="ixt:fixed-zero" scale="6" id="f-983">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-6" name="gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" scale="6" id="f-984">230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-6" name="gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" format="ixt:fixed-zero" scale="6" id="f-985">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-6" name="gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" scale="6" id="f-986">230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-6" name="gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" format="ixt:fixed-zero" scale="6" id="f-987">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-6" name="gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" scale="6" id="f-988">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-6" name="gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" format="ixt:fixed-zero" scale="6" id="f-989">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-6" name="gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" scale="6" id="f-990">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Investment securities</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-991">27</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-992">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-993">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-994">27</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-995">32</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-996">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-997">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-273" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="f-998">32</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Derivatives</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-999">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="f-1000">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-1001">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="f-1002">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-1003">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="f-1004">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-1005">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-273" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="f-1006">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Liabilities:</span></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Derivatives</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="f-1007">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="f-1008">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="f-1009">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="f-1010">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="f-1011">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="f-1012">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="f-1013">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-273" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="f-1014">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Contingent consideration</span></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="f-1015">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="f-1016">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="f-1017">40</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="f-1018">40</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="f-1019">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="f-1020">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="f-1021">34</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-273" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="f-1022">34</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:118%">Cash equivalents</span></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">As of March 31, 2025 and December 31, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">, Cash, cash equivalents, and restricted cash of $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1023">2,473</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1024">2,889</ix:nonFraction>&#160;million, respectively, included money market funds of $<ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-6" name="gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1025">230</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-6" name="gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" scale="6" id="f-1026">312</ix:nonFraction> million, and other cash equivalents of $<ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-6" name="gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1027">1,229</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-275" decimals="-6" name="gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1028">1,573</ix:nonFraction>&#160;million, respectively. The carrying values of the other cash equivalents approximates the fair value due to their short maturities and are valued using Level 1 or Level 2 inputs. Refer to Note 16, &#8220;Supplemental Financial Information&#8221; for further information.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:118%">Derivatives</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Derivatives are measured at fair value using a discounted cash flow method or option models using interest rates, foreign exchange spot and forward rates and yield curves observable at commonly quoted intervals, implied volatilities, and credit spreads as key inputs. Unobservable inputs relate to our own credit risk which is not significant to the overall measurement of fair value.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:118%">Contingent consideration</span></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Contingent consideration is recorded at fair value based on estimates of future cash flows in connection with business acquisitions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">. As the valuation of these liabilities is based on inputs that are less observable or not observable in the market, the determination of fair value is classified within Level 3 of the fair value hierarchy.</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:118%">Non-recurring fair value measurements</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Changes in fair value measurements of assets and liabilities measured at fair value on a non-recurring basis, such as equity method investments, equity investments without readily determinable fair value, financing receivables, and long-lived assets, were not material for the </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">three months ended</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"> March 31, 2025 and 2024, with the exception of the gain on fair value measurement of the NMP equity method investment as described in Note 7 &#8220;Acquisitions, Goodwill, and Other Intangible Assets.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:118%">Fair value of other financial instruments</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The estimated fair value of borrowings as of March 31, 2025 and December 31, 2024 was $<ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-6" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1029">9,223</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-6" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1030">9,374</ix:nonFraction>&#160;million, respectively, compared to a carrying value (which only includes a reduction for unamortized debt issuance costs and discounts and cumulative basis adjustment) of $<ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-6" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1031">8,759</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-6" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1032">8,951</ix:nonFraction>&#160;million, respectively. The fair value of our borrowings includes accrued interest and is determined based on observable and quoted prices and spreads of comparable debt and benchmark securities and is considered Level 2 in the fair value hierarchy. See Note 8, &#8220;Borrowings&#8221; and Note 16, &#8220;Supplemental Financial Information&#8221; for further information.</span></div></ix:continuation><div><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_169"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 13. <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock" id="f-1033" continuedAt="f-1033-1" escape="true">COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES </ix:nonNumeric></span></div><ix:continuation id="f-1033-1" continuedAt="f-1033-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">GUARANTEES.</span></div><div style="margin-bottom:0.08pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has off-balance sheet credit exposure through standby letters of credit, bank guarantees, bid bonds, and surety bonds. See Note 8, &#8220;Borrowings&#8221; for further information.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PRODUCT WARRANTIES.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide warranty coverage to our customers as part of customary practices in the market to provide assurance that the products we sell comply with agreed-upon specifications. We provide estimated product warranty expenses when we sell the related products. Warranty accruals are estimates that are based on the best available information, mostly historical claims experience, therefore claims costs may differ from amounts provided. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="f-1034" continuedAt="f-1034-1" escape="true">An analysis of changes in the liability for product warranties follows.</ix:nonNumeric></span></div><ix:continuation id="f-1034-1"><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at beginning of period</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ProductWarrantyAccrual" scale="6" id="f-1035">168</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" name="us-gaap:ProductWarrantyAccrual" scale="6" id="f-1036">192</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Current-year provisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" scale="6" id="f-1037">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" scale="6" id="f-1038">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Expenditures</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="f-1039">58</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="f-1040">55</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency exchange and other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="gehc:StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease" scale="6" id="f-1041">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="gehc:StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease" scale="6" id="f-1042">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at end of period</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:ProductWarrantyAccrual" scale="6" id="f-1043">171</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-6" name="us-gaap:ProductWarrantyAccrual" scale="6" id="f-1044">175</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="f-1033-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Product warranties are recognized within All other current liabilities in the Condensed Consolidated Statements of Financial Position. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">LEGAL MATTERS. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the normal course of our business, we are involved from time to time in various arbitrations; class actions; commercial, intellectual property, and product liability litigation; government investigations; investigations by competition/antitrust authorities; and other legal, regulatory, or governmental actions, including the significant matters described below that could have a material impact on our results of operations and cash flows. In many proceedings, including the specific matters described below, it is inherently difficult to determine whether any loss is probable or even reasonably possible or to estimate the size or range of the possible loss, and accruals for legal matters are not recorded until a loss for a particular matter is considered probable and reasonably estimable. Given the nature of legal matters and the complexities involved, it is often difficult to predict and determine a meaningful estimate of loss or range of loss until we know, among other factors, the particular claims involved, the likelihood of success of our defenses to those claims, the damages or other relief sought, how discovery or other procedural considerations will affect the outcome, the settlement posture of other parties, and other factors that may have a material effect on the outcome. For such matters, unless otherwise specified, we do not believe it is possible to provide a meaningful estimate of loss at this time. Moreover, it is not uncommon for legal matters to be resolved over many years, during which time relevant developments and new information must be continuously evaluated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contracts with Iraqi Ministry of Health</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2017, a number of U.S. Service members, civilians, and their families brought a complaint in the U.S. District Court for the District of Columbia (the &#8220;District Court&#8221;) against a number of pharmaceutical and medical device companies, including GE HealthCare and certain affiliates, alleging that the defendants violated the U.S. Anti-Terrorism Act. The complaint seeks monetary relief and alleges that the defendants provided funding for an Iraqi terrorist organization through their sales practices pursuant to pharmaceutical and medical device contracts with the Iraqi Ministry of Health. In July 2020, the District Court granted defendants&#8217; motions to dismiss and dismissed all of the plaintiffs&#8217; claims. In January 2022, a panel of the U.S. Court of Appeals for the District of Columbia Circuit reversed the District Court&#8217;s decision. In February 2022, the defendants requested review of the decision by all of the judges on the U.S. Court of Appeals for the District of Columbia Circuit (the &#8220;D.C. Circuit&#8221;). In February 2023, the D.C. Circuit denied this request. In June 2023, defendants petitioned the Supreme Court to review the D.C. Circuit&#8217;s decision. On June 24, 2024, the Supreme Court vacated the D.C. Circuit&#8217;s decision and remanded the case to the D.C. Circuit for further consideration. On November 19, 2024, the D.C. Circuit heard oral argument from the parties, and the D.C. Circuit&#8217;s decision is pending. The proceedings in the District Court are currently inactive.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Government Disclosures </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, we make self-disclosures regarding our compliance with the Foreign Corrupt Practices Act (&#8220;FCPA&#8221;) and similar laws to relevant authorities who may pursue or decline to pursue enforcement proceedings against us. We, with the assistance of outside counsel, made voluntary self-disclosures to the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and the U.S. Department of Justice (&#8220;DOJ&#8221;) beginning in 2018 regarding tender irregularities and other potential violations of the FCPA relating to our activities in certain provinces in China. We have been engaged in ongoing discussions with each of the SEC and the DOJ regarding these matters. We are fully cooperating with the reviews by these agencies and have implemented, and continue to implement, enhancements to our compliance policies and practices. At this time, we are unable to predict the duration, scope, result, or related costs associated with these disclosures to the SEC and the DOJ. We also are unable to predict what, if any, action may be taken by the SEC or the DOJ or what penalties or remedial actions they may seek. Any determination that our operations or activities are not in compliance with existing laws or regulations, including applicable foreign laws, could result in the imposition of fines, penalties, disgorgement, equitable relief, or other losses.</span></div></ix:continuation><div><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_172"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 14. <ix:nonNumeric contextRef="c-1" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="f-1045" continuedAt="f-1045-1" escape="true">RESTRUCTURING ACTIVITIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-1045-1" continuedAt="f-1045-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Restructuring activities are essential to optimize the business operating model for GE HealthCare and mostly involve workforce reductions, organizational realignments, and revisions to our real estate footprint. Specifically, restructuring charges (gains) primarily include facility exit costs, employee-related termination benefits associated with workforce reductions, asset write-downs, and cease-use costs. For segment reporting, restructuring activities are not allocated.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="f-1046" continuedAt="f-1046-1" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net expenses for restructuring initiatives committed to by management through March 31, 2025 are included in the table below.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.511%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.595%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Employee termination costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="f-1047">21</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="f-1048">25</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Facility and other exit costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:BusinessExitCosts1" format="ixt:fixed-zero" scale="6" id="f-1049">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="f-1050">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Asset write-downs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="f-1051">1</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="f-1052">7</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total restructuring activities &#8211; net</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="f-1053">22</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="f-1054">40</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These restructuring initiatives are expected to result in additional expenses of approximately $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1" format="ixt:num-dot-decimal" scale="6" id="f-1055">40</ix:nonFraction>&#160;million, to be incurred primarily over the next 12 months, substantially related to employee-related termination benefits and asset write-downs. Restructuring expenses (gains) are recognized within <span style="-sec-ix-hidden:f-1056"><span style="-sec-ix-hidden:f-1057">Cost of products, Cost of services, or SG&amp;A, as appropriate, in the Condensed Consolidated Statements of Income.</span></span></span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="f-1045-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liabilities related to restructuring are recognized within Current compensation and benefits, All other current liabilities, Non-current compensation and benefits, and All other non-current liabilities in the Condensed Consolidated Statements of Financial Position. <ix:continuation id="f-1046-1" continuedAt="f-1046-2">The activity related to our restructuring liabilities follows.</ix:continuation></span></div><ix:continuation id="f-1046-2"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;padding-right:-1.31pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Employee termination costs</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;padding-right:-1.31pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Facility and other exit costs</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at December 31, 2024</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-1058">67</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-1059">18</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-1060">86</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Charges</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-1061">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-1062">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="f-1063">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Payments and other adjustments</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-6" name="gehc:PaymentsForRestructuringAndOtherAdjustments" scale="6" id="f-1064">14</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-6" name="gehc:PaymentsForRestructuringAndOtherAdjustments" scale="6" id="f-1065">3</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="gehc:PaymentsForRestructuringAndOtherAdjustments" scale="6" id="f-1066">17</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at March 31, 2025</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-1067">73</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-1068">16</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="f-1069">89</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:0.08pt"><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_181"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 15. <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-1070" continuedAt="f-1070-1" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><ix:continuation id="f-1070-1"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The numerator for both basic and diluted earnings per share (&#8220;EPS&#8221;) is Net income attributable to GE HealthCare. The denominator of basic EPS is the weighted-average number of shares outstanding during the period. The dilutive effect of outstanding stock options, restricted stock units, and performance share units is reflected in the denominator for diluted EPS using the treasury stock method.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-1071" escape="true"><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.066%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.818%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Earnings Per Share</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:125%">(In millions, except per share amounts)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:125%">Numerator:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Net income</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="f-1072">588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="f-1073">388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Net (income) loss attributable to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="f-1074">24</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="f-1075">14</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Net income attributable to GE HealthCare</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-1076">564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-1077">374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:125%">Denominator:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Basic weighted-average shares outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-1078">457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-1079">456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Dilutive effect of common stock equivalents</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="f-1080">2</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="f-1081">3</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Diluted weighted-average shares outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-1082">459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-1083">459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Basic earnings per share</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1084">1.23</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1085">0.82</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Diluted earnings per share</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1086">1.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1087">0.81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Antidilutive securities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-1088">2</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-1089">4</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(1) Diluted earnings per share excludes certain shares issuable under share-based compensation plans because the effect would have been antidilutive.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:0.08pt"><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_184"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 16. <ix:nonNumeric contextRef="c-1" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="f-1090" continuedAt="f-1090-1" escape="true">SUPPLEMENTAL FINANCIAL INFORMATION</ix:nonNumeric></span></div><div style="margin-top:0.02pt"><span><br/></span></div><ix:continuation id="f-1090-1" continuedAt="f-1090-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="f-1092" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="f-1091" escape="true"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CASH, CASH EQUIVALENTS, AND RESTRICTED CASH.</span></div><div style="margin-top:0.02pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.177%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cash and cash equivalents</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-1093">2,454</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-1094">2,874</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Short-term restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="f-1095">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="f-1096">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Financial Position</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1097">2,473</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1098">2,889</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:1.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Long-term restricted cash</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="f-1099">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="f-1100">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Cash Flows</span></div></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-1101">2,476</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-1102">2,893</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Long-term restricted cash is recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position.</span></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:0.08pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="f-1103" escape="true"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">INVENTORIES.</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.177%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Raw materials</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="f-1104">991</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="f-1105">921</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-1106">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-1107">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Finished goods</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="f-1108">1,068</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="f-1109">926</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Inventories</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="f-1110">2,158</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="f-1111">1,939</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><br/></span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="f-1090-2" continuedAt="f-1090-3"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain inventory items are long-term in nature and therefore have been recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position and are not reflected in the table above. See the supplemental table &#8220;All Other Non-Current Assets&#8221; for further information. </span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-1112" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PROPERTY, PLANT, AND EQUIPMENT &#8211; NET.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.177%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Land and improvements</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-1113">146</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-1114">66</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Buildings, structures, and related equipment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-1115">2,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-1116">1,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Machinery and equipment</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-1117">2,905</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-1118">2,705</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Leasehold improvements and manufacturing plants under construction</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-1119">503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-293" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-1120">553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total property, plant, and equipment, at original cost</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-1121">5,661</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="f-1122">5,267</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Accumulated depreciation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1123">3,179</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-1124">3,080</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Right-of-use operating lease assets, net of amortization</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-1125">369</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-1126">364</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Property, plant, and equipment &#8211; net</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="gehc:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1127">2,851</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="gehc:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1128">2,550</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ALL OTHER ASSETS AND ALL OTHER LIABILITIES. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="f-1129" continuedAt="f-1129-1" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All Other Current Assets</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Prepaid expenses and deferred costs</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="gehc:PrepaidExpensesAndDeferredCostsCurrent" scale="6" id="f-1130">249</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="gehc:PrepaidExpensesAndDeferredCostsCurrent" scale="6" id="f-1131">188</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Financing receivables &#8211; net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="6" id="f-1132">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="6" id="f-1133">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Derivative instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:DerivativeAssetsCurrent" scale="6" id="f-1134">100</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:DerivativeAssetsCurrent" scale="6" id="f-1135">123</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Tax receivables</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:IncomeTaxesReceivable" scale="6" id="f-1136">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:IncomeTaxesReceivable" scale="6" id="f-1137">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousCurrent" scale="6" id="f-1138">46</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousCurrent" scale="6" id="f-1139">16</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All other current assets</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-1140">601</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-1141">532</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div></ix:nonNumeric><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="f-1142" continuedAt="f-1142-1" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All Other Non-Current Assets</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Prepaid pension asset</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:PrepaidExpenseNoncurrent" scale="6" id="f-1143">723</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PrepaidExpenseNoncurrent" scale="6" id="f-1144">657</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Equity method and other investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="f-1145">235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="f-1146">373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Financing receivables &#8211; net</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" scale="6" id="f-1147">186</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" scale="6" id="f-1148">183</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Long-term receivables &#8211; net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OtherReceivableAfterAllowanceForCreditLossNoncurrent" scale="6" id="f-1149">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherReceivableAfterAllowanceForCreditLossNoncurrent" scale="6" id="f-1150">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Inventories</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="f-1151">143</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="f-1152">139</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Contract and other deferred assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent" scale="6" id="f-1153">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent" scale="6" id="f-1154">208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Capitalized cloud computing arrangement implementation costs</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" scale="6" id="f-1155">113</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" scale="6" id="f-1156">84</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="6" id="f-1157">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="6" id="f-1158">164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All other non-current assets</span></div></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-1159">1,926</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-1160">1,950</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div></ix:nonNumeric><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="f-1161" continuedAt="f-1161-1" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All Other Current Liabilities</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Sales allowances and related liabilities</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="gehc:SalesAllowancesAndRelatedLiabilitiesCurrent" scale="6" id="f-1162">221</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="gehc:SalesAllowancesAndRelatedLiabilitiesCurrent" scale="6" id="f-1163">242</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Income and indirect tax liabilities including uncertain tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="gehc:DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent" scale="6" id="f-1164">286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="gehc:DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent" scale="6" id="f-1165">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Product warranties</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" scale="6" id="f-1166">171</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" scale="6" id="f-1167">168</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Accrued freight and utilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="gehc:AccruedFreightAndUtilitiesCurrent" scale="6" id="f-1168">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="gehc:AccruedFreightAndUtilitiesCurrent" scale="6" id="f-1169">163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Operating lease liabilities</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-1170">119</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-1171">115</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Derivative instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" id="f-1172">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" id="f-1173">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest payable on borrowings</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:InterestPayableCurrent" scale="6" id="f-1174">141</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:InterestPayableCurrent" scale="6" id="f-1175">92</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Environmental and asset retirement obligations</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="gehc:AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent" scale="6" id="f-1176">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="gehc:AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent" scale="6" id="f-1177">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="f-1178">355</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="f-1179">386</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All other current liabilities</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1180">1,583</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-1181">1,552</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><ix:continuation id="f-1090-3" continuedAt="f-1090-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="f-1182" continuedAt="f-1182-1" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All Other Non-Current Liabilities</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Contract liabilities</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="f-1183">724</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="f-1184">686</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-1185">266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-1186">270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Environmental and asset retirement obligations</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="gehc:AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent" scale="6" id="f-1187">395</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="gehc:AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent" scale="6" id="f-1188">291</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Income and indirect tax liabilities including uncertain tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" scale="6" id="f-1189">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" scale="6" id="f-1190">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Derivative instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" id="f-1191">39</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" id="f-1192">64</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><span style="-sec-ix-hidden:f-1193"><span style="-sec-ix-hidden:f-1194">Finance lease obligations</span></span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="f-1195">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="f-1196">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Sales allowances and related liabilities</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="gehc:SalesAllowancesAndRelatedLiabilitiesNoncurrent" scale="6" id="f-1197">24</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="gehc:SalesAllowancesAndRelatedLiabilitiesNoncurrent" scale="6" id="f-1198">23</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="f-1199">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="f-1200">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All other non-current liabilities</span></div></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-1201">1,840</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-1202">1,796</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div></ix:nonNumeric><ix:continuation id="f-1129-1"><ix:continuation id="f-1182-1" continuedAt="f-1182-2"><ix:continuation id="f-1161-1" continuedAt="f-1161-2"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(1) Derivative instruments include the related accrued interest. Refer to Note 12, &#8220;Financial Instruments and Fair Value Measurements&#8221; for further information.</span></div></ix:continuation></ix:continuation><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(2) Current assets Other primarily represents indemnity assets associated with separation agreements with GE as of March 31, 2025.</span></div></ix:continuation><ix:continuation id="f-1142-1"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(3) Non-current assets Other primarily consists of indemnity assets associated with separation agreements with GE, derivative instruments, and tax receivables.</span></div></ix:continuation><ix:continuation id="f-1161-2"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(4) Current liabilities Other primarily consists of miscellaneous accrued costs, contingent consideration liabilities, and dividends payable to stockholders.</span></div></ix:continuation><ix:continuation id="f-1182-2"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(5) Non-current liabilities Other primarily consists of miscellaneous accrued costs, indemnity liabilities associated with separation agreements with GE, and contingent consideration liabilities.</span></div></ix:continuation><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:118%">SUPPLY CHAIN FINANCE PROGRAMS. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="gehc:SupplierFinanceProgramPolicyPolicyTextBlock" id="f-1203" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Company participates in voluntary supply chain finance programs which provide participating suppliers the opportunity to sell their GE HealthCare receivables to third parties at the sole discretion of both the suppliers and the third parties. We evaluate supply chain finance programs to ensure the use of a third-party intermediary to settle our trade payables does not change the nature, existence, amount, or timing of our trade payables and does not provide the Company with any direct economic benefit. If any characteristics of the trade payables change or we receive a direct economic benefit, we reclassify the trade payables to borrowings. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">In connection with the supply chain finance programs, payment terms normally range from <ix:nonNumeric contextRef="c-294" name="us-gaap:SupplierFinanceProgramPaymentTimingPeriod" format="ixt-sec:durday" id="f-1204">30</ix:nonNumeric> to <ix:nonNumeric contextRef="c-295" name="us-gaap:SupplierFinanceProgramPaymentTimingPeriod" format="ixt-sec:durday" id="f-1205">180</ix:nonNumeric> days, depending on the underlying supplier agreements.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Included within <span style="-sec-ix-hidden:f-1206"><span style="-sec-ix-hidden:f-1207">Accounts payable</span></span> in the Condensed Consolidated Statements of Financial Position as of March 31, 2025 and December 31, 2024 were $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:SupplierFinanceProgramObligationCurrent" scale="6" id="f-1208">364</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:SupplierFinanceProgramObligationCurrent" scale="6" id="f-1209">394</ix:nonFraction> million, respectively, of confirmed supplier invoices that are outstanding and subject to third-party programs.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:118%">REDEEMABLE NONCONTROLLING INTERESTS</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:118%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Company has noncontrolling interests with redemption features. These redemption features, such as put options, could require the Company to purchase the noncontrolling interests upon the occurrence of certain events. All noncontrolling interests with redemption features that are not solely within our control are recognized within the Condensed Consolidated Statements of Financial Position between liabilities and equity. Redeemable noncontrolling interests are initially recorded at the issuance date fair value. Those that are currently redeemable, or probable of becoming redeemable, are subsequently adjusted to the greater of current redemption value or initial carrying value. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RedeemableNoncontrollingInterestTableTextBlock" id="f-1210" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Activity attributable to redeemable noncontrolling interests is presented below.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.900%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">2024</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at beginning of period</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="f-1211">188</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="f-1212">165</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net income attributable to redeemable noncontrolling interests</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="f-1213">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="f-1214">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at end of period </span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="f-1215">211</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="f-1216">177</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" id="f-1217" continuedAt="f-1217-1" escape="true"><ix:continuation id="f-1090-4" continuedAt="f-1090-5"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">OTHER INCOME (EXPENSE) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> NET.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.040%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center;text-indent:5pt"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">2024</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Net financing income and investment income (loss)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:InvestmentIncomeNet" scale="6" id="f-1218">1</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:InvestmentIncomeNet" scale="6" id="f-1219">16</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Equity method income (loss)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-1220">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-1221">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Change in fair value of assumed obligations</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" id="f-1222">8</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" scale="6" id="f-1223">8</ix:nonFraction>)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Gain on remeasurement of NMP equity method investment</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="f-1224">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" format="ixt:fixed-zero" scale="6" id="f-1225">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other items, net</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="gehc:OtherItemsIncomeExpenseNet" scale="6" id="f-1226">8</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="gehc:OtherItemsIncomeExpenseNet" scale="6" id="f-1227">14</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Total other income (expense) &#8211; net</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-1228">99</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-1229">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(1) Refer to Note 7, &#8220;Acquisitions, Goodwill, and Other Intangible Assets&#8221; for additional information on the NMP acquisition.</span></div></ix:continuation></ix:nonNumeric><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"><ix:continuation id="f-1217-1"><ix:continuation id="f-1090-5">(2) Other items, net primarily consists of licensing and royalty income, lease income, change in tax indemnities, and gains and losses related to derivatives. Additionally, for the three months ended March 31, 2025 it includes a realization of a gain contingency.</ix:continuation></ix:continuation> </span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_190"></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 17. <ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-1230" continuedAt="f-1230-1" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"><ix:continuation id="f-1230-1">On April 30, 2025, our Board of Directors authorized a share repurchase program for up to $<ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-6" name="srt:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="f-1231">1,000</ix:nonFraction> million of our common stock. Repurchases may be made from time to time in the open market, in privately negotiated transactions, or in such other manner as determined by GE HealthCare. The repurchase program does not have an expiration date, does not obligate GE HealthCare to acquire any particular amount of common stock, and may be suspended or terminated at any time at the Company's discretion.</ix:continuation> </span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">26</span></div></div></div><div id="i96f768675eb442d1b7b31e27beba1a3b_70"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_76"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following discussion and analysis of our financial results should be read in conjunction with the condensed consolidated financial statements and corresponding notes (the &#8220;financial statements&#8221;) included elsewhere in this Quarterly Report on Form 10-Q. The following discussion and analysis provide information management believes to be relevant to understanding the financial results of GE HealthCare Technologies Inc. and its subsidiaries (&#8220;GE HealthCare,&#8221; the &#8220;Company,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; or &#8220;we&#8221;) for the three months ended March 31, 2025 and 2024. For a full understanding of our financial condition and results of operations, the below discussion should be read alongside the Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. This discussion contains forward-looking statements that are based upon current expectations and are subject to uncertainty and changes in circumstances; see &#8220;Forward-Looking Statements.&#8221; Our actual results could differ materially from the results contemplated by these forward-looking statements due to a number of factors, including those discussed below and elsewhere in this Quarterly Report on Form 10-Q, and particularly in Item 1A,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 3, 2023, the General Electric Company, which now operates as GE Aerospace (&#8220;GE&#8221;), completed the spin-off of GE HealthCare Technologies Inc. (the &#8220;Spin-Off&#8221;).</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following tables are presented in millions of United States (&#8220;U.S.&#8221;) dollars unless otherwise stated, except for per-share amounts which are presented in U.S. dollars. Certain columns and rows may not sum due to the use of rounded numbers. Percentages presented are calculated from the underlying whole-dollar amounts, and unless otherwise stated, represent changes year-over-year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Effective July 1, 2024, Image Guided Therapies, previously part of the Imaging segment, was realigned to the Ultrasound segment. The Ultrasound segment was subsequently renamed Advanced Visualization Solutions (&#8220;AVS&#8221;). Following this realignment, the Company continues to have four reportable segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions (&#8220;PCS&#8221;), and Pharmaceutical Diagnostics (&#8220;PDx&#8221;). These segments have been identified based on the nature of the products sold and how the Company manages its operations. Historical segment financial information presented within this report has been recast to conform to the new reportable segments structure. For additional information on our segments, refer to Note 3, &#8220;Segment Information.&#8221;</span></div><div><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_79"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRENDS AND FACTORS IMPACTING OUR PERFORMANCE</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">We believe that our performance and future success depend on a number of factors that present significant opportunities for us but also pose risks and challenges, including those discussed below and particularly in Item 1A,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">KEY TRENDS AFFECTING RESULTS OF OPERATIONS.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Global Trade and Macroeconomic Environment</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In February 2025, the U.S. imposed new tariffs on products from China; in March 2025, those tariffs on Chinese products were increased and new tariffs were imposed on products imported from Mexico and Canada. These tariffs were in effect for less than a full quarter, and thus did not significantly impact our results for the three months ended March 31, 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the tariffs announced during the three months ended March 31, 2025, in April 2025, the U.S. announced additional new tariffs on imports from all countries in the world (except Mexico and Canada). China responded by announcing tariffs on U.S. imports, and subsequently both the U.S. and China announced additional tariffs. If maintained at current levels, we expect the U.S. and Chinese tariffs on imports from each other, as well as the U.S. baseline tariff on other countries (currently at 10% but subject to revision in July 2025), and the tariffs announced during the three months ended March 31, 2025, will materially impact our financial results through the incurrence of additional costs. Additional tariffs or other trade restrictions by the U.S. or other countries where we do significant business, or other restrictions on specific industries, such as pharmaceuticals, could further materially impact our results in the future. While we are taking actions to mitigate the impact of tariffs, it is highly unlikely that we will be able to fully offset the additional costs or other negative impacts resulting from the tariffs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continue to monitor the global markets in which we operate for changes in customer behavior, changes in government spending and reimbursement, and indirect impacts from the tariffs. Should these factors dampen economic growth, slow global trade, or impact inflation, we could see adverse impacts to our business as our customers adapt to the change in economic environment. We continue to monitor potential impacts on purchasing decisions by both public and private customers in China and other markets as result of the current trade environment, as well as other actions related to tariffs and trade frictions, investigations, or activities that could similarly increase our costs or otherwise impact our business. In addition, if negative sentiment towards U.S. companies influences the purchasing decisions of global customers, our business could be impacted materially.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:125%">China Market</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continue to monitor developments in the market in China. In March 2024, the government in China announced a new stimulus program (&#8220;2024 stimulus&#8221;) that includes the healthcare sector and is being implemented through China&#8217;s provinces. In addition, the focus of the government in China on combating corruption in the healthcare sector remains ongoing, and we expect it to remain a focus in the future. These factors contributed to delayed orders and revenues in our China business throughout 2024 and the first quarter of 2025. We expect the 2024 stimulus program will result in opportunities for our business in China in the longer term, but it has had short-term impacts as provinces develop and announce their plans and customers begin to make purchasing decisions. We expect these factors to continue to impact our orders and revenues in the near term, although we are unable to predict the exact duration or magnitude of the impact. We expect both of these impacts to be temporary, and we believe the focus of government policy in China on expanding access to healthcare will benefit our business in China in the long term.</span></div><div><span><br/></span></div><div><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Russia and Ukraine Conflict</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We had $143 million and $162 million of assets in, or directly related to, Russia and Ukraine as of March 31, 2025 and December 31, 2024, respectively, none of which are subject to sanctions that impact the carrying value of the assets. We generated revenues of $64 million and $77 million from customers in these two countries for the three months ended March 31, 2025 and 2024, respectively. The potential inability to repatriate earnings from these two countries will not have a material impact on our ability to operate.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continue to monitor the effects of Russia&#8217;s invasion of Ukraine, including the consideration of financial impact, cybersecurity risks, the applicability and effect of sanctions, and the employee base in Ukraine and Russia. Under the current U.S. Department of Commerce regulations, we are permitted to export, re-export, or transfer medical equipment and spare parts that meet stated criteria under a License Exception, which has eliminated the need for us to obtain individual U.S. licenses in most cases; however, licenses still may be needed for some transactions. The European Union and other countries have also expanded licensing requirements for certain spare parts, services, software, and other items. We will continue to apply for licenses to supply to these customers and to support our business in Russia, as required. The implementation of these measures affected our ability to supply customers in Russia during the three months ended March 31, 2025 and 2024 and will continue to do so as we confirm applicability of the U.S. License Exception to our transactions and continue to obtain licenses. There is no guarantee we will obtain all of the licenses for which we applied, that any approvals we obtain will be on a timely basis, or that our business in Russia will not be further disrupted due to evolving legal or operational considerations. The Board, together with management, will continue to assess whether developments related to the conflict have had, or are reasonably likely to have, a material impact on the Company. </span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_82"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUMMARY OF KEY PERFORMANCE MEASURES</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Management reviews and analyzes several key performance measures including Total revenues, Operating income, Net income attributable to GE HealthCare, Earnings per share, and Cash from (used for) operating activities. Management also reviews and analyzes Organic revenue*, Adjusted earnings before interest and taxes* (&#8220;Adjusted EBIT*&#8221;), Adjusted net income*, Adjusted tax expense*, Adjusted effective tax rate* (&#8220;Adjusted ETR*&#8221;), Adjusted earnings per share*, and Free cash flow*, which are non-GAAP financial measures. These measures are reviewed and analyzed in order to evaluate our business performance, identify trends affecting our business, allocate capital, and make strategic decisions, including those discussed below. See &#8220;Results of Operations&#8221; and &#8220;Liquidity and Capital Resources&#8221; below for further discussion on our key performance measures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The non-GAAP financial measures should be considered along with the most directly comparable U.S. GAAP financial measures. Definitions of these non-GAAP financial measures, a discussion of why we believe they are useful to management and investors as well as certain of their limitations, and reconciliations to their most directly comparable U.S. GAAP financial measures are provided below under &#8220;Non-GAAP Financial Measures.&#8221;</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">____________________</span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">*Non-GAAP Financial Measure</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">28</span></div></div></div><div id="i96f768675eb442d1b7b31e27beba1a3b_85"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following tables set forth our results of operations for each of the periods presented.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.540%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Income (Unaudited)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales of products</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3,117</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3,045</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Sales of services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,660</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,605</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;text-indent:-0.01pt;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,777</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,650</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cost of products</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,963</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,967</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cost of services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">802</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">782</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Gross profit</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,012</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,902</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,040</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,038</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Research and development</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">344</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">324</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total operating expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,383</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,362</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Operating income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">629</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">540</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Interest and other financial charges &#8211; net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">110</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">122</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-operating benefit (income) costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(74)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(102)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other (income) expense &#8211; net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(99)</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">8</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Income before income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">692</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">512</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit (provision) for income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(104)</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(124)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Net income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">588</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">388</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(24)</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(14)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Net income attributable to GE HealthCare</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.75pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">564</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.75pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">374</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">TOTAL REVENUES.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.819%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Revenues by Segment</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#160;% change</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#160;% organic*</span></div><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#160;change</span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;text-indent:-0.01pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Segment revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:25.57pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Imaging</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,140</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">2,062</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">4%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:25.57pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">AVS</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,239</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,227</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:25.57pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">PCS</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">753</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">747</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:25.57pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">PDx</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">632</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">599</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">6%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">8%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:124%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> &#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">13</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">15</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 3.77pt 0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Total revenues</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,777</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:122%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.75pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:122%">4,650</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4%</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:0.08pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Financial information not presented within the reportable segments, shown within the Other category, represents HealthCare Financial Services which does not meet the definition of an operating segment.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.150%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.818%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:123%">Revenues by Region</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#160;% change</span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:123%">United States and Canada (&#8220;USCAN&#8221;)</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:123%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,237</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,093</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">7%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:123%">Europe, the Middle East, and Africa (&#8220;EMEA&#8221;)</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:123%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,174</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,174</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:123%">China region</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:123%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">593</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">597</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1)%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:123%">Rest of World</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:123%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">773</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">785</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(2)%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:123%">Total revenues</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:123%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,777</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,650</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3%</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:125%">For the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:125%">three months ended</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:125%"> March 31, 2025</span></div><div style="margin-bottom:0.08pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total revenues were $4,777 million, growing 3% as reported and 4% organically*. Sales of products increased 2% or $71 million with strong growth in USCAN, led by PDx and Imaging segment revenues. Sales of services increased 3% or $56 million primarily driven by growth in new and existing customer contractual agreements.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">____________________</span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:125%">*Non-GAAP Financial Measure</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The segment revenues were as follows:</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Imaging segment revenues were $2,140 million, growing 4% or $77 million, with growth across all regions, led by Molecular Imaging and Computed Tomography (&#8220;MI/CT&#8221;) and Magnetic Resonance (&#8220;MR&#8221;) product lines;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">AVS segment revenues were $1,239 million, growing 1% or $12 million, with strength in the U.S. market largely offset by unfavorable foreign currency impacts and continued pressure in the China market.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">PCS segment revenues were $753 million, growing 1% or $6 million, driven by strength in the U.S., including growth in Monitoring Solutions, largely offset by declines in Anesthesia revenues due to market timing and unfavorable foreign currency impacts; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">PDx segment revenues were $632 million, growing 6% or $33 million driven by continued growth in price and volume.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The regional revenues were as follows:</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">USCAN revenues were $2,237 million, growing 7% or $143 million with growth across all segment revenues, led by strong growth in PDx and Imaging revenues;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">EMEA revenues were $1,174 million, flat to the prior year, with growth in PDx and Imaging revenues offset by unfavorable foreign currency impacts;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">China region revenues were $593 million, decreasing 1% or $4 million due to a decrease in AVS revenues and unfavorable foreign currency impacts, largely offset by growth in PDx and Imaging revenues; and</span></div><div style="margin-bottom:0.08pt;padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:14.85pt">Rest of World revenues were $773 million, decreasing 2% or $12 million due to unfavorable foreign currency impacts, partially offset by growth in Imaging revenues.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">OPERATING INCOME, NET INCOME ATTRIBUTABLE TO GE HEALTHCARE, ADJUSTED EBIT*, AND ADJUSTED NET INCOME*.</span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.372%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.208%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">% of Total revenues</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">% of Total revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#160;% change</span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:123%">Operating income</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:123%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">629</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">13.2%</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">540</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">11.6%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">17%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.55pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:123%">Net income attributable to GE HealthCare</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">564</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">11.8%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">374</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">8.0%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">51%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:123%">Adjusted EBIT*</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">715</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">15.0%</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">681</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">14.7%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:123%">Adjusted net income*</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">464</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">9.7%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">413</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">8.9%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">12%</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">For the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">three months ended</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> March 31, 2025</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating income was $629 million, an increase of $89 million and 160 basis points as a percent of Total revenues. The increase was due to the following factors: </span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Gross profit increased $111 million or 120 basis points as a percent of Total revenues primarily due to a reduction in Cost of products sold as a percent of Total revenues. Cost of products sold decreased $4 million or 160 basis points as a percent of Sales of products. The decrease as a percent of sales was driven primarily by cost productivity, partially offset by unfavorable mix within our product offerings and cost inflation. Cost of services sold increased $20 million but decreased 40 basis points as a percent of Sales of services. The decrease as a percent of sales was driven by cost productivity and an increase in pricing of our service offerings, partially offset by unfavorable mix within our service offerings. Included in our total cost of revenue as part of our product investment was $96 million in engineering costs for design follow-through on new product introductions and product lifecycle maintenance subsequent to the initial product launch, compared to $101 million for the prior year comparable period; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Total operating expenses increased $21 million primarily due to an increase in Research and Development (&#8220;R&amp;D&#8221;) investments of $20 million and an increase in Selling, general, and administrative (&#8220;SG&amp;A&#8221;) expense of $2 million primarily driven by increased investment in our commercial teams, largely offset by a decrease in Spin-Off and separation costs. As a result, SG&amp;A as a percentage of Total revenues decreased by 60 basis points and R&amp;D as a percentage of Total revenues increased by 20 basis points.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">____________________</span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:125%">*Non-GAAP Financial Measure</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income attributable to GE HealthCare and Net income margin were $564 million and 11.8%, an increase of $190 million and 380 basis points, respectively, primarily due to the following factors:</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Operating income increased $89 million, as discussed above;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Interest and other financial charges &#8211; net decreased $12 million primarily driven by repayments made on the Term Loan Facility;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Non-operating benefit income decreased $28 million primarily due to lower expected returns on plan assets;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;padding-left:14.85pt">Other income &#8211; net increased $107 million primarily driven by the remeasurement of the Company&#8217;s 50% interest in Nihon Medi-Physics Co., Ltd (&#8220;NMP&#8221;) based on the cash consideration exchanged for acquiring the remaining 50% equity interest. For additional detail on the NMP acquisition, refer to Note 7, &#8220;Acquisitions, Goodwill, and Other Intangible Assets&#8221;; and</span></div><div style="margin-bottom:0.08pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Provision for income taxes decreased $20 million primarily due to the release of income tax reserves in a foreign jurisdiction for tax years which are no longer subject to an assessment from the local taxing authorities. For additional detail regarding our income taxes, see Note 10, &#8220;Income Taxes.&#8221;</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adjusted EBIT* and Adjusted EBIT margin* were $715 million and 15.0%, an increase of $33 million and 30 basis points, respectively, primarily due to an increase in Gross profit, partially offset by an increase in operating expenses.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adjusted net income*</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">was $464 million, an increase of $51 million primarily due to the increase in Gross profit and lower Interest and other financial charges &#8211; net, partially offset by an increase in operating expenses.</span></div><div><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_88"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> SEGMENTS</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We exclude from Segment EBIT certain corporate-related expenses and certain transactions or adjustments that our Chief Operating Decision Maker (which is our Chief Executive Officer) considers to be non-operational, such as Interest and other financial charges &#8211; net, Benefit (provision) for income taxes, restructuring costs, acquisition and disposition-related benefits (charges), Spin-Off and separation costs, Non-operating benefit (income) costs, gain (loss) on business and asset dispositions, amortization of acquisition-related intangible assets, Net (income) loss attributable to noncontrolling interests, Income (loss) from discontinued operations, net of taxes, and investment revaluation gain (loss). See Note 3, &#8220;Segment Information&#8221; for additional information on our reportable segments, and &#8220;Results of Operations&#8221; above for discussion on segment revenue performance.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.372%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.208%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:122%">Segment EBIT</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">% of segment revenues</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">% of segment revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#160;% change</span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:122%">Imaging</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:122%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">199</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">9.3&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">%</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">166</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">8.0&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">20&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:122%">AVS</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">261</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">257</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">20.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:122%">PCS</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:122%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">48</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">6.4&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">%</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">81</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">10.9&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(41)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:122%">PDx</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:122%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">205</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">32.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">178</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">29.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">15&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">For the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">three months ended</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> March 31, 2025</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Imaging Segment EBIT was $199 million, an increase of $33 million due to cost productivity, growth in sales volume, and an increase in price, partially offset by unfavorable mix and increased investment;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">AVS Segment EBIT was $261 million, an increase of $4 million due to growth in sales volume and cost productivity largely offset by cost inflation;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">PCS Segment EBIT was $48 million, a decrease of $33 million due to increased investment, cost inflation, and unfavorable mix; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">PDx Segment EBIT was $205 million, an increase of $27 million due to an increase in price and growth in sales volume, partially offset by increased investment.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">____________________</span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">*Non-GAAP Financial Measure</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">31</span></div></div></div><div id="i96f768675eb442d1b7b31e27beba1a3b_91"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">NON-GAAP FINANCIAL MEASURES</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The non-GAAP financial measures presented in this Quarterly Report on Form 10-Q are supplemental measures of our performance and our liquidity that we believe will help investors understand our financial condition, cash flows, and operating results, and assess our future prospects. When read in conjunction with our U.S. GAAP results, these non-GAAP financial measures provide a baseline for analyzing trends in our underlying businesses and can be used by management as one basis for making financial, operational, and planning decisions. Descriptions of the reported non-GAAP measures are included below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We report Organic revenue and Organic revenue growth rate to provide management and investors with additional understanding and visibility into the underlying revenue trends of our established, ongoing operations, as well as provide insights into overall demand for our products and services. To calculate these measures, we exclude the effect of acquisitions, dispositions, and foreign currency rate fluctuations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We report EBIT, Adjusted EBIT, Adjusted EBIT margin, Adjusted net income, and Adjusted earnings per share to provide management and investors with additional understanding of our business by highlighting the results from ongoing operations and the underlying profitability factors, on a normalized basis. To calculate these measures we exclude, and reflect in the detailed reconciliations below, the following adjustments as applicable: Interest and other financial charges </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> net, Net (income) loss attributable to noncontrolling interests, Non-operating benefit (income) costs, Benefit (provision) for income taxes and certain tax related adjustments, and certain non-recurring and/or non-cash items. We may from time to time consider excluding other non-recurring items to enhance comparability between periods. Adjusted EBIT margin is calculated by taking Adjusted EBIT divided by Total revenues for the same period.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We report Adjusted tax expense and Adjusted ETR to provide management and investors with a better understanding of the normalized tax rate applicable to our business and provide more consistent comparability across periods. A</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">djusted tax expense excludes the income tax related to the pre-tax income adjustments included as part of Adjusted net income and certain income tax adjustments, such as adjustments to deferred tax assets or liabilities. We may from time to time consider excluding other non-recurring tax items to enhance comparability between periods. Adjusted ETR is Adjusted tax expense divided by income before income taxes less the pre-tax income adjustments referenced above.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We report Free cash flow to provide management and investors with an important measure of our ability to generate cash on a normalized basis and provide insight into our flexibility to allocate capital. Free cash flow is Cash from (used for) operating activities &#8211; continuing operations including cash flows related to the additions and dispositions of property, plant, and equipment (&#8220;PP&amp;E&#8221;) and additions of internal-use software. Free cash flow does not represent residual cash flows available for discretionary expenditures, due to the fact that the measure does not deduct the capital required for debt repayments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Management recognizes that these non-GAAP financial measures have limitations, including that they may be calculated differently by other companies or may be used under different circumstances or for different purposes. In order to compensate for the discussed limitations, management does not consider these measures in isolation from or as alternatives to the comparable financial measures determined in accordance with U.S. GAAP. The detailed reconciliations of each non-GAAP financial measure to the most directly comparable U.S. GAAP financial measure are provided below, and no single financial measure should be relied on to evaluate our business.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Organic Revenue*</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">% change</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Imaging revenues&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,140</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,062</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Acquisitions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">14</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Dispositions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Foreign currency exchange&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(38)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Imaging Organic revenue*</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,165</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,062</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">AVS revenues&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,239</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,227</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1%</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Acquisitions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Dispositions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Foreign currency exchange&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(19)</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">AVS Organic revenue*&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,258</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,227</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3%</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PCS revenues&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">753</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">747</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Acquisitions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Dispositions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Foreign currency exchange&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(7)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PCS Organic revenue*&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">760</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">747</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PDx revenues&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">632</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">599</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">6%</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Acquisitions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Dispositions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Foreign currency exchange&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(14)</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PDx Organic revenue*&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">646</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">599</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">8%</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other revenues&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">13</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">15</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(11)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Acquisitions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Dispositions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Foreign currency exchange&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Organic revenue*&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">13</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">15</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(10)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total revenues&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,777</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,650</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3%</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Acquisitions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">14</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Dispositions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Foreign currency exchange&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(78)</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Organic revenue*&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,842</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,650</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4%</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.150%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Represents revenues attributable to acquisitions from the date the Company completed the transaction through the end of four quarters following the transaction.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Represents revenues attributable to dispositions for the four quarters preceding the disposition date.</span></td></tr></table></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">____________________<br/></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:125%">*Non-GAAP Financial Measure</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.316%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.762%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted EBIT*</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 14.55pt;text-indent:-13.5pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#160;% change</span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income attributable to GE HealthCare</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">564</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">374</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">51%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Add: Interest and other financial charges &#8211; net&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">110</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">122</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Add: Non-operating benefit (income) costs&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(74)</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(102)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Benefit (provision) for income taxes&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(104)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(124)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net (income) loss attributable to noncontrolling interests &#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(24)</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(14)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EBIT*</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">728</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">531</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">37%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Add: Restructuring costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">22</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">40</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Add: Acquisition and disposition-related charges (benefits)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">8</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Add: Spin-Off and separation costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">24</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">60</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Add: (Gain) loss on business and asset dispositions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Add: Amortization of acquisition-related intangible assets&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">35</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">31</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Add: Investment revaluation (gain) loss</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(92)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">20</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted EBIT*</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">715</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">681</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">5%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.55pt;text-align:left;text-indent:-13.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income margin</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">11.8%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">8.0%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">380&#160;bps</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted EBIT margin*</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">15.0%</span></td><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">14.7%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 3.75pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">30&#160;bps</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.150%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consists of severance, facility closures, and other charges associated with restructuring programs.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Consists of legal, consulting, and other transaction and integration fees, and adjustments to contingent consideration, as well as other purchase accounting related charges and other costs directly related to the transactions.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Costs incurred in the Spin-Off and separation from GE, including system implementations, audit and advisory fees, legal entity separation, Founders Grant equity awards, separation agreements with GE, and other one-time costs.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Consists of gains and losses resulting from the sale of assets and investments.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(5)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Primarily relates to valuation adjustments for equity investments and for the three months ended March 31, 2025 includes the impact from the revaluation of our existing 50% interest in NMP as part of the acquisition transaction.</span></td></tr></table></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.316%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.762%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:4.5pt;padding-right:2.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Adjusted Net Income*</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 14.55pt;text-indent:-10.8pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#160;% change</span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Net income attributable to GE HealthCare</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">564</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">374</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">51%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Add: Non-operating benefit (income) costs&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(74)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(102)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Add: Restructuring costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:124%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">22</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">40</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Add: Acquisition and disposition-related charges (benefits)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:124%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">8</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Add: Spin-Off and separation costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:124%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">29</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">60</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Add: (Gain) loss on business and asset dispositions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:124%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Add: Amortization of acquisition-related intangible assets&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">35</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">31</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Add: Investment revaluation (gain) loss</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:124%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(92)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">20</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:7.57pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Add: Tax effect of reconciling items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(14)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Add: Spin-Off and other tax adjustments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:124%;position:relative;top:-3.15pt;vertical-align:baseline">(7)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(17)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Adjusted net income*&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">464</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">413</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">12%</span></td><td colspan="3" style="display:none"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.150%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consists of severance, facility closures, and other charges associated with restructuring programs.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Consists of legal, consulting, and other transaction and integration fees, and adjustments to contingent consideration, as well as other purchase accounting related charges and other costs directly related to the transactions.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Costs incurred in the Spin-Off and separation from GE, including system implementations, audit and advisory fees, legal entity separation, Founders Grant equity awards, separation agreements with GE, and other one-time costs. An adjustment is included to eliminate the associated impact on Net (income) loss attributable to noncontrolling interests for applicable costs that impact earnings attributable to noncontrolling interests.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Consists of gains and losses resulting from the sale of assets and investments.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(5)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Primarily relates to valuation adjustments for equity investments and for the three months ended March 31, 2025 includes the impact from the revaluation of our existing 50% interest in NMP as part of the acquisition transaction.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(6)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The tax effect of reconciling items is calculated using the statutory tax rate, taking into consideration the nature of the items and the relevant taxing jurisdiction.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(7)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consists of certain income tax adjustments, including the release of income tax reserves in a foreign jurisdiction for tax years which are no longer subject to an assessment from the local taxing authorities, discrete tax impacts resulting from the Spin-Off and separation from GE, and tax impacts of the NMP acquisition. As of the third quarter of 2024 this line additionally includes discrete tax impacts resulting from the Spin-Off and separation from GE previously reported under Tax effect of reconciling items.</span></div></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">____________________</span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:125%">*Non-GAAP Financial Measure</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.316%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.762%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Adjusted Earnings Per Share*</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 8.55pt;text-align:left;text-indent:-10.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:124%">(In dollars, except shares outstanding presented in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#160;$ change</span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Diluted earnings per share</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1.23</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">0.81</span></td><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">0.41</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Add: Non-operating benefit (income) costs&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(0.16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(0.22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Add: Restructuring costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:124%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.05&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.09&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Add: Acquisition and disposition-related charges (benefits)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:124%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Add: Spin-Off and separation costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:124%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.06&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.13&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Add: (Gain) loss on business and asset dispositions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:124%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Add: Amortization of acquisition-related intangible assets&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.08&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.07&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Add: Investment revaluation (gain) loss</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:124%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(0.20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:7.57pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Add: Tax effect of reconciling items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(0.03)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Add: Spin-Off and other tax adjustments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:124%;position:relative;top:-3.15pt;vertical-align:baseline">(7)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(0.04)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:13.55pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:123%">Adjusted earnings per share*</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1.01</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">0.90</span></td><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">0.11</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 14.55pt;text-align:left;text-indent:-10.8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:123%">Diluted weighted-average shares outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">459</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">459</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 3.77pt 0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.150%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consists of severance, facility closures, and other charges associated with restructuring programs.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consists of legal, consulting, and other transaction and integration fees, and adjustments to contingent consideration, as well as other purchase accounting related charges and other costs directly related to the transactions.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Costs incurred in the Spin-Off and separation from GE, including system implementations, audit and advisory fees, legal entity separation, Founders Grant equity awards, separation agreements with GE, and other one-time costs. An adjustment is included to eliminate the associated impact on Net (income) loss attributable to noncontrolling interests for applicable costs that impact earnings attributable to noncontrolling interests.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Consists of gains and losses resulting from the sale of assets and investments.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(5)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Primarily relates to valuation adjustments for equity investments and for the three months ended March 31, 2025 includes the impact from the revaluation of our existing 50% interest in NMP as part of the acquisition transaction.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(6)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The tax effect of reconciling items is calculated using the statutory tax rate, taking into consideration the nature of the items and the relevant taxing jurisdiction.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(7)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consists of certain income tax adjustments, including the release of income tax reserves in a foreign jurisdiction for tax years which are no longer subject to an assessment from the local taxing authorities, discrete tax impacts resulting from the Spin-Off and separation from GE, and tax impacts of the NMP acquisition. As of the third quarter of 2024 this line additionally includes discrete tax impacts resulting from the Spin-Off and separation from GE previously reported under Tax effect of reconciling items.</span></div></td></tr></table></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.790%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Adjusted Tax Expense* and Adjusted ETR*</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:13.55pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:123%">Benefit (provision) for income taxes</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(104)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(124)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:7.57pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Add: Tax effect of reconciling items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(14)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Add: Spin-Off and other tax adjustments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:124%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(17)</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:13.55pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:123%">Adjusted tax expense*</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(121)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(133)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:13.55pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:123%">Effective tax rate</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">15.0%</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">24.2%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:13.55pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:123%">Adjusted effective tax rate*</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">20.1%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">23.7%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.150%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The tax effect of reconciling items is calculated using the statutory tax rate, taking into consideration the nature of the items and the relevant taxing jurisdiction.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consists of certain income tax adjustments, including the release of income tax reserves in a foreign jurisdiction for tax years which are no longer subject to an assessment from the local taxing authorities, discrete tax impacts resulting from the Spin-Off and separation from GE, and tax impacts of the NMP acquisition. As of the third quarter of 2024 this line additionally includes discrete tax impacts resulting from the Spin-Off and separation from GE previously reported under Tax effect of reconciling items.</span></div></td></tr></table></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">____________________</span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:125%">*Non-GAAP Financial Measure</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.761%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.762%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Free Cash Flow*</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#160;% change</span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:123%">Cash from (used for) operating activities</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">250</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">419</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(40)%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:123%">Add: Additions to PP&amp;E and internal-use software&#160;&#160;&#160;&#160;</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:123%">Add: Dispositions of PP&amp;E&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:123%">Free cash flow*&#160;&#160;&#160;&#160;</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">98</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">274</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(64)%</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_94"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of March 31, 2025, our Cash, cash equivalents, and restricted cash balance in the Condensed Consolidated Statements of Financial Position was $2,473 million. We have historically generated positive cash flows from operating activities. Additionally, we have access to revolving credit facilities of $3,500 million in aggregate, described in detail in Note 8, &#8220;Borrowings.&#8221;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that our existing balance of Cash, cash equivalents, and restricted cash, future cash generated from operating activities, access to capital markets, and existing credit facilities will be sufficient to meet the needs of our current and ongoing operations, pay taxes due, service our existing debt, and fund investments in our business for at least the next 12 months.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes our cash flows for the periods presented:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.177%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cash Flow</span></td><td colspan="6" style="border-bottom:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 14.55pt;text-align:left;text-indent:-10.8pt;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash from (used for) operating activities</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">250&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">419&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.55pt;text-align:left;text-indent:-10.8pt;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash from (used for) investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 14.55pt;text-align:left;text-indent:-10.8pt;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash from (used for) financing activities</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(286)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(153)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Free cash flow*&#160;&#160;&#160;&#160;</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">98&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">274&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash generated from operating activities in the three months ended March 31, 2025 was $250 million and included Net income of $588 million, adjusted for non-cash items including depreciation and amortization expense of $136 million and gain on remeasurement of NMP equity method investment of $97 million, and $377 million in net outflows from changes in assets and liabilities. The changes in assets and liabilities are primarily driven by compensation and benefit payments, an increase in inventories to meet business demand, and company-funded benefit payments for postretirement benefit plans, partially offset off by an increase in accounts payable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash generated from operating activities for the three months ended March 31, 2025 decreased by $169 million compared to the same period in 2024, primarily due to timing of employee compensation payments, with the majority of annual payments shifted from the second quarter to the first quarter of 2025, and inventory build.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash generated from operating activities in the three months ended March 31, 2024 was $419 million and included Net income of $388 million, non-cash charges for depreciation and amortization of $148 million, and a $116 million outflow from changes in assets and liabilities, primarily driven by company-funded benefit payments for postretirement benefit plans, annual prepayments, and an increase in inventory, partially offset by a decrease in receivables.</span></div><div><span><br/></span></div><div><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash used for investing activities in the three months ended March 31, 2025 was $407 million and primarily included purchases of businesses, net of cash acquired, of $269 million related to the acquisition of the remaining 50% interest in NMP and additions to PP&amp;E of $152 million related mostly to new product introductions and manufacturing capacity expansion. Refer to Note 7, &#8220;Acquisitions, Goodwill, and Other Intangible Assets&#8221; for additional information on the NMP acquisition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash used for investing activities in the three months ended March 31, 2024 was $188 million and primarily included additions to PP&amp;E of $145 million related mostly to manufacturing capacity expansion and new product introductions.</span></div><div><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:125%">Financing Activities</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash used for financing activities in the three months ended March 31, 2025 was $286 million and primarily included a repayment of $250 million of our outstanding Term Loan Facility. Refer to Note 8, &#8220;Borrowings&#8221; for further information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash used for financing activities in the three months ended March 31, 2024 was $153 million and primarily included a repayment of $150 million of our outstanding Term Loan Facility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">____________________</span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:125%">*Non-GAAP Financial Measure</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Free cash flow*</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Free cash flow* was $98 million for the three months ended March 31, 2025 and primarily included $250 million of cash generated from operating activities, partially offset by $152 million of cash used for additions to PP&amp;E.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Free cash flow* was $274 million for the three months ended March 31, 2024 and primarily included $419 million of cash generated from operating activities, partially offset by $145 million of cash used for additions to PP&amp;E.</span></div><div><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:125%">Capital Expenditures</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash used for capital expenditures was $152 million and $145 million for the three months ended March 31, 2025 and 2024, respectively. Capital expenditures were primarily for manufacturing capacity expansion, new product introductions, and equipment and tooling for new and existing products.</span></div><div><span><br/></span></div><div><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Material Cash Requirements</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the normal course of business, we enter into contracts and commitments that obligate us to make payments in the future. Information regarding our obligations under lease, debt, and other commitments are provided in Note 7, &#8220;Leases,&#8221; Note 9, &#8220;Borrowings,&#8221; and Note 14, &#8220;Commitments, Guarantees, Product Warranties, and Other Loss Contingencies&#8221; to the consolidated and combined financial statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. We have material cash requirements related to our pension obligations as described in Note 9, &#8220;Postretirement Benefit Plans.&#8221;</span></div><div><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:125%">Share Repurchase Program</span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">On April 30, 2025, our Board of Directors authorized a share repurchase program for up to $1,000 million of our common stock. Repurchases may be made from time to time in the open market, in privately negotiated transactions, or in such other manner as determined by GE HealthCare. The repurchase program does not have an expiration date, does not obligate GE HealthCare to acquire any particular amount of common stock, and may be suspended or terminated at any time at the Company's discretion. </span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="background-color:#ffffff;color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Debt and Credit Facilities</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As part of our capital structure, we have incurred debt. The servicing of this debt is supported by cash flows from our operations. Additional information on our debt and credit facilities, including definitions of the terms used below, is included in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note 8</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8220;Borrowings.&#8221; </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of March 31, 2025, we had $8,759&#160;million of total debt compared to $8,951&#160;million as of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December 31, 2024. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The decrease in debt was due primarily to a repayment of $250&#160;million of the outstanding Term Loan Facility in the first quarter of 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average interest rate for the Notes and our Credit Facilities for the three months ended March 31, 2025 was 5.93%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the Term Loan Facility, our credit facilities include a five-year senior unsecured revolving facility that provides borrowings of up to $3,000&#160;million expiring in March 2030, and a 364-day senior unsecured revolving facility that provides borrowings of up to $500&#160;million expiring in March 2026. As of </span><span style="background-color:#ffffff;color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">March 31, 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, there were no outstanding borrowings on either of the two revolving facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Credit Facilities include various customary covenants that limit, among other things, the incurrence of liens securing debt, the entry into certain fundamental change transactions by GE HealthCare, and the maximum permitted leverage ratio. As of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">March 31, 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, we were in compliance with the covenant requirements, including the maximum consolidated net leverage ratio. </span></div><div><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:125%">Access to Capital and Credit Ratings</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We plan to continue to rely on capital markets, and we expect to have access to credit facilities to fund our operations. The cost and availability of debt financing will be influenced by our credit ratings and market conditions. Moody</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s Investors Service (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Moody</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">), S&amp;P Global Ratings (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">S&amp;P</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">), and Fitch Ratings (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Fitch</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) currently issue ratings on our long-term debt. </span></div><div><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Our credit ratings as of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">April&#160;23, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"> are set forth in the table below and remain unchanged since the Spin-Off.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.541%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Moody&#8217;s</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">S&amp;P</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fitch</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Long-term rating</span></div></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Baa2</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">BBB</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">BBB</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Outlook</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Stable</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Stable</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Stable</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are disclosing our credit ratings to enhance the understanding of our sources of liquidity and the effects of our ratings on our costs of funds and access to liquidity. Our ratings may be subject to a revision or withdrawal at any time by the assigning rating organization, a</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">nd each rating should be evaluated independently of any other rating.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_97"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For a discussion of recently issued accounting standards, see Note 1, &#8220;Organization and Basis of Presentation.&#8221;</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">____________________</span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:125%">*Non-GAAP Financial Measure</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">37</span></div></div></div><div id="i96f768675eb442d1b7b31e27beba1a3b_268"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING ESTIMATES</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no material changes to the critical accounting estimates disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.</span></div><div><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_247"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are exposed to market risk primarily from changes in foreign currency exchange rates, interest rates, commodity prices, and equity prices, which may impact future income, cash flows, and fair value of our business. There have been no material changes in our exposure to market risk from those disclosed in Item 7A, &#8220;Quantitative and Qualitative Disclosures About Market Risk&#8221; in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.</span></div><div><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_196"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. CONTROLS AND PROCEDURES</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the supervision and with the participation of the Company&#8217;s management, including the Chief Executive Officer and Chief Financial Officer, the Company evaluated its disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company&#8217;s disclosure controls and procedures were effective as of March 31, 2025, and that the information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported, within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the quarter ended March 31, 2025, there were no changes in the Company&#8217;s internal control over financial reporting that materially affected or are reasonably likely to materially affect the Company&#8217;s internal control over financial reporting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">INHERENT LIMITATIONS ON EFFECTIVENESS OF CONTROLS.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All internal control systems have inherent limitations; as such, they may not prevent or detect all misstatements or all fraud. Therefore, even those internal control systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and reporting. Additionally, projections of any evaluation of effectiveness to future periods are subject to the risk that the current control structure may become inadequate for changes in conditions or the degree of compliance with the policies may deteriorate.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_58"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. OTHER INFORMATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 1. LEGAL PROCEEDINGS</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Information on material pending legal proceedings is incorporated herein by reference to the information set forth in Note 13, &#8220;Commitments, Guarantees, Product Warranties, and Other Loss Contingencies&#8221; to the financial statements included elsewhere in this </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Quarterly Report on Form 10-Q</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_277"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_271"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were no unregistered sales of equity securities during the period covered by this report.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_274"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. DEFAULTS UPON SENIOR SECURITIES</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_61"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. MINE SAFETY DISCLOSURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">38</span></div></div></div><div id="i96f768675eb442d1b7b31e27beba1a3b_199"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5. OTHER INFORMATION</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">DIRECTOR AND OFFICER TRADING ARRANGEMENTS.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None of our directors or executive officers <ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1232"><ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1233">adopted</ix:nonNumeric></ix:nonNumeric> or <ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1234"><ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1235">terminated</ix:nonNumeric></ix:nonNumeric> a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the quarterly period covered by this report.</span></div><div><span><br/></span></div><div id="i96f768675eb442d1b7b31e27beba1a3b_292"></div><div style="-sec-extract:summary;margin-bottom:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. EXHIBITS</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:88.484%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:2.75pt"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Description</span></div></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #640acd;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3.1</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #640acd;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000119312522314166/d439598dex31.htm">Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant</a>&#8217;<a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000119312522314166/d439598dex31.htm">s Current Report on Form 8-K filed with the SEC on December 29, 2022).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3.2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000119312522314166/d439598dex32.htm">Bylaws of the Registrant (incorporated by reference to Exhibit 3.2 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on December 29, 2022).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">10.1</span></div></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">Credit Agreement, dated as of March </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">27</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">, 2025, among </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">the Registrant, as the borrower, J</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">PM</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">organ Chase </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">Bank, N.A., as the Administrative </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">A</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">gent</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">, and the le</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">nders party thereto (</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">incorporated</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm"> by reference </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">to Exhibit </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">10.1</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm"> to t</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">he Regis</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">trant</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">&#8217;</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">s</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm"> Current Report on</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm"> Form 8-K </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">filed </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">with </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">the </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">SEC on </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">March </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">31</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">, 2025).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">10.2</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit102.htm">364-Da</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit102.htm">y R</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit102.htm">e</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit102.htm">volving </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit102.htm">Credit Agreement, dated as of March </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit102.htm">27</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit102.htm">, 2025, among the Registrant, as the borrower, JPMorgan Chase Bank, N.A., as the Administrative Agent, and the lenders party thereto (incorporated by reference to Exhibit </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit102.htm">10.</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit102.htm">2</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit102.htm"> to the Registrant&#8217;s</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit102.htm"> </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit101.htm">Current Report on</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit102.htm"> Form 8-K filed with the SEC on March </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit102.htm">31</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/exhibit102.htm">, 2025).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">10.3</span></div></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit103.htm">Employment contract </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit103.htm">with Roland Rott, dated as of June </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit103.htm">3</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit103.htm">0, 2024.</a></span><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline" href="gehc1q202510qexhibit103.htm">&#8224;</a></span><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit103.htm"> </a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">10.4</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit104.htm">2</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit104.htm">025 GE HealthCare Restric</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit104.htm">ted St</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit104.htm">ock Unit </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit104.htm">Grant </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit104.htm">Agreement</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit104.htm">.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">10.5</span></div></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit105.htm">2</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit105.htm">025 GE HealthCare Sto</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit105.htm">ck Option </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit105.htm">Grant </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit105.htm">Agreement</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit105.htm">.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">10.6</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit106.htm">2025 GE HealthCare Performance Stock Unit </a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit106.htm">Grant Agreem</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit106.htm">ent.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">10.7</span></div></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit107.htm">2</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit107.htm">025 GE He</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit107.htm">althCare New Hire Restricted Stock Unit Grant Agreement.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">10.8</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit108.htm">2</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit108.htm">025 Global Addendum.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">31.1</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit311.htm">Certification of the Registrant&#8217;s Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">31.2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit312.htm">Certification of the Registrant&#8217;s Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a> </span></div></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">32.1</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%;text-decoration:underline" href="gehc1q202510qexhibit321.htm">Certifications of the Registrant&#8217;s Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">101</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">The following materials from GE HealthCare Technologies Inc.&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, formatted in inline XBRL (eXtensible Business Reporting Language); (1) Condensed Consolidated Statements of Income for the three months ended March 31, 2025 and 2024; (2) Condensed Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2025 and 2024; (3) Condensed Consolidated Statements of Financial Position as of March 31, 2025 and December 31, 2024; (4) Condensed Consolidated Statements of Changes in Equity for the three months ended March 31, 2025 and 2024; (5) Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2025 and 2024; and (6) Notes to the Condensed Consolidated Financial Statements.</span></div></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">104</span></td><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8224; </span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Certain portions of this exhibit have been redacted pursuant to Item 601(b)(2)(ii) or Item 601(b)(10)(iv) of Regulation S-K, as applicable. The Company agrees to furnish supplementally an unredacted copy of the exhibit to the Securities and Exchange Commission upon its request.</span></div></td></tr></table></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">39</span></div></div></div><div id="i96f768675eb442d1b7b31e27beba1a3b_295"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">T</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">able of Contents</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%;text-decoration:none" href="#i96f768675eb442d1b7b31e27beba1a3b_1099511629104">&#160;&#160;&#160;&#160;</a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.666%"><tr><td style="width:1.0%"/><td style="width:18.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:78.228%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">GE HealthCare Technologies Inc.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(Registrant)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">April 30, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">/s/ George A. Newcomb</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">George A. Newcomb, Controller &amp; Chief Accounting Officer (authorized signatory)</span></td></tr></table></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">40</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>2
<FILENAME>gehc1q202510qexhibit103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i97fb954a7ad6451c85a255992a4fb50e_41"></div><div style="min-height:86.4pt;width:100%"><div style="padding-left:20pt;text-align:right;text-indent:-0.4pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 10.3</font></div><div style="padding-left:20pt;text-indent:-0.4pt"><font><br></font></div><div style="padding-left:20pt;text-indent:-0.4pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT HAS BEEN OMITTED BY MEANS OF REDACTING A PORTION OF THE TEXT AND REPLACING IT WITH &#91;***&#93;, PURSUANT TO REGULATION S-K ITEM 601(B) OF THE SECURITIES ACT OF 1933, AS AMENDED. CERTAIN CONFIDENTIAL INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS&#58; (i) NOT MATERIAL AND (ii) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.</font></div><div style="padding-left:20pt;padding-right:69.85pt;text-indent:-0.4pt"><font><br></font></div></div><div style="margin-bottom:0.2pt;text-align:center;text-indent:-0.25pt"><font><br></font></div><div style="margin-bottom:0.2pt;text-align:center;text-indent:-0.25pt"><font><br></font></div><div style="margin-bottom:0.2pt;text-align:center;text-indent:-0.25pt"><font><br></font></div><div style="margin-bottom:9pt;text-align:center;text-indent:-0.25pt"><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">The following contract is hereby made and entered into by and between</font></div><div style="padding-left:0.25pt;padding-right:0.25pt;text-align:center;text-indent:-0.5pt"><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">GE Healthcare Austria GmbH &#38; CO OG</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="padding-left:0.25pt;padding-right:0.25pt;text-align:center;text-indent:-0.5pt"><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Tiefenbach 15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div style="margin-bottom:9.2pt;padding-left:0.25pt;padding-right:0.25pt;text-align:center;text-indent:-0.5pt"><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">4871 Zipf </font></div><div style="margin-bottom:9.2pt;padding-left:0.25pt;padding-right:0.25pt;text-align:center;text-indent:-0.5pt"><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">(hereinafter &#34;Employer&#34;)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div style="margin-bottom:9.2pt;padding-left:0.25pt;padding-right:0.25pt;text-align:center;text-indent:-0.5pt"><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">and</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div style="padding-left:0.25pt;padding-right:0.25pt;text-align:center;text-indent:-0.5pt"><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Roland Rott</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="padding-left:0.25pt;padding-right:0.25pt;text-align:center;text-indent:-0.5pt"><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#91;***&#93;</font></div><div style="margin-bottom:9.2pt;padding-left:0.25pt;padding-right:0.25pt;text-align:center;text-indent:-0.5pt"><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#91;***&#93;</font></div><div style="margin-bottom:9.2pt;padding-left:0.25pt;padding-right:0.25pt;text-align:center;text-indent:-0.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#91;***&#93;</font></div><div style="margin-bottom:6.7pt;padding-left:0.25pt;padding-right:0.25pt;text-align:center;text-indent:-0.5pt"><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">(hereinafter &#34;Employee&#34;)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div style="margin-bottom:9.9pt;text-align:center;text-indent:-0.25pt"><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">(the Employer and the Employee both together also referred to as &#34;the Parties&#34;)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%"> </font></div><div style="margin-bottom:12pt;text-indent:-0.25pt"><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">For reasons of simplification and readability, persons will be referred to in the masculine gender throughout. It goes without saying that the feminine gender is always included</font><font style="color:#3f3f3f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%"> </font></div><div style="text-align:center;text-indent:-0.5pt"><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Content of the Employment Relationship</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:9pt;margin-top:9pt"><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">As of July 1, 2024, the Employee shall be employed as CEO and President</font><font style="color:#3f3f3f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">, </font><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">GE HealthCare Imaging</font><font style="color:#3f3f3f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div style="margin-bottom:9.75pt"><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">It is specifically understood that in this position, the Employee is, under Austrian law, considered to be an Executive Employee (&#34;Leitender Angestellter&#34;)</font><font style="color:#3f3f3f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%"> </font></div><div style="text-align:center;text-indent:-0.5pt"><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Managerial Authority and Relocation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div><font><br></font></div><div style="margin-bottom:9pt;text-indent:-0.25pt"><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">Within the framework of business and operating requirements</font><font style="color:#3f3f3f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">, </font><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">the Employer shall be entitled to alter the Employee's duties for objective reasons and to assign other duties to the Employee that are in line with his knowledge and capabilities and that are at least of an equivalent nature</font><font style="color:#3f3f3f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%"> </font></div><div style="margin-bottom:10.15pt;text-indent:-0.25pt"><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">The Employer reserves the right</font><font style="color:#3f3f3f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">, </font><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">where required</font><font style="color:#3f3f3f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">, </font><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">to also assign the Employee to other business establishments of the company or to another place worldwide</font><font style="color:#575757;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">. </font><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">In such cases, appropriate consideration shall be given to the Employee's personal interests.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%"> </font></div><div style="margin-bottom:9.95pt;text-indent:-0.25pt"><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">With respect to frequently existing matrix organizations</font><font style="color:#3f3f3f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">, </font><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">the Employer expressly reserves the right to also transfer in whole or in part the right to issue instructions to other entities ultimately owned by GE HealthCare Technologies, Inc. (the &#8220;GE HealthCare Group&#8221;) inside and outside Austria.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%"> </font></div><div style="margin-bottom:6.55pt;text-indent:-0.25pt"><font style="color:#0f0f0f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">The Employee is covered by the GE HealthCare Directors &#38; Officers insurance for actions undertaken while as Officer of the Company</font><font style="color:#3f3f3f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:119%"> </font></div><div style="margin-bottom:6.55pt;text-indent:-0.25pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:86.4pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6.55pt;text-indent:-0.25pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div style="margin-bottom:9.7pt;text-align:center;text-indent:-0.5pt"><font style="color:#0e0e0e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Group Clause</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:9pt;text-indent:-0.4pt"><font style="color:#0e0e0e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the term of this employment contract, the Employee must accept any appointment&#47;election by competent bodies as managing director, member of the management board or the supervisory board in GE HealthCare Group companies or holding companies, provided that the Employee can be reasonably expected to do so with due respect to his workload and his professional training.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:9pt;text-indent:-0.4pt"><font style="color:#0e0e0e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Employee shall not be entitled to any claim against the Employer for remuneration for performing such functions in corporate bodies and shall assign claims for remuneration, if any, against any GE HealthCare Group company (except for attendance fees and disbursements, if any), to the Employer</font><font style="color:#4f4f4f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:9pt;text-indent:-0.4pt"><font style="color:#0e0e0e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Upon request by the Employer, which can be made at any time, the Employee shall, without delay, resign from any functions accepted in accordance with this clause.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:9.45pt;text-align:center"><font style="color:#0e0e0e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Commencement Date and End of the Employment Relationship</font></div><div style="margin-bottom:9.25pt;text-indent:-0.1pt"><font style="color:#0e0e0e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The employment contract will start on July 1, 2024. For all claims dependent on the length of service in the Company and regulated by law or contract the date of joining July 4, 2011 is valid</font><font style="color:#4f4f4f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. </font><font style="color:#0e0e0e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">This employment contract shall be concluded for an indefinite term&#59; provided, however, that </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">both parties agree that the Employee shall relocate to the United States not later than August 31</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> 2026 (&#8220;the Relocation Date&#8221;) at which point the Austrian contract shall terminate and employment shall continue in the United States with GE HealthCare Technologies, Inc., or one of its subsidiaries, under the terms set forth in the offer letter dated June 6, 2024, which is attached hereto as Appendix A</font><font style="color:#000000;font-family:'Segoe UI',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:9pt;text-indent:-0.4pt"><font style="color:#0e0e0e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each Party may terminate the employment contract prior to the Relocation Date with effect as of the last day of each calendar month subject to a twelve-months prior notice.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:9pt"><font style="color:#0e0e0e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">The right of both Parties to prematurely terminate this employment relationship upon important grounds in line with &#167; 27 Austrian Employment law, as may be amended from time to time, shall remain unaffected.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div style="margin-bottom:9.6pt;text-indent:-0.4pt"><font style="color:#0e0e0e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the event of termination with notice, the Employer shall be authorized to release the Employee from his employment obligations until the termination becomes effective (&#34;garden leave&#34;).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:8.8pt;text-indent:-0.4pt"><font style="color:#0e0e0e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The employment relationship shall end without termination at the end of the month in which the Employee receives notice from the competent social insurance organization stating that the Employee is unable to engage in gainful employment on a permanent basis, and the Employee does not withdraw the application prior to expiration of the period allowed for raising an objection or limit it to a fixed-term pension. If the relevant drawing of pension commences later, the employment relationship shall not end until the end of the day preceding the day on which the drawing of such pension commences. The Employer must be informed immediately when such notice of pension granted (Pensionsbescheid) is received.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0e0e0e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Voluntary Severance</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:6.2pt;text-align:justify;text-indent:0.1pt"><font style="color:#0e0e0e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If the Employer terminates the employment contract (termination reasons upon important grounds line with &#167; 27 Austrian Employment excluded) the Employee shall receive from the Employer the better of (1) what he would be eligible for under the GE HealthCare US Severance and Change in Control Plan for CEO and Leadership Team (the &#8220;Severance Plan,&#8221; as maybe amended from time to time ), the current version of which can be found </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">here</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">,</font><font style="color:#0e0e0e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> if he was an Executive as defined in the Severance Plan and the termination is deemed a &#8220;Qualifying Termination&#8221; as defined in the Severance Plan&#59; or (2) the sum of a gross severance payment of EUR 365,500 plus his base salary during the notice period. Any such payment is subject to signing a release of all claims (except rightful claims like outstanding remuneration) against the Employer and the GE HealthCare Group and complying with the post-contractual benefits included below. If Employee receives severance as outlined above the payment will cover all claims to severance under Austrian law or any other plan or law as well as all claims arising from the Employee's first 10 years of employment in Germany and those years of service will not be counted toward severance under Austrian plans or law. For the avoidance of doubt, this role has been offered to the Employee on the basis that he has agreed to relocate to the United States on US terms and conditions and, as such, if the Employee refuses to relocate to the United States prior to August 31, 2026, in accordance with the terms of Appendix A, such refusal by the Employee will </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:86.4pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6.2pt;text-align:justify"><font style="color:#0e0e0e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">be deemed a voluntary resignation and he shall not be entitled to any severance under (1), (2) or any Austrian plan or law.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:3.2pt;margin-top:3pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">If Employee receives severance under (1) it will be paid in accordance with the terms of the release and if Employee receives severance under (2) the severance payment under this provision is due at the time of termination of this agreement (provided that no such payment will be made if this agreement terminates due to the Employee&#8217;s relocation to the United States). The severance payment under (2) </font><font style="color:#232323;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">is </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">owed as gross severance payment, unless the Employer is required by law to withhold any amounts from the payment. All employee related tax and social security deductions shall be borne by the Employee. </font></div><div style="margin-bottom:9.45pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Remuneration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:9pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">It is noted, that the Employer is excluded from the personal scope of the Collective Bargaining Agreement for employees of the electrical and electronics industry and therefore no collective bargaining agreement is applicable to the present employment relationship. </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">For all activities performed under this employment contract, the Employee shall receive from the Employer a gross annual salary in the amount of EUR 630,000 payable in fourteen equal instalments of EUR 45,000.00 gross (&#34;monthly salary&#34;). The monthly salary is due and payable in arrears on the last day of each month&#59; the vacation allowance (13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:124%;position:relative;top:-3.15pt;vertical-align:baseline">th </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">salary) will be paid on 30 June and the Christmas allowance (14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:124%;position:relative;top:-3.15pt;vertical-align:baseline">th </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">salary) on 30 November of each calendar year to a bank account to be indicated by the Employee. If the service relationship begins or ends during a calendar year, then vacation allowance and Christmas allowance will be paid pro rata temporis. </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">The gross monthly salary consists of (i) a base salary in the amount of EUR 7,200 gross and (ii) a resulting overpayment in the amount of EUR 37,800</font><font style="color:#4d4d4d;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">00 gross. </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:-0.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fixed salary and any variable compensation shall fully compensate all the Employee's working hours, including extra hours and overtime work, work on weekends and public holidays, active and passive travel </font><font style="color:#232323;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">time </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">as well as readiness for work duty and stand-by, including surcharges, if any </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(&#34;all-in clause&#34;). </font></div><div style="margin-bottom:10.2pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">GE HealthCare Annual Long-Term Incentive (&#8220;LTI&#8221;) Grant &#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:0.2pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">As an Officer, the Employee is in principle entitled to participate in GE HealthCare's annual LTI grant (&#8220;GE HealthCare Class Grant&#8221;) at a target of $2,500,000 (USD). Actual grant values may be higher or lower than target based on individual performance, leadership and other factors, in GE HealthCare&#8217;s discretion. Annual equity awards are typically granted in March each year, with the award type and terms determined by the Talent, Culture and Compensation Committee of the Board of Directors (the &#8220;Committee&#8221;). All vesting is subject to the Employee&#8217;s continued employment through the vesting dates. This is a voluntary benefit, to which no legal entitlement exists, either in principle or in terms of amount, even if payment is made on a repeated basis. In particular, such legal entitlement shall not exist if the Employer or GE HealthCare decides to terminate the GE HealthCare Class Grant. Both participation in and also the amount of any benefit under this program shall be at the sole discretion of the Employer and subject to the applicable </font><font style="color:#232323;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">rules </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">of the program (as may be amended from time to time)</font><font style="color:#4d4d4d;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"> </font></div><div style="margin-bottom:0.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Variable compensation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="text-align:justify;text-indent:-0.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">The employee participates in the One GE HealthCare Annual Bonus Plan (the &#8220;Bonus Plan&#8221;) at a target of 100% of his base salary, although GE HealthCare reserves the right to amend that target percentage with advance notice. Any payment under the Bonus Plan is subject to the terms of the Bonus Plan, as may be amended from time to time. Payments are made in the Company&#8217;s discretion and are typically based on GE HealthCare performance, business segment performance and individual performance. For the performance year 2024, any bonus Employee receives will be based on 40% GE HealthCare and 60% Imaging actual full year results as well as Employee&#8217;s individual performance. </font></div><div style="margin-bottom:5.85pt"><font><br></font></div><div style="margin-bottom:9pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Employer reserves the right to withdraw the variable compensation, if there is an objective reason. Objective reasons are&#58; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:86.4pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">economic difficulties within the company (in specific decline in turnover of more than 25% or economic losses in the last fiscal year) and&#47;or serious breach of duty by employee. </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">The Employer commits to guarantee that in case of withdrawal or amendment of the target bonus percentage, the total target compensation will be reduced not more than 25%. </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">The employer reserves himself the right to annually determine bonus plan modalities such as targets weighting, the variable compensation composition and its calculation methods, using equitable discretion.  </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div style="margin-bottom:10.3pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Employee severance fund</font></div><div style="margin-bottom:0.2pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Employer shall continue to pay contributions into the following employee severance fund for the duration of this agreement&#58; </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div style="text-align:center;text-indent:-0.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#91;***&#93; </font></div><div style="text-align:center;text-indent:-0.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#91;***&#93; </font></div><div style="text-align:center;text-indent:-0.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#91;***&#93; </font></div><div style="text-align:center;text-indent:-0.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#91;***&#93; </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div style="margin-bottom:9.35pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Retirement Benefits</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:12pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Employee shall participate in the Employer's pension scheme in the attached plan, which the Employer may amend from time to time. The relevant scheme shall be provided to the Employee in a separate document. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Assignment and Pledging of Salary Entitlements</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:0.2pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Employee may not assign or pledge his salary entitlements. </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Place of Employment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:9.3pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Unless otherwise agreed between the Parties, the place of employment shall be Vienna</font><font style="color:#3d3d3d;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Austria until no later than August 31, 2026, by which time the Employee must relocate as noted in his offer letter, in accordance with the terms of that offer letter, attached as Appendix A</font><font style="color:#3d3d3d;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"> </font></div><div style="margin-bottom:9.9pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Without prejudice to the foregoing provision, the Employee agrees to undertake business trips, also on a regular basis. </font></div><div style="margin-bottom:9.25pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Hours of Work&#47;Overtime</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:10.1pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Employee shall perform his activities on his own responsibility and shall not be bound by fixed working hours. </font></div><div style="margin-bottom:9.9pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Employee shall be at the disposal of the Employer to the extent required for the performance of his tasks and shall perform excess hours and overtime work as required. </font></div><div style="margin-bottom:1.6pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Employee is explicitly excluded from the scope of the Austrian Act on Working Hours (&#34;AZG&#34;) and the Austrian Act on Rest Periods (&#34;ARG&#34;)</font><font style="color:#3d3d3d;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:124%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:124%"> </font></div><div style="margin-bottom:9.45pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Integrity</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:0.15pt;text-align:justify;text-indent:-0.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The guidelines concerning the Employer's business ethics, corresponding to the integrity guide (&#34;The Spirit and the Letter&#34;), have been handed to the Employee</font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Employee shall be required to comply with these guidelines within the framework of his work for the Employer. </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:86.4pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Absence and Incapacity for Work</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:9.8pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Employee shall be obligated to inform the Employer immediately - where possible prior to the start of work </font><font style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">- </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">of each instance of incapacity to work of any kind and to give notification of its expected duration. Where possible</font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">any urgent work must be pointed out. </font></div><div style="margin-bottom:9pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">If incapacity to work due to illness lasts longer than three calendar days, the Employee must provide the Employer with documentary evidence of this by no later than the following working day, by means of a physician's certificate stating the existence of his incapacity to work and its expected duration</font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Employer reserves the right to demand evidence at an earlier point in time. If the incapacity to work due to illness lasts longer than initially stated on the sickness certificate, this must be again notified without delay</font><font style="color:#575757;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">A follow-up certificate of incapacity to work must be submitted within two calendar days. </font></div><div style="margin-bottom:12pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">In the event of illness-based incapacity to work, the Employer</font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">'</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">s obligation to continue payment shall be based on the statutory or, where applicable</font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">internal provisions. </font></div><div style="margin-bottom:9.2pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Vacation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:-0.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">By the applicable provisions of the Vacation Act (Urlaubsgesetz) the Employee shall be entitled </font><font style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30 working days of paid leave of absence per year, based on a five-day week. In line with the applicable collective agreement, the vacation year shall commence on the 1</font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">s</font><font style="color:#262626;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">t </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">day of January of each calendar year. Vacation days in the year of joining the company shall be granted on a pro-rata temporis basis. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Business Trips</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:9pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Employee agrees to carry out business trips that are requested by the Employer in the interests of the business. </font></div><div style="margin-bottom:12pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Expenses and travel costs incurred by the Employee shall be reimbursed in accordance with the Employer's respective valid policies relating to travel expenses. The Employer shall be entitled to change the travel expenses policy on objective grounds, especially in the event of any change in economic or legal cond</font><font style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">i</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">tions</font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"> </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Company Car </font></div><div style="margin-bottom:0.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:-0.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Employee is currently entitled to use a company car for his work and is entitled to use the company car for private purposes in line with the Employer's valid company car policy. Any tax consequences relating to use of the company car shall be borne by the Employee. </font></div><div style="margin-bottom:12pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The company car must be returned to the Employer immediately when the employment relationship ends. The Employee shall not have any right of retention and&#47;or entitlement to payment in lieu in respect of use of the company car. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Secrecy </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:9pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Employee agrees to keep confidential any business and trade secrets as well as any operational matters of a confidential nature which are identified as such by senior management or which are obviously identifiable as such and not to use them for his own purposes and not to make such confidential matters and&#47;or information accessible or available to any third parties without the explicit consent of senior management, unless he is legally obligated to do so</font><font style="color:#424242;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"> </font></div><div style="margin-bottom:12pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The obligation to maintain confidentiality shall also apply to companies that are affiliated to the Employer from an economic or organizational perspective, and shall also continue to be applicable after the employment contract ends where communications to third parties could be detrimental to the Employer. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Inventions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:86.4pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:-0.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The parties hereto agree that any employee inventions as contemplated in section 7(3) of the Patent Act &#91;PatG&#93; shall belong to Employer. Employee shall be entitled to reasonable remuneration within the meaning of the legal provisions to determined in each and every individual case</font><font style="color:#383838;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:9.6pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Disclosure Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:12pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Employee agrees that he will immediately notify the Human Resources Department of any changes in personal circumstances and&#47;or of a change to the information in the master data sheet he completed when he commenced employment in Austria. Where the Employee works in the field, this shall also include any driving disqualifications</font><font style="color:#4f4f4f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"> </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Data Security</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:9pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Employer collects</font><font style="color:#383838;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">uses and processes personal data relating to its employees (&#34;Employment Data</font><font style="color:#383838;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">) for a range of human resources, business, administrative and&#47;or safety&#47;security purposes according to the provisions of the Federal Data Protection Act &#91;Datenschutzgesetz&#93; in its current valid version</font><font style="color:#383838;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"> </font></div><div style="margin-bottom:12pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Employer reserves the right to monitor, within the framework permitted by law, the use of its resources, including use of e-mail, the Internet, the Employer's intranet, the PC, and the telephone, as well as mobile phones or smartphones that are provided. Further information on the use of resources provided by GE is available in the document </font><font style="color:#232323;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">&#34;Acceptable </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Use of GE Information Resources&#34;. A copy shall be made available. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Secondary Employment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:-0.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Employee shall allocate his work capacity as agreed in this employment contract to the Employer. The</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Employer must be notified in advance of any secondary employment, regardless of whether it is paid or unpaid and such activities shall also require its consent. </font></div><div style="margin-bottom:9pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Participation in another commercial enterprise as well as involvement on the boards of any other company shall also require the Employer's prior consent. The acquisition or shares in publicly listed companies is not covered by this ban, provided that the Employee shall not, directly or indirectly, hold more than one per cent of the share capital of the respective company.   </font></div><div style="text-indent:-0.4pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If Employer gives prior consent, it can be withdrawn any time, when Employer's interests are affected which contradicts a continuation of secondary employment.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div style="margin-bottom:9.45pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Non-competition Clause</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:6.3pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Employee shall perform his activities on a full-time basis and shall make available to the Employer his entire working capacity</font><font style="color:#383838;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Employee is subject to the non-competition covenant of sec 24 of the Austrian Act on Limited Liability Companies and sec 7 AngG. </font></div><div style="margin-bottom:9pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Without the prior written consent of the Employer, the Employee shall in particular not </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-9pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%;padding-left:5.85pt">perform any other business activity, be it self-employed or as employee, for third parties, neither as a vocational activity nor in an advisory capacity&#59; </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%;padding-left:5.85pt">directly or indirectly participate in any company, except for participation for reasons of investment of personal assets, so long as no controlling influence is exercised by such participation&#59; </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%;padding-left:5.85pt">accept or perform functions in the corporate bodies of other legal entities as provided for in this employment contract&#59;</font><font style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"> </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-9pt"><font style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%;padding-left:5.85pt">accept or perform a role as a lobbyist nor be involved with other associations representing special interests.</font><font style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"> </font></div><div style="margin-bottom:12pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Activities which fall under the Group Clause are not subject to this covenant. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Post contractual Non-competition Clause</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:86.4pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9.9pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">During a period of 12 months after termination of this agreement, the Employee shall refrain from becoming active in a company in the same line of the Employer's business that the Employee has been working in during the two years prior to the termination date, be it self-employed, as a member of a corporate body, as an adviser, as an employee, or in any other form. The Employee shall, however, be entitled to invest personal assets in such a way that no controlling influence is exercised. This obligation is only applicable within the scope of sec 37 of the Austrian Employees' Act. </font></div><div style="margin-bottom:9.45pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Post contractual Non-solicitation Clause</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:9pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">During a period of 12 months after termination of this agreement, the Employee shall refrain from, without prior written approval from the Chief People Officer of GE Healthcare&#58; (a) whether self-employed, as a member of a corporate body, as an adviser, as an employee, or in any other form, directly or indirectly, solicit or encourage any person who is a Lead Professional Band or higher employee of any entity of the GE HealthCare Group (hereinafter </font><font style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">&#34;Restricted </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Person&#34;) to terminate his or her employment relationship with, or accept any other employment outside of, the GE HealthCare Group&#59; (b) directly hire, or recommend or cause to be hired by an entity for which the Employee works, or with which the Employee is otherwise associated or owns more than a 1% ownership </font><font style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">interest, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">any person who is, or was within one year before or after the termination date of this agreement, a Restricted Person&#59; or (c) provide any non-public information regarding any Restricted Person, including, but not limited to, compensation data, performance evaluations, skill sets or qualifications, etc., to any external person in connection with employment outside the Company and its affiliates, including, but not limited to, recruiters and prospective employers. The above restrictions do not apply once a Restricted Person has been formally notified of his or her impending layoff from the Employer or any of its affiliates. </font></div><div style="margin-bottom:12pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Should the Employee violate any of the obligations in the Post contractual Non-competition or Post contractual Non-solicitation clauses above, he shall be liable to a contractual penalty which shall amount to his six-fold last monthly net remuneration. The contractual penalty shall become due upon violation of this contractual provision. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:118%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"> </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Handling of Company Documents and Surrender Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:9.9pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Analyzing business information and data as well as analyzing and using records, statistics, drawings, copies and other business documents for private use shall be prohibited. </font></div><div style="margin-bottom:6.3pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">All GE HealthCare resources and items, business documents of any kind, information and data that have been handed over or made available to the Employee within the context of the employment relationship shall remain the sole property of the Employer and must be stored with care and may only be used for business purposes. </font></div><div style="margin-bottom:9pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">GE HealthCare resources and items, written documents, data storage media, business documents of any kind, copies, notes and other documents concerning operational or business processes that are in the Employee's possession and under the ownership of the Employer must be returned on an unsolicited basis at the time of departure or at the Employer's request at any time during employment, especially following declaration of termination. This shall also include documents of the Employer's customers that have been handed over to the Employee during the employment relationship or have otherwise been made accessible or available to the Employee, as well as any notes that the Employee has created himself. </font></div><div style="margin-bottom:9pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The deletion of data shall only be permitted with the prior consent of the Employer. The Employee shall not have any right of retention. </font></div><div style="margin-bottom:9.75pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Employee Innovation and Proprietary Information Agreement (&#8220;EIPIA&#8221;) the Employee has signed as part of his employment with the Company shall not be superseded by this agreement and to the extent the relevant clauses of this agreement are inconsistent with the EIPIA, the EIPIA shall control. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Group Insurance&#47;Social Benefits</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:0.2pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">For the duration of the employment relationship, the Employee shall be insured under a group accident insurance policy. </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:86.4pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9.35pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Preclusion </font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Periods</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:10pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Claims arising from the employment relationship shall be forfeited if they are not raised against the other party in written form within three months. The Employee must raise his claims with Human Resources. The limitation period shall begin when the claim has become due and the claimant gains knowledge of the facts that establish the claim, or would have gained knowledge thereof in the absence of gross negligence</font><font style="color:#464646;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">This deadline shall not apply in the case of liability for willful intent. </font></div><div style="margin-bottom:9.75pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Also excluded is an amount equal to the statutory minimum wage for any worked hour by the employee and corresponding wage compensation entitlements, for example in case of illness and holidays. </font></div><div style="margin-bottom:0.2pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">If the opposing party rejects the claim in form of a text or does not make a declaration within one month of the notification of the claim, the claim shall be forfeited, unless it is asserted judicially within three months of rejection or of expiration of the deadline. The filing of an action for wrongful dismissal shall not protect </font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">claim. </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div style="margin-bottom:9.25pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Voluntary Nature of Benefits</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:1.6pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Any benefits - whether pecuniary or non-pecuniary - granted over and above the benefits stated in this employment contract shall be provided on a voluntary basis unless otherwise expressly stated in writing. The Employee shall have no legal entitlement to such benefits in the future, even if they are granted on multiple&#47;repeated occasions and&#47;or over an extended period of time and even if a reservation of voluntary status is not agreed each time the benefit is granted</font><font style="color:#464646;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Instead, the Employer shall decide each year whether any additional benefits will be granted and, if so, the amount in which they will be granted and the terms and conditions under which they will be granted. </font></div><div style="margin-bottom:3.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:124%"> </font></div><div style="margin-bottom:9.45pt;margin-top:6pt;text-align:center;text-indent:-0.5pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Final Provisions&#47;Conditions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"> </font></div><div style="margin-bottom:9pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The law of the Republic of Austria shall be applicable to this employment contract. </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">This employment contract replaces all agreements concluded prior to this employment contract between the Parties</font><font style="color:#464646;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div style="margin-bottom:0.2pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Should one or more provisions of this employment contract be or become void, invalid or unenforceable in whole or in part, this shall not affect the validity and enforceability of the remaining provisions of this employment contract. In these cases, the parties shall agree to replace the void, invalid, or unenforceable provision with a valid provision that comes as close as possible to such provision from an economic standpoint and does so in a legally valid manner according to the intent and purpose of this employment contract, provided a supplementary contractual interpretation (erganzende Vertragsauslegung) does not take precedence or is not possible. </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font></div><div style="margin-bottom:0.2pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Employee has received a copy of this employment contract. </font></div><div style="margin-bottom:5.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:124%"> &#160;&#160;&#160;&#160; </font></div><div style="margin-bottom:0.65pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">___</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%;text-decoration:underline">Vienna_</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">______________&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;___</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%;text-decoration:underline">30.06.2024</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">____________</font></div><div style="margin-bottom:6.85pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Place&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Date </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:124%"> </font></div><div style="margin-bottom:0.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%;text-decoration:underline">_&#47;s&#47; GE Healthcare Austria GmbH &#38; Co OG&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%;text-decoration:underline">__&#47;s&#47; Roland Rott</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">_______________________</font></div><div style="margin-bottom:0.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">GE Healthcare Austria GmbH &#38; Co OG &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Roland Rott </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i97fb954a7ad6451c85a255992a4fb50e_44"></div><hr style="page-break-after:always"><div style="min-height:143.28pt;width:100%"><div style="padding-left:20pt;padding-right:69.85pt;text-align:right;text-indent:-0.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.825%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.975%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20pt;padding-right:69.85pt;text-align:right;text-indent:-0.4pt"><font style="color:#0c0c0c;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Appendix A</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:32.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:9.00pt">&#91;Logo&#93;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.2pt;padding-left:177.52pt;padding-right:72.62pt;text-indent:-0.4pt"><font style="color:#0c0c0c;font-family:'Source Sans Pro',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Peter Arduini</font></div><div style="margin-bottom:0.2pt;padding-left:177.52pt;padding-right:72.62pt;text-indent:-0.4pt"><font style="color:#0c0c0c;font-family:'Source Sans Pro',sans-serif;font-size:9pt;font-weight:400;line-height:120%">President and CEO</font></div><div style="margin-bottom:0.2pt;padding-left:177.52pt;padding-right:55.47pt;text-indent:-0.4pt"><font style="color:#0c0c0c;font-family:'Source Sans Pro',sans-serif;font-size:9pt;font-weight:400;line-height:120%">GE HealthCare</font></div></td></tr></table></div><div style="padding-left:20pt;padding-right:69.85pt;text-align:right;text-indent:-0.4pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:20pt;padding-right:69.85pt;text-align:justify;text-indent:-0.4pt"><font style="color:#0c0c0c;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:14.00pt">June 6, 2024</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:20pt;padding-right:69.85pt;text-align:justify;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Dear Roland, </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:20pt;padding-right:69.85pt;text-align:justify;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">We are pleased to offer you the position of President and CEO, Imaging for GE HealthCare Technologies, Inc. (together, with its affiliates, &#8220;GE HealthCare&#8221; or the &#8220;Company&#8221;) on July 1, 2024 (your &#8220;start date&#8221;). This position will report to me. The details of our offer are noted below&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:20pt;padding-right:69.85pt;text-align:justify;text-indent:-0.4pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:20pt;padding-right:69.85pt;text-align:justify;text-indent:-0.4pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.77pt;padding-right:15.57pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Location</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.77pt;padding-right:1.77pt;text-align:justify;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Through no later than August 31, 2026, this role will be located in Austria. Thereafter it will be located in Waukesha, Wisconsin, and you must relocate to Northern Illinois or Wisconsin (&#8220;NI&#47;WI&#8221;) by no later than August 31, 2026. You will receive benefits under the Company&#8217;s &#8220;Local Plus&#8221; relocation package, including temporary housing costs in Wisconsin until you relocate, immigration support for you and your family, and relocation benefits under the Company&#8217;s standard executive-level relocation policy, but excluding any education benefits. </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.77pt;padding-right:15.57pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Salary&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.77pt;padding-right:1.77pt;text-align:justify;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">&#8364;630,000 (Euros) paid monthly. </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.77pt;padding-right:15.57pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">One GE HealthCare Annual Bonus Plan (the &#8220;Bonus Plan&#8221;)&#58;</font><font style="color:#ff0000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%"> </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.77pt;padding-right:2.07pt;text-align:justify;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Your annual bonus target under the Bonus Plan is 100% of your base salary as of December 31</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:6.5pt;font-weight:400;line-height:118%;position:relative;top:-3.5pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%"> of each plan year. Payments are made in the Company&#8217;s discretion and are typically based on GE HealthCare performance, business segment performance and individual performance. For the performance year 2024, any bonus you receive will be based on 40% GE Healthcare and 60% Imaging actual full year results as well as your individual performance. </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.77pt;padding-right:15.57pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Long-Term Incentive Plan (&#8220;LTIP&#8221;)&#58;</font><font style="color:#ff0000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%"> </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.77pt;padding-right:2.07pt;text-align:justify;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Starting in 2025, your target annual equity award grant value will be $2,500,000 (USD). Actual grant values may be higher or lower than target based on individual performance, leadership and other factors, in the Company&#8217;s discretion. Annual equity awards are typically granted in March each year, with the award type and terms determined by the Talent, Culture and Compensation Committee of the Board of Directors (the &#8220;Committee&#8221;). All vesting is subject to your continued employment through the vesting dates.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:143.28pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.77pt;padding-right:15.57pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Benefits&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.77pt;padding-right:72.62pt;text-align:justify;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Until you relocate to NI&#47;WI, you will remain employed by GE Healthcare Austria GmbH &#38; CO OG (&#8220;GE Healthcare Austria) and continue on that company&#8217;s payroll and benefit programs. You will also be eligible to participate in the following Company benefit plans&#58;</font></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:38.77pt;padding-right:2.77pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:14.00pt">&#8226;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:14.00pt;padding-left:14.5pt">The Executive Physical Program which provides reimbursement of up to $7,500 (US dollars) annually for physical health examinations. </font></div><div style="margin-bottom:6pt;padding-left:38.77pt;padding-right:2.77pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:14.00pt">&#8226;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:14.00pt;padding-left:14.5pt">The Executive Financial Planning Program which provides reimbursement of up to $15,000 (US dollars) annually for financial planning services. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.77pt;padding-right:72.62pt;text-align:justify;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">After you relocate to NI&#47;WI, you will be employed by GE Precision HealthCare, LLC and will be eligible for only U.S. benefits, including the following&#58; </font></div><div style="margin-bottom:9pt;padding-left:38.77pt;padding-right:2.77pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:14.00pt">&#8226;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:14.00pt;padding-left:14.5pt">Participation in the Company&#8217;s Retirement Savings Program (the &#8220;RSP&#8221;), under which the Company currently matches 50% of the first 8% of eligible pay you save and contribute 3% of eligible pay each year (the &#8220;CRC&#8221;). </font></div><div style="margin-bottom:9pt;padding-left:38.77pt;padding-right:2.77pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:14.00pt">&#8226;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:14.00pt;padding-left:14.5pt">Participation in the Restoration Plan. Under this plan, 7% of your pay above the IRS pay limit that applies to 401(k) plans is currently credited each year and notionally invested as you choose. These amounts generally vest after 3 years of service.  </font></div><div style="margin-bottom:6pt;padding-left:38.77pt;padding-right:2.77pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:124%">&#8226;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:124%;padding-left:14.5pt">Participation in the Severance and Change in Control Plan for CEO and Leadership Team (the &#8220;Severance Plan&#8221;) under which protections and benefits are provided in the event of certain terminations, including, in some cases following a change in control of the Company.  While you are not an Executive eligible for benefits under the Severance Plan before you relocate to the United States, until you do so the Company will pay you, in the event of a Qualifying Termination, the better of the benefits you would be eligible for under the Severance Plan if you were an Executive as defined by the Severance Plan, subject to the other terms of the Severance Plan, and the severance, notice and other benefits you would be eligible for under local law. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.77pt;text-align:justify;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">All aspects of these and other benefits, including the Bonus Plan, will be governed by the terms of the applicable plan or program, and the Company reserves the right to amend such plans and programs at any time. </font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:143.28pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.77pt;padding-right:45.97pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Promotional Equity Grant&#58; </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.2pt;padding-left:22.77pt;padding-right:72.62pt;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:133%">We will provide you with a Promotional Equity Grant valued at $950,000 (US dollars), which will be granted on August 15, 2024, and will consist of 50% performance stock units (&#8220;PSUs&#8221;), 25% restricted stock units (&#8220;RSUs&#8221;) and 25% stock options. PSUs are earned based on GE HealthCare performance from January 1, 2024 to December 31, 2026, and vest on the date in the first quarter of 2027 on which the Committee certifies PSU performance results. RSUs and stock options vest 33% on September 1, 2025, 33% on September 1, 2026, and 34% on September 1, 2027. All vesting is subject to your continued employment through the vesting dates.</font></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:20pt;padding-right:4.5pt;text-align:justify;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:700;line-height:118%">Confidentiality.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%"> You acknowledge that you will have access to and become acquainted with proprietary and confidential information, which may include trade secrets, about the Company, its affiliates and its customers that constitutes a valuable asset of the Company and that is not available to the public. You agree that you will not use or disclose that confidential information, either during or after the termination of your employment, for any reason other than in the performance of your job and for the benefit of the Company and its affiliates, or as otherwise protected under applicable whistleblower protections. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:20pt;padding-right:4.5pt;text-align:justify;text-indent:-0.4pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:20pt;padding-right:4.5pt;text-align:justify;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Following your acceptance of this offer letter, we will provide you with an amended employment agreement with GE Healthcare Austria for your signature. You agree that once you relocate, you will no longer be eligible for any benefits under that agreement or Austrian law, including but not limited to severance as provided in that agreement. You agree that you will sign all documentation then required of U.S. executives when you relocate to NI&#47;WI. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:20pt;padding-right:4.5pt;text-align:justify;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Roland, I am incredibly excited about you taking on this new role with the Company and look forward to your acceptance of this offer and response by email within 72 hours. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:20pt;padding-right:4.5pt;text-align:justify;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">If you have any questions, please contact me at &#91;***&#93;.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:20pt;padding-right:69.85pt;text-align:justify;text-indent:-0.4pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:20pt;padding-right:69.85pt;text-align:justify;text-indent:-0.4pt"><font style="color:#0c0c0c;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:14.00pt">Sincerely,</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:20pt;padding-right:69.85pt;text-align:justify;text-indent:-0.4pt"><font style="color:#0c0c0c;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:14.00pt">&#47;s&#47; Peter Arduini</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:20pt;padding-right:69.85pt;text-align:justify;text-indent:-0.4pt"><font style="color:#0c0c0c;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:14.00pt">Peter Arduini</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:20pt;padding-right:69.85pt;text-align:justify;text-indent:-0.4pt"><font style="color:#0c0c0c;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:14.00pt">Cc&#58; Mark Russert, Total Rewards Leader</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:20pt;padding-right:69.85pt;text-align:justify;text-indent:-0.4pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:20pt;padding-right:43.2pt;text-align:justify;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Please sign below to agree to and accept this offer letter&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:20pt;padding-right:43.2pt;text-align:justify;text-indent:-0.4pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:20pt;padding-right:43.2pt;text-align:justify;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%;text-decoration:underline">         &#47;s&#47; Roland Rott&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%;text-decoration:underline">    10 June 2024&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:20pt;padding-right:43.2pt;text-align:justify;text-indent:-0.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:118%">Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Date</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>3
<FILENAME>gehc1q202510qexhibit104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i265b0f94755b46cea17e34a08cd64016_41"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.4</font></div></div><div><img alt="image_03a.jpg" src="image_03a.jpg" style="height:116px;margin-bottom:5pt;vertical-align:text-bottom;width:162px"><font style="color:#005eb8;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#91;Date&#93; Equity Grant Agreement</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GE HealthCare Technologies Inc. 2023 Long-Term Incentive Plan (&#8220;Plan&#8221;)</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">GE HealthCare Restricted Stock Unit Grant Agreement (&#8220;Grant Agreement&#8221;) </font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">For &#60;&#60;Employee Name&#62;&#62; (&#8220;Grantee&#8221;)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:16.05pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.429%"><tr><td style="width:1.0%"></td><td style="width:28.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.968%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.114%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.116%"></td><td style="width:0.1%"></td></tr><tr style="height:27pt"><td colspan="3" rowspan="2" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Grant Date</font></div></td><td colspan="3" rowspan="2" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">RSUs Granted</font></div></td><td colspan="6" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Vesting Schedule</font></div></td></tr><tr style="height:27pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Number of RSUs</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-right:-2.63pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Vesting Date</font></div></td></tr><tr style="height:38pt"><td colspan="3" rowspan="2" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#60;&#60;Date&#62;&#62;</font></div></td><td colspan="3" rowspan="2" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#60;&#60;Number&#62;&#62;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">33%</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:-2.63pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#60;&#60;Month&#62;&#62; 1, &#60;&#60;Year&#62;&#62;</font></div></td></tr><tr style="height:38pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">33%</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:-2.63pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#60;&#60;Month&#62;&#62; 1, &#60;&#60;Year&#62;&#62;</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">34%</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:-2.63pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#60;&#60;Month&#62;&#62; 1, &#60;&#60;Year&#62;&#62;</font></div></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">1. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Grant.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#160;&#160;The Talent, Culture, and Compensation Committee (&#8220;Committee&#8221;) of the Board of Directors of GE HealthCare Technologies Inc. (&#8220;Company&#8221;) has granted the above number of Restricted Stock Units (&#8220;RSUs&#8221;) to the Grantee, subject to the terms of this Grant Agreement. Without limiting any condition of this RSU award, the award is subject to cancellation and forfeiture if the Grantee does not confirm acceptance within 45 days of the Grant Date. Once vested, each RSU entitles the Grantee to receive from the Company (i) one share of Common Stock and (ii) a cash payment in respect of Dividend Equivalents (described below), each in accordance with the terms of this Grant Agreement, the Plan, and any rules, procedures and sub-plans (including country addenda) adopted by the Committee.<br></font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">2. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Vesting.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#160; In order to vest in an RSU, the Grantee must not incur a Termination of Employment from the Grant Date through the applicable Vesting Date listed above. All </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">unvested RSUs shall be immediately cancelled without payment upon the Grantee&#8217;s Termination of Employment for any reason before the applicable Vesting Date, and the Grantee shall thereupon cease to have any right to receive any shares of Common Stock or cash payments in respect of Dividend Equivalents accrued in respect of those cancelled RSUs, except as specifically provided below.<br></font></div><div style="padding-left:49.7pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">i. </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">   </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Death or Disability.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">&#160; </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">If the Grantee&#8217;s Termination of Employment is a result of the Grantee&#8217;s death or Disability prior to the final Vesting Date listed above, then any unvested RSUs shall vest as of such Termination of Employment.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%"> </font></div><div style="padding-left:49.7pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:49.7pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">ii.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:7.78pt;text-decoration:underline">Transfer of Business to Successor Employer.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">&#160; </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">If the Grantee&#8217;s Termination of Employment occurs prior to the final Vesting Date listed above as a result of transferring directly to employment with a successor employer in connection with the transfer by the Company or an Affiliate of a business operation, then any unvested RSUs shall vest as of such Termination of Employment.</font></div><div style="padding-left:49.7pt"><font><br></font></div><div style="padding-left:49.7pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">iii.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:4.47pt;text-decoration:underline">Retirement Eligibility.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">If the Grantee meets the requirements for Retirement while in continuous employment and has a Termination of Employment after meeting such requirements prior to the final Vesting Date listed above and after the one-year anniversary of the Grant Date, then the Grantee shall continue to vest in any unvested RSUs in accordance with the Vesting Schedule above as if the Grantee had remained in continuous employment. </font></div><div><font><br></font></div><div style="padding-left:49.7pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">For purposes of this Grant Agreement Retirement means the attainment of&#58;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">a.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%;padding-left:8.88pt">age 65&#59; </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">b.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%;padding-left:8.36pt">age 60 and completion of at least five years of continuous employment&#59; or</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">c.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%;padding-left:9.55pt">age 55 and completion of at least ten years of continuous employment. </font></div><div style="padding-left:50.4pt"><font><br></font></div><div style="padding-left:50.4pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">If retirement at an earlier age than noted in (a), (b) or (c) above is mandatory under applicable law or policy in the country where the Grantee is employed, for purposes of this Grant Agreement Retirement means the mandatory retirement date and the applicable service requirement closest to such date under (a), (b) or (c) above.</font></div><div style="padding-left:50.4pt"><font><br></font></div><div style="padding-left:50.4pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">For purposes of this Grant Agreement continuous employment means continuous employment with the Company, or an Affiliate (or with General Electric Company or any of its affiliates through the date of the Company&#8217;s spinoff from General Electric Company) ending on Termination of Employment. </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'GE Inspira Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Notwithstanding the foregoing, if the Company receives an opinion of counsel that there has been a legal judgment and&#47;or legal development in Grantee&#8217;s jurisdiction that would likely result in the favorable treatment applicable to the Award pursuant to subparagraphs (i)-(iii) being deemed unlawful and&#47;or discriminatory, then such favorable treatment shall not be applied.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">3. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Dividend Equivalents.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#160;&#160;The Company will establish an amount for each RSU equal to the per share quarterly dividend payments made to the Company&#8217;s stockholders during the period beginning on the Grant Date and ending on the date that such RSU vests or is cancelled (&#8220;Dividend Equivalents&#8221;).  The Company shall accumulate Dividend Equivalents and, upon vesting of the related RSU, will pay the Grantee a single lump sum cash amount equal to the Dividend Equivalents on the same date that a share of Common Stock is delivered with respect to such RSU, as described in Section 4 of this Grant Agreement.  Any accumulated and unpaid Dividend Equivalents attributable to a RSU that is cancelled will be immediately forfeited upon cancellation and will not be paid.</font></div><div style="padding-left:57.75pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">4. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Delivery and Tax Withholding.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#160; Subject to Section XX(d) of the Plan, if applicable, within two weeks of the date any RSUs vest, the Company shall deliver to the Grantee a number of shares of Common Stock equal to the number of vested RSUs and the Dividend Equivalent cash amount with respect to each vested RSU (in each case net of applicable tax withholding and fees).  Delivery shall be electronic, through the brokerage account established by the Company for the Grantee, or in such other medium as is determined by the Company.  </font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Except as would result in taxation under Section 409A of the Code, if any income tax, social insurance, payroll tax, or other related similar withholding becomes legally due from Grantee prior to the settlement of such RSUs after vesting on account of the Grantee meeting the requirements of Retirement, settlement of a portion of the shares necessary to satisfy such amounts may be accelerated by withholding shares, or by such other method as may be approved by the Committee. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">The Grantee is ultimately responsible for any and all applicable taxes, regardless of the amount withheld or reported.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Notwithstanding the foregoing, the date of issuance or delivery of shares of Common Stock may be postponed by the Company for such period as may be required for it with reasonable diligence to comply with any applicable listing requirements of any national securities exchange and requirements under any law or regulation applicable to the issuance or transfer of such shares of Common Stock</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">to the extent such postponement is permissible under Section 409A of the Code.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">5.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Reserved.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'GE Inspira Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">6. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Data Security and Privacy.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">  </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> <br></font></div><div style="margin-bottom:12pt;padding-left:49.7pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">i. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Data Collection, Processing and Usage.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Personal data collected, processed and used by the Company in connection with Awards granted under the Plan includes the Grantee&#8217;s name, home address, email address, telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any shares of Common Stock or directorships held in the Company, and details of all Awards granted, cancelled, exercised, vested, or outstanding.  In granting Awards under the Plan, the Company will collect the Grantee&#8217;s personal data for purposes of allocating shares of Common Stock in settlement of the Awards and implementing, administering and managing the Plan. The Company collects, processes and uses the Grantee&#8217;s personal data in compliance with Company&#8217;s Employment Data Protection Standards and the Uses of Employment Data for the Company&#8217;s Entities.  The Grantee may exercise rights to access, correction, or restriction or deletion where applicable, by contacting the Grantee&#8217;s local HR manager or initiating a request through </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">www.myhr.gehealthcare.com</font><font style="color:#000000;font-family:'Segoe UI',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:49.7pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ii.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Administrative Service Provider.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  The Company transfers the Grantee&#8217;s personal data to UBS Financial Services, which assists with the implementation, administration and management of the Plan (the &#8220;Third-Party Administrator&#8221;).&#160; In the future, the Company may select a different Third-Party Administrator and share the Grantee&#8217;s personal data with another company that serves in a similar manner.  The Third-Party Administrator will open an account for the Grantee to receive and trade shares of Common Stock acquired under the Plan.&#160; The Grantee will be asked to agree on separate terms and data processing practices with the Third-Party Administrator, which is a condition to the Grantee&#8217;s ability to participate in the Plan.  The privacy policy of the Third-Party Administrator may be reviewed on the UBS Financial Services portal. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">7. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Non-solicitation, Non-competition and Compliance with Agreements.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">  </font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">i.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:11.09pt">       </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Non-solicitation.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">During the Grantee&#8217;s employment with the Company or any Affiliate, and for a period of twelve months after his&#47;her Termination Date (the &#8220;Restricted Period&#8221;), Grantee will not, for the benefit of a Competitor or other business, directly or through assistance to others, participate in soliciting a Covered Employee to leave the employment of the Company or assist a Competitor or other business in efforts to hire a Covered Employee away from the Company without the Company&#8217;s advance written approval.  </font></div><div style="padding-left:35.8pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:35.8pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Competitor&#8221; refers to any business (person, entity, or organization) that is engaged in, or preparing to engage in providing a Competing Product. </font></div><div style="margin-bottom:12pt;padding-left:35.8pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Competing Product&#8221; is a product or service that would displace the business opportunities for, or otherwise compete with the products and&#47;or services (existing or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'GE Inspira Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:35.8pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">under development) that Grantee had material involvement with during the Look Back Period, so long as the Company remains in such line of business. It will be presumed that &#8220;material involvement&#8221; includes access to Confidential Information about a product or service, involvement with a product through assisting in cross selling the product where it is normally sold by a different part of the Company&#8217;s business, and supervision of other individuals who are selling or providing the product or service.  </font></div><div style="margin-bottom:12pt;padding-left:35.8pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Confidential Information&#8221; has the meaning described</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in the GE HealthCare Employee Innovation and Proprietary Information Agreement</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (&#8220;EIPIA&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:35.8pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Covered Employee&#8221; means an individual employed at the Lead Professional Band or higher (or any future equivalent management levels) to provide services to (or on behalf of) the Company that Grantee worked with, gained knowledge of, or was provided Confidential Information about as a result of Grantee&#8217;s employment with Company during the Look Back Period.  A Covered Employee shall be presumed to also include individuals who have, within the preceding 90 days, resigned their employment with the Company and have continuing contractual obligations to the Company. </font></div><div style="margin-bottom:12pt;padding-left:35.8pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Look Back Period&#8221; is the two years that precede the Grantee&#8217;s Termination of Employment.</font></div><div style="padding-left:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Grantee primarily resides in California, the terms in footnote 1 will apply to Section 7.i.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font></div><div style="padding-left:36pt"><font><br></font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If Grantee primarily resides in California, the post-employment obligation in Section 7.i will not apply. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'GE Inspira Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Grantee primarily resides in Washington, the terms in footnote 2 will apply to Section 7.i.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">2</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:35.8pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ii.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:12.28pt;text-decoration:underline">Non-competition.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">During the Restricted Period, Grantee will not provide services to or be associated with a Competitor in any role or position (as an employee, director, owner, consultant or otherwise) that would involve his&#47;her participation in Competitive Activity within the Restricted Area. <br></font></div><div style="margin-bottom:12pt;padding-left:35.8pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Competitive Activity&#8221; is activity that involves (a) providing services to or for a Competitor that are the same as or similar in function or purpose to those services Grantee provided to or for the Company during the period of his&#47;her employment with the Company (inclusive of employment with an acquired business that is now part of the Company) in the Look Back Period, (b) providing a Competing Product to a Covered Customer, or accepting business from a Covered Customer that involves a Competing Product, (c) owning, operating, or managing a business that is a Competitor, or (d) participating in other activity that is likely to result in the use or disclosure of Confidential Information for the benefit of a Competitor.  </font></div><div style="margin-bottom:12pt;padding-left:35.8pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Covered Customer&#8221; means a customer of the Company that Grantee had material contact within the Look Back Period. Material contact will be presumed present if in the Look Back Period (i) the Grantee (or persons under his&#47;her supervision) provided services to or had business-related contact with the customer on behalf of the Company, (ii) Grantee was provided Confidential Information about the customer, or (iii) Grantee received commissions or other beneficial credit from the Company for business conducted with the customer.  Customers will be presumed to include active </font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.15pt;font-weight:400;line-height:133%;position:relative;top:-3.85pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:133%">If Grantee primarily resides in Washington, the choice of law in the Grant Agreement, including the Global Addendum, shall not be applied to the extent it deprives the Grantee of the protections or benefits of the Wash. Rev. Code &#167; 49.62.005&#8211;900 (2020) (the &#8220;Washington Act&#8221;), and the Grant Agreement shall not be applied so as to require Grantee to adjudicate a covenant covered by the Washington Act outside the state of Washington. Section 7.i. is modified to only prohibit solicitation by the Grantee of any Covered Employee who is an employee of the Company to leave employment with the Company in accordance with the definition of an enforceable &#8220;Nonsolicitation agreement&#8221; under the Washington Act.&#160; Section 7.ii. is modified to only prohibit solicitation by Grantee of any Covered Customer of the Company who is then a current customer to cease or reduce the extent to which the customer is doing business with the Company in accordance with the definition of an enforceable &#8220;Nonsolicitation agreement&#8221; under the Washington Act.&#160; Section 7.ii. will only be enforceable against Grantee if as of the date enforcement is sought or Grantee&#8217;s last day of employment (whichever is earlier) Grantee&#8217;s earnings from the Company in the prior year (or portion thereof for which Grantee was employed), when annualized, exceed the inflation-adjusted equivalent of one hundred thousand dollars ($100,000) per year as of Jan. 1, 2020 (the &#8220;Adjusted Threshold&#8221;) (adjusted as provided for in the Washington Act).&#160; This Adjusted Threshold figure is published annually at </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">https&#58;&#47;&#47;lni.wa.gov&#47;workers-rights&#47;workplace-policies&#47;Non-Compete-Agreements</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.&#160; In the event Grantee&#8217;s employment is terminated as a result of a layoff, Section 7.ii. will not be enforced by the Company unless the Company agrees at the time of Grantee&#8217;s layoff to provide Grantee with the payments required by Washington Act to keep such covenants in effect.&#160; </font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'GE Inspira Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:35.8pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">customer prospects as of the Grantee&#8217;s Termination of Employment that he&#47;she had material contact with or Confidential Information about and will not be limited to the end user or purchaser of the Company&#8217;s products or services but shall also be understood to include customer representatives such as GPOs (Group Purchasing Organizations).  </font></div><div style="margin-bottom:12pt;padding-left:35.8pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Restricted Area&#8221; refers to the geographic locations of the Covered Customers and each geographic area, by state, county, or other recognized geographic boundary (as used in the ordinary course of the Company&#8217;s business) that is assigned to Grantee as a limitation on where he&#47;she is to do business for the Company in the Look Back Period if his&#47;her responsibilities for the Company and access to Confidential Information (through group management meetings or otherwise) is limited to a specific geographic territory.  If Grantee is not assigned a specific geographic territory that is limited in the forgoing way, or the forgoing scope of Restricted Area is not enforceable, then the Restricted Area shall be the geographic markets where the Company does business that Grantee has involvement with or has been provided Confidential Information about in the course of his&#47;her employment during the Look Back Period and that could be used to harm the protectable interests of the Company which will be presumed to be, if Grantee works or resides in the United States the state where he&#47;she resides, the state from which he&#47;she is assigned to work, if different from his&#47;her state of residence, the contiguous states, and each additional state within the United States where the Company does business or, if Grantee is not based in the United States, the country in which he&#47;she works and resides.  Grantee will not, through remote communications from outside of the Restricted Area, engage in prohibited activity that reaches into, relates to, or otherwise materially involves business within the Restricted Area. If the Restricted Area is not clear to Grantee upon his&#47;her Termination of Employment, he&#47;she will seek clarification from the Company&#8217;s Legal Department within 14 days after the Termination Date. Grantee agrees not to complain about any uncertainty he&#47;she may have regarding the Restricted Area applicable to him&#47;her if he&#47;she does not do so. </font></div><div style="padding-left:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If Grantee primarily resides in California, Colorado, or Minnesota, the post- employment obligations in Section 7. ii. will not apply.  If Grantee primarily resides in Washington, the terms in footnote 2 will apply to Section 7.ii.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">iii.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:4.47pt;text-decoration:underline">Compliance with Agreements.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Grantee will comply with, and shall not breach, any contractual obligations Grantee has to the Company or an Affiliate, including, but not limited to obligations Grantee has not to disclose the Company&#8217;s or any Affiliate&#8217;s Confidential Information. To the extent Grantee is subject to any existing agreements restricting Grantee&#8217;s ability to compete with the Company or any Affiliate (the &#8220;Prior Agreements&#8221;), this Grant Agreement will supplement and not replace or reduce the applicability or enforceability of the Prior Agreements. Grantee acknowledges that the scope of the restrictions in this Section 7 of this Grant Agreement may be different from those contained in other agreements with the Company or an Affiliate because </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'GE Inspira Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">the purpose of, and justification for the restrictions in this Grant Agreement may be different as described in Section 7.vii hereof.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">iv.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:4.82pt;text-decoration:underline">Relief.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Grantee agrees that any breach by him&#47;her of the foregoing obligations inevitably would cause substantial and irreparable damage to the Company and the Affiliates for which money damages may not be an adequate remedy.  Accordingly, the Grantee agrees that the Company and the Affiliates will be entitled to an injunction and&#47;or other equitable relief, without the necessity of posting security, to prevent the breach of such obligations.  The Grantee also agrees to indemnify and hold the Company and the Affiliates harmless from any loss, claim or damages, including, without limitation, all reasonable attorneys&#8217; fees, costs and expenses incurred in enforcing its rights under this Grant Agreement, as well as to repay any payments made hereunder (regardless of whether the RSUs are vested), except to the extent that such reimbursement is prohibited by law.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">v.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:8.13pt;text-decoration:underline">Consideration.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Grantee agrees that the payment and benefits provided for in the Grant Agreement constitute fair and reasonable consideration for Grantee&#8217;s compliance with this Section 7.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">vi.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:4.82pt;text-decoration:underline">Grantee Rights.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Nothing in this Grant Agreement prevents the Grantee from or interferes with the Grantee&#8217;s rights to file a claim or charge or participate, with or without notice to the Company, in an investigation or proceeding of a law enforcement authority or government agency, including any state or federal fair employment practices agency (such as the Equal Employment Opportunity Commission), the U.S. Securities and Exchange Commission, the Department of Labor, the Department of Justice, and the Financial Industry Regulatory Authority. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Nothing in this Grant Agreement prevents Grantee from disclosing information about acts in the workplace that Grantee has reason to believe are unlawful, including, but not limited to, harassment, discrimination or any other conduct.  If the Grantee primarily resides in Washington, the terms in footnote 3 will apply to Section 7.vi.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.8pt;font-weight:400;line-height:132%;position:relative;top:-4.2pt;vertical-align:baseline">3</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">vii.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:1.51pt;text-decoration:underline">Purpose.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> The purpose of, and justification for the restrictions in this Section 7 is to ensure Grantee&#8217;s conduct remains aligned with the interests of other stakeholders in the business and Grantee does not engage in conduct that is detrimental to, and inconsistent with the interests of the stakeholders and participants in the Plan if Grantee is going to be provided the opportunity to participate as a stakeholder in the business of the Company and benefit from the growth of the business, either as holder of RSUs, Options or any other equity granted under the Plan.</font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If Grantee primarily resides in Washington, nothing in this Grant Agreement will be construed to prohibit Grantee from disclosing or discussing conduct Grantee reasonably believes to be illegal discrimination, illegal harassment, illegal retaliation, a wage and hour violation, sexual assault or recognized as a clear mandate of public policy or disclosing the existence of a settlement involving any such event or conduct.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'GE Inspira Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">8. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Additional Requirements.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  The Company reserves the right to impose other requirements on the Award, shares of Common Stock acquired pursuant to the Award, and the Grantee&#8217;s participation in the Plan to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law or to facilitate the operation and administration of the Award and the Plan.  Without limiting the generality of the foregoing, the Company may require the Grantee to sign any agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">9. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Alteration&#47;Termination.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#160; Under the express terms of this Grant Agreement, the Committee shall have the right at any time in its sole discretion to amend, alter, suspend, discontinue or terminate any RSUs without the consent of the Grantee.  Furthermore, if the Company determines in its sole discretion that the Grantee has engaged in conduct that (a) constitutes a breach of this Grant Agreement, the EIPIA or any other confidentiality, non-solicitation, or non-competition agreement with the Company or any Affiliate, (b) results in (or has the potential to cause) material harm financially, reputationally, or otherwise to the Company or any Affiliate or (c) occurred prior to the Grantee&#8217;s Termination of Employment and would give rise to a Termination of Employment for Cause (regardless of whether such conduct is discovered before or after the Grantee&#8217;s Termination of Employment), any outstanding RSUs shall be cancelled immediately, and any amounts previously conveyed under this Grant Agreement shall be subject to recoupment.  In any event, the RSUs provided under this Grant Agreement and any shares of Common Stock previously conveyed or other payments made in respect thereof, shall be further subject to any recoupment policy that the Company may adopt from time to time, to the extent such policy is applicable to the Grantee, and to such compensation including, but not limited to the GE HealthCare Technologies Inc. Clawback Policy designed to comply with the requirements of Rule 10D-1 promulgated under the Act, as in effect and amended from time to time. By accepting the grant of RSUs under this Grant Agreement, the Grantee acknowledges, agrees and consents to the Company&#8217;s application, implementation, and enforcement of (x) such recoupment policies with respect to all covered compensation received or to be received by the Grantee, to the extent applicable, and (y) any provision of applicable law relating to cancellation, recoupment, recession, or payback of compensation and expressly agrees that the Company may take any such actions as are necessary to effectuate recoupment or applicable law without further consent or action being required by the Grantee, including issuing instructions to any Third-Party Administrator to (i) hold the Grantee&#8217;s shares of Common Stock and other amounts acquired under the Plan and&#47;or (ii) reconvey, transfer, or otherwise return such shares of Common Stock and other assets to the Company.  To the extent that the terms of this Grant Agreement and any Company recoupment policy conflict, the terms of the recoupment policy shall prevail. Also, the RSUs shall be null and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'GE Inspira Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">void to the extent the grant of the RSUs or the vesting thereof is prohibited under the laws of the country of residence of the Grantee.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">10. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Plan Terms and Definitions.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#160; Except to the extent that the context clearly provides otherwise, all capitalized terms used in this Grant Agreement have the same meaning as given such terms in the Plan.  This Grant Agreement is subject to the terms and provisions of the Plan, which are incorporated by reference.  In the event of any conflict between the provisions of this Grant Agreement and those of the Plan, the provisions of the Plan shall control.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">11.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Interpretation and Construction.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  This Grant Agreement and the Plan shall be construed and interpreted by the Committee, in its sole discretion.  Any interpretation or other determination by the Committee (including correction of any defect or omission and reconciliation of any inconsistency) shall be binding and conclusive.  All determinations regarding enforcement, waiver or modification of the cancellation and rescission and other provisions of this Grant Agreement shall be made in the Committee&#8217;s sole discretion.  Determinations made under this Grant Agreement and the Plan need not be uniform and may be made selectively among individuals, whether or not such individuals are similarly situated.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">12.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Severability.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  The invalidity or unenforceability of any provision of the Plan or this Grant Agreement will not affect the validity or enforceability of any other provision of the Plan or this Grant Agreement, and each provision of the Plan and this Grant Agreement will be severable and enforceable to the extent permitted by law.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">13.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Stockholder Rights.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  The Grantee shall not have any voting or other stockholder rights unless and until shares of Common Stock are actually delivered to the Grantee.</font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">14.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">No Employment Rights.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  The grant of the Award described in this Grant Agreement does not give the Grantee any rights in respect of employment with the Company or any Affiliate.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">15.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Discretionary Award, Extraordinary Benefit.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Awards under the Plan are granted to employees of the Company and the Affiliates in the Committee&#8217;s sole discretion.  The Award described in this Grant Agreement is a one-time benefit and does not create any contractual or other right to receive other Awards under the Plan or other benefits in lieu thereof.  Future grants, if any, will be at the sole discretion of the Committee.  The Grantee&#8217;s participation in the Plan is voluntary.  This Award (and each other Award, if any, granted under the Plan) constitutes an extraordinary item of compensation and is not part of the Grantee&#8217;s normal or expected compensation for purposes of calculating any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'GE Inspira Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">severance, retirement, or other benefit rights (unless otherwise expressly provided in an applicable benefit plan).</font></div><div style="padding-left:36pt"><font><br></font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">16.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">No Transfer or Assignment.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">No rights under this Award shall be assignable or transferable by the Grantee, except to the extent expressly permitted by the Plan.<br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">17.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Successors and Assigns.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  The Company may assign any of its rights under this Grant Agreement.  This Grant Agreement will be binding upon and inure to the benefit of the successors and assigns of the Company.  Subject to the restrictions on transfer set forth herein, this Grant Agreement will be binding upon the Grantee and the Grantee&#8217;s beneficiaries, executors or administrators.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">18.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Section 409A.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">To the extent applicable, this Grant Agreement shall be construed and administered consistently with the intent to comply with or be exempt from the requirements of Section 409A of the Code and any state law of similar effect (i.e., applying the &#8220;short-term deferral&#8221; rule described in Treas. Reg. &#167; 1.409A-1(b)(4) and&#47;or another exemption).  Where the Grant Agreement specifies a window during which a payment may be made, the payment date within such window shall be determined by the Company in its sole discretion&#59; provided, however, that if the RSUs are subject to Section 409A, then any payment of the RSUs on a Vesting Date listed above will occur no later than December 31 of the year in which such applicable Vesting Date occurs.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">19.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Entire Agreement.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#160; This Grant Agreement, the Plan, and any rules, procedures, and sub-plans (including country addenda) adopted by the Committee contain all of the provisions applicable to the RSUs.  No other statements, documents or practices may modify, waive or alter such provisions unless expressly set forth in writing, signed by an authorized officer of the Company and delivered to the Grantee.<br><br>By acknowledging this Grant Agreement, the Grantee acknowledges and confirms that the Grantee has read this Grant Agreement and the Plan (including applicable addenda), and the Grantee accepts and agrees to the provisions therein.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">20.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Electronic Delivery.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  The Company may, in its sole discretion, decide to deliver any documents related to this or other Awards under the Plan by electronic means.  The Grantee hereby consents to receive such documents electronically and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">21.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Global Addendum.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Notwithstanding any provisions in this document to the contrary, the RSUs will also be subject to the special terms and conditions set forth on Appendix A for </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'GE Inspira Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Grantees who reside outside of the United States.  Moreover, if a Grantee is not a resident of any of the countries listed on Appendix A as of the Grant Date, but relocates to one of the listed countries at any point thereafter, the special terms and conditions for such country will apply to the Grantee, to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan.  Appendix A constitutes part of this Grant Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'GE Inspira Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>4
<FILENAME>gehc1q202510qexhibit105.htm
<DESCRIPTION>EX-10.5
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i74471983d11a4874a7ba6263b9f1ac64_41"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.5</font></div></div><div><img alt="image_01.jpg" src="image_01.jpg" style="height:116px;margin-bottom:5pt;vertical-align:text-bottom;width:162px"><font style="color:#005eb8;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;Date&#93; Equity Grant Agreement</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GE HealthCare Technologies Inc. 2023 Long-Term Incentive Plan (&#8220;Plan&#8221;)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">GE HealthCare Stock Option Grant Agreement (&#8220;Grant Agreement&#8221;)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"> For &#60;&#60;Employee Name&#62;&#62; (&#8220;Grantee&#8221;)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">   </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.078%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.507%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.544%"></td><td style="width:0.1%"></td></tr><tr style="height:16pt"><td colspan="3" rowspan="2" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Grant Date</font></div></td><td colspan="3" rowspan="2" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Option Shares Granted</font></div></td><td colspan="3" rowspan="2" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Option Exercise Price*</font></div></td><td colspan="3" rowspan="2" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Option</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Expiration Date</font></div></td><td colspan="6" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Vesting Schedule</font></div></td></tr><tr style="height:32pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Number of </font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Option Shares</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:-2.63pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Vesting Date</font></div></td></tr><tr style="height:38pt"><td colspan="3" rowspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#60;&#60;Date&#62;&#62;</font></div></td><td colspan="3" rowspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#60;&#60;Number&#62;&#62;</font></div></td><td colspan="3" rowspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">$</font></div></td><td colspan="3" rowspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#60;&#60;Month&#62;&#62; 1, &#60;&#60;Year&#62;&#62;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">33%</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:-2.63pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#60;&#60;Month&#62;&#62; 1, &#60;&#60;Year&#62;&#62;</font></div></td></tr><tr style="height:38pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">33%  </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:-2.63pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#60;&#60;Month&#62;&#62; 1, &#60;&#60;Year&#62;&#62;</font></div></td></tr><tr style="height:39pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">34%</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:-2.63pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#60;&#60;Month&#62;&#62; 1, &#60;&#60;Year&#62;&#62;</font></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">*Exercise price shall be no less than the Fair Market Value of a share of Common Stock on the Grant Date.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">   </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">1.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:8.07pt;text-decoration:underline">Grant.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> The Talent, Culture, and Compensation Committee (&#8220;Committee&#8221;) of the Board of Directors of GE HealthCare Technologies Inc. (&#8220;Company&#8221;) has granted an option to purchase the above number of shares of Common Stock to the Grantee subject to the terms of this Grant Agreement (&#8220;Option&#8221;). Without limiting any condition of this Option award, the award is subject to cancellation and forfeiture if the Grantee does not confirm acceptance within 45 days of the Grant Date. Once vested, the Option entitles the Grantee to purchase from the Company the vested number of shares of Common Stock, each at the Option Exercise Price provided above, in accordance with the terms of this Grant Agreement, the Plan, and any rules, procedures and sub-plans (including country addenda) adopted by the Committee.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">2.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:8.07pt;text-decoration:underline">Vesting and Expiration Date.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> In order for all or part of the Option to become vested, the Grantee must not incur a Termination of Employment from the Grant Date through the applicable Vesting Date listed above. Upon the earlier of the Option Expiration Date and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:12pt;padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">the Grantee&#8217;s Termination of Employment for any reason, the Option shall be cancelled and forfeited in full (including with respect to any vested but unexercised rights), except as specifically provided below.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">i.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:11.09pt;text-decoration:underline">Death or Disability.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> If the Grantee&#8217;s Termination of Employment is a result of the Grantee&#8217;s death or Disability, then (A) any unvested rights under the Option shall vest and become immediately exercisable as of such Termination of Employment, and (B) all vested rights under the Option (after giving effect to the preceding clause (A)) shall remain exercisable until the Option Expiration Date.  </font></div><div style="padding-left:38.6pt;text-indent:-20.1pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">ii.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:7.78pt;text-decoration:underline">Retirement Eligibility.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">If the Grantee meets the requirements for Retirement while in continuous employment and has a Termination of Employment after meeting such requirements prior to the final Vesting Date listed above and after the one-year anniversary of the Grant Date, then (A) the Grantee shall continue to vest in any unvested Options in accordance with the Vesting Schedule above as if the Grantee had remained in continuous employment, and (B) all vested rights under the Option (after giving effect to the preceding clause (A)) shall remain exercisable until the Option Expiration Date. </font></div><div style="padding-left:34.3pt"><font><br></font></div><div style="padding-left:34.3pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">For purposes of this Grant Agreement Retirement means attainment of&#58;</font></div><div style="padding-left:34.3pt"><font><br></font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">a.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%;padding-left:8.88pt">age 65&#59; </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">b.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%;padding-left:8.36pt">age 60 and completion of at least five years of continuous employment&#59; or</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">c.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%;padding-left:9.55pt">age 55 and completion of at least ten years of continuous employment. </font></div><div style="padding-left:50.4pt"><font><br></font></div><div style="padding-left:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">If retirement at an earlier age than noted in (a), (b) or (c) above is mandatory under applicable law or policy in the country where the Grantee is employed, for purposes of the Grant Agreement Retirement means the mandatory retirement date and the applicable service requirement closest to such date under (a), (b) or (c) above.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">For purposes of the Grant Agreement continuous employment means continuous employment with the Company, or an Affiliate (or with General Electric Company or any of its affiliates through the date of the Company&#8217;s spinoff from General Electric Company) ending on the Termination of Employment.</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Notwithstanding the foregoing, if the Company receives an opinion of counsel that there has been a legal judgment and&#47;or legal development in the Grantee&#8217;s jurisdiction that would likely result in the favorable treatment applicable to the Award pursuant to subparagraphs (i)-(iii) being deemed unlawful and&#47;or discriminatory, then such favorable treatment shall not be applied.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">iii.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:4.47pt;text-decoration:underline">Transfer of Business to Successor Employer.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> If the Grantee&#8217;s Termination of Employment occurs as a result of transferring directly to employment with a successor employer in connection with the transfer by the Company or an Affiliate of a business operation, then (A) any unvested rights under the Option shall vest and become immediately exercisable as of such Termination of Employment, and (B) all vested rights under the Option (after giving effect to the preceding clause (A)) shall remain exercisable only until the earlier of (x) 90 days after such Termination of Employment, and (y) the original Option Expiration Date.  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">iv.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:4.82pt;text-decoration:underline">Termination of Employment for Cause.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> If the Grantee&#8217;s Termination of Employment is for Cause, the Option shall be cancelled immediately (whether vested or unvested) and shall be unexercisable.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">v.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:8.13pt;text-decoration:underline">Other Termination of Employment.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> If the Grantee&#8217;s Termination of Employment occurs for any reason not described, then the unvested portion of the Option shall be cancelled as of such Termination of Employment and the vested portion of the Option shall remain exercisable only until the earlier of (a) 90 days after such Termination of Employment and (b) the original Option Expiration Date. </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">3.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:8.07pt;text-decoration:underline">Notice and Manner of Exercise.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> The Grantee may elect to exercise all or part of the Option (to the extent vested) by notifying the Company (through such administrative procedures as it may establish) of the number of shares of Common Stock to be purchased (exercised) and the date or share price upon which such Options shall be exercised. The number of shares of Common Stock delivered shall be reduced to cover the Option Exercise Price and applicable tax withholdings and fees, except as otherwise approved by the Committee or its delegates. Delivery shall be electronic through the brokerage account established by the Company for the Grantee, or in such other medium as is determined by the Company.</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Grantee is ultimately responsible for any and all applicable taxes, regardless of the amount withheld or reported. Notwithstanding the foregoing, the date of issuance or delivery of shares of Common Stock may be postponed by the Company for such period as may be required for it with reasonable diligence to comply with any applicable listing requirements of any national securities exchange and requirements under any law or regulation applicable to the issuance or transfer of such shares of Common Stock to the extent such postponement is permissible under Section 409A of the Code. Likewise, the method of exercising Options under this Grant Agreement may be adjusted for compliance with applicable law in the jurisdiction applicable to the Grantee.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">4.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:8.07pt;text-decoration:underline">Reserved.</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">5.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:8.07pt;text-decoration:underline">Data Security and Privacy.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">i.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:11.09pt;text-decoration:underline">Data Collection, Processing and Usage.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> Personal data collected, processed and used by the Company in connection with Awards granted under the Plan includes the Grantee&#8217;s name, home address, email address, telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any shares of Common Stock or directorships held in the Company, and details of all Awards granted, cancelled, exercised, vested, or outstanding.  In granting Awards under the Plan, the Company will collect the Grantee&#8217;s personal data for purposes of allocating shares of Common Stock in settlement of the Awards and implementing, administering, and managing the Plan. The Company collects, processes, and uses the Grantee&#8217;s personal data in compliance with the Company&#8217;s Employment Data Protection Standards and the Uses of Employment Data for the Company&#8217;s entities. The Grantee may exercise rights to access, correction, or restriction or deletion where applicable, by contacting the Grantee&#8217;s local HR manager or initiating a request through </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%;text-decoration:underline">www.myhr.gehealthcare.com</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ii.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:7.78pt;text-decoration:underline">Administrative Service Provider.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The Company transfers the Grantee&#8217;s personal data to UBS Financial Services, which assists with the implementation, administration, and management of the Plan (the &#8220;Third-Party Administrator&#8221;). In the future, the Company may select a different Third-Party Administrator and share the Grantee&#8217;s personal data with another company that serves in a similar manner. The Third-Party Administrator will open an account for the Grantee to receive and trade shares of Common Stock acquired under the Plan. The Grantee will be asked to agree on separate terms and data processing practices with the Third-Party Administrator, which is a condition to the Grantee&#8217;s ability to participate in the Plan. The privacy policy of the Third-Party Administrator may be reviewed on the UBS Financial Services portal. </font></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:115%">6.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:8.07pt;text-decoration:underline">Non-solicitation, Non-competition, and Compliance with Agreements.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:115%"> </font></div><div style="padding-left:49.7pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">i.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:11.09pt"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Non-solicitation.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> During the Grantee&#8217;s employment with the Company or any Affiliate, and for a period of twelve months after his&#47;her Termination Date (the &#8220;Restricted Period&#8221;), Grantee will not, for the benefit of a Competitor or other business, directly or through assistance to others, participate in soliciting a Covered Employee to leave the employment of the Company or assist a Competitor or other business in efforts to hire a Covered Employee away from the Company without the Company&#8217;s advance written approval.  </font></div><div style="padding-left:35.8pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:35.8pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Competitor&#8221; refers to any business (person, entity, or organization) that is engaged in, or preparing to engage in providing a Competing Product. </font></div><div style="margin-bottom:12pt;padding-left:35.8pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Competing Product&#8221; is a product or service that would displace the business opportunities for, or otherwise compete with the products and&#47;or services (existing or under development) that Grantee had material involvement with during the Look Back Period so long as the Company remains in such line of business. It will be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:12pt;padding-left:35.8pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">presumed that material involvement includes access to Confidential Information about a product or service, involvement with a product through assisting in cross selling the product where it is normally sold by a different part of the Company&#8217;s business, and supervision of other individuals who are selling or providing the product or service. </font></div><div style="margin-bottom:12pt;padding-left:35.8pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Confidential Information&#8221; has the meaning described in the Employee Innovation and Proprietary Information Agreement (&#8220;EIPIA&#8221;).</font></div><div style="padding-left:35.8pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Covered Employee&#8221; means an individual employed at the Lead Professional Band or higher (or any future equivalent management levels) to provide services to (or on behalf of) the Company that Grantee worked with, gained knowledge of, or was provided Confidential Information about as a result of Grantee&#8217;s employment with Company during the Look Back Period.  A Covered Employee shall be presumed to also include individuals who have, within the preceding 90 days, resigned their employment with the Company and have continuing contractual obligations to the Company. </font></div><div style="padding-left:35.8pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:35.8pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Look Back Period&#8221; is the two years that precede the Grantee&#8217;s Termination of Employment.</font></div><div style="padding-left:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Grantee primarily resides in California, the terms in footnote 1 will apply to Section 6. i.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Grantee primarily resides in Washington, the terms in footnote 2 will apply to Section 6. i.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If Grantee primarily resides in California, the post-employment obligation in Sections 6.i will not apply. </font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Grantee primarily resides in Washington, the choice of law in the Grant Agreement, including the Global Addendum, shall not be applied to the extent it deprives the Grantee of the protections or benefits of the Wash. Rev. Code &#167; 49.62.005&#8211;900 (2020) (the &#8220;Washington Act&#8221;), and the Grant Agreement shall not be applied so as to require Grantee to adjudicate a covenant covered by the Washington Act outside the state of Washington. Section 7.i. is modified to only prohibit solicitation by the Grantee of any Covered Employee who is an employee of the Company to leave employment with the Company in accordance with the definition of an enforceable &#8220;Nonsolicitation agreement&#8221; under the Washington Act. Section 7. ii. is modified to only prohibit solicitation by Grantee of any Covered Customer of the Company who is then a current customer to cease or reduce the extent to which the customer is doing business with the Company in accordance with the definition of an enforceable &#8220;Nonsolicitation agreement&#8221; under the Washington Act. Section 7. ii. will only be enforceable against Grantee if as of the date enforcement is sought or Grantee&#8217;s last day of employment (whichever is earlier) Grantee&#8217;s earnings from the Company in the prior year (or portion thereof for which Grantee was employed), when annualized, exceed the inflation-adjusted equivalent of one hundred thousand dollars ($100,000) per year as of Jan. 1, 2020 (the &#8220;Adjusted Threshold&#8221;) (adjusted as provided for in the Washington Act).&#160; This Adjusted Threshold figure is published annually at </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;lni.wa.gov&#47;workers-rights&#47;workplace-policies&#47;Non-Compete-Agreements</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160; In the event Grantee&#8217;s employment is terminated as a result of a layoff, Section 7. ii. will not be enforced by the Company unless the Company agrees at the time of Grantee&#8217;s layoff to provide Grantee with the payments required by Washington Act to keep such covenants in effect. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:49.7pt"><font><br></font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ii.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:7.78pt;text-decoration:underline">Non-competition.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">During the Restricted Period, Grantee will not provide services to or be associated with a Competitor in any role or position (as an employee, director, owner, consultant or otherwise) that would involve his&#47;her participation in Competitive Activity within the Restricted Area. </font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Competitive Activity&#8221; is activity that involves (a) providing services to or for a Competitor that are the same as or similar in function or purpose to those services Grantee provided to or for the Company during the period of his&#47;her employment with the Company (inclusive of employment with an acquired business that is now part of the Company) in the Look Back Period, (b) providing a Competing Product to a Covered Customer, or accepting business from a Covered Customer that involves a Competing Product, (c) owning, operating, or managing a business that is a Competitor, or (d) participating in other activity that is likely to result in the use or disclosure of Confidential Information for the benefit of a Competitor.  </font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Covered Customer&#8221; means a customer of the Company that Grantee had material contact within the Look Back Period. Material contact will be presumed present if in the Look Back Period (i) the Grantee (or persons under his&#47;her supervision) provided services to or had business-related contact with the customer on behalf of the Company, (ii) Grantee was provided Confidential Information about the customer, or (iii) Grantee received commissions or other beneficial credit from the Company for business conducted with the customer.  Customers will be presumed to include active customer prospects as of the Grantee&#8217;s Termination of Employment that he&#47;she had material contact with or Confidential Information about and will not be limited to the end user or purchaser of the Company&#8217;s products or services but shall also be understood to include customer representatives such as GPOs (Group Purchasing Organizations).  </font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Restricted Area&#8221; refers to the geographic locations of the Covered Customers and each geographic area, by state, county, or other recognized geographic boundary (as used in the ordinary course of the Company&#8217;s business) that is assigned to Grantee as a limitation on where he&#47;she is to do business for the Company in the Look Back Period if his&#47;her responsibilities for the Company and access to Confidential Information (through group management meetings or otherwise) is limited to a specific geographic territory.  If Grantee is not assigned a specific geographic territory that is limited in the forgoing way, or the forgoing scope of Restricted Area is not enforceable, then the Restricted Area shall be the geographic markets where the Company does business that Grantee has involvement with or has been provided Confidential Information about in the course of his&#47;her employment during the Look Back Period and that could be used to harm the protectable interests of the Company which will be presumed to be, if Grantee works or resides in the United States the state where he&#47;she resides, the state from which he&#47;she is assigned to work, if different from his&#47;her state of residence, the contiguous states, and each additional state within the United States where the Company does business or, if Grantee is not </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">based in the United States, the country in which he&#47;she works and resides.  Grantee will not, through remote communications from outside of the Restricted Area, engage in prohibited activity that reaches into, relates to, or otherwise materially involves business within the Restricted Area. If the Restricted Area is not clear to Grantee upon his&#47;her Termination of Employment, he&#47;she will seek clarification from the Company&#8217;s Legal Department within 14 days after the Termination Date. Grantee agrees not to complain about any uncertainty he&#47;she may have regarding the Restricted Area applicable to him&#47;her if he&#47;she does not do so. </font></div><div style="padding-left:36.2pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If Grantee primarily resides in California, Colorado, or Minnesota, the post-employment obligations in Section 6. ii. will not apply. If Grantee primarily resides in Washington, the terms in footnote 2 will apply to Section 6. ii.</font></div><div style="padding-left:49.7pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">iii.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:4.47pt;text-decoration:underline">Compliance with Agreements.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Grantee will comply with and shall not breach any contractual obligations Grantee has to the Company or an Affiliate, including, but not limited to, obligations Grantee has not to disclose the Company&#8217;s or any Affiliate&#8217;s Confidential Information. To the extent Grantee is subject to any existing agreements restricting Grantee&#8217;s ability to compete with the Company or any Affiliate (the &#8220;Prior Agreements&#8221;), this Grant Agreement will supplement, and not replace or reduce the applicability or enforceability of the Prior Agreements. </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Grantee acknowledges that the scope of the restrictions in this Section 6 of this Grant Agreement may be different from those contained in other agreements with the Company or an Affiliate because the purpose of, and justification for the restrictions in this Grant Agreement may be different as described in Section 6.vii hereof.</font></div><div style="padding-left:13.7pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">iv.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:4.82pt;text-decoration:underline">Relief.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Grantee agrees that any breach by him&#47;her of the foregoing obligations inevitably would cause substantial and irreparable damage to the Company and the Affiliates for which money damages may not be an adequate remedy. Accordingly, the Grantee agrees that the Company and the Affiliates will be entitled to an injunction and&#47;or other equitable relief, without the necessity of posting security, to prevent the breach of such obligations. The Grantee also agrees to indemnify and hold the Company and the Affiliates harmless from any loss, claim or damages, including, without limitation, all reasonable attorneys&#8217; fees, costs and expenses incurred in enforcing its rights under this Grant Agreement, as well as to repay any payments made hereunder (regardless of whether the Option is vested), except to the extent that such reimbursement is prohibited by law.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">v.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:8.13pt;text-decoration:underline">Consideration.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Grantee agrees that the payment and benefits provided for in the Grant Agreement constitute fair and reasonable consideration for Grantee&#8217;s compliance with this Section 6.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">vi.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:4.82pt;text-decoration:underline">Grantee Rights.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Nothing in this Grant Agreement prevents Grantee from or interferes with the Grantee&#8217;s rights to file a claim or charge or participate, with or without notice to the Company, in an investigation or proceeding of a law enforcement authority or government agency, including any state or federal fair employment practices agency </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(such as the Equal Employment Opportunity Commission), the U.S. Securities and Exchange Commission, the Department of Labor, the Department of Justice, and the Financial Industry Regulatory Authority. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Nothing in this Grant Agreement prevents the Grantee from disclosing information about acts in the workplace that Grantee has reason to believe are unlawful, including, but not limited to, harassment, discrimination, or any other conduct. If the Grantee primarily resides in Washington, the terms in footnote 3 will apply to Section 6.vi.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.8pt;font-weight:400;line-height:132%;position:relative;top:-4.2pt;vertical-align:baseline">3</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">vii.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:1.51pt;text-decoration:underline">Purpose. </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">The purpose of, and justification for the restrictions in this Section 6 is to ensure Grantee&#8217;s conduct remains aligned with the interests of other stakeholders in the business and Grantee does not engage in conduct that is detrimental to, and inconsistent with the interests of the stakeholders and participants in the Plan if Grantee is going to be provided the opportunity to participate as a stakeholder in the business of the Company and benefit from the growth of the business, either as an Option holder or holder of other equity granted under the Plan.</font></div><div style="padding-left:49.7pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">7.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:8.07pt;text-decoration:underline">Additional Requirements.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> The Company reserves the right to impose other requirements on the Award, shares of Common Stock acquired pursuant to the Award, and the Grantee&#8217;s participation in the Plan to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law or to facilitate the operation and administration of the Award and the Plan.  Without limiting the generality of the foregoing, the Company may require the Grantee to sign any agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">8.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:8.07pt;text-decoration:underline">Alteration&#47;Termination.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> Under the express terms of this Grant Agreement, the Committee shall have the right at any time in its sole discretion to amend, alter, suspend, discontinue, or terminate the Option without the consent of the Grantee. Furthermore, if the Company determines in its sole discretion that the Grantee has engaged in conduct that (a) constitutes a breach of this Grant Agreement, the EIPIA or any other confidentiality, non-solicitation, or non-competition agreement with the Company or any Affiliate, (b) results in (or has the potential to cause) material harm financially, reputationally, or otherwise to the Company or any Affiliate or (c) occurred prior to the Grantee&#8217;s Termination of Employment and would give rise to a Termination of Employment for Cause (regardless of whether such conduct is discovered before or after the Grantee&#8217;s Termination of Employment), the unexercised portion of the Option shall be cancelled immediately, and any amounts previously conveyed under this Grant </font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If Grantee primarily resides in Washington, nothing in this Grant Agreement will be construed to prohibit Grantee from disclosing or discussing conduct Grantee reasonably believes to be illegal discrimination, illegal harassment, illegal retaliation, a wage and hour violation, sexual assault or recognized as a clear mandate of public policy or disclosing the existence of a settlement involving any such event or conduct.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:12pt;padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Agreement shall be subject to recoupment.  In any event, the Option provided under this Grant Agreement and any shares of Common Stock previously conveyed or other payments made in respect thereof, shall be further subject to the Company&#8217;s recoupment policy that the Company may adopt from time to time, to the extent any such policy is applicable to the Grantee, and to such compensation, including, but not limited to, the GE HealthCare Technologies Inc. Clawback Policy, designed to comply with the requirements of Rule 10D-1 promulgated under the Act, as in effect and amended from time to time.  By accepting the grant of Options under this Grant Agreement, the Grantee acknowledges, agrees and consents to the Company&#8217;s application, implementation, and enforcement of (x) such recoupment policies with respect to all covered compensation received or to be received by the Grantee, to the extent applicable, and (y) any provision of applicable law relating to cancellation, recoupment, recession, or payback of compensation and expressly agrees that the Company may take any such actions as are necessary to effectuate recoupment or applicable law without further consent or action being required by the Grantee, including issuing instructions to any Third-Party Administrator to (i) hold the Grantee&#8217;s shares of Common Stock and other amounts acquired under the Plan and&#47;or (ii) reconvey, transfer, or otherwise return such shares of Common Stock and other assets to the Company. To the extent that the terms of this Grant Agreement and any Company recoupment policy conflict, the terms of the recoupment policy shall prevail. Also, the Option shall be null and void to the extent the grant of the Option or the vesting or exercise thereof is prohibited under the laws of the country of residence of the Grantee.</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">9.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:8.07pt;text-decoration:underline">Plan Terms and Definitions.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> Except to the extent that the context clearly provides otherwise, all capitalized terms used in this Grant Agreement have the same meaning as given such terms in the Plan. This Grant Agreement is subject to the terms and provisions of the Plan, which are incorporated by reference.  In the event of any conflict between the provisions of this Grant Agreement and those of the Plan, the provisions of the Plan shall control.</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">10.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:1.74pt;text-decoration:underline">Interpretation and Construction.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> This Grant Agreement and the Plan shall be construed and interpreted by the Committee, in its sole discretion. Any interpretation or other determination by the Committee (including correction of any defect or omission and reconciliation of any inconsistency) shall be binding and conclusive. All determinations regarding enforcement, waiver or modification of the cancellation and rescission and other provisions of this Grant Agreement shall be made in the Committee&#8217;s sole discretion. Determinations made under this Grant Agreement and the Plan need not be uniform and may be made selectively among individuals, whether or not such individuals are similarly situated.</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">11.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:1.74pt;text-decoration:underline">Severability.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> The invalidity or unenforceability of any provision of the Plan or this Grant Agreement will not affect the validity or enforceability of any other provision of the Plan </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:9pt;padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">or this Grant Agreement, and each provision of the Plan and this Grant Agreement will be severable and enforceable to the extent permitted by law.</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">12.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:1.74pt;text-decoration:underline">Stockholder Rights.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> The Grantee shall not have any voting or other stockholder rights unless and until shares of Common Stock are actually delivered to the Grantee.</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">13.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:1.74pt;text-decoration:underline">No Employment Rights.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> The grant of the Award described in this Grant Agreement does not give the Grantee any rights in respect of employment with the Company or any Affiliate.</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">14.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:1.74pt;text-decoration:underline">Discretionary Award, Extraordinary Benefit.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> Awards under the Plan are granted to employees of the Company and the Affiliates in the Committee&#8217;s sole discretion. The Award described in this Grant Agreement is a one-time benefit and does not create any contractual or other right to receive other Awards under the Plan or other benefits in lieu thereof. Future grants, if any, will be at the sole discretion of the Committee. The Grantee&#8217;s participation in the Plan is voluntary. This Award (and each other Award, if any, granted under the Plan) constitutes an extraordinary item of compensation and is not part of the Grantee&#8217;s normal or expected compensation for purposes of calculating any severance, retirement, or other benefit rights (unless otherwise expressly provided in an applicable benefit plan).</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">15.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:1.74pt;text-decoration:underline">No Transfer or Assignment.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">No rights under this Award shall be assignable or transferable by the Grantee, except to the extent expressly permitted by the Plan.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">16.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:1.74pt;text-decoration:underline">Successors and Assigns.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> The Company may assign any of its rights under this Grant Agreement. This Grant Agreement will be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Grant Agreement will be binding upon the Grantee and the Grantee&#8217;s beneficiaries, executors, or administrators.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">17.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:1.74pt;text-decoration:underline">Section 409A.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">To the extent applicable, this Grant Agreement shall be construed and administered consistently with the intent to comply with or be exempt from the requirements of Section 409A of the Code and any state law of similar effect (i.e., applying the exemption for stock rights described in Treas. Reg. &#167; 1.409A-1(b)(5) and&#47;or another exemption).  </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">18.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:1.74pt;text-decoration:underline">Entire Agreement.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> This Grant Agreement, the Plan, and any rules, procedures, and sub-plans (including country addenda) adopted by the Committee contain all of the provisions applicable to the Option. No other statements, documents or practices may modify, waive or alter such provisions unless expressly set forth in writing, signed by an authorized officer of the Company and delivered to the Grantee.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:132%"><br><br></font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">By acknowledging this Grant Agreement, the Grantee acknowledges and confirms that </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">the Grantee has read this Grant Agreement and the Plan (including applicable addenda), and the Grantee accepts and agrees to the provisions therein.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">19.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:1.74pt;text-decoration:underline">Electronic Delivery.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> The Company may, in its sole discretion, decide to deliver any documents related to this or other Awards under the Plan by electronic means. The Grantee hereby consents to receive such documents electronically and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">20.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:1.74pt;text-decoration:underline">Global Addendum.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Notwithstanding any provisions in this document to the contrary, the Option will also be subject to the special terms and conditions set forth on Appendix A for Grantees who reside outside of the United States. Moreover, if a Grantee is not a resident of any of the countries listed on Appendix A as of the Grant Date, but relocates to one of the listed countries at any point thereafter, the special terms and conditions for such country will apply to the Grantee, to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan.  Appendix A constitutes part of this Grant Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>5
<FILENAME>gehc1q202510qexhibit106.htm
<DESCRIPTION>EX-10.6
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i959a98ce224849b68a5f91caee3807cd_41"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.6</font></div><div><font><br></font></div></div><div><img alt="image_02a.jpg" src="image_02a.jpg" style="height:116px;margin-bottom:5pt;vertical-align:text-bottom;width:162px"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#91;Date&#93; Equity Grant Agreement</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GE HealthCare Technologies Inc. 2023 Long-Term Incentive Plan (&#8220;Plan&#8221;)</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">GE HealthCare Performance Stock Unit Grant Agreement (&#8220;Grant Agreement&#8221;) </font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">For &#60;&#60;Employee Name&#62;&#62; (&#8220;Grantee&#8221;)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:4.63pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:16.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.038%"></td><td style="width:0.1%"></td></tr><tr style="height:27pt"><td colspan="3" rowspan="2" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Grant Date</font></div></td><td colspan="3" rowspan="2" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">PSUs Granted</font></div></td><td colspan="6" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Vesting Schedule</font></div></td></tr><tr style="height:27pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Number of PSUs</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.8pt;font-weight:700;line-height:122%;position:relative;top:-4.2pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-right:-2.63pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Vesting Date</font></div></td></tr><tr style="height:41pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#60;&#60;Date&#62;&#62;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#60;&#60;Number&#62;&#62;</font></div></td><td colspan="3" rowspan="2" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">100%</font></div></td><td colspan="3" rowspan="2" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:-2.63pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">The date in Q1 of &#60;&#60;Year&#62;&#62; on which the Committee (as defined below) certifies PSU performance </font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div></td></tr></table></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Actual number of shares of common stock delivered to be between 0% and 200%.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">1. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Grant.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#160;&#160;The Talent, Culture, and Compensation Committee (&#8220;Committee&#8221;) of the Board of Directors of GE HealthCare Technologies Inc. (&#8220;Company&#8221;) has granted the above number of Performance Stock Units (&#8220;PSUs&#8221;) to the Grantee, subject to the terms of this Grant Agreement.  Without limiting any condition of this PSU award, the award is subject to cancellation and forfeiture if the Grantee does not confirm acceptance within 45 days of the Grant Date.  Once vested, each PSU entitles the Grantee to receive from the Company (i) one share of Common Stock and (ii) a cash payment in respect of Dividend Equivalents (described below), each in accordance with the terms of this Grant Agreement, the Plan, and any rules, procedures and sub-plans (including country addenda) adopted by the Committee.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">2. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Vesting.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#160; A PSU shall become vested only upon satisfaction of the performance criteria described in Section 2.a and the employment criteria described in Section 2.b.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">a.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:8pt">Performance Criteria. </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Subject to satisfying the employment criteria described in Section 2.b, the number of PSUs to be vested shall be a percentage of the number of PSUs Granted (as shown above), determined as follows&#58;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">i.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:11.09pt">Financial Goals Percentage. </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">A percentage based on performance against the Company&#8217;s &#60;&#60;Year&#62;&#62;  Revenue and &#60;&#60;Three-Year Period&#62;&#62; cumulative adjusted earnings per share (&#8220;EPS&#8221;) (&#8220;Financial Goals Percentage&#8221;) shall be calculated. The Financial Goals Percentage equals the sum of the revenue factor plus the cumulative adjusted EPS factor with each such factor weighted as shown in the table below. If performance for a factor is below the threshold level, that factor will be 0%. If the performance for a factor is above the maximum level, that factor will be capped at 50% of 200%, or 100%. If performance is between the threshold and target, or between the target and maximum, the percentage will be determined by interpolation.</font></div><div><font><br></font></div><div style="padding-left:71.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.653%"><tr><td style="width:1.0%"></td><td style="width:37.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.991%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.293%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12.75pt;padding-left:2.77pt;padding-right:2.77pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Factor</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12.75pt;padding-left:2.77pt;padding-right:2.77pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Weight</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12.75pt;padding-left:2.77pt;padding-right:2.77pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Threshold</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12.75pt;padding-left:2.77pt;padding-right:2.77pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Target</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12.75pt;padding-left:2.77pt;padding-right:2.77pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Maximum</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12.75pt;padding-left:2.77pt;padding-right:2.77pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#60;&#60;Year&#62;&#62; Organic Revenue</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.8pt;font-weight:400;line-height:132%;position:relative;top:-4.2pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12.75pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">50%</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:12.75pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:12.75pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:12.75pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12.75pt;padding-left:2.77pt;padding-right:2.77pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#60;&#60;Three-Year Period&#62;&#62;  Cumulative Adjusted EPS</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.8pt;font-weight:400;line-height:132%;position:relative;top:-4.2pt;vertical-align:baseline">2</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12.75pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">50%</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:12.75pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:12.75pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:12.75pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12.75pt;padding-left:2.77pt;padding-right:2.77pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Payout Percentage</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:12.75pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12.75pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">50%</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12.75pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">100%</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12.75pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">200%</font></div></td></tr></table></div><div style="margin-bottom:10pt;padding-left:72pt;padding-right:-58.5pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:8pt;font-weight:700;line-height:133%">Organic Revenue (non-GAAP metric)</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:8pt;font-weight:400;line-height:133%">&#58; Organic Revenue (non-GAAP metric)&#58; Total Revenue (GAAP-reported), excluding the effects of (1) net sales from recent acquisitions and divestitures with less than a full year of comparable net sales&#59; and (2) foreign currency exchange rate fluctuations in order to present revenue on a constant currency basis. Assuming December 2024 MOR (Budget FX) for Target.</font></div><div style="margin-bottom:10pt;padding-left:72pt;padding-right:-54pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:8pt;font-weight:700;line-height:133%"> Cumulative Adj EPS</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:8pt;font-weight:400;line-height:133%"> (2025-2027)&#58; Sum of Adj EPS for the year 2025, 2026 and 2027. </font></div><div style="margin-bottom:10pt;padding-left:72pt;padding-right:-54pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:8pt;font-weight:700;line-height:133%">Adj EPS</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:8pt;font-weight:400;line-height:133%">&#58; Diluted earnings per share from continuing operations excluding the per share impact of&#58; (1) deemed preferred stock dividend of redeemable noncontrolling interest, (2) Non-operating benefit (income) costs&#59; (3) restructuring costs&#59; (4) acquisition, disposition related charges (benefits)&#59; (5) Spin-Off and separation costs&#59; (6) (gain) loss on business and asset dispositions&#59; (7) amortization of acquisition-related intangible assets&#59; (8) investment revaluation (gain) loss&#59; (9) tax effect of reconciling items (items 1-8)&#59; and (10) certain tax adjustments as described in Adjusted tax expense definition.</font></div><div style="padding-left:94.5pt;padding-right:-49.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Adjusted tax expense&#58; Adjusted tax expense excludes the income tax related to the pre-tax income adjustments included as part of Adjusted net income and certain income tax adjustments, such as adjustments to deferred tax assets or liabilities. In addition, we may from time to time consider excluding other nonrecurring tax items to enhance comparability between periods. </font></div><div style="padding-left:94.5pt;padding-right:-49.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:15.2pt">Volume of outstanding shares would be adjusted for any buyback or share split and Adj Net income for acquisition or disposition to make it comparable to target assumption.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">ii.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:7.78pt">Relative Total Shareholder Return Adjustment.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> The Financial Goals Percentage shall be adjusted based on relative total shareholder return for the three-year period of 2025-2027 (&#8220;rTSR Modifier&#8221;)</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.8pt;font-weight:400;line-height:132%;position:relative;top:-4.2pt;vertical-align:baseline">3</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> as follows&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:86.4pt;text-indent:-14.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">A.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%;padding-left:3.93pt">If the Company&#8217;s Total Shareholder Return (&#8220;Company TSR&#8221;) is equal to or below the 25</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.8pt;font-weight:400;line-height:132%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> percentile (&#8220;threshold&#8221;) of the Total Shareholder Return for the Company&#8217;s compensation peer group (&#8220;Peer TSR&#8221;), then the Financial Goals Percentage will be multiplied by 80%. The Company&#8217;s compensation peer group is listed on Exhibit A.</font></div><div style="padding-left:86.4pt"><font><br></font></div><div style="padding-left:86.4pt;text-indent:-14.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">B.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%;padding-left:3.54pt">If the Company TSR is equal to the 50</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.8pt;font-weight:400;line-height:132%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> percentile (&#8220;target&#8221;) of the Peer TSR, then the Financial Goals Percentage will be multiplied by 100%.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div><font><br></font></div><div style="padding-left:86.4pt;text-indent:-14.4pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">C.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%;padding-left:3.82pt">If the Company TSR is equal to or above the 75</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.8pt;font-weight:400;line-height:132%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> percentile (&#8220;maximum&#8221;) of the Peer TSR, then the Financial Goals Percentage will be multiplied by 120%.</font></div><div><font><br></font></div><div style="padding-left:72pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">If the Company TSR is between the threshold and target, or between the target and maximum, the TSR Adjustment shall be determined by interpolation. However, in no event will the PSU be adjusted to provide more than 200% of the PSUs Granted in total.</font></div><div style="padding-left:72pt"><font><br></font></div><div style="margin-bottom:10pt;padding-left:72pt;padding-right:-58.5pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:8pt;font-weight:700;line-height:133%"> rTSR Modifier&#58; </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:8pt;font-weight:400;line-height:133%">TSR is the change in share price over the cumulative three-year performance period plus reinvested dividends divided by the share price at the beginning of the three-year performance period. TSR is calculated by using the trailing 20-day average share price at the beginning and end of the three-year period for GEHC and the GEHC Peer Group. GEHC&#8217;s TSR is compared to the TSR of the GEHC Peer Group to determine GEHC&#8217;s percentile ranking.</font></div><div style="padding-left:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">All determinations regarding performance, both for Financial Goals Percentage and TSR Adjustment shall be made solely by the Committee in accordance with the customary accounting and financial reporting practices used by the Company for external reporting, and the Committee shall have discretion to include adjustment to the performance criteria as it deems appropriate to reflect the impact of corporate transactions, including merger, acquisition, disposition, sale, discontinued operations, share buybacks, recapitalization, split-up, spinoff, reorganization, restructuring, accounting, tax law changes, tariff changes, or other extraordinary, unusual, nonrecurring, or infrequent events, or other similar corporate transaction as determined by the Committee.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">b.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:7.53pt">Employment Criteria. </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">In order to vest in PSUs with respect to which the performance criteria are satisfied, the Grantee must not incur a Termination of Employment, from the Grant Date through the applicable Vesting Date listed above. All unvested PSUs shall be immediately cancelled without payment upon the Grantee&#8217;s Termination of Employment for any reason before the applicable Vesting Date, and the Grantee shall thereupon cease to have any right to receive any shares of Common Stock or cash payments in respect of Dividend Equivalents accrued in respect of those cancelled PSUs, except as specifically provided below.</font></div><div style="padding-left:49.7pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">i.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Death or Disability.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">&#160; </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">If the Grantee&#8217;s Termination of Employment is a result of the Grantee&#8217;s death or Disability prior to the Vesting Date listed above, then the employment criteria shall be deemed satisfied as of such Termination of Employment.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%"> </font></div><div style="padding-left:49.7pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:49.7pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">ii.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:7.78pt;text-decoration:underline">Retirement Eligibility.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">If the Grantee meets the requirements for Retirement while in continuous employment and has a Termination of Employment after meeting such requirements prior to the Vesting Date listed above and after the one-year </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:49.7pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">anniversary of the Grant Date, then the Grantee shall continue to vest in the employment criteria for any unvested PSUs in accordance with the Vesting Schedule above as if the Grantee had remained in continuous employment. For purposes of this Grant Agreement Retirement means the attainment of&#58;</font></div><div style="padding-left:49.7pt"><font><br></font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">a.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%;padding-left:8pt">age 65&#59; </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">b.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%;padding-left:7.53pt">age 60 and completion of at least five years of continuous employment&#59; or</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">c.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%;padding-left:8.8pt">age 55 and completion of at least ten years of continuous employment. </font></div><div style="padding-left:50.4pt"><font><br></font></div><div style="padding-left:50.4pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">If retirement at an earlier age than noted in (a), (b) or (c) above is mandatory under applicable law or policy in the country where the Grantee is employed, for purposes of this Grant Agreement Retirement means the mandatory retirement date and the applicable service requirement closest to such date under (a), (b) or (c) above.</font></div><div style="padding-left:50.4pt"><font><br></font></div><div style="padding-left:50.4pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">For purposes of this Grant Agreement continuous employment means continuous employment with the Company, or an Affiliate (or with General Electric Company or any of its affiliates through the date of the Company&#8217;s spinoff from General Electric Company) ending on Termination of Employment. </font></div><div><font><br></font></div><div style="margin-bottom:9pt;padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Notwithstanding the foregoing, if the Company receives an opinion of counsel that there has been a legal judgement and&#47;or legal development in Grantee&#8217;s jurisdiction that would likely result in the favorable treatment applicable to the Award pursuant to subparagraphs (i)-(ii) being deemed unlawful and&#47;or discriminatory, then such favorable treatment shall not be applied.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">3. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Dividend Equivalents.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#160;&#160;The Company will establish an amount for each PSU equal to the per share quarterly dividend payments made to the Company&#8217;s stockholders during the period beginning on the Grant Date and ending on the date that such PSU vests or is cancelled (&#8220;Dividend Equivalents&#8221;).  The Company shall accumulate Dividend Equivalents and, upon vesting of the related PSU, will pay the Grantee a single lump sum cash amount equal to the Dividend Equivalents on the same date that a share of Common Stock is delivered with respect to such PSU, as described in Section 4 of this Grant Agreement.  Any accumulated and unpaid Dividend Equivalents attributable to a PSU that is cancelled will be immediately forfeited upon cancellation and will not be paid.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">4. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Delivery and Tax Withholding.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#160; As soon as practicable after the Vesting Date, the Company shall deliver to the Grantee a number of shares of Common Stock equal to the number of vested PSUs and the Dividend Equivalent cash amount with respect to each vested PSU (in each case net of applicable tax withholding and fees).  Delivery shall be electronic, through the brokerage account established by the Company for the Grantee, or in such other medium as is determined by the Company.  The Grantee is ultimately </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">responsible for any and all applicable taxes, regardless of the amount withheld or reported.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Notwithstanding the foregoing, the date of issuance or delivery of shares of Common Stock may be postponed by the Company for such period as may be required for it with reasonable diligence to comply with any applicable listing requirements of any national securities exchange and requirements under any law or regulation applicable to the issuance or transfer of such shares of Common Stock</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">to the extent such postponement is permissible under Section 409A of the Code.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">5.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Reserved.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">6. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Data Security and Privacy.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">  </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> </font></div><div style="margin-bottom:12pt;padding-left:49.7pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">i. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Data Collection, Processing and Usage.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Personal data collected, processed and used by the Company in connection with Awards granted under the Plan includes the Grantee&#8217;s name, home address, email address, telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any shares of Common Stock or directorships held in the Company, and details of all Awards granted, cancelled, exercised, vested, or outstanding.  In granting Awards under the Plan, the Company will collect the Grantee&#8217;s personal data for purposes of allocating shares of Common Stock in settlement of the Awards and implementing, administering and managing the Plan. The Company collects, processes and uses the Grantee&#8217;s personal data in compliance with Company&#8217;s Employment Data Protection Standards and the Uses of Employment Data for the Company&#8217;s Entities.  The Grantee may exercise rights to access, correction, or restriction or deletion where applicable, by contacting the Grantee&#8217;s local HR manager or initiating a request through </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">www.myhr.gehealthcare.com</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:49.7pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ii.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Administrative Service Provider.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  The Company transfers the Grantee&#8217;s personal data to UBS Financial Services, which assists with the implementation, administration and management of the Plan (the &#8220;Third-Party Administrator&#8221;).&#160; In the future, the Company may select a different Third-Party Administrator and share the Grantee&#8217;s personal data with another company that serves in a similar manner.  The Third-Party Administrator will open an account for the Grantee to receive and trade shares of Common Stock acquired under the Plan.&#160; The Grantee will be asked to agree on separate terms and data processing practices with the Third-Party Administrator, which is a condition to the Grantee&#8217;s ability to participate in the Plan.  The privacy policy of the Third-Party Administrator may be reviewed on the UBS Financial Services portal. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">7. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Non-solicitation, Non-competition and Compliance with Agreements.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">  </font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:49.7pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">i.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:11.09pt;text-decoration:underline">Non-solicitation.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">During the Grantee&#8217;s employment with the Company or any Affiliate, and for a period of twelve months after his&#47;her Termination Date (the &#8220;Restricted Period&#8221;), Grantee will not, for the benefit of a Competitor or other business, directly or through assistance to others, participate in soliciting a Covered </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:49.7pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee to leave the employment of the Company or assist a Competitor or other business in efforts to hire a Covered Employee away from the Company without the Company&#8217;s advance written approval.  </font></div><div style="padding-left:49.5pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Competitor&#8221; refers to any business (person, entity, or organization) that is engaged in, or preparing to engage in providing a Competing Product. </font></div><div style="margin-bottom:12pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Competing Product&#8221; is a product or service that would displace the business opportunities for, or otherwise compete with the products and&#47;or services (existing or under development) that Grantee had material involvement with during the Look Back Period, so long as the Company remains in such line of business. It will be presumed that &#8220;material involvement&#8221; includes access to Confidential Information about a product or service, involvement with a product through assisting in cross-selling the product where it is normally sold by a different part of the Company&#8217;s business, and supervision of other individuals who are selling or providing the product or service.  </font></div><div style="margin-bottom:12pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Confidential Information&#8221; has the meaning described in the Employee Innovation and Proprietary Information Agreement (&#8220;EIPIA&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Covered Employee&#8221; means an individual employed at the Lead Professional Band or higher (or any future equivalent management levels) to provide services to (or on behalf of) the Company that Grantee worked with, gained knowledge of, or was provided Confidential Information about as a result of Grantee&#8217;s employment with Company during the Look Back Period.  A Covered Employee shall be presumed to also include individuals who have, within the preceding 90 days, resigned their employment with the Company and have continuing contractual obligations to the Company. </font></div><div style="margin-bottom:12pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Look Back Period&#8221; is the two years that precede the Grantee&#8217;s Termination of Employment.</font></div><div style="padding-left:49.7pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Grantee primarily resides in California, the terms in footnote 1 will apply to Section 7.i.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font></div><div style="padding-left:49.7pt"><font><br></font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If Grantee primarily resides in California, the post-employment obligation in Section 7.i will not apply. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:49.7pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Grantee primarily resides in Washington, the terms in footnote 2 will apply to Section 7.i.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">2</font></div><div><font><br></font></div><div style="margin-bottom:9pt;padding-left:49.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ii.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:12.28pt;text-decoration:underline">Non-competition.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">During the Restricted Period, Grantee will not provide services to or be associated with a Competitor in any role or position (as an employee, director, owner, consultant or otherwise) that would involve his&#47;her participation in Competitive Activity within the Restricted Area. </font></div><div style="margin-bottom:12pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Competitive Activity&#8221; is activity that involves (a) providing services to or for a Competitor that are the same as or similar in function or purpose to those services Grantee provided to or for the Company during the period of his&#47;her employment with the Company (inclusive of employment with an acquired business that is now part of the Company) in the Look Back Period, (b) providing a Competing Product to a Covered Customer, or accepting business from a Covered Customer that involves a Competing Product, (c) owning, operating, or managing a business that is a Competitor, or (d) participating in other activity that is likely to result in the use or disclosure of Confidential Information for the benefit of a Competitor.  </font></div><div style="margin-bottom:12pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Covered Customer&#8221; means a customer of the Company that Grantee had material contact within the Look Back Period. Material contact will be presumed present if in the Look Back Period (i) the Grantee (or persons under his&#47;her supervision) provided services to or had business-related contact with the customer on behalf of the Company, (ii) Grantee was provided Confidential Information about the customer, or (iii) Grantee received commissions or other beneficial credit from the Company for business conducted with the customer.  Customers will be presumed to include active customer prospects as of the Grantee&#8217;s Termination of Employment that he&#47;she had material contact with or Confidential Information about and will not be limited to the end user or purchaser of the Company&#8217;s </font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If Grantee primarily resides in Washington, the choice of law in the Grant Agreement, including the Global Addendum, shall not be applied to the extent it deprives the Grantee of the protections or benefits of the Wash. Rev. Code &#167; 49.62.005&#8211;900 (2020) (the &#8220;Washington Act&#8221;), and the Grant Agreement shall not be applied so as to require Grantee to adjudicate a covenant covered by the Washington Act outside the state of Washington. Section 7.i. is modified to only prohibit solicitation by the Grantee of any Covered Employee who is an employee of the Company to leave employment with the Company in accordance with the definition of an enforceable &#8220;Nonsolicitation agreement&#8221; under the Washington Act.&#160; Section 7.ii. is modified to only prohibit solicitation by Grantee of any Covered Customer of the Company who is then a current customer to cease or reduce the extent to which the customer is doing business with the Company in accordance with the definition of an enforceable &#8220;Nonsolicitation agreement&#8221; under the Washington Act.&#160; Section 7.ii. will only be enforceable against Grantee if as of the date enforcement is sought or Grantee&#8217;s last day of employment (whichever is earlier) Grantee&#8217;s earnings from the Company in the prior year (or portion thereof for which Grantee was employed), when annualized, exceed the inflation-adjusted equivalent of one hundred thousand dollars ($100,000) per year as of Jan. 1, 2020 (the &#8220;Adjusted Threshold&#8221;) (adjusted as provided for in the Washington Act).&#160; This Adjusted Threshold figure is published annually at </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;lni.wa.gov&#47;workers-rights&#47;workplace-policies&#47;Non-Compete-Agreements</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160; In the event Grantee&#8217;s employment is terminated as a result of a layoff, Section 7.ii. will not be enforced by the Company unless the Company agrees at the time of Grantee&#8217;s layoff to provide Grantee with the payments required by Washington Act to keep such covenants in effect. </font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">products or services but shall also be understood to include customer representatives such as GPOs (Group Purchasing Organizations).  </font></div><div style="margin-bottom:12pt;padding-left:49.5pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Restricted Area&#8221; refers to the geographic locations of the Covered Customers and each geographic area, by state, county, or other recognized geographic boundary (as used in the ordinary course of the Company&#8217;s business) that is assigned to Grantee as a limitation on where he&#47;she is to do business for the Company in the Look Back Period if his&#47;her responsibilities for the Company and access to Confidential Information (through group management meetings or otherwise) is limited to a specific geographic territory.  If Grantee is not assigned a specific geographic territory that is limited in the forgoing way, or the forgoing scope of Restricted Area is not enforceable, then the Restricted Area shall be the geographic markets where the Company does business that Grantee has involvement with or has been provided Confidential Information about in the course of his&#47;her employment during the Look Back Period and that could be used to harm the protectable interests of the Company which will be presumed to be, if Grantee works or resides in the United States the state where he&#47;she resides, the state from which he&#47;she is assigned to work, if different from his&#47;her state of residence, the contiguous states, and each additional state within the United States where the Company does business or, if Grantee is not based in the United States, the country in which he&#47;she works and resides.  Grantee will not, through remote communications from outside of the Restricted Area, engage in prohibited activity that reaches into, relates to, or otherwise materially involves business within the Restricted Area. If the Restricted Area is not clear to Grantee upon his&#47;her Termination of Employment, he&#47;she will seek clarification from the Company&#8217;s Legal Department within 14 days after the Termination Date. Grantee agrees not to complain about any uncertainty he&#47;she may have regarding the Restricted Area applicable to him&#47;her if he&#47;she does not do so. </font></div><div style="padding-left:49.7pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If Grantee primarily resides in California, Colorado, or Minnesota, the post-employment obligations in Section 7.ii. will not apply. If Grantee primarily resides in Washington, the terms in footnote 2 will apply to Section 7.ii.</font></div><div style="padding-left:49.7pt"><font><br></font></div><div style="padding-left:49.7pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">iii.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:4.47pt;text-decoration:underline">Compliance with Agreements.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> Grantee will comply with and shall not breach any contractual obligations Grantee has to the Company or an Affiliate, including, but not limited to obligations Grantee has not to disclose the Company&#8217;s or any Affiliate&#8217;s Confidential Information. To the extent Grantee is subject to any existing agreements restricting Grantee&#8217;s ability to compete with the Company or any Affiliate (the &#8220;Prior Agreements&#8221;), this Grant Agreement will supplement and not replace or reduce the applicability or enforceability of the Prior Agreements. Grantee acknowledges that the scope of the restrictions in this Section 7 of this Grant Agreement may be different from those contained in other agreements with the Company or an Affiliate because the purpose of, and justification for the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:49.7pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">restrictions in this Grant Agreement may be different as described in Section 7.vii hereof.</font></div><div style="padding-left:49.7pt"><font><br></font></div><div style="padding-left:49.7pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">iv.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:4.82pt;text-decoration:underline">Relief.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Grantee agrees that any breach by him&#47;her of the foregoing obligations inevitably would cause substantial and irreparable damage to the Company and the Affiliates for which money damages may not be an adequate remedy.  Accordingly, the Grantee agrees that the Company and the Affiliates will be entitled to an injunction and&#47;or other equitable relief, without the necessity of posting security, to prevent the breach of such obligations.  The Grantee also agrees to indemnify and hold the Company and the Affiliates harmless from any loss, claim, or damages, including, without limitation, all reasonable attorneys&#8217; fees, costs and expenses incurred in enforcing its rights under this Grant Agreement, as well as to repay any payments made hereunder (regardless of whether the PSUs are vested), except to the extent that such reimbursement is prohibited by law.</font></div><div style="padding-left:49.7pt"><font><br></font></div><div style="padding-left:49.7pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">v.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:8.13pt;text-decoration:underline">Consideration.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Grantee agrees that the payment and benefits provided for in the Grant Agreement constitute fair and reasonable consideration for Grantee&#8217;s compliance with this Section 7.</font></div><div><font><br></font></div><div style="padding-left:49.7pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">vi.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:4.82pt;text-decoration:underline">Grantee Rights.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Nothing in this Grant Agreement prevents the Grantee from or interferes with the Grantee&#8217;s rights to file a claim or charge or participate, with or without notice to the Company, in an investigation or proceeding of a law enforcement authority or government agency, including any state or federal fair employment practices agency (such as the Equal Employment Opportunity Commission), the U.S. Securities and Exchange Commission, the Department of Labor, the Department of Justice, and the Financial Industry Regulatory Authority. </font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-left:49.7pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Nothing in this Grant Agreement prevents Grantee from disclosing information about acts in the workplace that Grantee has reason to believe are unlawful, including, but not limited to, harassment, discrimination or any other conduct.  If the Grantee primarily resides in Washington, the terms in footnote 3 will apply to Section 7.vi.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.8pt;font-weight:400;line-height:132%;position:relative;top:-4.2pt;vertical-align:baseline">3</font></div><div style="padding-left:50.4pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">vii.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:1.51pt;text-decoration:underline">Purpose.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> The purpose of, and justification for the restrictions in this Section 7 is to ensure Grantee&#8217;s conduct remains aligned with the interests of other stakeholders in the business and Grantee does not engage in conduct that is detrimental to, and inconsistent with the interests of the stakeholders and participants in the Plan if Grantee is going to be provided the opportunity to participate as a stakeholder in </font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If Grantee primarily resides in Washington, nothing in this Grant Agreement will be construed to prohibit Grantee from disclosing or discussing conduct Grantee reasonably believes to be illegal discrimination, illegal harassment, illegal retaliation, a wage and hour violation, sexual assault or recognized as a clear mandate of public policy or disclosing the existence of a settlement involving any such event or conduct.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:50.4pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">the business of the Company and benefit from the growth of the business, either as holder of PSUs, Options or any other equity granted under the Plan.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">8. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Additional Requirements.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  The Company reserves the right to impose other requirements on the Award, shares of Common Stock acquired pursuant to the Award, and the Grantee&#8217;s participation in the Plan to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law or to facilitate the operation and administration of the Award and the Plan.  Without limiting the generality of the foregoing, the Company may require the Grantee to sign any agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">9. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Alteration&#47;Termination.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#160; Under the express terms of this Grant Agreement, the Committee shall have the right at any time in its sole discretion to amend, alter, suspend, discontinue or terminate any PSUs without the consent of the Grantee.  Furthermore, if the Company determines in its sole discretion that the Grantee has engaged in conduct that (a) constitutes a breach of this Grant Agreement, the EIPIA or any other confidentiality, non-solicitation, or non-competition agreement with the Company or any Affiliate, (b) results in (or has the potential to cause) material harm financially, reputationally, or otherwise to the Company or any Affiliate or (c) occurred prior to the Grantee&#8217;s Termination of Employment and would give rise to a Termination of Employment for Cause (regardless of whether such conduct is discovered before or after the Grantee&#8217;s Termination of Employment), any outstanding PSUs shall be cancelled immediately, and any amounts previously conveyed under this Grant Agreement shall be subject to recoupment.  In any event, the PSUs provided under this Grant Agreement and any shares of Common Stock previously conveyed or other payments made in respect thereof, shall be further subject to any recoupment policy that the Company may adopt from time to time, to the extent such policy is applicable to the Grantee, and to such compensation including, but not limited to the GE HealthCare Technologies Inc. Clawback Policy designed to comply with the requirements of Rule 10D-1 promulgated under the Act, as in effect and amended from time to time.  By accepting the grant of PSUs under this Grant Agreement, the Grantee acknowledges, agrees and consents to the Company&#8217;s application, implementation, and enforcement of (x) such recoupment policies with respect to all covered compensation received or to be received by the Grantee, to the extent applicable, and (y) any provision of applicable law relating to cancellation, recoupment, recession, or payback of compensation and expressly agrees that the Company may take any such actions as are necessary to effectuate recoupment or applicable law without further consent or action being required by the Grantee, including issuing instructions to any Third-Party Administrator to (i) hold the Grantee&#8217;s shares of Common Stock and other amounts acquired under the Plan and&#47;or (ii) reconvey, transfer, or otherwise return such shares of Common Stock and other assets to the Company.  To </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">the extent that the terms of this Grant Agreement and any Company recoupment policy conflict, the terms of the recoupment policy shall prevail. Also, the PSUs shall be null and void to the extent the grant of the PSUs or the vesting thereof is prohibited under the laws of the country of residence of the Grantee.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">10. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Plan Terms and Definitions.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Except to the extent that the context clearly provides otherwise, all capitalized terms used in this Grant Agreement have the same meaning as given such terms in the Plan.  This Grant Agreement is subject to the terms and provisions of the Plan, which are incorporated by reference.  In the event of any conflict between the provisions of this Grant Agreement and those of the Plan, the provisions of the Plan shall control.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">11.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Interpretation and Construction.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  This Grant Agreement and the Plan shall be construed and interpreted by the Committee, in its sole discretion.  Any interpretation or other determination by the Committee (including correction of any defect or omission and reconciliation of any inconsistency) shall be binding and conclusive.  All determinations regarding enforcement, waiver or modification of the cancellation and rescission and other provisions of this Grant Agreement shall be made in the Committee&#8217;s sole discretion.  Determinations made under this Grant Agreement and the Plan need not be uniform and may be made selectively among individuals, whether or not such individuals are similarly situated.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">12.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Severability.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  The invalidity or unenforceability of any provision of the Plan or this Grant Agreement will not affect the validity or enforceability of any other provision of the Plan or this Grant Agreement, and each provision of the Plan and this Grant Agreement will be severable and enforceable to the extent permitted by law.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">13.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Stockholder Rights.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  The Grantee shall not have any voting or other stockholder rights unless and until shares of Common Stock are actually delivered to the Grantee.</font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">14.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">No Employment Rights.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  The grant of the Award described in this Grant Agreement does not give the Grantee any rights in respect of employment with the Company or any Affiliate.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">15.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Discretionary Award, Extraordinary Benefit.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Awards under the Plan are granted to employees of the Company and the Affiliates in the Committee&#8217;s sole discretion.  The Award described in this Grant Agreement is a one-time benefit and does not create any contractual or other right to receive other Awards under the Plan or other benefits in lieu thereof.  Future grants, if any, will be at the sole discretion of the Committee.  The Grantee&#8217;s participation in the Plan is voluntary.  This Award (and each other Award, if any, granted under the Plan) constitutes an extraordinary item of compensation and is not </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">part of the Grantee&#8217;s normal or expected compensation for purposes of calculating any severance, retirement, or other benefit rights (unless otherwise expressly provided in an applicable benefit plan).</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">16.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">No Transfer or Assignment.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">No rights under this Award shall be assignable or transferable by the Grantee, except to the extent expressly permitted by the Plan.</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">17.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Successors and Assigns.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  The Company may assign any of its rights under this Grant Agreement.  This Grant Agreement will be binding upon and inure to the benefit of the successors and assigns of the Company.  Subject to the restrictions on transfer set forth herein, this Grant Agreement will be binding upon the Grantee and the Grantee&#8217;s beneficiaries, executors or administrators.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">18.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Section 409A.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">To the extent applicable, this Grant Agreement shall be construed and administered consistently with the intent to comply with or be exempt from the requirements of Section 409A of the Code and any state law of similar effect (i.e., applying the &#8220;short-term deferral&#8221; rule described in Treas. Reg. &#167; 1.409A-1(b)(4) and&#47;or another exemption).  Where the Grant Agreement specifies a window during which a payment may be made, the payment date within such window shall be determined by the Company in its sole discretion.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">19.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Entire Agreement.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#160; This Grant Agreement, the Plan, and any rules, procedures and sub-plans (including country addenda) adopted by the Committee contain all of the provisions applicable to the PSUs.  No other statements, documents or practices may modify, waive or alter such provisions unless expressly set forth in writing, signed by an authorized officer of the Company and delivered to the Grantee.<br><br>By acknowledging this Grant Agreement, the Grantee acknowledges and confirms that the Grantee has read this Grant Agreement and the Plan (including applicable addenda), and the Grantee accepts and agrees to the provisions therein.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">20.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Electronic Delivery.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  The Company may, in its sole discretion, decide to deliver any documents related to this or other Awards under the Plan by electronic means.  The Grantee hereby consents to receive such documents electronically and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">21.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Global Addendum.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Notwithstanding any provisions in this document to the contrary, the PSUs will also be subject to the special terms and conditions set forth on Appendix A for Grantees who reside outside of the United States.  Moreover, if a Grantee is not a resident </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">of any of the countries listed on Appendix A as of the Grant Date, but relocates to one of the listed countries at any point thereafter, the special terms and conditions for such country will apply to the Grantee, to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan.  Appendix A constitutes part of this Grant Agreement.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:18pt;text-align:right;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Exhibit A</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GE HealthCare Technologies Inc. Compensation Peer Group</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.455%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Abbott Laboratories</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Thermo Fisher</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Danaher</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Medtronic</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Siemens Healthineers</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Becton Dickinson</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Stryker</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Philips</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Baxter</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Boston Scientific</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Quest Diagnostics</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Agilent Technologies</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Intuitive Surgical</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Edwards Lifesciences</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Hologic</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>6
<FILENAME>gehc1q202510qexhibit107.htm
<DESCRIPTION>EX-10.7
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i087907fca6054e6cb65a5abde4f77f88_41"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.7</font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><img alt="image_02.jpg" src="image_02.jpg" style="height:116px;margin-bottom:5pt;vertical-align:text-bottom;width:162px"><font style="color:#005eb8;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#91;Date&#93; Equity Grant Agreement</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GE HealthCare Technologies Inc. 2023 Long-Term Incentive Plan (&#8220;Plan&#8221;)</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">GE HealthCare New Hire Restricted Stock Unit Grant Agreement (&#8220;Grant Agreement&#8221;) </font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">For &#60;&#60;Employee Name&#62;&#62; (&#8220;Grantee&#8221;)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:16.05pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.429%"><tr><td style="width:1.0%"></td><td style="width:28.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.968%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.114%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.116%"></td><td style="width:0.1%"></td></tr><tr style="height:27pt"><td colspan="3" rowspan="2" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Grant Date</font></div></td><td colspan="3" rowspan="2" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">RSUs Granted</font></div></td><td colspan="6" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Vesting Schedule</font></div></td></tr><tr style="height:27pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Number of RSUs</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:10pt;padding-right:-2.63pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:122%">Vesting Date</font></div></td></tr><tr style="height:22pt"><td colspan="3" rowspan="2" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#60;&#60;Date&#62;&#62;</font></div></td><td colspan="3" rowspan="2" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#60;&#60;Number&#62;&#62;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">33%</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:-2.63pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#60;&#60;Date&#62;&#62;</font></div></td></tr><tr style="height:22pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">33%</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:-2.63pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#60;&#60;Date&#62;&#62;</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font><br></font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">34%</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:-2.63pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#60;&#60;Date&#62;&#62;</font></div></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">1. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Grant.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#160;&#160;The Talent, Culture, and Compensation Committee (&#8220;Committee&#8221;) of the Board of Directors of GE HealthCare Technologies Inc. (&#8220;Company&#8221;) has granted the above number of Restricted Stock Units (&#8220;RSUs&#8221;) to the Grantee, subject to the terms of this Grant Agreement.  Without limiting any condition of this RSU award, the award is subject to cancellation and forfeiture if the Grantee does not confirm acceptance within 45 days of the Grant Date.  Once vested, each RSU entitles the Grantee to receive from the Company (i) one share of Common Stock and (ii) a cash payment in respect of Dividend Equivalents (described below), each in accordance with the terms of this Grant Agreement, the Plan, and any rules, procedures and sub-plans (including country addenda) adopted by the Committee.</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">2. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Vesting.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#160; In order to vest in an RSU, the Grantee must not incur a Termination of Employment from the Grant Date through the applicable Vesting Date listed above.  All </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">unvested RSUs shall be immediately cancelled without payment upon the Grantee&#8217;s Termination of Employment for any reason before the applicable Vesting Date and the Grantee shall thereupon cease to have any right to receive any shares of Common Stock or cash payments in respect of Dividend Equivalents accrued in respect of those cancelled RSUs, except as specifically provided below&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="padding-left:49.7pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">i.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Death or Disability.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">&#160; </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">If the Grantee&#8217;s Termination of Employment is a result of the Grantee&#8217;s death or Disability prior to the final Vesting Date listed above, then any unvested RSUs shall vest as of such Termination of Employment.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%"> </font></div><div style="padding-left:49.7pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:49.7pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">ii.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:7.78pt;text-decoration:underline">Transfer of Business to Successor Employer.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">&#160; </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">If the Grantee&#8217;s Termination of Employment occurs prior to the final Vesting Date listed above as a result of transferring directly to employment with a successor employer in connection with the transfer by the Company or an Affiliate of a business operation, then any unvested RSUs shall vest as of such Termination of Employment.</font></div><div style="padding-left:49.7pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:49.7pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">iii.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:4.47pt;text-decoration:underline">Retirement Eligibility.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">If the Grantee meets the requirements for Retirement while in continuous employment and has a Termination of Employment after meeting such requirements prior to the final Vesting Date listed above and after the one-year anniversary of the Grant Date, then the Grantee shall continue to vest in any unvested RSUs in accordance with the Vesting Schedule above as if the Grantee remained in continuous employment. </font></div><div><font><br></font></div><div style="padding-left:49.7pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">For purposes of this Grant Agreement Retirement means the attainment of&#58;</font></div><div><font><br></font></div><div style="padding-left:68.4pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">a.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%;padding-left:8pt">age 65&#59; </font></div><div style="padding-left:68.4pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">b.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%;padding-left:7.53pt">age 60 and completion of at least five years of continuous employment&#59; or</font></div><div style="padding-left:68.4pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">c.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%;padding-left:8.8pt">age 55 and completion of at least ten years of continuous employment. </font></div><div style="padding-left:50.4pt"><font><br></font></div><div style="padding-left:50.4pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">If retirement at an earlier age than noted in (a), (b) or (c) above is mandatory under applicable law or policy in the country where the Grantee is employed, for purposes of this Grant Agreement Retirement means the mandatory retirement date and the applicable service requirement closest to such date under (a), (b) or (c) above.</font></div><div style="padding-left:50.4pt"><font><br></font></div><div style="padding-left:50.4pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">For purposes of this Grant Agreement continuous employment means continuous employment with the Company, or an Affiliate (or with General Electric Company or any of its affiliates through the date of the Company&#8217;s spinoff from General Electric Company) ending on the Termination Date.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">iv.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;padding-left:4.82pt;text-decoration:underline">Termination without Cause or with Good Reason.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> If the Grantee&#8217;s Termination of Employment occurs as a result of an involuntary termination by the Company or an Affiliate without Cause or by the Grantee with Good Reason prior to the final Vesting Date listed above, subject to Grantee&#8217;s execution and non-revocation of a general release of claims in favor of the Company in the form provided by the Company, then any unvested RSUs shall vest pro rata as of the Termination of Employment. Pro rata vesting is calculated as an amount equal to (a)(i) the number of RSUs granted, multiplied by (ii) a fraction where the numerator is the number of complete calendar months from the Grant Date through the Termination of Employment and the denominator is the number of calendar months from the Grant Date through the final Vesting Date, minus (b) any RSUs that vested prior to the Grantee&#8217;s Termination of Employment.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline"> </font></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Notwithstanding the foregoing, if the Company receives an opinion of counsel that there has been a legal judgment and&#47;or legal development in Grantee&#8217;s jurisdiction that would likely result in the favorable treatment applicable to the Award pursuant to subparagraphs (i)-(iv) being deemed unlawful and&#47;or discriminatory, then such favorable treatment shall not be applied. </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">3. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Dividend Equivalents.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#160;&#160;The Company will establish an amount for each RSU equal to the per share quarterly dividend payments made to the Company&#8217;s stockholders during the period beginning on the Grant Date and ending on the date that such RSU vests or is cancelled (&#8220;Dividend Equivalents&#8221;).  The Company shall accumulate Dividend Equivalents and, upon vesting of the related RSU, will pay the Grantee a single lump sum cash amount equal to the Dividend Equivalents on the same date that a share of Common Stock is delivered with respect to such RSU, as described in Section 4 of this Grant Agreement.  Any accumulated and unpaid Dividend Equivalents attributable to a RSU that is cancelled will be immediately forfeited upon cancellation and will not be paid.</font></div><div style="padding-left:57.75pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">4. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Delivery and Tax Withholding.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#160; Subject to Section XX(d) of the Plan, if applicable, within two weeks of the date any RSUs vest, the Company shall deliver to the Grantee a number of shares of Common Stock equal to the number of vested RSUs and the Dividend Equivalent cash amount with respect to each vested RSU (in each case net of applicable tax withholding and fees).  Delivery shall be electronic, through the brokerage account established by the Company for the Grantee, or in such other medium as is determined by the Company. </font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Except as would result in taxation under Section 409A of the Code, if any income tax, social insurance, payroll tax, or other related similar withholding becomes legally due from Grantee prior to the settlement of such RSUs after vesting on account of the Grantee meeting the requirements of Retirement, settlement of a portion of the shares necessary </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">to satisfy such amounts may be accelerated by withholding shares, or by such other method as may be approved by the Committee.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">The Grantee is ultimately responsible for any and all applicable taxes, regardless of the amount withheld or reported.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Notwithstanding the foregoing, the date of issuance or delivery of shares of Common Stock may be postponed by the Company for such period as may be required for it with reasonable diligence to comply with any applicable listing requirements of any national securities exchange and requirements under any law or regulation applicable to the issuance or transfer of such shares of Common Stock</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">to the extent such postponement is permissible under Section 409A of the Code.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">5.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Reserved.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">6. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Data Security and Privacy.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">  </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> </font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:49.7pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">i. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Data Collection, Processing and Usage.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Personal data collected, processed and used by the Company in connection with Awards granted under the Plan includes the Grantee&#8217;s name, home address, email address, telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any shares of Common Stock or directorships held in the Company, and details of all Awards granted, cancelled, exercised, vested, or outstanding.  In granting Awards under the Plan, the Company will collect the Grantee&#8217;s personal data for purposes of allocating shares of Common Stock in settlement of the Awards and implementing, administering and managing the Plan. The Company collects, processes and uses the Grantee&#8217;s personal data in compliance with Company&#8217;s Employment Data Protection Standards and the Uses of Employment Data for the Company&#8217;s Entities.  The Grantee may exercise rights to access, correction, or restriction or deletion where applicable, by contacting the Grantee&#8217;s local HR manager or initiating a request through </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">www.myhr.gehealthcare.com</font><font style="color:#000000;font-family:'Segoe UI',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:49.7pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ii.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Administrative Service Provider.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  The Company transfers the Grantee&#8217;s personal data to UBS Financial Services, which assists with the implementation, administration and management of the Plan (the &#8220;Third-Party Administrator&#8221;).&#160; In the future, the Company may select a different Third-Party Administrator and share the Grantee&#8217;s personal data with another company that serves in a similar manner.  The Third-Party Administrator will open an account for the Grantee to receive and trade shares of Common Stock acquired under the Plan.&#160; The Grantee will be asked to agree on separate terms and data processing practices with the Third-Party Administrator, which is a condition to the Grantee&#8217;s ability to participate in the Plan.  The privacy policy of the Third-Party Administrator may be reviewed on the UBS Financial Services portal.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">7. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Reserved.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:49.7pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">8. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Additional Requirements.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  The Company reserves the right to impose other requirements on the Award, shares of Common Stock acquired pursuant to the Award, and the Grantee&#8217;s participation in the Plan to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law or to facilitate the operation and administration of the Award and the Plan.  Without limiting the generality of the foregoing, the Company may require the Grantee to sign any agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">9. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Alteration&#47;Termination.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#160; Under the express terms of this Grant Agreement, the Committee shall have the right at any time in its sole discretion to amend, alter, suspend, discontinue or terminate any RSUs without the consent of the Grantee.  Furthermore, if the Company determines in its sole discretion that the Grantee has engaged in conduct that (a) constitutes a breach of this Grant Agreement, the Employee Innovation and Proprietary Information Agreement, or any other confidentiality, non-solicitation, or non-competition agreement with the Company or any Affiliate, (b) results in (or has the potential to cause) material harm financially, reputationally, or otherwise to the Company or any Affiliate or (c) occurred prior to the Grantee&#8217;s Termination of Employment and would give rise to a Termination of Employment for Cause (regardless of whether such conduct is discovered before or after the Grantee&#8217;s Termination of Employment), any outstanding RSUs shall be cancelled immediately, and any amounts previously conveyed under this Grant Agreement shall be subject to recoupment.  In any event, the RSUs provided under this Grant Agreement and any shares of Common Stock previously conveyed or other payments made in respect thereof, shall be further subject to any recoupment policy that the Company may adopt from time to time, to the extent any such policy is applicable to the Grantee, and to such compensation, including, but not limited to, the GE HealthCare Technologies Inc. Clawback Policy, designed to comply with the requirements of Rule 10D-1 promulgated  under the Act, as in effect and amended from time to time. By accepting the grant of RSUs under this Grant Agreement, the Grantee acknowledges, agrees, and consents to the Company&#8217;s application, implementation, and enforcement of (x) such recoupment policies with respect to all covered compensation received or to be received by the Grantee, to the extent applicable, and (y) any provision of applicable law relating to cancellation, recoupment, recession, or payback of compensation, and expressly agrees that the Company may take any such actions as are necessary to effectuate recoupment or applicable law without further consent or action being required by the Grantee, including issuing instructions to any Third-Party Administrator to (i) hold the Grantee&#8217;s shares of Common Stock and other amounts acquired under the Plan and&#47;or (ii) reconvey, transfer, or otherwise return such shares of Common Stock and other assets to the Company.  To the extent that the terms of this Grant Agreement any Company recoupment policy conflict, the terms of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">recoupment policy shall prevail. Also, the RSUs shall be null and void to the extent the grant of the RSUs or the vesting thereof is prohibited under the laws of the country of residence of the Grantee.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Nothing in this Grant Agreement prevents the Grantee from or interferes with the Grantee&#8217;s rights to file a claim or charge or participate, with or without notice to the Company, in an investigation or proceeding of a law enforcement authority or government agency, including any state or federal fair employment practices agency (such as the Equal Employment Opportunity Commission), the U.S. Securities and Exchange Commission, the Department of Labor, the Department of Justice, and the Financial Industry Regulatory Authority. </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Nothing in this Grant Agreement prevents the Grantee from disclosing information about acts in the workplace that Grantee has reason to believe are unlawful, including, but not limited to, harassment, discrimination or any other conduct. If the Grantee primarily resides in Washington, the terms in footnote 1 will apply to Section 9.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:7.8pt;font-weight:400;line-height:132%;position:relative;top:-4.2pt;vertical-align:baseline">1</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">10. &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Plan Terms and Definitions.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#160; Except to the extent that the context clearly provides otherwise, all capitalized terms used in this Grant Agreement have the same meaning as given such terms in the Plan.  This Grant Agreement is subject to the terms and provisions of the Plan, which are incorporated by reference.  In the event of any conflict between the provisions of this Grant Agreement and those of the Plan, the provisions of the Plan shall control.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">11.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Interpretation and Construction.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  This Grant Agreement and the Plan shall be construed and interpreted by the Committee, in its sole discretion.  Any interpretation or other determination by the Committee (including correction of any defect or omission and reconciliation of any inconsistency) shall be binding and conclusive.  All determinations regarding enforcement, waiver or modification of the cancellation and rescission and other provisions of this Grant Agreement shall be made in the Committee&#8217;s sole discretion.  Determinations made under this Grant Agreement and the Plan need not be uniform and may be made selectively among individuals, whether or not such individuals are similarly situated.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">12.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Severability.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  The invalidity or unenforceability of any provision of the Plan or this Grant Agreement will not affect the validity or enforceability of any other provision of the Plan </font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Grantee primarily resides in Washington, nothing in this Grant Agreement will be construed to prohibit Grantee from disclosing or discussing conduct Grantee reasonably believes to be illegal discrimination, illegal harassment, illegal retaliation, a wage and hour violation, sexual assault or recognized as a clear mandate of public policy or disclosing the existence of a settlement involving any such event or conduct.  </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">or this Grant Agreement, and each provision of the Plan and this Grant Agreement will be severable and enforceable to the extent permitted by law.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">13.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Stockholder Rights.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  The Grantee shall not have any voting or other stockholder rights unless and until shares of Common Stock are actually delivered to the Grantee.</font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">14.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">No Employment Rights.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  The grant of the Award described in this Grant Agreement does not give the Grantee any rights in respect of employment with the Company or any Affiliate.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">15.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Discretionary Award, Extraordinary Benefit.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Awards under the Plan are granted to employees of the Company and the Affiliates in the Committee&#8217;s sole discretion.  The Award described in this Grant Agreement is a one-time benefit and does not create any contractual or other right to receive other Awards under the Plan or other benefits in lieu thereof.  Future grants, if any, will be at the sole discretion of the Committee.  The Grantee&#8217;s participation in the Plan is voluntary.  This Award (and each other Award, if any, granted under the Plan) constitutes an extraordinary item of compensation and is not part of the Grantee&#8217;s normal or expected compensation for purposes of calculating any severance, retirement, or other benefit rights (unless otherwise expressly provided in an applicable benefit plan).</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">16.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">No Transfer or Assignment.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">No rights under this Award shall be assignable or transferable by the Grantee, except to the extent expressly permitted by the Plan.</font></div><div style="margin-bottom:10pt;padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">17.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Successors and Assigns.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  The Company may assign any of its rights under this Grant Agreement.  This Grant Agreement will be binding upon and inure to the benefit of the successors and assigns of the Company.  Subject to the restrictions on transfer set forth herein, this Grant Agreement will be binding upon the Grantee and the Grantee&#8217;s beneficiaries, executors or administrators.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">18.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Section 409A.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">To the extent applicable, this Grant Agreement shall be construed and administered consistently with the intent to comply with or be exempt from the requirements of Section 409A of the Code and any state law of similar effect (i.e., applying the &#8220;short-term deferral&#8221; rule described in Treas. Reg. &#167; 1.409A-1(b)(4) and&#47;or another exemption).  Where the Grant Agreement specifies a window during which a payment may be made, the payment date within such window shall be determined by the Company in its sole discretion&#59; provided, however, that if the RSUs are subject to Section 409A, then any payment of the RSUs on a Vesting Date listed above will occur no later than December 31 of the year in which such applicable Vesting Date occurs.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">19.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Entire Agreement.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#160; This Grant Agreement, the Plan, and any rules, procedures and sub-plans (including country addenda) adopted by the Committee contain all of the provisions applicable to the RSUs.  No other statements, documents or practices may modify, waive or alter such provisions unless expressly set forth in writing, signed by an authorized officer of the Company and delivered to the Grantee.<br><br>By acknowledging this Grant Agreement, the Grantee acknowledges and confirms that the Grantee has read this Grant Agreement and the Plan (including applicable addenda), and the Grantee accepts and agrees to the provisions therein.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">20.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Electronic Delivery.</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  The Company may, in its sole discretion, decide to deliver any documents related to this or other Awards under the Plan by electronic means.  The Grantee hereby consents to receive such documents electronically and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%">21.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:132%;text-decoration:underline">Global Addendum.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:132%">Notwithstanding any provisions in this document to the contrary, the RSUs will also be subject to the special terms and conditions set forth on Appendix A for Grantees who reside outside of the United States.  Moreover, if a Grantee is not a resident of any of the countries listed on Appendix A as of the Grant Date, but relocates to one of the listed countries at any point thereafter, the special terms and conditions for such country will apply to the Grantee, to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan.  Appendix A constitutes part of this Grant Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>7
<FILENAME>gehc1q202510qexhibit108.htm
<DESCRIPTION>EX-10.8
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="idcf7f6f7658841d99e0c37cb91c79be0_41"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.8</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Global Addendum</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Global Information for the GE HealthCare Technologies Inc. (&#8220;GE HealthCare&#8221; or &#8220;Company&#8221;) 2023 Long-Term Incentive Plan (the &#8220;Plan&#8221;) </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">January 2025</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Addendum provides additional terms and conditions of your grant in </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section A</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and specific additional terms and conditions and&#47;or notifications that apply to participants who reside, are employed and&#47;or otherwise subject to the local laws, rules and&#47;or regulations in one of the countries listed below in </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section B</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Capitalized terms not defined in this Addendum shall have the meaning set forth in the Plan or the GE HealthCare Stock Option Grant Agreement, GE HealthCare Restricted Stock Unit Grant Agreement, or GE HealthCare Performance Stock Unit Grant Agreement (collectively, the &#8220;Grant Agreements&#8221;), as applicable.  References in this Addendum to &#8220;UBS Financial Services&#8221; shall apply equally to any successor broker designated by the Company, at its discretion.  Further, to the extent specified herein, provisions in this Addendum shall apply to stock options (&#8220;Options&#8221;), restricted stock units (&#8220;RSUs&#8221;) and performance stock units (&#8220;PSUs&#8221;, and together with Options and RSUs, &#8220;Awards&#8221;) granted both on or after the date of this Addendum. </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The parties acknowledge that it is their express wish that this Addendum, as well as all documents, notices and legal proceeds entered into, given or instituted pursuant hereto or relating directly to indirectly hereto, be provided to them in English. If you have received the Grant Agreement, this Addendum or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control, unless otherwise required by applicable laws.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">General Provisions Applicable to All Grantees</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:8.07pt">Nature of the Awards.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> You acknowledge that you have received materials describing the Plan and its terms and conditions, and that you understand the description of the Plan and agree to its terms and conditions.  Accordingly, you should understand that the Plan is established voluntarily by the Company, is discretionary, and can be amended and&#47;or discontinued by the Company at any time without any liability to you and (ii) no Affiliate of the Company has any obligation to make any payment of any kind to you under the Grant Agreements.  You acknowledge that Award grants under the Plan are subject to the Plan, are occasional and voluntary and can be amended and&#47;or forfeited at any time without liability to you, and that receipt of a given grant does not create any contractual or other right to receive future grants or benefits in lieu of Awards, even if Awards have been granted in the past.  All decisions with respect to future Awards, if any will be at the sole discretion of the Company. Further, you understand and freely accept that there is no guarantee that any benefit whatsoever shall arise from any gratuitous and discretionary grant since the future value of the Awards and underlying shares is unknown and unpredictable.  Neither the Company, nor any of its Affiliates shall be liable for any foreign exchange rate fluctuation between your local currency and the United States Dollar that may affect the value of the shares or any amounts due pursuant to the Awards or the subsequent sale of any shares acquired under the Plan. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 1 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You acknowledge and accept that taking part in the Plan is outside the terms of your regular employment and the Award, and income from and value of same, are not part of normal or expected compensation or salary for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, holiday&#47;vacation pay, bonuses, long-service awards, leave-related payments, pension or retirement or welfare benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company or any Affiliate.  This invitation to participate in the Plan and any subsequent acquisition of shares or other benefits under the Plan do not establish and are not to be interpreted as establishing or amending a labor relationship or employment or service contract between you and the Company or any of its </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Affiliates</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and do not establish any rights between you and your employer.  You also acknowledge that the termination of your employment or service under any circumstances will not give you any claim or right of action against the Company or its Affiliates with respect to any loss of any Award or other benefit under the Plan.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You agree that no claim or entitlement to compensation or damages shall arise from (i) forfeiture of your Awards resulting from your Termination of Employment (regardless of the reason for the termination and whether or not the termination is later found to be invalid or in breach of applicable laws in the jurisdiction where you are employed or providing services or the terms of your employment or service contract, if any) and&#47;or (ii) the application of any clawback&#47;recoupment provisions in the Grant Agreements. No recovery of compensation or other benefits as described herein will be an event giving rise to your right to resign for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or similar term) under any plan of, or agreement you have with, the Company or any of its Affiliates.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:8.07pt">Responsibility for Taxes and Other Legal Obligations. </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You also acknowledge that the tax and legal rules that apply to the Plan may change from time to time and that the Company is not responsible for providing updated tax information to you.  You should understand that there may be personal tax payment and reporting obligations that could result from the grant, vesting, and exercise of Awards and the sale of shares and the payment of any dividends or dividend equivalent payments that you receive through the Plan.  Please note that the Company is not providing tax or regulatory advice and you should discuss potential tax or regulatory issues with your personal advisor.  You further understand that, regardless of any action taken by the Company or, if different, the Affiliate employing or receiving your services (the &#8220;Service Recipient&#8221;), neither the Company nor any of its Affiliates are responsible in any circumstance for your individual liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items (&#8220;Tax-Related Items&#8221;), foreign exchange control or other legal obligations arising from your participation in this Plan.  You further acknowledge that the Company and&#47;or the Service Recipient (i)&#160;make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Plan, including, but not limited to, the grant of the Awards under the Plan, the purchase of shares, the issuance or disposition of shares purchased under the Plan or the issuance of any dividends or dividend equivalents&#59; and (ii)&#160;do not commit to and are under no obligation to structure the terms of the Awards or any aspect of the Plan to reduce or eliminate your liability for Tax-Related Items or achieve any particular tax result. Further, if you are subject to Tax-Related Items in more than one </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 2 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">jurisdiction, you acknowledge that the Company and&#47;or the Service Recipient (or former service recipient, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Prior to any applicable taxable event, you shall pay or make adequate arrangements satisfactory to the Company and&#47;or the Service Recipient to satisfy all Tax-Related Items.  In this regard, you authorize the Company and&#47;or the Service Recipient to withhold all applicable Tax-Related Items legally payable by you from your wages or other cash compensation paid to you by the Company and&#47;or the Service Recipient or from proceeds of the sale of shares sold on your behalf, either through a voluntary sale or a mandatory sale arranged by the Company, pursuant to this authorization.  In addition, you authorize the Company and&#47;or the Service Recipient to withhold applicable Tax-Related Items by withholding in shares issuable to you pursuant to the Award.  If the obligation for taxes is satisfied by withholding a number of whole shares as described herein, you will be deemed to have been issued the full number of shares subject to the Award, notwithstanding that a number of the shares is held back solely for the purpose of paying the applicable taxes.  You agree that the Company may use any other means determined by the Company and compliant with applicable laws that are not described herein. Further, if&#160;you have become subject to Tax-Related Items in more than one jurisdiction between the date of grant and the date of any relevant taxable event,&#160;you acknowledge that the Company and&#47;or the Service Recipient (or former service recipient, as applicable) may be required to withhold or account for&#160;(including report) Tax-Related Items in more than one jurisdiction.  You agree to hold the Company and&#47;or the Service Recipient (or former employer, as applicable) harmless in this respect.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company may withhold or account for Tax-Related Items by considering statutory or other withholding rates, including minimum or maximum rates applicable in the jurisdiction(s) applicable to you. In the event of over-withholding, you may receive a refund of any over-withheld amount in cash (with no entitlement to the equivalent in shares), or if not refunded, you may seek a refund from the local tax authorities. Finally, you agree to pay to the Company or the Service Recipient any amount of Tax-Related Items that the Company or the Service Recipient may be required to withhold or account for as a result of your participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to purchase or deliver the shares or the proceeds of the sale of shares if you fail to comply with your obligations in connection with the Tax-Related Items.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:8.07pt">Electronic Delivery and Acceptance.  </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You authorize the Company and the Service Recipient to deliver information about the Plan to you electronically through email or other web-based or electronic information delivery systems.  You further authorize future Plan transactions to occur electronically through web-based or electronic systems or through other designated means.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:8.07pt">No Tending Previously-Owned Shares for Option Exercises.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> If you are granted Options under the Plan, you understand that you are prohibited from tendering any other shares you may hold to pay the exercise price of the Option. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:8.07pt">Data Privacy.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> You hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this Addendum </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 3 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and any other grant materials by and among, as applicable, the Service Recipient, the Company and its Affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;You understand that the Company and the Service Recipient may hold certain personal information about you, including (but not limited to) your name, home address, email address and telephone number, date of birth, social insurance, passport or other identification number (e.g., resident registration number), salary, nationality, job title, any shares or directorships held in the Company, and details of all Awards granted to you or any other entitlements to shares awarded, canceled, exercised, vested, unvested or outstanding in your favor (&#8220;Data&#8221;) for the purpose of implementing, managing and administering the Plan.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You understand that Data may be transferred to any third parties assisting the Company with the implementation, administration and management of the Plan, including but not limited to </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">UBS Financial Services</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and its affiliates or any successor or any other third party that the Company or </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">UBS Financial Services</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (or its successor) may engage to assist with the administration of the Plan from time to time.  You understand the recipients of the Data may be located in your country, in the United States or elsewhere, and that the recipients&#8217; country may have different data privacy laws and protections than your country.  You understand that you may request a list with the names and addresses of any potential recipients of the Data by contacting your local human resources representative.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:35.3pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You authorize the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing your participation in the Plan.  You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom you may elect to deposit any shares acquired upon vesting and&#47;or exercise of the Awards.  You understand that you may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing your local human resources representative.  Further, you understand that you are providing the consents herein on a purely voluntary basis.  If you do not consent, or if you later revoke your consent, your employment status or service with the Service Recipient will not be adversely affected&#59; the only consequence of refusing or withdrawing your consent is that the Company would not be able to grant you Awards or other equity awards or administer or maintain such awards.  Therefore, you understand that refusing or withdrawing your consent may affect your ability to participate in the Plan.  For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact GE HealthCare Technologies Inc. Executive Compensation Administration by sending an email to </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">GEHC.Equity&#64;gehealthcare.com</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:26.9pt">Governing Law and Venue.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> You understand that the Plan, the Grant Agreements and this Addendum are interpreted and construed in accordance with the laws of the State of Delaware, United States of America and applicable federal law, including </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 4 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">securities laws, without regard to the conflict of law provisions.  For purposes of any action, lawsuit or other proceedings brought to enforce this Grant Agreement and Addendum, relating to it, or arising from it, the parties hereby submit to and consent to the sole and exclusive jurisdiction of the state and federal courts located in the state of Delaware, United States of America and waive any objection based on lack of jurisdiction or inconvenient forum, and no other courts, where this grant is made and&#47;or to be performed.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27.5pt">Restrictive Covenants&#59; Clawback&#47;Recoupment Provisions.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Please note that, unless otherwise stated in the Country Specific Provisions of </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section B</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> below, any restrictive covenants and&#47;or clawback provisions in the Grant Agreements, such as Section 6 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Stock Option Grant Agreement, Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Restricted Stock Unit Grant Agreement, Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Performance Stock Unit Grant Agreement, Section 8 of the Stock Option Grant Agreement (&#8220;Alteration&#47;Termination&#8221;), Section 9 of the Restricted Stock Unit Grant Agreement (&#8220;Alteration&#47;Termination&#8221;), and Section 9 (&#8220;Alteration&#47;Termination&#8221;) of the Performance Stock Unit Grant Agreement, shall apply to you to the extent permitted by applicable law. Notwithstanding any language in the Grant Agreements or this Addendum to the contrary, however, you understand and agree that, to the extent you have an employment agreement or other agreement with your local employer or Service Recipient outside the United States, any restrictive covenants and&#47;or clawback provisions in the Grant Agreements, whether or not revised by this Addendum, shall only apply to the extent these provisions are consistent with the applicable provisions of your employment agreement.  To the extent the applicable provisions of your employment agreement are inconsistent with the provisions in the Grant Agreements, the terms in your employment agreement will apply to you.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27.5pt">Imposition of Other Requirements.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The Company reserves the right to impose other requirements on your participation in the Plan, on the Options, RSUs or PSUs and on any shares acquired under the Plan, to the extent GE HealthCare&#160;determines it is necessary or desirable in order to comply with or take advantage of local regulations or the like, or facilitate the administration of the Plan, and to require you to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27.5pt">Waiver. </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You acknowledge that a waiver by the Company of breach of any provision of the Grant Agreements or this Addendum shall not operate or be construed as a waiver of any other provision of the Grant Agreements or this Addendum, or of any subsequent breach by you or any other Participant.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27.5pt">Insider Trading Restrictions&#47;Market Abuse Laws</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. You acknowledge that, depending on your or your broker&#8217;s country of residence or where the shares are listed, you may be subject to insider trading restrictions and&#47;or market abuse laws that may affect your ability to accept, acquire, sell or otherwise dispose of shares, rights to shares or rights linked to the value of shares under the Plan during such times that you are considered to have &#8220;inside information&#8221; regarding the Company (as defined by the laws or regulations in your country). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders you placed before you possessed inside information. Furthermore, you </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 5 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">could be prohibited from (i)&#160;disclosing the inside information to any third party (other than on a &#8220;need to know&#8221; basis) and (ii)&#160;&#8220;tipping&#8221; third parties or causing them otherwise to buy or sell securities. You should keep in mind that third parties include fellow employees. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. You are responsible for ensuring compliance with any restrictions and should consult with your personal legal advisor on this matter.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.93pt">Exchange Control, Tax and&#47;or Foreign Asset &#47; Account Reporting</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Your country of residence may have certain foreign asset and&#47;or account reporting or exchange control requirements that may affect your ability to acquire or hold shares under the Plan or cash received from participating in the Plan (including proceeds arising from the sale of shares) in a brokerage or bank account outside your country. You may be required to report such accounts, assets or transactions to the tax or other authorities in your country. You may also be required to repatriate sale proceeds or other funds received as a result of your participation in the Plan to your country through a designated broker or bank and&#47;or within a certain time after receipt. In addition, you agree to take any and all actions, and consent to any and all actions taken by the Company or the Service Recipient as may be required to allow the Company or the Service Recipient to comply with local laws, rules and regulations in your country of residence (and country of employment, if different). Finally, you agree to take any and all actions as may be required to comply with your personal legal and tax obligations under local laws, rules and regulations in your country of residence (and country of employment, if different).  You are responsible for ensuring compliance with such regulations and should consult with your personal legal advisor for any details.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.93pt">Method of Option Exercise.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Notwithstanding any provision in the GE HealthCare Stock Option Grant Agreement, the Company, in its sole discretion, may require that you (or in the event of your death, your legal representative, as the case may be) exercise Options by a means of a same day sale transaction (either a &#8220;sell-all&#8221; transaction or a &#8220;sell-to-cover&#8221; transaction), or may require you to sell any shares of Common Stock you acquire under the Plan immediately upon exercise or within a specified period (in which case, you hereby agree that the Company shall have the authority to issue sale instructions in relation to such shares of Common Stock on your behalf).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.93pt">Settlement of RSUs and&#47;or PSUs.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Notwithstanding any provision in the GE HealthCare Restricted Stock Unit Grant Agreement or the GE HealthCare Performance Stock Unit Grant Agreement, the Company, in its discretion, may provide for the settlement of RSUs and&#47;or PSUs in the form of&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.08pt">a cash payment (in an amount equal to the Fair Market Value of the shares of Common Stock that correspond to the vested Units) to the extent that settlement in shares of Common Stock (i) is prohibited under local law, (ii) would require you, the Company or the Service Recipient to obtain the approval of any governmental or regulatory body in your country of employment and&#47;or residency, (iii) would result in adverse tax consequences for you, the Company or the Service Recipient, or (iv) is administratively burdensome&#59; or</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:23.57pt">shares of Common stock, but require you to sell such shares of Common Stock immediately or within a specified period (in which case, you hereby agree </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 6 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that the Company shall have the authority to issue sale instructions in relation to such shares of Common Stock on your behalf).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.&#160;&#160;&#160;&#160;</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Country Specific Provisions</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Your participation in the Plan shall be subject to any additional terms and conditions set forth in this </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section B</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Addendum for your country, state or jurisdiction. Moreover, if you relocate to or otherwise becomes subject to the local laws, rules and regulations in one of the jurisdictions included herein, the additional terms and conditions for such country will apply to you, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your relocation). </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">All Countries </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">U.S. Estate Tax</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Please note that shares and Options or other Awards to acquire shares of GE HealthCare stock that you own may be subject to U.S. estate tax upon your death.  Some countries have estate tax treaties which may impact these requirements.  You and&#47;or your beneficiary should consult a tax advisor to determine how these rules apply to your situation.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Acceleration of Vesting</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58; If the Company receives an opinion of counsel that there has been a legal judgment and&#47;or legal development in your jurisdiction that would likely result in the favorable treatment applicable to the Award for accelerated vesting in the event of certain events being deemed unlawful and&#47;or discriminatory, then the Company, in its sole discretion, will not apply this favorable treatment.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">European Union, European Economic Area and the United Kingdom</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Data Privacy</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Please consult the addendum addressing the EU General Data Protection Regulation, which is attached hereto as </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Appendix A</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and which replaces any data provision consent in any grant documentation.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Algeria</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Local Cash Settlement of Award</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding anything in the Grant Agreement or the Addendum to the contrary, unless otherwise determined by the Company, the Award shall be settled in cash only paid by the Service Recipient through local payroll (and shall not be settled in shares issued by the Company).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Argentina</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Control Information</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Exchange control restrictions may limit the ability to remit funds out of Argentina in order to exercise the Option or remit funds into Argentina following the receipt of the proceeds from the cashless exercise of the Option.  The Company reserves the right to further restrict the exercise of the Option or to amend or cancel the Option at any time in order to comply with applicable exchange control laws in Argentina.  You are responsible for complying with exchange control laws in Argentina and neither the Company nor the Service Recipient will be liable for any fines or penalties resulting from your failure to comply with applicable laws.  Because exchange control laws and regulations change frequently and without notice, you should consult with your personal advisor before </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 7 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">accepting the Option and before exercising the Option and&#47;or selling any shares acquired upon exercise of the Option to ensure compliance with current regulations.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Law</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Awards granted pursuant to the Plan and the shares which may be purchased upon exercise of the Option or acquired upon vesting of the RSUs or PSUs are offered in a private transaction and are not subject to the supervision of any Argentine governmental authority.  This is not an offer to the public.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Australia</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Law</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The grant of RSUs and&#47;or PSUs is being made pursuant to Division 1A, Part 7.12 of the Corporations Act 2001 (Cth).  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Tax Notification</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Plan is a plan to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) applies (subject to conditions in the Act).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Austria</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">There are no country specific provisions.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Bangladesh</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Mandatory Full Cashless Option Exercise</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Due to local legal requirements, your Option must be exercised pursuant to a broker-assisted cashless method of exercise.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Belgium</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Acceptance of Options</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding any provision in the GE HealthCare Stock Option Grant Agreement to the contrary, Options granted to you shall not be accepted earlier than the 61st day following the &#8220;Offer Date&#8221; for tax at exercise.  The Offer Date is the date on which the Company notifies you of the material terms and conditions of the stock option grant.  Any acceptance given by you before the 61st day following the Offer Date shall be null and void.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Brazil</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Labor Law Acknowledgment</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. You agree, for all legal purposes, (i) the benefits provided under the Grant Agreement and the Plan are the result of commercial transactions unrelated to your employment&#59; (ii) the Grant Agreement and the Plan are not a part of the terms and conditions of your employment&#59; and (iii) the income from the Awards, if any, is not part of your remuneration from employment.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The definition of &#8220;Cause&#8221; provided under the Plan is revised in its entirety to read as follows&#58;  &#8220;For this purpose, &#8220;Cause&#8221; shall be determined by the Company in its sole discretion and includes&#58;  (a) breach of the Employee Innovation and Proprietary Information Agreement or any other confidentiality, non-solicitation, or non-competition agreement with the Company or Affiliate, or breach of a material term of any other agreement with the Company or Affiliate&#59; (b) engagement in conduct that results in, or has the potential to cause, material harm financially, reputationally, or otherwise to the Company or its Affiliate&#59; (c) commission of an act of dishonesty, fraud, embezzlement or theft&#59; (d) conviction of, or plea of guilty or no contest to a felony or crime involving moral turpitude&#59; or (e) failure to comply with the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 8 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Company&#8217;s or Affiliate&#8217;s policies and procedures, including, but not limited to, the Company&#8217;s </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">code of conduct set forth in the Company&#8217;s integrity manual,</font><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The Spirit and Letter.&#8221;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Bulgaria</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">There are no country specific provisions.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Canada </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Employment</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The following provision supplements Section A(1) of this Addendum&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Unless explicitly required by applicable legislation, the Termination of Employment will exclude and will not be extended by any period during which notice, pay in lieu of notice or related payments or damages are provided or required to be provided under statute, contract, common law&#47;civil law, or otherwise. Unless otherwise expressly provided in the Plan or the Grant Agreement, or explicitly required by applicable legislation, your right to vest in the Award under the Plan, if any, will terminate as of your Termination of Employment. In such case, you will not earn, or be entitled to earn, any pro-rated vesting for that portion of time before your Termination of Employment, nor will you be entitled to any compensation for lost vesting. Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires continued entitlement to vesting during a statutory notice period, your right to vest in the Award under the Plan, if any, will terminate effective as of the last day of your minimum statutory notice period, but you will not earn or be entitled to pro-rated vesting in the Award if the vesting date falls after the end of your statutory notice period, nor will you be entitled to any compensation for lost vesting. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By accepting the Awards subject to the Grant Agreements through the </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">UBS Financial Services</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> portal (or its successor), you declare that you expressly agree with the provisions regarding Termination of Employment described in the Plan, the Grant Agreements (including, but not limited to, Section 2 of the Grant Agreements) and the additional terms and conditions set forth in this Global Addendum.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Resale Restriction</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. You understand that you are permitted to sell shares acquired under the Plan through the designated broker appointed under the Plan, provided the resale of shares takes place outside of Canada through the facilities of the stock exchange on which the shares are traded. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Qualified Securities</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In accordance with subsection 110(1.9) of the Income Tax Act (Canada) (the &#8220;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Act</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), notice is hereby given by GE HealthCare that the shares to be issued in respect of stock option awards in excess of the CAD $200,000 limit are non-qualified securities for purposes of the Act.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">For Residents of Quebec</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A French translation of the Grant Agreements and the Plan can be made available to you as soon as reasonably practicable upon your request.  You understand that, from time to time, additional information related to the offering of the Plan might be provided in English and such information may not be immediately available in French.  However, upon </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 9 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">request, the Company will translate into French documents related to the offering of the Plan as soon as reasonably practicable.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Langue</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.  Une traduction fran&#231;aise Accords de Subvention et du Plan peut &#234;tre mise &#224; votre disposition d&#232;s que raisonnablement possible, &#224; votre demande. Vous comprenez que, de temps &#224; autre, des informations suppl&#233;mentaires li&#233;es &#224; l'offre du plan peuvent &#234;tre fournies en anglais et que ces informations peuvent ne pas &#234;tre imm&#233;diatement disponibles en fran&#231;ais. Toutefois, sur demande, la Soci&#233;t&#233; traduira en fran&#231;ais les documents relatifs &#224; l'offre du Plan d&#232;s que raisonnablement possible.</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline"> </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The following provision supplements Section A(5) of this Addendum&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You hereby authorize the Company and the Company&#8217;s representative to discuss with and obtain all relevant information regarding the Awards and your participation in the Plan from all personnel, professional or non-professional, involved with the administration of the Plan. You further authorize the Company, the Service Recipient, the administrator of the Plan and the plan broker that is assisting the Company with the operation and administration of the Plan to disclose and discuss your participation in the Plan with their advisors. You also authorize the Company and the Service Recipient to record such information and keep it in your employee file. You acknowledge and agree that your personal information, including any sensitive personal information, may be transferred or disclosed outside the province of Quebec, including to the United States of America. If applicable, you also acknowledge and authorize the Company, the Service Recipient, the administrator of the Plan and any plan broker that is assisting the Company with the operation and administration of the Plan to use technology for profiling purposes and to make automated decisions that may have an impact on you or the administration of the Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Chile</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Law - Ruling N&#176; 336</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Award constitutes a private offering of securities in Chile effective as of the grant date, and is expressly subject to general ruling N&#176; 336 of the Chilean Commission for the Financial Market (&#8220;CMF&#8221;). </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Neither the Company nor the shares that you may receive pursuant to your Awards are registered with the Registry of Securities or under the control of the Chilean Superintendence of Securities. </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Given that the shares underlying the Award are not registered in Chile, the Company is not required to provide public information about the Award or the shares in Chile. Unless the Award and&#47;or the shares are registered with the CMF, a public offering of such securities cannot be made in Chile.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">China</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Mandatory Full Cashless Option Exercise</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Unless otherwise determined by the Company, your Option must be exercised pursuant to a broker-assisted cashless method of exercise.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Foreign Exchange Control Laws</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Due to local legal requirements, shares acquired through RSU or PSU vesting must be maintained in the UBS Financial Services account until the shares are sold through UBS Financial Services with the net sales proceeds being paid to you through your current or most recent PRC employer.  As a condition of the grant of RSUs or PSUs, you agree that any shares acquired under the Plan must be sold on a date that is within three-months after the date&#160;of your termination of active employment with the Company and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 10 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">its Affiliates or within any other time frame as the Company determines to be necessary or advisable for legal or administrative reasons. You authorize UBS Financial Services (or any successor broker designated by the Company) to sell such shares on your behalf at that time or as soon as is administratively practical thereafter.  It, however, remains your responsibility to ensure that such shares are sold by such three-month deadline, and you acknowledge and agree that the Company is not responsible or liable for ensuring any particular price received in connection with the sale of such shares.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Under local law, you are required to repatriate to China the proceeds from your participation in the Plan, including proceeds from cashless option exercises, the sale of shares acquired through RSU or PSU vesting and any dividends or dividend equivalents paid to you in relation to RSUs or PSUs through a special exchange control account established by the Company or one of its Affiliates in China.  You hereby agree that any proceeds from your participation in the Plan may be transferred to such special account prior to being delivered to you through your current or most recent PRC employer.  Further, if the proceeds from your participation in the Plan are converted to local currency, you acknowledge that the Company (including its Affiliates) are under no obligation to secure any currency conversion rate, and may face delays in converting the proceeds to local currency due to exchange control restrictions in China.  You agree to bear the risk of any currency conversion rate fluctuation between the date that your proceeds are delivered to the special exchange control account and the date of conversion of the proceeds to local currency.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To comply with requirements imposed by the State Administration of Foreign Exchange (SAFE), to the extent that, under your GE HealthCare Stock Option Grant Agreement, you may exercise any Options after your termination of employment with the Company and its Affiliates, you shall be permitted to exercise such Options for the </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">shorter</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the period set forth in your GE HealthCare Stock Option Grant Agreement and three months from the date&#160;of your termination of active employment&#59; three months following the termination of your active employment with the Company and its Affiliates, any unexercised Options shall immediately expire.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company reserves the right to impose such further restrictions or conditions as may be necessary to comply with changes in applicable local laws in China.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you are not a PRC national, the above provisions may not apply to you, to the extent determined by SAFE or its local branch office in accordance with local laws.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The definition of &#8220;Cause&#8221; provided under the Plan is revised in its entirety to read as follows&#58;  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;For this purpose, &#8220;Cause&#8221; shall be determined by the Company in its sole discretion and includes&#58;  (a) breach of the Employee Innovation and Proprietary Information Agreement or any other confidentiality, non-solicitation, or non-competition agreement with the Company or Affiliate, or breach of a material term of his&#47;her employment agreement or any other agreement with the Company or Affiliate&#59; (b) engagement in conduct that results in, or has the potential to cause, material harm financially, reputationally, or otherwise to the Company or its Affiliate&#59; (c) commission of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 11 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">an act of dishonesty, fraud, embezzlement or theft&#59; (d) conviction of, or plea of guilty or no contest to a felony or crime involving moral turpitude&#59; or (e) failure to comply with the Company&#8217;s or Affiliate&#8217;s policies and procedures, including, but not limited to, the Company&#8217;s </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">code of conduct set forth in the Company&#8217;s integrity manual, </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Spirit and Letter.&#8221;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Paragraph (ii) of Section 6 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Stock Option Grant Agreement, of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Restricted Stock Unit Grant Agreement, and of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Performance Stock Unit Grant Agreement does not apply.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For the avoidance of doubt, in addition to the definition of Retirement contained in the applicable Grant Agreement and Plan, Retirement shall also include any earlier compulsory retirement under local law.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Colombia</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Nature of the Awards. </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following provision supplements Section A(1) of this Addendum&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By accepting the grant of the Award and pursuant to Article 128 of the Colombian Labor Code, you expressly acknowledge, understand and agree that the Awards and related benefits are granted by the Company entirely on a discretionary basis, do not exclusively depend upon your performance with the Service Recipient, and do not constitute a component of your &#8220;salary&#8221; for any legal purpose.  Therefore, the Awards and related benefits will not be included and&#47;or considered for purposes of calculating any and all labor benefits, such as legal&#47;fringe benefits, vacations, indemnities, payroll taxes, social insurance contributions and&#47;or any other labor-related amount which may be payable, subject to any limitations as may be imposed under local law.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Law Acknowledgement</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The shares underlying the Awards are not and will not be registered with the Colombian registry of publicly traded securities (</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Registro Nacional de Valores y Emisores</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">). Therefore, the shares may not be offered to the public in Colombia. Nothing in the Grant Agreements should be construed as making a public offer of securities in Colombia. In the event that the Company, in its sole discretion, determines that the offer of Options, RSUs and PSUs in Colombia may constitute a &#8220;public offer of securities&#8221; under Law 964 of 2005, you understand and agree that the Company may, in its sole discretion, cease to offer participation in the Plan in Colombia. In the event that the Company exercises its discretion to cease offering the Plan in Colombia, you will no longer be permitted to participate in the Plan as of the date established by the Company.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Czech Republic</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  The paragraph (ii) of Section 6 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Stock Option Grant Agreement, of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Restricted Stock Unit Grant Agreement, and of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Performance Stock Unit Grant Agreement does not apply.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Denmark</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 12 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Treatment of Awards upon Termination of Employment</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The global termination provisions under the Plan will apply for all grants. The relevant termination provisions are detailed in the applicable Grant Agreements and the Employer Statement for Options, Employer Statement for RSUs, and Employer Statement for PSUs, as provided separately to you. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Paragraph (ii) of Section 6 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Stock Option Grant Agreement, of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Restricted Stock Unit Grant Agreement, and of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Performance Stock Unit Grant Agreement does not apply.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Egypt</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">There are no country-specific provisions.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Finland</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">There are no country-specific provisions.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">France</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Nature of the Awards</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The RSUs and PSUs </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">are not granted under the French specific regime provided by Articles L. 225-197-1 and seq. and L. 22-10-59 and L. 22-10-60 of the French commercial code, as amended. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Option is not granted under the French specific regime provided by Articles L. 225-177 and seq. and L. 22-10-56 to L. 22-10-58</font><font style="color:#ff0000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">of the French commercial code, as amended.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The definition of &#8220;Cause&#8221; is revised in its entirety to read as follows&#58;  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8220;For this purpose, &#8220;Cause&#8221; shall be determined by the Company in its sole discretion and includes in particular, but not limited to, the following justifications qualifying as a real and serious cause for dismissal&#58;  (a) breach of the Employee Innovation and Proprietary Information Agreement or any other confidentiality, non-solicitation, or non-competition agreement with the Company or Affiliate, or breach of a material term of any other agreement with the Company or Affiliate&#59; (b) engagement in conduct that results in, or has the potential to cause, material harm financially, reputationally, or otherwise to the Company or its Affiliate&#59; (c) commission of an act of dishonesty, fraud, embezzlement or theft&#59; (d) conviction of, or plea of guilty or no contest to a felony or crime involving moral turpitude&#59; or (e) failure to comply with the Company&#8217;s or Affiliate&#8217;s policies and procedures, including, but not limited to, the Company&#8217;s </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">code of conduct set forth in the Company&#8217;s integrity manual, </font><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Spirit and Letter.&#8221;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Paragraph (ii) of Section 6 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Stock Option Grant Agreement, of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Restricted Stock Unit Grant Agreement, and of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Performance Stock Unit Grant Agreement does not apply.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 13 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The parties to the Grant Agreement acknowledge that it is their express wish that the Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Les parties reconnaissent avoir exig&#233; la r&#233;daction en anglais de la pr&#233;sente convention, ainsi que de tous documents ex&#233;cut&#233;s, avis donn&#233;s et proc&#233;dures judiciaires intent&#233;es, directement ou indirectement, relativement &#224; ou suite &#224; la pr&#233;sente convention.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Germany</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Paragraph (ii) of Section 6 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Stock Option Grant Agreement, of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Restricted Stock Unit Grant Agreement, and of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Performance Stock Unit Grant Agreement is revised in its entirety to read as follows&#58;  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;During the Grantee&#8217;s employment with the Company or its Affiliate, and for the one-year period following termination of such employment (the &#8220;Restriction Period&#8221;), the Grantee will not, without prior written approval from the Committee (a) whether on his or her own behalf or in conjunction with any other person or third party, directly or indirectly solicit or encourage any person who is a Lead Professional Band or higher employee of the Company or any of its Affiliates (a &#8220;Restricted Person&#8221;) to terminate his or her employment relationship with, or accept any other employment outside of, the Company and its Affiliates&#59; (b) recommend or cause a Restricted Person to be hired by an entity for which the Grantee works, or with which the Grantee is otherwise associated or owns more than a 1% ownership interest, any person who is, or was within one year before or after the Grantee&#8217;s termination of employment with the Company and its Affiliates, a Restricted Person&#59; or (c) provide any non-public information regarding any Restricted Person, including, but not limited to, compensation data, performance evaluations, skill sets or qualifications, etc., to any external person in connection with employment outside the Company and its Affiliates, including, but not limited to, recruiters and prospective employers. Except for the data related restrictions which apply indefinitely, the non-solicitation restrictions set forth above do not apply once a Restricted Person has been formally notified of his or her impending layoff from the Company or any of its Affiliates.&#8221;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Greece</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">There are no country-specific provisions.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Hong Kong</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Tax Election</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Please note that the Company is required to report any gain realized on the exercise of Options and grants of RSUs or PSUs to the Hong Kong Inland Revenue Department (&#8220;IRD&#8221;).  It is a condition of the grant that you agree to make appropriate filings with the IRD and to make an election to be taxed on a deemed exercise basis for all Option grants and on a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 14 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">deemed vested basis for all RSU and PSU grants.  If you are in any doubt about your tax reporting obligations in Hong Kong, you should obtain independent professional tax advice.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sale Restriction on Shares</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the event that the Award vests and&#47;or are exercised and shares are issued to you (or your heirs) within six (6) months of the grant date, you (or your heirs) expressly agree that the shares will not be offered to the public or otherwise disposed of prior to the six (6)-month anniversary of the grant date.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Law Notice</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Awards and any shares issued pursuant to the Awards do not constitute a public offering of securities under Hong Kong law and are available only to employees of the Company or its Affiliates.  The Grant Agreements, including this Addendum, the Plan and other incidental communication materials have not been prepared in accordance with and are not intended to constitute a &#8220;prospectus&#8221; for a public offering of securities under the applicable securities legislation in Hong Kong.  The Awards and any related documentation are intended only for the personal use of each eligible employee of the Company or its Affiliates and may not be distributed to any other person.  The contents of the Grant Agreements, including this Addendum and the Plan, have not been reviewed by any regulatory authority in Hong Kong.  You are advised to exercise caution in relation to the offer.  If you are in any doubt about any of the contents of the Grant Agreements, including this Addendum, or the Plan, you should obtain independent professional advice.</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Hungary</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Paragraph (ii) of Section 6 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Stock Option Grant Agreement, of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Restricted Stock Unit Grant Agreement, and of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Performance Stock Unit Grant Agreement does not apply. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">India</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Paragraph (ii) of Section 6 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Stock Option Grant Agreement, of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Restricted Stock Unit Grant Agreement, and of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Performance Stock Unit Agreement is revised in its entirety to read as follows&#58;  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;During the Grantee&#8217;s employment with the Company or its Affiliate, and for the one-year period following termination of such employment (the &#8220;Restriction Period&#8221;), the Grantee will not, without prior written approval from the Committee&#58; (a) whether on his or her own behalf or in conjunction with any other person or third party, directly or indirectly solicit or encourage any person who is a Lead Professional Band or higher employee of the Company or any of its Affiliates (a &#8220;Restricted Person&#8221;) to terminate his or her employment relationship with, or accept any other employment outside of, the Company and its Affiliates&#59; (b) directly hire, or recommend or cause to be hired by an entity for which the Grantee works, or with which the Grantee is otherwise associated or owns more than a 1% ownership interest, any person who is, or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 15 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">was within one year before or after the Grantee&#8217;s termination of employment with the Company and its Affiliates, a Restricted Person&#59; (c) provide any non-public information regarding any Restricted Person, including, but not limited to, compensation data, performance evaluations, skill sets or qualifications, etc., to any external person in connection with employment outside the Company and its Affiliates, including, but not limited to, recruiters and prospective employers. The above restrictions do not apply once a Restricted Person has been formally notified of his or her impending layoff from the Company or any of its Affiliates&#59; or (d) the Grantee will not, whether on his or her own behalf or in conjunction with any other person or third party, directly or indirectly, solicit, divert or appropriate or attempt to solicit, divert or appropriate any vendor, service provider or customer of the Company or its Affiliates, or interfere with or endeavor to interfere with any contract, arrangement, understanding or agreement or renewal of any of them, entered into by the Company or its Affiliates with such vendors, service providers and&#47;or customers.&#8221;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The definition of &#8220;Cause&#8221; provided under the Plan is revised in its entirety to read as follows&#58; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:31.5pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8220;For this purpose, &#8220;Cause&#8221; shall be determined by the Company in its sole discretion and includes&#58;  (a) breach of the Employee Innovation and Proprietary Information Agreement or any other confidentiality, non-solicitation, or non-competition agreement with the Company or Affiliate, or breach of a material term of any other agreement with the Company or Affiliate&#59; (b) engagement in conduct that results in, or has the potential to cause, material harm financially, reputationally, or otherwise to the Company or its Affiliate&#59; (c) commission of an act of dishonesty, fraud, embezzlement, theft, misconduct or for any incident of workplace harassment&#59; (d) conviction of, or plea of guilty or no contest to a felony or crime involving moral turpitude&#59; or (e) failure to comply with the Company&#8217;s or Affiliate&#8217;s policies and procedures, including, but not limited to, the Company&#8217;s </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">code of conduct set forth in the Company&#8217;s integrity manual,</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The Spirit and Letter.&#8221;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Tax Collection at Source</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. You understand that Tax Collection at Source (&#8220;TCS&#8221;) may apply to funds remitted out of India if the funds exceed a certain amount (currently INR 700,000) (&#8220;TCS Threshold&#8221;) during the Indian fiscal year. Therefore, your annual remittances out of India, including any remittances under the Plan, may be subject to TCS. Depending on the procedures established by the Service Recipient and the authorized dealer bank remitting the funds out of India, you understand and agree that the Company or the Service Recipient may deduct any applicable TCS via any withholding method set forth in Section A(1) of this Addendum.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You also understand that you may be required to provide a declaration to the Service Recipient or the authorized dealer bank remitting the funds regarding whether the TCS Threshold has been reached based on all of your remittances out of India, including any remittances under the Plan, and you agree to provide such declaration upon request. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 16 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Indonesia</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Option Exercise Method</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Due to local legal requirements, the Company may require you to exercise your Option pursuant to a broker-assisted cashless method of exercise. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Language Consent and Notification</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  By accepting the Award, you (i) confirm having read and understood the documents relating to the grant (</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">i.e.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Plan and the Grant Agreement) which were provided in the English language, (ii) accept the terms of those documents accordingly, and (iii) agree not to challenge the validity of this document based on Law No. 24 of 2009 on National Flag, Language, Coat of Arms and National Anthem or the implementing Presidential Regulation (when issued).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Persetujuan dan Pemberitahuan Bahasa</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.  Dengan menerima Penghargaan, Anda (i) memberikan konfirmasi bahwa dirinya telah membaca dan memahami dokumen-dokumen berkaitan dengan pemberian ini (yaitu, Rencana dan Perjanjian Hibah) yang disediakan dalam Bahasa Inggris, (ii) menerima persyaratan di dalam dokumen-dokumen tersebut, dan (iii) setuju untuk tidak mengajukan keberatan atas keberlakuan dari dokumen ini berdasarkan Undang-Undang No. 24 Tahun 2009 tentang Bendera, Bahasa dan Lambang Negara serta Lagu Kebangsaan ataupun Peraturan Presiden sebagai pelaksanaannya (ketika diterbitkan).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Repatriation Requirements</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  By accepting the Awards, you agree to repatriate all sales proceeds and dividends attributable to shares acquired under the Plan in accordance with local foreign exchange rules and regulations. Neither the Company nor any of its Affiliates shall be liable for any fines or penalties resulting from your failure to comply with applicable laws.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Iraq</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Tax and Regulatory Reporting Notification</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  You may be subject to certain tax, exchange control or foreign asset&#47;account reporting requirements under the applicable laws in your country as a result of the acquisition, holding or transfer of shares or cash resulting from participation in the Plan.  You are responsible for being aware of and satisfying any such requirements that may be necessary in connection with the Award.  You should consult with your own personal legal advisors to ensure compliance with local laws.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Ireland</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Director Notification Obligation</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If you are a director, shadow director or secretary of an Irish Affiliate of GE HealthCare who owns more than a 1% interest in GE HealthCare, you are subject to certain notification requirements under the Companies Act, 1990.  Among these requirements is an obligation to notify the secretary of the Irish Affiliate in writing when you receive an interest (e.g., Options, RSUs, PSUs, or shares) in the Company and the number and class of shares or rights to which the interest relates.  In addition, you must notify the Irish Affiliate when you sell shares acquired through the exercise of Options or pursuant to any other Award granted under the Plan.  You must notify the secretary of the Irish Affiliate of the acquisition or disposal of an interest in shares within five days following the day of acquisition or disposal of the interest in shares.  These notification requirements also apply to any rights or shares acquired by your spouse or children under the age of 18 </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(whose </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 17 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">interests will be attributed to you in your capacity as a director, shadow director or secretary of the Irish </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Affiliate</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Israel</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Mandatory Full Cashless Option Exercise</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Due to local tax requirements, your Option must be exercised pursuant to a broker-assisted cashless method of exercise.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Local Cash Settlement of RSUs&#47;PSUs</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding anything in the Grant Agreement or the Addendum to the contrary, RSUs and PSUs shall be settled in cash only paid by the Service Recipient through local payroll (and shall not be settled in shares issued by the Company).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnification for Tax Liabilities</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  As a condition of the grant of the Awards, you expressly consent and agree to indemnify the Company and&#47;or its Affiliates and hold them harmless from any and all liability attributable to taxes, interest or penalties thereon, including without limitation, liabilities relating to the necessity to withhold any taxes.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The grant of the Award does not constitute a public offering under the Securities Law, 1968.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Ivory Coast</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">There are no country-specific provisions.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Italy</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Option Exercise Method</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Due to local legal requirements, the Company may require you to exercise your Option pursuant to a broker-assisted cashless method of exercise.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictive Covenants</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Paragraph (ii) of Section 6 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Stock Option Grant Agreement, of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Restricted Stock Unit Grant Agreement, and of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Performance Stock Unit Grant Agreement does not apply.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Document Acknowledgement</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You acknowledge that by accepting this Award, you have been given access to the Plan document, has reviewed the Plan, the applicable Grant Agreement and this Addendum in their entirety and fully understands and accepts all provisions of the Plan, the Grant Agreement and this Addendum.  Further, you specifically and expressly approve the following clauses of the Grant Agreement&#58; Vesting&#59; Delivery and Tax Withholding&#59; Additional Requirements&#59; Entire Agreement&#59; Electronic Delivery&#59; and Global Addendum and the following clauses under Section A of this Addendum&#58; Nature of the Awards&#59; Responsibility for Taxes and Other Legal Obligations&#59; Electronic Delivery and Acceptance&#59; Data Privacy&#59; Governing Law and Venue&#59; and Imposition of Other Requirements.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Japan</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">There are no country-specific provisions.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Jordan</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">There are no country-specific provisions.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 18 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Kazakhstan</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The grant of the Award is addressed only to certain eligible employees of the Company and its subsidiaries and affiliates in the form of shares to be issued by the Company, which as of the date hereof are listed on the Nasdaq Stock Market.  Neither the Plan nor the Grant Agreements have been approved, nor do they need to be approved, by the National Bank of Kazakhstan.  The grant of the Award is intended only for the original recipient and is not for general circulation in the Republic of Kazakhstan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Kenya</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Tax Registration Information</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Under Tax Procedure Act, 2015, you are required to complete and submit a tax registration application to the Commissioner of Income Tax with 30 days of the first vesting date of the Award.  The registration should be completed through the online portal &#8220;I TAX&#8221; and is a one-time only registration.  You are personally responsible for ensuring compliance with all registration requirements in Kenya. You should consult with your personal advisor(s) regarding any personal foreign asset&#47;foreign account tax obligations you may have in connection with your participation in the Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Korea</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Foreign Asset and Account Reporting</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Korean residents must declare all foreign financial accounts (</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, non-Korean bank accounts, brokerage accounts, etc.) to the Korean tax authority and file a report with respect to such accounts if the monthly balance of such accounts exceeds KRW 500 million (or an equivalent amount in foreign currency).  You should consult with your personal tax advisor to determine how to value your foreign accounts for purposes of this reporting requirement and whether you are required to file a report with respect to such accounts.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Malaysia</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Director Notification Information</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you are a director of a Malaysian Affiliate of the Company, you are subject to certain notification requirements under the Malaysian Companies Act, 2016.  Among these requirements is an obligation to notify the Malaysian Affiliate in writing when you receive an interest (</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, Options, RSUs, PSUs, or shares) in the Company or any related companies.  In addition, you must notify the Malaysian Affiliate when you sell any shares of the Company or any related company (including when you sell shares acquired through exercise of your Option or pursuant to any other Award granted under the Plan).  Additionally, you must also notify the Malaysian Affiliate of the Company if there are any subsequent changes in your interest in the Company or any related company.  These notifications must be made within 14 days of receiving, acquiring or disposing of any interest in the Company or any related company.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Mexico</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Labor Law Policy and Acknowledgement</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  By accepting the Awards granted under the Plan, you expressly recognize that GE HealthCare, with registered offices at 500 W. Monroe Street, Chicago, IL 60661 U.S.A., is solely responsible for the administration of the Plan and that your participation in the Plan and your acquisition of shares does not constitute an employment relationship between yourself and the Company since you are participating in the Plan on a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 19 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">wholly commercial basis and your sole employer is the applicable GE HealthCare Affiliate in Mexico (&#8220;GE HealthCare-Mexico&#8221;).  Based on the foregoing, you expressly recognize that the Plan and the benefits that you may derive from your participation in the Plan do not establish any rights between yourself and your employer, GE HealthCare-Mexico, and do not form part of the employment conditions and&#47;or benefits provided by GE HealthCare-Mexico and any modification of the Plan or its termination shall not constitute a change or impairment of the terms and conditions of your employment.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Al aceptar los premios bajo el Plan, usted expresamente reconoce que GE HealthCare, con sus oficinas registradas en </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">500 W. Monroe Street, Chicago, IL 60661 U.S.A.</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">, es el &#250;nico responsable de la administraci&#243;n del Plan y que su participaci&#243;n en el Plan y su adquisici&#243;n de acciones no constituyen una relaci&#243;n de empleo entre usted y GE HealthCare.  Usted est&#225; participando en el Plan a nivel comercial y su &#250;nico empleador es la compa&#241;&#237;a correspondiente afiliada a GE HealthCare en M&#233;xico (&#8220;GE HealthCare-M&#233;xico&#8221;).  Basado en lo anterior, usted expresamente reconoce que el Plan y los beneficios que le corresponden a usted por su participaci&#243;n en el Plan no establecen derechos entre usted y su empleador, GE HealthCare-M&#233;xico, y no forman parte de las condiciones de empleo ni de los beneficios otorgados a usted por GE HealthCare-M&#233;xico.  Cualquier cambio en el Plan o la suspensi&#243;n del mismo no constituye un cambio ni un impedimento de sus t&#233;rminos y condiciones de empleo.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictive Covenants</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The following language replaces Section 6 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Stock Option Grant Agreement, Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Restricted Stock Unit Grant Agreement, and Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Performance Stock Unit Grant Agreement in its entirety&#58;  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;During the Grantee&#8217;s employment with the Company or its Affiliate, and for the one-year period following termination of such employment (the &#8220;Restriction Period&#8221;), the Grantee will not, without prior written approval from the Committee&#58; (a) whether on his or her own behalf or in conjunction with any other person or third party, directly or indirectly solicit or encourage any person who is a Lead Professional Band or higher employee of the Company or any of its Affiliates (a &#8220;Restricted Person&#8221;) to terminate his or her employment relationship with, or accept any other employment outside of, the Company and its Affiliates&#59; (b) directly hire, or recommend or cause to be hired by an entity for which the Grantee works, or with which the Grantee is otherwise associated or owns more than a 1% ownership interest, any person who is, or was within one year before or after the Grantee&#8217;s termination of employment with the Company and its Affiliates, a Restricted Person&#59; or (c) provide any non-public information regarding any Restricted Person, including, but not limited to, compensation data, performance evaluations, skill sets or qualifications, etc., to any external person in connection with employment outside the Company and its Affiliates, including, but not limited to, recruiters and prospective employers. The above restrictions do not apply once a Restricted </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 20 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Person has been formally notified of his or her impending layoff from the Company or any of its Affiliates. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In addition, the Grantee agrees that during the Restriction Period, the Grantee will not, without prior written approval from the Committee, whether directly or indirectly, perform activities or services in the Restricted Area for any Competitive Company which&#58; (a) are similar in nature to the activities and services the Grantee performed for the Company or its Affiliate (or gained confidential information about, as described in the Employee Innovation and Proprietary Information Agreement or &#8220;EIPIA&#8221;) during the last two years of Grantee&#8217;s employment&#59; and&#47;or (b) will include Grantee working on products or services that are competitive with the products or services the Grantee worked on during the last two years of Grantee&#8217;s employment with the Company or its Affiliate. The term &#8220;Competitive Company&#8221; means any company or other third party that provides </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">products and services that are competitive with the Company or its Affiliates.  The term &#8220;Restricted Area&#8221; means for any Grantees in the Executive Band on the Grant Date, the area in which the Grantee is performing the majority of his or her duties for the Company, and for Grante</font><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">es in the Executive Director and above Bands on the Grant Date, the country in which the Grantee is based, in each case where the Company or its Affiliate has substantial business operations as of Grantee&#8217;s termination of employment and in which the Grantee has provided services, had a material presence or influence, or received confidential information about (as described in the EIPIA and any other confidentiality agreements signed by Grantee) at any time during the last two years of the Grantee&#8217;s employment with the Company or its Affiliate. The Grantee understands and agrees that, given the nature of the business of the Company and its Affiliates and the Grantee&#8217;s position with the Company or its Affiliate, the foregoing Restriction Period and Restricted Area are reasonable and appropriate</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">to protect the Company&#8217;s legitimate business interests and goodwill.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Furthermore, during the Grantee&#8217;s employment with the Company or its Affiliate, and for all periods thereafter, the Grantee will not breach his or her EIPIA or otherwise disclose the Company&#8217;s or Affiliate&#8217;s non-public information.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Grantee agrees that any breach by him or her of the foregoing obligations inevitably would cause substantial and irreparable damage to the Company and its Affiliates for which money damages may not be an adequate remedy.  Accordingly, the Grantee agrees that the Company and its Affiliates will be entitled to an injunction and&#47;or other equitable relief, to prevent the breach of such obligations.  The Grantee also agrees to indemnify and hold the Company and its Affiliates harmless from any loss, claim or damages, including, without limitation, all reasonable attorneys&#8217; fees, costs and expenses incurred in enforcing its rights under this Grant Agreement, as well as repay any payments </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 21 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">made hereunder (regardless of whether the Award is vested), except to the extent that such reimbursement is prohibited by law.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Grantee agrees that the payment and benefits provided for in the Grant Agreement constitute fair and reasonable consideration for Grantee&#8217;s compliance with this section.&#8221;  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Alteration&#47;Termination</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The following language replaces Section 8 (&#8220;Alteration&#47;Termination&#8221;) of the Stock Option Grant Agreement, Section 9 (&#8220;Alteration&#47;Termination&#8221;) of the Restricted Stock Unit Grant Agreement, and Section 9 (&#8220;Alteration&#47;Termination&#8221;) of the Performance Stock Unit Grant Agreement, in its entirety&#58;  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Under the express terms of this Grant Agreement, the Committee shall have the right at any time in its sole discretion to amend, alter, suspend, discontinue or terminate any Award without the consent of the Grantee.  Furthermore, if the Company determines in its sole discretion that the Grantee has engaged in conduct that (a) constitutes a breach of this Grant Agreement, the EIPIA or any other confidentiality, non-solicitation, or non-competition agreement with the Company or its Affiliates, (b) results in (or has the potential to cause) material harm financially, reputationally, or otherwise to the Company or its Affiliates or (c) occurred prior to the Grantee&#8217;s termination of employment and would give rise to a termination for Cause, any unexercised portion of the Option or any unvested RSUs or PSUs shall be cancelled immediately, and any amounts previously conveyed under this Grant Agreement shall be subject to recoupment to the extent permitted under local law.  In any event, the Award provided under this Grant Agreement shall be further subject to the Company&#8217;s policy with respect to compensation recoupment, as in effect and amended from time to time, to the extent permitted under local law. The Grantee agrees that the Company may take any such actions as are necessary to effectuate recoupment or applicable law without further consent or action being required by the Grantee, including issuing instructions to any Third-Party Administrator to (i) hold the Grantee&#8217;s shares and other amounts acquired under the Plan and&#47;or (ii) reconvey, transfer, or otherwise return such shares and other assets to the Company.  Also, the Award shall be null and void to the extent the grant of the Award or the exercise or vesting thereof is prohibited under the laws of the country of residence of the Grantee.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The definition of &#8220;Cause&#8221; is revised in its entirety and shall include&#58; (a) breach of the Employee Innovation and Proprietary Information Agreement or any other confidentiality, non-solicitation, or non-competition agreement with the Company or Affiliate, or breach of a material term of any other agreement with the Company or Affiliate&#59; (b) engagement in conduct that results in, or has the potential to cause, material harm financially, reputationally, or otherwise to the Company or its Affiliate&#59; (c) commission of an act of dishonesty, fraud, embezzlement or theft&#59; (d) conviction of, or plea of guilty or no contest to a felony or crime involving moral turpitude&#59; or (e) failure to comply with the Company&#8217;s or Affiliate&#8217;s policies and procedures, including, but not limited to, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 22 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Company&#8217;s </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">code of conduct set forth in the Company&#8217;s integrity manual,</font><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The Spirit and Letter.&#8221;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Law Notification</font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Award and any shares acquired under the Plan have not been registered with the National Register of Securities maintained by the Mexican National Banking and Securities Commission and cannot be offered or sold publicly in Mexico. In addition, the Plan, the Grant Agreements and any other document relating to the Awards may not be publicly distributed in Mexico.  These materials are addressed to you because of your existing relationship with the Company or one of its Affiliates, and these materials should not be reproduced or copied in any form.  The offer contained in these materials does not constitute a public offering of securities, but rather constitutes a private placement of securities addressed specifically to individuals who are present employees and&#47;or service providers of the Company or one of its Affiliates made in accordance with the provisions of the Mexican Securities Market Law, and any rights under such offering shall not be assigned or transferred.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Morocco</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Mandatory Full Cashless Option Exercise</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Due to local legal requirements, your Option must be exercised pursuant to a broker-assisted cashless method of exercise.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Local Cash Settlement of RSUs&#47;PSUs</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In addition, notwithstanding anything in the Grant Agreement or the Addendum to the contrary, RSUs and PSUs shall be settled in cash only paid by the Service Recipient through local payroll (and shall not be settled in shares issued by the Company).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Nature of the Awards</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  You understand and agree that your Awards are granted as an incentive, for investment purposes, and to employees only.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Netherlands</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">There are no country-specific provisions.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">New Zealand</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Law Notification</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  You are being offered an opportunity to participate in the Plan.  In compliance with an exemption to the New Zealand Financial Markets Conduct Act 2013, you are hereby notified that, you have the right to receive, free of charge, a copy of the Company&#8217;s latest annual report and a copy of the relevant financial statements of the Company.  Such documents are available for your review on the Company&#8217;s external and&#47;or internal sites at the web addresses listed below.  In addition, in connection with the opportunity to participate in the Plan, you are being provided with a copy of the Plan, Grant Agreements, and the Plan Prospectus via the UBS Financial Services portal.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1.&#160;&#160;&#160;&#160;The Company&#8217;s most recent annual report&#58; </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Once filed, this can be found at </font><font style="color:#0000ff;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;investor.gehealthcare.com&#47;financial-information&#47;sec-filings</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2. &#160;&#160;&#160;&#160;The Company&#8217;s most recently published financial statements&#58;  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0000ff;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;investor.gehealthcare.com&#47;financial-information&#47;sec-filings</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 23 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><img alt="image_0.jpg" src="image_0.jpg" style="height:465px;margin-bottom:5pt;vertical-align:text-bottom;width:625px"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Nigeria</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">There are no country-specific provisions.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Norway</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">There are no country-specific provisions.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Pakistan</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Mandatory Full Cashless Option Exercise</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Due to local legal requirements, your Option must be exercised pursuant to a broker-assisted cashless method of exercise.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Forced Sale of Shares</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company reserves the right to force the immediate sale of the shares to be issued upon vesting and&#47;or exercise of the Award.  If applicable, you agree that the Company is authorized to instruct its designated broker, on your behalf, to assist with the mandatory sale of such shares and you expressly authorize the Company&#8217;s designated broker to complete the sale of such shares.  You expressly acknowledge that the Company&#8217;s designated broker is under no obligation to arrange for the sale of shares at any particular price.  Upon the sale of shares, you shall receive the cash proceeds from the sale of shares, less any brokerage fees or commissions and subject to any obligation to satisfy Tax-Related Items.  You also acknowledge that you are unaware of any material non-public information </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 24 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">with respect to the Company or any securities of the Company as of the date of the Grant Agreements.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Peru</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Nature of the Grant</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following provision supplements Section A(1) of this Addendum&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Award is being granted </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">ex gratia</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> to you by the Company as an incentive to reward you for your contributions to the Company.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The grant of the Award under the Plan is considered a private offering in Peru and accordingly, is not subject to registration in Peru.  For more information concerning the grant of the Award, please refer to the Plan, the Grant Agreement, and any other grant documents made available to you by the Company.&#160; For more information regarding the Company, please refer to the Company&#8217;s most recent annual report on Form 10-K and quarterly report on Form 10-Q available at</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, as well as on the Company&#8217;s investor relations website (</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;investor.gehealthcare.com&#47;financial-information&#47;sec-filings</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Poland</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictive Covenants</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Paragraph (ii) of Section 6 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Stock Option Grant Agreement, of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Restricted Stock Unit Grant Agreement, and of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Performance Stock Unit Grant Agreement does not apply.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Portugal</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You hereby expressly declare that you have full knowledge of the English language and have read, understood and fully accepted and agreed with the terms and conditions established in the Plan and the Grant Agreements.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Conhecimento da Lingua</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Pelo presente instrumento, voc&#234; declara expressamente que tem pleno conhecimento da l&#237;ngua inglesa e que leu, compreendeu e livremente aceitou e concordou com os termos e condi&#231;&#245;es estabelecidas no Plano e no Acordo.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictive Covenants</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Paragraph (ii) of Section 6 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Stock Option Grant Agreement, of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Restricted Stock Unit Grant Agreement, and of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Performance Stock Unit Grant Agreement does not apply.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Philippines</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Necessary Approvals</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Award and the shares underlying the Award are subject to certain securities approval&#47;confirmation requirements in the Philippines with the Philippine Securities and Exchange Commission.  Notwithstanding any provision of the Plan or the Grant Agreement to the contrary, if the Company has not obtained, or does not maintain, the necessary securities approval&#47;confirmation, you will not vest in the Award, Options cannot be exercised and no shares will be issued under the Plan.  The Award shall vest and shares shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 25 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">be issued only if and when all necessary securities approvals&#47;confirmations have been obtained and are maintained.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You will not be able to acquire shares upon vesting and settlement of your Award unless the issuance of Shares complies with all applicable laws and regulations as determined by the Company.  The Company assumes no liability if your Award cannot be vested and&#47;or exercised and will not provide you with any benefits&#47;compensation in lieu of the Award.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If Participant acquires shares upon vesting and&#47;or exercise and settlement of the Award, Participant is permitted to dispose of or sell such shares, provided the offer and resale of the shares takes place outside of the Philippines through the facilities of a stock exchange on which the Shares are listed. The Shares are currently listed on the Nasdaq Stock Market LLC in the United States of America.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Puerto Rico</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">There are no country-specific provisions.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Romania</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. By accepting the Award grant, you acknowledge that you are proficient in reading and understanding English and fully understand the terms of the documents related to the grant (the Grant Agreement and the Plan), which were provided in the English language.  You accept the terms of those documents accordingly.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Consimtamant cu Privire la Limba</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Accept&#226;nd grantul de atribuire, recunoa&#537;te&#539;i c&#259; sunte&#539;i competen&#539;i &#238;n citirea &#537;i &#238;n&#539;elegerea limbii engleze &#537;i &#238;n&#539;elege&#539;i pe deplin termenii documentelor legate de subven&#539;ie (Acordul de grant &#537;i Planul), care au fost furnizate &#238;n limba englez&#259;. Accepta&#539;i termenii acestor documente &#238;n consecin&#539;&#259;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Russia </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  You acknowledge that the grant of Awards, the Plan and all other materials you may receive regarding participation in the Plan do not constitute an advertising or offering of securities in Russia.  The issuance of securities pursuant to the Plan has not and will not be registered in Russia and therefore, the securities described in any Plan-related documents may not be used for offering or public circulation in Russia.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You further acknowledge that in no event will shares that may be issued to you with respect to the RSUs and PSUs be delivered to you in Russia&#59; all shares issued to you with respect to the RSUs and PSUs will be maintained on your behalf in the United States.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You are not permitted to sell shares directly to a Russian legal entity or resident.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Settlement of Award</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In addition, notwithstanding anything in the Grant Agreement or the Addendum to the contrary, the Company may, for legal or administrative reasons, decide to settle the Award in cash (in which case no shares will be issued by the Company).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Saudi Arabia</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Local Cash Settlement of Award</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding anything in the Grant Agreement or the Addendum to the contrary, unless otherwise determined by the Company, the Award shall be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 26 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">settled in cash only paid by the Service Recipient through local payroll (and shall not be settled in shares issued by the Company).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Serbia</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The grant of the Award and the issuance of any shares in settlement of the Award is not subject to the regulations governing public offerings and private placements under the Law on Capital Markets.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Singapore</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Director Notification Information</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If you are a director, associate director, or shadow director of a Singapore Affiliate of the Company, you are subject to certain notification requirements under the Singapore Companies Act.  Among these requirements is an obligation to notify the Singaporean Affiliate in writing when you receive an interest in shares (</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, Options, RSUs, PSUs or shares) in the Company or any related companies.  In addition, you must notify the Singapore Affiliate when you sell shares of the Company or any related company (including when you sell shares acquired through the exercise of your Option or pursuant to any other Award granted under the Plan) or if there is any change in the particulars of your interest.  These notifications must be made within two business days of acquiring or disposing of any interest in shares of the Company or any related company or any change in any particulars of your interest.  In addition, a notification must be made of your interests in shares of the Company or any related company within two business days of becoming a director, associate director, or shadow director, as applicable.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Slovakia</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">There are no country-specific provisions.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">South Africa</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Approval Requirement</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Optionees who wish to perform share purchase exercises must obtain local HR and legal approval (including Bank approval) before a share purchase exercise will be transacted.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In compliance with South African securities law, you acknowledge that you have been notified that the documents listed below are available for review as indicated&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.06pt">a copy of the Company&#8217;s most recent financial reports&#58; </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Quarterly Results &#124; GE HealthCare</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.06pt">a copy of the Plan is available at&#58; </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">GE HealthCare Technologies Inc. 2023 Long-Term Incentive Plan</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.06pt">a copy of the Plan Prospectus is available by sending an email to </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">GEHC.Equity&#64;gehealthcare.com</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You acknowledge that you may obtain a copy of the above documents, without fee, by contacting&#58; GE HealthCare Technologies Inc. Executive Compensation Administration by sending an email to </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">GEHC.Equity&#64;gehealthcare.com</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or by mailing a written request to&#58; 500 W. Monroe St., Chicago, IL 60661, Unites States of America.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 27 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">You are advised to carefully read the materials provided before making a decision whether to participate in the Plan and to contact your tax advisor for specific information concerning your personal tax situation with regard to Plan participation.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Spain</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Special Employment or Similar Rights</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  You understand that GE HealthCare has unilaterally, gratuitously, and discretionally decided to distribute Awards under the Plan to individuals who may be employees of the Company or its Affiliates throughout the world.  The decision is a temporary decision that is entered into upon the express assumption and condition that (i) any grant will not economically or otherwise bind the Company or any of its Affiliates presently or in the future, other than as specifically set forth in the Plan and the terms and conditions of your Option, RSU or PSUs grants&#59; (ii).  the Awards or shares acquired under the Plan shall not become a part of any employment or service contract (either with the Company or any of its Affiliates) and shall not be considered a mandatory benefit, salary for any purpose (including severance compensation) or any other right whatsoever&#59; and (iii) unless otherwise provided in the Grant Agreement, the Awards will be forfeited and will cease vesting upon the termination of your employment (as detailed in the following paragraph).  Further, you understand and freely accept that there is no guarantee that any benefit whatsoever shall arise from any gratuitous and discretionary grant since the future value of the Awards and underlying shares is unknown and unpredictable.  In addition, you understand that this grant would not be made to you but for the assumptions and conditions referred to above&#59; thus, you acknowledge and freely accept that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, then any grant of Awards shall be null and void and the Plan shall not have any effect whatsoever.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> For avoidance of doubt, your rights, if any, to the Awards upon termination of employment shall be determined as set forth in the Grant Agreements, including, without limitation, where (i) you are&#160;considered to be unfairly dismissed without good cause&#59; (ii) you are dismissed for disciplinary or objective reasons or due to a collective dismissal&#59; (iii) you terminate service due to a change of work location, duties or any other employment or contractual condition&#59; or (iv) you terminate service due to the Company&#8217;s or any of its Affiliates&#8217; unilateral breach of contract.  Consequently, the termination of your employment for any of the above reasons shall be deemed an &#8220;Other Termination of Employment&#8221; or any termination other than an enumerated termination circumstance under your Grant Agreements, unless otherwise determined by the Company, in its sole discretion.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Awards granted under the Plan do not qualify as securities under Spanish regulations.  By the grant of the Awards, no &#8220;offer of securities to the public&#8221;, as defined under Spanish law, has taken place or will take place in Spanish territory.  The present document and any other document relating to the offer of Awards under the Plan has not been nor will it be registered with the </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Comisi&#243;n Nacional del Mercado de Valores</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (Spanish Securities Exchange Commission), and it does not constitute a public offering prospectus.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictive Covenants</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The following language replaces Section 6 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Stock Option Grant Agreement, Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Restricted Stock Unit Grant Agreement, and Section 7 (&#8220;Non-solicitation, Non-competition </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 28 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and Compliance with Agreements&#8221;) of the Performance Stock Unit Grant Agreement in its entirety&#58;  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;The Award and related benefits deriving from this Grant Agreement (i.e., Dividend Equivalent cash amounts) are provided to the Grantee in consideration of, and as an adequate economic compensation for, the Grantee&#8217;s execution and due compliance of the post-contractual (after employment termination) non-solicitation limitations that he&#47;she undertakes pursuant to this Section of the Grant Agreement and&#47;or in any </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">existing non-competition agreement with the Company or any of its Affiliates</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">During the Grantee&#8217;s employment with the Company or its Affiliate, and for the one-year period following termination of such employment (the &#8220;Restriction Period&#8221;), the Grantee will not, without prior written approval from the Committee&#58; (a) whether on his or her own behalf or in conjunction with any other person or third party, directly or indirectly solicit or encourage any person who is a Lead Professional Band or higher employee of the Company or any of its Affiliates (a &#8220;Restricted Person&#8221;) to terminate his or her employment relationship with, or accept any other employment outside of, the Company and its Affiliates&#59; (b) directly hire, or recommend or cause to be hired by an entity for which the Grantee works, or with which the Grantee is otherwise associated or owns more than a 1% ownership interest, any person who is, or was within one year before or after the Grantee&#8217;s termination of employment with the Company and its Affiliates, a Restricted Person&#59; or (c) provide any non-public information regarding any Restricted Person, including, but not limited to, compensation data, performance evaluations, skill sets or qualifications, etc., to any external person in connection with employment outside the Company and its Affiliates, including, but not limited to, recruiters and prospective employers. The above restrictions do not apply once a Restricted Person has been formally notified of his or her impending layoff from the Company or any of its Affiliates. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Furthermore, during the Grantee&#8217;s employment with the Company or its Affiliate, and for all periods thereafter, the Grantee will not breach his or her Employee Innovation and Proprietary Information Agreement or &#8220;EIPIA&#8221; or otherwise disclose the Company&#8217;s or Affiliate&#8217;s non-public information.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In consideration for the post-contractual non-solicitation undertakings assumed by the Grantee pursuant to this Section of the Grant Agreement and&#47;or in any existing non-competition agreement with the Company or any of its affiliates, the Grantee will receive adequate compensation, which will consist of the economic gain that the Grantee will obtain from the Award (including any related cash amounts).</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">During the Restriction Period, the Grantee will commit himself&#47;herself to notify the Company and its Affiliates, within a period of five business days after his&#47;her commencement of a new activity (whether in his&#47;her own name or on behalf of any other person, any other company or entity or in any of those </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 29 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">cases specified in this Section), of the name of the company or companies that engage his&#47;her services, whether under an employment contract or a services agreement, the activity of the company or companies, and the duties that the Grantee will carry out in such company or companies. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Grantee agrees that in case he&#47;she would breach the non-solicitation covenants, the Grantee shall be obliged to reimburse to the Company and its Affiliates, without limitation, the full amounts he&#47;she would have obtained as post-contractual compensation (whether by means of the Award, any cash amounts and any additional cash lump-sum payment). </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the extent permitted under local law, the Company and its Affiliates will be entitled to an injunction and&#47;or other equitable relief, without the necessity of posting security, to prevent the breach of such obligations.  The Grantee also agrees to indemnify and hold the Company and its Affiliates harmless from any loss, claim or damages, including, without limitation, all reasonable attorneys&#8217; fees, costs and expenses incurred in enforcing its rights under this Grant Agreement, as well as repay any payments made hereunder (regardless of whether the Award is vested), except to the extent that such reimbursement is prohibited by law.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Grantee agrees that (i) the Company and its Affiliates hold an effective and evident commercial and industrial interest in regulating the non-solicitation covenants&#59; (ii) the compensation agreed is totally adequate and highly compensates the post-contractual limitations assumed by the Grantee&#59; and (iii) since any breach by him or her of the foregoing obligations inevitably would cause substantial and irreparable damage to the Company and its Affiliates, that the agreed money damages are fair.&#8221;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:9pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The definition of &#8220;Cause&#8221; provided under the Plan is revised in its entirety to read as follows&#58;  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;For this purpose, &#8220;Cause&#8221; shall be determined by the Company in its sole discretion and includes&#58;  (a) breach of the Employee Innovation and Proprietary Information Agreement or any other confidentiality, non-solicitation, or non-competition agreement with the Company or Affiliate, or breach of a material term of any other agreement with the Company or Affiliate&#59; (b) engagement in conduct that results in, or has the potential to cause, material harm financially, reputationally, or otherwise to the Company or its Affiliate&#59; (c) commission of an act of dishonesty, fraud, willful malfeasance or willful misconduct, embezzlement or theft&#59; (d) conviction of, or plea of guilty or no contest to a felony or crime involving moral turpitude&#59; or (e) failure to comply with the Company&#8217;s or Affiliate&#8217;s policies and procedures, including, but not limited to, the Company&#8217;s </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">code of conduct set forth in the Company&#8217;s integrity manual, </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Spirit and Letter.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 30 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Sweden</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Responsibility for Taxes</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The following provision supplements Section A(2) of this Addendum&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Without limiting the Company&#8217;s and the Service Recipient&#8217;s authority to satisfy any withholding obligations for Tax-Related Items as set forth in Section 4 of the GE HealthCare Restricted Stock Unit Grant Agreement and GE HealthCare Performance Stock Unit Grant Agreement and Section A(2) of this Addendum, by accepting the Award, you authorize the Company and&#47;or the Service Recipient to withhold shares or to sell shares otherwise deliverable to you upon vesting&#47;settlement&#47;exercise of the Award to satisfy any liability you may have for Tax-Related Items, regardless of whether the Company and&#47;or the Service Recipient have any statutory or regulatory obligation to withhold such Tax-Related Items.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictive Covenants</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Paragraph (ii) of Section 6 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Stock Option Grant Agreement, of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Restricted Stock Unit Grant Agreement, and of Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Performance Stock Unit Grant Agreement does not apply. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Switzerland</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The grant is considered a private offering in Switzerland and is not subject to registration in Switzerland. Neither this document nor any other materials relating to the Award (1) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (&#8220;FinSA&#8221;), (2) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than an employee or service provider of the Company or any of its Affiliates, or (3) have been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority (in particular, the Swiss Financial Market Supervisory Authority).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Taiwan</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Data Privacy Acknowledgement</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  You hereby acknowledge that you have read and understood the terms regarding collection, processing and transfer of Data contained in the data privacy provisions of the Grant Agreement and this Addendum and by participating in the Plan, you agree to such terms.  In this regard, upon request of the Company or the Service Recipient, you agree to provide an executed data privacy consent form to the Company or the Service Recipient (or any other agreements or consents that may be required by the Company or the Service Recipient) that the Company and&#47;or the Service Recipient may deem necessary to obtain under the data privacy laws in your country of residence, either now or in the future.  You understand that you may be unable to participate in the Plan if you fail to execute any such consent or agreement.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The grant of Award and participation in the Plan is available only for employees of the Company and its subsidiaries and affiliates. The grant of an Award and participation in the Plan is not a public offer of securities by a Taiwanese company.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Thailand</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">There are no country-specific provisions.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 31 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Tunisia</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Local Cash Settlement of Award</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything in the Grant Agreement or the Addendum to the contrary, unless otherwise determined by the Company, the Award shall be settled in cash only paid by the Service Recipient through local payroll (and shall not be settled in shares issued by the Company).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">T&#252;rkiye</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The grant of Awards under the Plan is only available to employees of the Company and its Affiliates, and is intended to be a private offering.  Under Turkish law, you are not permitted to sell shares acquired under the Plan in T&#252;rkiye.  Shares are currently traded on the Nasdaq Stock Market LLC in the U.S. under the ticker symbol &#8220;GEHC&#8221; and shares may be sold on this exchange only, which is located outside of T&#252;rkiye.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Ukraine</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Settlement of Awards</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Settlement of Awards shall be in shares, provided, however, that the Company has discretion to settle the Awards in cash if it determines that cash settlement is necessary or advisable in light of changes in the regulatory requirements in Ukraine.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">United Arab Emirates</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Plan is only being offered to Eligible Persons and is in the nature of providing equity incentives to service providers of the Company&#8217;s Affiliate in the United Arab Emirates.  The Plan and the Grant Agreements are intended for distribution only to such Eligible Persons and must not be delivered to, or relied on by, any other person.  You should conduct your own due diligence on the Award offered pursuant to the Grant Agreements.  If you do not understand the contents of the Plan and&#47;or the Grant Agreement, you should consult an authorized financial advisor.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Awards and the shares underlying the Awards have not been reviewed by or registered with the Emirates Securities and Commodities Authority, the Dubai Financial Services Authority, the U.A.E. Central Bank or any other governmental authority in the United Arab Emirates, and have not been authorized or licensed for offering, marketing or sale in the United Arab Emirates.  As such, the Awards and shares underlying them are not being offered or sold in the United Arab Emirates.  This offering is being made in, and any related materials are subject to, the laws, regulations and rules of a jurisdiction outside the United Arab Emirates. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">United Kingdom</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Application of the Addendum</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Addendum only applies to Awards that are not granted as tax-qualified awards pursuant to the UK Sub-Plan to the Plan. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Joint Election</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  It is a further condition of delivery of any shares pursuant to the exercise of Options or the vest of RSUs or PSUs that you enter into a joint election under section 431(1) of the Income Tax (Earnings and Pensions) Act 2003 of the United Kingdom (&#8220;ITEPA&#8221;) (the &#8220;431 Election&#8221;) jointly with your employer, the effect of which is that the shares will be treated as if they were not restricted securities and that sections 425 to 430 of ITEPA will not apply to those shares. By accepting your Award and the terms and conditions of the applicable Grant </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 32 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Agreement(s) and this Addendum through the electronic acceptance process established by the Company, you also are entering into the 431 Election attached hereto as </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Appendix B</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. You also agree that you will not revoke such election at any time.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictive Covenants</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The following language replaces Section 6 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Stock Option Grant Agreement, Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Restricted Stock Unit Grant Agreement, and Section 7 (&#8220;Non-solicitation, Non-competition and Compliance with Agreements&#8221;) of the Performance Stock Unit Grant Agreement in its entirety&#58;  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;During the Grantee&#8217;s employment with the Company or its Affiliate, and for the one-year period following termination of such employment (reduced by any period the Grantee spends on garden leave) (the &#8220;Restriction Period&#8221;), the Grantee will not, without prior written approval from the Committee&#58; in the course of any business concern which is in competition with those parts of the Company's or any of its Affiliates' business with which the Grantee was involved to a material extent in the 12 months before termination of his or her employment (&#8220;Restricted Business&#8221;) (a) whether on his or her own behalf or in conjunction with any other person or third party, directly or indirectly solicit or encourage any person who is a Lead Professional Band or higher employee of the Company or any of its Affiliates who could materially damage the Company's or any of its Affiliates' interests if they were involved in any business concern which competes with any Restricted Business and with whom the Grantee dealt in the 12 months before termination of his or her employment (a &#8220;Restricted Person&#8221;) to terminate his or her employment relationship with, or accept any other employment outside of, the Company and its Affiliates&#59; (b) directly hire, or recommend or cause to be hired by an entity for which the Grantee works, or with which the Grantee is otherwise associated or owns more than a 1% ownership interest, any Restricted Person&#59; or (c) provide any non-public information regarding any Restricted Person, including, but not limited to, compensation data, performance evaluations, skill sets or qualifications, etc., to any external person in connection with employment outside the Company and its Affiliates, including, but not limited to, recruiters and prospective employers. The above restrictions do not apply once a Restricted Person has been formally notified of his or her impending layoff from the Company or any of its Affiliates. <br><br>In addition, the Grantee agrees that during the Restriction Period, the Grantee will not, without prior written approval from the Committee, whether directly or indirectly, perform activities or services in the Restricted Area for any Competitive Company which&#58; (a) are similar in nature to the activities and services the Grantee performed for the Company or its Affiliate (or gained confidential information about, as described in the Employee Innovation and Proprietary Information Agreement or &#8220;EIPIA&#8221;) during the last two years of Grantee&#8217;s employment&#59; and&#47;or (b) will include Grantee working on products or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 33 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">services that are competitive with the products or services the Grantee worked on during the last two years of Grantee&#8217;s employment with the Company or its Affiliate. The term &#8220;Competitive Company&#8221; means any company or other third party that provides products or services that are competitive with the Company or its Affiliates.  The term &#8220;Restricted Area&#8221; means for Grantees in the Executive Band, </font><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the area in which the Grantee is performing the majority of his or her duties for the Company</font><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and for Grantees in the Executive Director and above Bands, the country in which the Grantee is based, in each case where the Company or its Affiliate has material business operations as of Grantee&#8217;s termination of employment and in which the Grantee has provided services, had a material presence or influence, or received confidential information about (as described in the EIPIA and any other confidentiality agreements signed by the Grantee) at any time during the last two years of the Grantee&#8217;s employment with the Company or its Affiliate. The Grantee understands and agrees that, given the nature of the business of the Company and its Affiliates and the Grantee&#8217;s position with the Company or its Affiliate, the foregoing Restriction Period and Restricted Area are reasonable and appropriate</font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">to protect the Company&#8217;s legitimate business interests and goodwill.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Furthermore, during the Grantee&#8217;s employment with the Company or its Affiliate, and for all periods thereafter, the Grantee will not breach his or her EIPIA or otherwise disclose the Company&#8217;s or Affiliate&#8217;s non-public information.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Grantee agrees that any breach by him or her of the foregoing obligations inevitably would cause substantial and irreparable damage to the Company and its Affiliates for which money damages may not be an adequate remedy.  Accordingly, the Grantee agrees that the Company and its Affiliates will be entitled to an injunction and&#47;or other equitable relief, without the necessity of posting security, to prevent the breach of such obligations.  The Grantee also agrees to indemnify and hold the Company and its Affiliates harmless from any loss, claim or damages, including, without limitation, all reasonable attorneys&#8217; fees, costs and expenses incurred in enforcing its rights under this Grant Agreement, as well as repay any payments made hereunder (regardless of whether the Award is vested), except to the extent that such reimbursement is prohibited by law.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="background-color:#ffffff;color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Grantee agrees that the payment and benefits provided for in the Grant Agreement constitute fair and reasonable consideration for Grantee&#8217;s compliance with this section.&#8221; </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Responsibility for Taxes</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following provision supplements Section 4 of the GE HealthCare Restricted Stock Unit Grant Agreement and GE HealthCare Performance Stock Unit Grant Agreement and Section A(2) of this Addendum&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Without limitation to Section 4 of the GE HealthCare Restricted Stock Unit Grant Agreement and GE HealthCare Performance Stock Unit Grant Agreement and Section A(2) of this Addendum, you agree to be liable for any Tax-Related Items and hereby covenants to pay any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 34 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">such Tax-Related Items, as and when requested by the Company or the Service Recipient or the HM Revenue and Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority).  You agree to indemnify and keep indemnified the Company and the Service Recipient against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on your behalf.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if you are an executive officer or director (as within the meaning of Section 13(k) of the Exchange Act), you understand that you may not be able to indemnify the Company for the amount of any Tax-Related Items not collected from or paid by you, in which case the indemnification could be considered to be a loan.  In this case, the Tax-Related Items not collected or paid may constitute a benefit to you on which additional income tax and National Insurance Contributions (&#8220;NICs&#8221;) may be payable.  You acknowledge that you will be personally responsible for reporting and paying any income tax due on this additional benefit directly to the HMRC under the self-assessment regime and for paying the Company or the Service Recipient, as applicable, for the value of any employee NICs due on this additional benefit, which may also be recovered from you by any of the means referred to in Section A(2) of this Addendum.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Vietnam</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Local Cash Settlement of Award</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font><font style="color:#0d0d0d;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything in the Grant Agreement or the Addendum to the contrary, unless otherwise determined by the Company, the Award shall be settled in cash only paid by the Service Recipient through local payroll (and shall not be settled in shares issued by the Company).</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 35 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Appendix A</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GDPR Notice for Participants in the EU and UK</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RE&#58; GE HealthCare Technologies Inc. 2023 Long-Term Incentive Plan (the &#8220;Plan&#8221;)</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dear Participant&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The EU General Data Protection Regulation (also known as the &#8220;EU GDPR&#8221;) came into force on May 25, 2018. The UK implementation of the EU GDPR (&#8220;UK GDPR&#8221;) applies following the UK&#8217;s withdrawal from the European Union (the UK GDPR, collectively with the EU GDPR, the &#8220;GDPR&#8221;). For the purposes of the GDPR, GE HealthCare Technologies Inc. (the &#8220;Company&#8221;) wants to make UK- and EU-based participants in the Plan aware that the Company holds certain Data (as defined below) about the participants. The Company also wants to explain why the Company holds this Data and to let each participant know how to raise any questions regarding the Company&#8217;s use of the Data. The purpose of this communication is to provide participants with this information.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This document constitutes a Notice under the GDPR. Copies of this Notice are also available by request using the contact details set out below.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This communication supplements information relating to the use of your Data set out in the relevant agreement, or agreements, including the Global Addendum, issued to you under the Plan (the &#8220;Grant Agreements&#8221;). Should there be any inconsistency between the terms of this Notice and the Grant Agreements relating to the Company&#8217;s use of your Data, then this Notice is the document that will apply. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The term &#8220;Data&#8221; as used in this Notice includes your name, home address, email address and telephone number, date of birth, social insurance number, passport number or other identification number, salary, nationality and job title, as well as details of any shares, directorships, awards or any other equity or share rights you may have in the Company (whether awarded, canceled, exercised, vested, unvested or outstanding).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Data Controller Entity</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58;  The Company is the Data Controller. The Company is a Delaware corporation, with its principal United States office at 500 W. Monroe Street, Chicago, Illinois 60661 U.S.A.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Purposes</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58;  Data is held for the exclusive purpose of implementing, administering and managing your participation in the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Legitimate Interests</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58;  The Company holds the Data for the legitimate interests of implementing, administering and maintaining the Plan and each participant's participation in the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 36 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">International Transfers of Data</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58;  As the Company is based in the United States and the Grant Agreements are performed in the United States, the Company can only meet its contractual obligations to you under the Grant Agreements if the Data is transferred to the United States.  The performance of the contractual obligations of the Company to you is one of the legal bases for the transfer of the Data from the European Union to the United States.  You should be aware that the United States may have different data privacy laws and protections than the data privacy laws in place in the European Union.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Retention Period</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58;  Records relating to the Plan are kept indefinitely, as they are part of the statutory records of the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Other Recipients</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58;  To fulfil its obligations under the Grant Agreements, the Company may share Data with its subsidiary companies who employ participants in the Plan. In addition, Data may be transferred to certain third parties assisting in the implementation, administration and management of the Plan, such as share plan administrators and transfer agents, including UBS Financial Services.  At your instruction, the Data will be shared with a broker or other third party whom you have instructed the Company to deposit shares or other securities acquired upon the vesting of any awards under the Grant Agreements.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Data Subject Rights</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58;  Participants have a number of rights under the GDPR.  Depending upon the circumstances, these may include the right of data portability (where the Company helps a participant move Data to someone else at the participant's request), the right to object to the processing of the Data, the right to require the Company to update and correct the Data, the right to require erasure of the Data and the right for the participant to review the Data held by the Company and to require the Company to cease processing it.  You must understand, however, that any such request may affect your ability to participate in the Plan.  For more information on the consequences of your refusal to consent or your withdrawal of consent, please contact the Company using the contact details below.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Data Security</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58;  The Company recognizes the importance of treating Data in a lawful, fair and transparent manner.  The Company will apply reasonable organizational and security measures to prevent the unlawful processing and&#47;or the accidental loss or destruction of these materials and, in particular, the personal data contained in them. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Contact</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58;  If you have any questions concerning this Notice, you should contact GE HealthCare Technologies Inc. Executive Compensation Administration by sending an email to </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">GEHC.Equity&#64;gehealthcare.com</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 37 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Appendix B</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notice to UK Participants</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Regarding the Impact of Accepting the 431 Election</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Because there is a risk that HMRC may consider the shares you acquire at settlement of your Award(s) to be &#8220;restricted&#8221; securities, you are required to enter into a 431 Election. This will ensure that you will be subject to tax on the full unrestricted market value of shares at settlement, thereby avoiding any subsequent taxable event (other than upon sale of shares acquired at settlement).&#160;  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Clicking on the &#8220;ACCEPT&#8221; box indicates your acceptance of Part A of the two part &#8220;Joint Election under section 431(1) of the Income Tax (Earnings and Pensions) Act 2003 for disapplication of Chapter 2 of the Income Tax (Earnings and Pensions) Act 2003&#8221;.&#160; Your employer will sign and maintain Part B on file.  You should read this Notice in its entirety before accepting the 431 Election.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Tax Impact of Accepting the 431 Election</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By entering into the Election&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">you agree that you will be subject to income tax and National Insurance contributions on the full unrestricted market value of shares at settlement of your RSUs, PSUs and&#47;or exercise of your Options notwithstanding GE HealthCare Technologies Inc.&#8217;s discretion to require you to repay any payments made in connection with your Awards in the event you engage in activity harmful to GE HealthCare Technologies Inc., as described in the &#8220;Restrictive Covenants&#8221; provisions in the United Kingdom section of this Addendum and the relevant terms of the Grant Agreement(s)&#59; and</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.8pt">you acknowledge that even if you have clicked on the &#8220;ACCEPT&#8221; box where indicated, GE HealthCare Technologies Inc. or your employer may still require you to sign a paper copy of this 431 Election (or a substantially similar form) if GE HealthCare Technologies Inc. determines necessary to give effect to the 431 Election.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Please read the 431 Election carefully before accepting the 431 Election.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Please print and keep a copy of the 431 Election for your records.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 38 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GE HealthCare Technologies Inc.</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">431 Election</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Joint Election under section 431(1) of the Income Tax (Earnings and Pensions) Act 2003 for full disapplication of Chapter 2 of the Income Tax (Earnings and Pensions) Act 2003</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Two Part Election&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Part A - To be completed by the Employee</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:8.07pt">Between</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Employee who has obtained authorized access to the joint election</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company (who is the Employee&#8217;s employer)</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">identified in the attached Schedule</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">of the Company Registration Number provided in the attached Schedule</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:8.07pt">Purpose of Election</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This joint election is made pursuant to section 431(1) Income Tax (Earnings and Pensions) Act 2003 (&#8220;ITEPA&#8221;) and applies where employment-related securities, which are restricted securities by reason of section 423 ITEPA, are acquired.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The effect of an election under section 431(1) is that, for the relevant Income Tax and National Insurance contribution (&#8220;NIC&#8221;) purposes, the employment-related securities and their market value will be treated as if they were not restricted securities and that sections 425 to 430 ITEPA do not apply.  Additional Income Tax will be payable (with PAYE and NIC where the securities are Readily Convertible Assets).</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Should the value of the securities fall following the acquisition, it is possible that Income Tax&#47;NIC that would have arisen because of any future chargeable event (in the absence of an election) would have been less than the Income Tax&#47;NIC due by reason of this election.  Should this be the case, there is no Income Tax&#47;NIC relief available under Part 7 of ITEPA 2003&#59; nor is it available if the securities acquired are subsequently transferred, forfeited or revert to the original owner.</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 39 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:8.07pt">Application</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This joint election is made not later than 14 days after the date of acquisition of the securities by the Employee and applies to&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Number of securities&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;All securities</font></div><div style="padding-right:-18pt;text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Description of securities&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Shares of common stock of GE HealthCare Technologies Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name of issuer of securities&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;GE HealthCare Technologies Inc., a Delaware corporation</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">acquired by the Employee on or after the date of this joint election under the terms of the GE HealthCare Technologies Inc. 2023 Long-Term Incentive Plan.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:8.07pt">Extent of Application</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This election under section 431(1) ITEPA disapplies all restrictions attaching to the securities.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:8.07pt">Declaration</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This election will become irrevocable upon the later of the date it is accepted electronically or the acquisition (and each subsequent acquisition) of employment-related securities to which this election applies.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Employee acknowledges that by accepting the Award(s) (by clicking on the &#8220;ACCEPT&#8221; box where indicated in the Company&#8217;s electronic acceptance procedure), the Employee hereby agrees (inter alia) to be bound by the terms of this election.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 40 of 41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Schedule to 431 Election &#8211; Employing Company</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The employing company(ies) to which this joint election relates are&#58;</font></div><div><font><br></font></div><div style="padding-left:47.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.807%"><tr><td style="width:1.0%"></td><td style="width:51.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.888%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Employing Company</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Company Registration Number</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">GE Healthcare Financial Services Ltd.</font></td><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">01102466</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">GE Healthcare Limited</font></td><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">01002610</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">GE Healthcare UK Limited</font></td><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">03337033</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">GE Medical Systems Limited</font></td><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:100%">00252567</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="padding-right:-36pt;text-align:center"><font><br></font></div><div style="padding-right:-36pt;text-align:center"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 41 of 41</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>8
<FILENAME>gehc1q202510qexhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ifcfade6ba90e4276b241ca6844aa822b_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Certification Pursuant to <br>Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Amended</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, Peter J. Arduini, certify that&#58;</font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this Quarterly Report on Form 10-Q of GE HealthCare Technologies Inc.&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.01pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.01pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.51pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.01pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.01pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.01pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58; April&#160;30, 2025</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.631%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; Peter J. Arduini</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Peter J. Arduini</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">President &#38; Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>9
<FILENAME>gehc1q202510qexhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="iaa47448f7db749f5b2b4b06e328ddc24_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Certification Pursuant to <br>Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Amended</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, James K. Saccaro, certify that&#58;</font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this Quarterly Report on Form 10-Q of GE HealthCare Technologies Inc.&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.01pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.01pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.51pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.01pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.01pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:28.01pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58; April&#160;30, 2025</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.485%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; James K. Saccaro</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">James K. Saccaro</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vice President &#38; Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>10
<FILENAME>gehc1q202510qexhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="if5634dc78e384d6a80abcd16ccf98924_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:4pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Certification Pursuant to <br>18 U.S.C. Section 1350</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of GE HealthCare Technologies Inc. (the &#8220;registrant&#8221;) on Form 10-Q for the period ended March 31, 2025, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;report&#8221;), we, Peter J. Arduini and James K. Saccaro, President &#38; Chief Executive Officer and Vice President &#38; Chief Financial Officer, respectively, of the registrant, certify, pursuant to 18&#160;U.S.C. &#167;&#160;1350, that to our knowledge&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">The report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the registrant.</font></div><div style="margin-bottom:12pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">April&#160;30, 2025</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.631%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; Peter J. Arduini</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Peter J. Arduini</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">President &#38; Chief Executive Officer</font></td></tr></table></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.485%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; James K. Saccaro</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">James K. Saccaro</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vice President &#38; Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>gehc-20250331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:d0a8a86e-df0d-464c-9ff8-447ea6f21cea,g:ade862ec-33b2-4b8a-bb85-176c06a683fa-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:gehc="http://www.gehealthcare.com/20250331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.gehealthcare.com/20250331">
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gehc-20250331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gehc-20250331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gehc-20250331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gehc-20250331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.gehealthcare.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofIncomeUnaudited" roleURI="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited">
        <link:definition>9952151 - Statement - Condensed Consolidated Statements of Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" roleURI="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited">
        <link:definition>9952152 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofFinancialPositionUnaudited" roleURI="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited">
        <link:definition>9952153 - Statement - Condensed Consolidated Statements of Financial Position (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofFinancialPositionUnauditedParentheticals" roleURI="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnauditedParentheticals">
        <link:definition>9952154 - Statement - Condensed Consolidated Statements of Financial Position (Unaudited) (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofChangesinEquityUnaudited" roleURI="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited">
        <link:definition>9952155 - Statement - Condensed Consolidated Statements of Changes in Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofChangesinEquityUnauditedParenthetical" roleURI="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnauditedParenthetical">
        <link:definition>9952156 - Statement - Condensed Consolidated Statements of Changes in Equity (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>9952157 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDBASISOFPRESENTATION" roleURI="http://www.gehealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATION">
        <link:definition>9952158 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITION" roleURI="http://www.gehealthcare.com/role/REVENUERECOGNITION">
        <link:definition>9952159 - Disclosure - REVENUE RECOGNITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATION" roleURI="http://www.gehealthcare.com/role/SEGMENTINFORMATION">
        <link:definition>9952160 - Disclosure - SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECEIVABLES" roleURI="http://www.gehealthcare.com/role/RECEIVABLES">
        <link:definition>9952161 - Disclosure - RECEIVABLES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCINGRECEIVABLES" roleURI="http://www.gehealthcare.com/role/FINANCINGRECEIVABLES">
        <link:definition>9952162 - Disclosure - FINANCING RECEIVABLES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.gehealthcare.com/role/LEASES">
        <link:definition>9952163 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETS" roleURI="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETS">
        <link:definition>9952164 - Disclosure - ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BORROWINGS" roleURI="http://www.gehealthcare.com/role/BORROWINGS">
        <link:definition>9952165 - Disclosure - BORROWINGS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="POSTRETIREMENTBENEFITPLANS" roleURI="http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANS">
        <link:definition>9952166 - Disclosure - POSTRETIREMENT BENEFIT PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.gehealthcare.com/role/INCOMETAXES">
        <link:definition>9952167 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNET" roleURI="http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNET">
        <link:definition>9952168 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) &#8211; NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" roleURI="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS">
        <link:definition>9952169 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIES" roleURI="http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIES">
        <link:definition>9952170 - Disclosure - COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGACTIVITIES" roleURI="http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIES">
        <link:definition>9952171 - Disclosure - RESTRUCTURING ACTIVITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://www.gehealthcare.com/role/EARNINGSPERSHARE">
        <link:definition>9952172 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATION" roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATION">
        <link:definition>9952173 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTS" roleURI="http://www.gehealthcare.com/role/SUBSEQUENTEVENTS">
        <link:definition>9952174 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDBASISOFPRESENTATIONPolicies" roleURI="http://www.gehealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATIONPolicies">
        <link:definition>9955511 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONTables" roleURI="http://www.gehealthcare.com/role/REVENUERECOGNITIONTables">
        <link:definition>9955512 - Disclosure - REVENUE RECOGNITION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONTables" roleURI="http://www.gehealthcare.com/role/SEGMENTINFORMATIONTables">
        <link:definition>9955513 - Disclosure - SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECEIVABLESTables" roleURI="http://www.gehealthcare.com/role/RECEIVABLESTables">
        <link:definition>9955514 - Disclosure - RECEIVABLES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCINGRECEIVABLESTables" roleURI="http://www.gehealthcare.com/role/FINANCINGRECEIVABLESTables">
        <link:definition>9955515 - Disclosure - FINANCING RECEIVABLES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSTables" roleURI="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSTables">
        <link:definition>9955516 - Disclosure - ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BORROWINGSTables" roleURI="http://www.gehealthcare.com/role/BORROWINGSTables">
        <link:definition>9955517 - Disclosure - BORROWINGS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="POSTRETIREMENTBENEFITPLANSTables" roleURI="http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSTables">
        <link:definition>9955518 - Disclosure - POSTRETIREMENT BENEFIT PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETTables" roleURI="http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETTables">
        <link:definition>9955519 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) &#8211; NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" roleURI="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables">
        <link:definition>9955520 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESTables" roleURI="http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESTables">
        <link:definition>9955521 - Disclosure - COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGACTIVITIESTables" roleURI="http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESTables">
        <link:definition>9955522 - Disclosure - RESTRUCTURING ACTIVITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://www.gehealthcare.com/role/EARNINGSPERSHARETables">
        <link:definition>9955523 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONTables" roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables">
        <link:definition>9955524 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails" roleURI="http://www.gehealthcare.com/role/REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails">
        <link:definition>9955525 - Disclosure - REVENUE RECOGNITION - Summary of Contract and Other Deferred Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONNarrativeDetails" roleURI="http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails">
        <link:definition>9955526 - Disclosure - REVENUE RECOGNITION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONNarrativeDetails_1" roleURI="http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails_1">
        <link:definition>9955526 - Disclosure - REVENUE RECOGNITION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONScheduleofRemainingPerformanceObligationsDetails" roleURI="http://www.gehealthcare.com/role/REVENUERECOGNITIONScheduleofRemainingPerformanceObligationsDetails">
        <link:definition>9955527 - Disclosure - REVENUE RECOGNITION - Schedule of Remaining Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONNarrativeDetails" roleURI="http://www.gehealthcare.com/role/SEGMENTINFORMATIONNarrativeDetails">
        <link:definition>9955528 - Disclosure - SEGMENT INFORMATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails" roleURI="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails">
        <link:definition>9955529 - Disclosure - SEGMENT INFORMATION - Schedule of Revenues by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails" roleURI="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails">
        <link:definition>9955530 - Disclosure - SEGMENT INFORMATION - Schedule of Significant Expenses by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONScheduleofSegmentEBITDetails" roleURI="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails">
        <link:definition>9955531 - Disclosure - SEGMENT INFORMATION - Schedule of Segment EBIT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails" roleURI="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails">
        <link:definition>9955532 - Disclosure - SEGMENT INFORMATION - Schedule of Depreciation and Amortization by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECEIVABLESCurrentReceivablesDetails" roleURI="http://www.gehealthcare.com/role/RECEIVABLESCurrentReceivablesDetails">
        <link:definition>9955533 - Disclosure - RECEIVABLES - Current Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECEIVABLESLongTermReceivablesDetails" roleURI="http://www.gehealthcare.com/role/RECEIVABLESLongTermReceivablesDetails">
        <link:definition>9955534 - Disclosure - RECEIVABLES - Long-Term Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails" roleURI="http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails">
        <link:definition>9955535 - Disclosure - FINANCING RECEIVABLES - Schedule of Financing Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCINGRECEIVABLESNarrativeDetails" roleURI="http://www.gehealthcare.com/role/FINANCINGRECEIVABLESNarrativeDetails">
        <link:definition>9955536 - Disclosure - FINANCING RECEIVABLES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetails" roleURI="http://www.gehealthcare.com/role/LEASESDetails">
        <link:definition>9955537 - Disclosure - LEASES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" roleURI="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails">
        <link:definition>9955538 - Disclosure - ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails" roleURI="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails">
        <link:definition>9955539 - Disclosure - ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Schedule of Business Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails" roleURI="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails">
        <link:definition>9955540 - Disclosure - ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Schedule of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails" roleURI="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails">
        <link:definition>9955541 - Disclosure - ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Schedule of Finite-Lived and Indefinite-Lived Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails_1" roleURI="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails_1">
        <link:definition>9955541 - Disclosure - ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Schedule of Finite-Lived and Indefinite-Lived Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BORROWINGSNarrativeDetails" roleURI="http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails">
        <link:definition>9955542 - Disclosure - BORROWINGS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BORROWINGSScheduleofLongTermBorrowingsDetails" roleURI="http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails">
        <link:definition>9955543 - Disclosure - BORROWINGS - Schedule of Long-Term Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BORROWINGSScheduleofLongTermBorrowingsDetails_1" roleURI="http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails_1">
        <link:definition>9955543 - Disclosure - BORROWINGS - Schedule of Long-Term Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="POSTRETIREMENTBENEFITPLANSNarrativeDetails" roleURI="http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails">
        <link:definition>9955544 - Disclosure - POSTRETIREMENT BENEFIT PLANS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails" roleURI="http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails">
        <link:definition>9955545 - Disclosure - POSTRETIREMENT BENEFIT PLANS - Components of Expense (Income) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.gehealthcare.com/role/INCOMETAXESDetails">
        <link:definition>9955546 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails" roleURI="http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails">
        <link:definition>9955547 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) &#8211; NET (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" roleURI="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails">
        <link:definition>9955548 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails" roleURI="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails">
        <link:definition>9955549 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivative Fair Values (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofCumulativeBasisAdjustmentforFairvalueHedgesDetails" roleURI="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofCumulativeBasisAdjustmentforFairvalueHedgesDetails">
        <link:definition>9955550 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Cumulative Basis Adjustment for Fair value Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativePretaxGainsLossesRecognizedinOCIDetails" roleURI="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativePretaxGainsLossesRecognizedinOCIDetails">
        <link:definition>9955551 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivative Pre-tax Gains (Losses) Recognized in OCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails" roleURI="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails">
        <link:definition>9955552 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Effect of Derivatives Instruments on Statements of Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" roleURI="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails">
        <link:definition>9955553 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESDetails" roleURI="http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESDetails">
        <link:definition>9955554 - Disclosure - COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGACTIVITIESScheduleofRestructuringActivitiesDetails" roleURI="http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringActivitiesDetails">
        <link:definition>9955555 - Disclosure - RESTRUCTURING ACTIVITIES - Schedule of Restructuring Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGACTIVITIESNarrativeDetails" roleURI="http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails">
        <link:definition>9955556 - Disclosure - RESTRUCTURING ACTIVITIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails" roleURI="http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails">
        <link:definition>9955557 - Disclosure - RESTRUCTURING ACTIVITIES - Schedule of Restructuring Liability Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREDetails" roleURI="http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails">
        <link:definition>9955558 - Disclosure - EARNINGS PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONScheduleofCashCashEquivalentsandRestrictedCashDetails" roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofCashCashEquivalentsandRestrictedCashDetails">
        <link:definition>9955559 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONScheduleofInventoryDetails" roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofInventoryDetails">
        <link:definition>9955560 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails" roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails">
        <link:definition>9955561 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Summary of Property, Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails" roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails">
        <link:definition>9955562 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails" roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails">
        <link:definition>9955563 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Noncurrent Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails" roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails">
        <link:definition>9955564 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails" roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails">
        <link:definition>9955565 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Noncurrent Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONNarrativeDetails" roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONNarrativeDetails">
        <link:definition>9955566 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONScheduleofRedeemableNoncontrollingInterestDetails" roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofRedeemableNoncontrollingInterestDetails">
        <link:definition>9955567 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Redeemable Noncontrolling Interest (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails" roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails">
        <link:definition>9955568 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Other Income (Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTSDetails" roleURI="http://www.gehealthcare.com/role/SUBSEQUENTEVENTSDetails">
        <link:definition>9955569 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" abstract="false" name="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent" abstract="false" name="ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" abstract="false" name="PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost" abstract="false" name="PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts" abstract="false" name="IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_SupplierFinanceProgramPolicyPolicyTextBlock" abstract="false" name="SupplierFinanceProgramPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts" abstract="false" name="ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_ImagingSegmentMember" abstract="true" name="ImagingSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gehc_AVSSegmentMember" abstract="true" name="AVSSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gehc_PCSSegmentMember" abstract="true" name="PCSSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gehc_PDxSegmentMember" abstract="true" name="PDxSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gehc_ProceduralGuidanceSubsegmentMember" abstract="true" name="ProceduralGuidanceSubsegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gehc_SpecializedUltrasoundSubsegmentMember" abstract="true" name="SpecializedUltrasoundSubsegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gehc_MonitoringSolutionsSubsegmentMember" abstract="true" name="MonitoringSolutionsSubsegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gehc_LifeSupportSolutionsSubsegmentMember" abstract="true" name="LifeSupportSolutionsSubsegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges" abstract="false" name="IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_AcquisitionAndDispositionRelatedBenefitsCosts" abstract="false" name="AcquisitionAndDispositionRelatedBenefitsCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_SpinOffAndSeparationCosts" abstract="false" name="SpinOffAndSeparationCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_AmortizationOfIntangibleAssetsAcquired" abstract="false" name="AmortizationOfIntangibleAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_OtherNontradeReceivablesCurrent" abstract="false" name="OtherNontradeReceivablesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_OtherNontradeReceivablesNoncurrent" abstract="false" name="OtherNontradeReceivablesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_ReceivablesNetNoncurrent" abstract="false" name="ReceivablesNetNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_FinanceLeaseReceivableMember" abstract="true" name="FinanceLeaseReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gehc_FinancialAssetGreaterThan30DaysPastDueMember" abstract="true" name="FinancialAssetGreaterThan30DaysPastDueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gehc_NihonMediPhysicsCo.LtdNMPMember" abstract="true" name="NihonMediPhysicsCo.LtdNMPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gehc_MIMSoftwareMember" abstract="true" name="MIMSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gehc_ContingentConsiderationPurchasePriceMember" abstract="true" name="ContingentConsiderationPurchasePriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gehc_ContingentConsiderationServiceRequirementsMember" abstract="true" name="ContingentConsiderationServiceRequirementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue" abstract="false" name="BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax" abstract="false" name="OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_TrademarksAndOtherMember" abstract="true" name="TrademarksAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gehc_SeniorUnsecuredNotesMember" abstract="true" name="SeniorUnsecuredNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gehc_A5YearRevolvingCreditFacilityMember" abstract="true" name="A5YearRevolvingCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gehc_A364DayRevolvingCreditFacilityMember" abstract="true" name="A364DayRevolvingCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gehc_FloatingRateTermLoanFacilityDue2026Member" abstract="true" name="FloatingRateTermLoanFacilityDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gehc_CommercialContractsMember" abstract="true" name="CommercialContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gehc_EquipmentResidualValueObligationMember" abstract="true" name="EquipmentResidualValueObligationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gehc_NumberOfDebtSeries" abstract="false" name="NumberOfDebtSeries" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gehc_OtherLongTermBorrowingsMember" abstract="true" name="OtherLongTermBorrowingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gehc_A5600SeniorNotesDue2025Member" abstract="true" name="A5600SeniorNotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gehc_A5650SeniorNotesDue2027Member" abstract="true" name="A5650SeniorNotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gehc_A4.800SeniorNotesDue2029Member" abstract="true" name="A4.800SeniorNotesDue2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gehc_A5857SeniorNotesDue2030Member" abstract="true" name="A5857SeniorNotesDue2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gehc_A5905SeniorNotesDue2032Member" abstract="true" name="A5905SeniorNotesDue2032Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gehc_A6377SeniorNotesDue2052Member" abstract="true" name="A6377SeniorNotesDue2052Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="gehc_GEHealthCareSupplementalPensionPlanMember" abstract="true" name="GEHealthCareSupplementalPensionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold" abstract="false" name="DefinedBenefitPlanPlanAssetOrObligationReportingThreshold" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_OtherCashEquivalentsMember" abstract="true" name="OtherCashEquivalentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability" abstract="false" name="DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember" abstract="true" name="ForeignExchangeForwardAndForeignExchangeOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gehc_InterestAndDebtExpenseMember" abstract="true" name="InterestAndDebtExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gehc_DebtBasisAdjustmentLongTermBorrowingsMember" abstract="true" name="DebtBasisAdjustmentLongTermBorrowingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" abstract="false" name="OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease" abstract="false" name="StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_PaymentsForRestructuringAndOtherAdjustments" abstract="false" name="PaymentsForRestructuringAndOtherAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_BuildingsStructuresAndRelatedEquipmentMember" abstract="true" name="BuildingsStructuresAndRelatedEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gehc_LeaseholdImprovementsAndManufacturingPlantsMember" abstract="true" name="LeaseholdImprovementsAndManufacturingPlantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gehc_PrepaidExpensesAndDeferredCostsCurrent" abstract="false" name="PrepaidExpensesAndDeferredCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent" abstract="false" name="ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_SalesAllowancesAndRelatedLiabilitiesCurrent" abstract="false" name="SalesAllowancesAndRelatedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent" abstract="false" name="DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_AccruedFreightAndUtilitiesCurrent" abstract="false" name="AccruedFreightAndUtilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent" abstract="false" name="AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent" abstract="false" name="AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent" abstract="false" name="SalesAllowancesAndRelatedLiabilitiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gehc_OtherItemsIncomeExpenseNet" abstract="false" name="OtherItemsIncomeExpenseNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>gehc-20250331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:d0a8a86e-df0d-464c-9ff8-447ea6f21cea,g:ade862ec-33b2-4b8a-bb85-176c06a683fa-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" xlink:type="simple" xlink:href="gehc-20250331.xsd#CondensedConsolidatedStatementsofIncomeUnaudited"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9d64d675-4fe5-445b-9da7-6f5c4b006664" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6ef126bb-be59-4a49-ae56-e9564ef0e226" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_9d64d675-4fe5-445b-9da7-6f5c4b006664" xlink:to="loc_us-gaap_ProfitLoss_6ef126bb-be59-4a49-ae56-e9564ef0e226" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e9c820b5-a98c-4827-ae7e-b914fba57f54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_9d64d675-4fe5-445b-9da7-6f5c4b006664" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e9c820b5-a98c-4827-ae7e-b914fba57f54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a0abc9d8-6ab9-4277-a431-ff8899c6901b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bf52131c-285a-450b-a743-119fa3d0e9d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_a0abc9d8-6ab9-4277-a431-ff8899c6901b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bf52131c-285a-450b-a743-119fa3d0e9d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_44fbbd53-fc41-4117-b3db-3119aeaf2017" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_a0abc9d8-6ab9-4277-a431-ff8899c6901b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_44fbbd53-fc41-4117-b3db-3119aeaf2017" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0b2832e7-fad3-4d88-96bc-05f502c97d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_a0ecf8e6-a66f-44cf-8543-95b844c5f491" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_0b2832e7-fad3-4d88-96bc-05f502c97d1b" xlink:to="loc_us-gaap_OperatingExpenses_a0ecf8e6-a66f-44cf-8543-95b844c5f491" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d36ff24a-a2ce-4c2d-a33f-925edea765df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_0b2832e7-fad3-4d88-96bc-05f502c97d1b" xlink:to="loc_us-gaap_GrossProfit_d36ff24a-a2ce-4c2d-a33f-925edea765df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_ae6601bc-a2f2-46e6-8074-a6f53bcf4bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_00799186-343d-4ad9-ac3a-1d2c44ef683f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ae6601bc-a2f2-46e6-8074-a6f53bcf4bb3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_00799186-343d-4ad9-ac3a-1d2c44ef683f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_99b05956-d27c-4f07-a933-42d0ede67515" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ae6601bc-a2f2-46e6-8074-a6f53bcf4bb3" xlink:to="loc_us-gaap_CostOfRevenue_99b05956-d27c-4f07-a933-42d0ede67515" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8539bab0-17c7-43fe-b037-1f89ec121b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_2fae2ccd-f32d-4a02-9feb-cd8e5948cbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8539bab0-17c7-43fe-b037-1f89ec121b6f" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_2fae2ccd-f32d-4a02-9feb-cd8e5948cbb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d93723f1-68c0-4bcb-9011-b35205dd6fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8539bab0-17c7-43fe-b037-1f89ec121b6f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d93723f1-68c0-4bcb-9011-b35205dd6fdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_6b18ba81-3408-4a4c-b07c-c61d160e1c45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8539bab0-17c7-43fe-b037-1f89ec121b6f" xlink:to="loc_us-gaap_InterestAndDebtExpense_6b18ba81-3408-4a4c-b07c-c61d160e1c45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b465b793-885c-4df2-8933-a95380d736dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8539bab0-17c7-43fe-b037-1f89ec121b6f" xlink:to="loc_us-gaap_OperatingIncomeLoss_b465b793-885c-4df2-8933-a95380d736dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_863560db-2b98-48f9-af47-7a72339999a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_5d2435d5-5393-4569-89a5-fa970e4d1fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_863560db-2b98-48f9-af47-7a72339999a0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_5d2435d5-5393-4569-89a5-fa970e4d1fd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_476c36ca-11f3-4e71-9454-a60e79a3ad7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_863560db-2b98-48f9-af47-7a72339999a0" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_476c36ca-11f3-4e71-9454-a60e79a3ad7b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" xlink:type="simple" xlink:href="gehc-20250331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f00ca93c-446a-4508-84da-9f63c4dda64e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9faad216-87b9-4504-be95-2e620e3f6be4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f00ca93c-446a-4508-84da-9f63c4dda64e" xlink:to="loc_us-gaap_ProfitLoss_9faad216-87b9-4504-be95-2e620e3f6be4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_85881b58-b9b9-45cb-b4e8-fb7d48cd9a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f00ca93c-446a-4508-84da-9f63c4dda64e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_85881b58-b9b9-45cb-b4e8-fb7d48cd9a7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_2c6b5af9-28dd-4dcb-83d5-b7422c75ad14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_12380bdb-4f3c-4b0c-8513-ea2887e8eae6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_2c6b5af9-28dd-4dcb-83d5-b7422c75ad14" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_12380bdb-4f3c-4b0c-8513-ea2887e8eae6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_98c2b25c-a918-4a66-8fa7-00c25d4cf3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_2c6b5af9-28dd-4dcb-83d5-b7422c75ad14" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_98c2b25c-a918-4a66-8fa7-00c25d4cf3c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ffc2858d-762d-4062-b408-bff6c8a8950e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3779a531-0616-40d7-9c71-8ca63a8a7453" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ffc2858d-762d-4062-b408-bff6c8a8950e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3779a531-0616-40d7-9c71-8ca63a8a7453" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a92fa212-b87a-445d-b17c-adbe1c19eb9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ffc2858d-762d-4062-b408-bff6c8a8950e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a92fa212-b87a-445d-b17c-adbe1c19eb9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_69cb8f52-a53d-4489-aad8-e6f4bb8a80b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ffc2858d-762d-4062-b408-bff6c8a8950e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_69cb8f52-a53d-4489-aad8-e6f4bb8a80b0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited" xlink:type="simple" xlink:href="gehc-20250331.xsd#CondensedConsolidatedStatementsofFinancialPositionUnaudited"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_15a842e8-26f9-415d-814a-066676de7218" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_a64c42e3-0885-483e-8c0e-ccbc89c9818b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_15a842e8-26f9-415d-814a-066676de7218" xlink:to="loc_us-gaap_OtherAssetsCurrent_a64c42e3-0885-483e-8c0e-ccbc89c9818b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_9442a402-6f9a-476b-b3b1-d94e93f8788b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_15a842e8-26f9-415d-814a-066676de7218" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_9442a402-6f9a-476b-b3b1-d94e93f8788b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_42ed138d-4566-438c-91f5-8e0ced29b300" xlink:href="gehc-20250331.xsd#gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_15a842e8-26f9-415d-814a-066676de7218" xlink:to="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_42ed138d-4566-438c-91f5-8e0ced29b300" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_36431cbe-bc58-4fad-9ebc-33d8a3f1bb5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_15a842e8-26f9-415d-814a-066676de7218" xlink:to="loc_us-gaap_InventoryNet_36431cbe-bc58-4fad-9ebc-33d8a3f1bb5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent_b9a1b1cf-98cb-4b6d-8a52-fc185e4f3863" xlink:href="gehc-20250331.xsd#gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_15a842e8-26f9-415d-814a-066676de7218" xlink:to="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent_b9a1b1cf-98cb-4b6d-8a52-fc185e4f3863" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_216eff82-1795-4254-b82e-21bd6f31cc04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f0edbb1f-58d7-4777-ab82-6a3966fa3db3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_216eff82-1795-4254-b82e-21bd6f31cc04" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f0edbb1f-58d7-4777-ab82-6a3966fa3db3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_79c8e7da-0598-4824-85be-731ec2422705" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_216eff82-1795-4254-b82e-21bd6f31cc04" xlink:to="loc_us-gaap_LiabilitiesCurrent_79c8e7da-0598-4824-85be-731ec2422705" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_b1e2b459-0e3a-41e7-a033-b30fc9d547eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_216eff82-1795-4254-b82e-21bd6f31cc04" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_b1e2b459-0e3a-41e7-a033-b30fc9d547eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_92b156e2-305f-48b8-a315-c65379d66211" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_216eff82-1795-4254-b82e-21bd6f31cc04" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_92b156e2-305f-48b8-a315-c65379d66211" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_0c6c48f1-1571-48b2-acd9-c25a853ee82b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_216eff82-1795-4254-b82e-21bd6f31cc04" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_0c6c48f1-1571-48b2-acd9-c25a853ee82b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_747f603e-203f-4976-9c3d-11e21ff9f24f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_d82fef12-2602-4ac3-974d-83eac4c85ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_747f603e-203f-4976-9c3d-11e21ff9f24f" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_d82fef12-2602-4ac3-974d-83eac4c85ce2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_78887ef1-6758-4d16-bb38-020cd5e48513" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_747f603e-203f-4976-9c3d-11e21ff9f24f" xlink:to="loc_us-gaap_AccountsPayableCurrent_78887ef1-6758-4d16-bb38-020cd5e48513" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_87f8c27d-e253-4e0b-85da-46d0169533bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_747f603e-203f-4976-9c3d-11e21ff9f24f" xlink:to="loc_us-gaap_ShortTermBorrowings_87f8c27d-e253-4e0b-85da-46d0169533bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_7071357e-3b99-4ff5-b5bb-cefedd6d38c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_747f603e-203f-4976-9c3d-11e21ff9f24f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_7071357e-3b99-4ff5-b5bb-cefedd6d38c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1cb95ecd-ffab-4cf0-be62-8d359a94216a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_747f603e-203f-4976-9c3d-11e21ff9f24f" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1cb95ecd-ffab-4cf0-be62-8d359a94216a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4e1b1b48-2ad7-471a-ba44-f307730665ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9f273351-022e-471a-a50b-6e606f9692a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4e1b1b48-2ad7-471a-ba44-f307730665ca" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9f273351-022e-471a-a50b-6e606f9692a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_8cccb8f6-8359-4f70-9f25-3f45a739e273" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4e1b1b48-2ad7-471a-ba44-f307730665ca" xlink:to="loc_us-gaap_AdditionalPaidInCapital_8cccb8f6-8359-4f70-9f25-3f45a739e273" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3258f997-496a-451a-958d-1c0934b7217d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4e1b1b48-2ad7-471a-ba44-f307730665ca" xlink:to="loc_us-gaap_CommonStockValue_3258f997-496a-451a-958d-1c0934b7217d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_039ab78b-9ed2-4bae-8086-09f20416d595" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4e1b1b48-2ad7-471a-ba44-f307730665ca" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_039ab78b-9ed2-4bae-8086-09f20416d595" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_9cb9cfeb-e2ae-495e-b725-4dedb8bc4918" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4e1b1b48-2ad7-471a-ba44-f307730665ca" xlink:to="loc_us-gaap_TreasuryStockCommonValue_9cb9cfeb-e2ae-495e-b725-4dedb8bc4918" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7f9084b5-6931-4907-b9f2-d91a2314a39b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_24dfb909-83df-4a2d-96cf-061227706c36" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7f9084b5-6931-4907-b9f2-d91a2314a39b" xlink:to="loc_us-gaap_MinorityInterest_24dfb909-83df-4a2d-96cf-061227706c36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_34cd4cb8-31cd-46ca-8f94-6347f58b20fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7f9084b5-6931-4907-b9f2-d91a2314a39b" xlink:to="loc_us-gaap_StockholdersEquity_34cd4cb8-31cd-46ca-8f94-6347f58b20fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d6e3534d-f14f-4a29-bb99-e89a5513e669" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c8471232-d8d1-4f6c-acf9-821c21e9fb02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d6e3534d-f14f-4a29-bb99-e89a5513e669" xlink:to="loc_us-gaap_Liabilities_c8471232-d8d1-4f6c-acf9-821c21e9fb02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_d920100e-0482-4d17-aa59-8b1b9c0a4046" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d6e3534d-f14f-4a29-bb99-e89a5513e669" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_d920100e-0482-4d17-aa59-8b1b9c0a4046" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e49a7723-9940-4665-9a89-55aa82811eea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d6e3534d-f14f-4a29-bb99-e89a5513e669" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e49a7723-9940-4665-9a89-55aa82811eea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a5b6e07a-a691-46f0-a3b6-5888e7528a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d6e3534d-f14f-4a29-bb99-e89a5513e669" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a5b6e07a-a691-46f0-a3b6-5888e7528a7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_88aa5818-1eb0-40fc-8224-abb2d2fd1129" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_bd9ff24a-ef57-42c0-8c78-839f5615ba7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_88aa5818-1eb0-40fc-8224-abb2d2fd1129" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_bd9ff24a-ef57-42c0-8c78-839f5615ba7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_4f014ff1-e07e-45a7-b91a-cf2f64aea88c" xlink:href="gehc-20250331.xsd#gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_88aa5818-1eb0-40fc-8224-abb2d2fd1129" xlink:to="loc_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_4f014ff1-e07e-45a7-b91a-cf2f64aea88c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fcd06bfe-513a-46e8-b630-584b1e334643" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_88aa5818-1eb0-40fc-8224-abb2d2fd1129" xlink:to="loc_us-gaap_Goodwill_fcd06bfe-513a-46e8-b630-584b1e334643" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dd655d14-7b17-490d-a263-186290d59779" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_88aa5818-1eb0-40fc-8224-abb2d2fd1129" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dd655d14-7b17-490d-a263-186290d59779" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8f05af0d-125a-4372-9f5b-18ff4a1894e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_88aa5818-1eb0-40fc-8224-abb2d2fd1129" xlink:to="loc_us-gaap_AssetsCurrent_8f05af0d-125a-4372-9f5b-18ff4a1894e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_d98c4f34-a0a5-4c77-84d4-ecb83629f182" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_88aa5818-1eb0-40fc-8224-abb2d2fd1129" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_d98c4f34-a0a5-4c77-84d4-ecb83629f182" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="gehc-20250331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5c0477fe-2ab0-43ba-ad48-48f38ed6d153" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_32b1ac49-9fa4-4776-88e2-87d2e031c35e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5c0477fe-2ab0-43ba-ad48-48f38ed6d153" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_32b1ac49-9fa4-4776-88e2-87d2e031c35e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_148abba5-fa07-4dcc-89e7-f286dd17d74e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5c0477fe-2ab0-43ba-ad48-48f38ed6d153" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_148abba5-fa07-4dcc-89e7-f286dd17d74e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtMaturingInMoreThanThreeMonths_b4138ace-cd1b-4463-8b0d-67d5804abcee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromDebtMaturingInMoreThanThreeMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5c0477fe-2ab0-43ba-ad48-48f38ed6d153" xlink:to="loc_us-gaap_ProceedsFromDebtMaturingInMoreThanThreeMonths_b4138ace-cd1b-4463-8b0d-67d5804abcee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_b43ced9a-c171-487a-908d-8abcdc7a6ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5c0477fe-2ab0-43ba-ad48-48f38ed6d153" xlink:to="loc_us-gaap_PaymentsOfDividends_b43ced9a-c171-487a-908d-8abcdc7a6ceb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_dfc5d197-b1b4-4238-ad51-efca31aac43f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5c0477fe-2ab0-43ba-ad48-48f38ed6d153" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_dfc5d197-b1b4-4238-ad51-efca31aac43f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtMaturingInMoreThanThreeMonths_2f76114b-ada2-4540-a2b5-1f689baa9697" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebtMaturingInMoreThanThreeMonths"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5c0477fe-2ab0-43ba-ad48-48f38ed6d153" xlink:to="loc_us-gaap_RepaymentsOfDebtMaturingInMoreThanThreeMonths_2f76114b-ada2-4540-a2b5-1f689baa9697" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8a889054-098a-4168-b9ca-a27c6e290f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5c0477fe-2ab0-43ba-ad48-48f38ed6d153" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8a889054-098a-4168-b9ca-a27c6e290f1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_84bd9b28-a297-4f58-b5ce-122ed5a73872" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d36d625e-2b6d-447e-bffe-e14497acf648" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_84bd9b28-a297-4f58-b5ce-122ed5a73872" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d36d625e-2b6d-447e-bffe-e14497acf648" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_033df81d-3500-451c-8e97-288e749f5e55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_84bd9b28-a297-4f58-b5ce-122ed5a73872" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_033df81d-3500-451c-8e97-288e749f5e55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e9ba06f6-8358-4af9-8109-a4e890324bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_84bd9b28-a297-4f58-b5ce-122ed5a73872" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e9ba06f6-8358-4af9-8109-a4e890324bcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ccb479b1-1179-4d25-8398-610105c846a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_84bd9b28-a297-4f58-b5ce-122ed5a73872" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ccb479b1-1179-4d25-8398-610105c846a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d82d0daf-ecf0-48e0-9bcb-436cb6d1e536" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts_8cf7f2b8-677a-4d35-a189-d95c05597e6e" xlink:href="gehc-20250331.xsd#gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d82d0daf-ecf0-48e0-9bcb-436cb6d1e536" xlink:to="loc_gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts_8cf7f2b8-677a-4d35-a189-d95c05597e6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_7652a5c2-13f9-4b6e-9c3c-96ccc5798aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d82d0daf-ecf0-48e0-9bcb-436cb6d1e536" xlink:to="loc_us-gaap_Depreciation_7652a5c2-13f9-4b6e-9c3c-96ccc5798aa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_55797617-a276-4210-9c6b-02d807ee7375" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d82d0daf-ecf0-48e0-9bcb-436cb6d1e536" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_55797617-a276-4210-9c6b-02d807ee7375" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_bef92a5b-addc-4032-8100-fb62cb80bf67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d82d0daf-ecf0-48e0-9bcb-436cb6d1e536" xlink:to="loc_us-gaap_ShareBasedCompensation_bef92a5b-addc-4032-8100-fb62cb80bf67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost_ccb7b7fe-8349-46e6-b53e-ec1960f4e17f" xlink:href="gehc-20250331.xsd#gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d82d0daf-ecf0-48e0-9bcb-436cb6d1e536" xlink:to="loc_gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost_ccb7b7fe-8349-46e6-b53e-ec1960f4e17f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_fec5ba08-b0b6-41a5-8a47-d7657aff9e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d82d0daf-ecf0-48e0-9bcb-436cb6d1e536" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_fec5ba08-b0b6-41a5-8a47-d7657aff9e0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_b9bd8abc-6eec-418b-a4c5-998ab8fe515f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d82d0daf-ecf0-48e0-9bcb-436cb6d1e536" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_b9bd8abc-6eec-418b-a4c5-998ab8fe515f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_be10c335-6bfc-41a7-aa74-648756ee5c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d82d0daf-ecf0-48e0-9bcb-436cb6d1e536" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_be10c335-6bfc-41a7-aa74-648756ee5c5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_3ac396a0-c6c7-405a-8a8d-456f0f9aed0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d82d0daf-ecf0-48e0-9bcb-436cb6d1e536" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_3ac396a0-c6c7-405a-8a8d-456f0f9aed0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_01b93242-c384-4373-a705-e9175f28984d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d82d0daf-ecf0-48e0-9bcb-436cb6d1e536" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_01b93242-c384-4373-a705-e9175f28984d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f993ea40-aabc-4eae-8c7e-d49d9de8fdf6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d82d0daf-ecf0-48e0-9bcb-436cb6d1e536" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f993ea40-aabc-4eae-8c7e-d49d9de8fdf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_4c7dcd3a-4205-424d-b4bc-bd75ca033e61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d82d0daf-ecf0-48e0-9bcb-436cb6d1e536" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_4c7dcd3a-4205-424d-b4bc-bd75ca033e61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_ba813f9e-0cd2-47e6-8ff5-acbc26e7e1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d82d0daf-ecf0-48e0-9bcb-436cb6d1e536" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_ba813f9e-0cd2-47e6-8ff5-acbc26e7e1e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_18707826-1736-4f19-a750-919b5c815bab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d82d0daf-ecf0-48e0-9bcb-436cb6d1e536" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_18707826-1736-4f19-a750-919b5c815bab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_d63fca27-14bf-460a-aee0-753710823eff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d82d0daf-ecf0-48e0-9bcb-436cb6d1e536" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_d63fca27-14bf-460a-aee0-753710823eff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c431b12d-94c5-4a90-9265-7b56765885e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d82d0daf-ecf0-48e0-9bcb-436cb6d1e536" xlink:to="loc_us-gaap_ProfitLoss_c431b12d-94c5-4a90-9265-7b56765885e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4aa43477-cf5e-4935-87e9-108aed55b0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_53ad028a-8491-4368-ab07-3cf88b4aa2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4aa43477-cf5e-4935-87e9-108aed55b0c5" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_53ad028a-8491-4368-ab07-3cf88b4aa2cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3235d5b2-143f-4255-bd73-40f98c4e2f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4aa43477-cf5e-4935-87e9-108aed55b0c5" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3235d5b2-143f-4255-bd73-40f98c4e2f7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d46f59d4-5b34-41f4-8320-63646355b5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4aa43477-cf5e-4935-87e9-108aed55b0c5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d46f59d4-5b34-41f4-8320-63646355b5eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_29fdf7a0-5a35-453b-9bc6-5d0108820257" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4aa43477-cf5e-4935-87e9-108aed55b0c5" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_29fdf7a0-5a35-453b-9bc6-5d0108820257" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent_987465c0-365f-41f9-a56b-24da4d35d063" xlink:href="gehc-20250331.xsd#gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_461eaf5e-869d-4a2e-a919-b858305f6812" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent_987465c0-365f-41f9-a56b-24da4d35d063" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_461eaf5e-869d-4a2e-a919-b858305f6812" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCurrent_b46e0c1f-d55e-43a3-8f90-544a97be7397" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent_987465c0-365f-41f9-a56b-24da4d35d063" xlink:to="loc_us-gaap_DeferredCostsCurrent_b46e0c1f-d55e-43a3-8f90-544a97be7397" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts_95e69dfd-6f24-418c-bbe4-a8b7887891fa" xlink:href="gehc-20250331.xsd#gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_5ce777c8-c14b-4d5c-a8ba-f3cfa78bfbd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts_95e69dfd-6f24-418c-bbe4-a8b7887891fa" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_5ce777c8-c14b-4d5c-a8ba-f3cfa78bfbd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCosts_8aa714fa-4967-4d01-8512-f5637abfd400" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts_95e69dfd-6f24-418c-bbe4-a8b7887891fa" xlink:to="loc_us-gaap_DeferredCosts_8aa714fa-4967-4d01-8512-f5637abfd400" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent_3cfda301-f2b9-4af9-ba1a-d9f13f82c49a" xlink:href="gehc-20250331.xsd#gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts_95e69dfd-6f24-418c-bbe4-a8b7887891fa" xlink:to="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent_3cfda301-f2b9-4af9-ba1a-d9f13f82c49a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_e29c3997-562e-4b28-bcf5-2a333393d53e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_26ff241b-aaa9-4cf0-9b37-3ac7de48993e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_e29c3997-562e-4b28-bcf5-2a333393d53e" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_26ff241b-aaa9-4cf0-9b37-3ac7de48993e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_28c866a4-00bc-4ce7-a975-5ae8e30fe23b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_e29c3997-562e-4b28-bcf5-2a333393d53e" xlink:to="loc_us-gaap_CostOfRevenue_28c866a4-00bc-4ce7-a975-5ae8e30fe23b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SEGMENTINFORMATIONScheduleofSegmentEBITDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d0b6ac9-08c8-4df4-91c0-b35f4bc5ab56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AcquisitionAndDispositionRelatedBenefitsCosts_55d54652-0510-434a-a0eb-8abfbb64cb7a" xlink:href="gehc-20250331.xsd#gehc_AcquisitionAndDispositionRelatedBenefitsCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d0b6ac9-08c8-4df4-91c0-b35f4bc5ab56" xlink:to="loc_gehc_AcquisitionAndDispositionRelatedBenefitsCosts_55d54652-0510-434a-a0eb-8abfbb64cb7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AmortizationOfIntangibleAssetsAcquired_92768a62-babc-4e2a-a746-81bf62fedeaf" xlink:href="gehc-20250331.xsd#gehc_AmortizationOfIntangibleAssetsAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d0b6ac9-08c8-4df4-91c0-b35f4bc5ab56" xlink:to="loc_gehc_AmortizationOfIntangibleAssetsAcquired_92768a62-babc-4e2a-a746-81bf62fedeaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_e4718716-bcd4-4fc8-af42-835ff572d2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d0b6ac9-08c8-4df4-91c0-b35f4bc5ab56" xlink:to="loc_us-gaap_GainLossOnInvestments_e4718716-bcd4-4fc8-af42-835ff572d2b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges_caee9d2f-4214-46b7-9018-d3b226b45d66" xlink:href="gehc-20250331.xsd#gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d0b6ac9-08c8-4df4-91c0-b35f4bc5ab56" xlink:to="loc_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges_caee9d2f-4214-46b7-9018-d3b226b45d66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_bb96ca1b-eeee-4838-88b8-03948d1f3724" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d0b6ac9-08c8-4df4-91c0-b35f4bc5ab56" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_bb96ca1b-eeee-4838-88b8-03948d1f3724" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_b7f5dc3e-dd8b-48b4-8f0c-8700bd80cdf7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d0b6ac9-08c8-4df4-91c0-b35f4bc5ab56" xlink:to="loc_us-gaap_InterestAndDebtExpense_b7f5dc3e-dd8b-48b4-8f0c-8700bd80cdf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_SpinOffAndSeparationCosts_6d7f5cd4-de20-4769-9b3c-0f74ed47512f" xlink:href="gehc-20250331.xsd#gehc_SpinOffAndSeparationCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d0b6ac9-08c8-4df4-91c0-b35f4bc5ab56" xlink:to="loc_gehc_SpinOffAndSeparationCosts_6d7f5cd4-de20-4769-9b3c-0f74ed47512f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_bb3f18ae-e78e-4c04-a214-027065ee82ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d0b6ac9-08c8-4df4-91c0-b35f4bc5ab56" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_bb3f18ae-e78e-4c04-a214-027065ee82ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_4303d4ef-ba68-4ce9-9716-57639f02c8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d0b6ac9-08c8-4df4-91c0-b35f4bc5ab56" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_4303d4ef-ba68-4ce9-9716-57639f02c8ef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/RECEIVABLESCurrentReceivablesDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#RECEIVABLESCurrentReceivablesDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/RECEIVABLESCurrentReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesCurrent_2fdcbc24-6b87-4c37-b782-4e4761581680" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NontradeReceivablesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherNontradeReceivablesCurrent_43f58422-5eb0-4147-81af-3de691638c8c" xlink:href="gehc-20250331.xsd#gehc_OtherNontradeReceivablesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NontradeReceivablesCurrent_2fdcbc24-6b87-4c37-b782-4e4761581680" xlink:to="loc_gehc_OtherNontradeReceivablesCurrent_43f58422-5eb0-4147-81af-3de691638c8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValueAddedTaxReceivableCurrent_775f059a-0898-426f-a5e7-6b82df87373b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValueAddedTaxReceivableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NontradeReceivablesCurrent_2fdcbc24-6b87-4c37-b782-4e4761581680" xlink:to="loc_us-gaap_ValueAddedTaxReceivableCurrent_775f059a-0898-426f-a5e7-6b82df87373b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_a4c4ff33-ff40-4593-af94-57c6608c662f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_406fb93f-c344-4eec-8e74-b367f640de2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_a4c4ff33-ff40-4593-af94-57c6608c662f" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_406fb93f-c344-4eec-8e74-b367f640de2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_f62c3ee2-ec74-4248-bb7f-8d86b8fa00ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_a4c4ff33-ff40-4593-af94-57c6608c662f" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_f62c3ee2-ec74-4248-bb7f-8d86b8fa00ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesCurrent_baebf8cd-78f5-434f-a6b8-27fa9a95ca55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NontradeReceivablesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_a4c4ff33-ff40-4593-af94-57c6608c662f" xlink:to="loc_us-gaap_NontradeReceivablesCurrent_baebf8cd-78f5-434f-a6b8-27fa9a95ca55" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/RECEIVABLESLongTermReceivablesDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#RECEIVABLESLongTermReceivablesDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/RECEIVABLESLongTermReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ReceivablesNetNoncurrent_4bb0ac0e-e03f-4b8a-b49f-c0bf72f55096" xlink:href="gehc-20250331.xsd#gehc_ReceivablesNetNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossNoncurrent_64abd441-0355-4453-9ee2-2bcf1a58d147" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGrossNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gehc_ReceivablesNetNoncurrent_4bb0ac0e-e03f-4b8a-b49f-c0bf72f55096" xlink:to="loc_us-gaap_AccountsReceivableGrossNoncurrent_64abd441-0355-4453-9ee2-2bcf1a58d147" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent_62847d75-c55f-4b92-94ed-03ee7aae8cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gehc_ReceivablesNetNoncurrent_4bb0ac0e-e03f-4b8a-b49f-c0bf72f55096" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent_62847d75-c55f-4b92-94ed-03ee7aae8cb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesNoncurrent_b494d88f-3a75-40f5-a8b4-2cfbd8cdc6b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NontradeReceivablesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gehc_ReceivablesNetNoncurrent_4bb0ac0e-e03f-4b8a-b49f-c0bf72f55096" xlink:to="loc_us-gaap_NontradeReceivablesNoncurrent_b494d88f-3a75-40f5-a8b4-2cfbd8cdc6b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesNoncurrent_2381be28-76f3-4a35-b238-63085e3f26b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NontradeReceivablesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValueAddedTaxReceivableNoncurrent_62a4f6af-e96d-4512-882f-aa0b8cedfe81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValueAddedTaxReceivableNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NontradeReceivablesNoncurrent_2381be28-76f3-4a35-b238-63085e3f26b9" xlink:to="loc_us-gaap_ValueAddedTaxReceivableNoncurrent_62a4f6af-e96d-4512-882f-aa0b8cedfe81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherNontradeReceivablesNoncurrent_d0b89160-d79f-47ea-85be-e9998a1a7eae" xlink:href="gehc-20250331.xsd#gehc_OtherNontradeReceivablesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NontradeReceivablesNoncurrent_2381be28-76f3-4a35-b238-63085e3f26b9" xlink:to="loc_gehc_OtherNontradeReceivablesNoncurrent_d0b89160-d79f-47ea-85be-e9998a1a7eae" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_37838a1a-67a6-453b-b264-738571222995" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForNotesAndLoansReceivableCurrent_27aae8f9-98c2-4165-af8c-2b4066274c61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForNotesAndLoansReceivableCurrent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrent_37838a1a-67a6-453b-b264-738571222995" xlink:to="loc_us-gaap_AllowanceForNotesAndLoansReceivableCurrent_27aae8f9-98c2-4165-af8c-2b4066274c61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableGrossCurrent_d33e60ad-f712-4cf3-a96f-30f8bca81434" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableGrossCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrent_37838a1a-67a6-453b-b264-738571222995" xlink:to="loc_us-gaap_NotesAndLoansReceivableGrossCurrent_d33e60ad-f712-4cf3-a96f-30f8bca81434" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_e82598b7-dda4-4617-86a8-30a7ac6ba012" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableGrossNoncurrent_fcc89f0f-b977-4b3d-b1a3-a5a1c5c93d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableGrossNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_e82598b7-dda4-4617-86a8-30a7ac6ba012" xlink:to="loc_us-gaap_NotesAndLoansReceivableGrossNoncurrent_fcc89f0f-b977-4b3d-b1a3-a5a1c5c93d8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent_b981a4d7-b8db-4d8f-a58a-c83bbe5f8e85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_e82598b7-dda4-4617-86a8-30a7ac6ba012" xlink:to="loc_us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent_b981a4d7-b8db-4d8f-a58a-c83bbe5f8e85" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7027918a-dfd1-4189-ae02-81b3992f0670" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_ffcd8d23-e9dc-4ba4-be28-f19d55ede391" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7027918a-dfd1-4189-ae02-81b3992f0670" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_ffcd8d23-e9dc-4ba4-be28-f19d55ede391" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e975a2cf-585e-4508-ab11-58951ca876b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7027918a-dfd1-4189-ae02-81b3992f0670" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e975a2cf-585e-4508-ab11-58951ca876b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_858f508f-9d24-400e-8c64-766e1035e7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7027918a-dfd1-4189-ae02-81b3992f0670" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_858f508f-9d24-400e-8c64-766e1035e7ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_20f81096-95e1-4cfc-b4ef-c2c234a61b33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_f7ed9a49-cf27-4bd4-9fc1-430712259ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_20f81096-95e1-4cfc-b4ef-c2c234a61b33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_f7ed9a49-cf27-4bd4-9fc1-430712259ae0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_2dccde83-f03a-488d-be73-80ab5e1be3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_20f81096-95e1-4cfc-b4ef-c2c234a61b33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_2dccde83-f03a-488d-be73-80ab5e1be3ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_9b4dcc32-16ed-48ca-afaa-437bb3d8df45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_20f81096-95e1-4cfc-b4ef-c2c234a61b33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_9b4dcc32-16ed-48ca-afaa-437bb3d8df45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_75f9d1a3-621d-4327-bf55-36b99921d738" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_20f81096-95e1-4cfc-b4ef-c2c234a61b33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_75f9d1a3-621d-4327-bf55-36b99921d738" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_e6b3db6d-b0c1-43b6-b34f-3dda7e499123" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_20f81096-95e1-4cfc-b4ef-c2c234a61b33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_e6b3db6d-b0c1-43b6-b34f-3dda7e499123" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_230475f8-3693-40c6-af2f-5cfb4bb6b89f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_20f81096-95e1-4cfc-b4ef-c2c234a61b33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_230475f8-3693-40c6-af2f-5cfb4bb6b89f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e4fdff16-d091-4939-beee-a05caf30925b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_20f81096-95e1-4cfc-b4ef-c2c234a61b33" xlink:to="loc_us-gaap_Goodwill_e4fdff16-d091-4939-beee-a05caf30925b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_48c29a44-d777-43be-8fc1-880866d330e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_20f81096-95e1-4cfc-b4ef-c2c234a61b33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_48c29a44-d777-43be-8fc1-880866d330e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_9687f471-1244-4a7e-995f-23614c725eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_20f81096-95e1-4cfc-b4ef-c2c234a61b33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_9687f471-1244-4a7e-995f-23614c725eb2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b8c7f027-ca9e-4cd3-8fa0-76212fb9a9a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2e167554-4126-4b95-b0f8-176fe523392e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b8c7f027-ca9e-4cd3-8fa0-76212fb9a9a7" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2e167554-4126-4b95-b0f8-176fe523392e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a12981c9-3933-4bf1-92a3-37ced135a5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b8c7f027-ca9e-4cd3-8fa0-76212fb9a9a7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a12981c9-3933-4bf1-92a3-37ced135a5a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_4474c40f-4518-41c5-8443-0a45da1e16b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ac5121c7-4d8c-481b-8ac6-e0e5535d68b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_4474c40f-4518-41c5-8443-0a45da1e16b9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ac5121c7-4d8c-481b-8ac6-e0e5535d68b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_90958661-17ed-47c1-a2f3-92b31db3e32a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_4474c40f-4518-41c5-8443-0a45da1e16b9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_90958661-17ed-47c1-a2f3-92b31db3e32a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_773c5b9e-3b0e-4b86-aaf8-9c5850246c03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_88eea022-bea3-4864-8ee2-3d62c927bfdf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_773c5b9e-3b0e-4b86-aaf8-9c5850246c03" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_88eea022-bea3-4864-8ee2-3d62c927bfdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b08456ee-a850-4c6a-86e6-19728b998458" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_773c5b9e-3b0e-4b86-aaf8-9c5850246c03" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b08456ee-a850-4c6a-86e6-19728b998458" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails_1" xlink:type="simple" xlink:href="gehc-20250331.xsd#ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails_1"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4b8aa428-7b35-426b-b547-b1061d1a15e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6ac0fed0-da52-4509-bd04-e79825dfda4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4b8aa428-7b35-426b-b547-b1061d1a15e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6ac0fed0-da52-4509-bd04-e79825dfda4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_64ad80bc-adfa-4830-bc47-08467a355ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4b8aa428-7b35-426b-b547-b1061d1a15e9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_64ad80bc-adfa-4830-bc47-08467a355ac4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#BORROWINGSScheduleofLongTermBorrowingsDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_25d76a08-1370-48c4-89eb-463322a63ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_211bbb32-7572-492d-a02c-c95fd894c60b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_25d76a08-1370-48c4-89eb-463322a63ee7" xlink:to="loc_us-gaap_ShortTermBorrowings_211bbb32-7572-492d-a02c-c95fd894c60b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ee6c5914-df9b-4d99-95b0-40fe7c8c7475" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_25d76a08-1370-48c4-89eb-463322a63ee7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ee6c5914-df9b-4d99-95b0-40fe7c8c7475" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails_1" xlink:type="simple" xlink:href="gehc-20250331.xsd#BORROWINGSScheduleofLongTermBorrowingsDetails_1"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_79728222-ce39-4f3a-8838-df12518ef2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_122cb6e1-55e5-494b-b09a-d8c08bceb30e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_79728222-ce39-4f3a-8838-df12518ef2d7" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_122cb6e1-55e5-494b-b09a-d8c08bceb30e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_977c4387-16da-4f8e-9187-4a84eb9ab5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_79728222-ce39-4f3a-8838-df12518ef2d7" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_977c4387-16da-4f8e-9187-4a84eb9ab5bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_57238020-e28c-4a99-83fd-a4366a278528" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_79728222-ce39-4f3a-8838-df12518ef2d7" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_57238020-e28c-4a99-83fd-a4366a278528" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_f29601c2-ee0b-4b18-b0ea-8e89466c91aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_dac5e378-860c-4186-9e1f-0e004b193f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_f29601c2-ee0b-4b18-b0ea-8e89466c91aa" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_dac5e378-860c-4186-9e1f-0e004b193f7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_a5d67043-3b75-4ad4-a64f-b882372dd80d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_f29601c2-ee0b-4b18-b0ea-8e89466c91aa" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_a5d67043-3b75-4ad4-a64f-b882372dd80d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_4a42cf0f-eef1-403b-b440-eda234d9d5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_f29601c2-ee0b-4b18-b0ea-8e89466c91aa" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_4a42cf0f-eef1-403b-b440-eda234d9d5f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_23ccecfb-61ef-48b0-9ba4-7334b97ceaf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_f29601c2-ee0b-4b18-b0ea-8e89466c91aa" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_23ccecfb-61ef-48b0-9ba4-7334b97ceaf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_74ab95e0-2b89-40e2-9823-faee51ee5aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_f29601c2-ee0b-4b18-b0ea-8e89466c91aa" xlink:to="loc_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_74ab95e0-2b89-40e2-9823-faee51ee5aa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a49f575d-710e-4b69-a642-a3911596115b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_5eccda15-0334-4cdc-a6c6-68219585bb93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a49f575d-710e-4b69-a642-a3911596115b" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_5eccda15-0334-4cdc-a6c6-68219585bb93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_919ed102-7380-4799-8a4b-94b7159d389e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a49f575d-710e-4b69-a642-a3911596115b" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_919ed102-7380-4799-8a4b-94b7159d389e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5ac02e6e-a7f0-4a86-92ec-5b3dd4917127" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_5e70cf46-88e8-4c1d-a0d0-0c7eff2b873b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5ac02e6e-a7f0-4a86-92ec-5b3dd4917127" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_5e70cf46-88e8-4c1d-a0d0-0c7eff2b873b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_88939604-340a-49c5-9b0f-943a3c40fddc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5ac02e6e-a7f0-4a86-92ec-5b3dd4917127" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_88939604-340a-49c5-9b0f-943a3c40fddc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringActivitiesDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#RESTRUCTURINGACTIVITIESScheduleofRestructuringActivitiesDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringActivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_aecb0e44-12fa-4a45-95d1-5841c88a8f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_e9370f5c-372b-456a-b3bb-d6eb17dde746" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_aecb0e44-12fa-4a45-95d1-5841c88a8f6d" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_e9370f5c-372b-456a-b3bb-d6eb17dde746" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_8d4ab8ce-2989-4d0a-91e7-29ccc599f5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_aecb0e44-12fa-4a45-95d1-5841c88a8f6d" xlink:to="loc_us-gaap_SeveranceCosts1_8d4ab8ce-2989-4d0a-91e7-29ccc599f5e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_8611a0fb-4006-45f2-a11b-4b8b4ff24df3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessExitCosts1"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_aecb0e44-12fa-4a45-95d1-5841c88a8f6d" xlink:to="loc_us-gaap_BusinessExitCosts1_8611a0fb-4006-45f2-a11b-4b8b4ff24df3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#EARNINGSPERSHAREDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3ffc63ab-9bca-4544-abf9-04cdab1ea68e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_ccac77d3-4d34-4664-8ea2-00ddb8fd69cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3ffc63ab-9bca-4544-abf9-04cdab1ea68e" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_ccac77d3-4d34-4664-8ea2-00ddb8fd69cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_81f97f39-b680-4504-a1fb-89b2acd040f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3ffc63ab-9bca-4544-abf9-04cdab1ea68e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_81f97f39-b680-4504-a1fb-89b2acd040f0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bd7cbf73-bfd5-4daa-9c4c-b9f4c1a768ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_79c24dc4-49e5-4db7-b369-3f7ded6b88ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bd7cbf73-bfd5-4daa-9c4c-b9f4c1a768ff" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_79c24dc4-49e5-4db7-b369-3f7ded6b88ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_cff3cced-b680-4edf-8f06-36d23a940fec" xlink:href="gehc-20250331.xsd#gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bd7cbf73-bfd5-4daa-9c4c-b9f4c1a768ff" xlink:to="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_cff3cced-b680-4edf-8f06-36d23a940fec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_c363aace-656e-4800-b3be-fc91c54112b3" xlink:href="gehc-20250331.xsd#gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_517299e3-7561-45e5-a869-a2add056a0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_c363aace-656e-4800-b3be-fc91c54112b3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_517299e3-7561-45e5-a869-a2add056a0d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_e33b5f50-38bb-4df4-b2d2-b6b249e240a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_c363aace-656e-4800-b3be-fc91c54112b3" xlink:to="loc_us-gaap_RestrictedCashCurrent_e33b5f50-38bb-4df4-b2d2-b6b249e240a3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofInventoryDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_7d1070fc-9aff-4dbe-b4dd-7acfe85a7920" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_807e2a52-54f1-43be-924d-4f79f9b6c46c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_7d1070fc-9aff-4dbe-b4dd-7acfe85a7920" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_807e2a52-54f1-43be-924d-4f79f9b6c46c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_6abffb33-b445-4ace-b113-861923cdb961" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_7d1070fc-9aff-4dbe-b4dd-7acfe85a7920" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_6abffb33-b445-4ace-b113-861923cdb961" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d852374e-36f6-4064-83f8-e730b54fa0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_7d1070fc-9aff-4dbe-b4dd-7acfe85a7920" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d852374e-36f6-4064-83f8-e730b54fa0a6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1e9f3e50-f26d-41c4-a177-93a0ac78828b" xlink:href="gehc-20250331.xsd#gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ea06c9e3-77b2-412b-922e-d6b036486e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1e9f3e50-f26d-41c4-a177-93a0ac78828b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ea06c9e3-77b2-412b-922e-d6b036486e8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d0b4d0fa-237e-4275-92c8-dfc1c6e90e91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1e9f3e50-f26d-41c4-a177-93a0ac78828b" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d0b4d0fa-237e-4275-92c8-dfc1c6e90e91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_50cd0ec6-fa59-4b6d-99dc-bb8234376142" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1e9f3e50-f26d-41c4-a177-93a0ac78828b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_50cd0ec6-fa59-4b6d-99dc-bb8234376142" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_50608637-4416-4ddc-be79-9b2c1e827793" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_ab7b9a18-e896-442e-b7c5-5ad0f3091404" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_50608637-4416-4ddc-be79-9b2c1e827793" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_ab7b9a18-e896-442e-b7c5-5ad0f3091404" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_cd237d11-4252-43d4-ab82-b84cbffd0f26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_50608637-4416-4ddc-be79-9b2c1e827793" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_cd237d11-4252-43d4-ab82-b84cbffd0f26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_16777c05-7788-43ec-b48f-3bc71804849d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_50608637-4416-4ddc-be79-9b2c1e827793" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_16777c05-7788-43ec-b48f-3bc71804849d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PrepaidExpensesAndDeferredCostsCurrent_314f1168-55ea-44b6-adb7-ce837f7030ef" xlink:href="gehc-20250331.xsd#gehc_PrepaidExpensesAndDeferredCostsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_50608637-4416-4ddc-be79-9b2c1e827793" xlink:to="loc_gehc_PrepaidExpensesAndDeferredCostsCurrent_314f1168-55ea-44b6-adb7-ce837f7030ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_b1045778-824d-4e7e-bb2c-1ac96527f16e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_50608637-4416-4ddc-be79-9b2c1e827793" xlink:to="loc_us-gaap_IncomeTaxesReceivable_b1045778-824d-4e7e-bb2c-1ac96527f16e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c821fe40-6c08-4329-bd0e-cd3d0579ad89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_3c3abc02-6f2e-4a1f-957e-fb6df4ea0a19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_c821fe40-6c08-4329-bd0e-cd3d0579ad89" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_3c3abc02-6f2e-4a1f-957e-fb6df4ea0a19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_59954bf7-fd16-4ef3-958c-9377eeb5b8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_c821fe40-6c08-4329-bd0e-cd3d0579ad89" xlink:to="loc_us-gaap_LongTermInvestments_59954bf7-fd16-4ef3-958c-9377eeb5b8d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent_67f6b79e-85d6-425b-a341-4fc7a2b6293d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_c821fe40-6c08-4329-bd0e-cd3d0579ad89" xlink:to="loc_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent_67f6b79e-85d6-425b-a341-4fc7a2b6293d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_25d1fa71-861e-43e4-9f9c-987576e14158" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_c821fe40-6c08-4329-bd0e-cd3d0579ad89" xlink:to="loc_us-gaap_InventoryNoncurrent_25d1fa71-861e-43e4-9f9c-987576e14158" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent_59db5794-039d-4cf7-a503-fa63cd129e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_c821fe40-6c08-4329-bd0e-cd3d0579ad89" xlink:to="loc_us-gaap_PrepaidExpenseNoncurrent_59db5794-039d-4cf7-a503-fa63cd129e4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_8fc0dcf4-cf79-4660-8fd3-27e470625a34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_c821fe40-6c08-4329-bd0e-cd3d0579ad89" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_8fc0dcf4-cf79-4660-8fd3-27e470625a34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent_b36990df-3f4f-4f49-bb30-69ec19f4e693" xlink:href="gehc-20250331.xsd#gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_c821fe40-6c08-4329-bd0e-cd3d0579ad89" xlink:to="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent_b36990df-3f4f-4f49-bb30-69ec19f4e693" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_d2dad984-6dff-4944-aad0-4c26ee461428" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_c821fe40-6c08-4329-bd0e-cd3d0579ad89" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_d2dad984-6dff-4944-aad0-4c26ee461428" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_0578c922-a0e6-4318-a7f2-1e0d3e67f9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AccruedFreightAndUtilitiesCurrent_b06f7bcd-3cb4-458e-a2c5-2c377710e870" xlink:href="gehc-20250331.xsd#gehc_AccruedFreightAndUtilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_0578c922-a0e6-4318-a7f2-1e0d3e67f9c4" xlink:to="loc_gehc_AccruedFreightAndUtilitiesCurrent_b06f7bcd-3cb4-458e-a2c5-2c377710e870" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent_5f4b5429-7b29-43f4-afd8-0f129679f95c" xlink:href="gehc-20250331.xsd#gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_0578c922-a0e6-4318-a7f2-1e0d3e67f9c4" xlink:to="loc_gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent_5f4b5429-7b29-43f4-afd8-0f129679f95c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_b9d2be50-a54e-4a1b-ba8e-365f560c81ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_0578c922-a0e6-4318-a7f2-1e0d3e67f9c4" xlink:to="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_b9d2be50-a54e-4a1b-ba8e-365f560c81ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_cf2c1d45-210a-454c-bca1-4b7530b3610e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_0578c922-a0e6-4318-a7f2-1e0d3e67f9c4" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_cf2c1d45-210a-454c-bca1-4b7530b3610e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_cec00255-01fc-4b38-8fa0-a1331faf4289" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_0578c922-a0e6-4318-a7f2-1e0d3e67f9c4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_cec00255-01fc-4b38-8fa0-a1331faf4289" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_9d5b4fc4-810f-49f4-8735-b37218e20f27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_0578c922-a0e6-4318-a7f2-1e0d3e67f9c4" xlink:to="loc_us-gaap_InterestPayableCurrent_9d5b4fc4-810f-49f4-8735-b37218e20f27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_SalesAllowancesAndRelatedLiabilitiesCurrent_a9e6a35a-1a07-4628-b4ee-9520b7a1629f" xlink:href="gehc-20250331.xsd#gehc_SalesAllowancesAndRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_0578c922-a0e6-4318-a7f2-1e0d3e67f9c4" xlink:to="loc_gehc_SalesAllowancesAndRelatedLiabilitiesCurrent_a9e6a35a-1a07-4628-b4ee-9520b7a1629f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_561bb33e-7993-4778-ba95-ef888d270ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_0578c922-a0e6-4318-a7f2-1e0d3e67f9c4" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_561bb33e-7993-4778-ba95-ef888d270ebd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent_8a2af2a1-28a6-4c46-8500-f549aa7750b6" xlink:href="gehc-20250331.xsd#gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_0578c922-a0e6-4318-a7f2-1e0d3e67f9c4" xlink:to="loc_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent_8a2af2a1-28a6-4c46-8500-f549aa7750b6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1bc2b040-51ad-48ef-9a53-1ba257d63460" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_f5629836-5718-425c-b494-5d9034f62113" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_1bc2b040-51ad-48ef-9a53-1ba257d63460" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_f5629836-5718-425c-b494-5d9034f62113" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_bc42c8d7-8a6b-4970-b511-2f40295c2bef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_1bc2b040-51ad-48ef-9a53-1ba257d63460" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_bc42c8d7-8a6b-4970-b511-2f40295c2bef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_466b5845-147c-4ac5-ae16-51fd9262e0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_1bc2b040-51ad-48ef-9a53-1ba257d63460" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_466b5845-147c-4ac5-ae16-51fd9262e0ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_fbedc269-388d-44b8-98ad-91bddd6cb5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_1bc2b040-51ad-48ef-9a53-1ba257d63460" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_fbedc269-388d-44b8-98ad-91bddd6cb5d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent_3d55078a-6315-40d1-9239-1a27edb0c9fc" xlink:href="gehc-20250331.xsd#gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_1bc2b040-51ad-48ef-9a53-1ba257d63460" xlink:to="loc_gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent_3d55078a-6315-40d1-9239-1a27edb0c9fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_e9c81c7a-7d12-456c-b050-b2ae5614ecc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_1bc2b040-51ad-48ef-9a53-1ba257d63460" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_e9c81c7a-7d12-456c-b050-b2ae5614ecc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent_e84315b6-d025-4a20-bb16-ba949f28aece" xlink:href="gehc-20250331.xsd#gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_1bc2b040-51ad-48ef-9a53-1ba257d63460" xlink:to="loc_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent_e84315b6-d025-4a20-bb16-ba949f28aece" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_09225c2c-393c-4ad7-a4b7-819820f16a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_1bc2b040-51ad-48ef-9a53-1ba257d63460" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_09225c2c-393c-4ad7-a4b7-819820f16a1d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7e7430c9-1fea-4b65-b89b-5aaa460263fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_872329dd-4c4f-4c3e-ab7b-e1e7b5577871" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_7e7430c9-1fea-4b65-b89b-5aaa460263fb" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_872329dd-4c4f-4c3e-ab7b-e1e7b5577871" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_af38e087-aaab-4f38-b142-413dc8da8840" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_7e7430c9-1fea-4b65-b89b-5aaa460263fb" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_af38e087-aaab-4f38-b142-413dc8da8840" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherItemsIncomeExpenseNet_57fe8e4f-cd97-43ab-8ed2-676fc1eda22d" xlink:href="gehc-20250331.xsd#gehc_OtherItemsIncomeExpenseNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_7e7430c9-1fea-4b65-b89b-5aaa460263fb" xlink:to="loc_gehc_OtherItemsIncomeExpenseNet_57fe8e4f-cd97-43ab-8ed2-676fc1eda22d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_f9cbed6d-68e1-454b-80ba-09097107a64f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_7e7430c9-1fea-4b65-b89b-5aaa460263fb" xlink:to="loc_us-gaap_InvestmentIncomeNet_f9cbed6d-68e1-454b-80ba-09097107a64f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_1bca6454-c6f6-431b-9f2f-f42b2c25a770" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_7e7430c9-1fea-4b65-b89b-5aaa460263fb" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_1bca6454-c6f6-431b-9f2f-f42b2c25a770" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>gehc-20250331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:d0a8a86e-df0d-464c-9ff8-447ea6f21cea,g:ade862ec-33b2-4b8a-bb85-176c06a683fa-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" xlink:type="simple" xlink:href="gehc-20250331.xsd#CondensedConsolidatedStatementsofIncomeUnaudited"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_deabb44d-5d41-4721-af90-438008d92ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_StatementTable_deabb44d-5d41-4721-af90-438008d92ea9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c3defb8b-8a1b-43f9-91cb-6507f8d36476" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_deabb44d-5d41-4721-af90-438008d92ea9" xlink:to="loc_srt_ProductOrServiceAxis_c3defb8b-8a1b-43f9-91cb-6507f8d36476" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c3defb8b-8a1b-43f9-91cb-6507f8d36476_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c3defb8b-8a1b-43f9-91cb-6507f8d36476" xlink:to="loc_srt_ProductsAndServicesDomain_c3defb8b-8a1b-43f9-91cb-6507f8d36476_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b2ead9e3-314e-4839-b6e9-d7f1ee0be9fc" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c3defb8b-8a1b-43f9-91cb-6507f8d36476" xlink:to="loc_srt_ProductsAndServicesDomain_b2ead9e3-314e-4839-b6e9-d7f1ee0be9fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_695b17fc-7623-4f34-a77e-73962c40646f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b2ead9e3-314e-4839-b6e9-d7f1ee0be9fc" xlink:to="loc_us-gaap_ProductMember_695b17fc-7623-4f34-a77e-73962c40646f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_c2dfe19c-451a-4c28-a4d8-86de87d529c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b2ead9e3-314e-4839-b6e9-d7f1ee0be9fc" xlink:to="loc_us-gaap_ServiceMember_c2dfe19c-451a-4c28-a4d8-86de87d529c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7bb06062-6b23-4ba0-87cd-bb03e3922fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7bb06062-6b23-4ba0-87cd-bb03e3922fb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_98f1d499-f680-481a-ac36-ea386863c2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_CostOfRevenue_98f1d499-f680-481a-ac36-ea386863c2b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_fad187ef-16c6-4bb4-a48e-29136bd6906c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_GrossProfit_fad187ef-16c6-4bb4-a48e-29136bd6906c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_95402c79-b426-4634-a31d-5d9fa43b2bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_95402c79-b426-4634-a31d-5d9fa43b2bd7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_7158bdd1-e335-4ab6-844e-567911b7c3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_7158bdd1-e335-4ab6-844e-567911b7c3ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_7124743a-0188-471f-b866-7689c22503b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_OperatingExpenses_7124743a-0188-471f-b866-7689c22503b6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4587cc86-1c7f-49c7-a73d-bd9a94f5a891" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_OperatingIncomeLoss_4587cc86-1c7f-49c7-a73d-bd9a94f5a891" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_8877785d-3b2f-4e91-b106-bead40009fce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_InterestAndDebtExpense_8877785d-3b2f-4e91-b106-bead40009fce" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_3bf74222-0785-49f0-ad19-8964d802fe38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_3bf74222-0785-49f0-ad19-8964d802fe38" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0cf6ca41-fad3-4133-8d80-e8e201c146ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0cf6ca41-fad3-4133-8d80-e8e201c146ec" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b0bb9e9b-1663-4e69-85d2-34eb6cb7b5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b0bb9e9b-1663-4e69-85d2-34eb6cb7b5ef" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_579f2424-1779-4d20-88ac-b5d552c45fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_579f2424-1779-4d20-88ac-b5d552c45fe8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c0eb258e-d8ae-4b38-9947-077709286824" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_ProfitLoss_c0eb258e-d8ae-4b38-9947-077709286824" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6d2bfa49-c078-4796-9eeb-c653b7a32f67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6d2bfa49-c078-4796-9eeb-c653b7a32f67" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4b7d6ec4-c4e4-475d-8b79-adda30c5b7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_NetIncomeLoss_4b7d6ec4-c4e4-475d-8b79-adda30c5b7d3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_32ec2ef4-e8b6-4e29-a60c-cf93a121d2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_32ec2ef4-e8b6-4e29-a60c-cf93a121d2c1" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b5a08557-bccc-432d-98b2-3243a9a8d67b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_32ec2ef4-e8b6-4e29-a60c-cf93a121d2c1" xlink:to="loc_us-gaap_EarningsPerShareBasic_b5a08557-bccc-432d-98b2-3243a9a8d67b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_40af56ee-af96-4240-a3a0-480360835955" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_32ec2ef4-e8b6-4e29-a60c-cf93a121d2c1" xlink:to="loc_us-gaap_EarningsPerShareDiluted_40af56ee-af96-4240-a3a0-480360835955" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_11230128-aee1-490c-9efd-5a3f622a0a49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_11230128-aee1-490c-9efd-5a3f622a0a49" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_08ea6dd4-77b8-4df1-8be7-81cee5f27413" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_11230128-aee1-490c-9efd-5a3f622a0a49" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_08ea6dd4-77b8-4df1-8be7-81cee5f27413" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bc0496bd-c97d-4d1b-9972-ad9727e314fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_11230128-aee1-490c-9efd-5a3f622a0a49" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bc0496bd-c97d-4d1b-9972-ad9727e314fb" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" xlink:type="simple" xlink:href="gehc-20250331.xsd#CondensedConsolidatedStatementsofChangesinEquityUnaudited"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dce17e1d-915d-4e69-82af-62b2669a8e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_40b4fed1-e025-4310-9bd8-2810f323a6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_dce17e1d-915d-4e69-82af-62b2669a8e9c" xlink:to="loc_us-gaap_StatementTable_40b4fed1-e025-4310-9bd8-2810f323a6d1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f63549b5-d7f8-4a8d-aac2-af5cc9877a54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_40b4fed1-e025-4310-9bd8-2810f323a6d1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f63549b5-d7f8-4a8d-aac2-af5cc9877a54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f63549b5-d7f8-4a8d-aac2-af5cc9877a54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f63549b5-d7f8-4a8d-aac2-af5cc9877a54" xlink:to="loc_us-gaap_EquityComponentDomain_f63549b5-d7f8-4a8d-aac2-af5cc9877a54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5c849c4f-8647-49da-90c5-244320785258" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f63549b5-d7f8-4a8d-aac2-af5cc9877a54" xlink:to="loc_us-gaap_EquityComponentDomain_5c849c4f-8647-49da-90c5-244320785258" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8bc882fd-e650-4276-8d1a-1de951acff17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5c849c4f-8647-49da-90c5-244320785258" xlink:to="loc_us-gaap_CommonStockMember_8bc882fd-e650-4276-8d1a-1de951acff17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_e7c89c6b-6272-4a61-859a-0790535054c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5c849c4f-8647-49da-90c5-244320785258" xlink:to="loc_us-gaap_TreasuryStockCommonMember_e7c89c6b-6272-4a61-859a-0790535054c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ef1c9f2e-6cd6-48a8-9a50-822b1bc98495" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5c849c4f-8647-49da-90c5-244320785258" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ef1c9f2e-6cd6-48a8-9a50-822b1bc98495" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_03c04159-fff9-42d8-816c-70fbe6e1dfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5c849c4f-8647-49da-90c5-244320785258" xlink:to="loc_us-gaap_RetainedEarningsMember_03c04159-fff9-42d8-816c-70fbe6e1dfd4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2a6f8989-36c1-46cf-956d-38604893792b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5c849c4f-8647-49da-90c5-244320785258" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2a6f8989-36c1-46cf-956d-38604893792b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_10906374-7900-4ca5-8d16-a9336bd25c88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5c849c4f-8647-49da-90c5-244320785258" xlink:to="loc_us-gaap_NoncontrollingInterestMember_10906374-7900-4ca5-8d16-a9336bd25c88" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dce17e1d-915d-4e69-82af-62b2669a8e9c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ac8a7ec6-f159-45c6-8374-1a0250b212ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_CommonStockSharesIssued_ac8a7ec6-f159-45c6-8374-1a0250b212ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_888fa791-7645-4928-9656-0c2d264df191" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_888fa791-7645-4928-9656-0c2d264df191" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_1df26add-dfe7-4143-8824-392432597af0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_TreasuryStockCommonShares_1df26add-dfe7-4143-8824-392432597af0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b952979b-1b9b-4cea-aeba-b1a38878ee3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b952979b-1b9b-4cea-aeba-b1a38878ee3f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3b21cbb7-0de2-4bcf-8154-ff23668c0066" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3b21cbb7-0de2-4bcf-8154-ff23668c0066" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1b6b9556-61fd-422a-a6e5-ac8583831edf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_NetIncomeLoss_1b6b9556-61fd-422a-a6e5-ac8583831edf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_cf6d62ab-da09-421f-bd42-571adafd5b52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Dividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_Dividends_cf6d62ab-da09-421f-bd42-571adafd5b52" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_04020471-2432-4961-9b0b-5bccba3c1b64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_04020471-2432-4961-9b0b-5bccba3c1b64" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_53aa4654-6b70-43c7-b7a7-1a6fb1e46fde" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_53aa4654-6b70-43c7-b7a7-1a6fb1e46fde" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f5c45203-c08d-41e2-97fa-db75069eddfa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f5c45203-c08d-41e2-97fa-db75069eddfa" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e97fc051-41d5-43b1-bd9b-86cafee5894c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d89798d5-6a63-46a4-9a24-a4aedf24f311" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_463adfa2-b0da-4725-8832-4b3761835ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#REVENUERECOGNITIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_f8801b44-782f-453a-bf2f-62ae61409ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c519690c-b369-4e87-b2ad-8c8bf2c34ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_f8801b44-782f-453a-bf2f-62ae61409ef9" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c519690c-b369-4e87-b2ad-8c8bf2c34ff6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ff5af240-af7c-4e97-80bf-e9f08250b7df" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c519690c-b369-4e87-b2ad-8c8bf2c34ff6" xlink:to="loc_srt_ProductOrServiceAxis_ff5af240-af7c-4e97-80bf-e9f08250b7df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ff5af240-af7c-4e97-80bf-e9f08250b7df_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_ff5af240-af7c-4e97-80bf-e9f08250b7df" xlink:to="loc_srt_ProductsAndServicesDomain_ff5af240-af7c-4e97-80bf-e9f08250b7df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_47dec004-8861-4bd9-a489-72665176272f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_ff5af240-af7c-4e97-80bf-e9f08250b7df" xlink:to="loc_srt_ProductsAndServicesDomain_47dec004-8861-4bd9-a489-72665176272f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_62d8cb85-561d-4ab1-b516-3da409ea996f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_47dec004-8861-4bd9-a489-72665176272f" xlink:to="loc_us-gaap_ProductMember_62d8cb85-561d-4ab1-b516-3da409ea996f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_ffad6ddd-c8f1-432a-9588-bfa77b1b6b63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_47dec004-8861-4bd9-a489-72665176272f" xlink:to="loc_us-gaap_ServiceMember_ffad6ddd-c8f1-432a-9588-bfa77b1b6b63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b3304412-d430-4b19-b906-eaacd09a75a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c519690c-b369-4e87-b2ad-8c8bf2c34ff6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b3304412-d430-4b19-b906-eaacd09a75a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_531a1673-66ac-428d-9385-49b9e69e0d30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_f8801b44-782f-453a-bf2f-62ae61409ef9" xlink:to="loc_us-gaap_ContractWithCustomerLiability_531a1673-66ac-428d-9385-49b9e69e0d30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_fd646579-0cd3-4046-b9be-dba6864ebcea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_f8801b44-782f-453a-bf2f-62ae61409ef9" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_fd646579-0cd3-4046-b9be-dba6864ebcea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_b19f9ad8-ba62-4b8b-adbb-e21a10bc6022" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_f8801b44-782f-453a-bf2f-62ae61409ef9" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_b19f9ad8-ba62-4b8b-adbb-e21a10bc6022" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_644ce1a7-a27e-4ec0-a03e-606ec8bcf9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_f8801b44-782f-453a-bf2f-62ae61409ef9" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_644ce1a7-a27e-4ec0-a03e-606ec8bcf9a1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails_1" xlink:type="simple" xlink:href="gehc-20250331.xsd#REVENUERECOGNITIONNarrativeDetails_1"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_f8801b44-782f-453a-bf2f-62ae61409ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c519690c-b369-4e87-b2ad-8c8bf2c34ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_f8801b44-782f-453a-bf2f-62ae61409ef9" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c519690c-b369-4e87-b2ad-8c8bf2c34ff6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ff5af240-af7c-4e97-80bf-e9f08250b7df" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c519690c-b369-4e87-b2ad-8c8bf2c34ff6" xlink:to="loc_srt_ProductOrServiceAxis_ff5af240-af7c-4e97-80bf-e9f08250b7df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ff5af240-af7c-4e97-80bf-e9f08250b7df_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_ff5af240-af7c-4e97-80bf-e9f08250b7df" xlink:to="loc_srt_ProductsAndServicesDomain_ff5af240-af7c-4e97-80bf-e9f08250b7df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_47dec004-8861-4bd9-a489-72665176272f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_ff5af240-af7c-4e97-80bf-e9f08250b7df" xlink:to="loc_srt_ProductsAndServicesDomain_47dec004-8861-4bd9-a489-72665176272f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_62d8cb85-561d-4ab1-b516-3da409ea996f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_47dec004-8861-4bd9-a489-72665176272f" xlink:to="loc_us-gaap_ProductMember_62d8cb85-561d-4ab1-b516-3da409ea996f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_ffad6ddd-c8f1-432a-9588-bfa77b1b6b63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_47dec004-8861-4bd9-a489-72665176272f" xlink:to="loc_us-gaap_ServiceMember_ffad6ddd-c8f1-432a-9588-bfa77b1b6b63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_531a1673-66ac-428d-9385-49b9e69e0d30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_f8801b44-782f-453a-bf2f-62ae61409ef9" xlink:to="loc_us-gaap_ContractWithCustomerLiability_531a1673-66ac-428d-9385-49b9e69e0d30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_fd646579-0cd3-4046-b9be-dba6864ebcea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_f8801b44-782f-453a-bf2f-62ae61409ef9" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_fd646579-0cd3-4046-b9be-dba6864ebcea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_b19f9ad8-ba62-4b8b-adbb-e21a10bc6022" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_f8801b44-782f-453a-bf2f-62ae61409ef9" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_b19f9ad8-ba62-4b8b-adbb-e21a10bc6022" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_644ce1a7-a27e-4ec0-a03e-606ec8bcf9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_f8801b44-782f-453a-bf2f-62ae61409ef9" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_644ce1a7-a27e-4ec0-a03e-606ec8bcf9a1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/REVENUERECOGNITIONScheduleofRemainingPerformanceObligationsDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#REVENUERECOGNITIONScheduleofRemainingPerformanceObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/REVENUERECOGNITIONScheduleofRemainingPerformanceObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_514b1f1c-1f93-4348-8f20-6ab336e72a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_dc9c1b14-58a0-4f29-ab0c-6eb7327d0250" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_514b1f1c-1f93-4348-8f20-6ab336e72a2a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_dc9c1b14-58a0-4f29-ab0c-6eb7327d0250" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ec349374-85b2-479e-b6a1-2be18b940eae" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_dc9c1b14-58a0-4f29-ab0c-6eb7327d0250" xlink:to="loc_srt_ProductOrServiceAxis_ec349374-85b2-479e-b6a1-2be18b940eae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ec349374-85b2-479e-b6a1-2be18b940eae_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_ec349374-85b2-479e-b6a1-2be18b940eae" xlink:to="loc_srt_ProductsAndServicesDomain_ec349374-85b2-479e-b6a1-2be18b940eae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c2ca56a1-ef84-45ca-9c19-791438ed8e09" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_ec349374-85b2-479e-b6a1-2be18b940eae" xlink:to="loc_srt_ProductsAndServicesDomain_c2ca56a1-ef84-45ca-9c19-791438ed8e09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_c2c289a0-3a3c-4845-8bd4-101504c3a78b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c2ca56a1-ef84-45ca-9c19-791438ed8e09" xlink:to="loc_us-gaap_ProductMember_c2c289a0-3a3c-4845-8bd4-101504c3a78b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_e9e135f0-2173-4886-ac1e-6de7ff0035e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c2ca56a1-ef84-45ca-9c19-791438ed8e09" xlink:to="loc_us-gaap_ServiceMember_e9e135f0-2173-4886-ac1e-6de7ff0035e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_f3a57b8a-2b18-41c2-969b-5f0c2afbdb85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_514b1f1c-1f93-4348-8f20-6ab336e72a2a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_f3a57b8a-2b18-41c2-969b-5f0c2afbdb85" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_b2f85d33-646d-4518-9954-11b88ff62a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10ee12b3-f9e1-478e-a7b6-7404835ac98c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b2f85d33-646d-4518-9954-11b88ff62a3e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10ee12b3-f9e1-478e-a7b6-7404835ac98c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a87df4d2-f8f0-42b5-be65-7ebb826eef37" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10ee12b3-f9e1-478e-a7b6-7404835ac98c" xlink:to="loc_srt_ConsolidationItemsAxis_a87df4d2-f8f0-42b5-be65-7ebb826eef37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a87df4d2-f8f0-42b5-be65-7ebb826eef37_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_a87df4d2-f8f0-42b5-be65-7ebb826eef37" xlink:to="loc_srt_ConsolidationItemsDomain_a87df4d2-f8f0-42b5-be65-7ebb826eef37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b8029adc-ffa4-475f-be01-e245547ca637" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_a87df4d2-f8f0-42b5-be65-7ebb826eef37" xlink:to="loc_srt_ConsolidationItemsDomain_b8029adc-ffa4-475f-be01-e245547ca637" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_ebee85d0-0dd6-4d82-b45b-57418d228dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b8029adc-ffa4-475f-be01-e245547ca637" xlink:to="loc_us-gaap_OperatingSegmentsMember_ebee85d0-0dd6-4d82-b45b-57418d228dd0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_292c651a-f931-4367-80f1-676d7ceafb10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b8029adc-ffa4-475f-be01-e245547ca637" xlink:to="loc_us-gaap_CorporateNonSegmentMember_292c651a-f931-4367-80f1-676d7ceafb10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a1f3ee9d-ce84-4137-ae3e-0ca5a53eb806" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10ee12b3-f9e1-478e-a7b6-7404835ac98c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a1f3ee9d-ce84-4137-ae3e-0ca5a53eb806" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a1f3ee9d-ce84-4137-ae3e-0ca5a53eb806_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a1f3ee9d-ce84-4137-ae3e-0ca5a53eb806" xlink:to="loc_us-gaap_SegmentDomain_a1f3ee9d-ce84-4137-ae3e-0ca5a53eb806_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_31d91c97-3cc6-473a-9619-246f868f6fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a1f3ee9d-ce84-4137-ae3e-0ca5a53eb806" xlink:to="loc_us-gaap_SegmentDomain_31d91c97-3cc6-473a-9619-246f868f6fb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ImagingSegmentMember_000ec284-6daf-4902-a027-76ee80b45ed7" xlink:href="gehc-20250331.xsd#gehc_ImagingSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_31d91c97-3cc6-473a-9619-246f868f6fb3" xlink:to="loc_gehc_ImagingSegmentMember_000ec284-6daf-4902-a027-76ee80b45ed7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AVSSegmentMember_0c986883-d2a9-405e-a087-1ad85ea4f43f" xlink:href="gehc-20250331.xsd#gehc_AVSSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_31d91c97-3cc6-473a-9619-246f868f6fb3" xlink:to="loc_gehc_AVSSegmentMember_0c986883-d2a9-405e-a087-1ad85ea4f43f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PCSSegmentMember_4d1923c8-71c2-4bac-a753-6317f4080fe4" xlink:href="gehc-20250331.xsd#gehc_PCSSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_31d91c97-3cc6-473a-9619-246f868f6fb3" xlink:to="loc_gehc_PCSSegmentMember_4d1923c8-71c2-4bac-a753-6317f4080fe4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PDxSegmentMember_0d79367d-709c-4cf3-ac53-8f3931f81e75" xlink:href="gehc-20250331.xsd#gehc_PDxSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_31d91c97-3cc6-473a-9619-246f868f6fb3" xlink:to="loc_gehc_PDxSegmentMember_0d79367d-709c-4cf3-ac53-8f3931f81e75" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_544b3a91-c4cc-4569-8ca2-d46f743b82ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10ee12b3-f9e1-478e-a7b6-7404835ac98c" xlink:to="loc_us-gaap_SubsegmentsAxis_544b3a91-c4cc-4569-8ca2-d46f743b82ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_544b3a91-c4cc-4569-8ca2-d46f743b82ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_544b3a91-c4cc-4569-8ca2-d46f743b82ce" xlink:to="loc_us-gaap_SubsegmentsDomain_544b3a91-c4cc-4569-8ca2-d46f743b82ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_b67696f0-81f2-43ed-b5c2-556f1d5eb00c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_544b3a91-c4cc-4569-8ca2-d46f743b82ce" xlink:to="loc_us-gaap_SubsegmentsDomain_b67696f0-81f2-43ed-b5c2-556f1d5eb00c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ProceduralGuidanceSubsegmentMember_36dca12d-cc4f-4c06-a0c5-0994e7361c63" xlink:href="gehc-20250331.xsd#gehc_ProceduralGuidanceSubsegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_b67696f0-81f2-43ed-b5c2-556f1d5eb00c" xlink:to="loc_gehc_ProceduralGuidanceSubsegmentMember_36dca12d-cc4f-4c06-a0c5-0994e7361c63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_SpecializedUltrasoundSubsegmentMember_254e72d2-348e-4f15-90be-3a7fb919c89c" xlink:href="gehc-20250331.xsd#gehc_SpecializedUltrasoundSubsegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_b67696f0-81f2-43ed-b5c2-556f1d5eb00c" xlink:to="loc_gehc_SpecializedUltrasoundSubsegmentMember_254e72d2-348e-4f15-90be-3a7fb919c89c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_MonitoringSolutionsSubsegmentMember_4495fb1b-5a77-4476-9964-e6cf34bc45af" xlink:href="gehc-20250331.xsd#gehc_MonitoringSolutionsSubsegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_b67696f0-81f2-43ed-b5c2-556f1d5eb00c" xlink:to="loc_gehc_MonitoringSolutionsSubsegmentMember_4495fb1b-5a77-4476-9964-e6cf34bc45af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_LifeSupportSolutionsSubsegmentMember_25da33b5-672a-4561-b180-458550353c07" xlink:href="gehc-20250331.xsd#gehc_LifeSupportSolutionsSubsegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_b67696f0-81f2-43ed-b5c2-556f1d5eb00c" xlink:to="loc_gehc_LifeSupportSolutionsSubsegmentMember_25da33b5-672a-4561-b180-458550353c07" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dd59e2cd-f751-4c1e-a0f5-47c74493c4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b2f85d33-646d-4518-9954-11b88ff62a3e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dd59e2cd-f751-4c1e-a0f5-47c74493c4f5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2be8a197-24c0-488b-8f75-4408bc45b9af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ddc88ccf-493f-4c55-a79c-7704d7c4c8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2be8a197-24c0-488b-8f75-4408bc45b9af" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ddc88ccf-493f-4c55-a79c-7704d7c4c8b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_96cb6059-ebe6-4333-acdb-d30b0ef7b212" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ddc88ccf-493f-4c55-a79c-7704d7c4c8b6" xlink:to="loc_srt_ConsolidationItemsAxis_96cb6059-ebe6-4333-acdb-d30b0ef7b212" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_96cb6059-ebe6-4333-acdb-d30b0ef7b212_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_96cb6059-ebe6-4333-acdb-d30b0ef7b212" xlink:to="loc_srt_ConsolidationItemsDomain_96cb6059-ebe6-4333-acdb-d30b0ef7b212_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2a689c50-65fa-47bf-b7a1-0c2f0b627906" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_96cb6059-ebe6-4333-acdb-d30b0ef7b212" xlink:to="loc_srt_ConsolidationItemsDomain_2a689c50-65fa-47bf-b7a1-0c2f0b627906" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_42645fbb-a9c1-4b48-8edf-24c0c50d0256" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_2a689c50-65fa-47bf-b7a1-0c2f0b627906" xlink:to="loc_us-gaap_OperatingSegmentsMember_42645fbb-a9c1-4b48-8edf-24c0c50d0256" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e6cd4d5e-e770-46a5-b3bd-8971a4b080eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ddc88ccf-493f-4c55-a79c-7704d7c4c8b6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e6cd4d5e-e770-46a5-b3bd-8971a4b080eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e6cd4d5e-e770-46a5-b3bd-8971a4b080eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e6cd4d5e-e770-46a5-b3bd-8971a4b080eb" xlink:to="loc_us-gaap_SegmentDomain_e6cd4d5e-e770-46a5-b3bd-8971a4b080eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5675e138-32a3-4a86-bfc9-6d6740b2b3bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e6cd4d5e-e770-46a5-b3bd-8971a4b080eb" xlink:to="loc_us-gaap_SegmentDomain_5675e138-32a3-4a86-bfc9-6d6740b2b3bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ImagingSegmentMember_d7e088e8-f189-4795-9d2f-a8f95d1b64cc" xlink:href="gehc-20250331.xsd#gehc_ImagingSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5675e138-32a3-4a86-bfc9-6d6740b2b3bd" xlink:to="loc_gehc_ImagingSegmentMember_d7e088e8-f189-4795-9d2f-a8f95d1b64cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AVSSegmentMember_421856c8-be72-4117-b20d-5e2cefa2185f" xlink:href="gehc-20250331.xsd#gehc_AVSSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5675e138-32a3-4a86-bfc9-6d6740b2b3bd" xlink:to="loc_gehc_AVSSegmentMember_421856c8-be72-4117-b20d-5e2cefa2185f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PCSSegmentMember_70aea79d-00c1-47b8-a556-764985133dec" xlink:href="gehc-20250331.xsd#gehc_PCSSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5675e138-32a3-4a86-bfc9-6d6740b2b3bd" xlink:to="loc_gehc_PCSSegmentMember_70aea79d-00c1-47b8-a556-764985133dec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PDxSegmentMember_75b35bb7-b853-4aad-a48d-f5e4417378af" xlink:href="gehc-20250331.xsd#gehc_PDxSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5675e138-32a3-4a86-bfc9-6d6740b2b3bd" xlink:to="loc_gehc_PDxSegmentMember_75b35bb7-b853-4aad-a48d-f5e4417378af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_1f5cdfac-d69a-42f2-aa88-32e2a738edfe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2be8a197-24c0-488b-8f75-4408bc45b9af" xlink:to="loc_us-gaap_CostOfRevenue_1f5cdfac-d69a-42f2-aa88-32e2a738edfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_e38ebea9-5617-444d-ba54-5ebec0537e12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2be8a197-24c0-488b-8f75-4408bc45b9af" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_e38ebea9-5617-444d-ba54-5ebec0537e12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_efcc3dab-2226-40cd-bd09-ef719393a5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2be8a197-24c0-488b-8f75-4408bc45b9af" xlink:to="loc_us-gaap_CostsAndExpenses_efcc3dab-2226-40cd-bd09-ef719393a5e9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SEGMENTINFORMATIONScheduleofSegmentEBITDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6110df9b-ac34-44dc-aa10-8ec875661ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6110df9b-ac34-44dc-aa10-8ec875661ed3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_abdd4be8-f507-4531-9d83-79def3178ba3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6110df9b-ac34-44dc-aa10-8ec875661ed3" xlink:to="loc_srt_ConsolidationItemsAxis_abdd4be8-f507-4531-9d83-79def3178ba3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_abdd4be8-f507-4531-9d83-79def3178ba3_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_abdd4be8-f507-4531-9d83-79def3178ba3" xlink:to="loc_srt_ConsolidationItemsDomain_abdd4be8-f507-4531-9d83-79def3178ba3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_68b1d024-dcb2-4ffa-9d22-1bb5105841e8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_abdd4be8-f507-4531-9d83-79def3178ba3" xlink:to="loc_srt_ConsolidationItemsDomain_68b1d024-dcb2-4ffa-9d22-1bb5105841e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_025655d5-4b5d-4fc9-864b-ba361561c96a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_68b1d024-dcb2-4ffa-9d22-1bb5105841e8" xlink:to="loc_us-gaap_OperatingSegmentsMember_025655d5-4b5d-4fc9-864b-ba361561c96a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_cff7652a-c0cd-4ba5-87c2-bac650f11fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_68b1d024-dcb2-4ffa-9d22-1bb5105841e8" xlink:to="loc_us-gaap_CorporateNonSegmentMember_cff7652a-c0cd-4ba5-87c2-bac650f11fd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b295c744-49cf-4c88-bc64-9ab43f8761af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6110df9b-ac34-44dc-aa10-8ec875661ed3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b295c744-49cf-4c88-bc64-9ab43f8761af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b295c744-49cf-4c88-bc64-9ab43f8761af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b295c744-49cf-4c88-bc64-9ab43f8761af" xlink:to="loc_us-gaap_SegmentDomain_b295c744-49cf-4c88-bc64-9ab43f8761af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b8c826b2-3caf-44a6-a6af-4c3e22843b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b295c744-49cf-4c88-bc64-9ab43f8761af" xlink:to="loc_us-gaap_SegmentDomain_b8c826b2-3caf-44a6-a6af-4c3e22843b6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ImagingSegmentMember_12a95063-7e67-498e-a572-0cc23a8bcbaa" xlink:href="gehc-20250331.xsd#gehc_ImagingSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b8c826b2-3caf-44a6-a6af-4c3e22843b6b" xlink:to="loc_gehc_ImagingSegmentMember_12a95063-7e67-498e-a572-0cc23a8bcbaa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AVSSegmentMember_1baf5993-6941-4e2c-9558-8053d14a47b0" xlink:href="gehc-20250331.xsd#gehc_AVSSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b8c826b2-3caf-44a6-a6af-4c3e22843b6b" xlink:to="loc_gehc_AVSSegmentMember_1baf5993-6941-4e2c-9558-8053d14a47b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PCSSegmentMember_758d0884-e550-46e5-bd21-6aee0895a78a" xlink:href="gehc-20250331.xsd#gehc_PCSSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b8c826b2-3caf-44a6-a6af-4c3e22843b6b" xlink:to="loc_gehc_PCSSegmentMember_758d0884-e550-46e5-bd21-6aee0895a78a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PDxSegmentMember_756d3f42-634a-4051-8c39-255e28c4ffff" xlink:href="gehc-20250331.xsd#gehc_PDxSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b8c826b2-3caf-44a6-a6af-4c3e22843b6b" xlink:to="loc_gehc_PDxSegmentMember_756d3f42-634a-4051-8c39-255e28c4ffff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges_89790689-0f6c-4e21-a974-070fe247782b" xlink:href="gehc-20250331.xsd#gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges_89790689-0f6c-4e21-a974-070fe247782b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_737e7314-4dbb-46a9-b3e6-f2e1430604a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_737e7314-4dbb-46a9-b3e6-f2e1430604a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AcquisitionAndDispositionRelatedBenefitsCosts_bddaaa5e-9de9-4b9d-bf24-89b6b0ef1f52" xlink:href="gehc-20250331.xsd#gehc_AcquisitionAndDispositionRelatedBenefitsCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_gehc_AcquisitionAndDispositionRelatedBenefitsCosts_bddaaa5e-9de9-4b9d-bf24-89b6b0ef1f52" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_a51d1b1e-0321-4d16-8094-7960fa1cce0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_a51d1b1e-0321-4d16-8094-7960fa1cce0a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_SpinOffAndSeparationCosts_f310d7fd-fab9-4407-b4ad-9f9bbb8c300b" xlink:href="gehc-20250331.xsd#gehc_SpinOffAndSeparationCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_gehc_SpinOffAndSeparationCosts_f310d7fd-fab9-4407-b4ad-9f9bbb8c300b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AmortizationOfIntangibleAssetsAcquired_e228e2c0-210a-4224-96c6-188472aad339" xlink:href="gehc-20250331.xsd#gehc_AmortizationOfIntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_gehc_AmortizationOfIntangibleAssetsAcquired_e228e2c0-210a-4224-96c6-188472aad339" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_c4250868-4aaa-42c3-89af-15231349abd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_us-gaap_GainLossOnInvestments_c4250868-4aaa-42c3-89af-15231349abd4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_a4cdbeb2-8744-4954-a337-40b00dfd941a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_us-gaap_InterestAndDebtExpense_a4cdbeb2-8744-4954-a337-40b00dfd941a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_6c3773ef-0550-4872-9cbb-eaea596e2b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_6c3773ef-0550-4872-9cbb-eaea596e2b2e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1bf9b8bd-e6c8-4ac1-bfe0-e99f9c123abf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1bf9b8bd-e6c8-4ac1-bfe0-e99f9c123abf" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_dc8f09cf-263f-46f3-855a-e4628a59e6cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8edee9e5-7bb3-46cf-af8f-d66353b399c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dc8f09cf-263f-46f3-855a-e4628a59e6cd" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8edee9e5-7bb3-46cf-af8f-d66353b399c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_bca6e74c-d263-431f-a7c5-39c7095bc845" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8edee9e5-7bb3-46cf-af8f-d66353b399c5" xlink:to="loc_srt_ConsolidationItemsAxis_bca6e74c-d263-431f-a7c5-39c7095bc845" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_bca6e74c-d263-431f-a7c5-39c7095bc845_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_bca6e74c-d263-431f-a7c5-39c7095bc845" xlink:to="loc_srt_ConsolidationItemsDomain_bca6e74c-d263-431f-a7c5-39c7095bc845_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_764adc18-7393-4c48-afed-06d3110e79dd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_bca6e74c-d263-431f-a7c5-39c7095bc845" xlink:to="loc_srt_ConsolidationItemsDomain_764adc18-7393-4c48-afed-06d3110e79dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_1dc19d6e-e9d3-4e5a-a380-9e832e14c5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_764adc18-7393-4c48-afed-06d3110e79dd" xlink:to="loc_us-gaap_OperatingSegmentsMember_1dc19d6e-e9d3-4e5a-a380-9e832e14c5e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_82b8cfa4-d73f-4478-9418-a715bf51d12c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8edee9e5-7bb3-46cf-af8f-d66353b399c5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_82b8cfa4-d73f-4478-9418-a715bf51d12c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_82b8cfa4-d73f-4478-9418-a715bf51d12c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_82b8cfa4-d73f-4478-9418-a715bf51d12c" xlink:to="loc_us-gaap_SegmentDomain_82b8cfa4-d73f-4478-9418-a715bf51d12c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d0f630d0-f035-4c62-aef3-59da89168483" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_82b8cfa4-d73f-4478-9418-a715bf51d12c" xlink:to="loc_us-gaap_SegmentDomain_d0f630d0-f035-4c62-aef3-59da89168483" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ImagingSegmentMember_222b35a1-e80c-4dd9-9df7-30f53786006b" xlink:href="gehc-20250331.xsd#gehc_ImagingSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d0f630d0-f035-4c62-aef3-59da89168483" xlink:to="loc_gehc_ImagingSegmentMember_222b35a1-e80c-4dd9-9df7-30f53786006b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AVSSegmentMember_2a35eaab-aa26-4a22-b586-0e4ba1e738da" xlink:href="gehc-20250331.xsd#gehc_AVSSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d0f630d0-f035-4c62-aef3-59da89168483" xlink:to="loc_gehc_AVSSegmentMember_2a35eaab-aa26-4a22-b586-0e4ba1e738da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PCSSegmentMember_46a5dc5d-b0c5-4b35-9a50-38e1677617ad" xlink:href="gehc-20250331.xsd#gehc_PCSSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d0f630d0-f035-4c62-aef3-59da89168483" xlink:to="loc_gehc_PCSSegmentMember_46a5dc5d-b0c5-4b35-9a50-38e1677617ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PDxSegmentMember_8b70080a-8542-4b0e-9ee5-a7bfc6a9c707" xlink:href="gehc-20250331.xsd#gehc_PDxSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d0f630d0-f035-4c62-aef3-59da89168483" xlink:to="loc_gehc_PDxSegmentMember_8b70080a-8542-4b0e-9ee5-a7bfc6a9c707" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a3f07b50-43e1-4d7b-b294-2b99fedb2478" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dc8f09cf-263f-46f3-855a-e4628a59e6cd" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a3f07b50-43e1-4d7b-b294-2b99fedb2478" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caeee163-a6db-42c1-87fe-838729694105" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_7c673c39-160b-4c28-bcb1-2748f5f0dd39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caeee163-a6db-42c1-87fe-838729694105" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_7c673c39-160b-4c28-bcb1-2748f5f0dd39" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_8fcbafdb-4d9c-4ca8-bba4-a18f5084bedc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_7c673c39-160b-4c28-bcb1-2748f5f0dd39" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_8fcbafdb-4d9c-4ca8-bba4-a18f5084bedc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_8fcbafdb-4d9c-4ca8-bba4-a18f5084bedc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_8fcbafdb-4d9c-4ca8-bba4-a18f5084bedc" xlink:to="loc_us-gaap_ReceivableTypeDomain_8fcbafdb-4d9c-4ca8-bba4-a18f5084bedc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_4980ac99-3c23-4044-83d2-68aa8152a562" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_8fcbafdb-4d9c-4ca8-bba4-a18f5084bedc" xlink:to="loc_us-gaap_ReceivableTypeDomain_4980ac99-3c23-4044-83d2-68aa8152a562" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember_4a687372-08f0-496f-acfb-d9e2f18c9e50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_4980ac99-3c23-4044-83d2-68aa8152a562" xlink:to="loc_us-gaap_LoansReceivableMember_4a687372-08f0-496f-acfb-d9e2f18c9e50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_FinanceLeaseReceivableMember_e3fd09fc-5214-43d1-9ac8-574607e0d2a8" xlink:href="gehc-20250331.xsd#gehc_FinanceLeaseReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_4980ac99-3c23-4044-83d2-68aa8152a562" xlink:to="loc_gehc_FinanceLeaseReceivableMember_e3fd09fc-5214-43d1-9ac8-574607e0d2a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableGrossCurrent_deeb5c44-5e35-403c-a4be-0643acd14656" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableGrossCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caeee163-a6db-42c1-87fe-838729694105" xlink:to="loc_us-gaap_NotesAndLoansReceivableGrossCurrent_deeb5c44-5e35-403c-a4be-0643acd14656" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForNotesAndLoansReceivableCurrent_2b714496-3f92-4dc4-a4f4-d50a3d2205f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForNotesAndLoansReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caeee163-a6db-42c1-87fe-838729694105" xlink:to="loc_us-gaap_AllowanceForNotesAndLoansReceivableCurrent_2b714496-3f92-4dc4-a4f4-d50a3d2205f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_307a8cf5-9d80-41f3-bc1c-5f294865a58a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caeee163-a6db-42c1-87fe-838729694105" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_307a8cf5-9d80-41f3-bc1c-5f294865a58a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableGrossNoncurrent_25d40950-94a5-4cb8-8b9b-878925f47a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableGrossNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caeee163-a6db-42c1-87fe-838729694105" xlink:to="loc_us-gaap_NotesAndLoansReceivableGrossNoncurrent_25d40950-94a5-4cb8-8b9b-878925f47a8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent_5d430a05-2d91-4813-8c43-2db27cfe8ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caeee163-a6db-42c1-87fe-838729694105" xlink:to="loc_us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent_5d430a05-2d91-4813-8c43-2db27cfe8ca7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_695c3483-faee-440b-b434-e48870b76e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caeee163-a6db-42c1-87fe-838729694105" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_695c3483-faee-440b-b434-e48870b76e0a" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/FINANCINGRECEIVABLESNarrativeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#FINANCINGRECEIVABLESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/FINANCINGRECEIVABLESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems_0f51ccfd-5c7d-46d0-b6d8-2f349f8f5dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivablesPastDueTable_4697290e-8d21-4b0a-bce7-e236e8699d42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFinancingReceivablesPastDueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems_0f51ccfd-5c7d-46d0-b6d8-2f349f8f5dbd" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivablesPastDueTable_4697290e-8d21-4b0a-bce7-e236e8699d42" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesPeriodPastDueAxis_0839baa5-9620-45d3-bd59-694a8745045e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablesPeriodPastDueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivablesPastDueTable_4697290e-8d21-4b0a-bce7-e236e8699d42" xlink:to="loc_us-gaap_FinancingReceivablesPeriodPastDueAxis_0839baa5-9620-45d3-bd59-694a8745045e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain_0839baa5-9620-45d3-bd59-694a8745045e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablesPeriodPastDueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancingReceivablesPeriodPastDueAxis_0839baa5-9620-45d3-bd59-694a8745045e" xlink:to="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain_0839baa5-9620-45d3-bd59-694a8745045e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain_6e4fced0-a81f-4374-abbc-14918dfcbb26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablesPeriodPastDueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancingReceivablesPeriodPastDueAxis_0839baa5-9620-45d3-bd59-694a8745045e" xlink:to="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain_6e4fced0-a81f-4374-abbc-14918dfcbb26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_FinancialAssetGreaterThan30DaysPastDueMember_23cb33fa-12b7-4546-8ebb-c2bb37e04525" xlink:href="gehc-20250331.xsd#gehc_FinancialAssetGreaterThan30DaysPastDueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain_6e4fced0-a81f-4374-abbc-14918dfcbb26" xlink:to="loc_gehc_FinancialAssetGreaterThan30DaysPastDueMember_23cb33fa-12b7-4546-8ebb-c2bb37e04525" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesEqualToGreaterThan90DaysPastDueMember_bc5a5ee6-c152-47a2-9ae3-400a372bfaaa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablesEqualToGreaterThan90DaysPastDueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain_6e4fced0-a81f-4374-abbc-14918dfcbb26" xlink:to="loc_us-gaap_FinancingReceivablesEqualToGreaterThan90DaysPastDueMember_bc5a5ee6-c152-47a2-9ae3-400a372bfaaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablePercentPastDue1_26cd1dff-a2aa-4449-beea-d34c0c5315bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablePercentPastDue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems_0f51ccfd-5c7d-46d0-b6d8-2f349f8f5dbd" xlink:to="loc_us-gaap_FinancingReceivablePercentPastDue1_26cd1dff-a2aa-4449-beea-d34c0c5315bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableNonaccrualPercentPastDue1_f3a141a5-364c-40a1-b18a-262af05d7605" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableNonaccrualPercentPastDue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems_0f51ccfd-5c7d-46d0-b6d8-2f349f8f5dbd" xlink:to="loc_us-gaap_FinancingReceivableNonaccrualPercentPastDue1_f3a141a5-364c-40a1-b18a-262af05d7605" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f7f285f4-3bc0-4cef-9425-d4aee56d9fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f7f285f4-3bc0-4cef-9425-d4aee56d9fd1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_52fe40fb-d6ed-41c7-88ad-38604873e03b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f7f285f4-3bc0-4cef-9425-d4aee56d9fd1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_52fe40fb-d6ed-41c7-88ad-38604873e03b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_52fe40fb-d6ed-41c7-88ad-38604873e03b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_52fe40fb-d6ed-41c7-88ad-38604873e03b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_52fe40fb-d6ed-41c7-88ad-38604873e03b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dfd3d3eb-d19d-4a5a-978f-cd721b8f5d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_52fe40fb-d6ed-41c7-88ad-38604873e03b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dfd3d3eb-d19d-4a5a-978f-cd721b8f5d4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_NihonMediPhysicsCo.LtdNMPMember_1ba1e311-cb41-48c3-8839-34940d099d57" xlink:href="gehc-20250331.xsd#gehc_NihonMediPhysicsCo.LtdNMPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dfd3d3eb-d19d-4a5a-978f-cd721b8f5d4d" xlink:to="loc_gehc_NihonMediPhysicsCo.LtdNMPMember_1ba1e311-cb41-48c3-8839-34940d099d57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_MIMSoftwareMember_da9aab10-78ff-463b-a070-798b5b83e401" xlink:href="gehc-20250331.xsd#gehc_MIMSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dfd3d3eb-d19d-4a5a-978f-cd721b8f5d4d" xlink:to="loc_gehc_MIMSoftwareMember_da9aab10-78ff-463b-a070-798b5b83e401" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_66008dd7-f000-446f-acee-fee6d2727467" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f7f285f4-3bc0-4cef-9425-d4aee56d9fd1" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_66008dd7-f000-446f-acee-fee6d2727467" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_66008dd7-f000-446f-acee-fee6d2727467_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_66008dd7-f000-446f-acee-fee6d2727467" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_66008dd7-f000-446f-acee-fee6d2727467_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_67e7c714-36e0-4af2-8c9d-55b5403b0968" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_66008dd7-f000-446f-acee-fee6d2727467" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_67e7c714-36e0-4af2-8c9d-55b5403b0968" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ContingentConsiderationPurchasePriceMember_961203a2-819a-49be-a484-a091ee2bce23" xlink:href="gehc-20250331.xsd#gehc_ContingentConsiderationPurchasePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_67e7c714-36e0-4af2-8c9d-55b5403b0968" xlink:to="loc_gehc_ContingentConsiderationPurchasePriceMember_961203a2-819a-49be-a484-a091ee2bce23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ContingentConsiderationServiceRequirementsMember_83efb983-90a0-4071-b1ac-a4f0488fb998" xlink:href="gehc-20250331.xsd#gehc_ContingentConsiderationServiceRequirementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_67e7c714-36e0-4af2-8c9d-55b5403b0968" xlink:to="loc_gehc_ContingentConsiderationServiceRequirementsMember_83efb983-90a0-4071-b1ac-a4f0488fb998" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ba0536a8-8fde-4ffd-bf6e-f2a1da5c7a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f7f285f4-3bc0-4cef-9425-d4aee56d9fd1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ba0536a8-8fde-4ffd-bf6e-f2a1da5c7a9d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba0536a8-8fde-4ffd-bf6e-f2a1da5c7a9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ba0536a8-8fde-4ffd-bf6e-f2a1da5c7a9d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba0536a8-8fde-4ffd-bf6e-f2a1da5c7a9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_40fba622-3e37-4869-b3cc-5e0728117f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ba0536a8-8fde-4ffd-bf6e-f2a1da5c7a9d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_40fba622-3e37-4869-b3cc-5e0728117f9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_684f7774-d624-4ba3-9288-98aaedf39cef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_40fba622-3e37-4869-b3cc-5e0728117f9e" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_684f7774-d624-4ba3-9288-98aaedf39cef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_6042c11f-629c-4b8e-b9aa-94c73445458e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_40fba622-3e37-4869-b3cc-5e0728117f9e" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_6042c11f-629c-4b8e-b9aa-94c73445458e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2cf7faa0-fe0a-492a-990f-20322c887aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f7f285f4-3bc0-4cef-9425-d4aee56d9fd1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2cf7faa0-fe0a-492a-990f-20322c887aeb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2cf7faa0-fe0a-492a-990f-20322c887aeb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2cf7faa0-fe0a-492a-990f-20322c887aeb" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2cf7faa0-fe0a-492a-990f-20322c887aeb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ebc08411-42fb-4150-9c45-33cc5ad4f47f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2cf7faa0-fe0a-492a-990f-20322c887aeb" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ebc08411-42fb-4150-9c45-33cc5ad4f47f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_83db6db6-10ad-4edd-a6b7-8bdfd28eeb8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ebc08411-42fb-4150-9c45-33cc5ad4f47f" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_83db6db6-10ad-4edd-a6b7-8bdfd28eeb8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_faca2437-7350-4bac-8822-d2ea43a9a395" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f7f285f4-3bc0-4cef-9425-d4aee56d9fd1" xlink:to="loc_dei_LegalEntityAxis_faca2437-7350-4bac-8822-d2ea43a9a395" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_faca2437-7350-4bac-8822-d2ea43a9a395_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_faca2437-7350-4bac-8822-d2ea43a9a395" xlink:to="loc_dei_EntityDomain_faca2437-7350-4bac-8822-d2ea43a9a395_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a9426aab-71a9-4881-a91f-8037b9e4731e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_faca2437-7350-4bac-8822-d2ea43a9a395" xlink:to="loc_dei_EntityDomain_a9426aab-71a9-4881-a91f-8037b9e4731e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_NihonMediPhysicsCo.LtdNMPMember_3a063662-83bb-4d03-b55a-ec0ece3f85ff" xlink:href="gehc-20250331.xsd#gehc_NihonMediPhysicsCo.LtdNMPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a9426aab-71a9-4881-a91f-8037b9e4731e" xlink:to="loc_gehc_NihonMediPhysicsCo.LtdNMPMember_3a063662-83bb-4d03-b55a-ec0ece3f85ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_1e5538d4-2107-42c9-a2fb-922da76afd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_1e5538d4-2107-42c9-a2fb-922da76afd6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_02fb4f0c-4222-4911-9448-66405130e4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_02fb4f0c-4222-4911-9448-66405130e4c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_4555e23c-2098-400f-94aa-58e968457b46" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_4555e23c-2098-400f-94aa-58e968457b46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_8baa865a-53f4-4b16-9cfa-465c1f932af1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_8baa865a-53f4-4b16-9cfa-465c1f932af1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue_786aba43-a2fd-43e0-b160-056adaa6f98f" xlink:href="gehc-20250331.xsd#gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue_786aba43-a2fd-43e0-b160-056adaa6f98f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_b70f88cf-7b52-47ea-b476-31c69ecf2205" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_b70f88cf-7b52-47ea-b476-31c69ecf2205" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax_9864fd79-a773-40c4-b291-4d760cd07388" xlink:href="gehc-20250331.xsd#gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax_9864fd79-a773-40c4-b291-4d760cd07388" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_3649f740-43ed-45fd-aa71-b6da06c84358" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_3649f740-43ed-45fd-aa71-b6da06c84358" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_5eb07a05-8f34-439b-8a74-630143d444ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_5eb07a05-8f34-439b-8a74-630143d444ca" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_2a33e739-8dea-47ca-aa8e-34bdd2c89822" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_2a33e739-8dea-47ca-aa8e-34bdd2c89822" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_83c33e61-415a-4170-abc2-6b6902bfc2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_83c33e61-415a-4170-abc2-6b6902bfc2ad" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities_4c068489-6d5e-49ac-b610-64bad92a9250" xlink:href="gehc-20250331.xsd#gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities_4c068489-6d5e-49ac-b610-64bad92a9250" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_09bd0ea2-9959-40fb-a50e-f1dfa5a5854a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_09bd0ea2-9959-40fb-a50e-f1dfa5a5854a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_8d919d3e-97d6-454b-bc71-7db1e1fc424b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_8d919d3e-97d6-454b-bc71-7db1e1fc424b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_72a1f857-141c-4e7d-b064-913c9fffb071" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_72a1f857-141c-4e7d-b064-913c9fffb071" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_0e38669a-01fd-4081-9b65-4aec2d5eb05a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_0e38669a-01fd-4081-9b65-4aec2d5eb05a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e5132009-73c3-407c-b134-ae42ccee497f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e5132009-73c3-407c-b134-ae42ccee497f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d0300859-0152-41cf-b6cd-c43c7cd1f202" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d0300859-0152-41cf-b6cd-c43c7cd1f202" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d025904f-dac5-4c7a-a9e7-8483e58e9102" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_Goodwill_d025904f-dac5-4c7a-a9e7-8483e58e9102" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_befd1872-faa8-4ee3-b49f-a555f7b69945" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_befd1872-faa8-4ee3-b49f-a555f7b69945" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d3c17b18-1431-4211-be19-c090a7bab9e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d3c17b18-1431-4211-be19-c090a7bab9e7" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets_19fc81a6-58b9-490f-81de-af8768ab9f37" xlink:href="gehc-20250331.xsd#gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets_19fc81a6-58b9-490f-81de-af8768ab9f37" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_8a9fccb7-b4af-44f5-9610-d7892a0aef16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_8a9fccb7-b4af-44f5-9610-d7892a0aef16" xlink:type="arc" order="22"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_30933f60-2017-4953-b81b-1f346d24f122" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8228fe93-da52-49cb-8e7f-8605be1417c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_30933f60-2017-4953-b81b-1f346d24f122" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8228fe93-da52-49cb-8e7f-8605be1417c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9586208e-b9a9-4215-bda9-76c50f24ec9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8228fe93-da52-49cb-8e7f-8605be1417c4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9586208e-b9a9-4215-bda9-76c50f24ec9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9586208e-b9a9-4215-bda9-76c50f24ec9b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9586208e-b9a9-4215-bda9-76c50f24ec9b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9586208e-b9a9-4215-bda9-76c50f24ec9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0652b0bb-5341-4bb8-ac57-43825593cda1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9586208e-b9a9-4215-bda9-76c50f24ec9b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0652b0bb-5341-4bb8-ac57-43825593cda1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_NihonMediPhysicsCo.LtdNMPMember_6ea39ac7-f29e-4d05-ae8a-3ced12d41075" xlink:href="gehc-20250331.xsd#gehc_NihonMediPhysicsCo.LtdNMPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0652b0bb-5341-4bb8-ac57-43825593cda1" xlink:to="loc_gehc_NihonMediPhysicsCo.LtdNMPMember_6ea39ac7-f29e-4d05-ae8a-3ced12d41075" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_791347bf-606b-4699-a453-746e4ac63240" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_30933f60-2017-4953-b81b-1f346d24f122" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_791347bf-606b-4699-a453-746e4ac63240" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f23dc49c-5102-4219-8cd3-a9086883f11c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_791347bf-606b-4699-a453-746e4ac63240" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f23dc49c-5102-4219-8cd3-a9086883f11c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_9e2b8479-9f45-43c3-8fb9-f572fff4a5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_791347bf-606b-4699-a453-746e4ac63240" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_9e2b8479-9f45-43c3-8fb9-f572fff4a5bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_b546a7a6-fe3c-4b6f-b7c2-9811c54962ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_791347bf-606b-4699-a453-746e4ac63240" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_b546a7a6-fe3c-4b6f-b7c2-9811c54962ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_4f64b25d-2180-42f2-88c7-b49e157fb663" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_791347bf-606b-4699-a453-746e4ac63240" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_4f64b25d-2180-42f2-88c7-b49e157fb663" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_30933f60-2017-4953-b81b-1f346d24f122" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_9d80d950-7c05-4a7b-909c-c5f8a079ed68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_9d80d950-7c05-4a7b-909c-c5f8a079ed68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1d0da40b-ea27-4fc1-a26a-12f1c3b78383" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1d0da40b-ea27-4fc1-a26a-12f1c3b78383" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_40626378-e2d4-41e4-8a55-e3cb49e01e79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_40626378-e2d4-41e4-8a55-e3cb49e01e79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2e8e6160-f4b8-469b-b458-9bb9c76266d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:to="loc_us-gaap_Goodwill_2e8e6160-f4b8-469b-b458-9bb9c76266d1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_df052ff0-0921-434e-89e7-8505ac53d8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_df052ff0-0921-434e-89e7-8505ac53d8a3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_07e6735b-b0ba-4bf7-8303-6497b09b57d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_07e6735b-b0ba-4bf7-8303-6497b09b57d0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d1ed9afa-c327-47f6-9541-02ac545fb217" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d1ed9afa-c327-47f6-9541-02ac545fb217" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_3d1959de-8a3f-4b4f-82ae-6771d0c5ed94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_3d1959de-8a3f-4b4f-82ae-6771d0c5ed94" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_603e3578-5440-4784-9b2b-5540cedbbbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_603e3578-5440-4784-9b2b-5540cedbbbaa" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_10e8ae16-8595-40fa-80f2-f5f732742a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_10e8ae16-8595-40fa-80f2-f5f732742a4a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets_44036720-4861-4cc5-bcc0-69a9be3da6d9" xlink:href="gehc-20250331.xsd#gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_30933f60-2017-4953-b81b-1f346d24f122" xlink:to="loc_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets_44036720-4861-4cc5-bcc0-69a9be3da6d9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_927ac8f1-971d-4a4f-a92d-8a6048e01e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_05d4d51c-486b-4001-a03f-90865e40e9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_927ac8f1-971d-4a4f-a92d-8a6048e01e2f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_05d4d51c-486b-4001-a03f-90865e40e9ed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0fc36386-5aa4-43e1-8442-479f7c5d7e35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_05d4d51c-486b-4001-a03f-90865e40e9ed" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0fc36386-5aa4-43e1-8442-479f7c5d7e35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0fc36386-5aa4-43e1-8442-479f7c5d7e35_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0fc36386-5aa4-43e1-8442-479f7c5d7e35" xlink:to="loc_us-gaap_SegmentDomain_0fc36386-5aa4-43e1-8442-479f7c5d7e35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4fd3cfaa-3507-4f9f-8c28-eb66f87e87ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0fc36386-5aa4-43e1-8442-479f7c5d7e35" xlink:to="loc_us-gaap_SegmentDomain_4fd3cfaa-3507-4f9f-8c28-eb66f87e87ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ImagingSegmentMember_930465d9-e914-454b-a58d-c549a725474e" xlink:href="gehc-20250331.xsd#gehc_ImagingSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4fd3cfaa-3507-4f9f-8c28-eb66f87e87ee" xlink:to="loc_gehc_ImagingSegmentMember_930465d9-e914-454b-a58d-c549a725474e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AVSSegmentMember_3688b500-b2f5-461e-a021-ae1901e55d87" xlink:href="gehc-20250331.xsd#gehc_AVSSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4fd3cfaa-3507-4f9f-8c28-eb66f87e87ee" xlink:to="loc_gehc_AVSSegmentMember_3688b500-b2f5-461e-a021-ae1901e55d87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PCSSegmentMember_060ef768-bb60-4e1d-8cc1-d7c1cc6a088f" xlink:href="gehc-20250331.xsd#gehc_PCSSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4fd3cfaa-3507-4f9f-8c28-eb66f87e87ee" xlink:to="loc_gehc_PCSSegmentMember_060ef768-bb60-4e1d-8cc1-d7c1cc6a088f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PDxSegmentMember_0c5114a1-01bd-4a9f-8800-478d176d9471" xlink:href="gehc-20250331.xsd#gehc_PDxSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4fd3cfaa-3507-4f9f-8c28-eb66f87e87ee" xlink:to="loc_gehc_PDxSegmentMember_0c5114a1-01bd-4a9f-8800-478d176d9471" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_12c116a0-9c96-41e1-a4b5-a8d10472bd75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_927ac8f1-971d-4a4f-a92d-8a6048e01e2f" xlink:to="loc_us-gaap_GoodwillRollForward_12c116a0-9c96-41e1-a4b5-a8d10472bd75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_571fd39a-bb56-463b-87b2-30f00c228a99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_12c116a0-9c96-41e1-a4b5-a8d10472bd75" xlink:to="loc_us-gaap_Goodwill_571fd39a-bb56-463b-87b2-30f00c228a99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_8b61b27f-24a7-4dae-83b6-f6de85c42d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_12c116a0-9c96-41e1-a4b5-a8d10472bd75" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_8b61b27f-24a7-4dae-83b6-f6de85c42d0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_7d784bc4-8f22-4a8a-bd5d-3e235d026207" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_12c116a0-9c96-41e1-a4b5-a8d10472bd75" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_7d784bc4-8f22-4a8a-bd5d-3e235d026207" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8a6a9262-d57f-4f66-a518-167dfc45d8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3845cf24-51e1-4ed3-a55a-3ff998eb5df4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f8ae2c5f-ce6b-4eb0-b641-c104e0d06394" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3845cf24-51e1-4ed3-a55a-3ff998eb5df4" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f8ae2c5f-ce6b-4eb0-b641-c104e0d06394" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83bbb19a-dcd9-461d-956b-a59e3e17eb39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f8ae2c5f-ce6b-4eb0-b641-c104e0d06394" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83bbb19a-dcd9-461d-956b-a59e3e17eb39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83bbb19a-dcd9-461d-956b-a59e3e17eb39_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83bbb19a-dcd9-461d-956b-a59e3e17eb39" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83bbb19a-dcd9-461d-956b-a59e3e17eb39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bc12a3d8-e68a-4c71-9875-a641586155fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83bbb19a-dcd9-461d-956b-a59e3e17eb39" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bc12a3d8-e68a-4c71-9875-a641586155fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_59786a21-7cfd-48f3-9061-6768408d7e48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bc12a3d8-e68a-4c71-9875-a641586155fe" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_59786a21-7cfd-48f3-9061-6768408d7e48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_60a5ed04-8969-4429-aeda-1da96376c0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bc12a3d8-e68a-4c71-9875-a641586155fe" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_60a5ed04-8969-4429-aeda-1da96376c0f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_216e9f65-0b4d-45d8-af36-6c4bf0d3f084" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bc12a3d8-e68a-4c71-9875-a641586155fe" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_216e9f65-0b4d-45d8-af36-6c4bf0d3f084" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_TrademarksAndOtherMember_310d53bc-7386-4f0b-8f6e-238c48727868" xlink:href="gehc-20250331.xsd#gehc_TrademarksAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bc12a3d8-e68a-4c71-9875-a641586155fe" xlink:to="loc_gehc_TrademarksAndOtherMember_310d53bc-7386-4f0b-8f6e-238c48727868" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4b2f67d8-574a-405f-bab3-84687b6573a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3845cf24-51e1-4ed3-a55a-3ff998eb5df4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4b2f67d8-574a-405f-bab3-84687b6573a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_466b2609-c7fd-4979-b44a-89c79c05f1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3845cf24-51e1-4ed3-a55a-3ff998eb5df4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_466b2609-c7fd-4979-b44a-89c79c05f1ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_43944e6b-2980-42a2-9680-2404701dd118" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3845cf24-51e1-4ed3-a55a-3ff998eb5df4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_43944e6b-2980-42a2-9680-2404701dd118" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1d3063a2-fa42-4f58-b1ab-e40e0ce68adb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3845cf24-51e1-4ed3-a55a-3ff998eb5df4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1d3063a2-fa42-4f58-b1ab-e40e0ce68adb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_47567a1a-1f35-4870-94ed-30bc8fe45435" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3845cf24-51e1-4ed3-a55a-3ff998eb5df4" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_47567a1a-1f35-4870-94ed-30bc8fe45435" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1c0514b3-392d-4f12-a6b5-9fe22889150b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3845cf24-51e1-4ed3-a55a-3ff998eb5df4" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1c0514b3-392d-4f12-a6b5-9fe22889150b" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#BORROWINGSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c825564b-c6f4-455d-af14-a026aa2dae8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:to="loc_us-gaap_DebtInstrumentTable_c825564b-c6f4-455d-af14-a026aa2dae8d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2bf8e7b9-d11f-40d9-b453-28616b60236d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c825564b-c6f4-455d-af14-a026aa2dae8d" xlink:to="loc_us-gaap_DebtInstrumentAxis_2bf8e7b9-d11f-40d9-b453-28616b60236d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2bf8e7b9-d11f-40d9-b453-28616b60236d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_2bf8e7b9-d11f-40d9-b453-28616b60236d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2bf8e7b9-d11f-40d9-b453-28616b60236d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_58851410-4e61-42dd-bf91-f0a438a0d125" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_2bf8e7b9-d11f-40d9-b453-28616b60236d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_58851410-4e61-42dd-bf91-f0a438a0d125" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_SeniorUnsecuredNotesMember_a785b508-6b55-4ef8-bb3f-78dbb69867c4" xlink:href="gehc-20250331.xsd#gehc_SeniorUnsecuredNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58851410-4e61-42dd-bf91-f0a438a0d125" xlink:to="loc_gehc_SeniorUnsecuredNotesMember_a785b508-6b55-4ef8-bb3f-78dbb69867c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A5YearRevolvingCreditFacilityMember_b24af7ea-1430-4030-9aa0-62f62c2e4ea2" xlink:href="gehc-20250331.xsd#gehc_A5YearRevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58851410-4e61-42dd-bf91-f0a438a0d125" xlink:to="loc_gehc_A5YearRevolvingCreditFacilityMember_b24af7ea-1430-4030-9aa0-62f62c2e4ea2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A364DayRevolvingCreditFacilityMember_57daa91c-fee9-4a24-ab14-fa3da1c6aa64" xlink:href="gehc-20250331.xsd#gehc_A364DayRevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58851410-4e61-42dd-bf91-f0a438a0d125" xlink:to="loc_gehc_A364DayRevolvingCreditFacilityMember_57daa91c-fee9-4a24-ab14-fa3da1c6aa64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_FloatingRateTermLoanFacilityDue2026Member_a536e50d-d7f6-46b8-a0c6-4d23381b4832" xlink:href="gehc-20250331.xsd#gehc_FloatingRateTermLoanFacilityDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58851410-4e61-42dd-bf91-f0a438a0d125" xlink:to="loc_gehc_FloatingRateTermLoanFacilityDue2026Member_a536e50d-d7f6-46b8-a0c6-4d23381b4832" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d687d8d0-0c89-45c7-8262-a16b5dd9cead" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c825564b-c6f4-455d-af14-a026aa2dae8d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d687d8d0-0c89-45c7-8262-a16b5dd9cead" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d687d8d0-0c89-45c7-8262-a16b5dd9cead_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d687d8d0-0c89-45c7-8262-a16b5dd9cead" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d687d8d0-0c89-45c7-8262-a16b5dd9cead_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_90fdd951-2912-4295-9772-220e12f97d90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d687d8d0-0c89-45c7-8262-a16b5dd9cead" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_90fdd951-2912-4295-9772-220e12f97d90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_0b5649e0-1f96-4ce1-b368-3a6ab10e7882" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_90fdd951-2912-4295-9772-220e12f97d90" xlink:to="loc_us-gaap_SeniorNotesMember_0b5649e0-1f96-4ce1-b368-3a6ab10e7882" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_9a744dc0-80d9-41f4-a7db-2542498084eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_90fdd951-2912-4295-9772-220e12f97d90" xlink:to="loc_us-gaap_LineOfCreditMember_9a744dc0-80d9-41f4-a7db-2542498084eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5191a3bc-4952-4a83-afc8-06c8b4c1fb2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c825564b-c6f4-455d-af14-a026aa2dae8d" xlink:to="loc_us-gaap_CreditFacilityAxis_5191a3bc-4952-4a83-afc8-06c8b4c1fb2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5191a3bc-4952-4a83-afc8-06c8b4c1fb2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_5191a3bc-4952-4a83-afc8-06c8b4c1fb2e" xlink:to="loc_us-gaap_CreditFacilityDomain_5191a3bc-4952-4a83-afc8-06c8b4c1fb2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9cd51f0a-0a29-4560-a5a6-c25fcd5729a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_5191a3bc-4952-4a83-afc8-06c8b4c1fb2e" xlink:to="loc_us-gaap_CreditFacilityDomain_9cd51f0a-0a29-4560-a5a6-c25fcd5729a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_ee772a89-7c82-4559-a973-b1a609ba6815" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_9cd51f0a-0a29-4560-a5a6-c25fcd5729a1" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_ee772a89-7c82-4559-a973-b1a609ba6815" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_fdabe3a5-de16-40ea-841a-9adba8690c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_9cd51f0a-0a29-4560-a5a6-c25fcd5729a1" xlink:to="loc_us-gaap_UnsecuredDebtMember_fdabe3a5-de16-40ea-841a-9adba8690c6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderlyingAssetClassAxis_d69898af-622c-47e5-a4e0-8d454748c072" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnderlyingAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c825564b-c6f4-455d-af14-a026aa2dae8d" xlink:to="loc_us-gaap_UnderlyingAssetClassAxis_d69898af-622c-47e5-a4e0-8d454748c072" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderlyingAssetClassDomain_d69898af-622c-47e5-a4e0-8d454748c072_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnderlyingAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnderlyingAssetClassAxis_d69898af-622c-47e5-a4e0-8d454748c072" xlink:to="loc_us-gaap_UnderlyingAssetClassDomain_d69898af-622c-47e5-a4e0-8d454748c072_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderlyingAssetClassDomain_b145ea8d-244a-4e00-b715-7def8b8d3234" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnderlyingAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnderlyingAssetClassAxis_d69898af-622c-47e5-a4e0-8d454748c072" xlink:to="loc_us-gaap_UnderlyingAssetClassDomain_b145ea8d-244a-4e00-b715-7def8b8d3234" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_CommercialContractsMember_d83f6067-bcd1-40f0-8e21-a312db428612" xlink:href="gehc-20250331.xsd#gehc_CommercialContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnderlyingAssetClassDomain_b145ea8d-244a-4e00-b715-7def8b8d3234" xlink:to="loc_gehc_CommercialContractsMember_d83f6067-bcd1-40f0-8e21-a312db428612" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_EquipmentResidualValueObligationMember_66802dcf-601b-4a95-9693-fe25797302fc" xlink:href="gehc-20250331.xsd#gehc_EquipmentResidualValueObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnderlyingAssetClassDomain_b145ea8d-244a-4e00-b715-7def8b8d3234" xlink:to="loc_gehc_EquipmentResidualValueObligationMember_66802dcf-601b-4a95-9693-fe25797302fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_44fc6e55-e820-4dd7-b854-8f68a1a0ee92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_44fc6e55-e820-4dd7-b854-8f68a1a0ee92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_NumberOfDebtSeries_8b61fd86-9f60-4324-8e3b-0c9c7283980a" xlink:href="gehc-20250331.xsd#gehc_NumberOfDebtSeries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:to="loc_gehc_NumberOfDebtSeries_8b61fd86-9f60-4324-8e3b-0c9c7283980a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_21b018d7-24be-41ff-8394-5eb5b287c1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:to="loc_us-gaap_DebtInstrumentTerm_21b018d7-24be-41ff-8394-5eb5b287c1c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_36d18c9a-77ae-4923-accd-d4728acc2996" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_36d18c9a-77ae-4923-accd-d4728acc2996" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_e9851a05-a546-4c6e-bfc0-5960ad418213" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:to="loc_us-gaap_LineOfCredit_e9851a05-a546-4c6e-bfc0-5960ad418213" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_ac2e4050-1535-4502-97d7-6f0477c88573" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_ac2e4050-1535-4502-97d7-6f0477c88573" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_8c198086-adc4-4339-bf73-026fca9d138e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_8c198086-adc4-4339-bf73-026fca9d138e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_4212993a-3a6e-45c5-8b98-1e2ceccfcb37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_4212993a-3a6e-45c5-8b98-1e2ceccfcb37" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_952c2b35-dbaa-4df2-bc05-e1e70baa04f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_952c2b35-dbaa-4df2-bc05-e1e70baa04f1" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#BORROWINGSScheduleofLongTermBorrowingsDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_aeade33b-97b3-4893-ac1e-601ed919f3dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b5a1b320-bbbc-4098-beb0-e624cea61a37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_aeade33b-97b3-4893-ac1e-601ed919f3dc" xlink:to="loc_us-gaap_DebtInstrumentTable_b5a1b320-bbbc-4098-beb0-e624cea61a37" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_933dd92b-f471-477e-a437-a9bacbc76f94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b5a1b320-bbbc-4098-beb0-e624cea61a37" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_933dd92b-f471-477e-a437-a9bacbc76f94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_933dd92b-f471-477e-a437-a9bacbc76f94_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_933dd92b-f471-477e-a437-a9bacbc76f94" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_933dd92b-f471-477e-a437-a9bacbc76f94_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7440640a-8a05-4891-864a-3d7caccad1ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_933dd92b-f471-477e-a437-a9bacbc76f94" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7440640a-8a05-4891-864a-3d7caccad1ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_daf95634-20c0-4dd5-ac18-6771f110ed54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7440640a-8a05-4891-864a-3d7caccad1ba" xlink:to="loc_us-gaap_SeniorNotesMember_daf95634-20c0-4dd5-ac18-6771f110ed54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_f8e13e5b-49f1-438f-9af7-96a5eafdf701" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7440640a-8a05-4891-864a-3d7caccad1ba" xlink:to="loc_us-gaap_LineOfCreditMember_f8e13e5b-49f1-438f-9af7-96a5eafdf701" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherLongTermBorrowingsMember_bac80d2a-ca6e-43e8-918c-a8e1c70835e7" xlink:href="gehc-20250331.xsd#gehc_OtherLongTermBorrowingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7440640a-8a05-4891-864a-3d7caccad1ba" xlink:to="loc_gehc_OtherLongTermBorrowingsMember_bac80d2a-ca6e-43e8-918c-a8e1c70835e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2df6ef19-90c0-4c53-ae2c-774795a449fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b5a1b320-bbbc-4098-beb0-e624cea61a37" xlink:to="loc_us-gaap_DebtInstrumentAxis_2df6ef19-90c0-4c53-ae2c-774795a449fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2df6ef19-90c0-4c53-ae2c-774795a449fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_2df6ef19-90c0-4c53-ae2c-774795a449fa" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2df6ef19-90c0-4c53-ae2c-774795a449fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a9cedfb0-5d58-4e38-b6a1-1d13793a8e90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_2df6ef19-90c0-4c53-ae2c-774795a449fa" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a9cedfb0-5d58-4e38-b6a1-1d13793a8e90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A5600SeniorNotesDue2025Member_305f31f3-ed0b-4a17-84ed-f48870b3a1b7" xlink:href="gehc-20250331.xsd#gehc_A5600SeniorNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9cedfb0-5d58-4e38-b6a1-1d13793a8e90" xlink:to="loc_gehc_A5600SeniorNotesDue2025Member_305f31f3-ed0b-4a17-84ed-f48870b3a1b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A5650SeniorNotesDue2027Member_c99d9b47-6bfe-4dcd-9365-c484512adab9" xlink:href="gehc-20250331.xsd#gehc_A5650SeniorNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9cedfb0-5d58-4e38-b6a1-1d13793a8e90" xlink:to="loc_gehc_A5650SeniorNotesDue2027Member_c99d9b47-6bfe-4dcd-9365-c484512adab9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A4.800SeniorNotesDue2029Member_18d4a10c-ef3a-41e8-83aa-da6145f45242" xlink:href="gehc-20250331.xsd#gehc_A4.800SeniorNotesDue2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9cedfb0-5d58-4e38-b6a1-1d13793a8e90" xlink:to="loc_gehc_A4.800SeniorNotesDue2029Member_18d4a10c-ef3a-41e8-83aa-da6145f45242" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A5857SeniorNotesDue2030Member_7023e798-328e-4f66-ab65-bd9c8ea2f23d" xlink:href="gehc-20250331.xsd#gehc_A5857SeniorNotesDue2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9cedfb0-5d58-4e38-b6a1-1d13793a8e90" xlink:to="loc_gehc_A5857SeniorNotesDue2030Member_7023e798-328e-4f66-ab65-bd9c8ea2f23d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A5905SeniorNotesDue2032Member_f84e1080-f8a9-472f-ae83-f08974b1a55e" xlink:href="gehc-20250331.xsd#gehc_A5905SeniorNotesDue2032Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9cedfb0-5d58-4e38-b6a1-1d13793a8e90" xlink:to="loc_gehc_A5905SeniorNotesDue2032Member_f84e1080-f8a9-472f-ae83-f08974b1a55e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A6377SeniorNotesDue2052Member_7d030f25-a147-42bf-b96b-50f861b31e79" xlink:href="gehc-20250331.xsd#gehc_A6377SeniorNotesDue2052Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9cedfb0-5d58-4e38-b6a1-1d13793a8e90" xlink:to="loc_gehc_A6377SeniorNotesDue2052Member_7d030f25-a147-42bf-b96b-50f861b31e79" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_FloatingRateTermLoanFacilityDue2026Member_930aa396-5daf-4fcc-bbff-9ee80ce46b01" xlink:href="gehc-20250331.xsd#gehc_FloatingRateTermLoanFacilityDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9cedfb0-5d58-4e38-b6a1-1d13793a8e90" xlink:to="loc_gehc_FloatingRateTermLoanFacilityDue2026Member_930aa396-5daf-4fcc-bbff-9ee80ce46b01" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9b2a79ed-6f91-45b3-8e2e-387866ab3098" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_aeade33b-97b3-4893-ac1e-601ed919f3dc" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9b2a79ed-6f91-45b3-8e2e-387866ab3098" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_dd3b9585-a401-4df4-8473-da11a977468b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_aeade33b-97b3-4893-ac1e-601ed919f3dc" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_dd3b9585-a401-4df4-8473-da11a977468b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_9ae89734-2eb0-4a16-a3b7-d4435a4ff9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_aeade33b-97b3-4893-ac1e-601ed919f3dc" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_9ae89734-2eb0-4a16-a3b7-d4435a4ff9e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_66588ffd-def4-4c72-b7bb-e7191c5b72d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_aeade33b-97b3-4893-ac1e-601ed919f3dc" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_66588ffd-def4-4c72-b7bb-e7191c5b72d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ef8d6ab3-aedc-4ed0-b21e-0621cb0b6fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_aeade33b-97b3-4893-ac1e-601ed919f3dc" xlink:to="loc_us-gaap_LongTermDebt_ef8d6ab3-aedc-4ed0-b21e-0621cb0b6fb0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_59e691e5-2de0-4449-825c-25feab7312dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_aeade33b-97b3-4893-ac1e-601ed919f3dc" xlink:to="loc_us-gaap_ShortTermBorrowings_59e691e5-2de0-4449-825c-25feab7312dd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_8412dc04-2a9e-4c9a-8ccc-740ff5c0ec36" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_aeade33b-97b3-4893-ac1e-601ed919f3dc" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_8412dc04-2a9e-4c9a-8ccc-740ff5c0ec36" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_eff53126-d825-4773-bbc8-da92690902e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_aeade33b-97b3-4893-ac1e-601ed919f3dc" xlink:to="loc_us-gaap_LongTermDebtCurrent_eff53126-d825-4773-bbc8-da92690902e8" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#POSTRETIREMENTBENEFITPLANSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7a343f68-2903-49f4-b5d5-84bb1753af28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_765d9063-86ed-49e0-be1d-667d093eb641" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7a343f68-2903-49f4-b5d5-84bb1753af28" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_765d9063-86ed-49e0-be1d-667d093eb641" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_47ec5e01-8a88-4532-9c1d-ed990677e4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_765d9063-86ed-49e0-be1d-667d093eb641" xlink:to="loc_us-gaap_RetirementPlanNameAxis_47ec5e01-8a88-4532-9c1d-ed990677e4f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_47ec5e01-8a88-4532-9c1d-ed990677e4f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_47ec5e01-8a88-4532-9c1d-ed990677e4f0" xlink:to="loc_us-gaap_RetirementPlanNameDomain_47ec5e01-8a88-4532-9c1d-ed990677e4f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_4f933181-f286-4f7d-aab4-eec44e1a505a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_47ec5e01-8a88-4532-9c1d-ed990677e4f0" xlink:to="loc_us-gaap_RetirementPlanNameDomain_4f933181-f286-4f7d-aab4-eec44e1a505a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_GEHealthCareSupplementalPensionPlanMember_33534b9c-50b0-4f86-ad07-1be6f3e40b72" xlink:href="gehc-20250331.xsd#gehc_GEHealthCareSupplementalPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_4f933181-f286-4f7d-aab4-eec44e1a505a" xlink:to="loc_gehc_GEHealthCareSupplementalPensionPlanMember_33534b9c-50b0-4f86-ad07-1be6f3e40b72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameOtherMember_cd8e58d1-886e-450c-8a71-5583d1cf82e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanNameOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_4f933181-f286-4f7d-aab4-eec44e1a505a" xlink:to="loc_us-gaap_RetirementPlanNameOtherMember_cd8e58d1-886e-450c-8a71-5583d1cf82e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_30d6adad-46e7-4348-858a-13f7656d66d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_765d9063-86ed-49e0-be1d-667d093eb641" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_30d6adad-46e7-4348-858a-13f7656d66d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_30d6adad-46e7-4348-858a-13f7656d66d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_30d6adad-46e7-4348-858a-13f7656d66d2" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_30d6adad-46e7-4348-858a-13f7656d66d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_59a682c0-0b5c-4bd7-8f7d-8dd0e2a57c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_30d6adad-46e7-4348-858a-13f7656d66d2" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_59a682c0-0b5c-4bd7-8f7d-8dd0e2a57c5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_e202a465-bb63-4cef-aa18-d4d85b26a544" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_59a682c0-0b5c-4bd7-8f7d-8dd0e2a57c5c" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_e202a465-bb63-4cef-aa18-d4d85b26a544" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_686e4dcc-d4da-401d-a861-769862810c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_59a682c0-0b5c-4bd7-8f7d-8dd0e2a57c5c" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_686e4dcc-d4da-401d-a861-769862810c5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold_b2884e6f-b040-430c-866a-70a7c3edd3b1" xlink:href="gehc-20250331.xsd#gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7a343f68-2903-49f4-b5d5-84bb1753af28" xlink:to="loc_gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold_b2884e6f-b040-430c-866a-70a7c3edd3b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_47ba6474-c3e2-4e7d-bf21-4a70993ce76b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7a343f68-2903-49f4-b5d5-84bb1753af28" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_47ba6474-c3e2-4e7d-bf21-4a70993ce76b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_0f549aaa-59d8-461b-a58d-0d60eb05b2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7a343f68-2903-49f4-b5d5-84bb1753af28" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_0f549aaa-59d8-461b-a58d-0d60eb05b2a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_70482dee-890b-4e03-b03b-2b80661ec8b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7a343f68-2903-49f4-b5d5-84bb1753af28" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_70482dee-890b-4e03-b03b-2b80661ec8b3" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87df3347-f753-4ba1-8dd6-d962bdf5a8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_86c4c1bb-d63e-4ec2-bc6f-6831d53a92a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87df3347-f753-4ba1-8dd6-d962bdf5a8d5" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_86c4c1bb-d63e-4ec2-bc6f-6831d53a92a8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_cdd66e61-ded9-4ee4-a395-6378d3b50bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_86c4c1bb-d63e-4ec2-bc6f-6831d53a92a8" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_cdd66e61-ded9-4ee4-a395-6378d3b50bc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_cdd66e61-ded9-4ee4-a395-6378d3b50bc9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_cdd66e61-ded9-4ee4-a395-6378d3b50bc9" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_cdd66e61-ded9-4ee4-a395-6378d3b50bc9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_ae96905a-47f4-4460-9baa-2968eb7c0324" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_cdd66e61-ded9-4ee4-a395-6378d3b50bc9" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_ae96905a-47f4-4460-9baa-2968eb7c0324" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_ce1060b6-0894-468f-af8c-0bc22bce6245" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_ae96905a-47f4-4460-9baa-2968eb7c0324" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_ce1060b6-0894-468f-af8c-0bc22bce6245" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_ff71df88-39bc-4625-8692-79efdc9d0c30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_ae96905a-47f4-4460-9baa-2968eb7c0324" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_ff71df88-39bc-4625-8692-79efdc9d0c30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_495cfca3-5b60-4176-9c46-78619541894c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_86c4c1bb-d63e-4ec2-bc6f-6831d53a92a8" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_495cfca3-5b60-4176-9c46-78619541894c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_495cfca3-5b60-4176-9c46-78619541894c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_495cfca3-5b60-4176-9c46-78619541894c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_495cfca3-5b60-4176-9c46-78619541894c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_e92b1bec-e2d9-4974-9e99-1370fdc7b7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_495cfca3-5b60-4176-9c46-78619541894c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_e92b1bec-e2d9-4974-9e99-1370fdc7b7f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_fe594edf-3d64-41e4-940c-b8bd5c990bab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_e92b1bec-e2d9-4974-9e99-1370fdc7b7f2" xlink:to="loc_us-gaap_DomesticPlanMember_fe594edf-3d64-41e4-940c-b8bd5c990bab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_274894f5-356d-48fd-b530-4a9e1e7041a1" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_fe594edf-3d64-41e4-940c-b8bd5c990bab" xlink:to="loc_country_US_274894f5-356d-48fd-b530-4a9e1e7041a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_18668a30-da73-4d2b-93e7-e955a5234b00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_e92b1bec-e2d9-4974-9e99-1370fdc7b7f2" xlink:to="loc_us-gaap_ForeignPlanMember_18668a30-da73-4d2b-93e7-e955a5234b00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_14cff163-b89e-4dcd-bbbc-42aab7c9152e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87df3347-f753-4ba1-8dd6-d962bdf5a8d5" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_14cff163-b89e-4dcd-bbbc-42aab7c9152e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_248f479a-3628-4151-ba34-e0f3e90f157b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87df3347-f753-4ba1-8dd6-d962bdf5a8d5" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_248f479a-3628-4151-ba34-e0f3e90f157b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_6901461e-5e12-498a-9fd9-8b9a66c8a4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87df3347-f753-4ba1-8dd6-d962bdf5a8d5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_6901461e-5e12-498a-9fd9-8b9a66c8a4b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_2b0a0eb3-6e6e-40e1-a2c5-0b5f53f56222" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87df3347-f753-4ba1-8dd6-d962bdf5a8d5" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_2b0a0eb3-6e6e-40e1-a2c5-0b5f53f56222" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_dc5ad831-7a34-4fca-9825-fa51f34ca942" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87df3347-f753-4ba1-8dd6-d962bdf5a8d5" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_dc5ad831-7a34-4fca-9825-fa51f34ca942" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_9712d857-3b47-4da7-a7c4-ace203859c02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87df3347-f753-4ba1-8dd6-d962bdf5a8d5" xlink:to="loc_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_9712d857-3b47-4da7-a7c4-ace203859c02" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_cdb0b6b4-3915-478e-9d4f-52d05795346f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87df3347-f753-4ba1-8dd6-d962bdf5a8d5" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_cdb0b6b4-3915-478e-9d4f-52d05795346f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e9b388ea-8d3c-420a-8fe2-b3998ac6cd6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87df3347-f753-4ba1-8dd6-d962bdf5a8d5" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e9b388ea-8d3c-420a-8fe2-b3998ac6cd6e" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_43568a41-7e26-4869-9278-9929cee5aad4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_27adc198-4f11-40f6-ae48-a2bc8e61080c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_43568a41-7e26-4869-9278-9929cee5aad4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_27adc198-4f11-40f6-ae48-a2bc8e61080c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6ba7f4a5-3383-475e-9060-31b287c53445" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_27adc198-4f11-40f6-ae48-a2bc8e61080c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6ba7f4a5-3383-475e-9060-31b287c53445" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6ba7f4a5-3383-475e-9060-31b287c53445_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6ba7f4a5-3383-475e-9060-31b287c53445" xlink:to="loc_us-gaap_EquityComponentDomain_6ba7f4a5-3383-475e-9060-31b287c53445_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cbf26570-fa65-4019-961d-d13cb59bee47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6ba7f4a5-3383-475e-9060-31b287c53445" xlink:to="loc_us-gaap_EquityComponentDomain_cbf26570-fa65-4019-961d-d13cb59bee47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_47e2c823-5d1d-4adb-83b0-20ad0d70c642" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cbf26570-fa65-4019-961d-d13cb59bee47" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_47e2c823-5d1d-4adb-83b0-20ad0d70c642" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_8f6fb67a-c527-4f83-bc0a-d3199adaa2ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_47e2c823-5d1d-4adb-83b0-20ad0d70c642" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_8f6fb67a-c527-4f83-bc0a-d3199adaa2ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_7cf2bc42-ca41-40b1-83af-b4509f3234ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_47e2c823-5d1d-4adb-83b0-20ad0d70c642" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_7cf2bc42-ca41-40b1-83af-b4509f3234ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_869cb670-d0f8-4627-9aab-16274b07b0dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_47e2c823-5d1d-4adb-83b0-20ad0d70c642" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_869cb670-d0f8-4627-9aab-16274b07b0dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5b1fdcb9-1145-452d-aab3-f30cd331de19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_27adc198-4f11-40f6-ae48-a2bc8e61080c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5b1fdcb9-1145-452d-aab3-f30cd331de19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5b1fdcb9-1145-452d-aab3-f30cd331de19_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5b1fdcb9-1145-452d-aab3-f30cd331de19" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5b1fdcb9-1145-452d-aab3-f30cd331de19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d1449898-988a-4efc-9669-e0bbf6bdb531" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5b1fdcb9-1145-452d-aab3-f30cd331de19" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d1449898-988a-4efc-9669-e0bbf6bdb531" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_NihonMediPhysicsCo.LtdNMPMember_d270579b-72e1-4f7e-84c8-99d2ab6980d5" xlink:href="gehc-20250331.xsd#gehc_NihonMediPhysicsCo.LtdNMPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d1449898-988a-4efc-9669-e0bbf6bdb531" xlink:to="loc_gehc_NihonMediPhysicsCo.LtdNMPMember_d270579b-72e1-4f7e-84c8-99d2ab6980d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_7c13b43c-c1cd-4a00-8312-52968f22b13a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_43568a41-7e26-4869-9278-9929cee5aad4" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_7c13b43c-c1cd-4a00-8312-52968f22b13a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_68ca22c7-88b3-4cd0-a844-01c14daf96f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_7c13b43c-c1cd-4a00-8312-52968f22b13a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_68ca22c7-88b3-4cd0-a844-01c14daf96f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_6b2b8655-9a09-40f8-b226-395bf7ed2222" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_7c13b43c-c1cd-4a00-8312-52968f22b13a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_6b2b8655-9a09-40f8-b226-395bf7ed2222" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_621524de-bef5-4d1f-bd3c-f6b181987c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_7c13b43c-c1cd-4a00-8312-52968f22b13a" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_621524de-bef5-4d1f-bd3c-f6b181987c0c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4975ef49-5133-4cd8-abd1-7c0042e7c089" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_7c13b43c-c1cd-4a00-8312-52968f22b13a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4975ef49-5133-4cd8-abd1-7c0042e7c089" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_9678c2cb-d925-4025-97f3-2f5a2c8ff766" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_7c13b43c-c1cd-4a00-8312-52968f22b13a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_9678c2cb-d925-4025-97f3-2f5a2c8ff766" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c6e24fdf-47f4-41c0-91c3-e985a8abff39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_dc1d5d2b-62dc-407f-bde6-26c168d21277" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_43568a41-7e26-4869-9278-9929cee5aad4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_dc1d5d2b-62dc-407f-bde6-26c168d21277" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_3592b994-9e51-4cce-b3a3-3763b382d45a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_43568a41-7e26-4869-9278-9929cee5aad4" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_3592b994-9e51-4cce-b3a3-3763b382d45a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax_e4e6e7cf-388f-4414-b413-fc35a16f79be" xlink:href="gehc-20250331.xsd#gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_43568a41-7e26-4869-9278-9929cee5aad4" xlink:to="loc_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax_e4e6e7cf-388f-4414-b413-fc35a16f79be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_ff8b45eb-2344-47b5-8c38-a13f828c31ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_43568a41-7e26-4869-9278-9929cee5aad4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_ff8b45eb-2344-47b5-8c38-a13f828c31ec" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_cd8e5c7d-26de-48b0-adf3-c8f54f771bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_dc69c354-0985-4f86-bc37-0cfd62883019" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_cd8e5c7d-26de-48b0-adf3-c8f54f771bb4" xlink:to="loc_us-gaap_DerivativeTable_dc69c354-0985-4f86-bc37-0cfd62883019" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd381ceb-474b-4e96-b2bc-3a72375f9a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_dc69c354-0985-4f86-bc37-0cfd62883019" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd381ceb-474b-4e96-b2bc-3a72375f9a1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_dd381ceb-474b-4e96-b2bc-3a72375f9a1f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd381ceb-474b-4e96-b2bc-3a72375f9a1f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_dd381ceb-474b-4e96-b2bc-3a72375f9a1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_55a9e064-ce12-45a5-a035-68fd8219f818" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd381ceb-474b-4e96-b2bc-3a72375f9a1f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_55a9e064-ce12-45a5-a035-68fd8219f818" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_0b724310-6cb3-44cd-bab4-591d09000b20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_55a9e064-ce12-45a5-a035-68fd8219f818" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_0b724310-6cb3-44cd-bab4-591d09000b20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_ef84783c-18c9-4be3-9b05-67f76f615738" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_55a9e064-ce12-45a5-a035-68fd8219f818" xlink:to="loc_us-gaap_FairValueHedgingMember_ef84783c-18c9-4be3-9b05-67f76f615738" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6d8f5b64-9284-4290-962e-bab74ec7c35b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_dc69c354-0985-4f86-bc37-0cfd62883019" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6d8f5b64-9284-4290-962e-bab74ec7c35b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6d8f5b64-9284-4290-962e-bab74ec7c35b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6d8f5b64-9284-4290-962e-bab74ec7c35b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6d8f5b64-9284-4290-962e-bab74ec7c35b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4b769ff8-17c7-4561-8d41-fa2cf0844bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6d8f5b64-9284-4290-962e-bab74ec7c35b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4b769ff8-17c7-4561-8d41-fa2cf0844bfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_efff3931-9243-40d5-add3-2cec556db0de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4b769ff8-17c7-4561-8d41-fa2cf0844bfa" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_efff3931-9243-40d5-add3-2cec556db0de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6481637b-fba5-4a2f-bdc1-f8389b0d1850" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4b769ff8-17c7-4561-8d41-fa2cf0844bfa" xlink:to="loc_us-gaap_InterestRateSwapMember_6481637b-fba5-4a2f-bdc1-f8389b0d1850" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b719f35f-2d41-42d3-9247-8c7802a158e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_dc69c354-0985-4f86-bc37-0cfd62883019" xlink:to="loc_us-gaap_HedgingDesignationAxis_b719f35f-2d41-42d3-9247-8c7802a158e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b719f35f-2d41-42d3-9247-8c7802a158e4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_b719f35f-2d41-42d3-9247-8c7802a158e4" xlink:to="loc_us-gaap_HedgingDesignationDomain_b719f35f-2d41-42d3-9247-8c7802a158e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_68986ddb-b1b5-465a-810c-1703f54bb514" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_b719f35f-2d41-42d3-9247-8c7802a158e4" xlink:to="loc_us-gaap_HedgingDesignationDomain_68986ddb-b1b5-465a-810c-1703f54bb514" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6231695b-94d7-45aa-9214-21a9b847ade6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_68986ddb-b1b5-465a-810c-1703f54bb514" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6231695b-94d7-45aa-9214-21a9b847ade6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_8b785d3f-2614-44e4-9656-2594cb21cb66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_dc69c354-0985-4f86-bc37-0cfd62883019" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_8b785d3f-2614-44e4-9656-2594cb21cb66" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8b785d3f-2614-44e4-9656-2594cb21cb66_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_8b785d3f-2614-44e4-9656-2594cb21cb66" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8b785d3f-2614-44e4-9656-2594cb21cb66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_450d01a7-88eb-4af5-a92f-8a56aa12a65c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_8b785d3f-2614-44e4-9656-2594cb21cb66" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_450d01a7-88eb-4af5-a92f-8a56aa12a65c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_c777195c-d9ac-4cb8-8e56-f7ad05ad7d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_450d01a7-88eb-4af5-a92f-8a56aa12a65c" xlink:to="loc_us-gaap_MoneyMarketFundsMember_c777195c-d9ac-4cb8-8e56-f7ad05ad7d4e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherCashEquivalentsMember_cb78db68-2c3c-4b7a-919a-58bcad940191" xlink:href="gehc-20250331.xsd#gehc_OtherCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_450d01a7-88eb-4af5-a92f-8a56aa12a65c" xlink:to="loc_gehc_OtherCashEquivalentsMember_cb78db68-2c3c-4b7a-919a-58bcad940191" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fa5325f4-b526-4d4b-a655-1cca5440823f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_dc69c354-0985-4f86-bc37-0cfd62883019" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fa5325f4-b526-4d4b-a655-1cca5440823f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_fa5325f4-b526-4d4b-a655-1cca5440823f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fa5325f4-b526-4d4b-a655-1cca5440823f" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_fa5325f4-b526-4d4b-a655-1cca5440823f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_41255372-baaf-4f18-9ab0-a258abd5f059" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fa5325f4-b526-4d4b-a655-1cca5440823f" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_41255372-baaf-4f18-9ab0-a258abd5f059" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_af70b531-5ee7-4042-a9ea-3a950bc846cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_41255372-baaf-4f18-9ab0-a258abd5f059" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_af70b531-5ee7-4042-a9ea-3a950bc846cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_993cbf8b-4c56-4783-b2d0-886350b3a8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_dc69c354-0985-4f86-bc37-0cfd62883019" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_993cbf8b-4c56-4783-b2d0-886350b3a8b7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_993cbf8b-4c56-4783-b2d0-886350b3a8b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_993cbf8b-4c56-4783-b2d0-886350b3a8b7" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_993cbf8b-4c56-4783-b2d0-886350b3a8b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_193d112d-8b4a-46bb-b6c7-30b8a9453506" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_993cbf8b-4c56-4783-b2d0-886350b3a8b7" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_193d112d-8b4a-46bb-b6c7-30b8a9453506" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ee8c7984-a994-407e-b20c-1222ba37abc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_193d112d-8b4a-46bb-b6c7-30b8a9453506" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ee8c7984-a994-407e-b20c-1222ba37abc2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_07172cdb-743d-42e0-a395-b616ecf75460" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ee8c7984-a994-407e-b20c-1222ba37abc2" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_07172cdb-743d-42e0-a395-b616ecf75460" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_7fae02e1-907c-4687-8e53-29d2f31d2459" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ee8c7984-a994-407e-b20c-1222ba37abc2" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_7fae02e1-907c-4687-8e53-29d2f31d2459" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_e67169f4-6c84-4fcf-a221-f14d785cc381" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_cd8e5c7d-26de-48b0-adf3-c8f54f771bb4" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_e67169f4-6c84-4fcf-a221-f14d785cc381" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability_8c27900e-aa54-4beb-a435-f7729f8b2737" xlink:href="gehc-20250331.xsd#gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_cd8e5c7d-26de-48b0-adf3-c8f54f771bb4" xlink:to="loc_gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability_8c27900e-aa54-4beb-a435-f7729f8b2737" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_b73927be-1c43-4357-ba23-b8e6f2cc7b68" xlink:href="gehc-20250331.xsd#gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_cd8e5c7d-26de-48b0-adf3-c8f54f771bb4" xlink:to="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_b73927be-1c43-4357-ba23-b8e6f2cc7b68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_3f56255c-e488-4803-95ab-aeb90e917d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_cd8e5c7d-26de-48b0-adf3-c8f54f771bb4" xlink:to="loc_us-gaap_LongTermDebtFairValue_3f56255c-e488-4803-95ab-aeb90e917d7d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e95ae0c8-400a-4c4d-a99b-6ec26791f325" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_bee063bf-cea9-469d-86c3-ce811d146124" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_e95ae0c8-400a-4c4d-a99b-6ec26791f325" xlink:to="loc_us-gaap_DerivativeTable_bee063bf-cea9-469d-86c3-ce811d146124" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_aa598ef8-ec2b-4d8c-a131-5e4d3a62f0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_bee063bf-cea9-469d-86c3-ce811d146124" xlink:to="loc_us-gaap_HedgingDesignationAxis_aa598ef8-ec2b-4d8c-a131-5e4d3a62f0d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_aa598ef8-ec2b-4d8c-a131-5e4d3a62f0d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_aa598ef8-ec2b-4d8c-a131-5e4d3a62f0d5" xlink:to="loc_us-gaap_HedgingDesignationDomain_aa598ef8-ec2b-4d8c-a131-5e4d3a62f0d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f5ab3d46-0f66-4077-b0cd-b7ce049bdc2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_aa598ef8-ec2b-4d8c-a131-5e4d3a62f0d5" xlink:to="loc_us-gaap_HedgingDesignationDomain_f5ab3d46-0f66-4077-b0cd-b7ce049bdc2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_679079c0-57ab-4db2-8b7c-21c77acfffd7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_f5ab3d46-0f66-4077-b0cd-b7ce049bdc2c" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_679079c0-57ab-4db2-8b7c-21c77acfffd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_ba5c38a0-7d58-45db-b710-bd99ce9b732b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_f5ab3d46-0f66-4077-b0cd-b7ce049bdc2c" xlink:to="loc_us-gaap_NondesignatedMember_ba5c38a0-7d58-45db-b710-bd99ce9b732b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d1fab150-6dd9-4032-9647-e5537b030cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_bee063bf-cea9-469d-86c3-ce811d146124" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d1fab150-6dd9-4032-9647-e5537b030cd9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d1fab150-6dd9-4032-9647-e5537b030cd9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d1fab150-6dd9-4032-9647-e5537b030cd9" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d1fab150-6dd9-4032-9647-e5537b030cd9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_8ee3da54-9832-4bb4-8be3-4caa320d0aae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d1fab150-6dd9-4032-9647-e5537b030cd9" xlink:to="loc_us-gaap_HedgingRelationshipDomain_8ee3da54-9832-4bb4-8be3-4caa320d0aae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_fa87b3c3-26b7-44da-8631-bbbf21f46833" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8ee3da54-9832-4bb4-8be3-4caa320d0aae" xlink:to="loc_us-gaap_CashFlowHedgingMember_fa87b3c3-26b7-44da-8631-bbbf21f46833" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_5e0c62dd-e65b-4a29-a7a6-2727ba15fe78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8ee3da54-9832-4bb4-8be3-4caa320d0aae" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_5e0c62dd-e65b-4a29-a7a6-2727ba15fe78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_dc01a42c-8b7c-4f77-9c03-953d267351a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8ee3da54-9832-4bb4-8be3-4caa320d0aae" xlink:to="loc_us-gaap_FairValueHedgingMember_dc01a42c-8b7c-4f77-9c03-953d267351a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0b4acc26-ead6-4311-9c9a-c19ff39c0224" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_bee063bf-cea9-469d-86c3-ce811d146124" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0b4acc26-ead6-4311-9c9a-c19ff39c0224" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0b4acc26-ead6-4311-9c9a-c19ff39c0224_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0b4acc26-ead6-4311-9c9a-c19ff39c0224" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0b4acc26-ead6-4311-9c9a-c19ff39c0224_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d59b4d8f-ffc7-49c2-ab00-4fbba00f87ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0b4acc26-ead6-4311-9c9a-c19ff39c0224" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d59b4d8f-ffc7-49c2-ab00-4fbba00f87ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_5bad07bf-8350-4cf4-b4f8-2e5c4021e024" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d59b4d8f-ffc7-49c2-ab00-4fbba00f87ea" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_5bad07bf-8350-4cf4-b4f8-2e5c4021e024" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_27c9f0e1-c5dc-4914-8797-2d099addd934" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d59b4d8f-ffc7-49c2-ab00-4fbba00f87ea" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_27c9f0e1-c5dc-4914-8797-2d099addd934" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember_25807e53-fbd6-4134-930a-74cce9d41756" xlink:href="gehc-20250331.xsd#gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d59b4d8f-ffc7-49c2-ab00-4fbba00f87ea" xlink:to="loc_gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember_25807e53-fbd6-4134-930a-74cce9d41756" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_a964df62-01a3-4866-ae63-dd1d1e036beb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d59b4d8f-ffc7-49c2-ab00-4fbba00f87ea" xlink:to="loc_us-gaap_InterestRateSwapMember_a964df62-01a3-4866-ae63-dd1d1e036beb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember_6a86aa98-abdb-4228-88f4-aea1ceb5a45c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d59b4d8f-ffc7-49c2-ab00-4fbba00f87ea" xlink:to="loc_us-gaap_OtherContractMember_6a86aa98-abdb-4228-88f4-aea1ceb5a45c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_174474a9-f94c-45c7-88b2-053983e3d4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e95ae0c8-400a-4c4d-a99b-6ec26791f325" xlink:to="loc_us-gaap_DerivativeNotionalAmount_174474a9-f94c-45c7-88b2-053983e3d4cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_241b7e36-adff-46c9-8c60-99b643a41993" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e95ae0c8-400a-4c4d-a99b-6ec26791f325" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_241b7e36-adff-46c9-8c60-99b643a41993" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_78f1b581-13a1-43ed-b172-40215a526c80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e95ae0c8-400a-4c4d-a99b-6ec26791f325" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_78f1b581-13a1-43ed-b172-40215a526c80" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_35b0d792-d9d5-415e-ab33-5eafbc2dd1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a7442a33-692b-4c37-b2e1-b37e874c3377" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_35b0d792-d9d5-415e-ab33-5eafbc2dd1fa" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a7442a33-692b-4c37-b2e1-b37e874c3377" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_635e8e9d-e16a-49e5-81cd-f17b4576f6d5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a7442a33-692b-4c37-b2e1-b37e874c3377" xlink:to="loc_srt_ProductOrServiceAxis_635e8e9d-e16a-49e5-81cd-f17b4576f6d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_635e8e9d-e16a-49e5-81cd-f17b4576f6d5_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_635e8e9d-e16a-49e5-81cd-f17b4576f6d5" xlink:to="loc_srt_ProductsAndServicesDomain_635e8e9d-e16a-49e5-81cd-f17b4576f6d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4b228c91-1c32-4380-a82e-4e8671e8e695" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_635e8e9d-e16a-49e5-81cd-f17b4576f6d5" xlink:to="loc_srt_ProductsAndServicesDomain_4b228c91-1c32-4380-a82e-4e8671e8e695" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_76d07e49-a116-4616-8895-78c83eca1697" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4b228c91-1c32-4380-a82e-4e8671e8e695" xlink:to="loc_us-gaap_ProductMember_76d07e49-a116-4616-8895-78c83eca1697" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_4cd0ad63-7af3-4032-80ab-6f9e49631a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4b228c91-1c32-4380-a82e-4e8671e8e695" xlink:to="loc_us-gaap_ServiceMember_4cd0ad63-7af3-4032-80ab-6f9e49631a5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_661cc621-59b7-4223-a005-12ff0da2e8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a7442a33-692b-4c37-b2e1-b37e874c3377" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_661cc621-59b7-4223-a005-12ff0da2e8e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_661cc621-59b7-4223-a005-12ff0da2e8e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_661cc621-59b7-4223-a005-12ff0da2e8e5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_661cc621-59b7-4223-a005-12ff0da2e8e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_24304f7b-3196-4e86-85fa-b5845f98c899" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_661cc621-59b7-4223-a005-12ff0da2e8e5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_24304f7b-3196-4e86-85fa-b5845f98c899" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_b1b5d7ef-60f9-481e-ad0e-5a32d130b7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_24304f7b-3196-4e86-85fa-b5845f98c899" xlink:to="loc_us-gaap_CostOfSalesMember_b1b5d7ef-60f9-481e-ad0e-5a32d130b7aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3b08391e-5618-4e90-84df-5f98907abfa6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_24304f7b-3196-4e86-85fa-b5845f98c899" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3b08391e-5618-4e90-84df-5f98907abfa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_InterestAndDebtExpenseMember_8f48269e-f673-4a75-a52f-b52c2200e48d" xlink:href="gehc-20250331.xsd#gehc_InterestAndDebtExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_24304f7b-3196-4e86-85fa-b5845f98c899" xlink:to="loc_gehc_InterestAndDebtExpenseMember_8f48269e-f673-4a75-a52f-b52c2200e48d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b92be240-e0de-42e6-ac1c-c1560d0ef95c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_24304f7b-3196-4e86-85fa-b5845f98c899" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b92be240-e0de-42e6-ac1c-c1560d0ef95c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_9d99db8b-2893-4fb6-94a1-a1e9a54f18e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_24304f7b-3196-4e86-85fa-b5845f98c899" xlink:to="loc_us-gaap_InterestExpenseMember_9d99db8b-2893-4fb6-94a1-a1e9a54f18e5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_edd4ecbb-90e7-44f8-8ca8-a7c0961583bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a7442a33-692b-4c37-b2e1-b37e874c3377" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_edd4ecbb-90e7-44f8-8ca8-a7c0961583bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_edd4ecbb-90e7-44f8-8ca8-a7c0961583bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_edd4ecbb-90e7-44f8-8ca8-a7c0961583bf" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_edd4ecbb-90e7-44f8-8ca8-a7c0961583bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1fff678d-2a5e-44cd-b80d-6814f0f35718" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_edd4ecbb-90e7-44f8-8ca8-a7c0961583bf" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1fff678d-2a5e-44cd-b80d-6814f0f35718" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_9e54aee4-720f-4147-b975-eb6476e7f6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1fff678d-2a5e-44cd-b80d-6814f0f35718" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_9e54aee4-720f-4147-b975-eb6476e7f6c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_68557994-224f-45eb-81e1-ad0bf28770f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1fff678d-2a5e-44cd-b80d-6814f0f35718" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_68557994-224f-45eb-81e1-ad0bf28770f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember_c37ddb2f-9469-4505-bdeb-ea8ce3b5c2e9" xlink:href="gehc-20250331.xsd#gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1fff678d-2a5e-44cd-b80d-6814f0f35718" xlink:to="loc_gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember_c37ddb2f-9469-4505-bdeb-ea8ce3b5c2e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_56dbc1e2-ce43-4de8-84e3-42388e742517" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1fff678d-2a5e-44cd-b80d-6814f0f35718" xlink:to="loc_us-gaap_InterestRateSwapMember_56dbc1e2-ce43-4de8-84e3-42388e742517" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_DebtBasisAdjustmentLongTermBorrowingsMember_c8e784d6-1037-4818-8eef-7042782bdcad" xlink:href="gehc-20250331.xsd#gehc_DebtBasisAdjustmentLongTermBorrowingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1fff678d-2a5e-44cd-b80d-6814f0f35718" xlink:to="loc_gehc_DebtBasisAdjustmentLongTermBorrowingsMember_c8e784d6-1037-4818-8eef-7042782bdcad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember_02b6b2b1-e1c9-45b5-a6f2-370681393918" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1fff678d-2a5e-44cd-b80d-6814f0f35718" xlink:to="loc_us-gaap_OtherContractMember_02b6b2b1-e1c9-45b5-a6f2-370681393918" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_89396d8b-5e05-4baf-8110-e55a5a549b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_35b0d792-d9d5-415e-ab33-5eafbc2dd1fa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_89396d8b-5e05-4baf-8110-e55a5a549b8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_86377eff-d3f6-4b2e-b845-b46641c77771" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_35b0d792-d9d5-415e-ab33-5eafbc2dd1fa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_86377eff-d3f6-4b2e-b845-b46641c77771" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax_cf42b3a6-022f-4f0d-8392-e9dd34437429" xlink:href="gehc-20250331.xsd#gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_35b0d792-d9d5-415e-ab33-5eafbc2dd1fa" xlink:to="loc_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax_cf42b3a6-022f-4f0d-8392-e9dd34437429" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_708a35de-22bc-4cea-960f-6b47065818e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_35b0d792-d9d5-415e-ab33-5eafbc2dd1fa" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_708a35de-22bc-4cea-960f-6b47065818e8" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f78330e8-c7dc-40f3-adaf-de6dd6a78c56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a6e9d6e5-de64-4c9f-81de-6c2c052f6dee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f78330e8-c7dc-40f3-adaf-de6dd6a78c56" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a6e9d6e5-de64-4c9f-81de-6c2c052f6dee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7af9dae2-548d-4dc2-a7cb-b59d9973dbda" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a6e9d6e5-de64-4c9f-81de-6c2c052f6dee" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7af9dae2-548d-4dc2-a7cb-b59d9973dbda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7af9dae2-548d-4dc2-a7cb-b59d9973dbda_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7af9dae2-548d-4dc2-a7cb-b59d9973dbda" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7af9dae2-548d-4dc2-a7cb-b59d9973dbda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c35ab707-3511-4bc2-b8b0-d72647633749" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7af9dae2-548d-4dc2-a7cb-b59d9973dbda" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c35ab707-3511-4bc2-b8b0-d72647633749" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_115b6372-ad67-4ca3-a370-400e718e87e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c35ab707-3511-4bc2-b8b0-d72647633749" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_115b6372-ad67-4ca3-a370-400e718e87e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_721f6b2f-9423-44e2-9347-877f1b9a8f09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c35ab707-3511-4bc2-b8b0-d72647633749" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_721f6b2f-9423-44e2-9347-877f1b9a8f09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_e07c8873-25a4-46e7-8996-600c9562a9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c35ab707-3511-4bc2-b8b0-d72647633749" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_e07c8873-25a4-46e7-8996-600c9562a9e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8b1cf889-38c1-4783-a321-acd3ca75e5ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a6e9d6e5-de64-4c9f-81de-6c2c052f6dee" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8b1cf889-38c1-4783-a321-acd3ca75e5ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8b1cf889-38c1-4783-a321-acd3ca75e5ea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8b1cf889-38c1-4783-a321-acd3ca75e5ea" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8b1cf889-38c1-4783-a321-acd3ca75e5ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f93eea2f-d519-4c94-8276-e3b0f7db3f92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8b1cf889-38c1-4783-a321-acd3ca75e5ea" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f93eea2f-d519-4c94-8276-e3b0f7db3f92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_16c612ab-3199-4ad2-9a84-49babf216314" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f93eea2f-d519-4c94-8276-e3b0f7db3f92" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_16c612ab-3199-4ad2-9a84-49babf216314" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_bff6b4b6-e641-491f-a65e-6cc5ec31d9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a6e9d6e5-de64-4c9f-81de-6c2c052f6dee" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_bff6b4b6-e641-491f-a65e-6cc5ec31d9e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_bff6b4b6-e641-491f-a65e-6cc5ec31d9e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_bff6b4b6-e641-491f-a65e-6cc5ec31d9e2" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_bff6b4b6-e641-491f-a65e-6cc5ec31d9e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0b68f04d-4fe2-4b72-b699-3dd1bb92f09f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_bff6b4b6-e641-491f-a65e-6cc5ec31d9e2" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0b68f04d-4fe2-4b72-b699-3dd1bb92f09f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_a3afd924-3df9-40a0-b0bb-e3fd3ed9468a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0b68f04d-4fe2-4b72-b699-3dd1bb92f09f" xlink:to="loc_us-gaap_MoneyMarketFundsMember_a3afd924-3df9-40a0-b0bb-e3fd3ed9468a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_3fbd567b-e039-428e-bdbd-4949e7ff41cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f78330e8-c7dc-40f3-adaf-de6dd6a78c56" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_3fbd567b-e039-428e-bdbd-4949e7ff41cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_def7d519-c0f3-43bc-8e12-5e9c7ec8e9d2" xlink:href="gehc-20250331.xsd#gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_3fbd567b-e039-428e-bdbd-4949e7ff41cc" xlink:to="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_def7d519-c0f3-43bc-8e12-5e9c7ec8e9d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_072f13af-dfb1-4f77-9cc1-03c974b63eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_3fbd567b-e039-428e-bdbd-4949e7ff41cc" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_072f13af-dfb1-4f77-9cc1-03c974b63eaa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_2c7cf4e2-7901-4221-8adc-9f2a871db415" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_3fbd567b-e039-428e-bdbd-4949e7ff41cc" xlink:to="loc_us-gaap_DerivativeAssets_2c7cf4e2-7901-4221-8adc-9f2a871db415" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_abf3ef7c-cde5-4c0f-a8fb-b04d0596f4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f78330e8-c7dc-40f3-adaf-de6dd6a78c56" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_abf3ef7c-cde5-4c0f-a8fb-b04d0596f4b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_0277ab3f-401c-4e82-b81c-ab7e7bcb16ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_abf3ef7c-cde5-4c0f-a8fb-b04d0596f4b2" xlink:to="loc_us-gaap_DerivativeLiabilities_0277ab3f-401c-4e82-b81c-ab7e7bcb16ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_98cefc51-0d02-4e7d-9509-56e26a3087e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_abf3ef7c-cde5-4c0f-a8fb-b04d0596f4b2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_98cefc51-0d02-4e7d-9509-56e26a3087e8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_a751fa98-ab93-45a8-b7f2-d820b0dec5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f13a85ec-9437-4d10-b2f7-f7f4f8de9e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a751fa98-ab93-45a8-b7f2-d820b0dec5a7" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f13a85ec-9437-4d10-b2f7-f7f4f8de9e3d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_d46672e5-97f4-4338-b526-b9805e9d531b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f13a85ec-9437-4d10-b2f7-f7f4f8de9e3d" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_d46672e5-97f4-4338-b526-b9805e9d531b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_d46672e5-97f4-4338-b526-b9805e9d531b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_d46672e5-97f4-4338-b526-b9805e9d531b" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_d46672e5-97f4-4338-b526-b9805e9d531b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_eaf47a10-88b3-427d-9001-d3992d7d8e78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_d46672e5-97f4-4338-b526-b9805e9d531b" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_eaf47a10-88b3-427d-9001-d3992d7d8e78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_d5919d32-4a6d-4fdc-94d0-1ea52852124d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_eaf47a10-88b3-427d-9001-d3992d7d8e78" xlink:to="loc_us-gaap_EmployeeSeveranceMember_d5919d32-4a6d-4fdc-94d0-1ea52852124d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_259747d5-a03c-4cfe-8615-a6f7b23b7abd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FacilityClosingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_eaf47a10-88b3-427d-9001-d3992d7d8e78" xlink:to="loc_us-gaap_FacilityClosingMember_259747d5-a03c-4cfe-8615-a6f7b23b7abd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_ffe1dbc7-ee40-4830-be46-4bf45f89123b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a751fa98-ab93-45a8-b7f2-d820b0dec5a7" xlink:to="loc_us-gaap_RestructuringReserveRollForward_ffe1dbc7-ee40-4830-be46-4bf45f89123b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_d15f4537-8b55-4a96-a764-65c698b13931" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_ffe1dbc7-ee40-4830-be46-4bf45f89123b" xlink:to="loc_us-gaap_RestructuringReserve_d15f4537-8b55-4a96-a764-65c698b13931" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_25da25ef-8929-4842-9950-d5dd9a42ad94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_ffe1dbc7-ee40-4830-be46-4bf45f89123b" xlink:to="loc_us-gaap_RestructuringCharges_25da25ef-8929-4842-9950-d5dd9a42ad94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_cdeadd8f-2915-4b55-98cc-ad50912921dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCharges_25da25ef-8929-4842-9950-d5dd9a42ad94" xlink:to="loc_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_cdeadd8f-2915-4b55-98cc-ad50912921dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PaymentsForRestructuringAndOtherAdjustments_c7bdccee-916b-46c4-8035-7196fb09a781" xlink:href="gehc-20250331.xsd#gehc_PaymentsForRestructuringAndOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_ffe1dbc7-ee40-4830-be46-4bf45f89123b" xlink:to="loc_gehc_PaymentsForRestructuringAndOtherAdjustments_c7bdccee-916b-46c4-8035-7196fb09a781" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_31a1b207-cbea-4d5c-b58a-64af3c65ac2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserve"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4619f091-b14e-468d-aa1b-8f5468abd87e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9bb1a9f5-5890-4afc-ab24-3aba2935ce2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4619f091-b14e-468d-aa1b-8f5468abd87e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9bb1a9f5-5890-4afc-ab24-3aba2935ce2f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_790b4295-389a-4293-90a6-cfde74f99e92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9bb1a9f5-5890-4afc-ab24-3aba2935ce2f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_790b4295-389a-4293-90a6-cfde74f99e92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_790b4295-389a-4293-90a6-cfde74f99e92_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_790b4295-389a-4293-90a6-cfde74f99e92" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_790b4295-389a-4293-90a6-cfde74f99e92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f455999-35a1-4b79-a330-b88f2fe8eb82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_790b4295-389a-4293-90a6-cfde74f99e92" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f455999-35a1-4b79-a330-b88f2fe8eb82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_d4e61551-bad6-4813-81a9-705c4175612c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f455999-35a1-4b79-a330-b88f2fe8eb82" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_d4e61551-bad6-4813-81a9-705c4175612c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_BuildingsStructuresAndRelatedEquipmentMember_7c34b200-a801-4dc3-b905-d448d65eb2c6" xlink:href="gehc-20250331.xsd#gehc_BuildingsStructuresAndRelatedEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f455999-35a1-4b79-a330-b88f2fe8eb82" xlink:to="loc_gehc_BuildingsStructuresAndRelatedEquipmentMember_7c34b200-a801-4dc3-b905-d448d65eb2c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_c3e9512c-55a3-4a79-a1c6-fb49f0e6da1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f455999-35a1-4b79-a330-b88f2fe8eb82" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_c3e9512c-55a3-4a79-a1c6-fb49f0e6da1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_LeaseholdImprovementsAndManufacturingPlantsMember_c8b48b2a-2d42-42e9-87de-56eaf45c5415" xlink:href="gehc-20250331.xsd#gehc_LeaseholdImprovementsAndManufacturingPlantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f455999-35a1-4b79-a330-b88f2fe8eb82" xlink:to="loc_gehc_LeaseholdImprovementsAndManufacturingPlantsMember_c8b48b2a-2d42-42e9-87de-56eaf45c5415" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9d095d63-687d-47ee-a659-badabfe9d71d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4619f091-b14e-468d-aa1b-8f5468abd87e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_9d095d63-687d-47ee-a659-badabfe9d71d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_715ff2f2-4c0f-49a6-bf05-711ec7cac8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4619f091-b14e-468d-aa1b-8f5468abd87e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_715ff2f2-4c0f-49a6-bf05-711ec7cac8bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b4efe1fc-a2fb-40eb-9571-cdbe0ae7c321" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4619f091-b14e-468d-aa1b-8f5468abd87e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b4efe1fc-a2fb-40eb-9571-cdbe0ae7c321" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0559a071-6ff5-4b89-accb-b84a021cc2b6" xlink:href="gehc-20250331.xsd#gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4619f091-b14e-468d-aa1b-8f5468abd87e" xlink:to="loc_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0559a071-6ff5-4b89-accb-b84a021cc2b6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONNarrativeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramLineItems_a6a0709b-3144-4d04-b3d8-a80c5d5942cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramTable_a0a8d130-21fc-460e-a758-59374c30ce7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SupplierFinanceProgramLineItems_a6a0709b-3144-4d04-b3d8-a80c5d5942cb" xlink:to="loc_us-gaap_SupplierFinanceProgramTable_a0a8d130-21fc-460e-a758-59374c30ce7b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c6329f33-94a4-4c41-b8cc-33f76fde96f3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SupplierFinanceProgramTable_a0a8d130-21fc-460e-a758-59374c30ce7b" xlink:to="loc_srt_RangeAxis_c6329f33-94a4-4c41-b8cc-33f76fde96f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c6329f33-94a4-4c41-b8cc-33f76fde96f3_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c6329f33-94a4-4c41-b8cc-33f76fde96f3" xlink:to="loc_srt_RangeMember_c6329f33-94a4-4c41-b8cc-33f76fde96f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_44965ab4-c759-4e51-b998-20a04f6328f9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c6329f33-94a4-4c41-b8cc-33f76fde96f3" xlink:to="loc_srt_RangeMember_44965ab4-c759-4e51-b998-20a04f6328f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7e3124d1-a33b-4728-a037-894a01ae4e5d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_44965ab4-c759-4e51-b998-20a04f6328f9" xlink:to="loc_srt_MinimumMember_7e3124d1-a33b-4728-a037-894a01ae4e5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3149d786-e8c5-4615-b761-d327fd358c62" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_44965ab4-c759-4e51-b998-20a04f6328f9" xlink:to="loc_srt_MaximumMember_3149d786-e8c5-4615-b761-d327fd358c62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramPaymentTimingPeriod_fab74ca8-5506-4ce9-ab0d-aa28d1eed87a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramPaymentTimingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplierFinanceProgramLineItems_a6a0709b-3144-4d04-b3d8-a80c5d5942cb" xlink:to="loc_us-gaap_SupplierFinanceProgramPaymentTimingPeriod_fab74ca8-5506-4ce9-ab0d-aa28d1eed87a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligationCurrent_c5f82996-bdbe-4053-a129-8a9a3753869b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplierFinanceProgramLineItems_a6a0709b-3144-4d04-b3d8-a80c5d5942cb" xlink:to="loc_us-gaap_SupplierFinanceProgramObligationCurrent_c5f82996-bdbe-4053-a129-8a9a3753869b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration_299a9dd6-37e3-4b9f-b3fd-3f2266090dec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplierFinanceProgramObligationCurrent_c5f82996-bdbe-4053-a129-8a9a3753869b" xlink:to="loc_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration_299a9dd6-37e3-4b9f-b3fd-3f2266090dec" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:definitionLink xlink:role="http://www.gehealthcare.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_3f3167b6-a717-4d9c-b489-ad9099eca4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_d8ee6e44-e5cd-4d55-ae03-00352acd0296" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_3f3167b6-a717-4d9c-b489-ad9099eca4a7" xlink:to="loc_us-gaap_SubsequentEventTable_d8ee6e44-e5cd-4d55-ae03-00352acd0296" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_fa212c16-84f2-45b0-9f22-10260c2878f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_d8ee6e44-e5cd-4d55-ae03-00352acd0296" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_fa212c16-84f2-45b0-9f22-10260c2878f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_fa212c16-84f2-45b0-9f22-10260c2878f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fa212c16-84f2-45b0-9f22-10260c2878f7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_fa212c16-84f2-45b0-9f22-10260c2878f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3358e266-d04f-4a76-9c44-9a22d8c868ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fa212c16-84f2-45b0-9f22-10260c2878f7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3358e266-d04f-4a76-9c44-9a22d8c868ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_80878000-6047-4077-8a55-ce495625ec64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3358e266-d04f-4a76-9c44-9a22d8c868ea" xlink:to="loc_us-gaap_SubsequentEventMember_80878000-6047-4077-8a55-ce495625ec64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_3a85544b-5b92-4499-91f7-253f177a74ab" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_3f3167b6-a717-4d9c-b489-ad9099eca4a7" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_3a85544b-5b92-4499-91f7-253f177a74ab" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="loc_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="41"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>gehc-20250331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:d0a8a86e-df0d-464c-9ff8-447ea6f21cea,g:ade862ec-33b2-4b8a-bb85-176c06a683fa-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent_0bfc1764-1096-4e23-b359-b3fd23d0996c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivables &#8211; net of allowances of $106 and $103</link:label>
    <link:label id="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent_6e966fb8-e6ab-41d1-a7d4-bd806b0a35b7_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current receivables &#8211; net</link:label>
    <link:label id="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts and Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:to="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0d8050ec-68ca-425a-8384-6b1882287cca_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile Net income to Cash from (used for) operating activities</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_65d0b6fa-7a12-463e-942d-14f043839728_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_98f585a7-9f30-4bf7-9fb7-22323fd22259_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_011ece31-4f65-475b-9703-d9eb03efdb92_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt repayments</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_4ac692f9-dbfa-4cfb-9c0d-3f6515f9759b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligationCurrent_34db90e2-02d6-4de3-b72e-3e75442d0340_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplier finance program obligation</link:label>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligationCurrent_label_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplier Finance Program, Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierFinanceProgramObligationCurrent" xlink:to="lab_us-gaap_SupplierFinanceProgramObligationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameOtherMember_76525074-54da-41b7-8f67-cbfc43e9919c_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Pension Plans</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameOtherMember_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Plan Name, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanNameOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameOtherMember" xlink:to="lab_us-gaap_RetirementPlanNameOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b3191c9c-b9ec-43a6-9fa9-641fbc045b89_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_fc18a30c-31e2-485f-a7e3-69a8efc4754a_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">IPR&amp;D</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_c257b8f6-a566-4ab0-b246-ea6ab2ca77cb_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">International Plans</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_7097505e-d426-44fb-8215-d92886bff0c4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_5692dfe6-4d92-470e-8dc1-f70eb7950ca5_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">All other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_297a2583-bb37-4d01-9f8a-80396eabc0f6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percent of interest acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_a3f88364-d756-42ca-a954-d695f8445a82_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration_ee30eda4-7247-42a9-ab6f-b634dab2b7a6_terseLabel_en-US" xlink:label="lab_us-gaap_HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedged Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedged Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_de038844-9703-4c11-b718-13654c5e7800_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_32a17be4-9a67-457c-87ea-39d68a418689_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value hedges</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9354c8a8-77de-4c30-8c34-789b97333c46_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember_df5f01c7-3201-457b-832d-2bde760ed93d_terseLabel_en-US" xlink:label="lab_gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency forward and options contracts</link:label>
    <link:label id="lab_gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember_label_en-US" xlink:label="lab_gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Forward And Foreign Exchange Options [Member]</link:label>
    <link:label id="lab_gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember_documentation_en-US" xlink:label="lab_gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Foreign Exchange Forward And Foreign Exchange Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember" xlink:href="gehc-20250331.xsd#gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember" xlink:to="lab_gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_6eb5fbbe-5c46-4cf8-8cab-5d2aee6ca2dd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value &#8211; Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_32709099-c457-474b-8a8b-67a34154d86f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_87ddec3c-919f-4d71-adc6-2abe2197cf5c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends declared per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_e914d9e6-00ca-4fac-b699-6f0c8d47b595_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_e150d41a-c3e6-4dd7-b793-b5003d499739_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash paid during the year for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_c0311007-ecf0-430e-bba6-c4d9e7422160_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_c965c1ab-13ac-4b12-ac51-ede8d738d859_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_A6377SeniorNotesDue2052Member_03ef7d3e-ed7b-403d-bdef-9eb9a9ccd46b_terseLabel_en-US" xlink:label="lab_gehc_A6377SeniorNotesDue2052Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">6.377% senior notes due November 22, 2052</link:label>
    <link:label id="lab_gehc_A6377SeniorNotesDue2052Member_label_en-US" xlink:label="lab_gehc_A6377SeniorNotesDue2052Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">6.377% Senior Notes, Due 2052 [Member]</link:label>
    <link:label id="lab_gehc_A6377SeniorNotesDue2052Member_documentation_en-US" xlink:label="lab_gehc_A6377SeniorNotesDue2052Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">6.377% Senior Notes, Due 2052</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A6377SeniorNotesDue2052Member" xlink:href="gehc-20250331.xsd#gehc_A6377SeniorNotesDue2052Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_A6377SeniorNotesDue2052Member" xlink:to="lab_gehc_A6377SeniorNotesDue2052Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_bb26e2ce-96cf-45e5-90fc-b17b36372206_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_9b8491a2-5767-460e-8eaf-3f5a8e808d7b_periodStartLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_e818ba76-7f39-405f-9bdc-5c1ca20e3025_periodEndLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_1ac63eb6-b689-4d39-a7f4-f6de19a76144_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_ecdc6048-7947-4773-ac93-ccad522d3c04_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_a6eaee44-9608-4312-9cc6-79d8b1f7585e_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ORGANIZATION AND BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_935db967-5d1c-40d8-9cb8-f214a85fc5a3_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_fa56ce41-35e5-4ccd-bbdd-e548ea73e0bb_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net investment hedges</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivablesPeriodPastDueAxis_99d04f95-74c7-43ab-98ad-4e8b3b0a915e_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Asset, Aging [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivablesPeriodPastDueAxis_label_en-US" xlink:label="lab_us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Asset, Aging [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablesPeriodPastDueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:to="lab_us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFinancingReceivablesPastDueTable_fe9ed9f0-85fc-4a02-b06a-83a258d19a5e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFinancingReceivablesPastDueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing Receivable, Past Due [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFinancingReceivablesPastDueTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFinancingReceivablesPastDueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, Past Due [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivablesPastDueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFinancingReceivablesPastDueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivablesPastDueTable" xlink:to="lab_us-gaap_ScheduleOfFinancingReceivablesPastDueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_52495492-529d-453b-a756-16259ea18711_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of assumed obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Actuarial Gain (Loss), Immediate Recognition as Component in Net Periodic Benefit (Cost) Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_e5fd14c8-f354-4854-8152-908b38a8a98b_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_40319946-6ce2-4392-b631-8af0bffa28d8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_6635310b-51c8-494c-816b-8bc4e34c9bd5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_91ae8d77-2c34-4d75-b64c-0a1176b6a26d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_7231b228-57bd-4465-9b93-6b5c8ecf1dcd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_5b62285e-aa10-46e3-a970-b8a2db267289_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flow hedges</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_AVSSegmentMember_9c66db8f-3233-4571-82d2-6816537ef264_terseLabel_en-US" xlink:label="lab_gehc_AVSSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AVS</link:label>
    <link:label id="lab_gehc_AVSSegmentMember_label_en-US" xlink:label="lab_gehc_AVSSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AVS Segment [Member]</link:label>
    <link:label id="lab_gehc_AVSSegmentMember_documentation_en-US" xlink:label="lab_gehc_AVSSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AVS Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AVSSegmentMember" xlink:href="gehc-20250331.xsd#gehc_AVSSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_AVSSegmentMember" xlink:to="lab_gehc_AVSSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_0da59126-b932-4e87-84a4-25ecb56242cb_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_98e6e1b0-e5b7-4f31-8aa3-b8bc937b4f39_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">U.S. Plans</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_A5650SeniorNotesDue2027Member_7888ced7-e5d2-4879-81f6-ac502ddc189e_terseLabel_en-US" xlink:label="lab_gehc_A5650SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">5.650% senior notes due November 15, 2027</link:label>
    <link:label id="lab_gehc_A5650SeniorNotesDue2027Member_label_en-US" xlink:label="lab_gehc_A5650SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">5.650% Senior Notes, Due 2027 [Member]</link:label>
    <link:label id="lab_gehc_A5650SeniorNotesDue2027Member_documentation_en-US" xlink:label="lab_gehc_A5650SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">5.650% Senior Notes, Due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A5650SeniorNotesDue2027Member" xlink:href="gehc-20250331.xsd#gehc_A5650SeniorNotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_A5650SeniorNotesDue2027Member" xlink:to="lab_gehc_A5650SeniorNotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_75fed83d-bd9a-467c-abd3-2c3075faceee_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dilutive effect of common stock equivalents (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_dd7f8cfb-0f38-4bf4-922a-86aae00d71e0_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Service cost &#8211; Operating</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_fff2b5f4-36a1-4ba7-9f27-d495c0156ad2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_2c98c7c4-d084-4385-ae8f-c1395c4dd2a0_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">All other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_caa65d88-779d-4b3e-b241-ca2b573e2f13_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_4e40f34f-c65e-4260-a5a6-8a4cab14132a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-lived assets, gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_effda71e-11f7-41c3-b324-7f39400703f0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Asset, Finite-Lived [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_6df47e81-10a8-4c53-a308-da6936ab6dc5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Borrowings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_ac4317b2-1297-46a4-99ea-143642e3b870_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_60fad2d7-a2d9-4dcc-b03e-8a5269dc7367_terseLabel_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RECEIVABLES</link:label>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_9ab920b9-6c72-417c-9e8f-46eb29056fea_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_d848e1c2-bbd9-4332-b58b-dafaa5390345_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_191e9930-def5-4c91-bff6-14d9e5edfe25_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SG&amp;A</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_e8df7a96-6c5a-40ca-bf55-d3162aea7c90_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_ca332530-d972-4698-8e6a-794b25795a66_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash from (used for) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_61c50231-18e8-4e8e-ae9c-f82891d2e6d4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows - operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_347aa469-15e6-45d8-a59e-0abf9907e7bc_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_1f6c57ab-7fff-43c7-a582-704ca060d86a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_aebf4c38-4c79-4035-b137-bb0078d7b5b4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings per share attributable to GE HealthCare:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_0a126027-de38-4283-b115-491037bdcaba_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_3043cb2f-456e-42ed-919f-6a958e51dda6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_bd2cb88f-f469-421f-a346-607174864b52_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">All other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FacilityClosingMember_fee8b049-9639-461a-870d-d7ee9ba4963d_terseLabel_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Facility and other exit costs</link:label>
    <link:label id="lab_us-gaap_FacilityClosingMember_label_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FacilityClosingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FacilityClosingMember" xlink:to="lab_us-gaap_FacilityClosingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_10286ef7-81c3-41d1-8221-cf90a407216d_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net periodic expense (income)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_6e8e9f8f-5434-431c-bfe3-ffef969e45b7_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_aac63436-6da5-4fb5-bc64-cecf058fa144_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_0da9763e-68b2-4fee-a136-557634ac914d_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_ee983b99-3425-4a77-9db0-86b789ffa392_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ESTIMATES AND ASSUMPTIONS</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_053c80ad-a859-46e5-942b-092c06a16235_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_662dbeae-8419-449a-a217-162c61d84d8a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_c033d556-1985-4fa9-b84b-123c4cb3d6ed_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_ImagingSegmentMember_5fbbbcd7-99da-402b-b120-3884f045df35_terseLabel_en-US" xlink:label="lab_gehc_ImagingSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Imaging</link:label>
    <link:label id="lab_gehc_ImagingSegmentMember_label_en-US" xlink:label="lab_gehc_ImagingSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Imaging Segment [Member]</link:label>
    <link:label id="lab_gehc_ImagingSegmentMember_documentation_en-US" xlink:label="lab_gehc_ImagingSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Imaging Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ImagingSegmentMember" xlink:href="gehc-20250331.xsd#gehc_ImagingSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_ImagingSegmentMember" xlink:to="lab_gehc_ImagingSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0729e797-ca08-4a96-8fab-a5e9a825a1a7_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash investing activities</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent_5acf824a-5b8d-423b-af85-736d8bf2aa90_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Chargebacks</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Refund Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_253fa71a-6ebd-407b-b391-e2985ca2091d_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_8e3ac1d4-b548-4372-a2c6-7c0286a9c33a_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_76beb19c-297d-4849-b9d9-4f860f3a0e76_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring Activities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_275bcc96-1469-40f4-90be-024ab0484483_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration_5370257e-f98e-422b-9ead-b69a4b19cfbf_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredAbstract_593fea32-0df4-4739-b361-22057af04563_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_f12bcdb5-a87a-4284-8760-f2d0d3464a49_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Definite-lived intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_7cd916d6-7d5e-4f64-b963-90b992d25026_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_eb3d9f6d-afbf-425e-8694-4168dc6032ae_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All other non-current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f8bb5db0-661f-4d1c-9485-8d129a890e90_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent_e900a41c-5969-4376-80f7-98b34784f61f_terseLabel_en-US" xlink:label="lab_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Environmental and asset retirement obligations</link:label>
    <link:label id="lab_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent_label_en-US" xlink:label="lab_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Retirement Obligation And Accrued Environmental Loss Contingencies, Noncurrent</link:label>
    <link:label id="lab_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent_documentation_en-US" xlink:label="lab_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Retirement Obligation And Accrued Environmental Loss Contingencies, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent" xlink:href="gehc-20250331.xsd#gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent" xlink:to="lab_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_582be989-0ca2-43ad-a5e6-4c5c875123b9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Remaining Performance Obligations</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_2a9d4103-b024-4879-ad18-4a179cd9d0a0_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_368a55dc-2bb9-46d0-b52a-abc13f5d4c21_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents, and restricted cash at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_077d131a-fd5f-4773-9c41-aa2c86f89102_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents, and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_634c282d-6317-4c8b-9dfe-00bf227d65a4_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Cash Flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_21ab65ee-a6e8-4952-a6c9-168a583f1385_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit pension plan loss, reclassification adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a9ee5671-3280-454d-adb8-28a469e1fd09_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts and Financing Receivables [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_50efd3b3-7ab6-4e0f-95f1-3b0241958ea9_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_64a1efc3-a0f8-4a46-9794-472c7eb08797_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_3687db0d-6104-4e36-8829-15168636d2ca_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_aaba0feb-47c6-412a-b36a-3fb07488ad0c_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_cf94b1a5-b71e-4d81-8244-d6bc711c8c4f_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_17e068d9-7ec1-4db4-9e45-104f9d79f082_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_23c2932d-1d78-4a38-8fcb-94803128d15b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_01545ee3-5d06-4bf3-a6b1-cc703d609ecd_terseLabel_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share repurchase program, authorized amount</link:label>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Authorized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableNonaccrualPercentPastDue1_a6e8b932-d776-4e2c-a38d-c28e37e74baa_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableNonaccrualPercentPastDue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing receivable, nonaccrual, percent past due</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableNonaccrualPercentPastDue1_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableNonaccrualPercentPastDue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, Nonaccrual, Percent Past Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableNonaccrualPercentPastDue1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableNonaccrualPercentPastDue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableNonaccrualPercentPastDue1" xlink:to="lab_us-gaap_FinancingReceivableNonaccrualPercentPastDue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_5ffa1f23-769b-4047-b994-5fe1eecc3b0d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Expenditures</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_66073bb2-536b-4475-a6ba-a8bd7c0cbb47_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_332a3ed4-ca5a-4a67-a1bd-aba42e2bc621_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_74658d01-eeee-4334-8d00-759c4f3ee3b3_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansReceivableMember_a1ba95a4-1532-45c7-9344-5c47cfb70740_terseLabel_en-US" xlink:label="lab_us-gaap_LoansReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loans receivable, at amortized cost</link:label>
    <link:label id="lab_us-gaap_LoansReceivableMember_label_en-US" xlink:label="lab_us-gaap_LoansReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loans Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansReceivableMember" xlink:to="lab_us-gaap_LoansReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_cded3e6d-bd21-4019-8a85-3bceb032579e_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_93baee18-66fe-4baa-be05-008dda78569b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_2896519c-13de-4f2a-8edf-cb8a56c7c568_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_c7514787-f1a0-45bc-9ff3-0fc40c4b54f9_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation of property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_5d5d52b7-eb8c-4568-b87e-a16516940e3f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All other financing activities &#8211; net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_53ede14b-8d4a-4b72-92f4-233522698769_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income attributable to GE HealthCare</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_d159e465-d21e-435e-8919-872597863f3e_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Plans</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease_87a4508d-2666-4337-b45a-a91a15e1d1c7_terseLabel_en-US" xlink:label="lab_gehc_StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency exchange and other</link:label>
    <link:label id="lab_gehc_StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease_label_en-US" xlink:label="lab_gehc_StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Other Increase (Decrease)</link:label>
    <link:label id="lab_gehc_StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease_documentation_en-US" xlink:label="lab_gehc_StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Other Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease" xlink:href="gehc-20250331.xsd#gehc_StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease" xlink:to="lab_gehc_StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_0bfdbe67-507b-43ca-b8a9-1f0b44f84f7e_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_fff54cf9-27de-4695-91bf-c8f9830dc2ac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: Other comprehensive income (loss) attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_1d79edcb-caf9-4df8-99c4-40960cdd0053_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Initial allocation</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_8a35f9de-40a5-402e-8142-5567b5dd361f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_f2049d65-6929-4d3b-9ca8-56dd16d55d17_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCosts_1fc1badb-02bb-4cfe-82ea-516902a2d668_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current other deferred assets</link:label>
    <link:label id="lab_us-gaap_DeferredCosts_label_en-US" xlink:label="lab_us-gaap_DeferredCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Costs, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCosts" xlink:to="lab_us-gaap_DeferredCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_SupplierFinanceProgramPolicyPolicyTextBlock_41b3cace-720c-42c2-80ab-51550d024923_terseLabel_en-US" xlink:label="lab_gehc_SupplierFinanceProgramPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SUPPLY CHAIN FINANCE PROGRAMS</link:label>
    <link:label id="lab_gehc_SupplierFinanceProgramPolicyPolicyTextBlock_label_en-US" xlink:label="lab_gehc_SupplierFinanceProgramPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplier Finance Program, Policy [Policy Text Block]</link:label>
    <link:label id="lab_gehc_SupplierFinanceProgramPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_gehc_SupplierFinanceProgramPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Supplier Finance Program, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_SupplierFinanceProgramPolicyPolicyTextBlock" xlink:href="gehc-20250331.xsd#gehc_SupplierFinanceProgramPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_SupplierFinanceProgramPolicyPolicyTextBlock" xlink:to="lab_gehc_SupplierFinanceProgramPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_709df309-737c-4e62-a72f-36c7b8b468ef_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_7932f48a-d272-43ff-80ef-587d57667c6f_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_be8983c2-968b-4edf-9ead-767db87a50a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_b8f83542-3061-4f09-bd96-bb42b6e64099_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_d8d1b55e-dfa1-454b-a6d6-6b07fdfd5a7f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Less: Short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_3db06ce8-e8bc-43b2-b62a-a8e1c70e19f0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_SpinOffAndSeparationCosts_155eac7a-dedf-4f03-8b2a-896289cc0d0c_negatedTerseLabel_en-US" xlink:label="lab_gehc_SpinOffAndSeparationCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Spin-Off and separation costs</link:label>
    <link:label id="lab_gehc_SpinOffAndSeparationCosts_label_en-US" xlink:label="lab_gehc_SpinOffAndSeparationCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Spin-Off And Separation Costs</link:label>
    <link:label id="lab_gehc_SpinOffAndSeparationCosts_documentation_en-US" xlink:label="lab_gehc_SpinOffAndSeparationCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Spin-Off And Separation Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_SpinOffAndSeparationCosts" xlink:href="gehc-20250331.xsd#gehc_SpinOffAndSeparationCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_SpinOffAndSeparationCosts" xlink:to="lab_gehc_SpinOffAndSeparationCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_8703fbd1-ca96-4c59-b4b9-4e6a19bd168b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_d93e821e-3494-4471-a6b7-12fd2ef0946e_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2489588c-301a-4938-b793-7a32ef8a9a1e_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired finite-lived intangible assets, weighted average useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_4d7829c1-61f2-4f3b-953d-663ec17f9ced_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d5fc96be-fc0c-4d2d-a672-a92023cbccb4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows &#8211; investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_bf3d67b4-b8db-4e82-bed7-74f2bdc135d9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ca901bfa-f024-4c7d-a7e3-9931e70baada_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_90d81f25-4eb5-4ae0-83b9-6b3b1701505b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Assets at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Assets at Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_ba90181f-c4e8-4496-aafa-3540940702e0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_69c9fcd0-4860-446d-be8d-22be1bf87c10_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_b5e80100-d0a8-41d4-9695-9ede03f2e2a6_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Equity, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_e0cf8a85-57f7-440f-bedc-9f44d1e0ae95_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Equity, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_e1a7f639-c8d1-4ede-a0e0-07f31bf79704_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameDomain" xlink:to="lab_us-gaap_RetirementPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossNoncurrent_260de698-3bba-49d0-865b-79266a12bfa2_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term customer receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGrossNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossNoncurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_1270f1e7-24cc-481c-856b-ba384ba1b82c_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent_693536a8-47fb-4e9f-b532-3c4195d4ee4b_terseLabel_en-US" xlink:label="lab_gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales allowances and related liabilities</link:label>
    <link:label id="lab_gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Allowances And Related Liabilities, Noncurrent</link:label>
    <link:label id="lab_gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent_documentation_en-US" xlink:label="lab_gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sales Allowances And Related Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent" xlink:href="gehc-20250331.xsd#gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent" xlink:to="lab_gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_439987f7-eed4-4ec9-8cf4-ef010a6bf957_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities_fa018158-e6d2-4892-86c5-40fafbc7391d_terseLabel_en-US" xlink:label="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset retirement obligations and decommissioning liabilities assumed</link:label>
    <link:label id="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities_label_en-US" xlink:label="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Asset Retirement Obligations and Decommissioning Liabilities</link:label>
    <link:label id="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities_documentation_en-US" xlink:label="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Asset Retirement Obligations and Decommissioning Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities" xlink:href="gehc-20250331.xsd#gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities" xlink:to="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivablesPeriodPastDueDomain_c6ae70e2-4f1f-4a22-8cdc-40c5ba1e8747_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Asset, Aging [Domain]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivablesPeriodPastDueDomain_label_en-US" xlink:label="lab_us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Asset, Aging [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablesPeriodPastDueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:to="lab_us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_f9394c6e-6337-46c9-be25-a2126000eb28_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Restructuring costs</link:label>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_6966f4bb-c189-4cb6-8a40-836a487a13da_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total restructuring activities &#8211; net</link:label>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Costs and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_c56ef5f0-1527-4396-8fa5-b8acde033460_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_OtherNontradeReceivablesNoncurrent_796af035-75c2-4ae4-bf36-7cba30f7f5cd_terseLabel_en-US" xlink:label="lab_gehc_OtherNontradeReceivablesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other sundry receivables</link:label>
    <link:label id="lab_gehc_OtherNontradeReceivablesNoncurrent_label_en-US" xlink:label="lab_gehc_OtherNontradeReceivablesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nontrade Receivables, Noncurrent</link:label>
    <link:label id="lab_gehc_OtherNontradeReceivablesNoncurrent_documentation_en-US" xlink:label="lab_gehc_OtherNontradeReceivablesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Nontrade Receivables, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherNontradeReceivablesNoncurrent" xlink:href="gehc-20250331.xsd#gehc_OtherNontradeReceivablesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_OtherNontradeReceivablesNoncurrent" xlink:to="lab_gehc_OtherNontradeReceivablesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b425716d-612c-4081-9763-47e513c3bfa2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_314aafce-b13e-457e-ae44-9e8179b54bb4_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_430bb39f-4741-407b-abe5-e58e88b7effe_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_10dd00d6-311c-4f33-a910-ce45edce7735_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameAxis" xlink:to="lab_us-gaap_RetirementPlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_e27d6ab4-c348-423f-a45c-607a4bca1d23_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_37419441-050f-4138-94ab-8033c49627bb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForNotesAndLoansReceivableCurrent_e02c15a5-316b-4cc2-944a-4b2919e159a4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForNotesAndLoansReceivableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Allowance for credit losses, current</link:label>
    <link:label id="lab_us-gaap_AllowanceForNotesAndLoansReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForNotesAndLoansReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForNotesAndLoansReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForNotesAndLoansReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForNotesAndLoansReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForNotesAndLoansReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_cb134750-e34a-42d1-9601-0a40768f6579_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cfa0c38d-1ba1-4ba8-a9fd-beec8dc04048_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_352b396e-3a35-4ff5-af7a-58570f11b440_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash consideration, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_9b11339d-6cb4-4c42-959a-31eea560a964_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0e81063f-952d-4546-bc01-1dcc57f9f590_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3557b693-8795-41a0-87d6-7b8b793dcc5e_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Diluted weighted-average shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_e7ca6382-fb14-4062-8e7c-b691c01bbd2e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts_5a234d82-abc6-4b66-b8cb-b32c23918f52_negatedTerseLabel_en-US" xlink:label="lab_gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Contract and other deferred assets</link:label>
    <link:label id="lab_gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts_label_en-US" xlink:label="lab_gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Contract With Customer, Asset And Deferred Costs</link:label>
    <link:label id="lab_gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts_documentation_en-US" xlink:label="lab_gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Contract With Customer, Asset And Deferred Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts" xlink:href="gehc-20250331.xsd#gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts" xlink:to="lab_gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_948975de-2993-4b07-a4d5-4a80ebb3430d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_SeniorUnsecuredNotesMember_dbc41d8d-5668-483e-896e-f6fd3d9656fc_terseLabel_en-US" xlink:label="lab_gehc_SeniorUnsecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior unsecured notes</link:label>
    <link:label id="lab_gehc_SeniorUnsecuredNotesMember_label_en-US" xlink:label="lab_gehc_SeniorUnsecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes [Member]</link:label>
    <link:label id="lab_gehc_SeniorUnsecuredNotesMember_documentation_en-US" xlink:label="lab_gehc_SeniorUnsecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Unsecured Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_SeniorUnsecuredNotesMember" xlink:href="gehc-20250331.xsd#gehc_SeniorUnsecuredNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_SeniorUnsecuredNotesMember" xlink:to="lab_gehc_SeniorUnsecuredNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_b3fdb35e-cf5c-48d3-8c21-5c398eacc16a_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total equity attributable to GE HealthCare</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_8ab1d2c7-edc6-484e-85dd-d8b72a81f8c5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Amortization of net loss (gain)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_c12e88a1-f181-468e-8646-2369e5e1059a_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_9fe74c04-e181-48df-8530-d311c6e169cc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsCurrent" xlink:to="lab_us-gaap_DerivativeAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_4d33a5c6-9cef-451f-a9a9-9539120c77ad_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effects of cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_e17d5975-d0ac-4a44-a5c3-ddcd8b61526a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_A4.800SeniorNotesDue2029Member_b1f4bc07-c0e1-469d-a445-bba73a863eb8_terseLabel_en-US" xlink:label="lab_gehc_A4.800SeniorNotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">4.800% senior notes due August 14, 2029</link:label>
    <link:label id="lab_gehc_A4.800SeniorNotesDue2029Member_label_en-US" xlink:label="lab_gehc_A4.800SeniorNotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">4.800% Senior Notes, Due 2029 [Member]</link:label>
    <link:label id="lab_gehc_A4.800SeniorNotesDue2029Member_documentation_en-US" xlink:label="lab_gehc_A4.800SeniorNotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">4.800% Senior Notes, Due 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A4.800SeniorNotesDue2029Member" xlink:href="gehc-20250331.xsd#gehc_A4.800SeniorNotesDue2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_A4.800SeniorNotesDue2029Member" xlink:to="lab_gehc_A4.800SeniorNotesDue2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_c7f8d378-9056-43bf-84f5-54bbd9b49418_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net financing income and investment income (loss)</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_53e7df60-2884-4238-8b24-8bb733f0486c_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general, and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0b2e3d05-f24d-4eb8-9145-acdd2d166074_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss) attributable to GE HealthCare</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_f6692204-3842-4263-a8b0-4b0099608275_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_PrepaidExpensesAndDeferredCostsCurrent_7d993601-4f06-4a04-b1e9-7e4a1f790d87_terseLabel_en-US" xlink:label="lab_gehc_PrepaidExpensesAndDeferredCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and deferred costs</link:label>
    <link:label id="lab_gehc_PrepaidExpensesAndDeferredCostsCurrent_label_en-US" xlink:label="lab_gehc_PrepaidExpensesAndDeferredCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expenses And Deferred Costs, Current</link:label>
    <link:label id="lab_gehc_PrepaidExpensesAndDeferredCostsCurrent_documentation_en-US" xlink:label="lab_gehc_PrepaidExpensesAndDeferredCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prepaid Expenses And Deferred Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PrepaidExpensesAndDeferredCostsCurrent" xlink:href="gehc-20250331.xsd#gehc_PrepaidExpensesAndDeferredCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_PrepaidExpensesAndDeferredCostsCurrent" xlink:to="lab_gehc_PrepaidExpensesAndDeferredCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_fc96bf82-d526-43a9-a8bf-805d24667078_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_28a189a7-5424-449c-8caa-e35515170912_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product</link:label>
    <link:label id="lab_us-gaap_ProductMember_207b775c-aa90-4e22-86e1-b794ccb485d8_verboseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Products</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_BuildingsStructuresAndRelatedEquipmentMember_f58f6bc4-389e-42c2-aa45-934fc3a3ef17_terseLabel_en-US" xlink:label="lab_gehc_BuildingsStructuresAndRelatedEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Buildings, structures, and related equipment</link:label>
    <link:label id="lab_gehc_BuildingsStructuresAndRelatedEquipmentMember_label_en-US" xlink:label="lab_gehc_BuildingsStructuresAndRelatedEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Buildings, Structures And Related Equipment [Member]</link:label>
    <link:label id="lab_gehc_BuildingsStructuresAndRelatedEquipmentMember_documentation_en-US" xlink:label="lab_gehc_BuildingsStructuresAndRelatedEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Buildings, Structures And Related Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_BuildingsStructuresAndRelatedEquipmentMember" xlink:href="gehc-20250331.xsd#gehc_BuildingsStructuresAndRelatedEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_BuildingsStructuresAndRelatedEquipmentMember" xlink:to="lab_gehc_BuildingsStructuresAndRelatedEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_642748bc-3c65-47c5-96f9-31455e089716_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total borrowings</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_759b50af-9fb9-47d9-b3c9-6ed370e89424_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_4cba3fc6-48c5-4fa5-9bfb-6a5006dd3248_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current customer receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_0bea6ef1-34c7-4999-8410-a0d4190ea97a_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in equity attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:to="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_e87d9c1b-4c99-4f59-9551-942e6464affe_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_21b650e8-103c-414c-a654-02749d5b0eb1_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_9f803fc4-fa4b-4839-a7de-cb7eb544c27d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_b2e7d05c-0ea2-4300-8ca8-c61aef00a9a4_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_8c90f518-446e-4adf-a6b0-ae542f857c3e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_4aaec202-fae5-4827-bb91-f18f4dfcded6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_de8b3632-c0d8-4279-b103-f9be1ac66d4f_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized software</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_NihonMediPhysicsCo.LtdNMPMember_e4c8d7cf-4b34-465f-8eb5-da0430791375_terseLabel_en-US" xlink:label="lab_gehc_NihonMediPhysicsCo.LtdNMPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nihon Medi-Physics</link:label>
    <link:label id="lab_gehc_NihonMediPhysicsCo.LtdNMPMember_label_en-US" xlink:label="lab_gehc_NihonMediPhysicsCo.LtdNMPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nihon Medi-Physics Co., Ltd (&#8220;NMP&#8221;) [Member]</link:label>
    <link:label id="lab_gehc_NihonMediPhysicsCo.LtdNMPMember_documentation_en-US" xlink:label="lab_gehc_NihonMediPhysicsCo.LtdNMPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Nihon Medi-Physics Co., Ltd (&#8220;NMP&#8221;)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_NihonMediPhysicsCo.LtdNMPMember" xlink:href="gehc-20250331.xsd#gehc_NihonMediPhysicsCo.LtdNMPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_NihonMediPhysicsCo.LtdNMPMember" xlink:to="lab_gehc_NihonMediPhysicsCo.LtdNMPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_MonitoringSolutionsSubsegmentMember_0b22047b-8b53-4677-a3a5-c2ca89965da2_terseLabel_en-US" xlink:label="lab_gehc_MonitoringSolutionsSubsegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Monitoring Solutions</link:label>
    <link:label id="lab_gehc_MonitoringSolutionsSubsegmentMember_label_en-US" xlink:label="lab_gehc_MonitoringSolutionsSubsegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Monitoring Solutions Subsegment [Member]</link:label>
    <link:label id="lab_gehc_MonitoringSolutionsSubsegmentMember_documentation_en-US" xlink:label="lab_gehc_MonitoringSolutionsSubsegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Monitoring Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_MonitoringSolutionsSubsegmentMember" xlink:href="gehc-20250331.xsd#gehc_MonitoringSolutionsSubsegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_MonitoringSolutionsSubsegmentMember" xlink:to="lab_gehc_MonitoringSolutionsSubsegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1ca847d2-8b96-40ca-b06e-c61eb611b903_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax_978f720e-a598-4ad7-8c64-dc60b7b6bf89_terseLabel_en-US" xlink:label="lab_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation gain, reclassification adjustment</link:label>
    <link:label id="lab_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax_label_en-US" xlink:label="lab_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Net of Tax</link:label>
    <link:label id="lab_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax_documentation_en-US" xlink:label="lab_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax" xlink:href="gehc-20250331.xsd#gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax" xlink:to="lab_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_e1ca1e0c-6dfa-44d8-8492-0810884a8f84_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Contract and Other Deferred Assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_ea2116d4-afff-4d36-bf90-63ddc5b48e65_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c63c3fdc-efc9-4c85-8382-98895cd085ac_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_62ce077e-e845-409c-b43f-cb94e86b10a1_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:to="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_74f91a7b-1d81-4a25-b71c-b04e38650c6c_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_e56ea2f9-8271-4200-bbf2-87172fd8a06f_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_8633a48c-a5e7-4214-8aa9-43dbb2a3a1c8_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of acquisition-related intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_ContingentConsiderationPurchasePriceMember_ac5d8506-72a6-484c-9733-241650592741_terseLabel_en-US" xlink:label="lab_gehc_ContingentConsiderationPurchasePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase price</link:label>
    <link:label id="lab_gehc_ContingentConsiderationPurchasePriceMember_label_en-US" xlink:label="lab_gehc_ContingentConsiderationPurchasePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration, Purchase Price [Member]</link:label>
    <link:label id="lab_gehc_ContingentConsiderationPurchasePriceMember_documentation_en-US" xlink:label="lab_gehc_ContingentConsiderationPurchasePriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Consideration, Purchase Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ContingentConsiderationPurchasePriceMember" xlink:href="gehc-20250331.xsd#gehc_ContingentConsiderationPurchasePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_ContingentConsiderationPurchasePriceMember" xlink:to="lab_gehc_ContingentConsiderationPurchasePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_16e69a19-3999-48c1-a240-19331bb566d5_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierFinanceProgramPaymentTimingPeriod_ca975c18-1c9b-4670-a731-541f2bfbca32_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramPaymentTimingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplier finance program, payment terms</link:label>
    <link:label id="lab_us-gaap_SupplierFinanceProgramPaymentTimingPeriod_label_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramPaymentTimingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplier Finance Program, Payment Timing, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramPaymentTimingPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramPaymentTimingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierFinanceProgramPaymentTimingPeriod" xlink:to="lab_us-gaap_SupplierFinanceProgramPaymentTimingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_ef152f21-3667-4252-9607-dd29249e10c2_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Finite-lived assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_ReceivablesNetNoncurrent_0d091103-3e2a-4d0b-a7b5-e404e6ae26dc_totalLabel_en-US" xlink:label="lab_gehc_ReceivablesNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total long-term receivables &#8211; net</link:label>
    <link:label id="lab_gehc_ReceivablesNetNoncurrent_label_en-US" xlink:label="lab_gehc_ReceivablesNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables, Net, Noncurrent</link:label>
    <link:label id="lab_gehc_ReceivablesNetNoncurrent_documentation_en-US" xlink:label="lab_gehc_ReceivablesNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Receivables, Net, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ReceivablesNetNoncurrent" xlink:href="gehc-20250331.xsd#gehc_ReceivablesNetNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_ReceivablesNetNoncurrent" xlink:to="lab_gehc_ReceivablesNetNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_3b7681b7-347e-4ccf-ad2f-1173a30bd837_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_7bdef1d6-14aa-48fc-a0b6-06d3f9bdf6d1_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income attributable to redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_A5600SeniorNotesDue2025Member_b395de42-8e99-470d-80a1-f62c22432470_terseLabel_en-US" xlink:label="lab_gehc_A5600SeniorNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">5.600% senior notes due November 15, 2025</link:label>
    <link:label id="lab_gehc_A5600SeniorNotesDue2025Member_label_en-US" xlink:label="lab_gehc_A5600SeniorNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">5.600% Senior Notes, Due 2025 [Member]</link:label>
    <link:label id="lab_gehc_A5600SeniorNotesDue2025Member_documentation_en-US" xlink:label="lab_gehc_A5600SeniorNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">5.600% Senior Notes, Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A5600SeniorNotesDue2025Member" xlink:href="gehc-20250331.xsd#gehc_A5600SeniorNotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_A5600SeniorNotesDue2025Member" xlink:to="lab_gehc_A5600SeniorNotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_45b4114e-8dc4-4af9-979f-5835262e2590_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_495dd2f8-e0aa-49b7-98f6-084be0d90f53_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_311d6aac-5673-437f-bd8c-20bd5e7b5b09_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_da624f49-96c0-4b1a-a099-8d81a11cf1d4_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_MIMSoftwareMember_a1aa1ae1-acc9-489c-9697-49ef08874be4_terseLabel_en-US" xlink:label="lab_gehc_MIMSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MIM Software</link:label>
    <link:label id="lab_gehc_MIMSoftwareMember_label_en-US" xlink:label="lab_gehc_MIMSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MIM Software [Member]</link:label>
    <link:label id="lab_gehc_MIMSoftwareMember_documentation_en-US" xlink:label="lab_gehc_MIMSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">MIM Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_MIMSoftwareMember" xlink:href="gehc-20250331.xsd#gehc_MIMSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_MIMSoftwareMember" xlink:to="lab_gehc_MIMSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Award Types</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_81492b6a-4943-4568-8d72-045b5af702eb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of previously held interest in NMP</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_2dc12e20-6d6e-4767-9688-797976da1b06_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss) before reclass, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_762a1534-4ba0-4418-b2c2-62c24556c578_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of shares under equity awards, net of shares withheld for taxes and other (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b5c567b5-eb5d-4aa4-93ac-bffd803c4c50_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total net assets post acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_02cbf04d-0add-4fdc-a5ed-5471cb261def_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current compensation and benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_93d15c54-d24a-423e-a45c-3046848b27b8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_111806ec-723a-4b64-b59a-14f0d6dbc9c6_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_3fbd05d8-fd8f-4e9d-9395-3bf8b84d7dc1_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_2d15f027-91b7-43e0-be8b-96d6956bc811_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_53d20e7f-0e69-4a9c-96cd-63c88e638770_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_410606ca-8f19-4662-8a81-d33aedbffa5c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Receivables</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_adaefd1e-8b27-41ce-a519-a1e9fba576e9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_c880ca51-319b-4e62-b1e1-ec3b66e572fa_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">POSTRETIREMENT BENEFIT PLANS</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_fc0fd39d-ebf7-4024-bdfd-30b20be38420_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0d827fbc-3359-43d8-877e-cfd6e0534f16_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_cf2f7a6d-73dd-428e-a8cb-2c9a7b79798a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_PDxSegmentMember_443ce7f6-d169-426c-88fb-a20cb3bda80f_terseLabel_en-US" xlink:label="lab_gehc_PDxSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PDx</link:label>
    <link:label id="lab_gehc_PDxSegmentMember_label_en-US" xlink:label="lab_gehc_PDxSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PDx Segment [Member]</link:label>
    <link:label id="lab_gehc_PDxSegmentMember_documentation_en-US" xlink:label="lab_gehc_PDxSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PDx Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PDxSegmentMember" xlink:href="gehc-20250331.xsd#gehc_PDxSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_PDxSegmentMember" xlink:to="lab_gehc_PDxSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f2f3bea8-3bec-4e73-ac99-389d71608ad7_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RECENT ACCOUNTING PRONOUNCEMENTS</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_89b47d90-6069-4746-8539-024d51a3b474_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of prior service cost (credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_dbac084f-d875-4ed4-adaa-bf2ae6fed55c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_bd7f4f0d-1e5f-4aca-b7b4-a44955e2705e_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4a9a6bfa-f772-4ce9-9012-17c16d6e337b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_971500f0-c1b6-447c-9b15-88150a72d01a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_e9012b22-1593-414b-8e4f-e8e0fe8bbc04_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_89c12153-5eee-4f08-b154-9d5feed3f70e_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_ab7a8858-b28f-48e1-834a-645fea71ad6a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValueAddedTaxReceivableCurrent_0f2b2971-1834-44c8-ba7a-25f419de1564_terseLabel_en-US" xlink:label="lab_us-gaap_ValueAddedTaxReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-income based tax receivables</link:label>
    <link:label id="lab_us-gaap_ValueAddedTaxReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_ValueAddedTaxReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Value Added Tax Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValueAddedTaxReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValueAddedTaxReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValueAddedTaxReceivableCurrent" xlink:to="lab_us-gaap_ValueAddedTaxReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_A5905SeniorNotesDue2032Member_b8cae897-7bd8-4cc8-b8e2-7411e6759aba_terseLabel_en-US" xlink:label="lab_gehc_A5905SeniorNotesDue2032Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">5.905% senior notes due November 22, 2032</link:label>
    <link:label id="lab_gehc_A5905SeniorNotesDue2032Member_label_en-US" xlink:label="lab_gehc_A5905SeniorNotesDue2032Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">5.905% Senior Notes, Due 2032 [Member]</link:label>
    <link:label id="lab_gehc_A5905SeniorNotesDue2032Member_documentation_en-US" xlink:label="lab_gehc_A5905SeniorNotesDue2032Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">5.905% Senior Notes, Due 2032</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A5905SeniorNotesDue2032Member" xlink:href="gehc-20250331.xsd#gehc_A5905SeniorNotesDue2032Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_A5905SeniorNotesDue2032Member" xlink:to="lab_gehc_A5905SeniorNotesDue2032Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NontradeReceivablesCurrent_8d3e1e97-ff49-4b10-a39f-dd3591db3156_totalLabel_en-US" xlink:label="lab_us-gaap_NontradeReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Current sundry receivables</link:label>
    <link:label id="lab_us-gaap_NontradeReceivablesCurrent_label_en-US" xlink:label="lab_us-gaap_NontradeReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nontrade Receivables, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NontradeReceivablesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NontradeReceivablesCurrent" xlink:to="lab_us-gaap_NontradeReceivablesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_fa362e43-638a-49c1-b67a-a3c96a7af62c_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_63df82de-6abb-452b-925a-83a262939fb0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_033f994f-70df-41bf-8127-c312745fb17e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee termination costs</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_0121c59f-ce94-4887-902f-30023b8c5218_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RESTRUCTURING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent_a9da187b-159c-4cee-829f-9248c46d52d3_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product warranties</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Warranty Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:to="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_0fecf85e-c7a5-412b-b519-4d22fad86d40_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_769e0def-5ee4-4405-bcec-6bf044886221_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_596345b3-a6d0-465a-8b7a-895c7f6b287b_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_95970fd1-ff8f-41db-a5df-18031ee942e6_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_4b3d6d26-2b56-4389-a182-a18a8375e392_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f3fd8dc2-80be-4f66-8c90-88a2c2345c3f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension and Other Postretirement Plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_8f08eb73-56a8-41cb-b919-d0ecc94ff5d7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_d3a851e5-da7a-4892-81a1-42a294d57ee0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effects of derivatives not designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_48944378-7d0a-4786-ba71-519c929f5197_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Benefit (provision) for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_66088dd5-1ebb-4ea6-8545-8991507fa924_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_533ca071-8998-41a1-af16-df271ba0221b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NontradeReceivablesNoncurrent_6cb4a080-de0b-4406-821f-69d9d18d8e90_totalLabel_en-US" xlink:label="lab_us-gaap_NontradeReceivablesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Long-term sundry receivables</link:label>
    <link:label id="lab_us-gaap_NontradeReceivablesNoncurrent_label_en-US" xlink:label="lab_us-gaap_NontradeReceivablesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nontrade Receivables, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NontradeReceivablesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NontradeReceivablesNoncurrent" xlink:to="lab_us-gaap_NontradeReceivablesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_20647a97-cb85-48dc-8e35-7451636f4b23_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_69f80f0f-4c67-46f0-baa6-a4612fba33bb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Notional</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_cf95b4a5-1dd4-4724-a35f-591f470f009a_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_ad5d201d-686c-4896-8d16-30b9a7dcf316_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_c49ed167-33d9-442f-bf79-ee7db4cb3be6_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosure of cash flows information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_12b8eedc-2464-42f0-92f5-481e80cc9dc2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_9499aff1-928d-40f8-9a73-df6d4d6e4924_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Pre-tax Gains (Losses) Recognized in OCI</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_0aaaab3c-3789-4c93-9adf-143801d366fa_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_6f065e30-abb9-4977-a796-4e3fc0ff81c0_verboseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_e9556da8-6506-42d0-b754-e918dd138268_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9539c247-6991-44ac-bdcf-59c6c1ff882f_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_59dcab93-d322-4bc9-9c1c-93f21c48311f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash from (used for) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_bfd6edf2-fb1b-49f7-ba5a-59bd60c5a936_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_ac94f628-ac5c-4227-abb6-7a30f96b084a_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_InterestAndDebtExpenseMember_d3feea17-520d-49bc-8621-bb4f157350ed_terseLabel_en-US" xlink:label="lab_gehc_InterestAndDebtExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest and other financial charges &#8211; net</link:label>
    <link:label id="lab_gehc_InterestAndDebtExpenseMember_label_en-US" xlink:label="lab_gehc_InterestAndDebtExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest and Debt Expense [Member]</link:label>
    <link:label id="lab_gehc_InterestAndDebtExpenseMember_documentation_en-US" xlink:label="lab_gehc_InterestAndDebtExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest and Debt Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_InterestAndDebtExpenseMember" xlink:href="gehc-20250331.xsd#gehc_InterestAndDebtExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_InterestAndDebtExpenseMember" xlink:to="lab_gehc_InterestAndDebtExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_5a3826d0-07a0-4036-b638-03e739e55147_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_e22f5479-c075-4fae-a6ec-dffbed89ff69_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_2bfb4edc-1f5a-4c7f-b623-d72b8950c494_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities, redeemable noncontrolling interests, and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_2badb54d-af3a-47ce-af2e-bedda4981569_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All other operating activities &#8211; net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_c540d290-b689-4d6c-8224-c995c97c4f9a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Dividends_d2c5e8bf-135f-4054-819d-18a0c316ce37_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_Dividends_label_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Dividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends" xlink:to="lab_us-gaap_Dividends" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_56dcf113-1401-4efd-8eb3-2191a01b8f43_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_bc1768ba-027a-4e6a-b77d-391e9cd72993_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_da3a5dcc-8140-4e5f-82dc-943d0592a558_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_53ede89f-9615-4bcf-aeef-0b16dd61e639_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_39a655cf-9e93-4c35-bc71-7e3512fe6d7c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_d719e296-b359-4932-abf9-f7e0a64b766f_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Guarantor obligations, maximum exposure</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Guarantor Obligations, Maximum Exposure, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:to="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_d64b65f8-443e-4ebc-8350-b74282183ebf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Income (Expense)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_70010969-bc65-44f4-9115-24d4c7ac6022_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1ba187fb-edc4-412e-b6ea-e3e8e9482da3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_51647875-f464-4df4-9fcd-1757024f30bb_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedge_6e98f66e-887b-4ddb-b9a0-269390d68e06_terseLabel_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term borrowings designated in fair value hedges</link:label>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedge_label_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedged Liability, Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedge" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgedLiabilityFairValueHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgedLiabilityFairValueHedge" xlink:to="lab_us-gaap_HedgedLiabilityFairValueHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_eaa8f042-4605-49e2-9d64-201e96abbea2_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_6f2f590b-5bb7-4daa-a2c1-218715597c3a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Dividends paid to stockholders</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_401fea7a-a7d8-460d-a5a1-999dc0779247_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_dfc23e69-8184-4745-9c6c-7e68fd80497c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_638d9abc-c726-4da1-9165-6c8ed903c23f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive income (loss) &#8211; net</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold_ef0d442f-0a3b-47c2-b26b-9de954da8ede_terseLabel_en-US" xlink:label="lab_gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan asset or obligation reporting threshold</link:label>
    <link:label id="lab_gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold_label_en-US" xlink:label="lab_gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Asset Or Obligation, Reporting Threshold</link:label>
    <link:label id="lab_gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold_documentation_en-US" xlink:label="lab_gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Asset Or Obligation, Reporting Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold" xlink:href="gehc-20250331.xsd#gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold" xlink:to="lab_gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_92e1b505-cf5e-4d03-894c-2f305c1ac275_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_084278a7-19be-42be-8da9-58d747fa7209_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining performance obligation, period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_9f310a30-2d72-467d-90db-9a2b347e0335_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flow hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_e40acefa-2061-4d09-a80f-b408740adeca_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_c8989b33-4942-40e5-afee-9b2ca515e46a_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_8f5d1bb9-c4cc-4855-9900-a43bf5e1ef7a_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_6a16ca3d-6f71-4226-8482-adb6a25d6beb_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_e4c9cddd-24c3-40cc-9b23-ab07690f0c3c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_68bfff92-00a3-4d7b-9855-691269462f92_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_a678f704-6256-4dbc-97c0-11e74546ee80_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_301fe1cf-88c9-4c8d-ae2b-86c00f64edd3_terseLabel_en-US" xlink:label="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-operating benefit (income) costs</link:label>
    <link:label id="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_2d96f8bc-2afa-4ec7-a06e-46ba513b6221_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Non-operating benefit income (costs)</link:label>
    <link:label id="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_5b7742e0-b8ef-4d42-88e2-38363a9e29ad_totalLabel_en-US" xlink:label="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Non-operating</link:label>
    <link:label id="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_label_en-US" xlink:label="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:to="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_fcd9fdee-1279-4636-a597-e7f17712c417_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_6d6c9012-578f-4bfa-8c66-47b531edfbf8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_2d1d8de8-ffc7-460a-8d7f-638023cc6db0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_a0db0e87-aff0-4901-9aeb-6b05f2bd7140_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_a9d6aea8-ae3d-4ede-a301-a0d6abcefe8e_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total allocable purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_cd729a32-a607-4c1d-8f23-55ee4eafde39_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit plan, liability</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_3ce7ad9c-425b-49a8-b5e0-32e3835c9685_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Components of Net Periodic Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_8c82591e-7d3b-41c4-bf58-a1a3a608f793_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts and Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_9451519b-6e90-4702-a04a-d481e44c1b4f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives and Fair Value [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:to="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_809abd53-4358-40d5-9fde-82d06bad0501_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: Unamortized debt issuance costs and discounts</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_FinanceLeaseReceivableMember_c80cad1b-5acc-437e-879c-a10da21e40e3_terseLabel_en-US" xlink:label="lab_gehc_FinanceLeaseReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment in finance leases, net of deferred income</link:label>
    <link:label id="lab_gehc_FinanceLeaseReceivableMember_label_en-US" xlink:label="lab_gehc_FinanceLeaseReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease Receivable [Member]</link:label>
    <link:label id="lab_gehc_FinanceLeaseReceivableMember_documentation_en-US" xlink:label="lab_gehc_FinanceLeaseReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finance Lease Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_FinanceLeaseReceivableMember" xlink:href="gehc-20250331.xsd#gehc_FinanceLeaseReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_FinanceLeaseReceivableMember" xlink:to="lab_gehc_FinanceLeaseReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent_d0f01060-2c98-42bc-ac9a-934547a065cf_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_d4e24282-6864-49cc-9d7c-8e2ff57feb21_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseNoncurrent_9db54aa4-9320-46e3-b634-988183be8bb9_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid pension asset</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseNoncurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseNoncurrent" xlink:to="lab_us-gaap_PrepaidExpenseNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_d6be4542-00d6-4971-ada9-3b52d978cd07_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_f1ebba7a-30aa-4681-a260-a9d07a2ffa87_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0bec766d-c537-495c-94bf-63f1065b4deb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent_a4782c3d-b217-49b2-b70b-93cdb8c9d41d_terseLabel_en-US" xlink:label="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract and other deferred assets</link:label>
    <link:label id="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent_701c9165-74f5-4afb-becc-db37c285dd84_totalLabel_en-US" xlink:label="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Contract and other deferred assets</link:label>
    <link:label id="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent_label_en-US" xlink:label="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract With Customer, Asset, After Allowance For Credit Loss And Deferred Costs, Current</link:label>
    <link:label id="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent_documentation_en-US" xlink:label="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract With Customer, Asset, After Allowance For Credit Loss And Deferred Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent" xlink:href="gehc-20250331.xsd#gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent" xlink:to="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_f26a3930-5127-4771-a9ba-a9ab79a47098_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use operating lease assets, net of amortization</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_adbef4bb-e168-487a-a57e-e2b43493b182_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebtMaturingInMoreThanThreeMonths_76e5f2dc-2310-49f5-a00e-7e55302198f7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtMaturingInMoreThanThreeMonths" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayments and other reductions (maturities longer than 90 days)</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebtMaturingInMoreThanThreeMonths_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtMaturingInMoreThanThreeMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Debt, Maturing in More than Three Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtMaturingInMoreThanThreeMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebtMaturingInMoreThanThreeMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebtMaturingInMoreThanThreeMonths" xlink:to="lab_us-gaap_RepaymentsOfDebtMaturingInMoreThanThreeMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_13eb36c8-fa5b-4d01-bbdd-77b3bbaf7e78_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">All other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_a7ced3de-569d-4a77-ad9b-8bd8c95cb560_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_d11e20bf-ff48-4948-9ac3-210240acd7b5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_1ed053ee-ed54-458c-9b79-506bc7cd78d7_totalLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Current financing receivables &#8211; net</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_26b31d39-6695-400f-bea6-af6b112ba4a5_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing receivables &#8211; net</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:to="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_8bcc88ee-7f1b-4b27-bfed-e9f7d059127e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Current Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_5269b0d5-cd82-4a82-8040-2a6d78808986_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principal debt issued</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_ee1eb252-118f-41bc-a5c6-37832879d9dd_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SUPPLEMENTAL FINANCIAL INFORMATION</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_89169ff3-b489-4fe7-9db3-622079cce025_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_fbdf497f-8e71-4be6-a7dc-9a13eb23e003_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current compensation and benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_9bf83f3d-e22b-41b6-b4a5-37a54c6828f7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_8dbefd63-36ce-474e-b954-3d350d77fa6a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_539ca07d-8424-40b6-9dc6-3ea9eb3ccdd1_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current-year provisions</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_db79943e-eaa0-4c11-b921-dfbc5854cfb3_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment revaluation gain (loss)</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_68e6ead3-6c00-43d7-85f3-9a0a9c14463a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_4077531a-a20f-4de3-abeb-0b26d25cd46c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity method and other investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_f70f0355-82a0-4bc6-90dd-4a553db9c199_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Liabilities at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Liabilities at Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_99af2736-6e6c-4c7f-a8be-20413fdd1778_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValueAddedTaxReceivableNoncurrent_ecb58bcc-ba8e-4b31-8d3e-376f2b2c1fef_terseLabel_en-US" xlink:label="lab_us-gaap_ValueAddedTaxReceivableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-income based tax receivables</link:label>
    <link:label id="lab_us-gaap_ValueAddedTaxReceivableNoncurrent_label_en-US" xlink:label="lab_us-gaap_ValueAddedTaxReceivableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Value Added Tax Receivable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValueAddedTaxReceivableNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValueAddedTaxReceivableNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValueAddedTaxReceivableNoncurrent" xlink:to="lab_us-gaap_ValueAddedTaxReceivableNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_b3697d22-fd60-4491-8c69-0e1c5a1f3a05_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt, term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_05bf901d-0363-4c8f-ab4c-550338dada93_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other (income) expense &#8211; net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_bb55654a-223c-4a5b-8e93-76003d8c2841_totalLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other income (expense) &#8211; net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivablePercentPastDue1_c2d1e6ea-b855-40f9-8455-253cecade0dc_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivablePercentPastDue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing receivable, percent past due</link:label>
    <link:label id="lab_us-gaap_FinancingReceivablePercentPastDue1_label_en-US" xlink:label="lab_us-gaap_FinancingReceivablePercentPastDue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, Percent Past Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablePercentPastDue1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablePercentPastDue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivablePercentPastDue1" xlink:to="lab_us-gaap_FinancingReceivablePercentPastDue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_4524ce6b-84e1-4b39-bda9-2ab07258ef66_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Postretirement Benefits Plan</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_045f30d5-4c60-4ebb-b868-1da02f05d525_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Asset write-downs</link:label>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Sale of Assets and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_863fa35a-2eb6-4949-ae4f-909b1cd07f68_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other intangible assets &#8211; net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_fe361f98-9dde-4ff3-baeb-dc34b4baa494_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_be61034c-b74d-4f69-b8b9-8b7889865a84_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net investment hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesAbstract" xlink:to="lab_us-gaap_ReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c170ad9f-1dff-4f1c-a8fa-fce96814d028_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1ba8669d-3e13-4387-9f6e-bbd3ac2afbc2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from stock issued under employee benefit plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_1640c07f-8b29-436d-ba1b-d3b10e1e95c7_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Equity method income (loss)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_76213e34-3c1e-49a1-9ee2-d56003ccddfc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, at cost, 291,053 shares as of March 31, 2025 and December 31, 2024</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_ac8b4d92-5424-4970-97fe-726d0d298a75_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments Contingencies and Guarantees [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:to="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_3361e7f5-31a5-409a-9972-b88dfca268c1_terseLabel_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Add: Cumulative basis adjustment for fair value hedges</link:label>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_c2818abe-e53e-43d3-b86f-234d36d6afef_verboseLabel_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cumulative basis adjustment included in the carrying amount</link:label>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:to="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_DebtBasisAdjustmentLongTermBorrowingsMember_7eeb6e8f-ca60-4de0-a473-efa733f73adf_terseLabel_en-US" xlink:label="lab_gehc_DebtBasisAdjustmentLongTermBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt basis adjustment on Long-term borrowings</link:label>
    <link:label id="lab_gehc_DebtBasisAdjustmentLongTermBorrowingsMember_label_en-US" xlink:label="lab_gehc_DebtBasisAdjustmentLongTermBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Basis Adjustment, Long-Term Borrowings [Member]</link:label>
    <link:label id="lab_gehc_DebtBasisAdjustmentLongTermBorrowingsMember_documentation_en-US" xlink:label="lab_gehc_DebtBasisAdjustmentLongTermBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Basis Adjustment, Long-Term Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_DebtBasisAdjustmentLongTermBorrowingsMember" xlink:href="gehc-20250331.xsd#gehc_DebtBasisAdjustmentLongTermBorrowingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_DebtBasisAdjustmentLongTermBorrowingsMember" xlink:to="lab_gehc_DebtBasisAdjustmentLongTermBorrowingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_a7557dc5-0923-495a-831d-3e683755fcca_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCurrent_63cf8220-921f-431a-abab-13cbfa0b9574_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other deferred assets</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCurrent" xlink:to="lab_us-gaap_DeferredCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_d9ab6f8e-b28d-47ee-8e8a-056aa39b8632_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_c66c76f4-6591-4f35-b82b-7f8124f3c21e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_98f16528-50ba-4fe9-9969-90e47cdcfc0e_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_bb86dbd8-1d42-401e-8dcb-38fcc8daed9d_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_2dbacacd-b2ea-4d0d-9602-1708cce6ce03_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Miscellaneous, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue_469d5a38-4d05-4152-a1aa-6c5fb933047f_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Guarantee obligation, carrying value</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Guarantor Obligations, Current Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:to="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_d666ecdd-99e8-4545-9223-78493bf0a34b_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_39ccd333-2a80-4e3d-b92a-6438fc635480_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_b1b9861c-d5a1-4cc5-87f1-32e286898b9c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_f42f4c0a-983f-419f-b140-5ce73f1b68fb_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7dcc30b3-b51d-4ac1-a590-77fdd4fcbe15_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities, excluding the effects of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost_b5e9030b-fc2f-46ee-8b9b-8dada2f09983_negatedTerseLabel_en-US" xlink:label="lab_gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Postretirement plan contributions</link:label>
    <link:label id="lab_gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost_label_en-US" xlink:label="lab_gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension and Other Postretirement Benefits Expense, Employer Contribution, Cost</link:label>
    <link:label id="lab_gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost_documentation_en-US" xlink:label="lab_gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pension and Other Postretirement Benefits Expense, Employer Contribution, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost" xlink:href="gehc-20250331.xsd#gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost" xlink:to="lab_gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_9992234e-6067-4314-924d-ed45e5739fde_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Facility and other exit costs</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_18ed02fd-01f4-4b9e-991a-0da158068d58_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value &#8211; Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a3f841a2-b286-4bb5-860b-8d708714d3ee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Pension and Other Postretirement Plans &#8211; net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_140846e8-b5eb-4486-ae88-3e0d320e4ed1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableGrossNoncurrent_05782897-0bb1-4603-b1ba-e0404cade504_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableGrossNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current financing receivables, gross</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableGrossNoncurrent_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableGrossNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, before Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableGrossNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableGrossNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableGrossNoncurrent" xlink:to="lab_us-gaap_NotesAndLoansReceivableGrossNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_eb0883ae-6929-47c9-b444-902b8d668e83_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest payable on borrowings</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_fe81d961-7ed1-413c-bdad-31d201c35bfe_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_1ba7c5f0-daf5-4723-927d-9d8e8f5e0c42_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d3ed978a-c28f-4055-9d6b-aab3fcee0c59_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of shares under equity awards, net of shares withheld for taxes and other</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_661fb038-392e-413b-9e46-5b40ba3bf147_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_2fbbb8ae-f857-4081-ae61-c838e8e34c68_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effects of net investment hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_03381853-771a-4ac4-9de9-b2c72765e46f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_47e1100b-91bc-4044-8f87-274d710e5649_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b95dee1b-1793-41cd-9a6d-82b3daa56e5a_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets_855ace4b-ce94-4816-97eb-479d3cc42f3e_terseLabel_en-US" xlink:label="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other net assets</link:label>
    <link:label id="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets_label_en-US" xlink:label="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets</link:label>
    <link:label id="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets_documentation_en-US" xlink:label="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets" xlink:href="gehc-20250331.xsd#gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets" xlink:to="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_9004ea1d-cc76-44cd-83a6-42132097b8ce_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue_b81960ee-a633-4653-81f1-4129effc47b1_terseLabel_en-US" xlink:label="lab_gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity interest in acquiree, carrying value</link:label>
    <link:label id="lab_gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue_label_en-US" xlink:label="lab_gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Carrying Value</link:label>
    <link:label id="lab_gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue_documentation_en-US" xlink:label="lab_gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue" xlink:href="gehc-20250331.xsd#gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue" xlink:to="lab_gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_41b67037-fda8-4659-8d95-00bb963c69a7_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other segment items</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Other Segment Item, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:to="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1a5d9a62-0f79-4c2a-91bb-b067568136ba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_bd677656-1027-483a-9e59-3e1cf144a90e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent_395c4c18-4dbe-49ba-a14b-62987f6167e6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Allowance for credit losses, noncurrent</link:label>
    <link:label id="lab_us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent" xlink:to="lab_us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_d8df9138-7b75-4608-a753-5de239ec3dc9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_660b4629-ee71-4a79-9283-4083f3899037_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit plan, net asset</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_aae66fcc-0dc4-4d7f-8b10-2952fd75e2e2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term borrowings, current</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_776e6643-9a3a-4ade-be3f-b0a1a1cef680_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_504dcd57-3162-4c5d-b31d-ba348cab8634_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Effect of Derivatives Instruments on Statement of Financial Position and Statement of Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts_32a75620-8a67-477c-a804-e9f2324ec92a_totalLabel_en-US" xlink:label="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total contract and other deferred assets</link:label>
    <link:label id="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts_label_en-US" xlink:label="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract With Customer, Asset, After Allowance For Credit Loss And Deferred Costs</link:label>
    <link:label id="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts_documentation_en-US" xlink:label="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract With Customer, Asset, After Allowance For Credit Loss And Deferred Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts" xlink:href="gehc-20250331.xsd#gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts" xlink:to="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_A5857SeniorNotesDue2030Member_6ab97c32-6e6f-4afb-a7f3-94b5e157a0b1_terseLabel_en-US" xlink:label="lab_gehc_A5857SeniorNotesDue2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">5.857% senior notes due March 15, 2030</link:label>
    <link:label id="lab_gehc_A5857SeniorNotesDue2030Member_label_en-US" xlink:label="lab_gehc_A5857SeniorNotesDue2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">5.857% Senior Notes, Due 2030 [Member]</link:label>
    <link:label id="lab_gehc_A5857SeniorNotesDue2030Member_documentation_en-US" xlink:label="lab_gehc_A5857SeniorNotesDue2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">5.857% Senior Notes, Due 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A5857SeniorNotesDue2030Member" xlink:href="gehc-20250331.xsd#gehc_A5857SeniorNotesDue2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_A5857SeniorNotesDue2030Member" xlink:to="lab_gehc_A5857SeniorNotesDue2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_94381e48-7f16-4ae4-a7ee-20d2022e3219_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reclassifications from AOCI &#8211; net of taxes</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_bc67e6b4-e915-4cb1-9f77-b0bb70d04b80_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_21b6dd57-4c8b-4f5f-af94-a4a404a43a01_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_98482980-f0ee-4ea5-b5cd-9a448b20c317_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_16b3766a-4c09-4ca4-9cc7-c107468ce648_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_d01ec407-424f-4e9e-bebb-71d9abbd8109_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income and indirect tax liabilities including uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Taxes and Other Tax Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierFinanceProgramTable_fc4fa8df-b2e7-4067-b0bf-aab84b2519b6_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplier Finance Program [Table]</link:label>
    <link:label id="lab_us-gaap_SupplierFinanceProgramTable_label_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplier Finance Program [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierFinanceProgramTable" xlink:to="lab_us-gaap_SupplierFinanceProgramTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_e718b982-3c98-4977-9f71-a1ee9f1addaf_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unsecured debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_af2c9f1e-65df-49b7-b9c6-3bf947895005_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_OtherNontradeReceivablesCurrent_7c6e3d80-2b32-4c73-9882-1ecb921e08e3_terseLabel_en-US" xlink:label="lab_gehc_OtherNontradeReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other sundry receivables</link:label>
    <link:label id="lab_gehc_OtherNontradeReceivablesCurrent_label_en-US" xlink:label="lab_gehc_OtherNontradeReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nontrade Receivables, Current</link:label>
    <link:label id="lab_gehc_OtherNontradeReceivablesCurrent_documentation_en-US" xlink:label="lab_gehc_OtherNontradeReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Nontrade Receivables, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherNontradeReceivablesCurrent" xlink:href="gehc-20250331.xsd#gehc_OtherNontradeReceivablesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_OtherNontradeReceivablesCurrent" xlink:to="lab_gehc_OtherNontradeReceivablesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_e284a663-76f7-4f47-950b-b7f3b64b6c83_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_2a8b9c1c-ff0b-4d71-b9f0-e84acfb00466_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net periodic postretirement benefit plan (income) expense</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_LifeSupportSolutionsSubsegmentMember_48b3be4a-6003-457c-9131-5bfeda3e0f41_terseLabel_en-US" xlink:label="lab_gehc_LifeSupportSolutionsSubsegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Life Support Solutions</link:label>
    <link:label id="lab_gehc_LifeSupportSolutionsSubsegmentMember_label_en-US" xlink:label="lab_gehc_LifeSupportSolutionsSubsegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Life Support Solutions Subsegment [Member]</link:label>
    <link:label id="lab_gehc_LifeSupportSolutionsSubsegmentMember_documentation_en-US" xlink:label="lab_gehc_LifeSupportSolutionsSubsegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Life Support Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_LifeSupportSolutionsSubsegmentMember" xlink:href="gehc-20250331.xsd#gehc_LifeSupportSolutionsSubsegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_LifeSupportSolutionsSubsegmentMember" xlink:to="lab_gehc_LifeSupportSolutionsSubsegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_255717a7-4388-4e5e-8d18-719f50ad25a2_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: Comprehensive income (loss) attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_9e878cc7-a0a9-43b9-b753-7756dbddac81_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_de85bd44-e27f-446a-a75c-931bd296f549_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_22cedeb4-6410-499a-8454-6ef8f9c27c16_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_1ce6ee66-aeab-480b-9925-f03945ef73f3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net increase (decrease) in borrowings (maturities of 90 days or less)</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_32d4e4f4-e454-4386-80a4-de8d59ad17e9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems_025d17a5-6ab7-4174-bdc1-94e330f8c712_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing Receivable, Past Due [Line Items]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, Past Due [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems" xlink:to="lab_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_f050f02b-3d67-4d69-bfbe-50fc9f83ecff_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash paid during the year for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_PCSSegmentMember_d5bd76b5-cc69-4da6-a615-c2cec9cbd643_terseLabel_en-US" xlink:label="lab_gehc_PCSSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PCS</link:label>
    <link:label id="lab_gehc_PCSSegmentMember_label_en-US" xlink:label="lab_gehc_PCSSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PCS Segment [Member]</link:label>
    <link:label id="lab_gehc_PCSSegmentMember_documentation_en-US" xlink:label="lab_gehc_PCSSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PCS Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PCSSegmentMember" xlink:href="gehc-20250331.xsd#gehc_PCSSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_PCSSegmentMember" xlink:to="lab_gehc_PCSSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_f9273c8c-dbe9-428f-b73a-7dba63e03cd6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected restructuring expense remaining</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Cost, Expected Cost Remaining</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_FloatingRateTermLoanFacilityDue2026Member_929318e1-e52a-4af5-9958-a183aa3e5b92_terseLabel_en-US" xlink:label="lab_gehc_FloatingRateTermLoanFacilityDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Floating rate Term Loan Facility due January 2, 2026</link:label>
    <link:label id="lab_gehc_FloatingRateTermLoanFacilityDue2026Member_label_en-US" xlink:label="lab_gehc_FloatingRateTermLoanFacilityDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Floating Rate Term Loan Facility Due 2026 [Member]</link:label>
    <link:label id="lab_gehc_FloatingRateTermLoanFacilityDue2026Member_documentation_en-US" xlink:label="lab_gehc_FloatingRateTermLoanFacilityDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Floating Rate Term Loan Facility Due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_FloatingRateTermLoanFacilityDue2026Member" xlink:href="gehc-20250331.xsd#gehc_FloatingRateTermLoanFacilityDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_FloatingRateTermLoanFacilityDue2026Member" xlink:to="lab_gehc_FloatingRateTermLoanFacilityDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_6a7a2ac9-2afe-4a73-879b-6f2533a681c1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Additions to property, plant and equipment and internal-use software</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_f49d110d-b678-4e1a-8cff-14fe694e9764_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4cfe85c6-b9ee-449f-8670-ef0397faed99_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation adjustments &#8211; net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_b53525c1-d8c2-49ac-b702-02564188fa3e_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain (loss) on business and asset dispositions</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_08a925de-0288-499a-bb8c-1dbfabdc8461_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_432045d1-7efc-4688-83ff-17bd7e2ed81a_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_18cbdd56-6787-41fa-83eb-005fb8e5ddf2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_f32a801c-a7d3-47e3-88b3-5fd0b5d4662c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit plan, employer contribution amount</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_861c3908-20be-4a0a-9051-79356e94101b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term borrowings</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_8d6dad19-ad1a-4539-8e62-f97537a93206_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Long-term borrowings</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73602bd2-1911-45b2-abc9-d21c32d73e1b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_b92e0c83-c75f-4dd8-acf7-3699b0d50f2b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_9c4af39e-22f8-4071-8f3b-6c49703f3913_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_69c7faef-d15c-4308-8929-9cb5733f7a44_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivablesTextBlock_769478ef-c312-4ba4-8f0c-380c6a961805_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivablesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">FINANCING RECEIVABLES</link:label>
    <link:label id="lab_us-gaap_FinancingReceivablesTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancingReceivablesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivables [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivablesTextBlock" xlink:to="lab_us-gaap_FinancingReceivablesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_d0085632-9447-4334-893c-12cdfa6639e0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_14df02ad-3ebe-46cc-9ffd-c46541599345_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_68e4c4d9-55d0-4adb-bfea-8687bb012be5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_c5513f76-7c8c-4d39-84b5-8ed6effdbda9_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_b835c5e6-367d-4990-adf2-7a3936b35df9_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_A364DayRevolvingCreditFacilityMember_c99f8cbb-973f-479b-a081-ea1e7381c5d4_terseLabel_en-US" xlink:label="lab_gehc_A364DayRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">364-Day Revolving Credit Facility</link:label>
    <link:label id="lab_gehc_A364DayRevolvingCreditFacilityMember_label_en-US" xlink:label="lab_gehc_A364DayRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">364-Day Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_gehc_A364DayRevolvingCreditFacilityMember_documentation_en-US" xlink:label="lab_gehc_A364DayRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">364-Day Revolving Credit Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A364DayRevolvingCreditFacilityMember" xlink:href="gehc-20250331.xsd#gehc_A364DayRevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_A364DayRevolvingCreditFacilityMember" xlink:to="lab_gehc_A364DayRevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_d8d952e0-1d8f-4e59-b8dd-bd0ee6656999_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency exchange and other</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Translation and Measurement Period Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_d2ce81ca-67cc-4456-b328-65c04ceae11b_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flow hedge gain to be reclassified within 12 months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_37c0a575-ccc9-40b0-a23a-606ca23a9596_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Domestic Plan</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_5d67598f-4a66-46f3-9091-c61d7615b07b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_OtherCashEquivalentsMember_4591fb8b-efc7-491b-8f5a-26d725f168d8_terseLabel_en-US" xlink:label="lab_gehc_OtherCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other cash equivalents</link:label>
    <link:label id="lab_gehc_OtherCashEquivalentsMember_label_en-US" xlink:label="lab_gehc_OtherCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Cash Equivalents [Member]</link:label>
    <link:label id="lab_gehc_OtherCashEquivalentsMember_documentation_en-US" xlink:label="lab_gehc_OtherCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherCashEquivalentsMember" xlink:href="gehc-20250331.xsd#gehc_OtherCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_OtherCashEquivalentsMember" xlink:to="lab_gehc_OtherCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_SalesAllowancesAndRelatedLiabilitiesCurrent_75a7a631-b46f-41c9-8035-324a07aceb50_terseLabel_en-US" xlink:label="lab_gehc_SalesAllowancesAndRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales allowances and related liabilities</link:label>
    <link:label id="lab_gehc_SalesAllowancesAndRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_gehc_SalesAllowancesAndRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Allowances And Related Liabilities, Current</link:label>
    <link:label id="lab_gehc_SalesAllowancesAndRelatedLiabilitiesCurrent_documentation_en-US" xlink:label="lab_gehc_SalesAllowancesAndRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sales Allowances And Related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_SalesAllowancesAndRelatedLiabilitiesCurrent" xlink:href="gehc-20250331.xsd#gehc_SalesAllowancesAndRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_SalesAllowancesAndRelatedLiabilitiesCurrent" xlink:to="lab_gehc_SalesAllowancesAndRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_3c3a3a30-3831-4be3-a464-6dcba99d66db_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_df030d75-3ce5-4ac3-b76e-1baa4e806741_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash from (used for) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_78eae356-7c55-471f-933f-daa0a2ef3a29_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a43854d7-31ed-4997-8c54-b2caa496c697_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableGrossCurrent_22c4df64-07aa-4225-ba96-3ab23b4416a7_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current financing receivables, gross</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableGrossCurrent" xlink:to="lab_us-gaap_NotesAndLoansReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_18c3605e-1ded-4ebf-8b62-4d3f060bd3fc_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_f3f932cc-4c19-4c8b-9ac1-616a177e5e31_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_bf0e40b1-496e-481e-8c05-136ee40b3853_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_7025bf8a-f1f0-4db0-ac8f-b6c2da5597f8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent_2df83c2f-28cd-4d10-9e30-fc509b775ad8_terseLabel_en-US" xlink:label="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract and other deferred assets</link:label>
    <link:label id="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent_label_en-US" xlink:label="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, After Allowance for Credit Loss, And Deferred Costs, Noncurrent</link:label>
    <link:label id="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent_documentation_en-US" xlink:label="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, After Allowance for Credit Loss, And Deferred Costs, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent" xlink:href="gehc-20250331.xsd#gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent" xlink:to="lab_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_d6f16235-2b66-4584-8805-e352d6adb002_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c8a9d038-b2fd-456b-978d-d17b5d91be76_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_06db25ad-518d-4314-94cb-f53cf24d509d_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_7820cba1-5e4c-4691-92a9-77526a9264ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restricted Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_6689cecc-843c-4137-b361-2de6e3744197_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_47d93d98-7494-4e01-b5a4-0e1fe2408596_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Product Warranties</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_7d1b31d4-3343-4752-b851-7bd4b87df54b_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit plan, asset</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_FinancialAssetGreaterThan30DaysPastDueMember_b40d1c84-072c-4a5c-9fe4-614717879d39_terseLabel_en-US" xlink:label="lab_gehc_FinancialAssetGreaterThan30DaysPastDueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Over 30 days past due</link:label>
    <link:label id="lab_gehc_FinancialAssetGreaterThan30DaysPastDueMember_label_en-US" xlink:label="lab_gehc_FinancialAssetGreaterThan30DaysPastDueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Asset, Greater Than 30 Days Past Due [Member]</link:label>
    <link:label id="lab_gehc_FinancialAssetGreaterThan30DaysPastDueMember_documentation_en-US" xlink:label="lab_gehc_FinancialAssetGreaterThan30DaysPastDueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financial Asset, Greater Than 30 Days Past Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_FinancialAssetGreaterThan30DaysPastDueMember" xlink:href="gehc-20250331.xsd#gehc_FinancialAssetGreaterThan30DaysPastDueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_FinancialAssetGreaterThan30DaysPastDueMember" xlink:to="lab_gehc_FinancialAssetGreaterThan30DaysPastDueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_f7765338-1e05-42df-a0db-46356fa35f57_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss) before reclassifications &#8211; net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_86b7810f-98e0-4fbb-b66a-21f65c79938f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_ab535739-b785-420e-80d0-98962be80eb5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BORROWINGS</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fe0830c-2521-48c1-bfcb-5f9c433ea542_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_49bd8110-68e7-4e9d-91b1-0763a80077d0_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer-related</link:label>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:to="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_7d498235-b8be-4ce5-b41d-e9a4e0fb0a23_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_c1f0f7a1-efb3-46c3-a4eb-e02762906310_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt, principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_EquipmentResidualValueObligationMember_6c16f09f-f312-4faf-bceb-176f8a944ce5_terseLabel_en-US" xlink:label="lab_gehc_EquipmentResidualValueObligationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equipment residual value obligation</link:label>
    <link:label id="lab_gehc_EquipmentResidualValueObligationMember_label_en-US" xlink:label="lab_gehc_EquipmentResidualValueObligationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equipment Residual Value Obligation [Member]</link:label>
    <link:label id="lab_gehc_EquipmentResidualValueObligationMember_documentation_en-US" xlink:label="lab_gehc_EquipmentResidualValueObligationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equipment Residual Value Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_EquipmentResidualValueObligationMember" xlink:href="gehc-20250331.xsd#gehc_EquipmentResidualValueObligationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_EquipmentResidualValueObligationMember" xlink:to="lab_gehc_EquipmentResidualValueObligationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_AmortizationOfIntangibleAssetsAcquired_058d9bbe-efab-414d-a753-d9bd4a0db676_negatedTerseLabel_en-US" xlink:label="lab_gehc_AmortizationOfIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Amortization of acquisition-related intangible assets</link:label>
    <link:label id="lab_gehc_AmortizationOfIntangibleAssetsAcquired_label_en-US" xlink:label="lab_gehc_AmortizationOfIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization Of Intangible Assets, Acquired</link:label>
    <link:label id="lab_gehc_AmortizationOfIntangibleAssetsAcquired_documentation_en-US" xlink:label="lab_gehc_AmortizationOfIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amortization Of Intangible Assets, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AmortizationOfIntangibleAssetsAcquired" xlink:href="gehc-20250331.xsd#gehc_AmortizationOfIntangibleAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_AmortizationOfIntangibleAssetsAcquired" xlink:to="lab_gehc_AmortizationOfIntangibleAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_9094ec51-ee93-4746-866c-b51ab0a6d80a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_9fddc878-f263-4a64-9389-510ae169b571_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Patents and technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_391509ec-a04a-40e8-930d-9d15d881e667_periodStartLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_f7787805-2d3d-43ab-bdbd-fc49461681c0_periodEndLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard and Extended Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrual" xlink:to="lab_us-gaap_ProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_85ebdcd3-3a86-4444-b8c2-23e55eb880e7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c390c301-d442-40dc-bf6a-6112a151acb5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Cost [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Cost [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_c1b266fa-cfe9-475d-aa33-fe75d57bd16e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_4547c2c9-a49f-4c63-b7ed-d313de5b2d33_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7a72446d-1361-4f60-9381-3b808e4dadd8_terseLabel_en-US" xlink:label="lab_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant, and equipment &#8211; net</link:label>
    <link:label id="lab_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_d867c875-cadc-4ff1-8c8f-51ef5d1e61e7_totalLabel_en-US" xlink:label="lab_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property, plant, and equipment &#8211; net</link:label>
    <link:label id="lab_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant, And Equipment And Operating Lease Right-of-Use Asset, After Accumulated Depreciation And Amortization</link:label>
    <link:label id="lab_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_documentation_en-US" xlink:label="lab_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Property, Plant, And Equipment And Operating Lease Right-of-Use Asset, After Accumulated Depreciation And Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="gehc-20250331.xsd#gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_99f59595-fa23-40b0-aa97-20112ece0c0c_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_5e86f51a-de2e-4de2-8086-4431e6ca1e89_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value $0.01 per share, 1,000,000,000 shares authorized, 458,134,263 shares issued as of March 31, 2025; 457,246,971 shares issued as of December 31, 2024</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_11f3e3ef-0c4a-4c16-9dc6-cb6dc283da4b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_a8a671b0-1cde-4335-bdfe-c17dceb333da_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit plan, expected future employer contributions, next fiscal year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3e80e99c-3420-4b2d-adc6-1917ef89f739_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_0783e94a-83c2-4a6d-9d3c-2c45cb6fd181_terseLabel_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:to="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_bddacb62-46d1-46e4-8518-3f377aa9c74d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">All other investing activities &#8211; net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax_84e4c9e4-098d-4e95-a05a-3ad29b02db0b_terseLabel_en-US" xlink:label="lab_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effects of fair value hedges</link:label>
    <link:label id="lab_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Fair Value Hedge, Gain (Loss), Reclassification, Before Tax</link:label>
    <link:label id="lab_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax_documentation_en-US" xlink:label="lab_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Fair Value Hedge, Gain (Loss), Reclassification, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" xlink:href="gehc-20250331.xsd#gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" xlink:to="lab_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_f4ba6577-b1bb-4c1a-8aae-fa9412aa3339_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reclass from AOCI, tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_5eb3e95e-35e1-4515-b57c-c2214ed51595_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_648204d7-67cf-4a64-9d92-82283cf5d334_terseLabel_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Land and improvements</link:label>
    <link:label id="lab_us-gaap_LandAndLandImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LandAndLandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Land and Land Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandAndLandImprovementsMember" xlink:to="lab_us-gaap_LandAndLandImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_CommercialContractsMember_058fe7d3-4d2f-473d-8b46-a430e84be84c_terseLabel_en-US" xlink:label="lab_gehc_CommercialContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commercial contracts</link:label>
    <link:label id="lab_gehc_CommercialContractsMember_label_en-US" xlink:label="lab_gehc_CommercialContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial Contracts [Member]</link:label>
    <link:label id="lab_gehc_CommercialContractsMember_documentation_en-US" xlink:label="lab_gehc_CommercialContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Commercial Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_CommercialContractsMember" xlink:href="gehc-20250331.xsd#gehc_CommercialContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_CommercialContractsMember" xlink:to="lab_gehc_CommercialContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f146b84d-e1ec-4bf1-8083-6ea8148a82b7_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows &#8211; financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_ProceduralGuidanceSubsegmentMember_db3fb9ae-5968-4dc8-91fe-c09780fef14a_terseLabel_en-US" xlink:label="lab_gehc_ProceduralGuidanceSubsegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Procedural Guidance</link:label>
    <link:label id="lab_gehc_ProceduralGuidanceSubsegmentMember_label_en-US" xlink:label="lab_gehc_ProceduralGuidanceSubsegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Procedural Guidance Subsegment [Member]</link:label>
    <link:label id="lab_gehc_ProceduralGuidanceSubsegmentMember_documentation_en-US" xlink:label="lab_gehc_ProceduralGuidanceSubsegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Procedural Guidance Subsegment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ProceduralGuidanceSubsegmentMember" xlink:href="gehc-20250331.xsd#gehc_ProceduralGuidanceSubsegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_ProceduralGuidanceSubsegmentMember" xlink:to="lab_gehc_ProceduralGuidanceSubsegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_99a30ad1-25cb-4afb-b648-148b1862f491_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_A5YearRevolvingCreditFacilityMember_cb79aa31-695d-4083-95ef-edb63490f5ce_terseLabel_en-US" xlink:label="lab_gehc_A5YearRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">5-Year Revolving Credit Facility</link:label>
    <link:label id="lab_gehc_A5YearRevolvingCreditFacilityMember_label_en-US" xlink:label="lab_gehc_A5YearRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">5-Year Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_gehc_A5YearRevolvingCreditFacilityMember_documentation_en-US" xlink:label="lab_gehc_A5YearRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">5-Year Revolving Credit Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A5YearRevolvingCreditFacilityMember" xlink:href="gehc-20250331.xsd#gehc_A5YearRevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_A5YearRevolvingCreditFacilityMember" xlink:to="lab_gehc_A5YearRevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_7b9d4b29-89b8-4b67-9b5b-2674e565054a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_6b87c47c-0a2f-4271-8069-43de3a34b9bc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_eb6b6a45-768e-452b-aec3-c18b69fe4e61_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_66b3da7f-e457-4926-8c02-be977f4cd268_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_80e353fa-cac0-4bb3-8cd7-ae3580d80e69_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash acquired from acquisition</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_36427507-e11b-4d4b-8b89-3af4bbcc5f99_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:to="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets_db0aee98-6eaa-47a2-bc6c-64267f1d8fa7_terseLabel_en-US" xlink:label="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indemnification assets</link:label>
    <link:label id="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets_label_en-US" xlink:label="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indemnification Assets</link:label>
    <link:label id="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets_documentation_en-US" xlink:label="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indemnification Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets" xlink:href="gehc-20250331.xsd#gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets" xlink:to="lab_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5bd2f1da-2fd6-4ab7-81b5-654976644ef8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_5d38a7e4-6a47-4c4f-a711-429043c6063c_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired but unpaid property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_461f7b9c-8d97-470b-935b-3c2f0f78f11e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_3dd8ce07-49fb-4bfc-b591-5da549b3b0fe_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Designated as hedging instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_3f421eaa-9401-42e3-b3ef-ce2dcd2cc83f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity interest in acquiree, existing percentage</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_8a71a909-f326-4ed2-9333-0aa0dc22e631_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_75ab9bba-fccd-49be-b039-d683b9741221_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_AcquisitionAndDispositionRelatedBenefitsCosts_6f410b04-46e9-4997-918f-4b9f0f6018ec_terseLabel_en-US" xlink:label="lab_gehc_AcquisitionAndDispositionRelatedBenefitsCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition and disposition-related benefits (charges)</link:label>
    <link:label id="lab_gehc_AcquisitionAndDispositionRelatedBenefitsCosts_label_en-US" xlink:label="lab_gehc_AcquisitionAndDispositionRelatedBenefitsCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisition And Disposition Related Benefits (Costs)</link:label>
    <link:label id="lab_gehc_AcquisitionAndDispositionRelatedBenefitsCosts_documentation_en-US" xlink:label="lab_gehc_AcquisitionAndDispositionRelatedBenefitsCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Acquisition And Disposition Related Benefits (Costs)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AcquisitionAndDispositionRelatedBenefitsCosts" xlink:href="gehc-20250331.xsd#gehc_AcquisitionAndDispositionRelatedBenefitsCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_AcquisitionAndDispositionRelatedBenefitsCosts" xlink:to="lab_gehc_AcquisitionAndDispositionRelatedBenefitsCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_OtherLongTermBorrowingsMember_4419cf19-c37d-4005-bf91-a8b1feec6614_terseLabel_en-US" xlink:label="lab_gehc_OtherLongTermBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_gehc_OtherLongTermBorrowingsMember_label_en-US" xlink:label="lab_gehc_OtherLongTermBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Long-Term Borrowings [Member]</link:label>
    <link:label id="lab_gehc_OtherLongTermBorrowingsMember_documentation_en-US" xlink:label="lab_gehc_OtherLongTermBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Long-Term Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherLongTermBorrowingsMember" xlink:href="gehc-20250331.xsd#gehc_OtherLongTermBorrowingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_OtherLongTermBorrowingsMember" xlink:to="lab_gehc_OtherLongTermBorrowingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_25217d12-39cb-4db4-ae81-3a70093a0d49_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_5c2adc5c-c68a-4488-8e6b-e73e66181e7a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax receivables</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_NumberOfDebtSeries_438c93e8-4ad5-409b-a5ea-70f1d7ceb377_terseLabel_en-US" xlink:label="lab_gehc_NumberOfDebtSeries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of debt series</link:label>
    <link:label id="lab_gehc_NumberOfDebtSeries_label_en-US" xlink:label="lab_gehc_NumberOfDebtSeries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Debt Series</link:label>
    <link:label id="lab_gehc_NumberOfDebtSeries_documentation_en-US" xlink:label="lab_gehc_NumberOfDebtSeries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Debt Series</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_NumberOfDebtSeries" xlink:href="gehc-20250331.xsd#gehc_NumberOfDebtSeries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_NumberOfDebtSeries" xlink:to="lab_gehc_NumberOfDebtSeries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_3fc94db8-4cb1-4652-8432-143304629276_terseLabel_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized cloud computing arrangement implementation costs</link:label>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" xlink:to="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_b9fbd41b-9ea1-4757-91ed-cc61d4365491_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_bb5f067c-2b77-4dd4-9cec-f2b2da06826a_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">All other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierFinanceProgramLineItems_40cc1686-fdbe-4667-93bd-f78f99cfb3dd_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplier Finance Program [Line Items]</link:label>
    <link:label id="lab_us-gaap_SupplierFinanceProgramLineItems_label_en-US" xlink:label="lab_us-gaap_SupplierFinanceProgramLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplier Finance Program [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierFinanceProgramLineItems" xlink:to="lab_us-gaap_SupplierFinanceProgramLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_87e37885-192f-4283-a395-0f6a130524d6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_4a1a2d8e-1234-45d5-83c9-337d3541bc55_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_c92b3ee9-711c-450d-ae6d-f972b7295ce8_terseLabel_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest and other financial charges &#8211; net</link:label>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_51760860-ecac-4aca-8aa4-a6a7c0851149_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest and other financial charges &#8211; net</link:label>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_label_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest and Debt Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDebtExpense" xlink:to="lab_us-gaap_InterestAndDebtExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability_38786c7e-8bf0-44d7-ace6-cd986bc091bf_terseLabel_en-US" xlink:label="lab_gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative, potential effect of rights of offset to assets and liabilities</link:label>
    <link:label id="lab_gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability_label_en-US" xlink:label="lab_gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Subject to Master Netting Arrangement, Potential Offset To Asset (Liability)</link:label>
    <link:label id="lab_gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability_documentation_en-US" xlink:label="lab_gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Derivative, Subject to Master Netting Arrangement, Potential Offset To Asset (Liability)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability" xlink:href="gehc-20250331.xsd#gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability" xlink:to="lab_gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_233bf3c8-9d05-4ccd-9d47-b5b030d0772d_terseLabel_en-US" xlink:label="lab_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_4285c353-3072-42e5-a03a-26f3655cbdf1_verboseLabel_en-US" xlink:label="lab_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_a783fe13-f32f-4b86-ae37-360e3246df5d_totalLabel_en-US" xlink:label="lab_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Financial Position</link:label>
    <link:label id="lab_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_label_en-US" xlink:label="lab_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Current</link:label>
    <link:label id="lab_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_documentation_en-US" xlink:label="lab_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" xlink:href="gehc-20250331.xsd#gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" xlink:to="lab_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ba6e9ea7-9b57-48d7-976d-94e8c0a2b974_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges_17c9d5e8-457a-4803-be50-26eff664b8c5_terseLabel_en-US" xlink:label="lab_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBIT</link:label>
    <link:label id="lab_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges_label_en-US" xlink:label="lab_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) From Continuing Operations Before Income Taxes, Interest And Debt Expense, And Other Charges</link:label>
    <link:label id="lab_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges_documentation_en-US" xlink:label="lab_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income (Loss) From Continuing Operations Before Income Taxes, Interest And Debt Expense, And Other Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges" xlink:href="gehc-20250331.xsd#gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges" xlink:to="lab_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_600cfd5e-48d7-456c-be4e-289be1ba1dab_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Not designated as hedging instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_8fd883cb-bcad-4c00-8c66-8781b1cdbb1a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_04007ed8-9aaa-4e91-b530-6e9598b9ef9a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent_c3c8f7db-3e96-46b0-99da-97271ccf414e_terseLabel_en-US" xlink:label="lab_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Environmental and asset retirement obligations</link:label>
    <link:label id="lab_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent_label_en-US" xlink:label="lab_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Retirement Obligation And Accrued Environmental Loss Contingencies, Current</link:label>
    <link:label id="lab_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent_documentation_en-US" xlink:label="lab_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Retirement Obligation And Accrued Environmental Loss Contingencies, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent" xlink:href="gehc-20250331.xsd#gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent" xlink:to="lab_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_318896df-88d8-4ef1-a163-95ed4bd0db8b_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income attributable to GE HealthCare</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_b61d1122-e94c-4ee5-af0c-6e27e5e2cf19_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income attributable to GE HealthCare</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnderlyingAssetClassDomain_43b32497-7cb3-4b71-a534-821a374d875f_terseLabel_en-US" xlink:label="lab_us-gaap_UnderlyingAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_UnderlyingAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_UnderlyingAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderlyingAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnderlyingAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnderlyingAssetClassDomain" xlink:to="lab_us-gaap_UnderlyingAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_1c452ef4-b454-4b8e-9069-c957258040cf_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) &#8211; NET</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_d9023d15-a8d6-4471-8c56-1c3ca284ce36_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined contribution plan, employer contribution amount</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_7c1815f4-d42a-4303-bb79-16117287aefd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gain on remeasurement of Nihon Medi-Physics equity method investment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_d4c910aa-9521-4e93-af7b-ebd11e43957d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on remeasurement of NMP equity method investment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_TrademarksAndOtherMember_2c7778ab-1ec6-44e3-9bef-ff22b6738e85_terseLabel_en-US" xlink:label="lab_gehc_TrademarksAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trademarks and other</link:label>
    <link:label id="lab_gehc_TrademarksAndOtherMember_label_en-US" xlink:label="lab_gehc_TrademarksAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trademarks And Other [Member]</link:label>
    <link:label id="lab_gehc_TrademarksAndOtherMember_documentation_en-US" xlink:label="lab_gehc_TrademarksAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Trademarks And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_TrademarksAndOtherMember" xlink:href="gehc-20250331.xsd#gehc_TrademarksAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_TrademarksAndOtherMember" xlink:to="lab_gehc_TrademarksAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_9b540e08-b6bc-40fb-9862-f96442b7a00c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_9d3ad1e0-4d09-4557-9136-eaba03f3ef8a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_b91a6acb-a992-4048-b77b-eea216c8e3ac_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Special termination cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Cost of Providing Special and Contractual Termination Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" xlink:to="lab_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_GEHealthCareSupplementalPensionPlanMember_94bf703b-cc83-443c-973d-eda9df7a49d9_terseLabel_en-US" xlink:label="lab_gehc_GEHealthCareSupplementalPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GE HealthCare Supplemental Pension Plan</link:label>
    <link:label id="lab_gehc_GEHealthCareSupplementalPensionPlanMember_label_en-US" xlink:label="lab_gehc_GEHealthCareSupplementalPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GE HealthCare Supplemental Pension Plan [Member]</link:label>
    <link:label id="lab_gehc_GEHealthCareSupplementalPensionPlanMember_documentation_en-US" xlink:label="lab_gehc_GEHealthCareSupplementalPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GE HealthCare Supplemental Pension Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_GEHealthCareSupplementalPensionPlanMember" xlink:href="gehc-20250331.xsd#gehc_GEHealthCareSupplementalPensionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_GEHealthCareSupplementalPensionPlanMember" xlink:to="lab_gehc_GEHealthCareSupplementalPensionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_bfadb819-9174-479c-a53b-d552d3b54e13_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_PaymentsForRestructuringAndOtherAdjustments_cc5bf985-3951-46fd-8782-e56b3b95e808_negatedTerseLabel_en-US" xlink:label="lab_gehc_PaymentsForRestructuringAndOtherAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments and other adjustments</link:label>
    <link:label id="lab_gehc_PaymentsForRestructuringAndOtherAdjustments_label_en-US" xlink:label="lab_gehc_PaymentsForRestructuringAndOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments For Restructuring And Other Adjustments</link:label>
    <link:label id="lab_gehc_PaymentsForRestructuringAndOtherAdjustments_documentation_en-US" xlink:label="lab_gehc_PaymentsForRestructuringAndOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments For Restructuring And Other Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PaymentsForRestructuringAndOtherAdjustments" xlink:href="gehc-20250331.xsd#gehc_PaymentsForRestructuringAndOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_PaymentsForRestructuringAndOtherAdjustments" xlink:to="lab_gehc_PaymentsForRestructuringAndOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_5a703d19-89af-43d2-95c3-0dbf214aa218_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_bfd0edaa-bbd9-4f0d-94a4-92f5e6e05321_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_fd3c0bff-c2b5-42e5-bb57-40feb91ff326_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flow hedges &#8211; net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_9fe95bc9-7530-40da-83da-639713946941_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">REVENUE RECOGNITION</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_982392cc-05f4-4e56-a0a8-b31bd4de1d06_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_OtherItemsIncomeExpenseNet_f3b4778d-2547-47d6-b979-b35ef7f85704_terseLabel_en-US" xlink:label="lab_gehc_OtherItemsIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other items, net</link:label>
    <link:label id="lab_gehc_OtherItemsIncomeExpenseNet_label_en-US" xlink:label="lab_gehc_OtherItemsIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Items, Income (Expense), Net</link:label>
    <link:label id="lab_gehc_OtherItemsIncomeExpenseNet_documentation_en-US" xlink:label="lab_gehc_OtherItemsIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Items, Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherItemsIncomeExpenseNet" xlink:href="gehc-20250331.xsd#gehc_OtherItemsIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_OtherItemsIncomeExpenseNet" xlink:to="lab_gehc_OtherItemsIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_4dfe23c1-c58f-446b-abd1-3fbc8de90f3e_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_b099b708-042c-4e59-b518-8ad82ecc0642_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtMaturingInMoreThanThreeMonths_62da49d4-f1e8-4615-ad7d-4333ada8aff3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtMaturingInMoreThanThreeMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Newly issued debt, net of debt issuance costs (maturities longer than 90 days)</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtMaturingInMoreThanThreeMonths_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtMaturingInMoreThanThreeMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Debt, Maturing in More than Three Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtMaturingInMoreThanThreeMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromDebtMaturingInMoreThanThreeMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtMaturingInMoreThanThreeMonths" xlink:to="lab_us-gaap_ProceedsFromDebtMaturingInMoreThanThreeMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_d24df50c-11e9-4047-9280-3dcb7ca5eae0_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average number of shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_636d111f-72c5-48b6-80b3-b4e137b70b94_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_60736948-0c19-4ab1-91c9-a5c91b4c9bfd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ae57be5-4c28-40f5-bad8-009a37e074d5_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of foreign currency rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_d388521c-49b8-461b-ac63-235a6d15afad_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee termination costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_679dac6e-11e2-4296-92c2-544cdc4f1f14_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnderlyingAssetClassAxis_1c280a8f-57a2-4831-8928-23e85bb49372_terseLabel_en-US" xlink:label="lab_us-gaap_UnderlyingAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_UnderlyingAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_UnderlyingAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderlyingAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnderlyingAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnderlyingAssetClassAxis" xlink:to="lab_us-gaap_UnderlyingAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_447596f5-7581-4926-8c7f-06fccf9ede17_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_f4369157-b98f-4a36-9b5e-80f47205a700_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_d153b57f-e21c-49c7-91c2-d3bdab68fc09_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent_aa836d1c-4077-4f0e-94b8-3043bd6a2044_totalLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Non-current financing receivables &#8211; net</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent_1e6b4a7d-2c5c-44d8-a79f-d8a0a03cc880_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing receivables &#8211; net</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:to="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_483f6922-63ba-4af2-bb43-45b9643a3f36_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cross-currency swaps</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_2bf03072-9ffd-4b31-9248-53365968fda2_verboseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cross-currency swaps</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_AccruedFreightAndUtilitiesCurrent_8bde45e7-b337-40c1-9747-dbb0f907ce87_terseLabel_en-US" xlink:label="lab_gehc_AccruedFreightAndUtilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued freight and utilities</link:label>
    <link:label id="lab_gehc_AccruedFreightAndUtilitiesCurrent_label_en-US" xlink:label="lab_gehc_AccruedFreightAndUtilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Freight And Utilities, Current</link:label>
    <link:label id="lab_gehc_AccruedFreightAndUtilitiesCurrent_documentation_en-US" xlink:label="lab_gehc_AccruedFreightAndUtilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Freight And Utilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AccruedFreightAndUtilitiesCurrent" xlink:href="gehc-20250331.xsd#gehc_AccruedFreightAndUtilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_AccruedFreightAndUtilitiesCurrent" xlink:to="lab_gehc_AccruedFreightAndUtilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherContractMember_255140c3-c907-4e64-8424-d081a75e748f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other derivatives</link:label>
    <link:label id="lab_us-gaap_OtherContractMember_label_en-US" xlink:label="lab_us-gaap_OtherContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherContractMember" xlink:to="lab_us-gaap_OtherContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_887dac75-f1b2-4fef-bc39-cecad2205df1_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_cf5b5f3f-b9ec-4aa4-976e-d7f959fd1d1e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_d7911f3e-00fd-42bf-8af2-3f479466dbb8_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract liabilities, revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e2be79f4-e866-4962-b223-92126d749462_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net (income) loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d0e0df5c-1344-4962-828e-1f74272157a7_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss) attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_f3e0df0e-1c02-4ff3-9f87-ef04d104ffd5_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RECLASSIFICATION</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_1b51044b-070e-4ec1-a7be-4df10e1e0d01_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_f3bf65ab-3099-46a3-914a-bd711fc90b26_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_SpecializedUltrasoundSubsegmentMember_48985422-0dc6-4629-a228-6b7486c34109_terseLabel_en-US" xlink:label="lab_gehc_SpecializedUltrasoundSubsegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Specialized Ultrasound</link:label>
    <link:label id="lab_gehc_SpecializedUltrasoundSubsegmentMember_label_en-US" xlink:label="lab_gehc_SpecializedUltrasoundSubsegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Specialized Ultrasound Subsegment [Member]</link:label>
    <link:label id="lab_gehc_SpecializedUltrasoundSubsegmentMember_documentation_en-US" xlink:label="lab_gehc_SpecializedUltrasoundSubsegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Specialized Ultrasound Subsegment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_SpecializedUltrasoundSubsegmentMember" xlink:href="gehc-20250331.xsd#gehc_SpecializedUltrasoundSubsegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_SpecializedUltrasoundSubsegmentMember" xlink:to="lab_gehc_SpecializedUltrasoundSubsegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_70d9bb12-7d85-473f-89cc-2159a2cd964b_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Redeemable Noncontrolling Interest [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2ced3dcf-f5d9-4854-b5f4-583f779ab7e3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a31352af-c6ce-4a4c-95b4-10c8abc4986d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive income (loss) &#8211; net</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_7552dedd-9b80-4a6c-9d6d-73a65842f1fc_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_39f9797d-e4da-4b0e-b378-5b6adfc42703_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_ebbf1429-7722-43ac-9220-073f9b5cbd68_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent_61f580b9-f6c5-49ba-85e3-ed6c6855d363_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term receivables &#8211; net</link:label>
    <link:label id="lab_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Receivable, after Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" xlink:to="lab_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7b438b60-aff9-4504-aed1-bf1b9d5a70ac_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ace76d0d-f692-4e0f-997a-ec656d63ffdb_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic weighted-average shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivablesEqualToGreaterThan90DaysPastDueMember_daf75f4a-02aa-44d2-bbb9-6263bea001e8_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivablesEqualToGreaterThan90DaysPastDueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Over 90 days past due</link:label>
    <link:label id="lab_us-gaap_FinancingReceivablesEqualToGreaterThan90DaysPastDueMember_label_en-US" xlink:label="lab_us-gaap_FinancingReceivablesEqualToGreaterThan90DaysPastDueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Asset, Equal to or Greater than 90 Days Past Due [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesEqualToGreaterThan90DaysPastDueMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablesEqualToGreaterThan90DaysPastDueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivablesEqualToGreaterThan90DaysPastDueMember" xlink:to="lab_us-gaap_FinancingReceivablesEqualToGreaterThan90DaysPastDueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent_b6b7c679-c0b3-4873-94b9-7d79c175c26d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNoncurrent_c51d9db4-532e-4b13-b5bf-ba28f844bbbd_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNoncurrent_label_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNoncurrent" xlink:to="lab_us-gaap_InventoryNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3dab9897-e194-4529-8dc1-002929e277fd_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_58376edb-1d38-491b-8ce7-23fdbfb0859f_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Equity, beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2ee5c6f9-370e-4f6c-b72f-c751f21474a2_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Equity, ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4d622230-7558-479a-81a8-a650174b5b82_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_261e1222-2137-42b6-be36-8f6cbe960532_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent_2d6e04e3-c0ff-469c-961f-3d348d0d02cf_terseLabel_en-US" xlink:label="lab_gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income and indirect tax liabilities including uncertain tax positions</link:label>
    <link:label id="lab_gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent_label_en-US" xlink:label="lab_gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Taxes and Other Tax Liabilities, Current</link:label>
    <link:label id="lab_gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent_documentation_en-US" xlink:label="lab_gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Income Taxes and Other Tax Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent" xlink:href="gehc-20250331.xsd#gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent" xlink:to="lab_gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_9af1cd5c-96bf-4b9a-8bb3-25707de90a6f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_LeaseholdImprovementsAndManufacturingPlantsMember_fc8faf23-0a50-45dc-9731-7fbaf0ed3a34_terseLabel_en-US" xlink:label="lab_gehc_LeaseholdImprovementsAndManufacturingPlantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements and manufacturing plants under construction</link:label>
    <link:label id="lab_gehc_LeaseholdImprovementsAndManufacturingPlantsMember_label_en-US" xlink:label="lab_gehc_LeaseholdImprovementsAndManufacturingPlantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements And Manufacturing Plants [Member]</link:label>
    <link:label id="lab_gehc_LeaseholdImprovementsAndManufacturingPlantsMember_documentation_en-US" xlink:label="lab_gehc_LeaseholdImprovementsAndManufacturingPlantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Leasehold Improvements And Manufacturing Plants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_LeaseholdImprovementsAndManufacturingPlantsMember" xlink:href="gehc-20250331.xsd#gehc_LeaseholdImprovementsAndManufacturingPlantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_LeaseholdImprovementsAndManufacturingPlantsMember" xlink:to="lab_gehc_LeaseholdImprovementsAndManufacturingPlantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gehc_ContingentConsiderationServiceRequirementsMember_bd3fdfaf-9075-4b99-893b-6806925aa6ea_terseLabel_en-US" xlink:label="lab_gehc_ContingentConsiderationServiceRequirementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Service requirements</link:label>
    <link:label id="lab_gehc_ContingentConsiderationServiceRequirementsMember_label_en-US" xlink:label="lab_gehc_ContingentConsiderationServiceRequirementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration, Service Requirements [Member]</link:label>
    <link:label id="lab_gehc_ContingentConsiderationServiceRequirementsMember_documentation_en-US" xlink:label="lab_gehc_ContingentConsiderationServiceRequirementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Consideration, Service Requirements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ContingentConsiderationServiceRequirementsMember" xlink:href="gehc-20250331.xsd#gehc_ContingentConsiderationServiceRequirementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gehc_ContingentConsiderationServiceRequirementsMember" xlink:to="lab_gehc_ContingentConsiderationServiceRequirementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_62dd7f2b-1666-46b4-ba41-3a4979ff139b_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_a7e4a6e9-508f-4504-9de7-d20bbc027731_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring liabilities</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_51b6cbbf-13cb-4920-8f7e-c493acdf11db_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_1194e439-f19c-4818-a68e-53029ae576c1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining performance obligations, amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_7c048220-4046-482a-8610-fd4bb5009849_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>gehc-20250331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:d0a8a86e-df0d-464c-9ff8-447ea6f21cea,g:ade862ec-33b2-4b8a-bb85-176c06a683fa-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.gehealthcare.com/role/Cover" xlink:type="simple" xlink:href="gehc-20250331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_a6db1fea-b7d6-4aa7-a469-6794bbbb737b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_DocumentType_a6db1fea-b7d6-4aa7-a469-6794bbbb737b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_af878f37-bb16-470b-b9ec-1843953edee2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_DocumentQuarterlyReport_af878f37-bb16-470b-b9ec-1843953edee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_c2b2f714-8cd9-474d-af0c-31e12bfd0af4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_DocumentPeriodEndDate_c2b2f714-8cd9-474d-af0c-31e12bfd0af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_c66ec2a8-a6c6-4ab1-9eea-89319e5def2e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_DocumentTransitionReport_c66ec2a8-a6c6-4ab1-9eea-89319e5def2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_63474a2f-b858-49f6-a2a1-0536559bf719" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_EntityFileNumber_63474a2f-b858-49f6-a2a1-0536559bf719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_c5f3cb4a-0a87-47fd-ace3-acbfd4e1b4ee" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_EntityRegistrantName_c5f3cb4a-0a87-47fd-ace3-acbfd4e1b4ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_4c48ab69-b59b-4bbb-aef2-ad404c3b1ae0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_EntityIncorporationStateCountryCode_4c48ab69-b59b-4bbb-aef2-ad404c3b1ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_1263f018-f3c4-49fd-8668-a0deade68cb4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_EntityTaxIdentificationNumber_1263f018-f3c4-49fd-8668-a0deade68cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_93dc4f2e-94a3-47b6-af00-5da29aba485f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_EntityAddressAddressLine1_93dc4f2e-94a3-47b6-af00-5da29aba485f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1e3691bb-6d43-4fcd-8c4a-63a13d82587c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_EntityAddressCityOrTown_1e3691bb-6d43-4fcd-8c4a-63a13d82587c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_2e997930-0d29-40f5-abfe-088bcaaa49cd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_EntityAddressStateOrProvince_2e997930-0d29-40f5-abfe-088bcaaa49cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_ad630ba0-405d-4e5b-ad63-464b0102d32e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_EntityAddressPostalZipCode_ad630ba0-405d-4e5b-ad63-464b0102d32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_0df62fab-7066-42ef-86b9-ff12754a5597" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_CityAreaCode_0df62fab-7066-42ef-86b9-ff12754a5597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_17aeb896-cef3-4e1d-ad0a-3345ca3dc86a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_LocalPhoneNumber_17aeb896-cef3-4e1d-ad0a-3345ca3dc86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9fca7dd4-6252-471c-a200-98e0eb95d011" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_Security12bTitle_9fca7dd4-6252-471c-a200-98e0eb95d011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9be3e1c6-157f-4f62-960e-4f68af0000dc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_TradingSymbol_9be3e1c6-157f-4f62-960e-4f68af0000dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f5dafed3-5538-4e96-b6b8-9fe48310721d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_SecurityExchangeName_f5dafed3-5538-4e96-b6b8-9fe48310721d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_8bf8a694-d7c0-4af9-97bf-1f9f41b7a2cd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_EntityCurrentReportingStatus_8bf8a694-d7c0-4af9-97bf-1f9f41b7a2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_bf33fa54-c185-4e52-9af6-49a61d37664b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_EntityInteractiveDataCurrent_bf33fa54-c185-4e52-9af6-49a61d37664b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_85dd47ac-70b9-479e-b5d9-a9ff227f5b57" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_EntityFilerCategory_85dd47ac-70b9-479e-b5d9-a9ff227f5b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_52a08d6c-b704-4669-80e6-5f664c9d32fe" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_EntitySmallBusiness_52a08d6c-b704-4669-80e6-5f664c9d32fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_5f399924-fa63-4d7f-b30f-737b1b961cf8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_EntityEmergingGrowthCompany_5f399924-fa63-4d7f-b30f-737b1b961cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_84511c03-f00d-47cf-8e2f-d25652014aad" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_EntityShellCompany_84511c03-f00d-47cf-8e2f-d25652014aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_2bbeeb6c-0079-4916-9122-578d0da87f1c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_2bbeeb6c-0079-4916-9122-578d0da87f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_2a2e9932-ca87-43ac-b344-9bdc21cc4bd1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_AmendmentFlag_2a2e9932-ca87-43ac-b344-9bdc21cc4bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_cdf5d3ee-12ea-4117-be5e-3802b09b53f8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_EntityCentralIndexKey_cdf5d3ee-12ea-4117-be5e-3802b09b53f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_cec55dc8-dba2-4708-88c8-22fd65a7825f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_DocumentFiscalPeriodFocus_cec55dc8-dba2-4708-88c8-22fd65a7825f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_e73e14a5-2a4b-43a3-b6f6-a9873ce9d2c0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_DocumentFiscalYearFocus_e73e14a5-2a4b-43a3-b6f6-a9873ce9d2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_139f9822-667c-49b3-906d-286ce9b145e3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7c34f1fe-1714-4788-a5ef-231d6184445a" xlink:to="loc_dei_CurrentFiscalYearEndDate_139f9822-667c-49b3-906d-286ce9b145e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" xlink:type="simple" xlink:href="gehc-20250331.xsd#CondensedConsolidatedStatementsofIncomeUnaudited"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_4e740d3c-7631-4c82-bb64-d2129ae0c042" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_deabb44d-5d41-4721-af90-438008d92ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4e740d3c-7631-4c82-bb64-d2129ae0c042" xlink:to="loc_us-gaap_StatementTable_deabb44d-5d41-4721-af90-438008d92ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c3defb8b-8a1b-43f9-91cb-6507f8d36476" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_deabb44d-5d41-4721-af90-438008d92ea9" xlink:to="loc_srt_ProductOrServiceAxis_c3defb8b-8a1b-43f9-91cb-6507f8d36476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b2ead9e3-314e-4839-b6e9-d7f1ee0be9fc" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c3defb8b-8a1b-43f9-91cb-6507f8d36476" xlink:to="loc_srt_ProductsAndServicesDomain_b2ead9e3-314e-4839-b6e9-d7f1ee0be9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_695b17fc-7623-4f34-a77e-73962c40646f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b2ead9e3-314e-4839-b6e9-d7f1ee0be9fc" xlink:to="loc_us-gaap_ProductMember_695b17fc-7623-4f34-a77e-73962c40646f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_c2dfe19c-451a-4c28-a4d8-86de87d529c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b2ead9e3-314e-4839-b6e9-d7f1ee0be9fc" xlink:to="loc_us-gaap_ServiceMember_c2dfe19c-451a-4c28-a4d8-86de87d529c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_deabb44d-5d41-4721-af90-438008d92ea9" xlink:to="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7bb06062-6b23-4ba0-87cd-bb03e3922fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7bb06062-6b23-4ba0-87cd-bb03e3922fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_98f1d499-f680-481a-ac36-ea386863c2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_CostOfRevenue_98f1d499-f680-481a-ac36-ea386863c2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_fad187ef-16c6-4bb4-a48e-29136bd6906c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_GrossProfit_fad187ef-16c6-4bb4-a48e-29136bd6906c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_95402c79-b426-4634-a31d-5d9fa43b2bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_95402c79-b426-4634-a31d-5d9fa43b2bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_7158bdd1-e335-4ab6-844e-567911b7c3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_7158bdd1-e335-4ab6-844e-567911b7c3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_7124743a-0188-471f-b866-7689c22503b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_OperatingExpenses_7124743a-0188-471f-b866-7689c22503b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4587cc86-1c7f-49c7-a73d-bd9a94f5a891" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_OperatingIncomeLoss_4587cc86-1c7f-49c7-a73d-bd9a94f5a891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_8877785d-3b2f-4e91-b106-bead40009fce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_InterestAndDebtExpense_8877785d-3b2f-4e91-b106-bead40009fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_3bf74222-0785-49f0-ad19-8964d802fe38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_3bf74222-0785-49f0-ad19-8964d802fe38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0cf6ca41-fad3-4133-8d80-e8e201c146ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0cf6ca41-fad3-4133-8d80-e8e201c146ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b0bb9e9b-1663-4e69-85d2-34eb6cb7b5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b0bb9e9b-1663-4e69-85d2-34eb6cb7b5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_579f2424-1779-4d20-88ac-b5d552c45fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_579f2424-1779-4d20-88ac-b5d552c45fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c0eb258e-d8ae-4b38-9947-077709286824" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_ProfitLoss_c0eb258e-d8ae-4b38-9947-077709286824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6d2bfa49-c078-4796-9eeb-c653b7a32f67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6d2bfa49-c078-4796-9eeb-c653b7a32f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4b7d6ec4-c4e4-475d-8b79-adda30c5b7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_NetIncomeLoss_4b7d6ec4-c4e4-475d-8b79-adda30c5b7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_32ec2ef4-e8b6-4e29-a60c-cf93a121d2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_32ec2ef4-e8b6-4e29-a60c-cf93a121d2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b5a08557-bccc-432d-98b2-3243a9a8d67b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_32ec2ef4-e8b6-4e29-a60c-cf93a121d2c1" xlink:to="loc_us-gaap_EarningsPerShareBasic_b5a08557-bccc-432d-98b2-3243a9a8d67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_40af56ee-af96-4240-a3a0-480360835955" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_32ec2ef4-e8b6-4e29-a60c-cf93a121d2c1" xlink:to="loc_us-gaap_EarningsPerShareDiluted_40af56ee-af96-4240-a3a0-480360835955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_11230128-aee1-490c-9efd-5a3f622a0a49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ef17fc12-617c-436d-87fd-914554714cd9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_11230128-aee1-490c-9efd-5a3f622a0a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_08ea6dd4-77b8-4df1-8be7-81cee5f27413" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_11230128-aee1-490c-9efd-5a3f622a0a49" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_08ea6dd4-77b8-4df1-8be7-81cee5f27413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bc0496bd-c97d-4d1b-9972-ad9727e314fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_11230128-aee1-490c-9efd-5a3f622a0a49" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bc0496bd-c97d-4d1b-9972-ad9727e314fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" xlink:type="simple" xlink:href="gehc-20250331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c254ddf6-3b54-4a3d-befb-3b67a51a9ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c590b828-7db7-4318-a183-b4b864f20664" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c254ddf6-3b54-4a3d-befb-3b67a51a9ac6" xlink:to="loc_us-gaap_NetIncomeLoss_c590b828-7db7-4318-a183-b4b864f20664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_49dccdbc-e818-40df-b587-0ef60bee7dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c254ddf6-3b54-4a3d-befb-3b67a51a9ac6" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_49dccdbc-e818-40df-b587-0ef60bee7dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_468c63fe-0f1c-4f31-ab8d-dc118f2f3a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c254ddf6-3b54-4a3d-befb-3b67a51a9ac6" xlink:to="loc_us-gaap_ProfitLoss_468c63fe-0f1c-4f31-ab8d-dc118f2f3a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_39a68ab7-91e1-46b7-a242-c49ecd75838e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c254ddf6-3b54-4a3d-befb-3b67a51a9ac6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_39a68ab7-91e1-46b7-a242-c49ecd75838e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c3ce22e3-9e38-43a7-8826-0cb63e510daa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_39a68ab7-91e1-46b7-a242-c49ecd75838e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c3ce22e3-9e38-43a7-8826-0cb63e510daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_18d46bd2-f98a-4547-9212-d648d4733607" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_39a68ab7-91e1-46b7-a242-c49ecd75838e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_18d46bd2-f98a-4547-9212-d648d4733607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_918df61e-e5db-435c-b6b5-a453b237380c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_39a68ab7-91e1-46b7-a242-c49ecd75838e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_918df61e-e5db-435c-b6b5-a453b237380c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f206a747-0c1c-4b61-b813-14a21975853b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_39a68ab7-91e1-46b7-a242-c49ecd75838e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f206a747-0c1c-4b61-b813-14a21975853b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a273c7ca-70ac-4781-a1ab-803799bc6258" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c254ddf6-3b54-4a3d-befb-3b67a51a9ac6" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a273c7ca-70ac-4781-a1ab-803799bc6258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b2571ff3-d74b-4edd-af91-c45e5ead32d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c254ddf6-3b54-4a3d-befb-3b67a51a9ac6" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b2571ff3-d74b-4edd-af91-c45e5ead32d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4c6580f1-7b00-4a45-89c5-a3abb8c0da87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c254ddf6-3b54-4a3d-befb-3b67a51a9ac6" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_4c6580f1-7b00-4a45-89c5-a3abb8c0da87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited" xlink:type="simple" xlink:href="gehc-20250331.xsd#CondensedConsolidatedStatementsofFinancialPositionUnaudited"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_ceeec1c9-d730-4b22-aca9-42465af3e6cb" xlink:href="gehc-20250331.xsd#gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_ceeec1c9-d730-4b22-aca9-42465af3e6cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_09386184-56b5-49b6-b33c-1f705dfbbb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_09386184-56b5-49b6-b33c-1f705dfbbb9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a5f8ec4b-a2cc-43b7-8c69-8324d1a958c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_InventoryNet_a5f8ec4b-a2cc-43b7-8c69-8324d1a958c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent_9420a797-b26b-4811-a4b1-93e3e16b995e" xlink:href="gehc-20250331.xsd#gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent_9420a797-b26b-4811-a4b1-93e3e16b995e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_0c797580-d455-4c98-8157-e69747b52ede" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_OtherAssetsCurrent_0c797580-d455-4c98-8157-e69747b52ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d300265e-6284-4434-80b5-9d5f78fa9e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_AssetsCurrent_d300265e-6284-4434-80b5-9d5f78fa9e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_ca3d5622-163a-4a98-b82f-881b1f2a1134" xlink:href="gehc-20250331.xsd#gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_ca3d5622-163a-4a98-b82f-881b1f2a1134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c4acfefb-ae1d-436b-a831-19fb0cbcd50b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_Goodwill_c4acfefb-ae1d-436b-a831-19fb0cbcd50b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9dd60cc4-b7ef-4d76-b5f4-73d20a5b34b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9dd60cc4-b7ef-4d76-b5f4-73d20a5b34b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_bfba30bb-baa3-436e-8cf3-1de730b7dbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_bfba30bb-baa3-436e-8cf3-1de730b7dbcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5edbd905-60be-44da-848a-a402d71c5833" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5edbd905-60be-44da-848a-a402d71c5833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_36f08b28-51ad-4ee1-bd77-142e9375f5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_Assets_36f08b28-51ad-4ee1-bd77-142e9375f5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_3bc51b14-3669-4fa0-a355-d677940923bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_ShortTermBorrowings_3bc51b14-3669-4fa0-a355-d677940923bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a55c2588-2b24-4c55-912e-fc1a0724502e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_AccountsPayableCurrent_a55c2588-2b24-4c55-912e-fc1a0724502e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_af21f13d-0d47-4b86-9f73-b35e7e85e778" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_af21f13d-0d47-4b86-9f73-b35e7e85e778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ca3eec8d-c78d-4e58-be1f-7ce711b3359b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ca3eec8d-c78d-4e58-be1f-7ce711b3359b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_3e0be526-b8bb-43ee-bdf3-9e65d50e5cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_3e0be526-b8bb-43ee-bdf3-9e65d50e5cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ce192445-ab37-4858-adee-ce4bd67e0c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_LiabilitiesCurrent_ce192445-ab37-4858-adee-ce4bd67e0c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_d0b6b08e-fb39-4385-8ddc-28f8dccbf7d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_d0b6b08e-fb39-4385-8ddc-28f8dccbf7d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_943cd0dc-cba8-4826-a392-eef0fa026f83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_943cd0dc-cba8-4826-a392-eef0fa026f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_66deeb1e-4136-4029-86a4-e4ff2d068ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_66deeb1e-4136-4029-86a4-e4ff2d068ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1ba68ca2-c5e9-43f6-8dd6-8b6f440e83b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_1ba68ca2-c5e9-43f6-8dd6-8b6f440e83b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_cbc4abf5-37d9-43b0-a370-766c5610a917" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_Liabilities_cbc4abf5-37d9-43b0-a370-766c5610a917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_bcbb165a-0a0e-4d34-ad44-509728eddac8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_CommitmentsAndContingencies_bcbb165a-0a0e-4d34-ad44-509728eddac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_01b6a0f1-5e4e-4f38-a3ca-039da866c099" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_01b6a0f1-5e4e-4f38-a3ca-039da866c099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_153930d8-f2d0-4fc7-a4ab-716bc03186c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_CommonStockValue_153930d8-f2d0-4fc7-a4ab-716bc03186c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_216a608c-ff59-4936-862c-b9880d156621" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_TreasuryStockCommonValue_216a608c-ff59-4936-862c-b9880d156621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_cfb3f3b5-5e9d-48e3-8f7a-f6312e400e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_AdditionalPaidInCapital_cfb3f3b5-5e9d-48e3-8f7a-f6312e400e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e5aaf9ad-7e51-4789-8a73-62573d6afb88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e5aaf9ad-7e51-4789-8a73-62573d6afb88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b5d1122b-4a14-478b-8d87-2758882575c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b5d1122b-4a14-478b-8d87-2758882575c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_92e94a29-1f02-478b-9b5f-7114ee165053" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_StockholdersEquity_92e94a29-1f02-478b-9b5f-7114ee165053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_e4ff62e4-6ebe-42cb-979a-343d2a451a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_MinorityInterest_e4ff62e4-6ebe-42cb-979a-343d2a451a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_de557c93-41dd-414f-b728-c3747ac764a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_de557c93-41dd-414f-b728-c3747ac764a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_3877f770-4e23-4dd7-a03c-e71c75ad5e50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f099374-fbc9-46db-811d-90358d7ce493" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_3877f770-4e23-4dd7-a03c-e71c75ad5e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnauditedParentheticals" xlink:type="simple" xlink:href="gehc-20250331.xsd#CondensedConsolidatedStatementsofFinancialPositionUnauditedParentheticals"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnauditedParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2b2ed346-fa12-4eba-a88b-f297d8025453" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3f366dc7-6694-401c-afac-5521dd5bbd15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2b2ed346-fa12-4eba-a88b-f297d8025453" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3f366dc7-6694-401c-afac-5521dd5bbd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_fbcbd164-4b35-411d-acf4-fb06925bc340" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2b2ed346-fa12-4eba-a88b-f297d8025453" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_fbcbd164-4b35-411d-acf4-fb06925bc340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_f58a98b6-9981-4315-9b0e-27c61e9da213" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2b2ed346-fa12-4eba-a88b-f297d8025453" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_f58a98b6-9981-4315-9b0e-27c61e9da213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_3ce5cbf6-fcb6-4845-8c0b-ea8f90e421a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2b2ed346-fa12-4eba-a88b-f297d8025453" xlink:to="loc_us-gaap_CommonStockSharesIssued_3ce5cbf6-fcb6-4845-8c0b-ea8f90e421a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_2d8e435c-1b7c-453f-b046-8d92696c619b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2b2ed346-fa12-4eba-a88b-f297d8025453" xlink:to="loc_us-gaap_TreasuryStockCommonShares_2d8e435c-1b7c-453f-b046-8d92696c619b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" xlink:type="simple" xlink:href="gehc-20250331.xsd#CondensedConsolidatedStatementsofChangesinEquityUnaudited"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_831e6d69-3238-4de2-a19c-7d6039ed2b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_40b4fed1-e025-4310-9bd8-2810f323a6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_831e6d69-3238-4de2-a19c-7d6039ed2b5e" xlink:to="loc_us-gaap_StatementTable_40b4fed1-e025-4310-9bd8-2810f323a6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f63549b5-d7f8-4a8d-aac2-af5cc9877a54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_40b4fed1-e025-4310-9bd8-2810f323a6d1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f63549b5-d7f8-4a8d-aac2-af5cc9877a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5c849c4f-8647-49da-90c5-244320785258" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f63549b5-d7f8-4a8d-aac2-af5cc9877a54" xlink:to="loc_us-gaap_EquityComponentDomain_5c849c4f-8647-49da-90c5-244320785258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8bc882fd-e650-4276-8d1a-1de951acff17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5c849c4f-8647-49da-90c5-244320785258" xlink:to="loc_us-gaap_CommonStockMember_8bc882fd-e650-4276-8d1a-1de951acff17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_e7c89c6b-6272-4a61-859a-0790535054c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5c849c4f-8647-49da-90c5-244320785258" xlink:to="loc_us-gaap_TreasuryStockCommonMember_e7c89c6b-6272-4a61-859a-0790535054c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ef1c9f2e-6cd6-48a8-9a50-822b1bc98495" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5c849c4f-8647-49da-90c5-244320785258" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ef1c9f2e-6cd6-48a8-9a50-822b1bc98495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_03c04159-fff9-42d8-816c-70fbe6e1dfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5c849c4f-8647-49da-90c5-244320785258" xlink:to="loc_us-gaap_RetainedEarningsMember_03c04159-fff9-42d8-816c-70fbe6e1dfd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2a6f8989-36c1-46cf-956d-38604893792b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5c849c4f-8647-49da-90c5-244320785258" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2a6f8989-36c1-46cf-956d-38604893792b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_10906374-7900-4ca5-8d16-a9336bd25c88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5c849c4f-8647-49da-90c5-244320785258" xlink:to="loc_us-gaap_NoncontrollingInterestMember_10906374-7900-4ca5-8d16-a9336bd25c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dce17e1d-915d-4e69-82af-62b2669a8e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_40b4fed1-e025-4310-9bd8-2810f323a6d1" xlink:to="loc_us-gaap_StatementLineItems_dce17e1d-915d-4e69-82af-62b2669a8e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dce17e1d-915d-4e69-82af-62b2669a8e9c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ac8a7ec6-f159-45c6-8374-1a0250b212ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_CommonStockSharesIssued_ac8a7ec6-f159-45c6-8374-1a0250b212ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_888fa791-7645-4928-9656-0c2d264df191" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_888fa791-7645-4928-9656-0c2d264df191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_1df26add-dfe7-4143-8824-392432597af0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_TreasuryStockCommonShares_1df26add-dfe7-4143-8824-392432597af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b952979b-1b9b-4cea-aeba-b1a38878ee3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b952979b-1b9b-4cea-aeba-b1a38878ee3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3b21cbb7-0de2-4bcf-8154-ff23668c0066" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3b21cbb7-0de2-4bcf-8154-ff23668c0066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1b6b9556-61fd-422a-a6e5-ac8583831edf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_NetIncomeLoss_1b6b9556-61fd-422a-a6e5-ac8583831edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_cf6d62ab-da09-421f-bd42-571adafd5b52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_Dividends_cf6d62ab-da09-421f-bd42-571adafd5b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_04020471-2432-4961-9b0b-5bccba3c1b64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_04020471-2432-4961-9b0b-5bccba3c1b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_53aa4654-6b70-43c7-b7a7-1a6fb1e46fde" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_53aa4654-6b70-43c7-b7a7-1a6fb1e46fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f5c45203-c08d-41e2-97fa-db75069eddfa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f5c45203-c08d-41e2-97fa-db75069eddfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e97fc051-41d5-43b1-bd9b-86cafee5894c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_CommonStockSharesIssued_e97fc051-41d5-43b1-bd9b-86cafee5894c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d89798d5-6a63-46a4-9a24-a4aedf24f311" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d89798d5-6a63-46a4-9a24-a4aedf24f311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_463adfa2-b0da-4725-8832-4b3761835ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7bb25cd5-e196-4daa-9a17-d6bb4a5878e6" xlink:to="loc_us-gaap_TreasuryStockCommonShares_463adfa2-b0da-4725-8832-4b3761835ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnauditedParenthetical" xlink:type="simple" xlink:href="gehc-20250331.xsd#CondensedConsolidatedStatementsofChangesinEquityUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_80a28392-6d4f-4046-9062-9a7117db957a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_4a40a613-c983-4c46-8f7d-a126e0fbf704" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_80a28392-6d4f-4046-9062-9a7117db957a" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_4a40a613-c983-4c46-8f7d-a126e0fbf704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="gehc-20250331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_cb6b0e12-aeb5-418d-85ab-b2ad7adbb3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_59698b0d-4b25-4aec-84dc-a5b1e1e74ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cb6b0e12-aeb5-418d-85ab-b2ad7adbb3f5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_59698b0d-4b25-4aec-84dc-a5b1e1e74ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4c899d77-e56a-4d96-9e5c-becd9992cc0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_59698b0d-4b25-4aec-84dc-a5b1e1e74ff1" xlink:to="loc_us-gaap_ProfitLoss_4c899d77-e56a-4d96-9e5c-becd9992cc0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ec3cb43-934e-4ad1-bedf-20194b17cb07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_59698b0d-4b25-4aec-84dc-a5b1e1e74ff1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ec3cb43-934e-4ad1-bedf-20194b17cb07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_1d2bb310-e6f6-443b-8ca6-f43c5ff7bd74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ec3cb43-934e-4ad1-bedf-20194b17cb07" xlink:to="loc_us-gaap_Depreciation_1d2bb310-e6f6-443b-8ca6-f43c5ff7bd74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2a958b9c-e3ad-4817-9322-ab76f8d5204d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ec3cb43-934e-4ad1-bedf-20194b17cb07" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2a958b9c-e3ad-4817-9322-ab76f8d5204d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_ea886d6f-b9e7-44c3-9cb2-d2c0820eda39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ec3cb43-934e-4ad1-bedf-20194b17cb07" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_ea886d6f-b9e7-44c3-9cb2-d2c0820eda39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_154c63ef-8e53-4417-93a2-fc8f202cc8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ec3cb43-934e-4ad1-bedf-20194b17cb07" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_154c63ef-8e53-4417-93a2-fc8f202cc8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost_95cdd2fb-1358-4ab4-b040-447951cd802d" xlink:href="gehc-20250331.xsd#gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ec3cb43-934e-4ad1-bedf-20194b17cb07" xlink:to="loc_gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost_95cdd2fb-1358-4ab4-b040-447951cd802d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c1e30f11-89aa-496e-b4e3-7d6d7fbe991a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ec3cb43-934e-4ad1-bedf-20194b17cb07" xlink:to="loc_us-gaap_ShareBasedCompensation_c1e30f11-89aa-496e-b4e3-7d6d7fbe991a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_dff96a90-eb80-4ce7-bc4f-414a672b4009" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ec3cb43-934e-4ad1-bedf-20194b17cb07" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_dff96a90-eb80-4ce7-bc4f-414a672b4009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_8d0f436a-168b-42b4-976a-71abc2999efc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ec3cb43-934e-4ad1-bedf-20194b17cb07" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_8d0f436a-168b-42b4-976a-71abc2999efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9bfdd2e-049a-47ad-911c-a3650d721b98" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ec3cb43-934e-4ad1-bedf-20194b17cb07" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9bfdd2e-049a-47ad-911c-a3650d721b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_2dcbaeb2-cdaa-4fc1-8ea2-e7d196495c31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9bfdd2e-049a-47ad-911c-a3650d721b98" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_2dcbaeb2-cdaa-4fc1-8ea2-e7d196495c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_609ef780-f512-4520-a0fc-1d8ec43be176" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9bfdd2e-049a-47ad-911c-a3650d721b98" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_609ef780-f512-4520-a0fc-1d8ec43be176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts_1815181d-d0e3-4c3d-8dd1-129b8f90ff18" xlink:href="gehc-20250331.xsd#gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9bfdd2e-049a-47ad-911c-a3650d721b98" xlink:to="loc_gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts_1815181d-d0e3-4c3d-8dd1-129b8f90ff18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_61761541-e567-423d-81e7-4d91ce649eba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9bfdd2e-049a-47ad-911c-a3650d721b98" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_61761541-e567-423d-81e7-4d91ce649eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2e9d3036-9eee-4adb-bdbe-b4e3e589db3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9bfdd2e-049a-47ad-911c-a3650d721b98" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2e9d3036-9eee-4adb-bdbe-b4e3e589db3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_b11f97d5-8f47-42bc-aa20-3c60b6bfd564" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a9bfdd2e-049a-47ad-911c-a3650d721b98" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_b11f97d5-8f47-42bc-aa20-3c60b6bfd564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_14983a58-d656-4038-95aa-58c93e214176" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ec3cb43-934e-4ad1-bedf-20194b17cb07" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_14983a58-d656-4038-95aa-58c93e214176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_95a4b46e-8dc2-4009-9659-f0830bf0a91c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_59698b0d-4b25-4aec-84dc-a5b1e1e74ff1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_95a4b46e-8dc2-4009-9659-f0830bf0a91c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93e1cadd-03f6-4b01-be08-c746f1ff9277" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cb6b0e12-aeb5-418d-85ab-b2ad7adbb3f5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93e1cadd-03f6-4b01-be08-c746f1ff9277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_38517c37-c15b-4bb7-a6cc-a5bf504295aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93e1cadd-03f6-4b01-be08-c746f1ff9277" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_38517c37-c15b-4bb7-a6cc-a5bf504295aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_5b3d57ed-59ea-4d87-884e-91ebd7b02a96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93e1cadd-03f6-4b01-be08-c746f1ff9277" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_5b3d57ed-59ea-4d87-884e-91ebd7b02a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_42af03b8-392f-461b-a277-28c2557aa8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93e1cadd-03f6-4b01-be08-c746f1ff9277" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_42af03b8-392f-461b-a277-28c2557aa8b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e170cfd7-6959-4c41-894c-fa39b1ae97c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93e1cadd-03f6-4b01-be08-c746f1ff9277" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e170cfd7-6959-4c41-894c-fa39b1ae97c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f8dfd9fd-dcb0-40f8-b8f4-4591bbc161d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93e1cadd-03f6-4b01-be08-c746f1ff9277" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f8dfd9fd-dcb0-40f8-b8f4-4591bbc161d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_280e5ba2-036e-4a8a-a3ce-d251f5730064" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cb6b0e12-aeb5-418d-85ab-b2ad7adbb3f5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_280e5ba2-036e-4a8a-a3ce-d251f5730064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_b7d4c491-454e-43f7-afd4-2b76a374fc63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_280e5ba2-036e-4a8a-a3ce-d251f5730064" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_b7d4c491-454e-43f7-afd4-2b76a374fc63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtMaturingInMoreThanThreeMonths_87c9f60a-84f8-4e23-85db-9fa43a0986c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromDebtMaturingInMoreThanThreeMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_280e5ba2-036e-4a8a-a3ce-d251f5730064" xlink:to="loc_us-gaap_ProceedsFromDebtMaturingInMoreThanThreeMonths_87c9f60a-84f8-4e23-85db-9fa43a0986c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtMaturingInMoreThanThreeMonths_f59cd2f5-4288-455b-bdf6-cc567967883a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebtMaturingInMoreThanThreeMonths"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_280e5ba2-036e-4a8a-a3ce-d251f5730064" xlink:to="loc_us-gaap_RepaymentsOfDebtMaturingInMoreThanThreeMonths_f59cd2f5-4288-455b-bdf6-cc567967883a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_e63bc2e9-46e1-4993-a5a6-baafc642201f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_280e5ba2-036e-4a8a-a3ce-d251f5730064" xlink:to="loc_us-gaap_PaymentsOfDividends_e63bc2e9-46e1-4993-a5a6-baafc642201f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_66d601f0-1818-4ecb-b443-f9fed109b748" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_280e5ba2-036e-4a8a-a3ce-d251f5730064" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_66d601f0-1818-4ecb-b443-f9fed109b748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_fcfbcc86-bad1-4c13-aade-2b80a1b354a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_280e5ba2-036e-4a8a-a3ce-d251f5730064" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_fcfbcc86-bad1-4c13-aade-2b80a1b354a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_cfaec842-358a-4c5f-af44-5aa3df199959" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_280e5ba2-036e-4a8a-a3ce-d251f5730064" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_cfaec842-358a-4c5f-af44-5aa3df199959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f6989ead-a9fc-4a25-b9f3-b65b36aabe90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_280e5ba2-036e-4a8a-a3ce-d251f5730064" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f6989ead-a9fc-4a25-b9f3-b65b36aabe90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_245c6fba-51b6-4e56-8c1f-2c84d2849eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cb6b0e12-aeb5-418d-85ab-b2ad7adbb3f5" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_245c6fba-51b6-4e56-8c1f-2c84d2849eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7464a49d-1b88-49ae-a381-fdc2d86d3ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cb6b0e12-aeb5-418d-85ab-b2ad7adbb3f5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7464a49d-1b88-49ae-a381-fdc2d86d3ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_49d48c03-08fa-44c3-b060-fcc0b1888f55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cb6b0e12-aeb5-418d-85ab-b2ad7adbb3f5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_49d48c03-08fa-44c3-b060-fcc0b1888f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_973ed46c-49bb-4ab8-94ed-c62f33d45d63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cb6b0e12-aeb5-418d-85ab-b2ad7adbb3f5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_973ed46c-49bb-4ab8-94ed-c62f33d45d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_f9c93d75-1faf-4076-ba32-d3d97a16f126" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cb6b0e12-aeb5-418d-85ab-b2ad7adbb3f5" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_f9c93d75-1faf-4076-ba32-d3d97a16f126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_df401d6c-4847-45fc-bcd7-da463459fcf2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f9c93d75-1faf-4076-ba32-d3d97a16f126" xlink:to="loc_us-gaap_InterestPaidNet_df401d6c-4847-45fc-bcd7-da463459fcf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_4f395d35-fe47-47ad-ab5c-6c8217573cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cb6b0e12-aeb5-418d-85ab-b2ad7adbb3f5" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_4f395d35-fe47-47ad-ab5c-6c8217573cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_b1fcb508-a3fc-4f6a-be22-ca2221aa1065" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_4f395d35-fe47-47ad-ab5c-6c8217573cf5" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_b1fcb508-a3fc-4f6a-be22-ca2221aa1065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATION" xlink:type="simple" xlink:href="gehc-20250331.xsd#ORGANIZATIONANDBASISOFPRESENTATION"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e9f58726-c303-42bc-a34c-859e0cd2b6f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_7a0db215-db9c-4d3e-8eb3-de4c4acf5768" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e9f58726-c303-42bc-a34c-859e0cd2b6f6" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_7a0db215-db9c-4d3e-8eb3-de4c4acf5768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/REVENUERECOGNITION" xlink:type="simple" xlink:href="gehc-20250331.xsd#REVENUERECOGNITION"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/REVENUERECOGNITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_116f8dbf-acae-45fa-8758-f5a14eec7c91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_f2108a86-99bc-4c62-9c8a-80e18e5c9678" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_116f8dbf-acae-45fa-8758-f5a14eec7c91" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_f2108a86-99bc-4c62-9c8a-80e18e5c9678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SEGMENTINFORMATION" xlink:type="simple" xlink:href="gehc-20250331.xsd#SEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_639f17f2-41da-42a9-b3d8-e5fe10f3b94b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_bb21ffb4-e2ee-470d-802a-eed8233dd7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_639f17f2-41da-42a9-b3d8-e5fe10f3b94b" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_bb21ffb4-e2ee-470d-802a-eed8233dd7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/RECEIVABLES" xlink:type="simple" xlink:href="gehc-20250331.xsd#RECEIVABLES"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/RECEIVABLES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_2e432e46-6593-4a26-b2b7-69cf84ade5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_c538cdd6-0d93-45a7-9200-2fd5af6fdf84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_2e432e46-6593-4a26-b2b7-69cf84ade5f6" xlink:to="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_c538cdd6-0d93-45a7-9200-2fd5af6fdf84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/FINANCINGRECEIVABLES" xlink:type="simple" xlink:href="gehc-20250331.xsd#FINANCINGRECEIVABLES"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/FINANCINGRECEIVABLES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_892baf0e-197b-41a7-9422-230a5ed2eeab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesTextBlock_a119e4f6-e613-4a2c-88e8-1e29dcc21470" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_892baf0e-197b-41a7-9422-230a5ed2eeab" xlink:to="loc_us-gaap_FinancingReceivablesTextBlock_a119e4f6-e613-4a2c-88e8-1e29dcc21470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/LEASES" xlink:type="simple" xlink:href="gehc-20250331.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_eb6525e8-2497-4ecc-b5f5-03d2dbbae38a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_1da9dd27-ed88-445b-b5d7-f8e4b2b4e963" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eb6525e8-2497-4ecc-b5f5-03d2dbbae38a" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_1da9dd27-ed88-445b-b5d7-f8e4b2b4e963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="gehc-20250331.xsd#ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_38a58785-3369-4320-9d51-9b6806202345" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_0494a9fb-431d-4f86-88c0-1cc32f44fba5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_38a58785-3369-4320-9d51-9b6806202345" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_0494a9fb-431d-4f86-88c0-1cc32f44fba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_4817f38a-c771-45bc-ad6d-fa3d3354dabc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_38a58785-3369-4320-9d51-9b6806202345" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_4817f38a-c771-45bc-ad6d-fa3d3354dabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/BORROWINGS" xlink:type="simple" xlink:href="gehc-20250331.xsd#BORROWINGS"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/BORROWINGS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a2aaf7e9-f584-4a76-bc05-b0b8b4e31227" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_86389b83-d838-424d-ad43-f58920521cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a2aaf7e9-f584-4a76-bc05-b0b8b4e31227" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_86389b83-d838-424d-ad43-f58920521cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANS" xlink:type="simple" xlink:href="gehc-20250331.xsd#POSTRETIREMENTBENEFITPLANS"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8648d075-b167-4a33-81d0-9184bd4a73d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_14a7c759-b4a6-4fd4-81bc-c66842906f95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8648d075-b167-4a33-81d0-9184bd4a73d8" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_14a7c759-b4a6-4fd4-81bc-c66842906f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/INCOMETAXES" xlink:type="simple" xlink:href="gehc-20250331.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5a504d27-9804-455c-ae63-f9d9fd86f7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_60c5bc95-5423-485b-a231-8e5bad5d3ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5a504d27-9804-455c-ae63-f9d9fd86f7b3" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_60c5bc95-5423-485b-a231-8e5bad5d3ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNET" xlink:type="simple" xlink:href="gehc-20250331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNET"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3fb56e8a-83e7-450a-8246-7972016ecef8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_a048ad40-c08f-4e1c-956d-d50d70e2dfb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3fb56e8a-83e7-450a-8246-7972016ecef8" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_a048ad40-c08f-4e1c-956d-d50d70e2dfb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="gehc-20250331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_86505af0-4222-42af-b808-8145809ed738" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock_7a8dbd6c-aaa3-4c0f-a7fe-3d17f93e986c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_86505af0-4222-42af-b808-8145809ed738" xlink:to="loc_us-gaap_DerivativesAndFairValueTextBlock_7a8dbd6c-aaa3-4c0f-a7fe-3d17f93e986c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIES" xlink:type="simple" xlink:href="gehc-20250331.xsd#COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1236f58a-3da7-45da-a769-3d374f2b2ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_2f7efdbc-00cc-4e87-b813-460cac6fb475" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1236f58a-3da7-45da-a769-3d374f2b2ee2" xlink:to="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_2f7efdbc-00cc-4e87-b813-460cac6fb475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIES" xlink:type="simple" xlink:href="gehc-20250331.xsd#RESTRUCTURINGACTIVITIES"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ed85c43c-a146-44fc-96c6-535d18df0efc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_69f8c55e-7bde-4649-9806-c05fbd07c1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ed85c43c-a146-44fc-96c6-535d18df0efc" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_69f8c55e-7bde-4649-9806-c05fbd07c1f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="gehc-20250331.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_57a9c8a3-c4a8-4fec-9974-827a599b4c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_8536f1c9-21e7-42ec-a18a-2c70fe6d2c93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_57a9c8a3-c4a8-4fec-9974-827a599b4c7c" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_8536f1c9-21e7-42ec-a18a-2c70fe6d2c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATION" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATION"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bf52b281-2639-41cf-a681-d5fa9097fd70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_8c904a0b-6abf-4d08-ac6e-67a6fd741b44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bf52b281-2639-41cf-a681-d5fa9097fd70" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_8c904a0b-6abf-4d08-ac6e-67a6fd741b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUBSEQUENTEVENTS"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SUBSEQUENTEVENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_a9f4959e-7205-4241-8c0b-f2db54b70034" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_30fb964d-a346-498f-bc33-3bf55f10a6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_a9f4959e-7205-4241-8c0b-f2db54b70034" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_30fb964d-a346-498f-bc33-3bf55f10a6b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATIONPolicies" xlink:type="simple" xlink:href="gehc-20250331.xsd#ORGANIZATIONANDBASISOFPRESENTATIONPolicies"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATIONPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_76416ea2-6585-4649-9b52-c50c84139c22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_eca5d0b7-358c-4d92-90c2-498461a228ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_76416ea2-6585-4649-9b52-c50c84139c22" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_eca5d0b7-358c-4d92-90c2-498461a228ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_d318e35b-5b4a-497d-943c-c12e5bc7e05e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_76416ea2-6585-4649-9b52-c50c84139c22" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_d318e35b-5b4a-497d-943c-c12e5bc7e05e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_4d4481ba-9c08-45b5-b207-86ea47bdff5f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_76416ea2-6585-4649-9b52-c50c84139c22" xlink:to="loc_us-gaap_UseOfEstimates_4d4481ba-9c08-45b5-b207-86ea47bdff5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_cde35728-bece-4694-9446-ee793541c539" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_76416ea2-6585-4649-9b52-c50c84139c22" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_cde35728-bece-4694-9446-ee793541c539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_SupplierFinanceProgramPolicyPolicyTextBlock_4d77bd12-53a6-4872-91a1-6117c0256ed3" xlink:href="gehc-20250331.xsd#gehc_SupplierFinanceProgramPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_76416ea2-6585-4649-9b52-c50c84139c22" xlink:to="loc_gehc_SupplierFinanceProgramPolicyPolicyTextBlock_4d77bd12-53a6-4872-91a1-6117c0256ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/REVENUERECOGNITIONTables" xlink:type="simple" xlink:href="gehc-20250331.xsd#REVENUERECOGNITIONTables"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/REVENUERECOGNITIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fc9478eb-7f85-4904-88ac-47d392cad58c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_4bb97ec7-96c4-4f3e-b3ad-76e6fb4a4de9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fc9478eb-7f85-4904-88ac-47d392cad58c" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_4bb97ec7-96c4-4f3e-b3ad-76e6fb4a4de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_9fdcbb34-5a7e-4e3a-a04b-c7a0ae096138" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fc9478eb-7f85-4904-88ac-47d392cad58c" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_9fdcbb34-5a7e-4e3a-a04b-c7a0ae096138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="gehc-20250331.xsd#SEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5ee341b1-2d0d-4c7a-a41c-5dcbcc5fd8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_2cff8a30-d2e3-443a-b6b0-10fb48b4cc60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5ee341b1-2d0d-4c7a-a41c-5dcbcc5fd8b6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_2cff8a30-d2e3-443a-b6b0-10fb48b4cc60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/RECEIVABLESTables" xlink:type="simple" xlink:href="gehc-20250331.xsd#RECEIVABLESTables"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/RECEIVABLESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_e0feea4d-e8d9-4d92-a78c-17a8f6f94ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_348ba103-355a-4dc6-8551-d9e5d4e201b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_e0feea4d-e8d9-4d92-a78c-17a8f6f94ca1" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_348ba103-355a-4dc6-8551-d9e5d4e201b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/FINANCINGRECEIVABLESTables" xlink:type="simple" xlink:href="gehc-20250331.xsd#FINANCINGRECEIVABLESTables"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/FINANCINGRECEIVABLESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_ebdc194d-7a64-4834-9daa-b9d87846288c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_75b8d4c4-e6ea-4dbd-a0b0-7e4a127060ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_ebdc194d-7a64-4834-9daa-b9d87846288c" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_75b8d4c4-e6ea-4dbd-a0b0-7e4a127060ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="gehc-20250331.xsd#ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_405accaf-64e9-4a2c-91a6-bf93cb95f359" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_bd19b24d-1e69-4e0e-a5ff-de706373b1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_405accaf-64e9-4a2c-91a6-bf93cb95f359" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_bd19b24d-1e69-4e0e-a5ff-de706373b1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_fd6edaf9-9c60-4f70-ae5e-caa2a38dcd24" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_405accaf-64e9-4a2c-91a6-bf93cb95f359" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_fd6edaf9-9c60-4f70-ae5e-caa2a38dcd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_1ccdb2ae-7bf5-45bd-b452-f782db54e2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_405accaf-64e9-4a2c-91a6-bf93cb95f359" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_1ccdb2ae-7bf5-45bd-b452-f782db54e2ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_f4f211c6-b011-4e2c-9543-55df48d522a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_405accaf-64e9-4a2c-91a6-bf93cb95f359" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_f4f211c6-b011-4e2c-9543-55df48d522a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/BORROWINGSTables" xlink:type="simple" xlink:href="gehc-20250331.xsd#BORROWINGSTables"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/BORROWINGSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fea1f04f-4d0a-4789-bd8a-2d57684974dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_e1cb47a5-b7fa-42fc-95fd-b3e6e3d39952" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fea1f04f-4d0a-4789-bd8a-2d57684974dd" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_e1cb47a5-b7fa-42fc-95fd-b3e6e3d39952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSTables" xlink:type="simple" xlink:href="gehc-20250331.xsd#POSTRETIREMENTBENEFITPLANSTables"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2b1cef6b-40f8-4d30-80b5-abe29ab223c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_064c2a48-3f16-4eb1-a17d-a09f48683cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2b1cef6b-40f8-4d30-80b5-abe29ab223c5" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_064c2a48-3f16-4eb1-a17d-a09f48683cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETTables" xlink:type="simple" xlink:href="gehc-20250331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETTables"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_42134efd-8ad0-487d-bb5a-15c3fae2ab55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_d8d9fdad-748c-48fe-982e-46a51c2c387f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_42134efd-8ad0-487d-bb5a-15c3fae2ab55" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_d8d9fdad-748c-48fe-982e-46a51c2c387f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="gehc-20250331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_61092b4d-510f-4781-b5aa-c4fd85028b92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_eff66c1d-0c76-4758-8270-7e7d4045d629" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_61092b4d-510f-4781-b5aa-c4fd85028b92" xlink:to="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_eff66c1d-0c76-4758-8270-7e7d4045d629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_aa077eeb-bcab-46ff-9b24-a0c5e69d1190" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_61092b4d-510f-4781-b5aa-c4fd85028b92" xlink:to="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_aa077eeb-bcab-46ff-9b24-a0c5e69d1190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_f85a08b7-9311-4d25-b8fe-d9632192b27f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_61092b4d-510f-4781-b5aa-c4fd85028b92" xlink:to="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_f85a08b7-9311-4d25-b8fe-d9632192b27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_8da06b27-fcb7-4bd1-a477-e6a0591d57a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_61092b4d-510f-4781-b5aa-c4fd85028b92" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_8da06b27-fcb7-4bd1-a477-e6a0591d57a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_6ae7bd24-cb29-4cdc-b048-5ded32792e38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_61092b4d-510f-4781-b5aa-c4fd85028b92" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_6ae7bd24-cb29-4cdc-b048-5ded32792e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESTables" xlink:type="simple" xlink:href="gehc-20250331.xsd#COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESTables"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e7a85b4a-54ae-44b0-8c2e-dde8719ec618" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_84eebc3e-fedf-4519-978a-b543a01ee155" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e7a85b4a-54ae-44b0-8c2e-dde8719ec618" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_84eebc3e-fedf-4519-978a-b543a01ee155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESTables" xlink:type="simple" xlink:href="gehc-20250331.xsd#RESTRUCTURINGACTIVITIESTables"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_47b9fdbe-1357-439a-ba80-fe725aad6d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_e78ae2b2-1bc2-4914-a853-807c7a01faa0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_47b9fdbe-1357-439a-ba80-fe725aad6d1e" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_e78ae2b2-1bc2-4914-a853-807c7a01faa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="gehc-20250331.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_93595b6e-37cd-47ae-81b3-114956f21589" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_30037523-c7d8-4fcd-95d0-9c23d3d2bc64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_93595b6e-37cd-47ae-81b3-114956f21589" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_30037523-c7d8-4fcd-95d0-9c23d3d2bc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e3429969-4594-48d9-ae21-8784e3836cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_642ed7b4-041b-4e25-8700-a8a34ac804d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e3429969-4594-48d9-ae21-8784e3836cf2" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_642ed7b4-041b-4e25-8700-a8a34ac804d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_662f860c-1279-40e5-89b5-540aeef1172f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e3429969-4594-48d9-ae21-8784e3836cf2" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_662f860c-1279-40e5-89b5-540aeef1172f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1ec5ecbc-aab7-4abf-b5d2-d8d042937a62" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e3429969-4594-48d9-ae21-8784e3836cf2" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1ec5ecbc-aab7-4abf-b5d2-d8d042937a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_23c80eed-ffc0-44c3-90f1-4ce40f73d950" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e3429969-4594-48d9-ae21-8784e3836cf2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_23c80eed-ffc0-44c3-90f1-4ce40f73d950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_b6f11430-0ab0-4387-8694-b0370aa57cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e3429969-4594-48d9-ae21-8784e3836cf2" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_b6f11430-0ab0-4387-8694-b0370aa57cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_55d919ac-4c94-4e97-abdf-526c36d2e843" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e3429969-4594-48d9-ae21-8784e3836cf2" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_55d919ac-4c94-4e97-abdf-526c36d2e843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_ce1b47f1-e39c-4c8f-8f33-f8f2f067c458" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e3429969-4594-48d9-ae21-8784e3836cf2" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_ce1b47f1-e39c-4c8f-8f33-f8f2f067c458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_44bfba53-b165-49f9-b426-7ff10447ffb4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e3429969-4594-48d9-ae21-8784e3836cf2" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_44bfba53-b165-49f9-b426-7ff10447ffb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_92636f97-b271-4e29-82e3-cedfc6c8cd82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e3429969-4594-48d9-ae21-8784e3836cf2" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_92636f97-b271-4e29-82e3-cedfc6c8cd82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_0cf4708b-5e5d-4663-8020-dfc55d99c74f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e3429969-4594-48d9-ae21-8784e3836cf2" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_0cf4708b-5e5d-4663-8020-dfc55d99c74f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_cd513f1c-7be7-445e-a0f6-23ae9261a923" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_0eedf06d-6daf-49bf-a2ef-2c17f373367b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_cd513f1c-7be7-445e-a0f6-23ae9261a923" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_0eedf06d-6daf-49bf-a2ef-2c17f373367b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCurrent_e6c79b1f-280f-44a2-ab75-efae9c793d89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_cd513f1c-7be7-445e-a0f6-23ae9261a923" xlink:to="loc_us-gaap_DeferredCostsCurrent_e6c79b1f-280f-44a2-ab75-efae9c793d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent_38d48130-1030-4d5e-ba43-3bd1026415ce" xlink:href="gehc-20250331.xsd#gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_cd513f1c-7be7-445e-a0f6-23ae9261a923" xlink:to="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent_38d48130-1030-4d5e-ba43-3bd1026415ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_28e901ac-be52-431a-b2aa-260634de3ece" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_cd513f1c-7be7-445e-a0f6-23ae9261a923" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_28e901ac-be52-431a-b2aa-260634de3ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCosts_ad27fe6f-f391-4179-bc07-ae135e814b08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_cd513f1c-7be7-445e-a0f6-23ae9261a923" xlink:to="loc_us-gaap_DeferredCosts_ad27fe6f-f391-4179-bc07-ae135e814b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts_d51a07e8-4d21-49a1-b141-03cb113a0ef9" xlink:href="gehc-20250331.xsd#gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_cd513f1c-7be7-445e-a0f6-23ae9261a923" xlink:to="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts_d51a07e8-4d21-49a1-b141-03cb113a0ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#REVENUERECOGNITIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3d479ad4-a1e3-47b8-9c91-ad5207340b15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c519690c-b369-4e87-b2ad-8c8bf2c34ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3d479ad4-a1e3-47b8-9c91-ad5207340b15" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c519690c-b369-4e87-b2ad-8c8bf2c34ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ff5af240-af7c-4e97-80bf-e9f08250b7df" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c519690c-b369-4e87-b2ad-8c8bf2c34ff6" xlink:to="loc_srt_ProductOrServiceAxis_ff5af240-af7c-4e97-80bf-e9f08250b7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_47dec004-8861-4bd9-a489-72665176272f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_ff5af240-af7c-4e97-80bf-e9f08250b7df" xlink:to="loc_srt_ProductsAndServicesDomain_47dec004-8861-4bd9-a489-72665176272f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_62d8cb85-561d-4ab1-b516-3da409ea996f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_47dec004-8861-4bd9-a489-72665176272f" xlink:to="loc_us-gaap_ProductMember_62d8cb85-561d-4ab1-b516-3da409ea996f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_ffad6ddd-c8f1-432a-9588-bfa77b1b6b63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_47dec004-8861-4bd9-a489-72665176272f" xlink:to="loc_us-gaap_ServiceMember_ffad6ddd-c8f1-432a-9588-bfa77b1b6b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b3304412-d430-4b19-b906-eaacd09a75a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c519690c-b369-4e87-b2ad-8c8bf2c34ff6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b3304412-d430-4b19-b906-eaacd09a75a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_f8801b44-782f-453a-bf2f-62ae61409ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c519690c-b369-4e87-b2ad-8c8bf2c34ff6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_f8801b44-782f-453a-bf2f-62ae61409ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_531a1673-66ac-428d-9385-49b9e69e0d30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_f8801b44-782f-453a-bf2f-62ae61409ef9" xlink:to="loc_us-gaap_ContractWithCustomerLiability_531a1673-66ac-428d-9385-49b9e69e0d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_fd646579-0cd3-4046-b9be-dba6864ebcea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_f8801b44-782f-453a-bf2f-62ae61409ef9" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_fd646579-0cd3-4046-b9be-dba6864ebcea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_b19f9ad8-ba62-4b8b-adbb-e21a10bc6022" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_f8801b44-782f-453a-bf2f-62ae61409ef9" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_b19f9ad8-ba62-4b8b-adbb-e21a10bc6022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_644ce1a7-a27e-4ec0-a03e-606ec8bcf9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_f8801b44-782f-453a-bf2f-62ae61409ef9" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_644ce1a7-a27e-4ec0-a03e-606ec8bcf9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/REVENUERECOGNITIONScheduleofRemainingPerformanceObligationsDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#REVENUERECOGNITIONScheduleofRemainingPerformanceObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/REVENUERECOGNITIONScheduleofRemainingPerformanceObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9a18b04d-7985-4138-bb52-c8387b529e06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_dc9c1b14-58a0-4f29-ab0c-6eb7327d0250" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9a18b04d-7985-4138-bb52-c8387b529e06" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_dc9c1b14-58a0-4f29-ab0c-6eb7327d0250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ec349374-85b2-479e-b6a1-2be18b940eae" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_dc9c1b14-58a0-4f29-ab0c-6eb7327d0250" xlink:to="loc_srt_ProductOrServiceAxis_ec349374-85b2-479e-b6a1-2be18b940eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c2ca56a1-ef84-45ca-9c19-791438ed8e09" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_ec349374-85b2-479e-b6a1-2be18b940eae" xlink:to="loc_srt_ProductsAndServicesDomain_c2ca56a1-ef84-45ca-9c19-791438ed8e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_c2c289a0-3a3c-4845-8bd4-101504c3a78b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c2ca56a1-ef84-45ca-9c19-791438ed8e09" xlink:to="loc_us-gaap_ProductMember_c2c289a0-3a3c-4845-8bd4-101504c3a78b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_e9e135f0-2173-4886-ac1e-6de7ff0035e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c2ca56a1-ef84-45ca-9c19-791438ed8e09" xlink:to="loc_us-gaap_ServiceMember_e9e135f0-2173-4886-ac1e-6de7ff0035e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_514b1f1c-1f93-4348-8f20-6ab336e72a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_dc9c1b14-58a0-4f29-ab0c-6eb7327d0250" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_514b1f1c-1f93-4348-8f20-6ab336e72a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_f3a57b8a-2b18-41c2-969b-5f0c2afbdb85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_514b1f1c-1f93-4348-8f20-6ab336e72a2a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_f3a57b8a-2b18-41c2-969b-5f0c2afbdb85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SEGMENTINFORMATIONNarrativeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SEGMENTINFORMATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SEGMENTINFORMATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_638c322d-465a-4da0-a097-61448bb85313" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_1751575f-ee75-40c8-8656-211904281bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_638c322d-465a-4da0-a097-61448bb85313" xlink:to="loc_us-gaap_NumberOfReportableSegments_1751575f-ee75-40c8-8656-211904281bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_378a4c91-816b-464e-8462-4439bf32efe1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_638c322d-465a-4da0-a097-61448bb85313" xlink:to="loc_us-gaap_NumberOfOperatingSegments_378a4c91-816b-464e-8462-4439bf32efe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_dba5bb40-a149-462f-a82f-d0b179791ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10ee12b3-f9e1-478e-a7b6-7404835ac98c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_dba5bb40-a149-462f-a82f-d0b179791ae6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10ee12b3-f9e1-478e-a7b6-7404835ac98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a87df4d2-f8f0-42b5-be65-7ebb826eef37" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10ee12b3-f9e1-478e-a7b6-7404835ac98c" xlink:to="loc_srt_ConsolidationItemsAxis_a87df4d2-f8f0-42b5-be65-7ebb826eef37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b8029adc-ffa4-475f-be01-e245547ca637" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_a87df4d2-f8f0-42b5-be65-7ebb826eef37" xlink:to="loc_srt_ConsolidationItemsDomain_b8029adc-ffa4-475f-be01-e245547ca637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_ebee85d0-0dd6-4d82-b45b-57418d228dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b8029adc-ffa4-475f-be01-e245547ca637" xlink:to="loc_us-gaap_OperatingSegmentsMember_ebee85d0-0dd6-4d82-b45b-57418d228dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_292c651a-f931-4367-80f1-676d7ceafb10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b8029adc-ffa4-475f-be01-e245547ca637" xlink:to="loc_us-gaap_CorporateNonSegmentMember_292c651a-f931-4367-80f1-676d7ceafb10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a1f3ee9d-ce84-4137-ae3e-0ca5a53eb806" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10ee12b3-f9e1-478e-a7b6-7404835ac98c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a1f3ee9d-ce84-4137-ae3e-0ca5a53eb806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_31d91c97-3cc6-473a-9619-246f868f6fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a1f3ee9d-ce84-4137-ae3e-0ca5a53eb806" xlink:to="loc_us-gaap_SegmentDomain_31d91c97-3cc6-473a-9619-246f868f6fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ImagingSegmentMember_000ec284-6daf-4902-a027-76ee80b45ed7" xlink:href="gehc-20250331.xsd#gehc_ImagingSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_31d91c97-3cc6-473a-9619-246f868f6fb3" xlink:to="loc_gehc_ImagingSegmentMember_000ec284-6daf-4902-a027-76ee80b45ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AVSSegmentMember_0c986883-d2a9-405e-a087-1ad85ea4f43f" xlink:href="gehc-20250331.xsd#gehc_AVSSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_31d91c97-3cc6-473a-9619-246f868f6fb3" xlink:to="loc_gehc_AVSSegmentMember_0c986883-d2a9-405e-a087-1ad85ea4f43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PCSSegmentMember_4d1923c8-71c2-4bac-a753-6317f4080fe4" xlink:href="gehc-20250331.xsd#gehc_PCSSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_31d91c97-3cc6-473a-9619-246f868f6fb3" xlink:to="loc_gehc_PCSSegmentMember_4d1923c8-71c2-4bac-a753-6317f4080fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PDxSegmentMember_0d79367d-709c-4cf3-ac53-8f3931f81e75" xlink:href="gehc-20250331.xsd#gehc_PDxSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_31d91c97-3cc6-473a-9619-246f868f6fb3" xlink:to="loc_gehc_PDxSegmentMember_0d79367d-709c-4cf3-ac53-8f3931f81e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_544b3a91-c4cc-4569-8ca2-d46f743b82ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10ee12b3-f9e1-478e-a7b6-7404835ac98c" xlink:to="loc_us-gaap_SubsegmentsAxis_544b3a91-c4cc-4569-8ca2-d46f743b82ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_b67696f0-81f2-43ed-b5c2-556f1d5eb00c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_544b3a91-c4cc-4569-8ca2-d46f743b82ce" xlink:to="loc_us-gaap_SubsegmentsDomain_b67696f0-81f2-43ed-b5c2-556f1d5eb00c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ProceduralGuidanceSubsegmentMember_36dca12d-cc4f-4c06-a0c5-0994e7361c63" xlink:href="gehc-20250331.xsd#gehc_ProceduralGuidanceSubsegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_b67696f0-81f2-43ed-b5c2-556f1d5eb00c" xlink:to="loc_gehc_ProceduralGuidanceSubsegmentMember_36dca12d-cc4f-4c06-a0c5-0994e7361c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_SpecializedUltrasoundSubsegmentMember_254e72d2-348e-4f15-90be-3a7fb919c89c" xlink:href="gehc-20250331.xsd#gehc_SpecializedUltrasoundSubsegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_b67696f0-81f2-43ed-b5c2-556f1d5eb00c" xlink:to="loc_gehc_SpecializedUltrasoundSubsegmentMember_254e72d2-348e-4f15-90be-3a7fb919c89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_MonitoringSolutionsSubsegmentMember_4495fb1b-5a77-4476-9964-e6cf34bc45af" xlink:href="gehc-20250331.xsd#gehc_MonitoringSolutionsSubsegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_b67696f0-81f2-43ed-b5c2-556f1d5eb00c" xlink:to="loc_gehc_MonitoringSolutionsSubsegmentMember_4495fb1b-5a77-4476-9964-e6cf34bc45af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_LifeSupportSolutionsSubsegmentMember_25da33b5-672a-4561-b180-458550353c07" xlink:href="gehc-20250331.xsd#gehc_LifeSupportSolutionsSubsegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_b67696f0-81f2-43ed-b5c2-556f1d5eb00c" xlink:to="loc_gehc_LifeSupportSolutionsSubsegmentMember_25da33b5-672a-4561-b180-458550353c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_b2f85d33-646d-4518-9954-11b88ff62a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_10ee12b3-f9e1-478e-a7b6-7404835ac98c" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_b2f85d33-646d-4518-9954-11b88ff62a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dd59e2cd-f751-4c1e-a0f5-47c74493c4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b2f85d33-646d-4518-9954-11b88ff62a3e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dd59e2cd-f751-4c1e-a0f5-47c74493c4f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_eb829be1-b3b8-44b5-9cf8-7e47ed71b3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ddc88ccf-493f-4c55-a79c-7704d7c4c8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_eb829be1-b3b8-44b5-9cf8-7e47ed71b3b6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ddc88ccf-493f-4c55-a79c-7704d7c4c8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_96cb6059-ebe6-4333-acdb-d30b0ef7b212" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ddc88ccf-493f-4c55-a79c-7704d7c4c8b6" xlink:to="loc_srt_ConsolidationItemsAxis_96cb6059-ebe6-4333-acdb-d30b0ef7b212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2a689c50-65fa-47bf-b7a1-0c2f0b627906" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_96cb6059-ebe6-4333-acdb-d30b0ef7b212" xlink:to="loc_srt_ConsolidationItemsDomain_2a689c50-65fa-47bf-b7a1-0c2f0b627906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_42645fbb-a9c1-4b48-8edf-24c0c50d0256" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_2a689c50-65fa-47bf-b7a1-0c2f0b627906" xlink:to="loc_us-gaap_OperatingSegmentsMember_42645fbb-a9c1-4b48-8edf-24c0c50d0256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e6cd4d5e-e770-46a5-b3bd-8971a4b080eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ddc88ccf-493f-4c55-a79c-7704d7c4c8b6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e6cd4d5e-e770-46a5-b3bd-8971a4b080eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5675e138-32a3-4a86-bfc9-6d6740b2b3bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e6cd4d5e-e770-46a5-b3bd-8971a4b080eb" xlink:to="loc_us-gaap_SegmentDomain_5675e138-32a3-4a86-bfc9-6d6740b2b3bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ImagingSegmentMember_d7e088e8-f189-4795-9d2f-a8f95d1b64cc" xlink:href="gehc-20250331.xsd#gehc_ImagingSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5675e138-32a3-4a86-bfc9-6d6740b2b3bd" xlink:to="loc_gehc_ImagingSegmentMember_d7e088e8-f189-4795-9d2f-a8f95d1b64cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AVSSegmentMember_421856c8-be72-4117-b20d-5e2cefa2185f" xlink:href="gehc-20250331.xsd#gehc_AVSSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5675e138-32a3-4a86-bfc9-6d6740b2b3bd" xlink:to="loc_gehc_AVSSegmentMember_421856c8-be72-4117-b20d-5e2cefa2185f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PCSSegmentMember_70aea79d-00c1-47b8-a556-764985133dec" xlink:href="gehc-20250331.xsd#gehc_PCSSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5675e138-32a3-4a86-bfc9-6d6740b2b3bd" xlink:to="loc_gehc_PCSSegmentMember_70aea79d-00c1-47b8-a556-764985133dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PDxSegmentMember_75b35bb7-b853-4aad-a48d-f5e4417378af" xlink:href="gehc-20250331.xsd#gehc_PDxSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5675e138-32a3-4a86-bfc9-6d6740b2b3bd" xlink:to="loc_gehc_PDxSegmentMember_75b35bb7-b853-4aad-a48d-f5e4417378af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2be8a197-24c0-488b-8f75-4408bc45b9af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ddc88ccf-493f-4c55-a79c-7704d7c4c8b6" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_2be8a197-24c0-488b-8f75-4408bc45b9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_1f5cdfac-d69a-42f2-aa88-32e2a738edfe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2be8a197-24c0-488b-8f75-4408bc45b9af" xlink:to="loc_us-gaap_CostOfRevenue_1f5cdfac-d69a-42f2-aa88-32e2a738edfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_e38ebea9-5617-444d-ba54-5ebec0537e12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2be8a197-24c0-488b-8f75-4408bc45b9af" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_e38ebea9-5617-444d-ba54-5ebec0537e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_efcc3dab-2226-40cd-bd09-ef719393a5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2be8a197-24c0-488b-8f75-4408bc45b9af" xlink:to="loc_us-gaap_CostsAndExpenses_efcc3dab-2226-40cd-bd09-ef719393a5e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SEGMENTINFORMATIONScheduleofSegmentEBITDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_28b3e61d-bace-436c-abbb-188f09e60dce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6110df9b-ac34-44dc-aa10-8ec875661ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_28b3e61d-bace-436c-abbb-188f09e60dce" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6110df9b-ac34-44dc-aa10-8ec875661ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_abdd4be8-f507-4531-9d83-79def3178ba3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6110df9b-ac34-44dc-aa10-8ec875661ed3" xlink:to="loc_srt_ConsolidationItemsAxis_abdd4be8-f507-4531-9d83-79def3178ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_68b1d024-dcb2-4ffa-9d22-1bb5105841e8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_abdd4be8-f507-4531-9d83-79def3178ba3" xlink:to="loc_srt_ConsolidationItemsDomain_68b1d024-dcb2-4ffa-9d22-1bb5105841e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_025655d5-4b5d-4fc9-864b-ba361561c96a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_68b1d024-dcb2-4ffa-9d22-1bb5105841e8" xlink:to="loc_us-gaap_OperatingSegmentsMember_025655d5-4b5d-4fc9-864b-ba361561c96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_cff7652a-c0cd-4ba5-87c2-bac650f11fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_68b1d024-dcb2-4ffa-9d22-1bb5105841e8" xlink:to="loc_us-gaap_CorporateNonSegmentMember_cff7652a-c0cd-4ba5-87c2-bac650f11fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b295c744-49cf-4c88-bc64-9ab43f8761af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6110df9b-ac34-44dc-aa10-8ec875661ed3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b295c744-49cf-4c88-bc64-9ab43f8761af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b8c826b2-3caf-44a6-a6af-4c3e22843b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b295c744-49cf-4c88-bc64-9ab43f8761af" xlink:to="loc_us-gaap_SegmentDomain_b8c826b2-3caf-44a6-a6af-4c3e22843b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ImagingSegmentMember_12a95063-7e67-498e-a572-0cc23a8bcbaa" xlink:href="gehc-20250331.xsd#gehc_ImagingSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b8c826b2-3caf-44a6-a6af-4c3e22843b6b" xlink:to="loc_gehc_ImagingSegmentMember_12a95063-7e67-498e-a572-0cc23a8bcbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AVSSegmentMember_1baf5993-6941-4e2c-9558-8053d14a47b0" xlink:href="gehc-20250331.xsd#gehc_AVSSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b8c826b2-3caf-44a6-a6af-4c3e22843b6b" xlink:to="loc_gehc_AVSSegmentMember_1baf5993-6941-4e2c-9558-8053d14a47b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PCSSegmentMember_758d0884-e550-46e5-bd21-6aee0895a78a" xlink:href="gehc-20250331.xsd#gehc_PCSSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b8c826b2-3caf-44a6-a6af-4c3e22843b6b" xlink:to="loc_gehc_PCSSegmentMember_758d0884-e550-46e5-bd21-6aee0895a78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PDxSegmentMember_756d3f42-634a-4051-8c39-255e28c4ffff" xlink:href="gehc-20250331.xsd#gehc_PDxSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b8c826b2-3caf-44a6-a6af-4c3e22843b6b" xlink:to="loc_gehc_PDxSegmentMember_756d3f42-634a-4051-8c39-255e28c4ffff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6110df9b-ac34-44dc-aa10-8ec875661ed3" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges_89790689-0f6c-4e21-a974-070fe247782b" xlink:href="gehc-20250331.xsd#gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges_89790689-0f6c-4e21-a974-070fe247782b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_737e7314-4dbb-46a9-b3e6-f2e1430604a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_737e7314-4dbb-46a9-b3e6-f2e1430604a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AcquisitionAndDispositionRelatedBenefitsCosts_bddaaa5e-9de9-4b9d-bf24-89b6b0ef1f52" xlink:href="gehc-20250331.xsd#gehc_AcquisitionAndDispositionRelatedBenefitsCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_gehc_AcquisitionAndDispositionRelatedBenefitsCosts_bddaaa5e-9de9-4b9d-bf24-89b6b0ef1f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_a51d1b1e-0321-4d16-8094-7960fa1cce0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_a51d1b1e-0321-4d16-8094-7960fa1cce0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_SpinOffAndSeparationCosts_f310d7fd-fab9-4407-b4ad-9f9bbb8c300b" xlink:href="gehc-20250331.xsd#gehc_SpinOffAndSeparationCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_gehc_SpinOffAndSeparationCosts_f310d7fd-fab9-4407-b4ad-9f9bbb8c300b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AmortizationOfIntangibleAssetsAcquired_e228e2c0-210a-4224-96c6-188472aad339" xlink:href="gehc-20250331.xsd#gehc_AmortizationOfIntangibleAssetsAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_gehc_AmortizationOfIntangibleAssetsAcquired_e228e2c0-210a-4224-96c6-188472aad339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_c4250868-4aaa-42c3-89af-15231349abd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_us-gaap_GainLossOnInvestments_c4250868-4aaa-42c3-89af-15231349abd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_a4cdbeb2-8744-4954-a337-40b00dfd941a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_us-gaap_InterestAndDebtExpense_a4cdbeb2-8744-4954-a337-40b00dfd941a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_6c3773ef-0550-4872-9cbb-eaea596e2b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_6c3773ef-0550-4872-9cbb-eaea596e2b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1bf9b8bd-e6c8-4ac1-bfe0-e99f9c123abf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_104bc786-1ec7-4fab-8ec5-ecad24ad5a26" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1bf9b8bd-e6c8-4ac1-bfe0-e99f9c123abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3db3fea9-7f78-4ab1-974d-dc2887adc51a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8edee9e5-7bb3-46cf-af8f-d66353b399c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3db3fea9-7f78-4ab1-974d-dc2887adc51a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8edee9e5-7bb3-46cf-af8f-d66353b399c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_bca6e74c-d263-431f-a7c5-39c7095bc845" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8edee9e5-7bb3-46cf-af8f-d66353b399c5" xlink:to="loc_srt_ConsolidationItemsAxis_bca6e74c-d263-431f-a7c5-39c7095bc845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_764adc18-7393-4c48-afed-06d3110e79dd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_bca6e74c-d263-431f-a7c5-39c7095bc845" xlink:to="loc_srt_ConsolidationItemsDomain_764adc18-7393-4c48-afed-06d3110e79dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_1dc19d6e-e9d3-4e5a-a380-9e832e14c5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_764adc18-7393-4c48-afed-06d3110e79dd" xlink:to="loc_us-gaap_OperatingSegmentsMember_1dc19d6e-e9d3-4e5a-a380-9e832e14c5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_82b8cfa4-d73f-4478-9418-a715bf51d12c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8edee9e5-7bb3-46cf-af8f-d66353b399c5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_82b8cfa4-d73f-4478-9418-a715bf51d12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d0f630d0-f035-4c62-aef3-59da89168483" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_82b8cfa4-d73f-4478-9418-a715bf51d12c" xlink:to="loc_us-gaap_SegmentDomain_d0f630d0-f035-4c62-aef3-59da89168483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ImagingSegmentMember_222b35a1-e80c-4dd9-9df7-30f53786006b" xlink:href="gehc-20250331.xsd#gehc_ImagingSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d0f630d0-f035-4c62-aef3-59da89168483" xlink:to="loc_gehc_ImagingSegmentMember_222b35a1-e80c-4dd9-9df7-30f53786006b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AVSSegmentMember_2a35eaab-aa26-4a22-b586-0e4ba1e738da" xlink:href="gehc-20250331.xsd#gehc_AVSSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d0f630d0-f035-4c62-aef3-59da89168483" xlink:to="loc_gehc_AVSSegmentMember_2a35eaab-aa26-4a22-b586-0e4ba1e738da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PCSSegmentMember_46a5dc5d-b0c5-4b35-9a50-38e1677617ad" xlink:href="gehc-20250331.xsd#gehc_PCSSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d0f630d0-f035-4c62-aef3-59da89168483" xlink:to="loc_gehc_PCSSegmentMember_46a5dc5d-b0c5-4b35-9a50-38e1677617ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PDxSegmentMember_8b70080a-8542-4b0e-9ee5-a7bfc6a9c707" xlink:href="gehc-20250331.xsd#gehc_PDxSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d0f630d0-f035-4c62-aef3-59da89168483" xlink:to="loc_gehc_PDxSegmentMember_8b70080a-8542-4b0e-9ee5-a7bfc6a9c707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_dc8f09cf-263f-46f3-855a-e4628a59e6cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8edee9e5-7bb3-46cf-af8f-d66353b399c5" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_dc8f09cf-263f-46f3-855a-e4628a59e6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a3f07b50-43e1-4d7b-b294-2b99fedb2478" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dc8f09cf-263f-46f3-855a-e4628a59e6cd" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a3f07b50-43e1-4d7b-b294-2b99fedb2478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/RECEIVABLESCurrentReceivablesDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#RECEIVABLESCurrentReceivablesDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/RECEIVABLESCurrentReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_26dd0071-a6a6-4a16-bf4f-57fe6b743365" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_3476faea-e276-4246-80e9-5dea9b5b3700" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_26dd0071-a6a6-4a16-bf4f-57fe6b743365" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_3476faea-e276-4246-80e9-5dea9b5b3700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValueAddedTaxReceivableCurrent_1e97858c-ec3e-4d27-8ec8-c117a0db795f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValueAddedTaxReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_26dd0071-a6a6-4a16-bf4f-57fe6b743365" xlink:to="loc_us-gaap_ValueAddedTaxReceivableCurrent_1e97858c-ec3e-4d27-8ec8-c117a0db795f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherNontradeReceivablesCurrent_a149af63-5324-42b3-8ad3-ce73045317f0" xlink:href="gehc-20250331.xsd#gehc_OtherNontradeReceivablesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_26dd0071-a6a6-4a16-bf4f-57fe6b743365" xlink:to="loc_gehc_OtherNontradeReceivablesCurrent_a149af63-5324-42b3-8ad3-ce73045317f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesCurrent_7f95a69e-f18c-44a8-9ca4-1b39b16aeca2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NontradeReceivablesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_26dd0071-a6a6-4a16-bf4f-57fe6b743365" xlink:to="loc_us-gaap_NontradeReceivablesCurrent_7f95a69e-f18c-44a8-9ca4-1b39b16aeca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_59d65e44-735e-47c6-a46b-d9238c204638" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_26dd0071-a6a6-4a16-bf4f-57fe6b743365" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_59d65e44-735e-47c6-a46b-d9238c204638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_31ed3200-e5af-45b6-95c5-7538efbad0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_26dd0071-a6a6-4a16-bf4f-57fe6b743365" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_31ed3200-e5af-45b6-95c5-7538efbad0a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_e0a43aa0-b8ca-4ab1-8d32-3dea874356de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_26dd0071-a6a6-4a16-bf4f-57fe6b743365" xlink:to="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_e0a43aa0-b8ca-4ab1-8d32-3dea874356de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/RECEIVABLESLongTermReceivablesDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#RECEIVABLESLongTermReceivablesDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/RECEIVABLESLongTermReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_e7f15cca-ea09-47e5-8415-90f8ccdf0c85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossNoncurrent_0ac3a7ad-3bd3-4b8b-a339-eb48aa589f38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGrossNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_e7f15cca-ea09-47e5-8415-90f8ccdf0c85" xlink:to="loc_us-gaap_AccountsReceivableGrossNoncurrent_0ac3a7ad-3bd3-4b8b-a339-eb48aa589f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValueAddedTaxReceivableNoncurrent_74fcfe1e-de8b-43ba-aafd-8be43aa5573f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValueAddedTaxReceivableNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_e7f15cca-ea09-47e5-8415-90f8ccdf0c85" xlink:to="loc_us-gaap_ValueAddedTaxReceivableNoncurrent_74fcfe1e-de8b-43ba-aafd-8be43aa5573f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherNontradeReceivablesNoncurrent_494723c6-a1f7-41ee-ad2b-9d1f5cecfe11" xlink:href="gehc-20250331.xsd#gehc_OtherNontradeReceivablesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_e7f15cca-ea09-47e5-8415-90f8ccdf0c85" xlink:to="loc_gehc_OtherNontradeReceivablesNoncurrent_494723c6-a1f7-41ee-ad2b-9d1f5cecfe11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesNoncurrent_4243be00-cfc9-42f5-964c-ceea25fbc530" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NontradeReceivablesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_e7f15cca-ea09-47e5-8415-90f8ccdf0c85" xlink:to="loc_us-gaap_NontradeReceivablesNoncurrent_4243be00-cfc9-42f5-964c-ceea25fbc530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent_f950a874-b975-483f-abce-322fe1b3adff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_e7f15cca-ea09-47e5-8415-90f8ccdf0c85" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent_f950a874-b975-483f-abce-322fe1b3adff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ReceivablesNetNoncurrent_6c9bf54d-e5ac-4132-84d1-e825e2b748e6" xlink:href="gehc-20250331.xsd#gehc_ReceivablesNetNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_e7f15cca-ea09-47e5-8415-90f8ccdf0c85" xlink:to="loc_gehc_ReceivablesNetNoncurrent_6c9bf54d-e5ac-4132-84d1-e825e2b748e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_219841e0-e158-4c07-bd7c-4038b759aee6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_7c673c39-160b-4c28-bcb1-2748f5f0dd39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_219841e0-e158-4c07-bd7c-4038b759aee6" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_7c673c39-160b-4c28-bcb1-2748f5f0dd39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_8fcbafdb-4d9c-4ca8-bba4-a18f5084bedc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_7c673c39-160b-4c28-bcb1-2748f5f0dd39" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_8fcbafdb-4d9c-4ca8-bba4-a18f5084bedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_4980ac99-3c23-4044-83d2-68aa8152a562" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_8fcbafdb-4d9c-4ca8-bba4-a18f5084bedc" xlink:to="loc_us-gaap_ReceivableTypeDomain_4980ac99-3c23-4044-83d2-68aa8152a562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember_4a687372-08f0-496f-acfb-d9e2f18c9e50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_4980ac99-3c23-4044-83d2-68aa8152a562" xlink:to="loc_us-gaap_LoansReceivableMember_4a687372-08f0-496f-acfb-d9e2f18c9e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_FinanceLeaseReceivableMember_e3fd09fc-5214-43d1-9ac8-574607e0d2a8" xlink:href="gehc-20250331.xsd#gehc_FinanceLeaseReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_4980ac99-3c23-4044-83d2-68aa8152a562" xlink:to="loc_gehc_FinanceLeaseReceivableMember_e3fd09fc-5214-43d1-9ac8-574607e0d2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caeee163-a6db-42c1-87fe-838729694105" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_7c673c39-160b-4c28-bcb1-2748f5f0dd39" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caeee163-a6db-42c1-87fe-838729694105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableGrossCurrent_deeb5c44-5e35-403c-a4be-0643acd14656" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableGrossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caeee163-a6db-42c1-87fe-838729694105" xlink:to="loc_us-gaap_NotesAndLoansReceivableGrossCurrent_deeb5c44-5e35-403c-a4be-0643acd14656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForNotesAndLoansReceivableCurrent_2b714496-3f92-4dc4-a4f4-d50a3d2205f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForNotesAndLoansReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caeee163-a6db-42c1-87fe-838729694105" xlink:to="loc_us-gaap_AllowanceForNotesAndLoansReceivableCurrent_2b714496-3f92-4dc4-a4f4-d50a3d2205f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_307a8cf5-9d80-41f3-bc1c-5f294865a58a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caeee163-a6db-42c1-87fe-838729694105" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_307a8cf5-9d80-41f3-bc1c-5f294865a58a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableGrossNoncurrent_25d40950-94a5-4cb8-8b9b-878925f47a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableGrossNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caeee163-a6db-42c1-87fe-838729694105" xlink:to="loc_us-gaap_NotesAndLoansReceivableGrossNoncurrent_25d40950-94a5-4cb8-8b9b-878925f47a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent_5d430a05-2d91-4813-8c43-2db27cfe8ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caeee163-a6db-42c1-87fe-838729694105" xlink:to="loc_us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent_5d430a05-2d91-4813-8c43-2db27cfe8ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_695c3483-faee-440b-b434-e48870b76e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_caeee163-a6db-42c1-87fe-838729694105" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_695c3483-faee-440b-b434-e48870b76e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/FINANCINGRECEIVABLESNarrativeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#FINANCINGRECEIVABLESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/FINANCINGRECEIVABLESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_44d08bb0-eb88-45ca-9c72-7d85360c02ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivablesPastDueTable_4697290e-8d21-4b0a-bce7-e236e8699d42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFinancingReceivablesPastDueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_44d08bb0-eb88-45ca-9c72-7d85360c02ed" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivablesPastDueTable_4697290e-8d21-4b0a-bce7-e236e8699d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesPeriodPastDueAxis_0839baa5-9620-45d3-bd59-694a8745045e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablesPeriodPastDueAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivablesPastDueTable_4697290e-8d21-4b0a-bce7-e236e8699d42" xlink:to="loc_us-gaap_FinancingReceivablesPeriodPastDueAxis_0839baa5-9620-45d3-bd59-694a8745045e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain_6e4fced0-a81f-4374-abbc-14918dfcbb26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablesPeriodPastDueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivablesPeriodPastDueAxis_0839baa5-9620-45d3-bd59-694a8745045e" xlink:to="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain_6e4fced0-a81f-4374-abbc-14918dfcbb26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_FinancialAssetGreaterThan30DaysPastDueMember_23cb33fa-12b7-4546-8ebb-c2bb37e04525" xlink:href="gehc-20250331.xsd#gehc_FinancialAssetGreaterThan30DaysPastDueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain_6e4fced0-a81f-4374-abbc-14918dfcbb26" xlink:to="loc_gehc_FinancialAssetGreaterThan30DaysPastDueMember_23cb33fa-12b7-4546-8ebb-c2bb37e04525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesEqualToGreaterThan90DaysPastDueMember_bc5a5ee6-c152-47a2-9ae3-400a372bfaaa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablesEqualToGreaterThan90DaysPastDueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivablesPeriodPastDueDomain_6e4fced0-a81f-4374-abbc-14918dfcbb26" xlink:to="loc_us-gaap_FinancingReceivablesEqualToGreaterThan90DaysPastDueMember_bc5a5ee6-c152-47a2-9ae3-400a372bfaaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems_0f51ccfd-5c7d-46d0-b6d8-2f349f8f5dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivablesPastDueTable_4697290e-8d21-4b0a-bce7-e236e8699d42" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems_0f51ccfd-5c7d-46d0-b6d8-2f349f8f5dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablePercentPastDue1_26cd1dff-a2aa-4449-beea-d34c0c5315bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablePercentPastDue1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems_0f51ccfd-5c7d-46d0-b6d8-2f349f8f5dbd" xlink:to="loc_us-gaap_FinancingReceivablePercentPastDue1_26cd1dff-a2aa-4449-beea-d34c0c5315bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableNonaccrualPercentPastDue1_f3a141a5-364c-40a1-b18a-262af05d7605" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableNonaccrualPercentPastDue1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems_0f51ccfd-5c7d-46d0-b6d8-2f349f8f5dbd" xlink:to="loc_us-gaap_FinancingReceivableNonaccrualPercentPastDue1_f3a141a5-364c-40a1-b18a-262af05d7605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/LEASESDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#LEASESDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/LEASESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1fedaace-7097-4980-9470-35844b73461a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_5fb14af2-6e6a-4631-a36f-985704fad2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1fedaace-7097-4980-9470-35844b73461a" xlink:to="loc_us-gaap_OperatingLeaseLiability_5fb14af2-6e6a-4631-a36f-985704fad2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_cb710613-c6ef-4a0c-97e7-a5f24c905b15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1fedaace-7097-4980-9470-35844b73461a" xlink:to="loc_us-gaap_OperatingLeaseCost_cb710613-c6ef-4a0c-97e7-a5f24c905b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6d24f715-16f3-4940-8bc6-1a05e0611b86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f7f285f4-3bc0-4cef-9425-d4aee56d9fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6d24f715-16f3-4940-8bc6-1a05e0611b86" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f7f285f4-3bc0-4cef-9425-d4aee56d9fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_52fe40fb-d6ed-41c7-88ad-38604873e03b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f7f285f4-3bc0-4cef-9425-d4aee56d9fd1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_52fe40fb-d6ed-41c7-88ad-38604873e03b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dfd3d3eb-d19d-4a5a-978f-cd721b8f5d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_52fe40fb-d6ed-41c7-88ad-38604873e03b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dfd3d3eb-d19d-4a5a-978f-cd721b8f5d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_NihonMediPhysicsCo.LtdNMPMember_1ba1e311-cb41-48c3-8839-34940d099d57" xlink:href="gehc-20250331.xsd#gehc_NihonMediPhysicsCo.LtdNMPMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dfd3d3eb-d19d-4a5a-978f-cd721b8f5d4d" xlink:to="loc_gehc_NihonMediPhysicsCo.LtdNMPMember_1ba1e311-cb41-48c3-8839-34940d099d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_MIMSoftwareMember_da9aab10-78ff-463b-a070-798b5b83e401" xlink:href="gehc-20250331.xsd#gehc_MIMSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dfd3d3eb-d19d-4a5a-978f-cd721b8f5d4d" xlink:to="loc_gehc_MIMSoftwareMember_da9aab10-78ff-463b-a070-798b5b83e401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_66008dd7-f000-446f-acee-fee6d2727467" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f7f285f4-3bc0-4cef-9425-d4aee56d9fd1" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_66008dd7-f000-446f-acee-fee6d2727467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_67e7c714-36e0-4af2-8c9d-55b5403b0968" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_66008dd7-f000-446f-acee-fee6d2727467" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_67e7c714-36e0-4af2-8c9d-55b5403b0968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ContingentConsiderationPurchasePriceMember_961203a2-819a-49be-a484-a091ee2bce23" xlink:href="gehc-20250331.xsd#gehc_ContingentConsiderationPurchasePriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_67e7c714-36e0-4af2-8c9d-55b5403b0968" xlink:to="loc_gehc_ContingentConsiderationPurchasePriceMember_961203a2-819a-49be-a484-a091ee2bce23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ContingentConsiderationServiceRequirementsMember_83efb983-90a0-4071-b1ac-a4f0488fb998" xlink:href="gehc-20250331.xsd#gehc_ContingentConsiderationServiceRequirementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_67e7c714-36e0-4af2-8c9d-55b5403b0968" xlink:to="loc_gehc_ContingentConsiderationServiceRequirementsMember_83efb983-90a0-4071-b1ac-a4f0488fb998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ba0536a8-8fde-4ffd-bf6e-f2a1da5c7a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f7f285f4-3bc0-4cef-9425-d4aee56d9fd1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ba0536a8-8fde-4ffd-bf6e-f2a1da5c7a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_40fba622-3e37-4869-b3cc-5e0728117f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ba0536a8-8fde-4ffd-bf6e-f2a1da5c7a9d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_40fba622-3e37-4869-b3cc-5e0728117f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_684f7774-d624-4ba3-9288-98aaedf39cef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_40fba622-3e37-4869-b3cc-5e0728117f9e" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_684f7774-d624-4ba3-9288-98aaedf39cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_6042c11f-629c-4b8e-b9aa-94c73445458e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_40fba622-3e37-4869-b3cc-5e0728117f9e" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_6042c11f-629c-4b8e-b9aa-94c73445458e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2cf7faa0-fe0a-492a-990f-20322c887aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f7f285f4-3bc0-4cef-9425-d4aee56d9fd1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2cf7faa0-fe0a-492a-990f-20322c887aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ebc08411-42fb-4150-9c45-33cc5ad4f47f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2cf7faa0-fe0a-492a-990f-20322c887aeb" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ebc08411-42fb-4150-9c45-33cc5ad4f47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_83db6db6-10ad-4edd-a6b7-8bdfd28eeb8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ebc08411-42fb-4150-9c45-33cc5ad4f47f" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_83db6db6-10ad-4edd-a6b7-8bdfd28eeb8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_faca2437-7350-4bac-8822-d2ea43a9a395" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f7f285f4-3bc0-4cef-9425-d4aee56d9fd1" xlink:to="loc_dei_LegalEntityAxis_faca2437-7350-4bac-8822-d2ea43a9a395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a9426aab-71a9-4881-a91f-8037b9e4731e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_faca2437-7350-4bac-8822-d2ea43a9a395" xlink:to="loc_dei_EntityDomain_a9426aab-71a9-4881-a91f-8037b9e4731e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_NihonMediPhysicsCo.LtdNMPMember_3a063662-83bb-4d03-b55a-ec0ece3f85ff" xlink:href="gehc-20250331.xsd#gehc_NihonMediPhysicsCo.LtdNMPMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a9426aab-71a9-4881-a91f-8037b9e4731e" xlink:to="loc_gehc_NihonMediPhysicsCo.LtdNMPMember_3a063662-83bb-4d03-b55a-ec0ece3f85ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f7f285f4-3bc0-4cef-9425-d4aee56d9fd1" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_1e5538d4-2107-42c9-a2fb-922da76afd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_1e5538d4-2107-42c9-a2fb-922da76afd6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_02fb4f0c-4222-4911-9448-66405130e4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_02fb4f0c-4222-4911-9448-66405130e4c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_4555e23c-2098-400f-94aa-58e968457b46" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_4555e23c-2098-400f-94aa-58e968457b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_8baa865a-53f4-4b16-9cfa-465c1f932af1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_8baa865a-53f4-4b16-9cfa-465c1f932af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue_786aba43-a2fd-43e0-b160-056adaa6f98f" xlink:href="gehc-20250331.xsd#gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue_786aba43-a2fd-43e0-b160-056adaa6f98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_b70f88cf-7b52-47ea-b476-31c69ecf2205" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_b70f88cf-7b52-47ea-b476-31c69ecf2205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax_9864fd79-a773-40c4-b291-4d760cd07388" xlink:href="gehc-20250331.xsd#gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax_9864fd79-a773-40c4-b291-4d760cd07388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_3649f740-43ed-45fd-aa71-b6da06c84358" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_3649f740-43ed-45fd-aa71-b6da06c84358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_5eb07a05-8f34-439b-8a74-630143d444ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_5eb07a05-8f34-439b-8a74-630143d444ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_2a33e739-8dea-47ca-aa8e-34bdd2c89822" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_2a33e739-8dea-47ca-aa8e-34bdd2c89822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_83c33e61-415a-4170-abc2-6b6902bfc2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_83c33e61-415a-4170-abc2-6b6902bfc2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities_4c068489-6d5e-49ac-b610-64bad92a9250" xlink:href="gehc-20250331.xsd#gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities_4c068489-6d5e-49ac-b610-64bad92a9250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_09bd0ea2-9959-40fb-a50e-f1dfa5a5854a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_09bd0ea2-9959-40fb-a50e-f1dfa5a5854a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_8d919d3e-97d6-454b-bc71-7db1e1fc424b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_8d919d3e-97d6-454b-bc71-7db1e1fc424b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_72a1f857-141c-4e7d-b064-913c9fffb071" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_72a1f857-141c-4e7d-b064-913c9fffb071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_0e38669a-01fd-4081-9b65-4aec2d5eb05a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_0e38669a-01fd-4081-9b65-4aec2d5eb05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e5132009-73c3-407c-b134-ae42ccee497f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e5132009-73c3-407c-b134-ae42ccee497f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d0300859-0152-41cf-b6cd-c43c7cd1f202" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d0300859-0152-41cf-b6cd-c43c7cd1f202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d025904f-dac5-4c7a-a9e7-8483e58e9102" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_Goodwill_d025904f-dac5-4c7a-a9e7-8483e58e9102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_befd1872-faa8-4ee3-b49f-a555f7b69945" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_befd1872-faa8-4ee3-b49f-a555f7b69945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d3c17b18-1431-4211-be19-c090a7bab9e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d3c17b18-1431-4211-be19-c090a7bab9e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets_19fc81a6-58b9-490f-81de-af8768ab9f37" xlink:href="gehc-20250331.xsd#gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets_19fc81a6-58b9-490f-81de-af8768ab9f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_8a9fccb7-b4af-44f5-9610-d7892a0aef16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b366d8-5195-4108-91d2-2847f7e7578a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_8a9fccb7-b4af-44f5-9610-d7892a0aef16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c322991d-084e-4cec-a369-5bd3ca44e428" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8228fe93-da52-49cb-8e7f-8605be1417c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c322991d-084e-4cec-a369-5bd3ca44e428" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8228fe93-da52-49cb-8e7f-8605be1417c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9586208e-b9a9-4215-bda9-76c50f24ec9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8228fe93-da52-49cb-8e7f-8605be1417c4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9586208e-b9a9-4215-bda9-76c50f24ec9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0652b0bb-5341-4bb8-ac57-43825593cda1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9586208e-b9a9-4215-bda9-76c50f24ec9b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0652b0bb-5341-4bb8-ac57-43825593cda1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_NihonMediPhysicsCo.LtdNMPMember_6ea39ac7-f29e-4d05-ae8a-3ced12d41075" xlink:href="gehc-20250331.xsd#gehc_NihonMediPhysicsCo.LtdNMPMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0652b0bb-5341-4bb8-ac57-43825593cda1" xlink:to="loc_gehc_NihonMediPhysicsCo.LtdNMPMember_6ea39ac7-f29e-4d05-ae8a-3ced12d41075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_30933f60-2017-4953-b81b-1f346d24f122" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8228fe93-da52-49cb-8e7f-8605be1417c4" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_30933f60-2017-4953-b81b-1f346d24f122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_791347bf-606b-4699-a453-746e4ac63240" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_30933f60-2017-4953-b81b-1f346d24f122" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_791347bf-606b-4699-a453-746e4ac63240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f23dc49c-5102-4219-8cd3-a9086883f11c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_791347bf-606b-4699-a453-746e4ac63240" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f23dc49c-5102-4219-8cd3-a9086883f11c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_9e2b8479-9f45-43c3-8fb9-f572fff4a5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_791347bf-606b-4699-a453-746e4ac63240" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_9e2b8479-9f45-43c3-8fb9-f572fff4a5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_b546a7a6-fe3c-4b6f-b7c2-9811c54962ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_791347bf-606b-4699-a453-746e4ac63240" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_b546a7a6-fe3c-4b6f-b7c2-9811c54962ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_4f64b25d-2180-42f2-88c7-b49e157fb663" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredAbstract_791347bf-606b-4699-a453-746e4ac63240" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_4f64b25d-2180-42f2-88c7-b49e157fb663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_30933f60-2017-4953-b81b-1f346d24f122" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_9d80d950-7c05-4a7b-909c-c5f8a079ed68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_9d80d950-7c05-4a7b-909c-c5f8a079ed68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1d0da40b-ea27-4fc1-a26a-12f1c3b78383" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1d0da40b-ea27-4fc1-a26a-12f1c3b78383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_40626378-e2d4-41e4-8a55-e3cb49e01e79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_40626378-e2d4-41e4-8a55-e3cb49e01e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2e8e6160-f4b8-469b-b458-9bb9c76266d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:to="loc_us-gaap_Goodwill_2e8e6160-f4b8-469b-b458-9bb9c76266d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_df052ff0-0921-434e-89e7-8505ac53d8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_df052ff0-0921-434e-89e7-8505ac53d8a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_07e6735b-b0ba-4bf7-8303-6497b09b57d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_07e6735b-b0ba-4bf7-8303-6497b09b57d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d1ed9afa-c327-47f6-9541-02ac545fb217" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d1ed9afa-c327-47f6-9541-02ac545fb217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_3d1959de-8a3f-4b4f-82ae-6771d0c5ed94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_3d1959de-8a3f-4b4f-82ae-6771d0c5ed94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_603e3578-5440-4784-9b2b-5540cedbbbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_603e3578-5440-4784-9b2b-5540cedbbbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_10e8ae16-8595-40fa-80f2-f5f732742a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract_f76ab29a-5d6f-4200-b11f-88e27a7de4d5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_10e8ae16-8595-40fa-80f2-f5f732742a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets_44036720-4861-4cc5-bcc0-69a9be3da6d9" xlink:href="gehc-20250331.xsd#gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_30933f60-2017-4953-b81b-1f346d24f122" xlink:to="loc_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets_44036720-4861-4cc5-bcc0-69a9be3da6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fb8aabab-6270-4db7-968c-cee8eca9e1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_05d4d51c-486b-4001-a03f-90865e40e9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fb8aabab-6270-4db7-968c-cee8eca9e1b1" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_05d4d51c-486b-4001-a03f-90865e40e9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0fc36386-5aa4-43e1-8442-479f7c5d7e35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_05d4d51c-486b-4001-a03f-90865e40e9ed" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0fc36386-5aa4-43e1-8442-479f7c5d7e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4fd3cfaa-3507-4f9f-8c28-eb66f87e87ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0fc36386-5aa4-43e1-8442-479f7c5d7e35" xlink:to="loc_us-gaap_SegmentDomain_4fd3cfaa-3507-4f9f-8c28-eb66f87e87ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ImagingSegmentMember_930465d9-e914-454b-a58d-c549a725474e" xlink:href="gehc-20250331.xsd#gehc_ImagingSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4fd3cfaa-3507-4f9f-8c28-eb66f87e87ee" xlink:to="loc_gehc_ImagingSegmentMember_930465d9-e914-454b-a58d-c549a725474e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AVSSegmentMember_3688b500-b2f5-461e-a021-ae1901e55d87" xlink:href="gehc-20250331.xsd#gehc_AVSSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4fd3cfaa-3507-4f9f-8c28-eb66f87e87ee" xlink:to="loc_gehc_AVSSegmentMember_3688b500-b2f5-461e-a021-ae1901e55d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PCSSegmentMember_060ef768-bb60-4e1d-8cc1-d7c1cc6a088f" xlink:href="gehc-20250331.xsd#gehc_PCSSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4fd3cfaa-3507-4f9f-8c28-eb66f87e87ee" xlink:to="loc_gehc_PCSSegmentMember_060ef768-bb60-4e1d-8cc1-d7c1cc6a088f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PDxSegmentMember_0c5114a1-01bd-4a9f-8800-478d176d9471" xlink:href="gehc-20250331.xsd#gehc_PDxSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4fd3cfaa-3507-4f9f-8c28-eb66f87e87ee" xlink:to="loc_gehc_PDxSegmentMember_0c5114a1-01bd-4a9f-8800-478d176d9471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_927ac8f1-971d-4a4f-a92d-8a6048e01e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_05d4d51c-486b-4001-a03f-90865e40e9ed" xlink:to="loc_us-gaap_GoodwillLineItems_927ac8f1-971d-4a4f-a92d-8a6048e01e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_12c116a0-9c96-41e1-a4b5-a8d10472bd75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_927ac8f1-971d-4a4f-a92d-8a6048e01e2f" xlink:to="loc_us-gaap_GoodwillRollForward_12c116a0-9c96-41e1-a4b5-a8d10472bd75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_571fd39a-bb56-463b-87b2-30f00c228a99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_12c116a0-9c96-41e1-a4b5-a8d10472bd75" xlink:to="loc_us-gaap_Goodwill_571fd39a-bb56-463b-87b2-30f00c228a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_8b61b27f-24a7-4dae-83b6-f6de85c42d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_12c116a0-9c96-41e1-a4b5-a8d10472bd75" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_8b61b27f-24a7-4dae-83b6-f6de85c42d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_7d784bc4-8f22-4a8a-bd5d-3e235d026207" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_12c116a0-9c96-41e1-a4b5-a8d10472bd75" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_7d784bc4-8f22-4a8a-bd5d-3e235d026207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8a6a9262-d57f-4f66-a518-167dfc45d8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_12c116a0-9c96-41e1-a4b5-a8d10472bd75" xlink:to="loc_us-gaap_Goodwill_8a6a9262-d57f-4f66-a518-167dfc45d8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cfa157ff-da2d-4954-8a27-5d6e7d014d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f8ae2c5f-ce6b-4eb0-b641-c104e0d06394" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cfa157ff-da2d-4954-8a27-5d6e7d014d0d" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f8ae2c5f-ce6b-4eb0-b641-c104e0d06394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83bbb19a-dcd9-461d-956b-a59e3e17eb39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f8ae2c5f-ce6b-4eb0-b641-c104e0d06394" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83bbb19a-dcd9-461d-956b-a59e3e17eb39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bc12a3d8-e68a-4c71-9875-a641586155fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83bbb19a-dcd9-461d-956b-a59e3e17eb39" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bc12a3d8-e68a-4c71-9875-a641586155fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_59786a21-7cfd-48f3-9061-6768408d7e48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bc12a3d8-e68a-4c71-9875-a641586155fe" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_59786a21-7cfd-48f3-9061-6768408d7e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_60a5ed04-8969-4429-aeda-1da96376c0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bc12a3d8-e68a-4c71-9875-a641586155fe" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_60a5ed04-8969-4429-aeda-1da96376c0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_216e9f65-0b4d-45d8-af36-6c4bf0d3f084" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bc12a3d8-e68a-4c71-9875-a641586155fe" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_216e9f65-0b4d-45d8-af36-6c4bf0d3f084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_TrademarksAndOtherMember_310d53bc-7386-4f0b-8f6e-238c48727868" xlink:href="gehc-20250331.xsd#gehc_TrademarksAndOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bc12a3d8-e68a-4c71-9875-a641586155fe" xlink:to="loc_gehc_TrademarksAndOtherMember_310d53bc-7386-4f0b-8f6e-238c48727868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3845cf24-51e1-4ed3-a55a-3ff998eb5df4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f8ae2c5f-ce6b-4eb0-b641-c104e0d06394" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3845cf24-51e1-4ed3-a55a-3ff998eb5df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4b2f67d8-574a-405f-bab3-84687b6573a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3845cf24-51e1-4ed3-a55a-3ff998eb5df4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4b2f67d8-574a-405f-bab3-84687b6573a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_466b2609-c7fd-4979-b44a-89c79c05f1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3845cf24-51e1-4ed3-a55a-3ff998eb5df4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_466b2609-c7fd-4979-b44a-89c79c05f1ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_43944e6b-2980-42a2-9680-2404701dd118" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3845cf24-51e1-4ed3-a55a-3ff998eb5df4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_43944e6b-2980-42a2-9680-2404701dd118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1d3063a2-fa42-4f58-b1ab-e40e0ce68adb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3845cf24-51e1-4ed3-a55a-3ff998eb5df4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1d3063a2-fa42-4f58-b1ab-e40e0ce68adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_47567a1a-1f35-4870-94ed-30bc8fe45435" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3845cf24-51e1-4ed3-a55a-3ff998eb5df4" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_47567a1a-1f35-4870-94ed-30bc8fe45435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1c0514b3-392d-4f12-a6b5-9fe22889150b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3845cf24-51e1-4ed3-a55a-3ff998eb5df4" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1c0514b3-392d-4f12-a6b5-9fe22889150b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#BORROWINGSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_40e21570-a20b-4476-8eb2-d991405a7fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c825564b-c6f4-455d-af14-a026aa2dae8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_40e21570-a20b-4476-8eb2-d991405a7fbe" xlink:to="loc_us-gaap_DebtInstrumentTable_c825564b-c6f4-455d-af14-a026aa2dae8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2bf8e7b9-d11f-40d9-b453-28616b60236d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c825564b-c6f4-455d-af14-a026aa2dae8d" xlink:to="loc_us-gaap_DebtInstrumentAxis_2bf8e7b9-d11f-40d9-b453-28616b60236d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_58851410-4e61-42dd-bf91-f0a438a0d125" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_2bf8e7b9-d11f-40d9-b453-28616b60236d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_58851410-4e61-42dd-bf91-f0a438a0d125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_SeniorUnsecuredNotesMember_a785b508-6b55-4ef8-bb3f-78dbb69867c4" xlink:href="gehc-20250331.xsd#gehc_SeniorUnsecuredNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58851410-4e61-42dd-bf91-f0a438a0d125" xlink:to="loc_gehc_SeniorUnsecuredNotesMember_a785b508-6b55-4ef8-bb3f-78dbb69867c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A5YearRevolvingCreditFacilityMember_b24af7ea-1430-4030-9aa0-62f62c2e4ea2" xlink:href="gehc-20250331.xsd#gehc_A5YearRevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58851410-4e61-42dd-bf91-f0a438a0d125" xlink:to="loc_gehc_A5YearRevolvingCreditFacilityMember_b24af7ea-1430-4030-9aa0-62f62c2e4ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A364DayRevolvingCreditFacilityMember_57daa91c-fee9-4a24-ab14-fa3da1c6aa64" xlink:href="gehc-20250331.xsd#gehc_A364DayRevolvingCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58851410-4e61-42dd-bf91-f0a438a0d125" xlink:to="loc_gehc_A364DayRevolvingCreditFacilityMember_57daa91c-fee9-4a24-ab14-fa3da1c6aa64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_FloatingRateTermLoanFacilityDue2026Member_a536e50d-d7f6-46b8-a0c6-4d23381b4832" xlink:href="gehc-20250331.xsd#gehc_FloatingRateTermLoanFacilityDue2026Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58851410-4e61-42dd-bf91-f0a438a0d125" xlink:to="loc_gehc_FloatingRateTermLoanFacilityDue2026Member_a536e50d-d7f6-46b8-a0c6-4d23381b4832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d687d8d0-0c89-45c7-8262-a16b5dd9cead" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c825564b-c6f4-455d-af14-a026aa2dae8d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d687d8d0-0c89-45c7-8262-a16b5dd9cead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_90fdd951-2912-4295-9772-220e12f97d90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d687d8d0-0c89-45c7-8262-a16b5dd9cead" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_90fdd951-2912-4295-9772-220e12f97d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_0b5649e0-1f96-4ce1-b368-3a6ab10e7882" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_90fdd951-2912-4295-9772-220e12f97d90" xlink:to="loc_us-gaap_SeniorNotesMember_0b5649e0-1f96-4ce1-b368-3a6ab10e7882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_9a744dc0-80d9-41f4-a7db-2542498084eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_90fdd951-2912-4295-9772-220e12f97d90" xlink:to="loc_us-gaap_LineOfCreditMember_9a744dc0-80d9-41f4-a7db-2542498084eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5191a3bc-4952-4a83-afc8-06c8b4c1fb2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c825564b-c6f4-455d-af14-a026aa2dae8d" xlink:to="loc_us-gaap_CreditFacilityAxis_5191a3bc-4952-4a83-afc8-06c8b4c1fb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9cd51f0a-0a29-4560-a5a6-c25fcd5729a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_5191a3bc-4952-4a83-afc8-06c8b4c1fb2e" xlink:to="loc_us-gaap_CreditFacilityDomain_9cd51f0a-0a29-4560-a5a6-c25fcd5729a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_ee772a89-7c82-4559-a973-b1a609ba6815" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_9cd51f0a-0a29-4560-a5a6-c25fcd5729a1" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_ee772a89-7c82-4559-a973-b1a609ba6815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_fdabe3a5-de16-40ea-841a-9adba8690c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_9cd51f0a-0a29-4560-a5a6-c25fcd5729a1" xlink:to="loc_us-gaap_UnsecuredDebtMember_fdabe3a5-de16-40ea-841a-9adba8690c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderlyingAssetClassAxis_d69898af-622c-47e5-a4e0-8d454748c072" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnderlyingAssetClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c825564b-c6f4-455d-af14-a026aa2dae8d" xlink:to="loc_us-gaap_UnderlyingAssetClassAxis_d69898af-622c-47e5-a4e0-8d454748c072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnderlyingAssetClassDomain_b145ea8d-244a-4e00-b715-7def8b8d3234" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnderlyingAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnderlyingAssetClassAxis_d69898af-622c-47e5-a4e0-8d454748c072" xlink:to="loc_us-gaap_UnderlyingAssetClassDomain_b145ea8d-244a-4e00-b715-7def8b8d3234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_CommercialContractsMember_d83f6067-bcd1-40f0-8e21-a312db428612" xlink:href="gehc-20250331.xsd#gehc_CommercialContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnderlyingAssetClassDomain_b145ea8d-244a-4e00-b715-7def8b8d3234" xlink:to="loc_gehc_CommercialContractsMember_d83f6067-bcd1-40f0-8e21-a312db428612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_EquipmentResidualValueObligationMember_66802dcf-601b-4a95-9693-fe25797302fc" xlink:href="gehc-20250331.xsd#gehc_EquipmentResidualValueObligationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnderlyingAssetClassDomain_b145ea8d-244a-4e00-b715-7def8b8d3234" xlink:to="loc_gehc_EquipmentResidualValueObligationMember_66802dcf-601b-4a95-9693-fe25797302fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c825564b-c6f4-455d-af14-a026aa2dae8d" xlink:to="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_44fc6e55-e820-4dd7-b854-8f68a1a0ee92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_44fc6e55-e820-4dd7-b854-8f68a1a0ee92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_NumberOfDebtSeries_8b61fd86-9f60-4324-8e3b-0c9c7283980a" xlink:href="gehc-20250331.xsd#gehc_NumberOfDebtSeries"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:to="loc_gehc_NumberOfDebtSeries_8b61fd86-9f60-4324-8e3b-0c9c7283980a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_21b018d7-24be-41ff-8394-5eb5b287c1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:to="loc_us-gaap_DebtInstrumentTerm_21b018d7-24be-41ff-8394-5eb5b287c1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_36d18c9a-77ae-4923-accd-d4728acc2996" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_36d18c9a-77ae-4923-accd-d4728acc2996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_e9851a05-a546-4c6e-bfc0-5960ad418213" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:to="loc_us-gaap_LineOfCredit_e9851a05-a546-4c6e-bfc0-5960ad418213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_ac2e4050-1535-4502-97d7-6f0477c88573" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_ac2e4050-1535-4502-97d7-6f0477c88573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_8c198086-adc4-4339-bf73-026fca9d138e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_8c198086-adc4-4339-bf73-026fca9d138e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_4212993a-3a6e-45c5-8b98-1e2ceccfcb37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_4212993a-3a6e-45c5-8b98-1e2ceccfcb37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_952c2b35-dbaa-4df2-bc05-e1e70baa04f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21f9ed4e-7abb-4b55-aed8-45aae1cb8c26" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_952c2b35-dbaa-4df2-bc05-e1e70baa04f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#BORROWINGSScheduleofLongTermBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_678964f4-f7c0-49e8-bf4b-cc5cc71cf21e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b5a1b320-bbbc-4098-beb0-e624cea61a37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_678964f4-f7c0-49e8-bf4b-cc5cc71cf21e" xlink:to="loc_us-gaap_DebtInstrumentTable_b5a1b320-bbbc-4098-beb0-e624cea61a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_933dd92b-f471-477e-a437-a9bacbc76f94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b5a1b320-bbbc-4098-beb0-e624cea61a37" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_933dd92b-f471-477e-a437-a9bacbc76f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7440640a-8a05-4891-864a-3d7caccad1ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_933dd92b-f471-477e-a437-a9bacbc76f94" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7440640a-8a05-4891-864a-3d7caccad1ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_daf95634-20c0-4dd5-ac18-6771f110ed54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7440640a-8a05-4891-864a-3d7caccad1ba" xlink:to="loc_us-gaap_SeniorNotesMember_daf95634-20c0-4dd5-ac18-6771f110ed54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_f8e13e5b-49f1-438f-9af7-96a5eafdf701" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7440640a-8a05-4891-864a-3d7caccad1ba" xlink:to="loc_us-gaap_LineOfCreditMember_f8e13e5b-49f1-438f-9af7-96a5eafdf701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherLongTermBorrowingsMember_bac80d2a-ca6e-43e8-918c-a8e1c70835e7" xlink:href="gehc-20250331.xsd#gehc_OtherLongTermBorrowingsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7440640a-8a05-4891-864a-3d7caccad1ba" xlink:to="loc_gehc_OtherLongTermBorrowingsMember_bac80d2a-ca6e-43e8-918c-a8e1c70835e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2df6ef19-90c0-4c53-ae2c-774795a449fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b5a1b320-bbbc-4098-beb0-e624cea61a37" xlink:to="loc_us-gaap_DebtInstrumentAxis_2df6ef19-90c0-4c53-ae2c-774795a449fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a9cedfb0-5d58-4e38-b6a1-1d13793a8e90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_2df6ef19-90c0-4c53-ae2c-774795a449fa" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a9cedfb0-5d58-4e38-b6a1-1d13793a8e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A5600SeniorNotesDue2025Member_305f31f3-ed0b-4a17-84ed-f48870b3a1b7" xlink:href="gehc-20250331.xsd#gehc_A5600SeniorNotesDue2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9cedfb0-5d58-4e38-b6a1-1d13793a8e90" xlink:to="loc_gehc_A5600SeniorNotesDue2025Member_305f31f3-ed0b-4a17-84ed-f48870b3a1b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A5650SeniorNotesDue2027Member_c99d9b47-6bfe-4dcd-9365-c484512adab9" xlink:href="gehc-20250331.xsd#gehc_A5650SeniorNotesDue2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9cedfb0-5d58-4e38-b6a1-1d13793a8e90" xlink:to="loc_gehc_A5650SeniorNotesDue2027Member_c99d9b47-6bfe-4dcd-9365-c484512adab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A4.800SeniorNotesDue2029Member_18d4a10c-ef3a-41e8-83aa-da6145f45242" xlink:href="gehc-20250331.xsd#gehc_A4.800SeniorNotesDue2029Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9cedfb0-5d58-4e38-b6a1-1d13793a8e90" xlink:to="loc_gehc_A4.800SeniorNotesDue2029Member_18d4a10c-ef3a-41e8-83aa-da6145f45242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A5857SeniorNotesDue2030Member_7023e798-328e-4f66-ab65-bd9c8ea2f23d" xlink:href="gehc-20250331.xsd#gehc_A5857SeniorNotesDue2030Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9cedfb0-5d58-4e38-b6a1-1d13793a8e90" xlink:to="loc_gehc_A5857SeniorNotesDue2030Member_7023e798-328e-4f66-ab65-bd9c8ea2f23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A5905SeniorNotesDue2032Member_f84e1080-f8a9-472f-ae83-f08974b1a55e" xlink:href="gehc-20250331.xsd#gehc_A5905SeniorNotesDue2032Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9cedfb0-5d58-4e38-b6a1-1d13793a8e90" xlink:to="loc_gehc_A5905SeniorNotesDue2032Member_f84e1080-f8a9-472f-ae83-f08974b1a55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_A6377SeniorNotesDue2052Member_7d030f25-a147-42bf-b96b-50f861b31e79" xlink:href="gehc-20250331.xsd#gehc_A6377SeniorNotesDue2052Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9cedfb0-5d58-4e38-b6a1-1d13793a8e90" xlink:to="loc_gehc_A6377SeniorNotesDue2052Member_7d030f25-a147-42bf-b96b-50f861b31e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_FloatingRateTermLoanFacilityDue2026Member_930aa396-5daf-4fcc-bbff-9ee80ce46b01" xlink:href="gehc-20250331.xsd#gehc_FloatingRateTermLoanFacilityDue2026Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9cedfb0-5d58-4e38-b6a1-1d13793a8e90" xlink:to="loc_gehc_FloatingRateTermLoanFacilityDue2026Member_930aa396-5daf-4fcc-bbff-9ee80ce46b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_aeade33b-97b3-4893-ac1e-601ed919f3dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b5a1b320-bbbc-4098-beb0-e624cea61a37" xlink:to="loc_us-gaap_DebtInstrumentLineItems_aeade33b-97b3-4893-ac1e-601ed919f3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9b2a79ed-6f91-45b3-8e2e-387866ab3098" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_aeade33b-97b3-4893-ac1e-601ed919f3dc" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9b2a79ed-6f91-45b3-8e2e-387866ab3098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_dd3b9585-a401-4df4-8473-da11a977468b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_aeade33b-97b3-4893-ac1e-601ed919f3dc" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_dd3b9585-a401-4df4-8473-da11a977468b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_9ae89734-2eb0-4a16-a3b7-d4435a4ff9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_aeade33b-97b3-4893-ac1e-601ed919f3dc" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_9ae89734-2eb0-4a16-a3b7-d4435a4ff9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_66588ffd-def4-4c72-b7bb-e7191c5b72d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_aeade33b-97b3-4893-ac1e-601ed919f3dc" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_66588ffd-def4-4c72-b7bb-e7191c5b72d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ef8d6ab3-aedc-4ed0-b21e-0621cb0b6fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_aeade33b-97b3-4893-ac1e-601ed919f3dc" xlink:to="loc_us-gaap_LongTermDebt_ef8d6ab3-aedc-4ed0-b21e-0621cb0b6fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_59e691e5-2de0-4449-825c-25feab7312dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_aeade33b-97b3-4893-ac1e-601ed919f3dc" xlink:to="loc_us-gaap_ShortTermBorrowings_59e691e5-2de0-4449-825c-25feab7312dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_8412dc04-2a9e-4c9a-8ccc-740ff5c0ec36" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_aeade33b-97b3-4893-ac1e-601ed919f3dc" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_8412dc04-2a9e-4c9a-8ccc-740ff5c0ec36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_eff53126-d825-4773-bbc8-da92690902e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_aeade33b-97b3-4893-ac1e-601ed919f3dc" xlink:to="loc_us-gaap_LongTermDebtCurrent_eff53126-d825-4773-bbc8-da92690902e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#POSTRETIREMENTBENEFITPLANSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0c15d84e-8888-42db-8936-2b6f1796aed7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_765d9063-86ed-49e0-be1d-667d093eb641" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0c15d84e-8888-42db-8936-2b6f1796aed7" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_765d9063-86ed-49e0-be1d-667d093eb641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_47ec5e01-8a88-4532-9c1d-ed990677e4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_765d9063-86ed-49e0-be1d-667d093eb641" xlink:to="loc_us-gaap_RetirementPlanNameAxis_47ec5e01-8a88-4532-9c1d-ed990677e4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_4f933181-f286-4f7d-aab4-eec44e1a505a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_47ec5e01-8a88-4532-9c1d-ed990677e4f0" xlink:to="loc_us-gaap_RetirementPlanNameDomain_4f933181-f286-4f7d-aab4-eec44e1a505a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_GEHealthCareSupplementalPensionPlanMember_33534b9c-50b0-4f86-ad07-1be6f3e40b72" xlink:href="gehc-20250331.xsd#gehc_GEHealthCareSupplementalPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_4f933181-f286-4f7d-aab4-eec44e1a505a" xlink:to="loc_gehc_GEHealthCareSupplementalPensionPlanMember_33534b9c-50b0-4f86-ad07-1be6f3e40b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameOtherMember_cd8e58d1-886e-450c-8a71-5583d1cf82e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanNameOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_4f933181-f286-4f7d-aab4-eec44e1a505a" xlink:to="loc_us-gaap_RetirementPlanNameOtherMember_cd8e58d1-886e-450c-8a71-5583d1cf82e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_30d6adad-46e7-4348-858a-13f7656d66d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_765d9063-86ed-49e0-be1d-667d093eb641" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_30d6adad-46e7-4348-858a-13f7656d66d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_59a682c0-0b5c-4bd7-8f7d-8dd0e2a57c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_30d6adad-46e7-4348-858a-13f7656d66d2" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_59a682c0-0b5c-4bd7-8f7d-8dd0e2a57c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_e202a465-bb63-4cef-aa18-d4d85b26a544" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_59a682c0-0b5c-4bd7-8f7d-8dd0e2a57c5c" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_e202a465-bb63-4cef-aa18-d4d85b26a544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_686e4dcc-d4da-401d-a861-769862810c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_59a682c0-0b5c-4bd7-8f7d-8dd0e2a57c5c" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_686e4dcc-d4da-401d-a861-769862810c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7a343f68-2903-49f4-b5d5-84bb1753af28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_765d9063-86ed-49e0-be1d-667d093eb641" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7a343f68-2903-49f4-b5d5-84bb1753af28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold_b2884e6f-b040-430c-866a-70a7c3edd3b1" xlink:href="gehc-20250331.xsd#gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7a343f68-2903-49f4-b5d5-84bb1753af28" xlink:to="loc_gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold_b2884e6f-b040-430c-866a-70a7c3edd3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_47ba6474-c3e2-4e7d-bf21-4a70993ce76b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7a343f68-2903-49f4-b5d5-84bb1753af28" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_47ba6474-c3e2-4e7d-bf21-4a70993ce76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_0f549aaa-59d8-461b-a58d-0d60eb05b2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7a343f68-2903-49f4-b5d5-84bb1753af28" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_0f549aaa-59d8-461b-a58d-0d60eb05b2a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_70482dee-890b-4e03-b03b-2b80661ec8b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7a343f68-2903-49f4-b5d5-84bb1753af28" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_70482dee-890b-4e03-b03b-2b80661ec8b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c6e253e7-23fb-4ffb-9e3e-a6c7342b55da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_86c4c1bb-d63e-4ec2-bc6f-6831d53a92a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c6e253e7-23fb-4ffb-9e3e-a6c7342b55da" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_86c4c1bb-d63e-4ec2-bc6f-6831d53a92a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_cdd66e61-ded9-4ee4-a395-6378d3b50bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_86c4c1bb-d63e-4ec2-bc6f-6831d53a92a8" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_cdd66e61-ded9-4ee4-a395-6378d3b50bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_ae96905a-47f4-4460-9baa-2968eb7c0324" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_cdd66e61-ded9-4ee4-a395-6378d3b50bc9" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_ae96905a-47f4-4460-9baa-2968eb7c0324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_ce1060b6-0894-468f-af8c-0bc22bce6245" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_ae96905a-47f4-4460-9baa-2968eb7c0324" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_ce1060b6-0894-468f-af8c-0bc22bce6245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_ff71df88-39bc-4625-8692-79efdc9d0c30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_ae96905a-47f4-4460-9baa-2968eb7c0324" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_ff71df88-39bc-4625-8692-79efdc9d0c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_495cfca3-5b60-4176-9c46-78619541894c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_86c4c1bb-d63e-4ec2-bc6f-6831d53a92a8" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_495cfca3-5b60-4176-9c46-78619541894c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_e92b1bec-e2d9-4974-9e99-1370fdc7b7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_495cfca3-5b60-4176-9c46-78619541894c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_e92b1bec-e2d9-4974-9e99-1370fdc7b7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_fe594edf-3d64-41e4-940c-b8bd5c990bab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_e92b1bec-e2d9-4974-9e99-1370fdc7b7f2" xlink:to="loc_us-gaap_DomesticPlanMember_fe594edf-3d64-41e4-940c-b8bd5c990bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_274894f5-356d-48fd-b530-4a9e1e7041a1" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_fe594edf-3d64-41e4-940c-b8bd5c990bab" xlink:to="loc_country_US_274894f5-356d-48fd-b530-4a9e1e7041a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_18668a30-da73-4d2b-93e7-e955a5234b00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_e92b1bec-e2d9-4974-9e99-1370fdc7b7f2" xlink:to="loc_us-gaap_ForeignPlanMember_18668a30-da73-4d2b-93e7-e955a5234b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87df3347-f753-4ba1-8dd6-d962bdf5a8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_86c4c1bb-d63e-4ec2-bc6f-6831d53a92a8" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87df3347-f753-4ba1-8dd6-d962bdf5a8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_14cff163-b89e-4dcd-bbbc-42aab7c9152e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87df3347-f753-4ba1-8dd6-d962bdf5a8d5" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_14cff163-b89e-4dcd-bbbc-42aab7c9152e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_248f479a-3628-4151-ba34-e0f3e90f157b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87df3347-f753-4ba1-8dd6-d962bdf5a8d5" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_248f479a-3628-4151-ba34-e0f3e90f157b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_6901461e-5e12-498a-9fd9-8b9a66c8a4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87df3347-f753-4ba1-8dd6-d962bdf5a8d5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_6901461e-5e12-498a-9fd9-8b9a66c8a4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_2b0a0eb3-6e6e-40e1-a2c5-0b5f53f56222" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87df3347-f753-4ba1-8dd6-d962bdf5a8d5" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_2b0a0eb3-6e6e-40e1-a2c5-0b5f53f56222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_dc5ad831-7a34-4fca-9825-fa51f34ca942" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87df3347-f753-4ba1-8dd6-d962bdf5a8d5" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_dc5ad831-7a34-4fca-9825-fa51f34ca942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_9712d857-3b47-4da7-a7c4-ace203859c02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87df3347-f753-4ba1-8dd6-d962bdf5a8d5" xlink:to="loc_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod_9712d857-3b47-4da7-a7c4-ace203859c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_cdb0b6b4-3915-478e-9d4f-52d05795346f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87df3347-f753-4ba1-8dd6-d962bdf5a8d5" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_cdb0b6b4-3915-478e-9d4f-52d05795346f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e9b388ea-8d3c-420a-8fe2-b3998ac6cd6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_87df3347-f753-4ba1-8dd6-d962bdf5a8d5" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e9b388ea-8d3c-420a-8fe2-b3998ac6cd6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3e9b278c-8178-4cdd-9381-3c49e6da105c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_94d95726-6bf2-4810-92ff-383f0dd33adb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3e9b278c-8178-4cdd-9381-3c49e6da105c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_94d95726-6bf2-4810-92ff-383f0dd33adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7a83b792-1fd8-44d1-83fc-49c90cbba6ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_27adc198-4f11-40f6-ae48-a2bc8e61080c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7a83b792-1fd8-44d1-83fc-49c90cbba6ed" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_27adc198-4f11-40f6-ae48-a2bc8e61080c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6ba7f4a5-3383-475e-9060-31b287c53445" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_27adc198-4f11-40f6-ae48-a2bc8e61080c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6ba7f4a5-3383-475e-9060-31b287c53445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cbf26570-fa65-4019-961d-d13cb59bee47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6ba7f4a5-3383-475e-9060-31b287c53445" xlink:to="loc_us-gaap_EquityComponentDomain_cbf26570-fa65-4019-961d-d13cb59bee47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_47e2c823-5d1d-4adb-83b0-20ad0d70c642" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cbf26570-fa65-4019-961d-d13cb59bee47" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_47e2c823-5d1d-4adb-83b0-20ad0d70c642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_8f6fb67a-c527-4f83-bc0a-d3199adaa2ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_47e2c823-5d1d-4adb-83b0-20ad0d70c642" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_8f6fb67a-c527-4f83-bc0a-d3199adaa2ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_7cf2bc42-ca41-40b1-83af-b4509f3234ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_47e2c823-5d1d-4adb-83b0-20ad0d70c642" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_7cf2bc42-ca41-40b1-83af-b4509f3234ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_869cb670-d0f8-4627-9aab-16274b07b0dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_47e2c823-5d1d-4adb-83b0-20ad0d70c642" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_869cb670-d0f8-4627-9aab-16274b07b0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5b1fdcb9-1145-452d-aab3-f30cd331de19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_27adc198-4f11-40f6-ae48-a2bc8e61080c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5b1fdcb9-1145-452d-aab3-f30cd331de19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d1449898-988a-4efc-9669-e0bbf6bdb531" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5b1fdcb9-1145-452d-aab3-f30cd331de19" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d1449898-988a-4efc-9669-e0bbf6bdb531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_NihonMediPhysicsCo.LtdNMPMember_d270579b-72e1-4f7e-84c8-99d2ab6980d5" xlink:href="gehc-20250331.xsd#gehc_NihonMediPhysicsCo.LtdNMPMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d1449898-988a-4efc-9669-e0bbf6bdb531" xlink:to="loc_gehc_NihonMediPhysicsCo.LtdNMPMember_d270579b-72e1-4f7e-84c8-99d2ab6980d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_43568a41-7e26-4869-9278-9929cee5aad4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_27adc198-4f11-40f6-ae48-a2bc8e61080c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_43568a41-7e26-4869-9278-9929cee5aad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_7c13b43c-c1cd-4a00-8312-52968f22b13a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_43568a41-7e26-4869-9278-9929cee5aad4" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_7c13b43c-c1cd-4a00-8312-52968f22b13a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_68ca22c7-88b3-4cd0-a844-01c14daf96f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_7c13b43c-c1cd-4a00-8312-52968f22b13a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_68ca22c7-88b3-4cd0-a844-01c14daf96f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_6b2b8655-9a09-40f8-b226-395bf7ed2222" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_7c13b43c-c1cd-4a00-8312-52968f22b13a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_6b2b8655-9a09-40f8-b226-395bf7ed2222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_621524de-bef5-4d1f-bd3c-f6b181987c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_7c13b43c-c1cd-4a00-8312-52968f22b13a" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_621524de-bef5-4d1f-bd3c-f6b181987c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4975ef49-5133-4cd8-abd1-7c0042e7c089" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_7c13b43c-c1cd-4a00-8312-52968f22b13a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4975ef49-5133-4cd8-abd1-7c0042e7c089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_9678c2cb-d925-4025-97f3-2f5a2c8ff766" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_7c13b43c-c1cd-4a00-8312-52968f22b13a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_9678c2cb-d925-4025-97f3-2f5a2c8ff766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c6e24fdf-47f4-41c0-91c3-e985a8abff39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_7c13b43c-c1cd-4a00-8312-52968f22b13a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c6e24fdf-47f4-41c0-91c3-e985a8abff39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_dc1d5d2b-62dc-407f-bde6-26c168d21277" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_43568a41-7e26-4869-9278-9929cee5aad4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_dc1d5d2b-62dc-407f-bde6-26c168d21277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_3592b994-9e51-4cce-b3a3-3763b382d45a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_43568a41-7e26-4869-9278-9929cee5aad4" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_3592b994-9e51-4cce-b3a3-3763b382d45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax_e4e6e7cf-388f-4414-b413-fc35a16f79be" xlink:href="gehc-20250331.xsd#gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_43568a41-7e26-4869-9278-9929cee5aad4" xlink:to="loc_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax_e4e6e7cf-388f-4414-b413-fc35a16f79be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_ff8b45eb-2344-47b5-8c38-a13f828c31ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_43568a41-7e26-4869-9278-9929cee5aad4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_ff8b45eb-2344-47b5-8c38-a13f828c31ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_22aad99d-eb79-44e0-a595-d5aff8e68ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_dc69c354-0985-4f86-bc37-0cfd62883019" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_22aad99d-eb79-44e0-a595-d5aff8e68ca2" xlink:to="loc_us-gaap_DerivativeTable_dc69c354-0985-4f86-bc37-0cfd62883019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd381ceb-474b-4e96-b2bc-3a72375f9a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_dc69c354-0985-4f86-bc37-0cfd62883019" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd381ceb-474b-4e96-b2bc-3a72375f9a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_55a9e064-ce12-45a5-a035-68fd8219f818" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd381ceb-474b-4e96-b2bc-3a72375f9a1f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_55a9e064-ce12-45a5-a035-68fd8219f818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_0b724310-6cb3-44cd-bab4-591d09000b20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_55a9e064-ce12-45a5-a035-68fd8219f818" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_0b724310-6cb3-44cd-bab4-591d09000b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_ef84783c-18c9-4be3-9b05-67f76f615738" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_55a9e064-ce12-45a5-a035-68fd8219f818" xlink:to="loc_us-gaap_FairValueHedgingMember_ef84783c-18c9-4be3-9b05-67f76f615738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6d8f5b64-9284-4290-962e-bab74ec7c35b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_dc69c354-0985-4f86-bc37-0cfd62883019" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6d8f5b64-9284-4290-962e-bab74ec7c35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4b769ff8-17c7-4561-8d41-fa2cf0844bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6d8f5b64-9284-4290-962e-bab74ec7c35b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4b769ff8-17c7-4561-8d41-fa2cf0844bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_efff3931-9243-40d5-add3-2cec556db0de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4b769ff8-17c7-4561-8d41-fa2cf0844bfa" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_efff3931-9243-40d5-add3-2cec556db0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6481637b-fba5-4a2f-bdc1-f8389b0d1850" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4b769ff8-17c7-4561-8d41-fa2cf0844bfa" xlink:to="loc_us-gaap_InterestRateSwapMember_6481637b-fba5-4a2f-bdc1-f8389b0d1850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b719f35f-2d41-42d3-9247-8c7802a158e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_dc69c354-0985-4f86-bc37-0cfd62883019" xlink:to="loc_us-gaap_HedgingDesignationAxis_b719f35f-2d41-42d3-9247-8c7802a158e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_68986ddb-b1b5-465a-810c-1703f54bb514" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_b719f35f-2d41-42d3-9247-8c7802a158e4" xlink:to="loc_us-gaap_HedgingDesignationDomain_68986ddb-b1b5-465a-810c-1703f54bb514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6231695b-94d7-45aa-9214-21a9b847ade6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_68986ddb-b1b5-465a-810c-1703f54bb514" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6231695b-94d7-45aa-9214-21a9b847ade6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_8b785d3f-2614-44e4-9656-2594cb21cb66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_dc69c354-0985-4f86-bc37-0cfd62883019" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_8b785d3f-2614-44e4-9656-2594cb21cb66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_450d01a7-88eb-4af5-a92f-8a56aa12a65c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_8b785d3f-2614-44e4-9656-2594cb21cb66" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_450d01a7-88eb-4af5-a92f-8a56aa12a65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_c777195c-d9ac-4cb8-8e56-f7ad05ad7d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_450d01a7-88eb-4af5-a92f-8a56aa12a65c" xlink:to="loc_us-gaap_MoneyMarketFundsMember_c777195c-d9ac-4cb8-8e56-f7ad05ad7d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherCashEquivalentsMember_cb78db68-2c3c-4b7a-919a-58bcad940191" xlink:href="gehc-20250331.xsd#gehc_OtherCashEquivalentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_450d01a7-88eb-4af5-a92f-8a56aa12a65c" xlink:to="loc_gehc_OtherCashEquivalentsMember_cb78db68-2c3c-4b7a-919a-58bcad940191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fa5325f4-b526-4d4b-a655-1cca5440823f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_dc69c354-0985-4f86-bc37-0cfd62883019" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fa5325f4-b526-4d4b-a655-1cca5440823f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_41255372-baaf-4f18-9ab0-a258abd5f059" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fa5325f4-b526-4d4b-a655-1cca5440823f" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_41255372-baaf-4f18-9ab0-a258abd5f059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_af70b531-5ee7-4042-a9ea-3a950bc846cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_41255372-baaf-4f18-9ab0-a258abd5f059" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_af70b531-5ee7-4042-a9ea-3a950bc846cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_993cbf8b-4c56-4783-b2d0-886350b3a8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_dc69c354-0985-4f86-bc37-0cfd62883019" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_993cbf8b-4c56-4783-b2d0-886350b3a8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_193d112d-8b4a-46bb-b6c7-30b8a9453506" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_993cbf8b-4c56-4783-b2d0-886350b3a8b7" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_193d112d-8b4a-46bb-b6c7-30b8a9453506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ee8c7984-a994-407e-b20c-1222ba37abc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_193d112d-8b4a-46bb-b6c7-30b8a9453506" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ee8c7984-a994-407e-b20c-1222ba37abc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_07172cdb-743d-42e0-a395-b616ecf75460" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ee8c7984-a994-407e-b20c-1222ba37abc2" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_07172cdb-743d-42e0-a395-b616ecf75460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_7fae02e1-907c-4687-8e53-29d2f31d2459" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ee8c7984-a994-407e-b20c-1222ba37abc2" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_7fae02e1-907c-4687-8e53-29d2f31d2459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_cd8e5c7d-26de-48b0-adf3-c8f54f771bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_dc69c354-0985-4f86-bc37-0cfd62883019" xlink:to="loc_us-gaap_DerivativeLineItems_cd8e5c7d-26de-48b0-adf3-c8f54f771bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_e67169f4-6c84-4fcf-a221-f14d785cc381" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_cd8e5c7d-26de-48b0-adf3-c8f54f771bb4" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_e67169f4-6c84-4fcf-a221-f14d785cc381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability_8c27900e-aa54-4beb-a435-f7729f8b2737" xlink:href="gehc-20250331.xsd#gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_cd8e5c7d-26de-48b0-adf3-c8f54f771bb4" xlink:to="loc_gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability_8c27900e-aa54-4beb-a435-f7729f8b2737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_b73927be-1c43-4357-ba23-b8e6f2cc7b68" xlink:href="gehc-20250331.xsd#gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_cd8e5c7d-26de-48b0-adf3-c8f54f771bb4" xlink:to="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_b73927be-1c43-4357-ba23-b8e6f2cc7b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_3f56255c-e488-4803-95ab-aeb90e917d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_cd8e5c7d-26de-48b0-adf3-c8f54f771bb4" xlink:to="loc_us-gaap_LongTermDebtFairValue_3f56255c-e488-4803-95ab-aeb90e917d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0c5f2a31-e495-40d3-ade2-13405f42980c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_bee063bf-cea9-469d-86c3-ce811d146124" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0c5f2a31-e495-40d3-ade2-13405f42980c" xlink:to="loc_us-gaap_DerivativeTable_bee063bf-cea9-469d-86c3-ce811d146124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_aa598ef8-ec2b-4d8c-a131-5e4d3a62f0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_bee063bf-cea9-469d-86c3-ce811d146124" xlink:to="loc_us-gaap_HedgingDesignationAxis_aa598ef8-ec2b-4d8c-a131-5e4d3a62f0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f5ab3d46-0f66-4077-b0cd-b7ce049bdc2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_aa598ef8-ec2b-4d8c-a131-5e4d3a62f0d5" xlink:to="loc_us-gaap_HedgingDesignationDomain_f5ab3d46-0f66-4077-b0cd-b7ce049bdc2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_679079c0-57ab-4db2-8b7c-21c77acfffd7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_f5ab3d46-0f66-4077-b0cd-b7ce049bdc2c" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_679079c0-57ab-4db2-8b7c-21c77acfffd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_ba5c38a0-7d58-45db-b710-bd99ce9b732b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_f5ab3d46-0f66-4077-b0cd-b7ce049bdc2c" xlink:to="loc_us-gaap_NondesignatedMember_ba5c38a0-7d58-45db-b710-bd99ce9b732b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d1fab150-6dd9-4032-9647-e5537b030cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_bee063bf-cea9-469d-86c3-ce811d146124" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d1fab150-6dd9-4032-9647-e5537b030cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_8ee3da54-9832-4bb4-8be3-4caa320d0aae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d1fab150-6dd9-4032-9647-e5537b030cd9" xlink:to="loc_us-gaap_HedgingRelationshipDomain_8ee3da54-9832-4bb4-8be3-4caa320d0aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_fa87b3c3-26b7-44da-8631-bbbf21f46833" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8ee3da54-9832-4bb4-8be3-4caa320d0aae" xlink:to="loc_us-gaap_CashFlowHedgingMember_fa87b3c3-26b7-44da-8631-bbbf21f46833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_5e0c62dd-e65b-4a29-a7a6-2727ba15fe78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8ee3da54-9832-4bb4-8be3-4caa320d0aae" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_5e0c62dd-e65b-4a29-a7a6-2727ba15fe78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_dc01a42c-8b7c-4f77-9c03-953d267351a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_8ee3da54-9832-4bb4-8be3-4caa320d0aae" xlink:to="loc_us-gaap_FairValueHedgingMember_dc01a42c-8b7c-4f77-9c03-953d267351a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0b4acc26-ead6-4311-9c9a-c19ff39c0224" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_bee063bf-cea9-469d-86c3-ce811d146124" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0b4acc26-ead6-4311-9c9a-c19ff39c0224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d59b4d8f-ffc7-49c2-ab00-4fbba00f87ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0b4acc26-ead6-4311-9c9a-c19ff39c0224" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d59b4d8f-ffc7-49c2-ab00-4fbba00f87ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_5bad07bf-8350-4cf4-b4f8-2e5c4021e024" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d59b4d8f-ffc7-49c2-ab00-4fbba00f87ea" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_5bad07bf-8350-4cf4-b4f8-2e5c4021e024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_27c9f0e1-c5dc-4914-8797-2d099addd934" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d59b4d8f-ffc7-49c2-ab00-4fbba00f87ea" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_27c9f0e1-c5dc-4914-8797-2d099addd934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember_25807e53-fbd6-4134-930a-74cce9d41756" xlink:href="gehc-20250331.xsd#gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d59b4d8f-ffc7-49c2-ab00-4fbba00f87ea" xlink:to="loc_gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember_25807e53-fbd6-4134-930a-74cce9d41756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_a964df62-01a3-4866-ae63-dd1d1e036beb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d59b4d8f-ffc7-49c2-ab00-4fbba00f87ea" xlink:to="loc_us-gaap_InterestRateSwapMember_a964df62-01a3-4866-ae63-dd1d1e036beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember_6a86aa98-abdb-4228-88f4-aea1ceb5a45c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherContractMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d59b4d8f-ffc7-49c2-ab00-4fbba00f87ea" xlink:to="loc_us-gaap_OtherContractMember_6a86aa98-abdb-4228-88f4-aea1ceb5a45c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e95ae0c8-400a-4c4d-a99b-6ec26791f325" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_bee063bf-cea9-469d-86c3-ce811d146124" xlink:to="loc_us-gaap_DerivativeLineItems_e95ae0c8-400a-4c4d-a99b-6ec26791f325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_174474a9-f94c-45c7-88b2-053983e3d4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e95ae0c8-400a-4c4d-a99b-6ec26791f325" xlink:to="loc_us-gaap_DerivativeNotionalAmount_174474a9-f94c-45c7-88b2-053983e3d4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_241b7e36-adff-46c9-8c60-99b643a41993" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e95ae0c8-400a-4c4d-a99b-6ec26791f325" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_241b7e36-adff-46c9-8c60-99b643a41993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_78f1b581-13a1-43ed-b172-40215a526c80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e95ae0c8-400a-4c4d-a99b-6ec26791f325" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_78f1b581-13a1-43ed-b172-40215a526c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofCumulativeBasisAdjustmentforFairvalueHedgesDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofCumulativeBasisAdjustmentforFairvalueHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofCumulativeBasisAdjustmentforFairvalueHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_aac164d7-53ec-41bd-966c-ae35f1070343" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedge_32fe0200-d924-4b19-a5bb-7ea8d069d88c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgedLiabilityFairValueHedge"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_aac164d7-53ec-41bd-966c-ae35f1070343" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedge_32fe0200-d924-4b19-a5bb-7ea8d069d88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration_add237f6-f356-4c8f-bbf1-4f44a0b01256" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgedLiabilityFairValueHedge_32fe0200-d924-4b19-a5bb-7ea8d069d88c" xlink:to="loc_us-gaap_HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration_add237f6-f356-4c8f-bbf1-4f44a0b01256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_fca01e17-db91-4c46-a40c-56c6f8856b83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_aac164d7-53ec-41bd-966c-ae35f1070343" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_fca01e17-db91-4c46-a40c-56c6f8856b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativePretaxGainsLossesRecognizedinOCIDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativePretaxGainsLossesRecognizedinOCIDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativePretaxGainsLossesRecognizedinOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bb85c1c1-ddf1-462a-bcff-78d7e4a1d30a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_5a5565e5-7f27-4dea-aba6-3c139063c8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bb85c1c1-ddf1-462a-bcff-78d7e4a1d30a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_5a5565e5-7f27-4dea-aba6-3c139063c8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_5b0d8c95-2c46-45dd-b850-3577c48007df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bb85c1c1-ddf1-462a-bcff-78d7e4a1d30a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_5b0d8c95-2c46-45dd-b850-3577c48007df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_83f18cd5-68e6-4b68-a547-e1d2b208830e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a7442a33-692b-4c37-b2e1-b37e874c3377" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_83f18cd5-68e6-4b68-a547-e1d2b208830e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a7442a33-692b-4c37-b2e1-b37e874c3377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_635e8e9d-e16a-49e5-81cd-f17b4576f6d5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a7442a33-692b-4c37-b2e1-b37e874c3377" xlink:to="loc_srt_ProductOrServiceAxis_635e8e9d-e16a-49e5-81cd-f17b4576f6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4b228c91-1c32-4380-a82e-4e8671e8e695" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_635e8e9d-e16a-49e5-81cd-f17b4576f6d5" xlink:to="loc_srt_ProductsAndServicesDomain_4b228c91-1c32-4380-a82e-4e8671e8e695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_76d07e49-a116-4616-8895-78c83eca1697" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4b228c91-1c32-4380-a82e-4e8671e8e695" xlink:to="loc_us-gaap_ProductMember_76d07e49-a116-4616-8895-78c83eca1697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_4cd0ad63-7af3-4032-80ab-6f9e49631a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4b228c91-1c32-4380-a82e-4e8671e8e695" xlink:to="loc_us-gaap_ServiceMember_4cd0ad63-7af3-4032-80ab-6f9e49631a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_661cc621-59b7-4223-a005-12ff0da2e8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a7442a33-692b-4c37-b2e1-b37e874c3377" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_661cc621-59b7-4223-a005-12ff0da2e8e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_24304f7b-3196-4e86-85fa-b5845f98c899" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_661cc621-59b7-4223-a005-12ff0da2e8e5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_24304f7b-3196-4e86-85fa-b5845f98c899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_b1b5d7ef-60f9-481e-ad0e-5a32d130b7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_24304f7b-3196-4e86-85fa-b5845f98c899" xlink:to="loc_us-gaap_CostOfSalesMember_b1b5d7ef-60f9-481e-ad0e-5a32d130b7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3b08391e-5618-4e90-84df-5f98907abfa6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_24304f7b-3196-4e86-85fa-b5845f98c899" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3b08391e-5618-4e90-84df-5f98907abfa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_InterestAndDebtExpenseMember_8f48269e-f673-4a75-a52f-b52c2200e48d" xlink:href="gehc-20250331.xsd#gehc_InterestAndDebtExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_24304f7b-3196-4e86-85fa-b5845f98c899" xlink:to="loc_gehc_InterestAndDebtExpenseMember_8f48269e-f673-4a75-a52f-b52c2200e48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b92be240-e0de-42e6-ac1c-c1560d0ef95c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_24304f7b-3196-4e86-85fa-b5845f98c899" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b92be240-e0de-42e6-ac1c-c1560d0ef95c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_9d99db8b-2893-4fb6-94a1-a1e9a54f18e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_24304f7b-3196-4e86-85fa-b5845f98c899" xlink:to="loc_us-gaap_InterestExpenseMember_9d99db8b-2893-4fb6-94a1-a1e9a54f18e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_edd4ecbb-90e7-44f8-8ca8-a7c0961583bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a7442a33-692b-4c37-b2e1-b37e874c3377" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_edd4ecbb-90e7-44f8-8ca8-a7c0961583bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1fff678d-2a5e-44cd-b80d-6814f0f35718" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_edd4ecbb-90e7-44f8-8ca8-a7c0961583bf" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1fff678d-2a5e-44cd-b80d-6814f0f35718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_9e54aee4-720f-4147-b975-eb6476e7f6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1fff678d-2a5e-44cd-b80d-6814f0f35718" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_9e54aee4-720f-4147-b975-eb6476e7f6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_68557994-224f-45eb-81e1-ad0bf28770f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1fff678d-2a5e-44cd-b80d-6814f0f35718" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_68557994-224f-45eb-81e1-ad0bf28770f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember_c37ddb2f-9469-4505-bdeb-ea8ce3b5c2e9" xlink:href="gehc-20250331.xsd#gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1fff678d-2a5e-44cd-b80d-6814f0f35718" xlink:to="loc_gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember_c37ddb2f-9469-4505-bdeb-ea8ce3b5c2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_56dbc1e2-ce43-4de8-84e3-42388e742517" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1fff678d-2a5e-44cd-b80d-6814f0f35718" xlink:to="loc_us-gaap_InterestRateSwapMember_56dbc1e2-ce43-4de8-84e3-42388e742517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_DebtBasisAdjustmentLongTermBorrowingsMember_c8e784d6-1037-4818-8eef-7042782bdcad" xlink:href="gehc-20250331.xsd#gehc_DebtBasisAdjustmentLongTermBorrowingsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1fff678d-2a5e-44cd-b80d-6814f0f35718" xlink:to="loc_gehc_DebtBasisAdjustmentLongTermBorrowingsMember_c8e784d6-1037-4818-8eef-7042782bdcad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember_02b6b2b1-e1c9-45b5-a6f2-370681393918" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherContractMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1fff678d-2a5e-44cd-b80d-6814f0f35718" xlink:to="loc_us-gaap_OtherContractMember_02b6b2b1-e1c9-45b5-a6f2-370681393918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_35b0d792-d9d5-415e-ab33-5eafbc2dd1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a7442a33-692b-4c37-b2e1-b37e874c3377" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_35b0d792-d9d5-415e-ab33-5eafbc2dd1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_89396d8b-5e05-4baf-8110-e55a5a549b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_35b0d792-d9d5-415e-ab33-5eafbc2dd1fa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_89396d8b-5e05-4baf-8110-e55a5a549b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_86377eff-d3f6-4b2e-b845-b46641c77771" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_35b0d792-d9d5-415e-ab33-5eafbc2dd1fa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_86377eff-d3f6-4b2e-b845-b46641c77771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax_cf42b3a6-022f-4f0d-8392-e9dd34437429" xlink:href="gehc-20250331.xsd#gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_35b0d792-d9d5-415e-ab33-5eafbc2dd1fa" xlink:to="loc_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax_cf42b3a6-022f-4f0d-8392-e9dd34437429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_708a35de-22bc-4cea-960f-6b47065818e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_35b0d792-d9d5-415e-ab33-5eafbc2dd1fa" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_708a35de-22bc-4cea-960f-6b47065818e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_759fcab6-8094-4bbb-a9ce-f740d9c29d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a6e9d6e5-de64-4c9f-81de-6c2c052f6dee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_759fcab6-8094-4bbb-a9ce-f740d9c29d4e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a6e9d6e5-de64-4c9f-81de-6c2c052f6dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7af9dae2-548d-4dc2-a7cb-b59d9973dbda" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a6e9d6e5-de64-4c9f-81de-6c2c052f6dee" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7af9dae2-548d-4dc2-a7cb-b59d9973dbda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c35ab707-3511-4bc2-b8b0-d72647633749" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7af9dae2-548d-4dc2-a7cb-b59d9973dbda" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c35ab707-3511-4bc2-b8b0-d72647633749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_115b6372-ad67-4ca3-a370-400e718e87e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c35ab707-3511-4bc2-b8b0-d72647633749" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_115b6372-ad67-4ca3-a370-400e718e87e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_721f6b2f-9423-44e2-9347-877f1b9a8f09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c35ab707-3511-4bc2-b8b0-d72647633749" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_721f6b2f-9423-44e2-9347-877f1b9a8f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_e07c8873-25a4-46e7-8996-600c9562a9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c35ab707-3511-4bc2-b8b0-d72647633749" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_e07c8873-25a4-46e7-8996-600c9562a9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8b1cf889-38c1-4783-a321-acd3ca75e5ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a6e9d6e5-de64-4c9f-81de-6c2c052f6dee" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8b1cf889-38c1-4783-a321-acd3ca75e5ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f93eea2f-d519-4c94-8276-e3b0f7db3f92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8b1cf889-38c1-4783-a321-acd3ca75e5ea" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f93eea2f-d519-4c94-8276-e3b0f7db3f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_16c612ab-3199-4ad2-9a84-49babf216314" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f93eea2f-d519-4c94-8276-e3b0f7db3f92" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_16c612ab-3199-4ad2-9a84-49babf216314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_bff6b4b6-e641-491f-a65e-6cc5ec31d9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a6e9d6e5-de64-4c9f-81de-6c2c052f6dee" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_bff6b4b6-e641-491f-a65e-6cc5ec31d9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0b68f04d-4fe2-4b72-b699-3dd1bb92f09f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_bff6b4b6-e641-491f-a65e-6cc5ec31d9e2" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0b68f04d-4fe2-4b72-b699-3dd1bb92f09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_a3afd924-3df9-40a0-b0bb-e3fd3ed9468a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0b68f04d-4fe2-4b72-b699-3dd1bb92f09f" xlink:to="loc_us-gaap_MoneyMarketFundsMember_a3afd924-3df9-40a0-b0bb-e3fd3ed9468a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f78330e8-c7dc-40f3-adaf-de6dd6a78c56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a6e9d6e5-de64-4c9f-81de-6c2c052f6dee" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f78330e8-c7dc-40f3-adaf-de6dd6a78c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_3fbd567b-e039-428e-bdbd-4949e7ff41cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f78330e8-c7dc-40f3-adaf-de6dd6a78c56" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_3fbd567b-e039-428e-bdbd-4949e7ff41cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_def7d519-c0f3-43bc-8e12-5e9c7ec8e9d2" xlink:href="gehc-20250331.xsd#gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_3fbd567b-e039-428e-bdbd-4949e7ff41cc" xlink:to="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_def7d519-c0f3-43bc-8e12-5e9c7ec8e9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_072f13af-dfb1-4f77-9cc1-03c974b63eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_3fbd567b-e039-428e-bdbd-4949e7ff41cc" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_072f13af-dfb1-4f77-9cc1-03c974b63eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_2c7cf4e2-7901-4221-8adc-9f2a871db415" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_3fbd567b-e039-428e-bdbd-4949e7ff41cc" xlink:to="loc_us-gaap_DerivativeAssets_2c7cf4e2-7901-4221-8adc-9f2a871db415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_abf3ef7c-cde5-4c0f-a8fb-b04d0596f4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f78330e8-c7dc-40f3-adaf-de6dd6a78c56" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_abf3ef7c-cde5-4c0f-a8fb-b04d0596f4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_0277ab3f-401c-4e82-b81c-ab7e7bcb16ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_abf3ef7c-cde5-4c0f-a8fb-b04d0596f4b2" xlink:to="loc_us-gaap_DerivativeLiabilities_0277ab3f-401c-4e82-b81c-ab7e7bcb16ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_98cefc51-0d02-4e7d-9509-56e26a3087e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_abf3ef7c-cde5-4c0f-a8fb-b04d0596f4b2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_98cefc51-0d02-4e7d-9509-56e26a3087e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_00b959fe-dd4a-4da3-ba9f-c90a37aaaf55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_97b1e829-8573-4164-8dc7-75d4b44d8c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_00b959fe-dd4a-4da3-ba9f-c90a37aaaf55" xlink:to="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_97b1e829-8573-4164-8dc7-75d4b44d8c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_99cbda5a-a215-4294-bd7f-da18b7eb8741" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_97b1e829-8573-4164-8dc7-75d4b44d8c9d" xlink:to="loc_us-gaap_ProductWarrantyAccrual_99cbda5a-a215-4294-bd7f-da18b7eb8741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_f34f7081-e9de-47ff-a9fb-8e60cca34664" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_97b1e829-8573-4164-8dc7-75d4b44d8c9d" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_f34f7081-e9de-47ff-a9fb-8e60cca34664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments_9863b7ad-9f36-499b-81c0-af258f2f3111" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_97b1e829-8573-4164-8dc7-75d4b44d8c9d" xlink:to="loc_us-gaap_ProductWarrantyAccrualPayments_9863b7ad-9f36-499b-81c0-af258f2f3111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease_20174aed-f867-4f82-a579-3d922f9947b7" xlink:href="gehc-20250331.xsd#gehc_StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_97b1e829-8573-4164-8dc7-75d4b44d8c9d" xlink:to="loc_gehc_StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease_20174aed-f867-4f82-a579-3d922f9947b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_c23bb990-58c6-4b5d-9d74-84914a6ce5cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_97b1e829-8573-4164-8dc7-75d4b44d8c9d" xlink:to="loc_us-gaap_ProductWarrantyAccrual_c23bb990-58c6-4b5d-9d74-84914a6ce5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringActivitiesDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#RESTRUCTURINGACTIVITIESScheduleofRestructuringActivitiesDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringActivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_a1708c9b-db21-4bd5-b7e8-bd224946622e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_4f3bb410-2527-405e-ba9b-52f389a3d034" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_a1708c9b-db21-4bd5-b7e8-bd224946622e" xlink:to="loc_us-gaap_SeveranceCosts1_4f3bb410-2527-405e-ba9b-52f389a3d034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_6c5de94e-f116-4c5b-b4a5-f7c8d69246f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_a1708c9b-db21-4bd5-b7e8-bd224946622e" xlink:to="loc_us-gaap_BusinessExitCosts1_6c5de94e-f116-4c5b-b4a5-f7c8d69246f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_6627597c-0599-454b-9fbc-9de7ee2c06e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_a1708c9b-db21-4bd5-b7e8-bd224946622e" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_6627597c-0599-454b-9fbc-9de7ee2c06e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_38be5a56-ae8f-4243-9562-ab632a48c63b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_a1708c9b-db21-4bd5-b7e8-bd224946622e" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_38be5a56-ae8f-4243-9562-ab632a48c63b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#RESTRUCTURINGACTIVITIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8f3be21a-6899-4dcf-ac65-be417db58bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_69e9efc4-b3e4-4389-bbbc-70fa6ad51529" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8f3be21a-6899-4dcf-ac65-be417db58bf5" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_69e9efc4-b3e4-4389-bbbc-70fa6ad51529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_56567ff0-0037-4cbf-ac64-f60860ce7493" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f13a85ec-9437-4d10-b2f7-f7f4f8de9e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_56567ff0-0037-4cbf-ac64-f60860ce7493" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f13a85ec-9437-4d10-b2f7-f7f4f8de9e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_d46672e5-97f4-4338-b526-b9805e9d531b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f13a85ec-9437-4d10-b2f7-f7f4f8de9e3d" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_d46672e5-97f4-4338-b526-b9805e9d531b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_eaf47a10-88b3-427d-9001-d3992d7d8e78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_d46672e5-97f4-4338-b526-b9805e9d531b" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_eaf47a10-88b3-427d-9001-d3992d7d8e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_d5919d32-4a6d-4fdc-94d0-1ea52852124d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_eaf47a10-88b3-427d-9001-d3992d7d8e78" xlink:to="loc_us-gaap_EmployeeSeveranceMember_d5919d32-4a6d-4fdc-94d0-1ea52852124d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_259747d5-a03c-4cfe-8615-a6f7b23b7abd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FacilityClosingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_eaf47a10-88b3-427d-9001-d3992d7d8e78" xlink:to="loc_us-gaap_FacilityClosingMember_259747d5-a03c-4cfe-8615-a6f7b23b7abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_a751fa98-ab93-45a8-b7f2-d820b0dec5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f13a85ec-9437-4d10-b2f7-f7f4f8de9e3d" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_a751fa98-ab93-45a8-b7f2-d820b0dec5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_ffe1dbc7-ee40-4830-be46-4bf45f89123b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a751fa98-ab93-45a8-b7f2-d820b0dec5a7" xlink:to="loc_us-gaap_RestructuringReserveRollForward_ffe1dbc7-ee40-4830-be46-4bf45f89123b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_d15f4537-8b55-4a96-a764-65c698b13931" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_ffe1dbc7-ee40-4830-be46-4bf45f89123b" xlink:to="loc_us-gaap_RestructuringReserve_d15f4537-8b55-4a96-a764-65c698b13931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_25da25ef-8929-4842-9950-d5dd9a42ad94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_ffe1dbc7-ee40-4830-be46-4bf45f89123b" xlink:to="loc_us-gaap_RestructuringCharges_25da25ef-8929-4842-9950-d5dd9a42ad94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_cdeadd8f-2915-4b55-98cc-ad50912921dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCharges_25da25ef-8929-4842-9950-d5dd9a42ad94" xlink:to="loc_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_cdeadd8f-2915-4b55-98cc-ad50912921dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PaymentsForRestructuringAndOtherAdjustments_c7bdccee-916b-46c4-8035-7196fb09a781" xlink:href="gehc-20250331.xsd#gehc_PaymentsForRestructuringAndOtherAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_ffe1dbc7-ee40-4830-be46-4bf45f89123b" xlink:to="loc_gehc_PaymentsForRestructuringAndOtherAdjustments_c7bdccee-916b-46c4-8035-7196fb09a781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_31a1b207-cbea-4d5c-b58a-64af3c65ac2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserve"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#EARNINGSPERSHAREDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_34c42ec5-0094-4e26-8d78-49670ba2cf51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_33cb611d-60ff-4e1b-b7f2-d5a7b8f173f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_34c42ec5-0094-4e26-8d78-49670ba2cf51" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_33cb611d-60ff-4e1b-b7f2-d5a7b8f173f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8774a790-218b-4177-a067-2175a0587850" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_33cb611d-60ff-4e1b-b7f2-d5a7b8f173f7" xlink:to="loc_us-gaap_ProfitLoss_8774a790-218b-4177-a067-2175a0587850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_feeabd76-a050-4ab1-b86b-1c33e2697ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_33cb611d-60ff-4e1b-b7f2-d5a7b8f173f7" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_feeabd76-a050-4ab1-b86b-1c33e2697ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d867796a-4532-40ed-9a04-c0b04dcf7005" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_33cb611d-60ff-4e1b-b7f2-d5a7b8f173f7" xlink:to="loc_us-gaap_NetIncomeLoss_d867796a-4532-40ed-9a04-c0b04dcf7005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_37cbe6d2-9a9c-48ed-a22b-f6d9d269dddb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_34c42ec5-0094-4e26-8d78-49670ba2cf51" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_37cbe6d2-9a9c-48ed-a22b-f6d9d269dddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8b54d1cd-d747-4627-ac54-2dbbbf400aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_37cbe6d2-9a9c-48ed-a22b-f6d9d269dddb" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8b54d1cd-d747-4627-ac54-2dbbbf400aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_0da0226d-8074-4cf7-98a5-8099632c2d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_37cbe6d2-9a9c-48ed-a22b-f6d9d269dddb" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_0da0226d-8074-4cf7-98a5-8099632c2d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c7b3a91b-bdcd-477b-975d-31f8394f7171" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_37cbe6d2-9a9c-48ed-a22b-f6d9d269dddb" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c7b3a91b-bdcd-477b-975d-31f8394f7171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_323c067a-c1ce-4551-b8e1-36993fc0b89a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_34c42ec5-0094-4e26-8d78-49670ba2cf51" xlink:to="loc_us-gaap_EarningsPerShareBasic_323c067a-c1ce-4551-b8e1-36993fc0b89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_fe4f42cc-81f8-4124-b3c3-6654f5fc4ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_34c42ec5-0094-4e26-8d78-49670ba2cf51" xlink:to="loc_us-gaap_EarningsPerShareDiluted_fe4f42cc-81f8-4124-b3c3-6654f5fc4ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4b4e85bc-ba0f-460c-b999-38042f4bbc97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_34c42ec5-0094-4e26-8d78-49670ba2cf51" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4b4e85bc-ba0f-460c-b999-38042f4bbc97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_886126cc-16b9-4070-90f5-99b9c27ae561" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7b5cee26-2504-41c4-b749-a5af2f69f48f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_886126cc-16b9-4070-90f5-99b9c27ae561" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7b5cee26-2504-41c4-b749-a5af2f69f48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_e3888c8d-2187-4a7f-9406-97b8a412ce26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_886126cc-16b9-4070-90f5-99b9c27ae561" xlink:to="loc_us-gaap_RestrictedCashCurrent_e3888c8d-2187-4a7f-9406-97b8a412ce26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_adaaec76-aadf-4e85-ae53-80d7338e4dbc" xlink:href="gehc-20250331.xsd#gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_886126cc-16b9-4070-90f5-99b9c27ae561" xlink:to="loc_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent_adaaec76-aadf-4e85-ae53-80d7338e4dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_2420d0ce-5e1e-49be-a600-3cbe96e54998" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_886126cc-16b9-4070-90f5-99b9c27ae561" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_2420d0ce-5e1e-49be-a600-3cbe96e54998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_92736a6e-8223-43af-a403-8eb8417cfaf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_886126cc-16b9-4070-90f5-99b9c27ae561" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_92736a6e-8223-43af-a403-8eb8417cfaf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofInventoryDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofInventoryDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_924e329d-9f82-4c87-be6a-a9c943d67789" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_8986eee3-69c7-4978-bf76-37707819a562" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_924e329d-9f82-4c87-be6a-a9c943d67789" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_8986eee3-69c7-4978-bf76-37707819a562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_a8ee1197-4c4a-43a7-8758-ce024061e341" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_924e329d-9f82-4c87-be6a-a9c943d67789" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_a8ee1197-4c4a-43a7-8758-ce024061e341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_f3e61513-2f4a-457e-8899-8ca11e055d82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_924e329d-9f82-4c87-be6a-a9c943d67789" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_f3e61513-2f4a-457e-8899-8ca11e055d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_115cee97-acb4-46f8-ab02-02cf565ada62" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_924e329d-9f82-4c87-be6a-a9c943d67789" xlink:to="loc_us-gaap_InventoryNet_115cee97-acb4-46f8-ab02-02cf565ada62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f62082af-a311-4619-b155-3a494800df4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9bb1a9f5-5890-4afc-ab24-3aba2935ce2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f62082af-a311-4619-b155-3a494800df4c" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9bb1a9f5-5890-4afc-ab24-3aba2935ce2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_790b4295-389a-4293-90a6-cfde74f99e92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9bb1a9f5-5890-4afc-ab24-3aba2935ce2f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_790b4295-389a-4293-90a6-cfde74f99e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f455999-35a1-4b79-a330-b88f2fe8eb82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_790b4295-389a-4293-90a6-cfde74f99e92" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f455999-35a1-4b79-a330-b88f2fe8eb82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovementsMember_d4e61551-bad6-4813-81a9-705c4175612c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LandAndLandImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f455999-35a1-4b79-a330-b88f2fe8eb82" xlink:to="loc_us-gaap_LandAndLandImprovementsMember_d4e61551-bad6-4813-81a9-705c4175612c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_BuildingsStructuresAndRelatedEquipmentMember_7c34b200-a801-4dc3-b905-d448d65eb2c6" xlink:href="gehc-20250331.xsd#gehc_BuildingsStructuresAndRelatedEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f455999-35a1-4b79-a330-b88f2fe8eb82" xlink:to="loc_gehc_BuildingsStructuresAndRelatedEquipmentMember_7c34b200-a801-4dc3-b905-d448d65eb2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_c3e9512c-55a3-4a79-a1c6-fb49f0e6da1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f455999-35a1-4b79-a330-b88f2fe8eb82" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_c3e9512c-55a3-4a79-a1c6-fb49f0e6da1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_LeaseholdImprovementsAndManufacturingPlantsMember_c8b48b2a-2d42-42e9-87de-56eaf45c5415" xlink:href="gehc-20250331.xsd#gehc_LeaseholdImprovementsAndManufacturingPlantsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4f455999-35a1-4b79-a330-b88f2fe8eb82" xlink:to="loc_gehc_LeaseholdImprovementsAndManufacturingPlantsMember_c8b48b2a-2d42-42e9-87de-56eaf45c5415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4619f091-b14e-468d-aa1b-8f5468abd87e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9bb1a9f5-5890-4afc-ab24-3aba2935ce2f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4619f091-b14e-468d-aa1b-8f5468abd87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9d095d63-687d-47ee-a659-badabfe9d71d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4619f091-b14e-468d-aa1b-8f5468abd87e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_9d095d63-687d-47ee-a659-badabfe9d71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_715ff2f2-4c0f-49a6-bf05-711ec7cac8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4619f091-b14e-468d-aa1b-8f5468abd87e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_715ff2f2-4c0f-49a6-bf05-711ec7cac8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b4efe1fc-a2fb-40eb-9571-cdbe0ae7c321" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4619f091-b14e-468d-aa1b-8f5468abd87e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b4efe1fc-a2fb-40eb-9571-cdbe0ae7c321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0559a071-6ff5-4b89-accb-b84a021cc2b6" xlink:href="gehc-20250331.xsd#gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4619f091-b14e-468d-aa1b-8f5468abd87e" xlink:to="loc_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0559a071-6ff5-4b89-accb-b84a021cc2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_51749f4d-be87-4616-b386-aa89498f4098" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_PrepaidExpensesAndDeferredCostsCurrent_61c987a4-24d3-4145-a333-cf3651b511eb" xlink:href="gehc-20250331.xsd#gehc_PrepaidExpensesAndDeferredCostsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_51749f4d-be87-4616-b386-aa89498f4098" xlink:to="loc_gehc_PrepaidExpensesAndDeferredCostsCurrent_61c987a4-24d3-4145-a333-cf3651b511eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_954015ee-f3a4-49e2-a8ef-c966018502fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_51749f4d-be87-4616-b386-aa89498f4098" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_954015ee-f3a4-49e2-a8ef-c966018502fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_8e9b3307-bbb2-427a-b696-a119a9229d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_51749f4d-be87-4616-b386-aa89498f4098" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_8e9b3307-bbb2-427a-b696-a119a9229d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_8479b7d5-a35f-4688-a6f3-a0fea20701b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_51749f4d-be87-4616-b386-aa89498f4098" xlink:to="loc_us-gaap_IncomeTaxesReceivable_8479b7d5-a35f-4688-a6f3-a0fea20701b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_9c3c5ce0-1262-4aa3-aa87-d8f81ee4e178" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_51749f4d-be87-4616-b386-aa89498f4098" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_9c3c5ce0-1262-4aa3-aa87-d8f81ee4e178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_42036f8e-f887-41c1-a764-6841fe6ae745" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_51749f4d-be87-4616-b386-aa89498f4098" xlink:to="loc_us-gaap_OtherAssetsCurrent_42036f8e-f887-41c1-a764-6841fe6ae745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ed193758-7790-4716-a940-17c66c7f628c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent_8b88defd-106c-47d6-95f4-da2510b3af79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ed193758-7790-4716-a940-17c66c7f628c" xlink:to="loc_us-gaap_PrepaidExpenseNoncurrent_8b88defd-106c-47d6-95f4-da2510b3af79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_6f0369b9-9592-4bfd-97f5-bfae7c722535" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ed193758-7790-4716-a940-17c66c7f628c" xlink:to="loc_us-gaap_LongTermInvestments_6f0369b9-9592-4bfd-97f5-bfae7c722535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_4cba66fe-a810-44a2-91f2-1a21a2cbfe7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ed193758-7790-4716-a940-17c66c7f628c" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_4cba66fe-a810-44a2-91f2-1a21a2cbfe7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent_b86c2d47-3834-4f3b-9863-7c5e1707f3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ed193758-7790-4716-a940-17c66c7f628c" xlink:to="loc_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent_b86c2d47-3834-4f3b-9863-7c5e1707f3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_6c7b4c48-3894-4ab6-be32-8f9d0caba933" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ed193758-7790-4716-a940-17c66c7f628c" xlink:to="loc_us-gaap_InventoryNoncurrent_6c7b4c48-3894-4ab6-be32-8f9d0caba933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent_69beb29b-cbb7-48ef-97b8-673a5dfdfa54" xlink:href="gehc-20250331.xsd#gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ed193758-7790-4716-a940-17c66c7f628c" xlink:to="loc_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent_69beb29b-cbb7-48ef-97b8-673a5dfdfa54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_26d8595e-7e3d-46a4-bcba-ccb9b05a4033" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ed193758-7790-4716-a940-17c66c7f628c" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_26d8595e-7e3d-46a4-bcba-ccb9b05a4033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_dd85aadb-18e7-4786-bd3c-9745fd1493e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ed193758-7790-4716-a940-17c66c7f628c" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_dd85aadb-18e7-4786-bd3c-9745fd1493e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d693ef34-cfa1-4c43-9234-aa65144b3c76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ed193758-7790-4716-a940-17c66c7f628c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d693ef34-cfa1-4c43-9234-aa65144b3c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c5cdad46-1ed4-4442-9a02-6b42116c1217" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_SalesAllowancesAndRelatedLiabilitiesCurrent_c2f4ffc7-df5d-4092-9a77-5e829045f5ca" xlink:href="gehc-20250331.xsd#gehc_SalesAllowancesAndRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c5cdad46-1ed4-4442-9a02-6b42116c1217" xlink:to="loc_gehc_SalesAllowancesAndRelatedLiabilitiesCurrent_c2f4ffc7-df5d-4092-9a77-5e829045f5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent_feb9a177-8a80-452b-a204-20c8d4a3441a" xlink:href="gehc-20250331.xsd#gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c5cdad46-1ed4-4442-9a02-6b42116c1217" xlink:to="loc_gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent_feb9a177-8a80-452b-a204-20c8d4a3441a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_8d8283f3-90cc-4997-aea5-e1e252e9bb10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c5cdad46-1ed4-4442-9a02-6b42116c1217" xlink:to="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_8d8283f3-90cc-4997-aea5-e1e252e9bb10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AccruedFreightAndUtilitiesCurrent_70b48d5a-5e0b-4bee-93dc-86cdda3c1503" xlink:href="gehc-20250331.xsd#gehc_AccruedFreightAndUtilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c5cdad46-1ed4-4442-9a02-6b42116c1217" xlink:to="loc_gehc_AccruedFreightAndUtilitiesCurrent_70b48d5a-5e0b-4bee-93dc-86cdda3c1503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7b4a29c0-deaa-4685-be15-7087fdbe8d72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c5cdad46-1ed4-4442-9a02-6b42116c1217" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7b4a29c0-deaa-4685-be15-7087fdbe8d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_d64b49ab-f52c-4a80-8a6b-76dd8786a5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c5cdad46-1ed4-4442-9a02-6b42116c1217" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_d64b49ab-f52c-4a80-8a6b-76dd8786a5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_5eeb4aba-4423-410c-be98-c21dbf41e84d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c5cdad46-1ed4-4442-9a02-6b42116c1217" xlink:to="loc_us-gaap_InterestPayableCurrent_5eeb4aba-4423-410c-be98-c21dbf41e84d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent_8fc21990-d12c-4744-8ef8-cc281d12e490" xlink:href="gehc-20250331.xsd#gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c5cdad46-1ed4-4442-9a02-6b42116c1217" xlink:to="loc_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent_8fc21990-d12c-4744-8ef8-cc281d12e490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_fe73fbd6-6b82-4cd0-8f43-b029d9ec78cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c5cdad46-1ed4-4442-9a02-6b42116c1217" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_fe73fbd6-6b82-4cd0-8f43-b029d9ec78cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_43cb3ed8-da9b-4705-b8d1-2a4d3e69ce1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c5cdad46-1ed4-4442-9a02-6b42116c1217" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_43cb3ed8-da9b-4705-b8d1-2a4d3e69ce1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0b8d715a-7345-4cff-a6ec-f6d850c83b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_6dab8b39-0b69-4467-a2b5-636c7b41b5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0b8d715a-7345-4cff-a6ec-f6d850c83b1d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_6dab8b39-0b69-4467-a2b5-636c7b41b5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e5a63aa1-bb7b-4814-a45d-542343d4c687" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0b8d715a-7345-4cff-a6ec-f6d850c83b1d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e5a63aa1-bb7b-4814-a45d-542343d4c687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent_b2b627f8-6910-4dbc-a8c6-14bab7fe8bdb" xlink:href="gehc-20250331.xsd#gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0b8d715a-7345-4cff-a6ec-f6d850c83b1d" xlink:to="loc_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent_b2b627f8-6910-4dbc-a8c6-14bab7fe8bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_5450cdd6-244b-47c3-9f12-5b0e69f5d97e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0b8d715a-7345-4cff-a6ec-f6d850c83b1d" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_5450cdd6-244b-47c3-9f12-5b0e69f5d97e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_fb050db7-a533-4dd6-9653-5706b52ab266" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0b8d715a-7345-4cff-a6ec-f6d850c83b1d" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_fb050db7-a533-4dd6-9653-5706b52ab266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_fadefae7-0ff5-47a9-9c51-728555df9145" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0b8d715a-7345-4cff-a6ec-f6d850c83b1d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_fadefae7-0ff5-47a9-9c51-728555df9145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_88103431-1882-4e40-a011-0ffd54717eec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_fadefae7-0ff5-47a9-9c51-728555df9145" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_88103431-1882-4e40-a011-0ffd54717eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent_77390ab2-d4d6-48fb-8056-ecf15df2ed20" xlink:href="gehc-20250331.xsd#gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0b8d715a-7345-4cff-a6ec-f6d850c83b1d" xlink:to="loc_gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent_77390ab2-d4d6-48fb-8056-ecf15df2ed20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_324d973d-a8cc-4a7e-835f-511af1142150" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0b8d715a-7345-4cff-a6ec-f6d850c83b1d" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_324d973d-a8cc-4a7e-835f-511af1142150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ac38c602-ce82-4e38-ada5-155552e646ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0b8d715a-7345-4cff-a6ec-f6d850c83b1d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ac38c602-ce82-4e38-ada5-155552e646ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONNarrativeDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2fc361bc-6253-4f58-8884-59acb66cadbd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramTable_a0a8d130-21fc-460e-a758-59374c30ce7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2fc361bc-6253-4f58-8884-59acb66cadbd" xlink:to="loc_us-gaap_SupplierFinanceProgramTable_a0a8d130-21fc-460e-a758-59374c30ce7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c6329f33-94a4-4c41-b8cc-33f76fde96f3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplierFinanceProgramTable_a0a8d130-21fc-460e-a758-59374c30ce7b" xlink:to="loc_srt_RangeAxis_c6329f33-94a4-4c41-b8cc-33f76fde96f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_44965ab4-c759-4e51-b998-20a04f6328f9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c6329f33-94a4-4c41-b8cc-33f76fde96f3" xlink:to="loc_srt_RangeMember_44965ab4-c759-4e51-b998-20a04f6328f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7e3124d1-a33b-4728-a037-894a01ae4e5d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_44965ab4-c759-4e51-b998-20a04f6328f9" xlink:to="loc_srt_MinimumMember_7e3124d1-a33b-4728-a037-894a01ae4e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3149d786-e8c5-4615-b761-d327fd358c62" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_44965ab4-c759-4e51-b998-20a04f6328f9" xlink:to="loc_srt_MaximumMember_3149d786-e8c5-4615-b761-d327fd358c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramLineItems_a6a0709b-3144-4d04-b3d8-a80c5d5942cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplierFinanceProgramTable_a0a8d130-21fc-460e-a758-59374c30ce7b" xlink:to="loc_us-gaap_SupplierFinanceProgramLineItems_a6a0709b-3144-4d04-b3d8-a80c5d5942cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramPaymentTimingPeriod_fab74ca8-5506-4ce9-ab0d-aa28d1eed87a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramPaymentTimingPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplierFinanceProgramLineItems_a6a0709b-3144-4d04-b3d8-a80c5d5942cb" xlink:to="loc_us-gaap_SupplierFinanceProgramPaymentTimingPeriod_fab74ca8-5506-4ce9-ab0d-aa28d1eed87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligationCurrent_c5f82996-bdbe-4053-a129-8a9a3753869b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligationCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplierFinanceProgramLineItems_a6a0709b-3144-4d04-b3d8-a80c5d5942cb" xlink:to="loc_us-gaap_SupplierFinanceProgramObligationCurrent_c5f82996-bdbe-4053-a129-8a9a3753869b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration_299a9dd6-37e3-4b9f-b3fd-3f2266090dec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplierFinanceProgramObligationCurrent_c5f82996-bdbe-4053-a129-8a9a3753869b" xlink:to="loc_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration_299a9dd6-37e3-4b9f-b3fd-3f2266090dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofRedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofRedeemableNoncontrollingInterestDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofRedeemableNoncontrollingInterestDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_56011dcf-1e3a-4422-80af-63e4008d3f80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_f4abe349-8b94-4852-8245-386f760572a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_56011dcf-1e3a-4422-80af-63e4008d3f80" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_f4abe349-8b94-4852-8245-386f760572a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_820a5ddf-dd98-43b1-a4af-00765547fbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f4abe349-8b94-4852-8245-386f760572a9" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_820a5ddf-dd98-43b1-a4af-00765547fbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_3cfd43a2-a43a-4b64-8883-090bd46e5a65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f4abe349-8b94-4852-8245-386f760572a9" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_3cfd43a2-a43a-4b64-8883-090bd46e5a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_53125dd0-51f4-4f06-b3b4-49590122baa4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f4abe349-8b94-4852-8245-386f760572a9" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_53125dd0-51f4-4f06-b3b4-49590122baa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_65343e7c-a53e-400f-8103-69aa94640f97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_7509bfa7-59a7-4c94-96d0-27b5fe13728f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_65343e7c-a53e-400f-8103-69aa94640f97" xlink:to="loc_us-gaap_InvestmentIncomeNet_7509bfa7-59a7-4c94-96d0-27b5fe13728f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_201bd66a-1dae-4ec2-a65e-eee076bb5369" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_65343e7c-a53e-400f-8103-69aa94640f97" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_201bd66a-1dae-4ec2-a65e-eee076bb5369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_3455b9dd-95f5-4827-8e8e-9c80eda586e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_65343e7c-a53e-400f-8103-69aa94640f97" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit_3455b9dd-95f5-4827-8e8e-9c80eda586e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_765e63c3-af52-4f8b-b174-e455613ee1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_65343e7c-a53e-400f-8103-69aa94640f97" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_765e63c3-af52-4f8b-b174-e455613ee1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gehc_OtherItemsIncomeExpenseNet_fc554e15-d16b-4069-be68-eca77c2af9ea" xlink:href="gehc-20250331.xsd#gehc_OtherItemsIncomeExpenseNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_65343e7c-a53e-400f-8103-69aa94640f97" xlink:to="loc_gehc_OtherItemsIncomeExpenseNet_fc554e15-d16b-4069-be68-eca77c2af9ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_752c27be-4429-4f42-af52-b6a3f20b3b61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_65343e7c-a53e-400f-8103-69aa94640f97" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_752c27be-4429-4f42-af52-b6a3f20b3b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gehealthcare.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="gehc-20250331.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:presentationLink xlink:role="http://www.gehealthcare.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_a6d1ce2c-4f8c-4704-9fb9-4d0bd02fa05d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_d8ee6e44-e5cd-4d55-ae03-00352acd0296" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_a6d1ce2c-4f8c-4704-9fb9-4d0bd02fa05d" xlink:to="loc_us-gaap_SubsequentEventTable_d8ee6e44-e5cd-4d55-ae03-00352acd0296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_fa212c16-84f2-45b0-9f22-10260c2878f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_d8ee6e44-e5cd-4d55-ae03-00352acd0296" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_fa212c16-84f2-45b0-9f22-10260c2878f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3358e266-d04f-4a76-9c44-9a22d8c868ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fa212c16-84f2-45b0-9f22-10260c2878f7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3358e266-d04f-4a76-9c44-9a22d8c868ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_80878000-6047-4077-8a55-ce495625ec64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3358e266-d04f-4a76-9c44-9a22d8c868ea" xlink:to="loc_us-gaap_SubsequentEventMember_80878000-6047-4077-8a55-ce495625ec64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_3f3167b6-a717-4d9c-b489-ad9099eca4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_d8ee6e44-e5cd-4d55-ae03-00352acd0296" xlink:to="loc_us-gaap_SubsequentEventLineItems_3f3167b6-a717-4d9c-b489-ad9099eca4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_3a85544b-5b92-4499-91f7-253f177a74ab" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_3f3167b6-a717-4d9c-b489-ad9099eca4a7" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_3a85544b-5b92-4499-91f7-253f177a74ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>gehc-20250331_g1.jpg
<TEXT>
begin 644 gehc-20250331_g1.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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MB*C(Z%(T)29B0]1Q@7)3TS4G1'56D8)SE8>X$0$  @$" @4%!1$+" 0. @,
M 0(#$00%!B$Q01('46%Q$PB!D2(R%*&Q0E)B<I*R(W-TM!4U=38WP8*BPM(S
M4Y.S%A?10],D-%15&/!CHT3A@\/C9)2DQ-3D)86E1F;Q)H1%_]H # ,!  (1
M Q$ /P"?P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M>_CO32)G2)^%$=<]$>=XLFWSXOYVEZ^F)CY[N;P/D
M
M
M
M
M
M
M
M
M
M
M
M
M
M QO[-\Q/$[IFN3:[6\E.C> 9N+Z_5U')^T>&:S?RE&<82MXW'KVXIO,R]"LO
MTH6<><XQI6M:4I2M:;7PCD7G3CVEN#<)XCN<<_18]OEM3W;Q7N1'GFT/?M^%
M<3W?3MMOFO$]L4M,>_II\UK_ .Q_GM^,?KZN78P^\=SV1L\*61"[K.N.M>>[
M2ERY8C&L(8F]WVBXWQ+.CE2K6-NY9V-RUZTK[I1IZ5K)?"O9M\7>)]VV3AV/
M:8;::6SY\->ORTI?)DC3MB:1/DB6<V_)7,6?29PQCK/;>]8^9$S;YC!+L'[H
M?QNU=;\>KO&KNOFLK<9TLSYSON#];V+]R,:>VOOT>;V?>M6+ESU])5M^^D/2
MM8>M:QI(_#/8_P":\VD\8XMP_;Q/7ZFF;/,?9QMXU]W37M[6:P>'/$+?[3N,
M-/K8M?Y_<84<\^Z+\AMC*]7K#QAZ8X?"4Y5QX\\Y/SCL>5JW6]*4(WI\>O\
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M8J8FLZ6C27TOP_@
M
M
M
M
M
M
M
M
M
M
M
M
M                     #S;LKN7J'IG4_K[M[M+KOJ[2^R<X[7L+F?'>'8%
MVEO^^I8R>0;'7VK\_7\*1A64JU_"E*UKZ,MPG@/'./9_DW ]GNMYN/I<.*^6
M?=BE;:>Z]&WVFZW=NYM<>3)?R5K-I^9$M5W<?SX_&MU)^9Q]=VSR/N3;XOU:
M7=/TYP;<[WW2M^ZD:8W).4_T-X/F?6E"M(5L[6Y'^2LJQC6E:S)P+V;/%CC>
MELNRQ;#!.GPMUFK3W\>/UN:-.W7''OMDVG)/,&ZZ;8JXJ3VY+1'S([UOX+57
MV[]TC_\ 3.'T-XH__1?D^1]N\_\ _P 7V_F>%<-U/_W_ %]F_P#]Q,G!/8\Z
MLG,G&O33;8?G9<MOGX6R[7PXZIWNY]RE?XUI_BM7W;/W GR6=G4R;&F[,X3T
MYK<N-87M;U-UQH,2M+=95E2&-N^>TY_RO E&OIZ3Q]A:N^D?2LO2LJ5E_@OL
MS>$W"-+9]IN-_EKU6W.>\^_3#ZG'/HM28\W4V/:\C\O[?IOCOEM';>\_.KW8
MGW8:UNTO+3RB[N_-P[=\B.Z>Q\3-A*U?U?+^R^7[O1_0G[_=BV-#F;:YIL3#
MK6Y*OT;5B%KUG*OM]95]98X/R5R?R]W9X'POA^TO7JMBP8J7U\LWBO?F>KIF
M9GHCI;!MN%\-V>GR7!AQS';6E8GW]-?FL?&SO<
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MCGT9-/5V]RTM9W?"N);'_;,&7''EFLQ'OZ:3[[(UJKP
M
M
M
M
M
M
M
M
M
M
M
M
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M\.VKU4I6*5CT5K$1'N0V''CQXJQ3%6*TCLB(B/>APK[OV
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M\6\5GYC5<^WW&VOZK<TOCR1V6B:S[TZ.[,>^(
M
M
M
M
M
M
M
M
M
M
M
M
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M'IE2E&_*]_0OB_+J2IKJ1I6]]/WUE25/I4NU]:4U3>>U3X5[;7U,\1W&FO\
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M=?2YL=\<SYZ]Z([T>2:ZQ/7$M.W6SW>RR>JW>*^+)Y+5F/>UZ_3#U1AGF
M
M
M
M
M
M
M
M
M
M
M
M
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M+)I&>+L^::/&ZLU&9;EZTC>P]QVEG<-U>98K6-:?4M7I0]:>GJCCC7C'X7\
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MJ^+\@
M
M
M
M
M
M
M
M
M
M
M
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M>SYLF6??O:TM<W&[W6[MWMUER9+>6UIM\^9>EL2\X
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M2R::BQP
M
M
M
M
M
M
M
M
M
M
M
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MKCVX^5\;W>YWFZ^GS9;Y;>_>UICT0U7<;K<[N_K-UDODOY;6FT_-F7HK%O@
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M\7X1K;<8YMMX^CI\*ON]&M?WT0V1(I8
M
M
M
M
M
M
M
M
M
M
M
M
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MR40MERY<^2V;/:U\UIUFUIF9F9ZYF9Z9GSRUBUK7M-K3,VGKF>M]KYOX
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MU/6[6/HZ:S$1]5'77SS,=WZJ6V!"[60
M
M
M
M
M
M
M
M
M
M
M
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MVNO1DKTU]WMK[L:>29;,D2->
M
M
M
M
M
M
M
M
M
M
M
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MY4TK:8[+9._?ZKIE'7$N/<6XM,_+,UIQ?21\&D?O8Z)],ZSYV;Z/6'
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MU*HIXIP;B/!\OJ]]CFL3/1:.FEO1;J]R=)CMB&7K1V+
M
M
M
M
M
M
M
M
M
M
M
M
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MBY&1WOW[UAUMDX]FF1^H=[RG7W.895FL:SI/6\(UMS.YAMO6-/7TQ<&]7_\
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MJSTQ:-)CWW=F/?$
M
M
M
M
M
M
M
M
M
M
M
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MQX_12E4>;[B?$.)9/6;[+?).O1$ST1Z*Q\&/<B&1#5W@
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M>4.(<'USXM<^QCZ*L=-8^KKV?71K7RZ=3=*@)J0
M
M
M
M
M
M
M
M
M
M
M
M                                                     #A^0<AT
M'$])M>3<IWFGXUQO18&3M-YR#D&SPM-I--K,.U*]F;':[;8WL; UV!BV8UG<
MO7KD+<(TK65:4??;;7<[W<4VFSQWR[O):*TI2LVO:T]$5K6L3-IF>B(B)F7[
MICOEO&/'$VR6G2(B-9F?)$1TS**1\COW%6NU%-]T_P" E+&WVGIE:K=^2&_U
M=+FHUMZ,I6;W^2;BNVQZV]Y?A*GI#<[:Q^2I6,JX^%DVYVLN-SO"OV6\N?U?
M'/$K7'AZ+4V-+?"M'7'RG)6?@1Y<6.>_U=[)28M1)? .0[6[NZXWT5ZXQ1/3
M/U\QU?6UZ?+,=,(CO-^=<T[+Y7N^==A\KY%SCF?)<VYL>0<JY7N,_?;_ '.=
M=]*3R=CM=G?R<W*N^V-(TK.=?;"E(T](TI2EV^'\.V'"=ECX=PO#BV^PQ5[M
M,>.L4I6/)6M8B(]R/.D_#AP[?%&'!6M,-8TBM8B(CT1#JKV/J   [1PK@_,^
MR>4Z;@_7O$^1\YYER/,AK]!Q7B6EV/(>0[G-G2LHXNLT^JQ\K/S;WLC658V[
M<JTC2M:^E*5J\?$.([#A.SR<0XIFQ;?88J]Z^3)>M*5CRVM:8K$>F7SS9L.W
MQSFSVK3%6-9M:8B(],ST)0G@G]MOS/E-=/V%YT\EO<"T-9X^=8Z,X!ML#/YI
MLK,9PNTQ><\WQ/S^CXQC9%(>V[B:F6=F3LW*T_-X5^/I&H'B-[5NPV?K.%^'
M6*-SN>F)W>:LQBK/5KAQ3W;Y)CLMD[E8F/B9*RCGC7/^''K@X-7OWZO66B8K
M'UM>B9]-M(\TPEE]&^/?2?C3P7!ZVZ'ZTXMUCPS ]LZ:GC6#]*]GY-(UC78[
M[;Y5S*W?)-Q<C7TGF[#)RLNY2E*2N5I2BEG,7,_,'-O$;<6YCW>;>;^WT62=
M8K'TM*QI3'7R4I6M8[(1EO-]O.(9IW&]R6R9I[9GJ\T1U1'FB(A[(P+R
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MW8[OAV>=MO<=L>:.R>V/+$]4QYXUA[.P+R
M
M
M
M
M
M
M
M
M
M
M
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MG*WW)7LI<G\&[F[YNSY>*[Z-)]7&N';1/7II6WK<FD]MLE:VCXV/2=$C<,Y
MX=MM,G$;6W&7Z6-:T]Z)[T^[,1/;5'U[$[.['[=Y1G<V[4YYS#L?F&SK2N?R
M?G'(]ORC>Y-*5K6%JYL]UEYF7]"S2OI;MTG2W;C^$:4I2E%FN%\(X5P/9UX?
MP;;8-IL:=6/#2N.D?O:1$:SVSUSVMXP;?;[7'&';4ICQ1U16(B/>AT=D7V
M              2N_AH^$+!Y]K.(>7/F5QK\QP[80P.3=.=%;K&MSQ>9:O(Q
MZY6JYWV=@7X2K/BN;2[:R=7II^E-E;I&_F4KASA8RJ8>//M"9.&YL_)'(>;3
M?UUQ[K>4GIQ6B=+8=O,?YR.FN3+'\W.M:?=(FU(SYLYPG!:_"^$V^ZQK&3)'
MT,]M:3Y>R;=G5'3TQ,<LV;.-9M8^/:MV,>Q;A9L6+,(VK-FS:C2%JU:M0I&%
MNW;A&E(QI2E*4IZ443M:U[3:TS-IG69GKF?+**9F9G6>M^C^
M                             #P?R&\8NA/*S@F1UQY ]8<9[+XM<^O<
MPK6[Q9V]OQ_,R+<;5S:<4Y)K[N'R+BFWK:C2-<K796-?E#]"4JPK6-=DY7YO
MYDY,XC'%>6=YFVF\C36:3\&\1T]W)CMK3)7ZF];1KTZ:]+V['B.]X9F^4;')
M;'D\W5/FM$]%H\TQ*'KY^?;L=Q]-1W/9'AML-SWUUQCQR-AE]7[*WB4[HXQB
M0I<NSM:6&%;Q-9VABV+=O]".%9P]Q.4XVK>#E2I*]*\WAI[4? N/3CX5SY7'
MPWBLZ5C<5U^2Y)ZM;ZZVV\SVS>;8NB;3DI&E4J<$Y\VF[TV_%HC!N.KOQ_-S
MZ>VGNZU[=8ZD;/9:W8Z;89NIV^!FZK:ZW*OX.QUFRQ;^#L-?FXMV5G)P\W"R
MK=K)Q<K&O0K"Y;N1C.$J5I6E*T6NQ9<6?%7/@M6^&]8FMJS$UM$],3$QT3$Q
MTQ,=$I K:MZQ:DQ-9C6)CIB7Q/H_H  #)GQ7\O\ R!\,>R<3M#Q_Y[L.([F-
M;%G?:2[[MAP[FVIM3K*>AYKQB_<IKM]K+L9RI"4J0RL2<OK8M['R(PNQU+G+
MD;EGGWA-N#\S;:N?!TS2\?!RXK?3XLD?"I;R]=;1\&];5F:SCN)<*V/%MO.V
MWU(M3LGJM6?+6>N)^9/5,3'0G/\ QM_--T!YSXVEZZYI<UO2?DM=LV,6YUWN
M=C2/&NP<^%F4LG,ZHY!FSC^LYW?IUNUTN7*&VQXUE2U3-M6;F4YV>*_@%S-X
M=WR<5X?%^(<I1,SZ^M?NF&NO1&YI'Q=.KUM=<=NWU=K11#?,'*.^X-,Y\.N;
MA_TT1TUCZN.SZZ/@SYIG1NC0&U(
M
M
M
M
M
M
M
M
M
M
M
M                                    !&S^3CY]^O/'ZO(>E/#S)T';
M'=>/7+T_(.SIUL[?JWK'-I&5F_#43M3GB=B\PU]SUI]*W*NGPK]*4OW<J=N]
MA4M=X1^S5Q3F;U7,'/49=ER_.EJ;?IKN-Q'7'>UZ<&*WEG[K:/BQ2)KD;_R[
MR3GWW=WG%>]BV?7%.J]_3]+6?LI[(CHE"M[.[2[%[HYQO^R^U^9\@Y_SSE&9
M+.WO*.3;&]LMKGWZTI"W"MV]7V8^'BV8QM8^/:C;Q\>S&-NU"$(QC2_G".#\
M+X!P[%PG@NWQ;;AN&NE,>.L5K$>B.N9GIFTZVM.LS,S,RES;[;!M,-=OMJ5I
MAK'1$1I$?].V>N>UT)DGW   9<>(O@WY*>;_ #FG"/'_ *_S-_;P[UF/)^;[
M:MW3]=\(Q[U*SCE<LY9=Q[V)@SE:I*=K#LQR-CE1C+\OC7JTK1I/._B'RGX>
M\._*',VYKBFT3ZO%72V?+,=F/'K$ST]$VGNTKT=Z]6+XIQGA_!\/KM]>*Z]5
M8Z;6^MK^[T1';,)L_P ?/P:^,OAO32=@]CV,+R%[^PXV<R'+N6:C'EP7A>RC
M*MV$NO.#YE,O&L9N%/V?3VVREE["EVU2]C?DO?*U3G[XG>T1S;SWZSAG"IMP
MOEJVL>KQVGUV6O\ U^:-)F)Z=<=.[32>[?UFG>1#QSG'B/%M<&WUP;&?H:S\
M*T?56_BQI'9.O6W>*]M/       :>/,WYOO"7Q$N[;BN%RRYWYVUKJ9%B77O
M4&7K]QK]3L[7NA'#YCV!.[/B?':V\F$K638Q[FRVN)*-?J8/\GK.G(7L]^('
M/$4WF3!'#>"7TGU^YBU;6K/;BPZ>LOT=-9F*8[=F1M7">3^,<4B,LU]1M9^B
MOK$S'U-?C3YIG2)\J)UYB_.1YP>6--GQO4\NM^/G5>=3*Q:\#Z<R]CI]KM-;
M?E.,;'+NP[EZG+MY<GBW*V<BUB7-7K,JW6OOPETN1?9X\/>2^YN\^">)\9KI
M/KMU%;5K:.W%@T]73IZ:S:,F2L]61)O"N3N#\,TR6KZ_<Q]%DTF(GZFOQ8\V
MNLQY6G.Y<N7;D[MV<[MV[.5RY<N2E.Y<N3E64YSG*M93G.5:UK6M?6M4ZQ$5
MCNUZ(AM?5T1U/\/Z                 )$'P0?%_A>5?8USR=[RX[^?\?NG
M^06+/%^-;;%I/5=M]GZ[Z&?:U^?C7XUAM.#\*I<LY.RM2I7'V&9.QAS^M8IG
MV:5>]H[Q?R<F<*CE#EW+W>9M]BF<F2L_"VVWMK'>B8^+FR]-<<_&I6+9([MO
M5V:)SIS'/#<'Y.V=M-]EKTS'72D]&L>2UNJ.V(UGHGNRG=1C&$8PA&D81I2,
M8QI2,8QC3TC&,:>E*4I2GX4<Y)F9G6>M##^@
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M6V'/6U,M9TF)C28GR3$NS/(^8
M
M
M
M
M
M
M
M
M
M
M
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M9+3,^;R1'FB.B/-#V)@GD
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MB@
M
M
M
M
M
M
M
M
M
M
M
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M8=<O#IGHMVU\D7B/F6CHGS3.C=&@-J0
M
M
M
M
M
M
M
M
M
M
M
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M2(SX<F+7T=^L=Z.V)C6)CICH:SN=EO-G;N;O%DQ6^JK-?>UB-7K#"O,
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M&4:TE&494]8RC*GK2M*TK^%5-IB8G2>M&S^@
M
M
M
M
M
M
M
M
M
M
M
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M_<JB++BRX<DXLU;4RUG2:VB8F)\DQ/3$^EKMJVK,UM$Q:.R7V/P_@
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MB>B8F-81!DQY,5YQ9:S7)6=)B8TF)CLF)ZI<V\[\
M
M
M
M
M
M
M
M
M
M
M
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MCUN73MF(K3JI6-;3:$>/\R[WCN72_P!SV59^#CB>CTVGZ*WS([(Z]=HB'VN
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M,2A+<[7<;//;;;JLTSTG28G_ *=,>28Z)CIAZ(Q;X
M
M
M
M
M
M
M
M
M
M
M
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M93+M-GMMA@KM=I2N/!7JB/GSVS,]LSTSVO+&8>D
M      ![UT1Y2>17C'O?Z1= ]S=@]5;"YDV<K.Q^*<AS<31;N[CUA6U#DG%[
ML[_&>3XT?I1_F=CB95FOMIZQKZ4:WS'R=RMS=MODO,NPVN]Q1$Q$Y*1-Z:]?
MJ\D:9,<^>EJSYWBWO#=AQ&GJ]]AIEKV=Z.F/1/7'N3"09XN?<T]V<0KKN/\
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M
M
M
M
M
M
M
M
M
M
M
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M<2M'1'7&.)[(\MO+;LZHZ-9F/ZLRW@  !OG^)OX7.=^:NRTW=G>N+O.O/%?
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M9F<71I2;PKSCRW;AFYGB&TK_ /3\MM9B/\W:>SZV9^+Y/B^360*K,T<
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M9[8G_P $Z3$PR&:P\(
M
M
M
M
M
M
M
M
M
M
M
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M;R8Z<EHZ?16.JL>CIGMF6K]+[8P
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M]+UFMZVCHFMJVB)K,=L3$3#1+TOCO./)$UR1.DQ,:3$^28GJ<L^#\@
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M8G_P3I,3#(9K#P@
M
M
M
M
M
M
M
M
M
M
M
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M)Z,75.2TR\K\H8N%Q7?<0B+\1ZXCKKC]'EO]5U1U5\LQZ%GV]
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M)KKQ@
M
M
M
M
M
M
M
M
M
M
M                                                  /SO7K.-9NY
M&1=MV,>Q;G>OW[TXVK-FS:C6=V[=NSK&%NW;A&M92K6E*4IZU?VM;7M%:Q,V
MF=(B.N9\D$1,SI'6@W_-G\PM_P E-SO/%'QGY'E8OC]QK;96O[)YYI\ZD+7>
M.]U>52W37:G)Q)5K?ZLTN;CRG9G2Y6UO<BD<CVUQK6-*[T.]G[P,KRG@Q\Z<
MVXJSS-FI%L&&T?[)2T?&M$]6XO$Z3&FN&NM=>_:\1,?*'*L</I'$^(5B=]:-
M:5G_ #<3VS]7/\&.CKF=(W"UK?P ']C&4Y1C&-92E6D8QC2M92E6OI2,:4]:
MUK6M?PH3,1&L]0F/_#1\(>-Q*SP[RX\R^+W+G-/J8/)NGNB=_BV_RG$[=(TR
MM3SCM#4Y=B4[_+:SK;R-9IKOMAJ?;&]F0GFUC8P:)>//M"7WML_)'(>:(X?I
M./=;RD].3LMAV]HGHQ]=<F6.G)TUQS&/6V2*>;.<)RS?A?";?<>J^2/HO+6D
M_2]DV^BZHZ.F97:F",P    '2NQNQN"]1<%Y3V9V9RG4<*X%PK496]Y1RC>Y
M5,36:C68E*?4O7KGI*Y>O7KDHVK%BU&Y?R;]R%JU"=V<(2R'"N%<1XYQ'#PC
MA&&^XXEN+Q3'CI&MK6GLCR1'7,SI%8B;6F(B9?;;[?-NLU=OMZS?/>=(B.N9
M_P"GN1'3/0@"?+%\OG/O/GDM[K7KFFWZ^\6N+;B[>T?%YY$\;?=G[#"OW(8'
M,^Q(X\J6X6H6Z4NZ[2TE<Q\"4ZW+L[^12$[72[P6\#N&^&NTCBW%>YNN<<V.
M(ODTUIMZS'3BP:]O9?+T6OII$5KK%INY9Y6P<$Q_*-QIDXE:.F>RD=M:_NVZ
MY[-(Z]*B?FW
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M>8
M
M
M
M
M
M
M
M
M
M
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M^COT3DF.RL5K$X<L<L8>!X?79M+\2O'PK=E8^EKYO+/7:?-I#38G=M@
M
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M$QUQ+L;ROF
M
M
M
M
M
M
M
M
M
M
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M+<3O'PIZ^['TE?XT]L^;1IC3TVP
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M0N6[D)4K&5*UI6E?6CG+:MJ6FMHF+1.DQ/7$^24,3$Q.D];]'\
M
M
M
M
M
M
M
M
M
M
M
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M\I<KUX3BC?;VL3Q*\?U<3]#'U4_13^]CHUF=!:RC=@
M
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MU2L>6>G<1&LZSZ[33UMHBWG7EC3O<:X?7HZ\M8_M(C[?[+Z:4N121%X
M
M
M
M
M
M
M
M
M
M
M
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MZYC2+ N.DD
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M];/T,^YV1,[XE<&E@
M
M
M
M
M
M
M
M
M
M
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MID
M                                     ;8/C,^6'N?X]>76='*NP[(\
M<N0[:F7SGJ'+V/TY:Z]DQ^CE<NZXS,OZN/QSE=J/MN7[/I'"W$+4;.3[)TLY
M>-"_BWX+< \3]E.XCN[3FK%33#N8K\:(Z8QYXC2;XYZHGX^*9FU-8[U+ZSS#
MRSM..XN_T8]_6/@WTZ_J;^6OS:]<=L38$^.ODATUY6]5Z#N3HOFNMYMPC?PK
M;_,8LJV-IHMM9A;GG\;Y1IKWMV''N1ZRMV/U\3)A"?LG"[#WV;EJY/F;S3RI
MQ[DSC.7@/,6WOM^(8NR>FMZS\7)CM'P;TMIT6K,QK$Q.EHF(@_?\/W?#-S;:
M;VDTS5]Z8[)B>J8GRQ\][DUUXP   'X96+BYV+DX6;C6,S"S+%[%R\3*LV\C
M%RL7(MRLY&-DX]Z,[5^Q?M3K&<)4K&4:UI6E:5?JE[X[QDQS-<E9B8F)TF)C
MIB8F.F)B>J7]B9B=8Z)A I^;;XH<CPYYUD>0_1FAOW?&#LG?W([#3X%F,[72
M7-]O>NY$>+WK5B$?RW -[>K/]1Y%8_3PYT_5UZ49TPYY?2/V??&BO/?#HY7Y
MBR1'-^TQ?!M:>G=XJQIZR)GKS4C3UU>NT?=:QIWXI-7*',T<5P_(-Y;_ .HX
MZ]$S_G*QV_71]%';\:.W30"LNW< !Z7TWW!V'T%VAPGN/JGD>9Q3L#K_ 'N)
MR#C>ZPY5];65BRK&]AYN/6M+6PU&TQ)W,7-Q+M)6,O$O7+-V,K<Y1KB>/<#X
M7S+P?<<"XUBKFX9NL<TR4GMB>J8GKK:LZ6I:.FMHBT3$Q#S[O:X-]MK[3<UB
MV"]=)C_IU3'7$]D]*R=^.OSQZ]^0+QZTG;7%J8>CYQJ/RW'NWNO+>3*]E\%Y
MQ;Q_?D6+/UJ_F,KC.^MPKF:C+K[J7\65;<ZTR;&1:M\H?%+PXXGX9\SY.";S
MO9.'WUOML^FD9L.O1,Z=$9*?%RU[+=,? M29K_Q[@N?@>^G:Y-9PSTTM]-7_
M "QU6CR^:89YHW84
M
M
M
M
M
M
M
M
M
M
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MKG69ZYF93YAPXMOAK@P5BN&E8BL1U1$=4.J/:^H
M
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MHUK:LQ:LS$Q*OVZVV?9[B^UW-9KGI;28GR_Y.V)ZICIAZ$Q;X
M
M
M
M
M
M
M
M
M
M
M
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M>MRZ1,_2UBM(U[LVM G,O'\O'=[WXUC98]8QU\W;:?JK=ODC2.S6=H:'VN
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M=:UUF8F9L)P7A.WX+L*[/!TVCIM;MM:>N9^=$=D1$,.6]LJ
M
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MA<Z\N_E#;_E/:5_UW%7X41UWI'S[5ZX[9C6.G2L)U3G2AH
M
M
M
M
M
M
M
M
M
M
M
M                   !@U\AOF]PCP'\:^5]U<FCA[;E=_W<8ZGX1D7;D)\W
M['V6'E7M+J[U+$[>19T.NMXUS.VN1&4*V<#'N4MUK?G8MW)$\+_#WB'B5S9A
MY?VG>ILH^Z;G+'^:P5F(O:->B;VUBF.O3K>T:_!BTQF>!<'S<;XA79X]8Q==
M[?2TCKGTSU1'EGR:JT;M+L[G'='8O,^U^R]_F<HYYS_D&QY-RC>YTJ5OY^UV
M5ZMZ[6%N%(V<7#QX>VUCX]J,;./CVX6K<8PA&-.LW!^$<.X!PO;\%X3BKAX;
MML5<>.D=45K&D>>9GKM,]-K3,S,S,RL%MMOAVF"FVV]8KAI6(B/)$?\ 3IGM
MGI="9)]P $W#X"OBX_R)<1UOFKWMQR%OM[L+15ETMQG;8GKF=:==[["]M[E^
M3CY-OW8'->?ZS(K"U[:4O8&CNUMUG2>?DV+7/KVE?&'^\.^OR!RYEUX'M<G^
MM9*ST9\])Z,43'QL6&T:SV7S1KIICI:T0<[<Q_+,L\(V5O\ 5<=ONDQ]':/H
M?/6L^_;ZV)F36J0CP     !!"^?#Y)Z^3?<,_%OJ3>RO]$]%<BRK7*-IK<F-
MS7=F]NZ[\QK=GLK5^Q<E;S^,<$C=OZ[75I_-Y&9++RHUNV98DX=&_9L\*/[H
M\"_OCQO'IS'Q'%'JZVCX6WVUM+5KI/5DS:1>_;6O<I\&T7B9GY)Y?_)VU_*6
MZK_KN:O1$]=*3TQ'FFW7/DC2.B=4>%:%O8
M
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M"JS-'
M
M
M
M
M
M
M
M
M
M
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MB.NWFTB?C*_UTP3>
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MEE U!C@
M
M
M
M
M
M
M
M
M
M
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M
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ME?PJY@S$Q.D]:"W]
M
M
M
M
M
M
M
M
M
M
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MYXQN(^[98TQQ/93MM^^GJ^IC7JLB_K>I%
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MGK;=P[F3@W$YBFUSU]=/T-O@V]$1;37][JU])-9P
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M,=\.^P9+4R4M&EJ7K.EJS'9,3&B",N+)@RVPYJS7+69B8GKB8ZXEV-Y7S
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M<9:Q$5BL(8YXX#\@WGY2VU?]3SV^%$=5<G7/N6Z;1Y^]'5HD3*N-$
M
M
M
M
M
M
M
M
M
M
M
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M8MGZ[1T3&'HF)C+$Q'7/7'_DV'\C[6WW?)&N28^AI/57TW[?J?-9-<4 1$
M    P ^3'S5T_@AXF\^[C^O@7NP]C9_H5TWH<VEF]3=]F<@QLFWI;][!NW;7
MYW3\7QK-_;["W[H_4P\&=J,J7+MNE9,\)>0,_B/SKMN!:6CA=9];NKQK'<V]
M)COQ$].ELDS&*D]EKQ,QI$LYR]PB_&N)TVG3ZB/A9)\E(Z_=GXL>>=59SOM[
MN>4[W=<GY'L\W=\AY'MMCO=]N=ED7,O8[?<[?,O;#:;/895VLKN3FY^=D3NW
M;DJUE.Y.M:_C5UJVVVP;/;X]IM:5Q[7%2M*4K&E:UK$5K6L1U16(B(CLB%A*
M4IBI&/'$1CK$1$1U1$=$1'HAQ+[/T
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MRWFT5U[*5^+2OU-*UK'9"/=YO][O\GK=[EOER?53,Z>B.J(\T1$/9V >0
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M:=[)BCN1K:F.LQ]SIRU\NQ3Q;8U_URE?AUCKO6.V/+:L>[:O1UQ$3.'<]$/
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MNVC6(G6%=N(;'/PW>9-EN8TRX[:>:8[)CS6C28\TO;VO/&
M
M
M
M
M
M
M
M
M
M
M
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M1U16(TK6L=%:Q%8B(B(5XW6YS;S<7W6XMWL^2TS,^>?G1'5$=D=#T5BWP
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M7$]OQ?8TWVV^+;HF.VMHZZSYX^;&D]4L7VWLB
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M?[U;),S\"L(_Y[X'\KVD<5V\?ZQAC2^GT6/R^FD]/ULSY(3B7/-#H
M
M
M
M
M
M
M
M
M
M
M
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M)EMI]%>\S;36=(F*QT1"Q7"^'X>%;''L<'Q*5Z9[;3US:?/,]/FZF.3:GO
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MO>17"RE*<I2E*LI2K64I2K6LI2K7UK*5:^M:UK6OXU=5(B(C2.I/C^
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MB([]Y2!R-QZ=GN_R3N;?ZKFGX&OT.3R>B_5]=IY90<W0U,0
M        #N_6G9'-NG^P.']H]<<@S^*\[X%R#6\GXMR#6W/IY6MV^JR89.-=
M]LJ2M9.-<K"MN_8NQG9R+$YVKL9VYRC7'\6X5P_CG#,_!^*XJYN';G%;'DI;
MJM6T:3YXGMB8TFLQ$Q,3$2^.XV^'=8+[;<5BV&]9B8GMB?\ IT3V3TPLJ/C>
M\[N%?(!XW\?[9TM,#3=@:7\OQCN+@N+>G*7$.>8V+"YE2Q+=^<\F7&>1VO\
MAVJO2E<]<>Y6S.<K^/?I'D]XK>''$/#/FO+P7<=[)PS)KDVN:8_G<,ST:Z='
MK*3\#)$:?"CO1$5M76OW'^"YN!\0MM;ZS@GIQV^FK_ECJGS]/5,,_$:,(
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M%+X*Q_JM_A8Y^IGL]-9Z/+U3VME:)FO@
M
M
M
M
M
M
M
M
M
M
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M;1/3$ZK%< XA^4^#X-Y:=<DTTM]=7X-O?F-?1+"!(3,
M  /[&,IRC&,:RE*M(QC&E:RE*M?2D8TIZUK6M:_A0F8B-9ZA-1^$OX9\3J?7
M<2\Q/*_BLKO;F=;L[[ISJ3D>![8]58DY5N:OG7,=9E1K[^R,VS2.1K<*['_Z
M@6IPO78TV=8PUU _:!\>;\:RY^1>2\VG!*S--UN:3_M$_18<5H_S$3\&]H_G
MIB:Q/J>G+$?-_-D[JUN%<,M_JL=&2\3\?RUK/TG9,_1=4?!^-*)4_1R
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MRC6DHRC*GK&494]:5I6E?PJY6S$Q.D]:!']
M
M
M
M
M
M
M
M
M
M
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MF;WTTB<E[VB([VBN_&^*Y>,<2R;[)K%9G2L?2TCXL?NSY;3,]K,EH;$@
M -:'RW>8-/"_PD[/[!TNPIA=E\WL4ZGZC]F1+'R[/..:X>=CUY!ASMRI=A?X
M5QO&V&YM2]*PED8-JU+TI=I5+7@GR-_?[Q!V?#-Q7O<)V\_*=ST:Q.'%,3W)
M\V7)-,4]O=O,QU-AY8X5^5^,8\%XUV]/AW^MKV?OITKZ)5JDI2G*4I2K*4JU
ME*4JUK*4JU]:RE6OK6M:UK^-76*(B(TCJ6!?P
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MDWU,L>:NXQ]W2/-WMO:?3,I>\.MS-]AN-I/^;RQ;W+QI\^DHPRW:1
M            $KKX$_B:M\QR..>=/DCQ>ESBNMS;>T\<N ;W&]8\CVVNR*5L
M=O[[69%JL9Z#59MJO]';5W\<O+M5V'LICVL*YE4P]I+QJG85R^'7*F;3>7KW
M=]FI/Q*VCIVU+1/Q[1_/S'Q:SZK7O3DBD:<Z\S^JBW!N'V^Z3&F6T=D3]!$^
M6?HO)'P>O729"HDB@              !#Y^Z*Z-QL;>^,'DCKL/VY.VUO+>E
MN79L;=8QE32W[7-N 6I3C'VSO7([GD7K[ZTE[+4*1]:4K[;R^Q]S%>^VXQRI
MEM\"E\>ZQ1]?$XLT^CX.#W9E*GASO)FFYX?:>B)KDK[OP;?.JB5+KI.
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M--
M
M
M
M
M
M
M
M
M
M
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M&\V.XQ3'E[M:Y_+']#KV^CMC<^0\TXN8*X^S)BO7WHB_\57_ +I>F\
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M:VK,:36T3I,3$],3$]$Q/5*O-JVI::6B8M$Z3$]DP^U\W\
M
M
M
M
M
M
M
M
M
M
M
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MQ;6#J='H=)A6-;J=1K,*Q&%G$P-=@8UNU:MQI2,(0I2G\CE=O-YNN(;O+O\
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M5"Y"U64:7)V[76G.(W9QAZ^Z4+<KT*2K2GI2LJ>O\M%M?9!B?[Z\3MV?DO\
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M^([EM/)?ZR[;_P 9_975S;J:GD                       !M$^)'STSO
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M9MY$@169HX
M
M
M
M
M
M
M
M
M
M
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MQ,3T3$Q.DQ,=DQ/1*O-JS69K:-+1.DOJ?A_
M
M
M
M
M
M
M
M
M
M
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M(5Q1/EC!AK;WM<\QU=>L:SIT2]X<X)KP_<;B?H\T5^QK$_QD8E;M(@
M         #-?X]/$/?\ F]Y8=7]#ZRSFPXUL=G'DO:&[PJ2I+C/5G',C%RN8
M;:N12DHXF5EX]VWKL"<Z>R6TS\:%?[]H'B?SQMO#WDO><QYIK\KI3U>WI/\
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MOTIDZO?[)W[P\P=_B^7//Q<>"8]VUJZ?,BR#*Z(ID
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MC2(0YXX5^3^+?*L4:;?<ZVCS7CX\>[,Q;]\WO*XM,
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M(\]+1\^'M,91G&,X2I*$J4E&4:TE&494]8RC*GK2M*TK^%6 F)B=)ZWD?T
M
M
M
M
M
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M8F/GNW/$^0
M
M
M
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M]VWU.3)%,4_7M@Y7X?\ E+C>##:-<5;=^WUM.G2?-,Z5]U6GNL:P0
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MNO6[FWG];DMZN?=Q1C3UR;MODW+V#6-+9.]>?WUIT_@Q#48FYM
M      "=)]N1X;4Z<\9=]Y1<LUMS'YYY)Y4+7%XY=F5K(U/3_$\_+Q-+.U;N
M4C=LUYIR..5L9R]/9DX%C778?A^->=?M4<^?E[F['R?LKQ/#>$Q]TTG6+;K)
M$3?7LGU5.[3RUO.6)0US[Q;Y7Q&O#L4_<-O'3Y[VCI^QC2/-/>2-U5VA
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MK'FF^>T3Y9IT]4)=\.MIZO8Y][,=.3)%8]%(U^?>8]Q&!6]2*
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M'S _ZG?G'UKR7>[.N!UCVE=CT[VI]6[=C@XG'N8Y^#;T_)LF%)_2A'A_+<;
MS[MZMNY<A@6\JW;I2MZJ'/';D;^_7AYN]IMJ=[B^SCY5M](Z9OBK/>QQV_=<
M<WI$:Q$WFDS\5K?-?"ORKP;)CI&NXQ_=*>76L3K'[ZNL>G3R+(URF0"
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M_P#B3^Y?,O\ NW_:8OY9_P!O!\4O^M3_ .H[R/\ ]#Y_RX^,_P#P;_VO8_\
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M:,=I\E<FDX[3YJVEAMYPOB/#YTWN')CCRVK.D^BW5/N2R):L\
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M)F*S6-4=<7X!Q+@EXC>4^Y3.E;UZ:3[O9/FM$3VZ:,\$<,*
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M2=+TM:LS$QKK$PCG?;#><-W$[;>X[8\T=D]L>6)CHF//$S#VMK[Q@
M
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M>CO?"QZS6L9)M/=1]QOE7B?!8G->(R[/Z>O5'UT==?3TUZHUUZ&V%"S60
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MJCC=;7<[+/;;;NEL>>O7$]?_ (8GLF.B>QZ2Q+S@
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M)KDK,Q,3&DQ,=$Q,3TQ,3UPT.8F)TGHF'[OR_@
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MK,=<36=)B8\DPUJ]+X[32\36\=<3&DQZ8<D^3\@
M
M
M
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MPT[/@XJ5I7H[.BL++[7!7:[;'MJ?$QTK6/16(B/G.@LD^X
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MC( YJX7^2N,Y<5(TV^3[I3ZVW7'[VVL>B(\K:*A]K@
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MN;TBFO1%[(XXKRKQCA.M\N/UFVCZ.FMHT^JC36ONQIYY;24/-<
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M%S%P6_ ^(SMM9MM[1WL=O+6>R?/6>B?<GHU;%46L"
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MI+$O.
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MTS5Z<L1U6CZ?ZZ/HO+'3/3$ZS-%#$3
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MT6ZZSZ+1T>YU^6&7C1V+
M
M
M
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M>T6Z)Z,ENYA].2.KK9[EGAL\4XSAV\QKAK;OW^MKTSKZ9TK[JL\=:5A
M                       $O'[:#S0NW(]B^#?--G64,>WLNWNE)9=[\+=N
MM[%L=E\,P_J2_DK>OX^[Q,>W3^66TO24@]K3D&(G:^(FPITS-=MN](\TS@RS
M[D6Q6M/_ %-81;XA<(T]7QG#'DID_B6^?69^MA+J4B1>   C>?<A^(=.V/&7
MBOE%Q?6TO<S\<=M^0Y;+'LREE;+J3G.?A:[.N7/HPG=R:\1Y?7!RK49>EO'P
M\S87JRIZ5];5^RGSQ^1>;LW)^\OIL.*TUQZST5W.&)M'7T1ZW%WZSVVM7%5O
MW('%/DO$;<-R3]QW$:U\UZQK'V5=8\\Q6$&=T13(  D,_;F>64NF/+W;^/O)
M-K'%X+Y-Z#]4ZRUEY5;.%@]L<,L9VZX=DVZWIUQK-SD&EN;34^R,8W<S-R<&
M'NK6W"$JP>U/R5^7^1Z<S[2FO$>$9>];2-9G;99BF6.CIGN7]7DUZJTKDG3I
MF6B\^\,^5\+C?8XUS;>VL_66TBWO3I;S1$IX3G$A<
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M)GU>2*9-(U[LUTF8EXOP'B7!<G=WE/N4S\&]>FEO=[)\TZ3YM&=*.F&
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M(RX=9[;>JO3O3]-JKGQK8?DOBN?8Q\2E_@_6S\*ON]V8U\[+II#%@
M               (!_W%'D+L>V?/G.ZHL9EZ?$O&[@_&^%:W"C?E<U]SEG,M
M7KNP.9[NQ:K<G"UGY%K>:W5Y-:4A[OU+;I6E?;[J]*_9;Y8Q<%\-:\:M6/EO
M%=QDRVG3X7J\5K8<5)GR1-,F2O7_ #L^5-O(>QKM>"1N9C[KN+S:?+W:S-:Q
MZ.B9CZYH461;J    D"?;C>0FRZO\Z[_ $QD;"Y;XIY'\ Y%Q^]K9W/9A2YM
MUYK-CV!Q3<7*UI[:96+H]7O,"S2M:4G+9^VGK.L**S>U3RQBXQX<QQ^M8G>\
M*W-+Q;M]5GM7#DKZ)O;%>?)ZO7JU:/S]L:[G@WRN(^Z[>\3K]3:8K:/?FL^X
MGKN;B%0                          'RYV=B:S"S-EL,BWB8&OQ<C.S<J
M]+VV<;$Q+,[^3D79?[VW9LVY2E7^Y2C]X\=\V2N+%$VR6M$1$=<S,Z1'NR_M
M8FTQ6O3:954GD]WCOO)7R&[E[YY)=OSV7:787).66K&1*DIZK2YN?=AQKC]N
MM/\ ]EXWQRSB:^Q2M:UI9QHTK6M?6M>RW*'+VVY3Y7V'+>UB/5;/:X\<S'T5
MXK]TOZ<EYM>?/:5E.';.G#]ABV6/XN/'%?3.G3/NSK,^EX2V-[0   $W+[9'
MR"SN;>-G='CON,N61>Z+Y_JN4\5C?OT]^/P[MZQN,R]J<''KZ5KBZWF?$]IF
MW9Q]?;=V]*2]/=#UY]>UQRSCX?S9L.:,%=*\1VUL>32.O+MIK$6F?+;%DQUB
M/)BZ.U$'B'L:X>(8=_2.C-28GZZFG3[M;1'[U)I5(1X
M
M                U)_.!WSMN@_CB[OV'&\^]K.3]G?J#I;29UB7LN6+'86P
MIB\OI;G&M+EN]D=>X.XM6KD*QG:NSC.E?6*;/9ZY;P<R^*G#\6[K%]GL^_NK
MQ/;.&NN+W(SSBF8GHF(F.UL_)^RKO>/X:Y(UQX]<DQ];'P?X7=5R#J@GL
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M;6Z-9F9G7DK95VG <>33[IFF<D^[.E?X,1/NRTPIZ;:    L%?M[N^]IW/\
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MV6]S8-9[8Q9+4BW[Z(B8\TJU[_;3LM[FVD]>++:OV,S&ONO9&!>0
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M6G2>B=)Z$6;_ (;ON%Y_D^^QVQY.S7JF/+68Z)CT2R!:R\(
M
M
M
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MB?+%*ST]&DQ>'W#O4<.R<0O'P\]](^LIK'S;3;WH1L%KT@
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MAGY*X/AVUHTS3'?O]?;IG7T1I7W&O5)[.@   )U'P%?&G<\;NK?^MAW'Q_\
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M[UI[)KCQ6CHE,?('"ODNPOQ++&F7/.E?-2O\JVL^>(K*-JM<W\
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MW$=EDX=OLNQR_'Q7FOICLGW8TF/2]V:X\0
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M+ER<JRG.<Y5K*<YRK6M:UKZUJ[11$5CNUZ(A9GJZ(ZG^']
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MBKQPK6_A-QV+Q$Q\BF>GIZ8O28GTQ,1,>28U8#FF(GE_=:_T7[L++UR85\
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M$
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M)5I3UK2-/7^2B@GM@Q']Y>#VT^%\AR_VO_AE$GB/_MVVGM]5;[9*.4^1P
M               QN\R>27>&>(/E7S"Q<OV;_%/&[O+DEF[BV[%[*M7=%UAR
MC:6[F-9R:QQKM^$\6E81N5I"4J4I+\/5M?(>TKO^>.#;&T1-<W%MICF)UB-+
M[C'7IF.F(Z>G3I\C(<)Q^NXIML4]5MQCCW[Q"JU=D5D@    %F)\2%RY=^-G
MP\E=G.Y*G3^JMTE.4IRI;L[+:6K4*5E6M:0M6H1C&G\D8TI2GX4<E?&V(CQ7
MX[$1I'RZWS:UF?FJ]\T=',&[T_I9^=#8NBU@0
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ML(Z9CZ.D>>(^-6/IHZNV(CI2"E9&C@
M
M
M
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MTKZ_JZOX)9\$.4XYQ\2^&\.S5[VPP9?E.;MCU>#X>EOJ<F2*8I^O;!RMP_\
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MFLSYYKT?O4I53M'
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MWZ[WGRST1'P:Q6L1$3=P[AFRX5MHVNRI%<<=?EM/EM/;/_\ 4:0QU;2]X
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M\?V\*K%V263                                   64_P ._1VS\?\
MXYO&KA^_PYX/)>1\3S>TN08UZW2SE6<KM3=[+G6KQ,ZS[8W+&?K.-;K Q+UN
MY_.6[F/6$O2L?;3D]XZ<Q8N9O%/BV^VUN]M,6:-O28Z8F-O2N&TQ/;%LE+VB
M8Z)BVL*_<U;RN^X]N,M)UQUMW(_>1%9]R9B9]ULT1(UX
M      !6'?)W_:'>:'\1O:?^-.>Z[^$7[+^ ?HK;_P!G"Q/+OYBVGWBGSF"J
M169    ;&/B-_M)_#S^M[6_X+VR+/&[]D_'?P&WVU6!YH_5_=_>I^?"S#<EE
M>P                          &.7F)^Z/Y3?PY=W_ +,^3MJY%_7?@WZ5
MVGXQC>_A7YTVWW_']O"JQ=DEDP    $F#[7_ />X\@/X<KW[3.!JE^U]^I'#
M/TK'XOF1[XB_FO!]_P#XEDWMSW0^
M
M CF_<Z?N%=2?Q=\"_8UWZM/[(O[2=]^@\WXULV^^'?YZR_@MO[3&@K.BJ90
M  &1GAY^]QXM?Q&](?M,XPU;GK]2>,?HK=_B^1X.*_FO<_@^3[25J>XV*V
M              *M_P"03]_7S<_B[\D_VR\T=A?#+]FW+WZ#V'XKB6.X'^9=
MG^"XO[.K$1N[*    )I?VN/_ *!?*7^MWAO^)MY07VPOUDX/^ Y?[6$2>(_^
MV[;[U;[9*04]1P                  Q$^03]PKS<_A$\D_V-<T;QX9?M)Y
M>_3FP_&L3*<#_/6S_"L7]I55ONPBQP    "S!^(S^S7\/?ZHM=_A;;.2WC=^
MUCCOX=;[6JO?-'ZP;O[[/SH;&D6,"
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MI,3'7$Q/5,.5?%^0
M
M
M
M                 $)?[F7R=KS7R!ZK\5]#L*7-)TGQ3^G7.,>Q=C6DNQ.R
M;%B_J-?GV/964;_'^ XF'EX\O=^-O?W*5C^%*UZ!>R3RA^3^6=YSEN:Z;CB&
M;U.&9C_,8)F+6K/DOFFU;1Y<,)>\/>'>IV.7B5X^'FMW:_6TZYCTVUB?K48Q
M;I(@ "?-]N[XLTZ.\)9]R;W6?D^<>3_(Y<UN7;]B-G-L]:\6EG<?ZXU]V5*S
ME=QLR5S:;K'GZTI+'W,/T:5IZUYL>U%SC_>'Q!_(.VOWN'<'Q>JZ)UB<^32^
M>WIC[GBM'TV*>E"?/?$OEG&/DE)UP[:O=_?STWGYU9\]6_56II(       "O
M'^?7O.O<_P CO9>EP\RN7H.C>-\2Z8TU8RC]&.5I<._RCET:6X5K&E_&YMR[
M8XLY5]9RIC1I7\(QC'J![-7+OY \*]IN,E>[N>(Y<FZMY=+S&/%[DXL5+1V?
M"GRRG7DG9?). 8[S&E\UK9)]WHK_  :Q/NM+B?&V@                -TW
MP&>/%KO?Y$.OM]M<*.9QCQ_T&\[PVT;L?2Q+<Z">#H.!PA=K^C'-PN=<DP-E
M:A3UE.&NN5]/2,JT@+VE.:)Y<\+MUML-N[O.)Y:;2NG7W;ZWS>Y.''>DSV3>
M/,U'G;?SLN!7I6=,F>T8X]$]-OX,3'NK#5S 06    @$_<7]P_Y1OD/V7!,;
M)^KKNB>JN < E9M_CCQW?(,3*[/VV3&?K*-S)EB\ZP\:]6-?2$L2ENM*3A)T
ML]EG@7Y*\+Z<2O&F7B.]S9M>WN4F-O6/1KAM:/+WM>J83=R'M/D_ HS3'PLV
M6UO<CX$?:S/NM#2R#=    $K7[8GQBM[OG?>7EUOL"%[#X1K<?I7KR_>M1NV
MX<GY):P.3<^V6-*=GUQ]EIN,V]7B0G"?K7&W=^$H^DJ5K3+VN^;YV_#N'<D;
M:VF3<7G=9XC^CQZX\-9Z>FMLGK+3$Q\;%64:>(G$>YAP\+I/3>?66]$:Q6/1
M,ZSZ:PF3*((H     0NON8/+V7+>U.M/#3BFUK/1=586/VAVGCXU^M;&1V'R
MO77+'"]-GV:2_#*XKP?,NYL?PK&4.11_WUO\+\>R7R/&RX-N^?-[3_6=[:=O
MMYF.F,&.VN6T3Y,F:(I_XCR2EKP]X7ZK;9.+98^'EGN4^MK/PICZZW1^]1:5
MQ$D     -VWPB_')/S8\AH=B]DZ.>5XW]#['6;WFT,W%I/5]A<TI*F=Q;J^%
M;\:V,W!R)6J9^]A&-VD-7;CC7/I2V&/<I7WV@_%2/#_E?\E\)R:<U\2I:F+2
M?A8,75DW'1TQ,:]S#/1KDF;QWHQ6AJ'.''_R1L?D^WMIO\T3%?+6O5-_3V5\
M_3T]V5A)&,81C"$:1A&E(QC&E(QC&-/2,8QIZ4I2E*?A1S%F9F=9ZT&/Z
M "+M]RQYBVN%=0\ \,^);>D.3=P96'V+VGBXUS^>PNLN*;:M>):K.I2Y&L+?
M+N=ZVN5;]*2K[>/SI+VQN1]]P/9-Y%GB''-SS[O:?ZIL:S@V\SU3N,E?NEH^
M]8;=V?OT:=,3I(WA]PJ<VZOQ;+'W/%'=I]?:/A3^]K.G[Y"M7\2X
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M+X'/"^'_ "O<1IO<\1,Z]=:?0U\TS\:WGTB?BM$JQC<P
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MO_9GR=M7(OZ[\&_2NT_&,;W\*_.FV^_X_MX56+LDLF
M                W5_#A\7O+/-_NG1=E=B\9S\'Q4ZPWN+M^:[O:8=_'UG:
M&ZU%^WE8G57&K]ZQ]+<0S\F%O]?W+-?;@ZNL[<KEK)R<6DH!\=O%_9>'O ,G
M">%YJVYSWF.:XJ5F)MMZ6C2=QDB)^#W8U]3$_'R:3$32E]-1YKYCQ<'VEMO@
MM$\2R5TK$==(GZ.?)I]#Y9\L1*PMMV[=FW"U:A"U:M0C;M6K<8PMV[<(TC"$
M(1I2,(0C2E*4I3TI1S"F9M,VM.MI07U],];_ &_@
M   K#OD[_M#O-#^(WM/_ !ISW7?PB_9?P#]%;?\ LX6)Y=_,6T^\4^<P52*S
M(   #8Q\1O\ :3^'G];VM_P7MD6>-W[)^._@-OMJL#S1^K^[^]3\^%F&Y+*]
M@                          ,<O,3]T?RF_AR[O\ V9\G;5R+^N_!OTKM
M/QC&]_"OSIMOO^/[>%5B[)+)@    ),'VO\ ^]QY ?PY7OVF<#5+]K[]2.&?
MI6/Q?,CWQ%_->#[_ /Q+)O;GNA\
M                                                           !
M'-^YT_<*ZD_B[X%^QKOU:?V1?VD[[]!YOQK9M]\._P ]9?P6W]IC05G15,H
M  #(SP\_>X\6OXC>D/VF<8:MSU^I/&/T5N_Q?(\'%?S7N?P?)]I*U/<;%;
M              %6_P#()^_KYN?Q=^2?[9>:.POAE^S;E[]![#\5Q+'<#_,N
MS_!<7]G5B(W=E    $TO[7'_ - OE+_6[PW_ !-O*"^V%^LG!_P'+_:PB3Q'
M_P!MVWWJWVR4@IZC@                 !B)\@G[A7FY_")Y)_L:YHWCPR_
M:3R]^G-A^-8F4X'^>MG^%8O[2JK?=A%C@    %F#\1G]FOX>_P!46N_PMMG)
M;QN_:QQW\.M]K57OFC]8-W]]GYT-C2+&!
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MS,3$QI,3'7$PY]YGX
M
M
M
M                 <'R?DFDX;QOD/+^2["QJ..<5T>VY)R#:Y4O9BZS2:/
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M][N<U\N2T]=KY+3>]O=M,RK9FRY,^:^?+.N6]IM,^69G69]]VAXWS
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M32^#AV"MNS[I..LY)T[-;S:=/.LAP;;?).$[;;=M,-(GT]V)GYNK%EN+)
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M56NNLSUWO-KV^%:4 <6XINN,;VV]W4_"GHB.RM>RL>:/FSK,],LIVG,:
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M1Z-9K[C80C%@@
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MM-KY,EIO>]IZYM:TS,SZ9:'ERY<^2<V:UKY;3K,S.LS/GF78WE?,
M               !6'?)W_:'>:'\1O:?^-.>Z[^$7[+^ ?HK;_V<+$\N_F+:
M?>*?.8*I%9D   !L8^(W^TG\//ZWM;_@O;(L\;OV3\=_ ;?;58'FC]7]W]ZG
MY\+,-R65[                           8Y>8G[H_E-_#EW?^S/D[:N1?
MUWX-^E=I^,8WOX5^=-M]_P ?V\*K%V263     28/M?_ -[CR _ARO?M,X&J
M7[7WZD<,_2L?B^9'OB+^:\'W_P#B63>W/=#X
M
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MMLY+>-W[6.._AUOM:J]\T?K!N_OL_.AL:18P(
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M,?7:^?66K;KF7CN\F?7;K+$3V5GN1[U.[\UG?H^/:#C&NLZ?C6CT_'M3C_\
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MYOY8Q1'-V"FN2E8T^5XZ1IIY/7XZQ]SMUWK'JIUTQ]W1.;^5XXGBGB.QK_\
M4:1\*(_SE8_C1'5/;'P?)I.YLWK.39M9&/=MW\>_;A>L7[,XW;-ZS=C2=J[:
MNPK*%RW<A*E8RI6M*TKZT<Y;5M2TUM$Q:)TF)ZXGR2AB8F)TGK?H_@
M
M
M
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M69Q5G2:S:^3JMCZ)+Y X+ZS+;C6XCX%-:X]>VW5:WN1\&.S69[:H;2]R5P
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MMZ)UM3WOA>_"8,HTBL
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M';'17/IUQIEF(TRWF,.>>7(F)XWLJ],?SM8_M(CYE_LOII3 %'$6
M      ,<O,3]T?RF_AR[O_9GR=M7(OZ[\&_2NT_&,;W\*_.FV^_X_MX56+LD
MLF     F]?:__NC^0'\1M[]F? W/CVOOUVX9^BH_&,R'_$7\Z8/P?^/9)A5*
M1Z                                                     K#OD[
M_M#O-#^(WM/_ !ISW7?PB_9?P#]%;?\ LX6)Y=_,6T^\4^<P52*S(   #8Q\
M1O\ :3^'G];VM_P7MD6>-W[)^._@-OMJL#S1^K^[^]3\^%F&Y+*]@
M                   ,<O,3]T?RF_AR[O\ V9\G;5R+^N_!OTKM/QC&]_"O
MSIMOO^/[>%5B[)+)@    ),'VO\ ^]QY ?PY7OVF<#5+]K[]2.&?I6/Q?,CW
MQ%_->#[_ /Q+)O;GNA\
M                                                   !'-^YT_<*
MZD_B[X%^QKOU:?V1?VD[[]!YOQK9M]\._P ]9?P6W]IC05G15,H   #(SP\_
M>X\6OXC>D/VF<8:MSU^I/&/T5N_Q?(\'%?S7N?P?)]I*U/<;%;
M      %6_P#()^_KYN?Q=^2?[9>:.POAE^S;E[]![#\5Q+'<#_,NS_!<7]G5
MB(W=E    $TO[7'_ - OE+_6[PW_ !-O*"^V%^LG!_P'+_:PB3Q'_P!MVWWJ
MWVR4@IZC@                 !B)\@G[A7FY_")Y)_L:YHWCPR_:3R]^G-A
M^-8F4X'^>MG^%8O[2JK?=A%C@    %F#\1G]FOX>_P!46N_PMMG);QN_:QQW
M\.M]K57OFC]8-W]]GYT-C2+&!
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MKCB9]9,3TQ;+;):.RVB+N*<P\6XO,QN\L^I^DK\&GO=OIM,SYV?*-6$
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MOWF(IYXY<C%:>-;*OW.T_=:QV3/T?HF?C>?X7;*5VI@C,
M
M
M
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M[P'#P+91BC2V[OI.2WEGR1]37L]V>N6MM*S8
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MKTBDS]+:8Z8G1AN8-A^4N#Y]I$:Y)I,U^NK\*OOS&GHE9\.0RNP
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M6;8YQVF=9F(@/FC@5N"<1FF.)^19=;8Y\W;6?/7YL:3VMJZ&6M
M   ,<O,3]T?RF_AR[O\ V9\G;5R+^N_!OTKM/QC&]_"OSIMOO^/[>%5B[)+)
M@    )O7VO\ ^Z/Y ?Q&WOV9\#<^/:^_7;AGZ*C\8S(?\1?SI@_!_P"/9)A5
M*1Z                                                     K#OD
M[_M#O-#^(WM/_&G/==_"+]E_ /T5M_[.%B>7?S%M/O%/G,%4BLR    V,?$;
M_:3^'G];VM_P7MD6>-W[)^._@-OMJL#S1^K^[^]3\^%F&Y+*]@
M                ,<O,3]T?RF_AR[O_ &9\G;5R+^N_!OTKM/QC&]_"OSIM
MOO\ C^WA58NR2R8    "3!]K_P#O<>0'\.5[]IG U2_:^_4CAGZ5C\7S(]\1
M?S7@^_\ \2R;VY[H?
M                                                  1S?N=/W"NI
M/XN^!?L:[]6G]D7]I.^_0>;\:V;??#O\]9?P6W]IC05G15,H   #(SP\_>X\
M6OXC>D/VF<8:MSU^I/&/T5N_Q?(\'%?S7N?P?)]I*U/<;%;
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MUZI\L:3VMF*)6O
M
M
M
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M<^?7MFM;1MZ^Y]PF8].L=>J;^0]KZC@-<LQTYLM[>Y$]R/M6B58QN8
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MY9KP;!\KW41/$LE>G_JXGZ&//]-/N1T1K.C!8EN0
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MMC^3N-;C;1&F/UDVK];;X5=/1$Z>XSS1NPH
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M'M??KMPS]%1^,9D/^(OYTP?@_P#'LDPJE(]
M                            5AWR=_VAWFA_$;VG_C3GNN_A%^R_@'Z*
MV_\ 9PL3R[^8MI]XI\Y@JD5F0   &QCXC?[2?P\_K>UO^"]LBSQN_9/QW\!M
M]M5@>:/U?W?WJ?GPLPW)97L                          !CEYB?NC^4W
M\.7=_P"S/D[:N1?UWX-^E=I^,8WOX5^=-M]_Q_;PJL79)9,    !)@^U_P#W
MN/(#^'*]^TS@:I?M??J1PS]*Q^+YD>^(OYKP??\ ^)9-[<]T/@
M
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M,_LU_#W^J+7?X6VSDMXW?M8X[^'6^UJKWS1^L&[^^S\Z&QI%C @
M                             (K/W%OR)WN$<7QO _J7>RQ^4\ZUF%R#
MR#VNMR96\O2<$RZ6<WC/6];UF/OLY7.:4CG[2%+EN=-/;L69QN8^RN1I<GV6
MO"ZO$-Y/B/QO'KL]M>:;*MHZ+YHUC)GTGKC#\3'.DQZV;6C2V*)23R'P&,V3
M\M;JOW.DZ8HGMMVW_>]4?5:SUU0RE\TL@     -D'QR?&EW5\A_9E--Q*Q?X
MCT[Q;9X5KM7N/88=+VGXMBWK=<NNET6+=O8U>3\VV&)#_@^!8E[;'U;=[+G8
ML2C.45>*GBSR_P"%_"?7[V8S\=S4F=OM:SI;),='?O,1/J\59^->>O2:TBUH
MF(P''^8=IP+;]_+\+=VCX&..N?//DK';/N1K*PD\4O$;HKPOZHU74/0W#<7C
M6AQ:6<K?;J_]/,Y;SKD%+$;.7RKFV_K:MY.[WF;6E?3UI#&Q+7MQ\2SCXUNU
M9AS%YSYWYCY]XU?CG,F><VYMK%*1T8\--=8QXJ=5*1[MK3K:]K7F;3!G$^*;
MWBVYG=;V\VO/5'T-8^EK'9'S9ZYF9Z62[4F/                 8O>6_AY
MT3YL]3;+J'O?BL-WI[WU\OCG(]=7'PN9\!Y!.Q*Q8Y/PG>WL7+KJ=OCTK2DH
MSMWL3+MT^CE6+]B4K<MPY)YZYC\/^-4XYRYF]7GC2+TMK.+-376<>6D3'>K/
MFF+5GX5+5M$2R/"^*[WA&ZC=;*VE^V)^+:/):.V/FQUQ,2KS_D.^.3NOX\NT
MH\3Y]9_I/UMRG)V-_JOMO4X=ZUQ_F6JQ+\O^ ["U*MV/'N:ZW$G:EL-7<NW*
MVOJ4N6;E_'E"]+I[X7^*G+_BAP?Y;PV?4\6PQ6-QMK3$WQ6F.NO5W\5IU[F2
M(C732T5M$UB=.!<?V?'=MZW!\'<5T[])ZZSY8\M9[)]_2>AKU2>SH    #8]
M\6GG1M_ KRMXCV5EY.?>ZFY;/'X-W=Q_$K.[38<#VN7:I+?XN%2DH9.]X-GU
MAM,*E*1NWJ6;N)2Y;MY5V2*O&+PZP>)/)F?A-(K'&L&N;:7GZ'-6/B3/93-&
MN.W9&M;Z3-(8#F3@U>-<,MMXB/E5?A8Y\EH[/1:.B?<GL65NIVVKW^JUF]T>
MQPMOI=UK\+;:?;:W*LYNNVFKV.-;S-?L=?F8\[F/EX6;B7H7;5VW*4+EN5)1
MK6E:5<G<^#-MLU]MN*6IN,=IK:MHF+5M6=+5M$],3$Q,3$],3T*_6K:EII>)
MB\3I,3UQ,=<2Y!\GY
M
M
M
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MN2T8_A3,S,=V(TF9F=--9F>E'G$:[:F_S4V?^RQEM%.G7X,6G3I]#W-KKQ@
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M:6FZ8^4>58X=2.(\1K_]0M\6L_YN)_CSV_2QT=>J.*M2WX
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MB.J(1/XB[+N[C;\0K'1>LTMZ:SWJ^[,3/O)6*F:-0
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M1_(#^(V]^S/@;GQ[7WZ[<,_14?C&9#_B+^=,'X/_ ![),*I2/0
M                                          %8=\G?]H=YH?Q&]I_X
MTY[KOX1?LOX!^BMO_9PL3R[^8MI]XI\Y@JD5F0   &QCXC?[2?P\_K>UO^"]
MLBSQN_9/QW\!M]M5@>:/U?W?WJ?GPLPW)97L
M  !CEYB?NC^4W\.7=_[,^3MJY%_7?@WZ5VGXQC>_A7YTVWW_ !_;PJL79)9,
M    !)@^U_\ WN/(#^'*]^TS@:I?M??J1PS]*Q^+YD>^(OYKP??_ .)9-[<]
MT/@
M                                   (YOW.G[A74G\7? OV-=^K3^R+
M^TG??H/-^-;-OOAW^>LOX+;^TQH*SHJF4   !D9X>?O<>+7\1O2'[3.,-6YZ
M_4GC'Z*W?XOD>#BOYKW/X/D^TE:GN-BM@               "K?^03]_7S<_
MB[\D_P!LO-'87PR_9MR]^@]A^*XECN!_F79_@N+^SJQ$;NR@   ":7]KC_Z!
M?*7^MWAO^)MY07VPOUDX/^ Y?[6$2>(_^V[;[U;[9*04]1P
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M\,:;?<3\+3LR1U_9Q\+SS%DCA5=H0
M
M
M
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MY<Y8HMS-:(M@P6C6-I$]5[QU3N)CJC_,_?-9I,/*7*4;"*\2XE77?3TTI/\
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M][\;^!-EBXY:(&
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M*UB(5]WN\W'$-U?>;JW>SWG69^=$>2(CHB.R'KC"/*
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M_P#W1_(#^(V]^S/@;GQ[7WZ[<,_14?C&9#_B+^=,'X/_ ![),*I2/0
M                                              %8=\G?]H=YH?Q&
M]I_XTY[KOX1?LOX!^BMO_9PL3R[^8MI]XI\Y@JD5F0   &QCXC?[2?P\_K>U
MO^"]LBSQN_9/QW\!M]M5@>:/U?W?WJ?GPLPW)97L
M      !CEYB?NC^4W\.7=_[,^3MJY%_7?@WZ5VGXQC>_A7YTVWW_ !_;PJL7
M9)9,    !)@^U_\ WN/(#^'*]^TS@:I?M??J1PS]*Q^+YD>^(OYKP??_ .)9
M-[<]T/@
M                                       (YOW.G[A74G\7? OV-=^K
M3^R+^TG??H/-^-;-OOAW^>LOX+;^TQH*SHJF4   !D9X>?O<>+7\1O2'[3.,
M-6YZ_4GC'Z*W?XOD>#BOYKW/X/D^TE:GN-BM@               "K?^03]_
M7S<_B[\D_P!LO-'87PR_9MR]^@]A^*XECN!_F79_@N+^SJQ$;NR@   ":7]K
MC_Z!?*7^MWAO^)MY07VPOUDX/^ Y?[6$2>(_^V[;[U;[9*04]1P
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M"M*OO%N*;GC&]MO=U/PIZ(CLK7LK'FCYLZSURRF:<QH
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M;F#AU>*<(S;68^Z=R;5^OKTU]^>B?-,K/!R)5V
M
M
M
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M7+M/Y+_*[=1R:9&)QOGF'UIA0A.L[.)'JWC.CX!L,:WZ_P!Y7]=\>RKEV/\
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MYG2M8F]JUGW<.X?N>*;RFRVE=<MI]R([;3/9$?\ @CIF(5L?G#YG=I>=??\
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MWO,O*O*5.%Q7?[^(MQ&8Z(ZXQZ_/OY9[.J/+,>=9]O0
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M)MLG\YCO:L^FLS$_-AWMCGQ
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M ?Q&WOV9\#<^/:^_7;AGZ*C\8S(?\1?SI@_!_P"/9)A5*1Z
M                                        K#OD[_M#O-#^(WM/_&G/
M==_"+]E_ /T5M_[.%B>7?S%M/O%/G,%4BLR    V,?$;_:3^'G];VM_P7MD6
M>-W[)^._@-OMJL#S1^K^[^]3\^%F&Y+*]@
M,<O,3]T?RF_AR[O_ &9\G;5R+^N_!OTKM/QC&]_"OSIMOO\ C^WA58NR2R8
M   "3!]K_P#O<>0'\.5[]IG U2_:^_4CAGZ5C\7S(]\1?S7@^_\ \2R;VY[H
M?
M                                  1S?N=/W"NI/XN^!?L:[]6G]D7]
MI.^_0>;\:V;??#O\]9?P6W]IC05G15,H   #(SP\_>X\6OXC>D/VF<8:MSU^
MI/&/T5N_Q?(\'%?S7N?P?)]I*U/<;%;                %6_\ ()^_KYN?
MQ=^2?[9>:.POAE^S;E[]![#\5Q+'<#_,NS_!<7]G5B(W=E    $TO[7'_P!
MOE+_ %N\-_Q-O*"^V%^LG!_P'+_:PB3Q'_VW;?>K?;)2"GJ.
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MCQ3TQW(M>LZ99A!_.7'IXKOODNWMKL,$S$:=5K=4V]'97S:S'QF\]79IH
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MFGFTZE8<L1&6T5^+WI^>[*\CY@
M
M
M
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MGIB9B^68BUXZ(BM9F)FSEKE7;\%I&XW&F3B4QTV[*>6*?.FW7/FCH:4T_MN
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M>6?=T[-4$<Z;/Y)S!EF(TIEBN2/WT:6_A19N.02U0
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MHJ/QC,A_Q%_.F#\'_CV2852D>@
M                  *P[Y._[0[S0_B-[3_QISW7?PB_9?P#]%;?^SA8GEW\
MQ;3[Q3YS!5(K,@   -C'Q&_VD_AY_6]K?\%[9%GC=^R?COX#;[:K \T?J_N_
MO4_/A9AN2RO8                          #'+S$_='\IOX<N[_V9\G;5
MR+^N_!OTKM/QC&]_"OSIMOO^/[>%5B[)+)@    ),'VO_P"]QY ?PY7OVF<#
M5+]K[]2.&?I6/Q?,CWQ%_->#[_\ Q+)O;GNA\
M
M         !'-^YT_<*ZD_B[X%^QKOU:?V1?VD[[]!YOQK9M]\._SUE_!;?VF
M-!6=%4R@   ,C/#S][CQ:_B-Z0_:9QAJW/7ZD\8_16[_ !?(\'%?S7N?P?)]
MI*U/<;%;                %6_\@G[^OFY_%WY)_MEYH["^&7[-N7OT'L/Q
M7$L=P/\ ,NS_  7%_9U8B-W90   !-+^UQ_] OE+_6[PW_$V\H+[87ZR<'_
M<O\ :PB3Q'_VW;?>K?;)2"GJ.                  &(GR"?N%>;G\(GDG^
MQKFC>/#+]I/+WZ<V'XUB93@?YZV?X5B_M*JM]V$6.     68/Q&?V:_A[_5%
MKO\ "VV<EO&[]K''?PZWVM5>^:/U@W?WV?G0V-(L8$
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M3$SIU5BUNJ)8GCG$*\+X5FWDSI>M)BOGO/17YLZ^B)E:(./ZN8
M
M
M
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MKAM<>NG]+FI;3O=FOJNKMTU^A2)X<X]>([C+]+AB/LK1/7^]]WW$)MT!2\
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M=(K6M8TK6M8TK6(CHB(B(B(CJA8:E*XZ12D1%*Q$1$=41'5#CGU?H
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MDQTSYH^EKYHZ^N=9:WDK,^
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MQ'VGP=MOHCJFV.9].EJ_.NE_*.(L
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M*9BDQY/63WLLQTZ6R3&NBO/,7%)XOQ;+NHG7!$]VGUE>KW^FT^>6P1&3!@
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M^(OYTP?@_P#'LDPJE(]
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M>E:Z]N_9:\5]O_,XMCG^][FL?VM<?5__ %J\>3D/F"GQ:XK^B\?QHJRJX/\
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M1/D$_<*\W/X1/)/]C7-&\>&7[2>7OTYL/QK$RG _SUL_PK%_:55;[L(L<
M  LP?B,_LU_#W^J+7?X6VSDMXW?M8X[^'6^UJKWS1^L&[^^S\Z&QI%C @
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M=8,V.([;4M$>_,:,@&LO"
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M&DH3A.-:QG"<:TK2M*^E:-.F)K,UM&EH8WJZ)ZW^W\
M
M                                                           $
M1'[I'MW]U'H;#R?_ ./^W>1X?N__ '3PWA63[?;_ /O^'KZ__@7>]CS@GYZY
MDR1_0[:D_99<L?V,I1\.-K_M.]F/I:1\VUOXJ(DN\E$ !8H_ YTW'J'XU.E\
MK(Q*8>[[=V?-.Y-]&-*>E^7*-]?T_%LOW^D97*Y77O&M-.M:T_1K7VT]:1I6
MO+CVC^/3QSQ9W]*V[VWV-,6UIYO5TBV2/<SY,L?-01SIN_E7,&:(G6F**XX]
MR-9_A39N*04U0 !QNXV^LX_J-KOMUF6==I])K<[;[;89%:QQ\'6:W%NYN?F7
MZQI*5+.+BV9SE6E*U]L:OK@P9=UGIMMO6;9\EXK6L=<VM.D1'GF9B'ZI6U[1
M2D:WF=(CRS/4K:?$3"V7FY\K_5.ZWV+>S[G<OEAE]Q<JU^12W.5S08/+=KW!
MRS7785E>LPQK7&]-E6:PC64+=J/MC^%*.KG.^3%X?>"^]V^VF*QL."QM<=H^
MGG'7;8[=DZSDM6=>N9ZT_P#%)KP?EG+2DZ>JVWJXGSS6*5GWYA94.3ROP
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M36\>Y.D_P9LL3W+A!
M  #&;S-[KIXY^)_D/W=;R88FQZYZDYKON.W+GL]ESF%-+DX7"\2M9TK"GY_E
MF7A6/QI+\;G\E?Y*[;R%R_\ WIYTX7R],=[%NM[BI?[UWXG+/N8XO/N,APG9
M_+^)X-GUUR9:Q/UNOPO>KJJP+ERY=N3NW9SNW;LY7+ERY*4[ERY.593G.<JU
ME.<Y5K6M:U]:U=CHB*QW:]$0LEU=$=3_  _H    VQ?"EXR0\G?D&Z?UFUP?
MSO"^H+U_O?FT)VZW,>6!UUF:[(XQAY-NL[=N_C;3L+/T^-?M2K6-S&NW?6,X
MTE&L+>/_ #=/*/ACOLN&W=W^^B-GB\NN>+1DF/)-<%<MHGLM$=,3I+6>;N(_
MD[@>6U9TS9?N=?WVNOO5BT^G18\N5B P                         '@G
MD)XN^/WE7PW^@?D'U3Q/L_CEN=V]KH;_  IPV^AR[]JMB[L.,<EUUW"Y'Q?9
M7+-:PED:_+QKTH5K&LJQK6E=DY8YPYFY,W_Y2Y8WN;9[J=(MW)^#>(Z8KDQV
MB:9*Z]/=O6T:].FKV['B6^X;E]=L<ML>3MTZI\TQ/1,>:8EH@[3^V,\3^2[/
M,V/5/=O='5MC+E6Y;T>YL\7['TFMN5G'TLZRN1A<6Y!^2C9I6E(Y>QR[WOK[
MJWJQ](4L=P;VNN=-IAKBXUP_8;RU?HZSDP7MY[:3DIKK]+2L:='=[6Z;;Q$X
MGCK%=SAPY)CMC6DSZ>F8]Z(]#JW!/M=_'?6;*WD=D^3'<7,M9;N>^NNXAQGA
MO7]Z]&-;586;VPVM.PZ_3E6,Z3K;M6YRC*GME"L?=7V\2]L#FC-BFO">$;'!
MFF/C9<F7-$>>*U]1YM-9F/+$]3Z9O$;?VKIM]OBI;RVFUOF1W6[SQ5\ ?$GP
MNU]ZQX^=.\?XEN\[&_*[?G6QGF<H[#W-B7LE>QLWFG(LC8[RSK;]VW&Y+!Q;
MN/KZ7*>Z-B-5>^<O$OG;G[+%N9]_ES[>LZUPUTQX*SV3&*D5I-HZN_:+7TZ)
MM+3^)<;XIQ>VN^RVM2.JL=%8_>QI&OGG6?.S':(Q0            #'+S$_=
M'\IOX<N[_P!F?)VU<B_KOP;]*[3\8QO?PK\Z;;[_ (_MX56+LDLF     F]?
M:_\ [H_D!_$;>_9GP-SX]K[]=N&?HJ/QC,A_Q%_.F#\'_CV2852D>@
M                                              *P[Y._[0[S0_B-
M[3_QISW7?PB_9?P#]%;?^SA8GEW\Q;3[Q3YS!5(K,@   -C'Q&_VD_AY_6]K
M?\%[9%GC=^R?COX#;[:K \T?J_N_O4_/A9AN2RO8
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M2M*UI5"63'?%>V++6:Y*S,3$QI,3'1,3$],3$]$Q/4U>8FLS6T:6A]+\/X
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MMSC24)PG&M8SA.-:5I6E?2M$+S$UF:VC2T-9ZNB>M_M_
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M/_\ G3_#;_TW_L?_ #I_M4__ +B/_P I_P#^=X/^3;_^1_\ X_\ ^=/\-O\
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M9:M>F-6M<V\2_)O!,MZ3IGR_<Z^FVNL^Y7O3'GB%D.Y4("
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M^RMK;YK#64I3E*4I5E*5:RE*5:UE*5:^M92K7UK6M:U_&K?(B(C2.IEG\
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MTUM6T36U;1T3%JSI,3$]<3&L-2O2^.TTO$UO$Z3$QI,3YX<D^3\@
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M/5QU=^6D<5Y3XSPJLY<E(R[:.N^/6T1'GC2+1YYF-/.VNH8:R
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M1';2TQW;U^JI-J^=I6[V.\V&3U6]Q7Q9/JHF-?1/5,>>-8>R,"\@
M
M
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MY4E&4:UC*-:5I7T<KK5M2TTO$Q>)TF)Z)B8ZXF.R80+,3$Z3UOV?E_
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M<7\F.^');%EB:Y*VF)B>N)B=)CW)5GM$UF:VZ+1+ZGX?P
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MW=K%O/3'C[T>2,L]/3.D1^(F^]9O</#ZS\''2;S]=>=(U\\177]\E$*?HY
M                                          8Y>8G[H_E-_#EW?^S/
MD[:N1?UWX-^E=I^,8WOX5^=-M]_Q_;PJL79)9,    !-Z^U__='\@/XC;W[,
M^!N?'M??KMPS]%1^,9D/^(OYTP?@_P#'LDPJE(]
M                                5AWR=_VAWFA_$;VG_C3GNN_A%^R_
M@'Z*V_\ 9PL3R[^8MI]XI\Y@JD5F0   &QCXC?[2?P\_K>UO^"]LBSQN_9/Q
MW\!M]M5@>:/U?W?WJ?GPLPW)97L                          !CEYB?N
MC^4W\.7=_P"S/D[:N1?UWX-^E=I^,8WOX5^=-M]_Q_;PJL79)9,    !)@^U
M_P#WN/(#^'*]^TS@:I?M??J1PS]*Q^+YD>^(OYKP??\ ^)9-[<]T/@
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MV7#L.+;[.D:5QXZ5I2L>2M:Q%8CT0WC%BQ8*1BPUK3''5%8B(CT1'0ZX]3Z
M             ,V/%3Y$O,'PQSL>71/<W(]+Q>&3^8S>MN07:<KZRV?U+GU,
MJE[A6\KEZK79.;_)=S-=3"V%:?WN1&M*5I'_ #GX7<C<^XYCF/88LF\TTC/3
M[GN*^33+32UHCLK?OT\M98CB? >%<6K_ *[BK.3Z>/@WC]]'3/HG6/,E@>$/
MW&/C[W3=U'!?+#0V/''L+*I:Q8<[PLC+W'26\SJ^V-9Y&?D5O\BZYKDW9_H6
M]C^L-?9MPE.]LX5K2-:7>(7LL\S\ B_$>2\D\5X7&L^IF(KNZ1YHC2F?2.N:
M=R\S.E<,]:,N,<A;[9Q.;AEOE&"/H>K)'N=5_<TGR52,=/N=1R'5:[>Z#:ZW
M>:3;X=C8:G<Z?.Q=GJMG@95N-[%SM=L,*[?Q,W#R;4J2MW;<Y0G&M*TK6BK.
M?!GVN:VVW-+X]Q2TUM6T36U;1T3%JSI,3$]<3&L-#O2^.TTO$UO$Z3$QI,3Y
MX<D^3\@                /-NVNX^J^A^#[;LKN3G_%NMN"Z2%:[#DO+MMB
MZG7TO5M7KUC7X=<B=+^SW&;&Q.F-A8L+V7E3I[+-N<ZTBRW!.!<9YCXC3A/
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M3-IM2)FD1-IQY4Y9Q<(VU=UNJQ/$[QK,S_FXGZ"//]-,=NL:Z1TZ.%AVX@
M                       /2NH>XNSN@^P^-=K]/<TWG .P>)9L<[1\ET&5
M7&R\>5:5AD8F5:E2YB;/4[''E*SEX63;O8F9CSE:O6YVY2C7$\<X%PCF7A>7
M@O'=OCW/#,]=+X[QK$^28GKK:L]-;UF+5M$6K,3$2\^ZVFWWN"VVW=*WP6CI
MB?\ IT3'9,=,3TPL9_BU^030?(5XX8?8%_%U^@[=X-E8G$.Z>(:ZMV.%K>4U
MP_S&%R/1V<B=W)M\4YGB6IY6%&<[LL:[;R,2MV]+%E=GRQ\8O#+<^&'-5N&5
MFV7@FXK.7:Y;==L>NDTO,:1ZS%.E;Z1'>B:WTK%XK$"\R<#OP+B$X(F;;6\=
M[':>V/)/U5>J?+T3T:Z-E2)VO@    ,1/D$_<*\W/X1/)/\ 8US1O'AE^TGE
M[].;#\:Q,IP/\];/\*Q?VE56^["+'     +,'XC/[-?P]_JBUW^%MLY+>-W[
M6.._AUOM:J]\T?K!N_OL_.AL:18P( #PCR \G>@?%CAMWGOD!VKQ+K#C=*7Z
M85SD.P_^JV]R,>%+EW XOQO"AE\CY5LX6Y4E7&UV+E7Z1_2K#VTK6FQ\L\H\
MR\X[^.&\L[+/O-WT:]ROP:1/5.3).E,=?JKVK'9J]NQX=ON)9?4;'%;)D\T=
M$>>9ZHCSS,(N7E_]S1N,J[M.)>%'5-C58D;E_%M]P=RX\<[8Y-JGI;IF\9ZU
MU>9'!UTOJ1K.QD;7/S/J6Y4^KK[4Z5C2X7(WLDX*13>^(&]F]](GY-M9TK'F
MR9[1K;R37'2ND_%RS'2D;A7AY6-,O%\NL_28^KW;SU^>*Q'FLC6]^>6/DGY1
M[O\ 7_D!W3S_ +2RX7YY.'@\DWE^O&]/=N>OU/Z/<0P*87$^-VY^ZOK;U^%C
M0_&OX?BMARUR7RGR?M_DW+/#]MLZ::3..D>LM]?EG7)D]-[VE(.RX9P_AM.Y
ML<-,<>6(Z9]-I^%/NS+'IL[W         .=XSRCDW"][K>4<.Y%O>)\FTV3#
M,T_(N,[?8:'>ZK,MU];>5K=OJ\C%V&#DVZ_WMRU<C*G]RKS[O9[3?[:^SW^+
M'GVF2-+4R5K>EH\EJVB:S'FF'XR8\>:DX\M:VQSUQ,1,3Z8GH;Q_$O[A'S9Z
M!NZG0=P9NL\HNO,.MC'OX?85VNI[+QM?;]E)0U?:.KP[V?GYLO;*4K^^P]Y>
MG65:>^-/;[:\<Z^S%X?\RQ?<\#K?@_%+:S$X8[V";?5;>TQ%8\V&V&(\D]NG
M<3Y&X1OHF^UB=MGGZ7IIKYZ3U>BLU2L/"OY?_##S:EJN-\0YU+K7MS8RLXT>
MGNU98/&^5;'/N5I;CC</V5,O(XWSF5^[25;-G79=S8UM1]][$L^OHIGS_P"!
MW/OA]%]WOMM\KX)76?E6WUR8ZU\N6ND9,.D=<WK%->BM[(TXORMQ;@^N3+3U
MFUCZ.FLUB/JHZZ^[&GDF6T=#S7                 $>3[E+N"?!O!7BW5^
M%DSMY_=_<_%]3L<6,Z0AD\1X'@[+G.SN3I^,KOY?E>MT7I#TI'UG[JRI6-(R
MM![)_ HXCXBYN,9(UQ\/V&2U9\F7--<-?1KCMFZ?-IITZQO7A_M?7<9MN9^+
MAPS,?76TK'\&;('[HXF@    !-9^V,\>K?%^A>[_ "6VV#"&W[7YWA=<\5R+
MUN-;]OAO6V%^>VN9@WJ4]88>]Y;R>[CWX^OK*[I(5K2E(QK6@/M=<T3O.9.'
M\I8;?<-EMISY(CJ];GG2L3'EICQQ:/-EGRRB+Q$WWK-[AX?6?@8J=^?KK]6O
MHK&O[Y*"5!1T                                            Z[RW
ME_%. \;W/,N<\FT'#>(\=PKFRW_*.4[?7Z#C^DU]FL:7<W:[C:9&+K]?BPE*
ME*W+MR,?6M*>OK6CU;+8[WB6[Q[#AV'+GWV6W=ICQUM>][3V5K6)M:?-$/IB
MQ9<^2,6&MKY;3I$1$S,SYHCIE&I\U_N2>G>N);C@_AGP^G=O+\>N1A5[3YI8
MVG'^I-9E6ZRMUR-)I(2UO,N?4LWH2C6M9:3#G2L;MC)R;=?2ML?#_P!E+CO%
M8Q\1Y\S_ )/V,Z3\GQ36^YM'DO?X6+#K'WVT=,6I24@<(Y W>XTS<6OZG%])
M72;SZ9Z:U_A3V3$(J/DYYU>6'F'N+FS\@NZN7\VUU,FN3KN&6\N&@Z[TDHS]
M;-=-P'C]O6\5Q,FS;C"%<NN+/.O1MQK>OW9T]RYG*/AUR7R+@C%RSP_!M\NF
MELNG?SW\O>S7[V28GIGN]Z*1K/=K$="2N'<&X9PJO=V.&E+=MNNT^FTZV]S7
M3R0Q*;JR@             #+_P 6_/3RR\-=O#/\?^Y>4<2T\\J.5M."9E^/
M(>N-[*MV%R_7:\&WD<[CTLK*A"MN6;8LV-A;MSE2UD6ZU]6C<X^&W)7/F#U7
M,VPPY\\1I7-$=S/3R=W-32^D=?<F9I,Q'>K+%<2X)PSBU>[OL5;7TZ+=5X]%
MHZ?<G6/+"6-X-_<;='=PY&GX#Y>\>P_'OG>7^7PK/9&GN[#:]+;O879VK,9;
M+\Q^<Y)UM^9O7J>E<V>RUEBW"=W(V./'THI;XA^ROS%P*N3B7(^6W%.&UUF<
M%N[7=4KU_!TTQY](CZ"*9)F8BF*THSXSR%O-I$Y^%VG/ACZ"=(R1'F[+^YI/
MDK*2#H][I.3Z;5\BXWN-5R'C^\P,7::7>Z/88FVTVWUF=9AD86QU>SP+V1A;
M# R[%R,[5ZU.=NY"M*QK6E?553<;?<;3/?:[O'?%NL=IK>EZS6U;1.DUM68B
M:S$]$Q,1,3UM O2^.\X\D36\3I,3&DQ/DF)ZI<J^+\@
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M2X3Q#A.;U.^QVI/9/76WUMHZ)^?';$,H6GL<
M
M                                                JI_+3M+_ "W>
M47D1V[#+AFXG8_=/9?+]7?M2]]C]1[OE^VS-#8Q9>^Y6N'B::Y8M6?64Z_2A
M'UE*OXU[*\E<'_N]R?PO@<U[M]IP_!BM';WZ8JQ>9\\WUF>B.F9Z%E.%[;Y'
MPW!M=-)QX:5GTQ6-?FZL?&SO< S_ /BNZHCW3\A_B1P:]CQR\*';^BYQM,6Y
M:I>L96GZKLYG:&WQ,JW+]&6+F:[A]RS<]?Y83K1&?C)QJ> >%_&^(UGNY)V-
M\-9ZIBVXF-O68\\6RQ,>>&#YEW/R3@6ZS1T3ZJ:QZ;_ CYMEFXY'J\@  (UG
MW./:_P#1CQ'Z8ZCQ<F=C/[6[LCO<RU&?I'-XQUGQ;:7MEBW(4E2LX0Y)R[37
MOY*TI*S3^[6BV'LC<%^5\[[_ (W>-<6RX?W(GR9-QDK%9_J\66/=2!X=[;UG
M%,VZF/@XL.GNWF-/F5L\B^UMZV_(]7^6/<%VQ.O])^>]>=;8&3*/\W;_ *"<
M>W7*-M8L2]?QG>_RBX4KM*_W(6_3^ZSGMA\6]9QC@O ZS_,[;/GF/OUZ8ZS/
MH]1?3TR]7B/N.]N=KM8^AI:\_OIB(^TE*P4S1J    A9_=&_^GOQ;_JAYC_C
MG:7Z]CW]6^,?AV+^RE+?AQ_L6Y^^U^U1<%PDC@                    )H
M?V_WRB8G8'%=+X*][<DC;[!X;K[MCQ^Y3N\[]/FO"]?9E>KUC?R,FONN<DX5
MAVIRU4??7\UIK?Y>$82P8_7H1[3'@_?AF]R>(O+F+7AF>VN]QTC^:RVG3Y1$
M1_F\LZ>LZ/@Y9[TS/K/@Q+SORY.#+/&=E7[A>?NL1'Q;3]'Z+=ODMT_1=$IA
M3I&X                  #4Q\D?RY]!?']H<SC5+^%VKY%;#"I/CO3FBVUB
M$]'7*QZ7L+?]F[3'IDRXAH?IW(7;6/6$MEL8RC2Q9I9E<RK,U>%/@CS+XF;F
MN[TMLN5JV^'NKUGX>DZ33;UG3UM^N)MKZNG3WK=Z(I;9^ <K[[CEXR=.+81/
M3DF.OS4CZ*?/U1VSKT3 ;\IO+/O7S)[3VG;O?7-,KE/(\R5VQI]79I<PN*<+
MTDKM;N/QGA?'Z7KN+HM'AT]*>V-9Y&3.E;V3=OY$[EZ?2?D[DKESD/@U."<M
M[>N':UTFUIZ<F6^G3DRWTB;WGW*UCX-*UK$5B:^&\,V7"=M&UV5(KCCKGZ*T
M^6T]L_,CJB(CH8WMK9    !-9^V'Z$IQGH'OGR,V>)]/9=J]AZOKKCEV_:A6
MY3BG6&JKL<_/P+U/64</<\HYK?QKT?6E97=-&M8^D8UK0'VN^9/E?,O#>5L-
MM<6SVML^33^DW%N[6MH\M<>*+1YLOGE$7B)O?6;[#L*S\'%CFT_77G2(GT16
M)_?)02H*.@    &!/R+^>/ /C]\>=WVSR6.'O.=;G\UQWI_K^[D5MY'-N=7,
M25W%ADPM7;658XMH8RCE[?*A6-;.+2EN%:Y%_'A<DGPL\..)^)G-&/@NT[V/
MAV/2^YS:=&+#KTZ:]$Y+_%Q5GKMTS\&MIC-\!X+GXYOHVN/6,,=-[?2U_P L
M]58\OFB5:WVOVISWN_LCFG;?:'(LWEG/^P-_G<DY1O\ /E3ZV=LLZ?K6%FS;
MI&QA:_"L1ACXF+9C#'Q,6U;LVH0M6X1IU@X+P;AO+W"MOP3@^*N'AFVQ1CQT
MKU16/+/7-IG6UK3K-K3-K3,S,K ;7;8-GMZ;7;5BN"E=(B/)_E[9GKF>F7GS
M)ON         VW_''\0'D-Y^;3 Y=<Q\KJ3QUQLVMO<]Q<CU5Z=>00QKT[.9
MJNK]%D3P[G,]G&_9G9NY=+EO58-R$Z7K\K\(XMV$_%3QRY7\-,-MC$QON:9K
M\':TM'P-8UBVXO&OJJZ3$Q72<EXF.[6*SWXU?C_-.QX)6<71EW^G12)ZO/>?
MH8\W7/9&G2G>>(?A1X\>$'6]CK?H/A&-HK.1#%N\JYALZV]ISWGVUQK7T_UQ
MS'DT[-K)V%[WSG.SBVHV-=A?5G'$Q[%N58.<?/'B!S1XA<5GBO,NXG):-?5X
MJ_!PX:S]#BQZS%8ZHFTZWOI$WO:8U0QQ3B^_XQN/E&]OWI[*QT5K'DK'9Z>F
M9[9EE@TMC      '3>PNP^#=3\*Y'V-V7RS1<&X)Q'6W-MR7E?)=CCZK2Z?
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M<;W6#LC-:8]%I[T?,F&;R/6'
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MLUCT4^!'OQ75GXC1A
M &.7F)^Z/Y3?PY=W_LSY.VKD7]=^#?I7:?C&-[^%?G3;??\ ']O"JQ=DEDP
M   $WK[7_P#='\@/XC;W[,^!N?'M??KMPS]%1^,9D/\ B+^=,'X/_'LDPJE(
M]                                                     5AWR=_
MVAWFA_$;VG_C3GNN_A%^R_@'Z*V_]G"Q/+OYBVGWBGSF"J169    ;&/B-_M
M)_#S^M[6_P""]LBSQN_9/QW\!M]M5@>:/U?W?WJ?GPLPW)97L
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MWJ:7F%^-<!W_  /-ZO=5UPS/P;Q\6W^2?+6>GR:QTL\T;L*
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M\],Z:SW:ZZ4BM=(3!PWA6PX3@]1L<<4KVSUVMY[6ZY^='9$0QF;:R(
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M1>*VUA$?$N%[[A.?Y/OL<TOV3UUM'EK/5,?.ZITEDLU-CP
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MO'%<>L:]V;:S,R\(X#PW@N+N[2GW:8^%>W3>WN]D>:-(\VO2P52*S(
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M2C*,J>L91E3UI6E:5_"JHTQ,3I/6CQ_0
M
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M4/,?\<[2_7L>_JWQC\.Q?V4I;\./]BW/WVOVJ+@N$D<
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M)"?-7*N3@^2=YLXFW#+3Z9QS/T-OJ?I;>Y/3I,[WU<6E@
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M$],+([;<8MWMZ;K!.N')6+1/FF-??\L=DNA,D^P
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M/@[_ (?@RS/EM3O[>8GSQ7#3W)A"?/VW]3Q[UL=67#2WNQK3YU8;\E:VD@
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MGS3-LM[3:TSUS,SK,^[*LMK3>TVMTVF=9?:^;^
M                      ,<O,3]T?RF_AR[O_9GR=M7(OZ[\&_2NT_&,;W\
M*_.FV^_X_MX56+LDLF     F]?:__NC^0'\1M[]F? W/CVOOUVX9^BH_&,R'
M_$7\Z8/P?^/9)A5*1Z
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M ^7MAP/#W<$=[<VCX628^%/FCZ6OFCW=9Z6NI*3/
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M[B^G>G@N;NZ^7Y3M.KS]WO=79JWOP\[OY;R:]?R:VGI[^/\ <U02W1E,X
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M)C':U:3"_,?*>ZX+:=QAUR\.F?C=M/->(]Z+1T3VZ3,0W4(":B
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MPMV[<(TI&-*4I2E/2CB]:UKVFUIF;3.LS/7,^659YF9G6>M^C^
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M;16\UBT*<S<JY^"WG<[;7)PVT]$]M)GJK;S>2W5/5.DZ:[N%?6H
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M$Q,:Q/1*&[TOCO./)$UR5G28GHF)CKB8[)ARSXOR
M
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M5DQQY>S+\SJ[8O\ $C!T;7=1]76?X,Q_&2]5'T6@
M                       *VGYIN1UY3\G_ );;.4ISKB\RXIQSUN6K=F5*
M</ZQX/Q*,:0M5K&4(1TE(QG7]*Y&E)2_2K5U<\ MK&S\(."88[<&2_7K_.[C
M-D_C]79U1T)_Y1Q^KY<VM?+2T_97M;]UJZ3 V,   !L"^*?A\><?(WX;:65J
M5ZF%WIP_F'LCZ>M)=>Y%SGT;OXWK'Z-B7&J3K^E7\(_WL_[R49^,V^_)WA7Q
M[<1.G>X=EQ?U\>I\D]?K-/W8ZV#YER^IX!N[^7#:OV7P?W5FRY'J\@
M                                      ,<O,3]T?RF_AR[O_9GR=M7
M(OZ[\&_2NT_&,;W\*_.FV^_X_MX56+LDLF     F]?:__NC^0'\1M[]F? W/
MCVOOUVX9^BH_&,R'_$7\Z8/P?^/9)A5*1Z
M                           K#OD[_M#O-#^(WM/_ !ISW7?PB_9?P#]%
M;?\ LX6)Y=_,6T^\4^<P52*S(   #8Q\1O\ :3^'G];VM_P7MD6>-W[)^._@
M-OMJL#S1^K^[^]3\^%F&Y+*]@                          ,<O,3]T?R
MF_AR[O\ V9\G;5R+^N_!OTKM/QC&]_"OSIMOO^/[>%5B[)+)@    ),'VO\
M^]QY ?PY7OVF<#5+]K[]2.&?I6/Q?,CWQ%_->#[_ /Q+)O;GNA\
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MY7XA3AG&\.XRSI@F9I:?)%HTUGS1.DSYH5I;K*L$
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ME*592E6LI2E6M92E6OK64JU]:UK6M?QJOS$1$:1U);?P
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M]+3,'<U<M7X)N/E&WB;<-R6^#/TD]?<G^+/;'7TQ.NZM +40
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MI2491K2491E3UC*,J>M*TK2OX5<Z)B8G2>M#+^@
M
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M'])@VN3^KOGKU_\ C?\ IHDSPWR:9]WB^FICG[&;1_&0X%[$K
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M+MJ["-RU=MRC.W<MSC24)PG&M8SA.-:5I6E?2M$&S$UF:VC2T-5ZNB>M_M_
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M"9UZ>J:UF)Z]==)C29:KSK?N<M[B.G6TXX_[2D_.B5BRY:H'
M                                 8Y>8G[H_E-_#EW?^S/D[:N1?UWX
M-^E=I^,8WOX5^=-M]_Q_;PJL79)9,    !-Z^U__ '1_(#^(V]^S/@;GQ[7W
MZ[<,_14?C&9#_B+^=,'X/_'LDPJE(]
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MK6*TK\&L+ <*X7M>#[.NSVL?!CKGMM;MM/GGYD:1'1#%IN+)        ,O\
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ME[W7%NE&4)2C*-8RC6L91E2M)1E2OI6,J5]*TK2M/QHN'$Q,:QU)'?P
M                    &9'A=X*>0?G9V;A]?=)\2RLC58N;@QYSV1M,>_C<
M"ZYU&5=I2YM.3;KV?1KE4QHW+F-KL>MW8Y];<J6+4J1G*&B<_>(W+'ASPBW$
M^8,\1FFL^IP5F)S9[1'Q<=.O372+7MI2FL=ZT:Q$XGB_&MCP7;SGWEH[TQ/=
MI'QK3Y(CY\ST1VRL9O"WQ!ZP\'>@.(]!]6V[V5K])^8VO*.5[#&Q\?><\YKM
M:6I;_E^\IC>Z$<G.G9MV<:Q[[E,+7X^/BQG.-F,J\L>?N>.,>(?,V?F7C$Q7
M+DTKCQUF9IAQ5U[F*FO9&LS:=([][6O,1-M$#<7XKN>,;Z^]W/1:W1%8ZJUC
MJK'[OEF9GM96M,8P    !B)\@G[A7FY_")Y)_L:YHWCPR_:3R]^G-A^-8F4X
M'^>MG^%8O[2JK?=A%C@    '=.7]C<YY_C\1P^9<IV_(L+@/$];P7A6#L<J5
MS!XMQ'4SR+V#H='A0I#%UV!'*R[V1<I;A&5_)OW;UVL[MR<Y>#8\*X=PRV?)
ML,./%DW.:V;+-8Z<F6VD3>\]=ITB(C6>BL16-*Q$1\<6WPX)O.*L5F]IM:8Z
MYM/;/EGL\T=$=#I;WOL       _2S9O9%ZUCX]JY?OW[D+-BQ9A*[>O7KLJ0
MMVK5N%)3N7+DY4I&-*5K6M?2C^6M6E9M:8BL1K,SU1'EDF8B-9ZGM.@\9_(_
ME>/7,XMX_=W<EQ(V\>]7*T'5/.]SCTLY=+DL6[6_KM#DVJ6\F-J=;<O7TG2-
M?3U]*L!N>;>5=E?U>\XGP_%?68TON,-9UCKZ+7CJUZ?(\=^(\/Q3IDSX:SY[
MUCY\N?\ ^IYY<?ZK7D;_ )D.S/\ FP\W]^N2?^,<*_\ 6]O_ *1^/RKPO_>=
MO_64_P KS/EG4W:G H7;G.NM.P.%V[%Z]CWKG+.&\CXY"SD8V19Q,BQ=EN-;
MAQMWK&5D6[4XU])1N3C&M*5K2E<MLN-<&XE,1P[=[7<3,1,>KRTOK$Q,Q/P;
M3T3$3,>:)EZ,6ZVV?^9R8[_6VB?G2\_9-]P        'T8>9EZ[+Q=AK\K)P
M<_!R;&9A9N'?NXV7AY>-=C?QLK%R;$H7L?)Q[T(SA.$J2A*E*TK2M'YR8Z9:
M6Q9:Q;':)B8F-8F)Z)B8GHF)CHF)ZW\F(M$UM&M93JOA)^7:/EAH-?XO^1?(
M;?\ UEN)ZF]7AO+MG>L6)]Y<4T^)/(OSN3K6W3([+XSK<>=S8VZ1^ILL&U+/
MC[[EO-K#G3[07@A_<O<VYOY6Q3_=//>/6XZQ,_),EITCT8,EIB*3U8[SZOHB
M<>L-<W\K_DR\\1V%?_I]I^%6/\W:?XDSU>2?@^1(I5;:&            JUO
M/?9V-SYS^9VVQ,F>7A['RM\ALO!R9TO1E=P+W;?+IX,J0R(POVH4Q*PI&$HQ
MK"-*1]*>GH[#^&V&VW\.^ X;QW<E>"[*)CHZ)C;8M>KHZ]>GM6/X)6:<&VE9
MZ)C;8O?[E6)K=63    ;M/M[]';VWR<]5Y\XXU9<8X%W!O+5;]F-V[&YD=?[
MCC598<ZTK7'R?I<AE2LZ>E:V:SA_)*M*U^]IW<3@\(MYBC73-N=M2=)\F:N3
MI\L? ZO+I/8U#GF_=Y=R5^FO2/X43^XL)W,1!@
M                  #1_P#-7\GUGP9Z?M=7=4[;&KY0=R:7-AQ*Y;E8R;G5
MO"KEV[K-GV?L,.4I5IM;M^W>Q..V[L/H7MC9O9$Z7;6!=Q[UA? 'PAMXB<<G
MC'&:3_=#89(]9UQ\HRZ1:NWK/TL1I;/,3K%)K2-)R1:NX<H\NSQG=?*=S'_T
M[%/POJ[=<4CS=MO-I'1WHF*^S,S,O8Y>5L-AE9.=GYV3?S,W-S+]W)R\S+R;
MLK^3E963?E.]D9.1>G*<YSE64Y5K6M:UJZ:X\=,5*XL58KCK$1$1&D1$=$1$
M1T1$1T1$=2<8B*Q%:QI6'SOT_H      #NG ^MNQ>U-]8XKUAP'FO8_)\GV_
MEN.<#XMO.7[[(]\XVH?0T_'L'8["[[[DZ1I[;=?65:4_E>#B7%N%\&VT[SB^
MYV^UV<=>3-DIBI'IM>:UCWWQS[C;[:GK-S>F/'Y;6BL>_,Q#:CT_\$/R6=N6
M,;/O=(X/56FR_9]+:=P<RX]Q*_'W?C/\SQ7"RM[SS"^C&M*R^MJ;?KZ^D?=6
MDJ1AOCGM'>$W!+3BKQ"V]SUZZ[;%?)'N9)BF&=?-DGSZ=#6]USIR_M9[L9IR
MWCLI6;?-G2O\)L0X']KAWGL;=FO9_E3U/Q"[+V_F(<#X/S#L>W:]8Q]_T;G(
M<WJN61[95K2GNA;]:4I7\/7TI%W$O;"Y=Q3/Y(X-O<\=GKLV+![_ '(W&GOR
MP6?Q'V=?]FVV6\?56K3YT79,:+[6GJO'QZQY-Y>=@;?*^CBQI>T75?'..X_Y
MB$)TS+M<;8<OY3<K9OW*QK:A]7W68TK24[E:^M-2W/MB<9M;7:<#VM*:ST7W
M%[SIV=-<6/ICMG3I[(ACK^)&YF?N>UQQ'GO,_.K#OV)]KUXMPP(V\[R,[^R=
MG2%ZDLS$Q.N\+ K<E.Y7'E'77N,9^1&%JW6%)Q_-5K.L:UI6%)4I'&W]K_G&
M<FN/A7#(P]'1,YYGS_"C)6/1\'H\_;\)\1N)=[X.#!W?WVOOZQ\YU#8_:V],
M7<:L-1Y8]GX.9[X5C?V/7G%-IC4MTK_.1KB8VZT]VLY4_DE]:E(_[E7NQ>V'
MQ^+ZY^"[.V/R5SY*S[\TM\Y]:^(^[U^%M<<QYK6C]R7@W,OM9N<8MO(N=?>8
MW%-]=K&Y/%P^9=.;?B=N,JSN_2Q\C9:3L#FDIQC;I"DKT<6/NE65:6J4I2E=
MDV'MB\.O,1Q/@6;'';.+=5R>F8K?#B\_1WO=>[%XD89_G]I:L?4Y(M\R:U^?
M[K!SM/[=#Y&N 0R,CB&HZB[JQK<[DK-OKSLK&U&RGC1K.L+E["[3UG75B&3]
M*-*SM6<B_P"DZ^V$KGX5K(?!O:F\+.)S%=]??</O/7Z_!-JZ^:=O;/.GDF8C
MHZ9B&8VW/G <_1EG+AGZJFL?P)M\Z&J7NSQ*\G/'#(G9[TZ'[2ZOL1O1Q[6W
MY7P[<8/&LR[.=;<(:SE4<:[QK:^^Y&L:5QLN[2M?PI5,W+_.W*/-5>]RYQ+9
M[RVFO=QY:SDB/JL>OK*_OJPV;9\4X=OXUV6?'DGR5M&ONUZX]V&/+:'N
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MLVM.MK6F;6F9F93[MMM@V>"FVVU8I@I&D1'9'_3IF>N9Z9=!9)]P
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MGO+::]W'EK.2(^JQZ^LK^^K#9=GQ3AV_C799\>2?)6T:^[7KCW88\MH>X
M    !-_^WS^22]WEUQ+PT[CY%/,[9Z@T4<KJ;=;6_66;SGJ361M8O]'9Y-V=
M:YO(.M*2MV84K6EV_I)V:QC.N%E7:\]O:;\**\N\5_OYP+%W>"[[)IN:5CHP
M[FVL]_2.JF?IF>R,L6Z8]92J'N>>7XV>X_*VTKIM<MOAQ'56\]OHO]MKY8A)
M<5,1\
M
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M+8>%;N\=7QHP9)K'3K&LVTB-8GIGJ3_QC+ZCA.ZS=M=ODGW>Y.GS5IZXY*W
M    (]'W+'!Y\E\!.(\JQ[4JW^NO(C@NZR[]*3E2&FWO$^?<1R;,H_F+5J$;
MVXWFOE]2L+DZ5MTC&D:3E)9[V3>(QM/$K/L[3\'=<+S4B/JJ9,.6)ZM>BM+]
M&L1TZ]D-Z\/LWJ^-VQSU9,%H]V+5M\Z)0.W1Y-
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MR)\IMMGSG2/YWB_2W#,/4QL2I3UG7%YWSF_NJY=)UKZ4I/CEGV^WU]9>[TC
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ML_7=O_=[TW'9Y/5:^3R]# <TX?7\O;JGDQ][["8O_%67#DRKX
M                                 JW_ )!/W]?-S^+OR3_;+S1V%\,O
MV;<O?H/8?BN)8[@?YEV?X+B_LZL1&[LH    W2_;]?VH/2__ !1[D_99RE 7
MM,_L@W_W_:_C&-J//'ZN9?K\?V\+#9S 06
M                   QR\Q/W1_*;^'+N_\ 9GR=M7(OZ[\&_2NT_&,;W\*_
M.FV^_P"/[>%5B[)+)@    )O7VO_ .Z/Y ?Q&WOV9\#<^/:^_7;AGZ*C\8S(
M?\1?SI@_!_X]DF%4I'H
M           "L.^3O^T.\T/XC>T_\:<]UW\(OV7\ _16W_LX6)Y=_,6T^\4^
M<P52*S(   #8Q\1O]I/X>?UO:W_!>V19XW?LGX[^ V^VJP/-'ZO[O[U/SX68
M;DLKV                           QR\Q/W1_*;^'+N_]F?)VU<B_KOP;
M]*[3\8QO?PK\Z;;[_C^WA58NR2R8    "3!]K_\ O<>0'\.5[]IG U2_:^_4
MCAGZ5C\7S(]\1?S7@^__ ,2R;VY[H?           ?'L-A@:C SMKM<[#UFK
MUF'D[#9;+89-G"P-?@85F>3F9V=F9,[6/B8>)CVI7+MVY*,+<(UE*M*4K5^\
M6++GRUPX:VOFO:*UK6)FUK3.D1$1TS,ST1$=,R_M:VM:*UB9M,Z1$=<RKH/E
M_P#D<W/GQY#YN/Q/99F/XY=29^TX[T[H_P">Q[/()4N1Q=YVCM\6?LG<VO,;
MV+26%"["$\'4QL6?9"_+*G>ZF>!OA7@\->5ZVWM*SS5OJUONK]$S3MIMZS]+
MBB?AS$S%\G>MK-8I%9YY5X!3@FPB<L1\ORQ$WGR>2D>:O;Y;:SU:::CTVMH
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M^HPZ3]#-,>DY(^^VR3YT?<0YDXUQ.9C<Y[1BGZ"GP*Z>28KIK^^F9;"D8,$
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MB]S<9-K-V]SCO!>P^1<7TD]KF6,;#L9>RGK=7:K?NPLVH7+ONE2$:5]M+_\
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MW^CD_P":_P 4/Z/A7]1D_P!.?X@<=\F#["?Y1_LV'QX_^._(W_.5Q;_1R?\
M-?XH?T?"OZC)_IS_ ! X[Y,'V$_RC_9L/CQ_\=^1O^<KBW^CD_YK_%#^CX5_
M49/].?X@<=\F#["?Y1_LV'QX_P#COR-_SE<6_P!')_S7^*']'PK^HR?Z<_Q
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M\.VWVTM,Y\_5^WWVGSY6 [F<A
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MZ9*Q/3W<E)K>NO3W;1KTJY\0V.;AN]R;'/\ SF.VGICLF/-,:3'FE[HUUXP
M
M
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MJ=O/G^4X[X*Q/[_)68\\0V'E3<?)N8=K>>JV3N?9Q-(^;,*UAUA6!
M                      >V^-7<.=X^>0G2?>.OC?O7NJ.T.$\[O8>-*D+N
MSUW'.08&QV^G]:UC3Z>YU5F]B3I6M/6%ZM/6G\K7^;.!8^9^6.(<O9=(KO=G
MEPQ,_0VO2:UM^]M,6CSP\?$-I&^V.;9VZLN.U?1,Q,1/N3TK5S3;C5\AU&JW
M^DSL;::7>:W!W&HV>'<I>P]CJ]GBVLW SL6]']&[C9>)?A<A*GX2C*E7&C/@
MS;7/?;;BLTW&.\UM6>B:VK.EHF.R8F)B5:[TMCO-+QI>LS$QY)CKAR3Y/R
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MOV59CS^7R+7YQ>5G
M5;_R"?OZ^;G\7?DG^V7FCL+X9?LVY>_0>P_%<2QW _S+L_P7%_9U8B-W90
M !NE^WZ_M0>E_P#BCW)^RSE* O:9_9!O_O\ M?QC&U'GC]7,OU^/[>%ALY@(
M+                                             8Y>8G[H_E-_#EW
M?^S/D[:N1?UWX-^E=I^,8WOX5^=-M]_Q_;PJL79)9,    !-Z^U__='\@/XC
M;W[,^!N?'M??KMPS]%1^,9D/^(OYTP?@_P#'LDPJE(]
M                                    5AWR=_VAWFA_$;VG_C3GNN_A
M%^R_@'Z*V_\ 9PL3R[^8MI]XI\Y@JD5F0   &QCXC?[2?P\_K>UO^"]LBSQN
M_9/QW\!M]M5@>:/U?W?WJ?GPLPW)97L                          !CE
MYB?NC^4W\.7=_P"S/D[:N1?UWX-^E=I^,8WOX5^=-M]_Q_;PJL79)9,    !
M)@^U_P#WN/(#^'*]^TS@:I?M??J1PS]*Q^+YD>^(OYKP??\ ^)9-[<]T/@
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M7'_T"^4O];O#?\3;R@OMA?K)P?\  <O]K")/$?\ VW;?>K?;)2"GJ.
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M>-UMLVSW%]KN*]W/CM,3'GCY\3UQ/;'2]%8M\          %5AYA_O<>4O\
M$;W?^TSD[LGR+^I/!_T5M/Q?&LGPK\U[;\'Q_:0QS;2]X   #>I]NK_:4<8_
MJB[7_P $X*NGM2?LGS?AVV^VEIG/GZOV^^T^?*P'<SD(
M                        (6'W*_F1L.7]O\&\+>)[;V\1ZHUNL['[4QL3
M(_\ TGV7RO77+W$]-M;,?7TAQ#@N=;SK-/=2ER?()5G&LK%J5+]^R;R)BV/
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M"-NU:MQC"W;MPC2,(0A&E(PA"-*4I2E/2E%89F;3-K3K:6B]?3/6_P!OX
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ML)<JD:+P
M
M             %9C\LG+Z\W^2'S&W-;\,C\EW5R+B'U+=RQ=C&G7UK"X%2Q6
M6/ZVZ3QJ<:^G*-?TX2A6,_TZ2=;?!78_D_PIX%@TT[W#Z9>W_/3.;7I\OK-?
M).NL=&BPO+&+U/ -I3RX8M]E\+]UKR2>SH#+7P(X;3L'S>\1>'7+,+^)N_)#
MIFSL[5RW"]">EQN?Z'.W?K9N6<BS=]-1BWZ^VY"5N5:>D_T?6K2O$G?_ ),\
M/>.;^)TOCX5NIK/5\.<-XITZQ,?"F.J=?)TL7QO+ZC@^ZR]L;?)IZ>[,1\U:
M3./"N(  "-]]SAS2>F\*NH>%8]_Z5_FOD;HLW*A2=/7)TW$^O^?Y&38K:K;K
M64([C;:^Y65)1K&MNE/2ON_"U?LC</C/S_ON(6C6NWX5>(\ULF;#$3]C6\>[
MYF_>'F'O\7RYIZJ;>??M:O[D2T#_ &_G'Y;GY0^D]C2S.[3B7$^Y>02G&];M
M1QHY/5/+.*_6N0G*,LF$I<FI;]D*2E25RD_3VQE6EE?:9W4;?P?XABUT]?FV
MM.KKTW./)IYOYO76?)IURW?GC)W.7,U?IK8X_AUM^XL.7+]!0    #JG.^'Z
MGL+@_,N [Z%9Z/G'%.1</W,(TC*4]3R;49FEV,(QG2L)5EAYLZ4I7\*_W7MX
M;OLW"^(X.);;HW&WS4RT^NQVB]?FQ#ZX<ML&:F>GQZ6BT>F)UA4[\XX?NNO>
M:\PX#R3'_*<BX/RGD'#]_B_I?\&W7&=MEZ7:X_Z<8R_F<["N1_&E*_A_([1\
M.WVWXIP_!Q+:3WMKN,-,M)\M,E8O6?=B869PY:9\-,^/IQWK%H]$QK'S'5WL
M?0                            !87_ MY76O)'P.X=P[<[/\YV)XVY,.
MF^3V;UZ5S,O<6UV/^;ZNW/T[ER]=A@7>&RMZJ$Y2];F5ILFM*1C[:4YA>TCR
M7;E3Q'S[_!3N\+XM'RK',1T1DM.FXIV=,9=<DQV5RTZYU07SKPR>'\:OEI&F
M#<?=(],_'CT][I]%H;K$ -1     1_OF0^'/&\V,*?D!X_6=1H/)WCFH_*;K
M29=RSK=/WEH];8LVM5J-EL\C(L:_1\XTF+8K9UFRO4C8RK,HX>;<A9MXV1B6
M8\"/'6_A_D_NSS--\O*&6^M+QK:VTO:9[UJUB)M?#>9UR4CIK.M\<3:;UON_
M*G-<\(GY#OM;<.M/1/7..9ZYB.N:SVQV=<=.L3!6[ Z\YWU3R_>< [,X?R/@
M?-N-9D\#?<5Y9J,[1[S5Y4:4E2&7KMA9L9$(7;<J3MS]*V[MN49PK*$J5KT6
MX9Q3AO&=CCXGPG/BW/#\M=:9,=HO2T>:U9F.CJF.N)Z)TE,V#/AW.*,^WO6^
M&T:Q:LZQ/NPZ<]SZ@ ,B/'_Q+\E/*??1X[X^]+<\[1S:7XXV9G\?T\[?&-/=
MG2DH?TCYGM)Z_B'&;<Z5IZ7-AG8T*UK2E*^M:-7YFYUY3Y-VWRKF?B&VV>/3
M6(O;[I:/J,5>]ER>BE+2\&^XIP_AM/6;[-3''DF>F?16-;3[D2DW>&'VS]G'
MO:CFOG'V-9SH0_+9LNDNHMADV\>Y7]&]77<S[,OX^-E5A2/\UE8NCQ[=?=ZU
ML;3TI25:C\^^UI:U;\/\/-K-9Z8^5[FL:^3O8L$3,>>MLUI^JPH\XMXA3,3A
MX-CT_P"LO'S:T^=-I]-4I?J'I?J?H+@^KZVZ7Z]XKUIP;3TE^1XYQ'48VIP?
MKW*1_,9^;6S#\QM-MFRC[\C,RIWLK)N>L[MR<JUJIUQSC_&N9>(WXMQ_=9MW
MQ')UY,MIM.G96->BM8ZJUK$5K'1$1"-]UN]UOLT[C=Y+9,T]MIUGT>:/)$=$
M=CTYB'G       0G_NANP:[3R3\;.K8WO?:X5TEN^<UM1NSG&SD]D\XV&CNT
ME:]GTK5Z>/U?9E7TE6<H5C6L:4]E9= /8_X9ZGE/BW&)C2=QQ"F'JZXP8:W]
MV-=Q/FUU\^DN^'.#N\/W&Y^GS17["L3_ !T81;Q(H   #>Q\?'P1>27ES71]
MB]R6]GXZ]"9DL?-M[;D6JNV^SN<ZR<;61;GP;A>QM69X&LV.-.GTMQM:6<6L
M+D+V-8SX>Z-*Y^)WM&\J<D>LX7P&:<4YDKK'=I;_ %?#;J^[9:Z]ZU9Z\6/6
MVL36]L<Z2TSCG.G#^%][!M-,^]CLB?@5GZJT=<Q]+7I[)FJ:MXF^$_C?X4<$
MAP3Q^Z[UW&+>39QJ<EY=G4M[;G_-\S'MPC^L.7\MR+4=ALYRNQE<MXMOZ&NQ
M)W)TQ<:Q"58J!<Z^('-?B!Q&>)<S;J^:8F?5XH^#AQ1/T.+'$]VODFTZWM$1
MW[VF-41\3XOQ#B^;UV^R3:>RO56OFK7JCT]<]LRRM:8Q@      ".C\E'S[]
M2>.$>0=0>*$]!W=WE9IE:K:<WADQV'4?66PC2=J]6>=@W/;V'RC7W*>GY'"N
MPUV/>_\ IG*E<LW,*=I?"?V:N-\U3BXYSIZWA_+LZ6KBT[NYW%>N.B?YC';Z
M>\3>T?$I$6C)&^<O\D[KB'=W7$^]AV?7%>J]X]$_%B?+/3/9'3JA3=T]W]L^
M1/8F][7[KYYR#L;G_([WU-ER'D697(O0L1G<GC:O5XEN-K7Z31:ZEV4,37X5
MJQA8EO\ 0LVH0I2B_P!P#E[@O*W"\?!>7]MBVO#,4?!I2-(U[;6GXU[VTUM>
MTS>T]-IF4N[39[788*[;9TKCP5ZHCY\]LS/;,ZS/:\K9EZ0&T3XNODR[!^.S
MMV[L?H;+F?0_/<G"Q.V^L[69*%RY9M3A:L<XX;;R,BUKL/G>AQ_6D/J^RQLL
M7W8E^=OUL9.+#_C!X2<,\4N!QBUIM^9-M$SML\QVSTSBRZ1-IPWGKTUG';2]
M8GX5+ZYS'R]@X]M>[T4WM/B7_BV[>[/S)Z8[8FQ#Z5[LZN\B.L^+=O\ 3?,=
M3SGK_F.OM[#3;W4WO=&E91C^9UNSQ+E(9FGWFKOUK9S,'*MVLK$R(2MW81G&
MM'+SC_+_ !CE?BV;@?'L%]OQ/!;NWI:/>M6>JU+1TUO69K:)B:S,()W>SW.P
MW%MKNZ33/2=)B?GQY8GLF.B8ZGJC#/,                CO?<.^#^B[N\8
MKOE1Q738UOMWQOQL>_O-CC6*1S^4=+YVRK:Y#I,V=N,997]"]GLZ;O$G=E6.
M)BTV,84]V35:'V7_ !"W/+W-\<F[S),\#XK,Q2LST8]U%?@7CR>MK7U5HCIM
M;U4ST4;WR+QB^SXC^3<D_P"J[CJCLC)$=$_OHCNSY9[OD0171M,X
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M)_MEYH["^&7[-N7OT'L/Q7$L=P/\R[/\%Q?V=6(C=V4    ;I?M^O[4'I?\
MXH]R?LLY2@+VF?V0;_[_ +7\8QM1YX_5S+]?C^WA8;.8""P
M                               &.7F)^Z/Y3?PY=W_LSY.VKD7]=^#?
MI7:?C&-[^%?G3;??\?V\*K%V263     3>OM?_W1_(#^(V]^S/@;GQ[7WZ[<
M,_14?C&9#_B+^=,'X/\ Q[),*I2/0
M                     %8=\G?]H=YH?Q&]I_XTY[KOX1?LOX!^BMO_ &<+
M$\N_F+:?>*?.8*I%9D   !L8^(W^TG\//ZWM;_@O;(L\;OV3\=_ ;?;58'FC
M]7]W]ZGY\+,-R65[                           8Y>8G[H_E-_#EW?\
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M;7M:9UFUK3,S,S/3,S.LH;R9+Y;SDRS-LEIUF9G69GRS,N9?!^
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MKRQ\/'/3]%36;4LG[E[C>+CG#XW,:1N:_!R5\EO+'U-NN/=CKB6O!*#.@
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M?ZW>&_XFWE!?;"_63@_X#E_M81)XC_[;MOO5OMDI!3U'
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M[3&*\],S6^/JKCE&G/\ P6+XZ\:V\?#KI7)IVUZJV]R?@SYIKV0F0J)(H
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MQTW^#,4B&^:^;;\1M;A_#K37A\=%K1T3D_=BGDCZ+KGHZ$C15AH0
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MZHBM(K2L#\;X[O>.;GUVYG3#'Q*1\6L?NV\MNN?-&D1GHC=A0
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M0*N@
M
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MXH]$8+XH]R=$\<F;V-[P#%$SKDPZXY_>_%_@35I\3FVH
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MK$3IK:,^.8C6>B-9Z-9Z([7OX5:U.)[:]/CQGQS'I[\*K!V363
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MVH/2_P#Q1[D_99RE 7M,_L@W_P!_VOXQC:CSQ^KF7Z_']O"PV<P$%@
M                                      ,<O,3]T?RF_AR[O_9GR=M7
M(OZ[\&_2NT_&,;W\*_.FV^_X_MX56+LDLF     F]?:__NC^0'\1M[]F? W/
MCVOOUVX9^BH_&,R'_$7\Z8/P?^/9)A5*1Z
M                           K#OD[_M#O-#^(WM/_ !ISW7?PB_9?P#]%
M;?\ LX6)Y=_,6T^\4^<P52*S(   #8Q\1O\ :3^'G];VM_P7MD6>-W[)^._@
M-OMJL#S1^K^[^]3\^%F&Y+*]@                          ,<O,3]T?R
MF_AR[O\ V9\G;5R+^N_!OTKM/QC&]_"OSIMOO^/[>%5B[)+)@    ),'VO\
M^]QY ?PY7OVF<#5+]K[]2.&?I6/Q?,CWQ%_->#[_ /Q+)O;GNA\
M!'%^Y)\J9]5>*?#O&[CNQKC<I\DN45O<CACSG&_8ZLZWR=7O-S:G<L2C<Q);
M[F&5IL>/NK2&5AV<VU[9Q^IZ6I]E+DV.,\YY^:]U379\)PZ4UZIW&>+4K/3U
M]S%&6?+6TX[=$Z-^Y X;\IXG?B&2/N6WKT?7WUB/>KWI\TZ2@O.B:9     &
MX?X=?C2S_/SO.[NN=8F9A>-O4&9K-KVELK<[V)/F.TO3_,Z3JS29EF=K(MYF
M_MV97MED694E@:N$J^^UD9&'6<%^.OBSB\-.78V_#K5MS7OJVKMZ]$^JK'1?
M<7B>C2FNF.L_'R3'1-:WTU7FOF&O!-GW,,Q/$,L3%(^ECMO/H[([9\T2L/M#
MH='Q71Z?C/&=/K./<<X]K,'2Z'0Z7!QM9I]-I]9C6L+6ZO5ZW"M6<3 U^!B6
M86K-FU"-NW;C2,:4I2E'+W<[G<;S<7W>[O?+NLMYO>]YFUKVM.MK6M.LS:9F
M9F9G69Z903>]\EYR9)FV2TZS,],S,]<S/;,N6?%^0              &JGYB
MO"C"\T_#+G.GTNGIG]P]18NP[4Z<R<?'N7MKD[S0X%R]R#A>)''C^9RK?/N-
MV;V#;QO7Z4]G3"O3I6N/#TF7P*\0,G('/NWSY\G=X%OK5V^ZB9TK%+SI3+.O
M1'J<DQ>;=<8_65CXTMEY4XO/".+4O>=-KEF*9/)I,]%OWL].ODUCM5O3JNGT
M    !NH^ #MV?5OR5=7Z:]E_D]3W+Q#L+J;;7)W:6[,ZYO'[G-N/X]R,OPNS
MS.7\&UUBW&GI7ZEV/_=I6 O:7X''&/"?>;BM>]GV&?!N:]'3T7]5>?<Q9KS/
MFAJ/.^U^4\OY+Q&ML5ZWCW^[/\&TRL,W,!!8     #R'R#X?L.P^A.[^ :FD
MY;7G/4/97#]9&W#ZER6PY-PS=:7#I"WZQ^I.N3FQ](^M/6OX,YRQOL7"^9.'
M\3S_ ,SM]]@RV^MQY:7GYD/5L<M<&]PY[?%IEI:?1%HE5!RC*$I1E&L91K6,
MHRI6DHRI7TK&5*^E:5I6GXT=H(F)C6.I9A_    <AJ=3M-]M=9HM)KLW;[K=
M;#"U.HU.MQ;V;L=IM-CDV\/7Z[7X6-"YD9>;FY=Z%JU:MQE.Y<E2,:5K6E'S
MSY\.VPWW.XO6FWQUFUK6F(K6M8UM:TST1$1$S,ST1'2_-K5I6;WF(I$:S,]4
M1'7,K!+X</BIT/@KUCC=H]JZC6;7RL[)TUJYRC/G''V%OJCC>=2.38ZUXSG4
MC.$=C6'TY[_-QZ^S*S8TQ[4[N+C6KU[F5X[>,NY\1>+SP?@U[TY,VF2?5UZ:
M_*<D=$Y\D?2]<8:6Z:T^%,1>\UK!_-?,M^,[CY-MIF.&8YZ(ZN_/T\^;Z6)Z
MHZ>N9B-W*OC3P              'YWK-G)LW<?(M6[^/?MSLW[%Z$;MF]9NQ
MK"[:NVITE"Y;N0E6DHUI6E:5]*O[6UJ6BU9F+1.L3'7$^6")F)UCK5T'S.^
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M>?O<>+7\1O2'[3.,-6YZ_4GC'Z*W?XOD>#BOYKW/X/D^TE:GN-BM@
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MO_@G!5T]J3]D^;\.VWVTM,Y\_5^WWVGSY6 [F<A
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M^-/5ER1T? K$WB'G/F>=WDMPG86_U2LZ9+1]':/H8GZ6)Z_II\T1K)S5%1V
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M&E(QC2E*4I2CFE>]\EYR9)FV2TS,S,ZS,STS,S/3,S/7*$9F9G6>F9?N_+^
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MM7S>3H5QXWM8V7%]SMHC2M<UM/K9G6OS)AEXT=BP
M
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MD6[](B*Q2)A?G;@$\/W?Y2VU?]2S6Z8CJI>>F8]%NN//K'5HD-JOM%
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M(QC&E(QC2E*4]%7+6M>TWO,S>9UF9Z9F9ZYF>V9:),S,ZSUOV?E_
M         &J7YIO)34^-WQZ]YW[FQLXO+NY./Y?0_!,"L_;E['9=EX.7IN37
ML3VU^K8GHN 5VV?2_2E*6[V/;C249S@F?P"Y3S\U^)_#JQ29V.PRQO,T]E:X
M)BV.)\O?S>KIIVQ:9ZHELO*7#[<0X[AC37%BMZRT^2*=,>_;NQ[JM^=54^@
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M]]%M/-H@;G/'ZOF3<:=5NY/OXZZ_-U;>4'M6
M                   5;_R"?OZ^;G\7?DG^V7FCL+X9?LVY>_0>P_%<2QW
M_P R[/\ !<7]G5B(W=E    &Z7[?K^U!Z7_XH]R?LLY2@+VF?V0;_P"_[7\8
MQM1YX_5S+]?C^WA8;.8""P
M      &.7F)^Z/Y3?PY=W_LSY.VKD7]=^#?I7:?C&-[^%?G3;??\?V\*K%V2
M63     3>OM?_P!T?R _B-O?LSX&Y\>U]^NW#/T5'XQF0_XB_G3!^#_Q[),*
MI2/0                                                    %8=\
MG?\ :'>:'\1O:?\ C3GNN_A%^R_@'Z*V_P#9PL3R[^8MI]XI\Y@JD5F0   &
MQCXC?[2?P\_K>UO^"]LBSQN_9/QW\!M]M5@>:/U?W?WJ?GPLPW)97L
M                    !CEYB?NC^4W\.7=_[,^3MJY%_7?@WZ5VGXQC>_A7
MYTVWW_']O"JQ=DEDP    $F#[7_][CR _ARO?M,X&J7[7WZD<,_2L?B^9'OB
M+^:\'W_^)9-[<]T/@         *[GYX_(:]WQ\BO:6GP\VN3Q7H77Z?HWCMN
M%Z5;,,WBT<C:<ZN3Q_2-JUFP["WVTQ)SI[IW+.'9I*7I&,8=1/9PY7KRWX6[
M//DKIO.)6MN[]'3IDTKAZ?)ZBF.T1U1-K:=<S,[<E[&-EP''>8^Z9YG)/N]%
M?X,1/NRTU)X;8    [IUOU[RWMKL#A75_ ]5>WG-.PN4Z+AO%M18_">?O>1;
M+'U6LQY3]*QLV9965'ZER7I"U;I*<JTC&M7@XKQ/9<$X9N.,<2O&/A^UPWRY
M+3]#2E9M:?/.D=$=<ST1TOCN,^+:X+[G//=PXZS:9\D1&LK/?PC\3>$>%'C7
MUQX_<)AC9->,:N&=S/DEK&CCY'-^P]M:LY',.7YGZ$;\OUGLHUMXEN[*Y<Q-
M;8QL7WRC8C5R&\0>=>(>('-F[YFXAK'KKZ8L<SK&+!69C%BCL^#7IM,:1:\W
MOI$VE7;C'$\W%^(9-]F^BGX,?2UCXM?<CK\LZSVLL&EL8
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MZHNU_P#!."KI[4G[)\WX=MOMI:9SY^K]OOM/GRL!W,Y"
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M>N9TM@P3Z(TSWB>B9G#,3T3"+>?^-3,UX)MYZ(TME^?2G\:?WJ7"I*B\
M            !&-^YM\>,?EOCITYY)ZS#I7?=/<_O<$Y'D6K5(SN\&[.Q*3Q
M\C.O1A6=VUI>8\<PK.-"5:1A+;WJT_&5?6W/LC\T6V7-._Y3S6_U;?;:,U(G
M^FV\],1'U>*]YMY?5U\B1/#S?SBW^7A]I^!EIWH^NI_EK,Z_6PA+.@:7@
M %@G]O!SJ?+_ (TN$:&=VMS_ "8=H]L<%A2585K:AF\BCV/&UZQK67I3_*#Z
MTI/TE2E?P_1]KF5[4/#HV/BSN-S$:?+-GMLWO4]1_P"1[/GZH.Y[P^JYAO?^
MDQTM\SN?Q6\A7AIP
M
M                   #'+S$Y!_1+Q'\IN5?6_+?T9\<N[^0?F/H_F?R_P"I
MNL^3['ZWY?V7/K_2_+>[V>VON]/3TKZMJY%VORWG?@VSTU]=Q7:4TUTU[VXQ
MUTU[-=>M[^%4];Q3;8NOO;C''OWB%5B[)+)@ ),OVOO'HY/EEY!\LK;MUGI?
M':O'HWJWKT;T(\G[*X3LIVX8\:_0NV[M>(QK.<J>^%81I'\)S5*]K[=33DKA
MFRUG3)Q3OZ:1I]SP9:]?7T>MZNJ=9UZH1[XBY-.&8,7ESZ^]2T?QDW9SX0^
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MZ[-\H;>-GRGPO:1U8N';:G5I\7#2O5V=74LMPZGJ^'X,<?0X:1[U8ALN^/\
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MMM.CUEYODF.B;:="(>+<<XCQG+W][>9QQ/P:1T4KZ(\OGG6?.S91^Q
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MJ=WC_>^FPTG[:/W&^Y6UI0
M    "K?^03]_7S<_B[\D_P!LO-'87PR_9MR]^@]A^*XECN!_F79_@N+^SJQ$
M;NR@   #=+]OU_:@]+_\4>Y/V6<I0%[3/[(-_P#?]K^,8VH\\?JYE^OQ_;PL
M-G,!!8                                            #'+S$_='\I
MOX<N[_V9\G;5R+^N_!OTKM/QC&]_"OSIMOO^/[>%5B[)+)@    )O7VO_P"Z
M/Y ?Q&WOV9\#<^/:^_7;AGZ*C\8S(?\ $7\Z8/P?^/9)A5*1Z
M                                          K#OD[_ +0[S0_B-[3_
M ,:<]UW\(OV7\ _16W_LX6)Y=_,6T^\4^<P52*S(   #8Q\1O]I/X>?UO:W_
M  7MD6>-W[)^._@-OMJL#S1^K^[^]3\^%F&Y+*]@
M      ,<O,3]T?RF_AR[O_9GR=M7(OZ[\&_2NT_&,;W\*_.FV^_X_MX56+LD
MLF     DP?:__O<>0'\.5[]IG U2_:^_4CAGZ5C\7S(]\1?S7@^__P 2R;VY
M[H?         =4YWS#4]>\'YES[?3K#1\'XIR+F&YG&L8RAJ>,ZC,W6QG&4Z
MTA&L</"G6E:_A3^Z]O#=CFXIQ'!PW;=.XW&:F*GUV2T4K\V8?7#BMGS4P4^/
M>T5CTS.D*G?G',-UV%S7F'/N29'YOD7..4\@YAO\K]+_ (3NN3;;+W6UR/TY
M2E_/9V;<E^-:U_'^5VCX=L=OPOA^#ANTCN[7;X:8J1Y*8ZQ2L>Y$0LSAQ4P8
M:8,?1CI6*QZ(C2/F.KO8^@   "3%]M3XGV.Q_(7L3RHY/K:9''^@M';XQP2>
M1;M3L7^S^P,/-Q<O88_U(7??<XMP>UEQG3TA*%W<8UR,O6%:*E>UCSI;A7+&
MUY-V=]-UQ+)ZS-IUQM\,Q,5G[YF[NG7K&*\3'2CWQ!XG.WV./AN.?AY[:V^L
MKV>[;3[&4WESX0^                  A'_ '/W7%G2>4?C[VE8LTM4[ Z1
MS^)Y=84A2F3L>N.:;3-GE7*4K[ZWZZWL#%LUK6E*?3LPI3^2KH+[(7%;;CD_
MB?![3K\FXA&2/-7/BK&GH[V&T^F92_X=;B;\.S[:?H,T6]R]8_=K*,HMND,
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MVQ.2U9BU-8TCG?C4\.X?\BP3IN]Q$QT==:?13YIGXL?OICIA/C<V$*
M           /!?)WQVZ_\K^B.R>@.S<.F1Q7L7CN5J9YMNQ8O[#CFYA[<OCO
M+=+3(I6U;WG%MY8L9V+67Z%;MBD9TE;E.-=DY0YIXGR7S'M.9>$6TWFURQ;3
M68K>O5?'?3Z#)29I;MTG6-)B)>WAV_S\,WN/?;>?NN.VOFF.VL^:8UB57]Y
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MPK*%RW<A*E8RI6M*TKZT<>[5M2TUM$Q:)TF)ZXGR2KC,3$Z3UOT?P
M 56'F'^]QY2_Q&]W_M,Y.[)\B_J3P?\ 16T_%\:R?"OS7MOP?']I#'-M+W@
M  -ZGVZO]I1QC^J+M?\ P3@JZ>U)^R?-^';;[:6F<^?J_;[[3Y\K =S.0@
M                                      \N[HZ7ZR\A>LN6]/=P\2UG
M-NO>;:RYJ]_H-I;E6%R%91NXN?@95J5O+U6YU67;ADX6;C3M9.'DVH7;4X3A
M&5,QP#C_ !?ECB^#CO L]]OQ3;W[U+U]Z8F)Z+5M&M;TM$UM69K:)B7IVF[W
M&QW%=UM;33/2=8F/G3Y8GJF)Z)CHE";\[?MZ/)/H[=;KF7BECY_D;U#<O9F?
MB\:PZX6/W+P_!I*Y>MZW/X]*[C6.?PQK7MM6LK34KG94_6LM=9I3W2Z ^'/M
M/\I\P[?'L.<YKPKCD1$3DG6=KEGJ[T7Z9PZSK,UR_ K'^=MU1+W!>>N'[RD8
MN)Z;?==6O^;MYXGZ'T6Z(^FEH#YEP3F_76\R>,=@\-Y5P3DN%6L<SCW,N/;?
MC&\Q)1G*W*.3J=WAX.?8K&<*QK2=NGI6E:?W%E]AQ'A_%-O&\X9GP[G:6ZKX
MKUR4GT6I,UGW);OBS8=Q3UF"];XY[:S$Q[\=#\.*<.Y=SO=XG&>#\6Y'S+D>
MPG&W@<?XII-GR+=YMR=VW9A;Q-5J,7,S\F<[UZ$*4A;E6LI4I_+6C];W?;'A
MNWMN^(YL6#:5Z[Y+UI2.WIM:8B.B)GIDRY<6&DY,UJTQQUS:8B/?GH2 _ ;[
M?#R,[TWV@YQY9:_:^/'2]N]:SLWBN=*Q8[LYEBPG"7ZKP>.7;67#K[&RJ1G"
M]E[F,,^QZ4K;U]V,Z785F\2O:<Y6Y=VV7AW)5J<4X_,3$9(UG:8I^FF\3'KI
MCHF*XM:3VY:Z:3I'&^>=ALZ6P\,F,^[ZN]'\W7SZ_1>BO1/TT=2;MU7U;U_T
MEUWQ'J?JOBVLX7U]P338^AXMQK46YPP];K\>L[DO6Y=G=R<S-S,F[<R,K*OS
MNY.7E7;E^]<G=N3G+GSQGC'$^8.*9^-<9S7W'$]SDF^3);KM:?1I$1$1%:UB
M(K6L16L16(A#^YW.?>9[[G<VF^>\ZS,]L_\ 3HB.J(Z(Z'?V,?
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M%\EHG32<>*W3JC+Q#XI-:8N$8IZ;?=+^B.BD>[.LS'FK*8@HNBH
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M7E2T?
M
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MMQ,?%K-:Q^]K$3\W5MA0LUD   !HX\)_@J\8O&SDN3VWW'9P_(SNK,WN=R'
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MP[9VT^'O+>IG^JB+YX_?8HCIZ^O3:-CR9Q[?1%IQ1AQSVY)[O\'2;^_6'CO
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MRVVJTN/3,W&SU^IQ*W(V:96RS<; QZWITE*%JE_*N6K5;DXPK6D?7UK2E?\
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MN';G6=;\'I7S? W.XG^/T^XAWQ%KIQ?#?R[:(]Z]_P#*DG*H(_
M                                 5;_ ,@G[^OFY_%WY)_MEYH["^&7
M[-N7OT'L/Q7$L=P/\R[/\%Q?V=6(C=V4    ;I?M^O[4'I?_ (H]R?LLY2@+
MVF?V0;_[_M?QC&U'GC]7,OU^/[>%ALY@(+
M                   8Y>8G[H_E-_#EW?\ LSY.VKD7]=^#?I7:?C&-[^%?
MG3;??\?V\*K%V263     3>OM?\ ]T?R _B-O?LSX&Y\>U]^NW#/T5'XQF0_
MXB_G3!^#_P >R3"J4CT
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M>=*@    "VLZ^_\ ,+A'_%#C7^!L)Q1XG^<MQ]_R?;RK%G_GK_73\]V]X7R
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M%\I?ZW>&_P")MY07VPOUDX/^ Y?[6$2>(_\ MNV^]6^V2D%/4<
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MZ?)97CF#BEN+\5R[O77#KW:>:E>BOO\ QI\\RSO1PPH
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MWJ^32_PHB/-&NGN-B*+F"        56'F'^]QY2_Q&]W_M,Y.[)\B_J3P?\
M16T_%\:R?"OS7MOP?']I#'-M+W@   -ZGVZO]I1QC^J+M?\ P3@JZ>U)^R?-
M^';;[:6F<^?J_;[[3Y\K =S.0@
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M;"_63@_X#E_M81)XC_[;MOO5OMDI!3U'
M
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MFU-I&;W-ODQ[B9]R,4S/FCIZ&O\ ->"=QR]NL<=<8^]]A:+_ ,597N3BOH
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M[$WB/68W>UOV3CM'O6C_ "I42FZ-@
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M "/ZM_YB'^ /A!_P3!_6[C_3']T>7/\ =:_97_E'_;4_*#_K;<O_ .1_5O\
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M7_E'_;4_*#_K;<O_ .1_5O\ S$/\ ?"#_@F#^MW'^F/[H\N?[K7[*_\ */\
MMJ?E!_UMN7_\C^K?^8A_@#X0?\$P?UNX_P!,?W1Y<_W6OV5_Y1_VU/R@_P"M
MMR__ )']6_\ ,0_P!\(/^"8/ZW<?Z8_NCRY_NM?LK_RC_MJ?E!_UMN7_ /(_
MJW_F(?X ^$'_  3!_6[C_3']T>7/]UK]E?\ E'_;4_*#_K;<O_Y']6_\Q#_
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M )B'^ /A!_P3!_6[C_3']T>7/]UK]E?^4?\ ;4_*#_K;<O\ ^1_5O_,0_P
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M?*7^MWAO^)MY07VPOUDX/^ Y?[6$2>(_^V[;[U;[9*04]1P
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MOP[;?;2TSGS]7[??:?/E8#N9R$
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MWM\_3YB3&J4CT
M
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M4K2494KZ5C*E?2M*TK3\:.ED3$QK'4FU_
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MZ=./%>U=)\LS$1';KIITO%Q+<?).'Y]UU3CPWM[L5F8^:M9G&56H
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M/]LO-'87PR_9MR]^@]A^*XECN!_F79_@N+^SJQ$;NR@   #=+]OU_:@]+_\
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ML'_JMO\ 3G^&^?\ WNG]7/\ */\ :FN!?ZFO+O\ /3IO]'!_R=<2_P"/8/\
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M[:N1?UWX-^E=I^,8WOX5^=-M]_Q_;PJL79)9,
M        !(>^ #Y#>0= >0>E\3NP-[<R.C?(/?VM/Q:QLLFY+'Z_[FV48XW&
M<[3^^4XX^O[$S(6M-FXT8>ES/O8.1[K=+5_ZU7O:7\+]MS-RQDYUX9CB.8N&
M8N]DFL=.;:UZ<D6\ML$:Y:6UZ*1DKI/>KW=$YWX%3?;&>)X*_P"N8*ZSI]%C
MCKU\]?C1/DUCMC2=ZYR(8                          5AWR=_P!H=YH?
MQ&]I_P"-.>Z[^$7[+^ ?HK;_ -G"Q/+OYBVGWBGSF"J169
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M*7%-U7IMCX=N;1TZ=-<-YZ^SJZWBXE><?#L^2.NN&\^]696M#C*K4
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MC']47:_^"<%73VI/V3YOP[;?;2TSGS]7[??:?/E8#N9R$
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M[^X]V-<$=?1KIVZ-+Y]SSBX!../\[FI7WM;_ ,1/V<TT(@
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MR:(3Y^R^LX]W/I,%*_-M;^,WZ*UM)
M
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MX\WEC^C_ /!/5.-YKQ>NY>W5/)CBWV-HM^XLK')Q7X        !"$^?;XO\
M_(9S?.\SNCN/?2Z>[+WM:]O\;U.+Z8G6W9&ZR?6/)<?'L1]F'Q#L#/O2K+\*
M6L+<RE;I6,,S&M0Z$>S5XO\ ]XN'UY"YARZ\=VF/_5LEIZ<^"D?S<S/7EPUC
MH[;XNGIFEYF8.2>8_EF&.$[RW^M8Z_ F?HZ1V?75CWZ^B49];1(0
M                                 #<7\$_2').V/D<Z*Y)C\6W6VX-U
M-G\GY_S3D6+J=IDZ/C>3J.#<HGPK];;;%QIZ_6Y.PYM+7PQX9-ZU]:M)4A[Y
M4]DH*]HSF':<%\*^([2V;'3B.]KCPXJ3:L7R1;-C];W:S/>M%<7?FTUB=.C7
M3K:ISGO,>UX!FQS:(S98BM8UC6=;1WM(ZYTKKKHL4'+A!          #1GY]
M_.YXO>(U=YU_U5?P_(WO7!^OA7>/<1VUG_)UP[9VYRL7+?..?8E,O$NY^!?C
M*EW5ZJ.9F1NVI6<F>%*M)K$>&OLY<X<[^KXGQF+<*Y<MI,7RUGU^6O7]QPSI
M.DQU9,G=KI,6I&2.AN7!.3.(\4[N?<Z[?93VVCX5H^IKY)\MM([8U0M/+[SR
M\G?./E].4]_]B9FZUV%F7LKB_7NDC=T?6O"HW?JPC:XSQ*SD7L>WDV\>]6S7
M/S+F9M;]KTC?RKOI1?KD?PWY0\/-C\CY9VM<>6U8C)FO\//EZOYS),1.FL:]
MRL5QQ/36E4M\*X+P[@V+U>QQQ%ICIM/3>WIM^Y&D>2(8=MZ94   !WOK#K'G
MG<_87$.JNL.-;#F'/^>;S#X[Q7C>KC;KE[/:9T_;;M_5OW+.+AXMBW&5W(R;
M]RWCXN/;G>O3A:A.=,=QCB_#> <+S\9XOFK@X9ML<WR9+=5:QZ-9F9ZJUB)M
M:TQ6L3,Q#X[G<8=I@ON=S:*8*1K,SV1_TZHZYGHA8C_%G\7W7'QY]56<G,LZ
MSEOD?SK38->V>RXVOKPPI3I8S+O7O [V19M9&!P;2YT*>Z[[+61N<FU'+R8P
MC'%Q<3EUXQ>+_%?$_C,UI-\'*NVR3\FP:Z:]<>OS1$Z6S7CLZ:XJS-*3.M[W
M@CF3F/<<=W.D:UV%)GN4_C6\MICW*QT1VS.UE#+6@     '@GDCY-])^)75V
MZ[?[WYOK>%</U$)6\?Z\OS.[Y'MI6YW,/CG$]'9K78<@Y!L*PK2UCV(U]L:2
MNW96[-NY=ALG*G*/,'.W&,? ^7-O?<;Z_7IT4I7MODO/P:4KVVGS1$3:8B?;
MP_AV\XIN8VNRI-\L^]$>6T]41'EGT1TH('R4_-!WUYU9^XZ]X3=VW2OC-3(N
MX^+USJME2')>?X=J4X6=EVOOM?*/ZSIEPK]3]1XL_P!3XM:PC<_/7K,,R71W
MPG\!.6_#K'CXIQ"*<0YMTUG/:OW/#/;7;4M\73J]=:/6VZ9CU=;3C31R_P I
M;+@U8SYM,W$?IICHKYJ1/5]=/PI\T3HTO)[;:
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M-G?R3ECW_5_Y$P)1M%@
M "K?^03]_7S<_B[\D_VR\T=A?#+]FW+WZ#V'XKB6.X'^9=G^"XO[.K$1N[*
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MEW67#KY?59+4U]WNZJS[K#\FW63;ZZ^KR6K]C,Q^X]'8IYP
M           %8=\G?]H=YH?Q&]I_XTY[KOX1?LOX!^BMO_9PL3R[^8MI]XI\
MY@JD5F0                                       $F#[7_ />X\@/X
M<KW[3.!JE^U]^I'#/TK'XOF1[XB_FO!]_P#XEDWMSW0^         C/?= ?N
MC^/_ /$;9_9GSQ;7V0?UVXG^BI_&,*0O#K\Z9_P?^/5"%=!TP    ,C/#S][
MCQ:_B-Z0_:9QAJW/7ZD\8_16[_%\CP<5_->Y_!\GVDK4]QL5L
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M*89C[&]IGS1+7>;-Q\FY>W-^VU(I]G,5^=,K*!R@5_
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MY_%WY)_MEYH["^&7[-N7OT'L/Q7$L=P/\R[/\%Q?V=6(C=V4    32_M<?\
MT"^4O];O#?\ $V\H+[87ZR<'_ <O]K")/$?_ &W;?>K?;)2"GJ.
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MM*.,?U1=K_X)P5=/:D_9/F_#MM]M+3.?/U?M]]I\^5@.YG(0
M                                                     1[ON-NT
MNM=?X+YW5.;S[A^/V?R#LOK?=Z7KNYR+4TYMLM)J\_/O;+=XO%Z95=U/38,*
MT^KE_1ICPE.,:S]THTK9WV5^#\6R^(M>-8]MGGA&+:9Z7S]RWJJWM6(K2<FG
M<[T]E=>].DSII$MYY"VVXMQF-S%+_)JX[Q-M)[L3,1I&O5KYNM U='TT@
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MTZZ?)J4V\Q'D^%CGH\NNO3K*OO-6X^4\P;J_9&3N?81%/GU;*T3-?
M
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MC?+/$>#1&L[O8;C#_6XKT_C/YO\ !\JV.;;1_G,5Z_95F/W5KRXP*T
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M/G+?'<7'=C&7HC>4TC)7R3]-'U-NN/).L=.FK6>EIL(
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M5K&LZSIPG@^RX-M8VVSKI]-:?C6GRVGYT=4=D,1&[LH
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MI@1GXD?S.T^NR?.HF.*)HI
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M?)3'6*5CW(B%EL&#'ML%-OAC3%CK%8CR1$:1\QTY[GU
M   ?[MW+EJY"[:G.U=M3C<MW+<I0N6[D)4E"<)QK24)PE2E:5I7UI5_)B+1W
M;=,2=?1/4LT/BR\H=GY>^#'1G<')L[]8<]_467P;L?*G6GYG,YOP#89/%]KN
M<ZD9W(1S.58VOQ]Q.D?2-/UA3TC"GZ$>27C'R?AY'\1.(\"VE>[PWUD9L$=D
M8LU8R5K'FQS:V*/K.N>M7GF3AU>%\9S;7'&F#O=ZGUMHUB/WNLU]QL(1BP8
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MZ*V_]G"Q/+OYBVGWBGSF"J169
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M9X>?O<>+7\1O2'[3.,-6YZ_4GC'Z*W?XOD>#BOYKW/X/D^TE:GN-BM@
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MF-U6OE^)BQT^;W=?-U*_<UV[_,.ZG_K(CWJQ'[C9BB5KP
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M?/U?M]]I\^5@.YG(0
M                   ?XN7+=FW.[=G"U:M0E<NW;DHPMV[<(UE.<YRK2,(0
MC2M:UK7TI1_8B;3%:QK:3KZ(ZVHGRV^;KP/\4I;304[$KWGV3KZ7K-> ](SU
M_+8XFQMUK:IB<AYO7-QN"Z*N-E>L,NS3/R=EB^V?KASG2D)3?R3[/GB/SG%-
MS\E_)W";:3Z[=][%K7KUIBTG-?6.FL]RN.W1]TB.F-IX7R?QKB>E_5^IV\_1
M9-:]'FK\:?-T1$^5&"\M_N$?-;R!KLN.]/Y6N\6^O<J=^U;Q^O,FYM>S<S!G
M.5;5O9]H[+$Q\[79-NE(5I>T.'I+U*TK2MR<:UI6WG)/LQ<@<L]S=<=B_&.)
MUTG7/'=V\3]3MZS,6CS9K98\T2D7A?(W"-CIDW<3N<\?3=%/<I'7^^FS1=N]
MYN^3;;8;_D>XVG(-[MLF>9M-UN]AE[7;;+,N^GU,K8;'/O7\S,R;GI^E.Y.4
MJ_W:K%;?;[?:8*[;:8Z8MM2-*TI6*UK'DK6(B(CS1#<J4ICK%,<16D=41&D1
MZ(AQ;[/T     MVW$-5T        !6?_ "ZW+EWY*?,*5V<[DJ=MYUNDIRE.
M5+=G3Z>U:A2LJUK2%JU",8T_DC&E*4_"CK1X(1$>$_ HB-(^11\VUIGYJP?*
M_1R_M=/Z+]V6N1*C/@   )=GVK$8UEYVSK&GOC3QAC&7I3W4C*OD+64:2_EI
M2584]:?W?2G^XI%[9,SIRY'9_P#4/_<D7>)/_<O_ !W_ ))+O4@1<
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M1M\BLO7*V^ZS+N;DQQ[592AAZ_%K<I9Q<:WZ6L;&MPM6Z1MPC&G7'@W".'\
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M$=U.NYW&:^2\^6U[3:T^_,JSYLML^6V:_P >]IM/IF=9=F>1\P
M
M                                                     &EG[@7^
MR^[H_P"-_3?[4N+)]]F;]K^P^\;K\7R-MY'_ %CP_6Y/M+*\IT_3J  G4_;%
M_N%=M_Q=\]_8UT$YU>UU^TG8_H/#^-;Q#7B)^>L7X+7^TR)&2K#0@  %4#Y
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M/I:5^+2ODI2*UCLB$:[O>[O?YIS[S)?)EGMM.ON1'5$>:-(>O,&\H
M#R;NKO?IWQSX'L^S>\>Q>+]9\'U-/3)WO)]A'$AD9%8RG:UNHP;<;VTWVYRJ
M0K2Q@X-C(S+]:>ENU*OX,WP#ESCO-/$J<(Y>VN;=\1OU4QUUTCZ:T]%:5CMO
M>:UCMF'JVFRW>_S1M]GCMDS3V1'S9[(CSSI$(CWGO]Q_S?FD=UUMX+:+,ZYX
MU<_,:_,[VYIKL+(Y_MK'U)V+M[@G$,FF?I^&X>59A6MK.V/YS9RM7J2ACZ[)
MMTDNUX;>RKP_8>KXMXBY*[K=QI:-GBM,8:SUZ9LL:6RS$]=*=W'K&DVRTG1)
M_!.0<.+3<<9M&3)U^KK/P8^NMUV]$:1Y[0B_\LY=ROGO)-SS'G')=_S'EW(L
MVYLM_P HY3M]AO\ D&[V%ZD:7<W:[C:9&5L-AE3I&E*W+MR<O2E*>OI2BWNR
MV.RX;M,>PX=AQ8-CBKW:8\=:TI2L=E:UB*UCS1$)%Q8L6#'&+#6M,58TB(B(
MB(\T1T0Z\]3Z      ):/V^7Q>VMUD:CSY[XX]2YK=9FWJ^-'$MOC^Z.;MM?
MD3QLSN;/P[M/;]#49MFYB\<I=I6LLNW>V$81^CK\BY2KVF_%^=O6_AKRYETR
MWK'R_)6>JMHUC:Q/EM$Q;/I]#-<6L][+6(QYYYCFD3P396^%,?=;1Y)_S<>G
MKMYM*]MH3"E&$5@     ,"OD*^0+J3X]NE;_ &5S_P!>0\SY#7.U'5'6.!DQ
MQ]SS_E&/CPNRM2R*VK]--Q?34OVKNUV5RW.&+9G&%N%[)O8^/>DGPP\,^-^)
MW,$<)X9]RV&+2VYW%HUKAQS.G5T=[);28QXXF)M,3,S6E;6KFN!<#W7'=Y\G
MP?!PUZ;WGJK'[LSV1V^:(F8KG?*'RA[C\P>X^3=W]W\FN<AY=R&Y2QB8EBEW
M'X]Q+CV/=O3U/$.(:F=Z_#3<:TT+\J6;-)3N7;D[E^_<O9-Z]>N=3.3^3^!<
MC<"P\O<O88Q;'%&LS/3?)>=.]ERVTCO9+:=,]$1$16L5I6M8GKAW#MIPK:5V
M>SKW<5??M/;:T]LS_P""-(B(8]MG>X
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M,6K:LZ3%JS$Q,3TQ,:2@F]+X[SCR1,7K,Q,3T3$QT3$QY8<F^+\@
M*VWYI>M(=6_)GY3ZG&L4M8')^7:3LO"N1]E(Y4^S.'<=YMN;](PE64*QY+NL
MZU+WTC*4[=9>E8UI6O5OP"XM/&/"3@V>\ZY<."^"?-\GRWQ4C^KI2>CLG3K3
M]RCN/E/+VVM/QJUFGV%IK'S(AJV3"V19X_&)_9X^&'\.75O^*^ Y$^+O[4./
M_I7<?VDJ[<Q?GW=_A%_MI9U(Y88 !@K\G?\ 9X^9_P##EVE_BOGI&\(OVH<
M_2NW_M(9GEW\^[3\(I]M"L.==EB0 $K_ .UE_P#/WS*_XH=+_P"&>QE+_;%_
M-O ?O^Z^TP(S\2/YG:?79/G43'%$T4@
M             *M_Y!/W]?-S^+OR3_;+S1V%\,OV;<O?H/8?BN)8[@?YEV?X
M+B_LZL1&[LH    W2_;]?VH/2_\ Q1[D_99RE 7M,_L@W_W_ &OXQC:CSQ^K
MF7Z_']O"PV<P$%@         ,._D-P]EG^!/FIB:B].QG7?%7O[V?3Q:9MW)
ML0ZMY1<S==:QZQG65[:8,+F-"4:5G"5VDH_I4HWKPOR8L7B3P"^>-<<<9V?;
MII/RC'I:9\E9TM/9.FD]#*\"FM>-[2;?%^4XOMXZ?<ZU70[!+&@
M            )R/VQ&\S\SPM[JT.1<^K@Z3R8WF9KO?.].Y8_7/6/67YO%A[
M[LK-K#I>UM+L(0A#^=O792K*L_PYX^UWM\5.?N'[FL:9,G"*1;JZ>YN-QI/5
MKKI;29F9Z(B.Q#GB)2L<7PWCKG;QK[E[_P"7YR24JBT         !CEYB?NC
M^4W\.7=_[,^3MJY%_7?@WZ5VGXQC>_A7YTVWW_']O"JQ=DEDP
M                    &P[XN_#7=^;GF#UGUC357,SKGC>VU_8/=&QG:]V!
MK^LN,;3!R-UK<B]*$[4,WF%^5K38<:QN5I?SJ7*PE:M7:QB_Q@Y\V_A]R-N^
M+]^*\5RTMAVM>VVXR5F*6B/)BC7+;JZ*::ZVA@N8^+4X/PK)N-=-Q:)KCCMF
M\Q.D_O?C3Z/+,+,UR35Z                          5AWR=_VAWFA_$;
MVG_C3GNN_A%^R_@'Z*V_]G"Q/+OYBVGWBGSF"J169
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M;]SI^X5U)_%WP+]C7?JT_LB_M)WWZ#S?C6S;[X=_GK+^"V_M,:"LZ*IE
M9&>'G[W'BU_$;TA^TSC#5N>OU)XQ^BMW^+Y'@XK^:]S^#Y/M)6I[C8K8
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M58>8?[W'E+_$;W?^TSD[LGR+^I/!_P!%;3\7QK)\*_->V_!\?VD,<VTO>
M WJ?;J_VE'&/ZHNU_P#!."KI[4G[)\WX=MOMI:9SY^K]OOM/GRL!W,Y"
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MRPG*_P"K^T^]1\^6N=*;/    )=OVK'_ +=W_P ,'_S0ZD/MD_\ ZY_]P_\
M<D7>)/\ W+_QW_DDNY2%%P                 "HD=O%H@    %@-]NK_9L
M<9_K>[7_ ,*8#F=[4G[6,WX#MOM90ASY^L%OO5/G2WJJZ-,
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M&''K,4B>F9FUYB)MI$\\N\!P<"V?JJZ6W5])R6\L^2/J:]GEZ9GKT:VTK-@
M    ;T?M[_&N[WAY\Z'L;::V>5PSQLXSM.S]GD781E@3YEGVKO%^N]9=EZ5G
M#/AMMED;C&]/;3UTD_67X>V==?:<YLKR]X:Y.%8;]W?\6S5V]8CK]57[IGM]
M;W:QBM]]CTQIO//$(V?!+;>LZ9MQ:*1Y>['3:?1I$5GZY8%.9J#P
M
M                                                        &EG[
M@7^R^[H_XW]-_M2XLGWV9OVO[#[QNOQ?(VWD?]8\/UN3[2RO*=/TZ@ )R'VP
MNUE>\*^[])6S2,-?Y1\@VL<CWUK*[+<=3]2XDK-;?MI2%+%-%25)>M?=]2M/
M2GI^//'VO,,5Y_X?N->FW!Z5T^MW.YG7W>_\Q#GB+73B^&_EVT1[U[_Y4DM5
M%H   "J:\I-5'1>3?D7HX7JY,--WMV[JHY$H4M2R(Z[L#D.)&]*W24Z6ZW:6
M?=6/K7T]?3UJ[,\G9IW/*/"MQ,:3DX;MK:>3O8:3I\U97AMN_P .V]_+AI/O
MUAX2V-[4^/[<;NO_ "D> $NMLW+^KMN@^U>9<-LXUR?U,B'%N6W,?LC1YDJU
MK67Y:[M^5;7%LTK7]&.%6-*4C2+FQ[5/+_Y*\3/RMCKI@XELL669[/68]<%X
M],5QX[3]?KUZH3Y]V?R?CGRB(^#GQ5M[M?@3\RL3[K?PK4TD         !%Q
M^XZ\";'/.MM-YP]<:3W<UZNLX'$^[,?7XOK=W_6>7D5L<>YEE1LU]][/X%NL
MF.)?G].4YZO8>^Y<A9U\*+A>RMXDVX;Q7)X><5R?_3]Y,Y-I-IZ*;B(UOBC7
MJC-2.]$:Z1DII$3;+*1^0>-S@W$\'W$_<<FML>O9?MKZ+1T^F/+9"R7Z2V
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M6UX/LJ[/:QT1TVMVVMVVGT^3LC2(Z(8J-R9(
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M_P @G[^OFY_%WY)_MEYH["^&7[-N7OT'L/Q7$L=P/\R[/\%Q?V=6(C=V4
M ;I?M^O[4'I?_BCW)^RSE* O:9_9!O\ [_M?QC&U'GC]7,OU^/[>%ALY@(+
M         <!ROC.GYKQ?DG#>18M,[C_+=!N.,[W"EZ>W,T^^UV3JMGBR]T94
M],C"RIPKZTK3\?Y'IV6[S\/WF+?[6W=W6#+7)2?):EHM6?<F(E^\62^')7+C
MG2];1,>F)UA53^0_27+/&_O+M7HGG%BY9Y-U;S;><1SKURQ/&AM,?6Y<Z:G?
MX=J<I2_5G)-//'V&)+UK2>+DVY4K6E797E?F#9<U\N[+F/A\Q.TWFWIEB-=>
M[-H^%2?JL=N]2WDM6864V&\Q<0V>+>X?YO)2+>C7KCTQ.L3YX>-L\]8
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MR3$3>8C2*TK2E87XWQS=\<W7RC<Z5QUZ*4CJK'[LSVV[?-$1$9THZ88
M                    !6'?)W_:'>:'\1O:?^-.>Z[^$7[+^ ?HK;_V<+$\
MN_F+:?>*?.8*I%9D                                       !)@^U
M_P#WN/(#^'*]^TS@:I?M??J1PS]*Q^+YD>^(OYKP??\ ^)9-[<]T/@
M  (SWW0'[H_C_P#Q&V?V9\\6U]D']=N)_HJ?QC"D+PZ_.F?\'_CU0A70=,
M  #(SP\_>X\6OXC>D/VF<8:MSU^I/&/T5N_Q?(\'%?S7N?P?)]I*U/<;%;
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MU\^2TVM:9UFUK3K,S/;,S,S,^57:UK7M-[S,WF=9F>V9ZY<@^3\@
M                ->GEG\I?A+X90S]=VWW#J]GSW"^I"G4_7$;7.NR9Y5JM
M:2PMAI-7DQU_$[TJ0E6,][F:JQ.L:QC<K+TC63^2O!WQ Y]FN7@FQO3AMO\
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M?*7^MWAO^)MY07VPOUDX/^ Y?[6$2>(_^V[;[U;[9*04]1P
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MWX=MOMI:9SY^K]OOM/GRL!W,Y"
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M_P#;N_\ A@_^:'4A]LG_ /7/_N'_ +DB[Q)_[E_X[_R27<I"BX
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M)\7MCQ3KMMOK2ODF=?AV]V>C7MBL2W0H$:D
M
M                                        T]_/7K\7-^*SR6R<B%9W
M=3F]);#!E2<XTMY5SO[J_53G*,:TI<I7"V=Z/MEZT]94K_+2E4Y^S=EOC\9>
M$TK\6]=W6?1\CW%OGUAM7)5ICF7;Q'5,9(_[*\_N*ZAU)3P  FU?:];/&N^+
MOD;IXTN?F\#OS"V=^M8TI9KC;;KSC6+BTA/W5E*Y2[I;WOIZ4I2E8_C7UKZ<
M_/:_Q6KSAPK/.G<MPV:QY=:Y\DS]O&GNH@\1JS'$MO?LG!I[UI_RI.*HR/
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M>ON6M'PZ>FE^]2?/65D.';RG$-CBWN/XN6D6T\DS'3'N3K'N/"FQ/:
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MLUC'%9XY5Y?IP38ZY8B>(98B;SY/)2/-7M\MM9ZM--12;FT
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M$QWXC?S,=L1/R.(GW=)T]$HM\29C791V_=?_ "?^1+G4C1>
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M\R?\0WW]?E_EM!^7;W^FR_9V_P I_P!7SH3_ *$.H?\ -KPS_P BG]Y^9/\
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M/EV]_ILOV=O\I_U?.A/^A#J'_-KPS_R*?WGYD_XAOOZ_+_+/EV]_ILOV=O\
M*?\ 5\Z$_P"A#J'_ #:\,_\ (I_>?F3_ (AOOZ_+_+/EV]_ILOV=O\I_U?.A
M/^A#J'_-KPS_ ,BG]Y^9/^(;[^OR_P L^7;W^FR_9V_RG_5\Z$_Z$.H?\VO#
M/_(I_>?F3_B&^_K\O\L^7;W^FR_9V_RN7T?3O4?&-C9W'&NK.N./;;'_ .\;
M31\'XSJ=C8_3A<_F<W UF/DV_P!.W&7Z,J?C&E?[CX;CCO&]YBG!N]YNLN">
MNM\N2U9],6M,/S?=[K)7N9,F2U?)-IF/FR]'8IYP
M       %8=\G?]H=YH?Q&]I_XTY[KOX1?LOX!^BMO_9PL3R[^8MI]XI\Y@JD
M5F0   &P?XI=/J.0?(KXDZ7?:K6[O3['MC78^PU.WP<79:S.QY:S:2K8S,#-
MM7L7*LUE&E:QG"4?6G\B,?&?/GVOA;QO<;:]\>>NRM-;5F:VB>]7IB8TF)]$
ML'S->U. [J])F+QBG28Z)CICM6.W_5\Z$_Z$.H?\VO#/_(KE;_>?F3_B&^_K
M\O\ +0'\NWO]-E^SM_E/^KYT)_T(=0_YM>&?^13^\_,G_$-]_7Y?Y9\NWO\
M39?L[?Y3_J^="?\ 0AU#_FUX9_Y%/[S\R?\ $-]_7Y?Y9\NWO]-E^SM_E/\
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M"?\ 0AU#_FUX9_Y%/[S\R?\ $-]_7Y?Y9\NWO]-E^SM_E/\ J^="?]"'4/\
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M>B4<:4I3E*4I5E*5:RE*5:UE*5:^M92K7UK6M:U_&JU,1$1I'4WY_
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MIG&&K<]?J3QC]%;O\7R/!Q7\U[G\'R?:2M3W&Q6P               !5O\
MR"?OZ^;G\7?DG^V7FCL+X9?LVY>_0>P_%<2QW _S+L_P7%_9U8B-W90   !-
M+^UQ_P#0+Y2_UN\-_P 3;R@OMA?K)P?\!R_VL(D\1_\ ;=M]ZM]LE(*>HX
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M_P""<%73VI/V3YOP[;?;2TSGS]7[??:?/E8#N9R$
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MCP4K$5K6(K6L1U1$1I$1'9$1HW"M:TK%*1$4B-(B.B(]$./?1^@
M  %NVXAJN@        *SSY<O[2?S#_K>V7^"]2ZT^"/[)^!?@-?MK+"<K_J_
MM/O4?/EKG2FSP   "7;]JQ_[=W_PP?\ S0ZD/MD__KG_ -P_]R1=XD_]R_\
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M2E*4I3\*.7<S,SK/6@E_0
M
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M?+?'DK/76]+36U9\\6B85MRXKX,ML.6-,E+368\DQ.DQ[[L;ROF
M @=?<H=1XG!_/#C?9.NQK=JQW;TIQ+?;J_&'LN97+>%;#<< S)7/2%(W:6N(
MZ+1PC.LJS_"L:TI&,:RZ/>RAQN_$?#C+PG+,S;A_$,E*1Y,>6M<T>_EOFGYO
M;*:/#_=3FX+;;VZ\.:T1];:(M]M-D>E9YO0
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MUP_%QSTQ.6;3$Q;#TR/R'P'U^6>,[JOW+'.F.)[;]MO17JCZK7MJA=+\);
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MI_>VO%OF>;K>S%QS@V;HQ[K;S/D]96)]Z9U8K[SC^^XQL;VHY+I-OQ[;8_\
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MC7OUVNXM/DTM?%$>[\"=>CR>Y$_B/:)W.UIVQCO/OS7_ ")5RFB-0
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M$Q&FN3!DB9Z>N?59\4:]G1$1IV:]+9<?B!QVD:6KM[^FEOXMZNJ?[,7X%?\
M2WY=_P#+WIK_ $!/;_S=>)/^X\#_ *G=?_&/K_B)QK^BVOV.3_2'^S%^!7_2
MWY=_\O>FO] 1_P W7B3_ +CP/^IW7_QA_B)QK^BVOV.3_2'^S%^!7_2WY=_\
MO>FO] 1_S=>)/^X\#_J=U_\ &'^(G&OZ+:_8Y/\ 2'^S%^!7_2WY=_\ +WIK
M_0$?\W7B3_N/ _ZG=?\ QA_B)QK^BVOV.3_2'^S%^!7_ $M^7?\ R]Z:_P!
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MAGZ*C\8S(?\ $7\Z8/P?^/9)A5*1Z
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M<>+7\1O2'[3.,-6YZ_4GC'Z*W?XOD>#BOYKW/X/D^TE:GN-BM@
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M8/Q&?V:_A[_5%KO\+;9R6\;OVL<=_#K?:U5[YH_6#=_?9^=#8TBQ@0
M             $./[IK_ ,_?#7_BAW1_AGKE>SV.OS;Q[[_M?M,Z5O#?^9W?
MUV/YUT4!=!)@   #:1\*W]J#XD_\;^8?LMYVA[Q^_9!QO[QB_&,+6^;OU<W7
MUM?MZK)-RD0"        JL/,/][CRE_B-[O_ &F<G=D^1?U)X/\ HK:?B^-9
M/A7YKVWX/C^TACFVE[P   &]3[=7^THXQ_5%VO\ X)P5=/:D_9/F_#MM]M+3
M.?/U?M]]I\^5@.YG(0
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M,'_S0ZD/MD__ *Y_]P_]R1=XD_\ <O\ QW_DDNY2%%P
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M8[9G_+,]$3*RM\-O$GK'PFZ!X9T)U;C?4UO'L;\[R7D^3BVL;<\\YIGVK/\
M2+FF^I:G>],[;Y-FE+5GZER&'AV[.+;E6U9@Y.\]\[<7\0.9=QS+QB=,N6=,
M>.)F:X<43/<Q4ZNBL3TSI$VM-KS&MI5^XMQ3<<7WU][N?C6ZH[*UCJK'FCYL
MZSVLI&G,:
M
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MIDI$_P!)BM%<N/\ ?TJWS8<4X?Q.GK-AEIDCMB)^%'IK.EH]V(8X-J>\
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MM=8TIPOOZ=L=_/EC7RZ3ZO2/1/G0_P"(M]>)X,>O5@U]^]H_<29U24>@
M                                      *M_P"03]_7S<_B[\D_VR\T
M=A?#+]FW+WZ#V'XKB6.X'^9=G^"XO[.K$1N[*    -TOV_7]J#TO_P 4>Y/V
M6<I0%[3/[(-_]_VOXQC:CSQ^KF7Z_']O"PV<P$%@
M      ,<O,3]T?RF_AR[O_9GR=M7(OZ[\&_2NT_&,;W\*_.FV^_X_MX56+LD
MLF     F]?:__NC^0'\1M[]F? W/CVOOUVX9^BH_&,R'_$7\Z8/P?^/9)A5*
M1Z         QR\Q/W1_*;^'+N_\ 9GR=M7(OZ[\&_2NT_&,;W\*_.FV^_P"/
M[>%5B[)+)@    )O7VO_ .Z/Y ?Q&WOV9\#<^/:^_7;AGZ*C\8S(?\1?SI@_
M!_X]DF%4I'H
M   "L.^3O^T.\T/XC>T_\:<]UW\(OV7\ _16W_LX6)Y=_,6T^\4^<P52*S(
M  #8Q\1O]I/X>?UO:W_!>V19XW?LGX[^ V^VJP/-'ZO[O[U/SX68;DLKV
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MVN2_3TQ$V[M9^+6L="2N'<)X=PK'ZK88JT\L]=I]-IZ9]&ND=D0Q?;>R(
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M%QXJ5QTCT5I$1&O;T=+><&WP;;'&';4KCQ1U5K$1'O1T.F/>^H
M     #+OX^_W]?"/^+OQL_;+PMI'B;^S;F']![_\5RL7QS\R[S\%R_V=EI X
M]*X@        (YOW.G[A74G\7? OV-=^K3^R+^TG??H/-^-;-OOAW^>LOX+;
M^TQH*SHJF4   !D9X>?O<>+7\1O2'[3.,-6YZ_4GC'Z*W?XOD>#BOYKW/X/D
M^TE:GN-BM@               "K?^03]_7S<_B[\D_VR\T=A?#+]FW+WZ#V'
MXKB6.X'^9=G^"XO[.K$1N[*    )I?VN/_H%\I?ZW>&_XFWE!?;"_63@_P"
MY?[6$2>(_P#MNV^]6^V2D%/4<                  ,1/D$_<*\W/X1/)/]
MC7-&\>&7[2>7OTYL/QK$RG _SUL_PK%_:55;[L(L<     LP?B,_LU_#W^J+
M7?X6VSDMXW?M8X[^'6^UJKWS1^L&[^^S\Z&QI%C @
M(<?W37_G[X:_\4.Z/\,]<KV>QU^;>/??]K]IG2MX;_S.[^NQ_.NB@+H),
M ;2/A6_M0?$G_C?S#]EO.T/>/W[(.-_>,7XQA:WS=^KFZ^MK]O59)N4B 0
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M@XJ17O3';>8CO7M]5>;6GMEONTV6TV&+U.SQTQX_)6(C7T]LSYYUEY&S;U
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MGW(Z&Q9%K @
M
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MM>][3:UK3.LVM:9F;3,],S,S,SUH]O>^2\Y,DS:\SK,S.LS/EF9ZY<J^+\@
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M"-NU:MQC"W;MPC2,(0A&E(PA"-*4I2E/2E%>IF;3-K3K:6G=?3/6_P!OX
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M?XGXL6L3ZGA."GHURY\FD^7^<U]$Q"%?$"_?X[6OTNWI'\*\_NI!"LK1P
M                                       %6_\ ()^_KYN?Q=^2?[9>
M:.POAE^S;E[]![#\5Q+'<#_,NS_!<7]G5B(W=E    &Z7[?K^U!Z7_XH]R?L
MLY2@+VF?V0;_ ._[7\8QM1YX_5S+]?C^WA8;.8""P
M       &.7F)^Z/Y3?PY=W_LSY.VKD7]=^#?I7:?C&-[^%?G3;??\?V\*K%V
M263     3>OM?_W1_(#^(V]^S/@;GQ[7WZ[<,_14?C&9#_B+^=,'X/\ Q[),
M*I2/0        &.7F)^Z/Y3?PY=W_LSY.VKD7]=^#?I7:?C&-[^%?G3;??\
M']O"JQ=DEDP    $WK[7_P#='\@/XC;W[,^!N?'M??KMPS]%1^,9D/\ B+^=
M,'X/_'LDPJE(]
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M[3-K6M,ZS:UIUF9F>F9F9F9Z913>]\EIO>9M>9UF9G69F>V9[9<D^3\@
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M,\//WN/%K^(WI#]IG&&K<]?J3QC]%;O\7R/!Q7\U[G\'R?:2M3W&Q6P
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M^THXQ_5%VO\ X)P5=/:D_9/F_#MM]M+3.?/U?M]]I\^5@.YG(0
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M/=K6M81XQQK?<;W/K]W;X$?%I'Q:QYH\OEF>F?1$1&:;0&(
M
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M;X./+IU6[E])[U[1%7/?+\UO/&]I7X$Z1EB.R>J+^B>B+>?2>V92S5*T9
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M?(?$=[I\++Q:U//,8]O@F/3&N2=//JF+PZQZ<)S9?IMQ,>]2G^5&M6P2
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M>:OTM<<?P*S^ZW-(%:F
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M<^/:^_7;AGZ*C\8S(?\ $7\Z8/P?^/9)A5*1Z
M                              K#OD[_ +0[S0_B-[3_ ,:<]UW\(OV7
M\ _16W_LX6)Y=_,6T^\4^<P52*S(   #8Q\1O]I/X>?UO:W_  7MD6>-W[)^
M._@-OMJL#S1^K^[^]3\^%F&Y+*]@                          ,<O,3]
MT?RF_AR[O_9GR=M7(OZ[\&_2NT_&,;W\*_.FV^_X_MX56+LDLF     DP?:_
M_O<>0'\.5[]IG U2_:^_4CAGZ5C\7S(]\1?S7@^__P 2R;VY[H?
M1GON@/W1_'_^(VS^S/GBVOL@_KMQ/]%3^,84A>'7YTS_ (/_ !ZH0KH.F
M !D9X>?O<>+7\1O2'[3.,-6YZ_4GC'Z*W?XOD>#BOYKW/X/D^TE:GN-BM@
M  #\,K*Q<'%R<W-R;&'A8=B]E9>7E7K>/BXN+CVY7LC)R<B]*%JQ8L6H5E.<
MJTC&-*UK6E*/U2E\EXQXXFV2TQ$1$:S,ST1$1'3,S/5#^Q$S.D=,RTQ^7'SO
M>"OC%3::#BW+[WD?V3@_4L0XGTUDX.VXSB9T84E"WO\ L^]<KP[$QJ7/6W>_
M5MS<9N/=I6-S%I6E?2>N2?9Q\1>;^YN=Y@CA7";=/K-U$UR3'U&WC[K,]L>L
MC%2T=,7;9PODOC/$=+Y*?)]O/T63HG3S4^-[_=B?*C >6GSY>='DE7:Z#@G)
M,/QFZYSOS&/;X]U'?R;/-<G NSK6S#==K9D+?*OS]FU*L)W=+316+T:_I6%O
M>2O9L\.N5.YN>)8K<7XK72>_N8B<43V]S;1]STGKB,OKICLLD7AG)/!N'Z7S
M5G<;B.V_Q=?-3XNGUW>]+2CL-AG[;.S-GM<[,V6RV&3>S,_8[#)O9F=G9F1<
ME=R,K,R\F=S(R<F_=E64YSE*4I5K6M:U6 Q8L>''7#AK6F*L1$5K$1$1'5$1
M'1$1V1#;ZUK6L5K$16.J(ZGR/V_H        #+/Q*\'_ "5\V^;QX3X_==[#
MDD<6_8M\EYGL??I^O>$V+T97*9?+>79%F>OUU:V(2N6L2W]?8Y=(5IC8]Z=/
M:TKG;Q"Y3\/N'_E#F;=5Q=Z)]7BK\+-EF.S'BB>];IZ)M.E*Z_#M6.EC.*<8
MX?P?#Z[?9(KKU5CIM;ZVO7/IZ(CMF$X/XXOA4\>O!J.F['YC3"[P\D,>W#(I
MV'OM7"/&>!YLZ0E.UU=QC+_,1U.5C>WZ=-UE5N[:Y3WULRP[5ZYC.>OBKX_\
MS^(DY.%;#O<.Y4F=/44M]TS1Y=QDC3O1/7ZJNF..CO1DM6+H=X_S=ON,Z[?%
MKAX?]+$]-H^KGM^MCX/EUF-6Z5 34@                 'XY&1CXF/?R\N
M_9Q<7%LW<C)R<B["SCX^/9A*Y>OW[UR4;=JS:MQK*4I5I&,:5K6OH_5:VO:*
M4B9O,Z1$=,S,]41';,O[$3,Z1UM#/FK]P/XB^-WZVX?TC<_ZT?:F)]?%]G"=
MK:P>I='G0];?NW'9GY?/Q=_]&4HW(VM!C[.S>I&5JYE8L_QI9#D#V9>=^:^Y
MON88_(_!K:3]UK,[F\?4[?6LTUZM<UL<QT3%+PW3A'(_%.(:9=Y_JVVGZ:/A
MS'FIT:?OICRZ2B1^8?RG>9_FSD;/7=K=HYFBZXS[U)6>G.N*9/#^M<?&A.5R
MQB['5XV9D;7EWT;DJSC=WF;LKL9_WDH1C&,;L\B^#G(7A_6F7@NSKDXK6.G=
M9],N>9[9K:8BN+7JTPTQQ,=<3.LS)_"N6^$\(B+;;'%MQ'^<O\*_N3U5_>Q#
M78E%G@          &UWQ*^%_SO\ +6FKWFHZPN=1=;["N+>_RD=T_GN%:O)U
MV1+W4S>/<;NX63S7E%J[C0E.Q>Q-?7 NR]M)95NDZ20QSKX]^'')/?V^?>1O
MN*UUCU&UTRVBT=E\D3&+'I/1,6OWXZ=*3IHUGBG-O!>%ZTOD];N(^@Q_"G7S
MS\6//K.OF2??$?[=WPXZ)IJ^2]YY&X\H>P,7Z=^Y9Y98_HUU1@Y<8U_^D>N]
M7F9-_=0C6Y*$Z;O9;+%OTC"=,6S*E:*A<[>U%SWS'W]IR[&/@_#+=&N.?6;F
M8\^>T1%/-ZK'CM'3'?M".N*<]\6WNN/9Z;;!/TO3?[*>K][$3YY;Y>-<8XWP
MS0ZOBW#^/:/BG&-'BPP=+QSC6IP-%H=/A6ZRE;P]7J-7CXNOU^+"4JUI;M6X
M0I6M?2BM^[W>[W^YOO-]ER9MWDMK>^2TWO:?+:UIFUI\\S,M+R9,F6\Y,MIM
MDF=9F9F9GTS/3+G'G?A%O^Z._P#0+XM?UN\R_P 3;*X7L>_K)QC\!Q?VLI'\
M./\ ;=S]ZK]LA:+]);    9=_'W^_KX1_P 7?C9^V7A;2/$W]FW,/Z#W_P"*
MY6+XY^9=Y^"Y?[.RT@<>E<0        $<W[G3]PKJ3^+O@7[&N_5I_9%_:3O
MOT'F_&MFWWP[_/67\%M_:8T%9T53*    R,\//WN/%K^(WI#]IG&&K<]?J3Q
MC]%;O\7R/!Q7\U[G\'R?:2M3W&Q6P               !5O_ ""?OZ^;G\7?
MDG^V7FCL+X9?LVY>_0>P_%<2QW _S+L_P7%_9U8B-W90   !-+^UQ_\ 0+Y2
M_P!;O#?\3;R@OMA?K)P?\!R_VL(D\1_]MVWWJWVR4@IZC@
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MWVTM,Y\_5^WWVGSY6 [F<A
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MO'I/Q9[MLE>KUDI0X3RCP?A4QDBGKMU'T=])TGZFOQ:^:=)F/*U()M;0
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M^G5.2\ZWR6^JO:UO.D#9<.V/#L?JMCBICIYHZ9],]<SYYF9>&-B>P
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MLVF=9G_I\QW-X'Q
M
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M=S?2[ZV/^JK7%_$]U7OFC)ZWF#=V\F68^QB*_N-BZ+6!
M                           5;_R"?OZ^;G\7?DG^V7FCL+X9?LVY>_0>
MP_%<2QW _P R[/\ !<7]G5B(W=E    &Z7[?K^U!Z7_XH]R?LLY2@+VF?V0;
M_P"_[7\8QM1YX_5S+]?C^WA8;.8""P                          &.7F
M)^Z/Y3?PY=W_ +,^3MJY%_7?@WZ5VGXQC>_A7YTVWW_']O"JQ=DEDP    $W
MK[7_ /='\@/XC;W[,^!N?'M??KMPS]%1^,9D/^(OYTP?@_\ 'LDPJE(]
M     8Y>8G[H_E-_#EW?^S/D[:N1?UWX-^E=I^,8WOX5^=-M]_Q_;PJL79)9
M,    !-Z^U__ '1_(#^(V]^S/@;GQ[7WZ[<,_14?C&9#_B+^=,'X/_'LDPJE
M(]                                                     5AWR=
M_P!H=YH?Q&]I_P"-.>Z[^$7[+^ ?HK;_ -G"Q/+OYBVGWBGSF"J169    ;&
M/B-_M)_#S^M[6_X+VR+/&[]D_'?P&WVU6!YH_5_=_>I^?"S#<EE>P
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MBL1$:(TW&YW&[S3N-U>V3-;KFTZS_P#UY(ZH['?V,?
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MM,=%[7TU2UP?EGA7!HBV"G?W7;DOI-O<[*QZ.GRS+6HEEL          #N'
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MF;Y8\V:^1'7%.9^,<6UKN,LUP3]!3X-?1/3K;]],MDB*6    1;_ +H[_P!
MOBU_6[S+_$VRN%['OZR<8_ <7]K*1_#C_;=S]ZK]LA:+]);    9=_'W^_KX
M1_Q=^-G[9>%M(\3?V;<P_H/?_BN5B^.?F7>?@N7^SLM(''I7$        !'-
M^YT_<*ZD_B[X%^QKOU:?V1?VD[[]!YOQK9M]\._SUE_!;?VF-!6=%4R@   ,
MC/#S][CQ:_B-Z0_:9QAJW/7ZD\8_16[_ !?(\'%?S7N?P?)]I*U/<;%;
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M[=7^THXQ_5%VO_@G!5T]J3]D^;\.VWVTM,Y\_5^WWVGSY6 [F<A
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M;+_!>I=:?!']D_ OP&OVUEA.5_U?VGWJ/GRUSI39X   !+M^U8_]N[_X8/\
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M%=MM,=,6VI&E:4K%:UCR5K$1$1YHAN5*4QUBF.(K2.J(C2(]$0XM]GZ
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M
M
M            K!ODQXE_0CY!_,O11MQLVKGD7VGR''LPC:A;LXG,>5;#F&'9
MLV[-NU;M6+6+O81MPI']"%*4_&M/6O7GPEWOY0\,> [G768X5MZ3/EG%CKBF
M9U[9FDZSVRL5R]E]=P/:7[?44C[&(K^XP=2&S #-OXU^71X/\@'AMR&Y=A8Q
MX^1O5&ES+]RMJ-K'P.5\NUG%<_(O2OTK;A9Q\+=7)SE_+&,:UC6DJ4JC[Q8V
M,\1\,^/;6(UM^2MS>(Z>F<>*V2L1IVS-(B&'Y@Q>NX'NZ1U_)[S]C6;1\Y:
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M:?(_"#@F'RX,N3R_SNXS9?X_N=2?N4<?JN7-K7RUM/V5[6_=:MDPMD
M2Z?M=^@83N^2_E'L\&59V8\?Z%X9L?;/V1K=_)=@=DXGK6/TI7*1AQ64?;6L
MHQE+U]*2IZTC]L#F68KPGD_%;HGO[S+7W\."?QCYGD1=XC;[_9^&UGRY+1_!
MI_'2\E'T7      *]7Y_>_KG=?R)\]XQA9OYKC/0/&>,=.:6EJY+\M7:8.-=
MY9S:_6Q^$89^/S#E.7K[T_2LIPUUNE:^V,:4Z>>S1RS'+_A;MMYDKIN^)YLF
MZOKU]V9]7BC7R3BQUO$=DWGMF4Y\D;'Y'P&F28TR9[3DGT?%K[G=B)]UI.6
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M/]LO-'87PR_9MR]^@]A^*XECN!_F79_@N+^SJQ$;NR@   #=+]OU_:@]+_\
M%'N3]EG*4!>TS^R#?_?]K^,8VH\\?JYE^OQ_;PL-G,!!8
M           #'+S$_='\IOX<N[_V9\G;5R+^N_!OTKM/QC&]_"OSIMOO^/[>
M%5B[)+)@    )O7VO_[H_D!_$;>_9GP-SX]K[]=N&?HJ/QC,A_Q%_.F#\'_C
MV2852D>@        ,<O,3]T?RF_AR[O_ &9\G;5R+^N_!OTKM/QC&]_"OSIM
MOO\ C^WA58NR2R8    ";U]K_P#NC^0'\1M[]F? W/CVOOUVX9^BH_&,R'_$
M7\Z8/P?^/9)A5*1Z
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MZ^$?\7?C9^V7A;2/$W]FW,/Z#W_XKE8OCGYEWGX+E_L[+2!QZ5Q
M1S?N=/W"NI/XN^!?L:[]6G]D7]I.^_0>;\:V;??#O\]9?P6W]IC05G15,H
M #(SP\_>X\6OXC>D/VF<8:MSU^I/&/T5N_Q?(\'%?S7N?P?)]I*U/<;%;
M             %6_\@G[^OFY_%WY)_MEYH["^&7[-N7OT'L/Q7$L=P/\R[/\
M%Q?V=6(C=V4    32_M<?_0+Y2_UN\-_Q-O*"^V%^LG!_P !R_VL(D\1_P#;
M=M]ZM]LE(*>HX                  8B?()^X5YN?PB>2?[&N:-X\,OVD\O
M?IS8?C6)E.!_GK9_A6+^TJJWW818X    !9@_$9_9K^'O]46N_PMMG);QN_:
MQQW\.M]K57OFC]8-W]]GYT-C2+&!                    0X_NFO\ S]\-
M?^*'='^&>N5[/8Z_-O'OO^U^TSI6\-_YG=_78_G710%T$F    -I'PK?VH/B
M3_QOYA^RWG:'O'[]D'&_O&+\8PM;YN_5S=?6U^WJLDW*1 (       "JP\P_
MWN/*7^(WN_\ :9R=V3Y%_4G@_P"BMI^+XUD^%?FO;?@^/[2&.;:7O    ;U/
MMU?[2CC']47:_P#@G!5T]J3]D^;\.VWVTM,Y\_5^WWVGSY6 [F<A
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M_&.;^+<6UQ1;U&TGZ"DSTQ]5;KMZ.BL_2MPR"VJ@
M
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ME*4]'%.UK7M-[S,WF=9F>F9F>N9GMF58YF9G6>M^S\OX
M                           JW_D$_?U\W/XN_)/]LO-'87PR_9MR]^@]
MA^*XECN!_F79_@N+^SJQ$;NR@   #=+]OU_:@]+_ /%'N3]EG*4!>TS^R#?_
M '_:_C&-J//'ZN9?K\?V\+#9S 06                           QR\Q/
MW1_*;^'+N_\ 9GR=M7(OZ[\&_2NT_&,;W\*_.FV^_P"/[>%5B[)+)@    )O
M7VO_ .Z/Y ?Q&WOV9\#<^/:^_7;AGZ*C\8S(?\1?SI@_!_X]DF%4I'H
M   #'+S$_='\IOX<N[_V9\G;5R+^N_!OTKM/QC&]_"OSIMOO^/[>%5B[)+)@
M    )O7VO_[H_D!_$;>_9GP-SX]K[]=N&?HJ/QC,A_Q%_.F#\'_CV2852D>@
M                                                    *P[Y._[0
M[S0_B-[3_P :<]UW\(OV7\ _16W_ +.%B>7?S%M/O%/G,%4BLR    V,?$;_
M &D_AY_6]K?\%[9%GC=^R?COX#;[:K \T?J_N_O4_/A9AN2RO8
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MO]46N_PMMG);QN_:QQW\.M]K57OFC]8-W]]GYT-C2+&!
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MB)O-[QWYF_@G+VPX'A[NWCO;F8^%DF/A6\T?2U^ICW9F>EKR2>SH
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MLY<NO;6]YQZ],4JC7BO-?&.+:X\F3U6VGZ"GP8]V?C6]$SIYH;5D--:
M
M
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MZM)TEL'*N?Y/S#M;^7)W?LXFG\96G.LBP0
M       #9G\=7Q;=_P#R&<OG/B>+/@72?'MC:P^>=V<AU^1<T&OO1I:O9''.
M(X?NQI\TYK7#NTN5P\>Y#'PX3MSS;^-&]C_6B3Q2\8>6?"_8Z;VWRGF#+37#
MM*6COVCIB+Y9Z?58M>CO3$VM,3&.MYK;NZ]Q[F38\"Q?=9[^\M'P<<3TSY[?
M2U\\],]D3I.D_3P[\)O'[P;ZPQ^L>B.(V]5:R(XM_EW--M3&S^>=A;C&MW(1
MW/,>0PQL:YGW+4K]VN-BVH6<#!C=G#&L68RE2O-/GKQ YF\1.,3Q?F//-YC6
M,6*NL8<-9^AQ4UG3JCO6F9O?2)O:TQ"$>*\7WW&=S\HWMM9^AK'16L>2L=GG
MGKGMF66C2F,       <!RGE?&.#<<W7,.:<BT?$>)\<U^1MN0<FY+M<'1Z#1
MZO$A6YE;';;?9W\; U^%CVZ>L[MVY"$:?RU>G9[+><1W6/8[#%DS[W+:*TQX
MZS>][3U5K6L3:TSV1$3+]X\63-DC%AK-LMITB(C69GR1$=,HF'R.?<6?_IWJ
M#P"I_P#E=;NO)/D.I_\ QX9,.I>([G&_#^Y".ZW./_\ E*8^#_WC.75\*_9:
M_F^.>)?UU-A2WO?*<M)]WU6*?)WLGQL:3N <A_%W7&_3&*)^WM'VM9]-NN$3
M7EW,.6<_Y-NN:<ZY+O>8\OY)GW=IR#D_)MKG;S?;K8W_ $^KF[3;;*_DYV;D
MSI&E/?<G*OI2E/Y*4HNIL=CLN&;3'L.'8L>#8XJQ6F/'6*4I6.J*UK$1$>:(
M2;BQ8L&.,.&M:8JQI$1&D1'FB'7'J?0    !9*?"[U?+JCXS_%G49&)7%V/*
M^'[;M#83G*LKF;'L_E6]YOI,N?\ )"-*\6W6!;A2-*?S5N/KZR]TJ\I/'SC$
M<:\6N,YZVUQ8<]=O7S?)\=,5X_K*7F?/,]G0@#FW<_*>8=S:)UK6\4C]Y6*S
M\V);1T/-<    ?+G9N+K<+,V.=>ICX6OQ<C-S+\HSE&QBXMF=_(O2C;C.<J6
M[5NLJTC2M:^GX4?O'COER5Q8XUR6M$1'EF9TB/??VL3:8K'7,JD_EW(LKF'+
M.3\MSHUCF\HY#NN19D93A=E'*W>RR=GD1E=MV<>%RM+N37UE2W;I7^6D8_R4
M[7[':TV.RP[+'_-X<5*1Z*5BL=L]D>6?2L[BQQBQ5Q1U5K$>]&CKSU/H
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MEK2*Q$WM,R%R'QN=KNIX3N)_U?-.M->S)Y/1>/X41IURA#N@Z8
M        $K?[6OGT\/L?RXZNN7I2M\BX1UCS[$QY?4K&U/AN^Y1QW87K/X_2
MMRR(\[Q8W/\ ?3^E#^Y%3'VQ.&Q?A7!.,1'3BW&XPS/E];3'>L3V]'J;:>36
M?*C3Q'P:[?:[GZ6]Z_91$Q]K*9(HBB@    !!<^YNY3+:><75'%[<O7%XKXS
M\6O7*2C=C*.UY!V/V?E9=(UE=E9G9KK</"K2481E[_?2594I&D>BGLC[.,/A
MYO=Y/Q\W%\D=GQ:8-O$=FNO>F_;U:::=.LR^'F/N\'RY.VVXGWHI3]W5G/\
M:T\"IB=?>7G:%RS[J\@YEU7P+"R)4A7Z-.':3EW(=G9L5^C2</S'].<25W^<
ME27TK?Z,?;ZRCKVQ.)=_B? ^#Q/\U@W&:8\OK;XJ5F>GL]3;3HZ-9Z9UZ,-X
MD9]<^UVWTM+V^RFL1]K*5XI@C,  !5M>?/._\IGF[Y:\XA>KD8F^\B.W;FIN
MRG=N2KH<+G&ZUG'HRE=OY%?6WH\+'C6D9?3CZ>D*1A2,:=AO#7AOY(\/>"<.
MF-+X^%[;O?7SAI:_9'T<V\_EUG65CN"8?D_!]KA[:X*:^F:Q,_-U8DMV90!G
M5\8W!/\ */\ (1X=<8E8_-68]_=><GS,:M/="_KN![NQSO9V;T/RV52>-<U_
M&[M+L:PI25NLJ5G;I7WQCKQ=XC^2O#'CN\B=+?DS/CB?);-2<-9CICI[V2-.
MGK[)ZIPW,6;Y/P+=Y.J?46CW;1W8^;*SQ<B%=@
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MZ^U__='\@/XC;W[,^!N?'M??KMPS]%1^,9D/^(OYTP?@_P#'LDPJE(]
M                                                5AWR=_VAWFA_
M$;VG_C3GNN_A%^R_@'Z*V_\ 9PL3R[^8MI]XI\Y@JD5F0   &QCXC?[2?P\_
MK>UO^"]LBSQN_9/QW\!M]M5@>:/U?W?WJ?GPLPW)97L
M         !CEYB?NC^4W\.7=_P"S/D[:N1?UWX-^E=I^,8WOX5^=-M]_Q_;P
MJL79)9,    !)@^U_P#WN/(#^'*]^TS@:I?M??J1PS]*Q^+YD>^(OYKP??\
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MZ!?%K^MWF7^)ME<+V/?UDXQ^ XO[64C^''^V[G[U7[9"T7Z2V    R[^/O\
M?U\(_P"+OQL_;+PMI'B;^S;F']![_P#%<K%\<_,N\_!<O]G9:0./2N(
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M5O[4'Q)_XW\P_9;SM#WC]^R#C?WC%^,86M\W?JYNOK:_;U62;E(@$
M!58>8?[W'E+_ !&]W_M,Y.[)\B_J3P?]%;3\7QK)\*_->V_!\?VD,<VTO>
M  WJ?;J_VE'&/ZHNU_\ !."KI[4G[)\WX=MOMI:9SY^K]OOM/GRL!W,Y"
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M;66$Y7_5_:?>H^?+7.E-G@   $NW[5C_ -N[_P"&#_YH=2'VR?\ ]<_^X?\
MN2+O$G_N7_CO_))=RD*+@                 %1([>+1
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MK/G9F-#8D
M
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MO#>Y'7T7S9<>D_88KQT^6>CMB0?#O!W^*9MQ/5CP:>[:T?N5E![="DP@
M -H_PX^*MGRT\]>HN)[W6SV/7W7&3=[H[(LRL4OX>1QSK[)P<S5Z?8PG:N6+
MFMY/S3*U6LRH2K&L\7+N^VONI1#WCMSG;DKPVWV]VU^YQ/=Q&UP3KI,7S1,6
MM7M[V/%&3)6>RU8UZ&N<U\2GAG!<N6DZ9\GW.GIMUS'GBNLQYXA9*.4B
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M(?\ $7\Z8/P?^/9)A5*1Z
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M(1I&$:4C&,:4C&,8T](QC&GI2E*4I^%$+3,S.L];67]
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MOZ^$?\7?C9^V7A;2/$W]FW,/Z#W_ .*Y6+XY^9=Y^"Y?[.RT@<>E<0
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M:_\ /WPU_P"*'='^&>N5[/8Z_-O'OO\ M?M,Z5O#?^9W?UV/YUT4!=!)@
M#:1\*W]J#XD_\;^8?LMYVA[Q^_9!QO[QB_&,+6^;OU<W7UM?MZK)-RD0"
M     JR?.751T7FQYAZ2%ZN3'3^4OD%JHY$H4M2OQU_;7+L2EZ5NDITMUNTL
M^ZL?6OIZ^GK5V+\.\T[GP_X%N)C2<G!]E;3R=[;8IT^:LAP:W?X1M+^7;8I]
M^E6+3<62    ;Q/MXMECX'R8\!Q;]+E;NZZR[;UN'[(TE&F1:XI=W$JWJUE&
ML+?Y34W:4K2DJ^^L:>GI6M:5Y]J##;)X2[F]=-,>[VUI]$Y.[T>[:/<U:=SW
M6;<O7F.S)2?FZ?NK!=S)0<
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MO>?<K6*TKI6M8BP/#.&[7A.SILMI&F.O7/;:>VUO+,_,C2(Z(AC:VMD
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MVR6]$3:9TK'96-*Q'1$1#0]SNMSO,LYMUDODRSVVF9GYO9YNIZ*Q;X
M
M
M              -$WW%O7E.9_&WR'DWT*7)=2=O]5\_^K[I1ECPVFRV'5DIT
M]MN=)QG/LF,*QE6,?TJ2]?6,:5L9[+7%/D'BOBVFND;W8[C#Z>[6NX_\AJW/
MD//ZGF"N/^EQ7K[T1?\ B*_UTP3>  FT_:_=CTW/C%Y$]4W,BEW(X#W=J^:6
M[4KDI7<76]E\)UNJQK485_"UBSV'6N7<A2G\MR=RKGY[7W"O4<W<+XU$:5W/
M#[8O--L&6UIGT]W/6)\T0B#Q%V_<XC@W/9?#-?=I:9^=>$G)49'@  "K4\[^
MLZ=.^:7E1UK:QZ8NOXMWUV?BZ.Q&,HTAQG,Y;L]IQ:7ME"W[:W..9V+*M*4K
M&E9?HUE'TE7L1X<<7_+O(/!N+6GO9<W#=O-Y_P"LC'6N3^'%OW=)6/X+N/E?
M"-MN)Z;6P4U]/=B)^;$L3VZ,F                              _L8RG
M*,8QK*4JTC&,:5K*4JU]*1C2GK6M:UK^%"9B(UGJ$NGXB/@BI=AQ?R=\Y^)_
MH2_)[_K/QQY!B0E2</7#V&GY9W!A3O2C6%R/K*UQ;(M>OI6-=G2E?J8"D7C?
M[1NDYN4/#O-T]-,^^I/IK;'MIT]_<5GR^I[,B+N:>=/C<.X-;S7RQ[TUI_+C
M][],EVV;-G&LVL?'M6[&/8MPLV+%F$;5FS9M1I"U:M6H4C"W;MPC2D8TI2E*
M4]**0VM:]IM:9FTSK,SUS/EE%TS,SK/6_1_       !&S^4#Y\N ^/<N1]'>
M'F7H.T^[\>F1J>1]HRIC[KJ[JS/K6Y8RL;4UMW)XG8?.=7[:^MJ%9:7 R*QI
MDW,N[:R=?&UWA![-G$N9XQ<P\]5R[/EZ=+4V_33<;B.N)MVX,-O+/W6]=>Y%
M(M3+._\ +G).??=W><5BV+9]<4ZKWCS_ $M9^RF.K2)BR%3V3V9V#W%S?D'9
M':?,N1<_YYRK-EL-_P JY3L\G;;C99%8QMVZ7<K*G.MK%Q,>$;./8MTA8QK$
M(6K4(6X1C2_O">$<,X%P_%PG@V#%MN&X:]VF/'6*UK'HCMF>FTSK-IF;6F9F
M92[M]O@VF&NWVU*TPUC2*Q&D1_T[9ZYGIET9D7V       ;"/BDZCEW;\B7B
M9PF6/7*P</MK3=@[>U6%96)Z?J>QE]G[*QF5]DXQQ<[&XC7'EZ^GOK>I"E:2
ME1&/C/QN.7_"[C?$(G3);96PU\O>W,QMZS'GB<O>\VFO5#!<S;KY'P'=9NJ9
MQ36/3?X$?;:K--R15Z     :J?FUYO3@GQA>4V?"[*WE[[CW#N$8D(^[W9%>
M;=D\.XUL+5*TI[8QCIMCE7)>ZM*5A"M*>M:TI69?9^X?^4O%[@V*8UICRY<L
M^;U6#+DK/V=:QZ9;+RAA]=S%MJ]E;6M]C2TQ\V(5O3JNGT     !(4^VIX):
MY-Y^<KY7E682M=;^/'.][@WY1MSE9W>^Y3P/AV/;MQK?MWK4[VDW^QK]2,+D
M:1A6$O;6Y&JL/M8\1MM/#3#LJ3\+=\4PTF/+2F/-EGLTZ+TIT:QUZQU2T7Q!
MS3CX)7%'7DSUCW(K:WSXA/'<X4+@     (:?W2O-9YG:/B-UU2]^AQS@/:'-
M;F/&=/[_ )KR'BNBLWKEND*2K^' 9QA64I4I^G2-(^LJROA['?#XQ\'XWQ33
MIR[G;XM?O5,EYC_MHU]SKZ-)8\.,.FVW6?Z:]*_8Q:?XR*@N8DH     !-+^
MV#Z$M\?Z1\@/)'9X/MV79'/=1U=QG(R<>-+UOC'7.JCN]UEZW(K'WUP-[R/F
M<<>_2E:TE?TD:>E*P_&@OM><RSN>8>&<J8;?<=IMK;C)$3T>LSV[E(M'EI3%
MWH\V6?*B3Q%WO?WF#A]9^#CI-Y]-YTC7SQ%=8^N2D%/4<     , ?DI\X^->
M OB]RWN'-CA;3G^UK7AO3O$LJ['TY)V+M\3)EK+V9CTN6[UWCO&,>S<V>SK&
M4*RQ<:MB$XWK]GUDOPG\/-WXE<X8.!8^]3AE/NNZR1_F\%9CO1$]7?R3,8\?
M7\*W>F)K6S-\O\'R<;XC7:1K&"/A7MY*QU^[/5'GG7JB5:KV)V'S7MGG7*^R
M^QN1[/EW.N;[S/Y'RCDFXR)9.PVVWV-Z5[)R+TZ^D+=N-:TA:M6Z1M6+,8V[
M<8VX1C3K%POA?#^"<.P\)X5BI@X=M\<4QXZQI6M:QI$1\^9GIF=9F9F9E8+!
M@P[7#7;[>L5PTK$1$=41'_3W73'O?4      !+;^!_Y=-I#;<5\&/)SE4\_7
M['\AQWQM[&WV5669K]C3UQM?TWR3:9,ZUR\#8TK;L\9O7I4NX]^--9[KEN]@
MV\>DWM'>".&<&;Q$Y1P]W+36^^P4CHM7KMNL=8ZIKTSN(CHM'W;2)KDFT8<Z
M<KU[MN,\.KI:.G+2.V.W)$>;Z/RQ\+LMK, 4<18      C4?<G^)-GLGQPX5
MY6\:U<;O,/'[>8_&^;9./9A^8SNI>>[&Q@6K^7<C261E4XESV]@RQ[=*>RS8
MV^=>E6E*5];9>RASM;A/->XY,W=]-CQ/'.3%$ST1N<-9MI'9'K,,7[T]<SBQ
MUA(/A_Q2=OQ"_#,D_<L]=:_7UC7^%777SUK"#VZ%)A                 ;
M?/@>WOZD^4[QHA<OV<?%W=GN#194[T?=[_S?1W9%_ L6I?C6W>R-QB8T(U_N
M^[T_DJ@_VC]M\H\'.+3$3-\<[6\:>;=X(M/HBLVEJW.E._RWN/+7N3_VE-?F
M:K%]RS0,     J]?D:YW'LKST\O^86KE+^'F^0O:6LU=^,J2CDZ7C/*]CQ?1
MY,:TLV/;')U&FL3I&L?6/N]*RE6E95Z_>%?#9X3X;\#V,QI>O"]O:T>2^3'7
M)>.N>JUIC_)U+%\ P_)^"[7%/7&"DSZ9K$S\V5A)\9G6E>H_C^\0^$7+%<7+
ML=%\'Y+M<67MK/$WG/\ 60Y_O\6Y6$IPE<QMUR>_"58UK&LHUK2M:>E7,7Q;
MXM^6_$SCG$(G6D\1S8ZSY:8;>II/NTQQ*#>8=Q\JXYNLW7'KK1'HK/=CYD0S
MF1VPP #7'\NO94.J?C:\O.2UR/R]S;=3Y_7&/*D:SN7+W;FTU?5E+5J$?TZS
ME#F$JUE3_O<:5N5]*1K6DJ>"/"9XUXK\#VFFL4WL9Y]&VK;<=/\ 5>[U=K/\
MK[?Y3S!M<?DRQ?[")O\ Q5: ZT+!@ )47VM_75=AW%Y6]M3Q:>G$^M.!==8^
M;.U'W>O87*=GR7,Q<>_+TG6G_P"K&Q.]"'K2G\U6?IZP]:;^V%Q3U7 N"\$B
M?Y_=YL\QK_08ZXXF8_\ ]B8B9\^G:C;Q'S]W:[;:Z_&R6M]C$1_'GYJ9RH6B
M8                                           !6G_ #$:"7&_DR\O
M==*%JW7)[+QM_2-JQ7&C6/*^)<:Y1"=;=8Q]UV['<4E.YZ?SLZUGZU]WJZQ^
M!>Y^5^$G \NLSIM)ITSK_-Y,F/\ B]$=D='8L%RI?UG+VUM_U>GV-IC]QK42
MRV    !LC^('E,>'_);X?[:=:QIE]J0XM2L:WJ5]W.>.[[A4*?S%*S])3Y!2
ME?7]#TK^G^CZHI\<=G.^\)N.8(^AV?K.S_,WIE[?K/3Y.EK_ #3C];R]NJ^3
M'K]C,6_<67#DRKZ                           U[_*]R[^A/QP^8^YK=
MG9_.](<IXC[X2OPE7_*!''X'2U6N/:O7*POUY)].5*TI"495I.485E*DG>"^
MQ_*'BKP'!IKW>(8\O9_F=<VO3IU>KU\ODUG2&<Y9Q>NX_M*>3-6WV/POW%98
MZW+#     )\GVW7&_P!1_'5D[/Z-NW_3'R [-Y)2<(78RR/RNGX1Q#ZUZMR,
M87+D:\5^G2L*UC[(1IZ^ZDJ4YL>U9N_E'BE&'69]1PS;X_1K;+ETC^LUZ>V9
M[-$)\_Y._P >[OTF"D?-M;]UOW5J:2         QR\Q/W1_*;^'+N_\ 9GR=
MM7(OZ[\&_2NT_&,;W\*_.FV^_P"/[>%5B[)+)@    )O7VO_ .Z/Y ?Q&WOV
M9\#<^/:^_7;AGZ*C\8S(?\1?SI@_!_X]DF%4I'H
M                               "L.^3O^T.\T/XC>T_\:<]UW\(OV7\
M _16W_LX6)Y=_,6T^\4^<P52*S(   #8Q\1O]I/X>?UO:W_!>V19XW?LGX[^
M V^VJP/-'ZO[O[U/SX68;DLKV                           QR\Q/W1_
M*;^'+N_]F?)VU<B_KOP;]*[3\8QO?PK\Z;;[_C^WA58NR2R8    "3!]K_\
MO<>0'\.5[]IG U2_:^_4CAGZ5C\7S(]\1?S7@^__ ,2R;VY[H?         1
MGON@/W1_'_\ B-L_LSYXMK[(/Z[<3_14_C&%(7AU^=,_X/\ QZH0KH.F
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M_F\<='P:][3O6M,V$Y?X/BX)PZFUKI.>?A9+>6\]?N1U1YHUZYE@(DIFP
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MCKW<79-;S'>F'>.\W<1XQ-L..9P["?H*STVCZNW7/HC2OFGK;F4#-3
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M9_9K^'O]46N_PMMG);QN_:QQW\.M]K57OFC]8-W]]GYT-C2+&!
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MY<W-8ZXK6WV-ZS/S(E9!N5* @
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MP?\ S0ZD/MD__KG_ -P_]R1=XD_]R_\ '?\ DDNY2%%P
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M]*(*M:U[3:TS-IG69GKF?++5)F9G6>M^C^
M
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M3&'%-L6&OHF8R9(\V2.CH37R'PZ-IP?Y9:/NVXM,_O:ZUK'O]ZW[YH!67;N
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M\>;'/EIDI%Z^[I,:^=93;9\>ZV]-SBG7%DI%H]%HUCY[HK(OL
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MG1K,-^(>X]9Q;%MX^+CP1[]K3,_,BJ2 JHT$
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MC6DHRC*GK&494]:5I6E?PJXP3$Q.D]:M#^@
M T3?<6=D6N$?&YR+BLKT87>XNW.K.O[=GV?4G?AI]IF=KW:_AZULV[5>M(UE
M<K^C258P]?6<:5L9[+7"9XAXK8M[I\'8;'<9M?)WJQMO=_G^KTSV-SY#V\YN
M/UR]F+%>WOQW/XZO]=,$W@    +(/X1N$RX)\8'BS@7K,K69OM#S7FV7.5*Q
MED1YKV;S3DFKO5C]6[&D::+88D(^WV^Z$*2K&DJU<J?:#XA'$?%[C.2LZX\>
M7%BCS>JV^+':/LZVGTSIU("YPS>NYBW-HZJVK7[&E8GYL2VL(9:T
M QR\Q/W1_*;^'+N_]F?)VU<B_KOP;]*[3\8QO?PK\Z;;[_C^WA58NR2R8
M ";U]K_^Z/Y ?Q&WOV9\#<^/:^_7;AGZ*C\8S(?\1?SI@_!_X]DF%4I'H
M                                                 "L.^3O^T.\T
M/XC>T_\ &G/==_"+]E_ /T5M_P"SA8GEW\Q;3[Q3YS!5(K,@   -C'Q&_P!I
M/X>?UO:W_!>V19XW?LGX[^ V^VJP/-'ZO[O[U/SX68;DLKV
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M^OA'_%WXV?MEX6TCQ-_9MS#^@]_^*Y6+XY^9=Y^"Y?[.RT@<>E<0
M$<W[G3]PKJ3^+O@7[&N_5I_9%_:3OOT'F_&MFWWP[_/67\%M_:8T%9T53*
M  R,\//WN/%K^(WI#]IG&&K<]?J3QC]%;O\ %\CP<5_->Y_!\GVDK4]QL5L
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M&\4GH\EM)_<EX.*X/E7#-QMX^-?!>(],UG3YJU,<;5;
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M=4?X4SUB_9;_ &L8?P'<_:PW/D/]8*_>K_.A7\NF*;P    %NVXAJN@
M   *SSY<O[2?S#_K>V7^"]2ZT^"/[)^!?@-?MK+"<K_J_M/O4?/EKG2FSP
M "7;]JQ_[=W_ ,,'_P T.I#[9/\ ^N?_ '#_ -R1=XD_]R_\=_Y)+N4A1<
M                J)';Q:(         ![/TAXZ=Z>2G++?".A^J>;=I\EE6
MS^8PN(Z/*V&+J;-^=;=K-Y#N/;;TO&M96=/2N7L,C&QHU_"MRC \P\T\N\I[
M*>(<R;W;[/:=.DY;Q6;3'92OQ\EOJ:5M;S/)O-_LN'XO7;W+3'C^JG37T1US
M/FB)E)$\2OME^P>1QUG*/,OMC%Z[UMRF-DW^J^HKNOY+S2MN=(3O8.\Y_L<?
M*X=Q_-QZTE"4=?B;^S<I7W1R(^GXU3YV]K?AFUF^SY#V5MUFC6(W&Y[V/%YI
MIAK,9;Q/7\.V&8[:RT#BGB'@QZX^$XIR6^GOK%?<K'PI]V:^A)N\7O ?Q(\.
M-;:Q>@.E>)\1W7Y:N-G\\S<:?(^R-O"[:A:R8;#GF_GL.2?D\JL*SEAV+]C
MA.4OIV(4KZ*C<X>)7.W/>6;\S<0S9]OKK&&)[F"O3T=W#3NX]8ZN],3>8TUM
M*/.(\;XIQ:VN^S6M3LKU4CT5C2/=TU\[,)HS%
M
M
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M'G&?@\;Y>R6[<&XI'V>++/\ 8PE'PXW/^U;.9^DO$>_6W\5$67<2B
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MGW[8[3,>695^YKW'RGF#=7[*Y.Y]A$4^?66S%$K7@
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M:_\ [H_D!_$;>_9GP-SX]K[]=N&?HJ/QC,A_Q%_.F#\'_CV2852D>@
M                                              *P[Y._[0[S0_B-
M[3_QISW7?PB_9?P#]%;?^SA8GEW\Q;3[Q3YS!5(K,@   -C'Q&_VD_AY_6]K
M?\%[9%GC=^R?COX#;[:K \T?J_N_O4_/A9AN2RO8
M      #'+S$_='\IOX<N[_V9\G;5R+^N_!OTKM/QC&]_"OSIMOO^/[>%5B[)
M+)@    ),'VO_P"]QY ?PY7OVF<#5+]K[]2.&?I6/Q?,CWQ%_->#[_\ Q+)O
M;GNA\        !&>^Z _='\?_P"(VS^S/GBVOL@_KMQ/]%3^,84A>'7YTS_@
M_P#'JA"N@Z8       '8.+<3Y5SGD&LXGPGC/(.8\IW>3'#TW&N+:;8\AY!M
M\R?K6&+K--J<;+V.?DSI3\+=JW.5?]QYMYO=GP[;7WO$,V+!L\<:VR9+5I2L
M>6UK3%8CSS,/QDRXL-)RYK5ICCKF9B(CTS/1#?;XD?;J^8/=]=9R3OS/TWB_
MP/*K:R)X7(;5KEO:^?A3C;NQKB<%U&PL:_0UOQK*U*FXV>%FXLZ>Z6%<IZ4E
M6WG;VI.1N7N_M.6JY.,<2CHUI/J]M$]73FM6;7TZ_N6.]+1T1DAI/%.?.%;/
M7'LHG<YH\GP:1^^F-9_>Q,3Y4H'Q)^&_P3\0Z:W<\9ZLL=H]CX%(7*=G]T?D
M.=<CL9D)5N1R]#J+^OQ.&<4OV)SE&S?UNLQ\V-KTC<R+M?65:@\[>.WB-SQW
M\&[WD[/A5O\ N^UUPTF/)>T6G+DB>V+Y+4UZ8K'4CKBG-?&N*:TR9?5[>?H,
M>M8]V=>];W9F/,VFH<:V                            K/\ Y9/);(\J
M?/;OWL&QG3S.)<:Y3D=4]=QI<G/$M<)ZSNWN,869KJ7+EV5K#Y/ML7-W58^M
M/Y[9W*^V'K[(]:/!7E.O)OAMPSAEJ]W>YL,;G/Y?6[B(R3%O/CK-,7HQQTSU
MK!\L</CAO!,&"8TRVKW[?77Z>GT1I7W&N1*C/@    -UWPZ?%7M_/?LJYV+V
M=BY^H\6NL=UC6N9YEFYDZ_/[-Y):M0SK/6W&<^Q6W>QL;Z-RU=W>=9G&[AX5
MV%JS*&1DVKUF /'7QEP>&W"8X5PB:WYQWF.9Q1.EHV^.>B<^2)Z)G76,5)C2
MUHFUHFM)K;4>:^9:\$V_R?;3$\2R1\'MBD?3S'VL=L],]$:38'<5XKQK@W&M
M#PWANAU/%^)\7U.!H>.<<T.!C:O3:/3:O&MXFOUFLU^);M8V'A8>-:C"W;A&
MD8QHYE[S>;OB.[R;_?Y+YM[FO-[WO,VO>]IUM:UIZ9F9Z9F4'9<N3-DMERVF
MV6TS,S,ZS,SUS,N?>9^                $6_[H[_T"^+7];O,O\3;*X7L>
M_K)QC\!Q?VLI'\./]MW/WJOVR%HOTEL   !EW\??[^OA'_%WXV?MEX6TCQ-_
M9MS#^@]_^*Y6+XY^9=Y^"Y?[.RT@<>E<0        $<W[G3]PKJ3^+O@7[&N
M_5I_9%_:3OOT'F_&MFWWP[_/67\%M_:8T%9T53*    R,\//WN/%K^(WI#]I
MG&&K<]?J3QC]%;O\7R/!Q7\U[G\'R?:2M3W&Q6P               !5O_()
M^_KYN?Q=^2?[9>:.POAE^S;E[]![#\5Q+'<#_,NS_!<7]G5B(W=E    $TO[
M7'_T"^4O];O#?\3;R@OMA?K)P?\  <O]K")/$?\ VW;?>K?;)2"GJ.
M            &(GR"?N%>;G\(GDG^QKFC>/#+]I/+WZ<V'XUB93@?YZV?X5B
M_M*JM]V$6.     68/Q&?V:_A[_5%KO\+;9R6\;OVL<=_#K?:U5[YH_6#=_?
M9^=#8TBQ@0                   $./[IK_ ,_?#7_BAW1_AGKE>SV.OS;Q
M[[_M?M,Z5O#?^9W?UV/YUT4!=!)@   #:1\*W]J#XD_\;^8?LMYVA[Q^_9!Q
MO[QB_&,+6^;OU<W7UM?MZK)-RD0"        @_\ W/'7$M'Y;=&=GV;'TL+L
M+H>G&[URE;M:96\Z[YOR*_G7Z^^E;<9QTW-M;:K&%?3TMTK6-*RK*?0KV1.*
MQN.2>(\'M.N3:\2]9'5T4SXJ1$?98LD]/EZ^R)A\.]QW^%YMM/7CS:^Y:L?N
MUE&D6R2"     M1_#?N*WY ^*7COW/3+KFY?8?4'!.0;N]*[]:Y#E%W086/R
MW$O7O6M;M_ Y/CY=BY+_ 'T[=:N-_/? IY9YSXIP'N]VFUWV:E(ZON<7F<<Q
M'9$XYK,>:5;>+;2=CQ//M--(QY;1'HU^#[\:2R4:FQX
M                    " 7]P_Y+WNZ_.S+ZHU>=+(X;XS<5U_ <*S;G*6'>
MYSR7'PN6]@[2U&=*2MY4+N7K]/D4]*1K/24K3UI7W5Z6>R]RE7E_PYKQK-73
M?\7S6S3/;&'',X\-?1I%\M?-E3;R)P^-IP6-S:/NNXM-OWL?!K'S[1]<T,+(
M-U     ;%_C2^/#L/Y#^];' ]-=V'&.J>(1P]WW+V;8P[>19XGQV_<O4PM1J
MOS58X>7S/EE[%N8^MQY?4]E(7LNY;G8Q;U*Q9XL^*'"_"_ER>)9XKFXUGUIM
M=O,Z3DO&FMK:=,8L<3%LENC76M(F+7JP/,/'<' MEZZ^EMS?HQT^FGRS]37K
MF?1'7,+&SH_I#K#QRZNXCTYT]Q37<.X%PK5X^LU&JU]BU;N9$[=N$<O<;C*M
MV[=W;\@W.1&N1G9M[W7\O)G*Y<E64G+#F'F'B_-7&,_'>.YKY^);B\VM:TST
M>2M8^AI6/@TI'16L1$1H@3>;S<;_ '-]WNK3?/>=9F?G1Y(CJB.J(>L,*\P
M              #15]Q5_9L<F_K>ZH_PIGK%^RW^UC#^ [G[6&Y\A_K!7[U?
MYT*_ETQ3>     MVW$-5T        !6>?+E_:3^8?];VR_P7J76GP1_9/P+\
M!K]M983E?]7]I]ZCY\M<Z4V>    2[?M6/\ V[O_ (8/_FAU(?;)_P#US_[A
M_P"Y(N\2?^Y?^._\DEW*0HN                  5$CMXM$        V%>)
MGQ:^;7F;/ V/4?3NUUO LWZ<Z]L=C2N\%ZUABW:4]N9K]WM,:6?RRS&LHTG#
M18>UOPI*DI6Z1]94C#G7QB\/^0HMBXWOJ7XE7_NV#[MGU\EJ5GNXY\DYK8XG
MLG5@N)\R<'X3K7=98G/'T%/A7]V(Z*_OIA)^\2_ML?&WK+]6<F\I^;[WR$Y9
MCSM9,^&:&>;P#J?%NQ_3_+9D<#*KSCE?Y>]&-8W9;#5XUZ'NA>PIQKZ*A<Z^
MU?S7Q?O[3D[;X^%[*>CUM],VYGSQK'J<>L=G<R6CKKDB4=<3\0.(;C7'PVE<
M&+Z:?A7^;\&OO3/DE(7ZWZMZUZ=XI@<%ZGX#P_K;ANKI6F!QC@_'-3QC28\Y
M_C=OQUVGQ<3&GE9$_P!*[>E&5V].M93E*5:UK6'BO&.+<=WMN(\:W.?=[^_7
MDS7MDO/DCO6F9TCJB.J(Z(B(:+N-SN-WEG-N;WR99ZYM,S/OR[XQKX@
M
M
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MUK'GM'G;AR-NODW,%,<]%<U+4^9WH^;6(]U7NNG*<@
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MN/TMWL&XWN3U<^7%2?5X?^RI17'C>\^7\6W&[B=:7RVT^MCHK_!B&7+2&+
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MEK'9.3;WB(B//./-DGSQ7S0D/P[W?J^(YMG,_!RXN]'II/\ DM/O(1SH*E\
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M+3Y<VWF,=M?_ !5L$1KY/-T0WX@[*</%<>]K'P,^/IGZJG1/\&:I'RJK00
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M /NC^0'\1M[]F? W/CVOOUVX9^BH_&,R'_$7\Z8/P?\ CV2852D>@
M                                             *P[Y._[0[S0_B-[
M3_QISW7?PB_9?P#]%;?^SA8GEW\Q;3[Q3YS!5(K,@   -C'Q&_VD_AY_6]K?
M\%[9%GC=^R?COX#;[:K \T?J_N_O4_/A9AN2RO8
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M3/\ 1XJ]W'C\GP*QT=:/M_Q3B'$\GK-]EODG7HB9^#'HK&E8]R&2+5&/
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M?Q]_OZ^$?\7?C9^V7A;2/$W]FW,/Z#W_ .*Y6+XY^9=Y^"Y?[.RT@<>E<0
M      $<W[G3]PKJ3^+O@7[&N_5I_9%_:3OOT'F_&MFWWP[_ #UE_!;?VF-!
M6=%4R@   ,C/#S][CQ:_B-Z0_:9QAJW/7ZD\8_16[_%\CP<5_->Y_!\GVDK4
M]QL5L                5?/R1ZNWI_D#\U<2W=G>C>\H>[]I6<XQC*ES>=A
M[_=7;5*1_#V6+NPK"-?Y:QC2M?Q=??"G-.?PRY?O,:3'!]I7[#!2D3[O=U6+
MY?MW^![.9_W;''O5B/W&%3?V7    3/?M;MABW.EO+#50G6N;A=H=?;#(M^R
M=(PQ=GQ3<8V'.ERM/9*MR[J;]*QI7UC[:5K_ "T]:$^V'BO''^"YI_F[;/-6
M/37)69^9:$2^(]9^5[:W9..T>]:/\J4\IRC<                 !B)\@G[
MA7FY_")Y)_L:YHWCPR_:3R]^G-A^-8F4X'^>MG^%8O[2JK?=A%C@    %F#\
M1G]FOX>_U1:[_"VV<EO&[]K''?PZWVM5>^:/U@W?WV?G0V-(L8$
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M:4+\_P"Q^3\8KNXCX&?'$_OJ?!GYG=GW4A=6!HH
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MX
M
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MVD:S/1$1%:Q6E:UB=N'<.VG"]K79[.O=Q5]^9[9M/;,_^"-(B(8_MF>X
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M:VV\1/F[V2)\VFO8V#E;<_)>8-KD[+9.Y]G$T^?96DNLJP0
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MK_\ NC^0'\1M[]F? W/CVOOUVX9^BH_&,R'_ !%_.F#\'_CV2852D>@
M                                               *P[Y._P"T.\T/
MXC>T_P#&G/==_"+]E_ /T5M_[.%B>7?S%M/O%/G,%4BLR    V,?$;_:3^'G
M];VM_P %[9%GC=^R?COX#;[:K \T?J_N_O4_/A9AN2RO8
M           #'+S$_='\IOX<N[_V9\G;5R+^N_!OTKM/QC&]_"OSIMOO^/[>
M%5B[)+)@    ),'VO_[W'D!_#E>_:9P-4OVOOU(X9^E8_%\R/?$7\UX/O_\
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M'PK?VH/B3_QOYA^RWG:'O'[]D'&_O&+\8PM;YN_5S=?6U^WJLDW*1 (
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M=&'K[)TSGGAWRW@L[BD:YMO;O^?NST7CT::6GZU8".9R$
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M3JU\_6D(JQ-&
M
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M<FWO,=7>P7B]=?/:N>8CRQ3S(E\1MIW-WM][$=%\<TGTTG6/?BWS$IA3I&X
M "LI^57I.[T!\@_E/P&.)7#U69VCM^PN-6HT_P"#0XSVK"QV1IL7"G3UI=Q=
M5B\HIA4KZRE&>-*$ZUG&3K?X-<P1S-X8\&XE-N]FKLZX<D]OK-OK@O,^>TX^
M_P#OHF.B86&Y:WGR[@6VSZZVC'%9]-/@3[^FONM?236<
M         =VZVZYYIV[S_AW5_76@S>4<ZY[R+5\6XKH-?"DLG9[G<95O#P[%
M)3K&SCV(W+GOO7[LH6<>S&5RY*-N$I4Q_%N*[#@?#,_&.*9:X>';;%;)DO;J
MK2L:S/EF>R(C69G2(B9F(?'<;C#M<%]SGM%<-*S:TSV1'_3W5F!\>/A)PGP*
M\:>(=*\;IA[/E=Z$.3]L<TL6/IWN;=C[/$QH;O91E.,;T-)K(V(8&KLRI2MG
M7XUOW^Z].]<GR7\4/$'B'B3S;GX_N^]391]SVV*9Z,6"LSW*^3OVUF^2>V]I
MT^#%8BOG'>,9N-<0ON\FL8NJE?I:1U1Z9ZY\\^31G*CMA@     &!7R%?(%U
M)\>W2M_LKG_KR'F?(:YVHZHZQP,F./N>?\HQ\>%V5J616U?IIN+Z:E^U=VNR
MN6YPQ;,XPMPO9-['Q[TD^&'AGQOQ.Y@CA/#/N6PQ:6W.XM&M<..9TZNCO9+:
M3&/'$Q-IB9F:TK:U<UP+@>ZX[O/D^#X.&O3>\]58_=F>R.WS1$S%<9Y'^1W;
M?E=V_P K[N[KY1E<IYMRO*K*4YUE:U>@T]B=W]4\6XSK:2E8TW&M'8NUMXV-
M;_#\97+E;EZY=NSZH\J<J\$Y+X'AY>Y?PQAX?AC]]>T_&R9+==\EYZ;6GS1&
ME8B(GSA^PVO#-K79[.L5PUCW9GMF9[9GMG]S1X8V)[            $G_P"V
M)Z"CRCO[O7R-VF'6Y@=3< U?7W&;U^W3Z/\ 2OL_87\S8YV#<K:K66;I^+\/
MOXUWVSI[+.XI[J5]\:QJ%[7?,L[/EKAW*N&VF3>[FV;)$=?J]O6(K$^:V3+%
MHZ.F<7FE'7B)OO5['#L*S\++>;3];2.B)],VU_>IKB@"(@    'DG?O9^%TG
MT9W+W%L90CA=5]6\^[#OTG2D_JTX=Q;:;^./"W7\;][)N8%+=NW3UE<G*D:4
MK6M*,WRUPC)S!S%L.!8OYS>;S#@C_P ;DK37S1'>UF>R.EZMEMIWF\Q;2O7E
MR5K]E,1^ZJALK*R,W)R,W,O7,G+R[][*RLB].MR]D9&1<E=OWKLY5K*=R[=G
M64JU_&M:NS]*5QTC'2(BE8B(B.J(CHB(]"R\1%8TCHB'X/T_H     ">']M!
MM+>P^/SF^)"U.W+1^4/8FKNSE*-8W[E[KSJ'=4NVZ4_&,*6MQ&'I7\?="M?Y
M*T<XO:TPSB\3=O>9UC)P?!:/-IGW--/X.ONH7\0J]WCE)^FVU9_A7C]Q(85@
M:*      K[_N(]!+3?);S/8UADPIROJKJ;?QE?K;K:NQQN/7.+>_#I"$)1QJ
M2XU6-:3K*7UHSKZ^VM*4Z:>R[N?7^$VWQ='W'>[FG1Y[^LZ?/]T[.S3M3AR)
M?O\ +]*_2Y;Q\W7]UHT6(;D      L_/C4Y_:[-\ /#WEUN_#)NW/'[K;CVQ
MR(?3I&]N^$<=Q.$;ZY6%FW9LVIRW?'<CW0A&,82]8TIZ4<A?%GAEN$>)G'=C
M,:5CB>>]8\E,MYRTZ]9^)>O3/7UJZ\P8/D_&]UBZH]?>8]%I[T?,F&;Z/6'
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M]%(T^?>)]Q-C<_D0@
M  *O#Y#/'RYXM^:GD9TG;POU?H^+]D[G8\+QZ4E]./7W,*VN9< A"Y6$(79V
M.(;_  [5V4*>VE^W.-/3VUI3L!X7\SQSCR!PKF";=[<9MI6N6?\ KL7W+-Z-
M<M+3'FF)6,X%OOREPC;[S76]L<1;ZZOP;?PHGW&&;?&6    <IH]WMN,[O3\
MCT&PR=3O>/[37[O2[3#G]+,UNVU679S]=L,6YZ5^GDX>98A<A+^Y*-*OCN-O
M@W>WR;3<UB^VRTM2]9ZK5M$Q:L^:8F8E^;TKDI..\:TM$Q,>6)Z)A:+^#GD[
MI?,3Q5Z:\@]3+#M9O.>)XW],-7A2C]+0=@:2Y<T?.M'&S]:_?Q\;"Y/K\G\K
M2[6ER[A3LW:T]+E*UX^^(?*.XY%YRW_+&?O3CV^>?56GZ/#?X>&^ND1,SCM7
MO:=$7[U>Q7+C'#K\*XEEV-M=*6^#/EK/36?>F-?/K#+!I;&
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M6WW7-/IB;5Q6\^+W9A#GK?\ ROC<[>LZXMO2*?OI^%:?FQ6?K6]Q7)I@
M     #'+S$_='\IOX<N[_P!F?)VU<B_KOP;]*[3\8QO?PK\Z;;[_ (_MX56+
MLDLF     F]?:_\ [H_D!_$;>_9GP-SX]K[]=N&?HJ/QC,A_Q%_.F#\'_CV2
M852D>@                                                    *P
M[Y._[0[S0_B-[3_QISW7?PB_9?P#]%;?^SA8GEW\Q;3[Q3YS!5(K,@   -C'
MQ&_VD_AY_6]K?\%[9%GC=^R?COX#;[:K \T?J_N_O4_/A9AN2RO8
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M/XM@IIW[\-W58UZM9P7B-??>+B=9OPW<4CKG!DCWZRM7W&=6H
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M#\1G]FOX>_U1:[_"VV<EO&[]K''?PZWVM5>^:/U@W?WV?G0V-(L8$
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M7KB5<N+\.R<*XCEV.3Z"W1/EK/36?=K,:^?6&4C3F-
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MM=OL_5[6GFC%2._']=;+/NH%YRW<[KF#/T_ QZ8X_>QT_P *;-NR$&K@
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MM/O4?/EKG2FSP   "7;]JQ_[=W_PP?\ S0ZD/MD__KG_ -P_]R1=XD_]R_\
M'?\ DDNY2%%P                 "I$Y9KL;3\JY+J<*DXX>KY!N==B4N3K
M<N4QL'8Y.-8I.=:4K.=+5JGK7^[5VSV66^?9X<^3^<OBK:?3-8F5GL5IOBK>
M>N:Q/OPZ^]+Z    )^?VXVTL[#XXL/$MV[D)Z/O'M'5Y$I^WVWKUZUQK=1N6
M?;*M?ITL;>$*^[TK[XR_#T]*UYJ>U3AMB\5+7F8TR<.V]H\T1ZRG3[M9GT(2
MY]K->/S/EPTGY\?N-]"MS2@
M
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M[EHB/)6^'6?/D\Z7/#K>=_99]A:?A8\D7CT7C2?>FO\ "1=%P4C
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M.(3UY^%[7)V_1X,=NV9GM[9F?.LIPO)Z[AFVS?3X,<^_2)8\MH>X
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M_7\;C;Q/P<&*M?WUOA3\R:^\D!*SM'
M                0YON>?&6[K>7]#^76CP:TU_)M9D]&=@Y%JU2%FQO]'7:
M<OZ\S+THTK]?-W>DRMWCSG*M*QLZBQ&GN_WMZ_9#YNC+L>)<D;BWW7#>-WAC
MMFE^[BSQ'DBEXQ6B.V<MI],K>'?$8MBS\+O/PJSZROHG2MO>GNS^^E$]7128
M     DY?;=^;MKK'N'EOAKSS<_EN'=Y7I\NZJEF794Q-7V_I-;"UM])9K7VV
M<;_*!P_71])W)>DLW2XMBU&MW*_&HWM6>'UN+\"P<^<-QZ[[AT>JW&G7;;7M
MK6\]L^IRVZH^@RWM/11'?/\ P>=QM:\6PQKEP_!OYZ3/1/[VT^]:9[$VES\1
M"                       \!\I/(G@OB?T#VAY ]B9,+7&^M^,Y>WC@_6C
M8RN1;Z]*&!Q?B>LG*,Z?K3E7(LO%P,>M:5A"YD4G.L;<92ILO)W*W$>=.9=G
MRSPN-=WN\T5UTUBE(Z<F2WU..D6O;MF*Z1TS$/=PW89N)[['L<$?=,EM-?)'
M7-I\T1K,^A5X=U=O<W[^[:[#[I[(V7ZVYQV;RS<<OY'EPI.&-'.V^5._' UV
M/.=S\GI]5CUABX6/2588V)9MVH_HPH[ < X'P_EK@FUX!PJG<X=M,-<5([=*
MQIK:>VUIUM>W7:TS,],K&;/:X=CM<>TV\:8<=8K'N=L^>>N9[9Z7F++O0
M ]I\<NDN3>2/?'4O1'#X3_7_ &ISOC_#\;)C:^M#58>SSK<=QO\ )M^L:RP.
M.::&1GY/I^-+&-.M/7T]& YJY@VG*G+F]YCWW^S;/;7RS'5WIK'P:1Y[W[M*
M^>T/)O\ >8^'[++O<OQ,5)MZ=.J/3,Z1'GE:C<"X1QOK3@W#>N>':^&JXEP+
MBV@X;QC66_2L-?Q_C.JQ-+I\.E:1C27Y?7X5N'KZ4]:T]7&_B7$-UQ;B.?BN
M^MW][N<U\N2WTU\EIO:?=M,RK;GS9-QFOGRSKEO:;3/EF9UGYKMCQ/D
M     QR\Q/W1_*;^'+N_]F?)VU<B_KOP;]*[3\8QO?PK\Z;;[_C^WA58NR2R
M8    ";U]K_^Z/Y ?Q&WOV9\#<^/:^_7;AGZ*C\8S(?\1?SI@_!_X]DF%4I'
MH                                                    "L.^3O^
MT.\T/XC>T_\ &G/==_"+]E_ /T5M_P"SA8GEW\Q;3[Q3YS!5(K,@   -C'Q&
M_P!I/X>?UO:W_!>V19XW?LGX[^ V^VJP/-'ZO[O[U/SX68;DLKV
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M&F2MIB8\DQ.DQ[ZL-HFLS6>N)?4_#^
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M7/W!OE&VKQ?!'W7%'=OYZ3/1/[VT^],SU0FP.?Z(@
M     %?S\]GG5=\I_+#-Z@X3O;F9TKXT96VX1J;6)>_^I7)>T(Y'Y7L?E_\
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MMP^N'73JMGS5O'HF8V]M/-KYTB>'.";<0W&YTZ*88K[M[1/\24)MT!2\
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MDK'3'5$1$SIT0[XB8N[Q;#F[+;>(]VM[?N3"2BJ>C\
M
M
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M28K-^[6?.6^ XN!;+U?1;>7TG);RSV5CZFO9Y9UGHUTC66EML(
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M7'N][ER4\V.;S&*/WN.*U]Q6WBN[^7\2S[SLR9;3'HU^#[T:0R0:HQX
M                                        #"/Y&/%O'\Q_#;N_HNSC
M8U[E6ZXM=Y!UO?R(PI7#[+X?<AR/A?LRI?I8%G;;?7QUN5>AZRC@YM^GI*DJ
MQE(/A9SC;D3GSA_,5IF-GCS13/$=N#+\#+T=LUK;OUB?HZ5ZM-68X#Q*>%<6
MP[V9^YQ;2_UENBWITB=8\\0K",S#R]=EY6OV&+DX.?@Y-_#S<+,L7<;+P\O&
MNRL9.+E8U^,+V/DX]Z$H3A.-)0E2M*TI6CKSCR4RTKEQ6BV.T1,3$ZQ,3TQ,
M3'1,3'3$QUK$Q,6B+5G6LOG?I_0   '-\9Y+O^&<DX]S#BFVS=!RCBF\U/)>
M-[W6WI8^QTN_T6?C[33[;7Y$?TK&;KMCBV[UJ=/QC<A2O]QY]WM-MO\ :9=C
MO:5R[/-CMCR4M&M;TO$UM6T=L6K,Q,>27XR8Z9L=L66(MCM$Q,3U3$QI,3Z8
M68'QI><7&O/?Q;X;V[BW-?@]BZBW:X?W1Q/#G&$N-]C:C%LTV63C8=9SNX_'
M>66)0VNKK65VD,3*ICRN2OX]^D>2_BSX>;OPVYQS\#O%K<*O/K=KDG_.8+3/
M=B9[;XYUQY.K6U>]$16U=:^<P<'R<$XE?:SK."?A8[>6D]7NUZI\\:]4PV (
MS8,                     !!;^X+^1*WY"=R8_B7U7O?S73_0>]RI\\V&N
MR8SU_.NZ,:%_6["W2Y:G.&7J.M,:[?UUBOZ%)[._GRK2Y"WC7*=%/9D\+IY8
MX#/.O&<>G'>)8X]36T?"P[6=+5Z^JV>8B\]>F.,<=$S>$R\C<!^0[3\J;FNF
MZSU^#$]=<?7'NWZ_1%?.CD+4-]     2K/MF_$*YR'L'M#S1Y7J_73]?X>5U
M+U->RL:M8W^:<CP;&5S_ )!K[TO96U>X[Q#)Q]92<:3A=AO<B'K&5JM*TT]K
M7GB-KPS9\@[*_P!WW-HW.YB)ZL5)F,-+1Y+Y8MD[)B<-9ZK(U\0N*13!CX1B
MGX=Y[]_K8^+$^FVL_O8\J9>H<B<          !CEYB?NC^4W\.7=_P"S/D[:
MN1?UWX-^E=I^,8WOX5^=-M]_Q_;PJL79)9,    !-Z^U_P#W1_(#^(V]^S/@
M;GQ[7WZ[<,_14?C&9#_B+^=,'X/_ ![),*I2/0
M                              %8=\G?]H=YH?Q&]I_XTY[KOX1?LOX!
M^BMO_9PL3R[^8MI]XI\Y@JD5F0   &QCXC?[2?P\_K>UO^"]LBSQN_9/QW\!
MM]M5@>:/U?W?WJ?GPLPW)97L                          !CEYB?NC^4
MW\.7=_[,^3MJY%_7?@WZ5VGXQC>_A7YTVWW_ !_;PJL79)9,    !)@^U_\
MWN/(#^'*]^TS@:I?M??J1PS]*Q^+YD>^(OYKP??_ .)9-[<]T/@        -
M3_S@<'O\[^,#R@PL.S.[G<>U'!.<8WLK_P!ZL<,[/X7O]U>E#ZUF-R$..8>9
MZTK6OM]?=2,I1C2LT>SUQ&O#?%_@^2\Z8\M\V&?/.7;Y:4CJGZ.:_.UB);-R
M?FC#S'MIGXMIM7[*EHCYNBN$=5$^     +17X]>SK/<?@WXH=APOV\C)W?1'
M76'N;MFL:VJ\EXWQW#XMRJ$*0_"$;/)=+EP]O\L/;[:_C2KC]XG\(MP+Q$XU
MPN8F*8^)9YK$_P!'DO.3'[^.]9\ZN7'=O.TXSN<'9&:^GHF=8^9,,QFB,4
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M%/[O<9M&GK/EN'7RZ>JMIKVZ:S;3W=.U+7AQI\CW,_1>MK]K.G[J+.N*D@
M !Z/TYMK.@[=ZKWN1"MVQI>Q^#[:_;C.-N5RSK>3ZO,N0C<G^A"LX6:TI6OX
M4_NL5QW!;<\#WFVK.ELFTS5CTVQVC]UY]W6;[7+2.N<=H]^)6RCBPK*
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M&WP\-NGZ;%:DSU],]<]:N'&-C;AO$\^RGJQY)T^MGIK/NUF)93M.8T
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M.".OI^4VKM](TZ>K)/FTUF>C5K_-.X^3<O[J_EQ]S[.8I_&66[DRKZ
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M7T6B)+XLF*>[EK:MO/$Q\]S[S/P
M
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M,QFM$2[R-R]&VPQQG=U_UC)'W.)^AI/T7IOV>2O;\*48!;U(H
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M8M6T3K%JS&L3$QT3$QTQ,=<)\K:MZQ>LQ-9C6)CMB7Q/H_H      #MW7_\
MY^\(_P"-W&O\,X3Q<3_-NX^\9/M9?+/_ #%_K)^<MK7%!6(     !6>?+E_:
M3^8?];VR_P %ZEUI\$?V3\"_ :_;66$Y7_5_:?>H^?+7.E-G@
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MY._Z*S/5#!\R;WY!P/<[B)TOZN:QZ;_!CWM=?<6;3D>KR
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MKX=_@R6QY,=HTM2]9TM68\L3" <V'+M\ML&:LUS4M,3$]<3'1,2[0\;Y@
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M !%_.F#\'_CV2852D>@
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M39UUMY<VWTQ7CW,7R?S]*&?$#8S@XO3>1'P,^.-9^JI\&?X/<2+56FA@
M             -6GR9_*=U!\=/"<''V.%#L3O?FFMR<SKGJ7#SZX/U,&U?\
MR=SE_-MK:L9<N.<0Q,NDH6OYN67M,BU.QBQ]MO)R,68O"3P<XYXI<0M;%;Y+
MRYM[Q&?<S&O3,:^JQ5UCOY9CIGI[N.LQ:\]-*WV3E[EO=<>S3-9]7LJ3\.^G
M\&L=MOF1'3/9$P:/*SY-_-+S%W&QR>V.Z.2X/$<NY=IA]6<!SLWA/66KP[E;
MGT\+^C.GR[?Z_K8C=E&.5N+VRSZQE6-;]8^D:=$.3/"/D'D7!2O!=ABMOJQT
M[C-$9=Q:?+ZRT? U^EQ12G;W=4Q\,Y=X1PJD1ML-9RQ]':.]>?=GJ]%=(\S
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MM%JQ?)6*^9.2\G#<=M]PV;9-E7IM6?C4CR_55CM[8CKUC68D>*K-!
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M6<=NG%AR[G)'E]9:,6*?<]5F]]%7B/N]<VVV,3\6MKS^^GNU^UM[Z6*I:C(
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M>/#+]I/+WZ<V'XUB93@?YZV?X5B_M*JM]V$6.     68/Q&?V:_A[_5%KO\
M"VV<EO&[]K''?PZWVM5>^:/U@W?WV?G0V-(L8$                   !#C
M^Z:_\_?#7_BAW1_AGKE>SV.OS;Q[[_M?M,Z5O#?^9W?UV/YUT4!=!)@   #:
M1\*W]J#XD_\ &_F'[+>=H>\?OV0<;^\8OQC"UOF[]7-U];7[>JR3<I$ @
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MY,=$QI,3,3$H SX,VVS6V^>LUS4M,3$]<3#N3P/D
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M,=$P];81Y0
M
M                  &B?[A[H>?;?Q[[KG6MP?S._P#'WL'B79MJY8LTN9TN
M,[&[D<"Y9B6Y?WT,"SC<LL;/)]/]YJZ2K^$5C/9>YDC@GB=CX=EMIMN)[7)M
M^F>CUE=,V.?3,XYQU\^33M;GR)O?DO'8PVG2F>EJ>['PJ^[\&8CTJ_QTP3>
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MK@-+Z:SP[';H\E];Q[NEHU\_EZUAN6:S7@&TB?Z&)]_I_=:^$G,X
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M%8TCWYM/V*9NH6B8
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MLH7+=R$J5C*E:TK2OK1SKM6U+36T3%HG28GKB?)*&IB8G2>M^C^
M         #7#\D_R.=6?'ETSE<IWU_7\E[BY9A;##Z;ZI_,U_/<HWEJW2U^O
M-[:QKMO+UG ^/Y%V%S8Y?NMUN?AC6)5R+L*4E7PG\*^,^*''HV>VBV+@6"U9
MW6XTZ,=)^@IK&ELUXB8I7IT^/:.Y66?Y?X!N>.[N,5-:[2LQZR_DCR1Y;3V1
M[L]$*Y#N?N/L7R"[1YKW+VSR3,Y9V#S_ '5_>\CW>97TK=R+D86,7"PL>/\
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MX/\ Q[),*I2/0
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M6T36U;5G2:VB=)B8F)B8F-8GHE"UJVI::7B8O$Z3$]$Q,=<3'E?>^;\@
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M (8/_FAU(?;)_P#US_[A_P"Y(N\2?^Y?^._\DEW*0HN
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M
M
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M3O7(&_\ DW%[;.T_<]Q33]]36U?F=Z/3,('[HXF@
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MCTQGMECW(0-SEOOEW'LL5G7'ATQQ^]^-_#FS< @UJP
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MM?\ ]T?R _B-O?LSX&Y\>U]^NW#/T5'XQF0_XB_G3!^#_P >R3"J4CT
M                                               !6'?)W_:'>:'\
M1O:?^-.>Z[^$7[+^ ?HK;_V<+$\N_F+:?>*?.8*I%9D   !L8^(W^TG\//ZW
MM;_@O;(L\;OV3\=_ ;?;58'FC]7]W]ZGY\+,-R65[
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M1/D$_<*\W/X1/)/]C7-&\>&7[2>7OTYL/QK$RG _SUL_PK%_:55;[L(L<
M  LP?B,_LU_#W^J+7?X6VSDMXW?M8X[^'6^UJKWS1^L&[^^S\Z&QI%C @
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M-L\N&_Q+XK1/HFLQ*V'<7%9@
M
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M7YOAWK/GQQ-<6L=<8XE8;ESAOY*X/AVMHTS=WO7^NMTS'N=%?<:_4F,X
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M:8YM6=.[>UXTUUUGGD[AEN&\$I&6-,^:9R6CMCO1$5C[&(UCLF9:@TX-I
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MU]^NW#/T5'XQF0_XB_G3!^#_ ,>R3"J4CT
M                          !6'?)W_:'>:'\1O:?^-.>Z[^$7[+^ ?HK;
M_P!G"Q/+OYBVGWBGSF"J169    ;&/B-_M)_#S^M[6_X+VR+/&[]D_'?P&WV
MU6!YH_5_=_>I^?"S#<EE>P                          &.7F)^Z/Y3?P
MY=W_ +,^3MJY%_7?@WZ5VGXQC>_A7YTVWW_']O"JQ=DEDP    $F#[7_ />X
M\@/X<KW[3.!JE^U]^I'#/TK'XOF1[XB_FO!]_P#XEDWMSW0^          UX
M_*AXH2\R/"#N;J;4ZO\ 6O/]9J(]C]3VK5NW<SJ]D<#A?V^FUFMK=I6U:S.7
M:_\ .:&LY>E(V=K<_&/]]24/!SG3^XGB%L.-9[]SAE[^HW,]GJ,VE;VMIUQB
MMW<VGEQQU]3.\M\3_)/&,.ZM.F"9[E_K+=$S/ULZ6_>JS.490E*,HUC*-:QE
M&5*TE&5*^E8RI7TK2M*T_&CK9$Q,:QU+"OX    #,OP/\U>S/ WR$XSWAUY*
MNRP+=/U!V+P>_D2Q]7V%U_GY6->W7&LV[2-S\GFQEBV\K79E(3KA[#'LW:PN
MVJ7+-W0_$?D#A/B1RQFY>XI\#+/P\&6(UMAS1$Q3)'ECIFMZ]'>I:T:Q.EHQ
M/&N$;?C6QML\_1;KI;MK:.J?W)CMB9[=)BR9\:_)'J7RRZ<XAWCTMR2QR/A?
M+<*%SV5E9M[CC>ZM6K4MOQ+E6NMWKTM/RC09%VEK*QI2E3^]NVIW+%RU=N<H
MN;.5.-\E<=S\O<?Q3BW^"WG[N2DZ]W)CMI'>QWB-:V],3$6BU8@#B'#]UPS=
MWV>[KW<U9]R8[+1/;$]D^_TZP]W:X\0            #H?9W:'7O2_ ^2]G]
MJ\OT? ^ </U\MIR3E7(LR&%J]9B4N6[%KWW*TE<R,K,RKUNQC8]F-S(RLBY"
MU9A.Y.,*Y+A'!^*<?XEAX1P;!DW/$\]N[CQTC6UIZ_<B(B9M:=*UK$VM,1$R
M^^WVV?=YJ[;;4F^>\Z1$=<_].V>J(Z90!/EH^7'FGR \HCUQP'&V'!O%WA6_
MN[#C'&LF5+?(.Q=SA5RL/ YWSSZ7K#&E##OSKKM1;E.S@4O2E=N7[]8SM=+O
M!3P1V'AGL_RKQ*:[GG#<8N[DR1\3!6=)MAP^7IB._EG2;Z1$16NL3-W+'*^'
M@>/Y1GF+\2O729[*1VUK^[;M[-(Z]+:?&V@    )>?VM76.="QY==S9F'.&M
MR+W5_6/'L_\ G/IY&=A0Y5RKF.'Z^E+7OP\?/T4_PK*7I?\ Q]M/3W4?]L3B
M^.;<$X#2WW:(W&XO'DB?5X\4^[,9H]SM[(M\1]Q&NUVD3\+X=YC[&M?G62Z%
M(T7@     .K<YX;H>Q>$\PZ^Y5B_GN,<[XMR#AO(\']#_AFAY/J<O2;C%_G;
M=VW_ ,(U^=<A^E"4?Q_&E:?@]G#M_N>%<0P<3V=N[O-MFIEQSY+X[1>L]G5:
M(E],.6^#-3/CG3)2T6CTQ.L?-53W=_5'(NB>X^T>F.6VIVN2=6<]Y5P/;UE;
MI;CDY7&-UF:FN?8I&Y=MSP]E;Q8Y%B<)SMW+-V,HRE&M*U[,<O<:VO,? MGQ
M_93KM-YML>:OFC)2+:3U=-=>[,3$3$Q,3$2LKL]SCWNTQ[O%_-Y*5M'NQKI[
MG4\N9AZ0    $]OX.OE)UGEKU5K/'+N?DEBSY-=3:/'U^LS-MF0CF=T]>Z?$
MI9P>48-W(N?7V7-N-86/2QO[-???R(0M[*,KGULN.)S:]H;P=S<D\9OS5P#%
M,\H[W)-K16.C:Y[3K..8CHKBR3.N&>B*S,XM([M)O"G./+=N%[F=_M*__3LM
MM9T_S=IZXGR5F?B^3XO9&L@!6AI              #4Q\G_RN=2?'MP;(T>#
M<UG8/DGRG4Y%SK_JNQEQNX^E^K",,7F?9D\/(MYFBXEC3N>^QCTK;SMS<MUL
MXWT[=,C+Q9J\(?!CC?B=Q&-QDB^UY3PWCUVXF-)MIUXMOK&E\L]4VZ:8HGO7
MUGNTOL_+O+.ZX[F[\ZTX?6?A7\OU-/+;S]5>N>R)KV.Y>X^R?('L[F/<?;W*
MMAS3L3GFVGN.2<AV584NY-_Z-K$Q,3%QK,+6)KM3J=?C6<3"P[$+>-AXEBW9
MLPA;MQC3IWP'@/">6>$8.!<#PUV_"]M3NXZ5[(UF9F9GIM:UIFU[3,VM:9M:
M9F9E.>TVFWV.VIM-K6*8*1I$1_TZ9F>F9GIF>F7F3+O0     FX_;:^&61UC
MTCS;R^YMI)X7+N^)UXCUI+-L3LYN%T]QO8PO;+:V(W(VKUG&Y[S7!I/VRC6-
M[$TF'D6I5MWZ5KSZ]J[GVO%^8=OR/P_)WMCPW[KGTG6)W62NE:SV3.'%.GFM
MER5F-:H@Y_XM&XWE.%X9UQ8?A7^OF.B/WM?FVF.Q)J5(1X           JY?
MD Z-N>-WFIY+],4P_P!7ZWB/;');_&,3Z<K7TN#\IOPYEP&OLE&%*?5X3R'
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MEJ7I:-+4O69K:MHGJFLQ,3'E5ZR8[XLEL66)KDK,Q,3UQ,=$Q/H<X\[\
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MNFO_ #]\-?\ BAW1_AGKE>SV.OS;Q[[_ +7[3.E;PW_F=W]=C^==% 7028
M  VD?"M_:@^)/_&_F'[+>=H>\?OV0<;^\8OQC"UOF[]7-U];7[>JR3<I$ @
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MHM772]:VUA"W$N%;[A.X^3[ZDUMV3UUM'EK/5,?-CJF(GH9.M18X
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M?@7X#7[:RPG*_P"K^T^]1\^6N=*;/    )=OVK'_ +=W_P ,'_S0ZD/MD_\
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MA;G#EFW#,T\0V5?_ *=DMTQ'^;M/9YJS/Q?)\7R:R$58FC
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M.&;C<VG3N8;S[O=G2/=G2%J8XVJV@
M
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M,O>R89GT6];CB.RN.J:N0^(_*^$3L[SKEV]M/WEM9K\WO5]$0C^+,-X
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MM[7O:TZVM>TS:UIGMF9F9F?+*NU[WRWG)DF9R6F9F9ZYF>F9]UR[X/R
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M1,:Y,&ODB,E(Z(KCI'2C[C/(.UW4SGX3:,.:?H)UG',^:>NG\*/)$)2GC?\
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MZBG3/\+N_-3J'.I#0
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M'+S$_='\IOX<N[_V9\G;5R+^N_!OTKM/QC&]_"OSIMOO^/[>%5B[)+)@
M)O7VO_[H_D!_$;>_9GP-SX]K[]=N&?HJ/QC,A_Q%_.F#\'_CV2852D>@
M                                                *P[Y._[0[S0_
MB-[3_P :<]UW\(OV7\ _16W_ +.%B>7?S%M/O%/G,%4BLR    V,?$;_ &D_
MAY_6]K?\%[9%GC=^R?COX#;[:K \T?J_N_O4_/A9AN2RO8
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MX_NFO_/WPU_XH=T?X9ZY7L]CK\V\>^_[7[3.E;PW_F=W]=C^==% 7028
MVD?"M_:@^)/_ !OYA^RWG:'O'[]D'&_O&+\8PM;YN_5S=?6U^WJLDW*1 (
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M7O9=:S&.;:+SIS%'#=M/#MI;_7\M>F8^@I/7/FM;JCMB-;='P=9XCG"A<
M   !$]^YN\3;NXXKT[YF<7U?U<GB%ZG3':V1C6;D[T>.;K+S=WUQO,SZ</HV
M<#4\CO[+77KUROOG?V^%:IZTI3TNC[(_.L8-[O\ D/>7TIGCY5MHF>CUE(BF
M>D=LS:D8[Q$=$1BR2DSP\XG%,N7A.2>B_P!TIZ8Z+QZ9C2?WLH<R]:5@
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MW6-927HRC.,9PE24)4I*,HUI*,HRIZQE&5/6E:5I7\*JES$Q.D]:/7]
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ML]&OUUHZ/K939G/U$(
M
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MS\6N2[;.2^)?D_C=*7G3!GCU<^F?B3]EI'FB95W[J$G8
M   !NU^WQZQIV'\EO7.\NXU<K#ZAX!V=V=F6ZVY7+,*TXY+KS6Y-^M(UI;IB
M;SL'$NVY5K2E+\(4]?6M*5K][3G%_P E^$VZV\3I??;G;[>/+\?U]HCTTPVB
M?-,M0YYW'J.7LE(Z)RWI3YO>GYE96$SF(@P    !X?Y,=PX7C[X\=W=WY_T9
MVNJNK><<ZQ\:_*D8;#9\=X]G[#3ZF-:_A6]N-M9L8MNE?PK<O1I_=;#REP+)
MS-S1P_E['KKO=YAPS,?0UO>*VMZ*UF;3YH>SA^UG?;_#LZ]>7)6OHB9B)GW(
MZ55)MMKLM[M=GO-QFW]CM]SL,W:[7894ZW,K/V6QR;F7G9N3<K^-R_E95Z4Y
MR_NRE6KLO@PXMMAIM\%8I@QUBM:QU16L:1$>:(C2%E*UK2L4I&E(C2(\D1U.
M/?1^@             $]W[?OP1N>-'C'=\@.?:;\EV_Y-X>IY!BV<RU6.PXK
MTYBQEE\%TTH78>["S.62RI[S,I;E3ZN/D:^W>C&]BUC3FU[3/B/'-O-T<L\-
MR=[@?"+6I,Q\7)NIZ,UO/&/2,-=>JU<LUF:W0ISQQK\H<1^0X)UVNWF8\ULG
MT4_O?BQYXMIT2W_*T-(      0$ON$/,2/D-YC2Z6XKM89O6WBYB9_!X5Q,F
MY>PMGVIMKF)E=F[&L:5A:I>T>5A8FAK"L92M7]3D2C.L;WI3I5[,7(O]U^1/
MR_O*=WBW&+1FZ8TFNWKK&WKY=+Q-LWGC)6)C6J;>1N%?(>%?*\L:;C<S%O12
M/B1[O3;T6CR-"*R3=0         &;GQQ^2=?$OS6\?\ N[+S:X7&=#S;%T7/
M;E;D86/\GO-L?(X?S2_D0N?S-ZFKT.ZO9UJ,_2E,G%MSI6,HQE&/O%3E/^^O
M('$^7J5[V[R;>;X?+Z_%,9<41VQWKTBDZ?0VF.F)T8?C_#_RIPC/LXC7):FM
M?KJ_"K[\QIZ)6?ENY;O6X7;4X7;5V$;EJ[;E&=NY;G&DH3A.-:QG"<:TK2M*
M^E:.0LQ-9FMHTM"NO5T3UO\ ;^      "'']RQX3RTO*N"><G!M/7]6<NIK>
MKN[ZX6/6L<;D^LPY0ZZYGGUM1G.E-WH<.YI<F_<K"S:GK=?;IZW,C\;V>R;X
M@1N-GN?#OB.3[K@[VXVFL]>.T_=\4?67F,M8C69C)EGJJE;P^XOW\=^#9I^%
M76^/T3\:L>B?A1Z;>1% 7028          R3Z[\RO+CJ2Q9P^LO)WOS@NNL4
MK&WI^,]M\ZU6BK&MJ=FD;NBQMY#3WZ6X7*^RD[$O9+TE'TE2E::IQ3D/DCC=
MIR<7X1PW<Y9^BR;;#:_E^/-.]'GTGIZIZ&/S\)X7NIUW&WP7MY9I69]_35[U
M?^63Y(<G"G@7/,;NJ-B=F-BMRQR*UBYM(1I&E)0V6+AV=C;O5]OXW(W:7*_C
MZR_&K6Z^"OA33)ZV.!</[VNO329C[&9FNGFTT>*.6. 1/>^28=?1^YU,1>T.
M\^Z^[MC9VW<O;W9W;&SQJRKBYW9'.^4<VR<.DHTA[,.[R3:;*6';I;I2-(6O
M9&,*4C2E*4I1N_!^7>7^7L4X. ['9[+#/7&##CQ1/I]76NONZ]+*;;9;/9U[
MNTQ8\5?J*Q7YT0\L9AZ0       'N'C3T5RCR:[^ZCZ#X=&Y3?=J<YT?$[>9
M;L5R8Z769F5&YR'DN58C*,KFOXMQZQE;+)I2ON_+XLZT]:_@U[FWF/9\H\M;
M[F7?Z?)MGM[Y--=._:(^!CB?ILEYKCK]5:'CXAO<?#MCEWN7XF*DV],]D>F9
MTB//*U X)PKCO6W!^&]=<0P::SB? >*<=X5Q?6QK[HZ_CO%M1AZ/2X,9>D?=
M3$UN#:MTKZ4]?:XX\2XANN+<1S\4WUN_O=SFOER6^FODM-[S[MIF5;LV;)N,
MU\^6=<M[3:9\LS.LS[\NUO$^0    ")=]T1WS;QN.>,_C)K<_P!<C:[?D?>/
M,-=&5(RLXFGQ;_!>OLBY2E:SN6<_)V_(Z>E?2-)XE*_I5]/;=;V/^6YMNN+\
MW9:_!I2FTQ6\LVF,V:/3$5P>Y;WY.\.=EKDW'$;1T1$8ZSZ?A6][2GOH>J\R
M5               %@E]O1TI_DJ^.CB?+LO$_+;GO?L'G7:>76[#VY<=5CYU
MCKSCEJ<ZT]?R>1J>#1SK$:5K'VY]9T]*SDYE>T]S!^6?%//L:6UP<-VN';QY
M.],3GO/IBV;N3]9IV0@[GK>?*>/6Q1/P,-*T]W3O3\VVD^AO)5X:<
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M.W$/EO';XZSKBP1&./3'3;W>],Q[C=8@!J(
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M,86[=N$:1A"$(TI&$(1I2E*4IZ4HYY3,VF;6G6TH<Z^F>M_M_
M   !CEYB?NC^4W\.7=_[,^3MJY%_7?@WZ5VGXQC>_A7YTVWW_']O"JQ=DEDP
M    $DCX6_E?\7_ /H;M3K?O/7]J9?(>9=N7.;ZB? ^)Z?D&NCII<-XQH:0S
M,G8\JT-VSF_GM/=K[(VYQ^G6-?=ZUK2E4O'WP7YP\2^9-GQ7EVVSKM<&Q]5;
MUV2U+=[UN2_1%<=]8TM'3K'3KT- YNY9XCQO>X]QLIQQCIB[L]ZTQ.O>F>R)
M[);C_P#:3_CQ_P#$GD;_ )M>+?Z1D$_\J'BA_2<*_K\G^@:G_A_QWRX/LY_D
MG^TG_'C_ .)/(W_-KQ;_ $C'_*AXH?TG"OZ_)_H#_#_COEP?9S_)/]I/^/'_
M ,2>1O\ FUXM_I&/^5#Q0_I.%?U^3_0'^'_'?+@^SG^2?[2?\>/_ (D\C?\
M-KQ;_2,?\J'BA_2<*_K\G^@/\/\ COEP?9S_ "3_ &D_X\?_ !)Y&_YM>+?Z
M1C_E0\4/Z3A7]?D_T!_A_P =\N#[.?Y)_M)_QX_^)/(W_-KQ;_2,?\J'BA_2
M<*_K\G^@/\/^.^7!]G/\D_VD_P"/'_Q)Y&_YM>+?Z1C_ )4/%#^DX5_7Y/\
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M .)/(W_-KQ;_ $C'_*AXH?TG"OZ_)_H#_#_COEP?9S_)/]I/^/'_ ,2>1O\
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M'G];VM_P7MD6>-W[)^._@-OMJL#S1^K^[^]3\^%F&Y+*]@
M            ,<O,3]T?RF_AR[O_ &9\G;5R+^N_!OTKM/QC&]_"OSIMOO\
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MG[I,1%(F.NN*N.D]M9E)7"N7N%<&K_J>./7:=-[=-Y]WLU\E8B/,P*22S0
M   #D=/I]MR';ZK0:'69^ZWF\V.#I]+I]7B7\_9[;;;/)M86NUFNP<6%W)S<
M_/S+\+5FU;C*=RY.D8TK6M*/EGSX=K@ON=S>N/;XZ3:]K3$5K6L:VM:9Z(B(
MB9F9Z(B-9?F]ZXZ3>\Q%*Q,S,]$1$=<S/DA8P?#_ /'5@^ ?CCCVN6X>%?\
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M>*W,7=O'#IV.VM]'O+1@TU\N+2V>/ZGH;'LN3N/[W2?4^JI/;DGN_P 'IO\
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M:?>C66CWRF^X@\(NCK6TTG3D^1>3_.\2EVS8Q^$6[O%^M[.?;K6GT=EV1R+
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MTF.BUIO?X4>KF(8YUYACB.Y_)VTMKLL-NF8ZKWZM?/6O5'EG6>GH2(U76B
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M:_[J"LV'-M\ML&XI:F:LZ36T36T3Y)B=)B?2U6U;4M-;Q,6CKB>B7WOF_(
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M(
M
M           "OI^X$\8Y="^?')>?Z?7PQ.$^2NBP^V]5/&L6[&'9YE27Z@[+
MUWNC+W7]ED\CP([O)G6-*5KO(?C6M)>G3;V9N;O[R>&V+AF>W>XAPG).VMK.
MLSB^/@MYJQ2?55C_ *F?,G'D?B/RW@E<%YUS;>W<GZWKI/HTGNQ]:T=+#-Q
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MQVFXW'F^)&"L^Y;/$QYXCM;AR+M_7\P4O/3&+'>_S.Y'S;0KXW3=.0
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M.@./)3+2N7%:+8[1$Q,3K$Q/3$Q,=$Q,=,3'6EV)BT1:LZUE\[]/Z
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M6X76*S7IR8XZM.V]8[-.NT1T:=,:3$ZR^U'46@
M *P[Y._[0[S0_B-[3_QISW7?PB_9?P#]%;?^SA8GEW\Q;3[Q3YS!5(K,@
M-C'Q&_VD_AY_6]K?\%[9%GC=^R?COX#;[:K \T?J_N_O4_/A9AN2RO8
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MOXE;]^)^=>9XSS;@W#[?<8G3+:/HICZ")\D?13VST=43K*N4T1J
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MZ6UK>NO1:)ZXTE8'8[[;<1VM-YM+=[!>-8\L>6)CLF)Z)CRO&6>>L
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M&D6,"                    AQ_=-?^?OAK_P 4.Z/\,]<KV>QU^;>/??\
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M/V'#L,;?A^##@V\?0XZ5I7[&L1'S&9Q8<6&O<PUK2GDK$1'O0ZT];Z
M   ,^OCV^/;N/Y".X['7_7]BYQ_@?'[F#G]K]KY^#=R./< X]D79TC&,:3L0
MW/+=S"Q=MZK56[L+F5<A*Y<E9Q;.1D68U\3_ !/X%X8\"GB?$YC+Q++$UVVV
MK.E\UX]_NXJZQ.3),3%8F(B+7M6ML)QWCNTX%M/7Y_A9[=%*1UVG]RL=L]GG
MF8B;%OQ=\7>G/#[ISC72'2'&K?'^(\?MUOYF9?K:R.0\MY#D6K,-MR_E^VA9
ML3W/)=S.Q&MZ]6,+=JW"W8Q[=G&LV;-OEISASAQWGGCN;F'F'-.7?99TB(Z*
M8Z1KW<6*NL]W'77HCIF9F;6FU[6M,#<1XCN^*[NV\WEN]EM[U8[*UCLB/_#.
MLS,LAFL/"         CC?/\ ?&UD>1G5=ORTZ>T'YSNGI'C]ZSSS1ZS&G/9=
MC=0X,[^?DW<:Q9C*N=R;KJ=^_FV(^E+N5J[F59I*[=LX5BMJ/9H\5Z\J\9GD
MKCN3N\ XAEB<-[3\'!N9TK&LSU8\^D4GLKDBEM(BV2S?>2.8(V&Y_)FZMIM,
MUO@S/52\]'N1;JGR3I/5,R@NNBB90       'NO37D]Y%^/&;^>Z-[P[2ZJG
M.]]?)Q.$<VW^BT^RG6L)5CN-#AYT-)NK,I6XUK;R\>];K*$:UCZQI6FN\>Y0
MY6YHQ^KYBX=L][&FD3EQ4O:OUMYCOTGSUM$];Q;OAVPW\=W>8<>7ZZL3,>B>
MN/<EM5ZM^X>^23KRUCX_(^7=7]RX^/'Z<8]G=9ZW'R)6J>M(QN9W66;UOFW[
MD(_A2Y=G<G*M/6=95]?6&N,>R]X4<4F;;7!O-A:?]WW%ICWMQ&>(]$1$>31K
M6YY$Y?S]..N3%/U%Y^=?OLY^'?=+]GX-F$>P/$#@?)\BE)?4N\.[9Y#P6S.5
M8QI"L+&[X7V).W2,_6M:5N2]:5I3UIZ>M8ZW_L=\(R6G\F<<W.&O_6[:F:??
MIEP?.8;+X;[>9^X;J]8^JI%OG6JR!U'W2G4UZ-ZN^\1NQ-;.-+/T(ZCL_C6[
MC<E*ES\Q2]+-XMQ^MBEJM(^RL:7/J>M?6D/2GNUG/['?&ZS'R;C>UO'3KWMO
MDIZ--,E]?/U:>?L\5O#C=1\3=8Y]-)C]V7,_[4=T+_JM=N_\LN&__F7G_P"3
MWF3_ (QL?ZK+_E?C_#C>_P"\XOL;.K\A^Z8ZYQHSKQ3P[YMNITL6Y6X\A[@T
M7&(RR:WI1NV9SUO N75A8ACTI*-RD92E.M8UA&E/?7V;7V.N*WG_ %WCNWQQ
MK]!MKY.C3K^%FQ=.O9Y.G7L?3'X;[B?YW=TCT4F?GVJQHYW]T;W_ +"E_P#R
M9>+O3W$92G6N-7G?+>:=BTLV_J9-8QOQX_3JVN1.EJ5F-91K:I64)R]*4G&-
MO;>'>Q]RSBT_*_&-]GCM]3CQ8->KJ[_RC3IU\O7'DUG(8?#C8U_VC<Y;_6UK
M3Y_?:^^V?GB^2_M6QD8%CN[7=7:C*A.%_6]3<'XOQB_^E2E(RQ^3[' WW-\"
M=NGKZ5Q]I:]?=ZR]:TC6DF\$]G#PEX-:,EN'WWF>O5;<YLF2/=QUFF*?WV.?
MGL[M>2^7MM/>G#.2T=M[3/S(TK/NPU:]B]K]H]O[RO)NV.R.>=G<CK&Y']?=
M@\NW_,MQ2%V=+ERW'9<BV&QS(6YSI2M8TG2/K3^1,7"^"\'X'M_DG!=IMMGM
M?I,.*F*OV-*UCYC8\&VVVUIZO:XZ8\?DK6*Q[T1#H+)/N        DQ_!;\2
M65WIR?0^8OD=QB]:Z1XALH;'J#A.[Q)6K?;G+]7DQEC\JV>'E6O^&=;<6S+-
M:VX>GTMQLK=+=92Q<?)M9%2O:*\;*<N[3)R)RKFB>8,].[N<M)_V;%:.G'68
MZL^2)Z9Z\6.=>B]Z6I'O.7,\;/';A6PM_KEXTO:/H*S]#'U<_P &//,3$WAS
MX0^            K//ER_M)_,/\ K>V7^"]2ZT^"/[)^!?@-?MK+"<K_ *O[
M3[U'SY:YTIL\    EV_:L?\ MW?_  P?_-#J0^V3_P#KG_W#_P!R1=XD_P#<
MO_'?^22[E(47                    ,/?.GPVZ[\ZO'3F/0_/_ &:[(V,(
M;O@7,K>);R]CP#L#5V<BG'N58%J4K<K]FU+(N8N=CQG;KF:W)R+%)VZW*7(;
MSX=<^<4\.N:<',G#/AUI\#-BUTKFPVF._CGR3T1:EM)[N2M;:3II.5X-Q;/P
M;?TWN#IB.BU>RU9ZXGY\3V3$2K1>^^BNR_&GMWG'2';V@N<<Y]P#<WM/NL&L
MI7L/*A2,;^OW6FS:V[4=EH-[KKUK+P<J,:1OXUZ$_2E:UI3K/RWS'PGFW@FW
MYAX'EC+PW<XXM2>J8[+4M'T-Z6B:WKV6B86#V6]V_$-K3>;6W>P7C6/W8GR3
M$]$QV2\@9QZ@      'NO37D]Y%^/&;^>Z-[P[2ZJG.]]?)Q.$<VW^BT^RG6
ML)5CN-#AYT-)NK,I6XUK;R\>];K*$:UCZQI6FN\>Y0Y6YHQ^KYBX=L][&FD3
MEQ4O:OUMYCOTGSUM$];Q;OAVPW\=W>8<>7ZZL3,>B>N/<EM6ZO\ N(/DEZ^M
MX]CDG+NK>Y<?'A"U&/9G6.KQ;\[,(TA"EW-ZOS.MLS(O1A2G\[=G<N3E3W7*
MSE6M:PSQCV7O"CB<S;:8-YL+3T_ZON+3&OFC<1GB(\T1$1U1HUK<\B<OY^G'
M7)BGZB\_Q^^SFX=]TOV?@V81[ \0.!\GR*4E]2[P[MGD/!;,Y5C&D*PL;OA?
M8D[=(S]:UI6Y+UI6E/6GIZUCO?\ L=\(R6G\F<<W.&O_ %NVIFGWZ9<'SF&R
M^&^WF?N&ZO6/JJ1;YUJL@M1]TIU)>MW:[[Q'[&UMVGT_HPU'9O&=W;N>L9?6
M^K<S.,<?E:^G*E*1](3]]*UK7V^GI76,_L=\;K,?)N-[6\=O>V^2GHZLE]?F
M:>=X;>'&ZCXFZQSZ:3'[LN8_VH[H7_5:[=_Y9<-__,OA_P GO,G_ !C8_P!5
ME_ROS_AQO?\ ><7V-G6=_P#=,=;XT9_T6\/.;[B5,:DK=-_V]H>-1EE_4G25
MB<M=P3E=;>-2U2,J7:4E*LJUC].E*4E7V;;V.N*W_P!LX[M\<:_0;:^3H\OP
MLV/IU[/F]CZ4\-]Q/\YNJ1Z*3/S[58S<[^Z-[_V%+_\ DR\7>GN(RE.M<:O.
M^6\T[%I9M_4R:QC?CQ^G5M<B=+4K,:RC6U2LH3EZ4I.,;>V\.]C[EG%I^5^,
M;[/';ZG'BP:]75W_ )1ITZ^7KCR:SD,/AQL:_P"T;G+?ZVM:?/[[7EVW\[/R
M8=L6<O AWMC]8Z;,]WU-7U)POB_$;UKU]:1_*<JOZ[;\\POIQE6E/I;:'KZ^
MLO6M(UI*'!/9S\)>"VKEGAT[S/7Z+<Y<F6/=QQ:N&?=QSYNUGMKR9R]MIBWJ
M9R7CMO:;?,UBO\%JQYSV+V#V?O;_ "CLKG7,NP^397K^9Y%SGD^[Y;O<CUKZ
MU^OM]_G;#87O6O\ ]%<JF/AW"^&<(VT;/A.VP;7:1U4PXZ8Z1Z*TBM8]YLF'
M!@VU/5[>E,>..RL16/>C2'3GN?4      !]&'AY>QR\77Z_%R<[/SLFQAX6%
MAV+N3EYF7DW8V,;%Q<:Q&=[(R<B].,(0A&LIRK2E*5K5^<F2F*ELN6T5QUB9
MF9G2(B.F9F9Z(B(Z9F>I_)F*Q-K3I6%@#\)?Q@4\(^I+W;_;NELV_)ON/2X?
MZ]Q,F$+F3U5P2_.QLL#KJQ<K2OTM]FY-NSE[^4*^W\W:LXL?='$^K>YG^T#X
MO?X@\;C@? \DSRCL,D]R8ZMQFC6ML\^6D1K7#K]#-K]$WTK"'-_,7Y8W7R7:
MS_\ 3L4]'U=NJ;>CLKYM9[>C>DKJTT
M
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M-,VCSX/?CCQ#XCZK:XN%TGX>6W?M];7HK$^:;=/IHFE*"HD
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M'#.+Y]E3^;I?X/UMHBU?>B8AFDT%B                       %8=\G?\
M:'>:'\1O:?\ C3GNN_A%^R_@'Z*V_P#9PL3R[^8MI]XI\Y@JD5F0   &QCXC
M?[2?P\_K>UO^"]LBSQN_9/QW\!M]M5@>:/U?W?WJ?GPLPW)97L
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MRTF>NEZZ3';$ZUMI:LQ$ <3X=N.%;V^QW,?=*3U]EH[+1YIC_)/3$LBFK/
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M$Z6I>O5:EXK>L]%HB>A-.TWFUW^WKNMG>N3!;JF/G3VQ,=L3I,=L/*V9>D
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M-]CKPOB%O]=K&E+3/\Y$=D_5Q[]HZ>N)UC4+8I!
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MM:UIUF;3,S,S,ZS/3*%[WODO.3),VR6G69GIF9GKF9[9ERSXOR
M  K//ER_M)_,/^M[9?X+U+K3X(_LGX%^ U^VLL)RO^K^T^]1\^6N=*;/
M)=OVK'_MW?\ PP?_ #0ZD/MD_P#ZY_\ </\ W)%WB3_W+_QW_DDNY2%%P
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M/2+X\E)BU;UM&L3$QUQ/_@GI3GAS8MQBKGP6B^&\:Q,=,3$]L.KO8^@
M                #^QC*<HQC&LI2K2,8QI6LI2K7TI&-*>M:UK6OX4)F(C6
M>H3/?A'^&;(ZKGQCS'\L^+PAV/>QL?<]*=.\@P(3N==V[]+>1K^Q><:_,MRK
M8[ G:])ZK73C2>CC+\Q?I38UMV]?0GV@O'FG&8S<B<E9M>%1,UW>ZI;^?TZ+
M8,5HZ\/9DO'1F^+7[EK.6)><.;(W/>X5PRW^K]62\3\;RUK/TOEGZ+JCX/QI
M3JG*-P
M
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MLQIDIWJ3K$3-;ZUB:N#<>X?QO#W]I;3-$?"QST7K[G;'DM&L>B>A@@D=F@
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MT5S4M/7YH>SAUZX^(8,EOBUS4F?1%HE5+NS2RP
M            "P,^W9R,B]\:G$;=Z_>NV\3MCMC'Q+=V[.Y#%QY;S'RY6,>$
MY5C9LRRLJ[=K&/I&MRY*7IZRK6O,SVHZUKXLYYK$1-MEMIGSSW)C6?+.D1'H
MB([$'\]Q$<P7T[<5/G-YZNS30                      %8=\G?]H=YH?Q
M&]I_XTY[KOX1?LOX!^BMO_9PL3R[^8MI]XI\Y@JD5F0   &QCXC?[2?P\_K>
MUO\ @O;(L\;OV3\=_ ;?;58'FC]7]W]ZGY\+,-R65[
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M$6B-)O2FL)IX'S-P[C=(KCGU>\TZ<=IZ?/-9^BCSQT^6(:P4O-B
M             ?KCX^1EY%C$Q+%[)RLF]:Q\;&Q[4[V1D9%Z<;=FQ8LVXRN7
M;UVY*D8QC2LI2K2E*>K^6M6E9O>8BD1K,ST1$1US,]D0_DS$1K/1$).?QF?;
M[<Y[:O:#NCSBU^[ZUZN]^/LM%T=&[D:;LWGEF/LOV9\XNPI#,ZYXME?A">+2
ML-_DP^I3TUU/HY%VHOBW[37#N"5R\ \/+8]WQCIK?=Z1;;X9ZI]5'5GR1V6Z
M<-9T_G?A5B/.8>>,.UBVTX/,9-SU3DZZ5^M^FGS_ !8^JZ83-^"\$X7UAQ#C
MW7_7?%M%PGA'%-;9U'&^*\9UF+I]'I==8K*4,7 U^%;M8]B$KDY3G6E/=<N3
ME.=93E*M:%\1XEO^+[[+Q/BF;)N.(9KS;)DR6FU[VGMM:=9GR1Y(B(CHA$V;
M-FW&6V?/:U\UIUFTSK,SYY=L>)\@           'P;35ZS>:S8Z3=Z[ W&FW
M&!F:O;ZC:8>/L-9M-9L,>YB9^NV.!EV[V+G8&=BWIVKUF["5N[;E6,J5I6M'
MTPYLVWS4W&WO;'GQVBU;5F:VK:LZQ:LQI,3$Q$Q,3K$],/U6UJ6B])F+Q.L3
M'1,3'5,3Y4(;Y=O@[Y+X^9?*O)/Q'T.SY9T)=NY_(.<=6ZS'R=ER;I3&_F\C
M-V.EMQNY.QY/UIC2G>NSG2%<O18L/7(K>Q;=S*M="/!#VAMIS/3#RGSODI@Y
MDB*TP[BTQ7'NYZHK?JKCSST1$:]W-:?@]V\Q29@Y7YQQ[Z*\/XI:*[WHBMYZ
M(R>:>R+_ #+3U:3T3&L6P2                      _7'Q\C+R+&)B6+V3
ME9-ZUCXV-CVIWLC(R+TXV[-BQ9MQE<NWKMR5(QC&E92E6E*4]7\M:M*S>\Q%
M(C69GHB(CKF9[(A_)F(C6>B(2M_BI^ ?;\ER.->0GGAQO*T?&K-S$W?"_&[:
MPNXF\Y%Z1CDX.S[AL4E;R-#IJ2K"=..UK'.R:TK#8TQ[4;F)D4Q\9?:5P;2N
M7ECPXRUR;N8FF7?5Z:4[)KM9ZKVZX]?\2O7B[TZ7K&G,O.]<<6V/!;:Y.JV6
M.J/+%/+/U75'T.O7$Q+6ZW7:;7:_3Z?7X6IU&IPL76ZO5ZW%L8.NUNNP;%O%
MP=?K\'%MVL;#PL/&M1MVK5N,;=NW&D8TI2E**+9<N7<9;9\]K7SWM-K6M,S:
MUIG6;6F=9F9F=9F>F9Z915:UKVF]YF;3.LS/3,S/;+[7S?P            !
M6>?+E_:3^8?];VR_P7J76GP1_9/P+\!K]M983E?]7]I]ZCY\M<Z4V>    2[
M?M6/_;N_^&#_ .:'4A]LG_\ 7/\ [A_[DB[Q)_[E_P"._P#))=RD*+@
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M=M:^7MMU=$:Q,FE4A'@
M
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M'Q+=,1%+5TG'E;F;'QO!ZC<36O$J1\*.KOQ]/6/MHCJGS3#2VGQMH
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M3$X\,9+Q;JB\5CKF&M<V<3_)G!<MZ3IGR_<Z>76W7/N5UG7RZ+(ARG0$
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M_4TK$3/PIUM,S,3[_B.]XGGG<[[);)E\_5$>2L1T1'FB//UO?6M/$
M            _DHQG&4)QI*$J5C*,J4E&494])1E&OK2M*TK^-")F)UCK%7C
M\@WC%M?$#S [PZ-S,&]B:'0<RV.XZ]R)VKD;.TZRY1>GON!YV/>E9LVLF=GC
M^=:Q,N5JDK5K88V19I6M;578#PQYOP\\\C<.YBI:+;G+@K7/';7<8X[F:)C6
M9C6\3:NO3-+5MVK&<#XC7BO"L.\B=;VI$6\UXZ+?-Z8\TQ+#-OC+
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MQ#-AV]//KDC+?W/58KQ/IC7K:CSONZ[;E_)CU^'FM6D>_P!Z?X-96&;F @L
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M>R<C35Q+5;?77)\Z5:UK6U:GJ,N][?J6L24[V76V'A+[3'%.6JXN <]>MWW
MZZ5IN(^%N,$=41;7^?QQYYC+6.J;Q%:) Y>YWS[&*[3BO>R[6.B+]=ZQY_IH
M_A1Y9Z(0P^W^F.UN@>>[GK#N?@7)>M^>Z"[6&RXWRC7W,#,I:K=O6;.PP+WZ
M>'M]-FRL3KC9V'=OX>5"GOLW9P])+Z\#X_P;F7AN/B_ -SBW?#<L?!R8[:QK
MT3-9CKK:-8[U+1%JST6B)2UM=WMM]@C<[2]<F"W5,3\R?)/EB=)CMAYDR[T
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MK"PY7+E:W,J_U%R3;Y,,3!C*Y7ZE-%M+]O'MQK.F'EVXQL8"ZOA/[47JJXN
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ML3K..E-9A#O&^9.(\<OIFGN;2)Z,=?BQYYGKM/GGH\D0V7(F:\
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M.^GT&2M;1Y$H;+?[/B.&-QLLE<F*?)/3'FF.NL^:8B7B;8'L
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MZ1%,71$^KFT=Z8BXYS9Q'C.N&)]3L?I*SU_7VZ)MZ.BOFUZ6W]!S5@
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MUM'76T?14M$6K/1,1*6=IO-KOL$;G9WKDPVZIB?F3VQ/EB=)CM>7,P](
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M,VVR>::Y+9*1V_YG)BGW>C2.A.W)6ZKN>7L-8G6^*;4GS:6F8_@VJTVIW;8
M   FZ_;$=3[3C/B[WQV]L<>_BXO:O;^MX]HJ7[5(0V&GZPXW2%S;XES^6]BW
M-]S3.P_7^2E[!N4_N5<^?:[XUAW?.'#>!XIBU]EL;7OI]#;<9/BSY)[F*EO1
M>$/^(FYKDXEAVM>F<6*9GS3>>KWJQ/NI,RI*/0
M&#_G#\?7CIY]=?1X?W3QJ5CDNFL97] NT^.0Q,'L'@69D^D[GZHVM['OV\_1
MYEV,:YFJS(7L'*]*3]D+\+-^U(7AYXF\T^&O$_EW ,NNTR3'KMODUG#FB/IJ
MQ,:7CZ')68O7JUFLVK.8X/QS?\$S^MVEON<_&I/Q;>F.R?),=,>C6)@B>?\
M\3GD_P" FXSMORK27.R.C[F;]'0]Y<+UN9=XS2UD9%NQ@8?.-=2N5F=>[_(G
M?MVZ6,V<\/(ORK##R\KVRK3HWX:>-/*'B5@K@V>2-IS#%=;[3+:(R:Q&LSAM
MT1FI&DSK2(M6.F]*:PF?@?,_#N-TBF.?5[S3IQVGI\_=GZ*/1TQVQ#5^E]L8
M                 #.CPJ^.KRA\\>5V]/TIP>_;X;A;"WA<L[<Y3;R]/UEQ
M#_O-S(MYW(/RUZNWW-G'OPG35ZVWF;&49QG6S&U6MR,=\_\ BER?X<;*<_,&
MXB=_:NN/;8]+;C+UZ:4UCNUF8F/67FM.B8[TST3AN+\>X=P7%W]W?[K,?!I'
M3>WN=D>>=(\^J=-\=_Q,>./Q]:BUON/XU>S>^-AKY8?(^[.5:[&M;:Q:R;5;
M6;I^ Z:ES,Q^"<=R8SE&["S>OY^9&OMRLJ];C;MV^=7BCXU<U>)N>=MN9^2<
MN5MK3:8[3W9TGHMFMT3FO'9,Q%*]=*5G69AKCO,^_P".6[F2?5[*)Z,=9Z/3
M:?HI^9'9$-IJ'&M@
M
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M^ZPTRX[1]%2]8M6?-.D],=<3T3TK&;?/BW6"FYP3WL.2L6B?+$QK#I;WOL
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MM[T:5\TQ/E2%U86B@
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M8CH1GQ;F/BO&)F-UDTV_]'7X-/=CKMZ;3,^1L+1@P0
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M6VD=R+Z/S=S/BX;M[</V=HGB-XTG2?YN)ZYF8ZKZ?%CKCXT]FL]9S<0J
M                    TG_-[\=VQ\W_ !RP^8]8:FNP\@N@Z;KDG!M9B6(R
MSN?<4V-C&N<RZ[M>RE+V1MLV&LL9NGC7W^N?C5QH4A^=N7(V ]GOQ1Q>'O-5
MMCQ>_=Y9XEW,>:TST8<E9GU6>>R*QWIIEZO@6[\Z^KB)V_D_CM>#[^<6XG38
MY](M/96T?%MZ(UF+>:=>Q7N9F'EZ[+RM?L,7)P<_!R;^'FX698NXV7AY>-=E
M8R<7*QK\87L?)Q[T)0G"<:2A*E:5I2M'3K'DIEI7+BM%L=HB8F)UB8GIB8F.
MB8F.F)CK3E$Q:(M6=:R^=^G]  ?V,93E&,8UE*5:1C&-*UE*5:^E(QI3UK6M
M:U_"A,Q$:SU"P,^"CX]MYX9>.FV[&[6TN1I>]_(6NEWW(]!L;$[&SX%P33V\
MR?"^&;#'O4I>P=_?_6F1LMK:K2W<M7LFSBWH4N8=:UYF>T7XG;?GWFFG"^"Y
M(R<N<+[],=ZSK7-FMIZW+68Z)I'=K3'/3$Q6UZSID0?SGQVG%M_&#;3KLL&L
M1,=5K3\:T>;HB(]$S'6WG*[--                            0G/N)/C
MSWW7G;5WSAZQX[>R^L.U9ZW [HM:C#G<M\&[0L6K&JPN5[2UCQ^G@\?[&P[6
M/"636/TX[ZS>^O<I>V&-&?0'V7?$_;<4X)'AYQ?+%>+[+O6VLVG^>V\S-IQU
MUZ[X)[T]WK]3->['=Q7F)>Y$X[3/M?R/N+:;C%K./7Z*G7W8\]>GH^ETTZ*R
MC#K=I$   >F]-=/=A]_]H\)Z;ZHX[E<J[ [ WF-H..:7%](?5RK_ +KE_+S<
MF?I9U^IU>':N969E7:QLXN+9N7;DJ0A*M,1Q[CO"^6>#[CCW&LM</#-MCF^2
M\]D1U1$==K6G2M:QTVM,5CIEY]WN\&QVU]WN;17!2-9G_IUS/5$=L]"SD\)O
M%CBWAAXQ]5>._%K]G94X/HO=R;D5K&KBRY9SC<W[NWYER>=F<KE^U9VF^S+U
M<6U<G<GBX4;./[I1M1JY&>('..\Y]YNWO-&\B:?*,GW.FNOJ\-8[N+'KU:UI
M$=Z8B(M?O6TULKOQ?B63BW$<N_R='?MT1]+6.BL>Y'7Y9UGM95--8T
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MM-K6M,VM:TSK-K6G69F9Z9F9UF>MHMK6O:;WF9O,ZS,],S/EF7(/D_(
M               #6Q\@_P 7?CI\A/%*?T[UU>$=QZ367,'@_=_%L'$KRO3V
MX?6OX>DY-BW*V+'-^&6\V]6Y+795R%VQ]2[7"R<.Y>NW)2OX8^,'-/AAO?\
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MZ]-:S,1,:]-9TF.V(;]M]SM]WBC-M<E,F*>VLQ,?,[?,\_9-]P
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MO8]>J\I-X9QWA?%ZZ[++6V33II/1>/WL],Z>6-8\["YOS+@
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MS,S/GF>F78WE?,
M
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M.B^:.G6O<I,:9-8W3DWE_P#*N\^6;FO^H8;1U]5[]<5\\1UV\VD=J 2Z6)N
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M6=<M[3:9\LS.LS[LNQ/*^8
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M_P#QS_\ (?\ R1_B3_Z%_P!M_P":/]E8_P#?N_\ DP?_ #PY_P Y/_\ '/\
M\A_\D?XD_P#H7_;?^:/]E8_]^[_Y,'_SPY_SD_\ \<__ "'_ ,D?XD_^A?\
M;?\ FC_96/\ W[O_ ),'_P \.?\ .3__ !S_ /(?_)'^)/\ Z%_VW_FC_96/
M_?N_^3!_\\.?\Y/_ /'/_P A_P#)'^)/_H7_ &W_ )H_V5C_ -^[_P"3!_\
M/#G_ #D__P <_P#R'_R1_B3_ .A?]M_YH_V5C_W[O_DP?_/#G_.3_P#QS_\
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M6VFPB<.RGHF=?AWCR3IT5B>V(UU[;:3HD)JQ-&
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M,?K>!;_9[S'Y<&;'E]_N6MI,=L3TQVMEVV^V6\CO;3+CRQ]3:+?.F7DK-/4
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MH1MVK5N,86[=N$:1A"$(TI&$(1I2E*4IZ4HAJ9FTS:TZVEK77TSUO]OX
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MVR9+VZ[7O,S:9]V>J.B(Z(B(0=GSY=SFMN,]IMFO:9M,]LSTR[>\+Y
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M8PX=/)./%%:WT\N3O6\[2^(<P\8XGK7=Y[SBGZ&/@U^QKI$^[K+.Q'+#
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M;F]\FXO.MK6F;6M,]<S:=9F9\LRU2][Y+3>\S:\]<S.LSZ9<D^3\@
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M5GX..)^#'GGZ:WGGW(B)T;'$5L                            ^/8:_
MVV#F:O:X.'L]9L,:]AY^NV&-9S<'.P\BW*UD8N9B9,+F/DXU^U*L9PG&491K
M6E:5H_>++EP9*YL-K4S5F)K:LS$Q,=,3$QTQ,=DP_M;6K:+5F8M'5,=;3MY,
M_!%\?/D7<V&YU77.?T!S/-^I=_I%T5F8?$]5/)K7ZENN7U_FZ_;< IC5N^OU
M:86NP<B[&5:?6C+VRC.O*7M&^)W*T5P9MU7B>PKT=S>1.2VGFS1:N;7R=^]Z
MQ]+/3$[7P[G/CFPTI;)&?%'9D^%/V6L6]^9CS-"'D!]LQY3\)N;#9^/?:W6W
M>.DM3G/#T7(Z9?57/KT)RE*UC6<?8W=]P?+GCP](3OWMW@4N2_2C:C2M8QLG
MRS[6W)W$(KAYGV6[X=N)Z[TTW&&//,UBF6->R(Q7TZN]/7.Z['Q#X;FTKOL6
M3#?RQ\.OS-+?P9]+3=W)\>WF]T!/,EVQXN]R<:U^OG>AE\CQ.'[#E7#;4K%*
MRN5_IOPZ._XA<A[(UE&4<Z49QI64:UI2M:3MP'Q/\/>9HK'!>,;#+EMII2<M
M<>6=?^JR]S+_  .CM;9M..\'WVGR;<XK6GL[T5M]C;2WS&'4HRA*491K&4:U
MC*,J5I*,J5]*QE2OI6E:5I^-&]Q,3&L=3*OX      #_ ';MW+MR%JU"=V[=
MG&W;MVXRG<N7)RI&$(0C2LISG*M*4I2GK6K^3,5CO6Z(@ZNF>IF9TW\=7G-W
M]^5N]5>+/<G(-9G3A;P^1[+B.;PWAV1.?K^%KFO-_P"CG$I?3IZ5G_PWTMTE
M&LO2DH^NA\>\4O#OEKO5XSQG88LU>O'7+&7+'_BL7?R>CX'3V=3$[OCW!MCK
M&YW.*MH[(MWK?8UUM\QN'Z%^V7\JN:UPMCW[VWUCT;J+T87,C3<?MYW;/.<:
MM(QG/&R<+79'&>%6*S]?92[8WN92$J5E].5*4I*"^9/:WY-X?WL7+6RWG$<\
M=5KZ;;#/GB;1DRSY=)PUUZM8[-4WOB'PW#K78XLF:WEG2E?FZV_@PWQ>,_P*
M_'UX]7,'<\AX%M?(;F6'.QD4WO>.=C<AT-G(MUA<NPP^NM7A:C@F1@7+L*5C
M;V>%M+T(T]OUJTK+W5PYM]I'Q-YHBVWVNYIPO86UCN;2)I>8\^>TVS1/GQWQ
MQ/7W>K32^(<Z\<WVM*7C!BGLQQI/V4ZVU]$QZ&Y#2Z33<;U.OT/'=1K-#H]3
MBVL'5:;2X&+J]3K,+'C2%C#U^NP;5C#PL6S"GI"W;A&$:?A2B"=QN,^[S6W.
MZO?)N+VF;7O,VM:9ZYM:9F9F>V9G5JE[WR6F^29M>9UF9G69],RY-\7Y
M
M
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MGP\GIGXL3Z(UM^^B>Q+!4N1F
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M?)^0
M
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M.]W>[OKKKFS9,LZSUSK>UNF?*PV?=[K=3KN<N3)/U5IM\^9>EL2\X
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ML];]GY?P
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M?77M;Y\R]H8!Y
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M#MIGS1>/X\N/_P!E_P#$?_6 \C?_  W6?_,-]?\ F^YV_P"&<*][<?Z9^O\
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M=>UOGS+V5@7D
M
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M=:\0Y'S_ )_R/4<0X7Q#49N_Y-R;?YMG7:?2:?7697\S/S\R_*-NU9M6X_\
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MQ6NOT-(TI6.RL1"N.]W>7?[O)O,_\[DO-I]WLCS1'1'FAZRPCR@
M
M
M
M
M
M
M
M
M
M
M
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ME)1E&M)1E&5/6,HRIZTK2M*_A51:8F)TGK14_H
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M>+Z5IP;#/3.E\GH^@K/N_"F/-6>U,&4:18
M
M
M
M
M
M
M
M
M
M
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MN6[D)5C.$X2I24)PE2M*TK3UI5U$B8M'>KTQ*=^OICJ?X?T
M   ;TO@V^2.QX7=ZY'4?:V]CK_''OC;:[#Y#L=AD5AK.M>PHVOU;QSL&M;LO
MR^#IMC&5K6[Z[6MN,<*F/EW9UCKXPE77VA_"FW/W+D<;X-C[W-7#:6FE:Q\+
M/@U[U\/EFU>G)ACI^'WJ1&N69C3><> 3Q?9?*MM77?X(G2(Z[UZYKYYCKKY]
M8^B6!$91G&,X2I*$J4E&4:TE&494]8RC*GK2M*TK^%7,V8F)TGK0>_H
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MY_YW)>9GS>2(\T1I$>:'M3 /(
M
M
M
M
M
M
M
M
M
M
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M)^+BK.D:1-IO?6\S;P/E_8\"P=S;QWMQ:/A9)^-;S>:ODK'NZSTM?236<
M                       ;2?CI^6#R&^/?D%O4:#(KV3T+M]G3-Y=TER38
MWK.J^K?N0KF[[@6X^EF7^#<KO6HUI.[9M7L#,]:?G,6_.W8N68>\4O!?E?Q.
MVTY]S'R3F2E-,6[QUB;:1U4S5UB,V.)ZHF8O7Z"]8FT6UOCW+.QX[3OW^Y[V
M(^#DB.GS1:/HJ_-CLF.G6>'X9>?'C9YV<%CS#HOFUC+W.OQ;%[F/6N^K8U?8
MW!,B[[(5M<AX[6_=N7-?*_.D+.RPYY.MR9>L;=^4XSA#G#S[X:\V>'/$?D/,
M6WFN"UIC%GIK;!FB.VE](^%ITSCM%<E>N:Z3$S"_%N"<0X-F]5O::4F?@WCI
MK;T3Y?-.DQY&9[0F)                      :/?DG^;GH;PJQ][UEU7?T
MW>/DK8CE8%SB6KSZY'".M=A&ERS]?LSD.NN>RNSPLF-?=H,&[795K"L<J>!&
M=J[.POA1[/G,G/\ ;'Q?C,9.'<ISI;UEJZ9<]>O3;TM]#,?YZ\>KZ=:1DF)B
M-QY?Y/WO%YKN-SKAX?U]Z8^%>/J(GL^JGH\G>07/(OR6[L\K^S=OVWWQSS;<
M[YEM:RM6KV;.-C4Z'5QNSNXV@XOH\:EK5\=T&%6Y7Z6+BV[</=65R?ONSG.7
M13E;E+E_DOA%."<M[:FVV%.N(Z;7MVWR7GX5[SVVM,SU1&D1$1,FPX?L^&;>
M-KLJ13%'OS/EF>N9\\_.>$MC>T                 !)#^V[\1/\K'DURSR
MAY3K/K\-\<M1^K^)3R;/KBY_;G.,+,P,&[9^I&5C*_HEQ"F?DW8TI[\;,S<"
M]2M*TCZU4]JSG?\ (O*.'D_9WTW_ !6_>R:3TUVV&8M.O;'K,O<K'9:M,M6@
M<_\ %/DW#Z\-QS]UW$ZV\U*]/\*VD>>(M"<PYW(<      ?R4HPC*<Y4C"-*
MRE*5:1C&,:>LI2E7TI2E*4_&I$3,Z1UBNH^:KSPIYL>6NVP^';:F?T;T37;=
M=]5SQ;TKFOY!E1S+/]-^PK'K&D9TY?N=?;MXMRGX7-5@8<O2DZS]>I/@#X<?
MX?\ )-,F_IW>8N)=W/N-8^%2-)]5@G[U6TS:.S)?)'5HGCE'@OY(X7$Y8TWF
M;2U_+'TM?WL3T_53+3XG-M0 "8']M;X-5P=;R_SO[ TU8Y.VIM>M.@8YEN/Z
M&KL7KF#V7SW$A6D_TL[.L?J#"O4K"<(XVTA*,H7H24;]K#Q$]9EP>''#,GP*
M=W/O-/IIC7!AGT1/KKQTQ/>PS$Q-9A%GB!QGO6IP7!/1&E\OI^@K[WPI]-?(
MEL*3HP
M
M
M
M
M
M
M
M
M
M
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MUUCO4M,=KU;'>9^'[O'O-M.F;';6/W8GS3&L3';$JR7S)\4.QO"KR%YYX_\
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M>L^>MHB8UZX[)CICH1QGP9MMEG!N*6IFK/36T3$Q[DNX/"^0
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M*4IRE*4JRE*M92E*M:RE*M?6LI5KZUK6M:_C5:"(B(TCJ;T_@
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M56L=%:Q%8Z(A73<[G-O-Q?=9Y[V;):;3/GG]SR1V1T/06,?
M
M
M
M
M
M
M
M
M
M
M
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MX-77:X]=QITY+=-Y]WZ&/-6(CRZM?236<
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MGOC7RW>QPS!.NVP3\+3MR=4_81\'TS;S)'*J[0@
M
M
M
M
M
M
M
M
M
M
M
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M#N"\+X5&FQPTI?Z;KM/[Z=;>YKIYF(;>&4
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MM4X8L6/#CKAPUK3%6(B*UB(B(CJB(CHB([(AM-:UK6*UB(K'5$=3Y'[?T
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M?+;-FM:^:]IM:UIF;6M,ZS,S/3,S/3,STS* +6M:TVM,S:9UF9ZYE]C\/X
M
M
M
M
M
M
M
M
M
M
M
M                        \G[UZ6X%Y%]/]A]']GZO]<<$[+XSG\8W^)"L
M(95FUE1C=PMKK+]RW=CA[O1;.S9SL'(]LJX^9CVKM*5K"C-<N<?XERMQS:\P
M\'OZOB.TS1DI/9,QUUM'1K2]9FEX^BK:8[7IV6[S[#=8]YMITS8[1,?Y)\TQ
MT3';$RK"_+;QDY_X>^0?9'CYV/9]V\X'NIX^!NK./>L:WEO&,ZW#/XOR_3_6
M]:RUO(=+D6K](^Z4L>[6Y8N5I=M7(TZ\<D\W<,YZY8VG,_"I_P!7W./6:3,3
M;'DCHR8K:?14O$Q]5&EH^#:)6*X7Q'!Q78X]]M_B7CICMK,=$UGSQ/O]?5+'
M!M3W@ )M'V\OR-P[9ZZIX0]M;R$NR>I=+=SNE-IL<FM,KFG5.!Z5R^'QN9$J
M_FM[UI]2GY:W&?U+N@G"ENU2&MR+LN?OM0>%<\%XK_B%P3'_ /2=[DB-W6L=
M&+<3U9>CJIG^BF8TC-$ZVURUK$0\]< ^2[C\L;6O^KY9TR1'T-_IO1?M^J[?
MA1"3FJ*CL  !QF[TNGY)IMMQWD.KU^\T&_UF?I=YI-MAX^PU6XT^UQ;N#L]7
ML\#+MW<7.U^PPK\[5ZS<C*W=MSK&5*TK6C[;?<9]IGINMK>V/<XKQ>EZS-;5
MM68FMJVC28M68B8F.F)C6'ZI>^.\9,<S%ZS$Q,=$Q,=,3$^6%>'\PWQC[OP$
M[JKR;@NNV&P\8>VMMGYG6&\E6_G4X3NITN[#9=2\BSITE=M['36*3O:>]D2E
M/9ZB'NI<O9.)G_2Z@^!?BYM_$O@'R3B-JUYOV5*QN*=$>MI\6NYI'TMITC+%
M>C'DG32M+X]9UY5YBIQO:>KS3$<1Q1'?CZ:.J+QYI^BTZK>2)JTYIU;6
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MUAF\&UVVVKW=MCQXZ^2M8K'S(AY^R;[@
M              /5NN^]^\>H9TN]3=R]K=7W(UG*-SKOL3E_"ITE<N1NW)4G
MQK<:R5*SNPI*M?[LJ4K7\6&XIRYR]QR-.-;#9;R/^OP8LOF_SE;/-GV6SW7^
MU8<63ZZM;?/B6;?"?F/^37K^U;M:+R\[%SX6J2C&O-M=PKLN[6D_K>OU+W8_
M%N5WKM:?7EZ5G*58^D?3T]D/;'W$/ GPCXG,VW/ ]K69_HK9<'D[,&3'$=79
MY_++#YN5.7L_3?:XX^MFU/M+591\<^XJ^2C2>W]9\GZBYA[?J^O](^J-5B^_
MZGI[/=_1'.XMZ?E_3]#V^GKZ_I>YI^Z]EOPGW'\SAWV#J^)N;3_:1DZ^WYFC
M&Y.0^7[_ !:Y:>B\_P :)>OZW[G'SOQJX5O8]3>*.SL6*6(9ER/">VL'89\+
M<8QO7?S%KNRY@XV5D>E95E#%^E&5?T;=(^D6"R^R-X<7[TXM[QJEIUT^Z[::
MQY.B=IK,1Y[:^?M>6WAWP6=>[EW,3]=28C_L]?FNV_[4!Y<?ZO\ XY?^![,_
MY^/%_P H/)'_ !/BOO[?_0OE_AUPO^GS_P #^2X'9?<\><%W(I+3]+^*F#B?
M3C2MC9<5[=VN16]2LO?.F5B]SZ:U2W*-:>D/HUK2M*_I5]?2GIQ>R)X>UKIG
MW_&;7UZZY-M6-/1.UO[^ON/I7P[X/$?#S;F9\TTC_P G+QOD7W&7R1;NS]+6
M[GI?B$_I^S\SQWJO'R;U)?4C/ZWMY9NN48_U/;&L/3Z?L]M:_H^[TE3/;7V6
M?"G;V[V7'O\ /&O5?<3$>C[G3'/GZ]?<Z'JQ\A< I/PHS7]-_P"3$,6N<_,M
M\FW84+]K=^6_/M79O^M/9P;4\(ZVG9AZ^L86,KK_ (MQK-M^RE*4]WU:W*T_
MOI5K6M:[CP[P'\(^&3$[?@FVO:/Z:V7/KZ8S9,D?,T\D,EAY3Y=P=--K29^J
MFU_MK3#!;L+N_NGMR]^8[7[>[0[.R*W*WJW^PN?\KYI>K>K*LZW?J\DVVRG]
M2LZUK[O7U]:^J1>%\O< X)7N<%V.SV==--,&''BC3_Q=:LS@V>TVL:;;%CQQ
M]36M?G1#R]EWI                         2)/MY?!&GD!Y%9?E'S[3UR
MNJO&K9X.3Q>WF8\I:_D_=]_'CG\;Q[=SW0C=IUUA7;6\OTC7W6LZYK/=25N[
M.E:N^T_XC?W9Y6KR?PW)IQGBU)C)I/PL>TB=,D^;U\ZXH\M(S::3$-$YZXU\
MAV$<-P3IN=Q$Z^6,?5/V?Q?1WD[=SE0P      UG?*MY^Z3X_P#QBW7.,#(P
M,ONCGWY_AG1?&\N%K*AE\NN8D9YW+-E@3K6M_C/ <'(CG9?NC]*_DRQ<.4K=
M<R$Z2UX->&FX\3.;L?#LD6KP#;:9=WDCHTQ:]&.L]F3-,=RO;%>_DB)]7,-A
MY:X)?CG$8PVUC:4TMDGZGZ6)\MNJ/)&L]BMKWV]W/*=[NN3\CV>;N^0\CVVQ
MWN^W.RR+F7L=ON=OF7MAM-GL,J[65W)S<_.R)W;MR5:RG<G6M?QJZN;;;8-G
MM\>TVM*X]KBI6E*5C2M:UB*UK6(ZHK$1$1V1"?Z4IBI&/'$1CK$1$1U1$=$1
M'HAQ+[/T ^[5ZO9;O9Z[2Z; S-KM]OGXFKU6KU^/=S,_9;+89%O$P<#!Q+$+
ME_*S,S*NQMVK<(UG.<J1I2M:OGFS8MOAON,]JTP4K-K6M,16M:QK,S,]$1$1
MK,ST1#^6M6E9O>8BD1K,SU1$=<K);XG_  +UG@/XJ\=X3ML+#EW3V%^3YYWG
MNK-<?(N2Y?F8<8X/#<3/L3OQOZ+KW67::^Q].[/'O9GYS-MTA^<G&G*/QH\2
M,WB3SEEXA@M;\@;77#M*3K'W*)Z<LQ.FE\UOASK$6BO<QSKZN)0!S-QJW&^)
M6S5F?DF/X../J?IM/+:>F>W32.QLW1&UT
M
M
M
M
M
M
M
M
M
M
M
M!'^^?'X\:^4O0,?(GK/1_F^\_'?2[+89F'K\6=[:=@=0VI7=GR3C5NUCVY9&
M?M^(W:W=OJ[?Z4I0KG8]N$[N5;I2S'LV>*']SN9?[K<7R=WEWBF2M8FTZ5P[
MGXN/)T]$5R]&+)/E]7:9BM);OR3QW\F[[Y!N)TV>>8CIZJWZHGS1;XL^Y/5"
M!*Z2)K  >C=1=L<\Z*[.X-W#UAOLGC//NNN1Z[E'&-SC5]?R^QUUZD_H9=BM
M:6L_5[''K/&S,6[25C+Q+URS=C*W<E&N+XYP7AO,?"-QP+C&.,W#=UBMCR5G
MMK:.N)ZXM6=+5M'36T1:)B8B7PW6UP;W;WVNYKWL&2LQ,>:?G3'7$]D],+,W
MP/\ ,O@'G7XW\+[WX/6SK]AG6::+L7A]+];^5P+L?5XN)/DO%\BY*D;F1AV[
MF5;RM?D2C&N7K<G'O5C"<Y6X<DO$?D/B?ASS7N.7.(ZVQ5GOX,NFD9L%IGU>
M2/)/1-;U^AR5M768B)FO7&N$Y^#<0OLLW36.FMOIJ3U3^Y,=DQ,,R&B,2
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MI,3T3WJQ8#@O&-MQK8UW>WZ+=5Z]M;=L3YNV)[8\^L1AFWQE@
M
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M$
M
M
M
M
M
M
M
M
M
M
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MQR:4W."9TKFQ:]7DC)36;8K_ $-M8G6EKUMFN!<:W/ ][&YP].*>B].RU?\
M+'76>R?-,Q-;SY">/_:?B]V]S/I#N3C=_C//.$;.Y@;#&E2[<UVTPY5K<UG(
MN/9]VS8IMN-;_"K#)P<N,8TO6+E*UI&=)0CU8Y8YFX-SAP/;\P\!RQFX;N*:
MUGH[U9^BI>-9[N2DZUO7LF.V-)F?=COMMQ':TWFTMWL-XUCRQY8F.R8ZIAXP
MSSU@
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M.B(5XW>ZS[W<WW>YGO9\EIF9_P GFCJB.R.AZ8Q#S@
M
M
M
M
M
M
M
M
M
M
M
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M@O&L3'5,?].N.N)Z)Z72&0?8
M
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MXSO_ %>&?]0PS,4^JGMO[O57R5\\RW)H(:H
M
M
M
M
M
M
M
M
M
M
M
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M.N)_\$]*<,.;%N,5<^"T7PWC6)CIB8GMAU=['T
M
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MKGGF#Y-A_(^TM_K&2/NDQ]#2?H?3;M^I^N37E $1
M
M
M
M
M
M
M
M
M
M
M
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MD7QY*3%JWK:-8F)CKB?_  3TINPYL6XQ5SX+1?#>-8F.F)B>V'5WL?0
M
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MT1I$1I$1$1$*_P"?/FW6:VXSVFV:]IFTSVS/_3W'<W@?$
M
M
M
M
M
M
M
M
M
M
M
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M-;1%HF$W[7=;?>X*[G:WK?!>-8F/^G1,=4Q/3$]$]+SAE7H
M
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ML]9?XV2W;;X,3W:UB*_\?XUFXYO[;F^L8(Z,=?I:_P"6>NT^7HZHAGVC5A
M
M
M
M
M
M
M
M
M
M
M
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ML_2VCLF/_#$S'2QS;2]X
M                                                      #)KQ"\
M3^U?-+O?AW0O4FN^MN^29/YG><@RK-Z>AX+Q#"N6?Z0<UY-?M4_X/I]+C7:>
MD:5I=R\FY9Q;%)Y%^U"6H\\<Z<&Y!Y<S\R<;OIM\4:4I$QW\V6=>YBQQ/7:\
M^Y6L6O;2M;3&.XKQ/;<(V5][NI^!7JCMM;LK'GGYD:S/1$K+/Q.\7>K_  YZ
M*X3T)U+K:8G'.)X5)[+;W[-FWN>9<IS+=J7(.9\DO68TIE;S?9=KWSKZUA8L
MQM8]JD;%FU"/)OG3G#C'/?,>XYDXW?O;K/;X-8F>YBQQKW,6.)ZJ4CHCMF=;
M6UM:9FOO$^);GBN]OO=U.N2T]$=E8[*QYH_\,],RR.:J\     "-E\Y_RT0\
M=.,;;Q%\=>3_ $^_>::CZ/9O--#G5CF=,\-V^-ZQU6NSL67OP.R>68%[W690
MG')T^NG3*I2W?R,.["U_L[>"D\T[NG._-.'7EK;WUV^*\=&ZRUGXUHGXV#',
M=,3'=RWCN=-:Y*S(')O+'R_)'%-_7_4J3\"L_P"<M';/EI6?<M/1U1,(.+H:
MF(  !.X^"GXLI>*_7]CRB[UXY3'\B>TM''^B/'MMCUIL.G>N-M8A=AA9&+=C
M2NNYYS/'E&[L_=3\Q@8/TL&OT;LL^W/G+[1?C''.7$YY/Y<RZ\K;/)]TO6?@
M[K/6=-8F/C8<4]&/Z&]]<GPJQCF(8YSYD_*6?\G;*W^H8Y^%,=62\=OGK7L[
M)G6>F.ZD1JNM$
M
M
M
M
M
M
M
M
M
M
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MF?A1YX^FK]5'NQ$]#74E)G@
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MSP?8V_UF\?=+1]!6?H8^JM'7Y*^>=8FON?Z(@
M
M
M
M
M
M
M
M
M
M
M
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MM\Y[?B?=V?$>[BW_ %1/53)Z/I;?4ST3/Q>ONQ'H6>;T
M
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M],S/GES;SOP
M
M
M
M
M
M
M
M
M
M
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MF)A+FVW6WWF&NXVMZY,%HZ)B=8__ +\L3TQVO/F3?<
M
M         !_8QE.48QC64I5I&,8TK64I5KZ4C&E/6M:UK7\*$S$1K/4)K?P>
M_#Q7IC"XUYC^4?&)V^X-IATV73W57(M;9]_5>LRZ1GA\ZY1@YENY=L=D[+&]
M)X&+*ENYH<>Y[[M/UA<]F!0#VA?'3\OY,O(G)^;7@5+=W=;BEI_UBT=>'',=
M$X*ST7MTQFM&E?N4:Y(BYQYJ^5S;A7#;?ZK$Z7O$_'GZ6)^DCMGZ*>KX/QI/
MZH2.@    &$GGIYV]0> '2.=VUV?=N;;=;*YDZ7K/KG69$+/(.Q>7QQ:Y%K4
MX5V=N_#5:; A6-[9[.[;G9P,:M/2%[(N8^-?D'PW\.>.>)?,->"<(B*;>D1?
M/GM&M,&+72;3U=ZT]6/'$Q-[=M:Q:]<QP7@NZXWO(VNVZ*1TWM/56OE\\SV1
MVSY(UF*XCRG\H^WO,/NGE?>7=/(;V[Y1R/)G:UVNM3NPT'#>-6+]^YI>&<2U
MURY<AJN.:*SD2C:MTK*[>NRN9&1.[DWKUZYU3Y-Y/X'R+P##R[P#%&/9XH^%
M;H[^7),1W\N2WT5[S'3/5$:5K%:5K6)[X;PW:\*VE=GM*Z8Z]<]MI[;6GMF?
M_!&D1$,=FT/>  SB\ /!+M3S_P"^-5U)U_"[I^,ZVF-N^T^Q[^)3*U'77#*Y
M-+%[:7[$\C#CL]YLKD:X^LUT+L;N9D^M:UMX]K(OV8\\3/$;@WAGRY?C?$],
MF[OK3;X(G2V?+IK%8G2>[2OQLEYC2M?+:U:VP_'.-;;@>RG=9^G)/12G;:WD
M\T1US/9'GF(FR1\>_'_JSQ>ZAX9TATUQNQQG@G"-9;P-?C1I:N;':9DJ4N;/
MD7(<^U9L5V_)=_FUGDYV7*,:WK]RM:1C"D81Y2\S\S<9YPXYN.8>/99S<2W%
M];3T]VL?0TI&L]W'2-*TKV1';.LS &^WVYXCNK[S=V[V:\ZSY(\D1'9$=41Y
M'M# /(
M
M
M
M
M
M
M
M
M
M
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MH
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M\]L^Y$9DM$8D
M
M
M
M
M
M
M
M
M
M
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M6U>V(2KM-[M=_@C<[/)7)AGMB?F3VQ/EB=)AY0S3T@
M
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MW?K+:UVE.BE->J/+/9-I[9[.J.B&R=%#7P
M
M
M
M
M
M
M
M
M
M
M
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MCJ;[6U;UB])B:3&L3'3$QY8EQ[Z/T
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M.JL=$=LSML0FU@
M
M
M
M
M
M
M
M
M
M
M
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M]5B:VK>L7I,328UB8Z8F)ZIB>V);E$Q,:QTQ+\G]?T
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MRI6E:>JWM;5O6+TF)I,:Q,=,3$]4Q/;$I$B8F-8Z8E^3^OZ
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M1 [4P
M
M
M
M
M
M
M
M
M
M
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MT3U36U9F)CSQ,PW7'DQY:1DQ6BV.8UB8G6)CS3'1+AWW?L
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M3A7$;:[.TZ4M/^;GLB9^DG^#];U0B709,
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MIC'$]MIM:8/YGYGS<<S>IPZTX;2?@U[;3]-;S^2.JL>?66Y1 [4P
M
M
M
M
M
M
M
M
M
M
M
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MBMW<M/W]*Z]C?=CQ7AW$Z=_8YJ9.CIB)^%'IK.EH]V(8WMK9
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MYNY77'L*3\&FO7/TUO+;R1U5CHC7IF=M2%&L
M
M
M
M
M
M
M
M
M
M
M
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M,=,3&L-QVV[VN\Q^MVF2F3'Y:VBT?,ZO0\U99Z
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M\^6TQUSV=4:0V2HH:^
M
M
M
M
M
M
M
M
M
M
M
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M!G%^,[WC6ZG<[NW1'Q:Q\6D>2(\_;/7/O1&8[1&)
M
M
M
M
M
M
M
M
M
M
M
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M3O?4X]+EZU>ZXY[@ZG<5Q85]?6_HNR;'!KTLWV?C6QAW<VM:T](2G+TI6;^
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MNJ+SU[5G-'&HOL>3,%>%["W1ZZ^F7=6CRQK'JL6L=D5R6K/37+$H[XKS_O\
M<Q.+AM(P8I^BGX5Y_BU]R)F.RR1;P_AG$.O>-ZGAO N+<=X5Q'08L,'1\7XG
MI==Q[C^GPX5K6.+K-/J<;$U^#8I*5:^VW;C3UK6O\M56M]O]]Q/=WW_$LV7<
M;[+;6^3)>U[VGRVM:9M,^F6AY<N7/DG+GM:^6T],VF9F?3,]+LKR/F
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M2NOP:5B*QY-9F9A/?;[=<1W-MWO+S?/;MGLCR1'5$1V1'0]G8%Y
M
M
M
M
M
M
M
M
M
M
M
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M^G+&.OIM#8^4MI.\X_MZ_0X[^LGS=SX4?PHB/=5MCJVG\
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M69F=9F9[9F>N7-O._
M
M
M
M
M
M
M
M
M
M
M
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M\.[V+8=4SU7OZ?I:SY.N?HIZ>[$AM5]HH
M
M
M
M
M
M
M
M
M
M
M
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M&^QS6>RW76WGK;JGT=<=L0RI::QH
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MZ5ZJTI6*UK'HB(Z9Z9ZYZ5@L&'%M\-=OAB*X:5BM8CLB(TB'5'M?4
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M:4B$^,\>W_',_K-U;3#$_!I'Q:_Y9\MIZ?1'0SR1NPH
M
M
M
M
M
M
M
M
M
M
M
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M%JSYIA'&7%EP9)Q9JVIEK.DQ,3$Q/GB>F'8GE?,
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ML]$=$1U1$1$1$1$(HSY\VYRVS[BUKYK3K-IG69]UW)X'R
M
M
M
M
M
M
M
M
M
M
M
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M4E"5*2C*-:2C*,J>L91E3UI6E:5_"JNDQ,3I/6TU_0
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MC5N)06U4
M
M
M
M
M
M
M
M
M
M
M
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M'JO(KI_KWN_5V8PM7N1\3RLGJ?G%WUI2-S,SORN'R;A>QN6_[Z-C&U.KC/\
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MM:UB*UK6(TBM:QI$1$=$1$:1'4WZM:TK%*1$4B-(B.B(CR1#CWT?H
M     !D/T3XD^3/DWLX:OH3H[LCM"=;\,;(V?&N-9UWC&LNW)UMP_7G,,N&)
MQ306JW(UI]3.S<>WZTK^/X5:OS'SMRERCAG-S)Q':;.--8KDR1ZRWUF*-<E_
M12EI>#>\4X=PZO>WN;'C\TS&L^BOQI]R);W/'#[9GR6YO<PMOY+=K<$Z-T5R
M$+U_C'$8U[3["]\90K=P,R>%DZ;@FH^I"5:1RL?;;>D)4_&Q*GIZURYJ]K;E
M+A\6P<I[+<\1W$=$9,G^KX?3&L6S6^MMCQZ_30TS?^(7#\.M>'XKYK^6WP*^
MGMM/HFM?2D!>-'P>_'KXV2P]I'J67=O,<2MF['EO?65A\^E;OVJQN4N8?#J:
M[5]=XE;61'WVKOZHGE6O2E/K5]/56?FWVA?$_FN+89WOY/V-M?N>SB</1Y\O
M>MGGHZ)CUL5GZ5H_$.<>.\0UKZWU.*?H<?P?X6LV_A:>9MLP<'"UF'BZ[6X>
M+K]?@V+6+A8.#CV<3#P\6Q"ENSC8N+CPMV,>Q9MQI&,(1I&-*>E*>B$\F3)F
MR3ERVFV6TZS,S,S,SUS,STS,^66L6M-IFUIF;3VR^I^'\       86>6WR$>
M)OA+I9Y_?7:VHT_(KN'7,TW6N@K'DO9W(H2C*N/76<-UUV6=BX>5*-80SMA+
M"UE)_A/)@W_DGPQYU\0=QZOEO97R;6+:6SW^Y[>GE[V6W1,QUS2G?R:=5)9?
MA? ^)\8OW=EBF<>O3>>BD>FT]'N1K/F1#?.+[ACR:\@Z;K@WC;AW_&7JS*N9
M&+#?:G8US.[>0Z[W3MPNYW,<6MK"X/3+M4A=_+Z2W',Q;E96_P!9Y%O\:W?\
M//9@Y1Y8]7Q'FNT<7XS$1/<M73:4MY(Q3TYM)UCO99[MHTGU-92CP;D7AVQT
MS<0GY1N8[)C[G$_6]=O3;HGZ6$?38;#/VV?G;7:YV9L]IL\S)V&RV6PR;V;G
M[#/S;T\G,SL[,R9W,C+S,O(N2N7;MR4IW)RK*5:UK6JS>+%BP8JX<-:TPTK%
M:UK$16M8C2(B(Z(B(Z(B.B(;S6M:UBM8B*Q&D1'5$/D?M_0  '(:G4[7?;37
M:31:S8;K=;?-Q=;J=1J<+)V.TVFQS;T,;"U^NU^';O9>;FY>1<C;M6K4)7+D
MY4C&E:UI1\\^?#ML-]QN;UQ[>E9M:UIBM:UB-9M:TZ1$1'3,S.D1UOS:U:5F
M]YB*1&LS/1$1Y9E)Y^/#[=;GW8_ZC[5\YK^UZNX/=^CL-=T5I<N&/V=R3'K]
M+(Q_Z<[>Q6_C]>ZK+M2I2Y@V:W=[6-9V[OZMO0I6M0_%#VI.&\*]9P;P[BF\
MXC&M;;R\:[?'/5/J:SI.:T=EYTP]4QZVLH[X[SY@V_>VW!M,F;JG)/Q(^MCZ
M*?/\7R=Z$POJ?J'K#HG@6AZPZ>X-QSKK@/&<;\MIN,<7UUK7:[']WI7(R[_L
MI7(V.US[M*W<K-R9WLO+ORE=O7+ER4I5HQQKCG%^8^)9.,<=W&7=<2S3K;)D
MM-K3Y(CLK6.JM*Q%:QI%8B(B$5[K=;C>Y[;G=7MDSVZYF=9_\$1V1'1'5#T=
MBGG
M
M
M
M
M
M
M
M
M
M
M
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MAZ<M-(Z;6B+XZ]N1&/%N3^,<+UR13UVUCZ.G3I'U5?C1YYTFL?3-P:#&J@
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MK1,U\
M
M
M
M
M
M
M
M
M
M
M
M                         !J9\[_AN\2/.6&VY7L-#_D;[RS87[UKN3KG
M6X6-F[?8W:SG3([$XI[\+2]@0G>G2MV_>EB[B4(1MPV%JW3VIJ\./'?G;P[F
MFRQ9/E_+M=(^2Y[3,5KY,&3IOAZ.J([V+69F<4STMGX+S7Q3@VF*MO6[./\
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M@YMM,>>UX_\ )R^__:=/ K_HD\N_^0737^GU\_\ E%\2?]^X'_7;K_X-_/\
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M):9F9F=9F9Z9F9GIF9GIF9ZVB3,VF;6G6TOI?A_
M
M
M
M
M
M
M
M
M
M
M
M
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MU[SY(UM,SI$=%8CHK&D1$1&B.-QN,^[RSGW-[9,UNNUIF9GW9^9'8[VQSX@
M
M
M
M
M
M
M
M
M
M
M
M
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M1>([T>28UB>B8G26F;G:;K9Y/5;O'?'D\EJS6?F]?I>EL2\X
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MD?2TK\6E?)2D5K'9$(XW>]W>_P TY]YDODRSVVG7W(CJB/-&D/7F#>4
M
M
M
M
M
M
M
M
M
M
M
M
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MQ;C6YC9\&VNXW>[GJIAQWRWG][2+3\Q]L&VW&ZOZK;8[Y,GDK$VGWHB6G;R
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MWFTQ'TM=>BM8[*5B*UZHB(1]NMYNM]FG/O,E\F:>VTZ^Y'DCS1T0]28=Y@
M
M
M
M
M
M
M
M
M
M
M
M
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MXIKCM,]LWQVUZ^MKV]Y4X#OM9R;>M,D]M/@3[U=*S[L2W(])?=%\NQ(X6O\
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M%DQ6Z/->M9:WN-INMK;N;K'DQW\EJS6?FQ#T=BGG
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M\F2UKWM,]<VM:9M:9\LS,M*R9<F:\Y<UK7R3.LS,S,SZ9GIES[S/P
M
M
M
M
M
M
M
M
M
M
M
M
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M/DW!MIMMIMOI,.*F*O1U?!I6L?,;!@VVVVM>YML=,=/)6L5CWHB'0F2?<
M    !D3T#XD>2_E+N/U)X_=)]@=HWX9-,3-V?'=%?IQ;3Y$K?U8V^0\SV-<'
MB'&_?"M/;7/SL:,JUI2E:UK3UU?F7G;E+D[!\HYFXAM=G68UBM[QZRT?48JZ
MY<G[REG@WW%.'\-IW]]FICCR3/3/HK&MI]R)2$O%_P"V0[6Y-^KM_P"6W<VD
MZQU5SZ5_)Z]ZGM6.:<VN69>GU<'8<RVENQPWCF?;_'TN8N-R&Q7\/Q_'\*Q<
MW^USP7:=[;<D[#)N\T:Q&;<S.+%KY:XJZY;QYK6PRT;B/B'ML>M.%X9R6^FO
M\&ON5CX4QZ9JDB>+/Q@^$7A[^0V/3W1W'*\VP?HW*=G\YI/GG8]<RS_^W:_D
M?(_SG]%KUWTI[[>DLZS&G6-*UM>OXJI\X^+WB#SUWL7'>(Y?R?;7_5\/W'!I
M/9:E-/61'9.6<EH\K0.)<Q<8XKK7=YK>IGZ"OP:>B8CK_?:SYV?B-&$
M
M
M
M
M
M
M
M
M
M
M
M
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M>UXK^'O&Z_%OMK1YK6CY](^?+VK3?<)_&1L_=^=[/[!X[Z7K=JGZYZ@YW?\
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M+:UIF9GSS+5+WODO-\DS:\]<S.LSZ9ERSX/R
M
M
M
M
M
M
M
M
M
M
M
M
M                          _DHQG&4)QI*$J5C*,J4E&494])1E&OK2M*
MTK^-")F)UCK&O?R!^*KP#\EY9F;V3XV<#Q.29E/=<YGU[BY'6/+)Y/K+VYN=
MM>"7]#3?94:3]/796\V%8TC2L:TC&E)/Y9\9?$OE**X^$\6W-MI7_-9IC<8]
M/)%<T7[D?>YI/GZ99W8\R\;X?I&WW%YQQ]#;X=?<BVNGN:-'W?GVO/$\R.7L
MO&'R3WFCO^LIXG$.\-!A[_"NRG2E?IUY[P?%T>7KK%B=*TC27'\ZY*%:>Z?N
MC64["<M>U_O:37%S?PG'DKVY=I>:3_4YIO%IG[]2->J.G2-PV7B-EC2O$=O6
MT?38YT_@VUU^RAI;[U^#SY(^BJYV5<Z(R>W>/X7O]O(NBMMB]D4S?9.L:_D>
M'XL,#LVY[HTI*/NT4/6DO3^^I*,9]Y<]H;PIYC[M(XE&QW-OH-Y6<&GIRSWM
MO_VT^]HV[9<X\ WND>N]5>>S)'<_A=-/X35AR;BO*.%[C*X[S'C>_P")\@P9
M>W-T?)M/L=#N,.7K*GMRM9M,?%S<>7K&M/2<*?C2J8]IO=GQ#!&ZV&7%GVUN
MJ^.U;UGT6K,Q/N2V3'EQYJ1DQ6K:D]L3$Q[\.!>E^P
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M9:S>]\EYODF;7GKF9UF?3,N6?!^0
M
M
M
M
M
M
M
M
M
M
M
M
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M#-CRQ_ M9L.WWFTW<=[:Y<>2/J;1;YTR\O9=Z0
M      '8^+</Y=SG;6-!PGBW(^8;W)_^EM+Q;2;/D&VR/_[&MU.+EYEW_P#I
MA5Y=YOMCP[!.YXAFQ8-M'7?)>M*QZ;6F(CWWSRY<6&O?S6K2GEM,1'ORV(=1
M_#I\DO<_T+W'/%;GW&-;>A;O3VO:D]+U)CV,:[Z>S(_(=B;3CF]S85]U*^W%
MQ,B[[:^[V>WUK2+N-^.OA1P#6NZXSMLV6.CN[?O[F9F.S7!6](_?6K'GU8+=
M<U\O[3HR;FEK>2FM_FUB8]^8;3.F_M@/(;D$L3+[U\A^J^L\*Y6EV_K.OM'R
M/M+?0M1K2M<2_/;?Y.-)B95[TK'ZEK)SK=JE:2]+GXP0[QWVO>5]M%J<N<+W
MF[R1U6S7IMZ:^6.[Z^\Q'DFM)GJZ.MK>[\1=C36-E@R9)\MIBD?,[\_,AMDZ
M4^W&\ .M_P IF]DR[5[\VUKV7,FSS+F5SB7%IY%OTK26'H^M\?BNWM8WNI2M
M;.5M<V,OQI*M8U]J%>8/:I\3.*]['PGY%PW!/5.+%ZS)IY[YYR5F?/7'3S=/
M2UC><^\<W&L;?U6"OU->]/OW[T>]$-N737B5XP^/-FS;Z1Z"ZFZQR+-KZ5=O
MQ/@W'];R/*A[?96NQY1'"ER/:7*P_1K/)RKLZQ_#U]$)<>YUYOYHM,\P\2WN
M\K,Z]W)FO:D?6X]>Y7T5K$-7W?$^([Z?]<SY<D>2UIF/<CJCW(9#-7>$
M
M
M
M
M
M
M
M
M
M
M
M
M
M!\>?K\#:X=_7;3!P]EK\J'T\K!S\:SF8>3;I*DZ0OXV1"Y9O0]T:5])1K3UH
M_>++EPY(RX;6IEKU369B8]$QTP_M;6K/>K,Q:.V&$W:GQG> 7=%<J[V!XD])
MYF=G3E<S=SQOAV%U_P BS+LI^^5[+Y+U]7B^_P F]*7\LYY,I>GX>OHD'@WB
MUXE\ TCAG&^(5QUZJ9,LYJ1YHQYO64B/-%68VW,/&]II&#=9HK'9-N]'O6UC
MYC79V5]M]\>/-)W[_#KO=_4%Z4_J8^+PSL7&W^JM5])TI9O8_9?'N<[6_C?I
MTKZ4SK=WUC3^<]/=24H\)]JOQ0V$17?QP_?5[9RX)I:?/$X+X:Q/[R8\W5IG
M=OS]QW#T9?4Y8^JII/\  FL?,:_>Q/M:-A".3E=3>8.'DRKZ_D]'V)U)?P8Q
M_G/P_,\JXUS;85E_-5_WFFI^E'_<EZ1DWA?MBXIF*<:X%:([;X-S$^]CR8J]
MO_6_.Z<Y@\2*]$;K:SZ:W_<FL?;,%>P/MO?D0XC3(N<6O=%=J6H3K7&M</[(
MSM-L+]FMZL+=;UCL7BW",#'R:6?2Y<A3*N0C^,8W)UI3UD7AGM5^%V^TC>1Q
M'9V[9RX(M6)T[)P9,LS&O1$]V)\L0S6#G_@67^<]=BGZJD3'\&;3\QA-SKXA
MODKZZID5Y!X?=L;"F-"<[G]!<71]HUE&$+LZTQZ=9[KEU<N=:6:^D;7OE*M8
MTI2M91I60.'>.'A/Q33Y-QW95U_IIOM_)U_**8M.OMT[?)++X>:>7\_Q-UBC
MZ[6GV\58?<X\?>^NLOS'^4GI'M[K[\I]7\U_3CK;F?$_RWT/S?U_S'Z^TN!]
M'Z/Y"_[_ '>GM^C<]?[R7IO7#^9N6^+Z?DKB&QW7>TT]5GQ9-==--.Y>VNO>
MC3TQY897#OMEN/\ 9\V+)K]+>MOG3/EAY$S;U                 .Z<0ZV
M[%["R*8G > \UYQE2O4QXXW$.+;SDN1+(K/&MTL4LZ7!S;E;U;F;9C[?3W>Z
M]"GIZRCZ^#?<6X7PRO?XEN=OMZ::ZY<E,<:=/3K>8Z.B?>GR2^.7<;?!&N>]
M*1]5:(^?++O@OQ?_ "&]C4QY\9\.N^[=G+A"[BY?*N [;@&#D6;D+5RUD6<_
MGMOC6%<QKUN]&4+E+GTYQ]:QK6E*^FC\1\7_  OX5K&[X[PV;5Z)C'FKFF)Z
M>B:X?63K&G3&FL=K%YN8^!;?^<W>#6/I;1:?>KJS5X%]O%\E_,:V/U_P/K+J
MR-ZL?=/GO;/&<VF/&5V</??AUI+L2]2E(1I<K2,93I&5*>GOI*,= XE[4'A+
ML-?DVYW>\F/Z';9(U]'K_41YO)[FDL1GYZY>Q?$ODR?6TG^/W6<G7/VMW;6?
M*Q<[<\K^NN*1C7'GDXO7/7_)>P)78^M996/8V')MOUI3'K6E/;;O2QKOIZ^Z
MMJOI[)1YQ7VP^"8XF."<%W6:>G2<^;'AT\DS7'7/KYX[T>37MC#;CQ'VM?\
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M^_+M#QOF
M
M
M
M
M
M
M
M
M
M
M
M
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MK4*1A;MVX1I2,:4I2E*>E&N6M:]IM:9FTSK,SUS/EEXIF9G6>M^C^
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
*          #_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
MB5!.1PT*&@H    -24A$4@  #+@   EZ" 8   "3D4YL    "7!(67,  $SE
M  !,Y0%USO"5  !U DE$051XVNS;,0Z ,! #P4MT_W]R0DN+B##%C+0?<.^J
MJBU)DB1)DB1)DB1)DB1)DB1)DB1]U5IKWY51)$F2)$F2)$F2)$F2)$F2)$F2
M])N#RYQ3DB1)DB1)DB1)DB1)DB1)DB1).M:C@\L88P,              ,!)
MW>W@ @              0(Z#"P               %$.+@
M $0YN                !#EX (              $"4@PL
M  !1#BX               !$.;@                0Y> "
M  ! E(,+                40XN                1#FX
M    $.7@ @              0)2#"P               %$.+@
M     $0YN                !#EX (          /#2!0  ___LV[$)P# ,
M $$;O/_(=JH4J1-X"'>@2JK4_SD   "\L=8Z8XS'[+T?-^->S#E]#
M        @$\)7                $@)7                $@)7
M         $@)7                $@)7                $@)7
M         $@)7                $@)7                $@)7
M         $@)7                $@)7                $@)7
M         $@)7                $@)7                $@)7
M         $@)7                $@)7                $@)7
M         $@)7                $@)7       X.<N    ___LW4^(E&4
M!G!=+5MW)41,RZ(0)$H0Q"PIB-9 .@6= JDL.X@'NP;90031[) 7\Z!=@HA.
MJ5#TAQ ))#K4QH)@!6:;Y6ZXR_J_M?6IUZ%@UM3Y9B:,YO>#EV%FOH]GYIWO
MG=/W\"8       #PWS9]^O1,F3*E;ERZ=*GNF"E_O3%UZE0S!@
M    0%LIN                '!#*;@               !P0RFX .TS,9&<
M.9,,#R?'CR>#@[7'\KR\7MX'             (!)%%R ]KAP(3ER)'GCC>2Q
MQY+;;DNZNVN/Y?F.'<FWWR:__6:N              "HH^ "M*Z45C[ZJ%9D
MZ>HJ_QI7CO+ZRI7)QQ\KN0              4$?!!6C-Q$1RX$#2U_?/Q9;)
MX_''DX,':^<!             $ 47(!6#0TE&S9<?>>6R6/:M.2EEVKG 0
M          ! .KW@4G:0*#?9__!#<O3HM4<YYI=?DO'Q]N67B3YW+AD<;"S_
MQ(GVYY\]F_STT_7SR_CQQV1TU*JAW@<?),N7-U9N^6N4XS_\T-P!
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M\^>3]]ZKEEW&HD7)P,"-R9\_WZX;7&GW[N2..ZI=2^7X/7O,'0
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M#AQH/K/LOK)N7?,%E[ESD]=?;SZ_%&QV[ZZ6>?_]R>>?6S$
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MXWMMPP;I_??#<UKNB[!6^;ODXX_#OOA>\5PR]U#99\%[ZOG[7O*S<"3G"
M                  "UB("+[=XM/?A@6L"D73MITZ;T:SG4\8M?5#_@TKQY
M;J$3!QH6+)#JU8N_5M>NT@LO5*_&/L#O (@/[R]>+$V9$NHP<*#4IX]TRBE2
MPX9A7G7J2%_YBM2HD=2A@W366=*0(=+$B=)SSX4 B0_XYQ(P*N^33T(HQ:&:
MM]ZJ_.4 Q-:MAP="'"AQ(.*55Z0[[I &#)"Z=0MS]QKJUP]KZ]]?^O6OI==>
M"Y\ISX$*WT_9YN&@@Z]7?AY>QY8MTL*%TKWW2D.'2KUZ22U;2B>>&$)9!052
MV[;2V6=+(T9(4Z=*RY>'T$=U@RY^AAP.R39__]WO\_MC.8CC4$ZVL1U8<5BM
M?.C#U_(>O_BB=/OMTA572*>?+C5K%NZW$TZ0&C20VK>7^O:51HV29LP(P1*'
M3FHK1.)QO3;/[=57I8<?#OO2KY]TZJE2X\92W;KAY7_WL_#UKX=G9MPX:<X<
M:>G2JFM2V1[XFOD:%@,                   !P5"+@8@Y*.*#@8$5LZ,.'
MXV?/3K^60PSGGU_]@(N#$U=>F7[X?N?.$&R(O8[WW $3=P3)128 XE"+ SE>
M>V%A[NOV87^'$VZY17K]]8H##2F6+ F! 8=1JJJ! P:C1X>U9#B<X&"" Q$.
M'&6;^W''2=__?NC 49[OOXLO#NNK:AXGGRR-'1N"4IE[]X,/0O#GJJO"WV-K
MZ?DXC./0AP,\*:&3\N;.#<$,AT6JNJ;_[K!/2F#*08YSSZUZ;-?&G88<[G&0
M*G/O.93TY),A>.3046QM_%W0NW<(G3A0Y0!137*MW8UEVK1P__G^JNYW0LHS
M=-EEH9,3                     .0) BX9#G"XTT;L(7&'-&Z]->T:+JP[
M**2$$*HZT.\.'0YXI/"!?W<2B;V..UPXE)$J$[R8/S\$0UJWKME#^@YG=.H4
MNKHX@+!O7V[[/G-FU>&6LB\'?5YZ*>RCZSY]NG3FF6GS=IBAN/CP>3SR2-7A
MEK(OAX3<J<4=.-QEY#>_"9U:<JVEUW_!!2&PY0!4+AR2R19N*1MR\?MCN5M)
M[-B#!X?@ACOB.+QTW752TZ:YU\;WOSN^>-\]9G7YWG$XZ>FGI8LN"D&U(Q5L
M*;_G147\ @(                   #(&P1<,G;L"$&.E /B#BND= ]Q%XAG
MGJFY0^H=.J1UPC"'0=R](?8:+5JDA1%<#W>G<+C 01I_OC8/ZA<4A/4L6I1;
MR.6))^*O]<UO2L\_'P(*DR9)'3NFS?6SATTC1E3<#>0/?X@?IV_?T#'%75]\
MS\:&/[*]W+'D\<=S"[G\[G=IU_+[8_WJ5_'C#AH4PC^NCT,[KGE-U,9=9]PE
MISHAEX,'I0T;I)MNDMJT^6*"+65??_D+OX                      \@8!
MEXQ=NZ0''DCKH-*E2UH8P"$:'VZOJ0/J[DPQ84+:.MW=HENW^&MT[1K" C%\
MXY26ANX49Y]]Y [J.^#A,(-#+@X1I$@-N,R:)4V>G-;M)R8LE!)P<2<9=ZZY
MY))P']9D+?OTD9YZ*CTLE"\!EV]_.]3FW'-KOC;NG.-.+OOWIW^_^-EPN,P!
MIX8-O_AP"P$7                     'F&@$O&@0/2JZ^F=<-HU2I\)M;F
MS=*%%V8?][CCI'KUXKK(#!@0YA[#X8_Y\\/G8D,\#JILW1HWOCN3S)XMM6Y]
MY _KNU[?^YZT?GW:OJ<$7'KVE$:-DGKTR&V.9YPAS9Q9\3Q2 BZ^[TX]M>8#
M')D]O^(*:?GRM#KF2\#%78W:MJV]VHP<*147IW^_;-LFC1XM-6J4'^$6 BX
M                    \@P!E[*V;)$Z=XX_(-ZDB31I4MS8+NJ*%5*S9MG'
M+2P,W2)BYM"]N[1Q8]P<W&UFRI3X]=6O+PT;%E^_=]^5?OG++^[ ?LN6(3BQ
M=V_\G%,"+MX7ATMRG9_#34N65#R/E(!+;;]\7]]V6^AJ%"M? BY'XAY[Y)$0
MYHKE^_&^^Z3V[8_L7+.%? BX                     ,@C!%S**BF1KKDF
M+0!R[;5Q8_M O ^4QQQ*=\CF3W_R[F1_?[MVTHP9<7-P)Y:4 (H[L?A@?DK]
M_/[8#C&U\3KG'.F--^+GG!)PJ<[+77F&#Y=*2RN>1SX%7#)AG(4+X^MXM 1<
M_!HR)*W#S>+%\8$UO^K4D1HWECIV# &VKWU-ZM8M/.L%!?'=:4XZ*01RW#6F
M_'=)W;I241&_@                     #R!@&7LG;OEB9/3CN(_HUOQ'4,
MV;$C[J"^#YY_YSO2RI5Q'1\:-I1NN"%N?6O62!==%+^^KWY5FC\_K8;N4.*0
M2;80C]?9M&E88]>NX1#_Z:>'?SK@XW"- T2IX8,6+:0)$T+'G!A'*N#BP,+X
M\97/(]\"+FW:2 \])!T\&%?'HRG@TJF3-&M67&T.' CW8_/F<6/[N? S,&Z<
M].]_A^\-?R^Y.]*SSTH__&'8&W_W9!O+S]78L=*8,5+?OB$DX]",GSG_M\<'
M                    @#Q!P*4L'UA?NC2M XD/F[_Y9O:Q-VV2^O6+"T+\
M]K?A_8,&Q85LSCM/VK6KZNM[4]U)HE6K^(XC/@1?6<>1RNS<*3WV6 C>5!1L
M<6BE0X<0M+G]=FGN7&GM6NGCCZ5]^\+UWGY;FC9-NO+*,-_8CA69>0\<*'WX
M8=Q\JQ-P<>T;- AA'(=RW&TC$]+ITD4ZY12I21/IQ!.EGCW#M2I3G8"+U^RZ
MEIU'CQXAT. YN)-'2@TS>_63GTCOOQ]7QWP-N+@VWJ.V;<.>>&\RM?'_<]UR
MJ8U#*S'WF(,IEU\>/]<SSY2>>Z[RT)R?\SON"/L:,V\_"PZ=N8-4<;'T\LO2
M"R^$L%M,, \                     CA "+N5MW1JZLL0>=G> 8=*DJL=T
M09<MDPH+LX_G0_=%15))B31Q8MP<3CM->N65JN?@ ^Y//QV_+L]UY,C<:NC
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M[.QCWW13V*N8,=WMQ]\5,5:O#L]6S+C=NDGSYO%K!P
M ""O$7 ISXM?OSZMHT/KUM*B196/65P<0C#9QFG21/K][P]]SIU<?/ ^9@[N
M_.+K5+8F=QMQ5Y:8L=PMQ9U!#ARH?BT/'JS^GGA=#G/$[D=AH73##7%CIP9<
MKKJJ9M947FK 9= @:=6JM&O,G"EUZ1)_C<:-I3OOC!L[GP(N#I-MW)A6FX<>
M"H&>V&NX:]+TZ=G'=:<?!]=BQOSC'^,['.W<&>Z!F'']O?+LL_S: 0
M             ,AK!%PJXBX*EUV6%@2X__Z*QW)(Q!U(8KI#^(#]/_YQZ+.E
MI=*]]\;-H4T;Z;''*IZ#N]+,F1,ZL\0>WH_M@'(DE)1(=]T5OQ_N:'/MM7%C
MIP9<KKZZ=M:8&G 9-2K]&DN72M_];OPUZM>7)DR(&SN? BYWWYU>FP4+I/[]
MXZ]QTDF5/V]EC1@1WPWJT4?CPU,.PL3NI0,V[DH%
M 'F,@$M%=NV2[KLO+5 Q=&CH6%+>1Q_%A3-\"+YG3VG'CD.?W;]?^M>_XCI
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M>Y_8>Z&F1MJ[5UJ_7AHV3$I-]1O/W@E3ITK[]O&U P
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M<,N.'=*D25*;-F<^V$+ I7X$7$)KJ("+=6)Y^FDI+>W,/@/6?<KND[(ROG0
M                    SGH$7.ISY(@+0"0D^"TH;]Y<>N01%RRIK)0F3@Q_
MC 5@^O:5#A\.78>%1HJ*I-:MPX^7E"3EYDK5U5)5E0O<^-1NU[9G3ZFX.+HY
MV[W;!0Q\:B7@<@(!E]#B/>!BUJ]W]Z1U23H3][\]SY=?+BU?+M75\:4#
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M9Z]>[M\M,&,!' (N!%SB.>!B5JV2!@]V][QO9Z@@FXW9N;-[_G?MX@L'
M                (&X0< G'NI+,G>N_&+U5*VGT:!<6";=O8J(+<QP\&+Z.
MNCJIH$!*3?7KQI*;*RU<*"4E^=5]V65245%T\S1OGE^HY^^M>7.I=V_II9>D
MY<M=UYM#AZ3:6C<G9672-]](DR9)_?H1<"'@$O\!%_/33RXTU[)E;,,M]CS9
M<SQ]NO3GGWS=                     ,05 B[AV&1LW2IUZ.#?D:1[=^FF
MF\+O:V&5\>/]:]FVS6]<VZSKR?WW^^UK@9C;;Y=J:B*?IQT[I*>>\E^,W[2I
M^RUKU_J-_]57!%P(N,1_P*6R4OKV6VGH4"DM+?I0B[V3+2C3K9L;TX)BAP_S
M90,                    0=PBX^-B[UW5<"++HW (<X?;+S'0=2GQ55+C.
M,#9^N+&MXXQ/#;99>&?RY.CF:,,&J7]__SFZ\$+IXX_]QR?@0L EW@,NNW=+
M,V=*/7N>VA'*.C]E9[NM8T>I=6O7#<FZ/-GS;IO]W9YIV]<";%E94DZ.-'RX
M],47TKY]?-$                     Q"T"+CZJJZ4Y<TY=E![-9HO5^_21
M#A[TKZ.N3BHH<)U?8E6'7=-++Y4*"Z.;HW7KI*Y=_<_;MZ]45N8_/@$7 B[Q
M''"Q\,G4J2Z4<KJQ;KY9^OIK:=DR:=HT:<P8:<@0*3?7!<=L&S! NOMN:<0(
M*3]?FC_?/4.UM7S)                     ,0] BX^;$)^_57*R(A=L,1"
M*L\\$[R6;=ND@0-C5T=RLG3''=*1(]'-T>K5KNN$[WEON$&JJO(?GX + 9=X
M#;@</2I]^*%T\<6AQWKU5=<I"@                    #.401<?-GB\[R\
MV 5+,C-=MX:@*BO= GZ[%K&HPT([D08"_M^*%2XL$R3@<N" W]@U-=+<N01<
M"+C$9\!ERQ87(JNO ]0[[[C['                     #.401<?%F'DWGS
M;,:B#Y4D)DK77",=/!B\CKHZZ?OOI;2TZ.NPZ]FSIU1<'/W\K%D3K(-+3H[T
MPP_AQZVME7[\41HVC( + 9?X#+C,GBWUZ%'_6%.G^@>^
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MC+1Y-(<R)%,T<SC]OQ8OP=<!S]X>]['MQ^\'BZ/GO'L]ZUWKW>_=GR<!
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M$0$7@$9ZX('R9JTO;/+\\\GNW4=?<]VZY+++:M?KW#F9/CW9MLTY 0
M      !-1< %H)$F3TZZ=:LOX'+;;<F&#4FKE^X1V;DSF34K&3"@=KV! Y-E
MRQK3-08             H($$7  ::?;LI'?O^@(N??HD\^8EFS<GAPX=69UR
M??G<HD7)T*&U:Y70S4,/)=]_[XP             @*8CX +02&^]E8P845_
MI8Q!@Y*I4Y/5JY.OODJV;T_V[$D.'$A:6JKN+B7,\L<?R6^_)5NW)ALW)JM6
M)5.F)(,'UZ[1N7-RZ:7)FC5''J0!             #@&!%P &FG+EN3>>Y/N
MW>L/N90 RI AR>VW)[-F)0L7)F^\D2Q;EBQ?7H5F7GTU6; @>?SQ9.S89,"
MI$N7VG.7:X8/3Y8NK8(S              !-2, %H-%6KDQ&CTY..JG^D$M'
MC)-/3D:.3%Y[+=FUR[D              $U+P 6@T0X>3%Y_/1DU*NG1X]@'
M6TI'F--/3R9,2-YY)]F[UYD              $U-P 6@(QPZ5(5+[K@C.>NL
M8]/-Y:\7>@8.3*Z\,IDW+_GNNZ2EQ5D              $U/P 6@(_WX8[)P
M83)Q8G+^^4G?ODG7KHT+M93@S&FG57./&Y?,GY]\^FERX("]!P
M  ".&P(N ,?"K[\FJU8E,V=689?++T^&#T_..2?IWS_IU2OIWCWIUBWITB4I
M[]ORL_R__+YGSZ1W[V30H.2\\Y(++TRNNJKJ$#-G3M4M9L>.I-4+'
M      #@>"#@ G"L[=N7?/EELF)%LF1),G=N,F5*,FE2<M==50#FYIN36VY)
M[KPSN>^^9/+D9-JT9,&"9.G29.W:9,N69/]^^PD             '/<$7
M             /A7";@      /^?_@L  /__[-NQ"< P# !!&[S_R':J%.X#
M3^ .5$F5^C\'        @)]8:YTQQC5[[^MFO(LYIX\!              #P
M*8$+                *8$+                *8$+
M*8$+                *8$+                *8$+
M*8$+                *8$+                *8$+
M*8$+                *8$+                *8$+
M*8$+                *8$+                *8$+
M*8$+                *8$+                *8$+
M*8$+                *8$+ !0>    ___LVZ$-P# , ,%$ROXC)R4M**_T
M!7>2D8W,_QP             X+;6.F.,U^R]7S?C6<PY?0P
M (!/"5P               !("5P               !("5P
M  !("5P               !("5P               !("5P
M  !("5P               !("5P               !("5P
M  !("5P               !("5P               !("5P
M  !("5P               !("5P               !("5P
M  !("5P               !("5P               !("5P
M  !("5P             @)^Y    ___LVR$*P# 0 ,$$\O\G)U45E87"BL[
MJ3MU?L\!X%_66F>,\9B]]^-FW(LYIX\!              #P*8$+
M        *8$+                *8$+                *8$+
M        *8$+                *8$+                *8$+
M        *8$+                *8$+                *8$+
M        *8$+                *8$+                *8$+
M        *8$+                *8$+                *8$+
M        *8$+                *8$+                *8$+
M        *8$+         +QR 0  ___LV[$)P# , $$;O/_(=JH4[@,/X0Y4
M297Z/P<     ^-9:ZXPQKME[7S?C7<PY?0P              (!/"5P
M          !("5P               !("5P               !("5P
M          !("5P               !("5P               !("5P
M          !("5P               !("5P               !("5P
M          !("5P               !("5P               !("5P
M          !("5P               !("5P               !("5P
M          !("5P               !("5P               !("5P
M          !("5P     ?N4!  #__^S=68B.:QP </N^1%%D#3>4K,7-B+@2
M-Y:RW(BXE"V[A)"MH61+7"@7EI)L%X02R2[;6 MQ@Y3LXW]ZWG.^&G/&<9QC
MYIN9?K]Z2^;KG>][WV?>[WW^R_-&          !4-77JU(D:-6I\MWW[]NV[
MU]3(_:!FS9J.&                +^5!A<               #R2H,+
M            >:7!!0              @+S2X (              $!>:7 !
M               @KS2X                D%<:7                ,@K
M#2X               #DE087                \DJ#"P
M 'FEP04              ("\TN "              ! 7FEP 0
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MI#A%BH,\>?*DVL0I4GR[].=,#2_5J8D'JELL(17+IIQ+:LPKG7,Y<." 6 (
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MW+G9O??>V_/>)V.!2R 0"$QF<-PD5[OM+K'3][[WO:&O+U M&L.M.TD;0HQ
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M1199) G/!_%OD%V*=<L$Y0I2SC[[["0,'S01T U%AXI9.LDX13F#3+R+ I=
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MX/@NXZ*+;!M1X%(#XUK@PN C1I!['/->XIU^'X<<1T$"9-C#0/!4Y"@XK.J
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M-]S0F!>Y7\ W %!N) YZWG6=RU>H?:U#1 K"'_E$=#UQ$ZA:VFQ*"5Q2A!'
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M2!4)7 X^^.!)B?R&$+B(74Z TI"-_(:&'I)9KM4B%\30J#9LFICG] 6" ;G
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M$BN5B-'&;M8D?VR"7"1(+"',+3,UB=HD(FTB2.3D65N!2[,9SB(/%8L!]<A
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MG:ZSJI_>)($+3"IUTA[_LDF<4C$"EI(ZV:G.@0A@NO0-*<YD[1^(R7-PB:W
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MB>^I8J+V75U/T;&N-?A24WM\SCGGG"*@?&H"EVNOO38Y<0?1O \PU_-,)1/
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MB8!XOSDGV>X* A=[)K=GAHL!6Y.#X%*J75)BV_D/<3KN99?^7RTG+N$8$^C
MX^0_$?;=]"'L//+((ZO<M,W0_4T2N#@E,>73/5?]4CWDL6#34[&MP*6%;;K
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M12$HMA6XY)O]EVI*U*3</A(Q 'T$4$BR 9>Y-C6!"\ ZE5@BMTH\N_Y$4_4
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MV0I<6MA6X%)F70I<Y@$RR1N F\-L.PG#OS-!3@,"P#V& -&EP*4V  QUI^2
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MEQVV%;CL; 0N8YB"[V,8RY#FMR.D1<\PYT2V(4Q_(YHLZ_2P=[WK7=G7&H/
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M/?O9SP[K+1/""0YS\IEH0 <"2A\U1*J..?KHH\.)RJM@%9Z5>E:#1O-+(Y*
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M/&X%+IMM>/11+U>-F(-#7W+)):&/QH$<8GB!O##*C]7LJYX^NLQP".0)!A7
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MEJ!^U2=_.)T;7"*N^+[O^[[DI'3X IQU:;GG/>^9W$<PCY*Y^18;7#0XI&)
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M()_._Q+O3<<NVY(C/RJTO?K5KQYTS:TUN!#[,45B-64!46A-$SU.0H.+:=]
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M7H:'\/-\"&QJ:.,SGR &$,_0DUQSBW@!*6-,(PT;+Z?*V63?20^!^C"+(<_
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ME=(S[\K$+$WK;=>W-Q&WA\8>(7P &]IFXX.X[F1,T[<5'^@F&^89W+\_Q6U
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MARZ3=7U]'0\/#X8#    S!@.AW%W=_?M+J';[<9@,# <      !R1^ "
M          ! J@0N                I$K@ @              0*H$+@
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MUJ!!@W+7O__^6^[?-"C[BV...882 P                      0%01< $
M                     ("G"+@                       # 4P1<
M                    X"D"+@                       / 4 1<
M                  !XBH +                        /$7 !0
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M>^YQ]?555UUEJ:FI;LQ-G[E:R*<_UR[:CSWVF"U:M,@V;=I$?0U$&0$7>(&
M"P"O?/_]]W;..>=$'/_122XZQ;>J"+@$FTX.:].F3<370\N6+6W:M&D4%
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MH+'D08,&N7H_TN.W:=/&;710<2(%"!)M#!8NT#5@P("H?R\"+O " 1< \8*
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MIEX;,CM_I^DYM_=A_VM:&PYVF$]TX9_LYW7V3<010H\^&Q*X6"-__==_W9+
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M$PZ.=!SE$?YMJ4AYDV:]:<B*/^O FE;Q1-/SYXI1<P(7/HGH!*E_:DV.\("
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MQ@T5=]8G?SV'D%$%+M,M$KBDR05=7V$O:@KP3<B!EUUV69LOB'5(2QIM_"9
M;XPB6@+,9^5B;[H.A"X),[_F,_EA$^G/.^^\UI\#//O\F@()^#YV@F%TG=;U
MT-IUK0]ZT(-:P80U;^V[/WR;& VDU] VR:>[]P%E[ML4DK3]);[G\A_[55P
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MT+Q/ A??4Y(0$>85+)+V$GX6F,]OY4@48PS0#I#L>Y[^OT25+^@^3^O0>M2
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M-*MTF=.I*2*FB?G:B-_X%J+J2&Q4]_<O$[#5927J7+J6W.'L47@%NB.Q(.
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M;]IZ%]$9RQ<I#@_%O"?3>%+[JYQGB+$4#*Q[L31AO7656]"^"@(7OMQUY Y
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MPKJGF, $@Y0A?L+KROF-R0014<Q](F*9F&86^8K?NN:::]:]'_=]\8M?7)N
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M&\*I#GP+$6#3-8(@&Q&R%.'>\8YWC)E41^9\./+((]>]!UWFKK[ZZDK7&)+
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M!HEB43%(3M)V7P0N3/YEHA5>5L0+5!>[XHHK:N\)WTU3E_(U$>,)\D9;;Z/
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M401_,@I<TG'0 P\\$.);>^RQ1ZUKN4ZTAS12SS6]2%SFG"C?0VTT%X_$,]$
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M^[K>K&Z5$F1.6""?N]C;E@$//,,4X<UH/VNE:D#$(6[?OKT MA049A$#-H+
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M(HMD.^RP0W;333?%RP@T OD[Z*"#LN666ZYO[<1..^V477WUU5$[$0@$ H%
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MN@T         G9+6H]/Z=&II?3JM4_^NI=>T BW6LNDT>R<  .#/!%P
M          #(2L %              " K 1<                R$K !0
M            @*P$7                ,A*P 4              ("L!%P
M              #(2L %              " K 1<                R$K
M!0              @*P$7                ,A*P 4              ("L
M!%P               #(2L %              " K 1<
MR$K !0              @*P$7 !^:30:\?CX&-5J]:75:K5H-ILZAZZ5ZK=>
MKQ>UG.J[5>.MQ^GY=%R= YTX_Z1SS.MQ-9UWNN5\DSZG_P4     ?%5:=$]K
M3^WS\ZUYLG]E?CY]S_9YP-9<6OO& [KS]VV?)TTMU2X_Z!D  /__"J1$P@
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M""&$$-$C@8L00A0C@8L((AT[=G2=S!<O7FP3(S.- P<.F)8M6WH*3DC8Y#2
MJ5.GVAW3$P&#AIW/QXX=:ZI7KW[:>^+_!04%";TG"5PD<!'>2."27AB?!@P8
M8$_"\AIO.<6*DU4^^>23A.]75%1D3])JV[:MO:<SSG/*!&,Z/Q<BJ&"3#!\^
MW%,HUK1I4]_M+OI,MV[=/$^-2<;)54(((8000OB)!"XB&[CKKKNL[R.\G>,7
M.W3H4%;U=PE<2B<2N @'"5R$$")Q)' 10@@AA(@>"5R$$*(8"5Q$$&'7?;?=
M\C=LV)"P0,1OV+E_T*!!KN5UDJWS\_/-QHT;?;TOALW6K5M-UZY=[6DNCDW#
MSN<XY!-! A<)7(0W$KBD=[R=/'FRJ5V[MN=XVZ1)$_/\\\^;HT>/^GIO'/#4
M1X,&#4Q.3HZY[[[[S)X]>]0A1*#!EMB\>;,I4Z:,:Y_B)"3$Q7Z!#8<MYW8_
M;)C<W-R$;1@AA!!"""&2C00N(AOHV[?O-S[GT.NYYYXS)TZ<R*K^+H%+Z40"
M%^$@@8L00B2.!"Y"""&$$-$C@8L00A0C@8L((B00NYV&PF[\X1-ZNEFX<*&K
MX>'8&)SLLGOW[J3=_^3)DZ:PL-#NJ,>)+DN6+$GX,R5PD<!%>".!2_I8NG2I
M:=>NG>=XVZQ9,_/RRR\G]:0ODA>6+5MF3](2HC1 0D>/'CT\16,(:?T2%Q\_
M?MSSQ!@2IP8.'*@*$4(((800&8\$+B(;Z-V[MSGKK+-.:^>S9\^VZ\ALZN\2
MN)1.)' 1#A*X""%$XDC@(H000@@1/1*X""%$,1*XB"#B%33*- <(B9HD5+N)
M<;CR\O+,CAT[DEX.$D_7K5MG5JU:Y<OG2> B@8OP1@*7]'#DR!%S^^VWFW+E
MRKF6GWECYLR95O0GA(@>'"7,.5YB7?H<IZ[X<9^=.W>::M6JN=ZG:M6JOMDQ
M0@@AA!!")!,)7$0VP$8(;C[O^?/G9UU_E\"E="*!BW"0P$4((1)' A<AA!!"
MB.B1P$4((8J1P$4$D=S<7-=VNW?OWHPJY^]__WO7G>R<A%!.&P@B$KA(X"*\
MD< E/<R:-<ODY^=[CK>3)DTRAPX=4@,5(@Z^^NHKT[Y]>]?^A9TS>/#@A$_0
M.W'BA'GXX8==[U&F3!G3LV=/58000@@AA @$$KB(;*![]^ZN[?R55U[)NOXN
M@4OI1 (7X2"!BQ!")(X$+D(((800T2.!BQ!"%".!BP@B01"X?/'%%Z9^_?JN
M.]GQ/?I>HLF@Z4("%PE<A#<2N*2>HT>/F@$#!IBSSS[;=;R][KKKE%0@1 )@
MKRQ8L,!3M%NE2I6$@U '#APPS9LW]_S\M]YZ2Q4AA!!"""$"@00N(AN0P.7_
M^[L$+J43"5R$@P0N0@B1.!*X""&$$$)$CP0N<8 CAV3=(T>.F,.'#YN#!P_:
M)!3GXO]\GY_S>_R^2#TT9-[]\>/'35%1D=VI.K2N0NN)77*__OKKM)65>U,&
MKS9%V3___'-S[-@Q<_+DR;0G@D<J+U]35MI^/.^49V-GY)+Z&.^$>G7>B1_U
M%ZO A;)^^>67M@P\,V4*+Z=3;_Q>4!/XXQT/P\?"=/:Q9/4!$HFI8Z]Y@#;*
M&$2;3A9!$+C,G#G3U>#@JEJUJA6)!!4)7+)3X%+2&.#,V_S<KSDJGGG4*5_X
M_)0J>S7;!"Z98!?\[6]_LWW0K=S5JE6SXW'0UR;.>W9L?#=;,=W],)+=%+HV
M"2\OW_?+UF<<H*V5M [2>C6^=]NN73O/$U8F3)@0]V?3MN?.G>OYV5VZ=)&?
M0[C..6ZV2*)KD9+6_>GTIX3[#2+9._S,*:?:;>K]!%[SG5_MAG9 ._=JI^%]
M(5U^&9Z5.3Z2?1YNNZ2BK,[[*\E>X'?4?U(WIKNM(TJ+?RU\+1W:[O;OWY]R
MGUJZZIKG]YI;:0=^/'.F^"TD</&__R0C)I/(^%3:XQ_14%H$+J'C1CSVOP0N
MF5^_C!%N/BFG?ITYP<V^3[7 )1;[*-TQ_O!WG(EKZ/"U="3_9.BX'DZJ!"[.
MFM(9C]S6*J&V3%#7^T'V;42R2YRZ\<LN*2D7(31GI#3:(['D8J2R;<0:I\F4
M/*=4V.6AX[W;\TK@(H000@@1/1*XQ&"@LR@@D94=4PL+"TV/'CW,A1=>:)/%
M*E2H8%]FQ8H53:U:M6QBV8TWWF@3^U:M6F6-6"\#-MJ%"Y]!H"?TXGM^!7F<
M9W0"2L[%HL/-H14O?!:&?>@]N">+FDCPG.'O@,50^//S'-QCW[Y]MJX>>. !
MFPAT_OGGFW/..<>4+5O67M1;RY8M;3#EJ:>>,ILW;[9E2)53R5GT\7[7K5MG
M'GWT4=MF+KKH(IL439MB]^U*E2J9>O7JF1_\X ?6:?3""R^8CS_^V#IL_%JD
M\KXH1^B[9=$5_OG\GW>T:=,F\_CCCYO>O7O;W84K5ZYLWVGY\N6M [M]^_9F
MW+AQYH,//HBIC?/9.W?N-(L7+[9_W[-G3UM'?";O@:2N<N7*F7///=><=]YY
MIJ"@P P=.M0\\\PSMDQ./XNW#J,5N/#Y+-9QY)& -FS8,%L_=>O6-3DY.;:<
MU!_EOO322^WGOOCBB^;33S]-:!QP@SX;WI\2&1=XKO#/XWOA[Y3/QUFQ>O5J
M\ZM?_<J.ATV;-K5U0[MUZHDQLE>O7C89F';.9P?9N41?8=Q9OWZ]>>RQQTR?
M/GUL@F/MVK7M^,\\0-TSOEQPP07FZJNO-K_\Y2_-ZZ^_;@4G;N\R&N@;X6.S
M<]6H4<.UW=+_W'X__&(L269]\-GT5;?36[CNN^^^0#NS)'#)'H&+$VQ@C-VX
M<:.9.G6J'0,NOOAB*S0CF,?XSUA0ITX=<]EEEYE!@P:9/__YS^;##S^T?2U9
MB3E.V;C'[MV[S9MOOFG'YIMOOME<<LDEUHY@'F5\9IRBK(Q;U-7UUU]O)D^>
M;%:L6&''&3_GJ7@%+LP3;G8OUZA1HSP_,YHQ+W2N= O2A1*MP,6QH9GG7WKI
M)7/777>9*Z^\TN3EY=GVX-@%O'/J8_#@P6;V[-EFQXX=]N_\>M_,+V/&C+'V
MKENY^_;M:[9LV1+8M1AMDSD8.YCW1UM@GL569+RE7=.^:><$!QHV;&AMTMMO
MO]W:BO1#M[5#(H3/SWSM5J?<DWLO7[[<V@6=.G6R_=*Q&VDGC1LW-MVZ=;-E
MY7?C;0/8&M@<G#)RSSWWF,Z=.]MW@;W.O;#7$9=BPU]SS35V7?O..^_XWO]+
M,[QGU@!NI[A@[_"^2UK;>D'=4V=N?9@Z?.VUUU+FYZA>O;JGGX-QT \_A]N[
MY1W$ZBN(Q[_B=A_Z3[J(UM_A]'/FD%FS9MDYA34G:T_&0<>'T*!! SO6,.8L
M6[;LFW58+&5AS?/((X_8=7^+%BWLV,$ZCWMPFA#K'4X&XW?X73]]%)%\*/@J
M\!LL6;+$"LIHDZS)F'<=OP'MEC&6]X*MAM^'A*R5*U?:=Y%(N^5OP]?,7*R/
MDV'KN:W1G6=(%6Y^!S?_&?5/_:Q=N]9,FC3))GOBNV%>IMW01IG_L-$??OAA
MZU-)=.S"[L7OQ[V:-6MFVRG^*=HJ[;1)DR8VT0J[@3$46SF5 @':!.\$&^S9
M9Y^U=LD55UQA_4>T5]HJ;9:O.?44WQ*_PQH"F\?--^?'6.O8"XL6+;(V+^^H
M4:-&=JX)]>GP3GFW^.C>?OMM^\[]'/<9-\)]'?2E:#X_?!QWQO)D] W*$^XW
M==84B=8%?8EVB7V+_[!#APZV?=!O:!_8;LS)C,.,QZS=&'-Y_FC']4RPG6AS
MU ^^07S*M'/63(P1CE\9VXKGQ:>6GY]ONG;M:M<WM%/\_/'ZU)*)FTWAYI<-
M73.2 '[KK;>:-FW:V&=UYE:^YGNT ]8-B?@&*-/[[[]OIDV;9M>!;=NVM;9<
MZ/H#OP4VQ&VWW683K!BG&'/BF<L</[';VINXBYMMB[\XEC4\?;"D_NWF2XCF
M[^+Q#_MQGUAC,OBB\$=C?SDQ&=H._8;Z9/W+IB#$N2+9,>'W9"P.[UM.DC8V
MU_SY\\V($2-,QXX=[5SE^)>X+^T*/\<==]R1%#]'JNR::.(I;N_.N9A'W=KY
M\\\_'U7[IO^D,UG9L>&()^#OQ';&U\*X1%TS1F-7L4YD+B*623OC;T+;CI\"
M%[=X".\IFGG ;3SR\M?X82.X^3!I*R7=B_?GUA:288\Z,2W\Q?C2G'@YM@;S
M$+8&Z_U^_?I9FW7/GCVGK(]3*7"ACAF76"L0#V=\P49FG'/L9WP5^ );MVYM
MUX-3IDPQ&S9L\-4^HASA;8EZ=1LKN"?CRIHU:^PZ"+\*ZV7Z3>@:FK'[VFNO
MM>^2/A'>AU+A6V4-P!IJ].C1=EV&[\#Q7U.7SGQR]]UWV_'?L?\=DBEP<>8>
MRLC: [N7^ 9MD_6^,^]QT7XI.VLK3C-G?B1>33UDNB \U+>Q:]<N&]_"M\'8
M6Y)OP\D]>O?==Q/V;21JE]#GF ^P2U@W.O5#_Z0=8>N/'S\^[GB$TV89O__Q
MCW^8B1,G6OO1\5G2MYB?: NL96G//_O9SVR[Q>;.Q+5#K#X6QY^ CX7^0-X,
MXXB3B\'S\S7C#3_[]:]_;<>A9.9BA,=I_OK7OYI[[[W7QC58LSIQ&M9VX7$:
M?)CX.K9NW>J[#\W-;J",?K<!ITZPRVG_V$6L7:D'^BQU@E\*.XK^BEVU;=NV
MTW(Q)' 10@@AA(@>"5RB--*W;]]N'3\LT+R2*+TNC'<6WR3)8Y#&(Q;YZ*./
M3*M6K4Y)$*;R6,RRJ/,##'T6ARR:G7N<>>:9UM$U8\8,WQ9L)/H3T Y]%AP[
M)&!%@@49R:+.W_'\!/UP6(0N*G &X( C0..6=!0I$7GX\.$V^)/L1 '*B8-F
MSIPYYJJKKK*+_5C:%(FT0X8,L<EH+- 37:"2C(E#P'FWM%D<*:$"%=KM>^^]
M9YU:O*N2RLB[9S?UDA:G3I 39PR.!YP0M+M8^QF+9=H#"T7Z2SP.K&@$+KP'
M%NP$BUB01UM6WBWCQQ-//&$=*WXMVG&$$OAVZH[RT$]XG_& \X,$7.?S:)L\
MJW,:"&V-^L+AAI,6QV>T=<2BGB2KEU]^V8XW0=I-A_K",3)]^G3KE,-Q%FL;
M)0!(8)[@3ZS]%F<S3CHOD4B\%WV=!'R_DP9#84SV>E]\GT!ID)' )3L$+HQ7
MC%LDUC#V,>?$TM=P:!(@_/O?_^ZKF-8)AC!&(PXE28;@03QC!>,!R30D&Q&H
M\D/<'*_ A5-(8K7C8KF8*TG X#Z1B$;@PGO"0<TZ@>2L6.P"$BX)P)( XD?P
M%?L"P8+;_9C/$4X$)0DNM(TS9[(6(S&*/AV+[1%Z$0PDT//JJZ_:.=V/?CAR
MY$@;O BU1PEL.,F.E)\^SST1+9  5%(Y"80PQL9JWV/[$AP:.W:LM0UCM:?I
M_W_XPQ_L>%*:=LE.%O1]$BF\QE/Z6SQS#6M[M[&/M2^"8;\"DXZ?@_$'^S\1
M/P?KFWC]'.'0UUDO..V7L9(^QGCL)]CC).B%W@?1>#). XN6DOP=SIQ//V=]
M1B)'M'7%V,/SSILWSP9AO=H1XR+)#,R/L=H[U-/ @0-MT)WQR.^Y@/9%.V,7
M[%MNN<4F4\9C[[ FQ09X^NFG[3HDGGF1L3(\<8_/1000[SK<"^9 ; S6%:'/
MR_U)F$P53_X?    ___LW0G<?555/_XFRV8*TP93F1IDR#23@D2!E#0('(H(
M126DR(&A,@1)DAC"BD$$4A!0B"P&33 %D2R11-(*0THLM)%**\OF[O_UOO_?
ML<OY[GW.WN?L>^Y]GF>OU^N^?K_P^]Q[AKW77NNS/I^U+KQPMN...\X^]W,_
M=_8YG_,YLP<_^,&SG_S)GYQ]_.,?GS7V;__V;[/;;KMM]ISG/&?V55_U5?-_
MU_7Y@B_X@MD55UPQ^^___N]9COW'?_S'[,___,]GO_S+OSS[MF_[MMF#'O2@
MWM]:_'SKMW[K[,PSSYQ]]*,?G7_7__[O_\Z68>[KG__YGV<WWGCC[(=^Z(=F
M7_F57YEUG3X/><A#9D<===3LO>]][^P?__$?9__S/_\S^KJ\)_?^RE>^<K;#
M#CO,/O_S/S_KFA[[V,?.+KKHHME?_=5?S?[KO_YK]/7\^(__^.S+ONS+/OO]
MG_=YGS<[\, #9__P#__0^[??]WW?M\W[]YPON.""V;__^[\7?9]_^9=_.5]O
MKJ_]//[S/_]ST'=^YC.?F7WXPQ^>O?C%+YYMM]UV6>_!=3SQB4^<_?JO__KL
MG_[IGXJLC67M VOW@Q_\X.QG?N9GYONO\2.Y]_OPAS]\_AWWW'//?!VOB_WI
MG_[I;-]]]_WL?=E3UL7O_N[O/N Y\)>_]$N_--MYYYU[[]=W[;???G,?E?N\
M[9UWO.,=LV<^\YD/V%LIGZ_^ZJ^>^_!WO_O=LW_]UW_-6E=WWGGG[( ##IC[
M]MSWF[H&=MUUU]D;W_C&SNNX^>:;9]_Q'=_QV;WJ67KFO_(KOU+TO?_F;_[F
M[#&/><P#?L?Z[KN^MEUSS36SW7??_;/KYXN^Z(MFSWWN<V<?^<A''G#NV4-\
MQ==^[=?V/BMK\%6O>E741[_I36^:?<NW?,L#?O/HHX^>GPV+O_DG?_(GL]-/
M/WW^;]N^KVOM?O,W?_/\C+[OOOL&^\=EVSGGG#-[Y",?^=EGX/Z^^[N_>Q['
M=)EU]$W?]$W)SR/UXRP[Y)!#9G_\QW\\^;,0!]GO?):UEQ+#+9ZYQQQSS/PL
MXY=]UZ_^ZJ_._77HW__A'_YAUK6]]*4O?4#\Y+D_[6E/F_WU7_]U[]]ZGM9V
M^WJ]^W_YEW\I^@S%1$]XPA.V\7]\A%BPR_C<Q>NT?_GO7/_?]7Y=P]O?_O;9
M]W[O]V:MW:_YFJ^9_=S/_=SL_OOOG^]E9XQS+/1OO_1+O[38]7[ZTY^>GRDO
M?.$+L^/G+_S"+YP]]:E/G;WE+6^9W_?8^,B[=;8US\W_R\<Y)QOS&W__]W\_
M/Q>>\I2G9)V#7_[E7SX[_/##YSY>7+A,<R;\Q5_\Q>QUKWO=[/&/?WQR/,8_
MB8%?__K7SS[YR4_.OT=,\Q,_\1/!?R\^'_KNQ>_./V>/6"HW3VG.-'OOYW_^
MY^<^QWY?ISC9?=K??_,W?S-[V]O>-O>[W_ -WS H/G:O>^ZYY_QL^L0G/E'D
MS)5;[+;;;@^($9[__.?/X^_&O*??__W?G[WH12^:/>QA#TN*2[S3W+S?_5BS
MUMYW?==W;>/3^SX[[;33[*233IK]T1_]T?R:EY7WCXE%'O&(1WSV67_Q%W_Q
M[.233Y[[G6:M\ NWWGKK[ =_\ >S_"%?*)?XC=_XC;D/SWWV7>O7-?W9G_W9
M'!/P&[GY1O/Q=\]^]K/GL3O?4F*?PJCD,XOQG3-A$;<:>_]\BC/@6<]ZUOSL
M2[U?^?X))YPP^]C'/O;9]7CII9=&WRL?4:U:M6K5JE6K5NW_+)1KMV/\SUD$
M*+>2-<#$&][PAGDB-!:H]+ ! ;_V:[\V#X!SDJF[[KIK#G:TO_,KON(KYD!"
M"0.BA(HLDL_]]]^_2'%0X/Z"%[P@^&PD UT&(&H#< KLDML&B+WEEEOF ,I0
MD-G?*48 !$H#G4WR ^Q]SWO>$P19<S_?^(W?."]**QB,25#//OOL;0 4Q2#/
MO %!%3\ 0ZG7)AE'&N@#U11/).TQX'O(9Y===IF=<<89LWOOO3<+U(F!<A=>
M>.'\.2C*7GGEE7, < BXUNPG";4$N 10C2C1?G?6L0+9$/N!'_B!;;[/?U.H
ML,84$$XYY939UWW=UXWRA<#[/_B#/UC;0M>B 6S>^<YWSLD#8_>L#]#O%W[A
M%^9 5>J^=08- 3E3]RH :5EV\<471_>+M;6N1(Q4^[N_^[OHLU5XWJP&Q([=
M-Q\YI;WK7>^*7HOBW=AS6_SS@0]\8%YP0N8;N_\!K>*AL80P_D.<RM\_^<E/
MSB;W=?EH10, N-AJ#/C_B[_XB\'?^*F?^JG.O^,CET6,6;S/L\XZJ_,Z?OJG
M?SKXMZ]^]:OGSP69[,UO?O.<"#'T>OE'A"@DI+&Q]O777S_[]F__]N#O[+//
M/KUDC74S,8("A**DF+\4B<19_KSG/6]>X!H;AR@DML_G0P\]='[=SC=GQ,M>
M]K)Y<26')))#;/$[8E0D(KG!V.?T/=_S/?/BV=C]OQ6P N2=4(QC3<C[<\F7
MB!R*EK%"V%O?^M:UQ3GVV&./V=577YV-<[1-?M!>PYZGW+2D(8N'?N=)3WK2
MRM84<D,([T! \<X^]:E/S:Z]]MKY&3WT72$I'7?<<7.20#L&YP_YGN.//WX0
M$7^11*!0SR^5\"'B'07YJZZZ:K;WWGL7C7><C?95+IE(G"*'"A7HFQBAE(E!
M85PA$AF<8BI#,&N?=W#"VV^_?7Z_UJ?W;LWF$!H0:'+B<GX2>5B\,S96]!W\
M.#)XZ9RTR1_@-2$L-_?C?2-Y(GP-C5W<H]CU_///GPM;QL8+>^VUU^RFFVZ:
MOY,Q:_Y1CWI4,#XF*.DS!,/0??COI3$.SRWD?XB0<K$][\+UP=:&$H+:9%_G
M9RDR;"G\6TR H/K#/_S#1;"TYJS^^J__^GF>:3VO0ZSZ>[_W>]NL0YBIV+SQ
M!^][W_OF6' .V?V@@PY*OK^&+*FV<\011P3/J-QXX=ACCYUC]JFX!?R@U!G=
ME3L[C[I,W!2*\9#P2YKWV_X=_S<,(<?4+]KGZW=^YW?.;KCAAL_69(A!Q=HY
M.*]X)&8GGGCB-K\IQH*M-;GEY9=?/C\GAYX5WA6<ZK=^Z[>*"PY+V(_\R(\$
MZRGPG2Z3ZY<6MRSB%.H/4YHXVWF+<+G]]ML/OG8$W=>\YC6SO_W;OYW'[*4$
M+H]^]*.#:XNPL,\6!6B+'P*EACQ<RI!\0R17S]1^ZK)0WB7&A<>,-?X;_HQ
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MDM(A;/'C'HEB8@98)/+0U689A0'?J9!"])0J(HB!<KH_2ER!83E=K+H^0':
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MITLQ I(8IXEWQ#X(7GRK=0L[ZR+YP^:Z"*&+& _L)I3G>![PP!)F/\B90FM
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MUZVKH=/K=&W7""@F<O&].7'(6($+S#5&[+KEEEM&3Z!S-L+L0S@.@FC*]VO
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M%U>N;RI6%;A4JU:M6K5JU:H]T*K Y?^9,8,2J*[)+;J>#C7)OXYO,5!!HJ&
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M9^X0'R5>"W4"]@QR)_EM5H'+SCOO/"<&CHT+^.DCCC@B>.X@V"K&IQI!3$Q
M*KX=(WK83":/.?300X-$1=WS<KO/QP0NKWG-:[(G'J6>.?9BVX=80PA_)0B$
M"$VQO'C(E)NM8ORG#J.AY@/.$23MMDC:&K'78\TEAI(.%J_)A*DNG /I=BS.
M@83<A7-8LZE$]"IPV?::D#X(*L>0E)T!1)4Q(9*F(V.G*RKL\A^AWWC"$YXP
M&*]:ALFU+KC@@B AS<32%.S'OCGSS#.#9R]RJ#AAC"G AXB2\"KXS=2^."9P
M$7\L8TJ<\TS,W :M^1334DK$S.)^:S^4KR(NIYRIWH.II;$83!,=>=/4>2_Q
MH6ZHH7A!?%MBTD6L>8V/G"$U3AXK<+&?"?1"^14<:RQ6;"^'_!I28\H:@0.&
MR*O>Q1B!Z6)L>_+))P?S"?'ND&D;ZVKVD?I!B PIUH$WK\)B A?K<AG/G]^!
M^89PBT<_^M&#"<R+)GXD  CM*T3<7-%J%;C$+29P.>RPPY+J94,L)G"!<YBV
M-!8[@'/H\![R2\C@N8U3EF%;4>#B[)?KA/:U_^:9C&URY]W+;V,3/J<6N(@1
M8J(,&.S8>(B((B0R5?=!7DV)_TH)7(AM8M,$O5\Q^]@S&*EY]]UW'RUP:7"*
M4/R,3(PT/-9@+>XY].XUA]0\(<5B A?7+@<8B\&I1:@WA&)-4_Y@]+DQ I\3
MPZ7$W?#*L=?L-T*-"'($+J;>A'P%;&D=ZIH;"8NT9T*-#>2BN?6LF,#%>E]&
MTP:YFL8>;5X.O^4\2=VK?6L-?A_*^W&+5K7>8@(7YQ..P%@,0=,PDT)B7 RQ
M6NDIO$-R60*DD- #'I3+QR@E<"$ND5>%UHSG25 *<QEC< +-$&+3MJO I5JU
M:M6J5:M6[8%6!2ZS_[\0?]999T4[<0!W2R1NP 7=Q&( 'V"E#[ 0A(<2541$
MA+\AR:_.A&VR-> G1,!&+,F=9-( ; "E4'$>F2R%S!TC?!!XE.IVH6M(* %2
M/#OOO/.RO@N)-92@(E'H8EMB''M#1+5VVK\#;-3Y(L5B A<%C]+FWF-=LU?5
M6;"QF,!%T:H4@<1DG5#G* #+$!+;5 (7A,92I P$S%B7>9V)2H!60\PS>_C#
M'QX5GNA.5&*ZC//$?<:$'\@).22,=1:XQ*[-I]3X9X4$9\S8C\+3$)'=U (7
MZ\;Z6;5M1H&+0EV(O*>X9GI3J7-;/!/R->+-2RZY9.7O%O@=(BJ+-9R'.;99
M!2ZNH=2T,87%$$E+$5['XYP8)@:((S6O.L9:)_,\0F1*$S%S.]O%!"Y#NBRF
M&)+E0Q_ZT* 86WQ1(E;3A6W???<-KB<%S54+TM?9Y LZ)\::18CQ&C&),P4V
M$"HT^K>>]5B3(\?RO$9T4X(XY[Z)%V(XAR[!J63_*G#9]IJLJ1(=);LFUB)1
MEO ?SJT0GF*M\;WK9*8FA+KEBM%2257R1V='B+ANVM88(2R!0(A )@\8FNN/
ML9C Y=)++UW*[\F]-0$*B8?XSA+K56RDF5&(#&AZ;4H#$G%SC$2!J&;=KV+Z
M)L$:4EQH_>AB6RI>0& +$?)R)M..%;@P341"1#[-(1!'QMPO7#=$CC3U,Z5S
M+1%+"/LA_BP5GUMCQ!2A>,+D[\UDUA5Q;@BSL^Y683&!"T+9,@S1BU@CU%F;
M3RN%6Q!NA_:G+LNYY.,J<(E;3. BCEB6Q00N2*VE< Y"XAC.86VMVK:BP,6]
MQ2;KP._E"B7\A_T>JZ],+7!AFD2%ZMRP7CCPF!A!=_Q0'*1)6NITF%("%PT1
M8B1F[[U$,Q3K(^;[<@0N_ Q1:BB',G6T1'SDO6JB)_8-G9?JDRD6$[B89%@J
MQH?EA2:A$N\BW^>8^I;8+S:E"9&\Q*1ISS962T\5N*@WA]8L_*/4=(BM8J;I
M(LJ'1%*F].983.!BZM6RKCV$RSB7X(@EL#"^2]THU/R'S\&16H7%!"Y77WUU
M,2X&WDUL<IM:)&QTU29F#'%FY,NY?+12 A>"[U@S#S&.[RNQ-N%I,(LJ<*E6
MK5JU:M6J5>NW*G"9_5_WFE  J=!9DN3?3'"(=?TX_/##.Q,7771"I$.%/"!J
M;D"-H*3K7BCQ#2570SM1"O;WVV^_;;X/02N5D!@C?+CO4H;@\X(7O&";W]AN
MN^VRUX&"/*"K_5T(8^]___N+7;.BNT[4(: .Z)"R)J84N !(0H2Y$TXXH0C0
M.L9BH-R%%UY8[#?>]:YWS3O8MG]#T=":R;6I!"XWWGACL6=PVVVW!4<.-^>,
MKC)3@YC\KB)YK-/5LY[UK+D(HI2=>.*)T0*&KL'.BE1;9X%+K&.X3^YXX9 !
M)YV;H6 F]P/DY_^'Q!!3BS:0!%=MFU'@8L2VSCRA;E=CN^@OFLY(_$V;Z"0.
M)*19U5CTQA!F0N<AL!4HGF.;5>!"K%K*K"W%E% LGBI49M94K)A-.+7J=;5.
M=OOMMP=)PYYYKC!E2H&+6 4)K"TBX$N0)TL2:'6U#TTV\(Q*QD.;S;RC.^ZX
M(]K)7W&L$91\\I.?#)(8O$^"PB%-)=JFFUP,YT! R25+=)G"6Q?.8>VF%&BK
MP&5Y> ?B3$RD4(I@:CHP<5:HR4=N#+%L$X^9!!(B$HE?4NQ#'_I0= H3C,;S
M&&+.;*0OQ+O0>EA%0X@I!2Y\A<8H[8F"_".28LF)K\1Y(6R"OX;=]/DMQ.08
M803)B)AD%6>1M=TF<WI^FCN5Q-V094/WCZ""-)IB)00N\*_0?O'1L7<H45)#
M+/<7$JB<??;9O41@[T*<W_Y[_S<"<"ES?XA!H=\QI:@$87E=#.'W]:]_?5#,
MHUZR"IM:X**F$!)7(G01;Y8R-:ACCCDFB%OD3@"L I?N<V1=!"[J0R5QCGWV
MV2>83XX1D92RK29P<1[9 [%:!*%HJ3Q_W00NUUUW77!*M<\UUUPS6-3E/'K4
MHQX5C!%./_WT9*%["8&+][OWWGM'FZF=<<891=YM*8&+Z2I[[KEG4'148@K9
M8APG]FT_%W4D9W1*?!03N%B;I4QM2:TP)-Z54^:8/1:*$7RL5U.'2E@)@8L8
M/210%\]58G>>R;M,E CQ6G+/]BD%+GR7QE_MQ@SV+%S)I*>2&& H+H%5V1=3
M3UQE,8&+9B<E\Y18[:+)25<]J5W3$#EK2$B2&S>4$+A8"]Y-K(F3NF8I3*4*
M7*I5JU:M6K5JU=)MRPM<W*PD*=1II>D24)*@9,0WPE"(@.;Y[KKKKIU=<1&"
M$?A"UPJXT*$CQY 8%1/: (]"+#"IW:5.H(U\F9/L^;>Z,(2*GCK,77_]]4G?
M,X7 !0DHE, KWN1TO0.,2LS;[]DZ _R4)._[+M-E0B,\C1B]__[[>[]C2H$+
M EZ(]*Y#)L+A*H"$QJ80N" 6N=<0D )4S[6-*'"Q9G7BB76:1^89.]XUUW0N
M0IR+C9P%<I6:%,6<*[%B#[^+W)=:+%YG@4N,X.E3HBN@M51"W+*X#W.M"EPV
MA\#%6E+(;L<]_!0_6Q+H14 2"X;V!Q^<&\N5-B3YD(A$T2F7#%T%+OUFFI5I
MAB&"K>[;J::0%2MF \NKP.7_3($@)#9&+%!4R;$I!2YR1+E3^STC 93JQMZ8
MF$=Q*92SZFQ7)P)UGR>(X*']*&9!.H8):!H1$]R.\9&+.3@R1@SG(*(AQBF)
M<RB,QG . M*4Z3]5X+(\O$-^%>J46Y)@"GO0#7?9@JH2AECEFD)[,'4Z,M(4
M,E(H']&T8$@#"X9@>,011P3S4M=<HE% KDTI<)&;BXW:?M0Z0O8H2=9'/M3)
M./0.D>B]XSY<(_2WKAW.MHIWQ=>&L WQ G%4R7B![S=I)^3[;[[YYB3LLX3
M14Z.&!4Z>S73<9U#C  J1+SSS@G<^IZE]Q\ZA\7Y8R8\Q7Q\2.1CWY28UK8N
M)@8U?3V$HXGO5V%3"ESL*63M$&YQ\,$'%\4M^%K8<@BW0#[-(<-7@4O<-JO
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MF(9SSCGGS/WH&.Q&G4;\%-L#JQ"X=-5?U)!+"NJJP*5:M6K5JE6K5BW=MKS
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M.%OLET/@XIPR32 V#6#//??,*D0<,^:8HL!%[&M:6>Q]Q&)X";G6PA0%+HR
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MG%-PU5P-^=9!X!)PN!@GX%G/>M9.I%+Q9RRO/N"  P8W:<LA<+GAAANB<7/
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MGEJ%6&T1ML'OJBW!&-IB&^L@<&&>MV>4.I_X7I,OU00\[\ ?B>7][I>\EL^
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MHCJ,>Y(S;BE6K%BQ8L6*%5N5%8%+PWQYW4LD-_.* T-? G6$)"3</H6!E%'
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M$0_,2S(E)KJ[ZBZ8P]99X,(4<TQA470:8UV%9ZN(J:M)6Z(L6X; A4DBB08
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MA7 IQX(9]24GN']^?Z^]]JK>+V?.+5Z %?41!\$Q8^=*UX8U;?%(/B#UW75
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MRS;QA4E1R O.J[Z$%W&S\U(\H F)23NY<G3O0WP:,#]KL&L,X_KJY[&8*(>
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M):T):X,XMWDFBI.\7_ ;[KGK1YKM8D1<\JOZL^./Q/BKREN1 ?AGYQ*_@WR
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M /S75%=71U55U:GK^/CXU/]4_?K#I4N7+ ;P/W;GSIV2+X7B]?KU:^,   !
M"@<'!_'TZ=.X<>-&R?DZF\W&V-A8;&UM&0H   "@0MR[=Z_LLQB+BXO& 0"
M,P0N "0$+@   /#GOGW[%LO+RW'KUJV2L_7ERY>CIZ<G\OF\H0     JB, %
M  #2$[@ D!"X    P)_Y\>-'K*^OQ\# P$G,<O9LG<OE8GY^/KY^_6HL
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M+@ D^OKZROX"K< %    (G9W=T_>T-+8V)B<F[/9;'1T=,3CQX_C\^?/1@(
M  #@E*&AH;+/8@A<  "@E, %@,3P\/#)@SE__U)H;FZ.-V_>& <   !^6EM;
MB\'!P:BKJXNFIJ:X??MVO'SY,@X/#XT#    0(D'#QY$;6WMJ6<QBO>57KUZ
M91P  #A#X ) XL6+%]'?WQ\W;]Z,[N[ND\^QL;'X^/&C<0   ."G0J$0^7P^
M[M^_'Q,3$_'V[=N2&ZH     \$OQ32UW[]X]]2S&HT>/XMV[=\8! ( S!"X
M              !<*($+                %TK@ @              P(42
MN                '"A!"X               !<*($+         / O^@L
M /__[-NQ"< P# !!&[S_R':J!)(Z\,T=J)(J]7\.     'RMM<X8XS5[[]?-
MN!=S3A\#              #@5P(7                4@(7
M    4@(7                4@(7                4@(7
M    4@(7                4@(7                4@(7
M    4@(7                4@(7                4@(7
M    4@(7                4@(7                4@(7
M    4@(7                4@(7                4@(7
M    4@(7                4@(7                4@(7     'A<
M___LV[$)P# , $$;O/_(=JH4Z4.>P!VHDBKU?PX         \+VUUAEC/&;O
M_;@9]V+.Z6,               "\2N "              ! 2N "
M      ! 2N "              ! 2N "              ! 2N "
M      ! 2N "              ! 2N "              ! 2N "
M      ! 2N "              ! 2N "              ! 2N "
M      ! 2N "              ! 2N "              ! 2N "
M      ! 2N "              ! 2N "              ! 2N "
M      ! 2N "              ! 2N "              ! 2N "\!L7
M___LV[$)P# , $$;O/_(=JH4[@,/X0Y4297Z/P<             X(_66F>,
M<<W>^[H9[V+.Z6,               !\2N "              ! 2N "
M          ! 2N "              ! 2N "              ! 2N "
M          ! 2N "              ! 2N "              ! 2N "
M          ! 2N "              ! 2N "              ! 2N "
M          ! 2N "              ! 2N "              ! 2N "
M          ! 2N "              ! 2N "              ! 2N "
M          ! 2N "              ! 2N "            P!\\    ___L
MV[$)P# , $$;O/_(=JH4Z1.>P!VHDBKU?PX \%MKK3/&>,S>^W$S[L6<T\<
M              !XE< %              " E, %              " E, %
M              " E, %              " E, %              " E, %
M              " E, %              " E, %              " E, %
M              " E, %              " E, %              " E, %
M              " E, %              " E, %              " E, %
M              " E, %              " E, %              " E, %
M              " E, %              " E, %        X'L7    ___L
MW0FTU/,;Q_$L61.R)*=06K20O>P=Y*0(QQ;1$0HM$H[HD+T%I=62I:*22F4M
M46@[299P*B65%$6+K&5Y_N?S_,]UYL[]S71G[C2_W\R\7^?\CMLVYL[<^?Z^
MW^?[/,_7#         "0T,X[[VSERI4K=OW[[[_%_DZYHC_888<=>,4
M                  "0412X                        (%04N
M                 "!4%+@                        @5!2X
M                (%04N                        "!4%+@
M               @5!2X                        (%04N
M             "!4%+@                        @5!2X
M            (%04N                        "!4%+@
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MB]4 17+%>H7J!S[P@<LJ"I$,$M2\[WWO*QM3AF E!2[6#['.2B($+H$VF(7
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MUXJX!<3Q3OE*_L.?3@#1_!B8+<X\\\QBBRVV6.*G"6#-P[X[H=@URDF93@]
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M.83 )1 (]$$(7$+@$@*7M8,0N 0"@5DC!"Z!0"#0#R%P"00"@4 30N 2 I=
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M/N^\\XKO?__[*W:O8CSO5GXF_W&O:1X88W_ZNUCK0Q_Z4#D7<#8K/<9MGXN
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M]1T<VJCDB9&:H"DT]^\T)XP)"5'3D9U=@!3-D5K(7 0TPG2LW94U5(A[ANY
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MS(KKZ%MGZ .G#N7J?]8C?FTH!VTS'\7XIC&3'XXAZE$[RN6?<IDNC0YR-$)
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M<W*MU[WN=</G4UXC?IN&:_"WZEDIC1-M%GXI-SZ,WNLYSWE.IVMXZ:67)CF
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MEVI^77*M"'TVN+@.>+1HBH77 0<<,,S)2L&SZ#Q*37[<O'ESJ^<B97#QWJ5
MUWC**:>$#574-W)1PN B3SOUU%/#/=G9WW7J,-V7I@717L4TM*I& ?<XBHW4
MV[KJ0%;!X&*_]CN:Z\'9_;K7O:[H9.:''WYXJ/MOKFEYA/7<I@Y1#2YYJ :7
MQJ:ZK@87#UC*>*+86L(MRD4XK;EEXUHD4LC%(B:X]&%TXB0"9%D-+N]YSWO"
M<8 ">L%AJ4X]X  B_HU<F((WWV61(%Z/B N'M^YF.:@&EW8):"2(M3YR.M"-
M,[@X/^H$EZ<^[ZD.#+F)SKP,+A)9)$(DL%&@+$4 C1)Y:X^1-.J0A2!;)*K!
M93+F87!12(S$F4A")HZVT('+NHJZ<RGJ+-KT61K+9G"Q7QY[[+&[? 8A![%S
M5\S#X"(?4TR*2"[K5"?WDMT172M=8R)!@^^@PVL?.O56@\M.$CD2A92<9E+J
M3&;T2)D\<C /@XM<7S$@*M(01>;$/8P]$9DL%E)4;-NY9E:<QS(87*QE9&MT
M/PC^<]!7@XM.N(P-T5Z/ ';NENK.5PTN_36XV-\(HJ,SV(0+W>5+C(SOBFIP
M63Z#RR.//!(:YYP_UEM).#N9::)]# <PCLN)1.7>1ZR]R#6_[,#;FE@:Q2"Y
MHI-Y&%R<<W*-R)"CJV!;$$;?<,,-8<U%_N3,+U7 70>#B]@IQ76XSJO"=;B7
M.D]'UTN76\UZ<G#SS3?OPD<RHMQTTTU#@7 SAY._B7=S:C>>&8*8: K6F6>>
M.3&')88W%2#%-3#BE\S]F1V9ME-<PVM>\YI6QH9J<-D5ZC(1ER$&D(?GQ V1
M86I47]3=M51MIAI<=O+2RV1P&:VWE%F-T:K+E(H^Q$S,W]'Z5]_L:I@@@KW@
M@@O":3=R\DD=U#T+\M0HIO$>N.Z232W%1W+.B,.R3_N\-N?A.AM</!\IDY#X
M*\=T"&(#C8&:SYEK3(?1;#!@[Q!KY,838ITHGE"W:=M8JQI<^A%W3-KK\*BI
M\Y?F9]P4576(:"( GD2\45*_@5\P;2$2;A+HEYKJT 6S-KB >E^*TY(?WWCC
MC0M=K_88$\:BLT(.E+MO3FMPD9-J!!>=EZ,&'Z6XI3X;7)SC&E1$UT$.)A<K
M-6D)1DWB4G&#SVMS[LW#X"+F-H$J:JAB8E(N2AA<[&.O?O6K0ZTETWC;R7E-
M,'M%Q@PY_BM?^<J5FL2[$>)J.J0H?^NJ UD%@POC3W2>V*MQO27/;N>@?"$R
M:%K/;=9>-;CDH1I<-J!.<(DGN.B 4"((2@E-N[X0TKF8I\'%\T+H=<DEE_3F
M/J^:P46B:U1XU&6#N*HT=*XY\, #PU&D)2<Q=#U HQ&,UB'Q=0ZJP64RD*U1
MP&$?S0DX"%:CPIJ7(*ND26O9@7@L46B9I\'%=X[V7<(]255I(/BC[A'.(N3P
M(E$-+I,Q#X.+KD)77755*/I!X+>%(E@TWM8>Z)XJ+"@ K8I);]D,+O:>$TXX
M(2P&$E%UQ3P,+KJN'7300>'G*"B7ZCX\@C6JJ-6<!CAZ(?M*DJ!=40TN.TF[
MJ%NZHF3?Q&8IX49NO#$/@XMX4RXS[<09\3%Q0/1]D>>*BHN,;9?%X.(:&7D?
M?5>$:0[Z:G A)DN)(/;==]]A<:H4JL&EOP:7^^^_?W#HH8<F"[MO?O.;%QI+
M5H/+\AE<Q+G1Y(733S^]F&EN(Q3Y(^&R@NVX\\Y$\NBW,J,K#NM>6IN==(OK
M=<^+KBTN-_?LF+7!A> JZ@(K_CKRR"-;OX^\VU2*U)0(4V)*81T,+I.XCNW;
MMZ\$UR%W8C:.NNRKM>2<07@F\4SSO9SQKB=C$,%*DX,BN,DQ'SI[CCGFF+!+
M?)M&*VI%*3&E6FV7#O"3]B1[>FIBH;.@C0"J&ESBO%/.$#VG1(,Y/&PDL/*R
MUN3T)?>G:G!93H.+>LN))YX8?I;UTZ4+=A^@ADEC$7''NFAK2I$+XM^H7H^_
M<N9, F.!N#VZUHR1S#.ESU^Q6--0L;'Y:QN=P3H;7)R]%UUT49B#B6>9S]N"
M\-4];L83[H.F/ 3NS::3XHGSSCLO:[VFUKYXXKKKKFO=6*L:7/H1=TP"O5%J
M:C!N=%SS6IJ@J-[!<-UECYP$L7$4F],2S(+/:(MY&%SDQFITT><XEYC9%\TU
M.*.B[[?WWGMGO5<)@TNJD>6H]E3R>O79X"(O/^><<\+O)@>3BY6.&^1@<L?H
M,TV&;#,Y9QX&%SEZ%#<X-[NLCQ(&%Z UC'1\]AFU^"Z:9!J=* <5WTW3\+/O
ML >_]*4O#3E%>6X7K(+!Q82UJ,$XS4Q;$W,.U/#D*5'=L4VL4 TN>:@&EPU8
M9X.+A"%*0+T<,H*7:5%R@LLL#"XZ[RE"EGI=<<45P^)^GT84CS.X,""4_/V3
M7BER/L?@XC!UWZ( 4(>ETC ! 2D3";05;!:-R*7K50TNY0TNDNT28@\BE$@0
MX77WW7<7)0B6':YYJGM'#N9I<"'$C<1?$NN2X]1'4!"+S NFW'3IR% 2U> R
M&?,PN CR=1B9MNB".$*"1/N79U*<2_BB\$!4UX=B[318-H,+05VJR#*-V6T>
M!A?BEZ@SEI?/GX6@4N?4E*C2<YPCD)@5JL%E9RP0&5R\^F9PT9TE)5[-P3P,
M+I JKA"CM85[K<B7*BI<=MEE"[TGRV)P 1,XH^^:.\6VKP87><X+7O""9#'H
MSCOO+/99U>#27X.+;L<'''! 4E0XC3&C!*K!9?D,+IZG5-<TQ=W28$:,FD6=
M=-))8PTN^,.H8_"H&09.CHC%6BO9I7H=P$ 975=[3>[9,6N#B]R<^"'Z'&=D
M6SSZZ*/#B2_1^RCHWW+++<6^\SH87.PY#$.3N YFW&7G.DQ'C<0YC ,Y$PE,
M:(RX@E-..678/9,X.#(-63,YI@?=JZ,ZD$88;<YF7$A*/*#.R"!7&B;;1!/@
M1Y_9IFY8#2XQ+Q")5KQR^!N"^U1-_-QSSRWZ?%>#RPXLH\'E_>]__] L&GT6
M(;(S81EA:L'EEU^>C)MR37]B7QH0TS8BHW&;'-\^D:I-V[^G:=J4@IJQCNO1
M9\J%G)5=XX]U,+B,\OHH;\0GMKE^(YB($0DU3S[YY*'>@UE&<]/F_Z[QIP8!
M;?&F-[UI&-,WWP?WSO#4%M7@TH^X8Q)<PV<_^]E)$]LXL2L.<+?==@OYM%(3
M,INQ;O1YFNPN<M+K/ PNSA UNNAS: NMZT4C%7=87SDH87!AS(H:'(Z:7#B7
M2J'/!A?\3XH+D8/E<-1M(6>,3)(C_J7-9\[#X()ONN:::\+/42O(12F#"WX@
M=7XZSW-S1GFAFF.T=^;&!\N(5 .YG/AK(U;!X$*C'4VII#\N/=T=?/=(9V%O
M:C,)LAI<\E -+ANPS@87POV4*.F00PX9'C;30G=&A',IDTMI@XL$8=4QSN"2
M&X!,BVA4<:[!18 >'1B*VN/&BG:%A"$B&B0=$L]I0 @O:.,J];NV;=LV)-F)
M:L\^^^QA\D"@KAN*@UGPZ\"TQXS&FU6#RP[,P^ ")<0>KDMJ>A8R;9%C9TN#
M,./>>^\="NTD500;UK2UK7ALK>NV8^K5M==>.RS"(RV=S0*3932XV(>B(NZ>
M>^XY% :4!M&.8D'4-1TYO$A4@\MDS,/@ @P$TQ9=D)?$MY&X8&,1E#""0)$9
M!O'KGB#P^B9$GX1E,[A -,UI&0PN8A_"_93  )$\B[TB12)LVK1I2)0N&M7@
MLA/S,KB8W",.$;>82A+%+>>??_XP;O'\*NB*<T8=G9?-X**0/*W!Q6\_XH@C
MDL6>:?.E:3$O@XMXC-"/Z$QA6W,'.9P]3%<QN9W_VWXGYY/[W7KKK<-<9?2\
MN%:K;' A*$CM:\0E.K^60C6X]-?@XME(F1HV;]X\W)<6B6IP63Z#B_PKXE>(
M9/ )I2$.BXPJ<MQQGZ?[JJEFXSAOQ5GO(Z87:XBW[6>+%+;,&JZ96((!2&Y\
MY957#O==^^3H_,1=XY,OO?32H0"&8,G]'77>72:#"Q#^3VMP$3]$(CTO^T+)
M"9CK8'#!=:2,%*O&=:1$O8R"8M2V'<SQUPS*S6M$.&V_DU>9?M"L"7HN<\26
M8J-(J(#O;).S^TW1WX]$/K/HYJGND5I+:J[JI9-0#2XQ2AA<" ,C8^S('%OR
M>:X&EQU81H.+?2S%V;L^770*?8![SL02<;!J5SB,'*AOJ^DU]WHB)/7F-J9M
M^4]JS\3/:I11&O8,-9$4C]6&^U]W@XM\,Q+[VE_E,6WC";&4_*?YC(G[<:S6
M$+-+<XW)67/X1CS$LY[UK%V^K_PLAXNJ!I=^Q!UMXMUHZIO7_OOO/U;_9KU%
M=0AK=1;:#4:NJ N\_:_D5+E<S,/@HI9B4E/*X#)M'N[]<0;R;]H3C4*95YM<
M@UH/C9II3B;XW'???1^J1_;)X")O4<](:5I+:J_Z;'!YX($'DERH>&(6&C37
M/L6URS6=69,P#X,+X"GZ9G"17\G+:;(BHZGG+@<X8QP5'7LS?C 52WS:5^!W
MQ1WJ9!JHC+2AKNE(&VJ/$I.+7=1<3+O'18],EM7@LBO4[B/#D[U_%M/0[.F1
MOL0>U$9C7PTN>:@&EPU89X,+MVEJG-ISG_O<(AV,B',(-P2-!/IM7CH]58/+
M[ F0936X*&Q$8]X%U 2DBDPE7\9C1@5^@K[<@ LDP,A]!)A@$M$G22,D0^I*
MG&W2]EZ=XP1C1'&ZX'"!(WNXCP4YV[=O3Q("U>#27X,+TBQ52-&1J"WYUU?X
M_D@)[GF$GW6@8Y.$WU01:]K:ML:M==="T*D0H=#IWRM47GCAA<-G;-D,+D2*
M4<%-=R\%]M)[E!'ND5"&Z*:TJ2,7U> R&<MD<!FM;PEW5!"("GY&-;O?"'O"
M7M-=%*YFT3&A-*K!90?F87"Q-Z8Z:#)'SH*00@BE1!ARP$5WD(=J<-F)61I<
M$%P*_'(1W==U!M2@812W.$^;<<ONN^\^C%O\.W$+D0RQ.Q)QW0PNWB/%*7B?
MDJ:%+IBEP46G.84R,8$\5SSF?1&4<C?W7<RJ*.?E_[:6%2Y-K2)P>]&+7C3D
M/Q0,4J:'53&X^%XI@2%>)D?0/@G5X-)?@XO?'A4<O AA%ATC5H/+\AE<<&+1
MU 5<Q!EGG%$\_Q:W1I]'*#/)4*.+(&ZD38,GSPENWCGA,XG&-<=AIFP6<98-
MOC^Q#K[1'BN.TB1$[.N<P-.(OYR=XB_G)X$P+GB???897A?B;_=8_,84LVX&
M%P;K5$QO?RDYC7(=#"XCKL,YW(7K4%]9%J[#5 )[8V0,-)6QK=&4V*(9U^F8
M:\K5*$XFRFC6<'"CXI$V>9P\S7=JF@KM#41$?DL;7B<2TGAYCUDT2R-4//30
M0\//M&X8^B:A&EQBE#"XC&L\YOJ6%&Y6@\L.+*/!10W79)+HL_!"GO%EA9B>
M63.J)1')M]E;-\8(>+3F>^$\<"1M8E9\7"HGT$RE1"/6)IY\\LGA&15])AY0
M0[ZN\<>Z&%QP]03BT7Z*-VB[+VLNU(R]&!/P1Z-X D]@O]CX;W!K=$=MXPG-
M-)J"??$$L7N.B: :7/H1=TP",3H]3?19]J=Q E*<4-30 F^I%C\+?B&J>W@.
M%IE7S,O@DFI6@0? G7>!&(L@7.,RAGMY-F[ 7C.J]8RX!F>Z6$VM1YR.KSGR
MR".'?V=_($#OB\'%>9B:$NE]2G)V?3:XX%/<JU2]9Q:-9N6,<L>4SJC-F;S.
M!A? 9T8<-GY C674V+L-3$6.&@WC97.FTLX+\HIWOO.=0\[(.>+,IFM4.W4F
MC;2A]B5\LSUJI WUFSQSQQY[[-#$84\Z[+##JL&E ;QRE'>;J#*+LUN\WXQ-
M1]J2-B:5:G#)0S6X;, Z&UR,LT^1K1ZJ-N-C9P&.Q6IPF3T!LJP&%Z+W%#$\
MSY? (H>TL,D:0>]^.$P%+5&2W/9%7">1D8Q5@\MR&5P4$@7LT?M(N/M0X.@"
M9*.D@OG*V1(%=CDO8F?"A64SN.A2&)GPYOV2!,W22-(&U> R&<MF<!D1:;K:
M$!?EK$E).F)6<>KE+W_YL/NN/3J'N)@GJL%E!^9A<!&/IP0&LS)^Z@"G$U:J
MF-FFJ^JL40TN.S$+@XNXA8 %(44(..W9+3=(B597V>"B:)"*^1"PLYC E(-9
M&%SD=001"NX*]P1=[G'7M8.@TRU5X6Z5#2Y,$*GK1"104F!8#2[]-;B( 5/-
M'G3_771<6 TNRV=P(5PI-35\FI<SNHW80Q.HU.2-U$MMQOO[.V9*@CS%X5D(
MLV<-SSC>7S,AL7C*\-;FY;X3HJ0*@ZML<,&KIJZ=]VG3,3TGUEL'@TM)KD/W
MW[YR'>)8\0!15O-W$$K@==OD*JYO,X<GU'CPP0<_].\(- \ZZ*!=/@<_TF9R
MBCI*="XSUGAO^=PD^)XI@9[[-(MNGG)APK@4#TW,/0G5X!*CA,'%=TW%#=9O
MR>EOU>"R \MH<+$.4ER"]:-9Q;)"_)C2#&CBTN8<&)TG)B#C?9KO@QLSZ:L-
M"/!3/ $CSBP$WLYGS593=?<V(M!U-[BX_^I-43XGUVUSUEF+C"?->,)]WW@.
MJ<-%4WY<ZS;&7 +Z:'H=X2@A;)MX8H1J<.E'W#$).-M4,R9Q^[C:BAPU:F@Q
M[Y<SLG1])0?S,+C .)TFX7<.3%=G;+&'6VNX@J[7'P>C1IBJSRW"X(*32]6O
M<"*C";<ET&>#B_,E%3?(QSW_I2%GE#NFXF9-&29AW0TNG@$3LE*Z&@:0MO&'
M^D'41(T)I ^-*S=^5WIL,:?OAC-*[:UM7J.IPJF];9T-+N*\E,9DGB_WQCV?
MA&IPR4,UN+0,G%;=X*+K6]3U?40(77_]]0OY7M7@4A:K9G A!NE#<FDCO>FF
MFUI]9^([Z]I4"AT"YE%\KP:7_AI<=+E+%:)+B[OF!449'7,40U."I9*O/AM<
M)/[3F-=*O<1OB@F+1#6X3,8R&EPD#6)(>QG"M\MZ]S?B;!V)&5=UL.R;N:\:
M7,876TH:7!A_4[&19ZTT<0Z*F:FBBO5I_UHTJL%E)TH;7.PW]C FAWF<V:ML
M<$&ZI6(_1-VB]_;2!A="%W&_G)01.R+72K]6Q>"BPU3J>3/%IJ3 L!I<^FMP
M$:ND^!S\BJYFBT0UN"R?P86P0.Z[Z/S;_M8F9B6@TE!*C)UJ?#+IA<=@NF Z
M4"379*/OD$,27&CJ(H><1^%QE0TN1!VIPCAA/0ZL%-;)X%**ZV"0P75LW;JU
MEUR'J=M1TSN&:_':)*&G"4)-SE\^_XI7O.(I>:!S0ZX?Q>%MIIC@RZ*<V!IO
MFZ_CV5-<P\TWWSP3KD%,FXHGK(\V306KP25&"8,+,7XJ;K!F2TY)JP:7'5A&
M@XMU\/###_>VYC(-<!I,+-'$,F)B1L^VO)IZ0S.FPY$0F;4UV]YVVVU)7L49
M,@LCHIPS52N1J[81JJZ[P074^<6O$7>IL=FD>.*^^^[;Y;QS9JO);%P_>,?C
MCCLN--*(:=IP9%%#(K%,;OY=#2[]B#LF0;,TN6!*VS-.?,KHUQ=^H633@ES,
MR^!B:M@XWJ/MF:V6LFW;MN$:FT>M9Q$&%S7!5 U&SE0RMNRSP86)*<4G'7WT
MT3.)&ZQ[W'<J;G V3,*Z&UP8T,0TD4E+XR*Y?]NUJ:E(,W:T9VW9LF4X8:X/
M4+=F]C8-2IXR#VWH.AM<7OC"%_:B^96]J8U9JQI<\E -+ANPS@87!X #*/JN
M#I=YFQ]&J :7LE@U@XOOW(?DTLLHN39D&4+"J+QY3IZI!I?^&EQNO_WV(<F7
M2@R709S0)(N(% 3H\WHV^VYPZ8,)S\MZ722JP64REM'@,H).*,X(TP^(?+N8
MV^P98D[%$ 0D<KED,7D:5(/+^&)+28.+(DSJ_-"=.J>36EN(SU+B4GNX(MNB
M40TN.U'2X")N(4R/BOG5X))O<!$#I^(><<BBQ>HE#2[V(L\?,\:TDPK7T> B
M%DD1S0H3);LE5X-+?PTN8MS4F6]JVRS._!Q4@\OR&5Q2L<@B&DRT%7O(=][Q
MCG<,KKSRRF$!'B_1=6JKHMC+7O:R89&_Y#Y:$GXOGHM @H!^7O=DE0TN=]UU
M5_),M:9*"H_6R> R*Z[CLLLNZQ7788_5/;5Y'EM3GM-)8CJBU69.J0LZT<[&
M?4C>Y?V:9CYQ]"1SB?=AF(DFUYL<_L033TP==Q"CSHIKT'T^M6^WF6I0#2XQ
M2AA<4GR(5YO)0KG[4S6X+*_!1:RVB@:7T=FNAA$)OX\ZZJAA?6L23#V+Q/YX
M*P+#MF>>Z8:IF$:WZUEP2LZ8[=NW)R?TB'NZQA_K9'#Q/+I643PAAII4YV:J
M;4XR%D^X-\UX H?RC&<\8Q<=D_>8%$]8CU'#R3/..&.H$<M!-;CT(^Z8!/6"
MK@:7U.271? +ZV!P(4:?UN#")'/>>><-]X]YW9]%&%Q,HTK58*SWDN=EGPTN
MF@6DX@9-)F81-\@9<=:I9[6-GF/=#2Z 6X_. 7R+<U[., E,VC27D4E&3:P/
MG(LU*+XU42A5UZX&E[*U%@VX^Z(?K@:7\J@&EPU89X/+!S[P@602+G!5I%C$
M(5 -+F51)[C,YD44UX9H4!!3S)K'5(MJ<%D.@\MCCSV6%'(@@(D-^U+T;$/V
MZVR(.)AGX%@GN+0;5>FY7B2JP64REMG@,BH2$,4S(5QTT47#.$UA(K>CO?T#
M*4B<I1MH'\19U> ROMA2TN!"A)PB)=_XQC?.I*LJ,4&JJ&+_K!-<VF'9#"[B
MELLOOSQI-*X&EVX&EU37+/Q'R0[B75#2X.)Z;=Z\.13:58-+NU@DE<<3H>KD
M50K5X-)?@\M))YTT]T[J.:@&ESK!I:OXQ'7+S6&(M9BJ[8^>KT,..:03=^@<
MEF-[GT4;2R,0K>"#HTZ-U>#2W>"2.E,)4[M..8RPC@:7$=>A;EB2Z[CGGGMZ
MP74X:]5A=M]]]U 4-"X7]CR+,YJB-^(-7$X38@1BD^8U(9@BC$W!M2>T:,8,
MQ*T:CK6-&\=-<)G5Y#CY3RJ><-WJ!)?N*&%P:8JI-[X(]NL$EVIP&9T!GH.4
M 4(,OLRPES,K1K$$P151WB1N33RSWW[[[?+W]@/BP[8PP27%*3E[3> N#6>(
MWY\R(K:)(:K!9<<>@L.(8GR&ZW&YK35XUEEG[1)/Z,!M;37!0-(T'H@GO,>X
MW)$A]OCCC]\E%F"^O?[ZZ[-CYFIPZ4?<T>;<2?$::@SC:BM]F.#B\^W%Z@.+
MPKP,+J:\IJY#FSJ(9U@#UGDVHEJ4P84Q*Y6+XC[P2Z6PS!-<9E&+DC/BK.L$
ME^GTI<YD<5*4GVL0,>DL$)]???7584W:6=_&6#"O-6KJ[+RUH76"R^(GN,B-
MZ$ GH1I<\E -+@VR=%T-+@X!I&BSB]+HO@M0QA'-LT(UN)3%JAE<+KSPPI 8
M)N0FM+_FFFOF\B)*GM35"2E^P@DGC'7G$M@C1!4%!9=^G\YN?HMNCNZ?___6
MK5N'9(T@6;%)DDTLETJTJ\&EOP87";<">40@^V]O><M;>BE*B'#__?</"T/C
M"!\=.JT%8B:"<60#XM/Z]I(@>?YUV/ ,V)<%HL25J8)]GPTN.A-%16*?Y7?/
M:X]"T+89T3U+5(/+9"R[P64$B<3[WO>^P8,//C@4UA*#$M(>=-!!P[.J;?)'
M-.P:$GXLVNA7#2[CBRTE#2[62LH8Z+N7)&<WDK2IV$%A[H$''ECX&5L-+CM1
MRN#B7%* &+</^4T(2#'WN+A%1^%1W$*0*!Y*Q2VK;'!!V*7V^?WWW[]5Y\]9
MHI3!1?%=9\AQ!3/[&!+SQ2]^\7#*BS5BK5@SULX55UPQ-%A=?/'%PSR<:$)'
MTN<][WE#LWB*A%T5@PLQ8JI 2MBM 4LI5(-+?PTN1-*I0N1UUUTW^. '/[C0
M=5H-+LMG<"&<CO9/SZC"Y[SR;^*\KOD+?IZ)@.CYVFNO'9HI<2(Y'4AQ,L01
M_KY/#5,("/'\XR;MB)^L!6($^\RYYYX[N.222X9GYL;STW^S?YYVVFE##M59
MOO?>>R?/SU4VN*CGI(KE^+<VG2_;8ET-+FVXCISI2_YM7[@.(%YFJHOJH>.$
M$:Z#9[7Y=VH641W1<Q7]>P:.<5-3U2,\>\V_._C@@[-,'CBO5/QIOYR%<%JW
M;8:?Z#/QQ6V^?S6XQ"AA<!$WI.H8OF_)J3[5X+(#RVAP49OSO*6Z_^L2O,RP
MSNW!T:0"W+Q\<MRSX)Y>==55NXB-1HU3==-O"_M]ZCQ5!R_-+X):H?I[])F>
M6=-'NL8?ZV1P 4;@Z+S>9Y]]AF+>%-3MHVEGUEZ4"S[TT$/AOQ?WBJU2D%_A
MW"(C5I<<OQI<^A%W3 (1=4H\2J\P3D"Z:=.FD-^7H]KWYL4O$!:7; 24BWD8
M7.1$*4VE6&W???>=R*,P5.ZUUU[)' Q7H&&QV%KM%!^/5QC5>G ->'O_#8^/
MB_%L.N?M8ZE:SR(,+FJ"J;C2>5[2$-5G@XOX+-5\3 XVB\E'<L:4<00O8S+]
M)%2#RX[<@U8EJL_B]M3>QG$EZM<:AS2?2[7)2R^]=":Y?2X\ZZ;E1OKKC=P0
M+@8_Y+[0@&[4AOI_MVW;-M2,FEYKC8B!3)#TMZE<=IT-+NJQD0G"GC[/LUL,
MUZ;&60TN>:@&EPU89X,+&+.+D$\)4A2AYHUJ<"F+53.XI#J"$,>7+."5( D5
MTU,B0K^!H,FARLF+0)=T$T\1<DK,O(=@CW@/*:B3@?U%LH\X$@2FGM]J<.FO
MP044AU-B38%L28'7K&"-*NJ.2_!//_WT(;F'9'2-F#\0R(@9Z]M+P8"02?+M
M3.:PO_ONNX=[=XIH[K/!!>GN_(P$LX\__OA:!9S5X#(9JV)P:1*3SC+/LC-$
M1S1D&*(=*9D2-6XD(Q!"3**+1#6X[, \#"[N=TH@C]#)*8RVQ;O>]:YD#(58
M5CA;-*K!92=*&%S$+?;HU-Y#$*&(;=RX[L/B%H0X8G12W$*HZ)F0IZR;P05I
MFQ(HV_-G(8C.00F#BW/-GG#HH8<F!4!(:3&\J5,,X*Z+^VBM6#/6CC5H+1$S
M65OB0B)TYG;Q<DH\NBH&%X6<E'!%W%.R %4-+OTUN-AG=5]/_?Y%<SK5X+)\
M!A>Y9<1)$&&7%*G.DV<1D^%$%"<9;0FI<%[CFN>,:CB,EK/@W+J",((X,65L
M(33&3;_^]:\?"BT99\614?SEO_G?-!O"H1*SW'+++4,ARKH97-SCU$0<8IR<
M9V@2UMW@,@NNPS5=-/ MZF(1WTI(D<K!33UIF@RL1?<A$KR)>YG2FB(Y!CY\
M6&J?)O"(<DTF\ISK9W])":#LKT\^^63Q:RM?EVND\BS[^R14@TN,$@87>5NJ
MEB$.*SEEJ1I<=F 9#2ZXIA3W3\BHKKOL4(N.\D9B8-S'N.?JD4<>"07U[H-Z
M7@[L:T2-T;5F^)Z%T$L\B;])&1'];UWCCW4SN%@G^)PHGCC__/.3\01^J%E#
M%4]H>A$U?[1GJC4WXPFQ@KI'*IY@DH^:!N VNJRM:G#I1]PQ">H^J9B!5F_<
M_H83BAJQV:N6I3%I"<S+X)+2$#B+F-/&P;Y -YCZ>W'W.>><,\PYQ'B>^52M
MQW^3%^!B:"??_O:W?ZBY05\,+K[_'GOL$;X/7F524^9<'J>O!A>Y5*J^B6N=
MMG8:P=J0.T:?N=MNNPT-<)-0#2X[8+^/#*L$[+[CN&9Y*5,M;GP1FN8F[">:
M#^.&4C&F/8NQC@'WX8<?'M:7Q4KCM*&>?=?-;Q1_1M=@W0TN&LY'>?<;WO"&
MF310G1;5X)*':G#9@'4WN/C]B.'4)BOPFW=7J6IP*8M5,[AP[T:CQ!6NB+3Z
M]&PA**(-5^)#U,)\,4V'4H%.*NBH!I=^&UP07JD.T +314S/RH6";JJ@3I0K
M64.43P,!_+(97'1V)$R(BC9(D75"-;A,QBH:7)I $"(EB,S$9!===-'P?J3(
MN%$,3BRRR"Y%U>"R _,PN!#0$.Y'GR,7*2G0&D%\@_A-"=^-_%XTJL%E)TH8
M7!0G4J)JDQ$96Z9=:P1OZV9P43R)NC^/Q UWW7770I^C$@87<:0Q]%&G=&M*
MAR!%XVD$<C@7I/$J&UP0RJD)2@1";<9WMT4UN/37X.*ZI<Y\7<GP*(M$-;@L
MG\&%P#X2H# <KH( Q1GDVEN#\B/="J.&&AM-(XK%_F[1</V9.*,X#J>#%R#@
MFF;:F_-3C+=N!A=[A7@M>A]"(->D%*K!9?P:U\BGR76DSKD1UT&\N4BN WR^
M&"<R?^"UB"VB_<A9W10.>);'39 6?S1S4'O5EBU;PKP1KTI VC0,V4MRI[V)
MK71MCNX%L]$L&A'9]U*&#\^G]3()U> 2HX3!Q;36E!D-UUORV:P&EQU81H.+
MYG,:[D2?A0-@W%MVX-/$RU'#(3%&*L=S]A$81KS^\Y___.R&06*:5$XC!F-H
M+HUQL8V._9I2=HT_ULW@8L^D[2#P;7['XXX[+EP/A.2T*<W]T?H9QR&J;S6U
M(43LS.Y1PQ3QA-PIBB<T)^W2Z;T:7/H1=TP"X? XX]RX&@C>*\I?[8F+GC@\
M3\S#X$+(39"=XC7&U=K]K743W2M_ZUS11(,X?!JD=*2+,+AH4)"J9Q+4M\DQ
MVJ+/!A>_,Z4)T]!0+E8:<D:Y8VHM,(),0C6X[(#Z*;UHE",=?OCAR;C/_HMO
M:39/HV47T_5!(XK+/O'$$T-M*$[",_7  P],-6F&-I29HQI<G@H\%6W[O!JH
M3HMJ<,E#-;BT"$S6Q>""F"9ZB[K6^&^$'_/N*E4-+F6Q:@:76V^]-1112> %
M!7T!X63DH#623@ C&"YA'DMUHJX&EWX;7(@!==:,Q@@2S]D'%UWLG 3=F**"
M$-,+85T),8E ?=D,+I(SQ&GT60JQZX0^&5R..NJHHEWXJL&E&YQ[B@O6AF(1
M0CD2#"M.$.(NLO-_-;CLP#P,+LS+*8$6T?,LNNX8%YL26GO^2G8\ZHIJ<-F)
M$@877?NBN(NH0E&_Q!F!G%PW@XM"T4M>\I+D][WVVFL7^AR5,+C8#TX]]=0P
M'O4^A*HEI@3<?OOM*VUP45@G-DZ)>MMTLVZ+:G#IK\&%0#]UYBNHE!1E=T&J
MZ'+''7<4;?Y3#2X[4,+@0M 4%48]HWWLTC8M/X*CEXLJKJ>F$H@[3(I>-(A#
M3=N.<CTF'7QCB?A+%_%U,[CXKBD>U.\N*6:K!I?V7 <1]S)P'1MYK<B8X!R(
MZ@K,"E']@-![7/[L;',]HEI.Q-O[]\0MS7_ON^8*E@A.U62C-<(,.,UYF<*-
M-]Z8[-KJF6F3SZ<,+CC/DO'(.AI<B(ZB9]-KV[9M4PF.HOUI&0TNC,,E!:S+
M:'#1O,(YDOK>^*55@"D'40U7#9N0/XJEW0.=RB/CCW@A-_Z6_Z7$^>+%G%RS
M+>@(CC[ZZ/ S#SSPP%:<][CXH^04R;X;7."VVVX+-1O$>]&UU#@QXFLF-3$5
M8S$I-O].TQF3E*-_'ZUO NBNN5(UN/0C[I@$L7C*<([78E!/X>*++PX-6_:]
M14\<GB?F87#!!="I19]#S(I+2(%^QKV*IMJ*">Q+);B&5-RQ"(.+VEUJNCSQ
MO,92I=!G@XO&A&K&J9J66G-IR!F=-:F&OR8+3T(UN.R$6JQX*ZHEFFX2Z<LT
MX(ABASWWW'-8?^Q#@R.Y.K-N%%>?<<890VZM1"X?3<Y;=X,+(TO4V&3SYLTS
M:: Z+:K!)0_5X+(!ZVYP<>,Y75-$[UY[[=7*=5H2U>!2%JMF<$%41.23-9QK
MZI@EB/^C8OU(O%.*Y*H&EQU8-H.+^__2E[XT65!Q7XD;^PR)1&2.1!"5ZF2R
MC 87O]WS'W4_XZI?)RS"X*+8'77P/>*((XH6#ZO!97H0/.G*A8R*[MG!!Q\\
M-+4N"M7@L@/S,+CH0JJXE"IFWGOOO<7S'T;$U#0/XZ:GF<10"M7@LA,E#"Y(
MZ,C@8III*0)T'0TNOFNJX.$98PQ9)$H87!#HNBU'Q2QG0JGBWJH;7.ZYYYY0
MW#@2D?C>I5 -+OTUN.CVFQ)!B@46/?&2,(3X..)72A;RJ\%E!TH87!3PHI@.
M']4'\>@L()9UAMLS%$HCON3TTT]?^/<4#T;[OOM%(%3JF5I'@XM\('7.Z3Q>
M,L^L!I=N7 =N2N?R%-=12BPP[;U5&VM^/X)\=9KF'DJ4TRS$:W(T:?JNCIGN
M1U,HI[,V(5:S1D*@$N6L\K;<1GQJ,"DQ)1,*@6M)PXCW.O/,,Y,&1*;,-IVD
MY:Y1/$*L5S(>64>#R]:M6Y-<$$Y-XZJ2^U/?#2Z1@-6^55+$NXP&ER>>>"(9
MKQ-/T3"L C2APFDT]QO<F;.JR<?:X^Z[[[Y0E*BKO&[YN<!%$OU%UUHG9AJ&
MTONTG+0Y"63C=(<VC32W;]\>-O^3,Y<TRBV#P<4>''43M__A4YK[G?RMJ4ER
MKS6CFA1/J+$T]RW/OQI;,YZX_OKKP^8:[E%7 6$UN/0C[I@$7'3JK)=#CSOK
MU;RB>L=AAQTV/(/6!?,PN'@O=?N4V7;<F4*'H:EE]'>XD%*UGCX97)A.4L)V
M.9F:9BGTV>""+TQ]-SF8F*)TW"!G3#4P4&.BA9F$:G!YZO-P\LDG[U*K%8_2
MSC7KW\YW>16N*VIN6UH_T!5XC.@[6B,FTY32AE:#RZZ0FT73SM5T<<9]0S6X
MY*$:7#9@W0TN@%1-!0(2= 46'17FA6IP*8M5,[@(J@4]$5E2NLO2-%"L;8[)
M\])Q8%QWB%Q4@\L.+)O!!1"IJ2XB.H00=O=YB@LB.Q***N*6"M*7T>""E"',
MBA(S<4!IT6^?L0B#B_TEZK"C*%5R1&DUN)2!/4ZWCJC+%R)YD9W_J\%E!^9A
M<$%**B!&9PHR_>:;;Q[NXZ6@NZQ]*!*,2)2=OSG&B5FA&EQVHH3!)37"G<BP
M%-;1X.(WVV.B]V&$WK1ITT)CGQ(&%P*.:.(3P6M)T=:J&UR0R2D"?H\]]AA<
M<LDEQ7*(:G#IK\%%E^!4 =M>Z<Q?Y-0-'&$D1E9(*RE$K :7'2AA</&]"*(B
M3D5AJ&1ANV\0+RC^1A,BK+%%0[TA$@\^\YG/+"IB6D>#"^'M66>=E=Q+3?@I
M=:96@\MLN XBSD5CU/DXVD/Q !NGJC'M6'--L?Y(K#$)3##-_4#NO67+EJ?D
M"L2KC"Q-49UU3:B:VU#)/J2>&'$-SONKK[YZ^-M*P;.I,5O4$,I_DS>UB7,\
M6U$\0E!=DAM91X,+'C9:\Z,.S&J/)?>G/AM<U%UT/8[J+F+V4E@V@XO:#@X@
MJB_82W!+7?BS/L(:T(@B$EFY/_+6C?&$>VDR0G-_LF;4E]L8^)KP+%QWW77A
M/FW?)-POV7F9L)U@,S*GB*'E@VT:#S(T.)NB\[/D]UT&@XMXXM)++QT*K*,I
MK9K&;+S?="E-GA=/WV9*FWVU*3(63S"0OO>][WW*?18/-QM,,CVH-W5MT%@-
M+OV(.\;!.M!!/Q6+$:J/,S\\]MAC80Y+.*]A=(FI(,N >1A<U.B<-='G:.0Q
M+KX3#T>& \]X2;%[GPPNSN 41VVOL]^6X@#Z;'!1BY(3I>(&N9B<K!3DBG+&
M*#<3-VAJT:998C6X[(0]6.P7U=L\$\[4C5RNO0(GU12YR[-H3_LR74LCA:C1
MA6>I2XR<0C6X[(K''W\\Y-Y&$\[[,.%G(ZK!)0_5X+(!U>"RXQ"Q@41CFT:N
MW[///KLHV3L.U>!2%JMF<)$\I4:$.H ?>NBA7EQWY$E$DDWJ:I:+932XM"E\
MY6(9#2Z*=D8J1^MDU"U(TEMRI'5)*,A&"63)0M R&EP$5)+G2$!LWYK%6/6^
M8A$&%^25+I!11^B2>T\UN)0#<H* (3*NENPZDXMJ<-F!>1A<Q'8(JJ@#]8CD
M>_>[WUWL\Y")*9.'0C5Q6Q_$D-7@LA,E#"Y1[N!5D@!=1X.+.%6\'17V1P4?
MG887A1(&%\;E:'\B1"TI3%IU@XMU3<28,D.)?4H5H*K!I;\&%WG922>=%!8&
MO4X[[;1A46)12,4C&I64+$8MH\%EVO@C0@F#"W[-=8@$+)ZI/IB69P5G\)UW
MWAF*+W4-7#3LZ5%\(%\OV2%_'0TNXH]4CD]D,>(32Z :7+I#?J6#=-^XCHU0
MAXLX==TO-^;\NMD3"S7_G0[);>(W?X\#;_X]L<-&4:-S\/###]_EWQ$J=FF8
MA5=FS$GE*FJ#)3MZBL.;7>E'K_WVVV_X_+?A&L1<43QR_OGG%^7=U]'@\NBC
MCR9Y#&+.M[[UK<7$F\M@<(G$-00D):=K+IO!18QBCTZM$77451(XV\.C"2IB
M:_OQQKJG1JA1QWS:$G%W%RY5/'O''7<D]2GB.8;14K OI81\UB1Q8IMZK&>$
M:;OY'LZZ-A-@VF(9#"[@'CJK(Z'J+;?<\J%_AS\\YIAC0AZ 7FL2_'TDE+0N
M&=-&\']'^@1->$R2[XIE,;C\/P   /__**Y$\P  5RM)1$%4[-T'N'5'53YP
MBBBH& *(4B02!&FA(Z$%J:&C($6-2HDH/2&$*F !-0224#21KF""H07$EAA-
M:*)(,T+H343I@0!*\_S_O\,S?)M]9_;99<X]^]Z[WN<YSY=\W[W[[#U[9JUW
MO6NMF0M<X *+"_S_SU_]U5\MYH2;W.0FR_MJ?_[YG_^YVG>\ZE6O6ES^\I?/
M?L]/_=1/+=[__O<O_N___J_X^U__^M<7M[[UK1<7N<A%MOS^;__V;R^^]*4O
M+?8"?N '?B [AM_\YC>K7/_;W_[VXJ233LI^QP4O>,'%]:]__<[O.O_\\Q<7
MO_C%M_SNC_S(CRS..^^\:N/PJ4]]*GN/YM@0?.0C'RG.R;[XW__]W\5IIYU6
M'+-K7O.:R_E= __]W_^]>/2C'YW]+NMXD[!^_^$?_J&XSG_ZIW]Z\1=_\1?5
MON^][WWOXC[WN4_VN_;??__%XQ[WN.5\7H4__=,_S5[C?O>[7]7Q^:,_^J/L
M]SS\X0\??*UG/.,9V6L]YC&/F7R?;WO;VQ9WN<M=MES[^[__^Q</>]C#%O_Y
MG__YW9]]]:M?O;C.=:ZSY6>O>]WK+E[[VM=VVO3MQ)%''KF\__9]'G_\\4O?
M4@N''798]KW\^9__^:CKW?.>]\Q>[S6O>4V5^[W#'>Z0O?[IIY]>;4R^\8UO
M+'[A%WYA<=&+7G3+]QQUU%&+__JO_YJ5CV6G<F/R@0]\8!'8BN_[ON_;,E;M
M=7^!ID/<S?B/__B/[.3Q.>"  T9=$WG(7>]J5[O:;,>!D^#82J3HP ,/7!)-
MQF'=>/WK7U]\)W>[V]T&7^\5KWA%\7KWO>]]=_V"?^8SGUE\_AH$9 A^Z[=^
MJW@OO__[O]_[.ASJ]:YWO2W7N.QE+[N<I__S/_^S\7%_\(,?G V :ZXCA+E$
M.I"](<B12)^__NN_'GU_M[G-;8J$I0_9'X(;W>A&V>]Z^]O?7O5[KG[UJV>_
M9VS0>/+))R\N?>E+9Z^)!#_J48]:?.$+7]B6.?NQCWUL\=&/?K3WN[G,92Z3
MO>_/?.8SU>X)X<]]A[4U!%_YRE>RUR%VK -$K@<\X '9^[[5K6ZU;>]TTWCK
M6]^:'?>;WO2F:_O.=[SC'8L;WO"&6<%),%[+]IYZZJG99Q- #;4!N>L(4&OB
M3_[D3[+?\YN_^9L;GR=\]I.?_.0M]W;A"U]X^?>;PM%''YT=,[QJ* @RN6L1
MFVJ"&);[GC_[LS\;?4U<62S0OJ:Y6].7/^]YSUM<Z4I7RM[_%:YPA:5X2\2=
MBL]^]K/+=7JQBUTL^UT/?. #%Y_XQ"=F84.O<8UK9._Q?>][WZ3KBG%SUQWS
MW#_V8S^6O99QKHD?_,$?S'[/D#FQWW[[9:]1,^GQY2]_.?L=$BY#\/G/?SY[
MG1_]T1^MSOURWV,M#L$G/_G)Q<_^[,]FK^7=_=(O_=+BJU_]ZD;6T5O>\I;L
M?=W\YC?O?8VSSSX[.P<],XY9 P2Y4I+JYW[NYP9=2Q(G=YU?_,5?W*A-^]:W
MOK5XT8M>M+CD)2^9O3_)2V-0 V+ N]_][MGOD7@:@M_]W=_-7D=B>RS<0^Z:
M3W_ZTZL\?TG;F\H[<O&-STM>\I)!USGVV&,7E[O<Y8J)2$48M9+F0_'$)SXQ
M&Y_?_O:W7_S[O_][E>_P;.*AW/.S64-P@QO<('N==[[SG:/O3U(\=\U_^[=_
MJYXTQ/%RW]5,9/9=4[DD%OV&KYM+LK,V/)>QRHWAI2YUJ8W?'W[PPS_\PUON
M[2=^XB>6G*D6K,W<&)C+0[6$W'7H"S7QAC>\(?L]>,403>+O__[OB[J</ Z?
M6P,?^M"'EC%2[GON=:][;7R>B2-S]_8;O_$;L] ZGO*4IV2UCB<]Z4FSL"/6
M*1WA0A>ZT/?<HZ(V]_[%+WYQ^7/R&>TXDK]\_O.?WRO/H0@-/VG'X>+)E[[T
MI=_U^R><<$+6-]#'W>L8N+Z\;&Z>X",*0;[VM:]-'DLQG+',V3V?7_[E7UY\
M\(,?['6MQS_^\4L[WK[&H8<>NBRRJL5'#C[XX"J%IHJ+2MRA)A0!YKY'T6!?
MT!!^YF=^9KD.<]=ZZ$,?6LU'63<E[<F:V#3$9^94^][8@\,//[S:]\@5U>(J
MI4)3=J,&^-=SSSTWFWM.]WS<<<?M*CXI__:ZU[UNJ3?EQO59SWK6\N=H.B][
MV<L6E[C$);;4CXAMSCGGG-'WP%;<]:YW+>IIO_[KOUXEG^897OSB%R]^_,=_
M//M=WKM"R3Z0-\_%3>)91:RUYB.-('>O"H_G!#$)NY'C$V+L]/[PAI_\R9_<
MPB=.//'$WGQ" 6G;MN+$WFWB$\]YSG.6,4=[W![QB$=,TOU_[==^+?L^<(VA
MN/>][YV]UBM?^<K!URJMG[W6X$*CI4&7\@ALR:<__>E>.F#;UOE<]:I77=JZ
MVO4M<\2Z&US8A!(/5<BZ*B_,%N0XMYJ/FDU(XH^Y-+C0?V@?:N%*>2.%]#6@
MP451^!P;7 !7DR_)W9]Y(283FTV%&%&L6!KS@PXZ:-E4UP?1X+)U#;.UUFQ.
M@TO^ZW.?^]SR^W[HAWYH2[Q"\_GXQS\^&[MYQ!%'9&M#:1RU&ESX'[K"3FIP
MN>,=[UCD*#7]*?N76ZOT43KLIG)-.42#RS!$@TL#T>#R'0@<__$?_[%8O,T8
M$RH%:36*R[H0#2YUL1L;7"2H?^57?F6+$,U>$67?_.8W;SR!36#*!5>20S6*
M_CS?W_W=WRT+@>;:X'*G.]TIFRQ0&%[;CNS4!A>)PI__^9\OB@4"TC_\PS]<
MZZX@2+5W0E!3]&O,^A!*/BU7]/RF-[VIROJ39/GC/_[C'=G@PJ?R9;E AC"F
MJ&LOB&";:'"1+.;;V]]IC=WC'O=8!L-3YR41L[1#0C2X#(?DDD1'KLF/P+$I
M1(/+=_"KO_JKV>!1HKY&$4@S?KKE+6^Y)1&6^-V08I N[O3"%[ZPV. A^?'R
ME[^\ZG--032X[$.-!A="5NX:__(O_U*-3TG\[\4&%SRUE'2W?B6O:S4N#$6-
M!A?7R!5 *(R:NAZ3;9+HLD'";FYP@;/..FMQLYO=K+A.%)0I6IH"Q:0*;TIQ
M6S2XC$>M!A?Q8JFP >? FVR\L DHBLGY"XU9-):I.H;?E]1L%_7,J<'%-7-\
MS/JMG0RJU>!BY[]<49[GP.DWU62Y;O ?.5_.]TKJ;1KL>>X=N[=WO>M=5;X#
M9\HU$.SV!A=XSWO>4TP4*_J3I#8_IFI;-BDJV9IH<%FM=>1R(;2.W_F=WYF%
M':%Q*03(<5VY O95(>"#'O2@+;N1FK/F<U^(Q:]RE:MLL=.I><7W*!QM?X^B
M53G)L1N&??C#'U[<^<YW+FH-=+PIA=G)'BLH*14J6).*>OLV-1BKW 8@^$B-
MS3_\/OYVQ2M><<\UN"2]KUTDU2SHKU$ (^?#1N;TM+DTN,A-//:QC\VN"W-C
M*!\KC4/)3]=L<%$@?^:99U:Y7W8[M_NR<;'&%57N-M!;<\5MQD%-!OOL9V@*
MN5S7(Q_YR$F%>PJ=%5&6U@M]E%X[-><H1J*OY'*:\GAR2GWU"%IBCH?1+\6S
MJ4%T+-@@=0[\UTYH<,$G-)7D"@N-DSRA9K>'/.0A6];7(8<<LJQ/Z@OQM$:#
M-I_0O*+FR_=HSL[Q"?'^E U(H\%E&DHZ$"Y:8P,J6J"\1VZ-FP\TG3X;Y+(5
M=*'V=<PS>MO4'/-.0*EF14/D5%N,?\BQEKY#W<:[W_WNSFNH^<CQ6'59M>J"
M?,<QQQPSFP:7Q(/$+J6Z&?G5J3E4_N=?__5?B_K]'!I<V(MG/_O9V1J<U(S&
M'DR=JV)$XYVS*3B+FI.^FS!$@\M6J'/,^07K6).;]WS&&6<L\WCMG['^7_""
M%\RJ:4&=2^YD*9M7U-@<VGRVT<V-;WSC'=7@@GOGZD7=;\U-ZS4 TBYSOEM.
M:T[-4-'@,@S1X-) -+CL@Z000IDSO(G\*Z:WD\(Z=Y^/!I>ZV(T-+LB*PO=<
M@9[YJV"W1K'1% AZ<LDA31]3@RL"#&'"D6XE,7X.#2Y$_%R JG"G1N=\$SNU
MP044BDCPY1)M:7?+W_N]WUN2W]J-6WR@I*JC'9%+]V"W8W^_ZKO,O]P]2TP2
M-*< H26(EHI1Y][@8NP<=TA,R.W4B+CVW0UJ)V,3#2[6B3E=VL64B#T6$L"*
MSA3:.WIV+S:X$&^)<;5VK <!FZ;57'(R[1*W"42#RW>@,"BWXR2QIN:QKK@-
MH:=TJIF_YPOM'C06CJZ6-"N)YTZ>LQOJ7';YC@:7?:C1X%(Z6;!&/,0F2L:5
M3B':[0TN>)_D?FYWQ-1D*J%M!_#M1HT&%P6ON:(M:TE1Y11(ZO&#=J L[2*Z
MFQI<%$F)%4IQ#XXL.3%6W-:@^)=_^9>+6]_ZUMFBI&APF4>#BZ8X'+2TP[DD
ME<+.=6[R4,(__=,_%7=LMH:F)(H5.3WWN<]=QMZE^3F'!A<Q;"YQH#"W9@P
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M^]AMO1>[ZI7N18)_J@@K\'O1BUZT["RON=,F6X"XVN%K3%>P!+.DC":,J4T
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M"6NUBA3& AG0 -&<CZDK7I"WG>#('1_6O)=TU/,8 2 'XC#2+1%'C!U;<*^
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ME2^5?\*/Q&4I]V1,V$2V3S.H.@%^NKWA2=+SFN_.F(S)RZQJ<$E<0Q&3N:R
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M$-*^UTM?^M*+8XXY9G;WJR'GQ!-/7%SN<I?;<L\7O_C%%_>___V7NR@' H%
M8/<C&EP"@<!VP"D>1QYYY&+__???8F\N>]G++HX]]MCEB42!0&#O(AI< H%
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M88<=MGCWN]^]I7@]$ CL742#2R 0" 0"@4 @$ @$ H% (! (! *!0&!M^'\
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M 6Q@ A=@K9(WL0P,#,3)DR=C^_;M!>\IR2YZ8V-C7+]^/3Y__FQHP#("%P
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M A<                R)7 !               @4P(7
M,B5P 0              (%,"%P               #(E< $
M "!3 A<                R)7 !               @4P(7
M    ,B5P 0              (%,"%P               #(E< $  #:L?P
M /__[-UY;!55&\=Q!$N!L)2F5%G%4,,.$4D@$0%!E$4# K(J"14A!864"":5
M+2"8B"2($MH*)5(%V0+A#P,BM#90JVRB$C8#B2)0FD"!4HH4GC?/26IZN>?Z
M>G4NS/+])/-'T<P]>>[,G9DSYW>."                 # #1Y^^&&I4:-&
MR';W[MV0_Z=&U7]XZ*&'J!@                        <1< %
M                #Q0!%P                       #Q0!%P
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MF=&C1YL!U/HRJ:*B@F+#,[IW[QYV3C1OWEQ*2DHH#GQ!?Y>3DY/#[E7T=QL
MHG7]^G43D-,!/_K,,V[<.!,,/7GRI!F@XC9ZOYJ2DA+R&UAUK?_UUU_Y0@$@
M@!8N7"@-&C0(Z<AMW+BQK%FSAN(  .!!*U:LD$:-&H5<V_7O9<N61;VO#S[X
M0!HV;!BRKX2$!%FY<B6%=L"M6[=DSYX]\M9;;TF?/GVD??OVYAVKWIOI>]J:
M-6M*K5JU3-^EOK=JW;JUZ;_7R7JV;=LFI:6E%!&!IX-0BHN+9?GRY6;239W4
M)34UU;SGY1P!      #5$7#QF!]__#%D@%/5]M133T6]K^^^^\ZZKUZ]>E%H
MN$YA8:$,&# @['C58_C##S_\Q_NY>?.F?/KII]*S9T\S"$1_!./BXJ1)DR;R
M[+//RHX=.\R+"L +FC5K9CTG+EZ\2''@"P4%!=9[%?V]!H!HZ(RINA)FY\Z=
MS> 3'712NW9M:=JTJ9G55F>^KZRL=%6;UZ]?;]IGN]:?.'&"+Q4  DA7L;5=
M%S[ZZ".* P" !RU>O-AZ;9\W;U[4^YHS9XYU7SJQ _Z;"Q<NF#KVZ-'#!) T
MS')OK2-M=>O6E4Z=.LGNW;M=.;D&<+_H !0]ET:-&B4M6K3X*QBFYTB;-FUD
MRI0I<NW:-0H%       , BX>HP$76P=IMV[=HMZ7!EQL^WKZZ:<I-%QG__[]
M\MQSSUF/V6@"+OGY^=*_?W_KCY\.<APS9HP</7J4@L,3; $7W0BXP"^^_?9;
MZS%.P 5 M+9LV2(=.W:T#D+1%^KIZ>GRQQ]_N*K-7WSQA5F]T_8[2, % (+)
M%G#136= !@  WO/>>^]9K^W_)N#R[KOO6O>U9,D2"OT?G#MW3MY^^VUIV;*E
MF2SCGP9;JF_:%[%APP8F5T.@5514F*"8!EIL8;RDI"3)RLJB4       P"#@
MXC$$7!!43@5<EBY=*LG)R1%?-+1JU4HV;=I$P>$)!%S@=P1< #AE\N3)9N66
M2/> ;=NVE2-'CKBJS01<  #W(N " ("_$'!QM^O7K\O\^?--/[QME>E_NJ6D
MI$A>7I[<N7.'HB*P='66KEV[1CQ/=-"*3E (      "@"+AX# $7!)53 1>=
M:2LN+BYB!ZK.X)V=G4W!X0D$7.!W!%P .&7@P(%_.].JSAY96%CHJC83< EU
M\^9-24U-E4&#!IGOLVH;,F2(S)DS1\K*RNY+.W1 TNK5JV7HT*$A[=!V39PX
MT;03 &*%@ L  /Y"P,7==-65SIT[6U>#C69[XXTWY,R9,Q04@7;ERA6I5Z]>
MQ/-$QZ$\]MAC% H      !@$7#R&@ N"RJF 2T9&AG7YZZI-9_;.R<FAX/ $
M B[P.P(N )PR;-BPOPTY)R0D2%%1D:O:3, EU*U;MZ1ERY9AL^;JWTE)2>8>
M/M:SX6IGR>'#A^7QQQ\/"TQI.UJT:&':"0"Q0L %  !_(>#B7N?/GY?1HT=+
MG3IUK'6M7[^^O/#""[)PX4+)S<V5[=NWFT#,)Y]\(M.F39,GGWS2O(O2Y]6-
M&S<R&0("K[2TU)P/D?KF-$C6OGU["@4       P"+AY#P 5!Y53 10>^/?'$
M$Q$[4/5<VK5K%P6')Q!P@=\1< '@E 4+%DB3)DTBW@/J[\KQX\==U68"+J&T
MHV+LV+$15^+IT:-'S,,EE965$0>7:[NT??=VJ " DPBX  #@+P1<W$N?R=NU
M:V>MJ:[J\O'''\O1HT?ETJ5+)KRBSXL5%15R]>I5^>VWW^3 @0/RY9=?RK9M
MVZ2XN)B"(O!TY5U=#3=2WUQ\?+R\_OKK% H      !@$7#R&@ N"RJF R]FS
M9R4U-=6Z#+:NWC)W[ES" ? , B[P.P(N )QR[-@QZ=>OG]2N73OL-Z5QX\8F
M!'WMVC57M9F 2[BOOOK*#'BPU41GU=VW;U], R8E)25FE1;;Y^NQI>T#@%@B
MX ( @+\0<'&G/__\4Z9,F6)]C]2V;5M9MVZ=7+ERY?\^?VKP12=B8"($0.3V
M[=NR>_=NZP0TNGI+2DJ*'#QXD$(!      "#@(O'$'!!4#D5<-%9M(X<.2*S
M9LTR2UWK$O&ZE+R>0XL7+Y;3IT_+G3MWHF[?SIT[9>+$B?+\\\_+@ $#S-+T
MZ>GI\O///_/E(68(N,#O"+@ <(J^1"\H*#!!Y]:M6YN01*-&C:17KUZ2F9EI
MKIUN&W!"P"6<AI Z=>ID^B9L=4E+2S/?=2SH,\)GGWUF!EW<^[G:GHX=.[HN
M) 7 ?PBX  #@+P1<W.G4J5/2OW__L&=/7;EST:)%9O(# -'355PV;MQHWJ/J
MA#,Z4"4Y.5E>?OEE,VF(ALL +](Q/#-FS##C _3XUO$"NB*1AKH /]!5Z73U
M\NIC83(R,LRJ=0   $"L$'#QX,,Q 1<$D5,!%Z6#WLZ=.R<__/"#[-V[5_+R
M\N30H4-F*7D-P/P;&IC1H$SU=B4F)IJ.6B!6"+C [PBX '"2OB0_<^:,%!86
MRIX]>R0_/]\\7Y66EOZK@'.L$7"QTX%>MHX,W;1>L;H/TN>$OGW[6C]7VS-_
M_GQ.,@ Q1\ %  !_(>#B3CMV[) N7;J$U;)#APZF/\&-?0B 5Y27E\LOO_QB
M^OZ_^>8;,R&-]G/I:D> 5WW^^><FM%7]FM&@00-S;0;\8-2H468%]>IC!S6@
M6%141'$    0,P1</(: "X+*R8!++$R:-,DZD_/:M6OY\A S!%S@=P1<  09
M 1<[G4GWWA?&U>^_UZQ9X_A@(^TD.7CPH-2K5\_ZN0D)":9= !!K!%P  / 7
M B[NM&+%"FG5JE58+<>/'R\G3YZD0 " $%E966&K?NG?4Z=.I3CPA7[]^EG[
MXO4]+@   ! K!%P\AH +@LJ+ 1?=<G)R^/(0,P1<X'<$7  $&0$7.UV-<=RX
M<5*K5BUK;9YYYAFS6H^3-#"3GIYN_3QMA[9'VP4 L4; !0  ?R'@XDX9&1F2
MF)@85DM=N;.XN)@" 0!"9&9F6J_!!%S@%_I>UG:,Y^?G4QP   #$# $7CR'@
M@J BX *$(^ "OR/@ B#("+A$IB_.XN/CK;6I6[>N%!45A75L_!<E)272O'ES
MZ^=I.PH*"CA@ =P7!%P  / 7 B[NE):69EW!<]6J55)65D:!   A"+C [PBX
M    X$$@X.(Q!%P05 1<@' $7.!W!%P !!D!E\C*R\NE=^_>4K-F36M])D^>
M+)65E8Y\EG:09&5E63]+_TVO2=H> +@?"+@  . O!%S<:<*$"=87Z+FYN8ZO
M& H \#X"+O [ BX   !X$ BX> P!%P05 1<@' $7^!T!%P!!1L#E[ZU;MT[B
MXN*L]4E*2I*S9\\ZLHI+146%>=ZV?8Y^_OKUZSE8 =PW!%P  / 7 B[N-&;,
M&.LD!YLW;W9TM5  @#\0<('?$7 !  # 7_X'  #__Y_(,CL  %'F241!5.S=
M"=AV554^<!LT;9ZTD0I-H\&0BBA+FA05"0G3PL0YDY+ $!&+H,@""@TI'(I"
MS*32K)0R(K4B4XR(RLS44AO(LC ;;'[^U^_HYG\XW]KG.<,^YWV_]]WKNIY+
M@>][SGGVL/9:][KOM3>;U>Q#/_1#-[>[W>UN\_F___N_V_R9VZ7_\$$?]$&;
M:CMK?_B'?WC A/E\T1=]T>CO^KW?^[WPN[[B*[ZB#G2U76>_^[N_N[GO?>\;
MKMD?^9$?V?'W>_SC'Q^^VT_]U$_5R:NVF'WJIWYJN.[^[N_^K@Y.M3UAO_5;
MOQ6N\:_YFJ^I@U.M6K4];R]ZT8LVG_S)GQSZP3_[LS_;]^-SRRVW;.YUKWLU
M.$4T1C_P S^P^=___=]9SP".7'WUU9L[W.$.!WR_YQYQQ!&;][SG/76Q5JM6
M;37[KN_ZKM#G_>B/_F@=G&K5JE6K5NT@-'E+=+9_[_=^[^CO^N[O_N[PNW[P
M!W^P#O1(>^A#'QJ.Y4M?^M(Z.-6J5:M6[0![[G.?&YX;W_[MWUX'I]J>,'79
M:(V_YC6OJ8-3K5JU:M6J5:M6;3&K I>#S*K I=I^M2IPJ5;M0*L"EVI[W:K
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MS6=^YF=N#C_\\(9\ "29 F#E#&G!?DB_$VCV\S__\P>021"]%&SO<Y_[-.O
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M(^P@=T-;VP\3@O,C8^,<[T1X$XDYG?_\/Y+P%.-W[2%=D9%SG:ES?+WQ<"M
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M5C# JFN;(R(+4MT8V^L"%PE01!I('<R(/G;*UA2X /0!(5U@5K&3D*+D%=.
M;H6/;N<3_ZP+1Q\PI&BJ.!)UJ_#QKD, [R%6!2[O7Q>>D[OAR&TYI<:; ;"B
MCHRI\X].=4- XC4%+HH646?3"R^\<-=?S3[%UBB\Z(06%8D =CLE.(Q,\$)T
M%14(O.L04UA3#(A(.\9@:E=/OI(P,>HP141&'+'MMRG\=3ON>$\W",R]):L;
MLWC7[C[R+/Z@Q$TD8_U0CEQ:RI!' .8Y4M2][WWOWJY&_*#B-K_8%5>YP4\1
MK)3ICOK,9S[S@ #>VG)33)^?<X98PU%LH?.4XF+)V (1(XHM3CWUU$%%IYS
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M,\P1HU2!2[5JU:I5JU:M6K6=L"IP6<$ 2@BS$6'F\,,/'_5=>UG@(L%$V(M
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M:M6J5:M6K=K!9E7@,L 4Y)!B=+P!SA$" %\1I-P(H N6+D0ZI"*@2I@4-'7
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M&B+\UZ K:D0 MUU"D$: [A;&L8)C8^==W<J1RT7@?A_]_P   /__?(KS#
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M$GV_O,Y___=_9[\'[W__^ZO?%GTG4I,SN W1>_V.7)"KB;[#OL\%>:?H.\2
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M_BH+QP/^X1_^(:Q1.V_VW7??7GE%^21GTN1GB9G$/UUP]]UW5^=;E*\:HF;
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M\X7$)=.0DWV7M;O33CM5343L]6G(M?; /'R=+B1K8IUYPG,P9139U435:>R
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MB6FPB@(7R6<)O'EVZ9Q&X*( _IK7O"9,M$M\=^FL^?&/?[PB7D6=?!2<NX+
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M[Y*J,12!2S>?@T\SA,^A'MOD<]QVVVV=/F>5!"Y G$6D$ITOZEY-=0RYL4B
MARC?-[=I;_&IHGNGH<D0?A(QFII.])UJ_UU(\T7@,C\4@<L39S011A2OXJ4T
MV4<^173&B=FOO_[Z7M=!T"G_&XEO";M7$6J*[J_S6EY97L29L]MNNR7MTS@O
MR!E"[-H71>#2'SD$+BE?0QVI:^.$>:((7 H*"@H*"@H*"@KZ8;,7N$A.Z]@3
MW0C=G1"8%&$EL&>!I&H1N#1#%X64T BY18)VD9BGP$5P&=V+@PXZJ',WR7D
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M"8F%^DY<+@*7_L@A<+GYYINK&M?D9\CK\ F7#47@4E!04%!04%!04- /F[W
M1>>6J)N/#C-(H[D*UT7@T@Y%'LF$Z)HD8 6YB\0\!2Y$ Y%@0F)8!\)E ;*(
M0D2*D)3JB#H-BL!E-+KGGGM"<DZ]-G09S5&<J\'^O>(5KTB2!<X___Q.W:]6
M3> R#F0*ME)!)R(P*!*W$5^&Q"H)7"2^^!$1 217X64(@8MK,T$LNG8=>Q'@
MQF$/Z@05=8W;:JNMINI,[#Y'':UUJEVS9LTF[:C.2^#BN>RTTT[A=_$3FQ+A
M;  2W.3[MMQRR]$YYYRS-/=2L0J18_(ZM]YZZZ40<TRB"%SF)W!AAU.=+OG?
M3>><#O?1>X\ZZJA*.);++UDF@<NZ=>N2YZ_.H#D[PQ6!RS"8M\ %B0AI*/I.
MUR)NRDV8U[4Z(BG5I(<NA4?Q>31]#\D!(247BL!E^04NBM_/?>YSPRDHNLWG
MLO5#"%S$JTBFD_O>?G>V3/IX?'_7$9UMG@NQSZ*10^ BMY@Z6\4XSI_<N84S
MSCAC]+2G/2W\SK///GOTV&./S>T>ZN#K69I"%TWBD.>Z__[[6VW$"U_XPHW>
M*Z88HOG(I@AQ+M)82N1BS[6=-_)@J2[QSWG.<[)WB;>6Y?*C_( 7N]YE[Q2!
MRQ/7&=E^N0Y-)#8UZ*B>BG/Y7,[FG#ZAM2B?E8HG=M]]]T[GVBH*7! =V9;)
M:S9)K.L^[8(B<.GF<Z2:V@WE<_"54CZ'R3Y=?8Y5%+@0V=K;D^>4_[8NQ8F3
ML>J11QX9QGWR;R8>] 6[XPQ.B0Y,L\I]-LOUI*:K:>H2B=HGP69$Y[O<5D[;
M7 0N1> R#O5'W(-HSVJ\-QF3>+[BD*CQSLX[[SQ5O$KLX;R)_$;"[DT5[)\<
MKM\>U<#9,9,G^Z (7/HCA\#%NH^$S9[A^O7KEV[M%8%+04%!04%!04%!03]L
M]@(7Q9BHHXW$?T[24!&XM,,T'=,B4L0?Q??)!.P\,4^!BV1F5/!2[#SAA!,&
M&>,]#738U&DSNB\*S(H\N9*_1>#RN4[,"KQ1HMW:N/#""[.2S=@MQ([H^Q0,
M%#B[=&]>98$+2'1>>NFE5=$M2I AC2\*JR1PT>T[6DL///! MNL<0N "2 B*
M@Q'IXM133WW2OT668OLF?ZL](\GJ&OM"X<)$K*C0H2/A(D560V,> A>%)+8Z
MU<'YH(,.JGR4%#QS@H/)Y\-W.>200Z8J!@\!^]4Y$9T?QQ]__-+X%C6*P&4^
M A?G!=)&).+T9[ZKR6[IN!P5 9%LF_9-7RR3P,5W1F2I.H:\[[[[LA%TBL!E
M&,Q;X&(]\!=3W[O%%EMD)<WSSV^]]=9P7_N-_-<N'6QU$HTZ[S[K6<_JW/6X
M"XK 9?D%+@@!A-J3GW'HH8=F]4.'$+C(1[@'T;0Q(M_)QC9B8#F>R?V*)(G$
MT84<-S1R"%R<T:;O1/&9WXX<F].'90.1*Z+ODYCFB^ND.^\XOYX@$MFY-M^
M>"IJ^"+NL^:68:VL IQ9%UUT44CVE$- N&N"=6HO1WO"VDIUJY\6&S9L2#:!
M$4]VW3=%X/)$KD-]8G/)=5COIEE$/J'?3'R1D_C-WY//C'Q"UT"<;X)U&U91
MX"*.TG1D\IH1"G-.CR@"EVX^AP9:*9]#3B:WSV%MIWP.$^6Z^ARK*'!A5Y&%
MH_7/YR'"'<]7\'>0XB?O%]]?3G8:L80\>B0"KL\ZTZ[E4G-!S7S;;;=-GLU=
M)\>KL4?V\NUO?WO6":9%X%($+I/Y(B(J^8^H61J!P:3ORVY.[ED32H\[[KBI
M8BIY7\3ZJ+:QSS[[9*\U+A/8!O[]P0<?''(<^C8O*P*7_L@A</GD)S]9U;>B
M<_^""RZH)H@N$XK I:"@H*"@H*"@H* ?-GN!BVX]47<:Q<R<2;8B<.F62!!4
M(?A$U_7\YS\_ZT20OIBGP,4FE.BU#B>_STAW7<B6 0IE4=?Z.OFE>*'S;PX4
M@<OGUH6$6E2@J,?MMG49[8/++[\\V6UKEUUVZ3S:=]4%+O#PPP]7Y(K)WR!Q
MS+XO"JLD<$EU5<V97!Q*X*(PH%M3BB0Z?K^)!.R/*"%^[;773GT-2*;.P6C"
M65\;N$J8A\#%U#1G>=,$N2:RNK^[_?;;JX[V40=GQ(IE@.N\X88;J@)?J@/[
M,J$(7.8C</'<(YOEA51&S-&T_M>N71L2 *Z__OJL1?5E$K@0W-LS*;+&%5=<
MD>UL*P*783!O@0L@#XK94Z2;G 7HFD06?1=QK@Z]74182*71U Y$8K%J+A2!
MR_(+7.1"(@+5L<<>FU64,(3 I8[E(E^/+7 ?QN,YYY?S;_+?[KGGGJ/;;KMM
M*6Q8#H$+&X#HD1(&6.?33)Y,0>?L2&14=QHF0E@$=.R-1"KRQ/S[MARFZ8A1
MK,P_6F0CC%4#0G\DJ"0L:VMTY#GLM]]^88'#RS/2T" 73"**?%\O!,"N!-@B
M<'D"CSSR2)CK4!]8IBGFN6)R8OC4]%A-V#3_R@6$63Y%BD0L%N[B$ZZBP(6(
M(?)=3CSQQ*R^2Q&X=%OW\BLIGT-^+[?/D=IC;$T?GV,5!2YPUUUW5?Y51/1%
M&!YOD.9<B^JQ1Q]]].AC'_O85-_O;.8+I02A/COGY#X$[%3=8:^]]NK<-)'_
M&_D3\NXYN0)%X%($+I-03R(8B'Q#? W"^AJ:C?C.R7^[_?;;3YW;9Z?5>B/A
MO]K7E5=>N4G'(L01YY]_?MBXX)133NGU62F!2]_/Z8(B<'GRN<//B2;Q:CIX
M]]UW+]6:*P*7@H*"@H*"@H*"@GXH I?''@L32@H*@MH<J#MP%(%+.W3RWW??
M?9,$91T8NG06&P+S%+B KB%1\*G03J#1I>ONT) T6+=N73C9HA9!Y!(EO?.=
M[TRNC640N"B019W!)+1R=HM45$QUP%+\?\,;WI!ECT@,ZW:6&NUN-'77(L>F
M('!1Q(@2QP[111),5TG@DK(3.;OTI4@<LPI<G.,$)M'$-R(G'3$!F84 <7+?
M(,^]Z$4OFLEN\TE./_WTL-!!^+BI=M(:6N!2=U!-$<@5A+L4AY"RHL0T(K'"
M[;),1S$A("*X\"W8]5R^;PX4@<OP A?^@@YR_(?H>Q"7V\XXW0$C7T%']%S$
M(<5YQ:AE$;BX'OL]:I+@Q7]'F,T5?Q2!2WXL0N!B/R"HI;Y7Q]D<9.BZ$WJJ
M:80_MS^[0-?\:._Q?<0^N7(EN@@7@<MR"UR(/B*"&N):7R)64VXA-=%W5H$+
M?X]8/8I'B%D0(0'Y[;333@M]>5,;QXE%BT0.@0L@->RVVV[A9]GGB.4YIK&Y
MK]9*BH1GD@P1TB)@RDIDY\18NG6WP=I!)HM$\N+"::9W;HX@0(EB;?F6+@18
MDYBLV:8I:3FF2W_P@Q^L_+(H]^?%AG7]GB)PV7QS'7)+_*C4U"'-G7),KK&O
M^'RI6.\%+WC!Z)9;;NF<BUXU@<M55UT5^B[.G)R^BPE41>#2S>>()F/7/H?[
MF*/6Q5[(P:5\#K7%/C['J@I<^#=\_2AG\=*7OG3TT$,/_?]<ILE1D_$Q6X1D
M.\LT.GFK5"Z#&(5P/$?.2.Y%K2P5X[_F-:_IW(!$ [NG/O6I&WT&(6VN?"G?
ML A<BL ERN,@X*<FZ%Y]]=75O[.6U7\GXU7_K3'0+,UV[*5H H9U)C]A,M.F
M"O5[S8JBAACL0A]X/E&LD%M@"T7@\F289!WE-]2VY4IR^7\YL,H"%SR=:(W+
MG^2(N0L*"@H*"@H*"@HB;/8"%Z2-J..VPC="?0Y(K")_%8%+.Q &4@E]Z\_]
MRMDMM@_F+7!!)- U)"(-(F'H1+8,P>([WO&.T=Y[[YWL$'SRR2=/W>VIAL2<
M>Y'J]+4, A>DFRBIC"";<T(%,<":-6N2'2,]"]UVNG3@2\%[W=.(8% +:11R
MNB;D-@6!B[,BZF"M(%$FN'2#+GE1XDMGW%G6:PWKT3X<0N "1$ZZVD6D"YW\
MW0O%V(,..B@LUBJHS0*)=F(/=C5*TB+CK4(!JR]2 A<=H E39@4!\B&''!(6
M0CU;0K\N9$;/7P$C.@>0EB7DE^',YELXER+?0I<V!>AE2407@4M:X'+,,<=4
M1(19@93)MXYL,UM#I-O6\9K=C4A3"F Y!(S6H^M(391;A, %"+Q39[ SAY\^
MJ^"8[6&?(H)%$;C,AD4(7.JF%REAE//#GI_5!B.*I(A8?K<]WY68@,03%9K=
M)UV19Q5R^:W6L;.V"%R66^""V!J1;9!H:H+<K/N#'4YU@IQ5X )BY,A/YQ,1
M>XKW^);1A"YQH$F,R^(CY1*XL 6(OJG)%WOLL<?HSCOOG#FW8#)L) *IXR13
M;Q<E!'$/HD8J?)LN'=Z)+TSMF#Q7V$GK68?E'+'NI@XBJ&VVV28DP';INEXW
MHT@)3TPNF]4OL_]-1TOEXHB:$"R[H@A<GISK< :D<AURN)M2KH.]DU.-?J^7
M\U8.?%;;H8:4RL<Z^^26NPH*5E'@HGX4U1'X6#GB*,_'&9FJB12!R\;G+1O:
MY'.H,<WJ<\@=-/D<XO0^HHU5%;@ @7IT+^07KKONNBK/+5<="<!-M^/CS_(\
MG(G\ZE3L;2\ZOV?=AV>>>6:R;L&/N/_^^SN?(82JD?A$#*^6/NM9Q!=!ED\U
ME"L"E\U7X%+_CF@2K^>,I"X_2VPM]HA\KUEJV\ FL!O1NB)68R\V5?*Z>RN6
MCNZ]AF!](+:-\G[$ESD;_4$1N#P9\NA1O"9&W'7772L!QK+$YJLL<)'#C?RY
MVK<H*"@H*"@H*"@H& *;O<!%<C5*]DMXZAXV"]Q(Q'[=CU/=LHK Y<F0?)/,
M3B6B)120$G*0^OIBW@(7ZP?Q.^IN9>,BZ/4E]0T!20/$ZE2R6B)1<FW:P%:Q
M32+#FDA]QS((7"2-HHZ11@_GZN(-DHBO>]WK1L]^]K/#WZ!(@:0RB^AB_?KU
M%:$L5;@_[+##>A&9YBEPL6_821VP<W;$4<R-!#^F.^1\OGVQ2@*7@P\^."2<
M(&K/FE@D(B.F2W5 RR%PL?>LK:@#I(*9Y#4BY&0"VV^V7V<5^@%RC_T7$4UU
M\T(>V]20$KCP!W09G*6HC)"F\!\]T_K\,IVG2_'&&D:<C,CS=>=9=F31<)W\
M+.2!R+=0Q-9%<1E0!"YI@0N;[*Q_\,$'I_[L=[_[W547RE1A7<%4K-!FGSVG
MJ"NG]YO*, N0OQ ,$.E31)A%"5P^\I&/5&2-%)'2U"XV8=HI?LYQ,8;S)?4=
M78E9GJ%]?<())XSVW'//RAX=?OCA%5F[3<"TJ6(1 A=POX\ZZJCD=V^UU5;5
MFI\6_+)SSSTW>:[)22A.=_6[D+\4*%.?):::UH<S48.-82M2(JXB<,F#' (7
M1'_365/BV%G 3OI\'>M3:R&'P,7^<[9'N3D^)9MX]MEGAX1C]IC=7Q;D$KCP
M<<4P42.'6NS*9IFT/,L:=_:DSO$##SRPD[_ UL@#RG/D)$WP(YS9T=KF*W6Y
MAQ=<<$'H"[E_?+D<<>"RP',P#44.).>D8G9JRRVWW.@>ZLC>I=F YT"HEA(,
MR-4A8<W2B?ZUKWUM<CJ:ES.QSSTI I>-/RN5ZY"+VY1R';4]VW___9/K0*YQ
ME@9?SBR=PE/GJF9O.I5W]>-64>""N&=*321:K3OAS^*[^'Q"QM0]+@*7C>VT
MJ3I#^QQ[[;77S#['.%99X*)9@=\<Y7P0:^5;U8$C(K#)A[-.\?/,Y=L(0%.Y
M>OMDE@F)&@W)W:;B>T3G/E,GWO6N=U4Q>?19ZAJS3'%YY)%'JO7D'$[E>(K
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M0T&-#I\*/5W)MYZA@J=1NJ:B>+;^?]=B["($+C;CA@T;PJ167932U9H(9)K
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MTF98X"(B(M(X<^;,"5.F3 F#!P\NU*NC1X_V!&L1$1$1Z17,G#DS[++++F'
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M?P[PO;76&6,\9N_]N!GW8L[I8P               +Q*X (
M $!*X (              $!*X (              $!*X (
M $!*X (              $!*X (              $!*X (
M $!*X (              $!*X (              $!*X (
M $!*X (              $!*X (              $!*X (
M $!*X (              $!*X (              $!*X (
M $!*X (              $!*X (              $!*X (
M $!*X (         \!L7    ___LV[$)P# , $$;O/_(=JH4[@,/X0Y4297Z
M/P<   #@C]9:9XQQS=[[NAGO8L[I8P               'Q*X (
M     $!*X (              $!*X (              $!*X (
M     $!*X (              $!*X (              $!*X (
M     $!*X (              $!*X (              $!*X (
M     $!*X (              $!*X (              $!*X (
M     $!*X (              $!*X (              $!*X (
M     $!*X (              $!*X (              $!*X (
M     $!*X (     ?.0!  #__^S;(0K ,!  P03R_R<G516UI;"B,W#J3IW?
M<P        #@C;76&6,\9N_]N!GW8L[I8P               'Q*X (
M         $!*X (              $!*X (              $!*X (
M         $!*X (              $!*X (              $!*X (
M         $!*X (              $!*X (              $!*X (
M         $!*X (              $!*X (              $!*X (
M         $!*X (              $!*X (              $!*X (
M         $!*X (              $!*X (              $!*X (
M         $!*X + 3UP   #__^S=28]-6Q@&X-*+)D@0;3!!(DPD!+] WS<3
MD3 0/X(8F.@&C"1&YB(Q(+I$!#$0W<! W_=]W_ODV\F1.JGC7G6O>W?5.<^3
M[,E1=HZUMK77_M9Z=T4              &U3Y\Z=HZFIJ>KX_OU[U<\T5?Z@
M0X<.6@P              ( _2L %              " 4@FX
M    4"H!%P               $HEX (              $"I!%P
M       HE8 +                I1)P 0              H%0"+@
M         )1*P 4              (!2";@               !0*@$7
M            2B7@ @              0*D$7                "B5@ L
M              "E$G !              "@5 (N                E$K
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M*RC\W';;;>T[\GN(<1(L*&F"CV+ _\.@/?[XXYLN%B^+E@4;2[GA>* 8W'=
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MQHPQ]]]_OUW;2;^BTL!^)W,SS EZK)BQ2?HGY.E"_HGC[\GED7-'3[)6G8W
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M4FHY\"]X1_RKK/P%&X' Q^7I'^#_.5E+ \WQR("O9_#7X)9CP?D:^*+5Y&O
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M)CJR ]+"5%M"X )0LT&'"!Y '/_=AI.$FTQDRH$D7.!R/X",F;/L)F5(+L?
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ME,L2"+EV>;><S7/PNX"(UA- 12Z9Q6[/$] [Y7A;]]%$V"S/4.!:)XB*KI'
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ML ]#/H:P#XW($I]MK2.89B1BM8;X5+,?_%MY_@M>\(+M=9J0!0C-FCAKVYC
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M^[D$&;P$1UQ#X-(-VU+WXV34FKT."XR&),E!#)">@],M)7 1P^RU(2X'C)H
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M'2]QBFR-K25PP2/0E]#'U\?0K^CW,?S9W_OOB#WZ'KNYSE'@,M_D1YF8P3V
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MB 29CS[OO/-&/^,H<)ENK00N"&;(MJWS#"=QC.49ITG@@H@G#XKR2SYC#$A
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M"W^0"=B17_<!$V(G+7#IX[VP3UC& Q_XP"VW",$1H9]O'CMQR[][VM.>MLB
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M+VT2#M.Y(@#:VI3H(F)$ZZ34K*=L$NI)"%PDV1*HJ#'/;TE.-#WG$'SL[TQ
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MW__]XM>RKL6F".S;-KFD:4C'$5G6SP__\ \7;2S*4:+KR(V'6)? I>3]'KK
M95^QC[$^3\,0(/V57_F5ZW<3Y=KVBF>BF;)-6TK@(K:>=MII61RMJS86@\2+
M*"<40W;%O/-<?2I_F*,99_]$S\:/VAZIHX\M)7"!.>7BIQC21_!60N#RU*<^
M=5V+17GOW_S-WZP.P0C.D +;ST!>J7YMVRM>\8K5^[W?^QWY_4LOO304Q"3[
M[N_^[C"'0;Q.&'L;^XI^7TXX%IO9%X&+YYC#(7U.G^;Z4$/\SI'C85?GG7?>
M[&L18>C!#WYPEB2K-BYM^DS(2CDB@W7;U_9-X )31UB-2",:R+MF5>"RV0Y5
MX*)7H4\8X38/><A#UMA<B7JN1-[!]DG@8G^IAW,8890G+&DE!"[R]B@/0HY"
M7$>6*F%5X#+=_O$?_W%USCGGA->"#S[YR4_>^!E+"EQ@'SEL%5E:?["T_?$?
M_W$VAW3-B+>13+V8JV%Q.$KZJ*4$+B5[9U,%+H26N>>+X_""%[Q@)W*471:X
M-(WO1&CT7G!!WO_]WW_U#N_P#F$NH.;G/[9I2PA<+KGDDC6V'%W'?ONS/_NS
MXM_+@(3<-;_HB[YH*SBG_@AN$!Y-1+#L^V,]R3,,GE"'E,@'YA"XV N&QT2<
MQD<^\I%9K",G&#4@)\)GNDQO+HH]\A-\D>-J5>!RTDH+7-1N,)3<^IR#^._Y
MY[ HHN0^Z[@*7+:;>[STI2\-!U+( ]3Q\M@2F "_>L@"%QAI5ZXQAY #3RXG
M$I=K]!EZ5P4NRUH5N#1L"8$+H$B CR9#>KX48OX[*R%PT32-"*_O^[[ONPX:
MNVH:3P)DU&Q#U#/5KVF(]VVBI\7-\71-^5-X*LS:("#GJ:G7W@PY,J)F_QQ3
M[L:8AN?SGO>\-3"4 ^00V(: L:43W"AYE$B7++BGFF0A4FSZ=X@Q]G()VR6!
MB[T0!7'@F(9.J<;\(0I<)- YT8G&7I>?&FK'5>"B." 4BF(GH+:+\#+$2@M<
MW%?4+ =B47^W"33BTJ,?_>@CY$1"B2Z_#1@2A]K$&L0=16Z[N)(?1,6-!M$<
M39"AMD\"%U.PNH@KB 2E!4. G;O>]:[A-0&C-]UTT\;/J *7\59"X(*(3W <
MY1E$(Z7RC$,1N*3]S%>V/U=-H"G9]K?VY4477;1N5$4^X'6O>]W6?>&2 A>-
MHV@:FQRS9)XRU<XZZZQL$\G>++5W6$F!2]0,E:^5%#D?NL!E7[&/J29W?/:S
MG[TFC49[@U^< [@>8DL)7,212+282,!=0@QD7.2%]M_)MX;4U$ODR+EZVKN&
M!94V QF0EJ)K$EB]]K6O[?4Y2PE<Y)NYYH08T@?X+T$TM>^BYH//WL43#.8P
M9"L^N/T,O!\-^W:-=.&%%Q[!,ORSAG!7LQ"A4!W;)E[8]Q&A ]X<"5(,G1H[
M-&-?!"X^ ]X=?0[,9HYA%P29)AKF)GX/Q3_'F$F*W_S-WYP5')]]]MG%O[<<
M*'>:E&G$!IOTM7T3N(@+$=[M)(,KK[QRYWQ5%;ALMD,5N,B!](:CG.M7?_57
MB_GX0Q2X>+91CN#G00]ZT.JO_NJOMKJ72@A<X/%1?@"WG3+AMVU5X%+F.KE!
M"<37??S&D@(7V$_.+YM\#!LKG=?8WY'@+YV:"Y/-&4)I;C@8'-QIJJ6LI, %
M=A\-V(&U#R5I=]E4@0L?G\NUO9N?^(F?V(D<95\$+DTCW-!KDL-&:X&XQ)"&
M;=H2 A=#1*(^EA\\#7RVDL9_6?_1(#,_!B0LS74PM,$@23X]8:_B+VX3W%"^
MR/^JS?UWV(0?_0#_SG^#J_E[Y'PU.;%BJ<%7<PA<F-HMPIKUTZ+!+00I$0?,
MLS"8>:C)3PC)HG[?G.3^;5L5N)RTT@(7>RYW\KO<$B99.G\R8"='@(<7]1D
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MSJV!'(E1+KOLLDG[9E\$+@Q^@D@8?19\14.Q35096XL0'YILFQ/3($LN9>H
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MZL:HGRA'QVLZCB>V5X'+22LM<&%.;K[7O>Z5Y7*HITMQ.>01N?YN&DK>QZK
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M.ZT%65/-OM:'R7UO:QVI8HCMH\ EG2P7#7JY[WWOVWL:XA)6!2Z;[5 %+@9
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MOC5.%;B,MQ("%QS<B,N!,S%5Q)"X')YK-.1YBL#%.H[\-AZNO+&DE1*XZ '
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M3JM]$6H1)<80J7VGBRZZJ+,!8ITY 8._[N-G^1]D9)^;F]*;)EGQX4/7:I?
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M#>\1KM4U@%XO31P8DFM4@<NR5@4N#=N6P$4 N_'&&[-'R980N#".%="?V[3
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M\TXY0(JIGCE_#O,C9M;0-A0&.<<>%*/4ZD,(Z*P*7#;;H0I<^#=$SH@T+:;
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MHS3M9:Z8IM"U%^0]8TA95> RWDH)7.09Q'A]1&]C\@PU@SPC.B7R$ 0N)G0
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MJS>_^<VS7?<UKWE->-U;W>I6JS>\X0WUQ52K5JU:M6K5#MJJP*5:M>-M_P<
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MZ-$L+"/4 @"0/P$7                FI6 "P               ,U*P 4
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M!R>??#(1 P                      0%!1X (
M ("PHL %                        846!"P
M ,** A<                       "$%04N
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M8!8$+]D;_\Z_UP0D<;/UA,^E<JS!A0XZ7Q*(M3:1_K-=B!%KO\7[VT\ 7_&
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M@'_+)&'2#[AF3N8:7& LR6\% 3#6TN=UEN!6066KPMTIEDG/":>O75=G'7%
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M;' 1N )W6Q8+(HZ1\*5DBTDBQZ[$XZ@D=A2%278C/5W9YVIB4VP9FV-7#0I
M),D57NQ%MFYPL6Z*A"* !P II&5<7!%E+05W# VR1]$<0#I')" <!+&EB5C!
M[D,>\I!PGR2*3:=K(0(>2?K(,0$YI04A)CE8BUPRA!Y97TD-0 I9@$A04.F<
M^C-_!UCD=,XS(=85-M8DM)WCN4F!]EZ :1_MK^(,^PN,V6//*LA7D$"W).ZC
M9T0X"& CD*QHP?2@K8H^?*YW*-59'=H2(7/-+=X1H :F%=)*7E@3-L6:F&(
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MV70&_;G/G9.HP<5YL/;1OO@.YX&?M/YT.O$H],+?X6;G[#E;8\C*FIP)731
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M^'WV'PG$#L&%L.\281]R4XBZG%;VW.#"]\ IDDS.6@FN2#B%O\K=["=)N:0
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M4]'H,3( <(D"6,[H'-= 1G*J!A<@4)(I!SX0C@JIUA CB'>!8([L%Q#YG5)
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M!Z<=#>-1S%7;^)MK<'%.\ =KIU#C47)80KZL=L 'NQ\55N(KY)):G!U\O!J
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M'7?<<46F+8@;<1HXP.A<KGW)!M-M,!E<]H*!-FJ,;-\OE1-9<\X\\\S1&%Q
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MA^;_'2O7%T<<<43VNQQQ5Q*.&\]=Q_&;I2%X(J2W%3=+"'.N8^^Z8>XPC,0
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M_+(OG+C1+*9+IVB*I4K"[FQ-(=9UV+[2XD2"1'D2?]-:8)LD-O&Z(04[0T&
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M0""P #CGG'.J][[WO=5M;G.;ZM*7OO220&WCC3>N"R44,P0"@4 @$ @$ H%
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MR<3T]'3RNKR\G&Q^!0  P%\"%P               %(E< $
M "!5 A<               !2)7 !               @50(7
M    4B5P 0              (%4"%P               %(E< $
M     "!5 A<               !2)7 !               @50(7
M        4B5P 0              (%4"%P               %(E< $
M         "!5 A<               !2)7 !               @50(7
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MV?I^[#BD(,CBQ8OC\.'#7;)M#0T-L7#APJP=;3W/!@X<&,7%Q8H
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M^/###[/01WIN?OWUUUT^W-+\/I!.("LK*SOZ/I#:N7W[]JS=
M +0/ 1=:^/'''V/,F#&MBF+(D"'9R2Y QQ!P$7 !            @.Y,P(46
M=N[<&5===56KHKCRRBMM((<.). BX (             W9F "RWLV+$C+KKH
MHE9%<<,--T1Y>;D.@@XBX"+@ @            #=F8 ++:1-XGWZ]&E5%+?<
M<DO4UM;J(.@@ BX"+@            #0G0FXT$)965F;17';;;=%8V.C#H(.
M(N BX (             W9F "RULWKPY&^=CBV+DR)$Z!SJ0@(N "P
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MO??>&U@PC)22RC?"1V!LUZU;9Q,S@N9RUJQ9";45)+B04)(N@@27 0,&I%P
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M1',B.SL[<%Q:MVY=;AM___O?G=__ZE>_ZK6O;[WUEO,X7__ZUWDS!P
M          #@_S$"+D4(N!3R'7!Y_?773>7*E9UM7GWUU::@H,#[M=3&X7GS
MYCF/J0W'84(J!%RB\Q%PF31IDG-Q.MN?)DV:V%!%D#%CQ@0&N)YZZBES\N1)
M;^.:J@&7ZZZ[+C PLGCQXD@!@R ^ BZ9F9F!U^QLAEO:M&ECGSM!6K1H$3BN
M.W?N]!J>BB(9 1=1Z%'/T*RL++L.=.O6S52M6C7N,=9:W[)E2S-Y\N2XPR0^
M BXY.3GFP@LO=+:3GIYNC^&;[K6-&S<ZCZDYW[9MVW+;(. "
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MS6N5AE0-N P=.C2P4L7<N7-MX,P7'P&7 0,&V*!;R>\O6K2HS,#)V=:U:]?
M*D::"PHS5*1D!UR*4[4:W??OO/..?48M6+# AE845JI6K5JY(1=53-'U#<M'
MP$7];=VZM;.=VK5KF_7KUWL?)XU]T+.K2I4J-B!4'@(N
M  "@(A%P*4+ I9#O@,O6K5M-Y\Z=G6UJ\^_2I4N]7\L]>_:8T:-'.X]YR267
MF$<>>:3<-@BX1.<CX#)OWCS3HD6+4FT,'S[<[-Z].V76C:E3IYI:M6HYSW?B
MQ(GFP($#WHZ5J@$7S<_JU:L[^_700P^9_/Q\;\?R$7"Y[;;;S,477USJ^S-G
MSC2'#Q].F;DU<.# P.#0DT\^F90@23S.9L"E) 61#AX\:,,865E99M*D23:
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M]IJI5*F2\WB777:9R<_/+[<= BX                  * B$7 I0L"ED.^
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MN"@HM7;M6AOD#%H?%)!+=*YIK52%%M<Q5 'HBBNN, </'@S5%@$7
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M?<W++[]L*ZG$2YOO535*;;1IT\;<?//-)B<G)^YV%&)0&T'A0&WJS\C(L/=
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MJ>]K#=/<4S!((2 ]YX/FK3ZZ/EK+X@DMR;D2<%$_]5Y2UII0MV[=R,\=
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M0Y6;%"3Q&7!1GQ7JZ-^_?YG5H'Q\%-I0%1B%'>*ERB\*!Y87<DFT?ZJ($B:
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ME]49E6?5^@S;W-Q\7\?<.SEG-S<W58_^=_G^SW,_YSM[E#W+<R3W P
M     /#S"+@               !0E( +                10FX
M        4)2 "P               $4)N                %"4@ L
M          !%";@               !0E( +                10FX
M            4)2 "P               $4)N                %"4@ L
M              !%";@               !0E( +                10FX
M                4)2 "P               $4)N                %"4
M@ L               !%";@               !0E( +     ,"W\ <  /__
M[-NA#< P# #!1,K^(R=%!64%E1[T3C*RD?F? P       /!7:ZTSQGC,WOMQ
M,^[%G-/'                ^)3 !0              @)3 !0
M    @)3 !0              @)3 !0              @)3 !0
M    @)3 !0              @)3 !0              @)3 !0
M    @)3 !0              @)3 !0              @)3 !0
M    @)3 !0              @)3 !0              @)3 !0
M    @)3 !0              @)3 !0              @)3 !0
M    @)3 !0              @)3 !0              @)3 !0!XX0(  /__
M[-NA#< P# #!1,K^(R=%!<5M]>1.,K*1^9\#             ']9:YTQQF/V
MWH^;<2_FG#X&              # IP0N                I 0N
M        I 0N                I 0N                I 0N
M        I 0N                I 0N                I 0N
M        I 0N                I 0N                I 0N
M        I 0N                I 0N                I 0N
M        I 0N                I 0N                I 0N
M        I 0N                I 0N              #O7    /__[-NQ
M"< P# !!&[S_R':J%*D3> AWH$JJU/\Y +RRUCICC,?LO1\WXU[,.7T,
M          " 3PE<                2 E<                2 E<
M            2 E<                2 E<                2 E<
M            2 E<                2 E<                2 E<
M            2 E<                2 E<                2 E<
M            2 E<                2 E<                2 E<
M            2 E<                2 E<                2 E<
M            2 E<                2 E<         .#?+@   /__[-NA
M#< P# #!1,K^(R=%!>&5ON!.,K*1^9\#     #^WUCICC&OVWM?->!=S3A\#
M              #@4P(7                4@(7                4@(7
M                4@(7                4@(7                4@(7
M                4@(7                4@(7                4@(7
M                4@(7                4@(7                4@(7
M                4@(7                4@(7                4@(7
M                4@(7                4@(7                4@(7
M                4@(7                4@(7     $H/    ___LW5]H
MEE4<!W#=_#-M*^?,FJYN)&AV460R"C*0("C#4&(@>*%2@: 2@A.\L$2A"RN\
MTHM*06%IT"""NHF\\$I$%*&+NL@"G0LU<VN:KD[\'GB'[[MG0^UM[]Z]GP\\
M*&X<7L_SO,\YSWG.]YR4         (":-VW:M#1ERI2BXY]__BGZG2F%'TR=
M.E6- 0              4%8"+@               %24@ L
M   5)> "              ! 10FX                4%$"+@
M     %24@ L                5)> "              ! 10FX
M        4%$"+@               %24@ L                5)> "
M          ! 10FX                4%$"+E7F[[__3@,# ^GWWW\?/JY=
MNY9NW+BA<H"RNGGS9OKCCS^*[C?]_?UI:&A(Y4PB?_[Y9]:.W'F>HYTI[0S
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M3^BLSE[*+K![FE4\N[S-%.%3ETA?+EU3<.E&,L^N!BN^G./C-?EKZI/36:;
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MK+\4,;0NMF%-JSVH5Z5P5,VWZHI;2I.G77OMM067*$6&KB-P<;]R^@@S<(;
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M^]$Z1V1OF^?#/E)DPSH"%[]?K##_^YVEA LF9+0U8FEQ9W0^'W_\\97SY)3
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M45,^?K#NGNM3X&(?PI#F:PKVBB;A.2<%F=1"O!9Q:@@7QU!K;VJ3P*6!K;O
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M%L45NCY'I#BY:FXR- PVPO^0 A9-BT%VB$0>9?P-^UW78IBS+D4,K5M;&8O
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M@0LLPWTL\LG.SM2Y2GPP-'.FPV+\;OO\K+/.*GPB48HX%L8C%I1[B"OD(N)
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MF((B0KJ$)%4H6C;=!7'%.<W7(8J.K4-\"7*DB.E CIRB@AP"%ZK_5-*)9(_
MF-N\5^KZ5'RAV#A4&Y/ 18R22OQTI[)G<YMKNG8*<%LT\G?>-HO 1>Q")''-
M-=<4W</ZB%V&+' !8#WWN<]-KJ&JL49? A= 4XITZ7ZKB!IR"ES\&X692""K
M ]"B[N@;31Z!$#Q_#?Y=3CLV E$? A?%@E0';V2?NA-TJA9X4AB#N$HG^:';
M)'!I%G<T$;CP-X1N!Q]\<$&(:H(YB''%F,@2SF-%X-P=MKHTQ+B4GR5^Z6*B
M)+^6$J:(P>M,MQN;P 4!M4E>V$6#'AVXEMDD<.E6X"*O3.7)]L*B_>?,&H+
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MITAHD6^3=P[5)H%+;#D$+C?<<$/R/$?@RXDQKI/ !:8\37"):RGPL+YK*9/
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MSF5#%+@P0@._-0JZJDX/,.8-4#I_#9W^<Y(OVPI<4IV=$&YRDK(G@<L.6X7
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M"5S4: BNYZ\C1Q![CS'^J&/(.X2148,*S2N6Y?_\2I3_'W#  46<VI7]+P
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M25U7D.<<UK[)7$/F LDB@),KH-E4X(+8E:R4.@;,O6X(9H!O3 !91;V$KR[
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MTLT0_88<[;/.WLD755"\*7@_%<,BBR7J+;&CC#$C%G.Z:LB/WQ<<Z-JW1ZW
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M\;*VDCDDO0B,M M<?)\:!2Z>L_0"%]]A6P4N'!U@5K>C*<#%F'5=1""[RAY
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M[&*_TC?-.1N+.4H%+G QC*BH!O:4S#N$Q$TV67=L^A$FKI'X6"IP2<4H.I;
M\.S5D.2CU$T9SGS4HQZU)M>FCA<>:8\!9IBK S*LD]/EOAM?:1]O;VGZ,_8
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MFO86DLC>M5<X&,;0'AMC#L  =?:@<2%IVN 1:!:\T;G+_#D?$BNF&$&$(:)
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M4/L^        _ X!E^Q*-B8GM['<N7,GQL;&:FN#C>:JHZ,CRN5RK*^O&S2
M)B7@ @  0"X(N&17<@I3J51J6(38KC<<.W8L%A<7X_/GSUYF        ?IN
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M< $              "!5 BX               "D2L %              "
M5 FX                D"H!%P               %(EX (
M $"J!%P               !(E8 +                J1)P 0
M    (%4"+M3Y#@  ___LW6EL%=4;QW&T6EEEDS5$EFHH"8OL;4&4$I: *"%$
M"X1-630$"+P $EY 6F+ @/#"%5&B00&W1K82J@64K: LRE*V@L6T!<H.;8&6
MY^]SDO9_E[GUWC(,=WJ_G^1&##K PYV9,V>>WSDB
M    SGGBB2>D6K5J7I_[]^][_3?5RG[BL<<>HV(
M  "P%0$7                        /%($7
M /!($7 !                      # (T7 !0
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M'$; !4 P"+@ L$->7I[,G3O7-+=875/T86#4J%%R_OQYB@7 M0BX  " <$?
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M3YJ)3Y(GA9KALU#XLR8CDE!\DR0.?\?[(#S73!1=,S^FN$/4X3KFQ +^F9^
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M1R/!!KSO'M8<G$"80V 4G4Q(E+5/4U ?KMF$FU.^AS_2C+4D5R<0(/*K=;K
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MJ9G M[CO7$.*P;!38RSCAS3[YKAZ=11^H)1K@R=@?M@P=Q!#:W"99ZW!99#
MYHI   I1Z5PR22(ID9<PY (A0#"U:'"F-+@0Y1'IER9\4\%;3D@G(? L=,#N
MVG(-+JZ)0R<R+B5&^J9AQS2'Z#/<CSDBY;2&[1%)_)*CO(=!B+@F FF:CZ86
M2TU\CT0K3CG99V!PSP"C2"!(( 7,+'G6GH4$-R(]B,%,)#B$(QR926W1%%*3
MN/8M3$#LYAKAK*L:HNN:Y(=K,I$=D;Z$I%3\S$V&)3XI3>[]O'T; 36$BP+2
M$L&Y:4/1Z27B)T)JZC/*-;BX;J(>!>FY16%%"-.><D 8GDB-;7/W)I\!%$>?
M(6$D>"HE$B28DM>(Z!0WYC1<]N]W:JB*WE]Q>RYQW^Q_!4*:/*/BB[4F#I2\
MET0VBJ?^3I%G:?RW]B-2 N%>4D [1N.O$4].*:A%\+MG)GQ%"9TB\*%-R\KA
M<OD+DF!N$W;.Y&W(P&C-R;OF$!-#DH)0,(JE8KCFS&UQFG C*@8I1B[!B#6L
M-;BT!I<^QI//1[[&\S.<86DL4_R,,*2]NBTGA&4(_TT)S!6"";9\A[DF7_$]
M<\0Z7J.DJ;0UN)QJN087(DZ"+V+ N=B94,![Y/ Y0ES1A&AM;F[E=W$PT6?@
M)$I/@>UC!\TB7K7R>CD9T66TGUWKE,*<.$!\$>U9C1WN^1*SW\372$ H-S^$
M$R!S#2[$:*;WP0!+</,UUUR3'9P@7YUS^BUQ>"[FXD/P(DN:HS7#:V3/"31Q
ML(I,I9S 26EP<<(U,=[<NH/[JA N-\@5SCQ_O,H4L\^B=<YWF*2^A&OES\1D
M,3["6=[_$!KUB?;$]JB90!R=N\?Y=CYB.%F>L!$_4LH_+FUPD8/AIZ.X0/RP
M="@)?R6WB;@\N= V<0;_I2DJ$@_!908+E!2PAZ:0KQDB&L"5>)"I(OM<@XMG
MJ[A/M+QD"!>AA_>)/N.BBRZ:C3=VQ8>H8]3D0PRS@/^CM4L04CKXJS6X[+_!
MA2A6(Y2Z[I*F#GLZ-PE?$V7I !!KEM^/N!N^20/&DAJ-?!<O%F%KL8(@[5"&
M^.RBP45\X),)T7SWN09+Y$1F)E67G&PWM#4:7#QCPY#$[QP7I0%ER8 1@E4B
M^1ROX>_QJ%/W7Z[!16XA/O/YM2W7X)).ME&'FHO1TLGS.;RN#L^_^]YS?=0K
M7_G*[CVBS\ 'S6T(XH/@(0VDM?0;\+ZZ?J3?\!W$X3EVC TN\.A3GO*4[.G.
M,".A\QS1<3)Z+/L_-[! G, ]36T@R#6XX-D,8/-Y2]:*840Y#0/-SB'P-CD[
ME@87FK&(7\$7U=KG<^W8&EP8_*>>6JL&Z?IH^J+:H'J]W*_$#JG!Q7<3;Z/G
MK('5*1M+S+.@0XJPKT;5N5K&VI9K<'$/<*Q+>(A2[D/MJ0;WH7D^QWUHGIG"
M?;A.ZR/G2^5A,#A<.Q<3VZNT<+E3;%N#RW3+-;CP!_;ATD'Q0X.1K:5(>RFW
M]9E+_##>"W<J%D0#<#1J3<'I<GS-^#G>0 QWK7,U)+A0C<]T%KDFE];@4@=_
MM :7 (00#RXED8 !0L.<D-KG /U32:\SH<'%$6-S@]NV>^WHQMRT#<Z3R+(F
MT)YJN0870>19SWK6XI,L.%D%E:CI 0%&/'0HYOX+Z)& 3D?DE"EN#(B,G-F^
MIY=IW!)@APDH@@+948/@LT?MQ^C[$\'7!M=SC:@H"MXF0NZS"0>85SS/'5T/
M](D-^[ <^0$<USB=0(% 8AP]%^NSU!<12T5^!V$F"5SJ;WU?4QLBP&K]6TM3
M?62NX$Q<MZ2 EHXTCY+#E" "PTN>';+:O99 1SB",*DT7GH^PR*==2$Y+9E6
MF3-DIF0S(GJLP:73/DZRB3,2L*AA"U%=2JI[%M'1MZEPL339,B$D\K<F;[9&
MIWD^YZJKK@I/<_,<%3T.R7(-+D]XPA.JDRB)%'8?AG&.+T+DU2BTF%A.G!'%
MTJNOOGJK %6A(OK=J23,FM8:7%J#2]\([(EOH^81XL0E@AXG-SWL80\+[[6F
M@6V8-/$L! VY*8H*T4NQ,]Z"># 2(MC'FH6G<ANMP>54RS6XN*>&DBS)(Q3-
M%"MR9+4\U>3D)>M#\8=0*,J%Y.J'A'7=2WQ1E$O<X0YWF(3]O0?1=W1/Q0YY
MV9+[J6'_W'//#9N1[/4E_J:6Y1I<\ <*R4NOD;#>=.8(-U]RR27%'(6< ,<6
M80X^S?2S)0+"E*_;:[DI:N+TG!-H3T*#B[\S97QIG+(WG506[>\4LQ5UMQD,
M:C+X$%NY3L^C!J^,E]'0$\5NN8VB_K[-OA$C(C]G"-H2PP=?>NFEI[WW.>><
M4SRT9&F#BW7G,R/L3^C*WR]9FQHGHX*Z9V^ZXK:<!T[$)PW]H?^O-2@#C\</
M1OF$IC$<W!3+-;BHQSB-8JD037ZD0!Z=XG+^^>=7X>^.C0^!OPC5A_=#(Y!I
MG"76&ESVW^!"Q*01:FD- 4;(G5J'?RQMHB0XQ_4/8[@:A5I%C=J6O"U7RU9+
M. 3\FW+OM1M<<'9.CE@J0'7/"/ C/88\AL^>:VLTN+BW8D54^TJ#S>3-2_&B
M/:9I(<=KX%&G#CO+-;@XV6$-W0?+-;@8L,?'+O$?XK33Q7/YC-B":U_R##QG
MN#_B0HEZ#RE.N)?T+-%IR_0L<T\S/,8&%UPX/C"G(S"@8RDFM:X(XIWJF..C
MU=:FQK!<@XN!''-/[1AR%CXC:OZ\^.*+%S7[K&W'TN!B4&[DJPT/WH>^K6_'
MV."RAN'1(O[2-6I&*+%#:G!A<N#H-'MY/'^X!)ORJ71($6](5[?O!JYDN087
M?.T:/@[W(;_-<1]S3E$NX3[4^*9P'[1U3F>)_(#\R^F6](M+S3JF<VD-+NLT
MN!@*L<:03<W63LN*=!D&"):>6AZ9006P?Y3OVT-3M!_R.>\1Q5G[PY#VI2?;
MN+].S,Z=SMD:7.K@C];@$G1GU2*0D&O$!+E"DZE#4T0X9TJ#B^^[A@$5G$5N
MD@<"I[8X:ZKE&ER<Q%%+Z$]L%P%JHB2??TB&$!+D(B'2U((A4!(5ZDV(VV?S
M!++-!,NH>4?QL,;DI21NC0K8"FASCO!>PX#9"" HC.^3H">0B0BZU(&/I-W7
M&LJ1'Y+<6E.[$'P1 >5YE3:' 7H1J%#4JY6,>A:1P,#^-T5XBN4:7 C2:I O
M1-J2^UPAHL:S Z@1D1%I(C$MQ27B3W0_'#5>8W_ZSDBWJ%B:!!/-YAD! ^P7
M"0!-&BU]?H0V&F8B?VW"KH;O)6:R2Q2OD7V'0EH=FQ%_*8 -[^EM;G.;R8W"
MN[)<@\M:UYF;)*8@B1RKX8_M,;XR$OF:'(C,&3.8,-IOIM_ONU#1&EQ:@TO?
M%"X5*"-1KN$12QKW-<]$)]V*9089;#.-WY===EFV@1D6K4&<BE-.*,B)K?G=
MJ;EV:W YU7(-+H2O-7QU+E9Z35EC4XRX RD>X:>ET^]K&WXNPN4*EU-/_S-0
MAA [*F0I#BUI7/;[T>DEA%)+3X>I9;D&EYK\AH$MD2"/Z*QT2K]3&G--#_@0
MO%R-B?J*^QK3<L(?/&WIZ10GH<%%?E1KW>!,HL:)]#E.^=S&<6G:N__][Q\6
M^)P26>M:8<HH_N,U<%7[-H7&L\\^^[3K(SJ;VO PQAL1-T83Y4L+]4L;7!CQ
M-F%>-$SF;G>[V^QA!&*XZR/*B6H4&I"WF4GGT<E$8I8FJ1HYD_<0QR.QFY.>
M3>:=8KD&ERNNN*(:MZR)U#X>?H:U2@1_TDS<C3@QZPO>+K'6X++_!A?-"+5X
M$/LN:@83=TJ%*D0R4=,!WU2*:W)&:,S?1B(=7%JMDX^6VBX:7-0*IIZ<M<T(
M!0DEHR8:3>-S;8T&%S@ZIVF P8@.:_$:?%'NM$@\*CYUBN4:7-3OUK)<@XO:
M8 W_H3E2/I/3<-0P0SPBGXM3*A5 KFTO?_G+NUIQ5.=T(M8<.\8&E^<][WDA
MWY/P.ZQ8PV\19%IG4?SR$B>FGFR0:W"!)6OE<X8V1X/7#$\YE!,8(CN6!I><
MGZ:!V_?);JW!Y7]-,RYM3*3Y+.7X#ZW!1;TFTJ'@M&@0EPQ8QC]$)Y/R)Z5\
MR)J6:W"9JD<J-2<N1QJH77$?:GP:?;<9_;"A=#D=E$&\2P>Z)XN&XK4&ES++
M-;@X]7 -H^_%HPT_#_;%[]7296BRB@9$&/XR)9[C9',#JV$^>OP:>T[S<NYS
M6H-+'?S1&ER"A+Z6F1Y)9) #?HK?)FALL];@LOVZH^/;TCU^^M.?OK=UEFMP
MN>]][UOM,]+1L=%T?]V8AV0 LJ/'HY,."%VF&!%O)&HCF%TZA7))8'W(0QYR
MFFA/0=G?URS&FPPB6 \+Y03J"+]]3P!G"CN1WP/H]CFUW[[+=<U:E_M:/S7(
MCRD&O$8%&GZR9$J6-1:)=!5E=%'7(EN\#R%T5.R1-$VYYK$&EUJDBR)]+K&K
M19J8UA.1)B4B!O=3O!@F&IZCXKADNI;I4G?-P^8&XB=8H%;AZB093.DXZFCJ
MK>1KSA0M!5/%B2@I5/PCY%_BLY_XQ">&)_GPMS5.-3N)]MK7OK8K<D8%X3E"
MC#5MEPTN<)AB]3#&B1].C*DYF43QD]!M& -A0(W&8R0((C>*:<30]O@^K36X
MM :7OHG3".Y(F*OXX"32N7N5:"J:D(F\WR8"@V44;2+A9)JR/K?H'AFNAK@W
M5V S=7A*H;@UN)QJN087$Y9KF.GQN0;T6@TNN:EB&A2F"'AW::;I$D9$?)'&
ME:G?U\2ZZ)Z*OZ4-&'U?X_<CGZX)V^F%AV"Y!I>:T_,-KE%<C(1/[G])/"/:
MC3!X.B&VAE@N&9R5FWHLQ_0,2_B!D]+@4LL\;Z=&Y9J,\%_RAS'3U!K%5?E%
MZ8D(V_)9 Q2&6-C_XY?V>2)W\G.^<R0*62IHAD\)Y2(L 6>46(T&%V)OT_*C
M]6EXTER!.Y^.]XT&ZVC6V[:>K&>-ET-QE^N$F0B,:YGZ!'\839E4.)\RD"/7
MX#+EY*2I]NI7OSJ+-_!#)\W@C4@$9.].;=I-UAI<]M_@ K/7LNNOOWYSZUO?
M.A1NE=1[U#S4W89U+;$*[UJS\42S0%2G\3UJG$!<PW;1X.+[UN0Q8-.(UX'G
MYUKM!I<T'"QW<@,\7'-PI9@GY\H]2_\VA=<XI 87/KP6YY-K-,+WU#!8/+K_
M<BC#+ _)Y&Z1R-*@)WMKCAU;@PL\2F ;Y06IZ00^JV5J]KD&#,,I[+LI^72N
MP:7&:9S)U/ZCP2?X7"+60[5C:7"ATXCR,_G?OG4_K<'E?\T0 TUCT: (V+K$
M#JW!Q6E1_'RT!L\ZZZS9IWA9N_Q85!.T-_F50[%=-KC8.SYOR(&Z_X:1U.8^
MQ,>(^Q"CQ[@/UZFI,S=$"0]UXXTW5KO6UN!R7 TN\@<X>MBH:ZU=??75W?"!
M6F8(FN$OD2X#+SZ6R_!#8[42_&BM_+LUN*R//UJ#RXH-+FXNXE7@CSX+8:_
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MCWO<HRNB \V$"KLX=<?GY8Y0E)R43/-:PW;1X.(^._HZ^IP2D>*#'_S@$%
MVK4;"H$4HNV( )XB@EN[P85Y1FLVN(PUT9Q]]MF3W\=>BX0OCKJN270F(_*.
MDE'[D!"@V7131'W\XQ^?G2B[I&& 7WC:TYX63NE'7%UZZ:6SC^9$TFE0B^*U
M[R)Q%/M-LS5Q?]>-C\=J4=.?UW7777=0U[G+!A>$411'-<'?=---U3^/6#UJ
M-'9"R]C$&X1/;LJYO!!9:#\2E?"ANVS2;PTNK<$EPE!/>M*3LB?1E@J[X1DB
MIDA4 3--(6QQ.!IAHFN"+]8X.0/!*??,%;>G\ VMP>546[O!Q7Z&+]9L</$9
MN4$KI46775B-@@M1E(F2T?LHQ)>(!YG"/+XJ$A$2KQ*2'8KMHL'%_3COO//"
MSR&RF6IR!B>T1N_COM:.Z^R1CWQD^!R]%&Q+3AEN#2[E!ON<P@G_?P   /__
MQD^L<P  >[])1$%4[-T+^&Q563]PNV?9/<M*,M$N1$"A2%)0'I(*HT2ABXB8
M@9TD$\@BN114$I00EX(D,3)"NZAA&104D(F49I):22>UBUJ8D=WO\W\^PW]W
MYC>_=^U9>\^:F;W/;[W/,T_).6?/GKW7>B_?]_M]UX,>-'G0@Q[X?/B'?_CD
M&[_Q&R<I^Y=_^9?)Z:>?_G]_O_E\_,=__.25KWSEI+3]\S__\^2RRRX+O^^\
M\\Z;;-+>^M:W3A[VL(=MN[<##SQP\F=_]F=+_^Z7OO2EVZ[]D1_YD9.G/.4I
MG:[UF[_YF]NNX_,U7_,UG:[SMW_[MY,?^($?F'S(AWS(MFOMVK5K\N=__N>=
MKO<?__$?DQMNN&'Z+N>O]]C'/G;R&[_Q&PNO\<8WOG'Z.^;__5=^Y5=.[K[[
M[N+O_$__]$\G)Y]\\K;O.^B@@R:_^(N_N/#?_]B/_5CX+K[W>[^WV#W^S__\
MS^3\\\\/O^>'?NB')CO13CGEE/!Y_-S/_5RGZWS3-WU3>)U?^J5?ZGQ/7__U
M7Q]>Z]=^[=<&^QP?__C'A_?\>[_W>\6_ZXN^Z(O"[_KC/_[C8M_Q7__U7Y-'
M/.(1X??\Y5_^9?9U+KSPPLG'?NS';KO&3_W43TW^_=__O?BSN?'&&R<?]5$?
MM>W[3COMM.EOVK3]V[_]6_A,/:.N]O=___?AM3[U4S^UZ#V_\YWO#+_G<S[G
M<Y:*%]$UO_ +O[#7]=[SGO=,GOG,9X;7_/1/__3)I9=>6OQ=[MFS9_+4ISXU
M_,[/_NS/GJ[Q12:61__^:[_V:U>V!OGDZ#OY\%)Q]KKKK@N_X]N^[=N*?<<5
M5UP1?L=W?==W#2X^R ^C>_W!'_S!7M>3%T77>]&+7E3\WK_C.[XC_*Z<]3V[
MYN2"T76..>:8R>___N\7OV]UPJ,?_>CP.Y_\Y"=/WO:VMRV\QM=]W=>%__[7
M?_W7B]WG?__W?T^..NJH\'M^YW=^9[ Y#U\=W?.?_,F?%/T>OC3ZGK_^Z[_.
M^O>WW'++Y%,^Y5/":WS")WS"Y%G/>M:TWGK3F]XTC:G_^[__N[9G"%>([HM_
M&V+.L4K[J[_ZJV0L[6(PAN@ZG__YG]_YGO[HC_XHO-87?_$7=[K.!S[P@<F/
M_,B/A-?Z@B_X@LGO_N[O=KJ>-?J&-[QA\LA'/G+;]?B\7_B%7QC4N_WE7_[E
M\+>W86I]32Q9)_;!WSW]Z4_?]GT''WQP:_U[YYUW3N\I>B[J27ZKI'W_]W]_
M^%T__,,_/,C<XSG/><[2>0?[UF_]UO Z/_NS/]OYGK[YF[\YO%8.QM75Y-#[
M[[]_B(F]][WO+?Y]:A$^,LJ5U#HIN_+**R>?\1F?D<SW<^-TCOW\S_]\\KM*
MYQT[P:+\8S[_>5#S!P#N?=E*)2"+3+/H9W[F9\+O^NB/_N@IJ+#(_O /_S#\
M]X]YS&.*WNOK7O>Z\'N^XBN^HM-U4LV6K_[JKR[^'H&N1QQQ1/+YW';;;1M=
M9S_]TS\=WMNW?_NW%_V>'__Q'P^_Y[N_^[N+?@\@U][Y@S_X@\FMM]XZ>?6K
M7ST%8J^__OII$%.("[8O?_G+)[_R*[\R_3N*K;_XB[^8[@5V[KGGAO<J:<Z]
MA\LOOWSR\(<_/+R.ST,>\I#)XQ[WN,ESG_O<R;777CL->!+\][___2L!A]W/
M?OOM%S:;%)JE[5WO>M?DB4]\8MAX'0*0X%U[]I_XB9^8?$?^3-/T^[[O^Z9K
MYK=_^[>G@?T?_N$?BA;%L\ELZGZ =@JW3=JRX$>N??(G?W+X/9Y[KFG ?]B'
M?=BV:VA&EP957(\/F?^N#_W0#YWN@46&2!#]7DWW4O8W?_,WX7=\YF=^9K'O
M0"Z(ON-S/_=SLZ_!#XOGT37>\8YWK,0/O.QE+PO!N._\SN^L67D'T_1]VM.>
MMNU9VH? E67]!&#J"4]X0KC&OOS+OWSJG_L8DHO\("IPF\_'?,S'3+[D2[YD
MLGOW[LG55U\]!=W?\I:W3 DW__F?_[G/O<M__==_G>Y%_E*^_*I7O6I:\$9Y
MU$TWW33YK=_ZK<F;W_SF:>X%Y&4*[NA9JC>&9-_P#=\0WN>O_NJO%O^N<\XY
M)VP >*;_]$__5/S[[KWWWFG.%=4>_JPM)FEB1X2)YB-.:Y@A^6E:W''''5,?
M_8__^(\K;5RD\NK20%0J%_/[NEA$ O'IZS?DGM'U/N(C/F+'QAZ-2S5?],[$
M<ONN:QV)Y#6?0\KI#CGDD&E]L\@T?XX\\LCP78DUJ_ O]L#SG__\\#L?^M"'
M3DF'B^RUKWUM^.\UH$N:QE#T/=_R+=\RJ+7UDS_YD^%]ELP/?_1'?S3\#K5G
M*2O5=%EDXC]BGIIH4>X @X&!S><.)1HN_#2R7>1_D1Q>__K7=]Y;QQUWW#9R
M-<*WQD/7N+!*^ZJO^JKP^?7-D5/VI5_ZI>'W="'1/.]YSPL)Y@TI:17XE"89
M?QA]Y]%''SW-ZW--#1U=1\T]1HO$ ^)>Z7@MOD;/3<Q5S[7M:WGG_+_[I$_Z
MI"PB59_Z4+T7]4<V':OD\(<==EA(B(5]+V/O>]_[PESBXS[NXSKW!TH)7&#C
M8D940R&OO.(5K^CLT\78: WJ?7D&BTS\DA-&S>HN!/5<TR,X^^RSMWV?NNBJ
MJZY:^._7(7!A*:+I& 4N\W@((=U\3@-';,-#JL"EC.UK A?&7R\K<$'\BG+=
MVV^_?24]1?U*,3#*K<7,3=L8!2Y\S- %+OH\*9*X^WS-:UY3_%V*PRFRGW>@
M9[_(]D6!"TOQ=TH)7-A/_,1/K$7@ G?3)X+ER:M2_ W_S9]%_(V=+G A1HJX
M'CZGGGKJTL+WR.0[>@K1=Q**(X@OLG4(7%B*Z%P%+LMS//2P]-/T(E)](_[Z
M24]ZTN2""RZ8YLN>NS6IY[3*OM&^(G#QC.0C;W_[VZ?/3A\!ELXO\H_\)'^I
M)R?^V#]ZY_* !DOS/O=5@8M<ES_2]YF_UJ=]VJ=-+KKHHLZUGV<9]8+D0:NH
M\9>Q=0I<Q-\(^SC^^..GM>\JL(\H'L,^Y"@IDRND?"A_=<\]]Q2]SRIP&9?
MQ7 (OF'^N_3^5M'7X3<//?30;=^'8V1H4<K@L7#N%#^Y9*^D"EQ6GW]4@<N*
M!2ZIYDU#F$'P7F15X)(V#>5'/>I1X?<A:THZ-VG[@L!%LU2C"I K()]QQAE3
M(H)@H="7Z"(A2$@EJ4!90<+4)$%&84WL@*1@+Z0:$;D"ER: /?O9STXV[N<;
MAB9NG'CBB5.RH.+$NG&-!K19UA";HL"H07O--==,UT')CT9;E/A^UF=]UG3_
M#<$TH#18(Y ^:IYK)&LB2%(!;/P18*T4P1DY')$Z^G[-LU)K85/@1ZZ5$+@
MU>SW^6MH[I9>ZSX*COGODJ.8++#(JL!EKU&O^_OSUY!H VY+OS?Q L%J_OL>
M_. '3_=CM7S035,\>G< 307DLD!B0[B)]K7)<4BB<H$^QH]_S_=\3[)XG!>[
M''#  5,0YP4O>,$44 3TR.56(5)8EWEVP#J_!5B$P'OLL<=.XS@ B3]J\BC%
MFCW"5VMJRO4!17(OH(!F8JIAL9,%+IJ.D6C$1&J^J+1_2S6[O#, >9LAC" :
M>N>+]H1U@.PJ=Y8G ]P1B.4&I<D55>!2!2ZI^!!-D_)<-"*Z^.:_^[N_"TF$
M?+\:(*<1AVR;FFI(=-8&9/8U.;+:*S5404VZR*K 9:M5@4M>[@"S1$KQO. I
MFMB:DSFY Z*E/%S>89J: 04E&B[N)2(/(DAK6G;QP3???'/8E)#SRIF&9&,2
MN,"]4AB,=[0*W /VDQ*F:,YWR26JP*5?#I/J&_@N8H6V&*?^BN*;03ZE<V@#
MB*+3*.05.0-,5FGRZPBOAGFKQ?KFWO(; QRB_>W$F$LNN:1(SZ6KP(6YKTC@
M)%_73^B" 2!'1H.88!;B94Z>1W 3U22''W[X-!<KO1X-V(CBHWB:0]ZI I?\
MG 8N-(N'($,OPD-,^H4_-WB(]P4/@:54@<OR5@4NL2'N1B0*^TT,*^V']'0C
M;$C^5 4N_6P, A?DI@CG]Y&7(:J6M@]^\(/).ES>ER/FJ *7_K9*@<LL?^/%
M+W[QY,PSSYSR-]3:>LYR61AJQ-_ \8 SB,VP;MB54R)VLL EQ?7PD=/>=]]]
MQ>_;8*O4\#GO">%\D56!2]K&(G!A>#'X3-& T2A^ZC'Q5>H2Y'QB*%A^Z2&R
M8Q>X$%K K0QQ( Z"DWMV>@R>H_K#,^<GY67BHEI=3,:1A!/HP\/=U:S[JL"E
MN2_<U?EKB2-J'IR;+A@+/#OBYQ &K/,4HAQ;I\!E$]@'WD6$?;3Q,PDL4CBM
M08Y.)2QI5> R+H$+_@4>[OQWZ9>N@I>!:QSQPN5*Q-TITWM.<43A2"5[)57@
M4M:JP&7&UB5PT0"1V*<:34Z96&15X)(VQ5F*L WP[C(I<!4V9H$+YZ")#-20
M"$BJHB"5^P&<* 92QX5W$;@PJGE)9=LI(6UB"D6?)-%Z759(H=&B .K[;$I]
M/ OO:RA&V0V8Z?ILJ'U-9U;XV$..0+27^Q*LF:9M:O(%<LVFFP9C$KC8PQ%1
M8YT?WY\3KZO 96LS)G7$\3H_]B&0O5J>V9M(FE$2K]E? J3F6Q7*T:0%N>K)
M)Y^\%% !/ 1V  N[K!7[5*,%@'C999=-?;6],(0F;VX>Q8<#J^0)?DNJB,[Y
M^+>$?:GB>"<+7$P%SA&,K/K#Q^8THDW80G+K<L_B'F!=7F4]>=]R8:*!$LV$
M*G"I I=4'I4B05@S\(-<([2%?41"6P,(<@PNDFHT\[$YT\&[F@8;\7WTG?9P
M3I.C"ERV6A6XM.<.<BY3R\\ZZZPIYM=VZE=.[J Y;A!&B88+ G/4Z/0AEL[-
M%_U.!)DH]]1TV/2@FGD;D\#%^TF1#Y#25G%"HO>>PC/D_UVF#U:!2S^_(<:F
M\D?[/V7WWW]_\O2==7Z026#.FS2YJ*;__#OSOA!#U+1]ZWFDQBAW)3ZR+TOT
M7/H(7!#T$'6BWZR' RO/,7X% 37RZ<B5N9@%PE'.(*M5?\3.G!/ZJL E#P_1
M&R"Z+8&'$,6HB:O 97FK I?TO4;#?];],6S(20R;MBIPV=M3*2EP@1NF>G1P
MWU7@&M93"B^ :\!5%UD5N/2W50A<Q%D]<WF683)JR1+\C90OW2D"%SE+:F"$
M_E07<G>NF:QO'Z4X'SFY=!6XI&U, A=FZ)]8D"-RF:_[85>&#<J+B5W4HB5$
M!&,5N*A3D9Z1HO4JY5=]?:3\4+U[Q!%'[-,"%_G:Q1=?G!3AWGWWW=G7TL=1
M \Y?A[!(3C(T6Z? 17]X*-B'_D;*#/%.W>?NW;N+GQ)>!2[C$KB<=-))R3[]
M.C_JJC8<@Y@[Q1%U<F9)SE$5N)2U*G"9L74)7"1WDJ=4PIF37%2!2]HT_E..
M4[*ZBF*SBXU5X$*894*N9HDUFBI>2GZZ"ESL+06:9XEPWZ78FRV,)->$%(A+
M]]Y[;R_PV#WT^?[2'V D(NU0S#M"Z#)%5-.\3X- XOQE7_9EDW/..6?ZVX !
M?80N&C>I[T<0748\,R3P8Y&5$+BDKK'NC^E#BZP*7/::QN$0"@W[$$&[6IZ9
M1L^'1B0@A6HI\OE==]T53ESU04A>!@QOIM8BY0.O^N04A)(:S>*M4[><D@'T
M'*H!3Y&@SCWWW"EQ:1UYU$X6N"!T#8&$P,>JVW+RHU>]ZE53L1^R?A_1J!BH
M1D-X0IP1BY9I*E2!2Q6XI)X+_QV17^52FF8Y!B2$$<PWB>U;1+5WOO.=6=>!
MJZ2$842?JSCM2UT,<T@1<G-$*E7@LM6JP"6=.]AO2+5.)%I'[M"UX:*VTKR)
M!EAH\N:*WI"J3SCAA&V_T?XV.=:$X2'9F 0N\O947N$4N%7@'MY7B@C%[^>2
MY%D5N/2KM5*8Q"+BJ&9TSJG+ZQA@TI<D6LKL#0W1*">6=YM V!6?4Z\Z14N.
M,G]-_H]OZ4IB+2EPD>-HYD9YGAH6Z2+'_ :8;91'(X/D[E]$K%33>9T?[X9H
M<Y%5@4M[3B-O=S(ODM8Z>B95X-*]3U(%+O$U-CW4J\F?JL"EGXU!X*+F2^$:
M>M6KPC7XI%2O)D>D4@4N_:VTP,7[Y$-?^,(73M?,.O*GG2)PD?.G\A9$WU4,
M7H.SI'()OD*^OLBJP"5M8Q.XJ$L19-6*3A+IDY?H-_GW? 3?;4#:,D*7L0E<
M_%:])CBY'N4Z,(]]1> BOMQQQQWAL%2X@0$9N>\3H3[J!1UUU%&=<,)UV3H%
M+C@.0\$^VOI[,/I4SBJ'*7U*>!6XC$O@XE2@(? RK%$<IY3AI*7NTREY?4_L
MCJP*7,I:%;C,V+H$+A[P/??<DVS@('0LLBIP29LI4*EBTS'SJYA.V,7&*'!1
M/%ESIYYZZEJ)[%T%+HTA?DNPJ"]-*.A#!+$7B60<OXMP:/))EV+/LQH"^.WC
M_H=F?*"B!_BA*.J3['B^&JPFV=YVVVV=@5X-Y=0[,HEVTT=ACDG@LLPDH-)$
MXAQPL I<'C""@"$4&CY$:]46&X 0J?:1CWQD2!8Y^NBCIT?/E_@ "!S+G&HV
M D.7+?(TE7W7DY_\Y&G,[0/@\./VELD0)KR:&#VTHXSE48IIA&)DJ'7MJYTL
M< '8#R4/:SL*=[Y&E'\@@]E[A!]]?+1_@S""M*V9Y,CU/E8%+E7@DC)UD6F>
MD;@#D5J3;)'Y.PANT90HIX3E^G%[)K5/W,LJ:G]K SDU%9-R"*55X++5JL E
MSAT0"IU>TO6$VG4*7)AIDFJ0J+YZR4M>DB5 MJ?@F?/7^+S/^[S)K;?>.KC<
M;DP"%\]UW;@'DD]4KS3-TBIP6:W A7W@ Q]H/6&P[=\-85B/SZ,>]:B-OR]"
MC10QSK36\\X[;]J07"04L\\(OQ!)4V0STV,ONNBBSO=84N#2X+7^;>33Q>4<
M$I\IKD[ACD[IZX+U:]X/!;,RG&.158%+.J<AJ$0^7B<>4@4NW:P*7&)+G7JX
MB4\5N/2S,0A<]-Y3\4XNOPH"/5Q#G97"-0R]6F15X-+?2@I<Q%DB*1R3B(!<
M!2[+X1[>>ZJ>AH6L8F $+!-)-#58)V>H:16XI&UL I>FGC3@%Q\&WHV3T:?W
M)=80P:DGY'A]^[MC$[C@#]GW*9RJ"ES:#1\E\BGZ9,<<<TS6J1W6O1@7#0\Y
M_?33!X?[LG4*7*Z__OK!8!]GGGEF\CXOO?32Y'T:"E)2&%"RUU(%+NL1N,!!
MAL++,,P\93AI;</ 2OJC*G I:U7@,F/K$K@TC>I48HETG0-X5(%+;&T"%P7A
MIH' ,0I<@,NF5*RS";&,P(4!_>P31\0B\!QZZ*&]A!3-%.%++KED.DDX-Z"=
M=MII@TA$ <(WWWSS('VNXA3( 0A#;M;<Z%.4V^\:I\"D+E,GV@0N?'3)0GS3
MX$>;E1"XK-LWI(!W)T$LLBIPV6L$+D.8"(&43(!:;;'=?__]T]BX:=*1_2:V
MEIBJ K"W%C5VD)H/.^RPZ>27KK]1S"5Z!,XJ"C?MPV?-R2V>EPE+ZWQ/.UG@
M E@= I#RL(<];'KJ4M?\R)00$_N=Z.*H;\!]G_QHUZY=4P"EJUB$58%+%;BD
MS"2F%.@.K"/$7-24T[2)II<C$.5.!V?(V:E<1CPI/36JP7/XK50L,F1AD56!
MRU:K I?MAJ B+UKW(($^ A<G_2)#1W$*SJ5N6>1O+[C@@BE9?/[?&SC"7PS-
MQB1PX0M3.002^BIR9C5WBE0J7E>!R^I/<($;I>HXL3IE!"Y#F1I)\+UI@RW?
M?OOM4[%=:A+N,Y_YS.F@!1BT=2GWT-27@\+58,DFGFJ<:Z*F)O,?>^RQDW>\
MXQV=[[&TP.7][W__5"@QOU;];P2V10U8?1?31R.<$($^]V0OYCKK.+ULT4<L
M%J<6616XQ&;@ ^+QNO&0*G#I9E7@$MM^^^TW"&S)?52!2S\;B\ EE7_I:Z\*
MUT!T3^$:.7E$%;CTMY("%[D9(<<Z!V/L)(%+&]?#X+95#-8QK"K51^$K%N&N
MK I<TC9&@<OLVO .SS[[[*FO5:?V.8U$W\B_-R"W3WXQ)H&+FIY?7[=H>5\2
MN, UKKSRRM 7XJ086K0(HU(3XMM%@XUP.X=HZQ2X$"X,!?MH.Y6G3>""@UH%
M+CM;X(+O.01^K %";WSC&Y/W><011R1K?,*8DK&L"ES*6A6XS-BZ!"Z*':2E
M5 ,G1SQ2!2YI<S3G@Q_\X"1A!#ETDS8V@8OFI@9)V^0/Q9/)ZX!P#3F!\I13
M3ID"/HI_IYEH^#WM:4^;BHQ,?S%A8/_]]V\]3G,9@4MC A#0VKJ0D+D'#47[
M.D6$2Q'331G6F,PQ9)SHB#X-6L_#^U['QX3]/7OV#-KW>D>:N!K""$8F0B-A
M((5V2>:M)P66-9MCUD&*0%WZ^+FA@!^1E1"X2,RB??R,9SQC;6L=6(D<M\BJ
MP&4K^.UW1R0-9+)UO3O3(/HTC'>BF:9*##2$Z0<:;#E@>JXI0!#G ;0FUR)U
M$B]J.*;RNM0DW><^][G%&^-]S4D')BNU-9G\/C%,7)*K(A[/YE'^KSS*?P<0
M(%4BAGLV3CM(Y5$[6>""4!+E$!JTGNFZ_!M"]7WWW=<[/[*.;[CAANFQT')H
MM9XUWD4 )BZ8H-_UI+LJ<*D"E[9G(X?@MZ(FDUJG37"N<:8VFW]GUO7AAQ_>
M:8T1$$:YC(^)='WW7YNY?W5+:GV<<,()"Z]1!2Y;K0I<MIIUJUDM)V_+'4P>
M!,@35<UC,%'NH,;V;]I$DWT$+O:$.!61F0\^^."%)[# 8MWC?&QSG]=>>^U*
M"%W+VI@$+D<==50R;W 2[BH(.4Z]2.$9\ ?O/->JP*5?726'[#,8!-DTVLMP
M7PW6=>70ZKD^C=M5F&=B>)(&:8H<)&^6J_.%XLU55UTUN?SRRZ?$/[\'%IPB
M]ZM9Y"Q],9'2 A>$5R1\F&R$N_++;89([/VEUE 7K/'&&V^<UKM1?2/.K6L]
M.F$SAZ17!2XQ/NKTF[;!2'(:)S;-XR%JBF7PD"IPZ695X!(;4F%$TI%[&PBX
M+C]TQ157K.24@*Y6!2X/6&F!"[P_A6L@@ZX*UTB)1> :\II%5@4N_:V4P$4O
M7!_%OFD;+H>_H;;$W_"L<O@;8G/;0,J=(G"!2Z4P9_G^*O *@SR]JU0?&Z:X
MR*K )6UC%KC,UFQ$# 90R;7EGL0+N%Q=A+D&J\&XN_)AQB)P<3^$%?Q9VS!'
M.)6:7)V!HZ0WK7;E(WWP)?!=3CSQQ"D&J[X_\, #IX,:4V3N?4G@XCD:D".6
MS%]3;T__NPWWY2?59O.\.>O(H,*AXGOK%+@@P8\!^Q#W4J)L.! .5DFK I=Q
M"5SDF-'ZD%NNDY=Q\<47M_:8<=U3OAO&6I(C6@4N9:T*7&9L70(7P $E:JK0
M!-0NLBIP29O3*E+%O._KTDA=A8U)X,(9>)Z(1JD&A&08F(N4@KA@"KM$%(F.
M*EZ1I6$N>564O^M=[YH6$XIH33&$$D7#J@0N\PFX8(9TH-DHT4*VM&^LF45D
M0<U,B8[?L<C\K@B4I&PNG=SM2V:]6", &HU!:PL@>M!!!TV?YR+5K^+JE:]\
M91:HI-D;B9!\^.A-3\4:D\!%8RH"313D0SM6M I<M@(FT3IS"@924K5AF1CF
M^/$(1-K$!^G2%%.Q?A6_5?,.D'+--==,05H-%L1,L7B1^%%,/^^\\S8.C/%_
MR,5B6 J,U3!R!+.<2'ZBH/7;^2KYTVP>99HNH:W)$X@1GHUC?^W9*G#9:D#H
M2!CE?0QAZF6?_(C?)PH S@ UU36 ]#:Q^"P933W69;]6@4L5N+29)GITK+Q<
M75[85G,3_LGQHUR,O^]B3DA*Q46^%_&DM%F;0.F47T<.6&15X++5JL!E:^Z@
MGH6SI-884B>BAFFA!C/('>PK&$PJ=W#:D75G[2)@IQKZ?00N3(X:W3-",T)>
MF\A20T4\BTYA:CM.?I,V)H&+_"L5(_D($T!+FU-]4M,QB2O>\Y[W9%^K"ESZ
MY3!WW757<B*W=94R0Z$B 2O<J#06-19K!C&(%ZFF9-\/3!)QE3_O6Z.4%K@P
MV#YBS_PU$2Z0>]IP[3OOO#/$^9&*%HECYDT\C(1%""6YPXW6:57@LGWO.)DQ
M)690Q^HYY>(A_KN:N,%#KK[ZZBD>DCIAJ0I<NED5N*2?2]0SU)\?TLG1Z[(J
M<'G 2@M<K/T4KN&:J\ UU&<IKH+WB5BWR*K I;^5$+B(L_+ E/^&B\LS$0H7
M\3?4A U_PR 9O)"&OX$_L9,%+@:?IH2ZGL$J<E(8SM%''QU^)[S>H(I%5@4N
M:=L7!"ZS9A\;(NLT%O@CP1HRL9YASN! N;1\KTM>,Q:!"U_'=Z>$+88Z&"AI
M+^,%J3/DB1_\X >GW^_W>+YJ=?_-NQ.SU;SJ' +#DTXZ:9\7N#"_7<\C&OA!
M\-.&\XDM^K51SG?^^></UE>L4^ "^XA.-I??# G[D$^DAK?@NI:^URIP&9?
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M#-]PD=R>K3Y -)#1!UE\F?O%([)'H_JO2\ZA9H\&-<#%FA/G^YK?YUT;\F(
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M"3'.;_'_ \M+-QY7%:NL?QA!A*/ 02+BO]^*)-ZWIIPU^_C""R],-@\!JIH
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M!5=BE9P%;?,+F*9W:%*E"$)C$KAHX%]WW77)))A#=?*#Y@- *C=X>Z^"/7(
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M\J'4I#?Q*FJ^ GSY]C;@SY_Q1P!"P*(IOM97DU?XR,_DW?X<X)DBM'L^_@Z
M=--&F'G,,<<D?SLP"C'0^[1W[*<F/VE^K[BBKHCVDCP P2/*UZO 9:]I>B%T
MMIU2B4PHWLA%Y,M-W>0C)Y$GJ!/DM1K)GGN4CR E$"NWQ7HUG"$(B_(C!!/W
M+>] $G,/_'3C<TT/:>HY.4QJG<E)^.>NIP7RT008J5-<FFLC>0#_Y-CNRQJV
M=S52O?>4B-CO%W^CYS $@8OF1:J>]WZ\&[X-!N"=^,WR583DYM_9MYK)D?F-
MBV(<?Z;9.0;S>Y";<D!H>: ZI[2)-WRI_=Q&]K7NO#_3VNPK]^(=\L'VFOP2
M&6!17;!KUZ[>A'8^0HV8(K WZTQ\A9N(!PU.T>Q_^X[/24V-4]=&]6<5N Q7
MX,),H))'M_ET#1_OT?"5^=R![X5]J$FC_, >M6:B/RLE<&GR>'LDI_'K]VJ,
MCL7&*G!AAA4X5;<-(_7.X'P:.-98DWO81V*]W$#L;\L/FOK7_NYZ8OG\.DH)
MM-PGC$5^UN!']@/? 3-K)G^*I?+BOB*;DI9#%IL=#L+_^WWR./N<_U<CP5'4
M36UBI6:8 ,RJK[A',Q$!KXUDV0S;@9F+JYKL_%ZS9F ]?*T_@[NJ?2+_(UZ)
M:\NLEY(&>Y.#Y[ZOG(]WP@?#?SU3SP)6#!M!9N4'<TYNR^FYE!2X,(0G>>ZB
M->S/^0>X=&E#B+"_HU,F9F.D'$[/#J8@7^+#FKZ=&L_SAN_SY>J4R)?IV5G[
M7=Y'%;AL-T0:S[D-#]$SLM=2>(B\?!$>$OU9%;AT,Q@&GQ3M<?_-GR%;-OB]
MN"OGA$4T)[3*+?A]Q*4V&ZO A1F" *=MRV]AFS C^*EUW<3PIN<AE](+AO7I
MXR&L1,]=?IQ[0O"ZK I<]O8\5R5P87J;^F6+< WYA/Z:_&D>UQ#K<G -6)H<
MKL\0K2IPZ6\E!"YLT01U[U?MIZZ#=:?X&^J*J/^JCE)/1&NQK\ %T5T>EL*)
MY6 X$-9T@W^I2>'+S31L'^]CT:F7I04N3>X-YVCK,33\+_F 6#G+1X$;B:>P
M/#EMV_[D#]5^?88#58%+NR$MJQ7:2*W>L5X1_,-[4$LT/0][AX_5HXS(E@WV
M'*WS11P/PIE%IX/X3G$,7T]OW/ZVMMRC^M__E6^HP?V=MK6F%L(IZ\HI4K>W
MG>+2Y/IR(GE/$Z<\0_DDOI-U&IWTT>RCR/=TR3E@0&V]"O=NGXE;UH-:D<]I
MGB%L ]=!;R8E)G0_47]G7Q>X,'FJFF#1Z14^_#=\<$RV*8%+'^P#;K@,]N'=
M=,6BU%1JG13/;);_2.C"E_)+[JVI]_F!AI^9*Q+L*W#A#PR;29WBTN +_EQ?
MI<F;/$_/56X.M_!;HMC!'_!Y$4Z[$P4N3<[$?[;U#\1*>:A\UGJU;L6*>5Z&
M?8=+JE<:^1PU$4Y0U]-4<7@6#0-K!%#J<_&_J>^M97BW/::NC_JPXGG*1^8(
M7. MB_:&?&!,XL%EK I<9BPE<)% Y:KO<C^N:1, &I:94(AT1*&=FJZS3,.%
M<U!\<=)C%;@T"?9--]TT=6JY$X/[/"_%=0XX.C:!BV1& SP%/"_SX8 T[#E]
M($M7@0MBK[_#:7=I$O?=LXHPQ7\?HAS"+W*E(FG1T;XE[E4B.H3II_RJHC#G
M6-9E/_:WQ(*"M\]1\$ %8-,J[]5U-;-RB!5C%K@ 0DR?:9N 4NHC*>XR7:H*
M7-(F 73O"LQ%A-L2>T&ROPB<-0EP$7'*WE? [VO&AZ=.ZI.C;6*BO[Q3T185
M:=Z#QD(DNM&T%)< OE-0]_\!  #__^R="[155?6'+0+$0% 1P53 1R"/( -$
M42HT1(G I%)\(9CB \EG!A(JD:5)IJ*"A2'B(]!249/$0BLQ2P2%A.)E&L1#
M5!!$H?4?W_Z/U5CNN\Z]9^^]]KGG<'_?&'<@ F?OL_9:<\WYFW.NO=MN9K?=
M\OGYY"<_:;IV[6H>?/!!LWW[=E/;;-VZU=QYYYWFT$,/#?Y=Z]>O;[[\Y2^;
MTT\_W;1MV[;*G]]SSSVFG!@X<*#W>SS^^..Y7WO'CAWFH8<>,L<<<XS9???=
M<YM__-2K5\_\YC>_,1]\\$'!^UFU:I4YZZRS3-.F3<TG/O&)W.]GT*!!9N7*
ME6;GSIV)QV[!@@6F>_?NYE.?^E3P^?O5KW[5''?<<=[/?N^]]Q+=9\.&#;W7
M^?###U//F_???S_Z[EEM$M_1-Q_XCHT;-Z[VWS,_VK1I8RH!YM?2I4MK'#.>
M/6MQQ8H5N=S#\N7+S?GGGV^:-6N6V[K"CO3NW=L\\L@CJ=:59=.F3>:NN^XR
MK5JU"KX7MF[=.EICG3IUJO+GIYUV6EG-G4F3)GF_Q\477QSL&C?>>*/W&E=?
M?76P:WS_^]_W7N,'/_A!HL_9MFV;N?ONNTV[=NUR\1V8NV><<88YY)!#JOPY
M\S$4V+WKKKO.[+???M7>T]Y[[VWNN.,.\^Z[[YI*X?CCC_=^EV>??3;H=7KV
M[.F]SE_^\I=,S^6VVVXS[=NW#[ZWNS\'''" &3]^O'G[[;<SSZ,33SPQFKM9
M[N?((X\TZ]>OK_6YX_/[B!.:-V\>=/RY#OO@55==E=BG\ODK$R9,, <==%"N
M/BL_[%WXR>4 ?N#,F3--RY8M<__>[-O8RI-//ME,G3HUT1C,F3/'^YG]^O4+
M.A[$UL0XOKC3_=EKK[W,I9=>FGG>%?+S%BU:9,X]]]S@:\:WAH8.'9K(;MQT
MTTW>SV(=AF3<N''>ZV!SRPWT$/P\G\\1PJ?ITZ=/I(<0+\7_?/KTZ8GN]5O?
M^I;W.MB!I'SM:U_S?M;LV;/+UK=AC3/G:XI/:_I!CWOMM=?,?__[WX+7\L4G
M_"Q9LB3H=_+-"W[>>..-U)_YT4<?11I?APX=(JTE;RWGU5=?K78L2PUQBN]>
M/_WI3R?^+'Q$WV=AWT.R>O5J[W6RZ"ROO_ZZ]S.9%Z'V._22"RZX(-I7\]0U
MCCWV6//PPP^GTC6>?OII[^?BN^<%-MEW36QX*-#3?=<8/GQXL&O<?OOMWFM<
M<LDEB6,E<B"?^]SG@L\/8L4>/7J8,\\\TW3LV+'*GU]__?6I[>A/?_K3S#K8
MP0<?;!YXX(%(\R\$:\CW;[/H'NC,S,.\<PPM6K0P(T>.-,N6+4NU#Z '^C[W
MR2>?#+HFO_2E+WFO\]QSSY6]KD-<@3[6H$&#X#XJL1BZD6^.O/GFF]7>US__
M^<\HE].H4:/<XU#6.1KQQHT;4XTAVM1G/_O9X/=%GH?8V#>_DO@<K)VWWGJK
MH&^>-5Y$SV1O\*TW]),D_.,?__!>!VTXS=PNY*>'CL]?>NFEZ'-K>IXGG712
MY)-5$K-FS?)^GV]^\YNY7YNYNW#API)I'^><<TXJS?3EEU^.XO$F39H$U\@.
M/_SP@O8E::[%0APX:M2HX'E#XK;/?_[SD0_\F<]\)K/?P?/P76?:M&F)O_.I
MIY[J_:Q?_>I7N<]C?#3RI]CRO/<TY@P^,?%JTK6&=H2O&SI/PESXWO>^5S W
M]O>__[W&^T,[J:F&9(\]]J@X^YH6WS.*^\F[N<9M5^9?__J7=T)0>'3EE5=Z
MC5%: X>H2W(HK</HLF'#ANBS#CSPP&#W1[)B[-BQYIEGGC%?__K7J_R=+W[Q
MBXGNL5"RY8033BC)LR6I\NBCCYJ^??M&"SRT\W_888>9'_[PAT4]3PH5?)]#
M$4Y($ A\U[G\\LL3?]:Z=>O,Q(D3HWD;J@C/%@6QT=QWWWWF"U_X0I6_<\,-
M-]1X;Q3K<6]''WUT9@&^NF=,8<&,&3.B(J0L CAK:LB0(;DYH]QKMV[=HH1)
MT@T\+TAJC!DSQG3NW+E@\6$HP6#NW+F9OC?SB<0C]C1TD@+;@PVB4)2Y4!.%
MB@=J$C^20@#NN\X[[[R3.3&&O6/MX%3F\=R93P,&##!KUJPI^KZV;-GB_:P]
M]]PSV)BN7;O6>XW]]]\_V#4HWO1=@_TH:]#,_6-_BW&:TP;+^^Z[;R30XL-4
MQXLOOEAC41S["79U5X,B89++ON],<@'?JC9X[+''O$D-ZQ_.FS?/^^\0$@GB
M:<A@O>65_$5,FSQY<HUSJY3\^]__-M=>>VVTMX1:4W9/H3F$[XO8HP:7FA-0
M%&4A:.<U!VWA_@LOO%!C8\4KK[P2^>6(U%F+-JN['\:]F/NICOOOOS]:6Z$$
M'@1/BJL10"^[[#)O(JD<&ERLN)55\&2^^6P2/DE-26AL!CI$I;!Y\^:H4+TZ
MGQ\?@.+J/(53DD(45^91C,O\Q?]$7RC&IR]&6*?)(E23"^N>PIH?__C'T9Z-
MYJ(&E\IJ< 'B&_X=Q=ZA? <2"238V0M__O.?>XL+0S:XP-_^]C?SE:]\I=K8
MFJ0U2;M*HI(;7.S^@_](TT<>&@USBS6'1AJB*)-D&/8\BZZ #T.A2&T7B?K6
M,T5C%(BA%X2*MVG*^.YWOQOIN2$2ZS2@W7+++5'"-B^-@/P+#> A[CD4V.+1
MHT<'RPD5DY E9D27++;0NU0-+D#"E,++0C:=YWC444<5U 1"0!$-.C,Q!/FK
M/.:CS=V1;TC2?*D&%U-0"\)'HO$QI!["''_BB2>B9@.:-M7@DAV*U;'S67(B
M_-L__.$/U<9)E=S@8G,>O_SE+Z/<9EY:#AH)<QR[JP:7['M7I36X6%T#WY7]
MCI@P#UV#@EQBP[2ZAAI<TA.JP04H2,5/IVD^9/T&^C8U$6C"OH-LTC:X #GR
MP8,'9XI%\9M_]*,?55L/D$>#B[6%Q*@4;.>18Z!YAUB.YI:TA^JHP:4X*&!'
M%PG5Y$*=$L7$\^?/C_1&7]U2,34>- U<>.&%4;R35WT%WYE"?9IILQS>](M?
M_"*J2PAU7^1AOOWM;T=-&B-&C,CL<["?4F= 0V<H&\DS0<<GSEN\>+$Y^^RS
MZV2#"Z#[H?]5MX88"W3H2J,V&URL]L'ZS%O[P'](JGVXZ^M/?_I3Y(>%:AHA
MOJ+6D;W:9P.R-+@ ]H"FG%#WB\]$;0S^$MI$B'S+KM+@ L09Z"#4G.=U("%S
MAEIAM,@T!]_BU_'LJ&4-%=_3G$7]^'_^\Y\H1DS;X(+F4%-=!IIUZ/K1<D4-
M+@Z%&EQ(+! @(E)3A)]%X".AC+./$0MU.B$/C.0/@1R+(^WFQK\C$"/Y3($!
MWYD"VE-..:7*W^4[).%WO_N=][[R%#KB<&(4 16=KHA7(9P 3D_A.U#$7:S1
MP(&+7YO?LT&'A 87WW6NN.**U.N#SSSBB",R!WJ</('S1R!-8IW"1AR5^+TR
MIXN! KC?_O:WD?C#&@W9Z$(!%@5,B!4AUBSKE8)&&CZZ=.D2](0/-J]O?.,;
MT;UF:<3) P(<FIEPR"C"#5E$P??&$?WC'_]8[6GIQ8*C@2!(L!NB(8ZY3 #*
M_$34*-:Q\@G7!,VA'91]]MG'>YVL#2XV^'KJJ:>BYQ/RU$O&E'G$F"*&)@&;
MX[/_.-6AH$'$=XV0!:KLS[YKI!$[?/#\:3[$_OGF2!8_",$0 9P&CII Q.4>
M:K(![$^[&A3(^0J?<=X)2)EGM0$)9]9T(9^9PN;JUA^);GP1"O8H8@HUM_#)
M*.)EWF8]*3H/6+,TI(<X!8+B-XJ_&$O\6Y)-\0 9^T#"O9S@Y"F?/2]ED0=^
M&,T>G-*"O0QY0A?[-L^%(C-.?"XV"7GOO?=&S1XD D(61R <XW=17)RER<,*
ME9R*AYB2-?E(P0P)'M8$?@*)@/AG\O>2-KCX3H#A<[)^=^P6C1)I[15SC*0B
MC1]Q\ FQ"]7%I7R'D$42I5AC)&1Z]>I5<#PH#*?Q+^\$ ,5T^ <DY4/X]*Q/
MBAUIND"XSY+\BX\9)[53^(<=R*+GX+,QW[#_Q%\TD5$8%?][Y=88C._@TRYH
MA@X%R3;?-3A%*104G/JNP3I/ X<OH(F$$-=)O++7<" $O@-O->-SX_=*TT-(
ML,&(^84:N&ADYVT%V-I* MW4MP9#-[A0*.Z[3M8&%[L'T:A'PQO/(431!#%U
M__[](W_<M^^EA403S>+,HS0V$AT?'9MFA=HN$HWG%/@^Z!KXCB24B96SY!WL
M2<L_^<E/@NN"/ =.^"9/@%8:,A%)H07^(8T+Y01[/7HX&FY-!V^$_.$@&N9%
M,?H?L4>I<BXDIM'R?<T$MBB9?95])F]_DX+EG_WL9U$A0<C"0G0%;#R^"<\^
M":P[GQ] @6)(L(>^ZV0I\L@;BK2Y/^*:$'H(1604+V"7:&2)STG&(VF#BZ_P
M@\^AL"DIOL,]2JU]I(&\"CD18I(T>Q'_!JV/HKKJ8J6X#VK')W2#B^^-4_@[
M61M<[/Y SIN#B6C>"EE\2C$,1=GX>Z%BSI"^@&_/H5DB*6BWOL\B=QP2GK?O
M.A20IX4&%]]GHOF&WN_03D+F*K'!Z!H77711E$_-,L=H</'M1Q3]YP4-+KYK
M8L-#@9[BNP:U):&@P<5W#?3J-. SXA=19Y%5Z\;/I_F$/8LX'=^/^")^KUD:
M:]$)?OWK7T?S.HW.C,UE[Z?FH#K=EP8!WSB'T#VX+C5'7(,U%4+3I[8%WY9#
M@7BF66)77TZ5[TZ^/B0<9N>[SO///U\1V@XV$%\/K3J+C65.DLLE[\D>02X%
MG3?^5H,D-1[4JDR9,B6JIZ*N+:2O@8_$P<O<:U:-A.^*KD<C7)9[Q(_$UA#K
MH.D3>_J:U%@G:>)8#B#F@)VL>REKG5HT=&9R>^@NOF+TI(VTY%-\O@6V+BGX
MXK[/(B^7QQHB_^!KA+0U(8Q[;=4S9 ';X-M#0C;55JKV$5]?Q"WXEEEK</%!
MB*7Q]ZA3"GF8F#NFU.O1N$SM6I9<'#4!:!/XQ/A,H?(MPX8-\\Z]- TNZ/Z^
M>R]5@XL=<QJ+./"3^KZ0=1G405"SA'^3)1>!CLGX9O4'J/T][KCCHIIPJ\O[
MFIYX!L4TN*!'U[3N^?XA7JQ1":C!Q:%0@XOML"79Q&D6."F('TF,'9LWC0$$
MISA0U;TR,RT(0A1(D6A*6DC,(N7^<+P).FQ B /)/;N!&9W1&.HD_/G/?ZYR
M\B1.?>BWEA3C9%$D@'B ,\4])175<;!)JE)$R:;*=TM2.(4SA!#OC@6)J^NN
MNR[H=\4 Q^<!B28:M;+,,9*9G"Z(T)UT\\%10K @.*')PYX,PQA2>.,*YR0.
M:1Q* LXQ"7H*Y?@\ K0T#20$8(P=K[FG2(7"P!"-$RX$/<P%3B&@T85UE?8-
M%H@G%(W>?//-42(@:R%?GE"\12$NA6$XXJR%-(DMY@KK%[&4(@ 292%.4';%
M*9+$W_G.=Z* FH YJ8/+W./94NR**,K)W4F$ IP?=XW91AE$C9!0-.,^ ]L\
M$K(@A>>.$$]0DN4D;=8) 3C[,$4S:0HV<%#Y?N[S9#Y12!(*GC7)*/<:[*-)
MFT-K2L[$BR"Q!Q04A8*B)VPUS2@$N6F;E+"I[',4N^)3((X7.[\H<"8I7>BD
M,N8$C7W%-,M4&IRZ'B\&9"SQ06^]]=9:*\XB2$=81:B()[PIK.7$^&+6"(VI
M!&;,64X(2?-Z4L8#P0/?@D(:"H[S+J;)NO<SGQ' \%&2)C[PX_!-*':U0CF0
M5&=]60'9OO&!1%$YP=[O!N)6 *)1I]10X$C<A$^;I?&6O1Z1F40#!P009Z2)
M\VCVP%>@X9UB?/S@M 4EV A.C"49QEX1JB""S\$W(K&0M.#%VB[&FUC"+63F
M9!2W><3Z(4F+G?$/W"0*GT-Q00C_D/ERS3771.)DL=^;>\&V\4P13 L)>_BP
MO@(?M_@@Y-Y>"K#Q- 45*K(O9?,=\PC]!9\>7R]-$@!_G'@+VXTPF<=I.,P%
MYAG[*TGH)(7#S'6T%7QZYBD)!3OO:13&;W9]??N&XG*"!KIXX3H^1=K&$!^<
M*!@O3F:<0S9)8W?CSXYK9BF>8#UQ AC)".QH4M^!<20&H<D$K<#N431B$(];
MF\;8$YN3B,G#I\5&^^8N GPQ8GZY01+,/5B%[X)O3+(F)#QW-ZG"=;!'G. 7
M"L:?HFR:XY@#:?P/.\_02#F (@]-RA[L1-(\B=]FDXV___WO@VI&:<$WB<?P
M)*JM#D4!&8G,0J?.5U=DP6>?=]YY4;R=UW?%AA"'\"QHH$C[9A/[QA;T-GQ+
M_,-0!X&%W)NQP1S*A!_!80ZE:G"Q!WF@=];T+(F!2YESH="6_9F";G</H<&-
MF(C3ADL%NA*Q)'X-\7"A-U074^R+_4/W&CMV;)0;2Z,K<.*[+Q?#<PP)>2V?
MOQ'Z+6QYZ"'$X+9(+XT>@E:.YH0&:'T:8E1.ZW3U$.8G_D<2*+:(QZ6L>XI5
MDD)QCT_[R//M1J&@, )M S\Q23X$FT6\A,VL*98G/^#F[+@&L3.Z2$A8T[[<
M2I(WP1>CS[,F.9$VRRGK^'L4QJ;-(Y4*<J2^O K^65+8]]'3W,_"'J.)A=ZW
MXCD4Y@7Y_;2L6+$B\LG=SV1.$\OG ;4I'%2 SI)6U\#F$D^R3LF[9REDM- @
MX_-!0A_FZ8)-CK\A'=N-#0\%>CHVS;T&M0WX"*$@1^[30&ZXX8;4GTFNE'O'
MCI";3%J_@2_'^J,F@IC.^J!HFNB2;IQ((QIZ;E8_CL,ZL9]\7K'[#>/$^D6?
MJ^GP'/*:KG]H=8^019WDOEE3K"WL0IJB3>8P:YM3^HE;0^3F:;QQFRNL+Q+Z
MS2K$VFY]"]=A/Z2NIE(@YX%&QB$[[$M)?%3V??Q:#A)"3Z,@V^[?Z)#NW.97
MUF;20G_\7G1%="@:B?&)TQ[\P7[(FD-_1F,)Y6LPAOB :-!)WSK&&#(N-!'R
M=D9[2"R^/EJ5NZ;X#C3RI;U'WK9"[$CLD+2 &1^%^Z2Y&5MK[Y/U2HV?>Y_V
M@*\DT,3@J_E JTL*^8"XGT+^G1K2/"!74NA-&]P'S8B5"'%FWCY'DCV3_<'.
MWU#:![Y<B)H*; G^,;4KU.[AXR2)BX@[T0?);;%_V/651X.+O5\.V"%?@N^3
MQ+=F/F#;J45%SR6_6U.^):G?P3C@>[K71..@#C8IU'_[= YJ=$H-^Q\^,+X#
M&G;:@^#Y=\3UU(>1CT-'"*&#\QQ99QPXQ$%,2>J6>.;<$QIW_%!VZM+=S[*Z
M!&NF)FA8).=2R+]D7^)9IGES326B!A>'FAI<K/-#TP?!"@DG3K%%?&,385)A
MJ!E4G'D,-\7-%!A1<(^SDW?G%,DPDI,4NI,()2#"D<1HX9#;^V.3P)AR?X@N
M;(8T[\3OS[[UA%/4"*SX(;BED"X)B(:([&SX? :_XNQA(&I+B&/3(@#'X>K;
MMV_4.<<S8VP8*XP0CB-CQUA1>$30C(--$02)ZS2G3++)L=FY8X%H$3H1SCS@
M/MWKT$U.%W56P\XF0=*& )G-F[$C@</FSSI@[/B5L6/^(7!RX@>-+0AQ\:)T
M$AP4M;!.[+TRA].>W$=!- DUUBF?Q;5Q]C#P.!P$+:P#^XRY;_N,"3A8VUR?
MA%:(MUC4)(+3Z,(:XSX)3G'V$6G<^V2C9CQ)6!%@4\S+W^?[<3("05GH)IP\
MH5F*I Y.!P6O)#9P7.UW9Y/G>_/#?R.NX;A1&,.<8]VR?IG/U;V".,1]$E#C
MY). X_D@!.-4\DRX/VOSN6^$&XK+>#;859XM(EN:XE)L,@7;UO;RK$EP%'LJ
M?+'0!<]I@NYU*, .792"<T$ACGVE),40)&YPHEF#K$7V*,:4N<\8(R2S3Q%H
M<>(P^P][:98F'QQ<OI^UC?Q@>T**FLQ)GI5[#=8X@FW(8):U[UZ#9@%$I-#@
M"_#& Y+R"%0DE D\L)N(I-;_8>]D#V4M8/LYQ81 %N&- AA\AS1OUN!Y<VT*
M%OALUAQV ?^+("CT2<GE D6(!.GV^?*#7>$T#7R)VH0B?D10[L>]/Y(&!&[%
M@A]%$Q4^!7:(1 #[&_L<^QVVU?7)L!7X&\P_&CU(V%#<P!RHE-,)L$'X:(C2
M%*!AWT@.\WU93^[WQ0ZRK[#W,#84$C&^\3=;( I@#^SSP"X@)(4N#L@*^SZG
MN[F^*?.Y-E^=RA@AJ' _- LCD#/FC+W/%V'^<>HL@@+/A'E+PR6?$V+?I(@!
M7QD?'C^;.,V])^M[N/?$/FKM+84T^+_LMWDU/)/\8,TR?QD'A'=LL[N/<Y\4
M72'2L&=08&<3Z'&?B-.IB!'<>4'A4]+[1RAW;1*?P[,-U>"#_T6BBC'F=#KB
M"CM/^-XV]L%/Q([1Q,ZZ9+QJBM^QIX6*=1E+]O=*@5AQX<*%WA/\&"M\9.9Y
M*<$'Q?^@:!A?DK5+;(@?05*0^\*WL,^1O8:X Q^4=46LPK/$=N=]@B[Q'(4$
MZ /$'L31UE>V]\@^P7[!/7)("0(I<X13BN)QMGW3J?7U61?X%DGVZE) XHUF
M>-<.X#N&+)(E7L:?=*_!X1])WP99'<Q]/M.]1A9=P_4=2&AC1ZU^Q5YD-1C7
M=V!?(+F.%L@<8M]%TXL7CN-?<RB*ZSN@4_$L0L)U218Q7WU)3F*P/./YO&"O
M1M-T]QSBW- G$K)^2>:YUV$>A+:CS#$2B/B/[%_H8NA\Q'M6(R4G8.,P=#7V
M>#1QFE=9K\RSO!O-F2L4+#,6K -\:*N=N?:1-8"=I_  W2CKZ;<AP3=Q8_C1
MHT=7.:S!-CP21^-KL5_%?2V> _$#SPEMA08,?*&:_(Z0^0<[9]#)K:[.6N<9
MV'NU>AEY$_8SJ^GQ;-B/T-M*[1<4^_V(Q_%1XTW4]F1E?$(W%J[IAZ)4DJ38
M<?0M<@RLHT(^(,\9G[(FN\Q\89Z7*N>"+T02E@)XJ^.3,,?6$^_E<:A;3: %
MH#<QIVB<Q#8QMG%- 3^/^4F<PAY$G(T>3=S%7$;W2OH6R;B&$_<UR,6$]#6
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MXD 9$G !              "@4 (N                %$K !0
M    @$()N                % H 1<                *)> "
M      ! H01<                *)2 "P               (42< $
M         *!0 BX                42L %              " 0@FX
M            4"@!%P                HEX (              $"A!%P
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M54S"6J:8@J)L!&NY!.[C%KA@'TE*4'P3-J!;4[*"A \W0.=2?$=?8;\H(B"
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M*YQGV*^I\N=LP=Y[[YU]/H:WOO6M2XD#U*@+"@H*"@H*"@H*"@H*5A=%X!)
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MG8]KFX2#J#HWO%=$"&0 OGCM)R640(!M_K?-#Y*F]9HBL'L6R (1F;HF-RD
M_?JO_WJU+JT]]\I&68_V3FW'?0]_1:R4*N;Q#]===UVG?R'HBNR9W\Q?C ';
MVQ6/(-N-B4=T%D9$C_R%-9=#^+!V$6-3Q%'[%3GK+6]Y2R508\.\#^_%,W3_
MR%($0<BJR!NIW^TW(_FPCWT0"5PB7^&[UZZA.JZW)YT-V!]G%/XQMR/FE$ X
M%V.TD70)7!69^1'W:>^X=S[4;_&;:MLL/F,WVXBB;!A_T^QDOA:>B?=K'S?W
M-@)9=%V^KLLNU!_V1CS2U?4])7")UJ2]XYYOO?76:OVYMN?CX__G?XGF?;_X
M)R4<X6OY.#9[*/B %+&T[F;-[^H&ZUF+BQ2KZW6)\$9DPS;SI<ZGJ>(\>X6
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M-*&);%I-Y)0/G6H"U-3QQRH+7.R]U-0^>\=9<PJ?)IZ1_XQ(W#X:7.2^OY3
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M"@H*"C8/BL"E1X+C@@LN"!^8) ?RN (T$D&4-$(H,HYW+'1'4F"-DE,2%PJ
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M%^\U)11=)8$+(")$SX.HL,_OC4CK=7?S(>_89#5BUBC6./KHHSO_7D?U*(Y
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M4^2CD4C;X/VRO=':Z>-/"0>0GB)"C%A$3'+000>-%I;HP&]"8O,ZIB+Q#UU
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M8IW-1%8<*W !Y(^(<.?[=]]]]RRB3 T$*4*,2"RCB)]3'$/&C.*(;;;9IBH
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M_,$?S/H@?F*2*?;V&V^\<4/<DGZ/><QC*ON^"&W/W!;W#,%__N=_9N_AV:>
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M=[RCBK?$,(]XQ"-:]^4O_=(OK<9O2%ZY-$H+7/[R+_^RBOO;!/>E">T@)TH
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MMKK+XQ[WN&)U%_'+T+K+.@M<-.AD"YK7U!Q.'J)4+"K>9(ODG<6DOJG['G#
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M[#H/VYK A;WF3\V;@_[,/%2O$-O9NU*N,-7R4LV"725$;(LCK0GD[B$GZI9
M"%SFUT?D)1>)].VM&EB4KB$ PC_;.*_IB3W0?F.OS^4AY%WE7U,>0LTH]T[R
MM.SJ/!_@W>]^]]Q3$I-/(N\KQK97^EXIO]BL3<C=S#NI3GQ@_@SQ2_C9;7DY
M[\_GY3.GYS)6QLG>GOPEX\X&SD,(7.;7731@&U-W,9^[UETT_>A3=UEG@8MZ
MB!I,FQ]@CY)#$ ?4_0 QF'@U^0'B5N*W)C1A7=1@U9BK-00"@4 @$ @$ H%
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M74Z4:'8>9-/8MJG\,@4R79R=>, .#.ULZ5L@]O-]$-O&=!?.04'2M0D1FK:
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MUNR\.HMKVN\TQF)'4ISD&N()>V(@$ @$ H% (! (!*9'"%RV.!3J%)<D.B2
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M2U?I@P\^.#[,Q.@C< D$ H% (! (! *!0" 0" 0"@4 @$ @$ H% ("$$+H%
M(! (! *!0" 0" 0"@4F@ ^QYYYTWN^]][WN/Y-/VVV\_.^ZXXZH3*J: $Q!.
M..&$#4DOB;"]]MHK/LS$"(%+(! (! *!0" 0" 0"@4 @$ @$ H% 8 #^#P
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MW@KSY,F3Z.KJBLN7+T=[>WOLVK4K-FS8,&=(D[R_M[>W[(B&?T;@ @
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M[MV[EW[V]_>G 1(         S$7@ @              0$4)7
M     *@H@0L                5)7 !              "@H@0N
M        5)3 !0              @(H2N           S.T'    ___LV[$)
MP# , $$;O/_(=JH4Z1.>P!VHDBKU?PX     GUMKG3'&8_;>CYMQ+^:</@8
M             ,"K!"X               "D!"X               "D!"X
M              "D!"X               "D!"X               "D!"X
M              "D!"X               "D!"X               "D!"X
M              "D!"X               "D!"X               "D!"X
M              "D!"X               "D!"X               "D!"X
M              "D!"X               "D!"X               "D!"X
M              "D!"X               "D!"X     \%\7    ___LV[$)
MP# , $$;O/_(=JH4Z1,>PAVHDBKU?PX         _,!:ZXPQ'K/W?MR,>S'G
M]#$               !>)7 !               @)7 !               @
M)7 !               @)7 !               @)7 !               @
M)7 !               @)7 !               @)7 !               @
M)7 !               @)7 !               @)7 !               @
M)7 !               @)7 !               @)7 !               @
M)7 !               @)7 !               @)7 !               @
M)7 !               @)7 !               @)7 !X"L7    ___LVZ$-
MP# , ,%$ROXC)T4%8065GMQ)1C8R_W,              #Y8:YTQQC5[[^MF
MO(LYIX\!              #P*X$+                *8$+
M    *8$+                *8$+                *8$+
M    *8$+                *8$+                *8$+
M    *8$+                *8$+                *8$+
M    *8$+                *8$+                *8$+
M    *8$+                *8$+                *8$+
M    *8$+                *8$+              0>    ___LVR$* #$,
M ,$6^O\GMZ=.E+,':V8@*E'Q>PX \%IKG3'&-7OOZV:\BSFGCP$
M     / K@0L                I@0L                I@0L
M       I@0L                I@0L                I@0L
M       I@0L                I@0L                I@0L
M       I@0L                I@0L                I@0L
M       I@0L                I@0L                I@0L
M       I@0L                I@0L                I@0L
M       I@0L                I@0L         'P\   #__^S=:XA5U?\'
MX'*RU#2O9=ZM\$64I%964&B()DDXI66A9D'THB"*A(KNES$JPZ+R19)15G8A
M2LFTFX1=+$J*B,BRLA"[-][+2ZT_WPW^_CJ>,S7..7-F]GD>V&"=8<->K+WW
MVFNMSUHI 0    "TG(,..B@=<, !>QW__///7G]SP.X?#CSP0"4&
M      ! 20FX                4%$"+@               %24@ L
M           5)> "              ! 10FX                4%$"+@
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M5:O2KEV[<G?= BYMK\V1YX!+]!4O6;(DFSO6\/HZ=NR8IDR9DC9LV* BY("
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M]0/Q\^)3]F4)G&43,<=4@DN((3;ESU*8L#6?4J=:PL8'/5)WU/< 2X)KT96
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M040Q.590R[EN6 $R1\+M8*D&Y1JD5E./2Y-@>VNZC6:$I6T08$3"6X.U[OP
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ML5,!J@F8.&V$W5$>IRCQE*<\I=)971*X -^R3#P:D3XF9(U%K0V!BYPPPEF
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M3> B2(I&T_L8W;B, IX@IU0,$5!6&0FX2@(7AB0U2RBY\>/9F'Y!%*JC(H!
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M I?^V"!PV6W9 A?QM^:CQ!>(EFU@+UM9X(( 6JK#:+#7=?R:+7"Q?I"K30'
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MAO0F\.:XD:R)9P32=3>8OP\0)*90"*M+4*XJ<+$@$6F,AU-8B^YSWWWW'0<
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M&GHM.L&E+P(7.,L\6S6!2VF]:I20Z1NS!"Y]P)"<F54(I(/ I5\V"%QV6Z;
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M@K'((=/63> B<(^>K_5C.HI.&LO^(.]1M"L4+6+6[5O?^M9Q\.9P=;U%Q&<
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MMXWSY5*,PC<@[HFIQ"B:491B%*0V(NQ;;KEE](I7O&+THA>]:$Q>+G5![[/
M1=QCC4U_UT477=1K?&00N.RR/@M<V(477CC&@*,"C;QA%AXK=E3PBXA^\[I
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MKDV!"S!$E\JH$PC@ID]Q%> M(CU,.MB_\(4O'!.CFGR'3AQ-!"Y\4&GOZ(H
M@,ZRO@M<Q(/$0Q$8![CG"Y'<FCP3@*+S?A"X5#=%TA) ZK=F=OO/$+AXEB4
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M$+CLM@R!BS5NK4<%&,+?OA'+!H%+^Z90^-K7OC8$:G5WDS-W8?*3$LD069W
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MWJ8!],6J-;B ^6(7VL;5_A!/RMMVU92,I0-U^(VV NVA#2ZIL+0M1^]@'CR
M'Q^B@:5\!;]L[?/A0PZ/6^4&%^^>*V*WON0:YO& E"^C)2SS@-4FHL'E?RC1
MX&(/MA7&TG#Q\#[SGVIE%'V*:=L*X#=2@PN-@KXR+P_C(&.V=BWS,"4:7!Q2
MVZ8QXO3>K0\_2IJ4^.+RE[]\]B#1S;7!Q=X1#[3%_^*<ODW@]JZ8S_IHN]UA
M*._HPCG8EKZ<0ZZG"^<HT> "8N_[W>]^FWP/[X];YP[)I/'(-Y9 R087F@D_
MTQ:WV$]T67:L3S-%RBF9<S[A_>]__\Q>=?WWN(8XI\U6B W5)HS5)\RE\?S(
M1S[2Z^#FM<"\!I>4'[/'<=XN/C<=$*\9I<V'IT-XQ7)]?$.7G N]?+WD7*9J
M<&%O:4B+:C[D-(;4?+3ET-.>Z'-["RRCP84.0[]MLSG^3LW=4*W$7J"5.+3V
MC6]\XTS/*W&XR"IA0S>XV%@$Q-SB8J!*!U:+0*!B -L2 FTGD)HP GHN</,]
M!#>O>]WK9@2<.&1C^>XV */AW_NQB?P9X^_W)% >\I"'9(LR!1VIVWR,X#&T
MP241144A.2.J\.D>][C';(,O<WT1"^<13N]N##A;"1H.DA$R%^8D=?TR<H(>
M!(1CF.<XQC2XF/.VCN'4-<SI6ZO>R;NE-936C^_ $0E0.?MYSFALL8=B1 F%
MMB0R8NCV(0X/"40&TJD-]76?3JNQ]@6*1#T-2@0M!5=(NV07<K*(2'H6X:!9
M7&!,!<?FQ2GYB*YQJK]3FO<T]_[<?D7>)!>=2)A+2G"2.D*[-N D"#;: CC)
M)04_UG%]CGU_[Z283*.5QAW!U2*24K+!!8PQT7]>829[2DQ X%/A6GV,C;GO
M9QZ0"6M_WFFLB@8D1/N2RE5H<#$63AYKVI9DZP52FBGL#7O$/D_[/Q$P_TUC
MZG?X!T%WVVTXQE.2:E% HJ!XGNT0@)8*G(=B&0TN8"W:^[E"HB0X:+ 3*/,A
M?")A*F=OV&]S9W_C -:G K-;W_K6L^<3N@0N7=>_YQ'=<AR"/<1KK#G\A>UB
M[W*<Q%KC[[V/)LOK7__Z"PNRAS2X^.YL_+S"%OO#<S5ZM/GL9+<%HMZW[::Q
M]=C@XOO8L[GUY#OP:VDMY6QJXBQ\J?&QO_&TRUWN<IW&(!I<%HMQA,5Y'!#G
MQ-T58[/#]GM]7R4;;4]):FM"FU=(,5;\()XI=IRW9_ER#=9X4>*6.5_MG7%+
M33.+]JD8;DCA$W_#;K>M5]_#J5&)5Z:$9HZ_V2/>0?Q%G+$/\#7%*?Y]']%!
M,<Z\TYEP+&,M06VLZG8I<3?OXYW]GA.NNL02T> ROL$E<2RVL\U76U=. <0Q
M<7Y[-\7J;;[:7C&FN!8!W;KDI]-I67U/]%SE!A>VHZU07M*%;\=_T@$#:2Q3
MPE-<1E#GVYM-<7X7_W"":JX(V(GEA$2)J:2SL+LYG27Y1[\GJ?V !SP@FT3$
M:^D#0QJ52B,E]=ML.%LI>:90P!KR_>?Q.6O;?(GC)/45Y[#GFF 7K5ECQR?G
M;%<Z<8VM[,I1--_BH>+%+AQE%1I<@/\7T\X[!1R7T)AD+28MHCEG.7U$80".
M9<X]GXY HQAZ>\Y4#2Z@ 'K>W"KV].YT@J8O;^Y78R5!W7;+VT9K<+&7O?.B
M1I^Z5B4Y-]9'BWD7%0*)8Y99A,'^M!7/L^UN"W180XK)T[Y+_B9Q7G_O63C;
M'>YPAX4%+!NEP<7XV(_S;@:W+G%NQ9#V;W-_US5V^Y^M4"31Q0\LH\$E\1"Z
M=FZNK \'CPWA(6TW>EMO"M?[\!"_RY>W-:#1A!PFHEE+O)+>LQFSI/EA9ZQ1
ML0M_+7>G^-CSQ1IBV"$%WHK-\:^V1#-.8DPU!7C/I%,M>D^_*S_!!CG]W?/%
M;GA&7YM4NL$ES0_?G_O>?)L\S[(/#=KH#2[6.OXV[R O_L4ZH.,T.7<S)T>_
M?\0C'M$:FX]M<$FY7C%L6YQ ]\ ;%5QXIWH>H6Z;["_[!">E^8B'<2EY;MJ,
MY[/K?0\;2UC4X)+&EH8DW]FFH_DSW\->5U@_;Z[8*O9@"/?AO^9QSG0SEGUM
MO-IR_/5Q]=Y\'MM&3TLZO3QCW]SY*C:X&!MYWGG\@>^C22@JS_&'NJYFC1I+
MC1Q=^$/?!I=4]] 6^R;=$Q\7-_7-]] H<0>^'G]4/\)'],UWKG*#BT)4W[\M
M3L0/<8"ZAF1LK0MZACH=\R->6R^G)D>#R_]0HL'%GG++5\[6\TMT5QHB_\V_
MM>4&K"/[SIISV*@<3!>[L1$:7!+O9=?GY6%HAPXH:>9A4JR4R\/(1]*#:.3X
M2)_;ITLTN(@-VFI7_)EXA#Z>]/]DN^NZ )O.;GN60]SPVWFU*YMK@XOQH*&T
M%97SA_*Z29->I+/@0^KL[)DN-09#;H[KPCG239I=. =;TY5SE&IP,69N86X;
M]YP.HVZC5 -%R087H(FJZYB7WU#')8>KKJ-+?@,7-S?VIE@B'3CK[[K"VI;+
M;XLK4HTO7I)TE"[Z!'LI'A0S*/ 7FXBKY+Z''K W!18UN*08@Q_@9]HTOE23
M0^_1&#FO<<U:E4<5TPW)N:B76JN<BR:\H3F7J1I<TO[$EQ?5?#B(L6O-AQO1
MY]D;MA[7[6MCEM'@ FS#12]ZT=8QHHE;_YI4DE;2):;G$]CF!S[P@3.MA^W2
M+.PY&^DFEPW=X&(A*/#)+2Q"M%-0UQ+(MX1 FQ/;:Z^]LD7D#  B-"_!:.X4
MO3G5S@F5"LD4<RCJ5J@N8<*8$V<(\!QF&P'S+"?&,R1C!8\Q#2X@"" HYPP$
M,J*Q9YE7K3,H$E&+3DHB7 J*-0P0<8FV$E0:3A0M$; 9X;;"J%(-+HSDO(+T
ME*!F+!5YN-F$0_>NYH)119@(3&VGS)BKW'P-+?8@*.D6GY?T-;Y.\D,.B&+$
M)P*[]S;6')GG6/OFRVTUN;&V7OW;><T<$K@28O,<N[UJ?1HGW]O^5>S(YB!@
MUHUW(E*R"83\-D'3YR#F1)*^$-@K!FI[+L&"\",@\U[&RIQ;6^G4;]]%(]>B
MYIK2#2[FP+Z85XB:QEHBU#@+7)%Z"0MC;,PUZ"#'BTX^$  H;AMRHM$J-+A(
MD,W;]VGOVVO&P2T!QM,Z]6\%8OYK/B4@[WG/>\YLP#QQRG,6$2[SW"8J-:^3
M7":6U>"2/EN":EYRC0\24 BP!16"03[?&L0!^!J<0''M/OOL,SO!+K<>$&9!
M?E>_2E@22,T[L43 1N#5C%;G)/:J!AD^17"CR#8W]_9X[KOW;7!)@@*!<9'/
M9B\$L@HM"(S\'W_"5@H0%2^QVTT_D&SF>FUP27XAG0Z;>T]"ZK6O?>V9326L
MX  $7C["_^8CB AX9,XF>:[QS8U#-+AT$P^,_Z)"-_N%F**P6P$3GX?W6*_V
M.>%-DUESGLU+&W\9(GZPX7BEHH)YO,CW40S$KRM\2O;)VB((X?/L7 K:Y_DI
M-L=^' *"TNZ[[S[W),XDK"G24@S$3FD(QBV,,3$*KR-0X/;L1?.=-:O[_:XG
M^A F\=AYMLD[L4MX&QO/)]N7QE*1C4(PL42;KVBS3='@,K[!!;P;'SSOIB1[
MA'@IB6K-BZL(?/:"/<S&BA/%\4]XPA-F:S!WRI.U8/WUB8%7N<&%$,KOY&R#
M/[,F)0L(BRG^$\_ALF([>\+O$6;MF3H(S1I8YME<\R:188^*V_ LMAJG,6^>
M:1X=:"%Q;][:X@[OP5XJY%X/L&X5 ])^YME>MDER#O_1-."[&V<_;! [:;S%
MV4[?:HXGCJK(9M&:%;N)*=O>Q=K7D"-A@Z,8]\11<%W^Y5G/>M;,5N:N"I_'
M45:EP07X('K-O'6+Y^-["E/H($U]Q/^GF_!S;)(]FM-'% ;Q>T-NS9BRP87P
M+QY=='B%?>L[TBOY<FM%#&*_6BMBHK8$B_'-K<7-O<$%:"AMMS7D;E91>#<6
M]O:BIAICN<Q#CN#1CW[TW/<4'^V]]]XSVXJC)RTE\70^7E%6VZV-?$Y.&]P(
M#2Z)J[/'\[2/-![\!8W7GDS[&Y>BL;/1"GN;=C+Y@?72X(*'6!-]> C>@H?0
MB)L\1&R;XI,V'H+[\=E#DOV>O2A>H4'C"VX4X]?3W-@+]!3OZ?/M$W.4L\%\
M$KXQ)(&;N,2\?:J9SF?3)\3 BNKX1N^)R_)[= \YG <]Z$$S#ID[V"45R?9Y
MSRD:7$"^K^WP%3$B/[C,A/A&;W !MDD^:E&Q'2[]T(<^]&0-%7>S?]@Z&J4<
MAQ@Q=^)RV[.'-+@ F[(H3I ;,%:*3>41[/,4)\B#V5]T*VO?N\LWY?:GFSF'
MY&2Z-+C4?9.UZ' */EH<0:-F-]ABQ5 Y?:?)#]4;]#UPH@ZY^T6:E'>EE>-D
M]'RQ3M+0V'SY&?$5'8C^E--I?(_'/O:QO72#56QP 7E+6O$B_D"OP5W5/=!C
M^"CC:DR3KH9O]N$/0QI<0$&8/;&HF8I/Q!W-MWFWK[PS;HD+B,6M$QR!_\LU
M4"D ]SM]UL(J-[C0OVA$;1J27"[-C5W%I?P86S:/STSVE$U8#P>30#2X_ \E
M&EP U[2_VFR^QFC:DEPI.YQJ.]CAE!O W^R[W$%=UI#]G>/Y&Z7!16QG+R]J
MW.!C^%:Q'=N#E]?S,(J Z>#T*6/=G+-==]UU5K3>1;<JT>"2./V\ ]KH*;@-
M?B'W)<;PG? .W @7P0?<V)+C1=8/'Y!;GYM3@PLH^L5]V_9B.DS3>.&4UH2U
MD6I6K$\QA;Q_V_S:A[F<S1#>L4S.4:K!)?&0MB+Y7$VM.HZ2.?"2#2Z*Z^4$
M\.=%^8T4:Z6UE/(*;#Q;O__^^\_B!6/=G!N-Z'Q-'SXEYO"]YNDHM :'2-(;
M:>9U?<(:]Y[LO7R26F)Y]MP!07(%8L[U4@C?I<&E7N?)QB<-W_<W-[@NKDAC
M,B?SQI'=%&\;@Z&W?Z]*SF7*!A?OPQ\O:MHU1C0H7(A^-K;FHYFW[8)E-;B
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M'IJ^QL3*^$8SQO1\!0"E$PEN*G78S)"DDWG$Z=T:RX:QWR"QK@FPJ6_@N7W
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M+/XK'JG/O?]-<Q[+.<2;8SF'^+_..33KYCB' YM* U\T-LT\KL]SH&WI0P1
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M#@0"@4 @$ @$ H% 8*- HE22Q4EBS=A<@G'*@Q(4KCBYK/FY3GY3*!*-O(%
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MY_GYV3@     F2B52B?G._O]_N@WA>\'%Q<7%H,_9C*9_'A0.Q@,C ,
MG-7K]:)2J?QXOGBX#[BZNHK9;!;O[^_& @#^/($+    0/X$+I Y@0L
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M$K@               "0E, %              " I 0N
M)"5P 0              ("F!"P               $D)7
M $A*X (              $!2 A<               "2$K@
M  "0E, %              " I 0N    N?@'  #__^S=6XC-71\'<,;Y.+AP
M2%$2!I&A*"[DPEE*+BAQ@Y'3A6/*E5!R(413C))2R#$N*!0Y'R.G$%(.D],T
MC,,8OZ?_+E[,S/,^KV;OM]G/YU.KF6;OUFK_UO3?ZV)]UXH           #(
M2O7KUX\Z=>K\TKY]^_;+>^I\?Z%NW;HJ!@              0(T2< $
M         .#_2L %  #^!^_?OX_;MV_'A0L7XOSY\ZEV[=JU>/[\>5K&2Q;G
MGSY]BN+BXGCX\&'<O'DSKEZ]&I<N78J+%R_&E2M7XL:-&_'@P8-X^?)EZKT
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M^_?OKS)8,F'"A!KI/PFW)#>;)=^7R7/^GP9;?FY) &?JU*FI&V
M  "@-A!P 3)J]^[=T;MW[VHWY/;MVS<.'CRH4#_9N'%C=.[<N=J:)3>YG#]_
M7J$ ,B2= 9?D%K-[]^[%[-FSHU&C1G\4;DE:PX8-HZ"@(,K*RDP8
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MXLF3)_'^_?LH+2V-1X\>Q8D3)V+ERI4Q=NS8&#IT:&S>O#DJ*BI,%@
M     +6&@ N04:=/GXX1(T94^?!)_C9FS)@X=^Z<0OWDT*%#,6# @"IO<4EN
MO)DZ=6K<O7M7H0 R)!T!EV0!?OSX\>C3IT^5-W4-'CPX]N[=&U^^?/G;?I+0
MRXL7+^+CQX\F"@          @%I%P 7(J&3#;5%14>3GYT=N;FXJM)$\B)+?
MDQ#'CAT[_FA3;G%Q<5RY<B45H#EUZE3JY[5KU^+-FS=I^RS)!N++ER__,N;U
MZ]?CW;MW-3K.AP\?8O7JU=&K5Z]HWKSYCYJU:=,FA@P9$D>/'OVO&YX!J#GI
M"+B4E95%86%AI<5YLOY.GO\[=^Y4>            +*:@ N0<4E@(PEES)T[
M-T:.'!FC1HV*^?/GITZN3S;X_HDM6[9$ERY=4L^I[\^KGCU[IC8AI\OZ]>NC
M4Z=.OXR9G+R??+::5EI:&GOV[(GITZ?'\.'#4S?=+%FR)"Y=NA2?/W_V3P60
M0>D(N#QY\B3FS9M7J<\F39K$S)DS4S>S            0#83< &RPJ)%BWX$
M3;ZWG)R<5 @E70H*"JH<<]NV;28$((NE(^"2W$(V>O3H2GUV[=HUMF[=JN@
M          !D/0$7("LL7+BPRLW&Z]:M2]N8,V;,J'+,HJ(B$P*0Q=(1<#EY
M\F3T[=NW4I^#!P^.,V?.*#H           !93\ %R H"+@!D2CH"+H</'XZ.
M'3M6ZG/,F#'Q^/%C10<          "#K";@ 64' !8!,24? 9>_>O=&B18M*
M?4Z<.#%*2DH4'0          @*PGX )D!0$7 #(E'0&77;MV18,&#2KU.7GR
MY/C\^;.B P          D/4$7("L(. "0*:D(^"R<^?.U%K[]SZG3)FBX
M         /PK"+@ 64' !8!,25? I:H^!5P           #XMZB9@,M?
M___LG0G4557=ARTSA(P9!$)0T1@,431!01!11$302"D#%,R(T40"1%*$$G&
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M%(>X@@M[=B[WJK9MV^K_W0@AA!!"""&$$$(((8000@@AA!!"""&$.&.1X.*
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M3!(']@*D-]?!3'4)*EEE S*=:QTCINS8L2/C/L$Y0,4OEP#(WW7HT,&>6]E
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MZ=!KV;!A@^]SS_G<+K[X8O/-;WXS[GK_^,<_.C\?Y+/GX]D#
M     ( +4<H'7%28Z]H)VBZ__/)/K<CYU5=?=18V:VO6K%F)K.N?__RG6;UZ
MM7-.'?L;;K@A[A@$7+P(N'@1< DO50,N,FW:-%.K5BWG=2DK*\L&-510'R]D
MH6O<6V^]9<^S:M6J.==VTTTWF=S<W*2X/PT>/-@9P%1P8M>N7?;[Q#-[]FQ3
MOGQYYWWDV+%C@==2H4(%WT! F''"\ NH:$M+2ROVYPFX>"E(-G_^?'MMJ%NW
MKC-0%F33N:9 FLX[_=;"!)_6KU_O^]QSOK?.G3O'72\!%P
M    HD? )4; 1075*I#]-*B#B]^Z]%;_#S[X(/(Y]2;_YY]_WK>#BXK5XR'@
MXD7 Q8N 2WBI''!1%Q*MN4R9,LZ02\>.'<V33SYIMFS98J_I[[__ONU(I6N:
MKN'OO?>>>>.--\SRY<MMYY9*E2HYUU6E2A7[VR].]XF2L&K5*M\@SO3IT^/>
M!_3]>_3HX0PK_.QG/PMU?_/;9]K>???=$OG^"EWXS1DDI$+ )1P%IO1;FS%C
MAKW>M&S9TE2O7MWW6<1OTV]2'7\4T-JZ=6N@()8HX!)VKI+8U$4FR+V>@ L
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MA[[^]:^;39LV!3H_-F[<:,_-HN,H7*5QNG;M6N*;PBE]^O2QW6SB(> "
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M?OOM-NQ2L6)%W]^9GJ6RL[/M[S>6[=NWVR!5T<\W;][<;-NV+>E^FP1<
M              "(7LH'7(X>/6INO?56WU#'M&G3/I5U'3APP'3OWMVW:%9O
M4H^:WK#>IT\?YYQZJWJ0H  !%R\"+EX$7,(CX/*?+E/Z;+MV[4RI4J6*'6Q1
M4*-6K5KVNJ1KJ<)]16]\R4+KZM&CA[GDDDN<G2T4-G"M?=VZ=<[0@>X?;[[Y
M9NCO.V3($-]]_L ##\0-+Q2'KBU^ 1>M)YY8 9<HPTRI%' I>FZ>/'G2K%RY
MT@9@6[9LZ3Q/=;P4@MFU:U?,\10RZ]RYL^?S]>O7-XL7+TZZ[T_ !0
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M8;D+(>"B[_;44T_9,'3UZM7MM4/[4-UT)DZ<:-YZZRW^)00
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M,6/,/??<8T,]"L6XGJ-TCNG:'*9#4+('7'2<XUT[U0%0(2$
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MUT.M22$SU_'JUJU;I,\>VHKS[+%FS1K3MFW;F-^_08,&9M:L6?QK"
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M/YQSSCEG92<U-C;JUU]_U<LOOZS)DR<K(2%!@P</5O_^_=6K5R\%!04I("#
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M-FPX[7/:-7CVV6=;G=/F?;NO3H<]?UANBXN+<^.[N4]L3$^9,D4;-V[D?T(
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M6;N[=NU23$R,1[LA(2$J+2WM\G[YZZ^_E)J:JM#0T'9C7+APH8X>/<H  @
M                P!F) A< @%^9,6.&PL+"/))3?GZ^ZNKJ?-9N=76UXN/C
M/=KMW;NW=N[<V:5]8K%E9&3H@@LN\(C/#MO5I:*BPB.! P
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M[-BAIJ:F3NV#O7OW:OGRY1HP8(#+O6WCLN0]<>)$[=Z]N]-C P
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MHMSN+KFYN3IX\*!'(NP,:6EI"@L+\XC/OO?HT:-57%Q,<0L
M      "Z+0I<  !^K;*R4NO7K]><.7.4D)"@BR^^6$%!0?]W84MX>+B&#Q^N
MB1,G*C,ST^W:TM#0T&7?L[R\7(F)B:UV<;GHHHLT??IT;=VZM4MC P
M             'R- A< P!FAIJ9&7WSQA2M&24Y.UI@Q8W3===<I-C96 P8,
M4)\^?=QN)U;\8OG*=F:Q?_?JU4L1$1&*CH[6L&'#=,LMMVCRY,E:O'BQ*YS9
MOW^_&AL;_>([%A04N*(;^QY#AP[5TJ5+77Q=L:,,
MT)DH< $ G'%J:VOUXX\_JK"P4&O7KE5&1H86+5JD^?/G*R4E1;-FS7*'_3L]
M/5W+EBU33DZ.WGGG'6W>O-GM"M/4U.1WW\MBRLO+T[QY\Y2?G^^^)P
M             ' VH, %                        78H"%P
M             '0I"EP   #@Y_X'  #__^S;L0G , P 01N\_\AVJA3I T_"
M':B2*O5_#@           /!O:ZTSQGC,WOMQ,^[%G-/'
M>)7 !0              @)3 !0              @)3 !0
M@)3 !0              @)3 !0              @)3 !0
M@)3 !0              @)3 !0              @)3 !0
M@)3 !0              @)3 !0              @)3 !0
M@)3 !0              @)3 !0              @)3 !0
M@)3 !0              @)3 !0              @)3 !0
M@)3 !0              ONL"  #__^S;L0G , P 01N\_\AVJA3I$Q["':B2
M*O5_#OS 6NN,,1ZS]W[<C'LQY_0Q                7B5P 0
M    ("5P 0              ("5P 0              ("5P 0
M    ("5P 0              ("5P 0              ("5P 0
M    ("5P 0              ("5P 0              ("5P 0
M    ("5P 0              ("5P 0              ("5P 0
M    ("5P 0              ("5P 0              ("5P 0
M    ("5P 0              ("5P 0              ("5P 0
M    ("5P 0        #@*Q<   #__^S;H0W , P P43*_B,G105E!94>]$XR
MLI'YGP,   #PPEKKC#$>L_=^W(Q[,>?T,0               #XE< $
M         " E< $              " E< $              " E< $
M         " E< $              " E< $              " E< $
M         " E< $              " E< $              " E< $
M         " E< $              " E< $              " E< $
M         " E< $              " E< $              " E< $
M         " E< $              " E< $              " E< $
M         " E< $     _NH"  #__^S;H0W , P P43*_B,G107AE;[@3C*R
MD?F? P       , OK+7.&..:O?=U,][%G-/'                ^)3 !0
M            @)3 !0              @)3 !0              @)3 !0
M            @)3 !0              @)3 !0              @)3 !0
M            @)3 !0              @)3 !0              @)3 !0
M            @)3 !0              @)3 !0              @)3 !0
M            @)3 !0              @)3 !0              @)3 !0
M            @)3 !0              @)3 !0              @)3 !0
M            @)3 !0#^Z0$  /__[-W):Q1- P=@=W%%Q/4@047\"_3JU8/B
M<HE&-"Y$XVY$#^(2<3L($A -N*,B2B[B$L$M*NC-FRA!)2J(H!(5#VX8ZZ4:
M(D[2'C*?7WHF>1YH").D**JGJ[NKZU<= @            !T$WWZ] D]>O3(
MV7[]^I7S-SU:?]&S9T\M!@              P#\EX (              $"F
M!%P               #(E( +                F1)P 0
M(%,"+@               &1*P 4              (!,";@
M  "0*0$7                ,B7@ @              0*8$7
M     ,B4@ L               "9$G !               @4P(N
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M[U6WW'*+&CAPH+KFFFM4GSY]](OQNNZZZ]2H4:/4].G3U>]^]SNU?OUZ=>#
M 9F8&<=G/_O9(];!__[WO\/><Y3YCT]]ZE,R8I^ 0=JS9X^:/W^^&CITJ.K9
MLZ=JW[Z].O'$$U7]^O75L<<>JZI6K:H'F''[S&<^HZI4J:*J5Z^N_[]ERY;Z
M_=V[=U??^][WU(P9,]2Z=>O4?_[SGU2N=]>N76K"A FJ=^_>ZK+++LO;Z_++
M+]<&Y8DGGLC4\]V\>;.ZXXX[#ALO[F7PX,%JR9(E>;T6C.W(D2,/NQ9^'C9L
MF%JY<J4LQ@+BN]_]KM69^/G/?YZ)Z__:U[YFO?[?__[W)?.,]NW;I^W/K;?>
MJK[^]:^KL\\^6YUTTDFJ8<.&VA[GVNG*E2NK8XXY1M6M6U<U;=I4M6W;5G7N
MW%E===55ZJZ[[E(OO/""^O###V7RERGV[MVK&C1H8%TWS*$33CA!!JE$0?!C
M>^[8%8% (!!D"Y_^]*>M-CT*/OKH(^TSVC['O.K5JR>#+8B-?_SC'YHKLLVM
M;WSC&S) @J+%TT\_K7[P@Q]H#BV7'QPT:)#FU/*94%BX<*%.*IGKX=_1HT>K
M+5NVR,,J,3SPP /J<Y_[G-5N_NM?_Y(!$F0.;[WUEIHX<6+>\SD5Y7JP\=CZ
M(/SVM[^UKL5O?O.;13G6]]]_O\[=^?GU\,4DS@4"@4 @$ @$@F+'5[[R%:M/
M^^233\K@"/("V_RC#J?8\,]__M-ZK9___.?E(0H$@M@0@8L[4)NY8L4*-7[\
M>'7EE5>JCAT[JC9MVJA&C1JIFC5KJFK5JFG.CKP_KTJ5*NG\0)TZ=523)DW4
M::>=ICIUZJ3_=LR8,6KQXL6ZAC17&.$*\*']^O4[(C>6]NN**ZY04Z=.5>^_
M_W[)S@41N$3$?__[7[5SYT[UDY_\1!<5M&[=6AUWW'&!A2U!+\;TZ*./UH74
M+"J49!1CNRZ@?OGEE]7QQQ^OOR_NM<9]83Q0S&4)), 1(GG'BY\IB$=8DD_,
MG3M7%]OG7DN-&C6T 184#B)P*5Y0O#!GSAS5MV]?+5*I5:N6;S%CF!=.$3;T
MG'/.4?W[]U<+%BQ0[[WW7FJ.CZ X@2K\6]_ZEG6.,+]:M6HE@U2B$(&+0" 0
ME Y<"5P@R(+B_,:-&\M@"V)#!"Z"K +.C*8_?OQ@UZY==5("?C4?('XGT9&;
MJ%ZZ=*D\K!*#"%P$I8;5JU?K1BJ%R.<$^;C8>$0N0<B:P 7[$21>)W\W8L0(
MF90"@4 @$ @$@J*'"%P$A88(7 0"03E#!"[)\<$''Z@__.$/>BQI8D[]MDW@
M$/;%WV+;SSSS3"T&F35KEFXLY#I'U:-'C\ &.FGRM<V;-U<[=NPHV3DA I>(
M"^C11Q]5EUYZJ1:DX(2YGG 0Z6><<8;N:DC"UU7Q])___.>")4/XWF[=NF7J
M6?_ZU[_V'2].<L@G.-W'=BW\CA-E!(6#"%R*#YR"M6C1(BVJXZ26-)P'BF.^
M\(4O:.7MLF7+U,&#!V4QE D^_OAC]<PSSQQ1(&6<8HJU!*4)$;@(! )!Z<"%
MP 6?P,^7-@D;.L((!'$A A=!5D$L'A1/<XHJ7%:^3E"QV6KX-!(D@M*""%P$
MI0;XIV(2MWAM*)T(@Y U@0O%?J>??KKO/;=LV5+-GCU;)J5 (! (! *!H.@A
M A=!H2$"%X% 4,X0@4LRK%FS1MUXXXU:C$(-O6MNE%->$(.0-V(<]^[=Z^S:
M.3&F4'PMM0_;MV\OV7DA I<08$!0.8T:-4J=>NJI>K+GHQ/6>>>=IX\0<K&8
M$+@4,O%QX8479NJ9(W#QNQ>Z]^<3G!;D=RT5=4L3I L1N!07]NS9HZ9,F:(5
MO @0TDX"\QWMV[?7Q^'MVK5+3G,I$[ GD\BW%6J)32Y=B,!%(! (2@<N!"[X
M?73_MYWB@@]*MVT:5@@$<2$"%T%6X9=T\;XX0I[D 8V$TL97O_I5ZS6(P*7T
M( (70:D!@4NQB5O,BP9P0<B:P(6NC<.'#[>>XL+I+8@W7W_]=9F4 H% (! (
M!(*BAPA<!(6&"%P$ D$Y0P0N\4"NB/NZZ**+5,V:-5.O]T0P0=-T:OQ>>>45
MW=@R*6B47DB^5@0N92QPX32 C1LWJCY]^JAZ]>KE=>+Q<)HU:Z:&#AVJMFW;
MEN@^"BEP8=YT[]X]4\]=!"Z",$A#X,+I(YS@=,DEE^@7"<.1(T>J39LV.;_^
M4A*X;-VZ57>!;=*D2:*CZ>*\&C9LJ!W+O__][\Z/L!,4'W!LERQ9<L0I;@A3
MY\Z=*P-4HA"!BT @$)0.7 A<O&1;ERY=--F&;U"[=FU-OCW\\,/JHX\^*HGQ
MVK=OGYHX<:*.2TR,PJFF<^;,D<F4(D3@(L@JP@A<X DYKOW%%U],_7I$X%(^
M$(&+H-3P[+//'L$]%<L)+KU[]PZ\]JP)7,@!DLR&@Z?;(K8$80N)[B%#ANC<
MFHM$MT @$ @$ H% D#9$X"(H-$3@(@B#-]YX0XT9,^:PO%/__OW5XX\_+H,C
MR#1$X!(=[[SSCAHW;IP^=*)*E2IYY3EKU*BA+K[X8K5LV3)U\.#!1/=12($+
M=;(B<"E3@0ND]4LOO:1Z]>JE">V*COJI6[>N/JF$(NM)DR;I8\M_\YO?J/GS
MY^NBUUFS9ND->L"  >K\\\_7[P^3,*!(YMIKK]4G!,1%H00N7#_W>>NMMV;J
MV8O 11 &:0A<;KCAAL.ZQ;&&$-<M7+C0^?67BL#EM==>TS826UF1BA<1 B>\
M\.S&CAVKG<AY\^9I.XV]YME-GCQ9"PL9GZ9-FX82S)#X?/#!!]6! P=D890!
MV(_I.NR= _7KUT\L1A44+T3@(A (!*4#5P(7@,B% FT2A!#O?_SC']6Z=>L2
MDV#%! @Q3J3Q^MF5*U=6G3MWELF4(D3@(L@JP@A<3&Q^YYUW)N(ZPT $+N4#
M$;@(2@WDI<XZZRQ?W[50N9X&#1IH^QV$K E< "(73G+A%$:X<;AXDMLT51)Q
MBT @$ @$ H$@*Q"!BZ#0$(&+( Q6K5JEZVN\>:=JU:KIYFH"098A I=H(#\T
M8L0(U;AQXPH;_6 CVK5KIT]:OOWVV]7,F3-U/3Y-)ZGWI$Z?>L]APX;IO%"+
M%BUT/KLBOI/WG'ONN6KERI7JW__^=^Q[*93 !>ZX4Z=.:O?NW26[KD3@X@.Z
M\%,TW;-GST!U& .(@HS%1E! ,0L%("3.*&J!&&= (<$I?,9)HE#A+W_YBR;*
M$;Q<<,$%@=_!N+=LV5(]]]QSL>\G2.!")RJ*<=)Z/?744YD[PET$+H(P2$/@
MPORRV0 V8]<H!8$+B4>4_!4=48<S1($8"=;5JU?KTU:PQQ0E8I^QT]CK#S_\
M4.W=NU=W#%B_?KU:NG2I7H,4L:/<]?N.6K5JJ<6+%Y=,IVY!,.AD[G5.*U6J
MI%7=S"%!:4($+@*!0% Z<"EP*0?@-]M\X%:M6LG@I @1N BRBK "%UZM6[?6
M0I,T"X=%X%(^$(&+H-3P_OOOJ^>??SYV3F;4J%&^]K=]^_:Q/Q?^$S\E"%D4
MN @$ H% (! (!*4 $;@("@T1N C"X)EGGK'FG6@J+Q!D&2)P"8]WWWU7GZ9,
MD\6@!C\TV[GZZJOU?2..V[QYLQ9S4(>/((4:?VKUJ-.GWO/--]_4]9Z<CHT(
MID^?/MJV!WT'^]3TZ=/U-<5%D,!EVK1IJ=7E+UBP0.L02KE>500N%C  .W?N
MU,I0/^$)8U&G3AU]1/GRY<O5VV^_?<3 5006%PN.288AZ]:MFU4YQN^Z=NVJ
M=NS8$?N>@@0NYYQSCNPP.1"!BR ,TA"X].W;U_J9(G Y$B1Z;[[Y9GU*E)_P
MA-.W2)ZRJ9-\C;.A\ST;-FS0JM]^_?II,4MN!VLZ%^[9LR?R/B#()C@BL6'#
MAH=U'^8D($'I0@0N H% 4#H0@4LT('"QC=>))YXH@Y,B1. BR"JB"%P@I7G_
MJZ^^FMKUB,"E?" "%X'@<'"RH)_]I>@M38C 12 0" 0"@4 @* Q$X"(H-$3@
M(@@#!"ZV\?_RE[\L@R/(-$3@$@X(4^ZYYQ[5O'ESW[P]M9CX-=1P<T@%#<NC
M@GI/\D_4>Y%SQ<;;ZDNI_UNT:%$BD4B0P.5O?_N;+(X$$(&+S^0>/WZ\+ECU
M<[XX]80B]FW;MB4N:.;O]^_?K]:L6:,F39JD.Z%ZCQ$Z^>23=4("Q5E<B, E
M&D3@(@@#$;@4%CB 0<X.#LBX<>.T.,6%4A4'B].H<!:[=.FBJE:MJO?% 0,&
MZ *T)#9:D!T@3F6_YM06LT^W;=M6"YP$I0L1N @$ D'I0 0NT2 "E\) !"Z"
MK,(OZ<+Q\2:&\KYH'C1CQHQ$G;&"( *7\H$(7 2"PR$"%X% (! (! *!H/P@
M A=!H2$"%T$8B,!%4*H0@4LX+%RX4+5KU\XJ7.!5LV9-==---^EZ]P\^^"#Q
M]WW\\<<ZW_W00P_I RC(5WD;IT^8,"%QS9\(7-*#"%QR0 $S&VGCQHU]':\V
M;=KHA880QB4HCJ8K/)_=HT<//=[UZ]?7B=XX*C0O1. 2#2)P$82!"%P*!TZ^
MZMBQH[5 AE>C1HVT[>0T+M?"$YRGM6O7JLF3)ZLQ8\9H1P1G2% >X/ES3**W
M4&OLV+$R,"4.$;@(! )!Z4 $+M$@ I?"0 0N@JS"+^E"@05\JNW_.G3HH%:L
M6)'*B:@B<"D?B,!%(#@<(G 1" 0"@4 @$ C*#R)P$10:(G 1A($(7 2E"A&X
M5 SRG^0Y$9;8[J]6K5JZ!H_WN:[%I/Y^W;IU:LB0(:IV[=J'FIJ3"T]:6RH"
ME_0@ A>+$].K5R_K9*,0IEFS9KK(\>#!@ZE= Y]-\?:4*5.T@7/1%5X$+M$@
M A=!&(C I3#@-):! P>JZM6K^SH[]]UWG[:=:13(&"!(9,_@1 ]!>0"'=N/&
MC:IITZ:'_ **M+9LV2*#4^(0@8M (!"4#D3@$@TB<"D,1. BR"K\DBY3IT[5
M20,Z;^7^'XD,NG%MW[[=^?6(P*5\( (7@>!PB,!%(! (! *!0" H/XC 15!H
MB,!%$ 8B<!&4*D3@$@QJ.!&O<."#[=YH,#UZ]&B=*W+=S-R+K5NWJMFS9ZM)
MDR:I#1LVZ ,QDD($+NE!!"X>H-*:-V^>;S*,)"QB@Z2GJ80!!=-[]^Y5^_;M
M<_)Y(G")!A&X",) !"Z% 03,*:><8BU.)#@>,6*$VK%C1ZKB%D%YXL"! VKP
MX,':'V*^X2_,G#DS5<=:4!P0@8M (!"4#D3@$@TB<"D,1. BR"J"DBYPDYT[
M=[;:X29-FNB":-><JPA<R@<B<!$(#H<(7 0"@4 @$ @$@O*#"%P$A88(7 1A
M( (70:E"!"[!X,"'#ATZZ'TA][ZHP^O?O[_:M&E37FKPWG__?9TW<'5*C A<
MTH,(7#S8M6N7ZMBQHW6B5:U:5?7ITT=W[,\B1. 2#2)P$82!"%SR#TYON>JJ
MJWR+%KIUZZ9>?OEE.55%D H0G;9HT4+/M4J5*JF>/7LZ.65-4/P0@8M (!"4
M#D3@$@TB<"D,1. BR"J"DBZ<6#UMVK1#)V+FGIJ-&.6EEUYR>CTB<"D?B,!%
M(#@<(G 1" 0"@4 @$ C*#R)P$10:(G 1A($(7 2E"A&X^ -!PBVWW*)JUZYM
MO:]V[=JI9Y]]ULEI*H6 "%S2@PA</@%%TQ0O(F2Q*<3H)(A()*L0@4LTB,!%
M$ 8B<,D_EB]?KMJT:7/H! WOZ]ACCU4//?20^N"##V1R"E(!W83OO/-.?5SB
MJ:>>JO[TIS_)H)0)1. B$ @$I0,1N$2#"%P* Q&X"+**BI(N;[SQAFY:<?31
M1Q_QGNK5JZL)$R;H!+,KB,"E?" "%X'@<(C 12 0" 0"@4 @*#^(P$50:(C
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M9W_'&FD2&_S!'_Q!!23+@12<O2?^'Q":*C):6_RB]3.?6SB;H_M$3FJ:G_@
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MS]R[2,7CZ@AP7QBR>U9?V%K7J.^YKLOC#,D'4N](7**.,F3S3,2^4=TIQ0_
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M(+&48#5Y[IZA0!%I!]@3?2]@VKO,,9V14LF&M3(V(K]@OB:,"KXELTAZ@%%
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MNVJ.U8  ]9AUOL/:7&5M(XP +J,NZM8%L"UW':8$+@HSQ-]($KGG\C(3.T?
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M+<EZ'^2^+DUW=:"-8!>Q5L< ^Q,X1]AC34O&K6__UW\+ #T3!&=B"" 2LAL
M/-4A=<@"%R3)Z+<\C](^RB<"&SS;-F=LCB$-Z=R@.+4L:*X)K7ONN6<U <MU
M*P@3[6TEQVR2\?<(.7QVD[&+UKKSIO;QQ!6(% #)DL]G$P0N"&_B4<4._A]!
M=Z^]]JK.2<_1N;GU+/7_^S/GK//6<[8.=>5 )DP5]8<L<'%>1%,GQ!1B@R[B
MH3WVV"/L\D=<M,B<:^(>/G[97A 'Z4CH+$ 0)TQ"F@1 C4%LL*HA1@)TB4*M
M3^0(Q$V$$6<H,=#\&8K\YXP#)A(-V \*/SJFVA=C$[@ ?*/.)ZY!QY+2:]O9
M'!$Q[*4<4L>Z;&@"%X Q,KZ\O$EL8%V+$X''WJ_X4?ZA(-5%;-"'P,6U1UV,
MQ4'&2I=>PYY;!#3R#3H]IHP?$)>E<)62Y*E-$KC(95.=CA&5NA QR7L45J+?
M% LT$8], I=V5KKH0@ "4XA\MS@+?K>H<-:EP*54#()TL"@&R2FV$MK('<3P
MR\X4L;[K($"3'_MWNJ7"WTH)3[R[5'<V>5_)#F-="EPT5=$\2''3LT*,,?D=
M9N/<3V$V_G?KU-\7EXG3-3-9A>PA9T[A)WZS]*3N2> R7IL$+GE60N#"8*:[
M=^].^O1Y4HBX!*$;K@NK018E/"0<V"2;!"[WF,G=42,O<407^;M\*L+XG6-M
M!/KB+@19]1I8&B*Q',E:7A3_J&/4\8_F&-8[<E<*]]ID@0N3 R&"-VF,Z7P7
M3WC6=4,L?D:-8=DTPS&9>"OR%=:2&B^Q5E.#JR+7SW^7->HWFIBU$Q'I?/AX
M.$YIL[_$G*G8G0]:9I/ )<\F@4NS_,-Y(6?5%$TM;A%'HZXK;>5HP.#X/&+(
M%&<@1^#"D/.C;NY^6YT\IS$F05R$$ZJU=#&!H6OK2^!"F)@2 LJ%%V$9<N.H
M&8;UU54\%,5?,)PNNO_W8;@EIHD3FL&E83M-<0KQ%UP!3D&DIG::PFZ&+' A
MFD[54,2<?> =XI,H7N"+NN"XV!^1[^.+QW8&]R%P42>/ZO0^SJ./?.0CQ>]+
M'*I!<4JP3)0Q=(-K:!"6@VOXNW -6+Q&Y;#W4K@&O+IO?@=_&O$[Q([+;!*X
M;#?\H4B87,> )?@LQ&4X_DUY^3ZI2723P&5XMN,%+I1W.@E$BTM!4J%T'98*
MQB:!2S^V:0(7WY%20_;Y<0U A9S$! D0X"'! H2DDJLF'P[/ODX5O">!RW %
M+LA%J>*!0F,.N#TD(W;PO($'@ =)S2J*8LFK)"U%W!RRP"7J7-?WIRZ6=&U(
M/+JN+^I\D!)T>"=U]S8)#9*\[B";9(!GX'3477#1!S@F,5+0!!HI8IEN5"(A
M&K/ 16!OJL>N7;LJ,A8?L:A#8)/GK"B=$AT.6>#B+$EUD.[S T@W.GN9Z>Z#
MW)(B4R\C*R)'Z)QBFIU<8-.ZP8H3Q1*Z?A!? ;=6F9@IQA1KI/;'D 4NBFVI
ML[_/#Q^<&VNLPX8F<*EC0FL,03HW=A$_ G*M [FJSHCUM*T2UH? 16>GE$"[
MSX]\<1'ATT2]5'P,]"XI\-HD@8LUF<(CQ+-==-F2KSA#4Q,.B$B;Q V3P"7?
M2A==Y$X(?!%ID0_4A7+1V=J%P$4,H@A;QR#.ORYCD-QN@IHAN+9<ORI&5;Q#
M*)'GF%""N+?*-#B%S=2Y*SXM.36F"X&+ZT-V0N1"CDA]?TZ<3J2Z"ME#_$'<
MGHI!2HL&)X'+>&T2N.19*8$+$XL3LT5=HI?AN@@3,&+3+S3JDO-V@</V;9/
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M2R)1G3$1%I# LC_% U-)5+A*8;RX>8Y=U':IP,5G/.E)3UH*F_E7(J>IMZ+
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MB'L4=ZR*B<<4N, @UF7TV?:Z-3$4@RC6LRZ=S:LP2)\"%UB33TNWS$JJ:AQ
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MDMZ/3_?N.;&WOY^+ ?L6N# %T;D;1Q)G8XS@I.:9[)^)@_#_<_[)>42<4:+
M!?]$Y*KA4)_Y-ZX)]Z5W;G(,T?K.K8,^@@]SWB5"2=_;>U0K;[7 99A-*7"1
MS^C3*,_YQ+_8B_PVG]&,PQ(^]/^=%[DSAX]6W#:G[M.UP"5OA!=$,UW%[BFG
M@:MSWC6QL;,\80W_'Q[)G>/B-D6-?05$"F+YZ%P,[=Q-W'P._XAW8(?H,_RY
M/1 UJ-O' A=Q]:H&0DGX:*[@2N=V,T>4\(8Q=Q9WX2J88RZWN_?A)0A ^S0S
MM%<4D90VV%?N=%5!?8H+S)&Y:^<NQ/FY1D1-/*SHVODRQF!$^I:N6V<2QPRW
MIEQI\BLI+K .HS'WN_X\BNEK@<M!FTN!"R,V=F;G^,6DT7#>M/ED_R[.M,;%
M -%G6#<I7EI7@4N*0^""/D65SN AN<(Y6)\"EV:.(/FL)F^9SO%TUG3Y+'E$
MHEU%)F/->8W/B1J$-M_5L_ "77C(&NS"0_A$N9ZQ'>"W87@?^Z9+6\)GXRDB
MW&#?^=ZY\94#)9"-\-JZ"ER:L8UW,W?)IS3Q3HX#:IY)<.#0_%WBJ$L6N# X
M6Y$HKJ7KG?E#<];4E38U+O[,]\<EYG1OYMTM!$/U/[MBL)6FS3D>UYX72SAO
MFK[)?#N+TGXPAGUC/H5$8M!(*Q@5=*0]E?!<.NO,2Y>_2@V13COMM+5JD$H:
M# ";E. UDF9S%:_A>9X[U$KH.])[.E-\3I>^0Z/'(4T#:H'+,+,O:;3YO57-
MK%)>V/[D"Q(>:&HJDTXP<23.SZZU&/UHF##F=K^N I=U_A@78S)F/\W%:H'+
M"B/44;F'+.^Z%FG=/S8Q8*?#SI@%N<T"E[3YYV3[7N!BDP-2KF:+;A0H[4B]
M9U]@3>SUZE>_>BD^+OTN @5%*;J>.^AVL<"%SR& S8F9^OX(='1)Z0K.]Z7
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M9(Z<VU=<<<6RN*I4@B>1KP@Y29X2V$"B"QY;=7U[;LW85X110WT/(E'!LZ2
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M;I 7$CCP/>*&#R:@=08;+S['/I4\XIMUY+ O)0>LEU)G!AP#<S@[$742"'R
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M$D5;<RT<[HM7TGHPUL:C>2:F_!Z!K/@_Q>)RZRG7Y/P1]^)XQ7,$X&FN-M5
MS?YQQLF+\4GREHHB<,]M3L,:A*5QQ1H)\776H?56LF''+ICQ%UN96]_36K>N
MS9<Y;/(4>"JZ1/&%PI H[D]CW<YGC=6$M',FSIXV3H%_^!;O!+_2G.%^$NY)
M\ZH)D/4)'^$X2C4V2N-H?37?U9BNHP-^PM%\,\V;W*WOY<R%#U+.QUDL3C06
M>!-%%_0P"AGMZY)"[%W,#3@O+[KHHF5>7NP#]UD3*?\MQKC'/>ZQ/(_D.:<T
M-VT^VWKD$^ENG&$:?]+CV%/)UZ3<EW<R-_*K>"WO8<UOFOO>) 87QS5Y#7DO
M!0?V9\1K.$_P&GRQAGZ)UU@W5L_I.Y*68E/ZCI+\QR9XCET_[^ .>\SWQT/(
M#YQXXHE+/,!76H-)\VF?PJ?X"?/.C]BK<LEB-?&D\>-+UZ%U2-J0;6CSVPVV
M]LUJ@4LALTAL*B0&4&5#<#*2EIRUQ00,6<C^W/^WN"QNSG&?.ZI4F^<AX4 $
M,H!ZP2K ;"TWU[$_]_^M>^3).D63Z?8D8, > P"\0_.=@ 3D-S(8@-P7Y^U[
M&%^@FN](<^''O_LS0,UWWH>.[.LRP1Y_:WT X&E=6SO64'-M Z[6&1)H4^-J
MC:=]9QT+<+U?>C?G2=ISWFNN7=-+&7^#"$ RF"_SUIQ+8\<G^'_^#M]1NGBK
M]/R;4^\9?:>TWZT+ZY??W22)N OGDOE#V!$O)E_8'I^T1^RCZA.[?:%UEO!J
M<QS]-U+1N6*-[>,5[4/.7^O(?DMX*&'[YID!DR0\M.XQ\]D(D%7O9&Z3[SL4
MSHM4%,!'Y+!K\I_\ ]+B4/8/B9"$+>UWYV7S#+6F_)EUQ.<BT/8M"3072_&/
M_6RN<M@ =L0MB!DV$0.EV PFM:^::RC%9?:B/;F.A$MZOK69^)<(%QB;=*8Y
M^S;5/2OY)/[&^'B/]KMY9WMP4W,V-Q_E/!6W6=MM'Y766)I;8W@HXY5J\\,@
MVSA/Q<_.?GLF\0W.^_;9+PY-/G.3A='VL/@>[H"MF^^6QM#X;K-@.XF[X'#^
MISF&YCMQ-OC^=9U_8^*9KG$UYVEMYOB2J04N*9XW)L;'6'FV,=QF4X-JU;;%
M+]AO_(0]&>5;_#E\:\\T;_FJ5K%QPL:Y,SRMG93/6&>,D01H*1Y,^"<ZN_V=
MNI;[&_S@[%[%U_A_U@1\=RC$D^GV/P*U=C=<#48U!BQ9+#SV'7%G.<XV<0$I
M7V6>MX$74_[?^DD\4_2.B:^HL7:UM+[Q<,W8(M)H)-\D?[%-WR1FU%!&$434
M:5^AQ%R;BJQCK,1E:5XC/B-QO-; MLYSOHA/2IR&]1;A(7QKPM)\W;[G@)IG
M3QLG1CS%+FH24X[!.FMRZ&E>K4OK<QU-:+?I3^5\?*\N/0B?ZCSF>_?E5I ^
MXR-V2&NZG7<R+M:S\5L'/VB-.</@SI37:7-I24=A;F#Q?6LL69K7V 87OHOZ
MCFKE> A<M?W7U%0VSXZF;LS?\7>3SJ%JQ^9KM<"E6K5JU:I5JU:M6K5JU:I5
MJU:M6K5JU:I5JU:MVJ>M1(%+M6K5JE6K5JW:%"-0<T.+6P7:F$17[0LNN*"*
ME:I5J_9I<R.$6S=U\F[[#%V\B1YKX66U:M6J5:M6K5JU:O.P6N!2K5JU:M6J
M5:M6K5JU:M6J5:M6K5JU:M6J5:M6[=-6"URJ5:M6K5JU:MLT7<[//__\Q6&'
M'78 CUSSFM=<W.<^]UEVVJY6K5HUIG,WOQ 5Q-WB%K=87'CAA3MQVV:U:M6J
M5:M6K5JU:M7Z62UPJ5:M6K5JU:I5JU:M6K5JU:I5JU:M6K5JU:I5J_9IJP4N
MU:I5JU:M6K5MV2<^\8G%JU[UJL5-;G*3 UCDZE>_^N+F-[_YXO+++Z\#5:U:
MM:6][WWO6SSL80];7.<ZUSG@,ZY][6LOSCSSS,6'/O2A.E#5JE6K5JU:M6K5
MJLW(:H%+M6K5JE6K5JU:M6K5JE6K5JU:M6K5JE6K5JU:M4];+7"I5JU:M6K5
MJFW#/OG)3RYO8KCUK6^]U*>TL8@;79[[W.<NBV"J5:M6[<,?_O#B<8][W.+Z
MU[]^&+\\X $/6%QQQ16+3WWJ4W6PJE6K5JU:M6K5JE6;D=4"EVK5JE6K5JU:
MM6K5JE6K5JU:M6K5JE6K5JU:M6J?MEK@4JU:M6K5JE7;M!&@7WGEE8LCCSQR
M<8UK7., #KG6M:ZU>/C#'[[XV,<^5@>K6K5JBX]^]*.+L\\^>W'XX8>'!7%'
M'''$XB4O><GBXQ__>!VL:M6J5:M6K5JU:M5F9K7 I5JU:CME_P\  /__[-TQ
M2%5M&,!Q4Z\@H4D9D8@@(CB(X!@130V.00ZV!&Z*NYM#2R"TN"B(0^#H($VN
M#F*0@3B%"0XJ6BHH*I9>>S[.@>_0I]=O*;MX_?W@+.KT#"]'??[WC0
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MM;5=&K?<O7LW)B8FTA &X,V;-Y?>]E1141$]/3WQ\>-'<0L  )00@0L
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ME978W=TU$.!_)4'+ZNIJ^GN*FYX  *"T"5P                H*H$+
M            125P 0              H*@$+@               !25P 4
M             ("B$K@               !05 (7                BDK@
M @              0%$)7                "@J@0L           # =?$/
M    ___LW0FTS/7_Q_'ZM=JB%(6$K$7V)2Z)#BEK2*13BD+(<DKJ"-V$I%!T
M2%GJ9"W$H4TANT1DSY5])Y6]^OS/Z_,_XXSQG;ES9__.?3[.^9YREYGOS-SO
MY_M9WN_WQQ@  ("D=/755YLKKKCBDN.___Z[Y&>N\'SCRBNOY!T#
M              ! 1)'@ @                      @+@BP04
M              !Q18(+                        XHH$%P
M             ,05"2X                       "(*Q)<
M            $%<DN                        ""N2' !,FC5JE6F:=.F
MYO;;;S?Y\^<W!0H4,"DI*>;33S]UQ?DO6+# -&C0P)ZWY_SKUJUK9L^>S8<+
M!)"6EF9Z].AARI4K9XH6+6J:-6MFEBQ98LZ=.\>;XS)GSYXUG3MW-@4+%K3M
MH(XB18J8EUYZB3<'R(0N7+A@MF[=:B9,F&#;AGKUZID*%2J8.^^\TQ[ERY<W
M#1LVM&W$K%FSS*%#AWC3 +C"/__\8]:L66,J5:ITL<^CHV3)DB8U-94W""%;
ML6*%:=*DR27S(C5KUC23)T_FS0$ ( *V;=MF6K=N?<F]MF+%BF;4J%&\.0
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MO6AT//GDDZXX?V7P.9T_.Q< _O7KU\_<=---EUTWZB0\]]QSYO#AP[Q)+J(
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M*8%,563]_6T7*E3([-^_GS<J29#@DI@6+EQH;KOM-K_78;9LV>PND8F,!!<
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M! 1Q[Y YY%O8CQ!L^(HA\R,(Q>2J4W0BM-[,.;FE=^\;@_@V013%5\Q5X$)
M%BNJ*#@!W7*8H@$A[_)WYANLI1PQLSF@:+F\)GPW.563\87+,9.U+@]O,OEO
MJD%&KA]C)+=L6Y]- A<Q*V& 9@QB["&X@O=4^$*V6/>II6TF#EM>KP@B!%#,
M?'-BLF)MUSV;GSKII)-Z[]D*@XH*0\8]C+U[$Z?*QW,536"0R#!BZS$X7\!
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MPN5ZL>N'IE3\D]C7Z<)PGJ%<$/$%?S<'[)H(?VHLP_=-G2H;K$W@8JQP7=3
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M^VD7 VJ(L6*^S3=T'X"'[[(\Q\*SU<?$\P-#?7.$&,1]28I.0PH8F] %:*C
MQ=BE8JWE]1-^B$;;XBOCW27&RFTQ@4N,"(!LB@R4VH_KZZG+_+"WI,CV_DQA
M#C'=6FGRBY['<P%BD!%2^[$.3$-.:Q"C(CTV > *>T!&1<%8[%!?^_R1?,.>
MC/3CNLA(CE'NLZX(=E(GRO@S^8E]Q5Z4BF=\+\\#R+7'I83[K@?8[4N4'2-P
M8>X9 V<!;F+#'(9L&2.9 (GXRRXFSDB!R,;.7M26Z_ASZQ^Q1^S15+Q MNIK
M[NTDD:8BM5@*P;,>*\:>T[@TD>OF)'!A -[8W Z%VS&&#-)V\J2\K.N<CYG?
MC?EI>SLA1UO^,U3@XGN;-_:FY?U*?A:[)A%7'US!7&HC;W<5N&BBH@B"H-:V
MUN0QWB%&BJL35MI.QUF'I0HNRP17<;NYTX2[]=FSD7SLRZD]!YZFD 2SJ>_9
M]?@R[-D*S.+;%/$UD*FZ"GZM<3EWBN@*[Y(/\+&I_&5YG[9W*D#!-Q43^4[W
M$$?T+73'!"ZQXBAAC6*J>[?M%>(C8]14P%2TE6OT)3@2_:>$3/X,H1+FUH27
MA/C"')0[R<M2>R3A[Y .7_:A%*Y3[P:L )H:T_IW#WNP6#X4>Q1(Y7^Q;^YW
M8O[13VI?,/>[^D?77B4Y->1^R\\AMDWA2WW\?=?W\6_XYR:2A/6"H.Y[M?E[
MWQZ^!UML:[HDEE\'AIO::_G=V+/*G_KNM6U-=[H*7&"?.DPBW;2-/2Q1<=E^
MVI1C]B$,+YLYT(0WV0\15^0P;?B,N2Z_2M4'PNE;R%'KQC]3Q$;"#CGV' QI
M6&P0>TYY>9^F'C&!2ZR@#B<E:C'W4OA!V)_X!?M/$]$0G@P#2>6$(2^*K3LB
MGM@U86E]_*9G;8O3<@M<Q#]\9M/^JFZ,9(/ L!P+A#PBQ'WR8/EK6[,FV'"?
MDWU84RR_[#?Y&CE 4WW)W]GW$4Q38F+CXI2/O@0QL1-A;VI/U90$B;5OS0;.
M*X8,X\LGSE&D/\16*7 QGOQ[:C^1:_:9G^)*N5%;<Q$QH^^'S+PNVR2!BUP4
MUIJJC7@?OK%O;02GA)A"3&._$5\0P,RE-@+3)>1MPJTUEX*;-^'ZP;_(6<1/
M*4PWS%_U3%AV'XL)7&+Q%N&*]\J%9TQEJQ:X$(^JTZ8P/J+_-NRD23@28BK[
M)K%RG\9[N6V3!"[626H]B0$T7TSE*TTQ ,P2WRT(7NTG0QI?SMGX[+83N>1&
M7;!@>[,\5IV[[917S53Z\BJZDH#5NW!Y A<D%4?;J\RQ)DQ1'*$NM0YKPC+D
M$['G%;OGQC*Z"ER,E?7"3\;PX?I<@7?*9YNX&W@2\-.A)K9 "$_%GC!SV/GR
MOAW#,N0X<AVBW-3SPGGEMG.QO@*7$*_[O1CF:APUCQG2-*&IWI)#X&).N4Z,
M2\AWJULTG41GC<'68S5L^#4A\!A."<$S;*2-QP8CP-/-59<?:D7@,ES@TE3+
M2-7IQ(Y=,?^MWA2Y;D7@4K--%;APSD"(&%AI4]'U >#6E80>@C@$<@!G+#D/
M1]JW=3):OJ; D1,V,053'+]@Q3OT77BNA[RN.V+L&?T9\D_?4T6&"ER:#$@7
MNR8B4VYK$[B$;K; W3YSPC=".D\5G @Y^A*[??]45Q?![I#3!=9I@AB@.-!*
M(D;E+YF0" P)<(RYPBH +Q9H"Z@4H/L6WYL"$/-#L&;LE\&V,2;)!(C&-B5)
ML@Y8@(2NH)CG,G_-2<!;##SE P">JR@N "ECY!'O]H8WO*'R0T/&TGB$(H\N
M(9*E.04IAQUV6-3_*E0"NX:>H!.$3,!4X]>5Z!JL3>!BONBT BSI4K2LSSN
M_5.>\I1DHJ&P/>0;^1W[KH*S]4Z$J/.IHN60/3(\JXY^L77G'HB??4^!:A*X
M&%?=J"3T.0-J\T@!-Q;GF'_B$7%0GSW-').X$LJEXAP 79?NEHIAB'>Q9U-P
M /(-V0.\BV]O#BAZB:$VH1,@&RIP:3*_&[NF MM<K4G@8MT^^<E/KDYK&>(#
M4F;-(SG$0!E_=OCAAU>=B[K.V; ? _:MQ=A^S-\HD/7I:N2Z]I@4,=./KEG
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M$CHY:"PHEFO\K \$A%CRYL\<>]['4F0/9$]CDCN1,M82HUBW/84GG:/'QCE
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MQ[K57WWUU1M[BHNY%"M.(%1*<-9EJQ"X & 4[F+[SDX[[32K[^19G284>U9
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MGV<4N.39*'")U\I(7&BNMU%AVOH+AXO6D$55\HD 4Y7/9M=,/K 8R9[BFR-
M5A5)5K6N!"X22SONN&.R*JB8)F7F4R3\]%[;P$OX%["1^>N)T\M$Q(1,L-GH
M&?M4^7P4N%3WUU-CU[M$]&S:C!4X6*IK#-QSU38*7&*#3T?QB7.T,<?,@8A\
M(::MDGMHRA0KB3IZ.NRA;0@1ZIC.:=&>7A!JY+URK2N!RT<^\I')P0<?'%Y+
M]S#YR%P;FL#%.TX5CI(G;:/X&[%:)*0NA+EPY$4V)($+N_+**TL+=,WF+A1.
M(\XVYV$!=;K6#MW:$KAXO_ <:[B8&Y;6I_=;8 KP"R(&Q55R26.>C<BEREZP
MG@0N!5YS_/''9^5&S$=$4T677+\O8OD<D^.';:>PGIPUM*J)TZQ+J7@S1Y0^
M"ER6.^#6N#<*075)MBS6)?P!^4>^@;T:%II+9"5LA5/GVGH2N!0^_%=\Q5=D
M\S;D@& <?.J-)GJU+J<$P7"T-@J+I>)4W\187&2CP&5S6X\"%V-O68$+;"LJ
MCHPOUX8/ LL0,\]?3]Y;?F&5UJ3 Q9IPW777)3N2*M:XJ,M<UP*7(A[6@3'7
M![ O5!6RMVV%;Z#KFP8%XO-<WX ?CH-2M7!GF<"E#8YI'VT4N+1OH\ EP_D8
MJL"% Q\YY05(X.,W?40D9@DHR<ZJ!L ">@)RD;"<NV@!6M8&M/AW?^N0#":(
M0>@=!2[#$K@@S:3 (.^[;\Y"'3 8(82@A=-:9XS[C60.(DAJ@^NSP$4UR*AR
M3YMK5/1N$?_; !?G'7F"GES5]VSRA$-D+02>MT$T;MN)1D)(5?9(C6W/+:BF
ME+_GGGL:!4?6@\#%>_WPAS\\#>ZT-Z^[1]JC@9ZI)&^?!2Z$KY$(LDT_)QK'
MB+$2-(OF/T!G$<$O DZM\< 8'3;L>WVK2-"&C0*73=:EP(7HS5B.P.(N]V/C
M'9$K9<"B%(&2WU@E(=.D\9TBD4?7_HS$94X7FR8%+H1_4;5BW\GYJJQ9R'I1
M/"E1F^O_2#9%[Z;+^-?U$83+_)!455SO$O#8E U!X&*,P"XB4I'WM(A 7]@#
M#SPP74/FJT'-)@94CHKV8@21G&Y5QN$--]P0KI6 [RHD[E'@DF>CP&6MP50B
M,E5;>[8C6E<EA!65632_)<>BKF.+8N""/&!<JZ[=M'4E<%&X(57%%UZ)P)>R
M@PXZJ!?^!;RD;&_2H2&5*$-*ZTNETU'@4LT4B$D1]LW_-I)IQDI*U&&,*F:Q
M:AL%+K$A[4=%?;K&9ZRK<,2N#?:^W7;;A>\1[M]&E^$ZYC[<3TJ\@)B;:UT)
M7(@X^+*I[I>Z N3:T 0N<JI1 0@'0F8; E(Y<EAP=$VYYAS2Z- $+OQ5!:-2
M[[K,7U7Y7=$CQ+B-4MF]+8&+]Z^H#5Y W[%O]^<^S1>Q61DY>G9_,LYRGVV]
M"5R83B.X&E5S(_Q.A4L4=]-=M,_C@U@@%7-8TPD@FC8^.WY'"F/4#6R1C0*7
M>@?L6W5Z\4$;!:ZJFIRQW,BMM]XZ)0[G[&OVL2J%EM:;P,5Z<N*))V8+%F=]
M +ZS8KS6R;8+M/3!4CD7A[6YC;TVQ9=T'P39BVP4N&QNH\ EMK>][6V]P#+@
M>;K4KM*:%+@4/HHN6!%F[#W %,J*5JY"X&+M(0J)BHO-'\0[L* ^^Z9\ _&;
M7*3\98I?,5]TL.J>/@I<1H%+%S8*7#*<CZ$*7+1+C(AJJVC+*2E;9=/0PA,1
M'.A31M3-/<H(OZ/ I;\"%PY!"A#?=]]]2XD ?3:.!"="8I:XHZDQGOJW/@M<
M )-EW3VZ.JPUUMVV3:>K4T\]-:S"FBO\0 X"FB#H#:5""#*@-3)'Y!(]=]$*
M6)):991E;<@"%WND8 ]9'Q&TB?6C; WIL\!%<)43B+5]",QSA+S6?J!.U.HV
M%S@U1H'3;WC#&UHA^O7%1H'+)NM2X"+)&@6&71]B%U7)4Z9R:^H^D<[MLZLP
MP&Q?_)D<<423 A>$(\37Z'RJ!.8*4PAS4LDDG7!R?9Y4AY\N#VLV@D.9'Q*)
M@HH*.3E"BUP;@L"%&7M100KO@^^<X]M%@@L X.R:HAM,1,:3I,N)F1Y__/$I
MH!]5V$+&J6*CP"7/1H'+6M/U-;?J5MMDCIQ*[X@>EUUVV;0+<UT?V)J*E*K@
M0U-BUJX$+CK@Z,(;78MX13&'E!&.],6_*"LP@UR2BO41V?J"6XP"EVH&=TCE
M%0A*V^B<:*P8,ZDJK3#B5=LH<$EC^+GD\#8/ZRK,M&M#;$NM];OLLLOD]MMO
M[\7:P2].W:?."67%)N:M*X&+>";5=88_5*7KS- $+L1(*3] YYHV!!5(2#OL
ML$,2KU%48)$-3>!2Y&Q..NFDRCCS;,Y&<0:Q*Y+G>N[L4B9PX3/:RZ-#3/#H
MHX]."<%E(A=8Z)#$0IX-MX30*2KD-]\I"W:98^M1X&)>(-++;=2-"XTQN94K
MKKBB%;'(LB9GDQH'QQQS3.5JV#DF/D[A$?RB')'**'"I=ECO74-< /?N&['5
M_8@7^3?(EF5Y>7.+[ZR88HZM-X%+X0,@E:>P^IRU"<;.C^#K]$'LU"6>XE#8
MI8UQ+%^0>N_(YXML%+AL;J/ )8V'] '+$-O:6U9I30M<F&*U?,;HO+A?NCA7
MS;>T*7!A]D3801D'2YRNVV ;757;\@WX+#?>>.,TWE^4;Q"358FK1X'+*'#I
MPD:!2X;S,52!"P"D*IFXK8,:,#>(H)(%<C5%VEUTC *7_@I<.+][[;57>![!
M:Y6$0%\,N8&S@Z#1U1COL\ %&-+5>UAT=%5-#Y![[;773E7==<DJWIE 1Z)+
M\G\(@(GGMM9%'3>J/#=0]J4O?>GDX8<?KGTO0Q6X2)CP#U0>[VK>]%G@HG5I
M7_P<I/O< !(YK$I5H%35$&1<0A!DW?5FH\!EDW4I<#GRR"-[LQ\C?:<,,)FZ
M3[];%8G &M>7]Y?3X;!)@0L[_/##PPKS_+Q<TN@%%UP0)H'=*U)3KO6AP$-!
M_BF+!Z+WY=ABBRT:K<0[%(&+A--YYYT7DEE5^%PDE(+E''7446OV2[^=)1 4
M(&[TWG.$-!*5$2F07T]<4L5&@4N>C0*7M2:IU)<]QSC(C061H^ [BXA?93XP
M$!L!%ZG36KJ,=25P$<,I;I(B[-]]]]W)WUIO^O*MR^+O;;?=-GF??M<7PL\H
M<*EF!"PIS JNTX:PW%@Q9I:ITMJVC0*7M _2%WQF48?=-@Q9Z)!##DE6]=1M
MHP^F^V8J0:[+>I7B3UT)7.RC2,&I=<$SY=K0!"X*@Z7V5SG4-O /:SOR?(K$
M(^>\R(8H<"G\57.5*+ON>E;D;.#$Q$!#*4Y6Q18)7!;M\Q_YR$>F_GSJ'&(%
M&.70.N+PS<Q+1+TRXB(!>TXN3P'3E!\F-]1%@9^B4&-JK!]PP &U?#US5#Q?
MATP^2RB'%^(;&%-],?G/U/H!YV\CCVN=2>52W,M99YVU\!RCP"4NWBM_!SN%
M+?(A8-?B]T]]ZE.][S15S#<%(Q7G*RNZJ6@/O";GF<0A*=]$@:HN<C.PW92O
MX;O5\3?<]W7773>--Y?E;? !%>A=;YW=RD3 316BF3=S+75-1;%R\@VCP&7S
MF'44N*RU6VZYI3=8AKAWE=:&P(6?HA!BBA\F;DH)$U<E<&%$Z2G!@D..@WAG
M:&:O)^!1]+3,%X>AWW;;;=G[^BAP&04N7=@H<,EP/D:!2S<"%X&]*E((FUW>
MVRAPZ:_ !4$/82XZS[.?_>Q216]?P5\=* 1.78[Q4>"2!SQT)7 IG$>!]447
M7;2TT 7HK[J("FM#<)HIV04DJ6KON<^-.&H]J0,2#5'@(H! ]- 6LLNY,0I<
M\@Y$AJH@K&K-@'&DVKK7M79(:EGGUU/2=!2X;+(N!2XJHO9E/RX3N"PB>*PJ
MN=07@8M[T ESD34M<"'<C< P:]1##SV4!8*I&A.MZ6*4*HG[/G3V6D0P1<I.
MC1=[0I/K^5 $+IY9XB,: P@BBZH 2EZJH#B?Z$*\BY(Y\\"@[X%D4T9R-HXE
M:Z.*7COOO'/E^3,*7/)L%+BLM;X(7-Q#KL!E-@Z[YIIKIO-MF>IX2 .*'L!.
MZQ(HNA*X(+NE2'R>HRP9UA>!BWLH$[@\[WG/*Q7>C@*7YFT4N*S.1H%+V@?9
MR (7Y%J%3%+"]S;\@3KSZ]QSSTW&2_SF*M67NQ*XP,_FA>RS),8JXJ%1X++8
MX.P;5>!2S!,Y%L47EA6ZR-G(!2XKRNZ;+2-P*=XQ'X,XHDSD(JX<&M:-XW#O
MO?>6BES@<7(:BXQ *E7 !1&UBVK1?#WDOM3Z6\5/B,ZM<!\QT[*Y$6O.]==?
MWXOQ,@I<^F%E I?7OO:UT_VSRF'=*HXAFGWMZ*./+A6YX/3D=$6R=J=B1"3Q
M+L1W]I 4B50\7$6P/;\_X6V\^M6OGFRSS38AB;**#Z"SEWL=ZKBIDG-ILEC7
MK(T"EV9M%+C$=O/--_<&RR Z6*6U(7!A!!7''7=<&-M:M^$4<,[<?$L7 A?"
MO11'PX%S.V0AH_7QA!-.*"W&*Y;-+;(["EQ&@4L7-@I<,IR/H0I<5/CH0SNU
MIS_]Z5D!-#5[F0IR%+@T8T,2N' <4LD2B]>%%UXXF%:?%E8@DY:978_Q/@M<
M]MUWWY4'#?:V77;9926.@''!^?5N@?8Z^]1Y'YY!]2=.YE JQP"Z5-Y%3 )$
MU/EVWI7Q6A4\&:+ Q;=%F.AZ?O19X(+L6K<"=).'=;TN60% ;NT!&JCL7)>8
M_9SG/&<JF.L"0.["1H'+)NM2X*(R3%W0OLG]>,<==YPF.%.&))+:)_D[JP*4
M=MMMMU[X,]:1QQ]_?.']-BUP 881GZ? Q@B<G(];4TDV2?TJQ)UE$N--'8L2
M_0@NJ?V+3]0DT78H A?VV&./31,J4=*I+(;D!ZJR-_\[A"2^YKP9YU$5:,E+
M1+&424I&^Y.]FTBPJHT"ESP;!2YK[8PSSNC%G@V_4Z2FCL%Q8(!P*(1U0H\Z
M]Z&S+P)X'3)35P(7:P<17(H$Z#VD;/?==^^%?\'/@9FGK*P+MSU^51WVYFT4
MN%0?NZGX]!G/>,;TWYLV<UDLD,)_$!A7;:/ )38^5Q_P&?[M)9=<TOFX$(<B
MQ*<(?_RCCWWL8RL=NW!%A)GH_G27E#.JLEYW)7!!;(,=I\1#;W[SF[//-32!
MBW.DQI0YUP;^@02K^$3J?8O/%]F0!2[SN0M5:Y&"[7MU1,=^8\U>3P37904N
MA1%HR VFSH7;@*0^M/?&1RL3?<(WX J+3#$^716B<VR__?:U\;LJ)C]_U557
M)45(1QQQQ-+7L.]X%G&_8HAUNS(KI@?[6G5NY,HKKTQV;(9#S788;O([I? (
M]Y(C4ME( I?7O>YUDXUH,%=Q?6HOXW,H4K7(%/I+C7'%3-H2.LR:KC3;;;==
MDI/VOO>];VD?@(\%(T;(MK[4Y6W =!"[UX,/4)9SJ2*2K_(=O+O4NY677V2C
MP&5S&P4N:3RD#U@&GL?%%U^\TC'2EL"%B8-3<:;_[CO,VRH%+F681QNXQRI,
MW+S//OLD?0,%-W(+A(\"EU'@TH6- I<,YV.H A>+#> MVB"0:F8K#K1]+#)5
MKFR,99LZ< QI2Z!]ZZVW3A<"B0& @$!#-2> -V=7 M4F")@G/-EVVVV38/ H
M<.FOP(6IE)#J>"*P%,@.P;2M+6N]78!P$C:77GKI-(D)< !^ T6-<<  X%=E
M;E4^)7  3!R&,F%$GP4NAQYZ: B&N!;22U_6J*X, 'O777=-18'6ZJI$'V.L
M#9)!%\^M(K:*)E4[E!CWDB%5DK!#$[BXW]3:/0M6 R&0^%76 E2X/K*.]<,[
MMO=+:/,/@'."+^I\Q+ 42:[/ A?K8+0_ $B\LS[Y.3F&S,,7O?KJJZ=[ 3"C
M:B*'\',]@*6CP&63=2EP46TV(K!)S%D_^C*7#COLL&02A8_>11(E,M7+HCW[
MSCOO[*4_T[3 A8F%(B#8/B)&*S-D[>B[VCNJMKCW;!$@]XE/?*(W^X(]*E49
MA\ E1Z24:T,2N/A&IY]^>B@80@I*O5?O2Z7N"/=PSNB=1.(,/L799Y^=O+]'
M'GDD)*KI'*,"9%4;!2YY-@I<8JPE$@4BUL+%AA9#VR?%)\3:>^VU5^7B!Y('
MA.]5[ZDK@0N,4L?%E/\N?BK#9J+]\5WO>E>O_ O/E\)<?9N^%*89!2[5#,DY
M)6!&'&HCF0:[2(DZ^ --DR'JV"APB0T)/)IC2'!\KZ'A,W4,3I^*L^2T?,]5
MVCO?^<YD;H+8],8;;ZQTOJX$+K!-^8.4V*[*?0]-X.)^4P4,=:YI _^ 2Z8$
M*OR6!Q]\<.$YUH/ )<I=P'=4L2W#T5.'-6"]=')I2N!28 #VM++.N.>??_[@
MWI%YE,JQ$G#H2K7($+1371+ESY8A2N4:+,^:'MT#3(N(H$F3WX/O(,F__.4O
MGV)65>:9'+GX>Y6^@'M/Q1R>*:=#1E5#X(:KIC#&G#DT"EPVAL%<4O$='M5]
M]]VW\!QX.:DB5;#1+O8Z_H0B12F?5A?9IGT 9'WY1=A'*C>5.A18;4, TK4I
M))4B03_ZZ*.-7\]:;J]+"5R,V9SU<12X_+^- I?T.2)1\8$''M@IEM$':U/@
M(H:0I^3?1W-:,0X8^JR- I?V3>Y-?C-Z1GNM&#C'1H'+*'#IPD:!2X;S,52!
M"P"$<S?_>Y7UD#/Z8D"+VV^_/2EB$("KB+K,Q$<:!2R, I?A"5RT!00:I\C\
M$OM]-\G\4TXY)5E]QOI"R+-,)3=$EH,//GAP A=DM(C@AU#;1C6;H1G T_?S
MG@!/.55"M'&L2@;MFTE>2@P#^U.5JN9;D;_F-:_)/O^0!"Z<L@]^\(-3@#Y5
M+6OOO?<N[7B0LP^G2!I]%KBX5I3HV6FGG1H',5=A@GUD/_LVLE\4]$?/7K>2
M=I]L%+ALLBX%+MY/M-[Z%LAM?3'[82J) E!:)*1HRXX\\LAPCEY[[;6]W)/;
M$+@0JJ8J>:E.GZJN[[\_][G/#1,DDHY5J]*^X 4O",]EG^P+4,P/28&&?)$F
M8_4A"5Q\:[A ]/WL]RE"%)Q@WA^P3I0)+?@0SWSF,]>(INVWXJK("&NC B*2
MFW6J XX"ESP;!2YK336W*#8X[;335EX=O@F3@$;"1=*!7^:0!U365@BDBG4E
M<+%VI8B>$A]E1%'/%?D72*U]\B_VWW__Y'>"9Z36U:YM%+A4,WYUU%G-X5WF
M)CFKQL */J0JN1]^^.$K?_>CP"4="VRUU59KSJ$@S49)O/(55;],"3&JX)9M
M&+(*<5IT?P<==-"T8%P5ZTK@8G]/Y2K$D57R%4,3N)Q\\LE)X:\"-PJA-6WW
MWGOOE!R:\EL>?OCAA>=8CP*7>>-S$U<=>^RQTPKB.3D;^.-ZZ+S=I, %1B/_
M5=:U'D:BF->0#,%;$<.48'?//??,6OM2HD0D8T5 VS9B$P7I4OO:.>><T[J_
M:]VP?\E_I?#@^0Z?L)95F=@GA;G:%W+6T*KVH0]]:+H6I?*0EU]^^<)SC *7
MC6'V^%3U_-SX[LPSSTSRN?",Y,2[F&<I7%V7FK;] /L6[I+BD8H4IHI]S!XP
MPZ$+70EU4@(7!36;SKO@+2BBD"I\FK.7C@*7S6T4N,1VQQUW3+;>>NLUYY G
MPL_92-:FP(7QZU+%*^3J8 FS!8U'@4O[=O_]]T_7]^@9Y?MS\991X#(*7+JP
M4>"2X7P,5>"B^T-4_03PVR=1@"HMJ>#91F;C:@+X:XKL,0I<\JPI@0N"EVK=
MJ<0MPDN5S@VK,,X: "YZ!H"_P"]%^JMB+WG)2P8G< &0140QXR2JN+R1C5!*
MH*9B0*IZFT,%?JV$^SXOJCRW,0RL2($GA9.=.V:&)'"1-'KC&]^8K/B%1-@$
M82CE=_19X"(@ (:DJCBO)^.<2U:HS*U*6VHN<.P1X88.EHX"ETW6I< E5:4#
M@7B^:LHJ38>S5!+EU%-/G7:%7(5)[D0"H0LNN& *I/?-VA"X\&6WWW[[D-@A
M(9XBXB+#1>1=1)XZOB#24G0/2$M]$;AX%SONN&,ROFF27#TD@0M#XC".HDJ<
MUJEYXP/=<LLMX;,A@*=,<B("T[?;;KMI B;R':.8G4^NZUJ=L34*7/+WIU'@
MLKDA?T<B;S[@>A!YS^\M2!A\HI3@OQ#]P^JJ8(=="5P0'^"PT;40H<LJ7>HJ
M%?D]8H(^"9"/.>:89$$7?GU?8I-1X%+-?+=4(1V%:NIT+UMD1#7\ZM0U=7I;
MM8T"E]CNN>>>R<X[[QQ6++:.;P03NR!^I/8J!=Q6U8E>\EOE^%0%9'A)U4)3
M70E<S(-H;#G\=YW0J\2*0Q*XV$.))Z+S(%6V@=4HTI$BC>I<FT.DV @"EUF3
MN_!=^99EPFPY&_<V],[;30I<F/=A;4P)JZQ1X@"%4X9BBG? NE*D7 6J%AF^
M2FK-PIOHHK,-,48J9L*9@9%T9<:)-4\'"KF?5&X$T?R((XY86?RA4$.J>R>?
MJ UNCH(^J9R^@A'77W_]PG., I>-8809N^^^>Q)3,7X7&<%4JKL2[D(7F!2<
M.R7:5H3LHQ_]:*>8%8Z/N-D^7^8#\(.&S-L0RZ0$O=;FIOT;[Q;VE<J#ZR:T
MR$:!R^8V"EQBT[WJA2]\X9IS**0'Y]A(UK; A<'OH^(H!=9U]]UW_]_?C@*7
M;G L<7[TC&+;7%']*' 9!2Y=V"APR7 ^ABIP45V#<S?_>Z#HJBM&S9IJIQ%(
MPME7O5_2K@D;!2Z;;&@"%P&,2C""ZU1;WS:JGC1I""A1NU0!N"X50/ F;(@"
MEZNNNFJZOD;S<J-NS+F!(7 R51G$/!MZ%Y=YXYRHZDT<D@(T+KGDDJQS#4G@
M\N233X9):,^K&DU3WWF( A=KA+UW_EH2L6V0;?IB %I[;(J@Y5V;*T.V4>"R
MR;H4N-QTTTUA\ W8 'SVQ<SM%-E"$F5572JON.**::>UR$\58_;-VA"X%',W
M(KA*?-G/(E-E\*E/?>J:W^C64T? *2D;^4?(\'U)(B&$''+((<F$E\Z.3=G0
M!"Z2K;I01$(2[VS>GGCBB1!H1JJ"AZ0,F?FRRRX+A331OD!D2CS0I,\Q"ESR
M;!2XK#7)\XCHB:A0A>0Y-$,&0+9.D0:(+*IT<>E*X"+1_ZQG/2M)3BWS$_A\
M*H+._P[9K4\"9.,\U<4-P23E W1MH\"ENK^2$IO8ET\\\<16_ #S/+HF#+6-
M.*BJC0*7V"1LHP)5\'"YE(UB"M2DUGQBQS(!=ILF-Y%*C!/-UNF.T)7 )957
M<1AS\,Q<&YK A=@D]=VL W6Z2"XR>&.*-'K**:=D56;?: *765/]WGA-$4!A
M)D/OXM*TP(7!:LSEU/KI?5I#AU)%6QY+5ZR48$>7D47&?T[EV/E[R_ 1<@WA
M,R74EYLDXEF%Z:!D+D6%AHHN+JLBTOGN\.G4?LM/:-I@2ZFNBWOLL4=6(;A1
MX+(QC/A.=\74.IN34WS[V]\^V7;;;9-CO&I'P#HFWY(JL $#7U4Q$*1L^?2(
M?%G,IZJ"\CZ9=3?%22%^:5K@8KPJ*I4B7>=P'4>!R^8V"EQBPS.4.XGB]S;V
M[3Y;%P(7/JZ"B-%:*4\L-U@4C1P%+MWX!JE<-=] X:X<&P4NH\"E"QL%+AG.
MQU %+A;^BR^^."3-M$%PJ&O:MT<3$T#29"O94>"RR88F<&$V3J!4=#Z"+>2:
M/E<^\BZBJIO&3%FUSJHV1($+Y;NY'JVY6N*-EC:D/56FHX2);B=]K!C?A"$8
M1EU_O(=<0N"0!"[$#-$<D6R4Z&S;[^BSP$40C(0:)7E>\8I7K.OYC["L6I(J
MMO//CP0'A!BRC0*73=:EP.6!!QX(.R)9KYKTQY<UI%Y=C*+WLN666ZZL.C!"
M<93T=4]MD$Z6M;8$+JINIL@P2$/ LEE3'2;:T^$.JG/6$:08KQ'(H1IH$QT3
MFS#"G11A5((&2;O)_6)( A=C1+(TJL8I@3H?.YE?\Y5>D6IRWJ$JERJ?S@N(
M]]MOOS6D(W]K/L_?D\J<.B?6L5'@DF>CP&6M&?<''710*-!:%7&V*^/_2W!'
M!5 D9.&+N=:5P,5Z%'4J<_#9R^)V">&(U&L?;YHDNBS>.K^>SNZ_J^JP-V^C
MP*7ZGHSTGDIR\LF;]JT05U-D17$NO&'5-@I<TACE&6><$>)L39(A^FY(?=$>
M71R*N74M4!2C$1N6=9:I4RBB*X$+,F!J7=#5J4S4/F]#$[C(C:1(RX2EQ!1-
MYL2LZ8BO40&* HO*(69N9($+X_=LO?7684QK_1YZ4;(V!"Y,$4#= U)B=J1:
ME;3[U,6P[%G@A*GGT,DCQ]=+Q?=%[--FEP+7EWM*=4KQ#*L4W)M', E^QOR]
M$4IUT>$F,CPC8L!401L\C":+[S@7S"05;Q("R*<NLE'@LC%,M\R]]MHK&4>*
M/1:9W(&X)R7@$S\V5;@X%7.D"*0.7;[K%,QJRJS+.I-'0A!%:>ITJ^^+$4"E
MQ#OPH*8%O'(:J3R3]30'_QL%+IO;*'")#9?GK+/."KL(BWDWDG4A<&'B6"+<
ME%BRX#^- I?V#2:>PBZ(26^[[;:L\XP"EU'@TH6- I<,YV.H A> I':G$0#A
M'*MJB3YO J8(I$;05HFC*1L%+IMLB (7XT!UY]2<(.QX\,$'>[NV(-]$U20(
MT 1H3=D0!2Y:1>^ZZZ[A]3BO //1TI8"<27^APR4E!DG1:>6"#Q#+LZQ(0E<
M^";(:E'%\"I)W+I^1Y\%+I)%B!B1GZ.=;)^J&K=AJHH@(D3)1$G^(=LH<-ED
M70I<^".JGT;SB;]BO^Z#F=<IO\'QAC>\H5'?JHH_DR*>Z([39F*GCK4E<&&(
MQT0:\^?>9Y]]UHPC@*D*X/-_ZQO7)7U(7*0Z/_9%;&3_TL4QE0PDI)@7 RTS
MMX<D<&&//?;89(<==@C)^[/=^E*$#SZ2][O()/FC2G $Y$#VV7<8B3F*CK-U
M;12XY-DH<%EK8F2=$Z(]6T)N"*2O90PN$1$G"28)87.M"X&+9,...^X87@=Y
M%&9;1G"R;Q+21;\WW_OB7Q E1)UYBP,1HJE];1D;!2[5L1>Y@U255N]3E=HF
MG^F::ZY)^D<$-7VH>C\*7&+S;73ICO8FZVV3^%6?S5JG&V.JJK1"7:H-=R6\
M=QTQ5TJ$:._4C;2.2*(+@0NA0*J:J,3VE5=>.8VM<FUH A<^G_F>(I@;:TWZ
M?=:W5%5V,;8B%#EC9:,+7)AYE>IN.^3J[<6X;$/@PI"2D<]38]XX1-CO2W?>
M,I\F%9M[!D+(')/SMF]$Y]%%NLT.]G"9U)H)QY.36+7IWJF80.0/GWSRR2OS
M V 8J2Y.OGV312_AN*G\@7U2<9V<?7(4N&P,,Z^)TU(8<6YL!V.,\/RB@VN.
MJ*JN77KII<EUD;BM;A&B)DW'AXCWAA?0IC"Q;8-/I42H#B+5ILP^GQ(N% *5
M'"'3*'#9W$:!2WKOQO^,_$_B_XV"9;"N!"Y\$WF^J$"XX_###Y_F<D>!2_LF
M=H8YI/ALN1T;1X'+*'#IPD:!2X;S,52!"T-^]/<1>-T70I\*K=% W'___2L!
MU(MLJ *7ICN3#%'@PB3)5#Y**?4Y,EV1+WV3*M^%."<"M) PFP1CARAP8<@Y
MD4A#\/'^][]_,EKYOA4E*8%+30H$^V8(--$8?=K3GI;U^R$)7!!*HLIY6VVU
M5:,DH2$*7)CJF%&'&TD>B=[U; BWT9Z.@'3""2<,^ME&@<LFZU+@4OAN43<-
ME53NN^^^WKP7R>Q4$D7R5;)F%<;?D\R/DI=]*2Q06)L"%X"7_3BJ] U$+WQ?
M_Q?Q)?*1D1N7B0-51(L :8GO/A AQ!&2?:F$MW%4A:2]:*\8FL#EDY_\Y#2)
M'G6W.>"  _[O&R*\Z=@6)65R_&#^H'@LZI(WN]\ "R-!*5]LF6X970I<) 6:
MQA5&@<OFUJ7 I7@O_-WYZZEJG)MX&*I]_.,?G^*%T1IQZZVW9I^G"X'+99==
M-BT^$5V'<$4,MLB./_[XL&OC@0<>V"IQI*H1IZ:J><)\^B"\2@E<5+(=FI4)
M7)I<[[V;% F*/XX\UM3U[-W&=>JY^A+CEF$>3>^U0Q*X,**]J.L4GTGN8Z.8
M;N7$_:G<GCE%^-=V-WKGEW=3 "9U+WS$G+THLBX$+M=??WV(^3F(WCQ?%4N1
MM:^[[KK&WW\3 A=VVFFG)?<O5=B7(4O,CQ?^;*I2-C(:,GF.C0*73<59(ES$
MWCE$8>VLM2EP*3",DTXZ*2ERX1>+A>JNH55SNW5,X3GQ:BK_E%L-'$:G&%%*
M+"\F:J-3 <S%GI[JG@5+0C)?M2F,(]Z*<B/+\#6:\*M4'T]5)<=U:,I4U7[^
M\Y\?7DLQP%S,:A2XK-[:7I>8[BJ1K^[8>>>=I[A]CA%KRW&GA /O?O>[6\'?
MK7?BH%2GN2...*(7W6/=0_1^^ !]Z6Y;U\J$U_SLIKX[[@/^7JH36BZW;Q2X
M;&YE I>FUZ A"5R8=4L'ZJB#]N677[YAL(RN!"Y,S';TT4>':PI_'T\DZA*\
MD00N7?@&-]]\<U*8L=-..TV+7.38*' 9!2Y=V"APR7 ^ABQP>>*))Z8;3E3Y
M3#*U#XXT17>4K.4D<SR;,-6J4E5R^R!P4=$G(C@ARC4-4 U5X((HCBR3(H*9
MHU=??76CHJ@4N$=TH?6E>\IQ+ "R425ICD]3%3<%>ZF*9GT7N-QXXXVA> E(
MT78[VZ&;]2&J5F)S7\\"%XF.9:J5#DG@(B&VQ19;A$'UDT\^V5B 1"@R1($+
MWPUA*B)2(S@/N2).CF]#Z! ]^W'''3?H9QL%+INL:X$+0GW4-<&>PF?I2Y5)
M@*(.#:E]0"OZ551W1HJ)[HL_(^'81M*YKK4I<.$K6_.C:M_6ZZ(S"_#9]XJZ
M;RQ+-#5>H^LC/_=%/,V7226AC1DQ:A, IGF;BLOZ*G"QOXFU(B$;,@"?A;WW
MO>]=DS"$*U@[<^W^^^^?OH?(ARB*)P!QYX4$\!3DQ&7\C#8$+N*J*%X^]-!#
M&X^I1H'+YM:UP.6NN^Z:CM,HT6O.#Y&P7P7[./C@@\-GYP/D6DK@8FXVL?Z*
MU1"<4Z(/W79R8G;DWJ@[BKW"\_;%OS#6(R)GL39;N[OJ6)"R%&E7-<8NDH9-
MFC4]\G54BV_29W>="RZX()FC((YOHD,>W]W<2V&^<"]DP3X8S"-Z][HUU>U
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M5ZM6;FK*1H'+)EN%P(4!U@ EJ?U8E1][*E^IS+^*]F.)?CZ,_=X>@4CB>G7
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MF;P-S"&JXCPOYA*#ZG0UNX[GK)'>";^,**1, &'_,*?X>DT4%5@D<"F^M;$
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M\8*(J-[A.6C6P,]K]U-;TFPVY@3^#6L_VL27IFO)<QQ^^.&%<BCX^^CQJ*V
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M\6 L".XE!4K1E^UPI*=H3RB8IW 3.Q4'G: >]BF-Y,Q=]!ARG:)D&E39C8:
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M'-UNM["/]GJ]F$ZGA@,     /(7 !0              @%0"%P
M     %()7                $@E< $              ""5P 4
M     (!4 A<               !2"5P               !()7 !
M       @E< %              " 5 (7                4@E<
M        2"5P 0              ()7 !0              @%0"%P
M         %()7                $@E< $              ""5P 4
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MU3E"B+Q"'63FS)EFR) A9I===C$U:]:T=1 .I8T>/=HL7KQ8=1 A1,8L6+#
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M/KR+Z-]^\B=_\DU_Y[_^Z[\V?_1'?[2Y^.*+-\<??_QV'Y;>PP=^X =N'O"
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M8#.\8<K>@;%'W&'YJSZYNKL5_@F?$=-;#'B1(Q@\92C2% %&U-LT%%GL'2M
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M:\!]^4YKP_=;*^['OLH]:\_-NU#X''0PFUO@XKUX9]%:2?O+6DO/,1%X/%L
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M> 8_$'!I?!-BES:*^)^<X$8L&S,!U7?;&P0.! QR0>2??3#Y2?0>$8E:6XG
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MTM,>5X%++'"1>P/3I]0B,!L397-B)(TKDURGK ?Y%>PGBBF U]:G)TXQ\8^
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M.<2SG_WLR;4G,UP5]RG* PC+EL06/>,<+HT,/X9,[YU%@RRCWRO?&S,X2?Y
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M,U O.CG6QXDII>LY)W"I.<%IR A_HQ-GB(%:#?'8=UL%+C,F'T.VA,!%TBG
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MB,-?.3ER""^R#F$6D7_C*V$$+1O7L$P]A=P)EL3%):2V5>!RN 0N\$;Q-R)
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M&%#D5S06X6*UM0 _==YYYX4G%LI%-+5+R;6:;_N B7C_3L<HM:-=X&+M[,,
M#;5\R=YRNH*F)%+Y6#^$O.!T#/X,5C_U9%3W],QG/G-+/!V+C2*TR+L1YN4M
M-22-I6P5N R;)AMRL\F\^AE+8!ZKP*4^EB)Q1N]&@]J).:77@2E$N0)1A@G=
M)>:$N9S?0,R8PQ?(<Q!N<N06><'8GLLJ<#DZ!"[R1Z+O*.]#TE$SE-:#ZO"H
MOP6/+26[&CBR+[V2DKQ9WB#'%M/&]IF)+P@HG? (3[:OI]H2 A<8R#X(XJV7
M/EZ&/"0WU=Y4^I98SBIPF==6@4N9R6F6X'B4"+OGX&\,V5("%WF=85<YX9U:
M<,@.J\#%B<^Y'M,55UQ1=8IB2]N7@:)RB-+!=BW-\-XHGY/GE0S5A+UU<S#/
M$Y%ZMT9V D34WX6C#!GAM#YPM&<,ZZFQ5>!29X1%.=Z-'*7ER0HM!"X&0"_1
MKR@14HLK);:4P,5^SN4+]F(?Y]10CGW)$9[[W.<._M;#)'!QC=RSA:VT%'_N
MJ\#EOO>];S8.Z^7-D1_P7;F>BEJUI*^R"ER6L57@,F/R,62'2>!BBO ^)/2E
M)(\E!2Z.1]V79X-,>1"&W.*(<,3L)2?N[+/ 1:*Y#T"Z3PD(TMI6@<N-MH3
MY?:WO_U>K#.?DD;KD@*7?2!AIXEMI:8!13@))$0,&5LD.HH7.'K999=MB4%3
M3@!80N#BE(I]B:4GGGAB]CXUIW/K"IA<.I6PQ%:!RY%&.& B>>ZTA;///GOP
M&H=-X,(<RTZ\UKW6;6][VVUCI63=R>6C>(KD;UV7^@B3KO<EO]'L6*+A,L8\
MSS>^\8W;*=QR <#OF.=F79L^:BH.G]#R=*ZCW9#'<N_$G[<F8S'$GUP,,95P
MCNETUJ(Z+;?&^)8A6P4NJ\ E6E>&6]A'2]8BM0(7]NI7OWJ+L46G)LD;2O:=
MM7G222<=<0U3Z_B*@SQI2ZV?._%&3BM6$KD.W:/_3NSZBE>\8GNR4PZK1-(N
M-:<O[TO.4#/TXV@7N!Q[[+%[@R^43G^T?C7FU&.(L6,;V/(NQ UD"Z<V3,$H
MW),<6^/="3-C":OP$_@:'Z[!OT\G^ZT"E^$U@/"*H!")!E>!RWX(7!CB2X0)
MP]6004MR!4UKM7(T[1%QHG3O$N;FL#%8QAS-?->$W>3\(@++V)[+*G Y.@0N
MS G#,*KN]>05^N E>P"I,;J&_5EZ\B);TN<.?4J%X9X/$8_\W>F^8_,&>Q8.
M=O'%%V^?V92\80F!B_IC7_HW?0/*$$US/2UDTY98W2IPF==6@4N9F>J^+[VZ
MDCRDM2TE<)&#X2WE_'D)P?2P"ER<E)+#BPQ=/JA!7TXPV9<<HN1$V]8&]XKP
M%,, 2O(*W*@(.^T.$2'^[PI'K0>GJ0W5.S@441[K'OGX&EL%+G7F].-</N3=
MM<R'6@A<Y-;[$LM*<8^E!"Y\[/.?__QL;]20@IS!-_;EN<)/ANPP"5P>]:A'
M99_M!1=<4'225JGMJ\#%(+U<?J#/-4=^P'?E^F%J5:=7#=DJ<%G&5H'+C,G'
MD!TV@<L^3%X$[)40,)86N.S+).L:@*+UOB%N,6UZR=^\SP*7O@1DR8]FW)Q
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M1@.( B+GZ9EY=IZ/P"O@:YX%&A2+!4^) ;"*C .0%!J[V#X$+DPBCH3-"3,
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M(DSS&] 274]CFX2VBPI[7P(7AK12]&YRC/X?)Z=(P>%*_"DQ/1O-!XH^3O5
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M]S?PPKI=!2[S%KB(/8HY39._AJQ50BP"O8@4+BEP(6PFMMEUBHMBBOQACF)
M6$;!K30.;6K0PL%HRNMS.@K_(X[#2%-P(AH>^MRG8KR"YU",B'/58#9E<\(8
M A>Y&P&N DI3,:G4>\.G-N6+&LX]VZ$<2UN?1*2ML-7T'CU?0KBQGT_B8.2(
M4XNG<C@&CMS51+GKAY_%;3>]]Z4)7/ ]A@M$N*8$;E*<5N@F&EP%+N,9K-"F
M.5^,U#S2=>)VV[6D&3I-@QW+MXAYUA3>?@@_2Q!/\-G4W-+7'ZO7PA"10'H5
MN'2WJ>HM\EUUHEWKEYAO%P88@F4(07:)7$K%Z5V#67#),%O38)^2>X=HK"]N
M\/>BNFS79Z)1K>V[]9F&7NTZD;C$C]RSZRDN3 U!'E;:UZ7A.)K4^@I<#%[=
ME1_"K'V;0Y=NJ\"E/_^O21#//C;_S6^I;^_S%)><P 6/4=IWRVOEM\2+70?P
ML8,@<&%.0L!/$@^V$5+TS:,T1G<18(A=YYY[[A:'CIWO6UL&M<SQ%!<UR#;?
MWTD1?3DPWUO_0)OG5(H?7@4NP\R^-4BA-!Y*0N^<?^N+8>!S.)Q(>I=0N82_
M,4RWZRDN.8&+=3]&KP5.37VD[RGHZ;D:S(&K+-UO$6$$ H0NN<U2!2Y\J6%-
M!/&EL0=AFKKCW>YVMUD+7%(M<HHXK(=-/4AO7Y\XM@I<IK%5X!*8YD^$UY!@
M[%E1DC4YUR4+7%*PTM"E.;#M<59]GB-G(IGL @#V*7!)(!R1!-0U'3DZ-( #
MV*9"4,_OTX!VY$C)[YK *]('F(L*]4L2N*2B%$6Z2?Z[%.U#P"AB5N%P"!@=
M:JO Y?^-0IH ; @I(UB[C[9%1@2-)A3*_+' GGL2K\2!I0A<4HR7S-@G8Q%E
MB@@:87852%*#H),HQDJF4].HR;1#0/0[W_G.[7,;TD#G7C3&M26GK0DB%X+A
ML7&&AIH^BGP$I\85/J\4N>\ZUH^UP7\L5>"";#-!U DCI0BN=*H*0J#KZ5&1
MW7###=LFCE*D"^SB>YL\@Q2*$MK2F,/Z4ZQN*M+[_QH%QL0W"H36[5@$EE@F
M<3>%9FX"%^9$0Q/9G HT5MQ-4TA,X1$_=AE_N^M>8/<Q&K&68OL6N"2BTM';
MR+-=$^G[KAMXD,BM[P2UJLD[G;942N3B'6A<(?(Q=4_^O I<YBUP8;@94Z'X
MO%)X6HZ 5)?#F!HFIHPI<&&$&IJMFGRE]6>2V!P-5E:<]ZQ*%Q.;1-A.%!"+
M^@CG80885WP>2]CG?2IZ6/-].1'/%3\P)*;[N_;VE"<NCR%P2?P"?.N9C"4L
M2?'*"3J[&CHT^1+"F58^5DZ?3HR$H=MP%:8.6M>[A.=#<PT3:_M,]AW+[#%3
M.X?64.#\IAK*T@0NB7LB#"[)/=DG8J\)G0:FP FKP&5<,]2'8*,I'LC[89>Q
M3.Y'Y"+>CQ$[^2WO&V=?HJ&./X232V&3:HW(B4=BQ2IP&6Y3U5N8]Q.=1E7-
MOW'.8P[Q@V4T?:MEC"4L<5UKM4T-1^Z+2Y97CXEEO&?8:DB=6PUVZ'Z6\YO,
MWI8CP3LX17+HL*U= EN->'TX,>\7-M&X6,HOX[QA;;PQ_-E7X*(?9!<>]5FE
MX_Q2;!6X]#=U,+[+<->Q<A[Q0+Q0:RI1^^EK.8&+4P@TFI9J,E9KE7.:8M]W
MD-M!$;@P0FGB0?6*TH)4?D^,AG>["HE@"(W0,/^8?(@3"XADYRAPT0?2=%I<
MBJM#^FG$?R=)-M79T[ '@T]*V"IP&6;6*L$(GKA479A_-=3 :7RXYY("EX3A
MU /$_%U#KX9P7#"^^*ZWIHOE!"X$T/H+2^'.=/*U_+K$ !T80;\%;#R62%U<
MT"L$YW01P2Y5X)*X(/A1#ELJ_EB;."[Q1N_8W 4N[)9;;MF>J"2.CS'XQ;IR
M J&#,/J*-%>!RS2V"EPR ,H$,L&X;R.GOZ=AKBD!(W")R"N->R4-H1%]CJ2I
MQ+,RR9)JSGV7;&H#8(B$'/O<%:AJ?HN^L^:%*=>1QEQ'J0&<)1L.@'O/V_%W
MB+0YF._J6%! ?6ACGT9O#;'()GM(<E\OU'N_704N"H 1R-2$.N6ZD.1+THD>
M2B;#FK0)UP"EKH"YM$4"%\^ZC\ %:11=:PJ!B\\9*G!1\.?'^C9? .R*]O98
M%Q&(W]4\I+%9,E&R6"+I<Y0N17Y7LB5:\^YM*H$+0V"9Z*LH4%)8XEW9UZ8_
MW'333:V3/FM,X@/\ECRMA"]V/T0&UL\0\WX4]KWWOM@(1C"!K$LS7&K\U>PX
M%L[P[(<08IK6O&^)X!"AI_7C[UL_B@6>N>D,T=Y=@L %V4_4Z;O U$,:T)(0
M"7FN,:;4"66>L28!C4&N/^3^D +\+>R"7+GJJJN.BBM^K[3 !<%^UEEG99O-
M^3@DU=A3S^Q5!)8F=2>(E<0W8IBB/'*OJZ@;Z1>]K]("%\97(5DT'CJ]IZ30
MQ3-P78UL;44*3AS817@Z>6;?F'&?EBN6>7=3\P^(9$,VD'0E"J7);UHW8DFI
MXIA[M68TF]CK0_"E[XE()Y@A"G[[V]\>"ESD@?LT I?H>Y84N)B$&7V&0G4I
MT^P??09"NX]Y9TX%(DH9VB0&W\'E\G*-3WQT)'"1SY<T&.ZE+WWIMEDX=U^F
M@ID\/5>3UQ!CV.M3G.22?IP:8-VV$5Q&?N3&&V_<-C67YD0TVN ZY7I#WIOO
M]9SG/&?;5-<GGMMK1#;XCS$FD>=,$WYT+PK.)7"S I=",EQ?LN%$\P"?JA&X
M+<[A@W"B!+VEA2YR,@V/&D*[\!2*27R&]U"ZH(N#@=N&\E-C8!CQ>\BIIO
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M'@0+J>6YKOT0K8<V A?X(-=\7ET?9Y]]]J'D 7.U%C\&SXQI^Q2X^,Z&I9;
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M:4O2"ZPA *=NP)R3^>X(+N_;>[<W%!DD4IZ7@(B$M5XT#2MV>&9S(GU6:V<
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MP( L!)/",0!0;%)@I:JJ*NOD5FBND+J7W7GGG5GX$P" ID/ !8#Z(. "4)B
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MN@30U FX                4*\$7                *A7 BX
M      #4*P$7                ZI6 "P               /5*P 4
M@*/Q+P   /__[-UIB)75'P=P]P4M%]+4]$6"B):6"R0:@A#A+H**BA+X0D4A
MB"0R!%_HFR1+0U!$S2T5<2%*Q7&G@A11$$VT%(LRE[2R'%&S7YP'1AR]^?\W
MVCSW,I\//#C7.S#GGO.<98;S?4X$        P&-2KUZ]J%6K5J7KK[_^JO0]
MM2K>J%V[MAH#              #@L1)P 0              (%<"+@
M         .1*P 4              (!<";@               "0*P$7
M            <B7@ @              0*X$7                ,B5@ L
M              "Y$G !               @5P(N                Y$K
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M(T<6+'^I!'2@NMV\>3-6K%B1!5ON__TPA=W22; 4MW1*U?WC7GH]9,@0E0,
M        #R'@DJ,4<"FT<3@]H96:Y?CQXS%V[-B"]\.T:=-4$)2 = I*Z]:M
M"_;C8@NX_/SSSS%__OSHT*'#OPJVW'NE!<1WWWWG%!> :C!Y\N2"8_&R9<M*
MHOPC1HPH6'X!%R@LA8C[]NU;L-\T;-@P)DV:I)**7 JX%&J_08,&J1P
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M.AZEX$NO7KUB^O3IV4DO:5Q,X1EJEA1.32'3?YJSGGWV6954Y 1<
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MDB,!%RH(N$#I*_: 2]H4.WCPX((3?SJ=X<,//\Q"+?_+A0L7LJ?5EX"_ 0
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M$<HCKDY_?]9LC+(WW723O?^, W)BK\W$#?8%Y!.#!P^.+1YG+)+KT29B#[D
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MIZIR0B<"'KX$1T@3M@T(#1!H//C@@_:TU5R>FHEP ($X@@>^R.=+\BC]A<
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MW[R5*U>:+-%3IDQ)Z)@Q8T9<F<-3:7#)BFV;-6N6H\\V$PTN&)+ON^\^Z[Q
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M+CS,;=NV6?M!/!XMB%\>>>21L#:J5:OF;=BPP?F]H3+&H$&#POHK6[9LS(+
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M-@*NVV^_W8CF.+\)$R888:Y?191,-KCP7N7-F]?:#@(AE^*]W&9PP>#H9X1
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M7YZ6IB_.B?'#]Y!9LV:9^9XYNF;-FC$9.%@'FC1I8@PKL5QGT PNF)\PAF*
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MSR"/WG???<O^['>OX]\3J9]RRBGEON<#'_A 6?ED,O:U<B-&#Z+RRA1E32;
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M=T( (BX"B/8!.-TAHB$6<D(WPY+Q8%QX3J<N$WP1G#C]E9AQ(L7D_4#@1E!
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M%.X##^$.5$F5^C\'         /C:6NN,,:[9>U\WXUW,.7T,
M  " 3PE<                2 E<                2 E<
M    2 E<                2 E<                2 E<
M    2 E<                2 E<                2 E<
M    2 E<                2 E<                2 E<
M    2 E<                2 E<                2 E<
M    2 E<                2 E<                2 E<
M    2 E<                2 E< '[D 0  ___LV[$)P# , $$;O/_(=JH4
MZ0-/R!VHDBKU?PX             P/>LM<X8XS%[[\?-N!=S3A\#
M      #@50(7                4@(7                4@(7
M        4@(7                4@(7                4@(7
M        4@(7                4@(7                4@(7
M        4@(7                4@(7                4@(7
M        4@(7                4@(7                4@(7
M        4@(7                4@(7                4@(7
M        4@(7             /[A @  ___LVZ$-P# , ,%$ROXC)T4%X96^
MX$XRLI'YGP, _-1:ZXPQKME[7S?C7<PY?0P              (!/"5P
M          !("5P               !("5P               !("5P
M          !("5P               !("5P               !("5P
M          !("5P               !("5P               !("5P
M          !("5P               !("5P               !("5P
M          !("5P               !("5P               !("5P
M          !("5P               !("5P               !("5P
M          !("5P         _N !  #__^S;H0W , P P43*_B,G105%)94>
M]$XRLI'YGP,     \%MKK3/&>,S>^W$S[L6<T\<               #XE, %
M              " E, %              " E, %              " E, %
M              " E, %              " E, %              " E, %
M              " E, %              " E, %              " E, %
M              " E, %              " E, %              " E, %
M              " E, %              " E, %              " E, %
M              " E, %              " E, %              " E, %
M              " E, %    >'<!  #__^S;L0G , P 01N\_\AVJA3I$Y[
M':B2*O5_#@          ?&:M=<88C]E[/V[&O9AS^A@               "O
M$K@               "0$K@               "0$K@               "0
M$K@               "0$K@               "0$K@               "0
M$K@               "0$K@               "0$K@               "0
M$K@               "0$K@               "0$K@               "0
M$K@               "0$K@               "0$K@               "0
M$K@               "0$K@               "0$K@               "0
M$K@               "0$KCP?Q<   #__^S;L0G , P 01N\_\AVJA3I T_"
M':B2*O5_#@              \&%KK3/&>,S>^W$S[L6<T\<
M  !XE< %              " E, %              " E, %
M  " E, %              " E, %              " E, %
M  " E, %              " E, %              " E, %
M  " E, %              " E, %              " E, %
M  " E, %              " E, %              " E, %
M  " E, %              " E, %              " E, %
M  " E, %            ?NT"  #__^S;H0W , P P43*_B,G107AE;[@3C*R
MD?F? P  ?[?6.F.,:_;>U\UX%W-.'P,              .!3 A<
M      !2 A<               !2 A<               !2 A<
M      !2 A<               !2 A<               !2 A<
M      !2 A<               !2 A<               !2 A<
M      !2 A<               !2 A<               !2 A<
M      !2 A<               !2 A<               !2 A<
M      !2 A<               !2 A<               !2 A<
M      !2 A<       !"#P   /__[-NA#< P# #!1,K^(R=%!0%EE9[<248V
M,O]S        UEIGC''-WONZ&>]BSNEC                _$K@ @
M        0$K@ @              0$K@ @              0$K@ @
M        0$K@ @              0$K@ @              0$K@ @
M        0$K@ @              0$K@ @              0$K@ @
M        0$K@ @              0$K@ @              0$K@ @
M        0$K@ @              0$K@ @              0$K@ @
M        0$K@ @              0$K@ @              0$K@ @
M        0$K@ @  \.D!  #__^S;,0[#(!1$09#@_B<&(A<N3!-%LKTI9J17
M\2OZ70L          (#GM=96*>72G/-R4\Z'6JL? P              X%8&
M+@               $09N                !!EX (              $"4
M@0L               !1!BX               !$&;@                0
M9> "              ! E($+                408N
M1!FX                $/73P.6H]RY)DB1)DB1)DB1)DB1)DB1)DB3=UCYN
M^3IPD21)DB1)DB1)DB1)DB1)DB1)DI[.P$62)$F2)$F2)$F2)$F2)$F2)$D&
M+I(D29(D29(D29(D29(D29(D23)P,7"1)$F2)$F2)$F2)$F2)$F2)$G2?PQ<
MQAA+DB1)DB1)DB1)DB1)DB1)DB1)>JM=60               !!DX (
M         $"4@0L               "[#P   /__^_^?C@  \&C#> ?B&*@
+    245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_01.jpg
<TEXT>
begin 644 image_01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" $+ 7,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH+ =:
M,CUH **,BC(Z4 %%&1TS1F@ HHHS0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%&1ZT%@.IH 8#N7DT#:4Q^5==\$/@1\0_P!H'Q>OA+X?::&\
MF,RZA?W#;+>RAQDRRN>%4>_X5]Z?L7_\$Y=-\<ZDME^S[\+X?B!J%K-Y6J?$
M#Q0C0Z%:OCYEMX^MP0<X/0D5\7Q-QOD_#=-^VE>:6RMIZM[?J<.*Q]#"Q]]_
M+R\SX \(_!SXK^/HWD\&?#S6-26/[[6EB[*OU.*W#^RE^TBJ9_X4MX@;V73W
M)_+%?M_XE_X)H:S\'/@YKGQ<^,/[0GB2_P#[%T:2YO/#O@6QCL+>98UR$14&
MXGMUK\Z_@GI_[:7[7?BJ^NOV5O@GXLM;&UN"%U"^\470\H$\;BWREO85^>9;
MXM8G.O:5</[.-.G:\IMI*^VZU^1YE#.XXI2E!I*.[;L?$OB;P9XP\'7KZ7XK
M\,WVG7$?^LCO+5XROYBLX$?PFOTS\=?LL?\ !6;X:Z9)/\3/V?K/XC:/S/JM
MIJUO%=$J!C;'(H$@P/KS7SIXQ_97^%GQWN[G3O@YH>H> ?B%;QLUU\-_$V4%
MX5&2+21@,G&2$/-?697XB8'%22K2@ULY4Y<R7JMUZVL=U#,J57=KU6I\MY]Z
M.:GU_P /ZYX4UJ[\.^)=+FL[ZSE:.YM;A"K1MG!!!]Z@W#&<U^CTJE.O34X.
MZ/3\PHH!!Z&DW#.*T 6BC(SC-&X>M !11FB@ HHW#UI-R^M "T49'K1GO0 4
M449H **,B@$'H: "B@D#J:,T %%&>](&!.!0 M%&:,T %%&:3>IZ&@!:**,@
M=30 449H!STH **,T9 ZF@ HHHH **** "BBB@ HHHH **** (R2!R:U/ ?@
M;Q)\3/&NE_#WP=8O=:GK%]':V<*#[\CM@?@":R\<XS7TC^P5I=WX!\%?$S]J
M>VLO.O?">@QZ5X8*@,4UC47^SPR >J)YK\="N:\7B#,I97E<ZT/B=HQ7>4FD
MOQ:,<14]C2;2]/5GU7^Q'^R5I/[0/QNC_87^$=]Y?@'P3Y=W\9O%%B=LGB"_
M5N;-9!_RQ5\H%!YPQ[5^UWPZ^'?@GX3>$;'P)X"\/VNEZ9IT"Q6MG:Q!410,
M=N_<]S7P?_P;??!O3/ _[%FH_$N39-J7C#Q5<RSZAR3<0PGRXR2>>OF'\:J_
MMQ?MS>./V7?V^?$,?C[Q?=Z7X1L?@S<7?@^S;Y;;4=7+/N4GHS@!<#U-?Q'Q
M9_:'$_%-7+Z,K^SOZRDK7=N[;^26A^<YBJV89A*A![?B^K/9OVJ_^"NG[+G[
M-OC;4/A?K=AJGB:ZTFU\WQ.N@V/VF'2X3QFX/1>O0]J^A_@SJ'PVU[X<Z7XV
M^&.CV=CH^N6,5_:"SM5B5TD0,"54#D@BOPJ^$?CY_BE^R3>?!#X812:CXH^)
M5U<>(?CI\0+J']WI.GB0L]OYA[E%^[GC?BOTH_8Z_;3T[XC?\$ZO$7Q(T#P9
M<>%-"\(:)<:9X4O=3F"G4(K:VVI<#.,98#CUKFS[A'^S<)3IT%)3YU"5WN]$
MGR]+N]M]%<SQF5^QI1C3O>]GY_+U-K]H/_@LW^RG\!?B9J'PTO[?6-<DT.14
M\2:AHEB9K;2MS ?OG'"GFNW_ &E_V'?V;_V\/AE:^)KW1H[/5+VSBOO#?B[2
MXQ%>6K,@>.4.,$]1D'M7Y/\ _!/?X2_%C]O7X00_L^>!_#TUGH.O>*I-9^,7
MCZ]3$E]B7>ME&W4_3WK]UO!7A?2_!'A/3?"&BQ[;/2]/BM+5?[J1J% _):YN
M)LOP_".(ITL'-QKQ?O>]>ZTL_*[OIKIN8YA1AELH*DVI==>A^ O_  4 _8]\
M=:G_ ,)%X7^(.CK'\5?AW8_:Y[ZVAVIXOT('B]4=YH^-_?%? BL",&OZ-/\
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MIOV2O^":Z1?NO^"@C%NW_%./7H?@KP;XL\??\$#YM!\%>'+S5+Q?C4LIM;&
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M+3;7QK+FXNM1,1\DVROR#SC([E?2OR]F\O[3(T(Q'YA*#T7/'Z5]4>*_ O\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_02.jpg
<TEXT>
begin 644 image_02.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" $+ 7,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH+ =:
M,CUH **,BC(Z4 %%&1TS1F@ HHHS0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=:G_ ,)%X7^(.CK'\5?AW8_:Y[ZVAVIXOT('B]4=YH^-_?%? BL",&OZ-/\
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MIOV2O^":Z1?NO^"@C%NW_%./7H?@KP;XL\??\$#YM!\%>'+S5+Q?C4LIM;&
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M+3;7QK+FXNM1,1\DVROR#SC([E?2OR]F\O[3(T(Q'YA*#T7/'Z5]4>*_ O\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_02a.jpg
<TEXT>
begin 644 image_02a.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" $+ 7,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH+ =:
M,CUH **,BC(Z4 %%&1TS1F@ HHHS0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=:G_ ,)%X7^(.CK'\5?AW8_:Y[ZVAVIXOT('B]4=YH^-_?%? BL",&OZ-/\
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MIOV2O^":Z1?NO^"@C%NW_%./7H?@KP;XL\??\$#YM!\%>'+S5+Q?C4LIM;&
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M+3;7QK+FXNM1,1\DVROR#SC([E?2OR]F\O[3(T(Q'YA*#T7/'Z5]4>*_ O\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_03a.jpg
<TEXT>
begin 644 image_03a.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" $+ 7,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH+ =:
M,CUH **,BC(Z4 %%&1TS1F@ HHHS0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=:G_ ,)%X7^(.CK'\5?AW8_:Y[ZVAVIXOT('B]4=YH^-_?%? BL",&OZ-/\
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MIOV2O^":Z1?NO^"@C%NW_%./7H?@KP;XL\??\$#YM!\%>'+S5+Q?C4LIM;&
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M+3;7QK+FXNM1,1\DVROR#SC([E?2OR]F\O[3(T(Q'YA*#T7/'Z5]4>*_ O\
MP4(_;I\">*OCC\8/$&I6_A?P?ILE[-)KA-G9LR](8(S@%R!TQUX]*^4XF8C_
M #^=?H' 67T</BL9B?:0<YRCS0I_!3LM+=+M;L]3+Z:C*4^9>\UHMEH34445
M^F'J!1110 4444 %%%% !03@9HHH :V -H->C?LF_'-OV>_C=I?CN_M?M>CS
M+)8>(M/;E;O3YT,<T1'NC'\0#7G.T]2?QIIR>#7'F&"I9E@YX:LO=DFGZ-6^
M]&=2G&I3<9==#^@G_@EI^U_X=^&\5G^QQ\1/&4=QIKVOVWX2>*+B4>7K.CR?
M-';ESQYT(.PKUXJ#X\?\$[OVROAS^V;XL_; _83^)&BV=QX^L8X/$6FZ[&6"
MR*$4.A';"*?8BOQY_9J_:LT/0_#,7P)^/1OKCPJEX+G0M:T^0K?^&[OM/ W7
M;G[R=#7Z#_"#_@K#^V9^RCX6M'\8:7:?&KX=IM%CXST)BUW%!Q@3HOS*X! P
M1C-?R/Q%P'GG#N;U:N!47[1-.,U[LU=.ZOI?9M::['P^+RG%87$2J4+.^Z>S
M1]9?L*_\$P/&/PL^--]^U]^UW\2/^$W^)U_#Y5O<E?\ 1]-CY!$(/3CC\Z])
M_P""C'_!/3X>_M^_"RV\-:]J$FD^(=$N/M7AKQ#:C$MG-_52>H]J^<]+_P"#
MC_\ 9DN_#$>NW?PF\61R3,R0VZPH[.XZKQSQ[BO/?@%_P65_;'_:P_;6T3PO
M\,?@U'HOPP_M!$UJXUJV,<D-K_%*\KX"GT KXEY#QY5QDLSJP]DZ*NFVE%)+
MX8KMNK?>>5]3SBI6]O+3E7RLNB.TTK]D_P#X+>Z1X3_X4M#^TGX8DTCROLZ^
M))(6^V);XVXS_>V]_6OHW]B/]BOX5_\ !-?X&ZS>ZGXJ^W:G>-)J?C'Q5J<@
M#W4H4DL2>BCG KK?C)_P4"_97^!5HW_"5?%;3[K4#'OATG1Y/M=S/Z!4CS7Y
MU?\ !17_ (* 7_QK\/>1\;M2N? ?PUW-)#X*M[H?VWXHV_=24+_J(2>N><5G
M@J?$7%4EA8TE"G-KFY(6YFOQ;_#J.C''YC+V;C:+:O9;G@W[0?[1EG\0_P!H
M?Q]_P4]\<1LNEZ>\FA_!O3;KAK^Z5#&MRJG^",%GW#C./2OSUU/5=0UO5;C6
MM6N7FN[RX>:XF<Y+NS%F/YFN^_:/_:*\2?M#^*8+^\L8M,T/2;?[+X=\/V?R
MV^GVX/"*.FXCJW4FO/%Z]*_LC@OAV628&,JJM)Q44OY8QVC^K\V?H6 POU:D
ME;6R5NR0^F137%M,EU:S-')&P:.2-BK(V<Y!'0@T\'-%?:2C&I%QDKI[G<]=
MSZ(\$?\ !5W]NGP'X8M/"FD?&6>XM[&/;9RZA;)/+$/0.X)^E>*_%3XM?$KX
MV>++CQU\4_&%]K6J7)_>7-[,6VCT [#T KG<G'- 9QT->-@^&\CRW%/$8:A"
M,WU2U,8X:C3?-&*3]#V'X!?MZ_M3?LR>"[CX??!KXF3:3H]U?M=RV0A61#*R
M@%@&!QT'XUVO_#WK]OIA_P EI;_P7Q?_ !-?-0Y&-M*I;;Q7/B.$N'<7B'6J
MX6#FVVVTKM]V9O!X>4KN*UW9K?$'Q_XO^*?C;4OB)XYU)KW5M7NFN+^X*A?,
M=CUXXK6\"_'?XJ?#;X=^*_A3X-\3RV>A^-H;>+Q)8HH_TM(&9H@?3!8_45R>
M2#@TAW_>(KU:F6X*MAXT)TTXQ:M'HFFFK>C2L;RI4Y12:T[#=HQBNMO?CC\4
M]2^"5C^SG>>*9I/!^F^(&UJST=E&R.]:-XS*#_NNX_X$:Y0%CQBE)^;(%;5\
M'A<3R^U@I.+3C?HULUYC<(2MI>SO\STK]GC]L3]HC]EB6\_X4M\0[K3+?4%_
MTW3WQ);RGY?F,;97=\HYQTK2_:!_;O\ VI/VG=!@\*_%CXF7-UI-NVY-+M8U
M@MW;(.61,!B"!UKR-2>I6D5L+7F2X:R.ICEC98>'M;WYK:W[F7U:A*?.XJ_<
M]-_9Y_;(_:+_ &6?MD/P8^(EUIEK?9-YI[8D@E/'S&-LKG"@9Q6E\?\ ]O3]
MJ?\ :7T"+PE\5?B?=76D0ON73+.-8(&;CED3 ;D=Z\?/7@4[&4X%$N&\AGCO
MKKP\'5WYK:W]>XOJM"53GLFSK/@A\=_BO^SAX[A^)'P<\776BZO""BW%NW$B
M9^ZR]&4XZ&H?BE\9_B+\8OB?=_&'QIK9DU^\F262\M8Q"0RJ K +C!PHZ=ZY
M<KCD?K3E(!P!77+*\O>*>)=*/M&N5RMJUV?EZFGL8<_,TM59ON>N?%']O#]J
M7XU?":+X*?$_XG7&L:#"T3)#>1JTG[M@R?O,;N"/7FN/^+OQW^*GQWNM'O/B
MAXHEU230M'ATO2VD  @M8@ J#'H._?%<FJD'I2%2HR#6&#R+*,%-3H48QLVU
M96LW:[7:]D3"A3I[)+?\3JOAU\</BC\)_#7B;PEX#\326.G^+]+_ +/\06Z+
M\MS;Y!V'\1UK,\ _$#QO\+O$UKXR^'WB6\TC5+5\V]Y93&-U]LCJ#62@YVYI
MHRS84XKI>78&2J7IQ_>?%=+WK*VO?30KV-.5[I:[^9],:E_P5Y_;YU/1Y-'D
M^,CQF: Q2WD-C&DY4C!_> ;L^^:^>Y/'OC<^,5^(+>*KXZXMU]H75OM#?:/-
MSG>'SG/O6:2V.10V3SMKAP/#F19:IK#8>$>96E96NF1'"X>G?EBE?<^DD_X*
MY_MYIH8T7_A<DC%;?R5O6LHS<!=NW_68W9QQG->!WWQ#\;ZKX]C^)FJ^)+JZ
MUY-02]&IW,I>4S(P97)/<$"L@@GI1\QX\NG@>',CRV4Y8;#PBYJS:7?=!3PU
M&G)N*2N='\7_ (P_$/X[>/[SXG?%/7Y-4UK4-OVJ\E R^U0%X] !6_\ L]_M
M8_M ?LN:I<ZE\%_B!>:2MXFV\M%.^";IRR'Y2>.N*\^9>.E(@)YKKK95EN(P
M*P<Z472LERM)I+IITMT+E1IRI^S:378]C^//[?W[5G[2'A>/P7\3_B?<7&CJ
MQ8Z99QK!#(W^VJ !L$9YKQF)=GWJ>OS?*12*&8Y'%&7Y5@,IH^QPE.,(WO:*
MMKW84Z5.BK022)****] T"BBB@ HHHH **** "BBB@ HHH//% #=JC)-=5\*
M?CO\6_@CJ7]J?#3QM>::2P,EO'(6BE]F0_*?RKEN1R6I&!8G%<N)PF%QE/V5
M>"DNS5R94XSC[RNCZ+TC]OW2-6U.'4OC'^SEX5UZ:"'9'>64)LYRW]\M'@$G
MZ5T=O_P4)^#-@'^S?LTW)1AAK=O%ESY;?4 \BOE#9@8-!Z8:OE\1P+P_B&TX
M-7W2D['/+!T9:?@>_P"M_P#!0[XG6=C)I?PC\$^'O!\1D<I=:;8A[H*W5?-D
MRU>'^*?%WBGQSK,FO^,-?O-2O9CF6ZO)B[M^)JB^_L*;N;%>QEO#^3Y2E]6H
MJ-NMM?\ .Q=/#T:?P*WF2  #@44#@8HKVC<**** #\**** "CIT%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Apr. 23, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GE HEALTHCARE TECHNOLOGIES INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">88-2515116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 W. Monroe Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Chicago<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">60661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">735-1139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GEHC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">457,884,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001932393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Income (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 4,777<span></span>
</td>
<td class="nump">$ 4,650<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">2,012<span></span>
</td>
<td class="nump">1,902<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general, and administrative</a></td>
<td class="nump">1,040<span></span>
</td>
<td class="nump">1,038<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">344<span></span>
</td>
<td class="nump">324<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,383<span></span>
</td>
<td class="nump">1,362<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">629<span></span>
</td>
<td class="nump">540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Interest and other financial charges &#8211; net</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Non-operating benefit (income) costs</a></td>
<td class="num">(74)<span></span>
</td>
<td class="num">(102)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense &#8211; net</a></td>
<td class="num">(99)<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">692<span></span>
</td>
<td class="nump">512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit (provision) for income taxes</a></td>
<td class="num">(104)<span></span>
</td>
<td class="num">(124)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">588<span></span>
</td>
<td class="nump">388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (income) loss attributable to noncontrolling interests</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to GE HealthCare</a></td>
<td class="nump">$ 564<span></span>
</td>
<td class="nump">$ 374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Earnings per share attributable to GE HealthCare:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 1.23<span></span>
</td>
<td class="nump">$ 0.82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 1.23<span></span>
</td>
<td class="nump">$ 0.81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted-average number of shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">457<span></span>
</td>
<td class="nump">456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">459<span></span>
</td>
<td class="nump">459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 3,117<span></span>
</td>
<td class="nump">$ 3,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">1,963<span></span>
</td>
<td class="nump">1,967<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">1,660<span></span>
</td>
<td class="nump">1,605<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">$ 802<span></span>
</td>
<td class="nump">$ 782<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to GE HealthCare</a></td>
<td class="nump">$ 564<span></span>
</td>
<td class="nump">$ 374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income (loss) attributable to noncontrolling interests</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">588<span></span>
</td>
<td class="nump">388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustments &#8211; net of taxes</a></td>
<td class="nump">257<span></span>
</td>
<td class="num">(76)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and Other Postretirement Plans &#8211; net of taxes</a></td>
<td class="num">(69)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Cash flow hedges &#8211; net of taxes</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">180<span></span>
</td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="nump">768<span></span>
</td>
<td class="nump">292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive income (loss) attributable to noncontrolling interests</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to GE HealthCare</a></td>
<td class="nump">$ 744<span></span>
</td>
<td class="nump">$ 278<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482739/220-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Financial Position (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">$ 2,473<span></span>
</td>
<td class="nump">$ 2,889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Receivables &#8211; net of allowances of $106 and $103</a></td>
<td class="nump">3,572<span></span>
</td>
<td class="nump">3,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">2,158<span></span>
</td>
<td class="nump">1,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent', window );">Contract and other deferred assets</a></td>
<td class="nump">931<span></span>
</td>
<td class="nump">974<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">All other current assets</a></td>
<td class="nump">601<span></span>
</td>
<td class="nump">532<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">9,735<span></span>
</td>
<td class="nump">9,901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property, plant, and equipment &#8211; net</a></td>
<td class="nump">2,851<span></span>
</td>
<td class="nump">2,550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">13,373<span></span>
</td>
<td class="nump">13,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets &#8211; net</a></td>
<td class="nump">1,238<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">4,462<span></span>
</td>
<td class="nump">4,474<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">All other non-current assets</a></td>
<td class="nump">1,926<span></span>
</td>
<td class="nump">1,950<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">33,586<span></span>
</td>
<td class="nump">33,089<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">2,002<span></span>
</td>
<td class="nump">1,502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">3,152<span></span>
</td>
<td class="nump">3,035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities</a></td>
<td class="nump">1,889<span></span>
</td>
<td class="nump">1,943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Current compensation and benefits</a></td>
<td class="nump">1,343<span></span>
</td>
<td class="nump">1,521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">All other current liabilities</a></td>
<td class="nump">1,583<span></span>
</td>
<td class="nump">1,552<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="nump">9,969<span></span>
</td>
<td class="nump">9,553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term borrowings</a></td>
<td class="nump">6,757<span></span>
</td>
<td class="nump">7,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Non-current compensation and benefits</a></td>
<td class="nump">5,443<span></span>
</td>
<td class="nump">5,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">159<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">All other non-current liabilities</a></td>
<td class="nump">1,840<span></span>
</td>
<td class="nump">1,796<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">24,168<span></span>
</td>
<td class="nump">24,437<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">211<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.01 per share, 1,000,000,000 shares authorized, 458,134,263 shares issued as of March 31, 2025; 457,246,971 shares issued as of December 31, 2024</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost, 291,053 shares as of March 31, 2025 and December 31, 2024</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">6,597<span></span>
</td>
<td class="nump">6,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">3,810<span></span>
</td>
<td class="nump">3,262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss) &#8211; net</a></td>
<td class="num">(1,199)<span></span>
</td>
<td class="num">(1,379)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total equity attributable to GE HealthCare</a></td>
<td class="nump">9,187<span></span>
</td>
<td class="nump">8,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">9,207<span></span>
</td>
<td class="nump">8,464<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable noncontrolling interests, and equity</a></td>
<td class="nump">$ 33,586<span></span>
</td>
<td class="nump">$ 33,089<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Asset, After Allowance For Credit Loss And Deferred Costs, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property, Plant, And Equipment And Operating Lease Right-of-Use Asset, After Accumulated Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph (12)(c)<br> -Section S99<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph (16)(c)<br> -Paragraph 3A<br> -Section S99<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (15)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (14)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Financial Position (Unaudited) (Parentheticals) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit losses</a></td>
<td class="nump">$ 106<span></span>
</td>
<td class="nump">$ 103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">458,134,263<span></span>
</td>
<td class="nump">457,246,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">291,053<span></span>
</td>
<td class="nump">291,053<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common stock</div></th>
<th class="th"><div>Treasury stock</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th"><div>Accumulated other comprehensive income (loss) &#8211; net</div></th>
<th class="th"><div>Equity attributable to noncontrolling interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Equity, beginning balance (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">455,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, beginning balance at Dec. 31, 2023</a></td>
<td class="nump">$ 7,145<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,493<span></span>
</td>
<td class="nump">$ 1,326<span></span>
</td>
<td class="num">$ (691)<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of shares under equity awards, net of shares withheld for taxes and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of shares under equity awards, net of shares withheld for taxes and other</a></td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to GE HealthCare</a></td>
<td class="nump">374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to GE HealthCare</a></td>
<td class="num">(95)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Changes in equity attributable to noncontrolling interests</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Equity, ending balance (in shares) at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">456,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, ending balance at Mar. 31, 2024</a></td>
<td class="nump">$ 7,423<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,504<span></span>
</td>
<td class="nump">1,687<span></span>
</td>
<td class="num">(787)<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Equity, beginning balance (in shares) at Dec. 31, 2024</a></td>
<td class="nump">457,246,971<span></span>
</td>
<td class="nump">457,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, beginning balance at Dec. 31, 2024</a></td>
<td class="nump">$ 8,464<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="num">$ (25)<span></span>
</td>
<td class="nump">6,583<span></span>
</td>
<td class="nump">3,262<span></span>
</td>
<td class="num">(1,379)<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Dec. 31, 2024</a></td>
<td class="nump">291,053<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of shares under equity awards, net of shares withheld for taxes and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of shares under equity awards, net of shares withheld for taxes and other</a></td>
<td class="num">$ (9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to GE HealthCare</a></td>
<td class="nump">564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to GE HealthCare</a></td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Changes in equity attributable to noncontrolling interests</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Equity, ending balance (in shares) at Mar. 31, 2025</a></td>
<td class="nump">458,134,263<span></span>
</td>
<td class="nump">458,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, ending balance at Mar. 31, 2025</a></td>
<td class="nump">$ 9,207<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="num">$ (25)<span></span>
</td>
<td class="nump">$ 6,597<span></span>
</td>
<td class="nump">$ 3,810<span></span>
</td>
<td class="num">$ (1,199)<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Mar. 31, 2025</a></td>
<td class="nump">291,053<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477787/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Equity (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 0.035<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows - operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 588<span></span>
</td>
<td class="nump">$ 388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile Net income to Cash from (used for) operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation of property, plant, and equipment</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Gain on remeasurement of Nihon Medi-Physics equity method investment</a></td>
<td class="num">(97)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash', window );">Net periodic postretirement benefit plan (income) expense</a></td>
<td class="num">(70)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost', window );">Postretirement plan contributions</a></td>
<td class="num">(98)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid during the year for income taxes</a></td>
<td class="num">(91)<span></span>
</td>
<td class="num">(86)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, excluding the effects of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables', window );">Receivables</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(154)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts', window );">Contract and other deferred assets</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="num">(68)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Current compensation and benefits</a></td>
<td class="num">(200)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">All other operating activities &#8211; net</a></td>
<td class="num">(101)<span></span>
</td>
<td class="num">(129)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash from (used for) operating activities</a></td>
<td class="nump">250<span></span>
</td>
<td class="nump">419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows &#8211; investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Additions to property, plant and equipment and internal-use software</a></td>
<td class="num">(152)<span></span>
</td>
<td class="num">(145)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Purchases of businesses, net of cash acquired</a></td>
<td class="num">(269)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">All other investing activities &#8211; net</a></td>
<td class="nump">34<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash from (used for) investing activities</a></td>
<td class="num">(407)<span></span>
</td>
<td class="num">(188)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows &#8211; financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess', window );">Net increase (decrease) in borrowings (maturities of 90 days or less)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtMaturingInMoreThanThreeMonths', window );">Newly issued debt, net of debt issuance costs (maturities longer than 90 days)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebtMaturingInMoreThanThreeMonths', window );">Repayments and other reductions (maturities longer than 90 days)</a></td>
<td class="num">(257)<span></span>
</td>
<td class="num">(153)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid to stockholders</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from stock issued under employee benefit plans</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">All other financing activities &#8211; net</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Cash from (used for) financing activities</a></td>
<td class="num">(286)<span></span>
</td>
<td class="num">(153)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign currency rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="nump">27<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (decrease) in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(416)<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at beginning of year</a></td>
<td class="nump">2,893<span></span>
</td>
<td class="nump">2,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at end of period</a></td>
<td class="nump">2,476<span></span>
</td>
<td class="nump">2,565<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flows information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid during the year for interest</a></td>
<td class="num">(78)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Acquired but unpaid property, plant, and equipment</a></td>
<td class="nump">$ 86<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contract With Customer, Asset And Deferred Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pension and Other Postretirement Benefits Expense, Employer Contribution, Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense (reversal of expense) for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtMaturingInMoreThanThreeMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment of more than three months. Includes proceeds from long-term and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtMaturingInMoreThanThreeMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebtMaturingInMoreThanThreeMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from a repayment of a borrowing having initial term of repayment of more than three months. Includes repayments of short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebtMaturingInMoreThanThreeMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">ORGANIZATION AND BASIS OF PRESENTATION</a></td>
<td class="text">ORGANIZATION AND BASIS OF PRESENTATION<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">GE HealthCare Technologies Inc. is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services, and data analytics.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The condensed consolidated financial statements (the &#8220;financial statements&#8221;) of GE HealthCare Technologies Inc. and its subsidiaries (&#8220;GE HealthCare,&#8221; the &#8220;Company,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; or &#8220;we&#8221;) have been prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, the financial statements do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments, including normal recurring adjustments, considered necessary for a fair presentation of the Company&#8217;s financial position and operating results have been included. All intercompany balances and transactions within the Company have been eliminated in the financial statements. Operating results for the three months ended March 31, 2025 and 2024 are not necessarily indicative of the results that may be expected for the fiscal year as a whole. The December 31, 2024 period presented on the Condensed Consolidated Statement of Financial Position was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Tables throughout this document are presented in millions of U.S. dollars unless otherwise stated and certain columns and rows may not sum due to the use of rounded numbers. Percentages presented are calculated from the underlying whole-dollar amounts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The financial statements and notes should be read in conjunction with the Company&#8217;s audited consolidated and combined financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 3, 2023, the General Electric Company, which now operates as GE Aerospace (&#8220;GE&#8221;), completed the spin-off of GE HealthCare Technologies Inc. (the &#8220;Spin-Off&#8221;). Following this transaction, GE continues to be considered a related party due to the nature of our relationship and board member affiliation. Net costs incurred with GE were not significant for the three months ended March 31, 2025. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain prior year amounts in the financial statements and notes thereto have been reclassified to conform to the current year presentation. On the Condensed Consolidated Statements of Cash Flows, new line items were added and amounts were reclassified accordingly for the following items: amounts related to current compensation and benefits that were previously reported within All other operating activities &#8211; net, amounts related to purchases of investments previously reported within All other investing activities &#8211; net, and amounts related to equity award activity previously reported within All other financing activities &#8211; net. Additionally, amounts due from related parties and due to related parties which were previously shown on separate lines on the Condensed Consolidated Statements of Cash Flows and Condensed Consolidated Statements of Financial Position were reclassified to Receivables, All other current assets, Accounts Payable, All other current liabilities, and All other operating activities - net as applicable.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><br/>ESTIMATES AND ASSUMPTIONS. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions, which affect the reported amounts and related disclosures in the financial statements. We base our estimates and judgments on historical experience and on various other assumptions and information that we believe to be reasonable under the circumstances. Although our estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations, financial position, and cash flows.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">RECENT ACCOUNTING PRONOUNCEMENTS.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-09 (&#8220;ASU 2023-09&#8221;), </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. ASU 2023-09 addresses investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This update also includes certain other amendments to improve the effectiveness of income tax disclosures. The provisions of ASU 2023-09 are effective for annual periods beginning after December 15, 2024, with early adoption permitted. We expect the adoption to impact disclosures in our notes to the financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU No. 2024-03 (&#8220;ASU 2024-03&#8221;), </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. ASU 2024-03 addresses investor requests for more transparency about expense information through the disaggregation of relevant expense captions in the notes to the financial statements. The provisions of ASU 2024-03 are effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. We expect the adoption to impact disclosures in our notes to the financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE RECOGNITION</a></td>
<td class="text">REVENUE RECOGNITION<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Our revenues primarily consist of sales of products and services to customers. Products include equipment, imaging agents, software-related offerings, and upgrades. Services include contractual and stand-by preventative maintenance and corrective services, as well as related parts and labor, extended warranties, training, and other service-type offerings. The Company recognizes revenue from contracts with customers when the customer obtains control of the underlying products or services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:118%">CONTRACT AND OTHER DEFERRED ASSETS.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Contract assets reflect revenue recognized on contracts with customers in excess of billings based on contractual terms. Contract assets are classified as current or non-current based on the amount of time expected to lapse until the Company&#8217;s right to consideration becomes unconditional. Other deferred assets consist of costs to obtain contracts, primarily commissions, other cost deferrals for shipped products, and deferred service, labor, and direct overhead costs.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Contract assets</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">572&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">589&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other deferred assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Contract and other deferred assets</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">931</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">974</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-current contract assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-current other deferred assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">113&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">105&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total contract and other deferred assets</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,144</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,183</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%;padding-left:2.52pt">Non-current contract and other deferred assets are recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:118%">CONTRACT LIABILITIES.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Contract liabilities include customer advances and deposits received when orders are placed and billed in advance of completion of performance obligations. Contract liabilities are classified as current or non-current based on the periods over which these remaining performance obligations are expected to be satisfied with our customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">As of March 31, 2025 and December 31, 2024, contract liabilities were approximately $2,613 million and $2,629 million, respectively, of which the non-current portion of $724 million and $686 million, respectively, was recognized in All other non-current liabilities in the Condensed Consolidated Statements of Financial Position. Revenue recognized related to the contract liabilities balance at the beginning of the year was approximately $752 million and $741 million for the three months ended March 31, 2025 and 2024, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:118%">REMAINING PERFORMANCE OBLIGATIONS.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Remaining performance obligations (&#8220;RPO&#8221;) represents the estimated revenue expected from customer contracts that are partially or fully unperformed inclusive of amounts deferred in contract liabilities, excluding contracts, or portions thereof, that provide the customer with the right to cancel or terminate without incurring a substantive penalty. RPO also excludes estimated revenue from arrangements where we lease equipment manufactured by the Company to customers.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.650%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Products</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">4,599</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">4,755</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Services&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">10,280</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">9,737</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Total RPO</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">14,879</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">14,491</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">We expect to recognize substantially all of the revenue for our product-related RPO within two years and services-related RPO within five years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT INFORMATION</a></td>
<td class="text">SEGMENT INFORMATION<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Effective July 1, 2024, Image Guided Therapies, previously part of the Imaging segment, was realigned to the Ultrasound segment. The Ultrasound segment was subsequently renamed Advanced Visualization Solutions (&#8220;AVS&#8221;). Following this realignment, the Company continues to have four reportable segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions (&#8220;PCS&#8221;), and Pharmaceutical Diagnostics (&#8220;PDx&#8221;). These segments have been identified based on the nature of the products sold and how the Company manages its operations. We have not aggregated any of our operating segments to form reportable segments. A description of our reportable segments has been provided in Item 1, &#8220;Business&#8221; of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Historical segment financial information presented within this report has been recast to conform to the new reportable segments structure.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s organizational structure is based upon the availability of separate financial information that is evaluated regularly by the Company&#8217;s Chief Operating Decision Maker (&#8220;CODM&#8221;) for the purpose of assessing performance and allocating resources. The Company&#8217;s CODM is its Chief Executive Officer. The CODM assesses segment performance using Total revenues and an earnings metric defined as &#8220;Segment EBIT.&#8221; Segment EBIT is calculated as income before income taxes in our Condensed Consolidated Statements of Income excluding the impact of the following: Interest and other financial charges &#8211; net, Non-operating benefit (income) costs, restructuring costs, acquisition and disposition-related benefits (charges), gain (loss) on business and asset dispositions, Spin-Off and separation costs, amortization of acquisition-related intangible assets, and investment revaluation gain (loss). Segment EBIT is also used in the annual budget and periodic forecasting processes and informs the CODM in decision making regarding the allocation of resources to the segments.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.844%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.929%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total Revenues by Segment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total Imaging</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,140</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,062</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">AVS:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Procedural Guidance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">641&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">651&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Specialized Ultrasound</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total AVS</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,239</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,227</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PCS:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Monitoring Solutions</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">556&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">527&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Life Support Solutions</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total PCS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">753</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">747</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total PDx</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">632</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">599</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">15</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,777</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,650</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Financial information not presented within the reportable segments, shown within the Other category, represents Hea</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">lthCar</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">e Financial Services (&#8220;HFS&#8221;) which does not meet the definition of an operating segment.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.844%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.929%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Significant Expenses by Segment</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Imaging:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cost of sales</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other segment items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">588&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">559&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total Imaging</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,941</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,897</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">AVS:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cost of sales</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other segment items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">380&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">371&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total AVS</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">978</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">970</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PCS:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cost of sales</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other segment items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">224&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">206&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total PCS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">705</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">666</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PDx:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cost of sales</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other segment items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">133&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">126&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total PDx</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">428</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">421</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:0.08pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1) Other segment items for each segment includes selling, general, administrative, research, and development related expenses, as well as other segment income and expenses.</span></div><div style="margin-bottom:0.08pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.844%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.929%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Segment EBIT</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Segment EBIT</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Imaging</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">AVS</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">261&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">257&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PCS </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PDx </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">205&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">178&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">715</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">681</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Restructuring costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Acquisition and disposition-related benefits (charges)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(8)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Gain (loss) on business and asset dispositions</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Spin-Off and separation costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(24)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(60)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Amortization of acquisition-related intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Investment revaluation gain (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">92&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(20)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Interest and other financial charges &#8211; net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-operating benefit income (costs)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">74&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">102&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Income before income taxes</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">692</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">512</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:0.08pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Financial information not presented within the reportable segments, shown within the Other category, primarily represents HFS which does not meet the definition of an operating segment.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">The following table represents the depreciation and amortization amounts reported within the Segment EBIT metric for our reportable segments. Depreciation and amortization expense related to shared property, plant, and equipment and intangibles, exclusive of acquisition-related intangible assets, has been fully allocated to our segments and those allocations are reflected in the amounts presented in the table below. These amounts are included within Cost of sales and Other segment items disclosed in the Significant Expenses by Segment table above.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.844%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.929%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Depreciation and Amortization by Segment</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Imaging</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">57&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">65&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">AVS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PCS </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">13&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">15&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PDx </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">16&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">The Company does not report total assets by segment as the Company&#8217;s CODM does not assess performance, make strategic decisions, or allocate resources based on assets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECEIVABLES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">RECEIVABLES</a></td>
<td class="text">RECEIVABLES<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Current Receivables</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Current customer receivables</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,379</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,382</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-income based tax receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">155&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">155&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other sundry receivables</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">144&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">133&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Current sundry receivables</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">299</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">287</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(106)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(103)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total current receivables &#8211; net</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,572</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,566</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Chargebacks, which are primarily related to our PDx business, are generally settled through issuance of credits, typically within one month of initial recognition, and are recorded as a reduction to current customer receivables. Balances related to chargebacks were $151 million and $153 million as of March 31, 2025 and December 31, 2024, respectively.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Long-Term Receivables</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Long-term customer receivables</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">68</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">59</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-income based tax receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other sundry receivables</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">76&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">68&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Long-term sundry receivables</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">99</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">88</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Allowance for credit losses</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(6)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(5)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total long-term receivables &#8211; net</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">161</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">142</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><br/>Long-term receivables are recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due to entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/310-10/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCING RECEIVABLES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivablesTextBlock', window );">FINANCING RECEIVABLES</a></td>
<td class="text">FINANCING RECEIVABLES<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><br/>Current financing receivables and non-current financing receivables are recognized within All other current assets and All other non-current assets, respectively, in the Condensed Consolidated Statements of Financial Position.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Loans receivable, at amortized cost</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">23&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">23&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Investment in finance leases, net of deferred income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(3)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(2)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Current financing receivables &#8211; net</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">90</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">90</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Loans receivable, at amortized cost</span></div></td><td style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">35&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">35&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Investment in finance leases, net of deferred income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(4)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(4)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Non-current financing receivables &#8211; net</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">186</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">183</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:0.36pt"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">March 31, 2025</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3%, 3%, and 3% </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of financing receivables were over 30 days past due, over 90 days past due, and on nonaccrual, respectively, with the majority of nonaccrual financing receivables secured by collateral. As of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December 31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4%, 4%, and 3% of financing receivables were over 30 days past due, over 90 days past due, and on nonaccrual, respectively, with the majority of nonaccrual financing receivables secured by collateral.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivablesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481933/310-10-55-12A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 44<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-44<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/310-10/tableOfContent<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/310-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivablesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities recognized within All other current liabilities and All other non-current liabilities in the Condensed Consolidated Statements of Financial Position were $386&#160;million and $385&#160;million as of March 31, 2025 and December 31, 2024, respectively. The total lease expense related to our operating lease portfolio was $62&#160;million and $60&#160;million for the three months ended March 31, 2025 and 2024, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text">ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">ACQUISITIONS.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:118%">Nihon Medi-Physics</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">On March 31, 2025, the Company acquired the remaining 50% interest in Nihon Medi-Physics Co., Ltd (&#8220;NMP&#8221;) from joint venture partner Sumitomo Chemical for net cash consideration of $269 million. The acquisition was funded with cash on hand. NMP is a leading pharmaceutical manufacturer in Japan, focused on radiopharmaceuticals, which are used to enable clinical images across neurology, cardiology, and oncology procedures, as well as nonclinical and clinical development of radiotracers and theranostics research. Their product portfolio includes several GE HealthCare radiopharmaceuticals. NMP is included in the Company&#8217;s PDx segment.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">On March 31, 2025, the fair value of the Company&#8217;s existing 50% interest in NMP was determined to be $301 million based on the cash consideration exchanged for acquiring the remaining 50% equity interest. The carrying value of our 50% interest was $204 million. The Company recognized a net gain of $97 million resulting from this remeasurement to fair value. This gain included the reclassification of certain amounts related to the Company&#8217;s 50% interest out of Accumulated other comprehensive income (loss) &#8211; net (&#8220;AOCI&#8221;) including foreign currency translation gains of $63 million and losses related to a defined benefit pension plan of $8 million. The net gain from this remeasurement was recorded in Other (income) expense &#8211; net in the Company&#8217;s Condensed Consolidated Statements of Income for the three months ended March 31, 2025.</span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">The following table provides a summary of the purchase price consideration transferred for the acquisition of NMP.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.595%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Purchase consideration</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cash consideration, net of cash acquired</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">269&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Fair value of previously held interest in NMP</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Fair value of contingent consideration</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total allocable purchase price</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">575</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><br/><br/>The estimated fair values of the assets and liabilities assumed in connection with the acquisition of NMP are as follows.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.595%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Initial allocation</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Receivables</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">53&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Inventories</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Property, plant, and equipment</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">243&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Goodwill</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other intangible assets</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">223&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">All other non-current assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Deferred income taxes</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(87)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">All other non-current liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(28)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total net assets post acquisition</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">575</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) All other non-current assets includes $12 million of indemnification assets, with the underlying indemnified liabilities recorded in All other non-current liabilities.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Other includes Accounts payable, All other current liabilities, and Current compensation and benefits.<br/><br/>The initial allocation of purchase price of NMP to the tangible and intangible assets acquired and liabilities assumed, as reflected in the table above, is based on the Company&#8217;s preliminary allocations of their fair values. The valuation of assets acquired and liabilities assumed has not yet been finalized as of March 31, 2025. While all amounts remain subject to adjustments, the areas subject to the most significant potential adjustments are property, plant, and equipment, intangible assets, decommissioning liabilities, and deferred income taxes. The preliminary valuation required estimates and assumptions including, but not limited to, estimating future cash flows and direct costs in addition to developing the appropriate discount rates. Accordingly, the purchase price adjustments are preliminary and are subject to further adjustments as additional information becomes available and as additional analyses are performed, and such further adjustments may be material. The Company&#8217;s management believes the fair values recognized for the assets acquired and the liabilities assumed are based on reasonable estimates and assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant, and equipment is mostly comprised of land, buildings, equipment (including machinery, furniture, and fixtures) and construction in process. The fair value of property, plant, and equipment was determined using a market participant approach.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other intangibles relate to $200 million of definite-lived intangible assets and $23 million of acquired in-process research and development. Definite-lived intangible assets consist primarily of developed product market authorization rights and customer relationships. The acquired definite-lived intangibles are being amortized over a weighted-average estimated useful life of approximately 12 years. The estimated fair value of intangibles was determined using the income approach, which is a valuation technique that provides an estimate of the fair value of an asset based on market participant expectations of cash flows an asset would generate over its useful life.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The goodwill associated with NMP, recorded within the PDx segment, is non-deductible for tax purposes and is attributed to expected synergies with NMP&#8217;s existing assets and workforce that are expected to allow the Company greater access and growth in the Japan market.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in All other non-current liabilities are asset retirement obligations and decommissioning liabilities of $96 million, which were assumed in the transaction. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NMP has a defined benefit pension plan which has pension assets of $73 million and pension liabilities of $34 million, a net asset of $39 million, which we acquired in the transaction and is included in All other non-current assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred income tax liabilities include the expected U.S. federal, state, and foreign tax consequences associated with temporary differences between the preliminary fair values of the assets acquired and liabilities assumed and the respective tax basis. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to the proximity of the acquisition date to the end of the Company&#8217;s first quarter, the revenues and earnings of NMP are not significant to our consolidated results. If the acquisition of NMP had taken place as of the beginning of 2024, consolidated revenues and earnings would not have been significantly different than reported amounts.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">MIM Software</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 1, 2024, the Company acquired 100% of the stock of MIM Software Inc. (&#8220;MIM Software&#8221;) for approximately $259 million, net of cash acquired of $11 million, and potential contingent payments valued at $13&#160;million pertaining to achievement of certain milestones, for a total preliminary purchase price of $283 million. The acquisition included up to $23&#160;million of other contingent payments based on service requirements. The acquisition was funded with cash on hand. This transaction was accounted for as a business combination. The final purchase price allocation resulted in goodwill of $189 million, customer-related intangible assets of $52&#160;million, developed technology intangible assets of $48&#160;million, net deferred tax liabilities of $13 million, and other net assets of $7 million. The goodwill associated with the acquired business, recorded within the Imaging segment, is non-deductible for tax purposes and is attributed to expected synergies and commercial benefits from use of the MIM Software technology in our existing GE HealthCare portfolio. MIM Software is a global provider of medical imaging analysis and artificial intelligence (&#8220;AI&#8221;) solutions for the practice of radiation oncology, molecular radiotherapy, diagnostic imaging, and urology at imaging centers, hospitals, specialty clinics, and research organizations worldwide. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue and earnings of MIM Software included in the Company&#8217;s financial statements since the acquisition date are not material to our consolidated revenue and earnings. If the acquisition of MIM Software had taken place as of the beginning of 2023, consolidated revenues and earnings would not have been significantly different from reported amounts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">GOODWILL.</span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Imaging</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">AVS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">PCS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">PDx</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at December 31, 2024</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,581</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,987</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,035</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,533</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">13,136</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Acquisitions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency exchange and other</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">12&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">20&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at March 31, 2025</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,587</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,999</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,037</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,750</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">13,373</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We assess the possibility that a reporting unit&#8217;s fair value has been reduced below its carrying amount due to the occurrence of events or circumstances between annual impairment testing dates. We did not identify any reporting units that required an interim impairment test since the last annual impairment testing date.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">OTHER INTANGIBLE ASSETS.</span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.151%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of March 31, 2025</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of December 31, 2024</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Net</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Definite-lived assets</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Customer-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Patents and technology</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,668&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(2,021)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">647&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,593&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1,987)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">606&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Capitalized software </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1,479)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1,437)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Trademarks and other</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">47&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(29)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">17&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">33&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(29)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">4&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total definite-lived assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,696</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(3,555)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,141</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,481</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(3,477)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,004</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Indefinite-lived assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">97</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">97</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">74</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">74</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total other intangible assets</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,793</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(3,555)</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,238</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,555</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(3,477)</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,078</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Indefinite-lived intangible assets relate to acquired in-process research and development prior to project completion and are not amortized.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization expense was $70 million and $80 million for the three months ended March 31, 2025 and 2024, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text">ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">ACQUISITIONS.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:118%">Nihon Medi-Physics</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">On March 31, 2025, the Company acquired the remaining 50% interest in Nihon Medi-Physics Co., Ltd (&#8220;NMP&#8221;) from joint venture partner Sumitomo Chemical for net cash consideration of $269 million. The acquisition was funded with cash on hand. NMP is a leading pharmaceutical manufacturer in Japan, focused on radiopharmaceuticals, which are used to enable clinical images across neurology, cardiology, and oncology procedures, as well as nonclinical and clinical development of radiotracers and theranostics research. Their product portfolio includes several GE HealthCare radiopharmaceuticals. NMP is included in the Company&#8217;s PDx segment.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">On March 31, 2025, the fair value of the Company&#8217;s existing 50% interest in NMP was determined to be $301 million based on the cash consideration exchanged for acquiring the remaining 50% equity interest. The carrying value of our 50% interest was $204 million. The Company recognized a net gain of $97 million resulting from this remeasurement to fair value. This gain included the reclassification of certain amounts related to the Company&#8217;s 50% interest out of Accumulated other comprehensive income (loss) &#8211; net (&#8220;AOCI&#8221;) including foreign currency translation gains of $63 million and losses related to a defined benefit pension plan of $8 million. The net gain from this remeasurement was recorded in Other (income) expense &#8211; net in the Company&#8217;s Condensed Consolidated Statements of Income for the three months ended March 31, 2025.</span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">The following table provides a summary of the purchase price consideration transferred for the acquisition of NMP.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.595%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Purchase consideration</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cash consideration, net of cash acquired</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">269&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Fair value of previously held interest in NMP</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Fair value of contingent consideration</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total allocable purchase price</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">575</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><br/><br/>The estimated fair values of the assets and liabilities assumed in connection with the acquisition of NMP are as follows.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.595%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Initial allocation</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Receivables</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">53&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Inventories</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Property, plant, and equipment</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">243&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Goodwill</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other intangible assets</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">223&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">All other non-current assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Deferred income taxes</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(87)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">All other non-current liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(28)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total net assets post acquisition</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">575</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) All other non-current assets includes $12 million of indemnification assets, with the underlying indemnified liabilities recorded in All other non-current liabilities.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Other includes Accounts payable, All other current liabilities, and Current compensation and benefits.<br/><br/>The initial allocation of purchase price of NMP to the tangible and intangible assets acquired and liabilities assumed, as reflected in the table above, is based on the Company&#8217;s preliminary allocations of their fair values. The valuation of assets acquired and liabilities assumed has not yet been finalized as of March 31, 2025. While all amounts remain subject to adjustments, the areas subject to the most significant potential adjustments are property, plant, and equipment, intangible assets, decommissioning liabilities, and deferred income taxes. The preliminary valuation required estimates and assumptions including, but not limited to, estimating future cash flows and direct costs in addition to developing the appropriate discount rates. Accordingly, the purchase price adjustments are preliminary and are subject to further adjustments as additional information becomes available and as additional analyses are performed, and such further adjustments may be material. The Company&#8217;s management believes the fair values recognized for the assets acquired and the liabilities assumed are based on reasonable estimates and assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant, and equipment is mostly comprised of land, buildings, equipment (including machinery, furniture, and fixtures) and construction in process. The fair value of property, plant, and equipment was determined using a market participant approach.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other intangibles relate to $200 million of definite-lived intangible assets and $23 million of acquired in-process research and development. Definite-lived intangible assets consist primarily of developed product market authorization rights and customer relationships. The acquired definite-lived intangibles are being amortized over a weighted-average estimated useful life of approximately 12 years. The estimated fair value of intangibles was determined using the income approach, which is a valuation technique that provides an estimate of the fair value of an asset based on market participant expectations of cash flows an asset would generate over its useful life.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The goodwill associated with NMP, recorded within the PDx segment, is non-deductible for tax purposes and is attributed to expected synergies with NMP&#8217;s existing assets and workforce that are expected to allow the Company greater access and growth in the Japan market.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in All other non-current liabilities are asset retirement obligations and decommissioning liabilities of $96 million, which were assumed in the transaction. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NMP has a defined benefit pension plan which has pension assets of $73 million and pension liabilities of $34 million, a net asset of $39 million, which we acquired in the transaction and is included in All other non-current assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred income tax liabilities include the expected U.S. federal, state, and foreign tax consequences associated with temporary differences between the preliminary fair values of the assets acquired and liabilities assumed and the respective tax basis. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to the proximity of the acquisition date to the end of the Company&#8217;s first quarter, the revenues and earnings of NMP are not significant to our consolidated results. If the acquisition of NMP had taken place as of the beginning of 2024, consolidated revenues and earnings would not have been significantly different than reported amounts.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">MIM Software</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 1, 2024, the Company acquired 100% of the stock of MIM Software Inc. (&#8220;MIM Software&#8221;) for approximately $259 million, net of cash acquired of $11 million, and potential contingent payments valued at $13&#160;million pertaining to achievement of certain milestones, for a total preliminary purchase price of $283 million. The acquisition included up to $23&#160;million of other contingent payments based on service requirements. The acquisition was funded with cash on hand. This transaction was accounted for as a business combination. The final purchase price allocation resulted in goodwill of $189 million, customer-related intangible assets of $52&#160;million, developed technology intangible assets of $48&#160;million, net deferred tax liabilities of $13 million, and other net assets of $7 million. The goodwill associated with the acquired business, recorded within the Imaging segment, is non-deductible for tax purposes and is attributed to expected synergies and commercial benefits from use of the MIM Software technology in our existing GE HealthCare portfolio. MIM Software is a global provider of medical imaging analysis and artificial intelligence (&#8220;AI&#8221;) solutions for the practice of radiation oncology, molecular radiotherapy, diagnostic imaging, and urology at imaging centers, hospitals, specialty clinics, and research organizations worldwide. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue and earnings of MIM Software included in the Company&#8217;s financial statements since the acquisition date are not material to our consolidated revenue and earnings. If the acquisition of MIM Software had taken place as of the beginning of 2023, consolidated revenues and earnings would not have been significantly different from reported amounts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">GOODWILL.</span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Imaging</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">AVS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">PCS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">PDx</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at December 31, 2024</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,581</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,987</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,035</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,533</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">13,136</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Acquisitions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency exchange and other</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">12&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">20&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at March 31, 2025</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,587</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,999</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,037</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,750</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">13,373</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We assess the possibility that a reporting unit&#8217;s fair value has been reduced below its carrying amount due to the occurrence of events or circumstances between annual impairment testing dates. We did not identify any reporting units that required an interim impairment test since the last annual impairment testing date.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">OTHER INTANGIBLE ASSETS.</span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.151%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of March 31, 2025</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of December 31, 2024</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Net</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Definite-lived assets</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Customer-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Patents and technology</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,668&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(2,021)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">647&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,593&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1,987)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">606&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Capitalized software </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1,479)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1,437)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Trademarks and other</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">47&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(29)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">17&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">33&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(29)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">4&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total definite-lived assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,696</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(3,555)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,141</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,481</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(3,477)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,004</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Indefinite-lived assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">97</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">97</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">74</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">74</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total other intangible assets</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,793</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(3,555)</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,238</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,555</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(3,477)</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,078</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Indefinite-lived intangible assets relate to acquired in-process research and development prior to project completion and are not amortized.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization expense was $70 million and $80 million for the three months ended March 31, 2025 and 2024, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BORROWINGS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">BORROWINGS</a></td>
<td class="text">BORROWINGS<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings include the following senior unsecured notes and credit agreements:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Unsecured Notes</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings include $8,250&#160;million aggregate principal amount of senior unsecured notes in six series with maturity dates ranging from 2025 through 2052 (collectively, the &#8220;Notes&#8221;).</span></div><div><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:125%">Credit Facilities</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the first quarter of 2025, the Company terminated its existing five-year and 364-day senior unsecured revolving credit facilities. These were replaced with new five-year and 364-day senior unsecured revolving credit facilities in aggregate committed amounts of $3,000&#160;million and $500&#160;million, respectively. The terms of the new facilities are substantially similar to those of the terminated facilities. </span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">The Company has credit agreements providing for:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a five-year senior unsecured revolving credit facility in an aggregate committed amount of $3,000&#160;million, maturing on March 27, 2030; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a 364-day senior unsecured revolving credit facility in an aggregate committed amount of $500&#160;million, maturing on March 26, 2026; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a three-year senior unsecured term loan credit facility in an aggregate principal amount of $2,000&#160;million, maturing on January 2, 2026 (the &#8220;Term Loan Facility&#8221; and, together with the five-year revolving credit facility and the 364-day revolving credit facility, the &#8220;Credit Facilities&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were no outstanding amounts under the five-year revolving credit facility and 364-day revolving credit facility, and there was $500&#160;million and $750&#160;million outstanding on the Term Loan Facility as of March 31, 2025 and December 31, 2024, respectively. In the first quarter of 2025, we repaid $250&#160;million of the Term Loan Facility.</span></div><div><span><br/></span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.179%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Borrowings Composition</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5.600% senior notes due November 15, 2025</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,500&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,500&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5.650% senior notes due November 15, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">4.800% senior notes due August 14, 2029</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,000&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,000&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5.857% senior notes due March 15, 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5.905% senior notes due November 22, 2032</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,750&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,750&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">6.377% senior notes due November 22, 2052</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Floating rate Term Loan Facility due January 2, 2026</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">500&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">750&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total principal debt issued</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">8,780</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">9,036</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Less: Unamortized debt issuance costs and discounts</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">30&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Add: Cumulative basis adjustment for fair value hedges</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">9&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(51)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total borrowings</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">8,759</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">8,951</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Less: Short-term borrowings</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,002&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,502&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Long-term borrowings</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">6,757</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">7,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(1) Short-term borrowings </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">as of March 31, 2025 </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December 31, 2024 i</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ncludes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$2,000&#160;million and $1,500&#160;million, respectively,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> related to the current portion of our long-term borrowings, net of unamortized debt issuance costs and discounts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See Note 12, &#8220;Financial Instruments and Fair Value Measurements&#8221; for further information about borrowings and associated derivatives contracts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">LETTERS OF CREDIT, GUARANTEES, AND OTHER COMMITMENTS.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of March 31, 2025 and December 31, 2024, the Company had bank guarantees and surety bonds of approximately $786&#160;million and $784&#160;million, respectively, related to certain commercial contracts. Additionally, we have issued approximately $24 million and $25 million of guarantees as of March 31, 2025 and December 31, 2024, respectively, primarily related to residual value and credit guarantees on equipment sold to third-party finance companies. Our Condensed Consolidated Statements of Financial Position reflect a liability of $2 million and $3 million as of March 31, 2025 and December 31, 2024, respectively, related to these guarantees. For credit-related guarantees, we estimate our expected credit losses related to off-balance sheet credit exposure consistent with the method used to estimate the allowance for credit losses on financial assets held at amortized cost.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>POSTRETIREMENT BENEFIT PLANS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">POSTRETIREMENT BENEFIT PLANS</a></td>
<td class="text">POSTRETIREMENT BENEFIT PLANS<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We sponsor a number of pension and retiree health and life insurance benefit plans that we present in three categories: U.S. Plans, International Plans, and Other Postretirement Plans (&#8220;OPEB Plans&#8221;). Please refer to Note 10, &#8220;Postretirement Benefit Plans&#8221; in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 for further information. Pension plans with pension assets or obligations less than $50&#160;million are not included in the results below.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.288%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.483%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.483%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.487%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Components of Expense (Income)</span></div></td><td colspan="24" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">U.S. Plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">International Plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">OPEB Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31,</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Service cost &#8211; Operating</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(287)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(298)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(36)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(48)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Amortization of net loss (gain)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Amortization of prior service cost (credit)</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(3)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(20)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(22)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Special termination cost</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Non-operating</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(60)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(71)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(10)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(21)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(24)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Net periodic expense (income)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(59)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(63)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(5)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(20)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(22)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">three months ended</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> March 31, 2025, the Company made cash payments totaling $43 million to its U.S. Plans, $10 million to its International Plans, and $45&#160;million to its OPEB Plans. In 2025, the Company expects to make total cash contributions of approximately $327&#160;million to these plans. The Company funds annually, at a minimum, the statutorily required minimum amount for our qualified plans. Non-qualified plans are unfunded and we pay benefits from our cash on hand.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Defined Contribution Plan</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">GE HealthCare sponsors a defined contribution plan for its eligible U.S. employees. Expenses associated with our employees&#8217; participation in GE HealthCare&#8217;s defined contribution plan were $45 million and $32 million for the </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">three months ended</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> March 31, 2025 and 2024, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/715/tableOfContent<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480126/715-20-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480266/715-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Our effective income tax rate was 15.0% and 24.2% for the three months ended March 31, 2025 and 2024, respectively. The tax rate for the three months ended March 31, 2025 is lower than the U.S. statutory rate primarily due to the release of income tax reserves in a foreign jurisdiction for tax years which are no longer subject to an assessment from the local taxing authorities, the remeasurement gain that was recorded due to the NMP acquisition which is not taxable, and research and development (&#8220;R&amp;D&#8221;) benefits, partially offset by geographic earnings mix, withholding taxes, and state taxes. The tax rate for the three months ended March 31, 2024 is higher than the U.S. statutory rate primarily due to geographic earnings mix, withholding taxes, and state taxes, partially offset by R&amp;D benefits.<br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is currently being audited in a number of jurisdictions for tax years 2004-2023, including China, France, Germany, India, Japan, Norway, the United Kingdom, and the United States.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) &#8211; NET<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) &#8211; NET</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) &#8211; NET<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in Accumulated other comprehensive income (loss) - net by component were as follows.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="margin-top:0.02pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">For the three months ended March 31, 2025</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Currency translation adjustments</span><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-right:-1.31pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Pension and Other Postretirement  Plans</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cash flow hedges</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total AOCI</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(1,973)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">576</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(1,379)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other comprehensive income (loss) before reclassifications &#8211; net of taxes of $15, $5, and $3</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Reclassifications from AOCI &#8211; net of taxes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(2)(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"> of $&#8212;, $16, and $&#8212;</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">63&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(49)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">17&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Other comprehensive income (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">257</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(69)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">180</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Less: Other comprehensive income (loss) attributable to noncontrolling interests</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(1,717)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">507</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">10</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(1,199)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31, 2024</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Currency translation adjustments</span><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-right:-1.31pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Pension and Other Postretirement Plans</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cash flow hedges</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total AOCI</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2023</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(1,706)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,033</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(18)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(691)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other comprehensive income (loss) before reclassifications &#8211; net of taxes of $(7), $(1), and $(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Reclassifications from AOCI &#8211; net of taxes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"> of $&#8212;, $12, and $&#8212;</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(38)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(37)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Other comprehensive income (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(76)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(35)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(95)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Less: Other comprehensive income (loss) attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2024</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(1,781)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">997</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(2)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(787)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) The amount of Currency translation adjustments recognized in Other comprehensive income (loss) (&#8220;OCI&#8221;) during the three months ended March 31, 2025 and 2024 included net gains (losses) relating to net investment hedges, as further discussed in Note 12, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial Instruments and Fair Value Measurements.&#8221;</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Reclassifications from AOCI into earnings for Pension and Other Postretirement Plans are recognized within Non-operating benefit (income) costs, while Cash flow hedges are recognized within Cost of products and Cost of services in our Condensed Consolidated Statements of Income.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) Includes net of tax impact of $63 million to Currency translation adjustments and $8 million to Pension and Other Postretirement Plans related to the derecognition of the prior NMP equity method investment. Refer to Note 7, &#8220;Acquisitions, Goodwill, and Other Intangible Assets&#8221; for additional information on the NMP acquisition.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/220/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesAndFairValueTextBlock', window );">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">DERIVATIVES AND HEDGING.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our primary objective in executing and holding derivative contracts is to reduce the volatility of earnings and cash flows associated with risks related to foreign currency exchange rates, interest rates, equity prices, and commodity prices. These derivative contracts reduce, but do not entirely eliminate, the aforementioned risks. Our policy is to use derivative contracts solely for managing risks and not for speculative purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For derivative instruments designated as cash</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">flow hedges, changes in the fair value of designated hedging instruments are initially recorded as a component of AOCI and subsequently reclassified to earnings in the period in which the hedged transaction affects earnings and to the same financial statement line item impacted by the hedged transaction. As of March 31, 2025, we expect to reclassify $14&#160;million of pre-tax net deferred gains associated with designated cash flow hedges to earnings in the next 12 months, contemporaneously with the impact on earnings of the related hedged transactions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cash flows associated with derivatives designated as cash flow hedges are recorded in All other operating activities &#8211; net in the Condensed Consolidated Statements of Cash Flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Hedges</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We use cross-currency interest rate swaps and foreign currency forward contracts in combination with foreign currency option contracts to hedge the foreign currency risk associated with our net investment in foreign operations. As of March 31, 2025, these contracts were designated as hedges of our net investment in foreign operations, primarily in Euro and Chinese Renminbi currencies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cash flows associated with derivatives designated as net investment hedges are recorded in All other investing activities &#8211; net in the Condensed Consolidated Statements of Cash Flows. Cash flows from the periodic interest settlements on the cross-currency swaps are recorded in All other operating activities &#8211; net in the Condensed Consolidated and Statements of Cash Flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedges</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We use interest rate swaps to hedge the interest rate risk on our fixed rate borrowings. These derivatives are designated as fair value hedges to hedge the changes in fair value due to benchmark interest rate risk of specific designated cash flows of our senior unsecured notes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We record the changes in fair value on these swap contracts in Interest and other financial charges &#8211; net in our Condensed Consolidated Statements of Income, the same line item where the offsetting change in the fair value of the designated cash flows of the senior unsecured note is recorded as a basis adjustment.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash flows for the periodic interest settlements on the interest rate swaps are recorded in All other operating activities &#8211; net in the Condensed Consolidated Statements of Cash Flows.</span></div><div><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:125%">Derivatives Not Designated as Hedging Instrument</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">s</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also execute derivative instruments, such as foreign currency forward contracts and equity-linked total return swaps, which are not designated as qualifying hedges. These derivatives serve as economic hedges of foreign currency exchange rate and equity price risks. We also identify and record foreign currency-related features in our purchase or sales contracts where the currency is not the local or functional currency of any substantive party to the contract as embedded derivatives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The changes in fair value of derivatives not designated in qualifying hedge transactions are recorded in Cost of products, Cost of services, Selling, general, and administrative (&#8220;SG&amp;A&#8221;), and Other (income) expense &#8211; net in the Condensed Consolidated Statements of Income based on the nature of the underlying hedged transaction. Changes in fair value of embedded derivatives are recognized in Other (income) expense &#8211; net in the Condensed Consolidated Statements of Income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cash flows associated with derivatives not designated but used as economic hedges are recorded, based on the nature of the underlying hedged transaction, in All other operating activities &#8211; net and All other investing activities &#8211; net in the Condensed Consolidated Statements of Cash Flows. The cash flows related to embedded derivatives are included in All other operating activities &#8211; net in the Condensed Consolidated Statements of Cash Flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the gross fair values of our outstanding derivative instruments.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value of Derivatives</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Gross Notional</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value &#8211; Assets</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value &#8211; Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Gross Notional</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value &#8211; Assets</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value &#8211; Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward contracts</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,474&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">25&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">15&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,210&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">43&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">11&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Derivatives accounted for as cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,474</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">25</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">15</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,210</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">43</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cross-currency swaps</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,075&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">12&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">97&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,995&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">15&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">46&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward and options contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Derivatives accounted for as net investment hedges</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,835</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">41</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,726</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">45</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">64</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Interest rate swaps</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,700&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">17&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,700&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">51&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Derivatives accounted for as fair value hedges</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,700</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">14</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,700</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">51</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">4,395&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3,925&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other derivatives</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">384&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">31&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">370&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">47&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Derivatives not designated as hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,779</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">53</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,294</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">57</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">29</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total derivatives</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">12,788</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">136</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">160</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">11,930</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">145</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">155</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) As of March 31, 2025, accrued interest is included in the above fair value and is not considered material. As of December 31, 2024, accrued interest is excluded from the above fair value and is not considered material. </span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Other derivatives are comprised of embedded derivatives and derivatives related to equity contracts.</span></div><div style="padding-left:13.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents amounts recorded in Long-term borrowings in the Condensed Consolidated Statements of Financial Position related to cumulative basis adjustment for fair value hedges.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.288%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.597%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Carrying amount</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Cumulative basis adjustment included in the carrying amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Carrying amount</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Cumulative basis adjustment included in the carrying amount</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><span style="-sec-ix-hidden:f-857"><span style="-sec-ix-hidden:f-858">Long-term borrowings designated in fair value hedges</span></span></span></div></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,704&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">9&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:0 1pt"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,644&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(51)</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the master arrangements with the respective counterparties to our derivative contracts, in certain circumstances and subject to applicable requirements, we are allowed to net settle transactions with a single net amount payable by one party to the other. However, we have elected to present the derivative assets and derivative liabilities on a gross basis in our Condensed Consolidated Statements of Financial Position and in the table above. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of March 31, 2025 and December 31, 2024, the potential effect of rights of offset associated with the derivative contracts would be an offset to both assets and liabilities by $55&#160;million and $77&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The table below presents the pre-tax gains (losses) recognized in OCI associated with the Company&#8217;s cash flow and net investment hedges.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.955%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.873%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Pre-tax Gains (Losses) Recognized in OCI Related to Cash Flow and Net Investment Hedges</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cash flow hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(14)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">20&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net investment hedges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(65)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">32&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Amounts recognized in OCI for excluded components for the periods presented were immaterial.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The tables below present the gains (losses) on our derivative financial instruments and hedging activity in the Condensed Consolidated Statements of Income.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.874%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Derivative Financial Instruments and Hedging Activity</span></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31, 2025</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cost of products</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cost of services</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">SG&amp;A</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Interest and other financial charges </span><span style="color:#454545;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8211;</span><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"> net</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Other</span><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward contracts</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(2)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">8&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward and options contracts</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of net investment hedges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Interest rate swaps</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">57&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Debt basis adjustment on Long-term borrowings</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(61)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of fair value hedges</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward contracts</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">15&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">4&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other derivatives</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of derivatives not designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">15</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(3)</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(15)</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.874%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31, 2024</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cost of products</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cost of services</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">SG&amp;A</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Interest and other financial charges </span><span style="color:#454545;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8211;</span><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"> net</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Other</span><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward contracts</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">8&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward and option contracts</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of net investment hedges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">10</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Interest rate swaps</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(45)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Debt basis adjustment on Long-term borrowings</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">38&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of fair value hedges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(12)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(3)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other derivatives</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of derivatives not designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(12)</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(3)</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Changes in fair value related to components other than the spot rate are excluded from effectiveness testing for the three months ended March 31, 2025 and 2024.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Amount includes $(4)&#160;million and $(6)&#160;million of interest expense on interest rate derivatives for the three months ended March 31, 2025 and 2024, respectively.</span></div><div style="margin-bottom:0.08pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) Other derivatives are comprised of embedded derivatives and derivatives related to equity contracts.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4) Amounts are inclusive of gains (losses) in Other (income) expense &#8211; net in the Condensed Consolidated Statements of Income.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FAIR VALUE MEASUREMENTS.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table represents assets and liabilities that are recorded and measured at fair value on a recurring basis.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value of Assets and Liabilities Measured on a Recurring Basis</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of March 31, 2025</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of December 31, 2024</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Assets:</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Money market funds</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Investment securities</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">27&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">27&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">32&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">32&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Derivatives</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Liabilities:</span></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Derivatives</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Contingent consideration</span></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">40&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">40&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">34&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">34&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:118%">Cash equivalents</span></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">As of March 31, 2025 and December 31, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">, Cash, cash equivalents, and restricted cash of $2,473&#160;million and $2,889&#160;million, respectively, included money market funds of $230&#160;million and $312 million, and other cash equivalents of $1,229&#160;million and $1,573&#160;million, respectively. The carrying values of the other cash equivalents approximates the fair value due to their short maturities and are valued using Level 1 or Level 2 inputs. Refer to Note 16, &#8220;Supplemental Financial Information&#8221; for further information.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:118%">Derivatives</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Derivatives are measured at fair value using a discounted cash flow method or option models using interest rates, foreign exchange spot and forward rates and yield curves observable at commonly quoted intervals, implied volatilities, and credit spreads as key inputs. Unobservable inputs relate to our own credit risk which is not significant to the overall measurement of fair value.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:118%">Contingent consideration</span></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Contingent consideration is recorded at fair value based on estimates of future cash flows in connection with business acquisitions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">. As the valuation of these liabilities is based on inputs that are less observable or not observable in the market, the determination of fair value is classified within Level 3 of the fair value hierarchy.</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:118%">Non-recurring fair value measurements</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Changes in fair value measurements of assets and liabilities measured at fair value on a non-recurring basis, such as equity method investments, equity investments without readily determinable fair value, financing receivables, and long-lived assets, were not material for the </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">three months ended</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"> March 31, 2025 and 2024, with the exception of the gain on fair value measurement of the NMP equity method investment as described in Note 7 &#8220;Acquisitions, Goodwill, and Other Intangible Assets.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:118%">Fair value of other financial instruments</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The estimated fair value of borrowings as of March 31, 2025 and December 31, 2024 was $9,223&#160;million and $9,374&#160;million, respectively, compared to a carrying value (which only includes a reduction for unamortized debt issuance costs and discounts and cumulative basis adjustment) of $8,759&#160;million and $8,951&#160;million, respectively. The fair value of our borrowings includes accrued interest and is determined based on observable and quoted prices and spreads of comparable debt and benchmark securities and is considered Level 2 in the fair value hierarchy. See Note 8, &#8220;Borrowings&#8221; and Note 16, &#8220;Supplemental Financial Information&#8221; for further information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesAndFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivatives and fair value of assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/815/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/820/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesAndFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock', window );">COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES</a></td>
<td class="text">COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">GUARANTEES.</span></div><div style="margin-bottom:0.08pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has off-balance sheet credit exposure through standby letters of credit, bank guarantees, bid bonds, and surety bonds. See Note 8, &#8220;Borrowings&#8221; for further information.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PRODUCT WARRANTIES.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide warranty coverage to our customers as part of customary practices in the market to provide assurance that the products we sell comply with agreed-upon specifications. We provide estimated product warranty expenses when we sell the related products. Warranty accruals are estimates that are based on the best available information, mostly historical claims experience, therefore claims costs may differ from amounts provided. An analysis of changes in the liability for product warranties follows.</span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.984%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at beginning of period</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">168</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">192</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Current-year provisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Expenditures</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(58)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(55)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency exchange and other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at end of period</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">171</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">175</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Product warranties are recognized within All other current liabilities in the Condensed Consolidated Statements of Financial Position. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">LEGAL MATTERS. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the normal course of our business, we are involved from time to time in various arbitrations; class actions; commercial, intellectual property, and product liability litigation; government investigations; investigations by competition/antitrust authorities; and other legal, regulatory, or governmental actions, including the significant matters described below that could have a material impact on our results of operations and cash flows. In many proceedings, including the specific matters described below, it is inherently difficult to determine whether any loss is probable or even reasonably possible or to estimate the size or range of the possible loss, and accruals for legal matters are not recorded until a loss for a particular matter is considered probable and reasonably estimable. Given the nature of legal matters and the complexities involved, it is often difficult to predict and determine a meaningful estimate of loss or range of loss until we know, among other factors, the particular claims involved, the likelihood of success of our defenses to those claims, the damages or other relief sought, how discovery or other procedural considerations will affect the outcome, the settlement posture of other parties, and other factors that may have a material effect on the outcome. For such matters, unless otherwise specified, we do not believe it is possible to provide a meaningful estimate of loss at this time. Moreover, it is not uncommon for legal matters to be resolved over many years, during which time relevant developments and new information must be continuously evaluated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contracts with Iraqi Ministry of Health</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2017, a number of U.S. Service members, civilians, and their families brought a complaint in the U.S. District Court for the District of Columbia (the &#8220;District Court&#8221;) against a number of pharmaceutical and medical device companies, including GE HealthCare and certain affiliates, alleging that the defendants violated the U.S. Anti-Terrorism Act. The complaint seeks monetary relief and alleges that the defendants provided funding for an Iraqi terrorist organization through their sales practices pursuant to pharmaceutical and medical device contracts with the Iraqi Ministry of Health. In July 2020, the District Court granted defendants&#8217; motions to dismiss and dismissed all of the plaintiffs&#8217; claims. In January 2022, a panel of the U.S. Court of Appeals for the District of Columbia Circuit reversed the District Court&#8217;s decision. In February 2022, the defendants requested review of the decision by all of the judges on the U.S. Court of Appeals for the District of Columbia Circuit (the &#8220;D.C. Circuit&#8221;). In February 2023, the D.C. Circuit denied this request. In June 2023, defendants petitioned the Supreme Court to review the D.C. Circuit&#8217;s decision. On June 24, 2024, the Supreme Court vacated the D.C. Circuit&#8217;s decision and remanded the case to the D.C. Circuit for further consideration. On November 19, 2024, the D.C. Circuit heard oral argument from the parties, and the D.C. Circuit&#8217;s decision is pending. The proceedings in the District Court are currently inactive.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Government Disclosures </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, we make self-disclosures regarding our compliance with the Foreign Corrupt Practices Act (&#8220;FCPA&#8221;) and similar laws to relevant authorities who may pursue or decline to pursue enforcement proceedings against us. We, with the assistance of outside counsel, made voluntary self-disclosures to the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and the U.S. Department of Justice (&#8220;DOJ&#8221;) beginning in 2018 regarding tender irregularities and other potential violations of the FCPA relating to our activities in certain provinces in China. We have been engaged in ongoing discussions with each of the SEC and the DOJ regarding these matters. We are fully cooperating with the reviews by these agencies and have implemented, and continue to implement, enhancements to our compliance policies and practices. At this time, we are unable to predict the duration, scope, result, or related costs associated with these disclosures to the SEC and the DOJ. We also are unable to predict what, if any, action may be taken by the SEC or the DOJ or what penalties or remedial actions they may seek. Any determination that our operations or activities are not in compliance with existing laws or regulations, including applicable foreign laws, could result in the imposition of fines, penalties, disgorgement, equitable relief, or other losses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments, contingencies, and guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 460<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/460/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING ACTIVITIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">RESTRUCTURING ACTIVITIES</a></td>
<td class="text">RESTRUCTURING ACTIVITIES<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Restructuring activities are essential to optimize the business operating model for GE HealthCare and mostly involve workforce reductions, organizational realignments, and revisions to our real estate footprint. Specifically, restructuring charges (gains) primarily include facility exit costs, employee-related termination benefits associated with workforce reductions, asset write-downs, and cease-use costs. For segment reporting, restructuring activities are not allocated.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net expenses for restructuring initiatives committed to by management through March 31, 2025 are included in the table below.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.511%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.595%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Employee termination costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">21&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">25&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Facility and other exit costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Asset write-downs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">7&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total restructuring activities &#8211; net</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">22</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">40</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These restructuring initiatives are expected to result in additional expenses of approximately $40&#160;million, to be incurred primarily over the next 12 months, substantially related to employee-related termination benefits and asset write-downs. Restructuring expenses (gains) are recognized within <span style="-sec-ix-hidden:f-1056"><span style="-sec-ix-hidden:f-1057">Cost of products, Cost of services, or SG&amp;A, as appropriate, in the Condensed Consolidated Statements of Income.</span></span></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liabilities related to restructuring are recognized within Current compensation and benefits, All other current liabilities, Non-current compensation and benefits, and All other non-current liabilities in the Condensed Consolidated Statements of Financial Position. The activity related to our restructuring liabilities follows.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;padding-right:-1.31pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Employee termination costs</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;padding-right:-1.31pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Facility and other exit costs</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at December 31, 2024</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">67</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">86</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Charges</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Payments and other adjustments</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(14)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(3)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(17)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at March 31, 2025</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">73</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">89</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/420/tableOfContent<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The numerator for both basic and diluted earnings per share (&#8220;EPS&#8221;) is Net income attributable to GE HealthCare. The denominator of basic EPS is the weighted-average number of shares outstanding during the period. The dilutive effect of outstanding stock options, restricted stock units, and performance share units is reflected in the denominator for diluted EPS using the treasury stock method.</span></div><div><span><br/></span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.066%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.818%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Earnings Per Share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:125%">(In millions, except per share amounts)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:125%">Numerator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Net income</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Net (income) loss attributable to noncontrolling interests</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(24)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(14)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Net income attributable to GE HealthCare</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">564&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">374&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:125%">Denominator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Basic weighted-average shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Dilutive effect of common stock equivalents</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Diluted weighted-average shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">459&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">459&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Basic earnings per share</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1.23&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.82&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Diluted earnings per share</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Antidilutive securities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">4&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(1) Diluted earnings per share excludes certain shares issuable under share-based compensation plans because the effect would have been antidilutive.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">SUPPLEMENTAL FINANCIAL INFORMATION</a></td>
<td class="text">SUPPLEMENTAL FINANCIAL INFORMATION<div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CASH, CASH EQUIVALENTS, AND RESTRICTED CASH.</span></div><div style="margin-top:0.02pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cash and cash equivalents</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,454&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,874&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Short-term restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Financial Position</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,473</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,889</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:1.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Long-term restricted cash</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Cash Flows</span></div></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,476</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,893</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Long-term restricted cash is recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">INVENTORIES.</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Raw materials</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">991&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">921&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Finished goods</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,068&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">926&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Inventories</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,158</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,939</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain inventory items are long-term in nature and therefore have been recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position and are not reflected in the table above. See the supplemental table &#8220;All Other Non-Current Assets&#8221; for further information. </span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PROPERTY, PLANT, AND EQUIPMENT &#8211; NET.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Land and improvements</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">146&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">66&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Buildings, structures, and related equipment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">1,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Machinery and equipment</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,905&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,705&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Leasehold improvements and manufacturing plants under construction</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total property, plant, and equipment, at original cost</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">5,661</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">5,267</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Accumulated depreciation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(3,179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(3,080)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Right-of-use operating lease assets, net of amortization</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">369&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">364&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Property, plant, and equipment &#8211; net</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,851</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,550</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ALL OTHER ASSETS AND ALL OTHER LIABILITIES. </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All Other Current Assets</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Prepaid expenses and deferred costs</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">249&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">188&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Financing receivables &#8211; net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Derivative instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">100&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">123&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Tax receivables</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">46&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">16&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All other current assets</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">601</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">532</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All Other Non-Current Assets</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Prepaid pension asset</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">723&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">657&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Equity method and other investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Financing receivables &#8211; net</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">186&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">183&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Long-term receivables &#8211; net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Inventories</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">143&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">139&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Contract and other deferred assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Capitalized cloud computing arrangement implementation costs</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">113&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">84&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All other non-current assets</span></div></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">1,926</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">1,950</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All Other Current Liabilities</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Sales allowances and related liabilities</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">221&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">242&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Income and indirect tax liabilities including uncertain tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Product warranties</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">171&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">168&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Accrued freight and utilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Operating lease liabilities</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">119&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">115&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Derivative instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest payable on borrowings</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">141&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">92&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Environmental and asset retirement obligations</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">355&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">386&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All other current liabilities</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">1,583</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">1,552</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All Other Non-Current Liabilities</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Contract liabilities</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">724&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">686&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Environmental and asset retirement obligations</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">395&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">291&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Income and indirect tax liabilities including uncertain tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Derivative instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">39&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">64&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><span style="-sec-ix-hidden:f-1193"><span style="-sec-ix-hidden:f-1194">Finance lease obligations</span></span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Sales allowances and related liabilities</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">24&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">23&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All other non-current liabilities</span></div></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">1,840</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">1,796</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(1) Derivative instruments include the related accrued interest. Refer to Note 12, &#8220;Financial Instruments and Fair Value Measurements&#8221; for further information.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(2) Current assets Other primarily represents indemnity assets associated with separation agreements with GE as of March 31, 2025.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(3) Non-current assets Other primarily consists of indemnity assets associated with separation agreements with GE, derivative instruments, and tax receivables.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(4) Current liabilities Other primarily consists of miscellaneous accrued costs, contingent consideration liabilities, and dividends payable to stockholders.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(5) Non-current liabilities Other primarily consists of miscellaneous accrued costs, indemnity liabilities associated with separation agreements with GE, and contingent consideration liabilities.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:118%">SUPPLY CHAIN FINANCE PROGRAMS. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Company participates in voluntary supply chain finance programs which provide participating suppliers the opportunity to sell their GE HealthCare receivables to third parties at the sole discretion of both the suppliers and the third parties. We evaluate supply chain finance programs to ensure the use of a third-party intermediary to settle our trade payables does not change the nature, existence, amount, or timing of our trade payables and does not provide the Company with any direct economic benefit. If any characteristics of the trade payables change or we receive a direct economic benefit, we reclassify the trade payables to borrowings. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">In connection with the supply chain finance programs, payment terms normally range from 30 to 180 days, depending on the underlying supplier agreements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Included within <span style="-sec-ix-hidden:f-1206"><span style="-sec-ix-hidden:f-1207">Accounts payable</span></span> in the Condensed Consolidated Statements of Financial Position as of March 31, 2025 and December 31, 2024 were $364 million and $394 million, respectively, of confirmed supplier invoices that are outstanding and subject to third-party programs.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:118%">REDEEMABLE NONCONTROLLING INTERESTS</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:118%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Company has noncontrolling interests with redemption features. These redemption features, such as put options, could require the Company to purchase the noncontrolling interests upon the occurrence of certain events. All noncontrolling interests with redemption features that are not solely within our control are recognized within the Condensed Consolidated Statements of Financial Position between liabilities and equity. Redeemable noncontrolling interests are initially recorded at the issuance date fair value. Those that are currently redeemable, or probable of becoming redeemable, are subsequently adjusted to the greater of current redemption value or initial carrying value. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Activity attributable to redeemable noncontrolling interests is presented below.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at beginning of period</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">188</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">165</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net income attributable to redeemable noncontrolling interests</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at end of period </span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">211</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">177</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">OTHER INCOME (EXPENSE) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> NET.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.622%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.040%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center;text-indent:5pt"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Net financing income and investment income (loss)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(16)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Equity method income (loss)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Change in fair value of assumed obligations</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(8)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(8)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Gain on remeasurement of NMP equity method investment</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other items, net</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">14&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Total other income (expense) &#8211; net</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">99</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(8)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(1) Refer to Note 7, &#8220;Acquisitions, Goodwill, and Other Intangible Assets&#8221; for additional information on the NMP acquisition.</span></div>(2) Other items, net primarily consists of licensing and royalty income, lease income, change in tax indemnities, and gains and losses related to derivatives. Additionally, for the three months ended March 31, 2025 it includes a realization of a gain contingency.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text">SUBSEQUENT EVENTSOn April 30, 2025, our Board of Directors authorized a share repurchase program for up to $1,000 million of our common stock. Repurchases may be made from time to time in the open market, in privately negotiated transactions, or in such other manner as determined by GE HealthCare. The repurchase program does not have an expiration date, does not obligate GE HealthCare to acquire any particular amount of common stock, and may be suspended or terminated at any time at the Company's discretion.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to GE HealthCare</a></td>
<td class="nump">$ 564<span></span>
</td>
<td class="nump">$ 374<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND BASIS OF PRESENTATION (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">BASIS OF PRESENTATION</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The condensed consolidated financial statements (the &#8220;financial statements&#8221;) of GE HealthCare Technologies Inc. and its subsidiaries (&#8220;GE HealthCare,&#8221; the &#8220;Company,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; or &#8220;we&#8221;) have been prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, the financial statements do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments, including normal recurring adjustments, considered necessary for a fair presentation of the Company&#8217;s financial position and operating results have been included. All intercompany balances and transactions within the Company have been eliminated in the financial statements. Operating results for the three months ended March 31, 2025 and 2024 are not necessarily indicative of the results that may be expected for the fiscal year as a whole. The December 31, 2024 period presented on the Condensed Consolidated Statement of Financial Position was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Tables throughout this document are presented in millions of U.S. dollars unless otherwise stated and certain columns and rows may not sum due to the use of rounded numbers. Percentages presented are calculated from the underlying whole-dollar amounts.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">RECLASSIFICATION</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain prior year amounts in the financial statements and notes thereto have been reclassified to conform to the current year presentation. On the Condensed Consolidated Statements of Cash Flows, new line items were added and amounts were reclassified accordingly for the following items: amounts related to current compensation and benefits that were previously reported within All other operating activities &#8211; net, amounts related to purchases of investments previously reported within All other investing activities &#8211; net, and amounts related to equity award activity previously reported within All other financing activities &#8211; net. Additionally, amounts due from related parties and due to related parties which were previously shown on separate lines on the Condensed Consolidated Statements of Cash Flows and Condensed Consolidated Statements of Financial Position were reclassified to Receivables, All other current assets, Accounts Payable, All other current liabilities, and All other operating activities - net as applicable.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">ESTIMATES AND ASSUMPTIONS</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><br/>ESTIMATES AND ASSUMPTIONS. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions, which affect the reported amounts and related disclosures in the financial statements. We base our estimates and judgments on historical experience and on various other assumptions and information that we believe to be reasonable under the circumstances. Although our estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations, financial position, and cash flows.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">RECENT ACCOUNTING PRONOUNCEMENTS</a></td>
<td class="text"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">RECENT ACCOUNTING PRONOUNCEMENTS.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-09 (&#8220;ASU 2023-09&#8221;), </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. ASU 2023-09 addresses investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This update also includes certain other amendments to improve the effectiveness of income tax disclosures. The provisions of ASU 2023-09 are effective for annual periods beginning after December 15, 2024, with early adoption permitted. We expect the adoption to impact disclosures in our notes to the financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU No. 2024-03 (&#8220;ASU 2024-03&#8221;), </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. ASU 2024-03 addresses investor requests for more transparency about expense information through the disaggregation of relevant expense captions in the notes to the financial statements. The provisions of ASU 2024-03 are effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. We expect the adoption to impact disclosures in our notes to the financial statements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_SupplierFinanceProgramPolicyPolicyTextBlock', window );">SUPPLY CHAIN FINANCE PROGRAMS</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">The Company participates in voluntary supply chain finance programs which provide participating suppliers the opportunity to sell their GE HealthCare receivables to third parties at the sole discretion of both the suppliers and the third parties. We evaluate supply chain finance programs to ensure the use of a third-party intermediary to settle our trade payables does not change the nature, existence, amount, or timing of our trade payables and does not provide the Company with any direct economic benefit. If any characteristics of the trade payables change or we receive a direct economic benefit, we reclassify the trade payables to borrowings. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">In connection with the supply chain finance programs, payment terms normally range from 30 to 180 days, depending on the underlying supplier agreements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_SupplierFinanceProgramPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplier Finance Program, Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_SupplierFinanceProgramPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483504/205-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Summary of Contract and Other Deferred Assets</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Contract assets</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">572&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">589&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other deferred assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Contract and other deferred assets</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">931</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">974</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-current contract assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-current other deferred assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">113&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">105&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total contract and other deferred assets</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,144</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,183</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%;padding-left:2.52pt">Non-current contract and other deferred assets are recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock', window );">Schedule of Remaining Performance Obligations</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.650%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Products</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">4,599</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">4,755</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">Services&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">10,280</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">9,737</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%">Total RPO</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">&#160;&#160;&#160;&#160;</span></div></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">14,879</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">14,491</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of expected timing for satisfying remaining performance obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.844%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.929%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total Revenues by Segment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total Imaging</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,140</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,062</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">AVS:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Procedural Guidance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">641&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">651&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Specialized Ultrasound</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total AVS</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,239</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,227</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PCS:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Monitoring Solutions</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">556&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">527&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Life Support Solutions</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total PCS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">753</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">747</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total PDx</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">632</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">599</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">15</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,777</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,650</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Financial information not presented within the reportable segments, shown within the Other category, represents Hea</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">lthCar</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">e Financial Services (&#8220;HFS&#8221;) which does not meet the definition of an operating segment.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.844%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.929%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Significant Expenses by Segment</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Imaging:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cost of sales</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other segment items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">588&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">559&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total Imaging</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,941</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,897</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">AVS:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cost of sales</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other segment items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">380&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">371&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total AVS</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">978</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">970</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PCS:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cost of sales</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other segment items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">224&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">206&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total PCS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">705</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">666</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PDx:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cost of sales</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other segment items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">133&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">126&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total PDx</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">428</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">421</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:0.08pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1) Other segment items for each segment includes selling, general, administrative, research, and development related expenses, as well as other segment income and expenses.</span></div><div style="margin-bottom:0.08pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.844%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.929%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Segment EBIT</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Segment EBIT</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Imaging</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">AVS</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">261&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">257&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PCS </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PDx </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">205&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">178&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">715</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">681</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Restructuring costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Acquisition and disposition-related benefits (charges)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(8)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Gain (loss) on business and asset dispositions</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Spin-Off and separation costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(24)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(60)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Amortization of acquisition-related intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Investment revaluation gain (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">92&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(20)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Interest and other financial charges &#8211; net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-operating benefit income (costs)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">74&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">102&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Income before income taxes</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">692</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">512</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:0.08pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Financial information not presented within the reportable segments, shown within the Other category, primarily represents HFS which does not meet the definition of an operating segment.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">The following table represents the depreciation and amortization amounts reported within the Segment EBIT metric for our reportable segments. Depreciation and amortization expense related to shared property, plant, and equipment and intangibles, exclusive of acquisition-related intangible assets, has been fully allocated to our segments and those allocations are reflected in the amounts presented in the table below. These amounts are included within Cost of sales and Other segment items disclosed in the Significant Expenses by Segment table above.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.844%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.929%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Depreciation and Amortization by Segment</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Imaging</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">57&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">65&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">AVS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PCS </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">13&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">15&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">PDx </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">16&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECEIVABLES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Receivables</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Current Receivables</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Current customer receivables</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,379</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,382</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-income based tax receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">155&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">155&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other sundry receivables</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">144&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">133&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Current sundry receivables</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">299</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">287</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(106)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(103)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total current receivables &#8211; net</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,572</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,566</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Chargebacks, which are primarily related to our PDx business, are generally settled through issuance of credits, typically within one month of initial recognition, and are recorded as a reduction to current customer receivables. Balances related to chargebacks were $151 million and $153 million as of March 31, 2025 and December 31, 2024, respectively.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Long-Term Receivables</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Long-term customer receivables</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">68</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">59</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-income based tax receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other sundry receivables</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">76&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">68&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Long-term sundry receivables</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">99</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">88</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Allowance for credit losses</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(6)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(5)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total long-term receivables &#8211; net</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">161</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">142</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Loans receivable, at amortized cost</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">23&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">23&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Investment in finance leases, net of deferred income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(3)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(2)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Current financing receivables &#8211; net</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">90</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">90</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Loans receivable, at amortized cost</span></div></td><td style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">35&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">35&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Investment in finance leases, net of deferred income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(4)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(4)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Non-current financing receivables &#8211; net</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">186</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">183</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCING RECEIVABLES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Receivables</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Current Receivables</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Current customer receivables</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,379</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,382</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-income based tax receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">155&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">155&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other sundry receivables</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">144&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">133&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Current sundry receivables</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">299</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">287</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(106)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(103)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total current receivables &#8211; net</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,572</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,566</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Chargebacks, which are primarily related to our PDx business, are generally settled through issuance of credits, typically within one month of initial recognition, and are recorded as a reduction to current customer receivables. Balances related to chargebacks were $151 million and $153 million as of March 31, 2025 and December 31, 2024, respectively.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Long-Term Receivables</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Long-term customer receivables</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">68</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">59</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-income based tax receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other sundry receivables</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">76&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">68&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Long-term sundry receivables</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">99</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">88</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Allowance for credit losses</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(6)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(5)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total long-term receivables &#8211; net</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">161</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">142</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Loans receivable, at amortized cost</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">23&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">23&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Investment in finance leases, net of deferred income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(3)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(2)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Current financing receivables &#8211; net</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">90</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">90</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Loans receivable, at amortized cost</span></div></td><td style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">35&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">35&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Investment in finance leases, net of deferred income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(4)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(4)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Non-current financing receivables &#8211; net</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">186</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">183</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions</a></td>
<td class="text"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">The following table provides a summary of the purchase price consideration transferred for the acquisition of NMP.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.595%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Purchase consideration</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cash consideration, net of cash acquired</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">269&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Fair value of previously held interest in NMP</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Fair value of contingent consideration</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total allocable purchase price</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">575</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><br/><br/>The estimated fair values of the assets and liabilities assumed in connection with the acquisition of NMP are as follows.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.595%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Initial allocation</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Receivables</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">53&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Inventories</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Property, plant, and equipment</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">243&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Goodwill</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other intangible assets</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">223&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">All other non-current assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Deferred income taxes</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(87)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">All other non-current liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(28)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total net assets post acquisition</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">575</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) All other non-current assets includes $12 million of indemnification assets, with the underlying indemnified liabilities recorded in All other non-current liabilities.</span></div>(2) Other includes Accounts payable, All other current liabilities, and Current compensation and benefits.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Imaging</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">AVS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">PCS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">PDx</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at December 31, 2024</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,581</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,987</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,035</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,533</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">13,136</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Acquisitions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency exchange and other</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">12&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">20&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at March 31, 2025</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,587</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,999</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,037</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,750</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">13,373</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.151%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of March 31, 2025</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of December 31, 2024</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Net</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Definite-lived assets</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Customer-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Patents and technology</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,668&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(2,021)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">647&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,593&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1,987)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">606&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Capitalized software </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1,479)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1,437)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Trademarks and other</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">47&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(29)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">17&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">33&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(29)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">4&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total definite-lived assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,696</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(3,555)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,141</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,481</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(3,477)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,004</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Indefinite-lived assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">97</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">97</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">74</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">74</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total other intangible assets</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,793</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(3,555)</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,238</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,555</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(3,477)</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,078</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Indefinite-lived intangible assets relate to acquired in-process research and development prior to project completion and are not amortized.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.151%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of March 31, 2025</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of December 31, 2024</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Net</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Definite-lived assets</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Customer-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Patents and technology</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,668&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(2,021)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">647&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,593&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1,987)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">606&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Capitalized software </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1,479)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1,437)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Trademarks and other</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">47&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(29)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">17&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">33&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(29)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">4&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total definite-lived assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,696</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(3,555)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,141</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,481</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(3,477)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,004</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Indefinite-lived assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">97</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">97</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">74</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">74</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total other intangible assets</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,793</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(3,555)</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,238</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,555</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(3,477)</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,078</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Indefinite-lived intangible assets relate to acquired in-process research and development prior to project completion and are not amortized.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BORROWINGS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-Term Borrowings</a></td>
<td class="text"><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.179%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Borrowings Composition</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5.600% senior notes due November 15, 2025</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,500&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,500&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5.650% senior notes due November 15, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">4.800% senior notes due August 14, 2029</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,000&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,000&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5.857% senior notes due March 15, 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5.905% senior notes due November 22, 2032</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,750&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,750&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">6.377% senior notes due November 22, 2052</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Floating rate Term Loan Facility due January 2, 2026</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">500&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">750&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total principal debt issued</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">8,780</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">9,036</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Less: Unamortized debt issuance costs and discounts</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">30&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Add: Cumulative basis adjustment for fair value hedges</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">9&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(51)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total borrowings</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">8,759</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">8,951</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Less: Short-term borrowings</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,002&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,502&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Long-term borrowings</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">6,757</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">7,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(1) Short-term borrowings </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">as of March 31, 2025 </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December 31, 2024 i</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ncludes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$2,000&#160;million and $1,500&#160;million, respectively,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> related to the current portion of our long-term borrowings, net of unamortized debt issuance costs and discounts.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-8<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>POSTRETIREMENT BENEFIT PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Components of Net Periodic Expense</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.288%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.483%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.483%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.487%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Components of Expense (Income)</span></div></td><td colspan="24" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">U.S. Plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">International Plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">OPEB Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31,</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Service cost &#8211; Operating</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(287)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(298)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(36)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(48)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Amortization of net loss (gain)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Amortization of prior service cost (credit)</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(3)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(20)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(22)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Special termination cost</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Non-operating</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(60)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(71)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(10)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(21)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(24)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Net periodic expense (income)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(59)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(63)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(5)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(20)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(22)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (h)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) &#8211; NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in Accumulated other comprehensive income (loss) - net by component were as follows.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="margin-top:0.02pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">For the three months ended March 31, 2025</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Currency translation adjustments</span><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-right:-1.31pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Pension and Other Postretirement  Plans</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cash flow hedges</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total AOCI</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(1,973)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">576</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(1,379)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other comprehensive income (loss) before reclassifications &#8211; net of taxes of $15, $5, and $3</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Reclassifications from AOCI &#8211; net of taxes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(2)(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"> of $&#8212;, $16, and $&#8212;</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">63&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(49)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">17&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Other comprehensive income (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">257</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(69)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">180</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Less: Other comprehensive income (loss) attributable to noncontrolling interests</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(1,717)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">507</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">10</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(1,199)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31, 2024</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Currency translation adjustments</span><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-right:-1.31pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Pension and Other Postretirement Plans</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cash flow hedges</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total AOCI</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2023</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(1,706)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,033</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(18)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(691)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other comprehensive income (loss) before reclassifications &#8211; net of taxes of $(7), $(1), and $(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Reclassifications from AOCI &#8211; net of taxes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"> of $&#8212;, $12, and $&#8212;</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(38)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(37)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Other comprehensive income (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(76)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(35)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(95)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Less: Other comprehensive income (loss) attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2024</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(1,781)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">997</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(2)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(787)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) The amount of Currency translation adjustments recognized in Other comprehensive income (loss) (&#8220;OCI&#8221;) during the three months ended March 31, 2025 and 2024 included net gains (losses) relating to net investment hedges, as further discussed in Note 12, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial Instruments and Fair Value Measurements.&#8221;</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Reclassifications from AOCI into earnings for Pension and Other Postretirement Plans are recognized within Non-operating benefit (income) costs, while Cash flow hedges are recognized within Cost of products and Cost of services in our Condensed Consolidated Statements of Income.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) Includes net of tax impact of $63 million to Currency translation adjustments and $8 million to Pension and Other Postretirement Plans related to the derecognition of the prior NMP equity method investment. Refer to Note 7, &#8220;Acquisitions, Goodwill, and Other Intangible Assets&#8221; for additional information on the NMP acquisition.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock', window );">Schedule of Derivative Assets at Fair Value</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the gross fair values of our outstanding derivative instruments.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value of Derivatives</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Gross Notional</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value &#8211; Assets</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value &#8211; Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Gross Notional</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value &#8211; Assets</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value &#8211; Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward contracts</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,474&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">25&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">15&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,210&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">43&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">11&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Derivatives accounted for as cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,474</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">25</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">15</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,210</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">43</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cross-currency swaps</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,075&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">12&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">97&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,995&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">15&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">46&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward and options contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Derivatives accounted for as net investment hedges</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,835</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">41</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,726</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">45</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">64</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Interest rate swaps</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,700&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">17&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,700&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">51&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Derivatives accounted for as fair value hedges</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,700</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">14</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,700</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">51</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">4,395&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3,925&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other derivatives</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">384&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">31&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">370&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">47&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Derivatives not designated as hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,779</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">53</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,294</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">57</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">29</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total derivatives</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">12,788</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">136</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">160</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">11,930</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">145</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">155</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) As of March 31, 2025, accrued interest is included in the above fair value and is not considered material. As of December 31, 2024, accrued interest is excluded from the above fair value and is not considered material. </span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Other derivatives are comprised of embedded derivatives and derivatives related to equity contracts.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock', window );">Schedule of Derivative Liabilities at Fair Value</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the gross fair values of our outstanding derivative instruments.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value of Derivatives</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Gross Notional</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value &#8211; Assets</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value &#8211; Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Gross Notional</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value &#8211; Assets</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value &#8211; Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward contracts</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,474&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">25&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">15&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,210&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">43&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">11&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Derivatives accounted for as cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,474</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">25</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">15</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,210</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">43</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cross-currency swaps</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,075&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">12&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">97&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,995&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">15&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">46&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward and options contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Derivatives accounted for as net investment hedges</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,835</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">41</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">3,726</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">45</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">64</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Interest rate swaps</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,700&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">17&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,700&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">51&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Derivatives accounted for as fair value hedges</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,700</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">14</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,700</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">51</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">4,395&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3,925&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other derivatives</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">384&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">31&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">370&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">47&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Derivatives not designated as hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,779</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">53</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4,294</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">57</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">29</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total derivatives</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">12,788</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">136</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">160</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">11,930</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">145</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">155</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) As of March 31, 2025, accrued interest is included in the above fair value and is not considered material. As of December 31, 2024, accrued interest is excluded from the above fair value and is not considered material. </span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Other derivatives are comprised of embedded derivatives and derivatives related to equity contracts.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Effect of Derivatives Instruments on Statement of Financial Position and Statement of Income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents amounts recorded in Long-term borrowings in the Condensed Consolidated Statements of Financial Position related to cumulative basis adjustment for fair value hedges.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.288%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.597%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Carrying amount</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Cumulative basis adjustment included in the carrying amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Carrying amount</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Cumulative basis adjustment included in the carrying amount</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><span style="-sec-ix-hidden:f-857"><span style="-sec-ix-hidden:f-858">Long-term borrowings designated in fair value hedges</span></span></span></div></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,704&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">9&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:0 1pt"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,644&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(51)</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The tables below present the gains (losses) on our derivative financial instruments and hedging activity in the Condensed Consolidated Statements of Income.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.874%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Derivative Financial Instruments and Hedging Activity</span></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31, 2025</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cost of products</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cost of services</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">SG&amp;A</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Interest and other financial charges </span><span style="color:#454545;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8211;</span><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"> net</span></div></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Other</span><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward contracts</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(2)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">8&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward and options contracts</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of net investment hedges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Interest rate swaps</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">57&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Debt basis adjustment on Long-term borrowings</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(61)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of fair value hedges</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward contracts</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">15&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">4&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other derivatives</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of derivatives not designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">15</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(3)</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(15)</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.874%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31, 2024</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cost of products</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Cost of services</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">SG&amp;A</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Interest and other financial charges </span><span style="color:#454545;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8211;</span><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"> net</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Other</span><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward contracts</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">8&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward and option contracts</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of net investment hedges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">10</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Interest rate swaps</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(45)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Debt basis adjustment on Long-term borrowings</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">38&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of fair value hedges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(12)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(3)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other derivatives</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Effects of derivatives not designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(12)</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(3)</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Changes in fair value related to components other than the spot rate are excluded from effectiveness testing for the three months ended March 31, 2025 and 2024.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Amount includes $(4)&#160;million and $(6)&#160;million of interest expense on interest rate derivatives for the three months ended March 31, 2025 and 2024, respectively.</span></div><div style="margin-bottom:0.08pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) Other derivatives are comprised of embedded derivatives and derivatives related to equity contracts.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4) Amounts are inclusive of gains (losses) in Other (income) expense &#8211; net in the Condensed Consolidated Statements of Income.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Schedule of Derivative Pre-tax Gains (Losses) Recognized in OCI</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The table below presents the pre-tax gains (losses) recognized in OCI associated with the Company&#8217;s cash flow and net investment hedges.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.955%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.873%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Pre-tax Gains (Losses) Recognized in OCI Related to Cash Flow and Net Investment Hedges</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cash flow hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(14)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">20&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net investment hedges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(65)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">32&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Amounts recognized in OCI for excluded components for the periods presented were immaterial.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table represents assets and liabilities that are recorded and measured at fair value on a recurring basis.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Fair Value of Assets and Liabilities Measured on a Recurring Basis</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of March 31, 2025</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of December 31, 2024</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Assets:</span></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Money market funds</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Investment securities</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">27&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">27&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">32&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">32&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Derivatives</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Liabilities:</span></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Derivatives</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Contingent consideration</span></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">40&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">40&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">34&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">34&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative assets at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative liabilities at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Schedule of Product Warranties</a></td>
<td class="text">An analysis of changes in the liability for product warranties follows.<div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.984%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at beginning of period</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">168</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">192</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Current-year provisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Expenditures</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(58)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(55)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Foreign currency exchange and other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at end of period</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">171</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">175</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING ACTIVITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Schedule of Restructuring Activities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net expenses for restructuring initiatives committed to by management through March 31, 2025 are included in the table below.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.511%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.595%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Employee termination costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">21&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">25&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Facility and other exit costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Asset write-downs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">7&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total restructuring activities &#8211; net</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">22</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">40</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div>The activity related to our restructuring liabilities follows.<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;padding-right:-1.31pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Employee termination costs</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;padding-right:-1.31pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Facility and other exit costs</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at December 31, 2024</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">67</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">86</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Charges</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Payments and other adjustments</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(14)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(3)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(17)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at March 31, 2025</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">73</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">89</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings per Share</a></td>
<td class="text"><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.066%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.818%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Earnings Per Share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:125%">(In millions, except per share amounts)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:125%">Numerator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Net income</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Net (income) loss attributable to noncontrolling interests</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(24)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(14)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Net income attributable to GE HealthCare</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">564&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">374&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:125%">Denominator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Basic weighted-average shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Dilutive effect of common stock equivalents</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Diluted weighted-average shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">459&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">459&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Basic earnings per share</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1.23&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.82&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Diluted earnings per share</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Antidilutive securities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">4&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(1) Diluted earnings per share excludes certain shares issuable under share-based compensation plans because the effect would have been antidilutive.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CASH, CASH EQUIVALENTS, AND RESTRICTED CASH.</span></div><div style="margin-top:0.02pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cash and cash equivalents</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,454&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,874&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Short-term restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Financial Position</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,473</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,889</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:1.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Long-term restricted cash</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Cash Flows</span></div></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,476</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,893</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Long-term restricted cash is recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Schedule of Restricted Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CASH, CASH EQUIVALENTS, AND RESTRICTED CASH.</span></div><div style="margin-top:0.02pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cash and cash equivalents</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,454&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,874&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Short-term restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Financial Position</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,473</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,889</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;padding-left:1.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Long-term restricted cash</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Cash Flows</span></div></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,476</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,893</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Long-term restricted cash is recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">INVENTORIES.</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Raw materials</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">991&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">921&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Finished goods</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,068&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">926&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Inventories</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,158</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">1,939</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary of Property, Plant and Equipment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PROPERTY, PLANT, AND EQUIPMENT &#8211; NET.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Land and improvements</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">146&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">66&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Buildings, structures, and related equipment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">1,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Machinery and equipment</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,905&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,705&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Leasehold improvements and manufacturing plants under construction</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Total property, plant, and equipment, at original cost</span></div></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">5,661</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">5,267</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Accumulated depreciation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(3,179)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(3,080)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Right-of-use operating lease assets, net of amortization</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">369&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">364&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Property, plant, and equipment &#8211; net</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,851</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">2,550</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All Other Current Assets</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Prepaid expenses and deferred costs</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">249&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">188&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Financing receivables &#8211; net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Derivative instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">100&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">123&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Tax receivables</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">46&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">16&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All other current assets</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">601</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">532</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(1) Derivative instruments include the related accrued interest. Refer to Note 12, &#8220;Financial Instruments and Fair Value Measurements&#8221; for further information.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(2) Current assets Other primarily represents indemnity assets associated with separation agreements with GE as of March 31, 2025.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Schedule of Other Noncurrent Assets</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All Other Non-Current Assets</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Prepaid pension asset</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">723&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">657&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Equity method and other investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Financing receivables &#8211; net</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">186&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">183&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Long-term receivables &#8211; net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Inventories</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">143&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">139&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Contract and other deferred assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Capitalized cloud computing arrangement implementation costs</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">113&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">84&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All other non-current assets</span></div></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">1,926</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">1,950</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(3) Non-current assets Other primarily consists of indemnity assets associated with separation agreements with GE, derivative instruments, and tax receivables.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Schedule of Other Current Liabilities</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All Other Current Liabilities</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Sales allowances and related liabilities</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">221&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">242&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Income and indirect tax liabilities including uncertain tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Product warranties</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">171&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">168&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Accrued freight and utilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Operating lease liabilities</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">119&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">115&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Derivative instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest payable on borrowings</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">141&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">92&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Environmental and asset retirement obligations</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">355&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">386&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All other current liabilities</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">1,583</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">1,552</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(1) Derivative instruments include the related accrued interest. Refer to Note 12, &#8220;Financial Instruments and Fair Value Measurements&#8221; for further information.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(4) Current liabilities Other primarily consists of miscellaneous accrued costs, contingent consideration liabilities, and dividends payable to stockholders.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Schedule of Other Noncurrent Liabilities</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All Other Non-Current Liabilities</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">March 31, 2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Contract liabilities</span></div></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">724&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">686&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Environmental and asset retirement obligations</span></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">395&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">291&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Income and indirect tax liabilities including uncertain tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Derivative instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">39&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">64&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><span style="-sec-ix-hidden:f-1193"><span style="-sec-ix-hidden:f-1194">Finance lease obligations</span></span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Sales allowances and related liabilities</span></div></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">24&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">23&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">All other non-current liabilities</span></div></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">1,840</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">1,796</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(1) Derivative instruments include the related accrued interest. Refer to Note 12, &#8220;Financial Instruments and Fair Value Measurements&#8221; for further information.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(5) Non-current liabilities Other primarily consists of miscellaneous accrued costs, indemnity liabilities associated with separation agreements with GE, and contingent consideration liabilities.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock', window );">Schedule of Redeemable Noncontrolling Interest</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">Activity attributable to redeemable noncontrolling interests is presented below.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at beginning of period</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">188</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">165</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net income attributable to redeemable noncontrolling interests</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Balance at end of period </span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">211</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">177</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of Other Income (Expense)</a></td>
<td class="text"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">OTHER INCOME (EXPENSE) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> NET.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.622%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.040%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center;text-indent:5pt"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">For the three months ended March 31</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">2025</span></td><td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%">2024</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Net financing income and investment income (loss)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(16)</span></td><td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Equity method income (loss)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Change in fair value of assumed obligations</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(8)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(8)</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Gain on remeasurement of NMP equity method investment</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other items, net</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">14&#160;</span></td><td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Total other income (expense) &#8211; net</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">99</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%">(8)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%">(1) Refer to Note 7, &#8220;Acquisitions, Goodwill, and Other Intangible Assets&#8221; for additional information on the NMP acquisition.</span></div>(2) Other items, net primarily consists of licensing and royalty income, lease income, change in tax indemnities, and gains and losses related to derivatives. Additionally, for the three months ended March 31, 2025 it includes a realization of a gain contingency.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>REVENUE RECOGNITION - Summary of Contract and Other Deferred Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract assets</a></td>
<td class="nump">$ 572<span></span>
</td>
<td class="nump">$ 589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCurrent', window );">Other deferred assets</a></td>
<td class="nump">359<span></span>
</td>
<td class="nump">385<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent', window );">Contract and other deferred assets</a></td>
<td class="nump">931<span></span>
</td>
<td class="nump">974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetNoncurrent', window );">Non-current contract assets</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCosts', window );">Non-current other deferred assets</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts', window );">Total contract and other deferred assets</a></td>
<td class="nump">$ 1,144<span></span>
</td>
<td class="nump">$ 1,183<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Asset, After Allowance For Credit Loss And Deferred Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Asset, After Allowance For Credit Loss And Deferred Costs, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">$ 2,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Contract liabilities</a></td>
<td class="nump">724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract liabilities, revenue recognized</a></td>
<td class="nump">$ 752<span></span>
</td>
<td class="nump">$ 741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-04-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation, period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-04-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation, period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-04-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-04-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>REVENUE RECOGNITION - Schedule of Remaining Performance Obligations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations, amount</a></td>
<td class="nump">$ 14,879<span></span>
</td>
<td class="nump">$ 14,491<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations, amount</a></td>
<td class="nump">4,599<span></span>
</td>
<td class="nump">4,755<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations, amount</a></td>
<td class="nump">$ 10,280<span></span>
</td>
<td class="nump">$ 9,737<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Schedule of Revenues by Segment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 4,777<span></span>
</td>
<td class="nump">$ 4,650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">2,140<span></span>
</td>
<td class="nump">2,062<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | AVS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">1,239<span></span>
</td>
<td class="nump">1,227<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | AVS | Procedural Guidance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">641<span></span>
</td>
<td class="nump">651<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | AVS | Specialized Ultrasound</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">598<span></span>
</td>
<td class="nump">576<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | PCS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">753<span></span>
</td>
<td class="nump">747<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | PCS | Monitoring Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">556<span></span>
</td>
<td class="nump">527<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | PCS | Life Support Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">197<span></span>
</td>
<td class="nump">220<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | PDx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">632<span></span>
</td>
<td class="nump">599<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=gehc_ImagingSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=gehc_ImagingSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=gehc_AVSSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=gehc_AVSSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=gehc_ProceduralGuidanceSubsegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=gehc_ProceduralGuidanceSubsegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=gehc_SpecializedUltrasoundSubsegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=gehc_SpecializedUltrasoundSubsegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=gehc_PCSSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=gehc_PCSSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=gehc_MonitoringSolutionsSubsegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=gehc_MonitoringSolutionsSubsegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=gehc_LifeSupportSolutionsSubsegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=gehc_LifeSupportSolutionsSubsegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=gehc_PDxSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=gehc_PDxSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Schedule of Significant Expenses by Segment (Details) - Operating segments - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">$ 1,353<span></span>
</td>
<td class="nump">$ 1,338<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment items</a></td>
<td class="nump">588<span></span>
</td>
<td class="nump">559<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">1,941<span></span>
</td>
<td class="nump">1,897<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">AVS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">598<span></span>
</td>
<td class="nump">599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment items</a></td>
<td class="nump">380<span></span>
</td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">978<span></span>
</td>
<td class="nump">970<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">PCS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">481<span></span>
</td>
<td class="nump">460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment items</a></td>
<td class="nump">224<span></span>
</td>
<td class="nump">206<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">705<span></span>
</td>
<td class="nump">666<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">PDx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">294<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment items</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">$ 428<span></span>
</td>
<td class="nump">$ 421<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=gehc_ImagingSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=gehc_ImagingSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=gehc_AVSSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=gehc_AVSSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=gehc_PCSSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=gehc_PCSSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=gehc_PDxSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=gehc_PDxSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Schedule of Segment EBIT (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges', window );">EBIT</a></td>
<td class="nump">$ 715<span></span>
</td>
<td class="nump">$ 681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Restructuring costs</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_AcquisitionAndDispositionRelatedBenefitsCosts', window );">Acquisition and disposition-related benefits (charges)</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gain (loss) on business and asset dispositions</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_SpinOffAndSeparationCosts', window );">Spin-Off and separation costs</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(60)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_AmortizationOfIntangibleAssetsAcquired', window );">Amortization of acquisition-related intangible assets</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Investment revaluation gain (loss)</a></td>
<td class="nump">92<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Interest and other financial charges &#8211; net</a></td>
<td class="num">(110)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Non-operating benefit income (costs)</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">692<span></span>
</td>
<td class="nump">512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges', window );">EBIT</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | AVS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges', window );">EBIT</a></td>
<td class="nump">261<span></span>
</td>
<td class="nump">257<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | PCS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges', window );">EBIT</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | PDx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges', window );">EBIT</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges', window );">EBIT</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_AcquisitionAndDispositionRelatedBenefitsCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition And Disposition Related Benefits (Costs)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_AcquisitionAndDispositionRelatedBenefitsCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_AmortizationOfIntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Intangible Assets, Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_AmortizationOfIntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) From Continuing Operations Before Income Taxes, Interest And Debt Expense, And Other Charges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_SpinOffAndSeparationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Spin-Off And Separation Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_SpinOffAndSeparationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=gehc_ImagingSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=gehc_ImagingSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=gehc_AVSSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=gehc_AVSSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=gehc_PCSSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=gehc_PCSSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=gehc_PDxSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=gehc_PDxSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Schedule of Depreciation and Amortization by Segment (Details) - Operating segments - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">AVS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">PCS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">PDx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=gehc_ImagingSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=gehc_ImagingSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=gehc_AVSSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=gehc_AVSSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=gehc_PCSSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=gehc_PCSSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=gehc_PDxSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=gehc_PDxSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>RECEIVABLES - Current Receivables (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Current customer receivables</a></td>
<td class="nump">$ 3,379<span></span>
</td>
<td class="nump">$ 3,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValueAddedTaxReceivableCurrent', window );">Non-income based tax receivables</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherNontradeReceivablesCurrent', window );">Other sundry receivables</a></td>
<td class="nump">144<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NontradeReceivablesCurrent', window );">Current sundry receivables</a></td>
<td class="nump">299<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit losses</a></td>
<td class="num">(106)<span></span>
</td>
<td class="num">(103)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Total current receivables &#8211; net</a></td>
<td class="nump">3,572<span></span>
</td>
<td class="nump">3,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent', window );">Chargebacks</a></td>
<td class="nump">$ 151<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_OtherNontradeReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Nontrade Receivables, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_OtherNontradeReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerRefundLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NontradeReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NontradeReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValueAddedTaxReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValueAddedTaxReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>RECEIVABLES - Long-Term Receivables (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossNoncurrent', window );">Long-term customer receivables</a></td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValueAddedTaxReceivableNoncurrent', window );">Non-income based tax receivables</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherNontradeReceivablesNoncurrent', window );">Other sundry receivables</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NontradeReceivablesNoncurrent', window );">Long-term sundry receivables</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent', window );">Allowance for credit losses</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_ReceivablesNetNoncurrent', window );">Total long-term receivables &#8211; net</a></td>
<td class="nump">$ 161<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_OtherNontradeReceivablesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Nontrade Receivables, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_OtherNontradeReceivablesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_ReceivablesNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receivables, Net, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_ReceivablesNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-7A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NontradeReceivablesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The noncurrent portion of the receivable other than from customers, that is amounts expected to be collected after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NontradeReceivablesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValueAddedTaxReceivableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due after one year of the balance sheet date (or one operating cycle), if longer of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValueAddedTaxReceivableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCING RECEIVABLES - Schedule of Financing Receivable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForNotesAndLoansReceivableCurrent', window );">Allowance for credit losses, current</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Current financing receivables &#8211; net</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent', window );">Allowance for credit losses, noncurrent</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Non-current financing receivables &#8211; net</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">183<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember', window );">Loans receivable, at amortized cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableGrossCurrent', window );">Current financing receivables, gross</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableGrossNoncurrent', window );">Non-current financing receivables, gross</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=gehc_FinanceLeaseReceivableMember', window );">Investment in finance leases, net of deferred income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableGrossCurrent', window );">Current financing receivables, gross</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableGrossNoncurrent', window );">Non-current financing receivables, gross</a></td>
<td class="nump">$ 155<span></span>
</td>
<td class="nump">$ 152<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481628/310-20-40-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForNotesAndLoansReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on financing receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForNotesAndLoansReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, before allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableGrossNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, before allowance for credit loss, of financing receivable classified as noncurrent. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableGrossNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=gehc_FinanceLeaseReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=gehc_FinanceLeaseReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCING RECEIVABLES - Narrative (Details)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems', window );"><strong>Financing Receivable, Past Due [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableNonaccrualPercentPastDue1', window );">Financing receivable, nonaccrual, percent past due</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivablesPeriodPastDueAxis=gehc_FinancialAssetGreaterThan30DaysPastDueMember', window );">Over 30 days past due</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems', window );"><strong>Financing Receivable, Past Due [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivablePercentPastDue1', window );">Financing receivable, percent past due</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivablesPeriodPastDueAxis=us-gaap_FinancingReceivablesEqualToGreaterThan90DaysPastDueMember', window );">Over 90 days past due</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems', window );"><strong>Financing Receivable, Past Due [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivablePercentPastDue1', window );">Financing receivable, percent past due</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableNonaccrualPercentPastDue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of nonaccrual financing receivable balance outstanding that is past due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableNonaccrualPercentPastDue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivablePercentPastDue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of financing receivable balance that is past due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivablePercentPastDue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 80<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479294/326-20-55-80<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivablesPeriodPastDueAxis=gehc_FinancialAssetGreaterThan30DaysPastDueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivablesPeriodPastDueAxis=gehc_FinancialAssetGreaterThan30DaysPastDueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivablesPeriodPastDueAxis=us-gaap_FinancingReceivablesEqualToGreaterThan90DaysPastDueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivablesPeriodPastDueAxis=us-gaap_FinancingReceivablesEqualToGreaterThan90DaysPastDueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">$ 386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Lease expense</a></td>
<td class="nump">$ 62<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Apr. 01, 2024</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash consideration, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Gain on remeasurement of NMP equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 13,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquisition-related intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=gehc_NihonMediPhysicsCo.LtdNMPMember', window );">Nihon Medi-Physics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Defined benefit plan, asset</a></td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent', window );">Defined benefit plan, liability</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Defined benefit plan, net asset</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=gehc_NihonMediPhysicsCo.LtdNMPMember', window );">Nihon Medi-Physics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percent of interest acquired</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash consideration, net of cash acquired</a></td>
<td class="nump">$ 269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Equity interest in acquiree, existing percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Fair value of previously held interest in NMP</a></td>
<td class="nump">$ 301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue', window );">Equity interest in acquiree, carrying value</a></td>
<td class="nump">204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Gain on remeasurement of NMP equity method investment</a></td>
<td class="nump">97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax', window );">Foreign currency translation gain, reclassification adjustment</a></td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Defined benefit pension plan loss, reclassification adjustment</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Definite-lived intangible assets acquired</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired finite-lived intangible assets, weighted average useful life</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities', window );">Asset retirement obligations and decommissioning liabilities assumed</a></td>
<td class="nump">$ 96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price</a></td>
<td class="nump">575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=gehc_NihonMediPhysicsCo.LtdNMPMember', window );">Nihon Medi-Physics | IPR&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired', window );">Indefinite-lived intangible assets acquired</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=gehc_MIMSoftwareMember', window );">MIM Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percent of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash consideration, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired from acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets', window );">Other net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=gehc_MIMSoftwareMember', window );">MIM Software | Customer-related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=gehc_MIMSoftwareMember', window );">MIM Software | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=gehc_MIMSoftwareMember', window );">MIM Software | Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=gehc_MIMSoftwareMember', window );">MIM Software | Service requirements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Asset Retirement Obligations and Decommissioning Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Step Acquisition, Equity Interest in Acquiree, Carrying Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479613/805-30-35-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefinitelivedIntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-17A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=gehc_NihonMediPhysicsCo.LtdNMPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=gehc_NihonMediPhysicsCo.LtdNMPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=gehc_NihonMediPhysicsCo.LtdNMPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=gehc_NihonMediPhysicsCo.LtdNMPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=gehc_MIMSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=gehc_MIMSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=gehc_ContingentConsiderationPurchasePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=gehc_ContingentConsiderationPurchasePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=gehc_ContingentConsiderationServiceRequirementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=gehc_ContingentConsiderationServiceRequirementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Schedule of Business Acquisitions (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract', window );"><strong>Purchase consideration</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash consideration, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract', window );"><strong>Initial allocation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 13,373<span></span>
</td>
<td class="nump">13,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=gehc_NihonMediPhysicsCo.LtdNMPMember', window );">Nihon Medi-Physics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract', window );"><strong>Purchase consideration</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash consideration, net of cash acquired</a></td>
<td class="nump">269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Fair value of previously held interest in NMP</a></td>
<td class="nump">301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Fair value of contingent consideration</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total allocable purchase price</a></td>
<td class="nump">575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract', window );"><strong>Initial allocation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Receivables</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant, and equipment</a></td>
<td class="nump">243<span></span>
</td>
<td class="nump">243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">All other non-current assets</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes</a></td>
<td class="num">(87)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">All other non-current liabilities</a></td>
<td class="num">(107)<span></span>
</td>
<td class="num">(107)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Other</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total net assets post acquisition</a></td>
<td class="nump">575<span></span>
</td>
<td class="nump">575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets', window );">Indemnification assets</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indemnification Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-5<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=gehc_NihonMediPhysicsCo.LtdNMPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=gehc_NihonMediPhysicsCo.LtdNMPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Schedule of Goodwill (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 13,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency exchange and other</a></td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">13,373<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=gehc_ImagingSegmentMember', window );">Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">3,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency exchange and other</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">3,587<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=gehc_AVSSegmentMember', window );">AVS</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">4,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency exchange and other</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">4,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=gehc_PCSSegmentMember', window );">PCS</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">2,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency exchange and other</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">2,037<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=gehc_PDxSegmentMember', window );">PDx</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">2,533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency exchange and other</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 2,750<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation and measurement period adjustments of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 16<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479405/805-10-25-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=gehc_ImagingSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=gehc_ImagingSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=gehc_AVSSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=gehc_AVSSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=gehc_PCSSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=gehc_PCSSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=gehc_PDxSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=gehc_PDxSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Schedule of Finite-Lived and Indefinite-Lived Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived assets, gross</a></td>
<td class="nump">$ 4,696<span></span>
</td>
<td class="nump">$ 4,481<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(3,555)<span></span>
</td>
<td class="num">(3,477)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived assets, net</a></td>
<td class="nump">1,141<span></span>
</td>
<td class="nump">1,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived assets</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="nump">4,793<span></span>
</td>
<td class="nump">4,555<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">1,238<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer-related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived assets, gross</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(26)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived assets, net</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Patents and technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived assets, gross</a></td>
<td class="nump">2,668<span></span>
</td>
<td class="nump">2,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2,021)<span></span>
</td>
<td class="num">(1,987)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived assets, net</a></td>
<td class="nump">647<span></span>
</td>
<td class="nump">606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Capitalized software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived assets, gross</a></td>
<td class="nump">1,751<span></span>
</td>
<td class="nump">1,743<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1,479)<span></span>
</td>
<td class="num">(1,437)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived assets, net</a></td>
<td class="nump">272<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=gehc_TrademarksAndOtherMember', window );">Trademarks and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived assets, gross</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived assets, net</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=gehc_TrademarksAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=gehc_TrademarksAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BORROWINGS - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>series</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal debt issued</a></td>
<td class="nump">$ 8,780,000,000<span></span>
</td>
<td class="nump">$ 9,036,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Guarantee obligation, carrying value</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnderlyingAssetClassAxis=gehc_CommercialContractsMember', window );">Commercial contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Guarantor obligations, maximum exposure</a></td>
<td class="nump">786,000,000<span></span>
</td>
<td class="nump">784,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnderlyingAssetClassAxis=gehc_EquipmentResidualValueObligationMember', window );">Equipment residual value obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Guarantor obligations, maximum exposure</a></td>
<td class="nump">24,000,000<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gehc_SeniorUnsecuredNotesMember', window );">Senior unsecured notes | Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt, principal amount</a></td>
<td class="nump">$ 8,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_NumberOfDebtSeries', window );">Number of debt series | series</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gehc_A5YearRevolvingCreditFacilityMember', window );">5-Year Revolving Credit Facility | Line of credit | Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt, term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gehc_A364DayRevolvingCreditFacilityMember', window );">364-Day Revolving Credit Facility | Line of credit | Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt, term</a></td>
<td class="text">364 days<span></span>
</td>
<td class="text">364 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gehc_FloatingRateTermLoanFacilityDue2026Member', window );">Floating rate Term Loan Facility due January 2, 2026 | Line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal debt issued</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Debt repayments</a></td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gehc_FloatingRateTermLoanFacilityDue2026Member', window );">Floating rate Term Loan Facility due January 2, 2026 | Line of credit | Unsecured debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt, term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_NumberOfDebtSeries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Debt Series</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_NumberOfDebtSeries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsCurrentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsCurrentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnderlyingAssetClassAxis=gehc_CommercialContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnderlyingAssetClassAxis=gehc_CommercialContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnderlyingAssetClassAxis=gehc_EquipmentResidualValueObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnderlyingAssetClassAxis=gehc_EquipmentResidualValueObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gehc_SeniorUnsecuredNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gehc_SeniorUnsecuredNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gehc_A5YearRevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gehc_A5YearRevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gehc_A364DayRevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gehc_A364DayRevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gehc_FloatingRateTermLoanFacilityDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gehc_FloatingRateTermLoanFacilityDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BORROWINGS - Schedule of Long-Term Borrowings (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal debt issued</a></td>
<td class="nump">$ 8,780<span></span>
</td>
<td class="nump">$ 9,036<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: Unamortized debt issuance costs and discounts</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease', window );">Add: Cumulative basis adjustment for fair value hedges</a></td>
<td class="nump">9<span></span>
</td>
<td class="num">(51)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total borrowings</a></td>
<td class="nump">8,759<span></span>
</td>
<td class="nump">8,951<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Less: Short-term borrowings</a></td>
<td class="nump">2,002<span></span>
</td>
<td class="nump">1,502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term borrowings</a></td>
<td class="nump">6,757<span></span>
</td>
<td class="nump">7,449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term borrowings, current</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 5.600% senior notes due November 15, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">5.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal debt issued</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 5.650% senior notes due November 15, 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">5.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal debt issued</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 4.800% senior notes due August 14, 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal debt issued</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 5.857% senior notes due March 15, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">5.857%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal debt issued</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 5.905% senior notes due November 22, 2032</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">5.905%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal debt issued</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 6.377% senior notes due November 22, 2052</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">6.377%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal debt issued</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Floating rate Term Loan Facility due January 2, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal debt issued</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=gehc_OtherLongTermBorrowingsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal debt issued</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4EE<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4EE<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gehc_A5600SeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gehc_A5600SeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gehc_A5650SeniorNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gehc_A5650SeniorNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gehc_A4.800SeniorNotesDue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gehc_A4.800SeniorNotesDue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gehc_A5857SeniorNotesDue2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gehc_A5857SeniorNotesDue2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gehc_A5905SeniorNotesDue2032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gehc_A5905SeniorNotesDue2032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gehc_A6377SeniorNotesDue2052Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gehc_A6377SeniorNotesDue2052Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gehc_FloatingRateTermLoanFacilityDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gehc_FloatingRateTermLoanFacilityDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=gehc_OtherLongTermBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=gehc_OtherLongTermBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>POSTRETIREMENT BENEFIT PLANS - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold', window );">Plan asset or obligation reporting threshold</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Defined benefit plan, expected future employer contributions, next fiscal year</a></td>
<td class="nump">327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Defined contribution plan, employer contribution amount</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Defined benefit plan, employer contribution amount</a></td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=gehc_GEHealthCareSupplementalPensionPlanMember', window );">GE HealthCare Supplemental Pension Plan | Pension Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Defined benefit plan, employer contribution amount</a></td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=us-gaap_RetirementPlanNameOtherMember', window );">Other Pension Plans | Pension Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Defined benefit plan, employer contribution amount</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Asset Or Obligation, Reporting Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=gehc_GEHealthCareSupplementalPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=gehc_GEHealthCareSupplementalPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=us-gaap_RetirementPlanNameOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=us-gaap_RetirementPlanNameOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>POSTRETIREMENT BENEFIT PLANS - Components of Expense (Income) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Non-operating</a></td>
<td class="num">$ (74)<span></span>
</td>
<td class="num">$ (102)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans | U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost &#8211; Operating</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">249<span></span>
</td>
<td class="nump">242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(287)<span></span>
</td>
<td class="num">(298)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net loss (gain)</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service cost (credit)</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod', window );">Special termination cost</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Non-operating</a></td>
<td class="num">(60)<span></span>
</td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic expense (income)</a></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans | International Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost &#8211; Operating</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net loss (gain)</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service cost (credit)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod', window );">Special termination cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Non-operating</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic expense (income)</a></td>
<td class="nump">9<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost &#8211; Operating</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net loss (gain)</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service cost (credit)</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod', window );">Special termination cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Non-operating</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic expense (income)</a></td>
<td class="num">$ (20)<span></span>
</td>
<td class="num">$ (22)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost of providing special or contractual termination benefits payable from defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">24.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) &#8211; NET (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,464<span></span>
</td>
<td class="nump">$ 7,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications &#8211; net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassifications from AOCI &#8211; net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: Other comprehensive income (loss) attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, ending balance</a></td>
<td class="nump">$ 9,207<span></span>
</td>
<td class="nump">9,207<span></span>
</td>
<td class="nump">7,423<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=gehc_NihonMediPhysicsCo.LtdNMPMember', window );">Nihon Medi-Physics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax', window );">Foreign currency translation gain, reclassification adjustment</a></td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Defined benefit pension plan loss, reclassification adjustment</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive income (loss) &#8211; net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,379)<span></span>
</td>
<td class="num">(691)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, ending balance</a></td>
<td class="num">(1,199)<span></span>
</td>
<td class="num">(1,199)<span></span>
</td>
<td class="num">(787)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,973)<span></span>
</td>
<td class="num">(1,706)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications &#8211; net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="num">(76)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassifications from AOCI &#8211; net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="num">(76)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: Other comprehensive income (loss) attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, ending balance</a></td>
<td class="num">(1,717)<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="num">(1,781)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss) before reclass, tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclass from AOCI, tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension and Other Postretirement Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">576<span></span>
</td>
<td class="nump">1,033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications &#8211; net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassifications from AOCI &#8211; net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: Other comprehensive income (loss) attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, ending balance</a></td>
<td class="nump">507<span></span>
</td>
<td class="nump">507<span></span>
</td>
<td class="nump">997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss) before reclass, tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclass from AOCI, tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications &#8211; net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassifications from AOCI &#8211; net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: Other comprehensive income (loss) attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, ending balance</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss) before reclass, tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclass from AOCI, tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482739/220-10-55-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482739/220-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-17A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482739/220-10-55-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-17A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=gehc_NihonMediPhysicsCo.LtdNMPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=gehc_NihonMediPhysicsCo.LtdNMPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Cash flow hedge gain to be reclassified within 12 months</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability', window );">Derivative, potential effect of rights of offset to assets and liabilities</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">2,473<span></span>
</td>
<td class="nump">2,889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimated fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Borrowings</a></td>
<td class="nump">9,223<span></span>
</td>
<td class="nump">9,374<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Borrowings</a></td>
<td class="nump">8,759<span></span>
</td>
<td class="nump">8,951<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=gehc_OtherCashEquivalentsMember', window );">Other cash equivalents | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">$ 1,229<span></span>
</td>
<td class="nump">$ 1,573<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative, Subject to Master Netting Arrangement, Potential Offset To Asset (Liability)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=gehc_OtherCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=gehc_OtherCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivative Fair Values (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross Notional</a></td>
<td class="nump">$ 12,788<span></span>
</td>
<td class="nump">$ 11,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value &#8211; Assets</a></td>
<td class="nump">136<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value &#8211; Liabilities</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as hedging instrument | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross Notional</a></td>
<td class="nump">1,474<span></span>
</td>
<td class="nump">1,210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value &#8211; Assets</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value &#8211; Liabilities</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as hedging instrument | Cash flow hedges | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross Notional</a></td>
<td class="nump">1,474<span></span>
</td>
<td class="nump">1,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value &#8211; Assets</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value &#8211; Liabilities</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as hedging instrument | Net investment hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross Notional</a></td>
<td class="nump">3,835<span></span>
</td>
<td class="nump">3,726<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value &#8211; Assets</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value &#8211; Liabilities</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as hedging instrument | Net investment hedges | Cross-currency swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross Notional</a></td>
<td class="nump">2,075<span></span>
</td>
<td class="nump">1,995<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value &#8211; Assets</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value &#8211; Liabilities</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as hedging instrument | Net investment hedges | Foreign currency forward and options contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross Notional</a></td>
<td class="nump">1,760<span></span>
</td>
<td class="nump">1,731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value &#8211; Assets</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value &#8211; Liabilities</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as hedging instrument | Fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross Notional</a></td>
<td class="nump">2,700<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value &#8211; Assets</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value &#8211; Liabilities</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as hedging instrument | Fair value hedges | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross Notional</a></td>
<td class="nump">2,700<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value &#8211; Assets</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value &#8211; Liabilities</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross Notional</a></td>
<td class="nump">4,779<span></span>
</td>
<td class="nump">4,294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value &#8211; Assets</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value &#8211; Liabilities</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not designated as hedging instrument | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross Notional</a></td>
<td class="nump">4,395<span></span>
</td>
<td class="nump">3,925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value &#8211; Assets</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value &#8211; Liabilities</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not designated as hedging instrument | Other derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross Notional</a></td>
<td class="nump">384<span></span>
</td>
<td class="nump">370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value &#8211; Assets</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value &#8211; Liabilities</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-7<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-7<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OtherContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OtherContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Cumulative Basis Adjustment for Fair value Hedges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgedLiabilityFairValueHedge', window );">Long-term borrowings designated in fair value hedges</a></td>
<td class="nump">$ 2,704<span></span>
</td>
<td class="nump">$ 2,644<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration', window );">Hedged Liability, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Long-term borrowings<span></span>
</td>
<td class="text">Long-term borrowings<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease', window );">Cumulative basis adjustment included in the carrying amount</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="num">$ (51)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgedLiabilityFairValueHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability hedged in fair value hedging relationship.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4EE<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4EE<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgedLiabilityFairValueHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4EE<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4EE<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes hedged liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4EE<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4EE<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivative Pre-tax Gains (Losses) Recognized in OCI (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Cash flow hedges</a></td>
<td class="num">$ (14)<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Net investment hedges</a></td>
<td class="num">$ (65)<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480627/815-20-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Effect of Derivatives Instruments on Statements of Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Effects of cash flow hedges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Effects of net investment hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax', window );">Effects of fair value hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Effects of derivatives not designated as hedging instruments</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">SG&amp;A | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Effects of cash flow hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Effects of derivatives not designated as hedging instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">SG&amp;A | Cross-currency swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Effects of net investment hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">SG&amp;A | Foreign currency forward and options contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Effects of net investment hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">SG&amp;A | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax', window );">Effects of fair value hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">SG&amp;A | Debt basis adjustment on Long-term borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax', window );">Effects of fair value hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">SG&amp;A | Other derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Effects of derivatives not designated as hedging instruments</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=gehc_InterestAndDebtExpenseMember', window );">Interest and other financial charges &#8211; net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Effects of cash flow hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Effects of net investment hedges</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax', window );">Effects of fair value hedges</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Effects of derivatives not designated as hedging instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=gehc_InterestAndDebtExpenseMember', window );">Interest and other financial charges &#8211; net | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Effects of cash flow hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Effects of derivatives not designated as hedging instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=gehc_InterestAndDebtExpenseMember', window );">Interest and other financial charges &#8211; net | Cross-currency swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Effects of net investment hedges</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=gehc_InterestAndDebtExpenseMember', window );">Interest and other financial charges &#8211; net | Foreign currency forward and options contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Effects of net investment hedges</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=gehc_InterestAndDebtExpenseMember', window );">Interest and other financial charges &#8211; net | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax', window );">Effects of fair value hedges</a></td>
<td class="nump">57<span></span>
</td>
<td class="num">(45)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=gehc_InterestAndDebtExpenseMember', window );">Interest and other financial charges &#8211; net | Debt basis adjustment on Long-term borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax', window );">Effects of fair value hedges</a></td>
<td class="num">(61)<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=gehc_InterestAndDebtExpenseMember', window );">Interest and other financial charges &#8211; net | Other derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Effects of derivatives not designated as hedging instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Effects of cash flow hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Effects of net investment hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax', window );">Effects of fair value hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Effects of derivatives not designated as hedging instruments</a></td>
<td class="num">(15)<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Effects of cash flow hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Effects of derivatives not designated as hedging instruments</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other | Cross-currency swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Effects of net investment hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other | Foreign currency forward and options contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Effects of net investment hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax', window );">Effects of fair value hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other | Debt basis adjustment on Long-term borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax', window );">Effects of fair value hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other | Other derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Effects of derivatives not designated as hedging instruments</a></td>
<td class="num">(15)<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest expense | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax', window );">Effects of fair value hedges</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product | Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Effects of cash flow hedges</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Effects of net investment hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax', window );">Effects of fair value hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Effects of derivatives not designated as hedging instruments</a></td>
<td class="nump">15<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product | Cost of revenue | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Effects of cash flow hedges</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Effects of derivatives not designated as hedging instruments</a></td>
<td class="nump">15<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product | Cost of revenue | Cross-currency swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Effects of net investment hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product | Cost of revenue | Foreign currency forward and options contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Effects of net investment hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product | Cost of revenue | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax', window );">Effects of fair value hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product | Cost of revenue | Debt basis adjustment on Long-term borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax', window );">Effects of fair value hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product | Cost of revenue | Other derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Effects of derivatives not designated as hedging instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service | Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Effects of cash flow hedges</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Effects of net investment hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax', window );">Effects of fair value hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Effects of derivatives not designated as hedging instruments</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service | Cost of revenue | Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Effects of cash flow hedges</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Effects of derivatives not designated as hedging instruments</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service | Cost of revenue | Cross-currency swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Effects of net investment hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service | Cost of revenue | Foreign currency forward and options contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Effects of net investment hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service | Cost of revenue | Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax', window );">Effects of fair value hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service | Cost of revenue | Debt basis adjustment on Long-term borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax', window );">Effects of fair value hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service | Cost of revenue | Other derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Effects of derivatives not designated as hedging instruments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Fair Value Hedge, Gain (Loss), Reclassification, Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4CC<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=gehc_DebtBasisAdjustmentLongTermBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=gehc_DebtBasisAdjustmentLongTermBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OtherContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OtherContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=gehc_InterestAndDebtExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=gehc_InterestAndDebtExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent', window );">Money market funds</a></td>
<td class="nump">$ 2,473<span></span>
</td>
<td class="nump">$ 2,889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investment securities</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivatives</a></td>
<td class="nump">136<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivatives</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent', window );">Money market funds</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investment securities</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent', window );">Money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivatives</a></td>
<td class="nump">136<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivatives</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent', window );">Money market funds</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivatives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent', window );">Money market funds</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479613/805-30-35-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-12<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 30: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-10<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 28: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-10<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward', window );"><strong>Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance at beginning of period</a></td>
<td class="nump">$ 168<span></span>
</td>
<td class="nump">$ 192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued', window );">Current-year provisions</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualPayments', window );">Expenditures</a></td>
<td class="num">(58)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease', window );">Foreign currency exchange and other</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance at end of period</a></td>
<td class="nump">$ 171<span></span>
</td>
<td class="nump">$ 175<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Standard and Extended Product Warranty Accrual, Other Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING ACTIVITIES - Schedule of Restructuring Activities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Employee termination costs</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Facility and other exit costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Asset write-downs</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total restructuring activities &#8211; net</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>RESTRUCTURING ACTIVITIES - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1', window );">Expected restructuring expense remaining</a></td>
<td class="nump">$ 40<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected cost remaining for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING ACTIVITIES - Schedule of Restructuring Liability Activity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring liabilities</a></td>
<td class="nump">$ 89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Cost of sales, Selling, general, and administrative<span></span>
</td>
<td class="text">Cost of sales, Selling, general, and administrative<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_PaymentsForRestructuringAndOtherAdjustments', window );">Payments and other adjustments</a></td>
<td class="num">$ (17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee termination costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring liabilities</a></td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_PaymentsForRestructuringAndOtherAdjustments', window );">Payments and other adjustments</a></td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember', window );">Facility and other exit costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring liabilities</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_PaymentsForRestructuringAndOtherAdjustments', window );">Payments and other adjustments</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_PaymentsForRestructuringAndOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Restructuring And Other Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_PaymentsForRestructuringAndOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482047/420-10-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes restructuring charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 588<span></span>
</td>
<td class="nump">$ 388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (income) loss attributable to noncontrolling interests</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to GE HealthCare</a></td>
<td class="nump">$ 564<span></span>
</td>
<td class="nump">$ 374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted-average shares outstanding</a></td>
<td class="nump">457<span></span>
</td>
<td class="nump">456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Dilutive effect of common stock equivalents (in shares)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted-average shares outstanding</a></td>
<td class="nump">459<span></span>
</td>
<td class="nump">459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share (in dollars per share)</a></td>
<td class="nump">$ 1.23<span></span>
</td>
<td class="nump">$ 0.82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share (in dollars per share)</a></td>
<td class="nump">$ 1.23<span></span>
</td>
<td class="nump">$ 0.81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,454<span></span>
</td>
<td class="nump">$ 2,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Short-term restricted cash</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent', window );">Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Financial Position</a></td>
<td class="nump">2,473<span></span>
</td>
<td class="nump">2,889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Long-term restricted cash</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Cash Flows</a></td>
<td class="nump">$ 2,476<span></span>
</td>
<td class="nump">$ 2,893<span></span>
</td>
<td class="nump">$ 2,565<span></span>
</td>
<td class="nump">$ 2,506<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Inventory (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 991<span></span>
</td>
<td class="nump">$ 921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">1,068<span></span>
</td>
<td class="nump">926<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 2,158<span></span>
</td>
<td class="nump">$ 1,939<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Summary of Property, Plant and Equipment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 5,661<span></span>
</td>
<td class="nump">$ 5,267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(3,179)<span></span>
</td>
<td class="num">(3,080)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use operating lease assets, net of amortization</a></td>
<td class="nump">369<span></span>
</td>
<td class="nump">364<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property, plant, and equipment &#8211; net</a></td>
<td class="nump">2,851<span></span>
</td>
<td class="nump">2,550<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember', window );">Land and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=gehc_BuildingsStructuresAndRelatedEquipmentMember', window );">Buildings, structures, and related equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">2,107<span></span>
</td>
<td class="nump">1,943<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">2,905<span></span>
</td>
<td class="nump">2,705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=gehc_LeaseholdImprovementsAndManufacturingPlantsMember', window );">Leasehold improvements and manufacturing plants under construction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 503<span></span>
</td>
<td class="nump">$ 553<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property, Plant, And Equipment And Operating Lease Right-of-Use Asset, After Accumulated Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=gehc_BuildingsStructuresAndRelatedEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=gehc_BuildingsStructuresAndRelatedEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=gehc_LeaseholdImprovementsAndManufacturingPlantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=gehc_LeaseholdImprovementsAndManufacturingPlantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Current Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_PrepaidExpensesAndDeferredCostsCurrent', window );">Prepaid expenses and deferred costs</a></td>
<td class="nump">$ 249<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Financing receivables &#8211; net</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative instruments</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Tax receivables</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousCurrent', window );">Other</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">All other current assets</a></td>
<td class="nump">$ 601<span></span>
</td>
<td class="nump">$ 532<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_PrepaidExpensesAndDeferredCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid Expenses And Deferred Costs, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_PrepaidExpensesAndDeferredCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Noncurrent Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseNoncurrent', window );">Prepaid pension asset</a></td>
<td class="nump">$ 723<span></span>
</td>
<td class="nump">$ 657<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Equity method and other investments</a></td>
<td class="nump">235<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Financing receivables &#8211; net</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent', window );">Long-term receivables &#8211; net</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNoncurrent', window );">Inventories</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent', window );">Contract and other deferred assets</a></td>
<td class="nump">213<span></span>
</td>
<td class="nump">208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization', window );">Capitalized cloud computing arrangement implementation costs</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousNoncurrent', window );">Other</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">All other non-current assets</a></td>
<td class="nump">$ 1,926<span></span>
</td>
<td class="nump">$ 1,950<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract with Customer, Asset, After Allowance for Credit Loss, And Deferred Costs, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of capitalized implementation cost from hosting arrangement that is service contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 40<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of receivable classified as other and noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Current Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_SalesAllowancesAndRelatedLiabilitiesCurrent', window );">Sales allowances and related liabilities</a></td>
<td class="nump">$ 221<span></span>
</td>
<td class="nump">$ 242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent', window );">Income and indirect tax liabilities including uncertain tax positions</a></td>
<td class="nump">286<span></span>
</td>
<td class="nump">279<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent', window );">Product warranties</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_AccruedFreightAndUtilitiesCurrent', window );">Accrued freight and utilities</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative instruments</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Interest payable on borrowings</a></td>
<td class="nump">141<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent', window );">Environmental and asset retirement obligations</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">355<span></span>
</td>
<td class="nump">386<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">All other current liabilities</a></td>
<td class="nump">$ 1,583<span></span>
</td>
<td class="nump">$ 1,552<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_AccruedFreightAndUtilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Freight And Utilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_AccruedFreightAndUtilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Retirement Obligation And Accrued Environmental Loss Contingencies, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Income Taxes and Other Tax Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_SalesAllowancesAndRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sales Allowances And Related Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_SalesAllowancesAndRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Noncurrent Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Contract liabilities</a></td>
<td class="nump">$ 724<span></span>
</td>
<td class="nump">$ 686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">266<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent', window );">Environmental and asset retirement obligations</a></td>
<td class="nump">395<span></span>
</td>
<td class="nump">291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent', window );">Income and indirect tax liabilities including uncertain tax positions</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative instruments</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease obligations</a></td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">All other non-current liabilities<span></span>
</td>
<td class="text">All other non-current liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent', window );">Sales allowances and related liabilities</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other</a></td>
<td class="nump">182<span></span>
</td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">All other non-current liabilities</a></td>
<td class="nump">$ 1,840<span></span>
</td>
<td class="nump">$ 1,796<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Retirement Obligation And Accrued Environmental Loss Contingencies, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sales Allowances And Related Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplierFinanceProgramLineItems', window );"><strong>Supplier Finance Program [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplierFinanceProgramObligationCurrent', window );">Supplier finance program obligation</a></td>
<td class="nump">$ 364<span></span>
</td>
<td class="nump">$ 394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration', window );">Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accounts payable<span></span>
</td>
<td class="text">Accounts payable<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplierFinanceProgramLineItems', window );"><strong>Supplier Finance Program [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplierFinanceProgramPaymentTimingPeriod', window );">Supplier finance program, payment terms</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplierFinanceProgramLineItems', window );"><strong>Supplier Finance Program [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplierFinanceProgramPaymentTimingPeriod', window );">Supplier finance program, payment terms</a></td>
<td class="text">180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplierFinanceProgramLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplierFinanceProgramLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplierFinanceProgramObligationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation for supplier finance program, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplierFinanceProgramObligationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes obligation for supplier finance program, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplierFinanceProgramPaymentTimingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period when payment is expected to be made to finance provider or intermediary in supplier finance program, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479468/405-50-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplierFinanceProgramPaymentTimingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Redeemable Noncontrolling Interest (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Balance at beginning of period</a></td>
<td class="nump">$ 188<span></span>
</td>
<td class="nump">$ 165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to redeemable noncontrolling interests</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Balance at end of period</a></td>
<td class="nump">$ 211<span></span>
</td>
<td class="nump">$ 177<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInMinorityInterestRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInMinorityInterestRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph (12)(c)<br> -Section S99<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Subparagraph (16)(c)<br> -Paragraph 3A<br> -Section S99<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (15)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (14)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Other Income (Expense) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Net financing income and investment income (loss)</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">$ (16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity method income (loss)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit', window );">Change in fair value of assumed obligations</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Gain on remeasurement of NMP equity method investment</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gehc_OtherItemsIncomeExpenseNet', window );">Other items, net</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Total other income (expense) &#8211; net</a></td>
<td class="nump">$ 99<span></span>
</td>
<td class="num">$ (8)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gehc_OtherItemsIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Items, Income (Expense), Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gehc_OtherItemsIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gehc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss), recognized immediately as component of net periodic benefit (cost) credit, for change in value of benefit obligation or plan assets from experience different from that assumed, change in actuarial assumption, or consequence of temporarily deviating from substantive plan. Includes, but is not limited to, amount in excess of 10 percent of greater of fair value of plan assets or benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480535/715-20-45-3A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Apr. 30, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramAuthorizedAmount1', window );">Share repurchase program, authorized amount</a></td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>109
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( $4SGEI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( $4SGEI(T$:W\@   "L"   1
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MNIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X8-DOV]:[MR_>X%<R)!%!,!FGK_#
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M"CS<_N\-L,+$CN'MB[\!4$L#!!0    ( $4SGEK8=)%$W 4  -,>   8
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MS^"+IXH=U.)$RTV^"?DHM99Q?K@6/!#*/ #WEU+JW8GY@7(?>_P?4$L#!!0
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M(>RS;A!V=Q#/"!TC;*F9N*GY5HITEUCW-6[-5U?*&UD[]K-E<^)F\^=GXMK
M$5E@W*L3BY07A -I:#F=N#E] =OA<A'3? "=98:<1MT>9)>:#*!KB9JXB?H.
MTI$E5AYV:[ZZ2-[(VK&?+;.3EPRLSB*QC*!1U!VHK%+>4)&T-$O<-/M\D<2]
MXHR][A;?(C3IL>KXX,BO8#!HFI-0!5/;CNOJ7*QY6IVV7N.+17DHV7E^A2^N
MRK/'<6NF.L*]@?DUXPKE; 4FO?,)A$M6IZ+5C1;;\F!Q*;0617FY831ET@C
M^Y40^NG&?* YFY[_#U!+ P04    " !%,YY:6L\\C\X#  !S#0  &    'AL
M+W=O<FMS:&5E=',O<VAE970S+GAM;*U7;6_;-A#^*X1:% FP1&^V9+NV@,3M
MU@+-9C3(]F'8!]HZ6UHITB-I._WW.TJ*;.MM+I8OMDC>/7R>.Y)'3@]"?E,)
M@";/&>-J9B5:;R>VK58)9%3=BBUP'%D+F5&-3;FQU58"C7.GC-F>XP1V1E-N
M1=.\;R&CJ=AIEG)82*)V64;E]WM@XC"S7.NEXVNZ2;3IL*/IEF[@$?33=B&Q
M95<H<9H!5ZG@1,)Z9MVYD[D[, ZYQ>\I'-3)-S%2ED)\,XW/\<QR#"-@L-(&
M@N+?'N; F$%"'O^4H%8UIW$\_7Y!_SD7CV*65,%<L#_26"<S:V21&-9TQ_17
M<?@$I:"AP5L)IO)?<BAM'8NL=DJ+K'1&!EG*BW_Z7 ;BQ %QVAV\TL&K.PPZ
M'/S2P<^%%LQR61^HIM%4B@.1QAK1S$<>F]P;U:3<I/%12QQ-T4]'<\%C3 K$
M!+^48&E,-38>-?YAMK0B8HU#&:Z1Q"1O#^0S7XD,R-47H=0UN7KB=!>GZ'1-
M;LC3XP=R]?::O"4I)P\I8Y@J-;4U,C7SV:N2U7W!RNM@Y9,'P76BR$=D%Y_[
MVZBPDNF]R+SW>@$?J+PEOOL3\1QOV,)G?KG[H(>.7T7=S_'\#KPJO)W1_?-N
MJ;3$1?Y76_0*]$$[NMGY$[6E*YA9"*Q [L&*WKUQ ^=]F_17 CL+Q* *Q* /
M/?H5#ZJT4$RUENERI^F2 =&"_/*1? +*=#*G$MJ"4" '.;(YK?;1,,#D[$^U
M-6W\\&AS1GE841Y>2OF*Y5N@SIP+'.9:"ES^?(/&&C!RNG4?%',-3PAZ=0U-
M$[=#0E!)""Z4T$8I:,PW'(UJG)HV_HG-&:FP(A7V[HG?= *2K,XVPUF<)VUD
MP]?<":\$=B9_5,D?]>9DOI,2^.H[P5W/%:-%D8O_QA)0G,/OWHP\UWU/..2G
MAJ;/T+JB1LT5-0QKZ6O:W(1!>_K&%?]Q+_]%6=HICTF1RH7 $PQT*HN3;L%0
MU\4JQDV&P;BFHL7&'[:K<)UC/73Z\T!50M9XNR$)Q!NXG'&)>T:GOFU:;-R.
MN+LG%=SM9?R?&Z>5K=MD,G+J=)M&-^.N"'M'OEY_A'^0J=<@$0:-P#:-O+'7
MP?18I=W>VA=] :4FI(?O_SKZR\E[S_X6FZ[#WSW67+>_Z+8*^N'RZS9K:SAH
M\&\:>6&]4-@GU]<,Y":_U2M<T3NNBRM>U5N\'.[-R\%<?VO]^**XR^_1]A&F
M>([@!6Z3XO'#8(V0SFV($97%#;]H:+'-+\E+H?'*G7\F^"H":0QP?"V$?FF8
M":IW5O0O4$L#!!0    ( $4SGEH>QNT0VP8  '(<   8    >&PO=V]R:W-H
M965T<R]S:&5E=#0N>&ULK9EM;]LV$,>_"N$%10LXL4A*LM0F!M)D?0#6+DC:
M[<6P%[3$Q$0ET:7HI-FGWU%6)%NDZ!3;B\22?:3^=SS>CZ1.'Z3Z5J\XU^A'
M653UV62E]?KU;%9G*UZR^D2N>06_W$I5,@VWZFY6KQ5G>=.H+&8D".)9R40U
M69PVWUVIQ:G<Z$)4_$JA>E.63#V^Y85\.)O@R=,7U^)NI<T7L\7IFMWQ&ZZ_
MKJ\4W,VZ7G)1\JH6LD**WYY-SO'K"QJ;!HW%'X(_U#O7R+BRE/*;N?F8GTT"
MHX@7/-.F"P8?]_R"%X7I"71\;SN==,\T#7>OGWI_US@/SBQ9S2]D\:?(]>IL
MDDQ0SF_9IM#7\N$#;QV*3'^9+.KF/WIH;8,)RC:UEF7;&!24HMI^LA]M('8:
MX'"D 6D;D.<VH&T#VCBZ5=:X=<DT6YPJ^8"4L8;>S$43FZ8U>",J,XPW6L&O
M MKIQ86L<A@4GB.XJF4A<J;AYD;#!XR6KI&\1>]$Q:I,L )=R5HTX7_YM6*;
M7(#M*W2,OMY<HI='K] 1$A7Z)(H"3.K3F0:!YC&SK!7S=BN&C(CYQ-0)HGB*
M2$ B1_,+?_-+GG7-P_WF,PA+%QO2Q88T_=&1_KH@C,3@K_-EK14DXM\N5[=]
MA^Z^S>Q\7:]9QL\F,/UJKN[Y9/'B%QP';UR._T^=[86!=F&@OMX7%ZQ>35$&
M_Q'_OA'WK#!Y,46LRF$B0P1$9E+&&+CBL.T\;CHW1>5^0<(Y/9W=[_KG,$J2
MM#/:TQUVND.O[FN><5"[+'B-7OR2$(S?H(HW@\D**%\PG+Q)[R,<Q(TW<$%=
M+FR?$^VHH]&<#%QP&<6QVX6H<R'RNO"QNH=82R6X<S9%UB,)CI*!+ML(IW0D
MM'&G*_:GA*R:Q&^B)O6**U,ZN5*0!ZRNN7;*C2TE*<4#M0Z;>>@6.^_$SKUB
MSXNBU9AM0"%,YW&)<^OQ<3"4:-M$E+@E)IW$Q!_/@\(21UQH-%#F,$IWY.])
M2SMIJ5?:E8(E@]*/4[0N6*6WT][4@753&7<FEDMV:F=H$@T#ZC"*HL M&P<]
MV *O\/=2Y@^ (B>& GM24&I5):<9IB.3&N\P%WNE_=YDHZ@TJ^X$U*=VW \%
ML^UU3PZAP_GNL@KFR8CFGH78RQB :SN_197)DB/-?KB+4MO/[O/#,!Y62Z?5
MV$S'/:JPGU7]7*]D=7QXOK?=[5='$@_%NJQ&,[3G$_8#ZHO4L)SPB',@A4:)
MI<YE%HS1$_?LP7[XW*RDTL>:JQ(MI8+FHKISZW1P* BL$7> * I&"B?N283]
M*#K/,KDQZ]0U>S2L=PJTJ4)Q9 ET6 4[-79?8$\?[,=/Q\I"L*4H8.DX,F]L
MKN#=-5 KTF&5AG1$9,\?_#P P=2&#6+-MELLJ/1+7O%;,9*?-F\P#:TBZK"*
MR B5<(\E[.>23?5#\;4Q XLE2ZW+*AK)4M+#B/AA=/$\C<0&3IK&PQQP6471
M2 Z0GDK$3Z7?9'7WG.E.;,#$\V@^%&E;S<-PI"B1G2V9'T.?=\KZ3R4KL8$3
MA5:RNJQVDV1?=8\EXL?2L^%)'*2)K/&WC:*1-0GI843\,'*3\U"^VNC!21@,
M]3JLYNF8XIY/Q,^G+3X/*72P*<3Q<-'D- OI?$1C3R=R:*-4ED)O#U),AF8
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M_'XKI7ZZ,:^=NM>,BW\!4$L#!!0    ( $4SGEKM&#S(Y (  " (   8
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M0E!:!$J+C0/5E=+!QR9F'_N<+= 6=7RW3.3-<G.YLY4"ZF(3U3Z7VQ^"5HQ
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M94DS&HUWH/.5UFZW\1?T4S__ U!+ P04    " !%,YY:_P\NLFX(  "_)0
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M&'*$$FS9J"#-C3U0^MG,)S2[#.#=X_$DBO=Q300=ZHJF )R5=JC9^%Z8B8,
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M:M1;M +PD9J>5",4+N0WZ\0WRJUHA9VDJ=-AH@SA"W4T--I45@.N^>#CN21
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M/)P2AM3H"$L;L+XVQI<O=$'U/XZKOP!02P,$%     @ 13.>6F/&V&<K"0
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MG'6X_?-Q;?3=XQJ;\_VX5MV6]&L?F_]Z)2[/KSAQ]TV-EQ+I(;'KD&'%*EO
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MFH#ORP)%1WBA#>J?W7CQ;U!+ P04    " !%,YY:'A#T:$0'  !O$P  &0
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MT;[J/@H.T_,;3U%;*Q9X4.Q#J4:'Y/4C><WK<I47+"%'#:JI@+3V!>&+=;W
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M!WN&A@7H>Z[IM&Q>>(/VWX3QOU!+ P04    " !%,YY:>3H1(\$#  "+"
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M7.; ZQ5\2F\B4R!5 \9A+TJ9/(]$!)/B&))7DC&D9B9](>:Q7!"[BK ?SLJ
M3@2Y#[1*6/642G@?/J2LHMHWA!%4ZCK#\13;7&$7J)8BV&(/T8%H]9YVX> 9
M8PU\I%:*F*GTUF )2N$=G9Y!4 ->R5>_>-UQ-<%(QM]F TF/6=#"'P$'AZ:U
M@]+1V,#EXP@@ $D:P8FZT?N2.P-9@IJ/VTCG#)X$:KD(N%%].JNG>M05#T;B
MHR:SN$(DX0,I>T\1[*7GW"W4SZ9(8Z$T[K7S #%;GEU2OT7$:7_G962$D@1D
M\[KL?$:'DEE]E_%"-!K5>6<HED!F@D".TQSI9)T?1M]VGDC0WFD8(?I.E;JP
MEL'+UQF:IV]@ +P^=BZJ]<+ZICW$K;FL)($]=(L'HYUI!2%$-, G"N1]#GI(
M);3IWN*<S=&#RS8B*<O7&O@GT6ZRV)<Q/<&WL3VA:890,L!1OC0122+)2)52
M9\L)L?"HC]TO.Q7/21TT'14;$;Q0-%$>PM,ENX3$KK5O*XL\"/_GEK-Q1K;C
MA!CU-J/[Q..W 68J@IT$J2.,!$Z1VYHLHA-J0P@*?1^6!$Z943_Q$:-I9\0'
MZGHP =XF6%@7&H8Q:"-4:D6 E4/ITBX[>F\P0O8(A*@(,V>4Y43[:\ \U<E*
MEC6UG1&/ \2Z?*1+GYW\H<6Y-N ;%/6Y^*1D20\,>O?>:\1(F+J:04,\^S:Z
M(2;I5N!L< \M0]U,KX#\TJ2 PO&: EIA$>DV8R*+\HF%AXD[-*V1Q;VGDZF^
MIDCAP-ZB9^TRCL7P"A6T%,_H26*OV_L2@WT._H<3J&WTU%X6$N[)5!V84)&2
M%=4T/L.?9$O&Y)QSLH/ECV?)&5/",,9T]#V(IZ0GBP/G,!KC(J)XXJ=<AKFD
M"*VTC92Q-7>"L+RX56#>3OM*3+(0QX/..5ZI.T^<2@7BR*E*&67IJ(95WCNI
MX7C@[X:U9V0U*< A'0AWN@4,_163I9DR8LB\1.7T./D2%*.FI*.J^ ]<N)58
MI-Y3R<4-\4N-Q 0]W!UNQSNFP8*GFKQG(45X[_41'!/1AWH>/*A]K(/T6;&7
MVD[%'@68M[LC($8%I*G)P=!A/.0F9%2[DV,55<'*9+E437=[,CFGVF6UID:'
M>O8IY@^S%%I0<\^8V+(B']3,]32Y%UBG?M2 'T6-;T471DG#1@0QIY[)_ZIS
M!GGSWYJQ56NCZ:AYT%3: ]5?ID#VWH62**H\0F4R) 4?+33NZ>=P8G_)=S<U
M6F^EDOZ(=W+ _5,>\>IE<\0^WZOL#Q\1N))96YJ_%9=8!Q Z3Z^#VT5"?=_>
M_@"]U2U9I0L@/6/2WIN^6EL2"K0 M 1JM](M:FZ@D<0W[$!U./MO]*;.IA@-
M(L;TZ&<#P??*CH NS3*H3@PE?/T(=M7Q^.X&R8L/]Z<+;K&5O..A>?XB[[T+
MI@[+>/*CBP&".\VS6 L7S1@WM<[5RX YK$$BH*1XEG+QP_1JTJ$]W7-H=!KP
MI5*N?<R2U"M[DP-ZJ65:P9C&E!9>HLL?!K>XJ*B-9HFS]%S5M)2:KQ"&G<*8
MES1=T&1I$ L4;QH;0,(PFU02WT#>P/VH1!YX)"50:JIP>U25;#IK!EB^S?,<
MS<8!-V?3+?N[3JHH/UA]J/,%1(!PN=GV_O)+NZV;PC6W^<->= *-\2#@+HY6
M/:42>;-X(Q EB\V-P3B!#\4FWI*PI'@'Q#G4CL1-"^5^9=+5SQ33M.3[&:9]
M,P4.KLP"=#6GQ^#*E@22\VKO$_E$$)0$04IGPRU=65Q^Z5M4**\:\L6G4)J#
MUI4T<Z:QC?A6$]>(,SR3QKVRN3ZE UA%33,$N9IH)5.#R+<XG]J'0UA14'Y$
MOM9<BG6YO[2E;@6WG1<LH4<OVZ&^-K+EJ'$DX3Y0NW1U!.J^5,,TDO(XW%Q8
MQ>LAI*O--"\TIL*V1S+RGBNCRTIOG]!B#3H"WD0<A2X%X@\75&R@H0%88)(C
M66[3>A A?*2MA%%@!3J.)@30N>ZF=WI[P]*(%Q%_VK136$-B((/\VAO [5;:
M-2,HI=\]W,$<Z#GXC!Y\/E\HW+\XD$MLR]CR>8(IVC%,EP31YPVH(O[I%H>2
M<TY7,\/.RB&Y? $>UJ3(#X W2XY4;]C-7C1J(!T>NU+?Z?UZ4BD(H]^(/(-/
MB#^DM*OMSU"3^.M+]WK\#>L<C08 AR%ECJV[H]<' ^'B[T+Q2[!+_BUF9D.P
M%7]$FP)*T MX/K? A/2%#FA_G#O]"U!+ P04    " !%,YY:ES/=I_D$  "U
M"P  &0   'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6R55FUOVS@,_BM$5@PM
MD":QD[YL;0.D6=L5N U%T^T^'.Z#8C.Q;K+DD^2FV:\_4G9<-]?F;A_BV#+Y
MD'Q$/M;YRM@?+D/T\)0K[2XZF??%QW[?)1GFPO5,@9K>+(S-A:='N^R[PJ)(
M@U.N^O%@<-S/A=2=\7E8N[/C<U-Z)37>67!EG@N[OD1E5A>=J+-9N)?+S/-"
M?WQ>B"7.T'\K[BP]]1N45.:HG30:+"XN.I/HX^6([8/!=XDKU[H'KF1NS ]^
MN$TO.@-."!4FGA$$_3WB%)5B($KC[QJSTX1DQ_;]!OTZU$ZUS(7#J5&_R]1G
M%YW3#J2X$*7R]V;U&>MZCA@O,<J%*ZPJVQ$9)Z7S)J^=*8-<ZNI?/-4\M!Q.
M!V\XQ+5#'/*N H4L/PDOQN?6K,"R-:'Q32@U>%-R4O.FS+REMY+\_/C^:O9P
M_VWZ\.W^]NL-3*8/M]]O'VZO9N=]3^ALTT]JI,L**7X#:0A?C/:9@RN=8OK2
MOT]9-:G%F]0NXYV 7X3MP3#J0CR(CW;@#9M2AP%O^%:IZ+PM$U]:J9<@= KW
MJ(3'%";<&M)+=/#'9$Y6U"M_OL9 %6#T>@">GX^N$ E>=&A '-I'[(S?OXN.
M!V<[TA\UZ8]VH?_23NU$>CW/M^!AB[9GJH1%0.=0>RD4> .F\#*7/Q%\AC O
M'85UCE;1"L^^N4E1 0D)W%S!9Q3*9U,&X:W(C?-J#5(_&O6(893),$$:_+0,
M ^RZ0-HCM/PI^)%"D@@IN=0D$9Y>,HK%1\ERX4(ZI0TFE*2G;:; QA=4A._!
MK,!$+F0BE%IWR:A=89()NZ3R]I<D:>X R(7D2H;D$E6F!"02J:1? SY)#PEE
M3N$Q+Y19(Q[:NJD\6IK7D"O,4>-">N+,.9/(\'XE??9&G61%<KRRTN-A:E:Z
MKBY!DI_#TF$5LP>D2^!PR020?V$LT[Q=S]:.:>.!RC8))]&#KQ0(GTCB';WG
MK7GI+#5Y"A9.1T'S7/I0FH'YFE1(DVR'X#ZSIEQF0".;9,W,AG@U:2G=A+[P
M8JZH._AK4!40%C.+2#T0] -9/QJH"HDN([BJ*7Y!;: "]B".^'($UYO-8<8,
M@=O6-L'[=Z=Q%)_!*4RV.88(3N#!^-!8;Q 8W*,ST.1*T6*ZC ;PD-$0[2 N
M# IQG-3<D25],Y@0D::R;N9F$\P"1%%8\T1MYY':;H]"Y%(ILNL&Z@.II:6.
M:36G><2*2XU/'J*X9K-+GUM2-!&&E,R:[C3_MV.)QG_U8V]+%9KD-T/#)5M,
MS)+&M>YU*G=*>\#U477<[)3<9H5%2"889AQF-^]%7IQ->! J+JA,RK"[Z:&I
MH1:A>"G?.:-D&O*?\9@'-6#(6TT-BSWX38HY=P3O7ZOZK3U^/5\F67/OY%Q?
MQ0P3LF&G"Q.EZBY+:F/U'*\+7XT^3/X;A9^>D73+J87V2]5?TT;JA(7YSKC0
M8SWNTTTSOVB$2BC;=+2C+@RIQ8JV?,?X[1ZZ:J@NA:*,* ,/GS#!?$Y&M5*,
M:(Z.3^@2G=+E]!BFM09''X % .[$NJKL&5^D?]'IJ%K=CT8'L#^D7W1RT ZT
MI4=[<#+D*,<<Y0.\]E'NMXY2.5(2?&!D[2NUKTY5S6IS)IU41[%G\^I 2\&7
M- R@<$&N@][)40=L=4BL'KPIPL%L;CP=\\)M1N=JM&Q [_F#M7G@ ,U)??P/
M4$L#!!0    ( $4SGEKB$&14WP,  . (   9    >&PO=V]R:W-H965T<R]S
M:&5E=#(S+GAM;)56WW/:.!#^5W;<3H?,M!ALDW $F(&$-GEHAH&[WD.G#\)>
ML":RY$IR2/_[6\G&Y2:$21^P96GWVV]7^X/Q7NE'DR-:>"Z$-),@M[8<A:%)
M<RR8Z:H2)9ULE2Z8I4^]"TVID65>J1!AU.M=A@7C,IB._=Y23\>JLH)+7&HP
M55$P_6N.0NTG03\X;*SX+K=N(YR.2[;#-=I_RJ6FK[!%R7B!TG E0>-V$LSZ
MHWGBY+W -XY[<[0&Y\E&J4?W<9]-@IXCA )3ZQ 8O9[P!H5P0$3C9X,9M":=
MXO'Z@/[9^TZ^;)C!&R7^Y9G-)\$P@ RWK!)VI?9WV/@S<'BI$L8_85_+QKT
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MQ>AU]L<S7,]ZKF?/H?_:]_B?$)\M7#:L#8RS+J<#H)9A3HI+H#6\TRPU0NQ
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MM@R0DF[3\M I2KOMV<$7L&IL9IO0_OO9AK!L2JB4EV";>X_/=>1+W KYK$H
MC5XJQE7BE5K72]]760D55G>B!F[>Y$)66)NI+'Q52\#$)57,#X-@[E>8<B^-
MW=I6IK%H-*,<MA*IIJJP?%T#$VWB3;SCPHX6I;8+?AK7N(!'T#_JK30S?Z 0
M6@%75' D(4^\U62Y7MAX%_"30JM.QLA6LA?BV4XV)/$"*P0,,FT)V#P.< ^,
M69#1^-TSO6%+FW@Z/M*_NMI-+7NLX%ZP7Y3H,O$^>(A CANF=Z+]!GT],\O+
M!%/N%[5=;/310UFCM*CZ9&-04=X]\4M_#B<)AG,^(>P30N?=;>0L/V.-TUB*
M%DD;;6AVX$IUV4:.<ONG/&IIWE*3I].-.5X"$CU)3"@OT$I*S LPQZY5[&NS
M@XWSLYZV[FCA!5J$'@37I4)?. 'R;[YOS :]\*BW#D>!#UC>H6AR@\(@G(WP
MHJ'<R/&B"[QS9=Z@_2O:<$(/E#28G:NZ@T[/0^V]6:H:9Y!XYF(HD ?PTO?O
M)O/@TXCR=%">CM'37<, 38+]['9RJHU61-3Z_T/N=,>!.68*1L1F@]ALE/-=
M\-LKY,:A;\G-![GY5:?V!-+<(GS!;9SYEMMB<%M<?7#C?N/<BW[^27^H0!:N
M"RJ4B8;KKE4,JT.C777]Y6]XUZ7-A2PH5XA!;E*#NX7Y.V77^;J)%K7K-GNA
M3>]RP])\+$#: /,^%T(?)W:#X?.3_@%02P,$%     @ 13.>6@2(LY.Y"@
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MK3\:75]=#UXM;-LI#*)I@+H(O1!O0;YM"=."+K*W@MV:G .F9-)[/=&P!MX
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M)J.Q6P-??S^"#L?6ZC )7@6-X'04)*WJVZ%1$&--DL36WL^@T63HUOA5T'"
MZHR25@&#1#1V:^@DMFFB.HDS9*1Y7*19-8=-;*&8'\L>+7F! LAZQ.;8B80=
MFW9+M06HN<TFWJ!3YVB(3)8.1/&,V1KG=6U 0M,:@/8J7](H4IESA["1WFOJ
MZ/ST\OX_%M,+U58Q(,=8$5Z;PRB!2NSF!])%2)B-5X04A*-QJ^$CMX[0] ED
M[CA\KU)3N5F3(D.(?!3M4G<8[-))^JT2VC>.BX?0I?3W'S;QF"&4"V'5TA53
M2VRVU!WODNW),#J@3_B:HFXF-9X#959I#'"M'1S3&@W: L40"QK-:2F*#S>+
MA1/5O&3*CYP-R2$,)99D;O>1[ZQI[V?2#4E1&%8LA9U&SBCT!S'T!PC%9?&
M(-0Y?F!9Y9&6+>(3!"T*K*CAJ!#C*/F<+YK)5+OO^8<'5,"W;AA"K1O:B%Z#
MS_/<J<.VJ96N\PIY&2($$0RYIS..6N8;&<,>7=\DH(,.#Z/_;RZ72N!#5V1/
M+R;TQ?27)NX]Y!8RP\>T?>PYM> ]#&[A7%.!K)ULW%16TOOTTL\7/9-SHT3J
M!H.LU+88[-''-TW5?=Q, 2,1-*;PKU36-6.#E&'O\(.#HP3]V+!WS]6'6/-'
M#".-8?.O:[5'*XR8&><%+:H,.6"(6;JA81W:>.&LF94$T5K&-15XVE.'/3XX
M?!>@3?">JZ1^X0,SLX<<ER/]+,M\,=IAV@3[Y52W!+;-9#1YBEYZMO)/VZUG
MP6;R@6_)S8N>_]5-VC:3_=9)8O\Q-B9L+G:,^F\C.T;1:V%"V[Z$^ZT#2\XQ
M .RQ3&-((6#^[-(\;4Y^)_[ \RSNCXU@"#J:,KZ :K WBCND_%',WQA9NN//
M3!H<IMS?%4ZO7%D!O%](:38WUD!S'C[^&U!+ P04    " !%,YY::A.)X/(#
M   9"@  &0   'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6R=5MMNXS80_96!
M-EC$0-:R+KYE;0-VDJ(!=ML@2;</11]H:2P1H4B7I.*D7]\A92L.:KO;!6Q*
M)&?.G$,-AYQLE'XR):*%ETI(,PU*:]>786BR$BMFNFJ-DF962E?,4E<7H5EK
M9+EWJD08]WJ#L&)<!K.)'[O3LXFJK> 2[S28NJJ8?EV@4)MI$ 6[@7M>E-8-
MA+/)FA7X@/:W]9VF7MBBY+Q":;B2H'$U#>;1Y2)U]M[@&\>-V7L'IV2IU)/K
MW.;3H.<(H<#,.@1&CV>\0B$<$-'X:XL9M"&=X_[[#OTGKYVT+)G!*R5^Y[DM
MI\$H@!Q7K!;V7FU^QJV>OL/+E#"^A4UC&Z<!9+6QJMHZ$X.*R^;)7K;KL.<P
MZAUQB+<.L>?=!/(LKYEELXE6&]#.FM#<BY?JO8D<E^ZC/%A-LYS\[.S^YNKF
M]MM\\>7F <X?V5*@Z4Q"2\AN/LRV*(L&)3Z"DL!7)6UIX$;FF+_W#XE12RO>
MT5K$)P&_,MV%)+J N!?W3^ EK<S$XR7'9&*&_-G+@S_F2V,UI<.?AX0V..EA
M'+=%+LV:93@-: \8U,\8S#Y^B :]SR=8IBW+]!3Z[(&V7%X+!+6"/<:':)X$
M.DSSJM8:I=U'AKEQL6BUL[)=;K@F@VJ)>C>2PLZU24B:T7L8YU$'SB"Y2(;C
MYCF*X1<E/W&9D:W?,SE8]O+.*>KW_?]76Z*K$3+7K^\-TA2B)&E#'S")QV.(
M1T.8"RHM3&8(5*0@TYAS"T(9X\GU!AW7)AUX5)8)TM  [B-]_#"*H^@S2*J"
M3D)_&#?/P<#+NRJ9+G#)LB=S 9N2TVHQC;#6G"H9%XZ68-;)5*!J#7?7+["L
M#7T50P[.M$")F@DR-6BM<*:E5G51 C>F]N3I0S3<R<6^KGGFS3?<EER"D@B5
MVV/.C$MN.4DA":IP[TI2%)G[2&Y0TRX$9H!1+Z^;^D?4LA.?L0L+)AP/LR\F
M>Q,.&R3TLZ@?41T2PI=4"DD#R=O H71R5O]*J0N*8M;H:[)X[<(7)8M/CZBK
M'TE/[VR=\\$$/8/!B)K^^+_3,DX(\7A2#@<.ZBW< 1/*R='H=$JZA.SOTE&T
M8,<3,AI$KDWC[U\0)LT>(&6'!58I;?G?I#I3QL&26-_<RF<TMG*909FVXM(3
M%T@K1*GH*%!,.NF0LB>'[?H-QNYW4B=MN?.XT^[@!IC+XH32<:]IOD] TF^:
M'Q+05*#XM(2TX_\N;[+_(2,:#7R;P*%3(=P[KBE7"W\I,22JEK8YN=O1]MXS
M;X[[-_/FTD294'!:*8$K<NUUA_T =',1:3I6K?WAOU26-H9_+>GNAMH9T/Q*
M*;OKN #M;7#V#U!+ P04    " !%,YY:UY \8/P#   C"@  &0   'AL+W=O
M<FMS:&5E=',O<VAE970S,BYX;6R=5N]OVS80_5<.:E#$0&I9DG^FM@';2;<
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M)_@TD?4MMUYHL;0WRWNAT;GV=<'0&M(P8'\FA-XLC('V7PV#OP%02P,$%
M  @ 13.>6H.*_YJU P  9 @  !D   !X;"]W;W)K<VAE971S+W-H965T,S0N
M>&ULE5;;<MLV$/V5'=;M.#.*2)&B+JZD&<FNVV2<V&,YS4.G#Q"YDM"   N
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M:&5E=',O<VAE970S-2YX;6R556&/XC80_2NC7'4"J27$"2R["TBPY52D+HN
M:S]4_6"2@5B7V*EMCFU_?<=.R-&67:D2]HP=O^<W]G@8GY7^8G)$"Z]E(<TD
MR*VM'L+0I#F6W/14A9*^')0NN:6A/H:FTL@S#RJ+D/7[P[#D0@;3L9];Z^E8
MG6PA)*XUF%-9<OWG' MUG@11<)G8B&-NW40X'5?\B%NTGZNUIE'8LF2B1&F$
MDJ#Q, EFT<,\<>O]@E\$GLV5#RZ2O5)?W&"938*^$X0%IM8Q<#)?\0F+PA&1
MC#\:SJ#=T@&O_0O[)Q\[Q;+G!I]4\:O(;#X)1@%D>."GPF[4^2=LXADXOE05
MQO=PKM?&M#@]&:O*!DP*2B%KRU^;<[@"C/IO %@#8%YWO9%7^2.W?#K6Z@S:
MK28VY_A0/9K$">DN96LU?16$L]/URW:W6>R6F\7S8K6#^6*U^+3<P?KGV6H+
MG1W?%VBZX]#25@X0I@WMO*9E;]#&\*RDS0TL9(;9/_$A26QULHO..7N7\)GK
M'L31]\#Z;/ .7]S&'7N^^ V^#5JAD;++PAPE'H0U\-ML;ZRF//G]5L U7W*;
MS[V=!U/Q%"<!/0Z#^BL&TX\?HF'_\1VU2:LV>8]]^J3*2DD2:T =8$5O=8U:
MJ$RDL'BE]VGPEN+_P]G00&<I4U5B%S[WMCU8%UP:6$J+6G+WBGC1S+VL%_/&
MI=<!-D=J&A'*^M[1W3O0K:5Y>VVN2VYZ6SHOD2*DRECX^&'$HN@17BK4M*D\
MPG<041M1&S3-C5DM# GB<2RYI\8@'D(\@"AV/Q=6:DF)1GO2$J@.5"0:N#%(
M@7?8Z*Y+_?V(^GA(74*>%\ >6SLKE;;B+W\ [JPDG7^A#,&/5/4<OD]=1$P#
MB,D9=.ONW[B*KHSJX76LG51C)JS;O4L!=:)ON]>LC'5A2S$(.GD*EBI 3>?1
MT7^DOF572OZ@KLZS,R1R,G>1,XESHWJ&1;5)NC[/JDN>X25!1),@M&AP[\TP
M=N;>S]3@AHIU;^5^>%6M2M1'7Y,-1722MBY<[6Q;]F=UM?NVO/[/H/PZ"DK!
M @\$[??N!@'HN@[7 ZLJ7_OVRE(E]6Y.?UVHW0+Z?E#*7@9N@_;/</HW4$L#
M!!0    ( $4SGEK^L;_L9@4  .0-   9    >&PO=V]R:W-H965T<R]S:&5E
M=#,V+GAM;,57VV[;.!#]E8$W*&0@M2WY(N=FP''=K8$F,9*T^[#8!UJB+6XE
MTB6IN-FOWT-*=MTV28T%%GVP15*<F3,S9T;D^4;I3R;CW-*7(I?FHI%9NSYM
MMTV2\8*9EEISB3=+I0MF,=6KMEEKSE(O5.3MJ-,9M LF9&-T[M?F>G2N2IL+
MR>>:3%D43#]>\EQM+AIA8[MP*U:9=0OMT?F:K?@=MQ_6<XU9>Z<E%0671BA)
MFB\O&N/P]++G]OL-'P7?F+TQ.4\62GURDUEZT>@X0#SGB74:&!X/?,+SW"D"
MC,^USL;.I!/<'V^UO_6^PY<%,WRB\C]$:K.+QK!!*5^R,K>W:O..U_[TG;Y$
MY<;_TZ;:.X#%I#16%;4PYH60U9-]J>.P)S#L/",0U0*1QUT9\BC?,,M&YUIM
M2+O=T.8&WE4O#7!"NJ3<68VW G)V-)Y,/EQ]>#^^G[ZAF_MWTUN:W%S-;Z?O
MIM=WLX]3FEUC/J7@_<W=79->_3:,PO",KJ?W%-RS1<Y-\[QM@<-I:R>US<O*
M9O2,S2Y=*6DS0U.9\O1;^3;P[YR(MDY<1B\JO&*Z1=WPF*).U']!7W<7E*[7
MUWU&W_1S*>PC_3E>&*O!F[^>\K%2T7M:A:NE4[-F";]HH%@,UP^\,7KU6SCH
MG+T L+<#V'M)^^@.M9F6.2>UI'&2E$69,\M3NK$9US11!6QFKG(>.,UDH@J.
M#"KS=+)>-C7)F%QQ0T)^8TEY2\DWED1M*7>6Z#5)])3%H]^D))>6-EQS8H:6
M*D<S,"U"81$4X:<YIZ)B!7>L(.0TR79)I4FI-9?)(R$AT@"#+^GT;U0(6H0U
M%(1-FM?-@LEM*.8*&>16:.YVT3R',$V8R6@)!(0H.M_NE64YC6\F,WK#$UXL
M(%E;[M$15!^?Q-TF1OUX@/]P6"UVXY-F;>>E0"PX>B='!TMR9HQ8BL2C-[MJ
M<G%"(BW[ BP8'(7]8SK"S_EQU*7PI$=!U&G")IP,!UVZ_4'74JNB\N!)K4'4
M#."!4^[?1V>P$ YJ$_4207/0@T\P&1_@6-2/*1A@?S $K&&'WG-C3@\09-9J
ML2BM:R!D%4F%U])JT$+(%39;$,78.D( ]MSS.Y+XK,1A[%/5B5VJ.M5B> *8
MA[*M]\O8UJU=Z R<"^%QIUNM#-T4H0[_'[X%<1-T@$\U'X(><AH#0T1AGX(^
MS/\7QGU/M^@[NFV?07?8W)O$ASCIX07=OJL'"D[P_+7DJ_M$/ Q=JDY.'/E<
M"/ ?#^.F)\P]N,<*54H?II]R# E4*RG^ 3W1? \(B0,6=<Z0$C\*SYJ4EMHY
M=5B/=<GQKD!O7KH-+J,KG.Q,90-?>Z!R4)U.Y5\+^< KQ#6_CWV'+[7'FPJ#
M0XRI7+A6EI-C00V4W@K)9")0#3.)RBDKOQV,MTQH^LCRDM,59Z:L*LJT:L=\
M:%^B)+*HB#,M@=1];_2AU<JJRMD&?B-LYI'+US@'Z\KS!9=\*2P%5?R;R KX
M<DR;3(!2/]3[TRHGD'$T6&N5EDGM]G;1G1=$4GUU5>F^Z,B7=&'$R*A<I/XC
M?&?QJ((&H>I#WR+7Z&=5!LU>39(H<![QLR,T^D* [X@'XO13)OJJ'>Z+'!A-
M3Q8 A82C8,KK.'@+#A86UUH@/==7<^+5L:O@-E/I'K%:2/42)J#%4RC>,6B<
M0,1X=8C_[TJE&V \WH,UDQ;G%^%J?0P>6K-ED.,$2U,O"P(*65UP/##I@3E(
M[*N!UE/GMO;>R;O@>N7O%P:$0)%7A_#=ZNX*,ZY.[E^W5_<?%./*55K.EQ#M
MM.)^@W1UIZ@F5JW].7ZA+&X%?ICA&L:UVX#W2X7@U!-G8'>Q&_T+4$L#!!0
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M M#E:"H/5N5^'"R5I>'BMRE-<]1.@>Y72MFW@W-0_1^Z?P!02P,$%     @
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MO3@D^N^BSJ#;]BP=S_(!CJ5P>-"!"F01OL_ZI"@UU<VHV6U:^:CN8"_F]7^
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MA]8+\/G6&#HNO('N]9S] U!+ P04    " !%,YY:@<!"RGT)  #['P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6SM67]OVS@2_2J$][!( #>69,L_
MVB2 DSJM@<3QV6GW#H?[@Y9HFZ@D>BDJ:>[3WQM*EN7449-V<8<%%G$D629G
MAL,W;X;DZ8/27]*U$(9]C:,D/6NLC=F\;;728"UBGIZHC4CPRU+IF!M\U:M6
MNM&"A[93'+4\Q^FV8BZ3QOFI?3?5YZ<J,Y%,Q%2S-(MCKA\O1*0>SAIN8_MB
M)E=K0R]:YZ<;OA)S83YMIAK?6J644,8B2:5*F!;+L\;0?7OAMJF#;?%9BH>T
M\LQH* NEOM"7<7C6<,@B$8G D B.V[VX%%%$DF#'[X701JF3.E:?M]*O[. Q
MF 5/Q:6*?I.A69\U^@T6BB7/(C-3#Q]%,2"?Y 4J2NV5/11MG08+LM2HN.@,
M"V*9Y'?^M7#$2SIX10?/VITKLE:^YX:?GVKUP#2UAC1ZL$.UO6&<3&A6YD;C
M5XE^YGS^:3J]'MV,)G?#:W8UG@PGEV,\C2=7M[.;X=WX=L*.[O@B$NGQ:<M
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MVR*M;92TW<.T!P=N$JL&,]LDW=_/!DI#2[-52J6^!(SO.9Q[.)#;WS)^*]8
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MF8L4 LNO+1F3*$J19!U_%Z!6><\T<?_X#?UCUKQLY@5S,J;1'V$@5D.K9X&
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MAP3@.1(,<[I) F7]VGN</%V&T.J,5/X'>N=4KE$_9 JM3D7EB*#6:1RC7/]
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M44&]]]1@HZU+4VC%5.2M"[(?0M1JL%\Y BOO;PPFK?*ZZ)X<%$=$[5OU^;D
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MWSX"+1S#"D70W &M"?'J0<,2-#P*^E/-P)R.+!/O'P&&>[.WHQW _9!*L;<
MHQ(P^N2"?PXRVB.XO-R!W ^)#T"V2\CV4<@>U=<*9BD@?4&A5$!&%*)<RGK&
M]AY 8[>0-2%A/6-<,L9'&9^XPE1#;<I9J2,Z_1('OG^-&*@ZWGAO?_B1OP-<
M$],*=HC=RH%O+EM]G$X)DXC"1*N\B[;.5Q076-%1?&[O@#%7>J_;YDS?^2!,
M@'X_X5QM.N9:*?]%)/\ 4$L#!!0    ( $4SGEKR:Q,]C@,  'T.   9
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MRKC^@,9?YS?D_=L/Y"UA@GQAG.,'TD/7()^=Q8T+ENN<)?@)RQ>J+DCHGY'
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MLTX^,'*='1>>I,'#1W:[PO,A*&N [Q<2UV8QL">0\L09_0=02P,$%     @
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M6VJX*W42GB2\H>J21+UW) S"?D<]T^?#XPYX=AJ>07X,?J F:HV/'%]TS'C
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M970U-BYX;6RU6FMSFS@4_2L:;V>GG4D*R(\X6<<SCJ&M9YK$&Z?;SPK(MJ:
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M%8)&R>4:HP S92#?+RD5;S>J@?P0R_@W4$L#!!0    ( $4SGEJ\'5<!(@0
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MP"C 3!60[V>4BNV-JJ#XK&+\'U!+ P04    " !%,YY:&\)CE0 &  "_(P
M&0   'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6RU6M%NVS84_17"ZX86:&R)
MM"0[<PPT";IE2-L@;M>'80^,1-M<)=$EZ:0=]O&C9%6T))J1 R8/L25?7IY#
MWZ-[3&GVP/@7L29$@F]9FHNSP5K*S>EH).(UR; 8L@W)U2=+QC,LU2%?C<2&
M$YR4@[)T!#TO'&68YH/YK#QWP^<SMI4IS<D-!V*;99A_/R<I>S@;^(,?)V[I
M:BV+$Z/Y;(-79$'DI\T-5T>C.DM",Y(+RG+ R?)L\,8_O4#38D 9\2<E#V+O
M/2BHW#'VI3BX2LX&7H&(I"2610JL7N[)!4G3(I/"\;5*.JCG+ ;NO_^1_6U)
M7I&YPX)<L/0S3>3Z;# 9@(0L\3:5M^SA=U(1"HI\,4M%^1\\5+'> ,1;(5E6
M#58(,IKO7O&W:B'V!OCC P-@-0#V'8"J :@DND-6TKK$$L]GG#T 7D2K;,6;
M<FW*T8H-S8NO<2&Y^I2J<7)^_N'V]L/GJ_>_+< )6*@B2;8I 6P)KEF^.OE(
M> ;.&5=):;X2X.4ED9BFXI4*_K2X!"]?O (O ,W!.YJFZEL1LY%4H(K4H[@"
M<+X#  \ >(?Y$"#_-8 ># S#+^S#+TE<#Q\WAX\4ZGH]8+T>L,R'#N:[D^ J
M%Y)O5;%*\->U"@!7DF3B;Q.Y7;:Q.5NAP5.QP3$Y&RB1"<+OR6#^RT]^Z/UJ
MHNHH68,XJHDC6_;Y#:=Y3#<X52)02T"%V)+$Q'B7)BS3%!>)^_DDFGBST?T^
MDV[0U$-A'=1 .*X1CJT(KXD0I^!3CC/&)?V7)!HISF,"8B:D #A7YZF(V3:7
MQG+<31+L04-M](809,8>U-@#*_8W27(*+K;9-L7%9:NX\E"%-?E'*;RL,W5!
M!DM,.;C'Z98 I<,5,<(/.MBF+?3=B)/ -\,/:_BA%?Y')E5AW-47 A.PL#/M
M) K:V Q!TT/@HAI<U*,N%FM5%2>RN&#9<48="*KEP1;.;I ?[ 4U<$YJG!,[
MSN**V@/@I#-W& 51"V W*!J/IV: TQK@]&B KU43XEQ5J GIM*-RM91M,4U-
M2^F9D?J>;EN>%>N"Y%1))F>2"/ ?"(:AY_T,Q/[91.GH/;LGV1WAP \.=IAS
M^U3'7L1=96LNS%X_]YTVL"J=*_*.LC7)Z^;M6UOD?"&Q5'V!YJJ*B9" JT,C
MZ5V:XJNJJ](;>D'8JEW[=$^EHUNR[Z@G^]U^VQ!9Q08=(T7=EGU[7^Y*,>@C
MQ<A(Q#K5T=7H*%MS873/]P.W4K1ZB*/).\K6)*\=@V^W#+VE&!Z08M"N7NM\
M3^6C389O=QG]M1AUM1@%'2T:',9^5!.EMAB^W6.TM#@>3HQM\<UVI8PG\,>E
M$J=&&M:)CBY&1]F:RZ*-C3]UJT2K43J:O*-LS1^TVBK!1ZQ23R56:=I*'$]:
MI6N?[JETM,&!5@_17XA5GH80N_:TB@H.1351[FTC/.)$VDUQ$D0&(;[#/%Y7
M';'X&6I@X7:'X3D,#=2&!B*WNRM6?W0T>4?9FN2U3X*/^*2^.MRE\?U61YQT
M?@3:)WPJ(>UOH'U3H[\2@ZX28:<EPN[&12.JB5(;$?B($6DK<>H%-GL*82E&
M:"3BR(-4A)_#T4#M:&#D5HQ6@W0T>4?9FN2U48*/&*6^8IR8Q:B*J%V^SV%Q
MH+8XT+YYTU^,W5T;@S^%AFV;@_X4:2^"CMJV"8<H,K7%EA@#HQCM4QU;CZZR
M-1=&NQKD=ML&.=VV<96M25Z;)>1FVZ9*TQ9CB*)PNO?7OA?Q++=5]NZKN+JQ
M8MC$Z?I59-C$.>A7D38GZ)&;*T6YL26(.4FH5-)\FS(L:;XJOPQ0W@B\9C@'
M;W%,4RJ_ESK] ^=;S+^#4J4P-+)RNJ/C*EMSE;3C06YW=)#3'1U7V9KDM9%"
M=B/5OY"[=WFZFY&&H,/]17L:9-^E^2#7A!LQ.34OKK(U66KS@B9NR]#I7HZK
M;$WRVN@@1T8'=8U.YTZO*:9]FWJT]W1%\6B+^LV^HKD *5FJ0=XP4C7,=T^+
M[ XDVY0/7-PQ*5E6OET3G!!>!*C/ETP9G>J@>(:C?F9G_C]02P,$%     @
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MAD.()1[T.-LBKI]6:OK"P#36*GR2Z/<^DUS=)<I.#J;?9@_WXX?;^_%D?/>
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M4E7+5?=J(_7L@CBE[!DX6J@<Y62^T9#$!4K@2:*5FH68HF? O(I1-G[KP.?
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MCOIOO.Z-.05S]S+98>($\S51E8#"2DDV+CLJ )Z=SV4-R5)S8C5G4K+87$:
ME\#U ^K^BC&Y:^@!BE/2P;]02P,$%     @ 13.>6MR0='XR!0  HAL  !D
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M64F#S>B6%8Y+4#8 WY=2FOW&?J ;P-D?4$L#!!0    ( $4SGEJDU1$XD0<
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MVGZ-M2YU#[3]@N)J1[^Z*B@):MIU7O&9 U+/'$PL>*EWH6W&[IF'(XFI6=1
M? * U!. _[7FI=;43EV<,:!.=2E$$E1_''!X1VIX?XV%+W47M,VR=BY]*4/*
M1G'Z1NJ%]/WA!TG6IZ%=7;X=[A?FR,-Z-3"'.,4B-<7J%LO#K Y(TS5*N$BR
M\-VI6B+!VQH:1!QND1INBX+(RV!]PD87O)$(M\+AK HII\OA%ZGA=UPL<[B1
M7YS]XSBE":%!0C+Z!6-V?,O/9J,(;%3-,:56-I4C,'I'"(R,(K!1-<>46OE&
M.T=@;!"!U5K:]\I%MNUL7:6+>^!B$&SCFML:F/,O?G/^5?= VRP)VJ)J]9,$
MH1JG./WBEZ=?]2ZTK1#)MFE5%T)D0;CFSC?>>B[E!0!8K:F=O81MNT+VDB!<
M<]\7<P#&;P_ ZBYHF[4;@)4A9:,X &-3 (Q%9.T(MW_W"7(D0?U^#>IACK[X
ME=!7O1_M<16QMDJ^DI!FS4P <_+%ILA7+:2=K^19#^%**8FIJ_Z<??&.A5\W
MG8-IR)K-B3^KJ>Y&*=>HFF-*K6P?IUS\CB@7&Z5<HVJ.*;7RLXR<<BV#E*O6
MTGZ<40*PE7O<CB2F"6M@Q>*,:[TYXZI[H&V5A'$AK'HE60BN(1N+0Z[U\I"K
MWH6V%R*_5E=X)2$UY&)QP+5> '#5FMJ92]A5.&'$&%BSOFMM/?'\]GBK[H*V
M5;OQ5AE2-HKCK64*;PNA[<<;8:6'0TOR'+.0A61EMX9M+,ZVUBNQK7H_VH,J
M@JMPYDO8UJJQ@[.M98IMU4+:^=K",2(,ORIDG6YKZ\V@!4EF^1M6*1O=5437
MK]%LOEV_Q36$1T[^LE/E^U-X=)J_T]3B,NM7PR[<A-%#"D(R99+M+S;S/UF_
M;;7>H/$R?_]H$E,:+_*/<^+Z),D"V._3.*;/&]D.-N^\#?X#4$L#!!0    (
M $4SGEHV<A@=)P0  .D1   9    >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM
M;+58;6_B.!#^*U9N==J5>@U)""\]0**4:I$*5\&R]^%T']QD0JPF,6L;V$KW
MXV^<I.$MI.HU]P5B>^;Q\XS'SCB]'1?/,@10Y&<<);)OA$JM;TQ3>B'$5%[S
M-20X$G 14X5-L3+E6@#U4Z<X,NU&HV7&E"7&H)?V/8I!CV]4Q!)X%$1NXIB*
MEUN(^*YO6,9KQYRM0J4[S$%O35>P +5</PILF06*SV)().,)$1#TC:%U,[(Z
MVB&U^,Y@)P^>B9;RQ/FS;DS\OM'0C" "3VD(BG];&$$4:23D\2,'-8HYM>/A
M\ROZ?2H>Q3Q1"2,>_<E\%?:-CD%\".@F4G.^^PJY(%?C>3R2Z2_9Y;8-@W@;
MJ7B<.R.#F"79/_V9!^+  7'*'>S<P3YU:%YP<'(')Q6:,4MEW5%%!SW!=T1H
M:T33#VEL4F]4PQ*]C LE<)2AGQK<3V;#V6@R?""3V>+;?#D=S[XMR'!V1^Z'
MDSGY/GQ8CLET/%PLY^-L[#<RHT)0'7WR^0X499'\@KW+Q1WY_.D+^4180J8L
MBG"59,]42%)/97HYH=N,D'V!D$.F/%&A)./$!__8WT1QA4+[5>&M70DXI>*:
M.-85L1NV6\)G5.U^!U[AWJR@XQ0!=U(\YR*>8-LL>G\]X!B9*(CEWV6!RH":
MY4!Z?]_(-?6@;^ &EB"V8 Q^_<5J-7XO4UD3V)'F9J&Y684^&%$9D@!/#!*"
MOP*RPN.%*$Z> $\"+Z)2LH"!CZFO0ARQ;!*G.5 6E&RF5CJ3/J.V PN797LH
MM9+,?Y3J%E+=2JG[Y;TB:ZX@48Q&!(( CRW" R+TL2+U$P\"B<<TA@'U _;1
MQ"<1HT\L8HI!J?AL;O= O.N>B'?/XM-N%R9'DEJ%I-:;JW=%/+V&\&.#ZB)4
M):]2OAA )9BG</&T01GGUAEGN]EV3EB7&'4ZW7+>[8)WNY+W6"J&YSQ2"R@3
M!'EOH(Q@)<I[MUE-8$>".X7@3EU'2Z=.S36!'6GN%IJ[E8M\RP5ZL&15NE^Z
M9VG5M>W3W"LQ<MK-\MRS&OOW:N.-72/$"_*ZG'?5 .]=A+K0CN4>E!%67;F7
M(]6ENR:T8]WV7K?]@?S+G0]SJ]-VNR<)6&;5=:T+&;@O-*S*=_H ZRAXP5I1
M/.-K)M@DOB3_D#EX&R&0;RG=6BN.NM".Y>]K#JM96T;65#'DNO^/^L/:%R!6
M=07RP=>U=5YCV$[C-&//C1S+OI"P^SK#JBXT_E AB#/F;R9M)>B[%Z\FM.,0
M[$L6JUU;TM9:M]2%=JQ[7[E8E47"AY.V<WXKL.VS<[;$RCTH13/NYL%E.@:Q
M2K\Q2.+Q3:*R>W716WS'&*:W=W-OGGT$P:OGBB621!"@:^.ZC1M&9-\5LH;B
MZ_1J_L057O33QQ"H#T(;X'C \0J1-_0$Q=>=P;]02P,$%     @ 13.>6B4$
M7REX!@  YRX  !D   !X;"]W;W)K<VAE971S+W-H965T-C8N>&ULM9IM;]I(
M$,>_RHI654^Z%O;!&%J"1$-RAY1P56AZ+T[W8@-+L&ILSKM *]V'O[4A7FSO
M.N4\>9. /3O^S^*9^7F]@WV<?),K(13ZO@XC>=%:*;7YT&[+^4JLN7P?;T2D
MSRSC9,V5_IH\MN4F$7R1#5J';=+I=-MK'D2MX2 []CD9#N*M"H-(?$Z0W*[7
M//GQ283Q_J*%6T\'[H+'E4H/M(>##7\4,Z'N-Y\3_:V=>UD$:Q')((Y0(I87
MK1'^<.EYZ8#,XFL@]O+D,TI#>8CC;^F7R>*BU4D5B5#,5>J"ZW\[<2G",/6D
M=?QS=-K*KYD.//W\Y/TZ"UX'\\"EN(S#/X.%6EVT>BVT$$N^#=5=O/]=' /*
M!,[C4&9_T?YHVVFA^5:J>'T<K!6L@^CPGW\_3L3) ,P< \AQ /G9 ?0X@&:!
M'I1E88VYXL-!$N]1DEIK;^F';&ZRT3J:($I_QIE*]-E CU/#Z\ET-+V<C&[0
M9#K[<G=_>S7],D.CZ1A=CR9WZ.OHYOX*W5Z-9O=W5X=S[]!,WTN+;2A0O$1C
MD00[GOX4Z)H'"?K*PZV0Z.U8*!Z$\A=M?C\;H[>O?T&O41"AVR ,]<\G!VVE
MU:<:VO.CTD\'I<2A])8G[Q'%OR+2(9YE^&7]\+&8Y\-9<7A;SUD^<22?.)+Y
MHTY_>>!_W>AS:*+$6OYMB^O@B-D=I7GZ06[X7%RT=")*D>Q$:_CF%>YV/MJB
M!')6B)GF,=,Z[\/?DEA*-(W3!.2A+=3#^&XV/JT@NR$F?J\W:.].8[!8X3[M
MY%8%<2P7QVK%F=L/O7G5(QA_1",IA;+>:@=7WJD"VBVIM-@PSZ[1RS5ZYVJ\
M"?A#$ 8J$%:A7E5$MU,2:K'Q'$*[N=!NK="QD,%CQ)58("Z13O?'('K4^2M5
MLM5%7*%_T267*[34;2 [;5=?>Y%S[WP@9X7Y\//Y\*&RW8>,&<A9(>9>'G.O
M8;;W+!GBL]+=:3$BV)'K_5Q:'R[7^Q4!Q"MIK)HP:E>(.Z:Q=H!S_>BPF,@E
MI38;[)!ZP@ 8.MOU(8U1&I(B32E)(J+Y#Z2A<L^3!9K'D4HTG]F#K)5R;GY
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M] .1Z'*6EQNK-GX<+I2EX>J7:_K\H78&=+]4RCYLW(2M/JCQ;U!+ P04
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M]>H#T5*%&183(]?.3^;2D#NYX8K^'ZAL L474IK]Q'Z@_".%?P!02P,$%
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MJN5[GY)P*8N"+ 1<L#00J=0DWV4,YP6NI*]]W=;"7[IR3:%5Q3CH7N 5<[@
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M&,DD5@;R_HI2\391YQ#EN=/@/U!+ P04    " !%,YY:A(24%2(#  "("
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M=V]R:W-H965T<R]S:&5E=#@R+GAM;*V7;6_B.!" _XJ56YUV);9Y@P ]0*)
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M'=K++2SP1!H!>+\60K_>F!6Q^)=@\!]02P,$%     @ 13.>6C63.F08 P
M#0P  !D   !X;"]W;W)K<VAE971S+W-H965T.#,N>&ULM5=K;]HP%/TK5E9-
MG<2:%\\.(E$>&E*AJ+3;AVH?3+B 52?.; ?HOY\=TI1,(6L[^H78CL_AGG.O
MK9OVEO%'L0:0:!?04'2,M931I6D*?PT!%A<L@E"]63(>8*FF?&6*B ->)*"
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M!O5^R9A\GNB.,/L"\/X 4$L#!!0    ( $4SGEJXF@&S[P(  ($'   9
M>&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;*U5T6[:,!3]%2NKME7:&A(@K3J(
M!+35D I%T&X/TQY,<B%6$YO:#K1_OVLGI- &U(>]@.W<<^XYU_9U9R/DHTH
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M<F]P<R]A<' N>&UL4$L! A0#%     @ 13.>6DC01K?R    *P(  !$
M         ( !PP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 13.>
M6IE<G",0!@  G"<  !,              ( !Y $  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    " !%,YY:V'211-P%  #3'@  &
M@($E"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 13.>
M6B;HQ9Q]!0  IQ8  !@              ("!-PX  'AL+W=O<FMS:&5E=',O
M<VAE970R+GAM;%!+ 0(4 Q0    ( $4SGEI:SSR/S@,  ',-   8
M      " @>H3  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4
M" !%,YY:'L;M$-L&  !R'   &               @('N%P  >&PO=V]R:W-H
M965T<R]S:&5E=#0N>&UL4$L! A0#%     @ 13.>6NT8/,CD @  ( @  !@
M             ("!_QX  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4
M Q0    ( $4SGEJ[VM1&HP<  ,P_   8              " @1DB  !X;"]W
M;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " !%,YY:P?48E9$"   !
M!@  &               @('R*0  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL
M4$L! A0#%     @ 13.>6O\/+K)N"   OR4  !@              ("!N2P
M 'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( $4SGEIKTG=?
M; H  .,;   8              " @5TU  !X;"]W;W)K<VAE971S+W-H965T
M.2YX;6Q02P$"% ,4    " !%,YY:R#C(4N4&  #O$   &0
M@('_/P  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( $4S
MGEICQMAG*PD  -$7   9              " @1M'  !X;"]W;W)K<VAE971S
M+W-H965T,3$N>&UL4$L! A0#%     @ 13.>6GL"YEY[ P  7P@  !D
M         ("!?5   'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
M    " !%,YY:R]3VB1<#   7"   &0              @($O5   >&PO=V]R
M:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( $4SGEH@FM5SM (  "(&
M   9              " @7U7  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL
M4$L! A0#%     @ 13.>6DRA/V7;#0  @D,  !D              ("!:%H
M 'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " !%,YY:'A#T
M:$0'  !O$P  &0              @(%Z:   >&PO=V]R:W-H965T<R]S:&5E
M=#$V+GAM;%!+ 0(4 Q0    ( $4SGEJI95@_4P4  #(,   9
M  " @?5O  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @
M13.>6GDZ$2/! P  BP@  !D              ("!?W4  'AL+W=O<FMS:&5E
M=',O<VAE970Q."YX;6Q02P$"% ,4    " !%,YY:2KA5:DX%   5#@  &0
M            @(%W>0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4
M Q0    ( $4SGEKRIMTV[@\  $$X   9              " @?Q^  !X;"]W
M;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ 13.>6L"ZZHF;"P
MJ!L  !D              ("!(8\  'AL+W=O<FMS:&5E=',O<VAE970R,2YX
M;6Q02P$"% ,4    " !%,YY:ES/=I_D$  "U"P  &0              @('S
MF@  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( $4SGEKB
M$&14WP,  . (   9              " @2.@  !X;"]W;W)K<VAE971S+W-H
M965T,C,N>&UL4$L! A0#%     @ 13.>6FN3[5-A"P  41X  !D
M     ("!.:0  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $4SGEK>&$_X,P,  )@'   9              "
M@1+#  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ 13.>
M6H@TZ;@O!@  &P\  !D              ("!?,8  'AL+W=O<FMS:&5E=',O
M<VAE970S,"YX;6Q02P$"% ,4    " !%,YY::A.)X/(#   9"@  &0
M        @('BS   >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0
M   ( $4SGEK7D#Q@_ ,  ",*   9              " @0O1  !X;"]W;W)K
M<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ 13.>6C$0<WJW!0  =A
M !D              ("!/M4  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q0
M2P$"% ,4    " !%,YY:@XK_FK4#  !D"   &0              @($LVP
M>&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( $4SGEJM\MW<
M0P,  !@'   9              " @1C?  !X;"]W;W)K<VAE971S+W-H965T
M,S4N>&UL4$L! A0#%     @ 13.>6OZQO^QF!0  Y T  !D
M ("!DN(  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " !%
M,YY:)<.5DE@(  !F(@  &0              @($OZ   >&PO=V]R:W-H965T
M<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( $4SGEI2WI'&_0(  "L&   9
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M970T,BYX;6Q02P$"% ,4    " !%,YY:@-]4W[D#  "E$0  &0
M    @(&G!P$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    (
M $4SGEK6G4<5Z0(  !T+   9              " @9<+ 0!X;"]W;W)K<VAE
M971S+W-H965T-#0N>&UL4$L! A0#%     @ 13.>6G6ZK.-$ @  *04  !D
M             ("!MPX! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"
M% ,4    " !%,YY:6U)O+M@$  "R'0  &0              @($R$0$ >&PO
M=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( $4SGEI28B%="P0
M %X3   9              " @4$6 0!X;"]W;W)K<VAE971S+W-H965T-#<N
M>&UL4$L! A0#%     @ 13.>6C8LIV8K!0  W1@  !D              ("!
M@QH! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " !%,YY:
MV*JIKU8#  "?#@  &0              @('E'P$ >&PO=V]R:W-H965T<R]S
M:&5E=#0Y+GAM;%!+ 0(4 Q0    ( $4SGEI76'4[\0(  .\(   9
M      " @7(C 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%
M  @ 13.>6B,= D[7 @  40@  !D              ("!FB8! 'AL+W=O<FMS
M:&5E=',O<VAE970U,2YX;6Q02P$"% ,4    " !%,YY:\FL3/8X#  !]#@
M&0              @(&H*0$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+
M 0(4 Q0    ( $4SGEKZEM&AJP(  'D*   9              " @6TM 0!X
M;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ 13.>6HF;2)Z,
M @  >@<  !D              ("!3S ! 'AL+W=O<FMS:&5E=',O<VAE970U
M-"YX;6Q02P$"% ,4    " !%,YY:J^G^^/X)  "&7P  &0
M@($2,P$ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( $4S
MGEK)!R1^L 4  - B   9              " @4<] 0!X;"]W;W)K<VAE971S
M+W-H965T-38N>&UL4$L! A0#%     @ 13.>6KP=5P$B!   &1,  !D
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M=#8Q+GAM;%!+ 0(4 Q0    ( $4SGEK<D'1^,@4  *(;   9
M  " @=%< 0!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @
M13.>6N2+)1M0 @  C 4  !D              ("!.F(! 'AL+W=O<FMS:&5E
M=',O<VAE970V,RYX;6Q02P$"% ,4    " !%,YY:I-41.)$'  #_-@  &0
M            @('!9 $ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4
M Q0    ( $4SGEHV<A@=)P0  .D1   9              " @8EL 0!X;"]W
M;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ 13.>6B4$7REX!@
MYRX  !D              ("!YW ! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX
M;6Q02P$"% ,4    " !%,YY:<5(1$?H"  !<!P  &0              @(&6
M=P$ >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( $4SGEIT
M/'YTQP(  )T&   9              " @<=Z 0!X;"]W;W)K<VAE971S+W-H
M965T-C@N>&UL4$L! A0#%     @ 13.>6EI(H"#/"P  F7@  !D
M     ("!Q7T! 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $4SGEK%RUG34 0  #H6   9              "
M@2J8 0!X;"]W;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ 13.>
M6E$ DW*T P  =@P  !D              ("!L9P! 'AL+W=O<FMS:&5E=',O
M<VAE970W-2YX;6Q02P$"% ,4    " !%,YY:W_SJ('D#  #W#   &0
M        @(&<H $ >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0
M   ( $4SGEIT$R:WPP(  !<'   9              " @4RD 0!X;"]W;W)K
M<VAE971S+W-H965T-S<N>&UL4$L! A0#%     @ 13.>6A9:,_X6!   @Q(
M !D              ("!1J<! 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q0
M2P$"% ,4    " !%,YY:A(24%2(#  "("   &0              @(&3JP$
M>&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( $4SGEI,5(FT
MFP,  +@*   9              " @>RN 0!X;"]W;W)K<VAE971S+W-H965T
M.# N>&UL4$L! A0#%     @ 13.>6F3"T+?7 P  ?0L  !D
M ("!OK(! 'AL+W=O<FMS:&5E=',O<VAE970X,2YX;6Q02P$"% ,4    " !%
M,YY:P-Y<3]\#   >#   &0              @(',M@$ >&PO=V]R:W-H965T
M<R]S:&5E=#@R+GAM;%!+ 0(4 Q0    ( $4SGEHUDSID& ,   T,   9
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M;',O+G)E;'-02P$"% ,4    " !%,YY:35,?_1<&  "C.   #P
M    @ &NRP$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 13.>6E(UQJ.*
M @  N3(  !H              ( !\M$! 'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ 13.>6H/1K $N @  1#$  !,
M ( !M-0! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     %X 7@#)&0  $]<!
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>296</ContextCount>
  <ElementCount>376</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>93</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>9952151 - Statement - Condensed Consolidated Statements of Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952152 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952153 - Statement - Condensed Consolidated Statements of Financial Position (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Financial Position (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952154 - Statement - Condensed Consolidated Statements of Financial Position (Unaudited) (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnauditedParentheticals</Role>
      <ShortName>Condensed Consolidated Statements of Financial Position (Unaudited) (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952155 - Statement - Condensed Consolidated Statements of Changes in Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952156 - Statement - Condensed Consolidated Statements of Changes in Equity (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Equity (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952157 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATION</Role>
      <ShortName>ORGANIZATION AND BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - REVENUE RECOGNITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/REVENUERECOGNITION</Role>
      <ShortName>REVENUE RECOGNITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SEGMENTINFORMATION</Role>
      <ShortName>SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - RECEIVABLES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/RECEIVABLES</Role>
      <ShortName>RECEIVABLES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - FINANCING RECEIVABLES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/FINANCINGRECEIVABLES</Role>
      <ShortName>FINANCING RECEIVABLES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETS</Role>
      <ShortName>ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - BORROWINGS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/BORROWINGS</Role>
      <ShortName>BORROWINGS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - POSTRETIREMENT BENEFIT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANS</Role>
      <ShortName>POSTRETIREMENT BENEFIT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) ??? NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNET</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) ??? NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIES</Role>
      <ShortName>COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952171 - Disclosure - RESTRUCTURING ACTIVITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIES</Role>
      <ShortName>RESTRUCTURING ACTIVITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9952172 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9952173 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATION</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9952174 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATIONPolicies</Role>
      <ShortName>ORGANIZATION AND BASIS OF PRESENTATION (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - REVENUE RECOGNITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/REVENUERECOGNITIONTables</Role>
      <ShortName>REVENUE RECOGNITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/REVENUERECOGNITION</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SEGMENTINFORMATIONTables</Role>
      <ShortName>SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/SEGMENTINFORMATION</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - RECEIVABLES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/RECEIVABLESTables</Role>
      <ShortName>RECEIVABLES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/RECEIVABLES</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - FINANCING RECEIVABLES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/FINANCINGRECEIVABLESTables</Role>
      <ShortName>FINANCING RECEIVABLES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/FINANCINGRECEIVABLES</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSTables</Role>
      <ShortName>ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETS</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - BORROWINGS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/BORROWINGSTables</Role>
      <ShortName>BORROWINGS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/BORROWINGS</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - POSTRETIREMENT BENEFIT PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSTables</Role>
      <ShortName>POSTRETIREMENT BENEFIT PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANS</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) ??? NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETTables</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) ??? NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNET</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESTables</Role>
      <ShortName>COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIES</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - RESTRUCTURING ACTIVITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESTables</Role>
      <ShortName>RESTRUCTURING ACTIVITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIES</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATION</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - REVENUE RECOGNITION - Summary of Contract and Other Deferred Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails</Role>
      <ShortName>REVENUE RECOGNITION - Summary of Contract and Other Deferred Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - REVENUE RECOGNITION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails</Role>
      <ShortName>REVENUE RECOGNITION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - REVENUE RECOGNITION - Schedule of Remaining Performance Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/REVENUERECOGNITIONScheduleofRemainingPerformanceObligationsDetails</Role>
      <ShortName>REVENUE RECOGNITION - Schedule of Remaining Performance Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - SEGMENT INFORMATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SEGMENTINFORMATIONNarrativeDetails</Role>
      <ShortName>SEGMENT INFORMATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - SEGMENT INFORMATION - Schedule of Revenues by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails</Role>
      <ShortName>SEGMENT INFORMATION - Schedule of Revenues by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - SEGMENT INFORMATION - Schedule of Significant Expenses by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails</Role>
      <ShortName>SEGMENT INFORMATION - Schedule of Significant Expenses by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - SEGMENT INFORMATION - Schedule of Segment EBIT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails</Role>
      <ShortName>SEGMENT INFORMATION - Schedule of Segment EBIT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - SEGMENT INFORMATION - Schedule of Depreciation and Amortization by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails</Role>
      <ShortName>SEGMENT INFORMATION - Schedule of Depreciation and Amortization by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - RECEIVABLES - Current Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/RECEIVABLESCurrentReceivablesDetails</Role>
      <ShortName>RECEIVABLES - Current Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - RECEIVABLES - Long-Term Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/RECEIVABLESLongTermReceivablesDetails</Role>
      <ShortName>RECEIVABLES - Long-Term Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - FINANCING RECEIVABLES - Schedule of Financing Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails</Role>
      <ShortName>FINANCING RECEIVABLES - Schedule of Financing Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - FINANCING RECEIVABLES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/FINANCINGRECEIVABLESNarrativeDetails</Role>
      <ShortName>FINANCING RECEIVABLES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - LEASES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/LEASESDetails</Role>
      <ShortName>LEASES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/LEASES</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails</Role>
      <ShortName>ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Schedule of Business Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails</Role>
      <ShortName>ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Schedule of Business Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Schedule of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails</Role>
      <ShortName>ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Schedule of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Schedule of Finite-Lived and Indefinite-Lived Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails</Role>
      <ShortName>ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Schedule of Finite-Lived and Indefinite-Lived Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - BORROWINGS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails</Role>
      <ShortName>BORROWINGS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - BORROWINGS - Schedule of Long-Term Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails</Role>
      <ShortName>BORROWINGS - Schedule of Long-Term Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - POSTRETIREMENT BENEFIT PLANS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails</Role>
      <ShortName>POSTRETIREMENT BENEFIT PLANS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - POSTRETIREMENT BENEFIT PLANS - Components of Expense (Income) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails</Role>
      <ShortName>POSTRETIREMENT BENEFIT PLANS - Components of Expense (Income) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/INCOMETAXES</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) ??? NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) ??? NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9955548 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9955549 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivative Fair Values (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivative Fair Values (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9955550 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Cumulative Basis Adjustment for Fair value Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofCumulativeBasisAdjustmentforFairvalueHedgesDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Cumulative Basis Adjustment for Fair value Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9955551 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivative Pre-tax Gains (Losses) Recognized in OCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativePretaxGainsLossesRecognizedinOCIDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivative Pre-tax Gains (Losses) Recognized in OCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9955552 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Effect of Derivatives Instruments on Statements of Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Effect of Derivatives Instruments on Statements of Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9955553 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9955554 - Disclosure - COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9955555 - Disclosure - RESTRUCTURING ACTIVITIES - Schedule of Restructuring Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringActivitiesDetails</Role>
      <ShortName>RESTRUCTURING ACTIVITIES - Schedule of Restructuring Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9955556 - Disclosure - RESTRUCTURING ACTIVITIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails</Role>
      <ShortName>RESTRUCTURING ACTIVITIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9955557 - Disclosure - RESTRUCTURING ACTIVITIES - Schedule of Restructuring Liability Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails</Role>
      <ShortName>RESTRUCTURING ACTIVITIES - Schedule of Restructuring Liability Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9955558 - Disclosure - EARNINGS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails</Role>
      <ShortName>EARNINGS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/EARNINGSPERSHARETables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9955559 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofCashCashEquivalentsandRestrictedCashDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9955560 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofInventoryDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9955561 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Summary of Property, Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Summary of Property, Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9955562 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9955563 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Noncurrent Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Noncurrent Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>9955564 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>9955565 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Noncurrent Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Noncurrent Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>9955566 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONNarrativeDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>9955567 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Redeemable Noncontrolling Interest (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofRedeemableNoncontrollingInterestDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Redeemable Noncontrolling Interest (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>9955568 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Other Income (Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Other Income (Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="gehc-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>9955569 - Disclosure - SUBSEQUENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gehealthcare.com/role/SUBSEQUENTEVENTSDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.gehealthcare.com/role/SUBSEQUENTEVENTS</ParentRole>
      <Position>86</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="gehc-20250331.htm">gehc-20250331.htm</File>
    <File>gehc-20250331.xsd</File>
    <File>gehc-20250331_cal.xml</File>
    <File>gehc-20250331_def.xml</File>
    <File>gehc-20250331_lab.xml</File>
    <File>gehc-20250331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>gehc-20250331_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2024</BaseTaxonomy>
    <BaseTaxonomy items="1078">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>115
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "gehc-20250331.htm": {
   "nsprefix": "gehc",
   "nsuri": "http://www.gehealthcare.com/20250331",
   "dts": {
    "inline": {
     "local": [
      "gehc-20250331.htm"
     ]
    },
    "schema": {
     "local": [
      "gehc-20250331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "gehc-20250331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "gehc-20250331_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "gehc-20250331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gehc-20250331_pre.xml"
     ]
    }
   },
   "keyStandard": 342,
   "keyCustom": 34,
   "axisStandard": 32,
   "axisCustom": 0,
   "memberStandard": 57,
   "memberCustom": 35,
   "hidden": {
    "total": 13,
    "http://xbrl.sec.gov/dei/2024": 5,
    "http://fasb.org/us-gaap/2024": 8
   },
   "contextCount": 296,
   "entityCount": 1,
   "segmentCount": 93,
   "elementCount": 714,
   "unitCount": 6,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 1078,
    "http://xbrl.sec.gov/dei/2024": 29,
    "http://xbrl.sec.gov/ecd/2024": 4,
    "http://fasb.org/srt/2024": 1
   },
   "report": {
    "R1": {
     "role": "http://www.gehealthcare.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited",
     "longName": "9952151 - Statement - Condensed Consolidated Statements of Income (Unaudited)",
     "shortName": "Condensed Consolidated Statements of Income (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GrossProfit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited",
     "longName": "9952152 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited",
     "longName": "9952153 - Statement - Condensed Consolidated Statements of Financial Position (Unaudited)",
     "shortName": "Condensed Consolidated Statements of Financial Position (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:AssetsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnauditedParentheticals",
     "longName": "9952154 - Statement - Condensed Consolidated Statements of Financial Position (Unaudited) (Parentheticals)",
     "shortName": "Condensed Consolidated Statements of Financial Position (Unaudited) (Parentheticals)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited",
     "longName": "9952155 - Statement - Condensed Consolidated Statements of Changes in Equity (Unaudited)",
     "shortName": "Condensed Consolidated Statements of Changes in Equity (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-27",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-27",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnauditedParenthetical",
     "longName": "9952156 - Statement - Condensed Consolidated Statements of Changes in Equity (Unaudited) (Parenthetical)",
     "shortName": "Condensed Consolidated Statements of Changes in Equity (Unaudited) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
     "longName": "9952157 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.gehealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATION",
     "longName": "9952158 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION",
     "shortName": "ORGANIZATION AND BASIS OF PRESENTATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.gehealthcare.com/role/REVENUERECOGNITION",
     "longName": "9952159 - Disclosure - REVENUE RECOGNITION",
     "shortName": "REVENUE RECOGNITION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.gehealthcare.com/role/SEGMENTINFORMATION",
     "longName": "9952160 - Disclosure - SEGMENT INFORMATION",
     "shortName": "SEGMENT INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.gehealthcare.com/role/RECEIVABLES",
     "longName": "9952161 - Disclosure - RECEIVABLES",
     "shortName": "RECEIVABLES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.gehealthcare.com/role/FINANCINGRECEIVABLES",
     "longName": "9952162 - Disclosure - FINANCING RECEIVABLES",
     "shortName": "FINANCING RECEIVABLES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FinancingReceivablesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FinancingReceivablesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.gehealthcare.com/role/LEASES",
     "longName": "9952163 - Disclosure - LEASES",
     "shortName": "LEASES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETS",
     "longName": "9952164 - Disclosure - ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS",
     "shortName": "ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.gehealthcare.com/role/BORROWINGS",
     "longName": "9952165 - Disclosure - BORROWINGS",
     "shortName": "BORROWINGS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANS",
     "longName": "9952166 - Disclosure - POSTRETIREMENT BENEFIT PLANS",
     "shortName": "POSTRETIREMENT BENEFIT PLANS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.gehealthcare.com/role/INCOMETAXES",
     "longName": "9952167 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNET",
     "longName": "9952168 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) \u2013 NET",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) \u2013 NET",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS",
     "longName": "9952169 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIES",
     "longName": "9952170 - Disclosure - COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES",
     "shortName": "COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIES",
     "longName": "9952171 - Disclosure - RESTRUCTURING ACTIVITIES",
     "shortName": "RESTRUCTURING ACTIVITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.gehealthcare.com/role/EARNINGSPERSHARE",
     "longName": "9952172 - Disclosure - EARNINGS PER SHARE",
     "shortName": "EARNINGS PER SHARE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATION",
     "longName": "9952173 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.gehealthcare.com/role/SUBSEQUENTEVENTS",
     "longName": "9952174 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R27": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.gehealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATIONPolicies",
     "longName": "9955511 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Policies)",
     "shortName": "ORGANIZATION AND BASIS OF PRESENTATION (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.gehealthcare.com/role/REVENUERECOGNITIONTables",
     "longName": "9955512 - Disclosure - REVENUE RECOGNITION (Tables)",
     "shortName": "REVENUE RECOGNITION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.gehealthcare.com/role/SEGMENTINFORMATIONTables",
     "longName": "9955513 - Disclosure - SEGMENT INFORMATION (Tables)",
     "shortName": "SEGMENT INFORMATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.gehealthcare.com/role/RECEIVABLESTables",
     "longName": "9955514 - Disclosure - RECEIVABLES (Tables)",
     "shortName": "RECEIVABLES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R32": {
     "role": "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESTables",
     "longName": "9955515 - Disclosure - FINANCING RECEIVABLES (Tables)",
     "shortName": "FINANCING RECEIVABLES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R33": {
     "role": "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSTables",
     "longName": "9955516 - Disclosure - ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS (Tables)",
     "shortName": "ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.gehealthcare.com/role/BORROWINGSTables",
     "longName": "9955517 - Disclosure - BORROWINGS (Tables)",
     "shortName": "BORROWINGS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSTables",
     "longName": "9955518 - Disclosure - POSTRETIREMENT BENEFIT PLANS (Tables)",
     "shortName": "POSTRETIREMENT BENEFIT PLANS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETTables",
     "longName": "9955519 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) \u2013 NET (Tables)",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) \u2013 NET (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables",
     "longName": "9955520 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESTables",
     "longName": "9955521 - Disclosure - COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES (Tables)",
     "shortName": "COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESTables",
     "longName": "9955522 - Disclosure - RESTRUCTURING ACTIVITIES (Tables)",
     "shortName": "RESTRUCTURING ACTIVITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.gehealthcare.com/role/EARNINGSPERSHARETables",
     "longName": "9955523 - Disclosure - EARNINGS PER SHARE (Tables)",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables",
     "longName": "9955524 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION (Tables)",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.gehealthcare.com/role/REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails",
     "longName": "9955525 - Disclosure - REVENUE RECOGNITION - Summary of Contract and Other Deferred Assets (Details)",
     "shortName": "REVENUE RECOGNITION - Summary of Contract and Other Deferred Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails",
     "longName": "9955526 - Disclosure - REVENUE RECOGNITION - Narrative (Details)",
     "shortName": "REVENUE RECOGNITION - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:ContractWithCustomerLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:ContractWithCustomerLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.gehealthcare.com/role/REVENUERECOGNITIONScheduleofRemainingPerformanceObligationsDetails",
     "longName": "9955527 - Disclosure - REVENUE RECOGNITION - Schedule of Remaining Performance Obligations (Details)",
     "shortName": "REVENUE RECOGNITION - Schedule of Remaining Performance Obligations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.gehealthcare.com/role/SEGMENTINFORMATIONNarrativeDetails",
     "longName": "9955528 - Disclosure - SEGMENT INFORMATION - Narrative (Details)",
     "shortName": "SEGMENT INFORMATION - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-50",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-50",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails",
     "longName": "9955529 - Disclosure - SEGMENT INFORMATION - Schedule of Revenues by Segment (Details)",
     "shortName": "SEGMENT INFORMATION - Schedule of Revenues by Segment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-51",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails",
     "longName": "9955530 - Disclosure - SEGMENT INFORMATION - Schedule of Significant Expenses by Segment (Details)",
     "shortName": "SEGMENT INFORMATION - Schedule of Significant Expenses by Segment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-51",
      "name": "us-gaap:CostOfRevenue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-51",
      "name": "us-gaap:CostOfRevenue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails",
     "longName": "9955531 - Disclosure - SEGMENT INFORMATION - Schedule of Segment EBIT (Details)",
     "shortName": "SEGMENT INFORMATION - Schedule of Segment EBIT (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails",
     "longName": "9955532 - Disclosure - SEGMENT INFORMATION - Schedule of Depreciation and Amortization by Segment (Details)",
     "shortName": "SEGMENT INFORMATION - Schedule of Depreciation and Amortization by Segment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-51",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-51",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.gehealthcare.com/role/RECEIVABLESCurrentReceivablesDetails",
     "longName": "9955533 - Disclosure - RECEIVABLES - Current Receivables (Details)",
     "shortName": "RECEIVABLES - Current Receivables (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.gehealthcare.com/role/RECEIVABLESLongTermReceivablesDetails",
     "longName": "9955534 - Disclosure - RECEIVABLES - Long-Term Receivables (Details)",
     "shortName": "RECEIVABLES - Long-Term Receivables (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:AccountsReceivableGrossNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:AccountsReceivableGrossNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails",
     "longName": "9955535 - Disclosure - FINANCING RECEIVABLES - Schedule of Financing Receivable (Details)",
     "shortName": "FINANCING RECEIVABLES - Schedule of Financing Receivable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:AllowanceForNotesAndLoansReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:AllowanceForNotesAndLoansReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESNarrativeDetails",
     "longName": "9955536 - Disclosure - FINANCING RECEIVABLES - Narrative (Details)",
     "shortName": "FINANCING RECEIVABLES - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:FinancingReceivableNonaccrualPercentPastDue1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:FinancingReceivableNonaccrualPercentPastDue1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.gehealthcare.com/role/LEASESDetails",
     "longName": "9955537 - Disclosure - LEASES (Details)",
     "shortName": "LEASES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:OperatingLeaseLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:OperatingLeaseLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
     "longName": "9955538 - Disclosure - ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Narrative (Details)",
     "shortName": "ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-78",
      "name": "gehc:BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails",
     "longName": "9955539 - Disclosure - ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Schedule of Business Acquisitions (Details)",
     "shortName": "ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Schedule of Business Acquisitions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-78",
      "name": "us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails",
     "longName": "9955540 - Disclosure - ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Schedule of Goodwill (Details)",
     "shortName": "ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Schedule of Goodwill (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-9",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails",
     "longName": "9955541 - Disclosure - ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Schedule of Finite-Lived and Indefinite-Lived Intangible Assets (Details)",
     "shortName": "ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS - Schedule of Finite-Lived and Indefinite-Lived Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails",
     "longName": "9955542 - Disclosure - BORROWINGS - Narrative (Details)",
     "shortName": "BORROWINGS - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:GuaranteeObligationsCurrentCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails",
     "longName": "9955543 - Disclosure - BORROWINGS - Schedule of Long-Term Borrowings (Details)",
     "shortName": "BORROWINGS - Schedule of Long-Term Borrowings (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails",
     "longName": "9955544 - Disclosure - POSTRETIREMENT BENEFIT PLANS - Narrative (Details)",
     "shortName": "POSTRETIREMENT BENEFIT PLANS - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "gehc:DefinedBenefitPlanPlanAssetOrObligationReportingThreshold",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "gehc:DefinedBenefitPlanPlanAssetOrObligationReportingThreshold",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "gehc:DefinedBenefitPlanPlanAssetOrObligationReportingThreshold",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "gehc:DefinedBenefitPlanPlanAssetOrObligationReportingThreshold",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails",
     "longName": "9955545 - Disclosure - POSTRETIREMENT BENEFIT PLANS - Components of Expense (Income) (Details)",
     "shortName": "POSTRETIREMENT BENEFIT PLANS - Components of Expense (Income) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-140",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.gehealthcare.com/role/INCOMETAXESDetails",
     "longName": "9955546 - Disclosure - INCOME TAXES (Details)",
     "shortName": "INCOME TAXES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails",
     "longName": "9955547 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) \u2013 NET (Details)",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) \u2013 NET (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-9",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
     "longName": "9955548 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Narrative (Details)",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails",
     "longName": "9955549 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivative Fair Values (Details)",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivative Fair Values (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:DerivativeNotionalAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
       "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:DerivativeNotionalAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
       "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofCumulativeBasisAdjustmentforFairvalueHedgesDetails",
     "longName": "9955550 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Cumulative Basis Adjustment for Fair value Hedges (Details)",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Cumulative Basis Adjustment for Fair value Hedges (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:HedgedLiabilityFairValueHedge",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:HedgedLiabilityFairValueHedge",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativePretaxGainsLossesRecognizedinOCIDetails",
     "longName": "9955551 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivative Pre-tax Gains (Losses) Recognized in OCI (Details)",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Derivative Pre-tax Gains (Losses) Recognized in OCI (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails",
     "longName": "9955552 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Effect of Derivatives Instruments on Statements of Income (Details)",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Effect of Derivatives Instruments on Statements of Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-193",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-193",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
     "longName": "9955553 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-269",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESDetails",
     "longName": "9955554 - Disclosure - COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES (Details)",
     "shortName": "COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-9",
      "name": "us-gaap:ProductWarrantyAccrual",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-9",
      "name": "us-gaap:ProductWarrantyAccrual",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringActivitiesDetails",
     "longName": "9955555 - Disclosure - RESTRUCTURING ACTIVITIES - Schedule of Restructuring Activities (Details)",
     "shortName": "RESTRUCTURING ACTIVITIES - Schedule of Restructuring Activities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SeveranceCosts1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SeveranceCosts1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails",
     "longName": "9955556 - Disclosure - RESTRUCTURING ACTIVITIES - Narrative (Details)",
     "shortName": "RESTRUCTURING ACTIVITIES - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails",
     "longName": "9955557 - Disclosure - RESTRUCTURING ACTIVITIES - Schedule of Restructuring Liability Activity (Details)",
     "shortName": "RESTRUCTURING ACTIVITIES - Schedule of Restructuring Liability Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:RestructuringReserve",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:RestructuringReserve",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails",
     "longName": "9955558 - Disclosure - EARNINGS PER SHARE (Details)",
     "shortName": "EARNINGS PER SHARE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofCashCashEquivalentsandRestrictedCashDetails",
     "longName": "9955559 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofInventoryDetails",
     "longName": "9955560 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Inventory (Details)",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Inventory (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails",
     "longName": "9955561 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Summary of Property, Plant and Equipment (Details)",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Summary of Property, Plant and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails",
     "longName": "9955562 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Current Assets (Details)",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Current Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "gehc:PrepaidExpensesAndDeferredCostsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "gehc:PrepaidExpensesAndDeferredCostsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails",
     "longName": "9955563 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Noncurrent Assets (Details)",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Noncurrent Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:PrepaidExpenseNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:PrepaidExpenseNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails",
     "longName": "9955564 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Current Liabilities (Details)",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Current Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "gehc:SalesAllowancesAndRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "gehc:SalesAllowancesAndRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails",
     "longName": "9955565 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Noncurrent Liabilities (Details)",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of All Other Noncurrent Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:ContractWithCustomerLiabilityNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:OperatingLeaseLiabilityNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONNarrativeDetails",
     "longName": "9955566 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Narrative (Details)",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:SupplierFinanceProgramObligationCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:SupplierFinanceProgramObligationCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofRedeemableNoncontrollingInterestDetails",
     "longName": "9955567 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Redeemable Noncontrolling Interest (Details)",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Redeemable Noncontrolling Interest (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c-9",
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-32",
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails",
     "longName": "9955568 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Other Income (Expense) (Details)",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Other Income (Expense) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentIncomeNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentIncomeNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.gehealthcare.com/role/SUBSEQUENTEVENTSDetails",
     "longName": "9955569 - Disclosure - SUBSEQUENT EVENTS (Details)",
     "shortName": "SUBSEQUENT EVENTS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c-296",
      "name": "srt:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-296",
      "name": "srt:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gehc-20250331.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "gehc_A364DayRevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "A364DayRevolvingCreditFacilityMember",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "364-Day Revolving Credit Facility",
        "label": "364-Day Revolving Credit Facility [Member]",
        "documentation": "364-Day Revolving Credit Facility"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_A4.800SeniorNotesDue2029Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "A4.800SeniorNotesDue2029Member",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "4.800% senior notes due August 14, 2029",
        "label": "4.800% Senior Notes, Due 2029 [Member]",
        "documentation": "4.800% Senior Notes, Due 2029"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_A5600SeniorNotesDue2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "A5600SeniorNotesDue2025Member",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "5.600% senior notes due November 15, 2025",
        "label": "5.600% Senior Notes, Due 2025 [Member]",
        "documentation": "5.600% Senior Notes, Due 2025"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_A5650SeniorNotesDue2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "A5650SeniorNotesDue2027Member",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "5.650% senior notes due November 15, 2027",
        "label": "5.650% Senior Notes, Due 2027 [Member]",
        "documentation": "5.650% Senior Notes, Due 2027"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_A5857SeniorNotesDue2030Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "A5857SeniorNotesDue2030Member",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "5.857% senior notes due March 15, 2030",
        "label": "5.857% Senior Notes, Due 2030 [Member]",
        "documentation": "5.857% Senior Notes, Due 2030"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_A5905SeniorNotesDue2032Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "A5905SeniorNotesDue2032Member",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "5.905% senior notes due November 22, 2032",
        "label": "5.905% Senior Notes, Due 2032 [Member]",
        "documentation": "5.905% Senior Notes, Due 2032"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_A5YearRevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "A5YearRevolvingCreditFacilityMember",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "5-Year Revolving Credit Facility",
        "label": "5-Year Revolving Credit Facility [Member]",
        "documentation": "5-Year Revolving Credit Facility"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_A6377SeniorNotesDue2052Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "A6377SeniorNotesDue2052Member",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "6.377% senior notes due November 22, 2052",
        "label": "6.377% Senior Notes, Due 2052 [Member]",
        "documentation": "6.377% Senior Notes, Due 2052"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_AVSSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "AVSSegmentMember",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AVS",
        "label": "AVS Segment [Member]",
        "documentation": "AVS Segment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsAndOtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsAndOtherReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.gehealthcare.com/role/RECEIVABLESCurrentReceivablesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited",
      "http://www.gehealthcare.com/role/RECEIVABLESCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivables \u2013 net of allowances of $106 and $103",
        "totalLabel": "Total current receivables \u2013 net",
        "label": "Accounts and Other Receivables, Net, Current",
        "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r1063"
     ]
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable Type [Axis]",
        "label": "Receivable Type [Axis]",
        "documentation": "Information by type of receivable."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r122"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r912"
     ]
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableGrossCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/RECEIVABLESCurrentReceivablesDetails": {
       "parentTag": "us-gaap_AccountsAndOtherReceivablesNetCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/RECEIVABLESCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current customer receivables",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r351",
      "r860"
     ]
    },
    "us-gaap_AccountsReceivableGrossNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableGrossNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/RECEIVABLESLongTermReceivablesDetails": {
       "parentTag": "gehc_ReceivablesNetNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/RECEIVABLESLongTermReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term customer receivables",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Noncurrent",
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r351",
      "r361",
      "r1065"
     ]
    },
    "gehc_AccruedFreightAndUtilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "AccruedFreightAndUtilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued freight and utilities",
        "label": "Accrued Freight And Utilities, Current",
        "documentation": "Accrued Freight And Utilities, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension and Other Postretirement Plans",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7",
      "r18",
      "r32",
      "r130",
      "r1034",
      "r1035",
      "r1036"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails": {
       "parentTag": "gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r241",
      "r723"
     ]
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flow hedges",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r269",
      "r270",
      "r635",
      "r865",
      "r1034"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r269",
      "r673",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive income (loss) \u2013 net",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r131",
      "r250",
      "r719",
      "r762",
      "r763"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r269",
      "r673",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive income (loss) \u2013 net",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r18",
      "r32",
      "r648",
      "r651",
      "r693",
      "r758",
      "r759",
      "r1034",
      "r1035",
      "r1036",
      "r1049",
      "r1050",
      "r1051",
      "r1052"
     ]
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedTranslationAdjustmentMember",
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency translation adjustments",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r18",
      "r32",
      "r128",
      "r129",
      "r269",
      "r270",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r1034"
     ]
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquired finite-lived intangible assets, weighted average useful life",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r379",
      "r853"
     ]
    },
    "gehc_AcquisitionAndDispositionRelatedBenefitsCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "AcquisitionAndDispositionRelatedBenefitsCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition and disposition-related benefits (charges)",
        "label": "Acquisition And Disposition Related Benefits (Costs)",
        "documentation": "Acquisition And Disposition Related Benefits (Costs)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r968"
     ]
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SUPPLEMENTAL FINANCIAL INFORMATION",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r912",
      "r1247"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r773",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1180",
      "r1248"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r65",
      "r571"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile Net income to Cash from (used for) operating activities",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1014"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r940",
      "r950",
      "r960",
      "r992"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r943",
      "r953",
      "r963",
      "r995"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1015"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r944",
      "r954",
      "r964",
      "r988",
      "r996",
      "r1000",
      "r1008"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r1006"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/RECEIVABLESCurrentReceivablesDetails": {
       "parentTag": "us-gaap_AccountsAndOtherReceivablesNetCurrent",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnauditedParentheticals",
      "http://www.gehealthcare.com/role/RECEIVABLESCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit losses",
        "negatedTerseLabel": "Allowance for credit losses",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r352",
      "r360"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivableNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/RECEIVABLESLongTermReceivablesDetails": {
       "parentTag": "gehc_ReceivablesNetNoncurrent",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/RECEIVABLESLongTermReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Allowance for credit losses",
        "label": "Accounts Receivable, Allowance for Credit Loss, Noncurrent",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r352",
      "r360"
     ]
    },
    "us-gaap_AllowanceForNotesAndLoansReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForNotesAndLoansReceivableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails": {
       "parentTag": "us-gaap_NotesAndLoansReceivableNetCurrent",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Allowance for credit losses, current",
        "label": "Financing Receivable, Allowance for Credit Loss, Current",
        "documentation": "Amount of allowance for credit loss on financing receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r352",
      "r360"
     ]
    },
    "us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForNotesAndLoansReceivableNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails": {
       "parentTag": "us-gaap_NotesAndLoansReceivableNetNoncurrent",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Allowance for credit losses, noncurrent",
        "label": "Financing Receivable, Allowance for Credit Loss, Noncurrent",
        "documentation": "Amount of allowance for credit loss on financing receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r352",
      "r360"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amortization of intangible assets",
        "terseLabel": "Amortization of acquisition-related intangible assets",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r376",
      "r383",
      "r881"
     ]
    },
    "gehc_AmortizationOfIntangibleAssetsAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "AmortizationOfIntangibleAssetsAcquired",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Amortization of acquisition-related intangible assets",
        "label": "Amortization Of Intangible Assets, Acquired",
        "documentation": "Amortization Of Intangible Assets, Acquired"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive securities (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r310"
     ]
    },
    "gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Environmental and asset retirement obligations",
        "label": "Asset Retirement Obligation And Accrued Environmental Loss Contingencies, Current",
        "documentation": "Asset Retirement Obligation And Accrued Environmental Loss Contingencies, Current"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Environmental and asset retirement obligations",
        "label": "Asset Retirement Obligation And Accrued Environmental Loss Contingencies, Noncurrent",
        "documentation": "Asset Retirement Obligation And Accrued Environmental Loss Contingencies, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r193",
      "r245",
      "r285",
      "r314",
      "r320",
      "r338",
      "r342",
      "r357",
      "r426",
      "r427",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r631",
      "r636",
      "r671",
      "r715",
      "r806",
      "r873",
      "r874",
      "r912",
      "r931",
      "r1104",
      "r1105",
      "r1201"
     ]
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r236",
      "r254",
      "r285",
      "r357",
      "r426",
      "r427",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r631",
      "r636",
      "r671",
      "r912",
      "r1104",
      "r1105",
      "r1201"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets:",
        "label": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r1003"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r1004"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r1002"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1001"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATIONPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BASIS OF PRESENTATION",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "gehc_BuildingsStructuresAndRelatedEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "BuildingsStructuresAndRelatedEquipmentMember",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Buildings, structures, and related equipment",
        "label": "Buildings, Structures And Related Equipment [Member]",
        "documentation": "Buildings, Structures And Related Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails",
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Acquiree [Domain]",
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r624",
      "r893",
      "r896"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails",
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Axis]",
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r69",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r624",
      "r893",
      "r896"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Line Items]",
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r624"
     ]
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percent of interest acquired",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase price",
        "totalLabel": "Total allocable purchase price",
        "label": "Business Combination, Consideration Transferred",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r2",
      "r17"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferredAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationConsiderationTransferredAbstract",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase consideration",
        "label": "Business Combination, Consideration Transferred [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of contingent consideration",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r2",
      "r72",
      "r626"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration",
        "label": "Business Combination, Contingent Consideration, Liability",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r168",
      "r627",
      "r660",
      "r661",
      "r662"
     ]
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS",
        "label": "Business Combination Disclosure [Text Block]",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r625"
     ]
    },
    "gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset retirement obligations and decommissioning liabilities assumed",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Asset Retirement Obligations and Decommissioning Liabilities",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Asset Retirement Obligations and Decommissioning Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivables",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities",
        "negatedTerseLabel": "Deferred income taxes",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indemnification assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indemnification Assets",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indemnification Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "verboseLabel": "Other intangible assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "documentation": "The amount of inventory recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r71"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "All other non-current liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "gehc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other net assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All other non-current assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant, and equipment",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r71"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial allocation",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total net assets post acquisition",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "gehc_BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity interest in acquiree, carrying value",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Carrying Value",
        "documentation": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Carrying Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of previously held interest in NMP",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value",
        "documentation": "Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity interest in acquiree, existing percentage",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage",
        "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gain on remeasurement of Nihon Medi-Physics equity method investment",
        "terseLabel": "Gain on remeasurement of NMP equity method investment",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain",
        "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_BusinessExitCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessExitCosts1",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringActivitiesDetails": {
       "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Facility and other exit costs",
        "label": "Business Exit Costs",
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquired but unpaid property, plant, and equipment",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r40"
     ]
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying value",
        "label": "Reported Value Measurement [Member]",
        "documentation": "Measured as reported on the statement of financial position (balance sheet)."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100"
     ]
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAcquiredFromAcquisition",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash acquired from acquisition",
        "label": "Cash Acquired from Acquisition",
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business)."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": "gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r238",
      "r858"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Axis]",
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r238"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of year",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period",
        "totalLabel": "Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Cash Flows",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r149",
      "r283"
     ]
    },
    "gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash, cash equivalents, and restricted cash",
        "verboseLabel": "Money market funds",
        "totalLabel": "Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Financial Position",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Current",
        "documentation": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (decrease) in cash, cash equivalents, and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r149"
     ]
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flow hedge gain to be reclassified within 12 months",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months",
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "us-gaap_CashFlowHedgingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowHedgingMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flow hedges",
        "label": "Cash Flow Hedging [Member]",
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash investing activities",
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r979"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r980"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r980"
     ]
    },
    "gehc_CommercialContractsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "CommercialContractsMember",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial contracts",
        "label": "Commercial Contracts [Member]",
        "documentation": "Commercial Contracts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r184",
      "r717",
      "r792"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsContingenciesAndGuaranteesTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES",
        "label": "Commitments Contingencies and Guarantees [Text Block]",
        "documentation": "The entire disclosure for commitments, contingencies, and guarantees."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r158",
      "r1096"
     ]
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockDividendsPerShareDeclared",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends declared per common share (in dollars per share)",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r919",
      "r920",
      "r921",
      "r923",
      "r924",
      "r925",
      "r928",
      "r1049",
      "r1050",
      "r1052",
      "r1180",
      "r1245",
      "r1248"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnauditedParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnauditedParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r793"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnauditedParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, issued (in shares)",
        "periodStartLabel": "Equity, beginning balance (in shares)",
        "periodEndLabel": "Equity, ending balance (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value $0.01 per share, 1,000,000,000 shares authorized, 458,134,263 shares issued as of March 31, 2025; 457,246,971 shares issued as of December 31, 2024",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r718",
      "r912"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r985"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r986"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r983"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive income attributable to GE HealthCare",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r265",
      "r267",
      "r274",
      "r712",
      "r731",
      "r733"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: Comprehensive income (loss) attributable to noncontrolling interests",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r76",
      "r79",
      "r265",
      "r267",
      "r273",
      "r711",
      "r731",
      "r732"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive income (loss)",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r170",
      "r265",
      "r267",
      "r272",
      "r710",
      "r731"
     ]
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) \u2013 NET",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r271",
      "r709",
      "r730"
     ]
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized software",
        "label": "Computer Software, Intangible Asset [Member]",
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks."
       }
      }
     },
     "auth_ref": [
      "r853",
      "r857",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1085",
      "r1087",
      "r1089",
      "r1090"
     ]
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Axis]",
        "label": "Consolidation Items [Axis]",
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r208",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r287",
      "r314",
      "r322",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r342",
      "r343",
      "r344",
      "r426",
      "r427",
      "r428",
      "r429",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r873",
      "r874",
      "r1026",
      "r1027",
      "r1104",
      "r1105"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Domain]",
        "label": "Consolidation Items [Domain]",
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r208",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r287",
      "r314",
      "r322",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r342",
      "r343",
      "r344",
      "r426",
      "r427",
      "r428",
      "r429",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r873",
      "r874",
      "r1026",
      "r1027",
      "r1104",
      "r1105"
     ]
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContingentConsiderationByTypeAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent Consideration by Type [Axis]",
        "label": "Contingent Consideration by Type [Axis]",
        "documentation": "Information by type of contingent consideration."
       }
      }
     },
     "auth_ref": []
    },
    "gehc_ContingentConsiderationPurchasePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "ContingentConsiderationPurchasePriceMember",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase price",
        "label": "Contingent Consideration, Purchase Price [Member]",
        "documentation": "Contingent Consideration, Purchase Price"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_ContingentConsiderationServiceRequirementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "ContingentConsiderationServiceRequirementsMember",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Service requirements",
        "label": "Contingent Consideration, Service Requirements [Member]",
        "documentation": "Contingent Consideration, Service Requirements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContingentConsiderationTypeDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent Consideration Type [Domain]",
        "label": "Contingent Consideration Type [Domain]",
        "documentation": "Description of contingent payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total contract and other deferred assets",
        "label": "Contract With Customer, Asset, After Allowance For Credit Loss And Deferred Costs",
        "documentation": "Contract With Customer, Asset, After Allowance For Credit Loss And Deferred Costs"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails": {
       "parentTag": "gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited",
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract and other deferred assets",
        "totalLabel": "Contract and other deferred assets",
        "label": "Contract With Customer, Asset, After Allowance For Credit Loss And Deferred Costs, Current",
        "documentation": "Contract With Customer, Asset, After Allowance For Credit Loss And Deferred Costs, Current"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract and other deferred assets",
        "label": "Contract with Customer, Asset, After Allowance for Credit Loss, And Deferred Costs, Noncurrent",
        "documentation": "Contract with Customer, Asset, After Allowance for Credit Loss, And Deferred Costs, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Contract and Other Deferred Assets",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability."
       }
      }
     },
     "auth_ref": [
      "r1108"
     ]
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerAssetNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails": {
       "parentTag": "gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract assets",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current."
       }
      }
     },
     "auth_ref": [
      "r468",
      "r470",
      "r481"
     ]
    },
    "us-gaap_ContractWithCustomerAssetNetNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerAssetNetNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails": {
       "parentTag": "gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current contract assets",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r468",
      "r470",
      "r481"
     ]
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract liabilities",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r468",
      "r469",
      "r481"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract liabilities",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r468",
      "r469",
      "r481"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails",
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract liabilities",
        "label": "Contract with Customer, Liability, Noncurrent",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r468",
      "r469",
      "r481"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract liabilities, revenue recognized",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "us-gaap_ContractWithCustomerRefundLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerRefundLiabilityCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/RECEIVABLESCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chargebacks",
        "label": "Contract with Customer, Refund Liability, Current",
        "documentation": "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1110"
     ]
    },
    "us-gaap_CorporateNonSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CorporateNonSegmentMember",
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]",
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r337",
      "r338",
      "r339",
      "r340",
      "r343",
      "r1057"
     ]
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of sales",
        "label": "Cost of Revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r285",
      "r357",
      "r426",
      "r427",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r671",
      "r873",
      "r1104"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenue",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total expenses",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r425",
      "r1102"
     ]
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r425",
      "r1102",
      "r1103"
     ]
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CrossCurrencyInterestRateContractMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cross-currency swaps",
        "verboseLabel": "Cross-currency swaps",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates."
       }
      }
     },
     "auth_ref": [
      "r1133",
      "r1179"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerRelatedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerRelatedIntangibleAssetsMember",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer-related",
        "label": "Customer-Related Intangible Assets [Member]",
        "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1085",
      "r1087",
      "r1089",
      "r1090"
     ]
    },
    "gehc_DebtBasisAdjustmentLongTermBorrowingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "DebtBasisAdjustmentLongTermBorrowingsMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt basis adjustment on Long-term borrowings",
        "label": "Debt Basis Adjustment, Long-Term Borrowings [Member]",
        "documentation": "Debt Basis Adjustment, Long-Term Borrowings"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BORROWINGS",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r284",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r424",
      "r425",
      "r437",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r453",
      "r460",
      "r461",
      "r463",
      "r682"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails",
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r105",
      "r106",
      "r180",
      "r183",
      "r287",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r444",
      "r449",
      "r450",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r910",
      "r1046",
      "r1091",
      "r1092",
      "r1093",
      "r1199",
      "r1200"
     ]
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails_1": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails",
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal debt issued",
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r183",
      "r464"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt, principal amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r438",
      "r682",
      "r683",
      "r883",
      "r884",
      "r910"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stated interest rate",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r439"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails",
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r287",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r444",
      "r449",
      "r450",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r462",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r910",
      "r1046",
      "r1199",
      "r1200"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails",
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r287",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r444",
      "r449",
      "r450",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r910",
      "r1046",
      "r1091",
      "r1092",
      "r1093",
      "r1199",
      "r1200"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails",
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-Term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r53",
      "r54",
      "r101",
      "r162",
      "r163",
      "r287",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r444",
      "r449",
      "r450",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r462",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r910",
      "r1046",
      "r1199",
      "r1200"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt, term",
        "label": "Debt Instrument, Term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails_1": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: Unamortized debt issuance costs and discounts",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r449",
      "r465",
      "r681",
      "r682",
      "r683",
      "r883",
      "r884",
      "r910"
     ]
    },
    "us-gaap_DeferredCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails": {
       "parentTag": "gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current other deferred assets",
        "label": "Deferred Costs, Noncurrent",
        "documentation": "Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r1031"
     ]
    },
    "us-gaap_DeferredCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCostsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails": {
       "parentTag": "gehc_ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONSummaryofContractandOtherDeferredAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other deferred assets",
        "label": "Deferred Costs, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1033"
     ]
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r601",
      "r602"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes",
        "label": "Deferred Income Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r601",
      "r602",
      "r716"
     ]
    },
    "gehc_DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income and indirect tax liabilities including uncertain tax positions",
        "label": "Deferred Income Taxes and Other Tax Liabilities, Current",
        "documentation": "Deferred Income Taxes and Other Tax Liabilities, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income and indirect tax liabilities including uncertain tax positions",
        "label": "Deferred Income Taxes and Other Tax Liabilities, Noncurrent",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value of assumed obligations",
        "label": "Defined Benefit Plan, Actuarial Gain (Loss), Immediate Recognition as Component in Net Periodic Benefit (Cost) Credit",
        "documentation": "Amount of gain (loss), recognized immediately as component of net periodic benefit (cost) credit, for change in value of benefit obligation or plan assets from experience different from that assumed, change in actuarial assumption, or consequence of temporarily deviating from substantive plan. Includes, but is not limited to, amount in excess of 10 percent of greater of fair value of plan assets or benefit obligation."
       }
      }
     },
     "auth_ref": [
      "r487",
      "r525",
      "r550"
     ]
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails": {
       "parentTag": "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Amortization of net loss (gain)",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r487",
      "r525",
      "r550",
      "r891",
      "r892"
     ]
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails": {
       "parentTag": "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of prior service cost (credit)",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r487",
      "r526",
      "r551",
      "r891",
      "r892"
     ]
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined benefit plan, net asset",
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position",
        "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Defined benefit plan, asset",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r485",
      "r486",
      "r508",
      "r805",
      "r891",
      "r1210"
     ]
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined benefit plan, employer contribution amount",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets."
       }
      }
     },
     "auth_ref": [
      "r502",
      "r512",
      "r554",
      "r889",
      "r890",
      "r891",
      "r892"
     ]
    },
    "us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails": {
       "parentTag": "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Special termination cost",
        "label": "Defined Benefit Plan, Cost of Providing Special and Contractual Termination Benefits",
        "documentation": "Amount of cost of providing special or contractual termination benefits payable from defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r539"
     ]
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails",
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined benefit plan, expected future employer contributions, next fiscal year",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r520",
      "r892"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails": {
       "parentTag": "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Expected return on plan assets",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r487",
      "r524",
      "r549",
      "r891",
      "r892"
     ]
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanInterestCost",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails": {
       "parentTag": "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest cost",
        "label": "Defined Benefit Plan, Interest Cost",
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r487",
      "r491",
      "r523",
      "r548",
      "r891",
      "r892"
     ]
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net periodic expense (income)",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r521",
      "r546",
      "r891",
      "r892"
     ]
    },
    "gehc_DefinedBenefitPlanPlanAssetOrObligationReportingThreshold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "DefinedBenefitPlanPlanAssetOrObligationReportingThreshold",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan asset or obligation reporting threshold",
        "label": "Defined Benefit Plan, Plan Asset Or Obligation, Reporting Threshold",
        "documentation": "Defined Benefit Plan, Plan Asset Or Obligation, Reporting Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanServiceCost",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Service cost \u2013 Operating",
        "label": "Defined Benefit Plan, Service Cost",
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r489",
      "r522",
      "r547",
      "r891",
      "r892"
     ]
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined contribution plan, employer contribution amount",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation of property, plant, and equipment",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r47"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r314",
      "r325",
      "r342",
      "r873",
      "r874"
     ]
    },
    "us-gaap_DerivativeAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives",
        "label": "Derivative Asset",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r256",
      "r257",
      "r658",
      "r659",
      "r666",
      "r670",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r799",
      "r800",
      "r839",
      "r842",
      "r845",
      "r846",
      "r847",
      "r848",
      "r864",
      "r903",
      "r906",
      "r921",
      "r1183",
      "r1184",
      "r1185",
      "r1246"
     ]
    },
    "us-gaap_DerivativeAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative instruments",
        "label": "Derivative Asset, Current",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r256"
     ]
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Contract [Domain]",
        "label": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r782",
      "r784",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r807",
      "r808",
      "r809",
      "r810",
      "r820",
      "r821",
      "r822",
      "r823",
      "r826",
      "r827",
      "r828",
      "r829",
      "r839",
      "r840",
      "r845",
      "r847",
      "r919",
      "r921",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1193",
      "r1194"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value \u2013 Assets",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r126",
      "r173",
      "r174",
      "r255",
      "r864"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value \u2013 Liabilities",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r126",
      "r173",
      "r174",
      "r255",
      "r864"
     ]
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument [Axis]",
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r90",
      "r92",
      "r175",
      "r782",
      "r784",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r807",
      "r808",
      "r809",
      "r810",
      "r820",
      "r821",
      "r822",
      "r823",
      "r826",
      "r827",
      "r828",
      "r829",
      "r839",
      "r840",
      "r845",
      "r847",
      "r864",
      "r919",
      "r921",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1193",
      "r1194"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Relationship [Axis]",
        "label": "Hedging Relationship [Axis]",
        "documentation": "Information by type of hedging relationship."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r88",
      "r90"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r88",
      "r90",
      "r92",
      "r96",
      "r97",
      "r642"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r642"
     ]
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effects of derivatives not designated as hedging instruments",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r1025"
     ]
    },
    "us-gaap_DerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives",
        "label": "Derivative Liability",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r256",
      "r257",
      "r658",
      "r659",
      "r666",
      "r670",
      "r775",
      "r776",
      "r777",
      "r778",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r807",
      "r809",
      "r810",
      "r840",
      "r841",
      "r842",
      "r845",
      "r846",
      "r847",
      "r848",
      "r864",
      "r1183",
      "r1184",
      "r1185",
      "r1246"
     ]
    },
    "us-gaap_DerivativeLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative instruments",
        "label": "Derivative Liability, Current",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r256"
     ]
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative instruments",
        "label": "Derivative Liability, Noncurrent",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r256"
     ]
    },
    "us-gaap_DerivativeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLineItems",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative [Line Items]",
        "label": "Derivative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r653"
     ]
    },
    "us-gaap_DerivativeNotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeNotionalAmount",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Notional",
        "label": "Derivative, Notional Amount",
        "documentation": "Nominal or face amount used to calculate payment on derivative."
       }
      }
     },
     "auth_ref": [
      "r1177",
      "r1178"
     ]
    },
    "gehc_DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative, potential effect of rights of offset to assets and liabilities",
        "label": "Derivative, Subject to Master Netting Arrangement, Potential Offset To Asset (Liability)",
        "documentation": "Derivative, Subject to Master Netting Arrangement, Potential Offset To Asset (Liability)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeTable",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative [Table]",
        "label": "Derivative [Table]",
        "documentation": "Disclosure of information about derivative instrument or group of derivative instruments, including, but not limited to, type of derivative instrument, risk being hedged, notional amount, hedge designation, related hedged item, inception date, and maturity date."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r80",
      "r81",
      "r82",
      "r86",
      "r89",
      "r90",
      "r94",
      "r95",
      "r97",
      "r653"
     ]
    },
    "us-gaap_DerivativesAndFairValueTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativesAndFairValueTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
        "label": "Derivatives and Fair Value [Text Block]",
        "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r176"
     ]
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DesignatedAsHedgingInstrumentMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Designated as hedging instrument",
        "label": "Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DevelopedTechnologyRightsMember",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Developed technology",
        "label": "Developed Technology Rights [Member]",
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1085",
      "r1087",
      "r1089",
      "r1090"
     ]
    },
    "us-gaap_Dividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Dividends",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividends declared",
        "label": "Dividends",
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r164"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r935"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r967"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DomesticPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DomesticPlanMember",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Domestic Plan",
        "label": "Domestic Plan [Member]",
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r1171",
      "r1172",
      "r1173"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r978"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited",
      "http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Basic earnings per share (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r303",
      "r305",
      "r307",
      "r308",
      "r309",
      "r313",
      "r622",
      "r629",
      "r655",
      "r656",
      "r713",
      "r734",
      "r866"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited",
      "http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Diluted earnings per share (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r305",
      "r307",
      "r308",
      "r309",
      "r313",
      "r622",
      "r629",
      "r655",
      "r656",
      "r713",
      "r734",
      "r866"
     ]
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareReconciliationAbstract",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings per share attributable to GE HealthCare:",
        "label": "Earnings Per Share Reconciliation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/EARNINGSPERSHARE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EARNINGS PER SHARE",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r310",
      "r311",
      "r312"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of foreign currency rate changes on cash, cash equivalents, and restricted cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r672"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://www.gehealthcare.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective income tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r604",
      "r900"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current compensation and benefits",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "us-gaap_EmployeeSeveranceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeSeveranceMember",
     "presentation": [
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee termination costs",
        "label": "Employee Severance [Member]",
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Option",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1017"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1013"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r1013"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1013"
     ]
    },
    "gehc_EquipmentResidualValueObligationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "EquipmentResidualValueObligationMember",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equipment residual value obligation",
        "label": "Equipment Residual Value Obligation [Member]",
        "documentation": "Equipment Residual Value Obligation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r232",
      "r268",
      "r269",
      "r270",
      "r288",
      "r289",
      "r290",
      "r292",
      "r297",
      "r299",
      "r301",
      "r315",
      "r358",
      "r359",
      "r388",
      "r467",
      "r612",
      "r613",
      "r619",
      "r620",
      "r621",
      "r623",
      "r628",
      "r629",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r654",
      "r673",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r684",
      "r687",
      "r693",
      "r730",
      "r758",
      "r759",
      "r760",
      "r773",
      "r832"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r940",
      "r950",
      "r960",
      "r992"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r937",
      "r947",
      "r957",
      "r989"
     ]
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated fair value",
        "label": "Estimate of Fair Value Measurement [Member]",
        "documentation": "Measured as an estimate of fair value."
       }
      }
     },
     "auth_ref": [
      "r451",
      "r670",
      "r883",
      "r884"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "us-gaap_FacilityClosingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FacilityClosingMember",
     "presentation": [
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Facility and other exit costs",
        "label": "Facility Closing [Member]",
        "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r658",
      "r659",
      "r666",
      "r903"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r658",
      "r659",
      "r666",
      "r903"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r451",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r657",
      "r659",
      "r660",
      "r661",
      "r662",
      "r665",
      "r666",
      "r668",
      "r697",
      "r698",
      "r699",
      "r883",
      "r884",
      "r889",
      "r890",
      "r891",
      "r903",
      "r906"
     ]
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementBasisAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Basis [Axis]",
        "label": "Measurement Basis [Axis]",
        "documentation": "Information by measurement basis."
       }
      }
     },
     "auth_ref": [
      "r451",
      "r883",
      "r884"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Axis]",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r658",
      "r659",
      "r660",
      "r662",
      "r903",
      "r1184",
      "r1195"
     ]
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosureItemAmountsDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement [Domain]",
        "label": "Fair Value Measurement [Domain]",
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value."
       }
      }
     },
     "auth_ref": [
      "r451",
      "r883",
      "r884"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueHedgingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueHedgingMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value hedges",
        "label": "Fair Value Hedging [Member]",
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r451",
      "r512",
      "r517",
      "r659",
      "r666",
      "r697",
      "r889",
      "r890",
      "r891",
      "r903"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r451",
      "r512",
      "r517",
      "r659",
      "r660",
      "r666",
      "r698",
      "r883",
      "r884",
      "r889",
      "r890",
      "r891",
      "r903"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r451",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r659",
      "r660",
      "r661",
      "r662",
      "r666",
      "r699",
      "r883",
      "r884",
      "r889",
      "r890",
      "r891",
      "r903",
      "r906"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Domain]",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r658",
      "r659",
      "r660",
      "r662",
      "r903",
      "r1184",
      "r1195"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r451",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r657",
      "r659",
      "r660",
      "r661",
      "r662",
      "r665",
      "r666",
      "r668",
      "r697",
      "r698",
      "r699",
      "r883",
      "r884",
      "r889",
      "r890",
      "r891",
      "r903",
      "r906"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recurring",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r903",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1195"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease obligations",
        "label": "Finance Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r689"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r690"
     ]
    },
    "gehc_FinanceLeaseReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "FinanceLeaseReceivableMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment in finance leases, net of deferred income",
        "label": "Finance Lease Receivable [Member]",
        "documentation": "Finance Lease Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_FinancialAssetGreaterThan30DaysPastDueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "FinancialAssetGreaterThan30DaysPastDueMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over 30 days past due",
        "label": "Financial Asset, Greater Than 30 Days Past Due [Member]",
        "documentation": "Financial Asset, Greater Than 30 Days Past Due"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancingReceivableNonaccrualPercentPastDue1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivableNonaccrualPercentPastDue1",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing receivable, nonaccrual, percent past due",
        "label": "Financing Receivable, Nonaccrual, Percent Past Due",
        "documentation": "Percentage of nonaccrual financing receivable balance outstanding that is past due."
       }
      }
     },
     "auth_ref": [
      "r1066"
     ]
    },
    "us-gaap_FinancingReceivablePercentPastDue1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivablePercentPastDue1",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing receivable, percent past due",
        "label": "Financing Receivable, Percent Past Due",
        "documentation": "Percentage of financing receivable balance that is past due."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivableRecordedInvestmentPastDueLineItems",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing Receivable, Past Due [Line Items]",
        "label": "Financing Receivable, Past Due [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r879",
      "r1066"
     ]
    },
    "us-gaap_FinancingReceivablesEqualToGreaterThan90DaysPastDueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivablesEqualToGreaterThan90DaysPastDueMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over 90 days past due",
        "label": "Financial Asset, Equal to or Greater than 90 Days Past Due [Member]",
        "documentation": "Financial asset equal to or greater than 90 days past due."
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "us-gaap_FinancingReceivablesPeriodPastDueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivablesPeriodPastDueAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Asset, Aging [Axis]",
        "label": "Financial Asset, Aging [Axis]",
        "documentation": "Information by period in which financial asset is past due or not past due."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r361",
      "r879"
     ]
    },
    "us-gaap_FinancingReceivablesPeriodPastDueDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivablesPeriodPastDueDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Asset, Aging [Domain]",
        "label": "Financial Asset, Aging [Domain]",
        "documentation": "Period in which financial asset is past due or not past due. For past due, element name and standard label in Financial Asset, [numeric lower end] to [numeric higher end] [date measure] Past Due [Member] or Financial Asset, Greater than [low end numeric value] [date measure] Past Due [Member] or Financial Asset, Less than [high end numeric value] [date measure] Past Due [Member] formats."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r361",
      "r879"
     ]
    },
    "us-gaap_FinancingReceivablesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivablesTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FINANCING RECEIVABLES",
        "label": "Financing Receivables [Text Block]",
        "documentation": "The entire disclosure for financing receivable."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r353",
      "r354",
      "r355",
      "r878"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accumulated Amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r362",
      "r382",
      "r881"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r375",
      "r377",
      "r378",
      "r379",
      "r381",
      "r382",
      "r385",
      "r386",
      "r705",
      "r706",
      "r853"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-lived assets, gross",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r362",
      "r382",
      "r706",
      "r881"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r375",
      "r382",
      "r385",
      "r386",
      "r387",
      "r705",
      "r853",
      "r881"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r375",
      "r377",
      "r378",
      "r379",
      "r381",
      "r382",
      "r385",
      "r386",
      "r853"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails_1": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Finite-lived assets, net",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r705",
      "r1087"
     ]
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Definite-lived intangible assets acquired",
        "label": "Finite-Lived Intangible Assets Acquired",
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition."
       }
      }
     },
     "auth_ref": [
      "r377"
     ]
    },
    "gehc_FloatingRateTermLoanFacilityDue2026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "FloatingRateTermLoanFacilityDue2026Member",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails",
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Floating rate Term Loan Facility due January 2, 2026",
        "label": "Floating Rate Term Loan Facility Due 2026 [Member]",
        "documentation": "Floating Rate Term Loan Facility Due 2026"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_ForeignExchangeForwardAndForeignExchangeOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "ForeignExchangeForwardAndForeignExchangeOptionsMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency forward and options contracts",
        "label": "Foreign Exchange Forward And Foreign Exchange Options [Member]",
        "documentation": "Foreign Exchange Forward And Foreign Exchange Options"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignExchangeForwardMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency forward contracts",
        "label": "Foreign Exchange Forward [Member]",
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate."
       }
      }
     },
     "auth_ref": [
      "r799",
      "r803",
      "r809",
      "r822",
      "r828",
      "r843",
      "r844",
      "r845",
      "r921"
     ]
    },
    "us-gaap_ForeignPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignPlanMember",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "International Plans",
        "label": "Foreign Plan [Member]",
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r1171",
      "r1172",
      "r1173"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r944",
      "r954",
      "r964",
      "r996"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r944",
      "r954",
      "r964",
      "r996"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r944",
      "r954",
      "r964",
      "r996"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r944",
      "r954",
      "r964",
      "r996"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r944",
      "r954",
      "r964",
      "r996"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r977"
     ]
    },
    "gehc_GEHealthCareSupplementalPensionPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "GEHealthCareSupplementalPensionPlanMember",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GE HealthCare Supplemental Pension Plan",
        "label": "GE HealthCare Supplemental Pension Plan [Member]",
        "documentation": "GE HealthCare Supplemental Pension Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnDispositionOfAssets1",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain (loss) on business and asset dispositions",
        "label": "Gain (Loss) on Disposition of Assets",
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee."
       }
      }
     },
     "auth_ref": [
      "r1043"
     ]
    },
    "us-gaap_GainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment revaluation gain (loss)",
        "label": "Gain (Loss) on Investments",
        "documentation": "Amount of realized and unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r143",
      "r1018"
     ]
    },
    "us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnSalesOfAssetsAndAssetImpairmentCharges",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringActivitiesDetails": {
       "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Asset write-downs",
        "label": "Gain (Loss) on Sale of Assets and Asset Impairment Charges",
        "documentation": "Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value."
       }
      }
     },
     "auth_ref": [
      "r1043"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails",
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r363",
      "r707",
      "r874",
      "r880",
      "r904",
      "r912",
      "r1069",
      "r1076"
     ]
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAcquiredDuringPeriod",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisitions",
        "label": "Goodwill, Acquired During Period",
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination."
       }
      }
     },
     "auth_ref": [
      "r366",
      "r880"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r1067",
      "r1079"
     ]
    },
    "us-gaap_GoodwillLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillLineItems",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Line Items]",
        "label": "Goodwill [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r880"
     ]
    },
    "us-gaap_GoodwillRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillRollForward",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Roll Forward]",
        "label": "Goodwill [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency exchange and other",
        "label": "Goodwill, Translation and Measurement Period Adjustments",
        "documentation": "Amount of increase (decrease) from foreign currency translation and measurement period adjustments of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1068"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r136",
      "r192",
      "r285",
      "r357",
      "r426",
      "r427",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r671",
      "r868",
      "r873",
      "r1054",
      "r1056",
      "r1058",
      "r1059",
      "r1060",
      "r1104"
     ]
    },
    "us-gaap_GuaranteeObligationsCurrentCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GuaranteeObligationsCurrentCarryingValue",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guarantee obligation, carrying value",
        "label": "Guarantor Obligations, Current Carrying Value",
        "documentation": "The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_GuaranteeObligationsMaximumExposure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GuaranteeObligationsMaximumExposure",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guarantor obligations, maximum exposure",
        "label": "Guarantor Obligations, Maximum Exposure, Undiscounted",
        "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions."
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "us-gaap_HedgedLiabilityFairValueHedge": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgedLiabilityFairValueHedge",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofCumulativeBasisAdjustmentforFairvalueHedgesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term borrowings designated in fair value hedges",
        "label": "Hedged Liability, Fair Value Hedge",
        "documentation": "Amount of liability hedged in fair value hedging relationship."
       }
      }
     },
     "auth_ref": [
      "r643"
     ]
    },
    "us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails_1": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofCumulativeBasisAdjustmentforFairvalueHedgesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Add: Cumulative basis adjustment for fair value hedges",
        "verboseLabel": "Cumulative basis adjustment included in the carrying amount",
        "label": "Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)",
        "documentation": "Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk."
       }
      }
     },
     "auth_ref": [
      "r644"
     ]
    },
    "us-gaap_HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofCumulativeBasisAdjustmentforFairvalueHedgesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedged Liability, Statement of Financial Position [Extensible Enumeration]",
        "label": "Hedged Liability, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes hedged liability."
       }
      }
     },
     "auth_ref": [
      "r645"
     ]
    },
    "us-gaap_HedgingDesignationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgingDesignationAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Axis]",
        "label": "Hedging Designation [Axis]",
        "documentation": "Information by designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r642"
     ]
    },
    "us-gaap_HedgingDesignationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgingDesignationDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Domain]",
        "label": "Hedging Designation [Domain]",
        "documentation": "Designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_HedgingRelationshipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgingRelationshipDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Relationship [Domain]",
        "label": "Hedging Relationship [Domain]",
        "documentation": "Nature or intent of a hedge."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized cloud computing arrangement implementation costs",
        "label": "Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, after Accumulated Amortization",
        "documentation": "Amount, after accumulated amortization, of capitalized implementation cost from hosting arrangement that is service contract."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r389"
     ]
    },
    "gehc_ImagingSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "ImagingSegmentMember",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Imaging",
        "label": "Imaging Segment [Member]",
        "documentation": "Imaging Segment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InProcessResearchAndDevelopmentMember",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IPR&amp;D",
        "label": "In Process Research and Development [Member]",
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process."
       }
      }
     },
     "auth_ref": [
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1087",
      "r1088",
      "r1089",
      "r1090"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r188",
      "r192",
      "r714",
      "r726",
      "r868",
      "r873",
      "r1054",
      "r1056",
      "r1058",
      "r1059",
      "r1060"
     ]
    },
    "gehc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBIT",
        "label": "Income (Loss) From Continuing Operations Before Income Taxes, Interest And Debt Expense, And Other Charges",
        "documentation": "Income (Loss) From Continuing Operations Before Income Taxes, Interest And Debt Expense, And Other Charges"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Equity method income (loss)",
        "label": "Income (Loss) from Equity Method Investments",
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r134",
      "r187",
      "r314",
      "r327",
      "r342",
      "r356",
      "r725"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r397",
      "r406",
      "r663",
      "r664",
      "r667",
      "r755",
      "r757",
      "r817",
      "r853",
      "r905",
      "r1216"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r397",
      "r406",
      "r663",
      "r664",
      "r667",
      "r755",
      "r757",
      "r817",
      "r853",
      "r905",
      "r1216"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/INCOMETAXES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INCOME TAXES",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r286",
      "r600",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r614",
      "r616",
      "r617",
      "r618",
      "r770",
      "r900"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Benefit (provision) for income taxes",
        "terseLabel": "Provision for income taxes",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r206",
      "r300",
      "r301",
      "r314",
      "r328",
      "r342",
      "r603",
      "r604",
      "r615",
      "r735",
      "r900"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cash paid during the year for income taxes",
        "label": "Income Taxes Paid, Net",
        "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r282",
      "r610",
      "r611"
     ]
    },
    "us-gaap_IncomeTaxesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax receivables",
        "label": "Income Taxes Receivable, Current",
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r1032"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsAndOtherReceivables",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Receivables",
        "label": "Increase (Decrease) in Accounts and Other Receivables",
        "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "gehc_IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Contract and other deferred assets",
        "label": "Increase (Decrease) In Contract With Customer, Asset And Deferred Costs",
        "documentation": "Increase (Decrease) In Contract With Customer, Asset And Deferred Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract liabilities",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r703",
      "r1042"
     ]
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current compensation and benefits",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities, excluding the effects of acquisitions:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-Lived Intangible Assets [Axis]",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r375",
      "r380",
      "r384",
      "r881"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails": {
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails_1": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Indefinite-lived assets",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r362",
      "r384",
      "r881"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company."
       }
      }
     },
     "auth_ref": [
      "r375",
      "r380",
      "r384",
      "r881"
     ]
    },
    "us-gaap_IndefinitelivedIntangibleAssetsAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefinitelivedIntangibleAssetsAcquired",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived intangible assets acquired",
        "label": "Indefinite-Lived Intangible Assets Acquired",
        "documentation": "Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition."
       }
      }
     },
     "auth_ref": [
      "r380",
      "r1088"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r944",
      "r954",
      "r964",
      "r988",
      "r996",
      "r1000",
      "r1008"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1006"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r936",
      "r1012"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r936",
      "r1012"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r936",
      "r1012"
     ]
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross Carrying Amount",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r242"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other intangible assets \u2013 net",
        "totalLabel": "Net",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r375",
      "r1087",
      "r1088"
     ]
    },
    "us-gaap_InterestAndDebtExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestAndDebtExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 3.0
      },
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and other financial charges \u2013 net",
        "negatedTerseLabel": "Interest and other financial charges \u2013 net",
        "label": "Interest and Debt Expense",
        "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "gehc_InterestAndDebtExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "InterestAndDebtExpenseMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and other financial charges \u2013 net",
        "label": "Interest and Debt Expense [Member]",
        "documentation": "Interest and Debt Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense",
        "label": "Interest Expense [Member]",
        "documentation": "Primary financial statement caption encompassing interest expense."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cash paid during the year for interest",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r280",
      "r281"
     ]
    },
    "us-gaap_InterestPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest payable on borrowings",
        "label": "Interest Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "us-gaap_InterestRateSwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestRateSwapMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate swaps",
        "verboseLabel": "Interest rate swaps",
        "label": "Interest Rate Swap [Member]",
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period."
       }
      }
     },
     "auth_ref": [
      "r854",
      "r926",
      "r927"
     ]
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished goods",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r861"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofInventoryDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited",
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "totalLabel": "Inventories",
        "label": "Inventory, Net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r859",
      "r912"
     ]
    },
    "us-gaap_InventoryNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Inventory, Noncurrent",
        "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle."
       }
      }
     },
     "auth_ref": [
      "r1031"
     ]
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryRawMaterialsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Raw materials",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r863"
     ]
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryWorkInProcessNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Work in process",
        "label": "Inventory, Work in Process, Net of Reserves",
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r862"
     ]
    },
    "us-gaap_InvestmentIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentIncomeNet",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net financing income and investment income (loss)",
        "label": "Investment Income, Net",
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r140",
      "r142"
     ]
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment securities",
        "label": "Investments, Fair Value Disclosure",
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method."
       }
      }
     },
     "auth_ref": [
      "r1181",
      "r1182",
      "r1192"
     ]
    },
    "us-gaap_LandAndLandImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LandAndLandImprovementsMember",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land and improvements",
        "label": "Land and Land Improvements [Member]",
        "documentation": "Real estate held and assets that are an addition or improvement to real estate held."
       }
      }
     },
     "auth_ref": []
    },
    "gehc_LeaseholdImprovementsAndManufacturingPlantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "LeaseholdImprovementsAndManufacturingPlantsMember",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements and manufacturing plants under construction",
        "label": "Leasehold Improvements And Manufacturing Plants [Member]",
        "documentation": "Leasehold Improvements And Manufacturing Plants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/LEASES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LEASES",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r686"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r105",
      "r106",
      "r107",
      "r110",
      "r111",
      "r112",
      "r113",
      "r285",
      "r357",
      "r426",
      "r427",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r632",
      "r636",
      "r637",
      "r671",
      "r791",
      "r867",
      "r931",
      "r1104",
      "r1201",
      "r1202"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities, redeemable noncontrolling interests, and equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r186",
      "r722",
      "r912",
      "r1047",
      "r1064",
      "r1196"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r237",
      "r285",
      "r357",
      "r426",
      "r427",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r632",
      "r636",
      "r637",
      "r671",
      "r912",
      "r1104",
      "r1201",
      "r1202"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities:",
        "label": "Liabilities, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_LifeSupportSolutionsSubsegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "LifeSupportSolutionsSubsegmentMember",
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Life Support Solutions",
        "label": "Life Support Solutions Subsegment [Member]",
        "documentation": "Life Support Solutions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit outstanding",
        "label": "Long-Term Line of Credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r183",
      "r1213"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum borrowing capacity",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r109"
     ]
    },
    "us-gaap_LineOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditMember",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails",
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit",
        "label": "Line of Credit [Member]",
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/RECEIVABLES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RECEIVABLES",
        "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]",
        "documentation": "The entire disclosure for claims held for amounts due to entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses."
       }
      }
     },
     "auth_ref": [
      "r682",
      "r1061"
     ]
    },
    "us-gaap_LoansReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LoansReceivableMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loans receivable, at amortized cost",
        "label": "Loans Receivable [Member]",
        "documentation": "Amount of money and property lent to borrower in exchange for promise to repay amount borrowed plus interest at date certain in future."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total borrowings",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r183",
      "r450",
      "r466",
      "r883",
      "r884",
      "r910",
      "r1213"
     ]
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term borrowings, current",
        "label": "Long-Term Debt, Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r246"
     ]
    },
    "us-gaap_LongTermDebtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings",
        "label": "Long-Term Debt, Fair Value",
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission."
       }
      }
     },
     "auth_ref": [
      "r1181",
      "r1183",
      "r1184",
      "r1185"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term borrowings",
        "verboseLabel": "Long-term borrowings",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r247"
     ]
    },
    "us-gaap_LongTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity method and other investments",
        "label": "Long-Term Investments",
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle)."
       }
      }
     },
     "auth_ref": [
      "r239"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails",
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r1091",
      "r1092",
      "r1093"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails",
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r50",
      "r1091",
      "r1092",
      "r1093"
     ]
    },
    "gehc_MIMSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "MIMSoftwareMember",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MIM Software",
        "label": "MIM Software [Member]",
        "documentation": "MIM Software"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MachineryAndEquipmentMember",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery and equipment",
        "label": "Machinery and Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r230",
      "r231",
      "r414",
      "r415",
      "r416",
      "r417",
      "r564",
      "r598",
      "r662",
      "r702",
      "r754",
      "r756",
      "r764",
      "r783",
      "r784",
      "r835",
      "r836",
      "r837",
      "r838",
      "r849",
      "r851",
      "r852",
      "r878",
      "r887",
      "r899",
      "r906",
      "r907",
      "r908",
      "r909",
      "r914",
      "r1106",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r980"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r980"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r230",
      "r231",
      "r414",
      "r415",
      "r416",
      "r417",
      "r564",
      "r598",
      "r662",
      "r702",
      "r754",
      "r756",
      "r764",
      "r783",
      "r784",
      "r835",
      "r836",
      "r837",
      "r838",
      "r849",
      "r851",
      "r852",
      "r878",
      "r887",
      "r899",
      "r906",
      "r907",
      "r908",
      "r914",
      "r1106",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208"
     ]
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling interests",
        "label": "Equity, Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r185",
      "r285",
      "r357",
      "r426",
      "r429",
      "r430",
      "r431",
      "r435",
      "r436",
      "r671",
      "r721",
      "r795"
     ]
    },
    "us-gaap_MinorityInterestPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestPeriodIncreaseDecrease",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in equity attributable to noncontrolling interests",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market funds",
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r1133"
     ]
    },
    "gehc_MonitoringSolutionsSubsegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "MonitoringSolutionsSubsegmentMember",
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monitoring Solutions",
        "label": "Monitoring Solutions Subsegment [Member]",
        "documentation": "Monitoring Solutions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MovementInMinorityInterestRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MovementInMinorityInterestRollForward",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]",
        "label": "Equity, Attributable to Noncontrolling Interest [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward",
     "presentation": [
      "http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]",
        "label": "Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1007"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Cash from (used for) financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows \u2013 financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Cash from (used for) investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows \u2013 investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Cash from (used for) operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r150",
      "r151"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows - operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited",
      "http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income attributable to GE HealthCare",
        "terseLabel": "Net income attributable to GE HealthCare",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r151",
      "r189",
      "r235",
      "r263",
      "r266",
      "r270",
      "r285",
      "r291",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r300",
      "r301",
      "r306",
      "r357",
      "r426",
      "r427",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r622",
      "r629",
      "r656",
      "r671",
      "r729",
      "r814",
      "r830",
      "r831",
      "r929",
      "r1104"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited",
      "http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net (income) loss attributable to noncontrolling interests",
        "terseLabel": "Net income (loss) attributable to noncontrolling interests",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r171",
      "r263",
      "r266",
      "r297",
      "r300",
      "r301",
      "r728",
      "r1036"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income attributable to redeemable noncontrolling interests",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "presentation": [
      "http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator:",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetInvestmentHedgingMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net investment hedges",
        "label": "Net Investment Hedging [Member]",
        "documentation": "Hedges of a net investment in a foreign operation."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited",
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-operating benefit (income) costs",
        "negatedTerseLabel": "Non-operating benefit income (costs)",
        "totalLabel": "Non-operating",
        "label": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component",
        "documentation": "Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits."
       }
      }
     },
     "auth_ref": [
      "r487"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATIONPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RECENT ACCOUNTING PRONOUNCEMENTS",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "gehc_NihonMediPhysicsCo.LtdNMPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "NihonMediPhysicsCo.LtdNMPMember",
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails",
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nihon Medi-Physics",
        "label": "Nihon Medi-Physics Co., Ltd (\u201cNMP\u201d) [Member]",
        "documentation": "Nihon Medi-Physics Co., Ltd (\u201cNMP\u201d)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r980"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r944",
      "r954",
      "r964",
      "r988",
      "r996"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r971"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1007"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1007"
     ]
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity attributable to noncontrolling interests",
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r467",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1248"
     ]
    },
    "us-gaap_NondesignatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NondesignatedMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Not designated as hedging instrument",
        "label": "Not Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_NontradeReceivablesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NontradeReceivablesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/RECEIVABLESCurrentReceivablesDetails": {
       "parentTag": "us-gaap_AccountsAndOtherReceivablesNetCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/RECEIVABLESCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Current sundry receivables",
        "label": "Nontrade Receivables, Current",
        "documentation": "The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1032"
     ]
    },
    "us-gaap_NontradeReceivablesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NontradeReceivablesNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/RECEIVABLESLongTermReceivablesDetails": {
       "parentTag": "gehc_ReceivablesNetNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/RECEIVABLESLongTermReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Long-term sundry receivables",
        "label": "Nontrade Receivables, Noncurrent",
        "documentation": "The noncurrent portion of the receivable other than from customers, that is amounts expected to be collected after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1031"
     ]
    },
    "us-gaap_NotesAndLoansReceivableGrossCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesAndLoansReceivableGrossCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails": {
       "parentTag": "us-gaap_NotesAndLoansReceivableNetCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current financing receivables, gross",
        "label": "Financing Receivable, before Allowance for Credit Loss, Current",
        "documentation": "Amortized cost, before allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r860",
      "r1065"
     ]
    },
    "us-gaap_NotesAndLoansReceivableGrossNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesAndLoansReceivableGrossNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails": {
       "parentTag": "us-gaap_NotesAndLoansReceivableNetNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current financing receivables, gross",
        "label": "Financing Receivable, before Allowance for Credit Loss, Noncurrent",
        "documentation": "Amortized cost, before allowance for credit loss, of financing receivable classified as noncurrent. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r1062",
      "r1065"
     ]
    },
    "us-gaap_NotesAndLoansReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesAndLoansReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails",
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Current financing receivables \u2013 net",
        "terseLabel": "Financing receivables \u2013 net",
        "label": "Financing Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r708",
      "r1062"
     ]
    },
    "us-gaap_NotesAndLoansReceivableNetNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesAndLoansReceivableNetNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 6.0
      },
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails",
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Non-current financing receivables \u2013 net",
        "terseLabel": "Financing receivables \u2013 net",
        "label": "Financing Receivable, after Allowance for Credit Loss, Noncurrent",
        "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": []
    },
    "gehc_NumberOfDebtSeries": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "NumberOfDebtSeries",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of debt series",
        "label": "Number Of Debt Series",
        "documentation": "Number Of Debt Series"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r874",
      "r1055"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r869",
      "r877",
      "r1055"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating income",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r868",
      "r1054",
      "r1056",
      "r1058",
      "r1059",
      "r1060"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/LEASESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease expense",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r691",
      "r911"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/LEASESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r689"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r689"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r689"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails": {
       "parentTag": "gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Right-of-use operating lease assets, net of amortization",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r688"
     ]
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating segments",
        "label": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r343",
      "r873",
      "r874"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ORGANIZATION AND BASIS OF PRESENTATION",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r169",
      "r765",
      "r766"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Accrued Liabilities, Noncurrent",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited",
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All other current assets",
        "totalLabel": "All other current assets",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r912"
     ]
    },
    "us-gaap_OtherAssetsMiscellaneousCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsMiscellaneousCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Assets, Miscellaneous, Current",
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsMiscellaneousNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsMiscellaneousNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Assets, Miscellaneous, Noncurrent",
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited",
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All other non-current assets",
        "totalLabel": "All other non-current assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r244"
     ]
    },
    "gehc_OtherCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "OtherCashEquivalentsMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other cash equivalents",
        "label": "Other Cash Equivalents [Member]",
        "documentation": "Other Cash Equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss) before reclassifications \u2013 net of taxes",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r32",
      "r269",
      "r673",
      "r676",
      "r679",
      "r730",
      "r1034"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss) before reclass, tax",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r268",
      "r730"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flow hedges \u2013 net of taxes",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r259",
      "r730"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativePretaxGainsLossesRecognizedinOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flow hedges",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r259",
      "r638",
      "r639",
      "r646"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effects of cash flow hedges",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r259",
      "r261"
     ]
    },
    "gehc_OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effects of fair value hedges",
        "label": "Other Comprehensive Income (Loss), Fair Value Hedge, Gain (Loss), Reclassification, Before Tax",
        "documentation": "Other Comprehensive Income (Loss), Fair Value Hedge, Gain (Loss), Reclassification, Before Tax"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency translation adjustments \u2013 net of taxes",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r730"
     ]
    },
    "gehc_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails",
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation gain, reclassification adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Net of Tax",
        "documentation": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Net of Tax"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativePretaxGainsLossesRecognizedinOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net investment hedges",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge."
       }
      }
     },
     "auth_ref": [
      "r640"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effects of net investment hedges",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax",
        "documentation": "Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge."
       }
      }
     },
     "auth_ref": [
      "r641"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other comprehensive income (loss)",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r28",
      "r264",
      "r267",
      "r271",
      "r297",
      "r673",
      "r674",
      "r679",
      "r709",
      "r730",
      "r1034",
      "r1035"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss):",
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: Other comprehensive income (loss) attributable to noncontrolling interests",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r18",
      "r170",
      "r264",
      "r267",
      "r297"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss) attributable to GE HealthCare",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r18",
      "r170",
      "r264",
      "r267",
      "r297"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Pension and Other Postretirement Plans \u2013 net of taxes",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7",
      "r130",
      "r131",
      "r730"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails",
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Defined benefit pension plan loss, reclassification adjustment",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r131",
      "r262",
      "r529"
     ]
    },
    "us-gaap_OtherContractMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherContractMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofDerivativeFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other derivatives",
        "label": "Other Contract [Member]",
        "documentation": "Derivative instrument whose primary underlying risk is classified as other."
       }
      }
     },
     "auth_ref": [
      "r855",
      "r864",
      "r889"
     ]
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Current Liabilities",
        "label": "Other Current Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of other current liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "gehc_OtherItemsIncomeExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "OtherItemsIncomeExpenseNet",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other items, net",
        "label": "Other Items, Income (Expense), Net",
        "documentation": "Other Items, Income (Expense), Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited",
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All other current liabilities",
        "totalLabel": "All other current liabilities",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r912"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited",
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All other non-current liabilities",
        "totalLabel": "All other non-current liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "gehc_OtherLongTermBorrowingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "OtherLongTermBorrowingsMember",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Long-Term Borrowings [Member]",
        "documentation": "Other Long-Term Borrowings"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Noncurrent Liabilities",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of other noncurrent liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited",
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofOtherIncomeExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other (income) expense \u2013 net",
        "totalLabel": "Total other income (expense) \u2013 net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense)."
       }
      }
     },
     "auth_ref": []
    },
    "gehc_OtherNontradeReceivablesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "OtherNontradeReceivablesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/RECEIVABLESCurrentReceivablesDetails": {
       "parentTag": "us-gaap_NontradeReceivablesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/RECEIVABLESCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other sundry receivables",
        "label": "Other Nontrade Receivables, Current",
        "documentation": "Other Nontrade Receivables, Current"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_OtherNontradeReceivablesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "OtherNontradeReceivablesNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/RECEIVABLESLongTermReceivablesDetails": {
       "parentTag": "us-gaap_NontradeReceivablesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/RECEIVABLESLongTermReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other sundry receivables",
        "label": "Other Nontrade Receivables, Noncurrent",
        "documentation": "Other Nontrade Receivables, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All other operating activities \u2013 net",
        "label": "Other Operating Activities, Cash Flow Statement",
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities)."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r980"
     ]
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails",
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Postretirement Benefits Plan",
        "label": "Other Postretirement Benefits Plan [Member]",
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits."
       }
      }
     },
     "auth_ref": [
      "r485",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r533",
      "r534",
      "r536",
      "r539",
      "r542",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r558",
      "r559",
      "r560",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895"
     ]
    },
    "us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherReceivableAfterAllowanceForCreditLossNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term receivables \u2013 net",
        "label": "Other Receivable, after Allowance for Credit Loss, Noncurrent",
        "documentation": "Amount, after allowance for credit loss, of receivable classified as other and noncurrent."
       }
      }
     },
     "auth_ref": [
      "r1031"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r942",
      "r952",
      "r962",
      "r994"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r945",
      "r955",
      "r965",
      "r997"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r945",
      "r955",
      "r965",
      "r997"
     ]
    },
    "gehc_PCSSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "PCSSegmentMember",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PCS",
        "label": "PCS Segment [Member]",
        "documentation": "PCS Segment"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_PDxSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "PDxSegmentMember",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PDx",
        "label": "PDx Segment [Member]",
        "documentation": "PDx Segment"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r969"
     ]
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "All other investing activities \u2013 net",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r1021",
      "r1038"
     ]
    },
    "gehc_PaymentsForRestructuringAndOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "PaymentsForRestructuringAndOtherAdjustments",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments and other adjustments",
        "label": "Payments For Restructuring And Other Adjustments",
        "documentation": "Payments For Restructuring And Other Adjustments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDividends",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividends paid to stockholders",
        "label": "Payments of Dividends",
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Taxes paid related to net share settlement of equity awards",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails": {
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of businesses, net of cash acquired",
        "terseLabel": "Cash consideration, net of cash acquired",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of investments",
        "label": "Payments to Acquire Investments",
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireProductiveAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Additions to property, plant and equipment and internal-use software",
        "label": "Payments to Acquire Productive Assets",
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r1174",
      "r1175",
      "r1176"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r979"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r979"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "POSTRETIREMENT BENEFIT PLANS",
        "label": "Retirement Benefits [Text Block]",
        "documentation": "The entire disclosure for retirement benefits."
       }
      }
     },
     "auth_ref": [
      "r484",
      "r509",
      "r511",
      "r517",
      "r535",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r556",
      "r557",
      "r558",
      "r891"
     ]
    },
    "gehc_PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Postretirement plan contributions",
        "label": "Pension and Other Postretirement Benefits Expense, Employer Contribution, Cost",
        "documentation": "Pension and Other Postretirement Benefits Expense, Employer Contribution, Cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net periodic postretirement benefit plan (income) expense",
        "label": "Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash",
        "documentation": "Amount of noncash expense (reversal of expense) for pension and other postretirement benefits."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined benefit plan, liability",
        "label": "Liability, Defined Benefit Plan",
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r486",
      "r508",
      "r1211"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current compensation and benefits",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r485",
      "r486",
      "r508",
      "r891"
     ]
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PensionPlansDefinedBenefitMember",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails",
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Plans",
        "label": "Pension Plan [Member]",
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits."
       }
      }
     },
     "auth_ref": [
      "r485",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r533",
      "r534",
      "r536",
      "r539",
      "r542",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r558",
      "r559",
      "r570",
      "r891",
      "r892",
      "r896",
      "r897",
      "r898"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r971"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1016"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r971"
     ]
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Portion at Fair Value Measurement",
        "label": "Portion at Fair Value Measurement [Member]",
        "documentation": "Measured at fair value for financial reporting purposes."
       }
      }
     },
     "auth_ref": [
      "r669"
     ]
    },
    "us-gaap_PrepaidExpenseNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid pension asset",
        "label": "Prepaid Expense, Noncurrent",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1031"
     ]
    },
    "gehc_PrepaidExpensesAndDeferredCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "PrepaidExpensesAndDeferredCostsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and deferred costs",
        "label": "Prepaid Expenses And Deferred Costs, Current",
        "documentation": "Prepaid Expenses And Deferred Costs, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "presentation": [
      "http://www.gehealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATIONPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RECLASSIFICATION",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error."
       }
      }
     },
     "auth_ref": [
      "r1029"
     ]
    },
    "gehc_ProceduralGuidanceSubsegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "ProceduralGuidanceSubsegmentMember",
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Procedural Guidance",
        "label": "Procedural Guidance Subsegment [Member]",
        "documentation": "Procedural Guidance Subsegment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromDebtMaturingInMoreThanThreeMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromDebtMaturingInMoreThanThreeMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Newly issued debt, net of debt issuance costs (maturities longer than 90 days)",
        "label": "Proceeds from Debt, Maturing in More than Three Months",
        "documentation": "The cash inflow from a borrowing having initial term of repayment of more than three months. Includes proceeds from long-term and short-term debt."
       }
      }
     },
     "auth_ref": [
      "r1040"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from stock issued under employee benefit plans",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r22"
     ]
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All other financing activities \u2013 net",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r1022",
      "r1039"
     ]
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net increase (decrease) in borrowings (maturities of 90 days or less)",
        "label": "Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less",
        "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months."
       }
      }
     },
     "auth_ref": [
      "r1040",
      "r1041",
      "r1044"
     ]
    },
    "us-gaap_ProductMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProductMember",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails",
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails",
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONScheduleofRemainingPerformanceObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product",
        "verboseLabel": "Products",
        "label": "Product [Member]",
        "documentation": "Article or substance produced by nature, labor or machinery."
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails",
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails",
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONScheduleofRemainingPerformanceObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r229",
      "r345",
      "r704",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r856",
      "r888",
      "r913",
      "r914",
      "r915",
      "r917",
      "r918",
      "r1028",
      "r1097",
      "r1098",
      "r1109",
      "r1215",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237",
      "r1238",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243",
      "r1244"
     ]
    },
    "us-gaap_ProductWarrantyAccrual": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProductWarrantyAccrual",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "label": "Standard and Extended Product Warranty Accrual",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r419",
      "r421",
      "r423"
     ]
    },
    "us-gaap_ProductWarrantyAccrualClassifiedCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProductWarrantyAccrualClassifiedCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product warranties",
        "label": "Product Warranty Accrual, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r1099",
      "r1101"
     ]
    },
    "us-gaap_ProductWarrantyAccrualPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProductWarrantyAccrualPayments",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Expenditures",
        "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments",
        "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails",
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails",
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONScheduleofRemainingPerformanceObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r229",
      "r345",
      "r704",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r856",
      "r888",
      "r913",
      "r914",
      "r915",
      "r917",
      "r918",
      "r1028",
      "r1097",
      "r1098",
      "r1109",
      "r1215",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237",
      "r1238",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243",
      "r1244"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossUnaudited",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited",
      "http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income",
        "terseLabel": "Net income",
        "verboseLabel": "Net income",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r263",
      "r266",
      "r278",
      "r285",
      "r291",
      "r297",
      "r300",
      "r301",
      "r357",
      "r426",
      "r427",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r622",
      "r629",
      "r630",
      "r633",
      "r634",
      "r656",
      "r671",
      "r714",
      "r727",
      "r772",
      "r814",
      "r830",
      "r831",
      "r901",
      "r902",
      "r930",
      "r1036",
      "r1104"
     ]
    },
    "gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited",
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant, and equipment \u2013 net",
        "totalLabel": "Property, plant, and equipment \u2013 net",
        "label": "Property, Plant, And Equipment And Operating Lease Right-of-Use Asset, After Accumulated Depreciation And Amortization",
        "documentation": "Property, Plant, And Equipment And Operating Lease Right-of-Use Asset, After Accumulated Depreciation And Amortization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r692"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails": {
       "parentTag": "gehc_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment, gross",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r240",
      "r724"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r692"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Property, Plant and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r692"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r969"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r969"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r230",
      "r231",
      "r414",
      "r415",
      "r416",
      "r417",
      "r509",
      "r564",
      "r594",
      "r595",
      "r596",
      "r598",
      "r662",
      "r700",
      "r701",
      "r702",
      "r754",
      "r756",
      "r764",
      "r783",
      "r784",
      "r835",
      "r836",
      "r837",
      "r838",
      "r849",
      "r851",
      "r852",
      "r878",
      "r887",
      "r899",
      "r906",
      "r907",
      "r908",
      "r909",
      "r914",
      "r921",
      "r1094",
      "r1106",
      "r1184",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r230",
      "r231",
      "r414",
      "r415",
      "r416",
      "r417",
      "r509",
      "r564",
      "r594",
      "r595",
      "r596",
      "r598",
      "r662",
      "r700",
      "r701",
      "r702",
      "r754",
      "r756",
      "r764",
      "r783",
      "r784",
      "r835",
      "r836",
      "r837",
      "r838",
      "r849",
      "r851",
      "r852",
      "r878",
      "r887",
      "r899",
      "r906",
      "r907",
      "r908",
      "r909",
      "r914",
      "r921",
      "r1094",
      "r1106",
      "r1184",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208"
     ]
    },
    "us-gaap_ReceivableTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivableTypeDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable [Domain]",
        "label": "Receivable [Domain]",
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r122"
     ]
    },
    "us-gaap_ReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_ReceivablesNetNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "ReceivablesNetNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/RECEIVABLESLongTermReceivablesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/RECEIVABLESLongTermReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total long-term receivables \u2013 net",
        "label": "Receivables, Net, Noncurrent",
        "documentation": "Receivables, Net, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Reclassifications from AOCI \u2013 net of taxes",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r32",
      "r269",
      "r673",
      "r678",
      "r679",
      "r730",
      "r1034"
     ]
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Reclass from AOCI, tax",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r262",
      "r268",
      "r730"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r937",
      "r947",
      "r957",
      "r989"
     ]
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited",
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofRedeemableNoncontrollingInterestDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeemable noncontrolling interests",
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52",
      "r160",
      "r161"
     ]
    },
    "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RedeemableNoncontrollingInterestTableTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Redeemable Noncontrolling Interest",
        "label": "Redeemable Noncontrolling Interest [Table Text Block]",
        "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfDebtMaturingInMoreThanThreeMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfDebtMaturingInMoreThanThreeMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayments and other reductions (maturities longer than 90 days)",
        "label": "Repayments of Debt, Maturing in More than Three Months",
        "documentation": "The cash outflow from a repayment of a borrowing having initial term of repayment of more than three months. Includes repayments of short-term and long-term debt."
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfLongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt repayments",
        "label": "Repayments of Long-Term Debt",
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r768"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r599",
      "r853",
      "r873",
      "r1209"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r938",
      "r948",
      "r958",
      "r990"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r939",
      "r949",
      "r959",
      "r991"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r946",
      "r956",
      "r966",
      "r998"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Domain]",
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r238"
     ]
    },
    "us-gaap_RestrictedCashCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": "gehc_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term restricted cash",
        "label": "Restricted Cash, Current",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r1030",
      "r1045"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term restricted cash",
        "label": "Restricted Cash, Noncurrent",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r1031",
      "r1045"
     ]
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RESTRUCTURING ACTIVITIES",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r403",
      "r405",
      "r408",
      "r413"
     ]
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringAndRelatedCostExpectedCostRemaining1",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected restructuring expense remaining",
        "label": "Restructuring and Related Cost, Expected Cost Remaining",
        "documentation": "Amount of expected cost remaining for the specified restructuring cost."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCharges",
     "crdr": "debit",
     "presentation": [
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Charges",
        "label": "Restructuring Charges",
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r409",
      "r410",
      "r1095"
     ]
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCostAndReserveAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Type [Axis]",
        "label": "Restructuring Type [Axis]",
        "documentation": "Information by type of restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r404",
      "r405",
      "r410",
      "r411"
     ]
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Cost and Reserve [Line Items]",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r404",
      "r405",
      "r406",
      "r407",
      "r410",
      "r411",
      "r412"
     ]
    },
    "us-gaap_RestructuringCostsAndAssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCostsAndAssetImpairmentCharges",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 9.0
      },
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringActivitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringActivitiesDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Restructuring costs",
        "totalLabel": "Total restructuring activities \u2013 net",
        "label": "Restructuring Costs and Asset Impairment Charges",
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "presentation": [
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes restructuring charges."
       }
      }
     },
     "auth_ref": [
      "r1019",
      "r1020"
     ]
    },
    "us-gaap_RestructuringReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringReserve",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring liabilities",
        "label": "Restructuring Reserve",
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r411"
     ]
    },
    "us-gaap_RestructuringReserveRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringReserveRollForward",
     "presentation": [
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Reserve [Roll Forward]",
        "label": "Restructuring Reserve [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained earnings",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r164",
      "r720",
      "r761",
      "r763",
      "r769",
      "r794",
      "r912"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained earnings",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r288",
      "r289",
      "r290",
      "r292",
      "r297",
      "r299",
      "r301",
      "r358",
      "r359",
      "r388",
      "r612",
      "r613",
      "r619",
      "r620",
      "r621",
      "r623",
      "r628",
      "r629",
      "r647",
      "r649",
      "r650",
      "r652",
      "r654",
      "r684",
      "r687",
      "r758",
      "r760",
      "r773",
      "r1248"
     ]
    },
    "us-gaap_RetirementPlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetirementPlanNameAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Name [Axis]",
        "label": "Retirement Plan Name [Axis]",
        "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r899",
      "r1023",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166",
      "r1167",
      "r1168",
      "r1169",
      "r1170"
     ]
    },
    "us-gaap_RetirementPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetirementPlanNameDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Name [Domain]",
        "label": "Retirement Plan Name [Domain]",
        "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r899",
      "r1023",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166",
      "r1167",
      "r1168",
      "r1169",
      "r1170"
     ]
    },
    "us-gaap_RetirementPlanNameOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetirementPlanNameOtherMember",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Pension Plans",
        "label": "Retirement Plan Name, Other [Member]",
        "documentation": "Retirement plan not separately disclosed by name classified as other."
       }
      }
     },
     "auth_ref": [
      "r1158"
     ]
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetirementPlanSponsorLocationAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Sponsor Location [Axis]",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r539",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r1171",
      "r1172",
      "r1173"
     ]
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetirementPlanSponsorLocationDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Sponsor Location [Domain]",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r536",
      "r539",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r1171",
      "r1172",
      "r1173"
     ]
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetirementPlanTypeAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails",
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Type [Axis]",
        "label": "Retirement Plan Type [Axis]",
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement."
       }
      }
     },
     "auth_ref": [
      "r485",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r533",
      "r534",
      "r536",
      "r539",
      "r542",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r558",
      "r559",
      "r560",
      "r570",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898"
     ]
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetirementPlanTypeDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails",
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Type [Domain]",
        "label": "Retirement Plan Type [Domain]",
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement."
       }
      }
     },
     "auth_ref": [
      "r485",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r533",
      "r534",
      "r536",
      "r539",
      "r542",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r558",
      "r559",
      "r560",
      "r570",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total revenues",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r191",
      "r314",
      "r321",
      "r322",
      "r336",
      "r342",
      "r345",
      "r347",
      "r348",
      "r479",
      "r480",
      "r704"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/REVENUERECOGNITION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "REVENUE RECOGNITION",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r483"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONScheduleofRemainingPerformanceObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining performance obligations, amount",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r202"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "presentation": [
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails",
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONScheduleofRemainingPerformanceObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "presentation": [
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining performance obligation, period",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r203"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r203"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "presentation": [
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails",
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONScheduleofRemainingPerformanceObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Remaining Performance Obligations",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]",
        "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation."
       }
      }
     },
     "auth_ref": [
      "r1024"
     ]
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving credit facility",
        "label": "Revolving Credit Facility [Member]",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1007"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1007"
     ]
    },
    "gehc_SalesAllowancesAndRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "SalesAllowancesAndRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales allowances and related liabilities",
        "label": "Sales Allowances And Related Liabilities, Current",
        "documentation": "Sales Allowances And Related Liabilities, Current"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_SalesAllowancesAndRelatedLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "SalesAllowancesAndRelatedLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONScheduleofAllOtherNoncurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales allowances and related liabilities",
        "label": "Sales Allowances And Related Liabilities, Noncurrent",
        "documentation": "Sales Allowances And Related Liabilities, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESScheduleofFinancingReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "label": "Accounts and Financing Receivables [Table]",
        "documentation": "Disclosure of information about accounts and financing receivables. Includes, but is not limited to, amount of receivable and allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r122",
      "r351",
      "r1063"
     ]
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESTables",
      "http://www.gehealthcare.com/role/RECEIVABLESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Receivables",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r122"
     ]
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r1197",
      "r1198"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofBusinessAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r69",
      "r624"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r69"
     ]
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash and Cash Equivalents",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "documentation": "Tabular disclosure of the components of cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-Term Borrowings",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r53",
      "r54",
      "r101",
      "r162",
      "r163",
      "r883",
      "r885",
      "r1048",
      "r1199"
     ]
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails",
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "label": "Defined Benefit Plan [Table]",
        "documentation": "Disclosure of information about individual defined benefit pension plan or other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r59",
      "r60",
      "r61",
      "r62"
     ]
    },
    "us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Derivative Assets at Fair Value",
        "label": "Schedule of Derivative Assets at Fair Value [Table Text Block]",
        "documentation": "Tabular disclosure of derivative assets at fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Derivative Pre-tax Gains (Losses) Recognized in OCI",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r90",
      "r642"
     ]
    },
    "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Derivative Liabilities at Fair Value",
        "label": "Schedule of Derivative Liabilities at Fair Value [Table Text Block]",
        "documentation": "Tabular disclosure of derivative liabilities at fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Effect of Derivatives Instruments on Statement of Financial Position and Statement of Income",
        "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/EARNINGSPERSHARETables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Earnings per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1053"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1181",
      "r1182"
     ]
    },
    "us-gaap_ScheduleOfFinancingReceivablesPastDueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFinancingReceivablesPastDueTable",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCINGRECEIVABLESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing Receivable, Past Due [Table]",
        "label": "Financing Receivable, Past Due [Table]",
        "documentation": "Disclosure of information about aging analysis for financing receivable."
       }
      }
     },
     "auth_ref": [
      "r879",
      "r1066"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]",
        "label": "Intangible Asset, Finite-Lived [Table]",
        "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r375",
      "r382",
      "r385",
      "r386",
      "r387",
      "r705",
      "r853",
      "r881"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r881",
      "r1086"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfGoodwillTable",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Goodwill [Table]",
        "label": "Goodwill [Table]",
        "documentation": "Disclosure of information about goodwill, including, but not limited to, change from acquisition, sale, impairment, and other reason."
       }
      }
     },
     "auth_ref": [
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r880"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfGoodwillTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Goodwill",
        "label": "Schedule of Goodwill [Table Text Block]",
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule."
       }
      }
     },
     "auth_ref": [
      "r880",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078"
     ]
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r881",
      "r1088"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Inventory",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r123",
      "r124",
      "r125"
     ]
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Components of Net Periodic Expense",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Noncurrent Assets",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "documentation": "Tabular disclosure of noncurrent assets."
       }
      }
     },
     "auth_ref": [
      "r1031"
     ]
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Current Assets",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amounts of other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Income (Expense)",
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Product Warranties",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability."
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONSummaryofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r692"
     ]
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restricted Cash and Cash Equivalents",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r177",
      "r1214"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Cost [Table]",
        "label": "Restructuring Cost [Table]",
        "documentation": "Disclosure of information about restructuring cost. Includes, but is not limited to, expected cost, cost incurred, statement of income caption that includes restructuring cost recognized, and amount of restructuring reserve."
       }
      }
     },
     "auth_ref": [
      "r404",
      "r405",
      "r406",
      "r407",
      "r410",
      "r411",
      "r412"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restructuring Activities",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r155",
      "r156"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45",
      "r46"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45",
      "r46"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r191",
      "r192",
      "r193",
      "r314",
      "r317",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r342",
      "r343",
      "r344",
      "r348",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r387",
      "r407",
      "r412",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r870",
      "r873",
      "r874",
      "r880",
      "r916",
      "r1215",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237",
      "r1238",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243",
      "r1244"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEGMENT INFORMATION",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r314",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r332",
      "r334",
      "r335",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r348",
      "r869",
      "r871",
      "r872",
      "r873",
      "r875",
      "r876",
      "r877"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other segment items",
        "label": "Segment Reporting, Other Segment Item, Amount",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r314",
      "r334",
      "r335",
      "r342",
      "r873"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general, and administrative",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "presentation": [
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SG&amp;A",
        "label": "Selling, General and Administrative Expenses [Member]",
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeniorNotesMember",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails",
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior notes",
        "label": "Senior Notes [Member]",
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors."
       }
      }
     },
     "auth_ref": []
    },
    "gehc_SeniorUnsecuredNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "SeniorUnsecuredNotesMember",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior unsecured notes",
        "label": "Senior Unsecured Notes [Member]",
        "documentation": "Senior Unsecured Notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ServiceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ServiceMember",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited",
      "http://www.gehealthcare.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSEffectofDerivativesInstrumentsonStatementsofIncomeDetails",
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONNarrativeDetails",
      "http://www.gehealthcare.com/role/REVENUERECOGNITIONScheduleofRemainingPerformanceObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Service",
        "verboseLabel": "Services",
        "label": "Service [Member]",
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service."
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "us-gaap_SeveranceCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeveranceCosts1",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringActivitiesDetails": {
       "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee termination costs",
        "label": "Severance Costs",
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Award Types",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597"
     ]
    },
    "us-gaap_ShortTermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSScheduleofLongTermBorrowingsDetails",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term borrowings",
        "verboseLabel": "Less: Short-term borrowings",
        "label": "Short-Term Debt",
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r180",
      "r912",
      "r1212"
     ]
    },
    "gehc_SpecializedUltrasoundSubsegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "SpecializedUltrasoundSubsegmentMember",
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Specialized Ultrasound",
        "label": "Specialized Ultrasound Subsegment [Member]",
        "documentation": "Specialized Ultrasound Subsegment"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_SpinOffAndSeparationCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "SpinOffAndSeparationCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Spin-Off and separation costs",
        "label": "Spin-Off And Separation Costs",
        "documentation": "Spin-Off And Separation Costs"
       }
      }
     },
     "auth_ref": []
    },
    "gehc_StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency exchange and other",
        "label": "Standard and Extended Product Warranty Accrual, Other Increase (Decrease)",
        "documentation": "Standard and Extended Product Warranty Accrual, Other Increase (Decrease)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StandardProductWarrantyAccrualWarrantiesIssued",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/COMMITMENTSGUARANTEESPRODUCTWARRANTIESANDOTHERLOSSCONTINGENCIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current-year provisions",
        "label": "Standard Product Warranty Accrual, Increase for Warranties Issued",
        "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties."
       }
      }
     },
     "auth_ref": [
      "r1100"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofGoodwillDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofDepreciationandAmortizationbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSegmentEBITDetails",
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofSignificantExpensesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r191",
      "r192",
      "r193",
      "r234",
      "r314",
      "r317",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r342",
      "r343",
      "r344",
      "r348",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r387",
      "r391",
      "r407",
      "r412",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r870",
      "r873",
      "r874",
      "r880",
      "r916",
      "r1215",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237",
      "r1238",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243",
      "r1244"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r115",
      "r119",
      "r120",
      "r232",
      "r268",
      "r269",
      "r270",
      "r288",
      "r289",
      "r290",
      "r292",
      "r297",
      "r299",
      "r301",
      "r315",
      "r358",
      "r359",
      "r388",
      "r467",
      "r612",
      "r613",
      "r619",
      "r620",
      "r621",
      "r623",
      "r628",
      "r629",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r654",
      "r673",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r684",
      "r687",
      "r693",
      "r730",
      "r758",
      "r759",
      "r760",
      "r773",
      "r832"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r289",
      "r290",
      "r315",
      "r687",
      "r704",
      "r767",
      "r774",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r793",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r813",
      "r815",
      "r816",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r832",
      "r922"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r289",
      "r290",
      "r315",
      "r350",
      "r687",
      "r704",
      "r767",
      "r774",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r793",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r813",
      "r815",
      "r816",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r832",
      "r922"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r941",
      "r951",
      "r961",
      "r993"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of shares under equity awards, net of shares withheld for taxes and other (in shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r114",
      "r115",
      "r164"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of shares under equity awards, net of shares withheld for taxes and other",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r114",
      "r115",
      "r164"
     ]
    },
    "srt_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share repurchase program, authorized amount",
        "label": "Share Repurchase Program, Authorized, Amount",
        "documentation": "Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": [
      "r1107"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total equity attributable to GE HealthCare",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r119",
      "r120",
      "r152",
      "r795",
      "r812",
      "r833",
      "r834",
      "r912",
      "r931",
      "r1047",
      "r1064",
      "r1196",
      "r1248"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMELOSSNETDetails",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total equity",
        "periodStartLabel": "Equity, beginning balance",
        "periodEndLabel": "Equity, ending balance",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r75",
      "r77",
      "r232",
      "r233",
      "r269",
      "r288",
      "r289",
      "r290",
      "r292",
      "r297",
      "r299",
      "r358",
      "r359",
      "r388",
      "r467",
      "r612",
      "r613",
      "r619",
      "r620",
      "r621",
      "r623",
      "r628",
      "r629",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r654",
      "r673",
      "r675",
      "r679",
      "r685",
      "r693",
      "r759",
      "r760",
      "r771",
      "r795",
      "r812",
      "r833",
      "r834",
      "r850",
      "r930",
      "r1047",
      "r1064",
      "r1196",
      "r1248"
     ]
    },
    "us-gaap_SubsegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsegmentsAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsegments [Axis]",
        "label": "Subsegments [Axis]",
        "documentation": "Information by business subsegments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsegmentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsegmentsDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/SEGMENTINFORMATIONScheduleofRevenuesbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsegments [Domain]",
        "label": "Subsegments [Domain]",
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.gehealthcare.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r680",
      "r695"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.gehealthcare.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r680",
      "r695"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.gehealthcare.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r680",
      "r695"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r680",
      "r695"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r680",
      "r695"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/SUBSEQUENTEVENTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SUBSEQUENT EVENTS",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r694",
      "r696"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of cash flows information",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplierFinanceProgramLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplierFinanceProgramLineItems",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplier Finance Program [Line Items]",
        "label": "Supplier Finance Program [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r398",
      "r399",
      "r400"
     ]
    },
    "us-gaap_SupplierFinanceProgramObligationCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplierFinanceProgramObligationCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplier finance program obligation",
        "label": "Supplier Finance Program, Obligation, Current",
        "documentation": "Amount of obligation for supplier finance program, classified as current."
       }
      }
     },
     "auth_ref": [
      "r399",
      "r400",
      "r401"
     ]
    },
    "us-gaap_SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration]",
        "label": "Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes obligation for supplier finance program, classified as current."
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "us-gaap_SupplierFinanceProgramPaymentTimingPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplierFinanceProgramPaymentTimingPeriod",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplier finance program, payment terms",
        "label": "Supplier Finance Program, Payment Timing, Period",
        "documentation": "Period when payment is expected to be made to finance provider or intermediary in supplier finance program, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r398"
     ]
    },
    "gehc_SupplierFinanceProgramPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "SupplierFinanceProgramPolicyPolicyTextBlock",
     "presentation": [
      "http://www.gehealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATIONPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SUPPLY CHAIN FINANCE PROGRAMS",
        "label": "Supplier Finance Program, Policy [Policy Text Block]",
        "documentation": "Supplier Finance Program, Policy"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplierFinanceProgramTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplierFinanceProgramTable",
     "presentation": [
      "http://www.gehealthcare.com/role/SUPPLEMENTALFINANCIALINFORMATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplier Finance Program [Table]",
        "label": "Supplier Finance Program [Table]",
        "documentation": "Disclosure of information about supplier finance program."
       }
      }
     },
     "auth_ref": [
      "r398",
      "r399",
      "r400"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r987"
     ]
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patents and technology",
        "label": "Technology-Based Intangible Assets [Member]",
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1085",
      "r1087",
      "r1089",
      "r1090"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r979"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r986"
     ]
    },
    "gehc_TrademarksAndOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.gehealthcare.com/20250331",
     "localname": "TrademarksAndOtherMember",
     "presentation": [
      "http://www.gehealthcare.com/role/ACQUISITIONSGOODWILLANDOTHERINTANGIBLEASSETSScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trademarks and other",
        "label": "Trademarks And Other [Member]",
        "documentation": "Trademarks And Other"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1006"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.gehealthcare.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r1009"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r1011"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r1009"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofChangesinEquityUnaudited",
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnauditedParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock (in shares)",
        "periodStartLabel": "Treasury stock, beginning balance (in shares)",
        "periodEndLabel": "Treasury stock, ending balance (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofFinancialPositionUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Treasury stock, at cost, 291,053 shares as of March 31, 2025 and December 31, 2024",
        "label": "Treasury Stock, Common, Value",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r56",
      "r119"
     ]
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfRestructuringDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/RESTRUCTURINGACTIVITIESScheduleofRestructuringLiabilityActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Restructuring [Domain]",
        "label": "Type of Restructuring [Domain]",
        "documentation": "Identification of the types of restructuring costs."
       }
      }
     },
     "auth_ref": [
      "r404",
      "r405",
      "r410",
      "r411"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "US",
     "presentation": [
      "http://www.gehealthcare.com/role/POSTRETIREMENTBENEFITPLANSComponentsofExpenseIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "U.S. Plans",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnderlyingAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnderlyingAssetClassAxis",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Asset Class [Axis]",
        "label": "Underlying Asset Class [Axis]",
        "documentation": "Information by underlying asset class."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnderlyingAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnderlyingAssetClassDomain",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Asset Class [Domain]",
        "label": "Underlying Asset Class [Domain]",
        "documentation": "Major types of referenced/underlying asset classes (for example, corporate debt, sovereign debt, and structured finance)."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r1005"
     ]
    },
    "us-gaap_UnsecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnsecuredDebtMember",
     "presentation": [
      "http://www.gehealthcare.com/role/BORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsecured debt",
        "label": "Unsecured Debt [Member]",
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.gehealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATIONPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ESTIMATES AND ASSUMPTIONS",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r42",
      "r43",
      "r198",
      "r199",
      "r200",
      "r201"
     ]
    },
    "us-gaap_ValueAddedTaxReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValueAddedTaxReceivableCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/RECEIVABLESCurrentReceivablesDetails": {
       "parentTag": "us-gaap_NontradeReceivablesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/RECEIVABLESCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-income based tax receivables",
        "label": "Value Added Tax Receivable, Current",
        "documentation": "Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1032"
     ]
    },
    "us-gaap_ValueAddedTaxReceivableNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValueAddedTaxReceivableNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.gehealthcare.com/role/RECEIVABLESLongTermReceivablesDetails": {
       "parentTag": "us-gaap_NontradeReceivablesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/RECEIVABLESLongTermReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-income based tax receivables",
        "label": "Value Added Tax Receivable, Noncurrent",
        "documentation": "Carrying amount due after one year of the balance sheet date (or one operating cycle), if longer of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities."
       }
      }
     },
     "auth_ref": [
      "r1031"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r975"
     ]
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "calculation": {
      "http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dilutive effect of common stock equivalents (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation."
       }
      }
     },
     "auth_ref": [
      "r1053"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited",
      "http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted weighted-average shares outstanding",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r309"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited",
      "http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basic (in shares)",
        "terseLabel": "Basic weighted-average shares outstanding",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r303",
      "r309"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "presentation": [
      "http://www.gehealthcare.com/role/CondensedConsolidatedStatementsofIncomeUnaudited",
      "http://www.gehealthcare.com/role/EARNINGSPERSHAREDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted-average number of shares outstanding:",
        "terseLabel": "Denominator:",
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r973"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "16",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-16"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-7"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-8"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(j)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(k)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-12"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-15"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-4"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(c)(2)",
   "SubTopic": "20",
   "Topic": "860",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4D"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13",
   "SubTopic": "20",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-13"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Section": "S99",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Paragraph": "3A",
   "Section": "S99",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-2"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-37"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-5"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-6"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-21"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "25",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480238/815-25-50-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-12"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-7"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/220/tableOfContent"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480581/330-10-S99-2"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-1"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "460",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/460/tableOfContent"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(14)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(15)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/805/tableOfContent"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479613/805-30-35-1"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/815/tableOfContent"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/820/tableOfContent"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r186": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r187": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r188": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r189": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r190": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r191": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r192": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r193": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r194": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-7A"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(1)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "40",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-40-50-3"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column A",
   "Publisher": "SEC"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(A)",
   "Publisher": "SEC"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(B)",
   "Publisher": "SEC"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(A)",
   "Publisher": "SEC"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(B)",
   "Publisher": "SEC"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(C)",
   "Publisher": "SEC"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "L",
   "Publisher": "SEC"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-15"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-17A"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/310-10/tableOfContent"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-42"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "44",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-44"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/310-20/tableOfContent"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-4"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/420/tableOfContent"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-4"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-4"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-3"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/715/tableOfContent"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-3"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-3A"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-8"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480126/715-20-S99-2"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480266/715-60-50-3"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480606/715-80-35-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-9"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4CCC",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4CCC",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480627/815-20-45-3"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-2"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-2"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-12"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(1)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(6)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(b)",
   "SubTopic": "20",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "80",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-80"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-18"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(1)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4CC",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CC"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(ii)",
   "Publisher": "SEC"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)",
   "Publisher": "SEC"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-9"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/310-10/tableOfContent"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481628/310-20-40-7"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482047/420-10-45-3"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-27"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-8"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480606/715-80-35-1"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-9"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480060/805-50-25-1"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-1"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-2"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1242": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1243": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1244": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1245": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1246": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1247": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1248": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>116
<FILENAME>0001932393-25-000014-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001932393-25-000014-xbrl.zip
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M/LG- #7A8@Z2*HZ?@J@)5]L@/%5T_OLE&44D_ZK?=9>_ [I9IX;/B/7-!U"
MC3!][C0EE)"Q*TF+QZ7%(\E%(8-\DA;A.R_@'IG$,O]%C9^6QXCK^+9QZJ)1
MR("H),>CD^.1I*.0P>/3(,><"BCA2IDD11Q91@A7:"4\13S='$9E_7!LTW/P
M")87Q_(1$NZ)VT]UX:K.)#$*0(S'D8QU&9\7E1B_FSV*Q^0XS#L;T2CS I(:
MQ9&-,A^Q-VK,J7R260%A*>)(,D+&YE-3Q.W'2<L(&1X7EB*.)"-R&:&^<1@8
M>[#F!\<^:7[-9;3X\-@Y$N\(%[F=V0+(CX]]<#SJ?G>([79L(SRDUNX_4YV:
M;WBN[)?Q]/?7\6BAK)6_.'T@>QSNI[RU(5P,,[]HR7"71T.X:%XV:.%6PNRI
MWCGD&.%"6_E&399<(UR<)T)-#!;<)[ZR)^)ZM_XR#DQB=5R7>M\8!97+7@?$
MKI1OR=@-7\@-NP@7:4F)DW6/W_WI$^O5F<%1*Y<X$B[VD5.^R5*6"1=].!&^
MR1)'PL4#(J!',9J._J=ONKRUSPRG/)@#/'_!,)\&8]?4W1NG]-TS'GX\Y49@
M">?J"P?XQ8#,+.@/%)!I".OR[P=+B3]_;QNT9]JF1[^;;]2XMX$1^B8(1JZY
MW"_C'^2?#KNQB+L0++JW^9X)%SQ:EQ*F#\# OZ5OU')&APGK'8&*FL)%* QJ
M7GVG?6+=\?F<DF!M"AMW6,^R/^Y_O#@][YVPO;?KJL[$3G<"M;!QA".">C%0
M74T>J)Y]="=Y(VP0(2N\)/[@#0 &#'>8)68Q8 F,9S&^C!>B1BN>>_)!0Q&7
M/K']]]?)CBV%C5?D#?UAHX]G"M-E-$DN6APB$#8@<G B^+J-G7KCNYXSI.R9
M\LZ:BR_FA@R$C<'D@PQ"UX0:KU0?V([E],?/9G^0(P(0-L C0J>1_035FL+&
M=HZ]_VY/\!8V2G/LJM3]P+LE7#Q#E J_/<%;V)"&"#)<@+J]EK"!D&,+?!&0
M(VPTY-C:003D"!NK.+8J$0$YPL801- [^TE?M(1UV(^M2O8$[US[QP?R';*$
M=ZY]XP/Y#EG"6UC?.'=AV0RQHI:%=:%SAY8,'6VU+*RGO15:ID'K+\3-,[<(
MZU_G#BV9<HNPGO5V0LP9CGR/LBCQM/!F?KA%6)\Z=VC)E%N$]:93H87;P:^,
M&'1(V"_<G\5/G<P/=PCK8 N/ADRY05B_^Y9VO7M8&O/QQ=F.QM0V'?;3ACGX
MC!I\CV)6Q0G?';L/,FZ('U_> AQ\.<D'!>(S81W]E0CNU/Z7$O!AWASKS;3[
M-X!DT_M*=-."Z6=6DC8WZN(9RGO]]'HB^V[:]+$7?/DDP]EJ6=A8R&J2K-2K
MMV0L:?)4:5(5-A DQ>012')/RE@5-JXE)=\ID9FP<;J59/;5<GBON6>0X*^
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MP"LZ&U+-4H(UA T>2E(] 5+-5*H*&RA=3ZI!S_M8WZ!C&PLW'D><?"35GHR
M%38\+*GVM*@V4UDK;"A=TL;1)9JP07U)&T>7&SG/+LQZ$"_O9"2*1OM*3,8[
M'YT-568JL7*>6)!4*0I59BHK3S:G<'YTD:FT.MFDPOG119;RHIGSK,)^T^.;
M:.#!L8T)&>1&%C1S'IX_%YQGRN<YC7//]3G*.OTB#JHS9>^<!H?/!-69<K6P
M$55QX)TI:PD;I10'WIG2=\XC?_NU5.YMW1G22=%Y?.O/&\?U'GLOQ-IX7,O&
M[[K,NWIBCN'KWB-[H>S-U!?[@P5WLZ<O$?I$-',>\#LW8@POGB@Q"AOG2T0(
M+]2R0%U]HS9EQ.K81L<8FK8)Q,O)^.YC!,/N3B0'8)"\TH^P\<"U],,+2*+,
M!9 -GN 4$HNDE7W12DO8&&$B6</]2;!_'5@TW,8P+;XER6;?9"-LF%$\6^6D
M#>>6L+%'\0CAI(W6EK"1R0,:K7G%G;"AQCT9C'G%D[ AROT;:WE%6<ZCG ?;
M+B6>NCYMNRWG <\SILO3-B-E[%,X7LDK*<DPJ"2;U&2CE65$5%+0;A0D;'!4
MW!V\XIE9IVS^PVB21/-/HJ?L"6AE&5 6F6WR2E7G%NJ6%)0U!9UQ$%X24];$
ME//TP+XVFHMG:YVV.Y#S;,#YD.%IF_PR^']LUL@KY<A8OZ22C52BRM"^))A4
M!)/G2#X*DR_$-6?. ?KNV/U7RH9?',:<=Z"@$PZ.GK3!KN8Y?G_FA'G2)KPJ
MH_;B,4M>:4G&ZB7=;$,W,D(O26A'$LIY7'XO?9;$,Z5.V\;/>5#^3&CPM,UY
M&9$_*E_DE6QD.%Z2R'H2T60L7E)+<FK):2#^7/NS'<8PKR8GQFJ6Q)C3X/NY
M$N-A+/1C$:,,N(O!('FE'QEDE[22E%9D8%V2S19D(VPP73Q;Y;0-9V$CVN(1
MPFD;K3*LG%_<G5ML-Z=XJIQQ@#6O*,MYE/.,F[*=M-U6R7G \XSI\J3-R(J,
M?0K'*WDE)1D&E62S!=G(B*BDH-TH2-C@J.S$)LW_@$2%#=M*$I6>0$"B,J L
M,MODE:K.+=0M*2AC"JJ><1!>$E/6Q)3S],#Y=&D[:7>@FO-LP/F0X4F;_%49
M_#\V:^25<F2L7U+)9BJ1H7U),*D()L^1_#/OR7;:!GN>X_=G3IBG;<++J+UX
MS))76I*Q>DDW6]!-34;H)0GM2$(YC\N?2:.VD[;Q:SD/RI\)#9ZT.5^3$?FC
M\D5>R4:&XR6);" 1&8N7U)*<6H0-Q">BEDBFG$.JYDCM)&O"1L0EA0@B0X0-
M3=\0=P#F!O[G[D\?$&;!^^X\CGXX-AW_(.P7];[ZMI&9S?J5F.R_B>73+^/)
MKW_ :@C3!^/O](U:"UVNHH?N[9'ON?P)=0^3^4&)ZS/.,5\9_=/'+60K9C+S
MJ/M,=9\QT,?9T[ )'$3@V67!%=W9CBR%C7+GG2PU29;;DV5=V"!ZWLFR(LER
M![(4-C O"%F>#R4(&QX7A!*D.9>4+*M%5<N,+(6-F.>=+,_.G,N4+(6-R.>=
M+,_.G,N4+(7- @A"EN=#"<)&^*5)=6Q+7]C0OC1KCDT:PL;TI6EQ;-(0-JY^
MCMAH"!M.ENK]R)9?0]B0KE3OQR8-86.\4KT?FS2$C;.>)39R&5[D];Y!]>3\
M[7-CS$PMO5R&]"0I[$,JY"&F-P/B8+/C'";N7,\<$H\^]B:O3'ZY-5W=<O#E
M_#!G'D)IPF,D4Q[)0P1K/49N"&-CD$O/=.0PCQJ=H>.#:,LSF^0L=B0L4K+D
ME*:P(:1GBK7UNN>C=L;-IV!EP#7*WA;VBMX-1Y8SIO0%W#]&['WL&MT7\(4-
MTB0&_E>BFQ;,_ ;H/D]65%/8((A(="_"'J2FL#$)<9A$"#P)&ZT0B:/V9%LU
MA8T/B,,D^P*]L/[X$\.-U-[XR8+% =@Q #/BENWX=3Q: /]W8N,Y ?B?^^&(
M.6]!?"0_:!#6"1<>#9G:5<)ZWHG0P".67WP3AK3[[DLHN:C+A98%NG'Z6GXX
M0UB_.U<HR9)+6L)ZW:F$U0^B#TR;LO'L@[GABY:PWK?@2,B4$X3UPY,+I^^4
MN'3@6',:&][X06R_1T+3EP^3'W.J):S7G3^\9,HOPGG9V,SO&<\4"R"/?_XP
M;7/H#_-#[,)YSW% )1_Y JJP?O&+WW5YA8!W]P8_EE7JP@/[!GFU6"FG!?FE
M^7$%1K#C,YVZP9\#2@P^'\-\:W^&'QP39JO>:]2;]4:-=JM5S5"[C6Y%I5JC
M2[M$)97N/X)#8:=ON=[8 IP,3;LXH&9_X%W5JB/O^MTTO,&56B[_>V'N.9Q/
MD5AFW[[2*?8\@MONB-CMSUUV">,&OP?#+WUDZ>5K?L6T$<U7E?K("T>+7M =
MRV%7?RGS?ZY[ (YBCPQ-:WSUGQUF$NL_+UQBNT47P-8+;KOFO^B5BBO@?[X'
M2VK VQ:83=$2U4H+UO7SX?[U[E9Y>>V\WKTH+W<W/Y_O7^_AU\[#K7+W/S=_
M=!Z^W2DWCS]^W+^\W#\^S*\N 5!V7$9KTRKJ&JSB[\0%B[#O.?:%<ENZ*2E:
MN59MI9YK' )GZ8.P/I!(U_$\9WA5+I6;,+D]K7LS^K0:+/SKX_./__B+6B]?
M?P9^L!W[P1_"2+H2LLTS[:%H4@N*35#L&-2\NG5T?QA*@0+GF!X\T%;+Q;]Q
MKIJ.LAH4.8#@1LKA /R$^RZ51YO^)AQE:USNI$;KWWS"8)+6.$C9%Y2>PX;$
M [GXX5WUS ]J%#WF3S /WLA__*75J-:N%Y$?T-7??G:>7^^>O_^O\GSW]/C\
MJCS]?'[YV7EX55X?45Z\@E!0U(KR^*RHM4_&;\KC5^7UC[M943(1(YV;5[P-
M"JZ:D$0JQZ0/A/]7ARG>@"I_1E!5 OVD4!#8QK:L]\3'N N23_,8,N!*<0A#
M#/"UHD'&Q3$EK$CM"&/@I_S ^G"EHEXHJ$\3<ZU@L'587F:ZA7!E\#43&S2N
M9L,>L=P)'U9#/JRNX,/7Y\[#RSWGMK-F1&\"V(@3>\P9*O^ ?Q3/X?\54Y+?
M.,.AZ:)=KO1,BRJVC\9T6@ERQVWLKS#  W\_(I\:N@YJL:K6M.9.6MP<]A67
MZ;\7,*!01/%2KE34?_35TC]'_8)"+"#A;W?%/[Z__G'S_(\7,-T-PHQ_/'_[
M4H05CI[8R J>#+\1PJ!9&WU<SY-4#<#V1IEGZL0*9\$G%-P.K6_X_.BC<'DX
M9*K:)FR6TTF$ &//M,_[Q=O> ]R)L 8.(W#C'W<=A&;G^4YYO;OYX^'Q^^,W
M9-?[AYO2SA99QK1=C87&I[L/HGM\T8K34]ADL0IQ%7=$=?1?#<6T%=-S%7W
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M0]/S@$2I!83''!N%KC56<(?\6.%GG!*=!ZQNB4<4+,589+[I&*,9?_79MV@
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M;&2S*:Q1+:F-;&K#5*U4KZT/OL7:R*T\[0I[Y>0!#'^#\M3VW&U\@&PW=\1
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ME%C>0 &HN5P@C$!/P91#^@!U//LG#&*"? 0$Q)#Z]=P"!B9 ?03Z->C^U7?
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M.Z] .E\FE)-6&FE\+U^YG%5=\''TL&2#DV:##7HX"S;@FQQK.6"#D\V(1#T
ME!$9X\Y_F0S9JI'&4P"]+6N/-0V;)J@UF0@1!N\)6V?LB/<*XKT<LP]"R"2(
M;):QR_YRRR1=TS(]V34CK9"-VTG\/83F>%O6JZ+ID5U+-9E>V;?(W0L5U'BV
MI9I55\J\F9D"9:&C?9IXK BU75XZSW?==*E->^9.J>@3ME,VB,Z[X<ARQI0^
M4[Y-X?M4!VW+,3PM7=F=8Z2I>B"YF3T)\!1U31.E#\O)FH[+S3>D#;E334X&
MM-_DM-\4Q6"0B$]4E9,!XEL<\;N':$2MR\E%:<Y-1G(P+3#$X)6]E['LSB:5
M,N^B4#^]+'M&R31)GMN+\@S(4T7RK-56MQ$_9_+,O XD%Z4@WQV[OZD2)(V-
ME3.NW;OEC?#%-/$M[7K;UT57M$*[?M&H-?:=*CZDG#]7BMDDY[.AF$JAW;BH
M5O=[:,JQ1._I!'X?9C8=R>!OEI+W"8^0Y_UHN!/\Y+@>HY[)^+&@MP!7FQI?
M @!C QQWQK[:@>VJA78-V$X&B(4ADPWB]CAD@GU1LPBDR2#RH;:\GW ,,>V6
M]UD6H'%M?RN8)JO)X@)A,)QV8_MF##= @(FR.?>,S<?XW>MQ 6)I.FZ?+MM!
MT?.,6;.Z\X9F:0\>*6.V ^YYTJS1RGNSM[P$.-?M9\^H="!GL:I#ILS2<D<5
M-X%5+]3Z<MLOT;,1,HAZ?,),GBQ+39@J)\QJ93G8+@E3C-*+O9 F'^;*!&UA
MZHEV-@R'IH=!(I?':I$\80G4UM?IF*P 548PI1;E'ZYY99O6[P6/^72YPGRR
MH(YMW,PN9\H;&GQSF2L$6F4KBU565J[R/&VH9VI0.L2M7NAF(L"98\%C?>RP
M2QEU=SL2[>R4UP:K:@KNASEHWX? QC[]WOB&,#:&JYTA[L6+4V154&1J_DYT
MD>;5\2ET@WF5%87B!J2F= "$M[,$BGBB G?P4X[^ZT(9$::\$<NGRE_7D?<3
M92\#PNA:,K]_^!IG+3CV"W[KB;!']N+A)I+_Q@].APS)NCPEZ_IZ9ELUF^9^
M9M,HM %-<7I@X8(RHDQQ<9@+9>7\^7UWAZGS>;H=WQLX#-!N)///9M;37 /=
M^-FE0//.L^-!/Z#[Z/\)P!Y,6B&3C^X?_/>NZZ=?7*U<:%=KS0NU4KW0ZLO)
MZV@E)A]=(:[B])0?A.D#I:)>*%I9JUVG75IJW&VY-!67UKC0JO6+5F.966*7
M=DMU.NP"TX2KJ^Z>;<F9I7& W>\3]')!%V-%U, IS:J'A!!&Y[F2PL8M\)M)
MH9(34CCCANNOC!+79^/(A"-8^.AZJ77>)L40?8<33$@[X4 I54,UM<&Q21]G
M-S?PH+06&!RQFSI6&1HQ>IG',+/49SFKIOF4H<Z*P>Y*@06N@K8LL7Z3-5*'
MQ^H&]9,&JPTQL'JZ??M@?@A28BDC8AI%TU9T,L+<C>S@EZZ#WP203P#'>_LF
M@&+:G&FMB?N3:JV=]R?),J=#M?#+"/$MCGA9R+YOU#]3C^!6!(429N^Z2?,4
MZ7UC3BV WUT(OKG3JWNF;J8N[ZN7L7UE4Q7EK!I) YNS5IG3@(HTH.U^AM]A
M##ZA6ICFQM:<4DG4C\H9CA@=X,:Q-QKM+/ID.:[[V\X'#.?,(MG-;79ATO!;
M3'OA".*\&OMF%M[!'I7O .P'ZCWV7LE':J;EIPZKK>7]2<D=-&FG[L_M/A)5
M\%.(*PT!J$*$(K-C'3Q'>>6(0CR/F5W?XS5GGJ-\NU/^H,3R!C>$;=>E_UPK
M>38=YX+1K(%C 5#<H&HG->-4L:N0VI3ETK+0+/MC5G8GSUJAW;RH5O-WRJ#(
M56;"6^T/6=8IY\S\RE ]_#!MAP'7186=<0R&*2RYOU48C&Z0J$DPBBVNEZMR
M\Q71/1UC6)J[^S1WP7.T? 3#D\-P],Z,Y_'JQ)>WI[9!FF@B:V5I(DL3^0 F
M\D%(NL7-ZGI5DG3VFS?"VKSY>9V$1IOIPW"AL,W;"B]X75J\'CP,,(4XN37;
M$]1WA4C.Y6GRGA8=V]@] -$H\[/7:\W\12"REDJ9GK\LN5QR>28-0K+A<I5S
M>3GF2$7)Y4FLI4MNGD:EYC/[%6;&T2G:!2'%M3]WV65[OD)]PS:'ZU5C[1TM
M9;2 !E0A.A8/$!NW18/1XV$U/H/+-C=Y^HP7M#(/Z_.] 74I$K5!;9?R!B,<
M[+P0H6?:Q-9A1C!SN,#[6924A,!8!XE44-UAH! RM2H,,7)<7HMXQ?"0-O.-
M7K^;AC>X4LL(MMFW(FQ.7R%= (KOK7[ED'303,2>]85=%3,_<=XH4,Q6O=>H
M-^N-&NU6JYJA=AO=BDJU1I=VB4HJW7_P(US#MP8LFO>(]&FQRRCY520]6-85
ML=[)V$4FFP4)P&,6_FE MQI0O5[6@/I,#O"9@!9 L#N,-UX/"IJ4 4,U\I<$
MB"BW6C55K6LMM0PH>?U\27(Y<>Z&@=C!EC@H3?*ZCD#Y+?_$]2BK;J;]&<?!
M&U164,HPD6-<G0)4+3)RZ57TRW5456?:'$S\I>MY/JR-EE0I_UYP.V3F5JO4
MK*O(0V$4(OQPR.HE8/7+Y>M:L]0L:[&WRB4U]OJJH6JE:J4N1]HX4KU4;S8S
M&DFM;,1=LG+/1-]302%HV0"A5:HVXN]L X3UX(P-S6GJ!!S;!M*X##B$)]2H
M\BXHD5EX,VL6ODR,02[*!\3N8\\"6PF<&N733YOXA@F/_K8@PE:W<$M6#CS?
MLBWSQS8$5-<.6\\"MUF8D]4:_AM#"LH#P;.WMJ4(55OHB[,!M^<!D/E]YHG)
M/5M"SA/S9$P$^T$Y'RVN2V<\$7RZMQ7XB 5VI7NAT ^=CKQIFR.%\,YD;G)A
M&!\'"1=URMP4M">0<-H$IZ#7G823I*>CT-,:4 1+2),(WN_"TF_AS^,RD^_;
MW=9H$!\&V>^@RR,4[N)WMJ1NJ)S'M:\L9\RVNK->+9=)SKJ<Q@/L"[&(K4]Z
M->VA,5-B".:RC"Z^+9=:3MQA;KZ7Y'*Z5^/M(G.7Z]V"?3(MVLB$^/)6EY%Z
MT7GBM)C2BTULEE7%ZC)7QK9_E#PIE4,2Y:"F[O\6U[.Q9WY0H_@ORIPX N4)
M2K!OM6M)IE)UG(?J2-4-8ID+5[2#V)\2J673O%$RBF24/=I8FHB[@AKU5>T
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MA,\BB,1@KKWWB'Z@'L*=;P$QJ/%E_!- ?V_',%D<3^$FK=JR>9GK5K<QM'
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MB/5.QBZ2ZBQ( !ZS\$\#NM6 ZO6R!M1G<H#/!+0 (L]A/ 08\+8R8"@._Y(
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M+\>@6)P=M)U$1Q<KL(SNPL.56)=!B>49 +@ESRP@]RZ:7N&-@'S8\Y0W^5"
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MH.Y56:16HRV<3]T51'3<#K;LZ*GVOT.<>/?]M]G^F^%L(G?_56RYM.*U<-A
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MM;A?2HK 6> Z6.7*FO^SIYQF7NZX S9.P\)*[!>TSS1E8;V#,+N_X_VT^-Y
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MZZA>U:DU!^< 96_P5ZY^\G^BC$U]85O1/Q%IMF!49@+L1XUL=%T_40BJT=D
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MY</UU<U3E7S[8_0PNGVZOGZLDM'M%;E[^OWZ@5S>_?AQ\_3C^O;IL0BG$5/
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MVS  MPMT)#B=356T1QEI<_F!U!\D;G.#NIOU>OL"P-ZJ(I/PI%1R.5<UI4J
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M<J7DRO/@RI1F9[&M3ASC7FWU]FG$D <CG?'XJKO8RY8QQ50#O-Q?**:ISN!
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M0:G%4>HNJZ';C@Q:G#U!5B?IX/C5Z+E4H->)97.(,XY*:FC6[5Q<]1K=PSO
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MFZL$JFISE4!5;:X2J*K-50)5M;E*H*HV5PE4U>8J@:K:7"5059NK!*IJ<Y5
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M WF]SXA;@O7VV3FB <QIKCESJ6_Q_!'58.!C%9FF^UX*M7 CB8*2QU!,  6
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MC<Z9^TA#K  >^MQY"6Y">6'>#,S%QEVF!31#<Q.H[S]52RA4=LJ_07GJ5'_
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M#CJ.: [Z^./[]Z\WWV[NGB9?I<^W=Y.[ZUOX[?;N\_W#M\G3[?U=UF:AR+J
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MK%UV)@?-^PS\\=S^:]LP8FK QGTQ;+Y*>$T0?NGQ.HB<P5:OJ>2G/I3U2;?
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M4K#YC[!P4TI,![!98F7C_L553QBS%<!M@L3<![>#JN#V7.W6PV:OG+4!<>@
MD@36&/)DZ^,;$^>.YT-';23@&:.=![<8%4;C^93]]T7/O;S*_A-8$^.HHX/[
M&0G3\UB5_SO1VVEAJ>VH$IV[#TR[/??B?\#>Y>$- ,0H;S'*.[\& /O/\^ZT
MJ$QX%.$85[U,^.CSO 5_"_XNIP? (?R-#9T;PW$XO5/P]^%M &+J7]N=\67[
M(OYK7HP:5:/:V7'7H!UY%WS<N3B@_T#AN!_]C8Y\I>AC:R>WATE \UXP4'8F
M#2E..]BF](#9"Y*E2W>ZQ:1VIR']UU]&G4[K(X\$8\':;>"A&%G\+"N&] ]9
MM9GTC<FFS3/(3+JO_1$925K8!AEUBL;9"L#=W++D0HT><FS]4 [H.^\EMS"5
M$E--IV)U;8#0,. M /8U0-G!QIRM0'*]N=?"/SJ %['RJEA+R61KF1>M2_*S
MP3A,^5=?;N!JK*??+(%,A&@<P?<ZQ$45!V_W/=7^SG:#&#9H*J9%X#D,Q@U0
M'5&,U""BQZPX@\T87 !RR]P;]O60*CV?M(/I@KN OU+,&5-566.Z;7J"9J:;
M",&9FSEJ\7OFS$%#X.D<S@ 8^%:;FUXW=Y!-IJ7/?BYU%6[;'_*.%J@XY/N;
M5)\+]'V^"#XN(W,@<M*@,1$_137T.2HVPZ8K8O/QQ_?O7_]7NOYS<GLG?;Z]
MF]Q=WTC?'^Z_/$R^/3:ET%;B]YFJM0<_S;#7:U5AAG.2^]W0GPUY]1W,M]D;
M_QEN[=%I=:-[>)1&]T]@I%SK*WC=&S ^6HW*&D@3]:;THJNV9LG&FV3BWH#P
MEYBGO'#R.]9\AT"J2P6T(_R)$B3P%$QO-AVHF&0.Z>NU;E@VL02*%^ <_!S,
M&E"U?S)9M9;7LL&" A^OLY:*,></1OZQZ%E@&#.06N8,RU* %8 9P:9>\N^\
MMY(*6;+-1S2E?S*)O8 E!5M-V!R\GFEH:]%C;)/ZZ\C\>9?XO#=NU*W87$%0
MT;8L"_OPV&#?&3*!Y(WO9:[##TVW\&7 SO1(3;;@Z0V)_0*9PN#=P/(K\!NL
MA@0&G:6L$(SPSHC'D=QV'^G"WPI@E(0(_N*DH3,@8'T%A#QE&ELH8(;>+NA[
M6 ^Z44!")B"/)!M!;?-]SJIA6:\NCAC (N;A#><J/@SU+>J! "Q_8(C/ET'J
MCXT9%\H6MQKRNL:XYTM@].@JCE0:N"^JCD)R0*2 !:ZB-4I06QCZ2MHI3SKC
MWK;C'"-4^'N>B#:^PY/T^88?C8E9'^:V,9?? J*F=W'5;6U[?(B"A$7UBUQ4
M'X\1PJN"BTRT"]=@D1#]:YS]0*,8ZEM0L 1T9H0&#/JV.^5\N5+WEKN(W
M4DI(J^NT!HFI=YW6D ;:HN3P;+C-5#N4Z5PZH&(VX?7P&\47R!AYM. ?;GP
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M!'1GZXYK3(]P7THV*DB-J=MY<@I/)XLU> W>#1+'A$7S!\CS?]DF[I_D#Y-
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MFH*HP7D]-+K&4E;4A(W^=;K:@[6AP27&3V;AM#,4GR# L#F^QIYUBP\YLPQ
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M\)D9;/^)^=\)-MM-M-E?KBWSXO-@<!LI<?@*9^_9=.N>Q0+M%MIA&\T-@E*
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ME;L,-E,G&*A#!+F\$>6$NIIN^)^"/?#5N*6%PG]*T9U)KBV7DFZ-B,T.PH=
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MH B[^HI9'MCEFSK(B]D(7W>F.^0/#W0@:H,*=,<:NV(WUD^6/2=*X^(/-LO
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M EN2A9W3Q-ZFNNVX:^W4VC5QYSF]+8'*=&-2@L--R -;G >VE'XB'MB,\L"
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MT",S2#_G%<KZ(NAN'*DN]B.[6%4-RCQFIJ\GIE_.=#HEPQ]T[+%[>(,3M+$
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M$'AH*]1PV:@O[Q()FQ*E87&Y][#8:B0.89($#=+YO>V^O-7H,LU>&@!?*@4
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MB_E2PY-;J(-3 AT(0[Z XB3Z'%<!:EVF-1FMX*ZQM+A!0!,I>G-+P:A$6Y+
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MNJ\>1\_P&MH>DL_ Z*81O'%7;ET/9ME9^@-.4A7204>#S 8(QI.0-H5!D-&
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M+1^"?TR,-6)?CP!;C0#M2$+.DB2WU,1220JU&XE58)2SFLC4="5Z1]0:09M
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M 2%X[B$Z[233Q3C>O#[^<;*&4'K]K!#[=OA%6U8V[^![8Z=1&62)%R#)3]I
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M1_\X>/GF\/U5:L%: ?Q.6?,;_-YVF?';;J+1N\C;+J,CX]IRJP0-47+M1:'
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M\)9+YK73EH> 3-1:9NF]*,S8UCF4V]#W?).>7H?QK(L_\5$I*;LL)*#/B30
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MD79)S#MMKU' MVN_4D7&C(B<S)</EM-SK#Y8-P;B-'P>Z9"80(,0;&'UK<B
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M.6<:57%==1S_YWCQ\=7E?#$]O]KW UKO=O!H;0.U_M&S7$ 654CW*3JA*.G
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M60)KCT$U-Z]NG;ZX8_>ZJ*@5278;Z0]%A@*$DAVP0DZ-J=5C>K/^$=NN/+C
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MSJG6+P)][VEPL<]^4#LH:+3Q/9:ZB YT?N.8ZK@ ;0LZI(N7LK>@ZG!:AUF
ML:8DCCD(D3=R)>Y?8W!QS[:X:7G"3=L%+ 7LDIY*2/$I8C89C,,ZQDP1(2P&
M8)YYRYD-1K5^3[F#C,'%-/O2?;LQH!D27E[.29Q57_0\DK-13^7] B\.$JGC
M>2>YEHIYE>AW-.F^-4,2;N?DEEPN_=TJ^JJG0S1J!:D;_B%Y!')7"Q0EHDA"
M!WN[-FAG!#4D?W ATWZ0]UP,W]#]O/J\_A')Z?W;G_X?4$L#!!0    ( $8S
MGEID<ZH(_VH  +_+!  5    9V5H8RTR,#(U,#,S,5]D968N>&UL[+W9<EM)
MDBWZWE^1M\[K]<J8A[+N/D9)5#;-E)2NI*PZYPGF,4GH @$5 "JE_OKK 8 B
M18(DAM@ ",FL.IN3L%>XKQWA'C[]^__^<C'XY7,>3_JCX7_\A?^5_>67/(RC
MU!]^^(^__/'^);B__.___+=_^_?_!^#_/'O[ZI<7HWAYD8?37YZ/,TYS^N7/
M_O3C+]./^9=_C,;_['_&7]X,<%I&XPN _YS]L^>C3U_'_0\?I[\()O35GUW]
M=ORWQ-"A,QE280F441%\*0Z4LAE-$3QF_'\__ U3=D;D"%(& 2HXA!"<!FY-
M9 :-DV7^H8/^\)]_J_\).,F_T/*&D]FW__&7C]/II[_]^NN??_[YUR]A//CK
M:/SA5\&8_/7JK_^R^/,O=_[^3SG[:^Z]_W7VVV]_.NDO^T/Z6/[K__G]U;OX
M,5\@](>3*0[C]0/H\6GZ[1_>1*-_G?^2_G32_]MD]N]?C2).9PIZ= F_W/L7
M]3NX^C.H/P(N0/*_?IFDO_SGO_WRRUQR.([CT2"_S>67Q9=_O#V[B[0_G/Z:
M^A>_+O[F5QP,"/'L$Z9?/^7_^,ND?_%ID*]^]G&<R[WHKY9<0>D*YW_53_MU
M:TP?"<@X7@:B5I\X6RG>$..R3]\>\[?/@I0+7@ZF#1'?_>RF>$<7V&\IX#L?
MW0#M[(/@(E^$/&X)];O/O8'S"N1MA/4C/^2/&0?3CQ''^:]Q=/'K#.+ST3#1
MLG.B+R:C03_57?;=E/Y;M]W)J)S1]GR1_QCB9>K3KQY?!3TG0MU[F9R_[?]K
M[6?<6!%1IS_LU]WH%7V[>%!%WOG:\I=IIG\_WZRNX Q&\;L_&M2M<O1-MP,,
M>3#[:>]R A\0/_6^/8_PYS/Z<M++A=L2:3<TW$90TB1PMB3P7&FM+%<Q^;O,
MF%PQK> DS+BQ> 1Q1*A?\V ZN?I)%;^:B?Y^%',A-UC7>PR#W$L90U J@4Z*
M@[*" Q;/:'6.,9>\R-C9FF8(OE_/-6U.QE<K6[R5:QTN93RZ:*K/Z:B9&.>:
M(M!_^64T3GE,]A3]:K95_"T.1L3[__C+='R9KW\X&DZ)U:>#V0/I[<T?ZA>;
M,F$RGO;>C$?I,DY?C]_E\>=^S"=?^I->E"3^X (XY(&@%T^BB &,9K:X)(VR
M9A4NT -N\("^N^; ?<]NR(('CO,'6+&!&D<-Q;F,$]NK=W(R3 M$DQ>SLV<E
M4+U;-L7VNKX+I*'"[[6%KM7=1D=W%=Y(P#O3?B ")Y\EV?,J@W+20S#90[*%
MY\Q"]B4^/:U_9U'N1>GKR+6ALJ]VL06PWV=V9<]X'>K!!M8(":I(!6AM!BN]
M$5$QHTQI?*1_!Z"EDI<9XDLUO*U21JTD>E>];&N3;;ZN!9@H4LG<D\&B.8**
MP@&JY,"9E)U-6OBH6EML-P$<@WHWEV@';^_;_#D/+_-+6C<Y/-,QQND_^M./
MSR\G4_)RQJ=?XN"R7K2=3":9_I?>XY>>#8$99LAT#961 1F9KC$!_5AFZ84H
MP38FP08P=T>5CJS\KE73P6;Q?#29OBX+X#WO"D_*>RC&D1GKB-\8I8&,TAEG
M9!3!->;)=P">/ ,V%V<'.\5OX]%D0CMBZ4][!1-W-A?@)AJB6: S2;D,PG-I
M0C*>F95,N34T>^/Q3UZOFXKRKE;%]L?[@'[UX;<\S&,<T$%WDBY(G!/:;J;]
MS_GTRZ=Z&=;S6C$1+9UR2A!*4XT0R:NKZ@LJ&41(K;?\U9 ]>2YTH("[-)';
MFPF33!_XD?"]H.UH,/I4)7 %SG+M0DH<LI0:% 8#3I%=I(WUG <;95QR:[VE
M0?  H"=/BG;BOLL%M2T77G_*E9O##PL\$P(DE%42@7'G@-96(#ACR&-Q/HIZ
MJ1]6NKM;0_]W0#QYG6\GUKMZULWT/(]XO*(SJZ<TF9/1&>#1%E ^6G)&)=F7
MR:-71:/SO"M-7\,X'EUO*-J[VC;;:OML.,WC/)G.MISP;:]QSEKK= (Z8@A5
M]AP"9P8"^;^*,49^;NNM?3F2)Z_S!@*^JW:[K=K/\_1-'O='J1]?5)GF](PL
M$3),)PN U?L83W#PNBQ^\,WO7-QC5"?E^>CBTVA(HNK)4*P20@"C11&+"P,R
M<#TX;U1R3)0L6_M\C9?PY(FV3Y7>9:C;^AB:?LSC\]%P]/V>>?7^L%A,1,6!
M'"D)BDL)CE!!=EDP'KDRN;4K^C"B)\^?A@*_2P>__3EU=6)>78SUAY<$<G&D
MCH:39[F,QGG^=^_Q2R;:DS-%S^\/<?QU)A]:78UKDY 'L_7-=^9>8"'X[ /Y
MXH:6E@V17"<!4N5@8K!!Y];!BPZ7\^2)>"BJ7G*9MO5-Z3?,B]=JL47WM/5%
M**& 6W+V51(,G,,(02>M152ZY-;GYSU0CH0^VXEXB>I;!$P)QLSFCRP'H5V&
MY#"#"M*!]\K226LM\\(9)UJ'TZZ?_N05O*$@E^ATZVM4LKFN=ZN3Z73<#Y?3
MFM7S?G3/!F22" 65ATAF%3GWWH#/.4 T6@:+4A33^D9U;9!/GB'=JF4)D;:^
M:/T.<4\%F\B<4A!55H2&W$07:-/"E%"RJ.G7LDN2'!<!UA+G$N5N?7-ZBN,A
MD6U"[MF[CS@F1XPH&/N#_LR:.0F369"W)T6.(A=%)G4P9)L(0FA8A%B\1"YX
M$K'U)=MJR)X\'3I0P!*>;'WS>AOF,YST8R]H9$YK"R'&NG!!:W:!3%:A)'IT
MR=C0,2UF0';/@B[4]@@SUA=Y!R'WVZ!>] >7TYQZBF'1)N>:'TP+%8H!2JPY
M 4P:YJ3V6G?,A 64'X(+FXB]@U#]/W*M4,SIY#.YOQ_R^645U.LR@SAY?3FM
MY7OU$F\!]T5_4A/Z+\?S??.;9#@7DO&:9I8S!^5)*#[3_JE1%B,$,K)^&I.G
M#?(G?_KL08%+-J6M(T6K+F.^A3*7T:2DP-I !G4JG&RN;,'QF+,NPBK>VH1=
M"^#N6;4/&FS(Q/55V,$I> _8A7CN8.Z%R)0W(4'T-A%<'L![*\C*I__:++DJ
MK>VD-2'^Y%QC-=Y[VO[[K[=$3#OY/SLM?7W^$8<?\J0_//W797_ZM=L:V'L?
MMJMBV-56VUU5;(J9V\SK^4O._/P:7V !(X(PABST[%M'_SJOBE4LJ))K>A=Q
M@4P,SL"'Y$ XSHH4DO;BUN[_P53%KJ//1ZIBUQ'COJMB[RQA_CI]B\%/9J5C
MQ4BM?-"URH3.87(_ 3'2CEATC-Y9B[IY\<U#@ ZD;G8M1=_'F:T%WH7[_SVF
M1>G1*J#6*:)=YQ)@&:#=%M-VH+C;WG\SJ>^,$CHZY:,JX(RR9)8E!#+-- BE
MI*A9.T*W#AKOD KW5-CNBPGK"+L#!A"<B]'PW704_[FH('0A.B?("L]&,U#"
M&G")(_"4O>882^&M(XEW0.SA'G![Y=RIMMI&LAU4T[T?9R0?[.L,TAS= EBV
MT?EH ME%Y!$I-.21:X_ K&=::J95;'V'=R^88U!]&TEW\+:?I#03)@[>8#^=
M#9_CI_X4!U?@"H^^B PF)@/*H0./Q%0G1."!MC?E6\<!'@1T#%1H)_$.0@!O
M\Q1K0N]5A&*!BLG(%-<>2BF>]JE:/LY-!,M*R(;<J9):.P;+D1P# 1K(N(,"
MO),8+R\N!_7^99:?6U<\SA^KC?1YD0"Y "K0%.>=!VDB!V5B :]- ND,4\Y+
MZT7KZ\^5P1T#/[K11 =U>LLSG!;8.//,2*N SC$R;2+J:MH80"]KV;$@"36O
MTW@ SS$0HYF\.ZCE(UY6$R>_R//_?S:W<S^.!O3YD[DLWA+PEZ/QGSA.M8\$
M04H:,J^A[H0D!^06D@E!H7;6Y=85G6M"/(AH\#;7E5VJI)/6'M^\HWFLYFPR
MN<RIA]&AS=% J8>CTO25JSSG6",907!16M=,W -E]XSH5(7W>Z<;R[\#!^7N
M@DDH\V*R-Z/Q3/RKI-TZYPI:S\$:56O,!-G51AM@421A:LBY>5UQ&^3'3;H]
M:+<#KVF)=S]_A7IDM0N#*4$JF8Y[KB0X)Q1(+^B\U]YB8=W?H\S!'#>3VNB@
M \=J!FB^E[ZX'%=BSVIGY^"N4D%K /RB%A'-D@Q[P6OA;2T>"_0?%3,"YH 0
M.$I7Q9!EZS-O YC'3:BN]=:!0W8/Y+_CX#+?@UC2 1Y#L,!2KA,ER(5T7"LH
M14AC7&3,M+;#UT?Y0Q*ME=8Z</:^+WKAP1#OZ;0UO)"/(@21WF0-9#AJ)YWD
M.;7>K/9<0[1+=FPNZPYZN+SH?^ZG/$R37BPF&8$!$K)Z6UE;!R4E0%N."4O2
M08O&2O_V\.-6^&8R[J!SRWV7CY6(Q,K7Y3U^66JDOZ$]:SCM,<4$4Y9#-;/(
M*#<<?& !=(@QH(S$Y=9!@RTA'S>Q=JG/#MJT_-X?CL8S!W'N],U/R=L"[&F)
MJ R=A2;8.MH@6@@6+7 T)?"L3$FM^TFMANRXR=6!=CKH[7*2_OMR,IVE%K\?
MW1.(G9E<X;;)]3:3N";]:5YT,)JOK]:&?9BK<6:N]8J.2@LF(3)'YS,GZ\S;
M@I""U<SXG%+!Y@'S;M=TW+P]*$9TT0?FOFO=3"@BTYP@I9K4&GAM!!C F8@E
M9^V\:IW8OM*U^MYNB),CS]V1+ S6ACT&%;%(U&;)2$:U4$7RIW!#W/+V4AF)
M1$\!@26L X,T.%?/_B"MX4[J7%JG_SQR>]F\W.;MZ=]/S_\X?7OZ_/5OYV?O
MSUZ?G^-XWAGY1<W3&$PVJ:M9X5,;%="LB[]1I<RB9?S;7#?T^95%'7=:QWN^
M#H/^A]D.6=LBQ6E.[_L7M:E6>4<_G12,BY4N0IS%.<:#4F!=[4])%@*$(FJ(
M$[/ABOE<6J<:MD/?:#K&YDCF%0I1T\E7B^6"-.0I9D=FE< $+CJ2992JE-:W
M>&V0[ZH2:$]\O6?BQB[5O>_*HWOG5)6BL<Q:')1:Z$[V"#@6"F1?F*N19;O:
MM>$3FL>W#_4_-L=O'37L;)+;*J!^H#E^:^EHI9%NFPAX9]I7-N7(F")CTY!_
M0FY)G5CBP0IC-+<U4;[ASG"H<_S:*WT=N78_QT\D%^OL>FUXJC,FR/_4W(!,
M6,]0]/['F..WEE(>GN.WAD0[G^-7"B:34H+H"J^-K1"\=HY,);0VU#"6:=V5
MY2#G^&VCWLTEVMT<O\UMEW=3'$]?X'2^NP4IF5)<0%*2D5RXA^!9G36&,3&/
M5F/KVY:V*_@!;<@#H$('R7O+1A^^ZF/H#_K3KSTM.7)C)1B#= H+E\#+V92"
MX+/QF279.H'O04"[OXT_$->YG9HZR5U_ %R]M;T<ST*H)1EEM/7 8AUMP)0A
MJM?W/J!Q1N40<^OPT(K0?O*JH>HZJ<I_ .8W4<YB3_^34X\VT>(QD76 IM[7
MNP"80H LZ#UA(1HF6J?GK(?P)]_:*[*3>N MA3:/BO*>42IFCA90V$SV1B2_
MELD,AIE,)D>D11Z<O;? _L-2=2_*OS<#?P^AO]XM5*V"?SV^N_#?[37\# #^
M#  >A@Q_!@!_!@!_!@!_!@!_!@!_!@!_!@!_!@!_!@!_!@!_!@ /-@#X,T[R
M)"YM?L9)?L9)?L9)?L9)CIIO/^,DAW21]S-.\H/%2=[%CSE=#O*H/+SF2=,2
MJK6?VEF,9;OU'UX$1G,5>.$1>/%T9DOEP!7!P&"0TF0K4+0VMXXN I.BCSQP
M!=K5B9VES@,-+(+)P4IA4^7VH<GPJ49@UN%K1Q&8==1]L!&8'*7RM9>GTT'4
M6?09@D$.(F3N@E<LXTJ],GZ\",Q:ZG\L K..&G9V![\*J!\H K.6CE:ZC-]$
MP#O3?A01=463BU.UZ2\"$=Z#]5Q)EY/+;*6<C,/2^KH1F/9*7T>NG4=@"(QP
MGO8OB3*"<DJ#"TD!9UPS%25:UWJ0PT%&8-92RH,1F'4DVGD$)OO,I2X,!+=D
M)3EG ",G;S)E6PIC4N?6%NE!1F"V4>_F$MU7"5:O2-0V.*1=BCM0/ KPQ@<@
MW%%@"2FXUDU;5@+VI*^'.O<XUE+;O5M'\[N?=Z>__7YZ_O[L_.7KM[^?W+[[
MF*UK$KZ^F_LG6]SV;/2<1O<[VZ^QU?CI^2/>YD^U^5-M\#3CR?=,#*(XG:0$
MHTRBW8S(XKVF(X8'YTHQ F7K_H:KX-KZZ%J(G%[ ^Y_V[$H+<R>,LYRY"!**
MK\/BK<N -ABPBBDG-4;OFL_F7A_FSH9=MV;/G;.P8Q4=PC7)]1AZ6LM,9#-'
M )U-124!Q94ZIS-H"-EHL#D$)TS.1:XT ?41=VCYT_<V!;MK?8^:RKVQ;WP7
MT<*<7 53PXN1^W#L_EZDA8X>5/D6 MZ5\H-CPF.*4 J2+V%U(6R,7 NAM%8V
MHNEH(]C3M<BN=+Z.7#OPK%[3MHAU9UML9E<S.7/(F<Y+!BS5::S)"0A*DU%N
M%7=)")=2:Q?Z'BB[=:;;Z.EV__$&0NXD)VU,QQI.\_EHN$!V-5[3BV@T1SK,
M9$VX-#4!NW PUB0;,SEEO'U.XSU@CD#_;03=R8BYQ=S%9Y<3LI0GDRN"SO<Z
M7F3./D',]?J(2PN890864:.6F432?D+. X".W1QLKY4.\KVN;@,6%LL*8-8Q
M"=?WS?=A$W:@J#NWK]M*N8O=XCM0DB?/H[<@8Z3#RTH$;[@'H4QQQA530OLR
MA\Y5?H]%N&N-KR/<AIJNUY.]LPO\<&VK7,UH9RQ'0:LR"0LHSP0@$Q8LF;R.
MD=62TRWS_^Y5Y[V?OH>!PYM+>]125 VMNAF@D[^_NP6&#AKCG(0DT(-BFLXA
MYNK8D>1T1E74[7F*]^CM]B<_69UM):+6[]J;Y[? J,2]D-&!K7$0%3"2W: E
M&,EM48R,PZQ6TM?M3WZR^MI*1 T-H#F8%U]ND2=93U9[ LM\!!6+!(P$QA5)
M%GUQ/%N]FKYN??+3U=<V(NIB"NUEF-P\I+520:+G$%4D.+H.EH]8>S":8I4,
M3L3F8:3O(?PP?LP6DN^6" N.KP*H*^_E-I@]>3#;J.A^=6\AWR[\ECO @K'&
MF\+ \4)'B,P)@J;#1&M3>-(Y,-8\?KH;A3_FOW2J[W7$VMR2&H\B[6YC'/QV
MV4\UQ>0:W^(@DB9%Y(+<LZC(,(_,D*$7-3#O5;;2\'B[,/^^L_K19^WA]-Y.
M&Z/N1-G:QWGW*<<^#FKQXQ^#Z1@GH\MANH-0: (BD@"IZ,Q2A6OPC,Y)B;8$
MSWUT/JZD[)4>]Z3UW5Z@K5_NWT<DSE&=$/YN-+B<%9C=P:>4UR7P !JM!:6L
M >^-@FS(XE0A*HVK>;HK/.Q)J[NU,%O[6*_ZA3:<3]4TO1^@T FE#!J,%5@/
M+@Z!.T9?.4WZU#*RU>ZC5GG:DU9W<W%V8)HOD@U?DAR65;^??EG,ACR93#+]
M+[W'+[V4M,\B)BBVSO*LV<C(BB8?)5JBKZ2#J:-LWW5@[LV-[RX;KFME'4:.
M[[O^AV&_]",.IS51>CCI/MUWE4?N(/-W[97O,@E8A.R0>PN"C,Y:B!# $:?H
MB&*N'DO!WS[ECS8).*7H7(PUQ""K#:XUH/41K&4J67+H7&@>GG_B2<#KL*=%
M$O Z*CK@)&!O8C!,>\@A&[(]9+W!30&29('E8H/@*_4*.OHDX+7T_7@2\#IR
MWU4>Z"J8?J0DX+5TM$I"Z"8"WI7R!1KR\C4#HTL=BQX*!(L<6!2%!2.L7RTC
M[*"4OGX2<'.=KR/7'28!*V&4+B$ ^E@[>-;:OYS*[/0DM+770VL+X["3@-?2
MTXI)P.L(N8O*Z0<SFK*)226=(=,1!LJ@AB!# N<M1Q688[EUH?S1I(!N8@RT
MUTKG*:"K@/E14T#74M2#"8&;2+GS%%!MK,Y<.I ")2AT!D*)'DPR5K$@*L*G
MI_*M4D#;:7P=X>XD!339S)S+#@IWOO:$T>"3*("N>)UX,"JN%E$[Q!30M:3]
M: KH.J+J/ 54">ZTB0Y"M@(4YW5F"DN@LXBT8=3?/LT4T(UUMI6(.D\!M0PS
M&0H)&*L&H0T.4&L#UBCO-)<RY=7>LT-+ =U87UN)J/,44*N#U"$099RNR\)4
MYQPD*#HKQ:VT;L7 \Z&E@&ZNKVU$U$%X\?EH,GU]U=&DQXN.J6"$9#PY<:((
M0'1UE5F@K7V12NL$T.\ '&A(<)N[\<T%W$DOL.]7^WKZ,8_K&D\N1I?#:2\3
M@I#1UV$Q-;=!)0BH%6WV(4>FI<VKW69O$4*Z!>D(&=%2"9T,2YC,&J9=!3A[
MN<0H$P800AA0+!*>Q#SD8KF77J+.K4=QWL9PA"S82LSW'MR[S0.8R^CTV=G[
MKL+^=Y^PBRC_(^O:95"?,Q6B)?."YTB;02%^N!PUY(A)*$P:1?-(]H$&]0WG
M+!4? *-4](ZE2&<G9U4>SFIC>$[-JVJ?>%!_'?:T".JOHZ(##NIC2$F%>D>A
MF:US/SCXY"206Y6+Y-8%7(EI1Q_47TO?*W3V6D/N.^OLM0*F'RFHOY:.5NKL
MM8& =Z5\XP)/I!Y(L?;Z+@7K9:4 'H+F3#O%LWMR2M^@LU=KG:\CUQT&]6L\
M6>M$!GS0B6!%#\ZH0.Z7-)R\L>A-ZY$WAQW47TM/*P;UUQ'R3CM[Q5*LT0(A
M5M]+D<\-SD9!P*+1K'!>DFJL_4/O[+6-_ML(>N>=O8+PNB;>@_(U/R'66;K1
M*/ 8E"S.&MX^B_I8TCHV,0?;:Z7SM(Y5P/RH:1UK*>K!(/\F4NX\K2.XZ(2A
MO5#&VL!(H0$T]:LHLQ!.R6":)WT=>%I'0XVO(=R=I'5P@5XS0X9N-F3W^MKA
M0UL!+$8AT848\)8]^(32.M:2]J-I'>N(JO.T#AZP:.\E&*\XJ"PB>*T=.*9E
MX@J5#6PEO1U:6L?&.MM*1-VG=6B7F',*LM8U,RQK"$EP,)@S<UZC=:N]9X>6
MUK&QOK82T0[2.DR210DP4F%M"\?!1>E!:)V%B^0GE*>9UK&YOK814<.TCOD&
M/8RCB_QJ-)E<%2+WAY<UT#SWR,G9>Y;)A,_SOWN/7_+D;#C-XSR9G@S3BQRN
MBEOINUEP^OE'''_(DY[S-8O?>6#%Q+II<$!O%3#+2A;*6B?":N=A1P@/-$Z\
M21CF<#39P27,6P(XOHS3R]IJXRH27HOBIV<7G[ _KB*]@FJES59RLB]3"#5M
MV$.0V4 1F2O)#%/8?H;RRO".B'%=*Z>U&7$2_W79G\RE363O3SZ-YM^]S0-R
M6-*S/"1U3">S)?1"2HBH,_B4/:C@$X0B%#A/>SK+A1<M5K,)UWGL$=&C8YEW
M<&OS&\FK[IVOAS> OBXS*D]X#S5/// ,3-+VIQ(W9/UZ!=8;5I#'F%GKV_Z'
M$1T163I006LKZ=VG/B$IL]&@GW!^G,YI6R1GR98$M%1?D[DL!%HG^.)#(!-1
M,K::F7/O(XY(TPUE>5?#:KL#XJ*N]7]PSCDRC'#XH1\&><Z^V58VSJE7+7OR
M?^L 5U9S<FF#\B:2$,C=L@(Q2>E7.QE6>MZQZ;X#*=\E@FYW%IP-/Y.!,[N_
M[$5%.G3&U;S["BI*.IO(W^-:2"Z5Q] \Y+<4R!%QHIW [[+ ;,N"Y<Y1#U5,
M(9/;[^;WV%H!2DDK9H&Q5))7O+4EL!S)$?*@@<CO$L%N2X3S/'V3Q_U1ZL<7
M5<K7ENL"8"W8&$]P\+HL?O"M=]MB^G<]WIZ/+CZ-AB2^GHG26ID+L-GUG+,"
M?"2/*&-&[4T60;0NG&F\A".DWCZ5?)>S;OO-:^W+H-,OTS'2\_M#''^="?1\
M-*QYM*2GP4SD\Y>SQP/98RZDVL6T;LZ1DZ>6&61/AEKD0F)HG?70X7*.D,N'
MHOR[O/9[J#QYD3^-:V/F^AP<IILF:->=*-=Y] YJ53:6Q"Z+6%)TA=7L &%J
MNQ=3R.K3&B$K(QQMG;4SQ ]2Q.)RRMEG#38$2:(@H6!Q!9(Q4LL@O8^M6_,^
M]2*6==C3HHAE'14=<!%+B&BR51$2R0V4Y+0,2Z>-]-$RKT-T:B6F'7T1RUKZ
M?KR(91VY[VQ"^0J8?J0BEK5TM-*H\@T$O"OE6T.V9>0.K/2$+2I'_,X)F$F2
M<Y:M3RN=O@>E]/6+6)KK?!VY[K"(A1,FGTPF\ST1K$PG)4K'P&<G:U0VZOQC
MC:=?2T\K%K&L(^2==Z9T(KA81[$G6PTF91UX1>M'RW4H->0FFH_P.I82ADV,
M@?9:Z;R$814P/VH)PUJ*>C"A?1,I=U["D%@QDB4&A4E-VZ$1@)E\*NT3.L^-
M4^Y'&T[>3N/K"'<G)0Q"B" U<LB.15 I>?"I6)"L:&F=8>QVP<H3*F%82]J/
MEC"L(ZK.2Q@$2IT1 R#6;D H! 3M#+"L O)LI4NKI<0?6@G#QCK;2D3=#R<W
MJ%/4"4*=]:B(2.!1,Y N<V.MX1;32OHZM!*&C?6UE8@Z+V%PP3+F&(+3JDY*
M9YEL]US;D(<2#5:?<+4A>8=6PK"YOK8140>=*6]&-NCK05XDG=X,<?10%F9#
MC<;*.H,[V0!!> 4B>$\^7A!TEC<V9E;!=: !R&UNTINK8W>S[%Z>G9^</S\[
M_^WMZ?/3L[^?/'MU^NXZ@O:R/\1A))&]S3'W/U<O<(O0X<;/:A0K;+/61L'!
MDQAK1\O)^6B::Q'!JQ$.)]>/OB9FQ)SI$)" )H6:%L;!V9+!26>%KR6*K'54
M;%5L[8*$WSUQ]CAZ[!*-S"\B;#16UHHQ;AB))(I:5ATX"*M<T86E=#LKM6&@
M<"VHNPH6=L*F^P.&W:EKWT'#I0)]8(7/OMY8+7WVW&<N,6"I\DV>O*6(M.!
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MLP6]+K>/BIY#PA>#I?, "RA5ZAA?SB!9YP4RS(6WKB1Y&-$1\*D#T2]AACB
M.7U7=?RCI77\.QK>MQJ(/4STVT ZNQCS)YF7LAA&$N>6=B1-QJ#C 7B1RB2A
M"F^>!7108_Z<$*YD+\DGK+Z^CP%<MK0M&Z;)7E#<1M5X_4]RS-\Z/-EZS-\Z
M2CGT,7]>.R/8O+V?KW:HAI#H*VNB9D6H'/W/,7];J'_%,7_KJ&$O4]M6 ?AS
MS-_:JEQ[?-LF>M@+89C1@@S2 %K6L6,A.,"H:6^63FCM94S85:WMCHFRX9B_
M;GFRCOAWW;7&9)0>HX4B?*Z=5S1@=@@RYL1%(L?%ZL>,[L/J6M.17M9I9[..
M4#ML9[-"!.LD3*9CC-.>]5PJ&PH89@(HXSV@(LO-*I,51B.%8AUM$6O / @6
MM;%TNU;2OKO8%"%3)(,,-&>B;JD>7$P2T#-GG).%\]@Z[^])=+'I3.';-+=9
M1UL'U=SF1BL*GT5PRGKP16G:Q.MPU1(\%&U%*46A#EVUXWJ:'45VQ<2=:W<W
M/6_ND]F->_VS>:9LZ@6M#%HT4+*L/?Q-@6"C ._HQ=+*F_:%3]LA_B%9V95&
M.QAIM5:6DBI&!:$3".Y8;8@LP+E8 P@^<VU+,*9U1[FGD3QV@%Q;3UN[:7>S
M2D#S*F=D:6#S%7U>+1L8#:>DIL&-%HW?Q%NLP2 \@D[T*BG!:I.?VEO496'1
MIJS2@>0@;;G2X_9A#HTJNS%6-X[X7U75S/Z2/B7W/]=_.>GYY%CRFH&-K.:Z
MVP">D7T>=7'(K,^I^2CE7:SK(+;Z@^-HARE/30AVX"_1V? S_?UH_+7'$TNH
M6(",@C:S$CF@, A<%!YEL$ZZ'1@ZVR_DYVNRX]=D,PKMQL_<>%%OQJ-/>3S]
M6LON:N%F];)G TQZBAEAI'6015*@>%;@4&L@5Z9:F8QGZP_X/;EW83_?FQV_
M-VTHUH%__"V%76273>T66E1PU6T+Y$AI!SX$'RUA-*EU['/_90=/B(T;*>IP
MW-X-"RM285J4PH!YP4%)E<'-ZHLTTQBU3 X/VU YV(J;)T3]PZ5<PRZU72QV
MMKCK-A2+O&AFL[%2T[;! H(*A=8FF02CO W,!VW3#D+8;1?U\SW:\7NT/;4Z
M:(2[BQHHGI/'@A!E=7ML,>"UXL $[0U*ER#XSS*XGV]/]^3JH"-NRQ5>;PTW
M?C?;-'HR<:]]HF,5)2DA*)*_P S&6IY8U"2#UO4!NUG9S]=HQZ]1(Y)UT#&X
M@ZOIFQN%83)+;1UH5?MG6Z?(_1,!M%8LYA1"P-8-EKI=T<]79S_QCDU)U4'#
MY"X4<IZG/<ZRP\P-.7"UPI31\>I8$5!TL73,*H'-.WEVM)2?+TEW+TE3&AUT
M;^?:/_UB>#W78>ZYT2LOC17TWKO:OSI&#2%&!L:C#UDF-.E6I&,';1"60CV"
MO) #U.F](;H#J7^_>C]W7O-^^\%[K7-_4 J-:MNOGG%-<4^;;G2%@R?;&122
M+8U>)#*M#5.NAJA$ZRZ-=T"TJV*_^NAY82S3B0Z3VD'5U6Q%QC@@(X^AYO/K
MK%CVN77"\3U0=E63OIU^[R]$WURNAU)O_FZ*T_GPHL76_&[^N9-9[2,K41KI
M#&C$.H,F<W!*U3EVOMBHDR7CN353'@*T_]KS+31^FT7-)-]!"M8"RU4QY I@
M.BHJ_P[(?@K(&RKJ-@6VEG+GJE<ER5@006I64YX\>211.,C!F.)LIO_EIZ?R
M1TK!=Z7Q=83;NOC[[ (_D!^Z +0H3O:2*:.3A^RYFO?L1^T2U*(5M$(KJQXU
M.>_]]-T[,5M(>]125 WK;6> 3O[^[GLPTC@7=+TR$(4<=<,SG4."#J/,/9DR
M6B>W6D._VY_\9'6VE8A:OVMOGM\"PPS+Q1H'(9 7K3*9H"Y&#LE&'J-!YE:<
M*G[[DY^LOK824<-<VSF8%U]N@8F:<X4<& _56ZC+<FQV89RX-<FKVY-![M/7
MK4]^NOK:1D0=YG2^'0T&+T?C/W&<>EQ$SHDIX*,W-<V4WG85-" A8LJ*D&[W
M+VGFP]^ L7L5M_5VMY5L!\TFON6M:<N)P!YID]"$P\@ S@8!DA7&HA .?>M<
M]?UE,6ZMB/NR:]>18@<.Q[<PQ.*V]\7EF*RM-WG<'Z6>"X8'80L(A;1!)<S@
M9#!03,I.1R42:^U_/(3G>+2^M;0[*'#Y=KER/9'^9)C>7([C1YSDDQCK>"A"
M>SV7>]*SR3H5H@)7!/E@Z(C&22>064B=F#""M4Y.VP#F\?"F*]UT6>=!QQP=
M=T9 TL1M58PA7ZWV=#<VE:C(],>N#(&#"BC=&/"+PW0]5'KIR-^=1YTV0K?7
MT-3V\FP4OWI@<O.U$2B=TK$(!;J^^"K7%DY:D^E?BO<N!YU*ZQS$57"UBW(]
M\+3Y=7UQF$74!6*NU_4Y, A&<8BT^V66F)'-LS!71[>K6%ASKMP?'FNJD$.)
MF#VPJ&=??\?_'HV?#W RORHFXRD$3I9UBLG72Z<$7IMZ4^BSS-SF(%O[)VO
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M 52,U[0R16ZDE61_<H[>6F5<ZYYN3R,_O!TWMI!XYU=S?PQQ/D<SIQ?]2:P
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MK3#>6M'K6XL+IIWRQ,E8+D( 7#>3A#-PWDH#,=5.8N\ :["'JB-UN.%DU%5
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MB3&E1.EJ.KW-A8)L:&F32%1*AD@J.=[&"8@ IZ@/5NI0.]^H"Z[^;9KJ"NU
MF*.TT3(O\=ZF>06ST=+[<TX$GRU:;0$MZY)#1SR/%"TY+1"? '0/>[%A;B"=
MKOURF-0;C.:\Z:IQ@_/F%[?3)E?\[0*UD0VS!\SG9,L<J.9)OSIJ>3O= BSU
M;6>7DRL\&%<'+G,B,L8CL5X"D=I[XG4P1%!OP4F%@&N'%KK@>D8631W^5%=&
M \+LP_&4;##.2KP]G2R-6A+*H@3C..<>A $?:C?;'.C\V=.XJ:;?(PZ@?933
MP,AY/9N/+F&>/N0.6*EAAH?HB9$B$LD3&GO"*10,TREDHZ2NG1>W#[[^F=1,
MT0]GXK724HL\7)A.KQ?5*]]1.BDNM]5NN"9#HJ6QO*,FX$:SICQ5"\)=Y%FP
MR&5U-WU/B*?+JY:Z:E ?<F_\T;IN\LODU9W^9"G^WVC^;33^\F>Z^)'>3<;S
M;[/SI W3+DNB0TEYSR&CD\H9R4Q&8U4(PM8>&'(@U"$3?M]6::K0AXYJ1ZQN
M9?#YRO\KA?F7R3N8S5-I.C/'[7$VG<+XZ\+"_#B9XX\CN/B0\RSA7SR;X4]O
M1^!'%Z/Y];D-W#A*$P% _U?ZY E(H0A*C3NT1[D1#QX%=D2XZF%ZN9P:4CFU
M)]>4??$@7+<1.+S_!W=#B,N&>>?>",>-3X2%4BXAE"$>.+HV-NG,0S!>VT[L
MJH'FA?.J=X4TN!#?3L9?OZ3IY:_)W][:YR(KS94*)$EK4214$*< N9Z\H\DQ
M$TVL?-UM!?)R"5)/OCLK%P9M._8Y?$OQZB)-\JW$;M8WZZD763<0 S0H.T Z
M#;N6)>16H@&)1BD0&60LEKXGZ,MQ;1S+@JO*N[F'KF4^):J%SR0D<.A)N$BL
M#K@KDV4L,JD9;]>+;?"N9?OH]*FN9?M(\KET+=M13H)FF;,I6X)B\$1&&THK
MQQ+_DU& YGEC>M^)E]WMI=MN97?[R+C/"JLNN'[FLKN]]-:UU.H0H?=)BHQF
ME8A2$YJU+F];:%[3TI[(A$2E\S'PVOGI+Z'LK@D7]I'U4&5WZ+T;%RA1!LJZ
M/2<6X1'.@C$0<LZQ=L;%RRJ[VTN'AY3=[:& !L&J]Q.TL=<H5Y \J" L4&*B
M0GM*E9I#PRCQT;F0'#KHO';*UA88)\*!8P7<4W^P+CT360;/%"4ZQC)S4'#B
MM#0DE90U3\L@['9=D5]B@]MC3,T>=-3@\>R13JH=@/W=X+:69KLWN#U +;TV
MN+4IB5A""\XB-NF]Q.LQE:%] (+32 %J%\"=1H/;)G391QM-\B!N Z&W.<T9
MK/$"SU6NO2%21L!C%DUW[WWF+$MMA6@8BGZ634WW4M0CX>;#I-S"3MW=:U<E
M&C2/D22M2KT?=P0,:,(--QZ8RLG4[FK[,GH;'T."2O)NF==['U4,E('D8>D]
ME2@40:^JA)%$Y-H(Q:!V0LKS[VU\# ,JR+EI/]LM?3BIEQ "UR1!1#]-,(;8
M')# 7.F)&"AO& %YOKV-:_LA!\F[0;^Y1QLK=L'V=V_CO;6X3_?:0U30=V_C
MJ)R7T6:2<^F_Z0(GX"G%@\U[H#1;DW[NWL;-V+&/Y%N8$<LIE*__"M]*KAO^
M]D^8KA_HE(=(#9Z85J +)4,IX979$IY4D)2S1*M?)(_A>68]:_?2W$.KHI;8
M6[2@Z]AAF9O@,DV,!%6F-#N&5I5QAO!(G8.(#K>HS8Z7V>[Z&**T4$;M!-3M
M9#X;QP?_X\/WA5V^1JPL-27%/_MRHC*!YKF@0$P9TNRB9$8]J#G<D7%ZT.=/
M@"(]R;Z!][*C8S<X+6/6G*!K)<JX6$T@:4%B1/,\4:%]JAUP>Q'-T8\Y/RJ(
MNH'+LAKN>^\$TV U@+.XMNB)Y-P2:_'J@P1E1)D"6;UCX!88)Z3Z8X7<H*_I
M[5K?3XI4X6)9%W;.C)1&HEN>G<3K2X72MLPC/95P5B019:B=6+X+R_/(+:^3
MQWF$E!L8EEMRGC_<281>E-2<<\F\24*75/I,I Z.V* IP<5K*4 RYVJ',;K@
M.B565))^TS>*K1AOZZV,S<PKRP@3P- =3Y%X9C@I[I$"Q76PM>O%NV([>:8<
MIH6=9N2@Y2JO<TYA?K<<8W8GOCP9?YZCW;3\=7XSQD]L'RU?OX3E<& #E+54
MDF+U4I<MJ0*W.T0H3Z-QG$07%?I *J%1) 11";(//);4@3[SN-[6+XCIFBKQ
MZGJIE1L]O2T?P?_YZGK7H^@RI )H4'! H6E7TH5+)RY?BOB],,FB,RF$J9\V
MV]?J^B_CJ<;7X]/H>J'$T$5#L^G\_.-T$J_"_,/T<YK^&(6TG&0H5++)19*8
MQMO3)44L"Y%D9KQ497AMMW(A_, =3N/O;OF\Z]O#1TN?%T4F%555T6*]@V=V
M-HXK1.L63UU [1-U[<:C32#]AEGKZ&A3X94$W)OVI>?<!H=F<2CI)L)2 I8G
M(I/5AB%N[2J>'GUI?4?TM$>E[R/7%HWQEL#6#8MTI"9)1X QC9XR_F"M4\38
M8$4*P+2K;?K< ]"?FUE1*0^[V1TLT0:O4ZMUK:<GA$@A:D$,9+%,'+84T'_.
M#B%JP4#5?I"\!^ 4U'NX1!OLWAVVRO*HTBP$S1E1KB3U<BX(4*H(XSG3"!R7
M6;LZ_!$X?UN 6RW VHIL$M?<"FUMLW0 UR@5[U%@P^3B55-C-WH<H8/^#J,5
M2"X%E=EX(IC3BY.66)6!>&6ER@ZO0U>[PG  @CR1C3<,/_81?8O*GLEL_B%_
MAHNTSM0H4TZC29EHFAV1EB4"D2:B0/#(!/4&:K]2;H#H/Z)144D/\ZF.DG 3
ML_,"_]?7?Z1QFL(%&F!G\1+EBW?FXO9\_==WW# W8(6G5CB$J#2SN'1'B94Q
MD[)L1PWX#+4;M>\%\)2HTDXSM1/PUDD^B+'TDULA6T\3S=)R[1+)VJ#=#481
M4#R783R!<TJ3M \\F1UY=H]]Y13T7E>4#<S+14+/^\EX@D8]S!==-(H,[F/T
M:%$G+BE)M#0EY$D3""R0P)2F>*YEUR:-Z@E<IT"09GIHD&&WYO%]4"XZ%[WU
MA%LG2A*9)DX"(\"2 U4&+35P=+< .24V'"_IIHEV6VI94HPR!>^)HV7Z52DM
ML $L 1.HTTQ9X6N/R'S>]8'/^KVCFBK[+CWL@NWOTL.]M;A/<=DA*NB[])#E
MC.:4C82#PHM2EH92ED:B+9.99J$,J]VWX&65'C9CQSZ2[[OTT"4E(25)#*>9
M2";QQ'1H;R>OI=')9%U]LM0+*CW<2W/[E![N(_8!2P^U5<J4H32<2X2IDB>6
MX7T*D?K,K3$TUT[_?9FEA\<0I84RGD?I(=I?,7ITW)W4#A%317Q$V EL2,*K
MP-.#!_83+CT\A"(]R;Z_TD.EHP\L<1)2F;81$]ZQLG2(X<+:9"17K'8VQXLH
M/3SF_*@@ZHHNRVKBCU]-\HS_NEHV=5H/XG@UF4XG?Z+#=T-4!&-EU(11=->D
M98@SI4P,E=Q8[F. ;N^F>WST!+3?5,X-7DJV54E2[K7GGI'$0CFCO"*@,R?"
M4%RZ<,)5=TF>?RGJ,4?!L4+>U+NJI/?+[]/TK7AIQ?4J;SOE\6?KI+G;*7.K
M-Y^4\9[[ G^=6\2JH_5$);S-I(>,!A"CI<DDX'_2>=NH<KD"^B%9UJS>82#E
M-O"('EO)1G/"+LO1PIB4,XDB:UP.3[B+)=I@4FM9>JT;4[L_8.4E_'2$;:WF
MVC[98VNYUTVQPSI"EMP+T(1R=!GPGHG$"A1Q<C$**06:B]T\M8J@3HJ @VJL
MI\:8L_>3^:,S*&YDB5OMW% +0L5$./>!R)" .$TST5ZB9:+0/DWMWJ,/!'U2
ME!Q&E3M=S6<R3O%F'RX:-<Q@'-=U^*.2@P1EEG:<C'%C7DVG*)*%^]7[O,6C
M4 XZD+&>?"N5L3\ =+85T(=;0/@7WD_&TWOX;C=B-E8(FBP)IO2'0W^-0$1;
M-B8=HP9CP\-N:_7Z0M=80+5VV4> 6<7R-5YE.JDB.HF'BBL. 9XQ.O! %<\Z
MIMJC&*J![ZND?3CN[FS?W:O>ARYLWUC]J^M;.VZ4IHCLV_7;]"-=+"+,!K*+
MD#A1TD8B8^DR9H(G7I4T)B.BC[63S+LA&RHU:"#6[.)N/>VU'$2PDLO""MO$
MNWI%[ *V45+07D"'R1)JH?%=I&JFKL$Y%H0";Z@A0C%&)/H9Q)?A[-'PDL4@
MT >M73_U#+CU1(K1LZ/6/EIJ2:DWX^]7\]E" FP5FF!,>2T,+CUJ4Z:$H,$A
M#"V]U)(I3J-)M:/!C\#IW[EOJ,A=E#E2"PU>WK=!X^M6!9QEO4QBX()(B?O%
M"6F(-28S[\!FVNR$V83SLQ'D$"WT=(*(%;1$3;#6",(5H-FG$Z)R3A--:7!*
M<W"IV1BF33@_&T$.T4*#M^@[5^X=,?PV3?^^*BEUB_O6>A:RM8X(&W#IZ.GB
M(<<9@1!% *.2JCYXI0.LO_VNFGIK2:UM -=3SSI [-'5>@!O< >KCFH[F, U
M]-*33_40:G8B)< ;-BKFRBZ2Q'*C21*>9A.]R*YZ%OY0U.GN/PW&G'W4T9<7
M?G,6KZUV'33CL"BE1(P0T2@#BT>P\U!&I&K!JL^,ZH#K>9A 1RFTB[=]C#9:
MU'/ [!O>T>6GU_^^&OV BP)RL5=\1MM=>ERKEJP,+,H$M"H7=% I"!9=JGVT
M[$;S<]L[E;34H+[T4YK-IZ,P3W$[QNU_NJ[ [X"]D?US#.YA#*-:')@,K, &
MU]Y1:Z!>VTQE)#*G,GK8H&NK\2@6,3+O'<_4U:ZU?W[D>\*T>H[<VT=O#3CW
M;C).U^]@^D>:_W8UCFM4("!'QR7"*+VJ*%#BJ?=H+^0H4G12V]JO!=N1]&].
M]:?-2755-+"LE@;#C?WPZVA6\@K07#CSLT65Q;G(/BIM$!$5")#;1'ST* (G
M73(Y2Q9J5R4\"6I *WSP3)2Z&JM(J44*<-DW#_;.QHZ[_P=W]]ZB2'A>[F*S
M\&1"D8P4/A";&"<JN6!2*-W ']CT.[*U:Z#IGVN5-3P94CU-FIZNBQBVR>B<
M&IZ9*)LI>[SJLS'$A< (%<$9- %$JM[I\G%$IT*@!O)OFKB_E,(Y#R;D$M,S
MCK+2Y)41"WCJNLS!&A:]9+5[E3W$<&H,.$K&#=S[.U?Q8TL&GP4>78&$F!21
M>'H1L-FCO24C54YGZ6L_%75#]C.;,PUTU[3SU!V\YY0; UYD7#(+I=U?B3?C
MK\";9'SP3*=VTV;O .F?/RVTMO.0.53D#7CPZFJ&K)_-?IE<^M%X4;)6RM%Q
M2^!UB+^:C>*BEV>I-UE/MW0VI!P4WH"1HM.83"1.44>43ER#H-94+P0[ .9)
M<JBUNOH;1OKI=:E!^N4+_NWW_SC[Y<N;?[[Y\N;UG;JCA=5^%>97Y7R^6<U9
MP V$/Q]1P%7IRY6*LEK(H5*AU;TOE_[P2U\J3>_.TP6C6%X.3B_]7!58XDWF
M)%I./8TI**B=$MH%U]'=YU?R_W!?_HLO7902R_+=58BI> =6);0.96G4$ADE
MGF=#LLDRVYA<$M5'(G6'UU=I4W6V;+2=;Z22YU*3](@ %T_^46IM.%X9#A=!
MI!"V]%?7Q#M+57)1">;[VVE#1H>;,6%;H*221AK8;J4'T0,1K-(GN@!K%.'=
M"6J8\&U5%4Y:RK]7@B3(T@#N!6M]Z3!7;$)*&8G".1Y-+*W'7C8QG@BM#L.+
M?<3>@ ^OT3R>7*?T.?U +V%\,X$P*L=<+&,,09=08'GH0E^$L 2*6\49E[4-
MF!U0^G?:*BEK4E_234IWPL)[^ 7-FMM<.*Z<D28J E24;B Y$:O9HNN<\5QX
M [ZV^K<".17E'R_E5LDZZT6N3KI/DXN+57?:\YP3BSX8DI*D1%J!=E*2I456
MEBI;QQ!B2^MR$]) J10M79B:2FAP/&R#=QZ9PH^C[6R]4GAN.4W :$FT"MI9
M7QI2UJ[8VH9C8#8<JZP.1-A+TJU/B%^^P?1KFN&I%8&KE(EUO P!E)PXIRB)
M*D8'DD-TM;/6M^$X8>T?(ND&8>9[F-Z,2UQLZ4??S/3YD)?-[SYLZXCWNCPY
MSD;H<;\>7UVNWJ#/0TP0H\V$.U9ZA"*MG0V!0%04)>0XB[4MBQ;K&/HF.H0A
MCU%N"/76;J;Y$:Z7&1N3Z<-'H$77QML&V[/S8'P,(27BF/9$ZB")I4(1PYS.
MGCHP]L$5MB/]:H^/GL:)U534K>HB'MZK@@'SG!H2? (BHPIE?AT0+2&+H!4$
MWO04NF?!5 ^D??[]X\>WBZ9]9V_O=/C[[<.G=V=?WGQX__GJ\A*FUY/\<5KF
M,LZO/U[ > [C6!+AOA>M'1%+J_?Q2N&T1M*H%%&[]]&S.Q^]=2^D9B[CZ4D\
MDPDWD(T$D+[$9E4RIWVTIG87O:=1U8NF[?S6\K7>><_ 9464=7A&02Z)$"67
M'#QP)U1(O'952%=L?<71*G-D=Q2MHBJ>2PAMYY)>79>GGF4C)T>]Y$X181W>
M!K@4XBAH$G),1F;G4O72[0ZPA@^EU:3#I*U:&CB_NU=_.^BC"\1&4;4.\(:)
MKU57;5?J'*F7@2@DT=16KA18*2@-?8PC((HA;FWF.=GD;6^'S\"C/9\#<_91
M1P/&O$6[LV0JXT]OT.6>_%CV*EC'BF323"F\Y2'J,O])$(M',#%4!<F,THS7
MKE-[%%#_'FUU%3Y,U:XF_]I59Z^N1A>QS +[O'(CT^PVN^5&#.MV;T%(]&\I
M 5N*%6(0Q#NJ2)321JV2YT$_Y<CM_=7384-;@;>H@8;P#7V!Z?5=(=Q,D4Q.
M(3&)4B#03"L"8$&3["6Z#$E'8+4=J$?@G Y):LN^X@O^@K]O$\S2M\G%O8,,
M,;Z#\56&U4/40BBWXP6]M)X#X5%RO%N3(];$5-+" 044U$89V8Y38^]/GPXK
M>A!]@T?2G=+X1QEL?.XB=2IJ032"(M*D5%I+N'(-@L_)1<-J/Y<^CN@9\:7.
M&TQ%!;3HH!#"U>75XN+[-7V?IC!:1'OPUQ=I(78TFBXGT_GH/XL_W[F8<\-4
MQJW#ES4NTJ'A[C,ML0"6@@F VZ#V750+^\E1;A"E-K!]/GQ?!!_'7Q>G[J?1
MUV_S#_GWV;+L\]S+E!,K3U,\>R)I\L0IPTB(/E%(:+?QZD,<'P-T<C2J)_[:
M!M#.A9<HY6.HS_(\37=LCP>[XIRBA0 45Z1S+@%OBS9"*$, K 3*60C<=_.T
M^D![,N1[GOKM;R[>4S'-]S"=+NJ*&P9R-[[14[SV\;55"LM^OOK^_6*4IK^-
MQB57&ZGV=0J7MZ0%C:2@KC0+E1+]?2J)%]$6]S^HJ)SDH79N[!.0C@[(;OWG
M5QTS*=C(T//AY2B7FJ+Y:90ER@DC@Z AF7Y6VVO8M28'-F*NE:0]=)AU-IV?
M?X+QU^7C?-""NRP$<;(,$0@2#_62_25$-CK'Y'0677B"_^H=CN#O;OEQ[X.#
MA4AK:6]RK!0KVM,W(-9/$AU@[!/;[*+4(=JZ'B'\A^H[0G(-%2FETPJ\),$H
M1V0J\0OG+(H?J,R(U>9.$WB&5N".Z&%]_>TCL,IZ>X>2NKRZ7$<5DBCE7ZP\
M.Z+W9+@MI4)E,@L:GPP20NOT[O:$YNY]M#\?X2BQ3VK(K.)3V0((_'4'"%H%
M+AJK2;(!/8=2V.6-+O5BW.0HE VZ4V#_*>7=_>@+5-[!,FOPE+3]7E\E.W\9
M7997^S0=3>)Y!H^W.>"UKJ@NX]+1+?2T>*X<;_^4T&FMW8&Q,[C^O?S^+>5C
M==+@D7P[T _^8O1UV95IU5HTJ&QY&:WE(UJ;DBI!@'%'+#@01@FK73_.U :T
MGX$XQ^FCMS-G ^:=HISEWQS!Q<?);*&?[:4XN"9P,6HB\$HDTKN,LLN1B,RY
MUM25PM1A>+;W6IX+,8\DSV$$;:OYG8QN\&;YZO/K__W]]?LOK_^)/WP^ZFER
M^S]5[06R ])J#XU^MAAT-'_]X]ZSN,B":>-+P2\K78I<(%Z6U^?HJ',I@*S>
M16T7EN./N'O_[O*=)-J4=,)3/:E0IB<K12!102@5BD.(E#O==GT]/R96T//F
M"7*D8(=^/MRUD'6V;P;.>&":6%GBR\K3TF^9$T:YIH%;8W/C33!X-<;1*GZ"
M,X>(NHD9M %K/?BM [!&-18[00U365%%=4_3X0BY]TH,(91-:- 0= MR2:[4
MQ 7<% XXCS98;:O/ ^Z9$$_42_3+AWW$W9X'JP<C2W$UE%*BJ<3;DQJ#IC<>
MAR'),K5:I:!K-R/9"F0(#Z6*HAY7_P%2KORF^GD^"7]\2M^OIN$;S-9.TMG5
M_-MD.OI/*LD:5^,Y.R\M/964GBCOD//2.>)8-H0KD9DQ8"1T>E5YXK6U(YS!
MZ7"<?=E*\#NY<:"SN;%]%Q)+*5[^]U;/^.UH-N_@<.YQ1)0/SFXI4CZ]GQ=:
M80F5/-$[O>IOAG;4/3FW?>'8>KG)^.N7-+W\-?GY^\FRB<VX.N[M'QERFL!#
M#6W4L3TJERV):L=7+MZ"6SU<M6?1PP\=G^9>SK391[@N;M8O3<BTXR-#DFF'
MOK8DC#\BGDU.R<=?$E=_7'[P>,'\SW_]/U!+ P04    " !&,YY:/(,9FTJC
M"0":GPP %    &=E:&,M,C R-3 S,S%?9S$N:G!G[+L)6%17FO^/L=-)QQ[3
M)C'NFI9$8RI8^X8L_]KW?2]0YE;5K7V]M=X"I;L38XP+,8JXPG0;)&E%HHB(
M""1NQ#U"!!4%%7<%7%@4!/Y7T,F>Z?G]^C<SSSSU>9ZZ2=U[SO?<<]YSWO.>
MXG7PS.#%N#_PV3QVW(CG1HQX=\2[<7&#;7'O2JV>@,=O]7C?P,_&Q%'H/-'(
MMK@G_.%)B;@1<2.>_7?P$@6T!@+>1#3:[9\-F#P&<+;1XT)' "\:.QN#CDM*
MC7@!HP,,O&$ +39W\O2.RIKI;]A,R=,U1!%&Y&6 5ALW"H&*J%AIC#J,5-/T
MU)27DB*)$9?7!0: -R(NI]N?&$F>/B2>B/S_D]OHZ6\,%0DXDJ?3GCQX0RN2
MOL'P0. ;Y-FX!",&@WF#3)V--9"( )GZ[ALX# Z'QI#06'P"EIQ(("5B"6\\
M97K*2\@U"3*9$^5,]M/VD&_)TY]V+!P.SP[C9WL@"QI+I5+1&!P:ATM 2B3X
M87< B"2X_?'#(L]TF*#?"-F\ 9O'_<:3[X#!$PPD3Y_^TAO?XVG'7-Y_;^AG
M1_ 7*G%X+LNO5[2@;2[++U47B7Z]LLOULS7] 3EH_O6:?B7L!=%RT.\)0D80
M*1[_\T*L4. _(\0*@>[ STJ9C/^NXPU"SB$[F8QHT FZD"I^1 O[LWWQFGZA
M)\@#I!+^9RO9G,Z@/P ! 0_T\Y6_5V#8?"G?J20A Y_(@$ @ #*13PHR*?$)
M&%P"#J?$$I 9F8@G)V"(B1A,$OI')7^D(4)6@ D( /^(R@_*_EC'8[*9X9^H
M4(=4*/JG M\5^KFN>""EQ^-,&5Z$O.]Z_P:./!OSQMLBP&AS/W$FL[[7J:=U
M?B2GM 9=!C=@<_I3?C#R0TN*Y@S\\.ZS!T[;T!+S I ??#)CDJ<_FS+3?U+A
M:4M/UDYBV&8*6%-P1-+0>WWOUJ]5LH(VBS600J%\5^GIK5^K9?9 +B"0PI>R
M.-_5>WKSU^K97( %3$%3[6@"C293./1\N85&IUE8="&-Y:?1F&BRC.97<:PA
M$X<:!3C4,(\I"HIH-(+,X1334!C:$'0:4OX)+-J,^ AM#DWVI#*"C$9'HP@T
MIH/M,.#X3AI'.5S!C#;0>,A#BXQ%IZE8=(N*3;<X.'29CL\(6SATBT7(I'D$
MC+!',"3(I--$3%KXR4?&I!&D+!I%PJ2+E&RZ3,F*A V<B-_(C5#,__X)L[CT
ML%',I&%T2 LZCE4E9\L]0\^&!']0^#_Y05.0CLHL- W275J8)1_N,HTGI\E$
M<J1K+!K >]))+NU)[V0LVG?(V+0PCX,,"Y=!<R#=0YY9>,P?EWLZAC0&TEMD
M7(P\ALPC1!XSD :8-(N,@=Q#1@01<HL08XGD=!J-S9/S(C(UB\/"L6Q&'4LE
M\G*L](@F(K-)Z4."J@#7*HKH;12&'+:$6$Y95*YT^ 2P#B]EB%4RMX,DB8JM
M)I6>JV1B@CP>WR/B,ZP6O96/#)U/@5$'Q&H!'8():"EK2! K46+T6@W;"6BP
M$9/62=7H<58OX KX#1IB2(>78TUN$P'4>LEF+A9EQDM85AW M?%< AL!%ML]
M*(:#J% [O:#.I1\2]!G<?!SH)@KL7H'&Y279O#Y?T \!I)!'CHPOTGT>DRY#
MIHM,QV(@$\+P9,RL+":=P5*(5"RV2BZV\BSZB$7/@H<$/09NF"WBR@D*,8.M
MYMN,(5:4SY0S+59 H8(U-AU9R*#CI0HQR&=9(B:5(VP9ZC+?KF=S;":'B:W"
M4WR2:!BV>(<$,2AIU,I7. (BI8HHE3M-.HW::]"RL: 6*W?J728/H/%"!@XV
M:,#]1]T?$D0QG7R-QDFTZ5W>H-&M)YD=/HG#"P!NG\#E\Y'@ .1#A=  ,M&8
M3V8$Z\D48U)H5!7!1V9K==^_# G^Z-[_U65(\)^F9Z7*AJ<-)XS!19TADRS(
M(VLP5JY  ^HM-H'4Z.;++'J.12B0"75L2$H,XP)^&ZQA6^B @N;BJL3J( N#
MX\A,+JO=P<2+?*@A05)$[]91:<JH!&VD1\Q^;M1 MZM,0K1(&+7Z B&J'@,C
MFP_5YC/;K3:L)>RG:SP* LIKY!@ =Q16485V&^#0,]&*8>=@B@AT-+.%'Z"C
M]*R E\4WBX)V+<>I"0DM.*],)(2C<JM?+J+H-!JNF4+#$UE2(U%EXILQ"I8=
M;[2C/&B:AR ANMC0L" N@#?(\6)(Y(P8E *NS6732>P"T*IV^ABB,%'.$W-=
M6%^0_L\PBI4JQS*B&%PX*):%]'(FH/$;E$HX@%&SV JCDT%WR.A19(C-4C?1
M YJ'WS B]06H9IF=*M0"9HV8A7&IZ(2 ..#BLTQ8*0?P\DVPW20+\^Q<(&A
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MFA"/;K,Q<5:[4>2(PB*6C:8'T RM3LTCZZT$L41/I#,=FJ#((!8I_&:!F1@
MAL,Y+P;T:\UN=D",U1!D2CF@9P(1%]9*9#K\2JQ8X]58^70T3J,W^E%N&\B2
M!:5FD"R";6*?7NK1N@PJ@Q!VB!44"L0<=K!8(N#'B/&\J(_G95@]?H>)829'
M_1X\A(ER8(+,Z&8B$U/(BN!Q:JDP1+2#"K/(A,.Z/3A(KE7C/'PJPQZ1R$(J
MWY"@W^?1T- P0.0*O<C!2RL0T^D6.3+F+FDT\,05N'@ WF<4.RAAB,TB"A4B
MB9N'Q, ^D"K0<]E>BDM)D@,1FQ)6F88$#6@1%]9[3$C4JO$! :8AC'?H7 '
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M[FR>[F@5<4@7EBQ; T:(%>@%?Q)P@$AU&\&46UO! 6JQ'YZQ-^I[M$J9P4-
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M;4\=1(^8X>'_+N$:O1+L^ELU>AV6-?^X:"82$SROA@/]YBOPH+B?BG2O>#Y
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M=^WIVJMLB_WMNL^M![5$L\Y]%N3T5??"[AKB2.6.TU^(*QV62.?RK09U?N;
M,7)N<0Q30&X2R[U^&L@F99JL%;8&9QDR%_SF]QB[H6(/U9ZA>ORT/ !WTFK%
MZ'-L9\H_2[+1B8P_$9?C[[-_6!/DBB&'X'! \VU9VFPUU4$[U@;:M872>1:?
MJ\T3 0-78[W^Y.\Z#0A)Z]V;EJ,HAJA[]EP-RIET_$$K<Q9;\!N*L3C[_MW
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MJS]^O-<S.<2_[I)[>=%8B&";;]D2%8L)&'F TKWB8]$(=B4S;RP"3'<#!_5
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M^M,=OEQ;83-G:Y$,B]R"LHUW;N_XF1-M74&Q[ KGJ=J:S@YGC\.I%UQZVIV
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M8S'T2%JT%OY?GJK\#P^Y_]LS>Z_:5^1%E((PE/$7K43C3\V+EDTVJ.N&X[P
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MYB?0[2GNS\"<P-FGNUN(;;=9G!@5E]]@/+LZ599++6%>0US=IYLK\^VF*QZ
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M\\L/;=!^Z7";3%BU)=Z@VFQSMC>U-+@_JEKW'@6_I^8@^T2P22[=Z7)SV^#
M2(]D-TT$M/=G/!1J!$5(1OI0K[-,QR='=56E\+KE,4B<^I2> PH9GEM/00CG
M>XO$<=IC+G^=I&8%,B92C\ED^C3<G5[/>U+PW4SO.W=Z'2UR55O$H)RU&7UR
MQ@ W**[$-C_JS6MQBBF#C-:$.SIA4XS1.W&#6BW^RI-M&4$G)BIO1[>D/4U$
M6)\2#?U$0L51N[=LZ50L['1D44.2J]74<1:KC3$VP^=1BAMY5I>,W&T:X4L3
MT#Y;+#M0VH?>9,)8MOD.,T*@/S[<G_6X3')RZ6; 8Q]' 0!S0@KN&PD]JM>Y
M00?&V>.EV\,&KYP>$?=(MVL_KKD45W2=<M5ASR'V[TL2+5N+J*R%O^1^+\V>
ME>!0M#?OWDEV<:)2&VH2WY(&]8L!]E8[=GMIHC*!O91S=R KNIK@A <3T<7+
MAII)W<&:B7[]3OIPTR>+@1C"(Q'Y*F1P,L7KG(0;\KS[A23PMOQFG2>-PGN/
M_4C?E\JR2&;@X]M5%AN\NPB;4=W^XF6QUKG#2>/+CE.P=P=LBS8HFW]9K4C]
MG</(;[>#94=&#'\,M!L$(?JS7DUZ_52L.VW>Q3@7(IAA!EALL%5!N;G^HHXJ
M;<W$VSVMIQ87\N\%!I,RQHBGJ %G#*P"YDJS,?>UB75AA/;L,Y"QQL92TJ^+
M1]+V=8P*_ )7= Z=58!3GS@4YN2:D ;>N!3T_^W?"9DC'6CMS?OW)T/*RW\<
M-Q4(/JQ%)8-E\0L.?;T,8++4*7C!0L/BEV5TF1N11='RL^CHZFK+1]QXI$\-
M+8VEK%:!_"U&U/(:X@AI2;/AU]M.3? V?4^FRWT?NS!CX +'^9O@*^'5PX;7
MHNFBMS49BV#V.7[<HY0(-*F&F8MH85>0OB7>[KUS]!\_9M_E-L,0*T;01$3V
M@N=JVB>GD>54\=3/41.8\)5RE9J&B&AB=8A#=SOME'3S2@:[D,):JA?0CKEQ
MK-8M#:-YGKF+R.&-K+@=XI(L= UK\A-/W\#3 OJ\^Y&^TU%;:?_=$EQ=0IL'
M-WZZ]:?1I:3ZA:2QKHX6D9BPUK+F.NC=K#+\%6Y6-L9?UB$B=XC"0$GJ4,4O
MW80=".',E&UJ2=OJ4T.^&A#?1=7P5P_2;AR5P%3V'1W,<G"_546S>GK0Q^3Q
MXM&0CW3"VZ5[P7]J[*),E(2[#>2]  O WAYCZQ**U +L[5D=82ZU0D$>'90B
M"NH=3GQ*WUP16#B2'"U&EIFAXG]W6T/Q79*N3_EEH<;%:C]L6/^\YOMVQK.\
M;AYC^"X.?@E(:UI["+G\!(XBM3&3G"YA"E)+AR8C @B-."*A2GW<;!EI%(<0
M3-%[7X\LP%T\7*9>>(H)(;7=ZG=83LD TFPBE6X=V@GZM#$$*F)4S(ES7=98
MS1=_B\JLC/-&P ]*FCXK%:5<9VW?=S_V-#>?L\7S']WWVABP\;990ROW%$-#
MH9(?Z7N\\'1NAI<MF$=>JYP(2;@S>^Q.3L@XDNI0R.@ECL;WA7+J8RRF\+%7
M2XFL(M[:RLS=4?>.?EP0K,-<<&*WZ+/2P=;TRFSMTH6SI9.$GJC[NV$85^ '
M!O_YFUE;(DEG&3A44/.G>4"$D.+>\(8/LJ9"0I?[LA+]-H?G&AI+%@EXH[C%
M5[_'%=]O/1UKBC+5F-@T[J@E;#&/T7X>L+.DB.M$&?-9@RS0\J6C>KWH\(=@
M".]4N=EJ@OSV1J23Z<(SO=<%8>W_NM[[V+3PEW9\1O)V?H(?[%Z_CK-$%DIH
MKIO2#/\MC*][P+SSLY+;X+8UA,V.I$;=3\YC9& S$<Q(;9?3R5T"9.@W7,/V
MQ''5:;9!6M:B(].3JM(.73/WB2^I/+O656OV/AJ@WUC7#U$)*$E9I^&9O8Y(
M>^!(J=BND[5C%]ZK\M[LO=FS ^/GQP]5Y$T<Q8PW)4=JL#E+4196?B8QT^"U
M-/-/W]SI\2&]FEU_/?^V=!0F5(R9[ [6)NXN0,K?#3&,+'KF%NX'.]TC?$OD
M_@)?\"/-JO,G)<*N9F[]4&34<P/(Z[[^%FD.Q)_L<W>Z'B)8>LSD(H6LSF=V
M+;6ICNC\:4)(#%A=_*PJ$_JSTKZ[J:?:SJ4PEH1#3W9"/.KC_HYF0=)0Y.1\
M@_-D:JK W9^:E+N?@9DW6]5<.;!?^:%!B$=0!?8G5F\5Z#!*_OJS4B;FV*+S
M\<00(8J&B6B_GMTZHUM+'8Q,%[>>PG&R<R(A7C3?K=F+RS/\W)_E@)NH:W*U
M76,ZI70CO-X^+,9X:>$=IG*Y^%73;%P\TIR_ CW0#6';;,IQVZ=&&#A'XUVB
M2)%Y.\\]:4O[RJN*(9;N,?UO:0?=+*KTH(A9D] 59Z,EMI?(-O&8V<^-XQEA
MN#*.!X"T!'-W;6<8KUK5]7E_J85P.=4Z!&V"S@@\I_5+)</3.=U?*C&ZTRB4
MC:S_ J+R3_QWQY\Z8DVNL.0YF; >V^"%F\PFO@Y_&D*EWT]YW?E!3-ZB:_BT
ME1*'YU?JASK:WW:1#K*G!:2LT^K)//)>T >QM^,\<;U:R[+E$2,W'Q)XA&MW
M!>R?45J*VZ.:$=NLG$W8R247@5[-M3WF&=6M_+6.HDO!6J"SQJ1HS-("C"+"
M75C:*8R1KJ^G6KX:W6@5A*3RQL83PFX12W_AER19O8SS>TF[QCD/SX'&&R:7
MR(>"-!>-WE10ST#$?:,<MXA933*/4F$<5 '1425Q57#AS_6OS=6!<S4W4/QN
MB^6:\S<?^E@+YC+A1JXN"4P;W+ME02^4_?L<+]*YUGQLCUEM[NKOJMF.E]&,
MK1'(>I,5@H/?F_Y'5\_6P@QN]Z(:9%K;L;27$[&,:&%_ZC?ES^UM!?*M[9I3
MX3^C%@9V%.?'17ZYY=:_F=V9W@UL=.3; EJ\;Q.EEKG9Q=[9Q:] :=U5RZ!@
M:2PHD-/?E'@E*JJAI+NSVM&2-4LM&G/;;IP;T$=60'CT S5-IJ<D3H3)Y.!C
M;YJ@!!U/9E.;3L<C59+?+]G>;U6E+&&<KOY.MYOLZA5QX+ON-ELAPU98/AL<
M"X<:=S8M*/=WR9EH;(X>;B6FU-1NA%=9H3P(8!;6N?@2E96_#H<W<6C]$.8,
M%[WQ1_?'W8H;@\KOM8XNLIR^W_."2_N6GZ[\PG?2%DQIZ8KZI6K1218:MNK2
M5MB'',[?XGF!+U=KX@J"NVCN@6EED[Z4K61W:\<F:KALR&N\L:19-:2]+:K>
MB&.169+TS#QFT]V?$CXY(W3="?1 '[XI* J?<%VY8;<AH2V/&\AL",BDUH6P
MB1WX< PN5P]32YU#$_<[?9!BWLEV4>]HEQLWJS\KO;;]K'2AOPCS6:D@UD,\
M&T,B)/L(L1?Q*8T7*7)?70V;II)%2F9&[M< $E3X^]7C<\7[/]*-BIN@)L?:
MK>2-HQ9'4&16SJ4ZUYC-2*ZC%:4: BJE5$=&WM07@*G#'^L%8#?N5^'7TC]]
M5MI>[EOM6^WEE%J/_KLA\I>UUJ,8GS5<0 *BEMDZ/3[$6O9[V23-TKJ*X)@H
MOY-!&>]%0.;;J40_TQ[KN.8V]3>40_:]VE33:2!5J]#(+K WQ]3:\:E"J[\[
M,$PQ_ ;NL8S;N-#_C/B>PDGB@>P2PKHA4<=7KT1&J5TMP+ZEBWH1$]C220VW
MSTJKBD9>F'/_",JI,6IRT\DT/^#/M1:N7W[4@6/O;(_>SQ!;T;$%"Y<4X.RY
MU^8(+/NO[ZP2 1!];$!:M!_)RCZHD;ENM9^V3[4/;%],"'S8=+6PKM;-:1M2
M/XMJJN9&Y6PBDXQ/5!D&4*2@N3]*$#PX+BXN?6WQ+#0U*W$2\H3[PN4JR6(J
M/:>TP*G59_>C8ZYAVMDYG7W6I5M>MHA3@.#0J1P'\X3R-/@I7X0%9<?^T <2
MED4A4210^J-YXWFHKT]1Z\FQ7ELJS/1^:]]08UQF*?H:*Q#[^X"\T:+J9?!0
MH\0S;%VZ9F9Q[5.O-6](8K@\KLO70:8P:U7RZYM:)AWR\WN=;PZNCJQV7M'0
MU=4U/;,;'+0];!M@73]U9VHJJ&(^*RN36]C+7QAK-@RD)4N[?7T*:@/<;N/!
M(;<Y>+!;EZ'R\?2!+^/<OE06G=;K=+F:]_Y;125_]7^S)Z:&&_YXHR#"O\?R
MQ?-S/')!A-O6P V\HY'; %EQWL.%F?_!JFW2KU\'IZW']ZL:7$]@3TA2T'#X
M2]Z.P#C-:G!2 G^^:CP!'W./<U;#PE'^)0UU9G5A\R "Y?R/I"[:29^O0RKH
M^Q9%%:CM+('-T!(0[-0&$G:!R*L2=,IP5WZ F#Q2L2D>6+*H#9@LKVI/Q%$;
MG6\W53YG546%.("$E4Y$ NZ[@L7/2K*]"'Z7 4YDP0/WF!6Q8?=A;N_Z_K?,
M\=IU6ZILY]S(A_6BH_I'35J^S5TIAL)>7RI9%X?$P(+PCK<6<"DEFQN%D]OL
MKTZ(',ZWL)O EJ.^9RQY@J12;-*9B^,7.(&\W\<?+UNK#H'SP=6S,!UW]6#'
M2]*=><'[(Y)/B!'\.FE?PK-AR08 4FU<+HT4W,1F$WDQ]QI"W9LV2T[)D:9A
M,V'CU/-N:L;LGPK $C?>8W'E?D@C&+)QJ=%AE=Q5>[=LA*0%-[/S\$!T,O%6
M@Q3C2W2/8(/K&7,EJQV_H2O_48!_H*N!)Z':21]5P@EO!=%60P$ 834A(C/<
M/JB!'^7?G%E!&/IY&DC++GU8FHWPE8TTGP(V0V]GO03XDE/,(GJIO8%RX^BH
MJF>#E,BP0;(7,;H/9&9F5N<1W[G:L0T$%&4.1!JKU'WA3XBWZCHFJ7\IW8%Y
M>4ZQ'J"CK.'\#T61*\2M ][ANJ'-'W^K>XFRSEO#G#7*P](FWA?,(HT\#[H;
MW#CHF]CF=XC'.[*TZ#IBK7-BS:%J\FBT:#+E>#N=W 7&-A@VX=*K@W^O#Y#;
M1CW;&:T\=);8HY@-8B'3EC)=HCY5!\QE)A&FJ$^$OM*!Y,@+AW*>_*"TOP-C
MW^J*JA%U4 QZ;<Y^5JI* ?? 0L,1E3<@)()H:3>BCEG9.,8*23[.\'+N3[ R
M\5[#L(6UA509OG9]0<2>+KVJ?4[N]\;AIX_C9R:=X9-#85&PYCJ7\1,U<Q M
M+85OA;U\)CRXI1^B?+<=+OL3642#W<9^E!DMF6HE5)[=!#L29<S\ :)NU_BY
MEK@^[7)1T/B 9M'X]Y,.OPIC(D/'J^HPESN;CSK66@C@1T->/I2L<&.#+BTP
MB^MX-ZF(4>DXJQFEOH;EV\:Q-2M921HY,].RT X;ZE"-?XFXVLV+,=J$?X$D
M"KR^O.$O&S%*'B'^!:ZM19L TF(V"F73!,;=>4I4H\%GI;^(S2Z^BWS]_[C4
M^4_\$WM"]\%4>?Y?.YK6-XJ6&6QJSE*.6<UP[-$K;:,1PV\^B"^5H>T%1ZKY
M415Y]@BSBY9R_Q4:8FKZVEOEO2/"S5'#LWHVM875,!S>&C034UAEZ(\%;.S%
M+* SOF\D<N_4F/["8V/]5,]A[Y [_[4^+VGZ3Y4E.B7:[K/']#ABKP*. )YZ
MW*9UI/"!D4=%\"S-VHY>YJU6%-L7,,#STOFNHYOB/@*Q_.1SJ_ T%GNL/^70
M22V#1>LWPIHTK-O*@8N^I<U<2P=>]4!13GGB;+7!V4YQ\86D)1%N-GE8GWU[
M.A"MHPFSSE.=1.1ZA&=LJ>_X<8&C.=F1\6Y$?)^2TO79B=F/V^'"V,G=&YN9
MS)7X'5L)?BH(R!78N&I$"(I2PHOO=S>WGF7$KCF"$ 4/ENY!?7B^6R>JAE,<
M$R#\T)\4\>L/N][H6ALLFP"F1&T'L=F#R>!&W$O6HV0\SBZ,GPU^E*P;V++U
M^T)9,Y/FM7%DPC=#N-JUH'5KN0M-7>;<QM F^[W]:GEWU\JD^OE!?V2M+ZXE
M9U\E'/O7K/7ZTD7+D?G#[HA_9*W?#F*MGG[)6N=E&[KY/#Z M8(PP3)KM4:/
M36,K"MX"#.!51/)*>9%?$!6 *W5!4 @@QDSDBET?9\\$@7V;(:@9Q=^4E)PU
ML[+0'JC-).3\Y.3D,"TO/S\/H0I?6II_ZV<:TI8\]1PZB/45!;CYX'5/#E#P
M*3JO>'RR3YY%4L49W>K(J%=G["-#AC)*!^S>_V7S[J:$023H+U';C]Y&:H2X
MS2[M=BY?]K0=Z>94A6\&/4JK6DG]4::OIP=LA,7>O5ILPL/M>(@.!@P%TH,/
MHJS]U%[.M"DO=D[+K=N)U%L(WO;O4MS+;/JJJ^_=TH6P#/<BV_-&PDG-Z+9#
MS\"/47O<9E,G0G#+#1;,R$O>X_:"XH7Q9OL]*E->/\9(GJ^U+X:.5D3\,5"I
M[H\IM2G1+6MXD#\^[ Q1W<7UENN3[] N+B M[_Z=?S\T_C3<%&4QS4CHD7]6
MLON(SD_HV"P^/C()E?,-1%A-O->*:V-[L_L0]@B4=7"ZKCP0:U$S<:X'1UZK
M2@$!WD^-SUL%WHPH3H-?\%^9M_ !Y6M)5*LDCBI WX2,#/1*:%?EB=>S=2$G
MGE_/R X+0^FK.,C'MQ^V\$D)Y:B7#B(./P$9!52TUH8(%YG4^X.C(PD%%\+O
MK-@GOJZJ;QP;JWNYF57Z8]DW/ N&4=.WZ\,_$4ZDE"12O^XMSI8G 1=L7"1@
MB"4?GMD8KMK&&7!ZU+(U-U=W-8#WKCAWV40$ T.;+GEYM@6*MNQV8%S6$R?K
MR"+)]4KOY@^Q6KXTU+^,2)!EGJU:V8]JXFK87<.?&A-/^8I0:O9!K]_24E6L
MC^E_>&F$A+!_*@>[#5">O8AJKP27"2#]IKEP=T\(T(4W2([W )!>=':N=3)?
MY\+<1>2!)4NZ5[Z*NH<W3C-_:L_[CH1MUBY/3% ?)-(\G2UFY<*'@D1$E(=7
MB>1"EI-KWVFL=#>:=;Z?E-QR]*O()^4&=I#8F$BWSM9J)RO7FL:&A>\3]3BX
M[\=*US5 (XONWEX2N$JN*BX0;C;>[PC7KB<%)1LGKS6:*/<H@%D>(4<,M'FI
M[)!GK;.0-I2*=L #@]8?G (<*C:5AL>XL3M5K52QIF?:;.)GI6OWZN;+X'->
M_3W\0Z']R)O4#.+\D5T'0QWWX7ND^V'31G$JAU1)S;*Y X\P!Y?3'B6&PXDO
M9)N_#@YLTXE:N[B6R1K/>P/HPE(ZZ\IRR+6!H(]H8D>3%DK^G ?3MXL%V*6<
MR'G%^F,V1YN[]#_(+?T)B]-#/TY*FG!Z^Z%%IW'#KM[PPDCD_%;'D]2U09Y&
M*7OV0Z^"<VR$/:-?:Q2J*%Y)B.//UZC[%+RKJ7+4E2$6J7F*'[K,^E":R+&-
M^'J1SNC&B650$</J\?I- TS>:IWS\8\.IIG\'>1QKR [4RVUW''78-QUGD-W
MI/SVAEHB7UCY*C&J(#EUB[*N[_WWSMVB%#1CP1VZ$B6EKJ4&[Q@NV.C,F/ :
MME! OT4S/)<WPZ;XM*:N V;8(0L+F\X&TU U=4[M@&'+BR3[2A4K7&"<&GDM
M[&I@R&_R1YS 43O,C?OBY ;7YD'8V"IGX(7MT_&Y9B]LP#LY4W+SG7Q]X9!.
M1/7X780-*L5J/*@86@R/6\-ZILQG:2HN8'U>X(646,2L^M:>_Q%D"$$%;G([
M:,Q^4AA.YJTR(JGXY\^^W'<"FPE4E"^^-W47T47=*H%Y=E]N/3E=S_@4R[G_
MCT%W2IFN?<?:<3IW/RM=5SQ=)&6*P#2[N+:6>7;Z>Y%_!P]A*> 3[DB34H-%
M ]/E02%V!?4\6>2KXX^L)@L*1Y.!G T@IPFW?]OESL?=FOS-[4OC#^)O[E]>
ML8A15E8.#*BIAJ0U-!L P^8RP;G7N\[&$FR]!+2.)@9%L';S[!JW&Y@$GL*U
MK"MT,@\[]#DP$,&^;:&9^?<K[^>G'K,^9-XU&D-WH(,;B/F9A=F8BXS<_-SD
M[QY,V S\5+@GJPJ?;8=W>Y#K WTSP\DN7_KFJ7!55+3V/F9FO**PL/>J=9(
M] )W2^GPEGQ]\QN9<RY&1!S22L7,?O\1_>O,T0/@M:N8A%&,(T>^[CC\Y9K5
MH45NK/"2J;#YU8B 8E]"-3!"ZJ)4UZ\ZSO$[/RL=ME'+&#V8&*62WM5)=!%
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MCTF4["QU/1&'K+?1R.G63"O331/;; ![O+V\>D,%(P;/=8)B(W+**RQ99KG
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M\D;^,UW+\(!-)V \6L.KM9[K'$N7+$$2*VZ6V<+4- 7)HV8G)OU%'SE<UP$
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MZ":;9*-@>-->.35M\,AE.2;]?+; O24J8PALAKY@9*2 W8<X**J9Y1*;VMM
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MYB%+QTVPJF\/&_EZ695O?!\3ZX)RB1U/@*T>."QH(Y1^J?8?;[:@O9<#:^V
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MIZJHA-#)]QDM:0 YLR!=-"S-G<&0D/&#J41#W\K9SI8!QA0VRBAZS/'#4]Q
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M6J"M+64.2\>_6?#\;):6K2+J.92Y$&_\QJVM%([8_3P)97S4^63U<*R->T9
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M>[/C8))U>$WB^.E.0Z,B7=5S6W&N!&-AQD9:UWR7+\4V_-'.\J\)Z?$J[E]
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MR+S2:<V7[B;HPMX7+DDUSGV7Y?-/$KE<)A:[MZ74]MC@=L[2V_YN&QH^4-Q
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MS]%[FV@^B*X[G<3(GD"N&^3F8LF+<>'-TI+,_DB;HQ=F KRX* P,_PS_$-I
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M3I'9OB?Y<W%R,#@G,T9LN)A37TT$7EYIM#KSRW-[C=.4Y F17]_5(A.W?ZM
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M.ACI:@#-Y?0+@Q-B#>_MRX^!'SF4 63;'([5_&(Q8OP2M985Z!GNFHG]IC.
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M\NV,DCI;WNRSH!NI&(P!HU*C9F]OD'KD"2YA(WN 8K%66867+32:\^G4UKV
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M3FTX3M7&1]]+\ZN;90%GC+<#+NI=7!9V!:@?'^^O@#EA]P"!\,+4S>&!EJF
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MQXPM1@]-J,<.FM_CRJ990Y5+L\0/0>"Y[+#(Q:\ @&/@[4Y%>=GS]2$I,<I
M3BGL7O^\I8KGFRC.0X0 %^/'B439@G]NTT!M>:GV-VQ&]"DB.?IBGYF\/-[
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MK.]26AU>.M4%>E5MB_DQ."UEH7:A+L'B:;96Z@+>#?+Q%(_A!VSOI-T@U_8
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M5*B[TA8%SXH#+!>?*LI>#629-U3V*BE?VK[;Y>JSF/_M?&9#8:'TBF.=O70
M= P3-M6B$\,:Q-JML&.0.&"X(/K$V9$)_UQ:0%KQ+-,?'MDEENO+&9OO184C
ML3^GB_U&&Y J+T&A.LX1LW@K8E3?MH Q$_^.'\A%NQDX_/6)_7$-K,?#3 /?
MP9H@2$UP0 SEJZX.R\Q A1MV/K8 =Q[\C"3Q_NDN_SKX%\!G_KMS6N*=J_WC
M5OOK@4?Y"]T+[LQIS<)F4@@V'UHN=OOZLE\/9GB@A9$] K<YZ$T88#R6B.,3
M\HXD+SQB[P&^FS$RZ!DQ6#:G^=U^P1F<96 'M>)XQ[-G&*4ZZU%U2TL6ZO.9
MZ3&36?/-8OM5[YG?[S'T0_>55%;+N1AYBY32A<U?D>'BT;YVI7U1UFYEV,OZ
M2$GVD^$<1?-@UL 870=9$IDBED56J>T!$C82PAS4^E_)6)?#J*8YE&U.TP"T
MGC\JK][1NK9N^7)KFUQN*U@$'M=OJ3PZL4$9L28-A.BPX:]8-&C*FE?^BKOQ
M;^^W01G++?I5'0,1V+._#:Y@+<K?4M0M_3(./@K,>#GX87F!-6!."C<;SEOT
MSW#XHO7KYYE\P<QL"N+2TAJ%[#:#(7<]E0V:TQ?-&RK0(=S"0EDW1=2%&3$L
MOM@S3:\(@9!#H@K7@CG-G#< P(&3S;/2M*L3E">"MFF5F1B*:2-$M;.N5>[[
MH'I1JM4^WFT-_/)9;AK*$$1/+>XRC1#E^T>MC;RE8-?6R"(_>(NF%+L_PFPP
M^[1-/RZB2,_P^=SW-R9F6N@FRJ<G!8(X79F?G*WWMC%JG7*R@U31!!0>QN1F
M%GO0:\KBSWI3OIO>V@WKHJI>$A6']J[IBV@"AMXTK3>10\!3A4OD,^J!?7SK
MI1?8FA 6.!\I'XF[(;#BUC 6%,5P[?J.UR.>C8H8$YZ6M?>S^G*#4X0@V]SJ
M*TY%*J9:UG=8 3[/##(;4E(R_TC).&?7&>[QHV)_QGP:)P3@M5&8VRN2/4!6
M8.[O-0Q:<\:[]Y [=Q8B7L+"WC;!+7ZOG=S&3AOQRW>P;47"1,(XD]>42RB"
M$8"/C2?',JRHBX:3H9$)IBR#\))2"7#"N]Z5BST>QBT=RY?Z-3X/N(DW)C2$
MP&)R#/JVD9:96]/J:%@=OX?E=*LVRG5CDJ'B$&_2K_]IE>G'/?)81D1TI?*<
MY.4"?&K6%]DZL0-NLU*UG/8F;,&R#"$:0],+4I/7A+[KY3M)82;S$+4A PD-
M.WW6@WDS.$;UX+CLA-KHLM''THFQ'TLG0M#GGY%,IZMAA,K:<Q#2W&C8WRLG
M%OQCY<17>X!F&W0>:BTB&A$=6;S*8-NX%".-$+1RJKO/,-5_)\\1$U7P-7X*
MYON2%'VZD;P'..S'K/O",^<%U F\@7ZX0(4]#+-*2'8L-BP;+W@I*B@/LAF4
M>Q44^Z'#3 UTZD8GAQ=-%I;W &:963YK.FX0CEWD;"SX^]5?_CUT':4M:__.
M$%O,0#)VM-%'Y)G/BZ/SM7;S[NPX$.2-VNK4R/SH$[(H2O3)38SV7U_CYQU?
M5U*XH.<?!FROS7A(<&=7@'<(M$+%ELTF]<.@N0?USAZ@@:[#GIX/6A]?DZ*^
M'$.<>]!@PD&)*]_SUF\<<9HZW6KR6.>GULLOP*<'LM+!:G&.)AEV^LZ>.=O?
M3;WKZ1';W9_\J%H.^(&,M9P].A@?+[*]K_B:%VGO_UNR9Y2\4Y!8PI@'!7=C
MHF-'1]R?9D1K(-+'1^"&@_O!IZIJ_3S^,RMW*U9[BWI;G3?]]=M\D14-//1^
M/<[_ _+NDR \,52#T+8'T(]H/AVF-DF@*39''\S;0TL-)%77HS)N[S=]4GU=
M=[V)*G(*!L?^*"B)\[:-_F!T-0@#ND9F/EY&I]4]6*N>\1GR.''N9!+KX3*_
MGI(0IL]L'-F(:GCH#$HT_XKDO?/<]G:FVX1IUS8CW_V>, CO&\=QYR'N%13#
MM%7-?;@F\\LO@0K0(_M78<]D>)-=-_ZNVPA_)\$P+L1Z90"-X5)NH8/,*$YO
MN3''(W[_^*GKZ<A91MXVI-5!!>W H SMY]JY*--!.4^[C\ I9Z-MT"&[>D>F
M:BE!T5+XG< 1)YF5O,$OH*ZZHXONL<5'+_.?HK#?R#(Y>63!W-NG.PMK.!DZ
MSM7=?W45=FK],N\9TB]W,3A&[T@7TS+/+L/LB5]4_8ZASI0'O5\K-L5+LX>:
M\.V"5F!W[.PE?C!B V4V[5_CW6U1./A"9J'QZ-<%9#0_H^SFRY^8U#/\H[1\
MR+SS#8%Q:\[S&OZQS,&DT/!E0:)!&IC2X1HSKWGK8Y  ]YY*24SM2-,Z>NOM
MDW.-+WVJG9Z>NYRR5AHFC@?\2[@5+U9*)8$/^P6)DZH71CR7OIT3)/9%\<QK
M+QE<+&DAS/!=LH4P4JCSTY+J\-WX?!L*W N8D_P-J^'T0-X.C".$&?V4>:;'
M'Q@S,NA6J41\R3'15&KL #V$XHT"3)24]@ WH(7S5^R_669<;V9UF#B-R9RB
M]P @GSF\T'LQQ#/JYLUH . L:<TBIMQ-U7J>8Q+#?94G'YL]LIT9G>EE5N@H
M7*7A@D22N"U$J27S)JVX>3)/MGS>RNMR1JF6K;XSMTJX@.M+T)_@[UX5" -H
M:$P50MEAAF@2,(3[]H8><C,VTL^3D5SBP4@V/MSE<#A;K"^OZ[^'NS+OT)+C
MR3,[_\NG]X2A^3E1(KNK8_;?(H_E&H4U$6./OQ/W^*^!-U*7@8BLH\=!A#=U
M\GAAU;K0O YV280MM3.6&C.1\G3P7W=JK!RF,0AP']\/FAR+F]Z8T7G."\I4
M&+CNF+O>,,LLJ]8$^F2WVZM_6/-I+-=Y+R(BA8' HIZ-&;HVW?F6>_^;_[9.
M'?+H2NCF.&_'+H_<7^(<(6&2IYO85(TCE:]-JXX4<.&MHF8L:-BWL9]J9-JV
M(M7WJ/S2RVK+E^E%.KN0Y.Y^D3UA_,@VH7UG#U!#1,.ZUXD58>]8 2S@126'
MON ",3XUTQIAW:L?GY]/A:%8R+7G >C#G-;F'0*&O)$K+NLL^#36082(BTT=
M53?B+[6$%;,W[(/UTJK:R@V2F>MY^6+W70?UB<TC-_)4DIU2#7()AGPY+4X$
MB]YA\V9M:N=1WR$A1E+C0Y6?B0CT\%#Q(%3<E;<)M;HDK%G#7UR]@E';7V8I
M681+SM1.^-\;77AYBJ6)]??(&^0[[ &NOS 9JJ>__T^D'%O?OK[-4V@GT8X=
MNH92A(AK,7X,M*I_#=4*-"ISSZ(@Y6<UDT^4LI_2&R=.K]!\@^>");E_..9'
M#318"I@]A#+3+8?E%DQ'?D'L_49%R922.>56!'S3W@C8/8/_O9=O=R8J-6UJ
M(+8XY_N(^_Q84@JKO6FVEFK+E?IW(6JE[8N;2Z08B[!EK,E((+3[P1C_H<S.
MW5Z6CBP]>->TP3\^Q,W@)Q"+?N+:#XM5KW.KN'!/5=(2O[3J=6*G^^59XZ\G
M,$Y_B] 8TTN[TT69]$?W7@(W0^^/VNC:[D285/OIZNH&!?W<ASE#IA(H8U[0
MHNP7[?+V/<"@4)P<&:/]C]M(!ZUB4[>>;[AM6Z$2%CC9Y)JK.ZCWPO)H?#H8
MO>X]ZT81KNPT7R!%7[O[?W>YSW/V ,=W-.M6]@!3Q<P:;49;V8GSTQ@/BWKJ
M03/Q@[I<B$&#!=HHJJJ]KVXQ@WUFL\^LZ4T['3XKRY. N2=7J^/KI]<R2SK2
M"IMO3/(7&VA\5]_GB&N9!07\@<8P$SM2: []&?A9T&@K(])+2I/8-;*O\33#
MQG#C5[SBNPH*U_PO7\F(^4]F>6E*43N_C]]+4*)7[EZ>;5J:4%U@_()]PM\#
M0(XHLQD%9'Q,9=_M5U=#_@( J)]>S]@=2#CA0%A$K!N'IMG"=[)7A&_"%$.W
M8Y_+$U!K+S>6ZXYU!:/_%0&G13-Z$IS(8EDDV /4V;N/4E7EPD?8W%&L2<;2
M!*C47)C 4BR_ZA@YG[W_[T]T3S3L =8:I0?6D?0MU_?W\Q?C-[/:')Q9DQM9
M2RF,HN7X/<!ZGMLBYX']?WN:_U?XU(H162DY]0[?(?QT)P/U87#KW.X 2OB;
M#&M6AVC1W(UCKQLRZIE_JWOV,N>CTB_3PJYI&>[3=G;+=>J8?QG#,X8U1Q!.
M;F@=-]@@1J[;>]3GOI28&]S^QS8(>X!?/82\7L[D4I<#W_ARM&J;\0C%&/MH
M&&N0"F[4G@G$OV]DU%4IJ=,^7I=<!!J=V@/\!M)/((RK[^J._PP*->:ZGU@_
M#EJ\\W%#CD_>&FH9T?_<SNF?^]+N\:O'F$$O9T*YRV&8=QFA=08[$(M>G6E;
MJ7:M/+ MK]LV4%7DWFI9./?QC!*@[M"DZ9;9MMWN'PW"B;"ZI^,66*[ET@1W
MRZ]*>!G[&KZ[Y6"MKG8U_5]6X/E'M.'-FF?F0 <V*_7JT,0LS_&0J.8%["'>
M:%K!V@8#O!2^.)+3H 'VCEYDK-M?KJWF6=COA$W<]J>= 5*ON;\S0F >3@@O
MQ>"8X,?(74.H;VIOT2CSXM>E6!676,@UB:<9?4;70.U*3W",T\'Q%0*G2Q$U
MA\N KM?C+G+Z,JD+WBO23Z2^T\:=3M8[82/J?BM88G^H\734DDM$S]BK\'%]
MV( \/;Z,+5P-9EN5+!.=514CT?.1&^Q?F0UI. ?V8(7]F74WMM;IY:7KK2_%
MC4SG=H@ J,.=+DLMXA&')KEFZ5&EUN<0%LVH[.0#HAW<@38!GX6.O+?NJS?E
M462?U^+,HE6O-DSFG/D7+RM.8M;Q&]/3]*M9S&:4S#^^3B1PT;\]M^Z!FF7K
MP=B;?4)"M:L=R);F-]XG*CFA):RLL]@0U-0H$<YO-,>UGFXXP<1!CE5JU,#O
M31]]\):YB<B'JGFK8$?(6G^PBM#0?MRW.^<;BED!O5TQ:]?#]@!?5-^(XH5&
M]/MOB$?\8YLJ>^TBG?N7'I3@75Y.E\ B7DW;HA((K6/W**-V2;I\EZ9WH:3%
M&1BYJ;3B\X5TS4R*P\E5HQ%&R/1B(.6"\Z5JF/,?1E.(QA&)<;U@JL60:]"+
M<.'"XOSJRJON]USA#A7L(S5U+N=:'$AS5NNGHNGJ>1.3%^VL %>/FVU_KY?[
M_T?\ )($2Z.;>9U:52N@'U^7]^I=6_&8YUFR2-%F+VC*M:$^C#]XL\,*K^L,
MUOIQ72V@+5V80=_I]G)(-  ^1'\K39[>]1V/S)MI@ELF(6XDA3CTW"Y,\ZN;
M;H$VA&D%?)_?;#<Q7@G.3P7::\%0,'F]N&"5[X,G.)K GWX#T.M52-;KW#.7
M\^*[Z%RL1TFL0Z>H%Q[("#*/#)435?)0VN*,^!'/NMRQT*Z 43AI5NSLHAUY
MHK\<*@:&HJ]'XM:2V[4[;6!KC:A#'1^:]'Q*-BZWH./ DAB"MMN3N)_Q=BO&
M>1&XIYY1;60B:DTV&+LQA+?SEWM5//VW_A.U9WG-XK$]@ X]O[RMIP;XZ'F,
M\.1\AAGXNYW3(FCXDC0S4,T_$:8&8LZ,T<!I5MY<9,5E**C5)#WNX<(0F_&K
MK<$H_)(WC3IIA8031 .RTROH[+13AIKXPYC:TEB]8*G[)YDR-9 9X6G\^),]
MP$&2O=@E=>7CQ^[_#H'%&PA.A2:<_I%(X0=\-Q.!TUY5[UOF.R[$7W2)_*WL
M^*.'K:JP39/>UMF [ /!][^6YTS44$$>/W77_T(OMWH6&]FZR.4?H]'Z]/**
MG>=Y@A9*K\1= _6"<W?<MM>IE"*K?>]=#G$M7#P]U6]GOGO4%5UU+.#-7V\#
M %]\MM.QT[9[O>5'18"RNMX'<9/>J\9#@-SBA$Q;%.:1LD&=8L0$7_T\4M>G
M67Q"30X&_>1R,D_L['[R0=T(Y"'6>;FEQ'FE JA#[RT&CHMTS>4XQ\:P>]*U
MA@\%;F/)]1L.GZ8/:A\Q]_<?PSW4AIE*ZB_7'ML/'Y\8@,AZ3 -T"VH<&(AX
M?19]XC$L8M.;:#S>H$Z>Z-HX7WW<C4/V&2C%!\3G%:?SAR9_",<3(BBHB>\V
MG7,)EQ2TF0W^LD2S2QT&S8Z(%4!2=G%:C<O<N#A8:%GMH+*V^JE@M9C4=G1!
M^'*3A]LLU[]?K0/<;UJ]"?LR^[N_?<P_GQPA4A^Q1Y#C[\0>QRPKN'7]45XJ
M#O>BR^S--KE,ISM2>A1;P]@-'_)T^U(C\5 /K5B[E91C]76"T'_;F%4+TF&R
M'\$W9&@/>>EB)8)2F%GP-G-45.^1K7OO2<*D[=.\?=_'5H5EIP7CDO/0.9NC
MG-:"3?$#K%PEM_W:QV'?%W]I*UT.YK9)R4$*]\Q8H,6J/<N7/O-G;\<+>7QB
MK_X%2 2<F(A@DDW#D>?O%VX-.UI CP4V3@5L>@Z#Q\KC%8]6/&T=1 E=&#W=
M$E[[R_M! UB5HX&^%IJ:)B;$R*.KL*<A*^/I7DF_]VDD2!U9TUMH**-7^924
M2[^1X!&,V;&S&_&Y=IJIE'Y6S5&I7.<T,R<=?'IPP"0=.N_LF5,YX602$@+Q
M%?\5-[=O[KG%M8NQ:;#$J!. 94YJV/QQM[$S/O%IHS&-/(>R5K&1/ID0D_=_
MV'O3L#2S;5V46EE5J:IT95G1Q+82*QICU!AC+[JKTAC[2F>##:5$"4'!OD.T
MJM(88T.,?118E=A4HJB(BHI*8AM%I90("HA11*.(V &BH->LM?:]:SWG['/6
M?NY^SKT_]O@]OV?.;\PQQQCO]\WQCBK;O!:-SBF3^22VP&^CK$K$7R]K)[;H
MHE]+W6=]9[2BH^D4=NJK,+BUY3KP1G,_N!7D('DX.;&] 6.HEF5-R[XLY52M
MAA%E]M<F*UELAV]VI*1*\1,"N+OY'T_,4T^.Z2B>X6AJ!VE=CW0TJUK0^:V@
M"IRSM M8. QC;S]:;)#M$& @I\65'?.WU=NP!4.T)\A[]'S9J\)&ZKGD>SE2
M?VHV.W1&<UGR@I81'BAYL<4M,N"N;]S1.2$&>A[H(:5O^M8+'9)&+?#3[C>>
M1K\Y_''>--/)3V>_6Y=79J<8+S8Y-)=&7VQ9WH'7-I[Q)T6'OUTC67M_HAA\
M 1KM3:GT+>?1%[Q'4R]"$;&531$$)+C^R-DKQFE'Y[7&-A.CO&&/&:S)LBO^
M[,1@9L<Q5I5_M':DH5\7 1-_F)\.L@V_T^>[[M1);C&WD.4X!'Q3! !8 E<+
M5Z?I'3]LB_?=A_,;^9/ +O%/B.W:^D@SD=+!HA>:%-OXV^BL@--R#U4:M<CG
M]C)]\TS1&M>70VA69JO(*T3OC)33$5,';1#<BZ;1IMIT5?>*+_#SYV$,5'=,
M[UE03[WGE?9C,R-PIL_A('ZSM=I M)\K0EP-J2Q()DDLA/@H"V809!?@)4G[
M\T(@97KR&M,^>E]ZA,ZGSSOYI7X8^(LS$'ACT3EIY].6.._SY]?/(P:\ZZ-,
M/>+7HDP\1!/#LX(S:U69D2FG^C8K4BQZUCB.7W-G2V;;6T4P>8[*&*@W!]3M
M=?+DR:]TYJ-+XG';V)Z*"7%X*+0)NH-5&5,9.:SH[?BX$48[\BGY?J)@ZJG*
MPG+C9%?0'SS;>5&SM-)JGX$0;C,?ZB&(2*RT),5U"S/PO[-<-9YA+X\K?3QZ
M,C,I5D9P1XY.$<IZ$X)P$GC2VOQTXXNMR^&HRR]<@SB2F1XSH$5CHZ1X#V^$
M-C3 ,;XE<M-?Z >F=P%&W"LEW%556PD3?Q%\@=Y+QE_%/QXYTVOU'S!209UZ
M6?F).L?EQ:.3DZF6<Z:'.V=_G,'^=O?"VQ:X475B(?DR;3FPIV<'9;F<=N2,
M79C?34D922(U GDS1HFLQXKBP.19AQ.TL6H_=%@@"3E6C3!+M@>Y;3BE0,;8
M*4^E02WW'CJI3=LT16H(GLE>2B0+M=15Z-!Y$OD_>8G&Z23![SK#M;MG)J8(
MEYZ>W5RT5.2=^+$[V!1I;0>P[XN=2PIP[_J!+L3:A[<S?@.S'-ZIW'9A5>Y6
M9$O&A/\/UV9+]19N^[?<+2J0^@V%MQTLP2VFOJX77^D@YL-\]W7RD-23Z_.'
MYPP;>ADZ"16I#@>IT;01SF1YA01328#6'$_9UPU]$!EF-Y0R[P=#5I,OMW_
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M4KQIO?6]\]&J'L>=%W OV_K^8 UM,)<6LW&_?QYG!8FNF9SWKR39F>>)Y+7
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M_C[,<UDOJU<8W4:SD26:%MI+V-(2$-H<5AQ4^U1N/-5O#D\,C<4_F]/=_QX
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M:*U87Z^:S<:U%"R-R7__:..//;D9\]@.N^Y-V:_:D90TX7+((4][,6=+\6A
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M(O09GZ;R@?JRC>Z17]Y&,M;$)\0/-+LA8;JQ' Z8YW>5/+1,?W[*/LWZJSH
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MMMYW6QT^78M@HJWJR[L 44G/#J6O*M(>^3"O;&Z",8_3M2IC5M<(JW22O+9
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M><9D:(!@+\U]?\G]U4O9TSPF-@CB5D,<ZLC<2)^#8#"CP)'NH-J 4 ?G[/F
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MGLQ[+9%TWK(#C"%%A4"N#B8\>:-"\&!HA.*'>-@787=@4=Z>(MOI9EZW_!F
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MUWNQ.J"I8WP^%/B]>2B>W^BB6#5_RZJU3 (N[5D)UM4@3'/,@]N)(R)_XM7
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M(TC5EQ9:<C(ASFQ4\HFY8M^O,AVT@OII8NT[VVO,=Q2#75P#+5[T]I%Q\#3
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MQ=;GT2L\<::F]@]1A<D0WX $_/-BCP??#>/:;TA.KA8M ):D_ELZ2F&ZC*J
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M7A2J9!&M03/][U8EKNG-8,"^;H(2$Q0"H!*_E9H_@?E50'83:B2UW7:_$9?
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MTN-]IO@XF_AX!EZT%@2\L;</8M0?%P.LKG:Z*W<( OB;.FQ+59(N@V_/?4C
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M?/+(Y4B5K>[OTK=+R,9<C]NK^[#H4<?"C+-T3*E@R):U+0\VGUO2"&GR#]O
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M1JC[>XD7K \1,1S8Y#'2V]M?J*:CIJ;&4%.;L !XAT6 +8/=2K+H<I>?_P5
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M:#WT/HORJ&)(2"PDM^5 # Q'G7%D!JO1'0P8U@HO21 W:>2!-<YMO:_UWLL
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M"3!T<LA3)V.]RN&%3PPW8,@.[I;J/"Q7U=%A,]0T 1,U:-6S1H@?'R^E?#Z
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M0=KN2^>O+RF&QG3J+V)7T@W)FB%!TCC;.D&AZ[8Q5#]Y^P]N=;-"M!K0ZO;
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M)CA:>C#",YO%2N]M-BCD^;H_6FWT&A&V"=+B47QW>@ >Z@K=B@ETLZ_#/TV
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MY<2ROJW0K%3=3C2.<:XI[HOO67K8+/SQD/*KSP]J?I@/PW&];?&SA;"-3A\
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M#4.:7 H2DMM70-FBQUTVVL-Z2J>4=#$+P4LAP0MNT]D@D)_2HDTQX+O77^5
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MM^:9?['!C!^Z(<#@%Y>?7+V]H&FA5+7FVBW_CCE!%N52/:<$S<E4[C47Y3N
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MY/-'64?J!J>:#CPX)W<4G1H;V(]ZTT*[#O5CHL#UPXTY_51 _MV)"+$WN('
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M*(<R+R\>9A8QJ*C>A"1R45./KI^-;<EX8")/Y<<QQO5]G/RK6EV1_M#4^!-
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M,OUZ&)T)ZJ'?QH2J\KD0SCKK\QHJ?IQ M-Z^-)=CLQ/C$N^1=YB80YV$""_
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M$YH3R)@67,&::[50:K7N@=IAI);O>7>CWKEWL>=+-@(@V[JYY2Q1N"A;/=&
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M<Y5K!WO* _-9'7[!X<W]5*=AYGQPR%.*,#,G? G\%UJY_!NB GN.+P[O^:C
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ME%I( 6^!NY3;+GJQT$E#]-IZBN\54=KY 0&<. >?@2A= ].-4*>]L0GCS_=
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MS?'Z39.=M]P=[/&ZP]:+HZ?A5%!8C)RQ>C) [VL\M .]Y3SH>O?DX-7]WF)
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M,:">%Y3%:+:W=]I"5MJ[<D"\7&[=(P9KD15:UJ01.669W]6AQ]^&F)H[#-:
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M..QJ]!;K&J;@?0VTMCP^&( EIW8R)GXL6ZVZ]F0GQF:N-.E<.=/(M._HX@7
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M\(X\(S_0_<5^+.RY+3:R1M_(M\MI9RB K.6:(+V>%)AH#9U0F4**^Y(7R"I
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M9&S6.%81JUF1^'>[6(>,ZSJZ(\<*W%V4.=)]OZ/D&V[%6)/M^!],Z.-0((U
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M9<']S:K&/BNH/4!5FN_F'%PYH9.0OX7#L\V?26>AM?R\)K"QOV:C/]?C3-I
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M2Z8=E"?[4K1:TRI355!B3_4OE[!L3H_6@//<@"^)HP3T$VHM(<**_"R:\Y+
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MKL:.3.8C)QZRFR>X,=JK(=U"(@$?UR^A>9&8*_6 UOQ16"0Q"HLW(>QE/K?
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MUY[>K+GFN+HO=<<3A08J1>?:_7[ZXD:H\MEJK1 QUKR$U#OB7R!2 SF6XLD
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M_1[D?Z[JN&+!@I9S412F>/=.+>I+)FB\YEN->]#(L=$;>;T%;^(;ET$_MZK
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M9")OI;H4'!,C6R?B/T3Y>M+.3@P$%&&I&6#NJ?A)B/I=)\668>'KN<6I S5
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MU_+J7E.[TN0N]>;I0XGL]<'=@3-0BDLFR'U/KDRM6^%C6/Y+BH3$"2GQJ83
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MX4!H6Q[XF<NS_IQS8=+FH$>HJ9+WWL2!/O&')Y$R)T[3)D2S$%&P\L;=,:.
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MFRQ0O]!47I+(<*7,\Q92=Y5N-RLO5?[=,J#-A.(=HA=+_6F5[=)FHGT>?&G
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M?ZO!&O2"JD2T&24E"]W$@\.G'Z\/BL,&.;^*M=+FO/G[MPM@4B/CM=5N>_[
M7F^= G&+$O!!;2" BWRB!*02<]68!T4YCQ2?%>QX7R_75@*:>>TB1+/C-VZW
MWOQAIDQ4]^0<V)-S?4^.^; &[4E 4[G_KM5K.5Q5[XT2  Q5 @[T[%;>09 _
MK__X4Y!O4E)&6_J)PGSC>XOWV 1,9B;F ;+!U-38U6)MLCZ8%13)XWYDVC2I
M#-+SS*T$!@R"FVK9FT=O9 ;#GG]$5XEGM?H+G](3SAZ/DC^0YN#7:[JRGJ^
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MWY7EI+'>2XSJTR3-3159AH_UE"8C[#C0AT"</'VLK_=Q+=R:[13K=5YO1^^
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MG^&LY_&RY3LK,OP/#\OU.F/:I^U-Y"G'WGY___5N?2;Y5B7(^$<M1W<3[.X
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M+#+YLFV[X<9P$\2J(:EQ>(9J#7>VW@.@VQ7'+KUN:VC=@7S, !;21C-TK(M
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MFNJ;L<M/0/;N=;DPGQ/NMS'(=ES]W6J,3;/WZ'UI7E5@3V+ -QP$#3/R_1[
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M_9PDJ](JE&5/P=K$53X7)3HL'PIZW\C#L-L'PB][6P=U-O/6AN)F-K5P2V9
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MF6_*L_A6%CPA.YPJ-J]3:*W?E\BC%"DI8/+1OHO#LVNV"2ZI_ CN*'MKL@=
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MNAVS-I]91F,'4#$9U'M+2O?FW&':+]?66T\DP5/S3U"@R0R"\8EF;QT142/
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M:XV,R>'X-INYU^>"O&EXP:L8#,B^!Z1P["GEC/D+R^\GY\]HW%Q#0-[OTVB
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M Z]K#H_+)/!,S)7)=90+[63T;O:301^E!3/QS]P#)F5GH9[S)=Z%!I$AM#U
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MSS?Y]\^<923S?,O4H+YHJ4V\87:H<=GS\#-&'>?IKPQ=+49/K9[4KK!E7*Q
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MBL?8E%XX9Z4_BR;'.K/&LHM9-+6JMF%J5$869T&ID^!EC5Q62 W[@MA@ 6T
M5SZ%OG[M]Z.MOQW;YAF!*4:*'P))A\ZS%Z\J*!N>=N@))7-@DPL"!5R4\AM(
MSW!@O3LK\-['"9^11%@8?Z1E;%_NSJ7?BH.V1,+8^?K105&TB?8IG*8[ ><_
MM^]=Y?3U+61EY:[L.N9V/2@S+O"&W7R2[@?KDE5^,!([*SP3P;KM&LGR5E@P
MV%T9-M1$'90"_)<M35(8YN%7GE$"7.OJEWKD8D=BW7+YC#5:SL&R*9AB?7C-
MJUM@7.7J^ @,'4IW;3=9WYIHNA*1QV;=XGB;FNI6UKV74[4?[U*P RMKE/[^
MH?<USG(=O;WLX=W%9>N-S/FE<C*NJ?KPC[%GIXU0L;#^=81\YXF^J?C4SF70
M^1=BA%W>\"]KO>:I621MB!S/^'+'+Z'ISA=L4'J):#^Y; N&T(&0'2)_<3U:
M.\SU1,:I'C,[L!?6G[O<0>S2VW2_XD#L"K'@FT9:/?LEJU[)"-IZ>2<]PY1'
M8Y=[BO@6X<!\J-COWSIS!^D)WP(MB4!4K-'K2;"G5Y+N3<%0Y'X*;:*B^Z':
M%AE\UK&L-G%QXY5;!^W\[$A#;2L-ZRL(]+FFJZ.'F89_>1UX-2:?N,K("J&T
M!M O+Y.'Z[.*,8W^JS6C9OY)ZMK!776#F7KC0Y4;1DKEGT\P<FKEFKIPH31,
M/6,&[RF"W>2['Z<U[&6FS%U%@M,6JJYZAJ3["PI1Z#E!#+-*\")(O>!(/]GI
M+>O>2%K@Y$=XE1YNI#;X9,F]X)/IFO/6%XW 11W"\,Q8,J4F>)W+HO!-1UEU
M?3BXW6;OJ)^?7]S,GT[;CFO/JM\JN%_7VTOW[-WLI1?[]@)EWNW_^6-AZ]1N
M'=SJ["N3\OBH9?HZ$IXR(3;8P<)S-,DS2I@K\M"?)YI@"KL]H;W<E3 <TY"W
MN%3K)W]%AWGZ$H=TO.*YR#(M?%PO2!3R X-"[@M)]&>14I602)*ZZ9N;B_S\
M/%PDX:7&>*MQU.S3%<V:T0Z2MH7^B!N_3O1*"O@\HE?+<T._]\3(!HI" L5N
M<3L(_6S/2NK34#N[ E:,T'NUUU98_FJB*:RODYUVF<#$NT2OB,]%FUV97JK@
M$D,<*JO"5-4>@F1BPV5T5FUV^Y]QNY[[G!?5]%JC=&ZML^W/&^25^M3AWV,O
MR7PY ?:6J:FDPY5E&?"H44X]!I19<_7)7-)%(_7_H@WW.2YA7 K(HL\EL:]]
M#$D(.RL%6)FH=+L5FX0K=\!PS19=AJ[3T9)G@5=J8#;70%WAE=UQ"DSO^JAH
M^",%&Q.W@6H[2IFYLBCJ6/,W84Q=0>\=5OS3ZK4UIN4H7';3;?)JWS1-I2;B
MA7>00CA5>V>4G1Y8(;2A<>#*U:K6*C$[ND8M2T5^=B\/__DW?DX!9X*/VQ\J
M+/+OTZM>#)'#;,^WEV8G5&5K/J-.CO$P\QOQ1+74@-YYV T++PNM*/XPDR!$
MG /?P=^@/(]!=R/-.$O:IN-![6'^*C;W6Y,&V'C[7=A]ZTSWH2O;L074]S7W
MBAN#-;@OF D)KV=Q^O'_3+?TH.2E+_2>)$I4$'UQMPGAM+98HP<-6YH_W*-A
M]L?,Q&2?;'RI5KB&[OG3$Z#IK%D;I[6W-U<3<JA/S0_6I>1+WOP89_XL)A\3
M=MX/^4M?V)3=&K_$&H(O[\WVZ6^\] ? !<Q6%3Q,9QUM0)3%4;OOSIG*@1.R
MLS_!W@>A@Z=]F%]M,:\0;3W W)V=P3H<=-MU/RA5L%4-M&JG)7+XA)'H'+1Z
M=N6H!I\'BCRSG?D@#6&ZU5<#HIR4 B[>>WKYZ;O_(DGZGY^M_=F[L&;]\IDF
MR/.'W!NI=LN6/1&*&?J4EMQRHCZHF75_H3ZF1FAU9[.SI;M0:]&&L;9G7>Y+
MIO\Z/Q <'>UVA75!HRO X[?SX.ZZR1?">$6ZX.NT,@TW9]"4Y:TPNJ*XAQ"G
M4>A&@F5&AAAR0Y4669= "HIV\<&>\V_&)T8+2W6'"C-!YO%)WU#@MR:GV-E:
M'LXCWJXSQW,-UI=[\K:1;7RC@CC?)RSOI5'@*8V%:C;%-E;;/3%K.$0O]'BQ
M]K+JS+JC]ARKTD+/M$TTP0O<8/Z-''\7 H%+ <OHJ4-KBH@MV+NQ[:WFW:@)
MS,M7:VF=J#9(?Y[EH3V+Y_?NE/S6Y/P_/LY[P"]!57(SMG8&..X:G1+ILEBY
MP[ZX=6G+@CPZRLD]/I&WT[.1'NRW)@9? H,K(^-RXKD]<<C "I33H%'E<'I"
MZ7F'V#5BZ][U]S'<E=#E!NQU810;[JKC7A<%(>O;Z>$]IPDPAQ?MY3_C0[T?
M3"BI9YX-Z["G^6KJP>&SC)?4YKR-Z^6HCZK?*^NNK3#&I^@5K[([3=3W]M1Y
MM6:6B-1T:&:4C!JM Y<:*[_$<^'C-!0^=$QW!A ,*SF$1P%3TV:DLZXU834F
MM$G7E$)4V[*9")(6'1H4>IT50BSIY;5FP+S.PWA3Q.M377IRL4\&M6P&LQ.W
MQY4X:WVL;B-35^4XS9L+V(0E>A 9.2 K6_3M?-(_4O#_B_O'GZFJ9EL6>I/7
M].6?1:#2S8X?@HET;;R&EHURRM&-B\MY7273\"ODQ7H=D%SF1J]"QY^27HPM
MP@ZI;=9_71KD>O1\?XS1TD:["7.;E%R@E0OK]CJ-T_#PXUC#PC3*5<XN%M8J
M<"EG7DW$=:^8$[I&M@M9L6WGA[=1GM;.-7'FV3N5P]N4N#;Y6);93'Q1KXGJ
MW2U5#4XX,*BG/M^LV;;;Y'2KFG\C)^C*]#(UMZ@@TX1#-AW,2O-?O,DFGFDY
MF::FX/02:98<:&Q%DS\V$1/*WTXX<D./MQ_C2J%OSZN]DM1BZ79E=L:A06NN
M!X^T7V9>??)D\+QY_^NMYC_O_WM])QZ[#4<O4/&(M+QV=[0[68F]#.TTTPU*
MM7U6^0AKW,L/).5TD$Y+ 3M.6KJ_N\KZV.]< J_IZTB$@Q!_7+,LJM]377<1
MYE^Q3W"VB^\]A7DU=G_;N*(\\+K$C+89T;2EIQ3]U.GQPR;R"(-YW?_F.C=.
M2Y4,?)!=O%/D4'OM+?-!7<.91HIA+B3QS8?%RX&MBD>]L"PHN/7=NU8:X2:[
M.C4YU>\TO^5J"?3P8);DVRE#I(AH@B>->;#HSQEP#]A^2FO:V[O5NT\BYU$F
M@6_4U,N%N>?S\Q=S?R^R_/W?:Z'!_#2F&_*X^>PU2R]V?&O%R,:8[ILCD9:>
M5BS3I?QI#YS_)>U/#1]EE!SEXG?.:4+2BPHY+/S,&):BYF[YO$EY[0#&[U._
M9W.B_M=^3\9Q<P+E%>6Y>7422=T,:A6=%#8N/SD*AC^%?KZKO'?<HJNX(&'K
MPAG=2WM3*]\@#,T<]";IAP>VA>UA:N9P3P;"3@4U.N*B=>L[]S.$X7N,QZ$!
M4Z-%_N _O1N9&L[6U#)YEJVY'[QLMOXT[2![E1N>P=,XR;4&O2UKB!H WEJF
MX[I*MOK6F'&XC'OG5^DRVPGC=H4V6_3<>:@'8P:I*9PTKT);WH_*]8V6UQH.
MKQR>'6NMB<T9K*M$:<PJI09U"?._2IX(:*LW2\,VY?GP6C>#W-/>!/1JWFS1
M2]>T<=\[]7X;]+L1U^2'7O7'RUJ*W-8<&^95W)>9YPV*1Q;SY_/S0\#Q]>/^
M3R_S_>UB7KW5DI5=N?;RBNYO1G:,O"W>W46J[>E( G=K5NN?388LL?-0?UR1
M DYUMZ_1>\GT]V%2 ,RWY(2%UF]8JO_O#M_\7:_J$_H2:U6X\Y*%2JSOMXWA
MB-UXU&0P/P"/'-AY3Q8O2>8"_4]?_AO%/ARZRX"(Q!-XR9^6T:MT3SRLFC7#
MM1#NXD=A-EQ%*4"?O+.$,IW[L\Z/=OL_#U*; (O_A+PE!:1+6K? _;\(T>,U
M)XR$:9"T>W D9X?4N#.Z2W&Y1;KY_1]^O?\IM]AD\5BLK<1*B.+K9Y(U.JEO
MS%4W71AK2+A&"]6 3SU$V_J)9C@HW)>QT9M/9SO]K<_LO29#)'(_5A9_P-0@
MQY.#FD<]8, $/'NE3K1>I=P[]0^L\W])QRS6D^GHK\V-F9Q/3UDFD=:1HH!/
M3UDNY:\#.]DM_#><CF+J#W/GJJ8PF=U8S<,SD&KH[^2R$DJW'9MQLYD2@]E@
M1,_)Z6+5 N"XE\956O@7<7&($3R'AHT4^OAM*,R[^\9$?SY9Z#$:^'#T Y_H
MK,;P'[3HB]Q0.S==/L881F84>.M.X)WN"9@ULS-ZU60GXKD?NDC8I?ZO$PMW
M=2&+*_=7N688=/A@:&6K_D]N))L=AS;XMC;] N*;AQ1\>"R]@!U<:Y5I%E_?
ML 9GR_<]2".F+&R?:M4;\;^)U&WM/;/9U5[3;QM_P>#ICCICM7SLZ<[MIF4I
MX+R8T>7@'EX@I,'#@QE3-;B5GIEU_HQ+J[R3GV0^;%E>A2'&S<<P:VK+<7H&
MV]O# WB>;81'O_=TL->T1=;#/?!(T!;"(1UZZGRM?P:;O9\.#'DSB474I2U%
M'=74#TO53BJ6;](--NF>]&(_7]ZQ_TC,CD:-7?MW<-M3Q4@2RM\R#\7<ZI'(
MOXDL?Z\Z8OD[R4%JD._C:=30;CGWU6R/Y[S])Q@36R+?30I@DZ6 ))F]!Y'G
MMKJD  %];T(*()U?^1JU#-E>D3SWZOXN]2\-$O#9;35BZO5/1O NA.@J-C2F
M"RBC4L"$W2%]RAM+^%GJ9^QX[,\GD+MWB=PW&Z44YPC_O[C^P&ESXH;^G\TO
M+"KU#ZQ4PM)_?H^]$KA6K/V#)W(YE!Y]9NM-F*F*/.U")AH55&3:?Y(4%5:;
MF'QV<,99?)H"LZ<]CY7);_KCI."CA$@LS#?54+_%O#R!I=-ZXM6UE..L[?EE
M6;CRGY]/(#7BVX6R]2..0<$CQ4^9YO7%G:+:$;F+NPE6>P[DUJEK5>>*NBNY
M'SGZ'?KK.@*J[7Q]?JR"LH'%B$M@F(-3'/4[NM8L:_6*K]],2U20!XV@.=I6
MNU^G+'C-8Q(39,.$B6/Z0TN31DH( Q_]99Q;*OLM3,5XOC#&!^I68M=7?HN"
MT_/2./%9#QGXQ2,[E$ST@^U8=5-8'Z2TDE)$"=<?*",XMM[]))(ODB%?%)_A
MK!FUX Y],QU'[8RB/B,2.(2^>\_2%<V4K95Z6+O NDD31ZSV%$-@?;8[IX6?
M^J&TUSZ#IS/DOZ,#0=P(Y\>R,.O\*->5A]ZG3K-]!B-Q^-/B9K>E;7<UDISR
MZ;*+8,(7X;FG,S3:^>B3B_7L11N1>N1VE!#VRGL8:QOQK>R;?\+&_S>(,4[W
MILH;3=9V!18^<8F.-*%<J'J?K6$\R'7NWUO8O3/[;4==:;?K45@<<"2.P;R#
M7Q_,=DCH&PE!=WC+V4C K&CW320Z- 3C%N29[9_ARVZ+M+N/%FO1E[5>1UXP
M!_PN" )GTA564INMYGFVF()W*[W:13O,JZ4O>$&-&^D^DX-R0A='DFWC?G49
MYYA5"MUF,9L+)5O4]H"-Y"-TTVCM5K_J:29IW6ZWR7_YI8QLA5Y;O7"I4 '!
MQ*R73+[N7 4 G%$SS60-T PD9R=M]#N3%U1U\:)7KF)X:4]$UWN^@VMZPD\D
MD(W#27) <_8>7SEC50K0UE]7_9R.%I%7TXM>#9@APX^JM6B?GC #6]_AK]%7
M+W98C766H+?HT9(8U1Q._B^(2YW#0]%"#U=8:;59G:![MN@6P@Q5V5'M=QN/
M@[T7>B;M=EG=P9==BO>_&.=RRG:4D0-+"7-@Y(>Z>H[I1W.:1)>7?33]\\6"
MR]?C(P11<RKG N.CC](H6.2ELU<Q..IU*>"(UDKYM[,__GL /.0TVZ2:&A5R
M>$8YO-_@#'M/D6[<OY&\CE/WTO(,(JI,Q8T56?$@"+:'P^7N=STDF0CX+6L6
M,[O4WX;29/1DQ=CZJ_?M,9&S^[EGT(O\4*[I8IR'-MCZI<\%P?L"]7$#HS,P
M<DY.J@LR4PX+:JZ0[^*F<[?I4[JAFZIJ)/-TS)TM&;5)V6$'3I!3Y%L6;&P/
MO:[HLG@T+,E([1?/#CK!IL-@QUU64*JU[53=]*H7'!PTG9Y\A0^U W-P5X1Q
MXIPZI&F<?X) @^[N?D*YJ?RKX4DN;YOD?YK1I:^LM^Q0O6RN66WQYW^LE@?X
MS,4HLZ*DT^6W?R@@C"[58.\N$EZ,@47LXTG!SL,C':TM+>W$: TM+?7-^:-1
M_ ZGP@H;QVP<Q)P4>K<]4,3WN%?J%P2WNP&79?S:K%76UQ^0F<9YN 3%/L%:
MU>H/?/63%/ ($SS^;)>_@RF*M:_J72O'UNA"IUV?<-MH])43UCC\(#F,4VF1
M:=M8V2CI(SE\"%Y^$PU-CU*I'7+@0#6=I8"O=E^37',M8">F%EBIH3$I:'<Y
MO;K2YN:K]?&FF^VEVLKN+R,9UWGFPJH1>')26["1JOU0A@:#%<+=!#$N\">3
M?^3J;#NWO^EHBE_HTSW=V]61!)0""F9I@A6?]>[!*I+).A!>4\KO][ZZ?DYP
M+S$@RJ"!D8W23?<SV'HM-(U)[5?:3Z%%$/V5*WXE#G7MJ@<.6E(F*[-3&"]#
M]$RT516V;C2!TM94=#.9(37VKVJJ!SQVM)155CRW>FNF2_3N_B;M :,Q+VH.
MA@?_"?XJ,Z'=!!(J</DQ"CM((.8K!>Z6?UMFZ.POR5$#&ME^P$L!V80OTK8\
MV%:H4VN^@QH?EHSDYY>86FBWC5T&Z'I/^)1IM.C'^AU/5TR^K/BM%.!UV?[C
MKZN<@&:L\6=UIA1T-#L,W,E<VRZA:;\%K>X%6ZY[>-FH ,M6X#A4'%#@:(6K
M&=W#9 ;WO;9>*^H:S-IS;8UL9"]%D8S(/2P5Q@DS;V'=O,?@,T,"SN*96TI^
M<6<R3]W&AQ9(4O\5R<+B]OZF Y^X1ZYE?IQY] Y]:AOE9,6DZM8(ZXA]B(K,
M"9?<><J25[.ZA?[JPXV*8$YOAEE;=1!X:!%E-1;LUE%I']2Q9;_3DPG4B4DF
MK6D4UJZ1"EP?\\0Y+*7-Z,LNL%MY2\WN+'4'BCJGSZ^N,EN8%].W/?YU\V*9
MH6#;F-?EMB ,8@&+3%\J?FEU[-,)'YE'_G7,.4&!,G/64L:YG/'1+\B0;)]T
M VM^/)@(08?KFEF:Z4A^ALK+R)SNK?0BF3A^]1A^D9GU:C[YA%='0-"JRWZY
M-N#!K-:'>S!*7,Z;^OG!;CZ9S__+N7FD_(7$2-7+JM\@T);FWU.3VPS/-A0;
M"=2#&=<^F)KN(L'(%[LAKHKAH^0FLP%"'#G82Q3#.#@T]YT'W^[2Z$[4NHZ?
MC="QZ?AJ^:&DPMJS1D,X$A[A,1Z>D"((+2.P!Z&OR&A(LIZ^?)=A?:T;[52Q
MB6ON_'M#T^DGQ>=RSH< 01?4^KS'M0G%N*L?'(.#_JO LWN)2T'',:TLV#FZ
MPZ2C3-V10IQW;=R'-V;109Z)4+-H[?ZK6%^;P3J<Q8,]#P+%K_[)BUY_/0LG
ME5OJYZ&W%MPT5W/7?>%]W.=XEZBR=?FFPGD+JQ.ZVM2"9\'YE)];U,),=S7\
M)ME%4(06W"^2\*C3_XAG*>4Q=MJFGE=%\!N_0ODS\@(Q>>R]"/8(RLB*2;I5
M&"H[0.Q9PQ.+.[&;XR<:X0X"-?=VPSRS E%<#'!CVNR!%# _4H:@W@XFE;^J
M;PZ"SOF!6UUS?H/ ?'*(8]:N!@^9B#:IA3)C1[D;DP5*+[[[$/]L:#K2CV?K
MXVKQ@1J^P K%?,L8K$JNH:9K67:LB956_!Z&[BG[S^&V\K64+6\H/N4BBY1'
M8V<A5YQ6QW7?<R:*NV@/A(@U2U-9-:^LXEHI@.?JE5FQ+5K%*^K\5,INOA+1
MT7'R\;SQ'CCT_54R\B*S;N]6CXPIQQ<DK!&4"Y4>KT&U]6.*:"L.KR?%;\6$
MOCAZ7XJK]]TZ<$;PC&GS[><6BW;ZH:J7/P)8AWJ85D#=CO(\HRLA(S2BSNM.
M6GJ/\%[ UYT]W'D]O4M6KA?.,+=<G.? 1-65\K#0=$T/9I9-\R$F:PWVPXWS
M?@E@N0'&P,FFWIWSY_V0SQ1J)3@Y\_<$Q@YD+/M!<"WV#.#"_!;.9^J:8G_A
MB#M)R2YU[ZK/<"=6R]8H3$];R!^KN(PIKW?5X_N-9,V#.JZ25"'3+]'B^]S:
M!"^:G/)VNJ0WJ@W4.:G!&8S8M-%>4X=Z947MLJ0 C;WKI _I\M__%UKW3U:M
M!R*H(:RM/V]2);>702,PS3]X,RQKCDL!XUO4-&B ^=H.*7=Q;;?IDF'X9U_\
M^]*'MR0LY'68"(/M6->BI4?5LYX7FMF&.'5NMTNP058:8:L<!Z O/^IX$[D>
MFGRB8Z#_-HTYY<NMANH>A&1W4LX,M^$JS#X>2M\6';VZ3KSJO=$=NQ[]YOGY
M(#//^KQ4AQ>+"[J,P&RL'5,*.$'()PBXL=8OX"U!9L<E]"EQ?[5%0B6#9>EN
M$2Z+;=MLB^BO<IE&@K)6':Q)$Q)V^DI,LC:/)"0@]O2Z!"8[.G\L&8&RV*@#
M0>6C;NW#\(U+3&II,+_!H9C:.5??@ZB=-/-$+*OFJL3G>+2_R51^N4F!O1TB
M^,$?8"[9M?BUYZH$AN8>KT"ZI/OL$[1'3OGKQ17;K;^1>@%KOPX1OQ)])K'B
M[N:O&@$M\%2O!MC<:PGTBNJ:_$:9S'LI 'T_SUE3Y3<ITG3U+"-0FM1DG97=
M_/6HH4YJI41QLY*QEA:".B*9KQ?O61(3772Z+N7M__C+G^/K=J',,5X[<'LX
MW)OR44*UE.NT'8XAC;U*F8L]Z&>H;,I[-%ZF W1@'] 1% 9XDTW$:A>M.1=9
M#";A3VBXCFY[ \ID=0Q\G,D[:/:P,S\M5O=FOD $=7\Z>AYVDW''=O($+S0Y
M9:)2*;<4=NB.!W2./Y65(04LB'[!;)[[8#G#2D)-.;OL;6QH2*[%[R9 INM4
M<T-093U;45* IA3@VO]8"OCYQ,]2@&&3_GY%BN$FW)<"GH10\3V2VFGV^'S-
M;A&U&S6T\;/EW+77J#[\,2F@LUR(R;><5%Q97)<"+HFBA#N!5%C(.D: G /M
M?+6@N@%OM5S7W)V= 6TGB7<DU!Z@%V6O0'>$+2G?A9C*[3TV39:,KM(E3U&Q
MHLR]<\U[5-UU^K^8^A=3__<P50FQ9E"L.PP-HY7@%:8\=%"U%+"B:*]ZB&=:
ME(YF)-)GPA\:Y(D,I0"',=^=*^4\!5<Q.HF7L4:9T7Q/Y@;7?"QN'->Q=8G7
M@]M9&G&6:UQ)F>JVKEV&^>@"76N?XH> ?T#_S,.<SZI03[V KWY"/MW.+!T/
M() I0%J]P;#XN,/X(7E?;#\MI];_XG#ONSX"0OYBGZ^"2W7A!54/U'F]-0PP
M'I_8%!):3UF;K>QF@%W\ZE-67,O4K^9AKE<A^Q!.WR_C;^4U^12IFZJ;0@E0
MXE_OSW3(7\A4^S,)&;%K"*DEBD [S1$:NX<C942$"8SHY%\X+(P.5PJPSUWB
M[SGMX8N^E *^4[ZV%Q0#V[MAV23IVB]UQE&07!&LATAE^(K-4%E20,7L=ZA?
MDO^T7Z]XGY4"GH%6+*^@VHS&6=-[[NO\E<V1A/[Q:<N_\I!.8GHO9NVX4"!"
MY2#_Q=*_6/H72__M+$''<W;E!G963C85#,-W0MY6A:\B$<MIO4I+P*9)8U)>
M;!XEI$N7Y^LS-<QHV0(Z6,Q9/2R\<.N[3Z/97-(QSV/1>6$;F,/MN2A*O5FH
M/=;. 5DK)X=1LK.SK\O+F\LK)I*30J)S)L%Q;!UW["QMTV4G9J/B8.2TSZ?4
M[=8C/FIWV?S[/25\ L-8H50,22AY2!^LWFZ^CYC4G6E21>U=R$2$<V1^R_/2
MA)S/Q*^VI0")U<AN_D8[8>N/NU&3J)?E:VF:1UOQ_?E2P*$]BS\E1BA_PK&X
MHM]*Y_+:\9-&)9;^A?<JPED+H#.[I\@2B-K[=I3!,NI0U]9S@D5'>^!_NNM#
M3X7T9_'G>#*?T9>X.TO%^DRD_@'.X27205]H+J$W32O,M-*DI)6839D2D^OG
MW:\=]4K/S#8>K"EM[## Z4N(W6.M?1*;)K6<K7PB0AQ_7.UE]2:K:=XN8IV[
MA8-6N.)]J[BA2FO$$>BG-ZB5BV.+7Z/->[\[JZHV_E C,%86&OVA^!OP5+P\
M(Q_E>B"$OCQ%\QIK$AZI*PD>J2YXTTN%5\;L><7[:YTQD:]W-WP#JLCUX_0,
MI\Y/N-8:?3&-@/*0?.,&M#+>_F%;='T#K$?O00H]9IU;G5$[9&OG,@_[/@S(
MOJ?7.%DTQFZ8?RK@X:EKLPP%Z^=Q%Y3\;9RR2C5='+/AFC;..%]-EV9"5@7$
M@TG H11P=M>O^RO;BR2_B@DT^S&<QU)K"U$.B;;VF_/%K>#/$W:*F*V'H&@P
M(OC0T-:\YYYRJ^XH91$!KA_;@PJ:N?32BFI*M+S\^9/D'T ._@CK;8QW]$S>
M1R4U753.MA?.I@_V<68LTK='(<*#P!CR*<X;U(T#19^7G74P4W)"K=M3""-W
M\Y_D+1!V<"'FUNUXLMZ WW;V^]*_J^).:$53!D.+'%I1748*E98O/_! ^O!&
MSI*>@4=1L#(>5)%=-0+CTEI;.XB+.TXDXPX,IX)/9"\;Q2[6CT*;O?IF;0:S
M"SP84S@?=3_D@,R0)C+G*32%,/OVO$'^YO6KX&GJF-H$"+TY$LHM[AJ)O37L
M5D4-X%IZ3[4Z,=UB?WE<$<"EUQFZY9\!7X)G8R_8CBII<UX,$M*#OXO :?J0
M-$92,:("4B.OVD&F9?83S U13M6)B&UCQNWH@T^*RA0Q1Z>"=9L9Z@MJ03\F
M%)3MQ+Y1AC2_>/7E-*V/7L1U=?+_,_J>%/!3,V$XWO;41V6-\'MMT_D_&#OV
M5L?*&$NF]\(I22Z6V#!L D(5G+F2K95RQN6GTJ8I#(Q^PD2?1"K"3ZMH>V.\
MR,M3@W&",F6UXU>+7]##1K1*D";%62DM(LL?5_MT%_9M"YBJGC._X3I)>Q&1
MC]:Z;:3C20Z+#NZ/#N845GJ2PAR+>G(U+G:'%TY[[']4?!K+@@LHF#Q?S<%?
MO^:_,)=1OHWZPV^[\J]A"/_D, 3W1VMG=U_LJ4@!=SQ65NM'ND(4J7"EZ-7%
M>)SSR@M+-R-4/*;H>/KYCL__:A7 9R<L&^%2@"720 IXJCRP=W8Q>VG+5,*F
M-4L!!+'=/+@5-1.-\D+/>IW\XI=;^RL=+T%JH0)D4BS7J'D)/;&C*FOBK3]V
M[*VEKJ5IAQ1078T@8 CQ;9>1YE>'?UW@=Q4REZ4 !%H3]82[LEL6%GU?)"_0
M>+3W=#1!-_W^MNL,A?AQ>V_PS,RH]RH <%  Y$#XW_)4A^3WN?KQH3-C-',+
M5+"Z;W&V=K/T(7'\%@;H<H!4^/@?Y<__D [-Q@D*X49A5W38U6B?L4] <J$$
MO[Z"V]AE#CDJ,DV;33S\:4Z0C6.6H$+\"7V/J1ZD7W(]LE?T^R?Y16JX<I!V
M<SA2=BU$4)SLU%\^I7K_XQY4=4=^,+?*Y'3%T7MP]F'>NDY;L7VS7$5B$SJR
M*36&9*:<=(G?G=DF='R&7>P"]N^IA:/#PS%!(OW'[%L"<@-!VZ!X]"Z#R7Y5
M5ALPF).2KEMN"Y] %G0TY.02+*RX":GJU::Q%6OE?=A_P\IJ_JAK)$DMZT%'
MYC @DRO>?H._@@ VI36W=+=EO3%N#6(K'@OTXJ=5A)67ZCZHKE/93DCCF;IX
M+R*Z@+U[*NO$\,CV^6"]=BT&=^RZU1G,&[:+7Z9*(+.O9+.MY<8$$OU^2^'^
MV/7E<%K0GB[IYIQ8L_:F8E ]*[Z6S@DQ1!SOY_EG(\Q@]6R_J:4HA-)8/G/9
MRB\AP;=GQ#W?==FFIJ@G,VOVX@Z3\+9EXGUR4!(YGJ*%_D)+UH-YGH"UOG/=
MZIFL\C/95P\_(?5IRI[\A-1WWN(KWKCUW'^H8C#[24#COWW_72T]5Y>OL2&S
MPQU!_2C0J=M6$VM\A'S/XF.K"O$[U#KQ!Z0(7J19^PX ^#)JMT)5'(U:?2\%
M])TH 8Y8[I&D@+&_P;LBW;S]WX=W=6C=,4U-L_].FII-MV.V_YD.O7)LJ:;K
MX'Y$!'647.^=5_8!JI[;-ROEHSP#W*Q'3)^%_$^<:;2@ZHJ1<6QM]WSS@:K'
ME:,4K_%SS/L>I+ZM;==S(*^HEP*]^8O=1AM+7D2MKVN+Y<4&X1J&;-73,^/N
M+:*HB#H7J#TS0$ +RT&37!(PEZ+)\(P!O0?<&/EO5F+26*%M9L.&\7&HPKK8
MEPF78OF,*2S-YF3Q=[%JG.([40[L>K/9*J.B1WV&0[B&:;ZN%9=H6UDR;:8
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MZL39>./DK[#WQWI!]H9#=4+_ =.VF2YOS$ZC1ZW"_<?1]#'XE#A@-4U.&#C
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M]%5&Z/-,!J'UP7QE]5KX-';3VML\W&BN )KS0S^RSROC[ 1"$57)!2JU[?M
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M-(D:I;U^[[_";;8;V<2MS.+45$Q2!C_4=;S.30]//CDY.E&RDUZX^P6L#+J
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M^@JVZC10K^<JD  ^84TLB"+LUB ^.2]2TH82N@$=Z(CF1*,*3>BJ9:F^R;F
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MPWNBXAC?DP?3/68\7VKY8LCF2V9BAEAO':J 8Z1N!C#B=P)003S)C3A":*#
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M?JG'4L!-H?_P\6BNP0#4&AH6\*/E=:_,GH7T;>WG>G,CL!#7 =>FO^&Q_86
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MT1B=&.^GU$$HJ\:9EX*++\;U\Q]G*QX[I4T&TDIZ!L<VHB'Y7Q9Q8]5.]#"
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M\+9NV";%)'LRH&B#^V!ZYP:H. RV1V25MSNQJ*873U"W_>ID^U][NMQS&0=
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MR]W("@.O4;;;>;CV^;[X(>5,'9_?9\<:LX[8U:?%HHJI]SX43K]O[M4>P=A
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MV8NZA(SA2XK>TCZ(J@(?7+2LO,EXA@_02!BJ1B1'BEE;V*\-AS:.[@0Q$O<
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MG)J*]2 W#2^S9@GA>P _S2H@G%2%J3X3:0!R>VT.%\SB$H?>RU=&\-J3\P#
M91J_9 $#>B8*>H/UKTUROR\AY@=S^A;8,#:-( NJHOIW!+^J>$[3VK4N4(\H
MKSB?X#71G&FKIS>R&MG(YUD(E0I%8K/".61I_XSWN#*-PJ[K3.&NYMF8]U;:
MLB"\DFCABTU[.R4#OWLE  4CNV\L1F(+^L:2G[\D,WSK,),1H<!JZ\[F1:)^
ME7%&!^5)&X6M(:S'4R8T.^GNS15Z_HXB!E$<FB:%FT^L85&[+VFJ&[:3B,4,
M-+[0/$805"@YF2;G!'S _=L2]7^W3H1*?TF4=X8DJ28ZR*?CREYUGDH<(2"V
M-+LW?)TT7N\!C%?W )_VRDH]4YC3'Y7OP>5$=CWON^4D4=D,IG'4]:>.RJ1[
MZGL $B_I9-^[.,YVI"&-(XGU?+CX-X7_:+^3"XLZ?-2"^?H"<P_09.=")ZAN
MLQ\EYM$3C3+79D&E9NPD\L[ZR][ILSG[,FY>C]L#"*\+/A%E=DA,WH<@$:!$
M8MC8^"U1WSW[.<,E9ZW]M-7 Q9>NMO_4"O^E;CKE^/UNNJBDK^Q3&.PFNX-+
M9)R0BS\B.Z&5$7Q9?D8>]49DO[&:\WF%]K\?COC_0,]D9.D>X#[\N59/*&0/
MD&G))XJN2@S?:[WXZ*Q/=_4(UA;UJUBZFX7GL[T^ZM>#?7;:2<V8[C$NPD>N
MP#@SIDZZ)X6OJR?@/#7ORT!,V4HB\D)WA)?_Z_]@K_]:#Z;#(UZ2C&_SD_QT
M?2+%0JU" DHL#QN;:!!UWD/,&2ZV:R7)S^8@(IG'?OK'KV<(F0<D9:(]@/3:
MM*QHLQ>W\YTL9B[I1=5&AJY"=_UHT1[@D-SVAR=1&ON4_*_T?VCZ,1(8[S0^
MZQ'$C47M@#];X9]-=T+SELSGXT?M4[/C9W3M!Z#5K_J;$+"F#NX->D_OD]5B
M2N[=D)F*\ZZ$K,^&I)%%Y@W=K0<IX>TLQ@<C5UHA2I_88.1-AF$K JR" [Y>
MIJ\*?68:DB%98N.QH  PF_+29O-M%BI_#Q"QYKCNO=I*2K&%-?#K+C^ ;]3N
MV-]E3*^C&\F$D(B*6AY8/2-<+#3H(ZQN86O3PND3.>5E,8EYF3##;R3GPN7:
M,ZS(/GZ)/=3*^?T;YE KQK0Q:K;7+GY7CCVGC>T,(QW#QS4/]$9<4TLX&X63
M38MP0FO6X[O(EV+-39WA]MH:OUFF;T%03_U,^6ITP<D.?PVJQ:]/^IGD#%'P
M4\_GS$FI)5E<VU&UM/D[USLAR7$RU-*\J^[RO-45@?!8[\W5ZRZ<;^*9/>)$
M;@+L!IK.X;LFYIU99QWHBG6^WK].-9;92/5DN5OD%Y=0)H=<U?]U.,^Q[U;X
M5:NCO,6V+,**G<*@M7K)6HC,%G1RSBJC8Y1VQBA7&W$^QDA_IO(<Z7A.>?T\
M"]N.1"0V$2VNY6&-2@(SP]"@6>%<>VAD,K2[@=PU\&S<F_S,%$T$!@7Z>,>?
M.0<Z.LH-;>JVSISDHH[&+U+*DV1B[3K7%^O6/-Q@A[YY8-QR_W+J@[R&TD R
MJYWY/?_FH&L3-HRHWF */XM".5(O[1;ZQO/H@\<K($V/.ZBY[)ZD!RONQF'U
M1S?@6(IRQ]A-;<JC3]O (\AQ#?O%X$NYL#Z"7-N/]&E=![IE?"</@PEMX#DN
MU5K58-L\GD#BEZICS56Y=0KD6C>M6[VB+,PQI^K>JI9+'3D7D-;N'^/C5\,E
MB94N=U9F!@8[O&>(EC.Y%=Z!O:(Q%8[TLLX)#B*#4:>=']WBW%),1V;7;KM;
MU7A.X++2>J[<SS17+^U;N\0W]VAQIG*+79H^FJGYK#]6X3M&?T5P/%@FW187
M;%B_:>7')O!Z$9C.BS!V$[1J=P]P-S4B_F:)K@6C84I*FBZJ>M\R&W.I8B:^
MVSS\\*!)UM^Q0VP'?'?H 0*M!^C166?_:\1"Y3FX98V]8J?OR3;]XK*7=,J7
M6^3:U ^PTZJY(LPIRH7KU=/ <;H59T6/%@J\FEBML <PDWM(29L8\[LUJYJ1
M\,?1IEQADL=6O0][E"-5*\1X-_:AOLV-J(,1%KN8K=\W$G&D)$W5,EU.X%S?
M';P3;U;XBS1SEF6U.%L<.Q/^1\I:2%,/R*PM:K<SBZ^VO168TDR^RDLP=?+5
MRH_U.)C2\CE<Z$<P+&?,K-;&6R&;]!^<S?]7S:4X^WI7B-XI^):ZGM4\ZUOS
M*BYK<6EB,MQ?E;S3COGU88AK<WEU\A^4@$4PN]SV76V->G0Y1$1M+NON::TZ
M^EYBO:&HW]J-FPK,A.7H<[/RMN@4)4W) L;N:(OE2&M'^%P6H;GG"J+I[:\>
MJ2#84FXI[F;H.4%@WH=VV*Q8RT7:.I(R%\F?'B'7ZK,>Z_PQ^5 _W,#H"#%R
MQW71G:)MKK*@Y]2JE=R"RRGMJ+&T_@6^4U*1K*/"OGZ]MC2,]R*^T[3&TAA"
MJPBGYJ/2\\K"79)FB7[AZRN,\(*A#<C:,+QJ)B5UM1'8^0WR9JSM+-:T.*1E
MQ=G 8^HYW;O$&HJK2!^5_,TROR(D;&JE,?)B>*OPBY$,+&5B$>57FP?QGNCL
MQ&W_X<OC>*0@Q>PWO?B6[JZU/4 ,@YNLF+-EEE+4Z;D9W'DENM<2DQ$.@[8.
MF;ZQ_P[X"'1EBQO*=FZYD>;YT?:I[ ':K/=S8OI)/NU#TIN-K?YD4FU)X/II
M$'WP^CI'AH\4OI0UJJ1O[9_**?B&4+(KNB[U$TU+@F9AVCWL:?Q%^2.V7"\O
MG8,I@F-^69"/#MTX'>_QS[R0THBDU#ZLKEQN(%)=A9+<,=.J.SF=LD/%&]CB
MA/6U32KH#4Q6>>E$Z0GGW_X;K>3_/8_D[Q-RFI;L;V(G6<@Z>\-,\(OD;F)C
M6-+KB#T ]'!.3](.$\_"[@S<T%VQ^*MHGD'^DCCK'Y)T&.T@[R.4Q:X/[>0,
ML:O,M#(#@BRTEK"864]2\TNL\*[*_A<_+;17PDS7SZYM7ZW; RC 2O(WB#L-
MY"1%/'W27URV_0@NG!:_G9JX\..__-5*?\&15)(VA=T@T>],K5DTP7\LL'ZD
M';$F 36/YK6;R\'P[2EY]/B_^/U]O_*&?KT+O_.;*&</H"Y.7L67_KZF1;IW
M.G3M).ED%U5,W(Z,WL9)XFMS(K(!_[#3YU]M'A.V"@I$F?P] !VL$P/,3G*-
MM?^ K9H348%/$J&,Q&,HWM=9L(JUCY\.=>--RB>RC&2W8D@BG4_];*OM[XE)
MBHR$YN91I R$9T,V%WZT+NK_-__A/W(^VJ5LL<W&Y=<CMHP$W(ANQVI[B6[0
M?:O 1T['XJ:(P.H _*N(F/@]P(A7S^RNS2 5/2S#SOAX_.Z0Z%^D_ 16O@<X
MAOQZ"7C<I&?])JEFU@AFV#:"O>A1Y9#&<"C!9]$#TYVCX,0&JZ9VK8)8C!II
M%VM-3(B/\'G1\ 'S F,:O?GAJ6JIO;F_O[A@=RD98G[G@R9J:H)_-IZ&W?$R
M:Y$^\M/+R;T[AOAD^:Y \[(/%>P#WS#2Q;X#X9>="B/S["I"\<G^8R6H_L3Z
MI%:R&%@(I7 WJ=;->)F+YG,WA^5T'^J]U)4!I;?YK>8ZZYW*E3[D>M;U<9;5
MF<3*CEN+15163+$;$?I/<AS2+1_GB\T8H-\XSQ.JOF+Q&N\FUTPLFXH1?BU#
MQFOUE%X:]]4%]O#P &%Y]R+^,T?23!FG=0:V4ZA/8,Y7ZN.T??QWTJ@-"[C*
M@#,VFX8C:\[1Q?.%6.VZX*B4K6'\[W,>#.8B^=?;-($FJX\:V_3:F!N\VDA4
M/;[(:12L+WT[ 8_N\*H=Z1E[38).W,[+W(G)$F)U/;MNY7U3-\/C6<_N 2X(
M6]H50_MB2Z,_O+&=4;*_T]KL[*TS]+2H;,A(WSPM<NSP%!<%K5NR23"\:LL8
MNR+?N9"SEK('.-QY6%3AYR]/0,C]K/5 6VL4##RH(TGOJ2929[LLC]QJOW!A
M'79Z(\)6)SVQU=+ZPH,NTTK?*L=1G$)IQV_2:TMV<KHY**?U9INM"Z4#Y;DR
M(<:5T*AVE^!<)ZC])RZ//VJU[LQP6PC7UH65F*R)^[#)X #1IBD8[9 ='J,I
M1 7[O0K6^S&,C@LQ>D+<1P'XXK&VX\<+Q-$UMZKBV\?G_@&;].!_P28=/9'0
M"YIN&"!A^7_L 3X'UX(:V;S 8^^M,;BG2_U)M2<DD_(H/7%4K_F^%.%A/:9^
M_SC' UY+0P4[.>)D6>A#TIOX F^DDBQGW? U=(?JZ>(A ]$35NR0N-'<Z?<?
M-0\Q<1(E(Y)$/^X!%I-=M1YB]@"^>P"^EN29P8:.?&$/D+4'&#@[4_YMZU]$
MY\1QZ]CF?0F[<% 2G=04F+$'\&'6R[]\'6E-S]EI*%[7P-,'OU@:HRHDK&"L
M?"8]KA4"CFU$+!#-EF)69Q],_N&XP,"?/>F##U'Z\TEQ^=W#'WTTJ/>N*VKU
M"CT EPG3 5V)QBDMD$=HO]CI>D!^2[Z;5. R2),YG7AOJQ,)&IQ-QGPF.Q4@
MT P7$VW4K]OXHCR#/"MC7(;47N7II>I._%K+'K ;0VM'8B(CK4$#,^>8=D0X
MBUP;S76V<H%RM500>14X5'*5$V06B>EK11=L)U;ME]!Y;\75;%2-6%T!YIT\
MIF\WJV76_K,,3&Y#Z7G,T4 +HSQB;$=D#APV761A(A>,4G!FA84$D9=9E:.C
MI=IIC:,K\8@@W6NX"MC:6811;-*0[0A-/7TC2\?/*I(,#U5>J&,U&1DM?G0
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MY?JL73<\"%@=L,11*QI#4WVU T^9G?ZYI71QQ31E9BG=[>\)=XR0IPDVS#V
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M9HSS/N<@JUG]@GU(V:4;WW?/._'_MG;L3%VH57>O9:@T<1DZ,40+CEA%M@;
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M44Q3[+%<EGU$BF^3CZ"7NK/T:1U-A7F6AXU1<Y(0K3/O+7M3MB(N>!=40$!
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MJ-A,S@MAU/70$D;Y+ L)WHCVEY4&@*(Y/^]8.+$=V6I+T5V3@YN3F96;&H<
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M5B&FI$P(G=V+L(.^%F]A%>SNN@=W \E0V_!^D6UR%-MT]2'7=#4SX+/EBW_
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M:$122WB,C-QU-+Y[:@#8UY"$=;!1A:XL>/IR^5W<J. THSB2H<[S\YS92(N
MA'!UORUFSO-;B%5XA/:7RYUR9@E%!LEB/^7[3'.Z)=M3^K3)ZOE:UZ%433>W
MA0K1JP3@XB27S-!Q&_4BE*X=;+@GC?TH-)R'OSA2U5K##,RV=PZ1X-SI3S;?
MR./E4<HCA0G^8_M[VXD"=3*N9]X^>$4OL-X>)FY?C[S<^ZAZJVG@;&6$HJU8
MLN!D*]J3D KP\[XL!V<F]2$AX.V8Q(Y9HH<?_8XH+6#67-1_QS1'>L?)%(FM
MASM]@0'V8I/85,?4<"]SRY=JO4HY%]2=E6ITU7H+<R!JS'>O$=?><3'-7S,R
M,[-E@ +^2SG\8;NCN_P+:S\Z"0,R[AYY0'J40+HL$VBL!=.&:-;,QUN"P5X_
M*XT4:W94&/.!\&3 QX-3@20[;XKK5'<ZQV^K8>1QR7WL>82BLN27"A/-.=4/
M7]9ZL+[#K AA0IC9*#=FS8*NK%SGL4(  L_S@]\DM?'WK_@!>?7,Q[.N$MWU
MQG'MC;5J5]((FQ?\4G"Z=T6+.-7Q-'Q(>KR2#Q<D.7W"F=TGEY_BCI+"QMN<
MS7,K'-)HIX<;(NU!IB1,1E;83/:5]/J[]Y-Q+Q.M3BWSS]W[\6ZD.6=SN-6Z
MUCX^]R)>R[&,6!O&:N'"@&&LLI:ANIE6SH<,N$?3%-[];.Y%7<(AX-3NT.[0
M#L.-468U_4XE.A.]/H40-99W$52MU[PQU,"WLS 'ZO7N6"/ZA+*I4L.N E^L
MM7EAV:KHF['MV652T:*3:[AW;U0EQN1U,&4*10J**2!'H[R:ML+3"^I?#:6W
MIR1H4$I5Y$7<)+56,YYOBY^)TD&UQ*X@7%_AC5FPT= YEEY;HXX^';X_)&P
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M4KR?IQRTMF.>-T(!PEQEAM>NVAL^B+;NW"O7:D'9>;GO^>+9T&V7X<J+MJ%
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MJ_T><H_)K7E91-BA-.R^BQ?#BG7J]R%],%I:K;&+2EQ_O0>@'2L#CMO*FO<
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MC@)<>_Z'G?ST*>^$O] ^@DBN$*4-0F#X*V']RQTPK+A$>^*T1N;Z=4E V.B
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MQ)9ERH[$^52/P5C1@JJ9H&4P?FQB*VTPA23(OBMO%<.=,[-&K8>),NMG07N
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M=F:JXYB5,15RGZ]@#G3M3#Y>6?;Z&9$N3S6Q#KB&M9"9P:F^E3W=O26@RWL
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M+D)/+N(,4'!L:YFX8IP#C"44>!LDM]8N=L'KT]OR@T8^E 5O\M0W8$\!R?<
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MBJ+9AM1VLHL:N.Y-4XJIZ6E^]<<.CM[9W>]$9O$0^/$[.'[,\T+<^TQ8PCC
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M5%DG5M(;+%5]U\=[%B9UY&9E22CP]7L2T$FJ9<JWG8\-/&^:H=MM;C0+U]W
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M&R7 -L%//;'M![>*$'6?=9WGV[WGV*7[W_/),XEJ4>4#"NKB;XKA@>PQ]QH
MJ\Z!Y#/C;/\A65LBUO;]$,DX"%)URCDB- U$919\1_&M?J7[*N\9O=6MX:L=
MI4=+F/I]8RP(%OE0RQ2(P\.J:787+C[]^,00KWKMW^=F;YK=GG;@CM(OH5E9
M-6.0:1>UG)@>:M2DQOH$5H2:D2>=Q_JHX^KZL64#MG4$7FM&BRO=)'. F)=I
MY]!8<(Y4(4=M]DV7KZ@"8G"EYKEC#)=S1K 2L"VDW8M6W/#QJ6Z9Q:01;PSJ
MR=(^GH'8Y):D'()I\\*OG7SU23M#C58?YOH*9&83X!F@+R$F\V8X!ZI79<'A
M1W)K"%Q*OL3PP??@S,6AI:QCV"8/RG(EW W<IUY=']2^3P[M+LN'VB=\T7D(
M-E@A#)X7@& 79BF@N3(,_GDTV6#N:[?RXFE,/6@F)F#=[7'LN=_T_[AW_)D%
M&;NCE.*$.D+<44I/#GI>5](KW-R83OKJJIM!7SSU)^C+')]B=B6< =@P\* ?
M+:T)_<C$5B:MUA(614DX<03Y:V[P%G__,V@]N(83A"N.#A9:KPI8@\/*Z^DW
M+*N^+O=M+Y>*['JN_W1S^(]*Q6\79;:[.\!(NW]DC"4^*+]60M,Z?]$=\N5X
MYH5H6[L&PMR531E 7>$YF;7O;!?>J[\<Y<PQ<-@^MOH1TJB]R908'YE:L68K
M'\/R!GU:SG?9YSBOV;A4!9K$QA20.IKNBNJF(1PL8!.;"U5]^^TGC9\GV,%D
M$>,+.I^%;U#TS2W,)PZP;2D9GF_J>0DZSU:@^38Z-TJ\-IAY#46]5J?G!H!)
M (=IA_+R\G%62?)(XN>QD+3;TZMUA9;Y5-7KY7U]Z3ZJ2"=7;0-4W2, C7W]
M;0\/<60I8KI6R*]_@RHZ)J-_[A;]*=S9\RJB[DBWC>ECR1"1[^5T[GJG%46+
M@W"^_>LH>Z/%)O.+S<^WFZ!U?9F $TFVM;9%E EU.@*3%.#ED(L!MMD\#8UU
MWE%2/CHU9I2>@J?Z%"[ZM7)S5#$5PR8J,Y+VEHA ]EQ=HJG9H..5&I,Q$^NN
M&HC<;'UK;D=)!W1)%/M%HJD,>&/ .$2N?SV"NA;H[9/^U/4<2*%-/6L^E:FX
M,(4J:4K#8M4O37IZ]F><A)P=U/)90G9Q=:9C (PT_V(>S^-4BRS6/SZXP 7I
M(91Z1I8$E)>!CIT.>M^8,BNV2LT*T05&9HY<S,B3>%-U7.$MLH ZO7\2VWP2
MJMWG<8_6E4NXIR0?)S)+K$._B_<3)\Y&J^KZ7K6_\_$\WAP=O_#;@X'0!^&A
MWS?E)37(XEE+:"_W-)OCTW[:RX,9/;B^#OP/6N3]Y[G!PVST"_VKIIG3TBV=
MJ'1<M/SBJBPH8 YS!C'UQZ7+SVZ[%R1ZV6I0E?5;G'074I4E&JTMS;KB)KN0
MV!VE>Q)?IX!%"M:_2V&0)A!^^?VQ[9E@%P<;@SZ-OFG;@@[+1U+^5()/&=G^
MH18Q"(+'!24*#3HD\>(3N,'5=1,:^5J^+2[UWR\![<KU%-&/TV8T"8\<-_";
M)YNG;3/!,\E+PN*A^D71]E^-L@D.[MI1F1N\I9KAC)?1QRKUK!,@U^,[T)M^
MBR3P=TM#6BJ,DF=772)4O\9*I+LNJ%_M7,BH BZK&<<\_M"Y.B;=5/>RRRCA
M_=%D(PH>,7"1%-<1EVHW4["C!*#$6JC.:':FY&U<W,(59,R'R[R]MYMJ [:&
M#AWK2S9#V^UK2@V)T71]>F>JY-HB''_BY;/LV7;'*P#MA0%0(0(,>G"'PGB^
M]HQ2!;DF?\7<TOO 1IIO.VPD@/L1T,9>T>2I"PFN#0O>F:'>?<-3H;BDIE'F
MK-7W#8_;2.?JK2?..8-R\_K=FNLE[K7:WRYK:NO$WFBG-N'#B=IJ&HDJ(^BY
M//8=6?T#Y^P9#VV3XE*= @E;4W#\=8R!@&X +CG?9-9G%J^D=.3JY@N;3FD*
M.':0E_6%"V;H!ZJ577AX8D),4H&A?Y@"O&J12M\RV'!'X.)\.A%G;V+7Z'-[
M 0(ONEDF;<UN=M&[:YUL%IB588D0(6CYX6SF+*//+,.#1-V4@%-M0&M)/=O#
MPUX]EHI5&68Q!KKX6ROII8^2RMAFZ(:7;\P'\]"@()X;E]9.A!1(VIS2>EX3
M(IZ%3?9+F2CUAGHT%,[<Q?1BXP[P8D7.>K)V7KVYXM7Z%L+EFYH.DZ&66#A5
MU0JY,=#*;]YL[GNF+_Q[O1U<D:*1V>;R]NTSK$+:?G2KK[[MEV^:FO^,3/^E
M7"H1QRWGB_$%JW8%7K;J#' ?M@AX8M1*%7-3-21T-6H\?+MM@'2&3@9;Q%3V
M3_"&PC$ #>OT(]5$A4BX=FGN([5AVB>[!3\1QK6(#< %)XL-E[6OH7G'7MA
MC*H9@-B8+O_1IB4BK:-VHW]#WX'-+5_8WO@!Z'OT4[;W<V<P;+($UTIIB0M]
MTK82(8=K<=VKJ:VO/ L"G6Z 0P5FK[%XNB<F"8<@]^]39MG38_0$AA/GC-)_
MP'#J>RH2W&*3X,9O7D?P#U+J-E/M7W&"63"L"!,*;)H/9[\"/302 8_:)^XH
MO>4CL/6JG>JSG4NA_$K:Y>TUQJ(7I,&\P.[(E__))DLZ!K9I']KU5Y7OQ^T9
M+3J/[=F8S)@5\1Y**P( V:'U#L<UP6E"_3-#*(R5^REJ]QL*)MCC^[DK^M8]
MG,"S(6UE_1S[,JL""-7VG-F$>.5*%,,#K5M]VC')V?I*/7SLF4#+]+ L;.()
M7+^=TO!6)[(/9B:Q]QE/'%8?V#@6&^,>&I&\+:KK%)?WCB7C^%HE5 M-<O9L
M1\Z3BQ$XN2M9\V"T+3]"$I_D!KR;_AAYW>WX:#YL'/FQ(^M-V*%]G7+HS[#8
M??NK(U)AYUG'=/$./<7C";!@)@OOBS$U90!.-(U/C8H0(O/E*LVH9Q0"&Q0G
M+!*5%Q0V+OYU]^P83PP7G+LQ@TR,,KX<MNXBW5%Z$-%NU[G<&  57KJ=VC2$
MU^K943H]60LU/&15]>1JLDLUS_$X P-, AX_]&#N8/79\#E9H6QR@0W$2@:B
M8JH:EH*U$R:)#G*1\ND=I3ADZD+C8OB6TZV2^,AYI--0MG:<5^:;%GL-H?/!
MSGA^*G3JU;3/@?3[EJ''F=ZKM69;*1GS#1=;$ZW=LC/UY$G)QUKB-UR9S5($
M.0UQD*4Z;;5>MS&A$//-)#-X!EBO:@T5S;B (:S<XP2U)S;5>8_#3&>+RB!S
MQ(!_9^7\/^2S__/(9W_5(1@C*1'+$[6CS)&2O.GD2]+J;S/$',)7H_DNVOPM
M[WE>CTY%M#2@#[J_)Z7",2*7W)[A!AZSCYBW_:'=* B8<H#FXES0F5/=IQ/!
MJL"=TB!_"R90JL@W?EY>@=JU_*12^;+V#^H U,F^:9^:#$G;66?/4L@OP81#
MW\&X5<"^>X)H2S;@Z..-<;*C"H;S(-YES Z6H@-+ FK#Q,R2B7)8OLO<BC]6
MO\(OG0D%:JE+I5#E'A]$P;$&E]LU)HL]Z2%A$8AH#X\$38WWO1VC_KRYJ<D,
MR/')[OZF ^NR"HWL1SS'_+J;MRI?.C!8RQ5I<I-)54?_/O5[F*K3MCDJE93V
M6O.TVD%(G9[43OG#?S'IJ:D3P-?]!*HM8,0YLDY536LQ\PF0?,_@3&#(FN^-
MS")K#AHH05.]2HY60KWHH'%F>3E62M*F''^Y&ST6VY7B?,L@PU[B(! ,?78]
MU$/J38T>;*"0U':4SIZ&_IZSNW*U>+66HG+PF&]<EP14AI#;6WWJ:VV<Y%+A
M;8/9)GO'S"M.?"]CK-UC32Q@] 1;>6@/L7$KCO)(C,>R2*FASY>K_9K1F.%Z
M^P >H<\2)[] \0T.EKT(A&D\>];SY]&<C)'9K^EE5L?&UHP<)ET'3VFY#VU^
MKBB^R<(41L<8,A'""[D5^_UDOKL1-UUQPJ$!K>O0DRO-"TP&(F-]7TMD)WBN
M.OL0;9U/]*NK9]9%<2LIW!3J6"5VJN>K.EH$8:'=@;4 ,-V*]%([\BG?;.Z[
MQ.]&#X"<MKY_W]-] 9 V=J*M"C>+]'EUU58G-3P9:K.CY)!7C6L9YDD)CBA%
MU>L-%!(_K!(K;,M$/BJ-L!TJ$U4&"!GRA9;E8+%LE8'WM?&2F<U(?4BM^ )-
M^S$OP&8-P*?4_9_3][^%LO7PKYN_M8Y[(;^S#1&UC*.)FC*TC+/_YN/BCH*5
M5G+Q;.@%8Q^BRS4PV0DTTH,'RY;Q\*.8I/9QUU^U>S6]3"75JA]RK-DP<A6\
M_7>._[/+P6/J(A'H1E"B(*:SC)*2*C8G-0^J?F*:N7[U8.@WGRZ#W-E1.JKH
M"WT!NM1VDR_W!.>,<$5&,9]S[SDCLLPR=:!W(=(G#%/S'/1=0R#<^%S=+:&7
MV^N-HZ4ISB8879T3+5^OZ#S>@CZAVXQ50$+>9XVUCP<@/)# :K5HVU8!4,50
MYX((Y/T&;WG*#%]38E^5HX9,(5:W-OW0=RSN3_[SWX1%5NF),4? ,QL"CB?I
MSN8CP0OOH_5UR.\U5TYWO^H9K OLA!:0IL;D+*CP.E\"TD,5I,-SZ]&&B(WD
MH_4\@' A?;"A]0/GTG.\ZF8[RQ >UB7=J&UU-;0O+CJ%0X'N-4U-'I&6A' N
MK"PUL,E@#/Y*Q;#J4]3DJ;86P:=5\9?R;?:.DA6/.='09PO@;\8&+ WQ^ZAS
M6HX)%V9IZ%<B4A!16R/+XL$,VO%X"V?QV0/%FD**!C2,>#8]R",6@;U21>Y3
MD[/P ^FH]4"SR853)G!_:Q$.6TU\GA 4-H/+J7YW#UO]@6?OHWC;_@.N7NVM
M3E2W%ELN,!VV(S5O,DQ'OGIMM?WT7QP\[BLK8_S;DP9;KP?G#ZF0"$7T]HN!
ML):K54R]Q6UTN-^[+/O9!)W=D,(,7/T:_[ L]>"YO6-NLZ\"/OB2D6<OF<]"
M&#I!DX<J<@CGVB*>!CQ;WC;RFFT>2#1,2#)[FSX?E5:*STI;] / 2Q&5DWT^
M&I+0KS.9#P1$SF6OQ :77^M+P)F@PK3Y^R_]V;LS.X[L1!9J( ]O3<U/Y"G0
M'+]&\<&AFFH;B&]XE (<\;>!Z-AQA9I>[^.DY::41^$EZR4Z]5\Z*,YC9CU2
M*\,AUR\EVX2;'XI=6HE[UIPVO:D9/0'#K/INW2X!:\8%G+/$7BQBD"\VK]+5
M)\V67B&<E9\WJ(M-+L]4K@D]F &RX=K@67J"ZA4KYQ__^H]R!1S9OJ,\>UBA
M'"/4,;!<8ZV W1D?MZOFX9RN#1U[ 6L^&2)=)$XL(IL$\?&.$T(-WX745!)M
MZQ*BOON#K*[<;XT/LQ;.B>.LHU8B%[>UW/V,B[=O-%/(\2G9_ZQ64#IPT_8B
M#S'%_7:]OHN7+C?^R,KRU:LH-X)[D0!JV"1HS^O%CMG-;_)*TR>]!FILLFM?
MAB<W2NOK:S(Y<F+9CI(MHFR!EL!<]IV0"C+]QR1.D2Y.5W.&M;+?8=J\]3'3
M):6M0B[G'BI9TF?^.^5/+O"YB4ZDOO_X^_5A7NIM^[/YC01:#-R*-EL1,Q9C
M#&:6Z@2BJ5*\BP.WNZ%D_'AC&0 < D^R9I:WC],G-K\-(] &V]PS!J W\,IU
M6I'SN,21MOC3 :$PVW$Y73_5\C3G$H+ >%'HWRX2J6Q=_Q[V[NBG[/Z:G58L
MAALUHW8E+%VU.CNE4*;CL>QM;M0_ _<C]L;A<GZ O]<+FF /E_7-W<RMO6MP
M$[MEX+7]M=K%1=W4<,J1:=4RP,.[+7VF,V)_$E9 M[$)G)F<R;#1'*M^55@/
MD@:YM5F^P?QSA !;>?@V/>7\CA)&5+!N?%/H\K-=8_+>]8/)X]2O^G>4:C9=
M2/:T? *]Q';WZ8+0\88=)7S,CM+7.EOOYB^)=G<8(4K1N:,4?H7[W8X2A[P\
M*?^.F/M8[4]KZ//?%_4L%]93LY,VN\0>#>D1Z3+P P2[</0U(51-.]XOBL3L
M[S$CXFI]'Z??[%GK>/Y([QH]MS88_':,ZSIQ=3.O)6CM=)!IF((D+2<L3J&Q
MY>U%K.HJ-^_4&2GQZQ/))0?U)VL=NSUEKW?QE64]3B/?]?]B[\W#V4[;_F&]
M^\QT.FUU.J84Q3T,JK$4M0OW=*%%F=):$F1(46+?B233NPMJ2>V[W%/;M$1*
M)!$1F=IB-Z@$"2D12FRQ183XZ=S/^S[/_?Q^Q[L=O]_[QWN\U_$]\D]RY+RN
M\[RN<_E>YWE^?&9I\>&],^0XM?0$-?S,#1/=1XZ%4VM@!C4A(P/M:Z(C 0V^
M7!0D4=I845ADU63??71+-L;R$&?L75N^%RM1524W/PR<' M.V!H8V!U8RFX8
M4[I_0<8\^F:;JN^:(-B,HD-*$<+@R/EVNZOEZ-__>\7QOWJ<<!ONX=P9ID/,
M6G]==O=!XL8?P\.RU^*)2FIWQE2>194P1(M?X!7HVYK;\<D:[<_]%&RR<V&0
M8!2U!I($6+BT@)'>LU8LB<,_FH36W]WD=2C77!>3(XZ]%T9#TLF$3<DYXC0,
MBWVIBFRA?<EI3_5Q0?G]GCA\8[>-\]J"\INXYJ9]#BO&Z5'XT.\=#4'1),])
M@=6/3UK(]60/9R(/ZA<@[2Z$7G65(47>SP,H,-+U#,(]+]/[66LGR&,?PF*+
MP@=$0#\=1V$U'OAI-37#AS>S"J-.\J8@<SQZT&&N VPM!AO$9:TZ7?WCL<CJ
MJ?%0_^W>Z_N#NP50M![2JL.EN1W_CK$P42#FF[DG?$-6.)**-:A(+\$2$>6+
M&L-1'M6+%U?M&8G\H '&B%5\8:%K72X1,&3175 WX)"@8:X^8'7^=ZGK14*I
M;1V+"FYM>63P92V_3:NGO"2W9H*US;?U]V+B/4SVD@U('NT&!?,-\04Z_1/>
M&8CO(3TW'A[X7'RR&[#@U*.L%4(LTIF>$FB;&1.9M51]^0@X/D<I4(DF#26"
M43^$(>_2WV2.55ON$,VVA]MQ&[47UFJ9T:MFO_QW C58?^\D(S(IEMS?"4.7
MQB:8NB?5ANDD&\^;[K95F=9X?])A!@XDG.5=L>MJ+5$H^;;AN6(;*V[7XQ(#
MB @=J8S/&"IQ.B^R3A@08W5RSEDTOS$\6( ?7'ZPN61<%E;C ,6N;FM#%.;B
M]VS/];;UCAEE %3N!7ZJ@Q\:+J26=Y6WRCV+\,;/>MK6-QN7R&5N#)WN;BJ]
M^?)Q^!OKOL"]=24&-RAZGYTX7=:/)R4_20V=5C>SB]S=[R/DP4";*BF"<XNR
M<_)[-1=Z@RF'0V!>;P*?L!Y(P ++C(O*,]&J%/_!@HCBR2T'EM&J<9/(/\ #
M@YB:T>PY7O@IE\4D?DI,\AD>,'7B<C*XR]3V]$BPR.3J? E\O*%^]-/V'LDP
M5E[DDAX0^5,#.HA0^;T\FZQWYX9!Z1L%<7R8-"<"(5&6Z]"'F'S#?E1O&<]7
MF!(V+8'HU0'UT2G\HA1$^&Q_\Z#G)8#Q(/R6JUJ]?^*OGII]3CTT?=&Y=7:Y
MBT+PGO!.N&*)SJD[&Y?[9PJ,6@#"U3'KPDAMF$G]+.H>N>G="F=P/Z;TFF"5
M.WN#]XF+]!4^M%3:P/O,HG1LAN!%"<E1%]O6K]MVM]K:7'7H='K;5==E-!H2
M2+S[<E!,P)B%_3+W$:SG-A+"VR[-WQSV@R[#)GEE 15>:AZ!(>_^8R\(]>1;
M;!/F"UXA3/XX2#2[/K&+\Q%D*EFVNMOPIAUK O$-TC_V:,K;S*-TZ-<O] Y3
M0=W>+--1'-&[/(]))A7&'KSI5Y0\F@Y<)H(]BZ(QKPDP8%]B)(1R9VM*V4JM
MM>;\!&]F?J^Y89!J>&%$>65)>?G#FA$]FGTS\[$IYO+O^%HN&W+W+;=%R1\(
M<$#$EMQ]"@77_MY@QR!4E3I<?@Q&'TE!%4PG*=,!G-#&]3C7DC7\HV,Y\PDX
M0YB#:,'?#VSPJ,TSOS\[IC>PJ&AS8 BO&[*(_+RTFV-K:>OG!R(AERQ#?^_=
M'7.IY)5-]C5HQ4W;,TTFFSZRI7="7$;S:YZ'H3>ONC8*7:-[:VI(+ AB<=>*
MM[8VEA[E[;XGTE_5'\XA*U.NPU@XU*D*"@MWZ\WLT+ #O/S[Q_QB+HZ\@=WB
MKZMZM[PQ_9.A]HNK4)[DX+QA\T7^5E7$YO[- GY$;>0VMG\K'VY]KY6F^! ;
ML3+$F8\1Y+Y9LFC*TX* P#55RKO=$TLYOT1<I7O%Q6.!2CDD@IHWF4\K!GX
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M^Q.FE 7BW1^[)8(T0;I.6 G-S00"AI#>]IIH??/O"3%GSXFN"9RM_.+!TT#
MD^=0O9)'CZVKE;PB=P)/0W?=SI3%M4*5AVY1H:F.-Z.4UUX?3HUZ#]S+F-I/
MW/\!?3IA*.$\IAFETAN(.Y_>5AM1$WJ6=O*'@5BA47J#$K'*H]Y[#I(=WZ8T
M7>, 7%N5-$[+K">%.=QH:$U/2G=(VRN*U8/Z0;TIZ)R,K*#82/U-[2'7=7>:
M_SPT<ISOIN;>9U"E+G_L* *]HK"UB5U+^M<+&1KFOKZ)U9I$=9\Y7ZC[4BK2
MB?\Y@?[/6J6-/VN5OF/Y?S*S_;-627&&'V:O JWB?,(+=HL11)JJ=174Q*NA
MBY3X86FO>UX+LO8?Q4JCY-B$!I:R'<@(NQ1?/$7,G"#X^T)[];H=H@<S)QH[
MP4JO/Y/6N%Z(<= F[?5ME62*!'.<;U?A;H0]KX)?J]H4IRU=OOV)9&4]8=X*
M-NH?[FX7VO$R+?H%?N?*B=[X9\'S]LKXO!78-EJC%;RQ'C.+,UW\B)<EG>X5
M>M7?W;<T+AH]]@U?'ON&;V/J('>P?"QB0?E<SM\C "$U'BS69]\0/[F$>[!O
MM%P8K'[IVG^Q8\<AMI/*==1?XR7G]TCX#^&#7?I)3]8MO>BGEM/<28'WT'+O
M\W4HE^GX6CM/DF5BQ+G0=MD=H;4=8=IOSI6XYD'*6BFS/+G1)_D^*L-P72 D
M!R2#R'&&^AN1CBUS+-%A2*UAO.0E:2GM7LP4V?[)\*6Y^\$-]?2S7;AY3%7-
M>K4YLEJ3=#LF.[=&R\ZYKNHJPSFW%M3GC$7 M%S;"%@82&(4HZJJ>CVS<N.S
M=3N,V#30-]#VFX-0,_(R$ADVQH[ R<D>>@_>E(U'=O$C,_K=L)X9ZO(V3;E^
M=JYY.R@=T S>OO/>L03*"PO+FPM74U$:JM"[2ZG@D$ZBF44FH#M61'B&-RY%
MW6OHSVMVGFZ97X0U-(8Q9)?X=VZ00IFC&'9%*HO]X#UU\*G*5G1_(OVUCO[7
M'?D-GOEU,;>KK6!_0O%*I0NG3X@K]HZD#FPF#XNVN@B[/Q[&SJ%>UPC2M<YT
MX(:*CJ1.28 _/8]6^A.%A@#IS%C<QG3IR9OI,;I[)*_VA*/B85SRD=1HP9$4
M.(:F.+P_0:N)DIR+VE+^A,REV30=!''=+$(DMD-)D,!*^MNYDK>!P(CIX>P6
MI^,H"[17!81\RX;N>XK49EH[OE?H:/\7*7^E<MA;MA[0T,KA*EG7#>0=NJ'+
MW*H^! L.!66MR)@)$JI&L3^?FI,+52RUU42#RP!VC@7!0WD'0*"YV4I%?_ZL
MM_("MZBV.E2SE5IKY6EJQ;N'$F250_%WGXW,2OIB#Y19M;;MP_G^5D3:E];/
M9VRS'BL>N_LG'V&^ 49$-2'MDFYQ-[K+;U/U J&QP/UNX]JS<,2]:M9NL$&8
MXX%?$%MG7F 1G0%;NLK.A8;2G'^Z;64J</\HD1$,#@SEY 28JN%J>,;UG#MC
M-;4_B)H8 16NM$$+=$ZD9%GBB1C&%]8(\L%D ]P__KG>_W?NX1IQ>4/GK:@B
MI2VU'R.G0^Q]9BSQI<X&E4N@#GR]^TIMG'5I3V]!%3^I,:=FR=DJ^_ 2N*92
MC7$D]:5I>H33UWO2"YK>Z]+T8ZF[,4]EFU.],11@E \YP 3W4=%>=(U!\]FP
M?LGLNQ=P3.S;6K&GA0V#0DBJ6X()L8QUO8^73^%C\G6=1GDM,8O?LP2( <&O
M:U7J#L6Q_G+C!^H@Q*5$U]R=G>JV"4_ER(W0,W2^3/6YH1!JS?IVO1W_TX[<
MV-@59B>"! \A3M/_\/Z X=QR0%16__SK;_^E3]<)INB\SERKK4)1*RXG0J*?
M?,6;?+GM)ID9&%$5IDQ\@XRF-?9V$]P]L'MP/G]))0F! #[>"8D%#ZX>>O=+
M>TZ:FVN!O1,36P RS,JE3TC!7&]^=!<8E#1BN(69 ?;MT70Z#WVZ$C2>YOP,
M#^G?:H5'U$_[PD/%DER:(;:W%[]*V>:MXBC;5,*VQ(Y6@LW?\D,]I'852#NI
M\X.<;"&W7__0IEU80\DG8EL%^EML\<#!?U5S__/'5S<0@X>*A]]LIE5;+$*>
M;AN5#8^3/2$1.:%6GWA1NK^Q;@PYNCHL@1CC_ /;@J45<"55R]3'KF%G=WCL
M5^4>=M?FFA-G<P8,*_%I3<]#:^@,QJ2@K_MUY0?TFF0DSEZ+3VC=:;4P[AO;
M>#?/L"(*#MY.(3X$,$:^E_H+'?TL4XQ#'D1$&X>&!BR(5!Y\7&DQS!XE:2:Z
M"UM&#ZEQLH3(U>&Q,OYT5%XES1HR7[8\6MY4!?!VA?\8R1'"NKS5T4IPBM=J
M+84^61>0N7MWVR:^_\+"LU.#8KU7@H.=E#%EC_0LL:1((I>H"+TQ^$A*206?
M>"2%CAT&;TFPO.8CJ9*YZ:QVLM/)^<*9K+RP3^38'(L?"20%QSQTF[O%Z5&K
MI@/ IYZ-3,V6CZUN(=W&+M,S(2:7MJ 8=8&W'J3$'4$4;8;$?<>>^]2;*7B\
MS8A!E[YUP;>(7^WH/=H]_W!S)7YNLYZPP*[]9=/S,9,A:\*^F5!&WV6L]A_N
M-"_RUYR-)';TT?K!\$Q- C=)$]8=:S@S&;J[=TQ!QV!4#U+TV".$F 3'M@&'
M=$L]M&31MU]K6#UJL5 5_W>2/$T_;"Z7M?VM-7'>&[2E\U![BZ,*\[+^HOY>
ML:VA_=AE6( IF!K46*G'=<-LL@%%))^K=G(;,2VL#5SE\B*:X&0]?'DAR3/G
M75NKR?,#[2FGVT(/P/@\QB73MP$8D50$ ]Z)PC33^DCCLX4U:Y?,0Q9[]0]
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MQZVP!-P?6.2AD\]4I@>B Y)%K0]>TC%WQC[G^I3QSHZ-'J\Y.XZE->:6@"H
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M8 ?'L=)[$_O:5K#E8VH $U7O1BPBP%QB]'8HQ!ALI?)W8\I9]W<AM>,.,5B
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M6.K%(,MQ3Y_^("(P[UUG>BPG/WTYGVZI%Y6/3/[RKO"- 0'8W17\F=P7?B@
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MH6G#TJ4-#MXSKWI!69WK4C0=I*)_CRN[M^;EM>)6*@8:E@)?;4\]7MBL.CT
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M^M=HP<Z> W67!6^ 2DJ*)M^A=>SRP]T,:(4S-?,F)A5M'-_#">=<'#O^;Q-
M(RDWO,_DM57?3L&JVS]^GVQT3E^@1A?CGZ+73P\3C;+<212[XJ5<'JP@7&"D
MJ6F8'ID]9^V13= DYG)CVQ@QZVI?>?6R>V,()OU4Q)B@Y!RM!F%J"OQ)8<S
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M0^05B=O=,L85>T_X*/Z;:38V6$M>(WPJ5YU0TG!X%ND]9G-GK<SUUB!YF:@
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M9T0]G.Z/F@+6#MS>N;0VY+LU6&SWV-L8]Q<[IAMXYAX'E?1CE-^0.MS)X4B
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M?7-B[3OHT<KF.XEA)[G"=D'S=.2JG;_=RU^LTEA)-S,JUM*6Z%M8*O%,G'>
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M<_U,Q4 &$:$YF0K,EAE%MR=N*(-:$FYH.XM:-\VND:L%:?<_LIOH-?S!C?/
MR' (8 5LX99\<GEU23K@N[PZ!BR5MSZ:'J;[]M%,O$"5;_YDGLW%_ED8]C-<
M][FE/C((+DHS00;DD:E?\;B%D>L^).S9K0OKN-ZXX);Q-L#Q.@H0E0"5KD@Y
MAYPWP@77NH-CW;P.U=SNUD,@*^L'FZR!T.N#Z0S;QK8BC+M3N7]:9ULTHI*
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MS4;@CD8M2JFYW7T\*6]' [ZCP42)GLE\C@;_CRC5K8N5* \JJWF3P?>[;8:
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M0BO#P=!>W%P(&E>/#Z&]@]>!4NIR<.Q(L UL2RSMJJYXI1/0G]Z?_KVB= +
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MJT(/L<B4@E<"B8F3NS;"!9:0G?.FG7K6W4ZQ1.AI()B*@^7F<<>_F0:X-<P
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M3F+,8F)+2259LOH^12 R*N6%43WY\9/!NH' 3E^G4\>V$,WLMK$)!)6"!'B
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MO^+MU,7]Y1D3T#Z?1]=<5HF_\RBR;G<Z@@RH3T3HP5BQQU*G58[:K=6ZZ[5
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M&>;#CH,TW+NCP1 !SD4H'5NPI>!=648R9S^.\\&O$B^LZ*H6>")J/K-1M3U
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M# /:AD7#4*T8Q.LH,0Y4VNWL\.KL\$@WHC<5D"NS!#P.0V?A>>G56-V@7_^
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MM56B2]07:H^6G++>=YB&T\$[/J"?W+PZ8[J2^5%-F5.3'N(%OY U)EJ:RUP
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M@DL +@&&/<31@*;L]/S\*HR &/J %$H[A3/JT7XFD%0#$S(QE5:)HX%+.S!
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MO85C*=<V&H$]#7XP)#,1PU< J<_.U?;PQV3+!YU\GB*'CJ4^I?,C(T6R@FJ
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MX:U*"]A[:EZK#OY-8<S(P^AI=\W!^\(,:\^&D4?]#S@;+BY-'J*$HK@C*7E
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MG-"<4TZ*O8($W&70K4V)N*NN0MV[L:OK+PO;KN+K"U7I/VWGFYBFI(TD D6
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M[ICH5T1BDN+Q8JM!I]OLK)&1_&^1HJ=8F19P,58/X>XBG?@T9(-VJGX7JLJ
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MDI*O>/^.&>(5-BMAZ/+T4'[./H AS],X49PIT 'RYH;#Q6(UN?S*:?^LC-C
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M\X-$Y]E&QG^><.9@;F%]PL]F'ACCO"F*&1_*K]_G]X@[;/(7G73'^\F=AA_
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M+8$4 L08$^Z$7(!:14 @$9$[A%.Y52%@N"1 "*ERB5Q3B"20!) $"! 2"-=
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M^=1TW2D,9:MWXIJ"<7A:/AURV>!-,S'P6*=YN#)&J-L*Z_.;:\13+?40\]Z
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M6#,*"J^H&9]+I"1,5JN,?E2@QWE+L:\8]L.#3MM[QUV J=S)TKQH)>7]LE3
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MC;AF40D\<;=W8E" LEQ!0SDB]$:!18ZHIK\Z+\K"M+>^6*;"?=\>/.MD-4"
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M\&&3<#4U=<W-QR[N\7B4YR,%Z:X_L,%>$QX[1PB$+:WHH):1V,&DOT<[3K[
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MM+ZSHV;+2@<0M;7K>*>F*,O.]_:V@M!8D%:CHZ7 ,'0NKA0+5]PK!G<-=3K
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M8CS>>'A8C=41 J(\8+I=[$KN^&;*%@ZA7ZQI"$YD"T,"%C!>P4GN%V+GG'C
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MOB8QMEX/$I;>C)5T6N$"W X[[.C#D@:!2>@BXWO!Y,"1VU6T8;Q!YF2:<S*
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M!?SI/T#OH59M05S]U[UD/J,DEN@0EK4*]T3LO%@#R!!6#1Z5K >K]1&+5FF
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MYK@#US+2\>1.X+U[">CF.WO_,86?PB&MG2IYTQ;YL3Y H#W,N&(3JS+5<F:
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M_K[*$"*N9I,^LD?XB,A1SJ*691/%[(Y^D-6[[1>/15O:H1X5:I=NM Z-"8?
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M K8U=_( 3CX6O&_J)V>IA?6>8^.>8SR? FKADO/?*)"9B_Y#JH]K;GW_L."
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M&T[YYNCI-ZQVH-ZK!KSW*IR;=-ZT]E^#!4QSK$LWTDW>K0"-(YCRJ,M5KSI
M[ AJ-/EX<?A"\T&C4";C-V6WYQH >W=\)CIC#'6G]^I>QZ?T?%#;8^'+X(M[
M9&%NID]0:]#$K3P^X@:ZK54XI_V88[ 991?"\FO:7EM\\M_^.V9NS0\[F#&]
MLA8G'TKYNBX9ZZ@ON5&IJ=M^-*@AJAA[[#[*UH Y^I([:JU5DYI?V#A8[^3L
MEQ@/ +GY#+,F'\PY7A@4]+3-!1G9+<67RI\.$QM\<9E0(@,HB,T45W=<]_4Q
M.?@XR_K^Y/Q!_,4YV*#DB?(&_-1<.N6RZM?_AY+GW_C7AN4II?N4:#_. 2AQ
M&C;1E08M+:ARM?/?X8O36T.I>^V6V 769SU[<+"(XVC_$-0_7E,SRK\WM</-
MRTG]H%!5VFX<3,4,F15)%-&;7RJF!-(51#V[=M 1=#=Q 3<0W\LW>5[0S);D
M B!@NW EW'U;?P&Y.R[=*6VDTV[?_DWERJ<]>'U;44;E/C?HSW%<#_FJ8XLD
M@>]>MB,)8'5)DC17<*H&,\FNX*K00!_#W^Y+@B%[@&^O;;8[YF<C/&$5B3[I
M,223B&U8)K,UD&M$2O:$:8MK=-SVO>U[4#J!5W$9Q>D9X9=7@+F>N6ESJSZ>
M*?GC/RB[%P!_L;.@;^GF ?_"2Q5QP7;R9K.PJ-1X(_&V3["F'SH\K+.A;U2V
M,ATMB[*V\WQ4-^9'!8X0LMN2BZ3^7-._*-559@((+.L 1L^"8,;>@\M*D)7F
MUGDG(Y(6'H"088:40.MR#_X)KB=NYNI@+D=-@6:50:L-J1<798 !%96O29N?
M[$7WLW(EI"+&W1>%N)(EXLU"TSC2:YK_3-RA2FRX41YYG$M]KN&C_I?QRY2T
MT!Q_[T@RF58.VRZ_U44QS=RU2*C5&G[=07> &;2E/9[!WH9+!RG$0E+UEF4V
M>K&492-?KK[BX=&&9;5#FO:*Z?CUMC-;%DXW<^WTA34W0.6N"Y6A6CTUJ/_X
MSW0PL%UV6A5GO5VO<'^3=I'^C?FVU7,-9CH+TRN",<\F&M3H%*VL!P+?DLFH
MI*Z\17F2K[BX#E)3GO$YHN.ZP9")Q;?XIOB_^TR$L6?,C&9X\,3RI<A;#!LY
MT$HPHN=XL47)"C2Q**XNZJC+3.04SFL3F FIF'F@+?S4*)#V9!4TG&@X'>>Q
M %@W<[[W7WCZAF33?JTM>EG];^Y%\6:&CWV,^<&BUM<[Y;FB[@&98V)A!,W$
MV7_0L_^#@/*.VCUO)=5BM(<B[T&3DHWL2[^BA,@RIN<?:XW.^*AMJW_25=U7
MA VDMWG<Z]*]BW0\,^=H:B=-CELXD^5OX:#[(VIK,NUN$['D&>;,_ R/ R1+
MZF/9S_W^;,_^((R=OL9<2_Z#UD,R^JH8&,521IO%L3U6!(+2985ZB,34]S':
M0P%FTOOHCYU->ET 4<4/K&%+E6W)"<VCN5?M?*9K'CF0I]._V+;^O(8X0T><
MPL<E8,%%26NY'3Z9AC,S]0L:-R90J2@+U*>S^]@_O!'P61]%B)^A&#PX1WK:
MH) "35*_X4;^+_:RINO6PO:]54VQZ&?PNQ^N ,:!QVGC'.OBV.)OQB;)+W=H
MBFOT5L4?FW?\BK>L 8P'EB\4XY3D3RVX^(J>#GNTJ5]ZVZUE2.&>%]\K=2 E
MO]3(TSQBA6LPX7+7PL<W>VPFZ5F8&>0_&"'(L]RM36-9@MQ^<Q>WH3\E>;*@
MO/G\?9T2V@BM\9O>"IUGY>#0D;[*DUESW"N;=GM@=3K6?ZD.ZC,F4--;:CQ#
M>9L@1PGI,1" \H6Q[-5\/J&WN!XI*A#;7*]PV)TF627$=&.N#X 3B<?]H6>3
M$.'GG]G#4_6GX1P;^9G>(#HQ7^URQ]FIBNL/P];!$W!7_,.$!0)#;5;IE:_C
M#&LR^.8?+:,!W#;<IK]'_:EADQ$Z&K\F%$L(3V;O!<SXM^U((G,I8\[%QON8
M 8F=%-<G6VZ$0M /C\C1=^L!6K53SFCB4.?6][+M@8I#E? 42#;32[LOIHH1
M6E<=L"[EH-Q3OV!M2UEU"]R\IR$AUCH0R?Z2>IG"VFYZ>C]U ?LH8><)COT2
MAS5,_"-;;Z](P0;L6J/XJ2ML*\%2*1(!\":%#5E9VFD'1 PIK!YFO5^I1?BP
M8L_=I4.JLK(B!,#1PMY=Q5!,\4U;< $][>G631M#$WDM=>PV4;^:1T.N!F'.
M+ &I30/K'T+Z*36#KG395MBD5>NEF^8N'1:SI=)2)7LHP1V:_.?_;)!/OG&B
M+G6#5ALD/./5] *I8\>)E?[O=SHR0 9LHFE:1$RV\< 7FE3,BU H8.=BMQ$^
M'WVUID/3POH/ZQ\R8D?*[0ERY:&*WFJN#FA<Y'FH<J8CV2"?$T@]G^7%:)!>
MV01H%Q&NC/Y'S*'*Z6UK5=()EE.<P(NJO,5PZJ3FS3]I,KP\'ZWU\4..KM[*
MUC<:NI.M[];WL>Z+:5Y37V7D\[&I-(CYXL; @G9("[:,Y& TQRIJ#7?4IE:G
M.:]YHH7QHS$]#$#9P5\*M?J=.)C.!JF&<^SL;F5J:P+-:"M@]%YP_TA^_7Y2
M_I1JNNZ'W.,;CL%!Y63(3*!@-P<Z?>LJ_N[?,>M@CPG[*Y!OXG[ V;K\_>"[
MZ2A;J.<<TB3-.-4D+5F-LW[;Q-'0ZIW*L1_W*>TG?(Z"^_>69"<LH?G4:A[!
M[HAMD7A'HU6=>&\# NQ^!'<:&1IJV'GXIW7 L4X;_G=N5QZ]=W7>KW>XL5X:
MF1#5=27E3_$Q2U=WX#F1P?@;(&);;/?FJP$/S[!3L"=:,,:#R "U80V(6<U[
MP%**T1KO;5%G_O/_P]C^;_RKXX])ARIVF&/]W4XF5*W=1PN_/!QQ_"Y(L*%Z
M_/$1D[94B/I<;!\EIF%+N\X;X>Y+C=M%YA!P)YK!9"PJL(F"#7M*-)E@U6"&
M</II&%N#-NNT?,: PR5 NBF9T!@RDNH,YQ&1_D/V P,#(FT2TG[=*Z64V7$I
MLOE-6=PD<HU D9;M_Y$QEF-(\^4F3;_H^1$YI5*HRD^?%]CX6 FWS,;+W_J*
MM3-*\0-V^M90S*N&E[+COB.]LQ4GA;LCA+IS HY/QO;>\2 J@0-+QPB,8O2#
M/Z]E47P>D[MM,$ZG$IR!\>7^O+.K &VK+F*)$JYM84, ]K,]=EJ]86XSI<Z"
M_3= ]#FQ?=(^1^MF-)P/^86V!'N6PM$N]%BXEG=9167UY/[[R;95GQK[X\]V
M?;[7YGTFR[4O9&TF#.^8#W05]H)[N2A+]:7QM[1''>+RE.3S.WN9G6G%@TQ*
MS$B[R&W>%E'27&.T(B291R)VVB\V]:N_6%L %E4],["LDEJX\WR7;G&T2=ZL
M1'RZ8F7)BE,=CN8ZH0T'S>L]T-UU%Y6&/2>9RW5O@Q+%ARJA?H5"[-G!/9Z6
MI*@A(F1QFWUL/( 1DZ7TO!KA)7>ZV-))\P^DN!<CTLL?')CT>LNS"FH";%4K
M;7R<5IG\TF:/A2S+V';;2F2Z2>QZ"6F4X[I8J<]P)<S84Q\]GG8 H7HVKHJ0
M!R;/J^T1/TCK=QS#X<!;/=RIWO],&"=W:Q)TDI*'1<]F;9A>6\_:@ %\ZB<I
ME[R$?)\+OD/"_IB<W[M( $#^3D4$E!_AF0%9PP-TA_74]4G)2%+^V:WL;1$W
MVCC(7NQ3J=7.K'LZ5MWAPFV_OK34I7O[;?BU2<<CJIIR.6%A9)+\,_/[FA%)
MXIE<TW  A&MM++E&MXWU82[!M%K!LW/LDZ\\-_(GVU,+]<&WDL*BD76Z&KB
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MPF*,3]*M2ANX:PR8_T3Q$PK23YYUH[M[H[O>P*&@/Y<>-0#6?F9@8%=M6&T
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M()Q5V$FTCH>))"0LY#ZXL)5*=+:@V7"O5 '<AM\%^$7!>@+&D.!I1L@H)<R
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MGAL1.!G<=P<!ZB&U C'?9>!ZRAD6[QR._D<+Z<<UML^"\8KB4YY6S*?9481
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MT3-Q9WQP4$W%))IO_"Z)8;05%Y B2-</E5HE]"Z ! 6$Q_SNDZ>8QH,J[FL
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M(KM<TK+K40KU%F_\Y?7>-*+5IL<:'93:71C'N>ZAV>I\T'CMF,WUC,;\(1A
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M-"MO$U\U/A$JP 6&O?Q];.\^#N%ELA-NWJ^<N[-VWTM[A%CDJD/L+8-F9U\
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ME^5QA?.IGMCDX5R0A/"-K^LVS.5 ROA3S_U+':+4F#$'T28\\6KSI)+])4_
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M=W&TCI9&W\OD8 =#Y\1<NN_O?C66O4H^''IOBU"Z%C,DKCW:/-U,N!<F\.6
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MZ-> *QFB9=>$X#,%TT)PYMVZ3:H]Z0JOAI% \(8$LVN]L4^R-XL,HM-.\?S
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M_(',CLF&F U^)TAP>PU[>[NA_]($ V(T7)^-H2Y+)FF'N!83%8@)1M0BU#$
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M%=2\YOH]2@>+8MJ@V:5"@F)"C0_(EDQ8*M\CDD"MA(JTK!BXV]&L2S4\"4L
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M&\@%KB<#'-,7]H[&-=,+/E8;=& A NTCU5,I@V9'/D5-453C%\'#Q5LK]+2
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M;Z0N2;0OTW'J#8GI;B,7G2-L19H<A^R8"5]6-\4(;R&D%E +,A)"W9A?4 -
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M(<KW@ZY?5PP0Q;;-"%H%L>BG+!BEA).R>2_N7HSC8UNUC(0__OL3W'_B?P+
MYOEV&O'KRXZ?4<<[?Y"T%I6)#-X=Q: IW!IZ\::<=Z+@UC09M0%,<T8WV);H
M3J;"^H:X8+[#M^0<F.3-^^FX&7<!+FS)34O5O= \P4Q6ZW9D9Z;?J'&W2%5^
MAN$BK$?6-;24\JI_G9_R3GD7?7"$>5A-!3>T[@!HGCN+I(=W55AB\F$_45F/
MLF:D4M>^[5UC7(LVW"!YUS\_K'TAHNWD@ZD+@+K'Y.&;F^L<10J^DB3A'R!A
MHL:(.Y[5DDTV%UQ (8]M=D(DB3I8MYR9%OH8@K=Z"R@KP57HEL:LOF2B7>X
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M6]YDP#M  R\;$Y]Z_4=/__LJ/5/9YDX?QG%+12TJ:H@QL#_%>,<-+:Z!HI-
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M(C:T_9X8"0\AQ#)U='2D?1N9@6=C*L]87EVM8 %$<<8O/"*RO3-!%67IY64
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M?8[FPP"3S;O1(N"-]CYGIP-S71[77G=6PQHYH@L+C><V4Q#Z0:T;!I\=[N1
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MJN5?76;WM1!F(NE;U&9.,'FS';J[92%*I,JB3*F8Z;R!4<^QU6U2IL>3I,<
M^I-[R73R<KKL+7< U)Q,_&5K=_K)RWM[B=GGG?2L9OK7>X)C@FY='>_Q?RF+
M-.P>#-AFE+5(NZG@>YK=G+(+)0T^V0[8NL/5TX)!]V,ZV0<S<E61@^/[6K;5
M>7Y9> >26Z4YTPVR8UV8G2+D.^QK70#K&[B'Q$1EY$QN2R*:!2?B3(:V7&[@
M2*RO=N8DZ=NZL.Z@CEW]X5GS<]GV6PV0("?K'RB6MZB)&NT,1U3#5BHJFUBA
MQ!>0@BN@KOYL4PK,;-F7*-X+V'/M3'\U.KAA]Y^68:30P0M3J9_572_UX:!O
M66<?82WIPEX&M?Z7N,%/K!]0S'^/>R!WK$YT?V9"Q@Y1XDM)<%10,KH1B9BL
M5+Y24R5NO]_UB]C7.D4=+__]LM^.0'-&?G'ODX&<+01F,3NGIS=MEYFPK;NO
M=?JC^.;34*IEA7 ON8NZKY6&F==[9KQVQ&)?JVGQX_/=60%56HUZ150:+X'-
MJ$;'\AO =IIDG(G/< ?J;D+E"*-D"]]Y=+Q$"-XQ]_EH.>:-CBI^ML,N_I\B
M8-9='U(B/1SJ3OI0;J480O2#;M8G[>B4-YB+P7&GL?\S@&#6Z'-%Z\<(ECMD
ML-"#/YO]_;Y6RHC,6QFI';61)H<U#;: @&7NV9*7_D>;'6;3N)Q\3+(X+*#C
MS?NMP=0[/P.!@S>($M0.U,M7KWTYWP7/Q?YE1&<K=)N RIY>\(!*0, E-_\B
M0B<E*PJ%N9O1LB']DZ+W/=NTPG!V6.GYCOC%3 NJL2?*J+*M).K<].#>\P0C
M0$@$,32H%">KTPX+9MS$-D#+.&H[Q>MJ8&C?VCPK&Y72B7;?6%GG+T$]8G^I
M*1I-99(?$S87L=YD2/KR7]7%>^[)_/"MU.*WO/!-"JI=Y<GJ#3?8\ R>EJD\
M&2V# @_^2%:33(4!LCG@V)ZUK7$)LL3][W0L;NC-*RB>1G^>O*GJ/>FJMF?3
MZ]A ;85DSUXB%O7N:^FVK=4"=RXJ)G)]^>^H^FIZ3@C;;GUS45WX23\D]4()
M!(];62&Z\S\$GSN.@P?8DS8M? (<R&+Q-53L:LX8D2G4A#^YO<*>9#N"6YCD
MB##1]"0>GK)*FZ<?PRP33T _Y(4SV<?WM?J6HK#GU5BG'0JNY>!\(292HIIH
MQXRX49V2MLC9**%T]KU(U7=1"<>*DOA?QLSNJ.M$SFKH59B;=12:D%QK0I/%
MXZ*,&!98$/5+3IYXNG['Q+\V=W5G88U7Q*Q.LUMJ 7C$\;*3])1/N.SE(TOE
MY^5&S?*>1X+A]F9;LT&W3Y]++0/:R+X)C4%]K:T$VWQ+?R-9Q)>LX-/2!LC)
MH,/4J-6B^:7#EA1> FR@M[;]B.MV:O"?.2.;R$"AZ$YK>L9K$;/<:F%#U.P]
MVD)UR$6PE_.$!RJ1T"#$H_[Y+B<R;_7(\<G=\)?;F2H5TK 3KCV3:.$Q'-2!
M)3K64D? 88S21DG?;HW[7Z<@CO.I].=NB5(GW1WQ2>A5]6= [;/K2U:5KYTP
MEOB,?Y:?/E#6,KMZ%AT^L>P1IM0F]U/%6RFV$@H,_\Z'@)YF71=TX\://-/9
MR[Z^XVU4NIUY43TU6,)WAC^F&*T5F#VY[Z]7*-\$FPY MY&&34ZKJGA*+:DL
M_,"?Y]0Y2ZE=%AX@80Q2F8NI&KA6.!)%'*.V<F*7)(XG;^:W)6V[!&\D)9X]
M>)_P!7AXB)2Z._-FLFNPM*1)=(*!&?(2YNF>/R'0U6=5U+VT.';,D'S,\.@0
MBU"?!CUVO/ M EBG^N^J0/N^R%/?_<?UBRFJ![^X0ENS@F\=E ^.8@XM<"([
M\8&)]_,%EMLJ%L >D4GK3-A+<S,SF@1,;)6+ MF@I2,P8>$-C@9;L:..+#,O
MB&(MXF#PYGIZ]L92 \PC%I71[^CN@=Z51J0W;04>L_M02-HY$SXLITM>K&^T
M-CTBK!]$I^QK%79;4*;OB!)D,Y+"?H+(-:A3^'*!XVYU.$;OHS+\N$-,XKF]
MTBI5T#/9F ?+'?6F9RHC"M:]4%VQTMLO>84L\QF',(=6SIB)JN+WM?J-](BL
M'GTP0$/]BJ*A92D\5O[#PT%S4).EV#5,9?Z4LC3RUBKVP6J/U>79ZA.R37Y%
MPW DR2^[=W+Z_9I%1;9BL&P>\\,K\N?>#&*#V'6X?2.V Y7+'>/W$68#'\=9
M3G!G@DDP=Z7$<0Q?!LF\M'L^&5*?<"1%T".!^A4].+0=56"VB@W/8AH]7N@(
M.ZRG]_[[A#V[AO?RV2,O!VQ2,J_I]FA?_Y6U,!A0DO#*H5OMK A)-3$/ZGC4
MY66/@RK^2AY?3NJEPUBRL^M2N.O,3L<,"V.)@U16;HP2?'E*:Z<A.R@]8E1L
M)ZI,I#]8__](L__!OPO:BW4G!_]> _G6IS2_[ES ]9)HX%6OZWB<A0^#6O!Y
M92[+=9"L^4'Q<DU[*",F9AM84*.M\SPF<#:I<DMJY1VR/K2H&N%4HPESY9OV
M_&BOXLVMZ?"Q1U%7&*TX$_T H!!S$N$K_+;%0V> Z#@3K&%!"@8![D41$]F+
M2"G$([LR-M5]9%"1743D@A)H[SCS;&X>%$NJ\YY5;O?*W=\*5WMOK0,SZJAB
M\X6$(VOO;LG66H:3&[+1&;(# Q-"<7,(VN(*(R+'=?'GL"RLM"#:[8L1$%L]
M<RTA*><+VG,R*;6\"KCETBB'8*@!#BN%:)/[T^D%9?;X8QS6Q.;4,G".$YD]
MK!\N S^@/_=XUI)Z<_SID(3G^4BVO6[UC'-[^[(=LK@9JC0RSCMT9(PD+3#_
M5MWQ]ZUZLB>EON[D3CG@YU[S)0^)2:X7+0G^G[R@^Q#1"$!"W>U0SSA*RIW7
M#DN+Q.2;R^W?I'D^8@+G'6X-=>&_G<_*;W$;3>?M:^6N'SJ9E92,J :VOI->
M$(K/9242JOT0$=R,S,&.S1IS!>,%"D*>EA\ZUCT5/8"!Q3<)"/#0S;!V&X_%
M3K^,A*7Z.P/W9HHY.CI&&F>]!O7_8J,_486V9YW9:D9D!5OSJ8FZ<2'M7T22
M,[>F W0E8<0O?=*L(FI>7!DLP4'#5-<UA":?,9S-\:>LF,Q?W-O\^KW:WT]Y
M>B$"- \R#D>X%WZRL*]UY_N[&]"3H4) 7DO[)")FZ7S=U6#/@Y"I- 4W+>1Z
M Q(PHXAF!31$Z?O<:(:<V-#+YYU8IV;V O-AEEUXD+LN>O!:=AGT1]LT,[&:
M$LHX8;ELNP8H;,4D%<(-2VHU*ON6[JQNIXOO,%!9+"SV2=LZ^"WO=-\%D5M:
M8CK6_VXJ@I-07.":2?]*9B4LZRIL\L; V7(T.89'QP',0P,HBP=&:]E<DT/A
M>N;WFY6RR9-.P2WG^I7((,]P**TJ,0KC'1C 4^016PCSZBQ>=O4W U&K4%XE
M*A7'5:C7X/*A=\=_HV-]F"2EQV%SH,@:"3L[E3R,[RS!):;?:"5$WG)5BZ3Y
MU.O(*VSE686%S"[KHN+%Z.PJN,3C;[]W-$<CO6KSNSD)^UHP;"561J*A9 1\
MRY;S<ONIM)Q'S)QYQ]>_O+O;1:G[%"5'6V$+/Z0$F><U,>X2IC(+O(BZMB5U
M!3_@V-.T-WVM)WT(]99O;!J@X-<'I6ENZ*6L>&*&=7E2!HM-;F1U*&%0OU%Z
M;70S;V<H@W*U&I2Y%!N*\1LI0QC_]+\X$7_P!_\/,4J8C@2\)X\U[!6F[H2D
M[-S]X.G?RDS5.R+@TL+O!9M(2D=.(!Z 7[7>WL&N^Q_+%X$'2QON#J_5N@TJ
MC@B$".V,[FEI=O61\ 5BCSTA)FH,H.W%3^F> ;-@B6!##:&#E7VG[P: N798
M3N0PAD;>IY1;B #C$0UN/:"J);4E /,B3$7[(*\%QU;?[S6XO@>,L>KLAP+5
ME-+ZB=\ #;W!<PE?TWOZ^B\$O^QIOMFA)MGXGV\7=5Z-Z_%/6SK<4A17.G9E
M=2@$4PV2D)5E6+=BR?W%5$^':H&LU/4:AI*D*3\I]==&_Z(A=V<&\9=(]"_&
M%L$U-;M(BU5!I[DQ$,S8VLQG_H9\U=DI%2QE'WY>&U$=,8%$GD@<L-])HBM3
MD=BGBN4K?%BCNT*"7X-A.0ZAG'VM/U//DJ^>ZNU!&N3-9,:Y^@=R4P[8"&JZ
M@U]\Z=6AP>J-C#*2N-WCI?C.G][[4!\AD18BL>U]S[OT+[JXK.)^6#L=_C-W
M@6()<#EC_1C +2B&CB/(W0PS^X7>;5 [N)H)GG? 3!N>GC5T*3]UA+OB,;;"
MG8XHK;B=:O:IT-WZC' J!WDPB&34%.[6UN!I/-&0HSU@N=9R:^Y4:FW[C_#.
MZM%,:,NAJ77:FF5,'Y$'<TK@S0AISST:)^!HV_7M2-'_Y6GX9$I!U!9REV%1
M?WN33C19,N!B]LH8<I@I_2=8F^?>(#$PK[PR;5]+] @4N:2.ZGOEO_PT9N !
MS#!M*)/1*B(TG@'LT*TB0J#\L7N,VG"_2UGK4T^N:UP1SW<\WY%I[D'+W*CP
M3%T9$#I3S-@R!>1#*;6CJ+>IILQ">-(M<(J%9*#_;8\$WS,MV<*=D3H)\(].
M?1HF[1KG.(9\D$K4ZLK*PK'[09LH?ECK\N2/LTE@:XFK;3P$FF&.VX/=CN)7
MP.P:]Z:T3Y/^W&JK9K_-;A*[6Y0V<%3CE(EU#P;_N_=0'_97FFW^HN!J;FD6
MHU55UI:$FVF 6/MB\H_*#+?)0F1'6 WIS4YU;]%D'+N15Z6,ZA'+;(RNXDPS
MNUUG>++^R *'@K)#E68CD&?>HS+ZZ.-IUT#)X-JGN'TM\^II6PE(PPG;CAAJ
M'R65CI\=P!;!&1UE1BB<7-'"8SEUE^#BA+"D*.O!Y[@H\+WC2]KW,#K.^"SC
M+Y1ZAU\# O/TFH>PM<KELS&(+1K0">@;PDN2G>)"#7)N_D@-!&VJ=V3>Y*.<
M\FOII0)ME&,<1V3TXTI\Z]MVJ"@8WJ]P,F:MN_^:A2QMH95X?QF!@B2^VM6G
MFYU;%1OWL2>^2)"F+.W=[:!?D%M*U]M==Q)CR"^,PU$@(?)X\\7@6;F'"06S
M-:I,]'[.JD0ENM9Q'U]T2'OX+_Y%^H-_8P[0,/C?9N;Y;-B%^]MAFE^1[LVG
M-%"7B@Q'T3G_GZ@%10?+X!=G]8,9UW& N[L+(^5'KHP\9C6&;5V+N1TU8</4
MEL#NT3/;;>Y*'NND8@?3_A$Y$=%$_F$!>'4I-M8_V"[-'?[D5LJ^UIG1'G.U
M,,OZ^=96.F5?RW2S0=->Z]<@4F2JOC$ZO,#.17QZ9;X&_C38,/-%\?FE^HPZ
M(WCH%93]S0I.DK;!#.2$4^@OK=..'Y,-%K7D,#T-ANW04/9HM<95EK;U%Q%P
M)6IA;7Q@D+^""V8D-U1/[9;32..L/2<1@U(R3DQCV>\E,6>O^KB;S> '#C^\
MG";OVYF4U'29EF'<_0_.-P-EINZS8;&IFEW:_<WH+9>HE1?U^UI_@AK;X'G]
MZC#'HX7^P8$9#YX4GU/M ;VGT%=S/K/92UK3T,\)(CBW0G,<P#M5][)+<KCE
M]7=X>I*\9S'F@UW'?W&#/TC2D44-/2-3MZAN6)<'_<\VO<10CRK^CFGK]NCQ
M5>W.G<6+3YEGEG7)$Y$O[NG@$G#W]]Z.,^.LIW$K;V;A(:L@RS<7;-8AL0SA
MV\!SBR:*02>SL$#6Y?G:R6P]>$?!8H(ANB?6ZG/"[>35FI.VHX/D8X IS/F+
M#@\P"EWP,B#57/7R$FTMAKEQXMHXY33%1[52>7S1R#AU\$W%NQIISM\2DI%U
MH5Y'>UR91NC8;N'D"!H20RDBR$J:0A@EN&C]H/^8YSFG P?LE4Z&T\%@4:,Z
MQPP\;)[G3YEU0SP?F5^J!=/E3B%U8@*6,Q""''='REK:-#3E59$13RP;1H+'
M<OQ=.95RSQ&D]MANSF@VA3&'-*Y3'MS;UTK#$C]PM_;60=5L[:7X\ 55ML^"
M@2$[ZQH@"!'JP+YF+P7-B'D% !OAX^ CZNBN?:W8L3Q3JF\F9]E/>6O1C_/^
MOQ[E3[L3CG2N@MZ\;33[9,Z=71/MLV4C*.AW[MQXONA[IGV0Z/MU>\/K,5+X
M)*DZQH,/3.O>-!>)OU4IG+CAC]:&=Q1ERW!B8Y6X_*S-(!K@RHNJ^P4I6O<5
ME"<07^LOD\V-;]Y%8<[WS%'U]K5.DPO\,N28(SW2V9JN[Z16X'-S;O&?/"B*
M6;2,(!3%>M9R!"'!-OAP\LGOA%9(%QJK%0?Q4=W5> _L:QU4!+7V"'H=8:#<
M_(RFJMN9F:9=R#MB_>3!*AI4K[I"H<M7CO$.1XE@NIC,[O;@'Y"]X+.:P4Y/
M\)I'V\I;7C.2N4QN'TR"H$Y&U@!VYEG/5WW?-YS6C\"9G/0O*C47R>KK##_-
MS?I[NN\K]B('S5N/4AEV7F%/B'<O9?36+CWOCUUN 0W(K8O-6(P<U&RL6<0N
M;I: L=!S2QK>ZUXH*DA8+LYC W*&LOX4'"4.C8Z:FDJ$4<,"C0@-@$Z9K[X,
MB^_N;!*MEF0,(%\I3)TKYFKT4JHRDVN4K?/,(;N(%#J^UFUBD=UY@8,ZMDW8
MUXKFW"&R9RPVSEAO[+*06WB.W3SP9(M'<-1V#G([.^57'Z<U2;P"<T#@8ENR
M"TGLWO74'5\LB_T\H A+3)!HHL,8E-;MP9KP&4[_85['?+B'03L-$,@=JOXF
M6S5]IG@W>.^4J:#?RKJX#H[ZS'DSC"D;%6ET^UW[YM4"\ N/? 4_%Q#;.TPX
M>*,6'',Q@U-,S>0S<8FQ!=/JPM"6]DS)2/8*8RPO2!#&^NEAE.I;:GZZ<(%F
MP')"P-,*B_%>1Y8X5]:AQ!8WO\R8V!$[P'G=Y2K2@Q3-DO@;[_<08,>SD>]/
M^3Z\3_GT!>'GN9J+>6LXPV??.=IS??_V4E!5;4,TCNZ:84/D%]8D#*[GYXR?
ML V>7YH 9$?Y\O-,TH++1KR3#CNNG"#QI'2,:EC:5G'3$OX8%+07[C>J7I=H
M&_SQ5ZH_^'^?=6GDQ*[%E)XU:!G]MTGNC/0RQ&(G(PTL][B:J'F12;(O%4E3
M7-I(87=\B(#HL#TTDC^B:#<PNB70V)[I=4+V<EBNY*"XBLT/S+J>NZL?-@'.
MQ.I>PQ.)B_7(:SACUY"^H3WK/3=2VCQAC49# !D/J:HIL8?;FQR#U)9IE*#/
MQO[X-DNO*310>?:<5\!625083.VII[D^M:]E1U,T4)2U2L2^UG+,'I"[4GDG
M8</8<$">EK',S"!R[M&R+Z]=E4/>DMF>*W15WCFP#Z9*0&Z?=:7'66;N/;SO
M.6RX"_!HL% E:HCOR_>U+J_,.%(F*#:P3$\+U7#R)AA&(((G,Y\2Z^8A2UFM
M&QC;J'VMWK0ZNE_21E:WAOT(GLVU+KQ&W=>J6]TAZGYT6/A]K;^E/K;RQB\!
M,+[[6BY=6)./GUK#LLO5E)5=X M%9EP6_![^^(4<-W<WIV :9S3EH^YQ>HY&
M4NV\.VMV:6(Y^1K9?E_KFSY:)R;.[!&Q):REN-?]9_9,O87OV@R\NRXA44A/
M^S \R?7'3@R.FAN_:6VV"B)HD!!-_I(Q=#R[&3CLG': T./6P67SV4E(I")3
MO&"MAT(]@=DMY='DPH\"BT!L;!$P7'/.]SA]:KWB1:"VB5LL.FFXJ@"0(E!/
M+Z.AQ_=Y*20,^-_:N=.?I@\P#N!-7&:B1K-IQIQ!XA@25QE#!!4LW=B\T-!X
M4)&K4>0LT%0N.7]9%E1 9"K'0*"+V#$&I0/L@);2!=&"@,U::.5J.8=2JERE
MM/88VS^Q%_M^7CZOGN1YGCQYWCQ:>A&73(O/RHHI>Z*[*:V+3UP(Y=;6!"1.
MUVM?ES/4BK%TYJ3/&^<)';LOC1=MZ4DJX ^+J\5D#WF:Z'=5YT'.7XZ"Q=EM
M;'(3+WQ%&QE8J7C(S?,MX@OO<66I/ J91I,ZWAQQ9 =RBJ[I72B58_/K.3.S
MLL-UC ]9#@Y1VU_UUEC]0UGAJPUQNG!Z>N'A!?=FRL*CN+A,=O?@%'V,:9ZN
M*RU09^0_KH@QWS5Y/)*,5:OR1QRW:,Z81;%32ZJL]?V84FQ\R\T\U2#9'.6V
M.TYH(TU/J&RDH8A9B;:XB]K7,6MQI%"7\Y\0XT=L)/VOQ$_9-E+7;>J;$FL3
M]0>BJ5=&J,BWB+(LF>DX==;NAHWT1Z*-I+U@(WU%Y'Y,C+E8KA)[GL=:!ZW'
MTF>&$\S#<JWNW Y>[IR9>#$:TI8X9CHK8KJVKK";-YU8?%3K7<PCMOD1Y*D'
M(P[,P,+[2];3P2UB<=Z[X7@67[RMO_V4U&%[E+M/II"8GAGZLF.PGIQ&CUKO
M/C)YDP=?)>U<;%*^']#]SNFD_$6$U3@4U!A$DPOJZT/TZ[7R2S<I>NZ/.'XF
M#[?[0MGFO3=U.=IPQ3.YS#"QW)+KJ1B?GW26E3+,%9F&ZX,67FA I+XGH5TT
M;W^#$F\*$M3-J8_\(MZL?J727+,R7-2^.DD$F1;ATMDAX&9I;G+91G'CX?XZ
M!^?QC* 1QL/1JX]C7MU.,N@YWTRQ/C"X.VQ@WG&6I7$FG\A7.$S#K57J/HOC
MTH;N?GZSQF@C#90*95\;.8S:E?6KV_AF8P_AI-,7\B7+N]_ZF=+3%2.YHQF,
M1(%(XS11\7F5OSG!M:;FS$N]P5LRLZSI"MOG96K?=7V)J>%41END#=$^PS92
MH0N%K6U4&^V?6W-82MTAR_VG;K5EIQO;=K&[K?G)DEWU,067Y+^9/ 1!RAT&
M99+A7"!%)B#R=NKU@6MT^Z2U'P_XEZ=1(C,KLX1:U9\UQZN"U[Z3LA;#68QC
MS@:6*VM*0K*1[+R\@AI2?5G&T!%Z_;/2-#NVX3VRMS+BU,6]NBKO_M95I]Z6
M.IHB)]ZR2;' %9[E)XBYF9='F7-K)?O=W"D[AG7"FN;@R?:5%'^A47VT0M>7
M.B<+DCZPIZ8T6^F^;"*74="QAWQM8"U5<2FY9><SJKQ@;]2A@ACOA1[^0.'!
MEZRIE MM"47<"#^EI^4R[:3?V8;&]D7^T_C5#M&=MUK^2NKMT'*BG$>UFM)-
M85LJ9-(E<[PZ>H66JKNRTZWK*'WQ>SXSMGVC=&O.N+[1-3EO<2M'J_8(/F!J
MX6?PLKE3K0Q_1O"GTY:8UZ;SQ41)@'Z@972FWWR>\3SD8FZ"AU8OJC!ZS!56
MMZ]^>Z)M2W:84]?Z"%!;942#N&:V=ZQ^J+D@4NE#J4MQFP_.>?#1_D[/]5#L
MP9PZ.L_W;HXH9>*3?Q]HG:LJ8I8(^#&"GR,57GVR$%E)V+Y_GI]JJM?^ZTT'
M
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M[E50#'&BBBZ2@"6">FF"$_-8K8WLUF'7-^LX*B4+=7ME"448IPFG'H>Q[TD
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MBU..82*8+VT:11 +%$'IH&>8)SCSTL#BGL66GWFN2"0SH@)/)%=WW^TT@[H
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MFE@B6,J9ASQD4RAHPL,\IX(;^?,'(NFKKDMTS<V%*FI3/V(JAD<ZE@RO1TT
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M]50YBX=Q[*5!8C2K28?HQ*9P3<W,J&G!I6>Y7(-@9IX4];98N;E;:HE.T)S
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M$UE)HA(EFBA=+:8B1&(<HJA4;X#2-,LXZ*IH5)KG:+F^:IUW HU;#IEA9;9
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MF:XPZES3Y#5_W"NIYPNN>R[I<YJ/RR<R6X!*'SW(]WW?/9\'C?! 2X=60_K
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M+.&RB+E &:$4X32FJ(Q3@HJ$Q%E<JM4K!9&P.=7.\QPY)#[?-'([ZS/'W[+
M]#H'RT6PUCIHU+;EF7?Q!LU"W+N]%U@0=/=*)J*F=XBF<[)Z%[J]$WV]0U@/
M$]J[%&)9Z?GT/%^^"G$GOJLUDL*H.\D*DT26)98H#[E$.*(2%5&<(Y:H/W$J
M:92#,JH.R/$<7WNI0<L/WQ9,Z]IS8+P\A))9Y'-@.RR&K<U>2_30,_"(5:Z*
M% ](F;9(<=S4G2+%(Q^W7'7U-R0J;+0M+\C\=EDWO0B!NPV3H3S.L.N[.3W%
M]O*#7@$O6PZ(Q:YF01.1TTYN !!VYBS(LR?0-/?YALT.IJU?T5G$S82XC_$\
MC.*(I:5$3)08X:+(41G&$B5A&">T8&D<%6 *9Z 2OF_[+^_NO_YZ<?_K5\WS
M='YQ?_7;U?W5)9#CR0I=LW#B&S/H*<8P>5BOUSM]@HU"@U;9GGCF3\'$):4T
M5(7IZ:8M0=I+16T[EF5#C&K)E<2_D4K-\JO7<\:J%S)OZH)G<B9X?]%$2DZB
M(J>ZEHAIR@"!BEB%K#+&!<,93V.>@/I?F,GU')8Z+8(_6C7 R<NFZ)G%( ^8
MP,).#T>O0="IX.'>#FBKJY85AE*G[5 !@V*G(07P<<N5NV8J^:!S<(=GM ^A
M%$P6J4 L)ZG:8L<44=WV"O,XEH07&<>P@\^]8GR?8&JAJ$TP9@.QP//(_0@9
M[F9.MANX?VE,;@0&M^2UV<F<ZR_08[- ;MM0D/I;</E#:^.@GM?,4E?[EOU"
MIMVIC!JZLS<9_[3M'5]#(JE>J/I;/>/-#>)R,6C$EF>E"+F0NNA05PN$*:),
M,)11&6*U$\GB.(+X[U&)GEUY(S_84N"4-G;'432]'W6(#<S=3X3%XG;4T%1G
M=Z+'Y$U\$VIH_N[]I^F#UJM].5OI1ML/:9DE.*4)(AD/$<[T;27-U1]ERG*9
MT;C0'&#F67:;H3UGU5V+5=<7!+Q6[VTOTS(/)8^0E+HF,^(4D91+%!5A$@E1
MXEB &N=8VFZ1CW2Z[9@F/.-QAF*:9@@GA>Y16L3Z#U(D>2J2,H:1.MI9;\7C
MZ,!^XZV8A4VPH*R-N6J+VW[2DGX^T_^<O_"&WEL3WJ@ ?;Y:53/ZLFIN85?+
M9EVF\_F6\[G^6,-1(&JW&[,WEKO;>_4#3[V]>F/0GAW4VT_8A=<!8]$NY6U]
MSO_Q4J\&/2)D(GG!68R*D&K&ARQ#!2M#5!0D9K&*SBPQZOUA)][WT4K;)[$Y
MO&PZ)0;;K1(;&FC@<0L07S-7]X<:+!P,:<WV46;7P4:7G;!P2RJCSB7@<&"'
MCJ.0 10^:5BQ ^9MZ+$<Y?U;$EXM=%_F9?7Z4,BP$#1/4)J10G<^IXB648EX
M*!@KL90IK$N)%RT]![M>SKOV&MR\$K/ ]^Y P^*CIV9T:\W_G-WG=H#]$S:<
MV^CXO[;'W [,/MO*[0JS;=U2S;X3S4]VM= 7ATU9P/5R]5'4L\=%<W-8_U7P
M1[51&'S@%S);Z+6NVGX\\(04:212Q#5%""Y*M1:-2(1P3.(2\S07 G1\?[)&
MOG/II!1,A86E#/A:U99Z@*]5#$@=?&N55)O-M9;0#B^GOANS(#XIXK" O5$M
M&(AN> P^;H'=Z3?\U%F@55SOBY6>+IO .(+,63^84_69N#6,(_AVN\2X&MB:
MV6WY).[)C^[.JUN)/ZBPB'&2%RCGH0J2>9%I1J4(I5')RKB4ZK]YSU1N%B8/
M2#)RQ6TF<ECXZ[>3/SU7R^\SO3W_.9#+ZH0VRX<PR[*P*#A/421T08P@NCT8
M3E%1EE$:YI*4,8B%ZA3$3DH/:6'RA))9B'=@.RQP=X>2FF6J$QG\U EUV(OK
MB%GN^.?V2IF:9V[,U#U\<J,?=]7HKS\\UBVW'M(D821484VYJ-[&JU4@D5&&
MN(SSB)(PCB-03YAQ<=[WXZVHID[BU-9\6S"9KLI<&0]=<NUKM;=&XV(,#0?-
M]/89Z:UIWI:P=VZ.M\_PXTWP]C[EC$Y%WQ1UZ8<9HYB$18BX"*G.\E"S<1Q)
ME)6\Y%'!"U&&)S*J;*1YOO[]O%P\(ET*Y8-698"9F:,[0P)X=;B77&4CV2N_
MRJZ!_BA6!K+>FV5EUVP#HI4]#]G.WG2UV?7TD>.KV@,T52W\5JAORF)%'L5#
M'&8X)V6.&"U2A O.4"&2%.4XC;(DDYC&H%1M<]&>9_56G%J'=]-9I?X)G=R-
M432=Z'U@ YWTZ6IP=C*8[[4>9T$'VT85ETL J/G.E@/&@B=>&D !V5TF@$<X
M]?3X>JF/L\G\_$EW'7_(2EF$,I0(LRQ'.),AHD1MX G.HEA2DB04N!/8+\AS
MM/BE6M;-:6,CTO;T]@TVT$-9>XMMSUK/UB8'K5 ?!Z?[S7)^'OI&S#L=<^XW
M]O#IY8'/VZ9P5\]+/=&IE43'_-1EMS!9IFI9GZ*(<XQP'F-$DE2BM(PDSI4#
MAR6HL<1!29[]M$D.@F9D'P+%S#^=F IST$Z,6K _Z\R^Q6-[=;U@LWES];$2
M3V?!6B^]E.]XYCSD]!PUWUE6]B$Y$V=C'S%W-PO[V .GSKCM)?$#X2F/PXBC
MK,B8OGY5^W(>92@):4ERSF02@?*0WPKP[+D;<=:7HQT0T&D5;I[M=-HFDOB8
M0[=M<#YW=L._TYRY;=SAN?+-YRQK$U^>G^=-4BF97Y#ZVZ?Y\H^KA5Q63V2+
M6(3A4BCWRE&2\!)A'$M$95XB(7).,:,)A:7]&\KUO2L>:!'P#2? 4@9-!9]4
M6M5JT[S6"UC6: BNF0M[@ PX#P_1TAH$6H5@H(,?[A:8W:[*( VE3EL7"8-B
MIU 2^+@MC\MWL7@1GY3V^WHY7?[HZC1T_%+_I_N^/$0Q+83@#,4X4POR6.V;
MRUCJ$[A(%"%C)6<QC,8%K(/G4'.OC^N#JM4+..?;(&H64SSC!(LOG3*!_MX?
M[/*V5BGH==*7[2Z)6ZP1<<;; M=@8MH6:XAV65OLASJ5O'9OSE2?$G6UV,MX
M):HF6BJ8-B1))2Y+(F6D(E;!$0YE@=0.)$%<9ASS3&!@OHYS#7TOH@:,J8/%
M_VTED&XYI_6MVVQ$4?\\3#J?+8*;BRM;YEI7K\]P\?6>+\5Z W8H*W0B:EK'
M4#FGIW6EWSM1U#J&]S!-K6M!EI%;5-]G&X):HOZ')@PE>:$VI*Q,5-35=>@X
M*<*()UDF04>X6Z/[CIBM+&#DVS(_DV&6BB1$A%)E?IGGB.1EAK!() NE+"(6
MPDK1K0&PJD;OI$%YR[<P,(S<MG9!#ZD;,1Z.G/<:X"H6;HT];1S;9]9.#-K[
MH9,)=-LLT?-%0QA4B6^ZWEH'M^:GUERZ)J-Z_ (.:76W-.B9$CP3ZT+,=\^Q
M:R3]O>AV(=",,.^"AK%SDG8"%Y]U+^YUU^U-)M88#?#ECY562*TK/\_JU8,H
MTS3CI$!9&JIY*>8AHGF*D2BC@O,H*>(,Q,SK3#//DWNG9] H.NA*/\PQ[!*+
MQDBP-SH'EPNUXFK9C(#T6^[>IEDP?)=W! N3[_1ZP('5.92.0JX[O28-QL[A
M?!NFW0NP;.C1E.FNIP7=5%U);LG17F:+QZX7VG*AJ;R2DL4X1UE91@ACPA#E
M3&?!L(Q%:@]1Q" .'7/1GD/P6I%!W9E%QBL 2K/PZ <@6/S;8#,H5=-J;')J
M.GJ(+EO28<<0L/FNFHB8"YZVKP@8D)U6(_ 1+(MDQ$K?&#95G5SP#Z^_UIJ,
M0=,QU#HE:\.S_I"6G!%:)H@G<8PP924J6<10F<@X8KA(HDB"*F:,18/"BD5/
MXB8E0%]._?2B[YWDLOI919A.C8"L]0#6TIA#:Q9F_  &"S.:H*_!J]<BH*_!
M3UH1A=C/P5J705,&AX4W8 !<5>&8"YZV) <,R$Y]#GP$NT"S[M7:1K2&=Y)*
MG@DN8R1I1!$N98XH28E:J%">A2PE90+J:KY'AN?0L>D";$/!N0\3LU!PHJ4P
MG]\8N47-Z<ZO1ZQQY,#[)$SJJ2,FOG7)L8_:9NZPKO4!:Q8-^EI^P++79)OO
M.7KJNB2H]>)LR56@N)%J';(^1B6:R"Z+"T18RA".XUS?660H)TDHRXR&!09=
MU/A0TO-^Y/SFXLJ>G[:A\-'G$'JE_OM7]=O@T[+Z@U0<>!KDY?6:Q:'W?FFP
M0#;]^[)(4_('J+,\)@\J3ISHY _DW4PHC[)@T\&C^,8>^F_S^8+KLLJ.3J6[
M>>6)%()$.4KCD*L%&66HR.((48IEE.9)&@IN$M./2O(<F-?5OIKB<MDP+<OU
M82_[1JI'40?_^1]%'$7_'2Q&:AF ^(T'3:>HP"+?%B!-<73/8G3T7AOZ%5JR
M)H^D[?0S"11;(D^'Y/1@;FQ=&Y'UQW683<,DB9I0>WR 2>*EL1U]T#-_X#2V
MYH9*M#UD_ZQ^H"L%ZX>4Z+M''J(P)R'"89(AFB4%"A.1)Z5(TPA;D2[O$^8Y
M?JUY?0>R@]^U]*8JL@8N$$=A,UOHN0(#%K;L<; F*!XST#'/\%Y1[T(7/&;T
M(=;?T6<L#Z-?=(RXD6U!L%Z.=Z6F]8.(8YGBO$0LS%.$)1&(9((A+B45O"BE
MS$J(<Q\6Y=FU6\%Z&U&M10==73/T@/DP7(8'RDY  !X@K^W?2 WNCMD//RH^
M:IJKH^'#@J8]"CYJ\,[1[_$G[-QXR.Z]X'>K)?OGM^5</5]?JI"Q>GV(J:18
M5X5%,B4(LURJF3I.$,]C6I1IR'")(>>^QP1Z/@1N2\#F&R7.E&]S(9Z:[_9B
M^S2A9VI2'](+3]$H"//[H_B:>;]+U& Q8-AT0(-P.0X"V/E-+7,4 HZ*FS00
MF!K_-AP8/V=Y_Z-WX>NC[<VU4E^ONDZD4=&!<)IBCHA,-+<T4U.]C 52\SPG
MN"RB%#;5&TOV?5H\GW=G$<OUA<KF;AE^' %'UO!NR0=>P!NG!J;-O=-&B;-!
M@?I:$8<W45#;7=U/&<N=]M8*"L?.719X %NZ"UJKJ50-=*G[B-2;,D"6XI#'
M9:A6&+J>B&<,%7&,$2O+E)4YPQ)&"750DN?H<??KA[O+__GU\OH^N/Q-_7D'
MI:PX!)!94'!B-BP(;$0&K<S@=S]UC<=,<\8\<4C.Q%P31\S=99<X]H E]=-,
MIYPL>/W 8Y:*@DH4:;(V'*88%5')4520D"51QD2R[B9Q#Z!^Z@48?4>WFTC<
MPSUT+2[@^LY';0& #%!K/,Q<$F:>7<EQ+\(AV=-;K5VQ/*W'G9;>Z:TY.[Q.
M.Q^ >8M@_.'KRUQ$(4VC\ZJZKYX6*_YI3AY-9JW#3WN>KK300$M%4:#DJE^U
M91?*KYYF3>,:,^<8,7_<2]Q8#G.7XT8'OVL-'$Q>Q\W;XU>U8']Y7'[_?^KA
MSJ48WWC2R)"3N-1QDWK?,O@DW,G4]NR<_^-^J2_CN[M,0P?;?7*"G>2F#VJM
M<U:T;+&H 61F!VP^[E6GF0OSJ".6.JS*'K?,RIGV##>9(QTV9>A$(Y^R+#,E
ML^HW,G\1'U[7?_WK3&W_*O;M];/XKNS],:L?THPS&44)BG 8(2PD1X6@"8JC
M,B)A1 N)073\9F(]>Z66'#2B@[7LYGCS^ORWX'>M +3*TPQ,L]6B>XA@GGP*
M.O B2Y"QKBHHS81.6QX) F*G]A'VM&5AX]/S?/DJQ%?1),0-CJ&['+@'RJ(\
M*RA!8:P[LHJ,()KG'"5E)$K&\[@L0='BJ$3/@:*3$K#A3*9=@;9]D(#7P,<!
M-(L03F&!!8=>-*I:V<.VU&?!A>L&/L:6NJI3/"IOVO)$4_-WJA*-'[0+!>><
MS]H^ ;=DQJ\6%^1YMB+S!TX2DG+&4*'6"RH I!(5,6>HQ D/TS(F:0JBG#@@
MQ_>J?2TU>%9BT6P1L%8PS-\/H63FY0YL!R[A-V9KB9H=\.*(V6"'/F*4(S<^
M)&52YSUBZEN7/?9Q.T?M6@[W78@UQW"SK$\$%T4I49E%J:X0EH@((5%(HXSS
M+!)9 KJYW2_&LYOVG;<'4JU6[P<P,O/2TRV'.:F%T6 G';?)D8\>$#*IBXX;
M^M9#CWSZU+8:>Y:#24FR-%7.68HR09@E*:(LCU NDC2*I<AXSNQ:;$R^E!YP
MHLXV%):VG3>LE\ZN$ #>SFR,'] =.5\MFQCGO%7'>Z^138P^W,+#^<KXEQ=2
MD<5*B!LZGSVVS!]?R(_9T\O3Y8_GIKG% \^C4L1EAFB2:NK0)$:$RA+)7(0D
MPS3/,A#MCX%,S][=:;"L@N5&A;/@J54B$)T6,'<W@=+,ZQT#!'/^#38W0VPZ
M^4&OP%GPZT(W0-%MUT;NW,!! 6"[H]A@(G'2$ & X&VD@#QZ*AU^DX)UO5PL
MMVD%NK*LAB]\DPS$59S(4ED@C!.A=MJZ #1)-<,CCHLX*A)!03'$3@W/865(
M;-]F&O:\%ITVAZDM7&)M%F3\(PB+.[O@#57:07(B1GH;;)S3SH.4>"=N>1N@
M#A/(6XUFRV&BE_=L]5(I,1=M"?=#'H916&:EVK]DJ8I9$J,RBE(48XY93E@6
MQC&,+7V?&(@S69&F=W*@K!][ #&+*:<:"8L86]*"8[9:,&8<-L89X\4>$1,S
M5APV<I=Q8N2SIQXG[&D4\>&U.\)HK@7T4N;;[/G#:QL*U@G>GY<M_\6'UWV#
M?9W5_VS"Q4-$253DDB+!&48XTH4?F2!()*(0)2YB3D"7?=.I/MU1QY'V+\"#
MR@E?+O0TY<_TRJS/9JS?U@DG-5,!Y_S<Q[OB[W2*--4+.7PF-9D&EG>_QSF1
MM,J?-W0?48;S(D^1;%I+<KWVDXRC*$]S]?V224@IZ%(8J(#OV^*-.MT^:V_O
MCSZ4?+;E!@'C;GC-[!%-X/VS>R#A]].6:+BZN(:*G_9&VQ*<G:MNVW'L I8:
M_FG6IB4WG5LT-?>C6+"9J#^N.TX#Z11!8_ISF8$:35[:EB+!1A,OG8>L,'#D
M*##9DWJ)%2QO7<1N$/L<D4V.V""!5/_\(1-E(;-,H*+(J9J].46T)"&*LS(I
M0YX5(@3UG1^5YGFJ_KQ</"+UW%- EU6U_$-AJFL V_O\MA^JU-G/WYOLYV]:
M(^!9SSB69K'%&4*P6-**'5Y0#S/!]2_=9I@<-=%AHLEA69/GFQPU>U_:R?&'
M8*[/Q>SALW@D\TL56%:O3;Z3(*20(8X1SL(4X5+$J.1JP1Z'D2@S0JD@1AW@
M]XSMVZVUM* 5!\H VP?#N(^>:!S,(R%V&;O@B 4CM5/JJ=;7U%\V+K9OK$D<
M:L2(WGW&/F(W3]Z2UV9"OI&; O!,QC(M0XI22G,U.Q*"2,PB%$=%'J5IF;.$
M6!3$[Q%E]#5S6!JO,Y]U%5\]X!>"S87[\#*; 6W-M_*R7EC3/=U]&?V(+8XF
MN'T2)IW61DQ\.YF-?=2Z7^9L)3ZKG2._6JS4B]5MW,[K6JSJ+^0?R^I"DWI?
MDR?Q<?E$9HL''$92D%SY:<X+/==Q1%(2H;(L.0OSO(QAY+- ^9ZGPE8;U*@3
M;/0)6H5TUI%2*6AT"K12P>^M6O"VEB#0S=S>(Y2PD. >19ONDS98N.LQ"9(^
M=2=)&VCV](NT&@9.6/#K@E?SU\<[P5XJM13Y\L_5;35CXN+;XO&6K4S)"\9'
M\1Q7E'"AI.N\@%X!Y075/\4J:+30V0*+D1TB%)/Q@.$6#EAL,$3"8?=&<VNM
MR ^.##T9$8*9B4-2!,,G;#,IY&PA^(>VTO=6?0=TLA13R^JO8O52+6X6^F=M
MO'C@DL6)R$I41 5&.,<ITBU<42ZR0O(BQ&HC8,.+!=!AFOU!+S^H&@6"Y2)X
M5A\(2*,#-)T!@+#9"L(Y8)8I!8T60:=&H&6>!6OH6E7Z>RR%H/Y]M[9PF6(
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MSC'_ZY@M=L0'^P:<COY@Q)PM$H2QS]D<@RYA7K)^P/<1Y^4-Y"1S:>P#5@8
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MS$2FU@98:,ZII$14K;%03&B8QVDA9 ;B9K;0P7/H:.?);96"3H$ZT%I9+!J
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M2M8N' !WA8--"4]=/1@(R($2PM 1+,JGW.I>377'I>.]PY>M3735M%(H==7
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M(J-Q@+T\R3#A =4!!PPS+TZB./7#F('N*DT)CVR.]J.:UXS81GZ?@-!0(XP
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M=2 .?2:"+,XC8A2N/$1D9%6T11;5=('W#8,(#>L=5W)#+2D+D8T5A8E,0SI
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M8 $H_8DC!RSAV0\CL!W((BQWW;*GIO%[*=6N6]X_T47H?:9ORUNZK#ZONCH
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MEXX'W/:V!=;H-<+-3(,X1P.F.=9 =-U7-PQTM>Y&J,L+D=E5-5XCFM/6X(7
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MQP&L,-@IN P.C&Y!@"F= _*C#76;,Z3)5PA4ZLPA-M:%R@8P<E=0S%#04^7
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M2W6.%\4DH0%F/.98J?<XR7V1YM0HY6L:=D=6[SLTV_K?@-B-\>=K6%O_>K,
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MDH6)>:F+_?%'7H<-0:W_A2*)EC5-@,5Y ! #8_L\,6$KL)7P)D>:&KIS("'
MD#Y/4COK&28QS' ^+L^@M7S@M>E,Y.,\;]G% X_9[=Y_*>I;J4M=R^>QKOG3
MYLIT'=FOGU_F<CV_VC709F'I--#+7"WG2ZZ^ *O:@W#Y7)35['^:[UR8\TP9
MU$KI<.9C$D<!3DD88)^$H4?B( N2&&("C,?JR/JKQP7B\V*E_BV>7U;U;2#=
M2(-F6_RKAY;06Y$19]/,<ODUY@BF?%N>48_IBU[&6,/W!=KFO$XE4Q;2AOD+
M1#7[J,<_Z@O@SHH:'V1'IMB(C$YJSXT/^*Y1. %%N_VB<<QL@FJ^%TT"[J)Z
M8%G.!/$9SB15^CZ)]/6:%)CSV!<DU%560$U+CY,:^SIM/D=%[=U;% O,SPU(
M&X*,1;D7)\H:84F"B1 $9UQRG <L$-2+TR"FD$M[1Y#!+_*G@\QL'W(#A)6;
MO!_9MR'K3ON?%LV1]AX@-*GV/2WPKO8T>,,R)7GU\C*?R?++;*%;1M^6Q6-)
MG[4S33<14^=LCW,_3F.<"R:5R:L;_H5,8)V5G&4\9Z$0H-3D87HCZ\&..FK)
MHY8^^J/VQ]8L0'.53P!HMKH=P@);XN<A D]H-I/356+S"6K3)CB;B;Z7Z&SX
M&CSV]XN2I%A(70+I599OGU?ROOC;K)C71M5-_I?B6=EF*V6<O7VE/R^?*]/0
M7^BX(Z_YEAW4\8/$2J*J0&N6M!M.,X5:KI!BZP(U_1/-8WW!: XKAK&!A&F)
M<3 $A?3:@F$5T0LF-EE KRT,_7A>ZS'L3(P?\E4N5HJ<[D2JCH"WLLR+\EEK
MLQLVGSW69'4%)-WTO>E,<9/?J4^7N3H6JK]M-M,TD6&2IA'VL[KE:!IB&F81
M]O*8^J$7!42 ''#N6!M9B;6,ZH**+:NHQRO:,'N!.G:[)A]J9?8Y/L/4<3B1
M9E;1^TP/3#5./3-@D\L]B(ZL,X>,36K(N0=TU^8;@8)E4<KB^7G65!R[7 CM
MJ5.DY(+7-[#4IX%()?:#D& 2B0BG(<]P&"8BC(C/>!2!ZE >IS7V;<:&<AUL
MSONT@54F!P STWF.8( IL5T$/ADA "\=>5HV5]4B!RA-6R#RM,A[-2$-7K$-
M;&KJ-^A8:<FJNNKD4C[P+&"AE!E.?)^KE>P)3&4L<)XE 4N"+.(2V.?X$)F1
M%_&ZG(G^_C:.V[P^,L_H'+4)(NC?_RT-?/^_T$("BUH=02[RD]A+8P]+3A5R
ME%.<4DHPC6G"O33R?9)9U%\_ \"SZZ:_"XYFJO'\[Q5,*VY!40=UM"1=AH\-
MB>0L?NP@D8D#R(8$W8\@&WS:(H3LLRQGK\I">I5W*_8/93C=%]_H4E'Y+JN=
M>\G;HM*EP'6N:[Z4ZL$ZJZ]SOK\]A&F2QCR1.&6YAPG1O:&YC#$761HS[F4^
M,ZK@Y9BOD?7KAM$+]-)Q@F2>*Y[U2::</3XIZT']5-3L:?=0DP9;+Q_PQ9GK
M61M6,>\X%S"=U)^&EDN-=,,G:AG=#OQ8\XH:9G7/W9I=]&'-,"0'T.&D $+Z
MWF=R[$(!)Y\D6#2A>R@'HQ =DILN>M$]1EM1CR,,#[\ NB^%HJ/34=JB;[J0
MA^DMS\&71]Z#>M3JHB/FMS.'13U]!7.VE##M?E]2L:,:D+'0H.N40<&L[DP.
MCSC9Q<B@0/W;C^$'+4S+3W3YI/_3-6]>Z5R?VW\HV[6<:>^<_H.R8K<_Z#W9
M%?0*PI#E(4]Q)KP($UWQ)!,DP2QB7N@)+TD"HS@+9QR-[7-31"\05__6#5U:
MVDV'EW+-6OT P#1Q,A4D2",>1B$.O230%7HC3+V0XB#.PSB*.!.Y__ J2U;\
MDI/1Y\QX.KX5"_F&GFGY3V5QY*N%@%CI3E"G21KFT@]UF3]=P"2-,95A@L/8
MDV% 8I%'PB1P\'T6@&VA(, RT&7(7]1G<M'6SZJ>ZF!NH8_&M<MV6<QGHH[2
MOE,&JVS<N>I ]F7MO[EMRR-,/;D&AZ^IIPSH(*_G2?^+KOKSM.&HG4H]<3L?
M;K]Q*@-QI!D G+2FG@F[,]9T,P([7+E$;_!8Y830= <JE[AL':6<#FQWKZ)K
M']:E#]O&@5L- ]L*N>)&-QM4Y/3I;B&^%XNR^_4C7<Z6ZRO;!T9CF4F:X(Q%
M"2:I4#\EL;('B4RY1P-=^PYR'>.4N[&#]=95)"^Z'J&[K4$[CE%=BJEELGZJ
MSS6JV3XCV,7MG)I=<+S;3,$VPW>9)/#5RBA@.KJ1<<O;I!<YH\"Z>_\S#A&+
MLWU3RN!KL5Q^44@T=_$K'6[S(LO:7EE^E'E1RE[)@\-W5^JW.H?C4W.#^N G
M/!.1KE\0)50I>2_$3$:>.F3*/(]C=?[A1M$SHW(YLK*_^GA]#["#1YL+@]/)
MKX P]/*Z+H'R0?/\&])<HPW;:,,W:AA'_9(I%YOF,)<[5]\7]2=-8E@KPZ\P
MA8#CS:\PE79'GE]@2F%GH;&A'CP?C49\NC/3V/AMG:-&)V9WMOJN/5Q=9[>V
MI&+L>3Q7NV=S.")1S-7F220.THQ)GU%?J $ )Z0#-$;>^G1K;N&T[>(AG,Q.
M'6=*#]N6M.#OT%IQ0$9')OTA"I,:Y@,B[IK70X_"5JF0LX<KI2FJMTLA2MU"
M3/UX4]X7/Q</:2[2-.0,,TX%)MSS<,KC&*=)ZC.?"\9\HX)Y S3&-E!KJJ@E
M>X$T804+TJ3-5N<0/L.KTY'4L-5I);#Q8C00:>#F6;W=K$/UPV;Y#8TYR?(S
M$*I;?B:/VO8M9M5&?U[^.5L^>,3S$BE2G%&J#I@R\S&+0@_',HNRE&4RST#E
M*O=)C!YPJ$S4_J:@:0*=> =P,=L3SY,6MNB @EJT%3XFB[,NPGL$)FX:?$S
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M_O&W]F_T/QA=RW_\[?\!4$L#!!0    ( $8SGEIH=A?/Z<$  /+U"  5
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M^]I]&:)?-PC9\\R]1&MJ(PB3.)BL'63%*4N"D"2KO]A93<IF@'JY"?L:&FC
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M1T^3KN'!L+>K8MK#VMO)%*484HJSMRCF14BV0HR#1#4).6I0M@QK":)4O(D
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M/JW31OB'-EL^!FH1=-HIC!\-NM4V.CR=;#3:",5,!YF0ILR6EMY$@<%S4JG
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M$P_Q)@/M4S)EG".)4:'W:1AX(3U(+:B)C)D8:^?WUY#2$F1VT?'C+MX5!-X
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MM*=6!56JI(1FSD7.[6:'VD;K;00?]3+ATX'$^\?24_-Y,OZ*7N'B:F<0!,+
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MMV1XFB^N_;\Z[H2H@*SKJ!T=#'@=-5@M72X!$VMNRC8B;-P&OJ&<\':ZZ,#
M'2]-=;SXQ^3BZ_'EXF+VK3)6+J?IW03#Y'QR\?.*L\Q0240&P45<54DZ8A4D
M11F.1*=-:K^?:5/JQFWJ:PVU@;3R0EZ>WLVF7\B$?FO^]/3$!P_Q]K0I'P,^
M/F5;N(X$C(RLKI3-&ISB&CPK+L946'0O]_&IMJ2L3P'#*-%B AEJT5IPH78F
M>LA!.43M?&GO>3U'5']/4-N@8<,GJ!UUT$%H^,@[R"V&K"JQ9)XA9>)%R8"
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MI[/SV9>?'R=?OMZPPVH'-"]@1)U=&5R&X!'I/HE6*J65=JUMX#,DC5X#>##
MM=1-!U![.TVY;'%EB$A^3%UW5S*KT90@SCPK!!@I1'3.8FZ=AMR2Q'%GNQS4
M+1Q2>?UC\\&CG4F*3G%>-\<$4+Q.MHE*@Z3SK3&IHFSK&WD',L>]GP>%S780
MW5N'7<#TPWP6Z:1_)#42)5^/IFE]2]1W@NMG@A0,_1]PA@E43@G0! LNI)*$
MRSFXUK'T1H1U#<7]X7$/CJUU-2( 4YZ<O<M?\/QD>C&Y^+D\JP4C"D5>C94D
M%_)T(SA'GDX2N>ZI]2C]4X6YBQS_Z\OLQ_^BCUXAC'ZX =8#7SCN"*N#W+;[
MBGEDA*RH7I\=)&X-8@#+T9/GZSB@)V?5,6F#S\I*_E3D\#P\;G_;.*9E;W7-
M&LAN[$3"<Z4C$IF1Q@AP,M05"$Q"T!HA1Y9CEH7.R!TWZ275YNRGNFU*<+:1
M8P>NR@-6\MUU3UQ@@5A)#C3WFNY5YL#S)$ XNE!MMMHV'P[[%#WC3J8;N\QT
M-[7T";%U3R1^(6G^?5:S:^3G95+HQ6)=&97.>-9:NJ1 <&;K@#\/6-T[+T1"
M:[ D<X "U TH[:[:<$>D/ _!UFKK )P?\.<R=?MYMN;@BNWERL?WY1@77Z]Y
M8\2(*BP26^0J*$\1AU?*@3&*:2Y95E$VAN0V]'57Y=@&B(.IJ /X7;%R//L6
M)M-57<%%_GY+AB?TT\7/JW/V]KIR].8LGBFM=1:R.F/>U0DP]:)!!.VR-TYI
M&U3KYJP6=(^;K1_<;AY,I2\:QF]P,O\[GM?!""X@UL'VH&6I*3ENP,=2NZ%U
MY,5+@:5U2UT+NL?-+G0(XQU5.G: O#O#QSB?_R1G:,GTF74& RI9W9X$2F8&
MQ#<#I@TF1%/\W14'CP32C0@:]SVN.3Y'T]6+-K,?\[>,M>.V>E*_U0>08%EQ
M+A:P83E +B,$90U('HW/L=25-MU8VWODC_L4T*'1W4_!8]O>]Q=?\YR8IB__
MFJ>+R8_\=AIGW_*[V6+Q9C;/DR_3U5Z<^//S'*<+C$M53]/R5^=+07W,L::%
M)F425T!(_[Q<S7IZ0PH\>G_\=ADM?,8_S[PSJB1+D:FU=61B5!!$72]1AR_%
MQ*QTF]5('Y;NC4!O7PSH>]=\!P;_*>D\S_6'^I\LA;7\G ^SQ<4\7ZR+U5_E
M:2Z3BP_G),:ZB24OK4;]X&MA2:-\L8K5BY%N1TU7)&(M9C<)F8E.2=VZ#VI4
MAC<Z7^[%G*\N9+H5B/I9X+.J'SQ_J +AZJF)G^D<F*V[B5R1=2UO79*%5H&1
MC"N9E%)Q@%G*S]*U$8S]BX-Q<Y5T8-]OBEV>Y.M,H)392@\ND1NG;$0Z1"Z#
M5"$E$9UWHO7^E0U)VRSYP5X<VH;03 > NZ+[B?KH?^1:O)S3T8\\QR_YCT4N
ME^?O)B6?.1F)6<-KA17QRBT##%& "<8S$4H4V#HCMP^]FT'SY27F#J;#L:/"
M!Z+A.LCWRW3R/\1R(AV0WX+WSF1=[+8>K#G)"_JSRV_TF_6O?+QV7-Z'\\F7
MY2<NEO5^Y ]]FRRJHU-G+M[\UV<J,N.4\V"2SJ \1O)<. .C B8OT%-(N.MK
MWJ&9V>Q O)P$82]RW0HD'5P"K^O-EM,MYWTE&_+@ZR_6OW][)RSS(;%<=TQX
M[6$Y[ HURU!X*EA7$6O5VM/=FLC-T/WR\HG#:FMG.-+-$F:MBC">BC'O\[^X
M=?;6Z[+I/[TE )<\]TEF\#:9NLTG0(@4<]H4>.8E*J%:MR0U9F$S,+^\K.*8
MFN[3\GY;KKN]=65-7^%Y78_\Z6O.%V=6("].6^"*1U#9)@C,*)*XC+Z40N%N
MZZ3XUD1N!M:7DV(\C+8Z@./MRJGE>]^-!,]8ELX8C\!X38TRQ\$'0R+$'$6J
M[RRZ]97_!#F;0>SE)?Q::: #,#W@B#\R.>=F[4'67-977+ 4EM9).>0X<ZD
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M!H"#JJR+N9T/NA7W^5)6&XL<ZT@##10Q,? D2I L1%>RTJIY?^EFE(T[Q_8
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MM9.)Q^)$;K\_YPF"QLT/-H55>P5TAZ;KQF_)DL&$=,&;;$%)Y<!IA\!E(0?
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M41FPSG"O%:=C-VQ=RP-$O:22J79^V+[:Z1UNZQ.;O0@\Y A95._#6T71D??
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MQXFOG M8IH1U(J2(F[V1;O&E'8\OV]DD#27S#@S10V/9F @FB, A\UAM:="
MI@B0EI&HI)>^>=RWZQP\\V* U$K@'6#FR7>:=]>3<63MBK%>0/))4[!!HL(@
M)>B,)421ZN:<0]:\O^MM6MZ+>^7:4\D=0'?K/L>[#5^K-K#:\^7H6)KD K%*
MSJ8*6"BVX:PN?D+Z7^5#\[$M[:COY?&C';;V;6AMH^C.(?YX>^,3[!NR$KD4
M2++4%AJ1Z;)3%%XI8U1=UVEMZSTZC5GHY1%F%+ /K?*QXZ&G>/]U0LGS?,>B
M1)!H@ E1@%RY!$Z22K)/22HE*1+<[#&G(5&]//$T!^^HVNO 3C\HVM/9Q9/K
MDZ]E3\?ZS#*'4J<,0H1([EU&\(85,$%1X* I],S#Y>=V)+ICW[N-+3ZL6O\J
MPP1N!OQ<G_KEC-T%3J\'3DUJ$2/6_MXTFY(9N)S/28C+=YF#STW:B\J11RBU
MD_ A9@Y8[4O$8, Q7R?KA0#H8X9B%4L^"I_42YHY<$?X1P\*__V-\.DOG,ZF
M\U]TL0[N#5UL)FM(V9!@HJ]A"5D-$T5D6A23\F""V9?XCB<&;(.W1[=B'E2Y
M'?@RUXR_NC45<)+G1-37G^_RCWR^+).Q6'S"+$ KET"ENC_$Q@!!UYH^*U-(
M@TU&>Y*R3O!X6-@\!MYV.NP)F6LY+KVM^_RM'_:CU!@LLR UYW3XB;G@ H-D
M12V0D11#M.ZIVXK 3G#:$"&/@;"YNGK"XMOI]\N+Q5)B?)T"XEP'(RV)*AE;
M5S!+0&E9W2J0;?7X;6Z=^7^"G$YPUAX$C\%M3XUT"BYQ-:Q!\&)6Q3%"@E)T
M-KU4%IRUA0>/KK#!S-I]<CH9*S@*N';12*?@DFM6,K/1.2M!:"2?PV3BPGL#
MAK'HM1'H<^O\P!/DC/M<.BZX=M%(3^!Z]?.6V-[,\[\N:WGITJ=P@<?BG ?I
M(HG*NFJ,!0>,24:T.NOFJ]0W(*L32]9+V-!$>ST!\B&&UF>W>)DSD@%/FOLJ
M,@5.6 -9!E9L"K+XYLT,SY/5B=_6"@H;! ?[Z*53J"VN3^R5)VJBX0*7+93$
M$R9R%M#10?4!0Q'<2-YZ/?LF='4"ME9@V"02W4<S':"M%K[0+5#_=?*OR\D/
M/*],+<]E*.2/JD"R,8K73?,%T.AZ!42=H^3)Y];V['%J.G'B1KU7&^FJ ]1]
MS(N+^21>Y/0P3P__[E5I;# 4"ZD$JE",I +%X\'069,I\1"\H#BI=8/T/O2.
M:Q-;868VD@([ .OOLVG^^3O._SM?O+F<IBLN4&)9KO:2J4YN8L@@L!#H)BE)
MYN25<:WCCX<I&1=@AT/"K+E:.@!7BYOEIDJED/,L6780;8K$?"%7.F&IETU*
M!JV+S5?X-65@W%*@/F[Y\1#1P7%8\?Q -OXZ&2]+2-I8.M!,TOD6+D-(@2R(
M5S[;4A2/K6OLGR6JD[#G\("9#:F]L<N(ZY5UY]JZ=]G]^ANWK[UE)_S%6<H4
M5=90,U9)*ADBN,P%Z.RCS;$.9[\31#U2/]R"FG%QVA@=LS%5U7 GY3X=XU=%
M_ ])]8Q94;BL1[>$NOG56O Q<F R>DM^O\S-![D^3=&X;^/#P&\ 771P#=]4
M+*^D=B:BC:6F)*UGO,Y+YN"0[@=?!#K+4U"\]5B[NS2,^P(T+'KVDG<'>+GE
M<#PE(@Q%DI&-$!/YQHKL+* K@0(TE9CVIJC0^D5Q,\I>?M:NC0,W@!X[0.?-
MZ;K%WQD3UF*0A43$8YU"65/M]!,&FVV(@9O<>N/'@X2,ZY0-H?%'C=NNXN\
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MIP[L4K*!@"2J7_<:$4>L.W],$N*^ZIP"4;@HF1)%.9-^BG;HI.HF.A+2I*%
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M<&@)X%QRE17"$!K:W0]"^)%FTC>?15T_.SO0#@FY+R11QEL=I\#._B#_Y+_
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M8ZRNQ>2A%>FMJ9]*999BN? 70>,E!I[;S^*Q;,2H_+?1ZQ50;TJ>,JH9X<2
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MKGJM/F/@WZ[="<14+K!VBB>ZM[/F>0\]?AL7[ 172A=0N\02NT.M=Z@\1X$
MV[1>)[Q2NC#:(904KOB#3#5;7:@30"G=\FP20W0GI!I<*KE<HQ,>*=W!K#&?
M1IGW8#@.K5?-4KHF2;!,M9K\XAR7!6%?S%3599N&"52GNG_Y3B"F= '27631
MOTNZ]'2)$8;9TRMWH=+/^U;OA&Q*=R&=!1;[LS:93CY-;..?$ 6K/]ZR9J<W
M 2G=BNP13O0*@M?77^%*!3:OV0FZE*Y!]@@GU>D#%Y-IZ81Y5XMV\F1=^[II
M/U5A[09@X"B"'=L$F4O0E8T 0PK>;?5.+7HV^]VZ[) ;Z)?E/OE)-L/'$VQ<
M,&(GW'U8O+ESWB&,V)F"%](&OR5=6RH:-CNEO1&5A%Z7GHU&&VQ)F':YVQ=.
M *L=G7/W"N3OSNNQSM#?7=C_[L)^V(U64X_N3#V>7MF[6CO]"N/-[U@VVADZ
MS$?8+YCHGH*G*L3DQK<K17L_?Z@/MX']5""Y*YO![O6;I:(]A.\)RAL!1$;E
M9C8R"$J"O%>CJ\?&Z*\C\3 (GFUK1GOD?AA.>T02_SK_&)CM6#;:J_;#8-LO
MF"0,8$N7?P0CFA!&\,URT5ZT]S&$FP21D#&\J\>3)JPM7%DRVEOV_J;PO4#2
MLH2! -N^:K1G[(/L8'*P+0.&>ES.A\('LH3K*\9[N=['&FZ11Q)8G?_U6-8A
MH5I;,-Z[]#Y(;99&$D!]F<T)"P#1RU+Q7IGW 6== DG <FO4K"Z;TDS/'A[.
MGD0Y&OR^8<>Z\=Z)]P%LIVQ^CG3P=34JE6/@NJ[4$=/!;[8Y0CIX.QO!T\&K
M6[W3D0!YX<WK#TJ:+);7JTN'BKWWKYY(ZG@G;F\S+1WE%3T9MHG.RZI9D!KF
MOK_[+HE<_P_$>8?\CF_1%[_P_Y)B:O[GO_X_4$L#!!0    ( $8SGEK_J'?9
MV#L  &*' 0 ;    9V5H8S%Q,C R-3$P<65X:&EB:70Q,#,N:'1M[7UI<]M&
MUN[W^RMPDYE$2E&,]L7.I$J6%4>YCJ57DN.9]TNJ"33)CD" @P8D,[_^GJ6[
MT0!!2K(I"K)E5=D6B:67TV=]SCD_#?-1_/-/0RFBG__/3_]W;2UXG8;%2"9Y
M$&92Y#(*"JV20? ADOHJ6%LS5QVEXTFF!L,\V%S?W D^I-F5NA;\?:[R6/YL
MG_/3C_S[3S_22W[JI='DYY\B=1VHZ%_?J(.]?N]@9UOLB6AW>V<CW-\1FSL[
M!P>;8KO?VUF7?VYO? /WPO5\D\XGL?S7-R.5K TE#N#%_FYW>YR_O%%1/GRQ
ML;[^SV\J5XY%%,$$UF+9SU]LKL.5N?R8KXE8#9(7- 7^0"41C/;%VCH^#1[1
M3V$-S#/"-$ZS%]^NA_CS$K]9ZXN1BB<OOC_,E(B_[VB1Z#4M,]7GK[7Z6[XX
M@)?1;S<\TKWU]9>Q2J0=^<8F#O;XXU#U5!YLK'>W?OH1KV^8[XQ9- T:ECC[
M>1$/^LS9[]=FOUV?/6W5T?'YY>')N^#H]-TO)Z^/WUV>'+X-3M[]<GK^^^'E
MR2E]@1<<OX9/@\M?3RZ"UZ='[W^'*X-?#R^"5\?'[X+3WT\N+^&*5_\)?C\^
M?'<1G/X2G!^_/CRZ/'GW)C@,SD[/Z5GP\>6OQ\'E\;\O@\-WK^&:L[>'1WC-
MR67PX>3RU^"[;P\V7O[PPP_P[];+3G#V_OSB_2&\ZO(4+G[S_BV/Z6+M_\$=
MQ[\'N^L;*Z]6[7,OCH_>GY]<GAQ?!/!J_'3C8&NK$\ P#V' KX]?=X-;Y^LF
M=?SOH[?OX9[@E_/3W^GYQ__^]>05C/35\='A^XMC'/3)Q7??[NR_#%;4:O#N
M]#* AQR?XR-Q>BL*/H4%HSG_YPS^^O7PDGZ#N9Q<7)[3S,Z/#R\O<(QGYR=_
MP.W!Z7EE=-U[T)+]A,[5B]V#[O[./4EU^J2+; "'O9?F>3IZL=[=K)[@$!XJ
ML_HK-G?N>!R^G*<?W//9]=/=QY]/YVU3IWOC $[WY5 &_32.TQN4(2%<GXDP
M#Y0.AC*3O4DP$I$,1!(%-%R0-BK)TP"^P,]Z,K^1,KD;_?'D:A1H/KQU71YL
M6:99_C8LRYOCX%<IXGP8BDP&AX7.X9'!FU$/&= 6'.>CT^#TC9UWT[#HSZ*'
M%3SEE9XB0)K2I9)]F?1$. PV=AYP09O?/GM!:V>7.,.37>3M_;V-X'_5N/^5
MS'<%F9=*1!^&@@=V^^7Q:!RG$YG1+ZO/=/8PZPXRH45+^P26L9G-GZ<Q2M=S
MH(EG$?/Y%%(Q&;Z.@]CN*3\('_B4*>]V]Y[R+L\4<[(U8JX5@J!.YZVTQ%9R
M,,6LFD+6E?>!#&#PPR!/!Q(^A:]CG089:,X9FF1@D G-!(#WG(DL5U(OGP9H
M'G?=A@UG:S_>FO^29K"*0J>)#M)^H!6LMNJK4.0J36@/X-M(]%2L\DDG&,N,
M+KU1<0RV;V4#5$+[-1(Z+/!%P4#"M#+X,$N+P3 M\FYPD@>#5.+].7X0:#%!
MJSL?BIQN[LN12KQ[P0H7\8V8:'AZ&!>1G*==;?7Q9]$KU&T1_;1-33N"*] /
M#Y13'E7RS)_+F$A(#]6X11K<M#_*?)*G8_QUF;+KD$[<;T4\"38Z&*/8[E09
MGAX*/F62/XF0QQT=G]*Q/,ND5A$%+Y9W(&C<G6#>AC[(4CEGU!$ZHTY& K9L
ML/2)+Y43W%.@[RU9;IR0AU2/94C2(@8B+I!CZSQ-(^;G) _@HG&J%;*"&G4K
MW>%;K',Q"6)QTT$/+!*V$2H]=+T&QQ]E6.3JVKM]A83[6ZEREA2'R4#J7,9Q
M?@<7Q[.D6+:D^%TD8B#Q,;#=(/LS4">(CX&@2%G;:(&8:,'+/RF>\GCZXP=0
MY(SBU\_$2-ZDV16*M1Z&Y*76M,<IJ(VPQ:#H9?*_A<HDJ@AZZ>=SN8*+7EFQ
M:$IYGA#>@,T69%@5SOB]#J("S9>@#\IYVOM+AL3ZK)I.AA':.QI.=Y"2-61N
M@(\K/);X,(I,V")2R5'O#I I7R7I#8Q@P)&M4(Q9Q<>'L.%E;H1_8G@OJ7C
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MG.C(Z=%6<U3,+83-?7E"P(T[[+,U]MTV=TQZ*2P06LJ4_'H[.?!)ZE!+7/]
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MIIJ1FN5<BB17,:V"78 .]OY6 P-3QQ ]BC04SGB56;,L8*+@1?3&<8?I$.1
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MP-SV(DWZE!FF!%;CNV]MQ<7":3!V)$*_.01P N?%Y$9DU >.NU%'MEBA"('
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MCM[#.D1OB[QO14ZV6I%OOQE='#_;_M]PU>@?_F)<?+_RVQ_?\SN>ZY/1LY=
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M1ZT7'#JS\M;&RW5GZ/2A=%W'B3I_"*=]=NFZ6X"][DG*UCK$]Z[15K>$@K?
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M)U2/8M<2 L?;W\@5^WB8PP9*V5;_^UQQV$V$?=6BM?=TR?5AI%3> Y<#V=W
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MQ;3(RQ'P"O3^04^LJZ_UI[)%CU=-Q6<UA058\LQ0S&8XBSPX[OT#5PH=:9T
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M.O+L#BP.TR+OGDRY7>DT3R"?YK1[2@OTT2CPQL2[PL. H$:@_8\2= 8KN:@
MP%;FUZS*+2GS(RT1N"0<:[W ><7):V_R&4_>ZN$Y!:%)&V?6QID71H=WZ3'9
M]=7'X+<TPGI'6;V.^#,(1A]NYPE8E;'Z@(SF[*1[M,!JCKI?P7Y:D]E<;"-5
M5GG-8?><RM:;5*AZBELKYZE51 F N%R6F=*<-(:BAM*7;&+6X/@9T5L^V<+-
M!8(SF6 J+K,%7699O1I.Z_9:WEH_#Z%?=F<FX0:<[*PL:(-?>6>!DM,X<VV)
M&+ 9:],BSA4H.YRQ=H8I<]=W& 2<NUB9<A6![3ATL:9NP\SC&3"='Y\"TV&G
M5I7IX+FI\ [\[;BW8QD;81ED(M3YA27O+R'K_M+B<B^N.$4=0[@K3O$\/^_5
M]>ZIRZ++IR"+S@9KR"+TM+A2 *<[/78C0LE4//@J4FG0))7NY>O:-@A*\\E^
ML,H3^+S2#U6Z=):5GPA^26\EG,@.AE^2-,"0?LX[0QMZ]6?%*431_Q2#<<$T
MS20##Q!9XTZ 7T +(SYHUZRI^'M;=I<*ML\6E=/H1WHL)$#-28<QH V&GPVI
M4%T;AJC V6*?_"Q3\!80"%F][$W5'>F*O1C7)!7*R20'0&7D8LS:_.7J>?JO
M$5Q_:"CA_"44 !HU>#YKK^I:2B]K_>"SN8<QW9T)CJ,.>@>1F <")F.<LNUO
M1O(W(?%FWRMZ#GY^]\NE*_-(_R 6_3-:Z5WZHG0PF3%2?*(,WN'7MF!L]7X.
MKAG64GV6)S& %7SRJVVN[6[<&JY] ;S0SM,@&C(Y%AG%D+S=[@3 D":T[$N$
M'FY&&Z.>"N"K8"W)>+Y03+:MTFT(3P'; .O1AE29UIZ-D1L#8]!HM!F6"PW!
MIBATI6 MR2,<.2BL,DO\FSKN_)1CX1%/X)QBF"O,I(URF7BN%X-U0>"FRJ1"
M8T@,\1PZ$#.0+'#6$7I&)89',16&G'A $3B=(+H(G08TDV@N?JH[05F==RI!
M.((X:\-L= @)1U\9M IZJ1Q8I6.(SH3^X-^9#,5,@10S((L.1P$/BAG^I9)T
M-,*+4L((VDLJ<)*.MS4=B@_'XM;P,8U?P+$<E?^&7>"P,NQ%)E(\9["]G:!(
M"@TZ<*<2;J;+53+*0#_&U2;Y[3]$*R )8 J-*\< #%\[N$\!X[5C!"LJSV]5
MK=?AI@VF=:*3QQ0Q>%=62MWR:J_O/10IBEUD:J0Q$CNS-<#AQ[)K2C/?P%@\
ME8M5TI1/M]7)I\!WJ XZL(0"*\A=EXP;.4BY6)VR?'E9"AWE:%J,^=W DF+0
MS#!6[[=TL[YM,D.[ <J'PFH1-!O'T-5T*B/D:,#032UWN.;6U(>WY<^IFK,W
MAU(DMPW=(10R*32BQ>2(M?'6,9=<W"X4#Q)YA*0!A/ HXKS$UNGAN'-^N7?\
MLNQC42GM#N/Q2[KK=6JZ U?,"C83O$MA;;3T5@M7E,#3<I9364*X$)12T*5@
M48TQ8HK"K\FOCLZ[IVMPFHV77%?=9U)Q_:T40-YP1-XJ;3!0V\A=7?7U[>2=
MHSOR"*R9B815Q'FEY8-W<[2X,6ANI)G5VEK9GN?A:2K4[?D>"-#KF#52,';#
M0:Q>Z] ;#\=CG8$UP7@KF,A=^M6OQXYVN*PZ+FL9R_D()DE&W3Z"=[$:JR5<
MY]$/UA:S%3"?$!_+=85!5/,2:M(WO"4%]2PFB]284&FA?3: J@8VY%FB? 44
M/:/7$103^4'EC>NQ(8;'TZ/PNC0Q+I!=5--&_0YW4<T7\?E0)?=9&FV;#TXD
M";;)T^CG6FA?Y>DB5>/&.GA\<[--8[$65=62:W&Z67YT%4YD5,2VW1BZLZKL
M="(B8&M30>Z5-G[9#7["PNU%!MQ%MG:M\OGO5.*JDKF78TX$?6GRJ.ZB=-Q=
M63GO;9&JLO%^/*N#VK0XZ/<].>:<J">XS!MWA:U>9NL*HY7N<;I0"@0F75I<
M'L12  L8H2,#=033B[.!'GFCZM6ZG\16A=N_56==1Q/'Q\MV*@>>OGRCUDV<
M.N[=#U%:N6]+%I,T]JP4!0+5;4S(C14HP;BJ%)-/4A. WQ/[G6!ON(]6_EZX
M;R05B!?0O"*1IQF*/'3)>HY##$^@1$KAB[D5FK;MX2UZ#"M"3MD]05_LZ-ZB
MK!R0-SUJM&U=E]X08>UN,"SJV0Q!&.-+N9<8VA-T+T^N<176=!<^K].SEJK1
M;-;Q5C7_YE0C$TRD"!2<PXO1""QOW(@]VW3F9YG(3,1@E\L0JV>X^*/1P&!0
MV)E5V#MUQ2=/FYHVYTB8<!S[]=M>LX]1<PK=)TL\4(N<Y8%:*V_;>?@]S7%7
M7%(DKBL&$\8I11=5%;)D(@&8EAZDL-IFX9 W:!ES*QX**9#]/T3$D@!V/H9]
M^!MK?5CWP+??')V^P2Q<^BG"1C[IS/:"K7LI_RXRI2/%$4MZ!:=LQNH3!E:,
MB].PJ9&X24UZ)=BS'(+V^(9Q*%Q0LUV@ UV(Q'",(>9ECC,QFV J^_X!=:H=
M2EP4X\4L$N",HR+V9T#Q;T6G*,4H+9DBIJ72XDC8+L'PU-"P,QD]9)O8Q](S
M#I]--]BFR-0V*E&+W;@M31)8#^0>'#6E)TB98HJRFO$<KI6SG\M1UN" ;S,P
M@(&,7(T-%\(C.(JY8X'58M2/,Y5T$''5#/-DQ!YY *FD9JU;X)+W8\2!5R!L
M(AP<+AKAE*=/L"D;"[3PTZ9-LUC4;N"G*AF* R.><6&R)129@.I"8= ;8]J[
M[FJ,UX(Q=7BE87DJVH\($,>%6E,QG5%C-@J$FCVH+'OCJ\T::#'U%T*TM-!6
M&+2)T1=B LE^U-RN7F>AL(;ME7JTI&WY13+WUHD1J$4R$RIJ6;,<Q.JPR"U?
M%;1Q-/K*IEF8KQ\,-WW,D:=2[+G>YYSN,6P21_#(78>WBM<>/1]>RR=WSB X
M\3GX"PXP,A&U[>VX@>&E#)<R$#HZ]&7@H0JUR!?XCZ%9RPA*WE&V'FX!5E08
M2'FU[Z2TYE$#E59X49U=D&PH'X2UD?B[$)$@6'T%S7%/=X(=NRUWC%&&4FID
MN6YK7>17DMZ=)BKL5!3X899^8GBK0<65LJL9DN@MF$&[,:-C?!OR%."YZ'IM
MP;+A@XQ0\"Q6S#F8,C/:!8ML,.5H%RQZ$9\/%2S:1H,6&1P6:D*.98,Z%"5&
M-;#"S"2A>Q')344TC<;G,<N)!"LSS0);Q/.1X ,M:5C;B1]8X3_P739*H[6-
MR1J9%8CS)9(/BW"A^I?J'#:T63:0(# VA]#V%N,4Y!0(Y00?0B5I[R,%K%;B
M2$ *DO=YSM?06?'\H(JE>@68@#(1+F.O$=;#02@VU1$KZZ?B>:O<9%RL<)_Q
MK<("%5;?7?!.^ M%:.V141%PMLVKM=&3N94'TZPE)C0DQK"T1\G"XV:H+&AF
M%;Q#SD[JG5^47L:HP57\=6R*C2,@CY\+YO2CQ!#!PWC7OMCIN_W[?O)\C$R1
M"Z1C9,HL^3]D8 V%&P;_?9WLR;MRZ%6IM(/ZZ=T><"HI\.KI'%,L1KGJF%ZF
M<<P2IX/O"D$-M8;UGQK,K*USBM F!)C/J$GYB7 6(<\"H[\SGH3U'C8D&3((
M*C%REK0N"L;H8&RRQED24S)Y+!*;4J@; >R)F,I.,.&RLA'H19@J,A4J+O\)
M)KZ<34#J&^])Q^FC0Y7EDTZ@4\J25(DN,M*ZK)?%IM"A4R6GE!,:LWV,%C'E
MY86@_/U;)GJB9IW@[W08Y"J/*>%F6;9,!+HAMH3'VW1 EH:)8+D(*A7\ESG,
MAK5.,&"J2]4IO:R8(2.S4&G\DWTZG 18UCOM!ECGEF[%0V8>55WMJN^*O+!F
M=QN7?U8Y!_70/PPX#;G\=LLZH"M'YK!:!L!6QN;8JZ40&(*_<19E-%4)@G\S
M2R13D8BQM3IP_)4R97;HNCR7VI[+YN-4G0\=51B!*L%_]3"(!V@F@@;:RLW1
MOL)E=S/!M_UIUJ5^4UN)MW<P;ZY/7'%>H9%C-YMSM*C4L A#.N_ ;#++4\C0
MT!C]=E5II4':,(RCM#TZ2*@8VT?WIEG1^O+@=L;!+Q]YW9E$J#0W;[(@FX<0
M&,;?MX7L:QE/OKV][4[GDZP[EA,IXGP2PJGMPAG8PGF\^F'M/AE;+]3OENBV
M>=E]81A1QG4FK@P6Z0,G(V:;<A,9X>QS0.L]6(?= 0_Y\\<KKW:!F1?P%$['
M%:"=8%3687T<>S99[\);%Q/(8T[ALW<2ZGOXEPGF7D]4%AU\$!FHZ][*IJXT
ML#D=*+W(NU1@^YNJI$*>J"GB %PH4B.8,KZR]='<C($BK*L7QKB&6!D([<I2
MN!I-3$:)NT1[F'$"9X#WH7T )%O3&0)D$A<)J84[JKFW$>YF)-MD*14\R!;T
M)[MXO@2Q$5FA/W&A#X%A8(Q$F_X4\&:934W+(5R"6:F<EC4DW#EHG:4].92*
M",(E<N70FU;=9B!BD2&!-7'4#(=BU"(6[S2/&1MT%J!H2ZBVKK5S"]XH><M%
M24D>-Y[V 'V](EX76_HTS/O3IV,WK3#OL:T+-KX#K=MP'?R&"M'FRK&=RYK>
MYG .S=B>Q_<"/ Z.8=L$_:;MV49!7UWY?K=WOCRUM'X"-W6B6-QOI6KZM@2$
MU9G\$LRP!0 [S#";P!3$\QH*Y+<ROL'Z<TD^T0:#,5&: )DHH7U0+P'.?&7C
MHS&'$/) 3RSK8U>D(TC[CA/'MGD4VK0T6&0UJ><AL-V:.L:LCVDNU@IBO4F8
M>!/=@29I5<29$\5VU&7* *\=,L&>J.,=,N%%?#[;-%;:9?;\L&(?2V&*V'HL
ML9K80 R1F,<*OH,,1(Z 7;$K"!1AZ7$1]U9QZ_I:5;Q\7(ZHR04EHAM6HC(L
M")9PD;8;U([7+Y-Q?*\X6J/7XBM4\%R;/EV3#=X$(S<"ZE3(#CCJ&&4V9(]-
MR$Z SLN<TV'\$G'[#B@KDS&P+?3^TD6S#$TPDIZI^0UWEPL=6>E @X"_85I1
M$2[+@WM"BUK.QZXMF8TS_HZ:<!E'BY<#@I7]8A$R(;G53V=HQ!4)PS)&:(A:
MFKE%KRF;"UY"MWF)]C,[M#4(]^1G P2!;]FZ]C)6S$[Z&=^(*\PXIG"3@JY2
M:CL>4O[7-/T4_(CMQ5@1P4!$$*>XP[J6<X/YX]KA'G$=*7QA9ML-WN?.I,?>
MO 7FJM"@7+7FQ?&X-;;A%?8?XZF[3),1QSS@EO<)E5]CRVJ(?*)I2SJ+4RTO
MJ^I!W*DS"+-4X\'AUIW>'AC/M"+B2/#=6.A+8TWDX;SBW;$- YL85ZF1D:>G
MF.$XM4E7,F&=A%(>"BS0>3M)N:B<&0\1HJ4X?W#EE)>QP*=!=<V[; _&Q!Q#
MS/KC'"@OGP!_<&+E?9* 3'"V]P<JXRESK-7@GYXRO="F<;Q[_^']A?/R/?'5
MK,I:NXJ<,TEA3'O:7+*LK>G[JQ2T:B/TL)';\4=<QQ3-FC&>U#UC&+'G$R'A
M%M[MN5=C9$EZWR_1[3@8?(?/H$J!$Q$#!8SV*SRFPL)NT^R3R2[I!&.N7?$I
M26]C&8V1\Q SO24LO*F^MXIC5"N1K3()[:"6,$M,5UG4;QSVO.2"0-:Q+NO2
MUFD>:QUVZ*WF4,_0WTI4?]X+(C >J)8KF#_$4J7*EAJP7/CH1OJ-D*E#L<!.
MZG&0#L&2,C6$JXE53UR$U_?'D^ XR?PV-:G\=-!XD9M=[ZN+PCU%Q;]690OX
M(^RJXN15%7$(X1+,;*"<1 F.;; +7F$+L#3'?/Z@SV(>@[;D);=HQ=-NLV?M
M,=I=D ?M7NTN^@]>J69(Q64=I<QR\JI$@5V!*B5AUUSS#0Z7V@BD,Q&"NOZZ
M;]T"QSUZ=\T<?; %/J'>O?==X$.Z>_4"/RQCZ*T7AWP_NMMQ1W#N@6\*.U[I
M)S#"42^3 XD0[IFJ_^(\:"<[#]J+^'S>'K1U!.E?0H,Z-\[3I$V0#IZ5(!W<
MBP&N@*TWM94?#!Y%TVQ%"6U_]'#0':PH3%N+5F\8*[3MT<.%<-UBF*[1VJ6.
M6>AP0FQO;DLE5)SH"-I![UH:2RYVQ:07[ FRUXV1+CL.J0MF[VV"P%^PZ-"4
MQ?H)OE=QW_=+&G=8)3!91OR,4F-'@_B>"^! -XA^\8Q1;_87().?N(W8-%O?
MTVL7@!WCO'X:*W=YKKC:'G-HV-M4KIUA4%U44D-0%1$+SD(A4"0.#6O0RFR+
MXQ_N^:6 ,2Z.\H6^P;]8^01L5G_/EWD+]L@KH7$]X*[ZE00+,Y NY]BV08,D
MO6UR?^Y;W]RB<QF+GRT-(G )#^M3N:2V0I(=Y^@:GM&U;B 415J\O+9Y#:_I
M4/TUH"1N7L.-=TP?&P?G%HLS]K>9+MZ+]GV*8J\R>W9K1TG;2E$$I_.+116:
MDU&5QMIQA:VWTN+,6@$'>/H.X>I>UER8IM,49Z*V^@XKX0\#)_=9VJ(C[[?%
MJVM.//R#,C9';<<;ZW55]$+T=G($SF8X^$3IA0/V2PJO\1:<B3V%![8,D#\C
M>F&Y*)YOM9K&077$G-2Z@]O4?SX?>>4_RB!#J7XFI;'B9,O0,!U20C:&L*MP
M7!<"OWB>'9TA.K,(G:CTWPT'VYX)W1!H\KI^A<3<W9K 1*G8B#9='^[D[^-S
M-9&T:WJRY&CAI%=YH&LUA6*0!WG9Y$YR4DAF9$(X$7KAG+L1[]Q/Z[F?!EOM
M?JH;B>$DI3Z2(\K05W[5,A>X\OO,T<]Q.H3C=A%AU1WLPMI4WB^H)J)3OSL$
M,%=3D.QAF[D$(LU*+(D:1STXZB[HA3==2DLG4._IFP#$Q\F@V^L=TR'MOSGO
M]8*]06_0VZ^ W\HYHP)6(M\JK:&\.%WC='1* >K4%CCPP>K8]B_"/#E)>.\;
MF0BJ)LJ"Q60"5D=!&6K*! -T;E+SRFNZ%>.<"M=R4U)6R1)N C510Y4'/BK3
MOLU;7^1Y"S$CC *IBL:_(-\L5F>9+M=2*#Z"W4N4*VT,+T'6%$JJ]F!V!2S"
MRL"%77\K@$M ?W7I++3?6Z"[KE#+ZERVB'JS6/F$ZGIB"T*J,>64O]1T$:.\
M,Q GTC_YE;9N[AZLVI165,LM7EM.VL 5Q0)7WNL$ADEUJ0:!JE**/,HW-5?;
MTA,:$1%D/RXDV6'M:^P"6[4)]FCML%4S@8:XWO/^8BQ59*A9ZT5I[P*<V%>%
MFJ20DH1-/CD?(I/P1M0)>)=\C<5&K/<QH8-25I("&V)RWFDH.3B*?2BYILF!
M:QCMQ:H1>)& &(<EI_ZRD[30E&"2QC&&!O?^3[_7ZX!8V*?ZE#1$7L3_Q,R/
M?B= CE9A:!?V-=>V;[;K2+[GAN!K7",V_!?W>[_,DX'E77QN,%)CM ^P:DAA
MBY7Q,L!I $5E<\)NF;=IDN<S36TA2(VBCSA1W5O1':<W]$^*]F>:^V1K]Q6A
MJ@XHPT9)_AI=5VSNR(,RH6*34KZ6&<;-RY? "Y!W&7V3#X8/2Q! >G/JYMI
M]$8(&BI>R&HODIB-50\+@"ND+<8C5U/9A'W@5_J@C=*_9;%IMAZK*VL$+Z\)
M4;C_DY0S!HA9P6MAH;(1(;C,1[P+H#4<MM-= .U%?'Y! &VKW3P.X^IC6X>%
M5?,))S4TA;! .4LKIKW3US)IW#%$YYHY#G#2GS_\ 2*<&\-_8!,:M;H_/,PS
M%0I]TBZRFD-^$0.._'HL4ZHBK\* ZU^0+6<5Z:J"S2FV5'35NTW LZD> ]E#
M'6Z],?>:>F<@[,<)ZE_^;4.,V2#J$D,85'O%J#JVAS@^*-.M[1.L!EYBTQ&Q
MR]"WM*Q9BU*3_"?&:6-K27BN&D6+$:6>O[CF.&]SY*FJ^]P5<\3,8(/E7D#<
MK8%<WK,8Y#$=4 \V:3H0ZEHHAYS&SD<D7-=A?[V!O6?H^,7JLIZ[@=SS>;EV
M*V[VG-3\/MO((,VHAB(HX+SUE2]UF,YH(VM'TK[=,TZ\]FCUBQU@LG9N@18_
M81_(LM>+"WBD4M><\Z7K5R^BP,F1:CI!K.OW+!O.F,/:$E!9@@\U+@V!S@<,
MQPTE$P2UM\ZFOJN%[#>%>@67G*];O&@+-3D]AY*Z8_B@66T*KE@?$R69)[2I
M5[GI9&*=' LT8^[K>->0#<<CJ!*73Y?X8AI)"8RG^RH.;^M7X9<DH2F?0##5
M,?5RH4L,7)[X$?)>6^*21UQZ\:N36G5*,&"C%N@#'851XRK9L7&_(94L+@$O
M-E?9I%4#"EQ,W[0TG\DI@C[035XDRG)D6B3K?#*[7J./3C4!AUPH2-"5\%*&
MJT7[G:<=TR\ F5$MY<1ZKN-Y&1ZKN#S:8K[O&X=F5S&,T4SVV#/5TV]+AZTX
MV#N5%<55TU)^@B>*K"QV57<C.&'Q*W5N>8O)2KDC=YA#_XA@TUYM]'H^;K<4
M)6PBX3QL(5:A2I<]FE6AS+#!(2RV-UBLYT P:Z[>VP 6H"6J%E:=J*E;$Y0R
MY>/HM.(@0&#I=-W"#UN+CUH;=7F)8Q(1G]3?5 )',<U7HC%U#8[I6\@&D'E7
MW_N= %KJ/D#P)UDSP;3CWC[<TT)/OZ/NT>ERV-,="W)LO'IP59Q4:T1'?F D
M8V&9S%L3/7S]J)KT4>^1YL67.F29X1L\-;3MJ8:!&AB#;.37]=H*[H<V9:P;
M7%<"5Y[XUL7P;]-# I_ITB.==UV79>?@ZR5U?A82,=M*053<OA_(AUT>H3*2
MU=C-CF5;,3/%JF@'<<G E*74T6JTPDH-'B.V4+*JM/G&E+&JC<&3:J%+EC(:
M,FET5F'/6=>S1?F,H@C#=CRNM2V?J6-44_08N40!<=MFV,!@RNUH7E]O>8<R
M%(4Y.A85A9E>N%;H"_<T F.*[!R#5N:>[1R#+^+SV2+K;=^,19ZTD@.U-1H[
M[=XH%7!0\<4H;(Q3O]FT1K,:IW[4/1LLU]<^REC)T6;1Z34SD;&]6&2#=:[A
MO&+3&='J>H_43!8)%CN8@G.#SV9I!XH,%F8BU8?J#6=4?8.;A(@I=5.N:FP6
M*G-1=J<M0^;3-)%S<R,W(['8&3!J(^SDE:/LG\H(7887A&G WH'<-K1QOBO>
M;1U35&4D-LY*Q);_;5'.7D$+U@HPB,A.KXSVN%,I )-(JO/(>@X:@8RZYFKZ
M'8Y3<IB5D+"\$[8UB;?BM9K%%%RP\\*H0B2GB1J9C&F,KZ^8*'KMXA)XC(U4
M4JIV' LU)0/6+'M%A[8S*]W5'2JC[?6"$:!V9+!MVJBGU-$,7>XZ-\[YSS.9
M:#)<"?!";(YU0@(=H[++19@MEF21;U)#QEN)%JV!3F$729Q%M=DF\DO3L+K:
MF.AV(FGS2/.DGF^9-&6^]QF",<MK0+.RGV8FU72(OE37]Z3T90VI(\V+X= D
MZ;:/02\8U&?=_N$J@SI!?TJVT1*$6]S^IXV9&H(CTG;HRB9\4$-/=."&>8%^
M>:$RXWUV?"3T]X.>4S=[Z[7DJT;? W08VC8R>Q*.JU6*D#U''XG'[PBMJ0'<
MQ&3?-)H,1E^HHITY^))QW U-"<]%4:>;LL4!: ,$+$:9CW>'H!6,.7NO+*;9
M<8%'*_U!"5-A79/K< (@!F.P=ZNI-,!UGQ#0:'I "X*#^^!-4<!3,^,;&F,\
M/^'OL:/<W(>(4P,0CKQEH%8@<XB9=WB.];*<-C\@V+.("ASL.^K^ZB5%_.$J
MF\VI_#?G?>RS OEG]ZIK6Q\IT^OBG>U)5U[-%WNA&YCGKV*(8;K%'_X3G3^A
M+$'B9<7L]TD$/V;SX",WL\-@]H5=G7N695BO=<&VV<YKTT#E_!M_+=^XD+$2
MYBZ&[/"8BP%WED <CP9M'@O%9XCA@5,[*N(5#N4.JM5":U91<3B9*F.%[(&U
M5>\3+C08/$P"_F%K?*=%:CQ&!CY)AWMEX!^N)Z"/>]VCK1+03T!"][O'_>42
M^@.[JS<]E98XTO7:#O4500'&5,F$TE07=4NB3U<KD@ZHG\M7 ;@P38-H^B31
M]D88FN$T#I& P[0T[N+C)1K"OL]BER()0Z=.(#'Q%7*F)*03Z[R2,+. M*D,
M ^]SLCPI.2!W JM@2-C)0XS/R])&M)LG(FNM) B[YKT0'[]+YULOG>_PZZB^
M7R&=+UDAC:W3C"RZK&"OF4N1:A/1)D^\X"XHE@#*9%QC"<ZM(-;F;,++""I3
M%:\=][TO@NUWF01"4M9A%=P*TU,8U-DLN%%I;'[2\C/JAW"_H"2&"C*4#COC
M@Z;8BHP18)2]$KK6*9D_1?8>$<5R*J3PV[,Q;,DIMJBELB<P+?6#75#0GMCS
M75#P17P^5%"0=<-M,VPJ.D$-&NMYT$J8((SV-I_82\LJS%(Q)$$'1O+"%>C(
M[H!%Z[*=2WN#@A3SEI:@:WJK#T_NXZM^&OV<SIY-/Z>+$F;\D?/;MAD55FFN
METG3_XVT=[R,8EM3UO5-HD8Y)=MVC/J;=E:V<0.C01<B<6$=<ULE5]]O65<O
M+N74YGI8R(-I2\Z&Y*@9A;(TEL,B547FQE5DPT@-,T)? T<,,;L$*3BZ4=H@
MZ@/2GQVRU\#GN(<H.M52^FT$*G*LR$O&RKOTN@?6&@KZ#6+=0IB^<'_YH3ZK
MS(R!/67"AVVY\/!B_T!;S\!W;\  $6D?N(1.LY.F#P!8$I0[0HMDL!'E>G!3
M5O+ZZTGU[7?H2O^56-AC<:KSY\.IXMR<30JH>[#V[616O,C!GTYVRL^8OZ*-
M.ZX%9.CH8HH=7VQ-]8GM5<-LS@ Q**FYF7'0X8?G(<?"=0-^5^@9_1LO2JD\
M.CG&74(V/9*"VSX@ 8TTKS..(4P@^)^*#!G2-,TX$:>9L;4.S\8#?6=JV8JE
MZN# &G1E^ _-JA+XT+Z&U-U@P8WJL+:$IT@6NAG"]4F]H:%GN:[LF(9UWCBG
MG>:^9Q*P&-.?&Y@O\F0$P.R7!94H+6ID??L(2<GDK.!1\;\KZ2Q-0&8?KHO5
MJK#.6V@P$UQVHJ7Q9WL-**K;1("=,5:6RLRKQ9);T)UV2>B>%@R%R9'G_47?
M%9Y'4Z%&(H>FV;CTE;4'N\\MW[V.ZWR:79*=:]8..L)41KA.L6GS3O)EBAE/
MFH(%*BUT3)#R&SGW%. &;X9[O(?*1B] 0=UIN.D[H;1OW,FD83F?V9)GVZ&U
MZ"I-(W4XHRJR!8XBYG*:1O*("NR4(Q\Q*==QY>4LK+MB 1*%,E=$Z<Q:(,B0
M\)#!?SLUQ8>VW3P'4^@JR4'>1AL5*[7G9(KP'ZM5+4/GTS/>!;]0Y_!+5(VN
M93A)@-N/,1CW/@F[P24H/D-*4^2!1+),Y/.U)/8'^[KC*/A8P%C[O;<'?=R[
M:1&/1=4VN@@9:.2J/O#^(1=&:$-]@>!H_#CW:CNR^2:8U](1609HJ@#6/,1[
MQQ6^2"++O.MY#V4F &^"<8C5NTDC^,H+O,*H]C[O6TA3]6@H&T!VARPEH)<E
M[,HVNL)YS)&&7BF]:M&H^A$JSPR/;F^^SR N)"7;7,@[6*CELH^+/=6& 9CY
ME7.@OZ6)S5(T>TZ'!)Y6&;B!HZ$0C^>M,$&D"71QEVXZ88(*HJZQ8T"!3HI!
M)KI%10Y8G8>5R996G5S.S.-A'7&:?I&2RE*6<7&E=<'^672_AJX="HZWO8DS
M]K!1^R58L,Z7V^PI[*3#O@?#7UL:9?M(22K9B,N!3*WCNJC79""H$D5FFG*M
M?KO6<H$0$"69[C(IG%.QW]MY35_$YT-Y33?KFVOWF?H8W!(!T9;79=6LTK%4
M5WS0<( _\D[]:;+A8M:K4#D3*NX&%[%./;W/:5U)$3/J_295]2J5%5W W6H"
MU0288H6!:L95$<4E5P6QX49IL_G]&@1UF^YQ>Z,O/J>QO<'&7;W]WK/QH)"8
MO:;#B^?NK2O@N'%W;PO@<CL1E^]:X?[&88);P)'?>&[M/%TJ+IP#$8J9RKF(
MHV$H9<F@!A[E/$!45=\VA02-$@USHP0YG)?GE[UN>E@UA[AD:03_L,JTXQWX
MI(Y)L4']%8$EV0S/%ZN95'X)&0H;N[0H-\9B,(G9Q#R!Z>6W4MHZF-77M+!E
M3JZM#*3I;J-",F^E1/ T?@!$]Y/A4?WN,V%1[U'[G2'^PEE<EVEIIVR:3[6'
MI5K/;^5H5E O#-(R\ZW4M&3?;UM0"'/7J(179:F<X\<Z7RMEF$N'\EYI",(&
M9 ;?9D@UDN2WP&<9L++)LX!1A\I 8NS%'L L!$O<S7"H$H._)@^$Z;&!HX;?
M*Z/37@49S]4 S$:H&RX'S[64PTH RK?C;16BT!NN<8"MYC!NR-9'5EFJTK1=
M6/^WU5G0[2O\>.XD)%BNUR0F%@E6@YG2!29^1<_2,I94S#\FOR09ZY'MG-IQ
MKE1R5AO7FM]:E5HI<\L5[-VLR+\0O22&.'@N#/$*2TZ;VA?;R_V0>&Y F8E,
M7D:1+%;M6/#4.8I(6\BFK&O$[E0R?KRW-+^C1OWKO,DKN]9\'Q/P$BRCYFV*
MI>\V];W;1DV<(=O([YSY^5!8FBVEUL-G0ZWH=30(JR49:UM"LS9^4)93(BL#
MB>@FS0WHUH+5RXFY=.O8(M6+)%=QJP\VH\XT7*D]DK'BD$ UZG-OYT/E1#\\
M;3P:"1P]%Q+X/?6CP=M/!!4W&T.;*A55&MF^2\F@L'@E%H?^0R80+^;:T%]N
M6?C^)6EJQ\_EX+]U!@*&]@Q<\-WG/!.N_O./#-?=5%F7;7:JT7KIA9A@)AT(
M&8.EID50(Q8ZKU8LN8,U=WT'RJ=6B"F,GD+Y%G_-?50,3X '6SA5I2:AJQYN
MH:HF[&V^;EZ!6D,Y9BNQDH5U_Q,4*R_L0FD"8U&"M=5-;06\&@2K7$)>H&K)
MF#6 K; 4-VD,LE]0"6[NW$++N.?4:6]JY<":8>4UC%>"*K-'.RJ7T\:(O*G$
MNXOBNBAN?Q?%?1&?SSF*ZW?7K;.D!'/UB:%B<:@PKP.,1F5K89(4H8C#PL"
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M.8$/<E5:G7G #WOL8'B(]L%!<NCT+"B2*9">ETJCPL884N3 S?@<+R\4?+#
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ME'1+GIW5+19AI@#$<0O[(Z&IJB*(%G],+NUQ:>K@1'=<"61$?<XR%7VU3X5
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M+'26T:0-/? Z/##B!YIR9M&YY#RCA:??YU_P[I$;^]-S4Z7A4WQ$8/1( I$
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M,F#X@UOF#[<8Z:80A.2-)6LCHS>&N'VQ[EV[P+F&0S5>UFH4Q4HB+W5N"D+
M-!GPQP8?+]NK="BI04QC/4KJDH$2I"JV:HK2NJC*/)>?IU6&S></.K[H5UH!
M$QX.M7 DT@W>B"3#=Q%0!22SCM[H+R_Q2QB(-?^@1F3#:T56Q/L):E97=PHF
M':LWBJW0!1POD4&IY$,+0;? Y;7I@U(GOAD.$!0XN@$'H)^T9:4N0G%IU+H
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M4]+HH"NJZ7#EN<4QP<^O6"]:FQ+2&UZJ&B&'N"ZHMIF7%?7[VE_SB\'!/'4
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MWJT-PO! B14\$-OYK6+$:K<(QW#-\4Y%XL0HJ0%W%9\((>"A^O(N%LSRG#J
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M\E2^^J6O 2#U@Z&Z+J4DA]09CLIHT0>ZQ89)\]&)4J4(C!.N5!4LHC1TFWE
M?+Z)VI;:>58R\= ^(M&-2'R[CTCL1D3BIH61[B84HH'5T=E+*%2CT%F?QY5$
M'.1:DHIYR+2PJO#PDZ 5J<4U3WW-$L8P><'C"B\P+40Y!B\9ZXU+KEO+KM]@
M+N*5*%XUL;N67GMM;A=4#XH=!O3_OV5"CBV?6=MTE0[S50B9%99NEVRHBHN#
M,L(M%/+*ZKH-E8)0NXR7+()7]:$S:NOL0W+PZ- 5B1BH@#WT<$2,U27RT,_'
M7#?#A"H=C%>:U4)M!,(;5_&(7R>MTP)DIBA0_T8JO/4;NEMJZR?2(/W* <1;
M@+J-"+ZB8IRZ\F+>M8@4:8AV;*AZ=.BR8-F#'I?3$/ G8="<F2SGI-FRD%Q5
MYV"K!SQL/9-7.M'/MHW+H76(\T81>0O4+7:8T;V,ZV3D]V+1%NKX\(C'FJSW
M,ZO;P2(-&'JG>+?[U25<KW"SUC5/!1TXP,>C7HS6\^_P:7:EL>SE&T>_YZ!Q
MRCVICA_TX0EW[A$7[E1X+)^8VGJ>%N=3$:</#54K6CPC5BUM/:X*>(%KM.<3
M=:6^5,:D8)X"&YN,5M_)JVUGP*8:"D/$31OGW:=?"TEH=SH1J[#GSH^)(9F!
MFP[$H%I0LEGU1_+?JE9PD<I> ::):=W@QR7O/(O3I8J)>G>:3^GQR%6+EQY?
M0WU1U>5V<9/MF")U;:=&6\SH4-S'M/<Q[7U,^U;&M/NXT3LMCEX6Z1<AA=X+
MH[TPV@NCRX71;D-KMAXXVV-NT%6LA3WPYO8";P+2.ZLD'W0 BK,SL)M]$*L;
MQ'JX#V+=@=)Q6S_*;AN:;0]ENR$H&]R=@B_K@,]N#=@L@!G3PTTZRI=5-$9.
MT\ -9[82^H8(RH$_215:+#F><<G-: 29A6E9C4 ZP=57=*%7?!R3?"@7PJ-_
MH:=[)*VD^48437K(JE!JS9D$RGJ_XC5<G<1,<+Q6%:J&BR$22/@Y+E!UR]-6
MMK#GM)H=6P2W;#'JY*/UV3S6/?/<!M96I?_U^@!T0IAN)#X#_G '1?)',>ML
M_1BY,N7.9ZS-?8-FZ,GQP]L3!=X.Y<Z>_>;K9+\9"?<--9#6A?:-/N+*>[G8
M-MX$8W"9&UKFU >R]1:<D;KGS-G=BL-;+?[Q]3+@ )S]C(XVM1-(D,B'MQL_
M^'>W2!,+N$TM]0[L=\_>>D\8X!AB6-#.G-*K<,9K%23X&FFI<F HR>1DD5OL
M!_ > &--6C2 !5HG[V#25J200DU_^>N;Y/&]>R,:@</XR[2$:-_.R]R[.Y,T
M^&CY6V3"D%PC40)+MU/\B]%LIL ^T&;"%*P[+8W1$8+L"/=U%9J1J]$7%?*C
M%AX#8JX6DD+8@\ 9*OBT5JC1(T\42@(P/&G^.<I,F>*]-LGU68:TVX6K%]]2
ME_1Z&] W4N(@9-AH#;@AS,(932DN0PIC,EA^D^E6IEV1=&%)TIM$[VV=Q(S1
M/J@CW-]?F!M=.'$:A/>(T*A/<E-U,$#KT^,*)E]]A01_BC.R\5MG2P4G .M5
M IC6O(0\]\5!/\?6P7!TLBA<_]F*C(> *XA@I&CK7!!#_TI]Q(_V/N*O+='A
M(Y 9, ;N.#I#,0$O'*+R%SZ-MJM>;577?MZR7-62P4PXI>>-HD!C-0 'DO[*
M8CG&IK+,U^&-T=V&S._RO:V.R"[,.+UF8NIY#GHL5040-="WW 'B]:O0F]&
M%K53X7XM S_QEG%":U73&=*M>1[9H;AJJ@50SKA#G'%%ZI27LA2%-!!<>>HQ
MU5 D)^/"ZL1?G@DL.[X8DWS3 ]]+'1@ 8Q]J?/T<GGSO.%5;7GG:DEP7UTB
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M:&8EOG&S$M5D[_#L.CQ/]@[/O</STQ<3)X7@M):=>2#QFUR5:.<4Z]"*@/'
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M'M["Q:$FF39,WK-3&^+:IU);UYG9?1ZC7;2]G7P>2#[U>&6A10U\]^(X(4M
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M3__9^MK-NVA$QB32%VR\7ULT,N=% -7=\:,\+\_,^SN@X^_A03JA98M,JBG
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ME;S!:[9-)H2]U<GU(VVFJW\@S:$M,L0^*I.#TA[5)UI0S-7X"X^E63VI+$8
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M5#@BO)\PTLC5)89</<Z.);4AL].PG'@-<VE-%3I8((*?9M2$(!V7E=#TX^Z
M;F.9$IC7:HW0^ZV4UZ7?3YPW8!<%PX6H3_,R3R_KZ-Q4"\:0>8 QV8^T%2:Y
MR18,-30+DL67HR0-&PU SFF">E-6A5UY[-[4XB63LM85;3]@2S!1)%>0XT/#
MP@2=,+,S:BDQ'-1C>];#4HQ-.@>OF %>F/:!$F*M7'&(%)*ELO** W%W"61N
M&E*>8F)*J:%(!Y;](##BSH(24#&FQ,L5B3)RBM4\&[,WB38VK;&]J;))Y@-*
M>]FR+!F"K2!HH0RD-</1QT;,BHH3B?C9(FUA"=&?,;.:0\6IM;3Y%(DPN4X=
M\-*:V\TKHRD;=MEYBYBW&'4W7X5';#WL)(C#A\,N@7Y:A(#X.3- A,$8WO*%
MCV%,-36!>EDRM5R0$=1Y&BG(HI4>4>)0K]LQ0*6-'[<*>Z;B_2K;_"J'I%>$
M=&@6)6US)R8X_@L8]+'ZIS[3)GAR>Z+J%U>DH'&^!0 NQFMFSJ&D;L-G@C\7
MMZ&/T?>0DUG-%$2UR.,8.B':E&$-1R)_]=>)IOBIU--(,Z)&@P,\E([0A61O
M0&2K2,-A:]T((Y89= *\XY/\R+'3I)BR3"69P(I(7TIR@.MZ+L;(:0Z> -]L
MXQ.2.?+5]>=<\94AA"@VHL/X( .AG>@!72FC42:M9X0R"^5&.BKITBUFSK<(
M>E!@<$+Z ,G&5L9 _NXXVGMRLA\NT&9.#L7]QC%>Z6_"UND4\STGP5ECS*>5
M:=,1ZYQD:5";\BDI4@)?J<)E6B'22U).%F/[YY]Y7.UBVNA'4WRT.,N</YE;
MOLRMP6=G;9:+9ZR03&YA:Z"YF=J\5+.URA8 ZYR5.:."%B42+AI:[%E#:S+$
M&.TA1'V.##/."U\@^-6?OHO##TM>:M:'W"8V;:LK!.N&/K!-Y,RD% )5MP[7
MLH[ZC86B,H/NC\Q+TA!&%S;_2VAJ;Y<9M8<GXI4EH^GR(_SK])D^N+?WF>X&
M8'6+7 [GE@[5.YU:]<;62T3^QB@E+YB<=^;#=O-1CGO9"YYBF$R?Y3)7-GL7
M:CT]N*]H8M+E7*VH3R3;O"43]\T/_XI=-,X$[A]"SL6]5I4GW-'2:_B80NDX
M6@3U5'PL..9AI/=-3UT'1V\T>ONRL>!5Z.7ANBGXUL>[.P0;5\K X-9WG[LB
M)CS.W!A<!,Q!-E!A7//.94S^7$,<.7_@X)!B -V@>5;UJE_>\?]O[TJ;V[:N
M]E_!I#.--$,Q)+78CJ>9D66E5;U4H^7MY"-(0A(B"F !T#+SZ]^SW@4$2%$;
M%_-#4UDBL=SEW+,\YWG<3DZ2V*3@7!KGJ0%:" TX!VT$5NB?+H&^36J5)@[\
M+]FR2M%&^>O*>6L$]1FS![^W:6C/P9L>$<4$X?TH.4/_\G0E[!AAFFWBD38-
M8:^=3SA5S@O.D,$R6'0+F/,(2]$%]BK/\T#;9AHL"8KXE(K02KA9<?$7_ -&
M<J7><[W:V+G1'(Y/CU!(-;I,4R\>^W:^.,LU(03&S=F9$>IVOM&$R":6XR?.
M;6MXXB6T+.==N65<0&;M;:?W.*<'-1RW<.2G#(?&E @RS\')%^SN!Q%&]/]K
M&O,$)W0>_![UB8KB$#,Z2?"[H?\^5]R!V@+XT_FA;7- ET,8O1AZR9PAP@K6
M]S--5,,R'[,4O*7A%.2TMBL4'LV$Z26P3%*2_S6%A%FX8LHB;>UN.RSWVE:/
M]$M$E\3M MR8P:\!;C?>+U<$_UB&CEGN<:"[:7]<.>[!?CN@<=-'TF\:O\'Z
MIBA=;%5P&NX<F4EA';C@7)X(+W"H%UAST<B+,+Y_"J_V"EC(CV$1PO7!Y/1@
M7BTQU!)HD""?(-:@*:2HDXW@PHI2<N4%\@45-TI+9]LTE.\'_0E*E^8YXV7[
MK"0BK!@T'$34274'R4%B@P;;91@D*[\S!7/LAT7TF^[8)>6T&LQ8/9+X"*]
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M0@J4/G?9/&P>-X.C""-KX@:\]?MVKE-8M@E.+TZ:*81/V5OL'OLOZ2P!N/H
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M=KL\J<?69_U[E=/X.YE_ U!+ P04    " !&,YY:L-L#:I,'   8(P  &P
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M:&,M,C R-3 S,S$N:'1M4$L! A0#%     @ 1C.>6BEP;[+J%   ?O8  !$
M             ( !5)8! &=E:&,M,C R-3 S,S$N>'-D4$L! A0#%     @
M1C.>6I4';#<&-P  L3 " !4              ( !;:L! &=E:&,M,C R-3 S
M,S%?8V%L+GAM;%!+ 0(4 Q0    ( $8SGEID<ZH(_VH  +_+!  5
M      "  :;B 0!G96AC+3(P,C4P,S,Q7V1E9BYX;6Q02P$"% ,4    " !&
M,YY:/(,9FTJC"0":GPP %               @ '830( 9V5H8RTR,#(U,#,S
M,5]G,2YJ<&=02P$"% ,4    " !&,YY:?+?>DYD[ 0"6' P %0
M    @ %4\0L 9V5H8RTR,#(U,#,S,5]L86(N>&UL4$L! A0#%     @ 1C.>
M6FAV%\_IP0  \O4( !4              ( !("T- &=E:&,M,C R-3 S,S%?
M<')E+GAM;%!+ 0(4 Q0    ( $8SGEK_J'?9V#L  &*' 0 ;
M  "  3SO#0!G96AC,7$R,#(U,3!Q97AH:6)I=#$P,RYH=&U02P$"% ,4
M" !&,YY:H44;CB O  ".-0$ &P              @ %-*PX 9V5H8S%Q,C R
M-3$P<65X:&EB:70Q,#0N:'1M4$L! A0#%     @ 1C.>6G9@+Y#%+0  T20!
M !L              ( !IEH. &=E:&,Q<3(P,C4Q,'%E>&AI8FET,3 U+FAT
M;5!+ 0(4 Q0    ( $8SGEK'=P7$CC@  %:1 0 ;              "  :2(
M#@!G96AC,7$R,#(U,3!Q97AH:6)I=#$P-BYH=&U02P$"% ,4    " !&,YY:
M+QE?Q!TA   ]WP  &P              @ %KP0X 9V5H8S%Q,C R-3$P<65X
M:&EB:70Q,#<N:'1M4$L! A0#%     @ 1C.>6C*%G46JD0  Q@0$ !L
M         ( !P>(. &=E:&,Q<3(P,C4Q,'%E>&AI8FET,3 X+FAT;5!+ 0(4
M Q0    ( $8SGEI6.4:LF <  "XC   ;              "  :1T#P!G96AC
M,7$R,#(U,3!Q97AH:6)I=#,Q,2YH=&U02P$"% ,4    " !&,YY:L-L#:I,'
M   8(P  &P              @ %U? \ 9V5H8S%Q,C R-3$P<65X:&EB:70S
M,3(N:'1M4$L! A0#%     @ 1C.>6@>HKSDV!   9!(  !L
M ( !080/ &=E:&,Q<3(P,C4Q,'%E>&AI8FET,S(Q+FAT;5!+!08     $  0
+ %T$  "PB \    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>gehc-20250331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:gehc="http://www.gehealthcare.com/20250331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="gehc-20250331.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
        </entity>
        <period>
            <instant>2025-04-23</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:ImagingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:ImagingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:AVSSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">gehc:ProceduralGuidanceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:AVSSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">gehc:ProceduralGuidanceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:AVSSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">gehc:SpecializedUltrasoundSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:AVSSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">gehc:SpecializedUltrasoundSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:AVSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:AVSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PCSSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">gehc:MonitoringSolutionsSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PCSSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">gehc:MonitoringSolutionsSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PCSSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">gehc:LifeSupportSolutionsSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PCSSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">gehc:LifeSupportSolutionsSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PCSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PCSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PDxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PDxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">gehc:FinanceLeaseReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">gehc:FinanceLeaseReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">gehc:FinancialAssetGreaterThan30DaysPastDueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">gehc:FinancialAssetGreaterThan30DaysPastDueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gehc:NihonMediPhysicsCo.LtdNMPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gehc:NihonMediPhysicsCo.LtdNMPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-31</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gehc:NihonMediPhysicsCo.LtdNMPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-31</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">gehc:NihonMediPhysicsCo.LtdNMPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gehc:MIMSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-01</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gehc:MIMSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-01</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gehc:MIMSoftwareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">gehc:ContingentConsiderationPurchasePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-01</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gehc:MIMSoftwareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">gehc:ContingentConsiderationServiceRequirementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-01</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gehc:MIMSoftwareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-01</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gehc:MIMSoftwareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-01</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:ImagingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:AVSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PCSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PDxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:ImagingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:AVSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PCSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PDxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:ImagingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:AVSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PCSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">gehc:PDxSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">gehc:TrademarksAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">gehc:TrademarksAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:SeniorUnsecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5YearRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A364DayRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5YearRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A364DayRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:FloatingRateTermLoanFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:FloatingRateTermLoanFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5YearRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A364DayRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:FloatingRateTermLoanFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:FloatingRateTermLoanFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:FloatingRateTermLoanFacilityDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5600SeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5600SeniorNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5650SeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5650SeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A4.800SeniorNotesDue2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A4.800SeniorNotesDue2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5857SeniorNotesDue2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5857SeniorNotesDue2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5905SeniorNotesDue2032Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A5905SeniorNotesDue2032Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A6377SeniorNotesDue2052Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gehc:A6377SeniorNotesDue2052Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">gehc:OtherLongTermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">gehc:OtherLongTermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">gehc:CommercialContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">gehc:CommercialContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">gehc:EquipmentResidualValueObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">gehc:EquipmentResidualValueObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">gehc:GEHealthCareSupplementalPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">us-gaap:RetirementPlanNameOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:DebtBasisAdjustmentLongTermBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:DebtBasisAdjustmentLongTermBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:DebtBasisAdjustmentLongTermBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:DebtBasisAdjustmentLongTermBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:DebtBasisAdjustmentLongTermBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:ForeignExchangeForwardAndForeignExchangeOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:DebtBasisAdjustmentLongTermBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:DebtBasisAdjustmentLongTermBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:DebtBasisAdjustmentLongTermBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:DebtBasisAdjustmentLongTermBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">gehc:DebtBasisAdjustmentLongTermBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">gehc:InterestAndDebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">gehc:OtherCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">gehc:OtherCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">gehc:BuildingsStructuresAndRelatedEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">gehc:BuildingsStructuresAndRelatedEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">gehc:LeaseholdImprovementsAndManufacturingPlantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">gehc:LeaseholdImprovementsAndManufacturingPlantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001932393</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-30</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>gehc:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="series">
        <measure>gehc:series</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-25">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-26">0001932393</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-27">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-28">2025</dei:DocumentFiscalYearFocus>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-29">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration contextRef="c-8" id="f-857">http://fasb.org/us-gaap/2024#LongTermDebtNoncurrent</us-gaap:HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration contextRef="c-9" id="f-858">http://fasb.org/us-gaap/2024#LongTermDebtNoncurrent</us-gaap:HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="c-7" id="f-1056">http://fasb.org/us-gaap/2024#CostOfRevenue http://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpense</us-gaap:RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="c-1" id="f-1057">http://fasb.org/us-gaap/2024#CostOfRevenue http://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpense</us-gaap:RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="c-8" id="f-1193">http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="c-9" id="f-1194">http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration contextRef="c-8" id="f-1206">http://fasb.org/us-gaap/2024#AccountsPayableCurrent</us-gaap:SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration contextRef="c-9" id="f-1207">http://fasb.org/us-gaap/2024#AccountsPayableCurrent</us-gaap:SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2025-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-41528</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">GE HEALTHCARE TECHNOLOGIES INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">88-2515116</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">500 W. Monroe Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Chicago</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">60661</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">833</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">735-1139</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-15">Common stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-16">GEHC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-17">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-23">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-24" unitRef="shares">457884998</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-3" decimals="-6" id="f-30" unitRef="usd">3117000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-4" decimals="-6" id="f-31" unitRef="usd">3045000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-6" id="f-32" unitRef="usd">1660000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-6" id="f-33" unitRef="usd">1605000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-6" id="f-34" unitRef="usd">4777000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-6" id="f-35" unitRef="usd">4650000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue contextRef="c-3" decimals="-6" id="f-36" unitRef="usd">1963000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-4" decimals="-6" id="f-37" unitRef="usd">1967000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-5" decimals="-6" id="f-38" unitRef="usd">802000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-6" decimals="-6" id="f-39" unitRef="usd">782000000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit contextRef="c-1" decimals="-6" id="f-40" unitRef="usd">2012000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-7" decimals="-6" id="f-41" unitRef="usd">1902000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-6" id="f-42" unitRef="usd">1040000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-7" decimals="-6" id="f-43" unitRef="usd">1038000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-6" id="f-44" unitRef="usd">344000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-7" decimals="-6" id="f-45" unitRef="usd">324000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-6" id="f-46" unitRef="usd">1383000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-7" decimals="-6" id="f-47" unitRef="usd">1362000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-6" id="f-48" unitRef="usd">629000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-7" decimals="-6" id="f-49" unitRef="usd">540000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndDebtExpense contextRef="c-1" decimals="-6" id="f-50" unitRef="usd">110000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense contextRef="c-7" decimals="-6" id="f-51" unitRef="usd">122000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent contextRef="c-1" decimals="-6" id="f-52" unitRef="usd">-74000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent contextRef="c-7" decimals="-6" id="f-53" unitRef="usd">-102000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-6" id="f-54" unitRef="usd">99000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-7" decimals="-6" id="f-55" unitRef="usd">-8000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-56" unitRef="usd">692000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-7" decimals="-6" id="f-57" unitRef="usd">512000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-58" unitRef="usd">104000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-7" decimals="-6" id="f-59" unitRef="usd">124000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-6" id="f-60" unitRef="usd">588000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-6" id="f-61" unitRef="usd">388000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-62" unitRef="usd">24000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-7" decimals="-6" id="f-63" unitRef="usd">14000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-6" id="f-64" unitRef="usd">564000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-6" id="f-65" unitRef="usd">374000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-66"
      unitRef="usdPerShare">1.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-67"
      unitRef="usdPerShare">0.82</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-68"
      unitRef="usdPerShare">1.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-69"
      unitRef="usdPerShare">0.81</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-6" id="f-70" unitRef="shares">457000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-6" id="f-71" unitRef="shares">456000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-6" id="f-72" unitRef="shares">459000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="-6" id="f-73" unitRef="shares">459000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-6" id="f-74" unitRef="usd">564000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-6" id="f-75" unitRef="usd">374000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-76" unitRef="usd">24000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-7" decimals="-6" id="f-77" unitRef="usd">14000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-6" id="f-78" unitRef="usd">588000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-6" id="f-79" unitRef="usd">388000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-6" id="f-80" unitRef="usd">257000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-7" decimals="-6" id="f-81" unitRef="usd">-76000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-1" decimals="-6" id="f-82" unitRef="usd">69000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-7" decimals="-6" id="f-83" unitRef="usd">35000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax contextRef="c-1" decimals="-6" id="f-84" unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax contextRef="c-7" decimals="-6" id="f-85" unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-1" decimals="-6" id="f-86" unitRef="usd">180000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-7" decimals="-6" id="f-87" unitRef="usd">-95000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-88" unitRef="usd">768000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-7" decimals="-6" id="f-89" unitRef="usd">292000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-90" unitRef="usd">24000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-7" decimals="-6" id="f-91" unitRef="usd">14000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-6" id="f-92" unitRef="usd">744000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-7" decimals="-6" id="f-93" unitRef="usd">278000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent contextRef="c-8" decimals="-6" id="f-94" unitRef="usd">2473000000</gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent>
    <gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent contextRef="c-9" decimals="-6" id="f-95" unitRef="usd">2889000000</gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-8" decimals="-6" id="f-96" unitRef="usd">106000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-9" decimals="-6" id="f-97" unitRef="usd">103000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="c-8" decimals="-6" id="f-98" unitRef="usd">3572000000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="c-9" decimals="-6" id="f-99" unitRef="usd">3566000000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:InventoryNet contextRef="c-8" decimals="-6" id="f-100" unitRef="usd">2158000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-9" decimals="-6" id="f-101" unitRef="usd">1939000000</us-gaap:InventoryNet>
    <gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent contextRef="c-8" decimals="-6" id="f-102" unitRef="usd">931000000</gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent>
    <gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent contextRef="c-9" decimals="-6" id="f-103" unitRef="usd">974000000</gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-8" decimals="-6" id="f-104" unitRef="usd">601000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-9" decimals="-6" id="f-105" unitRef="usd">532000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-8" decimals="-6" id="f-106" unitRef="usd">9735000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-9" decimals="-6" id="f-107" unitRef="usd">9901000000</us-gaap:AssetsCurrent>
    <gehc:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-8" decimals="-6" id="f-108" unitRef="usd">2851000000</gehc:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <gehc:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-9" decimals="-6" id="f-109" unitRef="usd">2550000000</gehc:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:Goodwill contextRef="c-8" decimals="-6" id="f-110" unitRef="usd">13373000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-9" decimals="-6" id="f-111" unitRef="usd">13136000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-8" decimals="-6" id="f-112" unitRef="usd">1238000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-9" decimals="-6" id="f-113" unitRef="usd">1078000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-8" decimals="-6" id="f-114" unitRef="usd">4462000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-9" decimals="-6" id="f-115" unitRef="usd">4474000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-8" decimals="-6" id="f-116" unitRef="usd">1926000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-9" decimals="-6" id="f-117" unitRef="usd">1950000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-8" decimals="-6" id="f-118" unitRef="usd">33586000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-9" decimals="-6" id="f-119" unitRef="usd">33089000000</us-gaap:Assets>
    <us-gaap:ShortTermBorrowings contextRef="c-8" decimals="-6" id="f-120" unitRef="usd">2002000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings contextRef="c-9" decimals="-6" id="f-121" unitRef="usd">1502000000</us-gaap:ShortTermBorrowings>
    <us-gaap:AccountsPayableCurrent contextRef="c-8" decimals="-6" id="f-122" unitRef="usd">3152000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-9" decimals="-6" id="f-123" unitRef="usd">3035000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-8" decimals="-6" id="f-124" unitRef="usd">1889000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-9" decimals="-6" id="f-125" unitRef="usd">1943000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-8" decimals="-6" id="f-126" unitRef="usd">1343000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-9" decimals="-6" id="f-127" unitRef="usd">1521000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-8" decimals="-6" id="f-128" unitRef="usd">1583000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-9" decimals="-6" id="f-129" unitRef="usd">1552000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-8" decimals="-6" id="f-130" unitRef="usd">9969000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-9" decimals="-6" id="f-131" unitRef="usd">9553000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-8" decimals="-6" id="f-132" unitRef="usd">6757000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-9" decimals="-6" id="f-133" unitRef="usd">7449000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="c-8" decimals="-6" id="f-134" unitRef="usd">5443000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="c-9" decimals="-6" id="f-135" unitRef="usd">5583000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-8" decimals="-6" id="f-136" unitRef="usd">159000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-9" decimals="-6" id="f-137" unitRef="usd">56000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-8" decimals="-6" id="f-138" unitRef="usd">1840000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-9" decimals="-6" id="f-139" unitRef="usd">1796000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-8" decimals="-6" id="f-140" unitRef="usd">24168000000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-9" decimals="-6" id="f-141" unitRef="usd">24437000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-8" id="f-142" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-9" id="f-143" unitRef="usd" xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount contextRef="c-8" decimals="-6" id="f-144" unitRef="usd">211000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount contextRef="c-9" decimals="-6" id="f-145" unitRef="usd">188000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-9"
      decimals="INF"
      id="f-146"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-8"
      decimals="INF"
      id="f-147"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-8" decimals="INF" id="f-148" unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-9" decimals="INF" id="f-149" unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-8" decimals="INF" id="f-150" unitRef="shares">458134263</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-9" decimals="INF" id="f-151" unitRef="shares">457246971</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue contextRef="c-8" decimals="-6" id="f-152" unitRef="usd">5000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-9" decimals="-6" id="f-153" unitRef="usd">5000000</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockCommonShares contextRef="c-9" decimals="INF" id="f-154" unitRef="shares">291053</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-8" decimals="INF" id="f-155" unitRef="shares">291053</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue contextRef="c-8" decimals="-6" id="f-156" unitRef="usd">25000000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c-9" decimals="-6" id="f-157" unitRef="usd">25000000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-8" decimals="-6" id="f-158" unitRef="usd">6597000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-9" decimals="-6" id="f-159" unitRef="usd">6583000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-8" decimals="-6" id="f-160" unitRef="usd">3810000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-9" decimals="-6" id="f-161" unitRef="usd">3262000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-8" decimals="-6" id="f-162" unitRef="usd">-1199000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-9" decimals="-6" id="f-163" unitRef="usd">-1379000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-6" id="f-164" unitRef="usd">9187000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-6" id="f-165" unitRef="usd">8446000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="c-8" decimals="-6" id="f-166" unitRef="usd">20000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="c-9" decimals="-6" id="f-167" unitRef="usd">18000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-8" decimals="-6" id="f-168" unitRef="usd">9207000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-9" decimals="-6" id="f-169" unitRef="usd">8464000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-8" decimals="-6" id="f-170" unitRef="usd">33586000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-9" decimals="-6" id="f-171" unitRef="usd">33089000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesIssued contextRef="c-10" decimals="-6" id="f-172" unitRef="shares">457000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-10" decimals="-6" id="f-173" unitRef="usd">5000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-11" decimals="-6" id="f-174" unitRef="shares">0</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-11" decimals="-6" id="f-175" unitRef="usd">-25000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-12" decimals="-6" id="f-176" unitRef="usd">6583000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-13" decimals="-6" id="f-177" unitRef="usd">3262000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-14" decimals="-6" id="f-178" unitRef="usd">-1379000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-15" decimals="-6" id="f-179" unitRef="usd">18000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-9" decimals="-6" id="f-180" unitRef="usd">8464000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-16" decimals="-6" id="f-181" unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-17" decimals="-6" id="f-182" unitRef="usd">-9000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-1" decimals="-6" id="f-183" unitRef="usd">-9000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NetIncomeLoss contextRef="c-18" decimals="-6" id="f-184" unitRef="usd">564000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-6" id="f-185" unitRef="usd">564000000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1"
      decimals="3"
      id="f-186"
      unitRef="usdPerShare">0.035</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends contextRef="c-18" decimals="-6" id="f-187" unitRef="usd">16000000</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c-1" decimals="-6" id="f-188" unitRef="usd">16000000</us-gaap:Dividends>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-19" decimals="-6" id="f-189" unitRef="usd">180000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-6" id="f-190" unitRef="usd">180000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease contextRef="c-20" decimals="-6" id="f-191" unitRef="usd">1000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease contextRef="c-1" decimals="-6" id="f-192" unitRef="usd">1000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-17" decimals="-6" id="f-193" unitRef="usd">22000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-6" id="f-194" unitRef="usd">22000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockSharesIssued contextRef="c-21" decimals="-6" id="f-195" unitRef="shares">458000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-21" decimals="-6" id="f-196" unitRef="usd">5000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-22" decimals="-6" id="f-197" unitRef="shares">0</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-22" decimals="-6" id="f-198" unitRef="usd">-25000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-23" decimals="-6" id="f-199" unitRef="usd">6597000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-24" decimals="-6" id="f-200" unitRef="usd">3810000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-25" decimals="-6" id="f-201" unitRef="usd">-1199000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-26" decimals="-6" id="f-202" unitRef="usd">20000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-8" decimals="-6" id="f-203" unitRef="usd">9207000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesIssued contextRef="c-27" decimals="-6" id="f-204" unitRef="shares">455000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-27" decimals="-6" id="f-205" unitRef="usd">5000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-28" decimals="-6" id="f-206" unitRef="usd">6493000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-29" decimals="-6" id="f-207" unitRef="usd">1326000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-30" decimals="-6" id="f-208" unitRef="usd">-691000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-31" decimals="-6" id="f-209" unitRef="usd">12000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-32" decimals="-6" id="f-210" unitRef="usd">7145000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-33" decimals="-6" id="f-211" unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-34" decimals="-6" id="f-212" unitRef="usd">-24000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-7" decimals="-6" id="f-213" unitRef="usd">-24000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NetIncomeLoss contextRef="c-35" decimals="-6" id="f-214" unitRef="usd">374000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-6" id="f-215" unitRef="usd">374000000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-7"
      decimals="2"
      id="f-216"
      unitRef="usdPerShare">0.03</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends contextRef="c-35" decimals="-6" id="f-217" unitRef="usd">14000000</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c-7" decimals="-6" id="f-218" unitRef="usd">14000000</us-gaap:Dividends>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-36" decimals="-6" id="f-219" unitRef="usd">-95000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-7" decimals="-6" id="f-220" unitRef="usd">-95000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease contextRef="c-37" decimals="-6" id="f-221" unitRef="usd">2000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease contextRef="c-7" decimals="-6" id="f-222" unitRef="usd">2000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-34" decimals="-6" id="f-223" unitRef="usd">34000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-7" decimals="-6" id="f-224" unitRef="usd">34000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockSharesIssued contextRef="c-38" decimals="-6" id="f-225" unitRef="shares">456000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-38" decimals="-6" id="f-226" unitRef="usd">5000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-39" decimals="-6" id="f-227" unitRef="usd">6504000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-40" decimals="-6" id="f-228" unitRef="usd">1687000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-41" decimals="-6" id="f-229" unitRef="usd">-787000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-42" decimals="-6" id="f-230" unitRef="usd">14000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-43" decimals="-6" id="f-231" unitRef="usd">7423000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-6" id="f-232" unitRef="usd">588000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-6" id="f-233" unitRef="usd">388000000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation contextRef="c-1" decimals="-6" id="f-234" unitRef="usd">66000000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-7" decimals="-6" id="f-235" unitRef="usd">68000000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-6" id="f-236" unitRef="usd">70000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-7" decimals="-6" id="f-237" unitRef="usd">80000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain contextRef="c-1" decimals="-6" id="f-238" unitRef="usd">97000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain contextRef="c-7" decimals="-6" id="f-239" unitRef="usd">0</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash contextRef="c-1" decimals="-6" id="f-240" unitRef="usd">-70000000</us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash>
    <us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash contextRef="c-7" decimals="-6" id="f-241" unitRef="usd">-90000000</us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash>
    <gehc:PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost contextRef="c-1" decimals="-6" id="f-242" unitRef="usd">98000000</gehc:PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost>
    <gehc:PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost contextRef="c-7" decimals="-6" id="f-243" unitRef="usd">87000000</gehc:PensionAndOtherPostretirementBenefitsExpenseEmployerContributionCost>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-6" id="f-244" unitRef="usd">22000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-7" decimals="-6" id="f-245" unitRef="usd">34000000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-246" unitRef="usd">104000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-7" decimals="-6" id="f-247" unitRef="usd">124000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-1" decimals="-6" id="f-248" unitRef="usd">91000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-7" decimals="-6" id="f-249" unitRef="usd">86000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables contextRef="c-1" decimals="-6" id="f-250" unitRef="usd">-81000000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables contextRef="c-7" decimals="-6" id="f-251" unitRef="usd">-165000000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-1" decimals="-6" id="f-252" unitRef="usd">154000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-7" decimals="-6" id="f-253" unitRef="usd">59000000</us-gaap:IncreaseDecreaseInInventories>
    <gehc:IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts contextRef="c-1" decimals="-6" id="f-254" unitRef="usd">-52000000</gehc:IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts>
    <gehc:IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts contextRef="c-7" decimals="-6" id="f-255" unitRef="usd">-32000000</gehc:IncreaseDecreaseInContractWithCustomerAssetAndDeferredCosts>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-6" id="f-256" unitRef="usd">146000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-7" decimals="-6" id="f-257" unitRef="usd">31000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-1" decimals="-6" id="f-258" unitRef="usd">-68000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-7" decimals="-6" id="f-259" unitRef="usd">-18000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-1" decimals="-6" id="f-260" unitRef="usd">-200000000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-7" decimals="-6" id="f-261" unitRef="usd">-34000000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement contextRef="c-1" decimals="-6" id="f-262" unitRef="usd">-101000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement contextRef="c-7" decimals="-6" id="f-263" unitRef="usd">-129000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-6" id="f-264" unitRef="usd">250000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-7" decimals="-6" id="f-265" unitRef="usd">419000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireProductiveAssets contextRef="c-1" decimals="-6" id="f-266" unitRef="usd">152000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets contextRef="c-7" decimals="-6" id="f-267" unitRef="usd">145000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-1" decimals="-6" id="f-268" unitRef="usd">269000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-7" decimals="-6" id="f-269" unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireInvestments contextRef="c-1" decimals="-6" id="f-270" unitRef="usd">20000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="c-7" decimals="-6" id="f-271" unitRef="usd">19000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-1" decimals="-6" id="f-272" unitRef="usd">-34000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-7" decimals="-6" id="f-273" unitRef="usd">24000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-6" id="f-274" unitRef="usd">-407000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-7" decimals="-6" id="f-275" unitRef="usd">-188000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess contextRef="c-1" decimals="-6" id="f-276" unitRef="usd">1000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess contextRef="c-7" decimals="-6" id="f-277" unitRef="usd">1000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:ProceedsFromDebtMaturingInMoreThanThreeMonths contextRef="c-1" decimals="-6" id="f-278" unitRef="usd">0</us-gaap:ProceedsFromDebtMaturingInMoreThanThreeMonths>
    <us-gaap:ProceedsFromDebtMaturingInMoreThanThreeMonths contextRef="c-7" decimals="-6" id="f-279" unitRef="usd">1000000</us-gaap:ProceedsFromDebtMaturingInMoreThanThreeMonths>
    <us-gaap:RepaymentsOfDebtMaturingInMoreThanThreeMonths contextRef="c-1" decimals="-6" id="f-280" unitRef="usd">257000000</us-gaap:RepaymentsOfDebtMaturingInMoreThanThreeMonths>
    <us-gaap:RepaymentsOfDebtMaturingInMoreThanThreeMonths contextRef="c-7" decimals="-6" id="f-281" unitRef="usd">153000000</us-gaap:RepaymentsOfDebtMaturingInMoreThanThreeMonths>
    <us-gaap:PaymentsOfDividends contextRef="c-1" decimals="-6" id="f-282" unitRef="usd">16000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends contextRef="c-7" decimals="-6" id="f-283" unitRef="usd">14000000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="c-1" decimals="-6" id="f-284" unitRef="usd">20000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="c-7" decimals="-6" id="f-285" unitRef="usd">16000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-6" id="f-286" unitRef="usd">28000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-7" decimals="-6" id="f-287" unitRef="usd">11000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c-1" decimals="-6" id="f-288" unitRef="usd">-6000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c-7" decimals="-6" id="f-289" unitRef="usd">7000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-6" id="f-290" unitRef="usd">-286000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-7" decimals="-6" id="f-291" unitRef="usd">-153000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-6" id="f-292" unitRef="usd">27000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-6" id="f-293" unitRef="usd">-19000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-6" id="f-294" unitRef="usd">-416000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-7" decimals="-6" id="f-295" unitRef="usd">59000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-9" decimals="-6" id="f-296" unitRef="usd">2893000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-32" decimals="-6" id="f-297" unitRef="usd">2506000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-8" decimals="-6" id="f-298" unitRef="usd">2476000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-43" decimals="-6" id="f-299" unitRef="usd">2565000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-6" id="f-300" unitRef="usd">78000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-7" decimals="-6" id="f-301" unitRef="usd">55000000</us-gaap:InterestPaidNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-6" id="f-302" unitRef="usd">86000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-7" decimals="-6" id="f-303" unitRef="usd">53000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-304">ORGANIZATION AND BASIS OF PRESENTATION&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;GE HealthCare Technologies Inc. is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services, and data analytics.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements (the &#x201c;financial statements&#x201d;) of GE HealthCare Technologies Inc. and its subsidiaries (&#x201c;GE HealthCare,&#x201d; the &#x201c;Company,&#x201d; &#x201c;our,&#x201d; &#x201c;us,&#x201d; or &#x201c;we&#x201d;) have been prepared in accordance with United States (&#x201c;U.S.&#x201d;) generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, the financial statements do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments, including normal recurring adjustments, considered necessary for a fair presentation of the Company&#x2019;s financial position and operating results have been included. All intercompany balances and transactions within the Company have been eliminated in the financial statements. Operating results for the three months ended March 31, 2025 and 2024 are not necessarily indicative of the results that may be expected for the fiscal year as a whole. The December 31, 2024 period presented on the Condensed Consolidated Statement of Financial Position was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Tables throughout this document are presented in millions of U.S. dollars unless otherwise stated and certain columns and rows may not sum due to the use of rounded numbers. Percentages presented are calculated from the underlying whole-dollar amounts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The financial statements and notes should be read in conjunction with the Company&#x2019;s audited consolidated and combined financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On January 3, 2023, the General Electric Company, which now operates as GE Aerospace (&#x201c;GE&#x201d;), completed the spin-off of GE HealthCare Technologies Inc. (the &#x201c;Spin-Off&#x201d;). Following this transaction, GE continues to be considered a related party due to the nature of our relationship and board member affiliation. Net costs incurred with GE were not significant for the three months ended March 31, 2025. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts in the financial statements and notes thereto have been reclassified to conform to the current year presentation. On the Condensed Consolidated Statements of Cash Flows, new line items were added and amounts were reclassified accordingly for the following items: amounts related to current compensation and benefits that were previously reported within All other operating activities &#x2013; net, amounts related to purchases of investments previously reported within All other investing activities &#x2013; net, and amounts related to equity award activity previously reported within All other financing activities &#x2013; net. Additionally, amounts due from related parties and due to related parties which were previously shown on separate lines on the Condensed Consolidated Statements of Cash Flows and Condensed Consolidated Statements of Financial Position were reclassified to Receivables, All other current assets, Accounts Payable, All other current liabilities, and All other operating activities - net as applicable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;&lt;br/&gt;ESTIMATES AND ASSUMPTIONS. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions, which affect the reported amounts and related disclosures in the financial statements. We base our estimates and judgments on historical experience and on various other assumptions and information that we believe to be reasonable under the circumstances. Although our estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations, financial position, and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;RECENT ACCOUNTING PRONOUNCEMENTS.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In December 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2023-09 (&#x201c;ASU 2023-09&#x201d;), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. ASU 2023-09 addresses investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This update also includes certain other amendments to improve the effectiveness of income tax disclosures. The provisions of ASU 2023-09 are effective for annual periods beginning after December 15, 2024, with early adoption permitted. We expect the adoption to impact disclosures in our notes to the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU No. 2024-03 (&#x201c;ASU 2024-03&#x201d;), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. ASU 2024-03 addresses investor requests for more transparency about expense information through the disaggregation of relevant expense captions in the notes to the financial statements. The provisions of ASU 2024-03 are effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. We expect the adoption to impact disclosures in our notes to the financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-305">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements (the &#x201c;financial statements&#x201d;) of GE HealthCare Technologies Inc. and its subsidiaries (&#x201c;GE HealthCare,&#x201d; the &#x201c;Company,&#x201d; &#x201c;our,&#x201d; &#x201c;us,&#x201d; or &#x201c;we&#x201d;) have been prepared in accordance with United States (&#x201c;U.S.&#x201d;) generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, the financial statements do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments, including normal recurring adjustments, considered necessary for a fair presentation of the Company&#x2019;s financial position and operating results have been included. All intercompany balances and transactions within the Company have been eliminated in the financial statements. Operating results for the three months ended March 31, 2025 and 2024 are not necessarily indicative of the results that may be expected for the fiscal year as a whole. The December 31, 2024 period presented on the Condensed Consolidated Statement of Financial Position was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. Tables throughout this document are presented in millions of U.S. dollars unless otherwise stated and certain columns and rows may not sum due to the use of rounded numbers. Percentages presented are calculated from the underlying whole-dollar amounts.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="c-1" id="f-306">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts in the financial statements and notes thereto have been reclassified to conform to the current year presentation. On the Condensed Consolidated Statements of Cash Flows, new line items were added and amounts were reclassified accordingly for the following items: amounts related to current compensation and benefits that were previously reported within All other operating activities &#x2013; net, amounts related to purchases of investments previously reported within All other investing activities &#x2013; net, and amounts related to equity award activity previously reported within All other financing activities &#x2013; net. Additionally, amounts due from related parties and due to related parties which were previously shown on separate lines on the Condensed Consolidated Statements of Cash Flows and Condensed Consolidated Statements of Financial Position were reclassified to Receivables, All other current assets, Accounts Payable, All other current liabilities, and All other operating activities - net as applicable.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-307">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;&lt;br/&gt;ESTIMATES AND ASSUMPTIONS. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions, which affect the reported amounts and related disclosures in the financial statements. We base our estimates and judgments on historical experience and on various other assumptions and information that we believe to be reasonable under the circumstances. Although our estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations, financial position, and cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-308">&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;RECENT ACCOUNTING PRONOUNCEMENTS.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In December 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2023-09 (&#x201c;ASU 2023-09&#x201d;), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. ASU 2023-09 addresses investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This update also includes certain other amendments to improve the effectiveness of income tax disclosures. The provisions of ASU 2023-09 are effective for annual periods beginning after December 15, 2024, with early adoption permitted. We expect the adoption to impact disclosures in our notes to the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU No. 2024-03 (&#x201c;ASU 2024-03&#x201d;), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. ASU 2024-03 addresses investor requests for more transparency about expense information through the disaggregation of relevant expense captions in the notes to the financial statements. The provisions of ASU 2024-03 are effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. We expect the adoption to impact disclosures in our notes to the financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-309">REVENUE RECOGNITION&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;Our revenues primarily consist of sales of products and services to customers. Products include equipment, imaging agents, software-related offerings, and upgrades. Services include contractual and stand-by preventative maintenance and corrective services, as well as related parts and labor, extended warranties, training, and other service-type offerings. The Company recognizes revenue from contracts with customers when the customer obtains control of the underlying products or services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:118%"&gt;CONTRACT AND OTHER DEFERRED ASSETS.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;Contract assets reflect revenue recognized on contracts with customers in excess of billings based on contractual terms. Contract assets are classified as current or non-current based on the amount of time expected to lapse until the Company&#x2019;s right to consideration becomes unconditional. Other deferred assets consist of costs to obtain contracts, primarily commissions, other cost deferrals for shipped products, and deferred service, labor, and direct overhead costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.955%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.873%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other deferred assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Contract and other deferred assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;931&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;974&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Non-current contract assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Non-current other deferred assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total contract and other deferred assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,144&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,183&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%;padding-left:2.52pt"&gt;Non-current contract and other deferred assets are recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:118%"&gt;CONTRACT LIABILITIES.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;Contract liabilities include customer advances and deposits received when orders are placed and billed in advance of completion of performance obligations. Contract liabilities are classified as current or non-current based on the periods over which these remaining performance obligations are expected to be satisfied with our customers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;As of March 31, 2025 and December 31, 2024, contract liabilities were approximately $2,613 million and $2,629 million, respectively, of which the non-current portion of $724 million and $686 million, respectively, was recognized in All other non-current liabilities in the Condensed Consolidated Statements of Financial Position. Revenue recognized related to the contract liabilities balance at the beginning of the year was approximately $752 million and $741 million for the three months ended March 31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:118%"&gt;REMAINING PERFORMANCE OBLIGATIONS.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;Remaining performance obligations (&#x201c;RPO&#x201d;) represents the estimated revenue expected from customer contracts that are partially or fully unperformed inclusive of amounts deferred in contract liabilities, excluding contracts, or portions thereof, that provide the customer with the right to cancel or terminate without incurring a substantive penalty. RPO also excludes estimated revenue from arrangements where we lease equipment manufactured by the Company to customers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.650%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.650%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"&gt;Products&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;4,599&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;4,755&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"&gt;Services&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;10,280&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;9,737&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"&gt;Total RPO&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;14,879&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;14,491&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;We expect to recognize substantially all of the revenue for our product-related RPO within two years and services-related RPO within five years.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock contextRef="c-1" id="f-310">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.955%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.873%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other deferred assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Contract and other deferred assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;931&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;974&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Non-current contract assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Non-current other deferred assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total contract and other deferred assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,144&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,183&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%;padding-left:2.52pt"&gt;Non-current contract and other deferred assets are recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position.&lt;/span&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNetCurrent contextRef="c-8" decimals="-6" id="f-311" unitRef="usd">572000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent contextRef="c-9" decimals="-6" id="f-312" unitRef="usd">589000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:DeferredCostsCurrent contextRef="c-8" decimals="-6" id="f-313" unitRef="usd">359000000</us-gaap:DeferredCostsCurrent>
    <us-gaap:DeferredCostsCurrent contextRef="c-9" decimals="-6" id="f-314" unitRef="usd">385000000</us-gaap:DeferredCostsCurrent>
    <gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent contextRef="c-8" decimals="-6" id="f-315" unitRef="usd">931000000</gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent>
    <gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent contextRef="c-9" decimals="-6" id="f-316" unitRef="usd">974000000</gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsCurrent>
    <us-gaap:ContractWithCustomerAssetNetNoncurrent contextRef="c-8" decimals="-6" id="f-317" unitRef="usd">101000000</us-gaap:ContractWithCustomerAssetNetNoncurrent>
    <us-gaap:ContractWithCustomerAssetNetNoncurrent contextRef="c-9" decimals="-6" id="f-318" unitRef="usd">103000000</us-gaap:ContractWithCustomerAssetNetNoncurrent>
    <us-gaap:DeferredCosts contextRef="c-8" decimals="-6" id="f-319" unitRef="usd">113000000</us-gaap:DeferredCosts>
    <us-gaap:DeferredCosts contextRef="c-9" decimals="-6" id="f-320" unitRef="usd">105000000</us-gaap:DeferredCosts>
    <gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts contextRef="c-8" decimals="-6" id="f-321" unitRef="usd">1144000000</gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts>
    <gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts contextRef="c-9" decimals="-6" id="f-322" unitRef="usd">1183000000</gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCosts>
    <us-gaap:ContractWithCustomerLiability contextRef="c-8" decimals="-6" id="f-323" unitRef="usd">2613000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-9" decimals="-6" id="f-324" unitRef="usd">2629000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-8" decimals="-6" id="f-325" unitRef="usd">724000000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-9" decimals="-6" id="f-326" unitRef="usd">686000000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-1" decimals="-6" id="f-327" unitRef="usd">752000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-7" decimals="-6" id="f-328" unitRef="usd">741000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock contextRef="c-1" id="f-329">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.650%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.650%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"&gt;Products&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;4,599&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;4,755&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"&gt;Services&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;10,280&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;9,737&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:13.55pt;padding-right:2.75pt;text-indent:-10.8pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:124%"&gt;Total RPO&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;14,879&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;14,491&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-44" decimals="-6" id="f-330" unitRef="usd">4599000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-45" decimals="-6" id="f-331" unitRef="usd">4755000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-46" decimals="-6" id="f-332" unitRef="usd">10280000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-47" decimals="-6" id="f-333" unitRef="usd">9737000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-8" decimals="-6" id="f-334" unitRef="usd">14879000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-9" decimals="-6" id="f-335" unitRef="usd">14491000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-48" id="f-336">P2Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-49" id="f-337">P5Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-338">SEGMENT INFORMATION&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Effective July 1, 2024, Image Guided Therapies, previously part of the Imaging segment, was realigned to the Ultrasound segment. The Ultrasound segment was subsequently renamed Advanced Visualization Solutions (&#x201c;AVS&#x201d;). Following this realignment, the Company continues to have four reportable segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions (&#x201c;PCS&#x201d;), and Pharmaceutical Diagnostics (&#x201c;PDx&#x201d;). These segments have been identified based on the nature of the products sold and how the Company manages its operations. We have not aggregated any of our operating segments to form reportable segments. A description of our reportable segments has been provided in Item 1, &#x201c;Business&#x201d; of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Historical segment financial information presented within this report has been recast to conform to the new reportable segments structure.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s organizational structure is based upon the availability of separate financial information that is evaluated regularly by the Company&#x2019;s Chief Operating Decision Maker (&#x201c;CODM&#x201d;) for the purpose of assessing performance and allocating resources. The Company&#x2019;s CODM is its Chief Executive Officer. The CODM assesses segment performance using Total revenues and an earnings metric defined as &#x201c;Segment EBIT.&#x201d; Segment EBIT is calculated as income before income taxes in our Condensed Consolidated Statements of Income excluding the impact of the following: Interest and other financial charges &#x2013; net, Non-operating benefit (income) costs, restructuring costs, acquisition and disposition-related benefits (charges), gain (loss) on business and asset dispositions, Spin-Off and separation costs, amortization of acquisition-related intangible assets, and investment revaluation gain (loss). Segment EBIT is also used in the annual budget and periodic forecasting processes and informs the CODM in decision making regarding the allocation of resources to the segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.929%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total Revenues by Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;For the three months ended March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total Imaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,140&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,062&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;AVS:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Procedural Guidance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Specialized Ultrasound&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total AVS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,239&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,227&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;PCS:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Monitoring Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Life Support Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total PCS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;753&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;747&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total PDx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;632&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;599&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,777&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,650&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Financial information not presented within the reportable segments, shown within the Other category, represents Hea&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;lthCar&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;e Financial Services (&#x201c;HFS&#x201d;) which does not meet the definition of an operating segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.929%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Significant Expenses by Segment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;For the three months ended March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Imaging:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other segment items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total Imaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,941&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,897&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;AVS:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other segment items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total AVS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;978&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;970&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;PCS:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other segment items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total PCS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;705&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;666&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;PDx:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other segment items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total PDx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;428&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;421&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1) Other segment items for each segment includes selling, general, administrative, research, and development related expenses, as well as other segment income and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.929%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Segment EBIT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;For the three months ended March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Segment EBIT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Imaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;AVS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;PCS &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;PDx &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;715&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;681&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Acquisition and disposition-related benefits (charges)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Gain (loss) on business and asset dispositions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Spin-Off and separation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Amortization of acquisition-related intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Investment revaluation gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Interest and other financial charges &#x2013; net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Non-operating benefit income (costs)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Income before income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;692&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;512&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Financial information not presented within the reportable segments, shown within the Other category, primarily represents HFS which does not meet the definition of an operating segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;The following table represents the depreciation and amortization amounts reported within the Segment EBIT metric for our reportable segments. Depreciation and amortization expense related to shared property, plant, and equipment and intangibles, exclusive of acquisition-related intangible assets, has been fully allocated to our segments and those allocations are reflected in the amounts presented in the table below. These amounts are included within Cost of sales and Other segment items disclosed in the Significant Expenses by Segment table above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.929%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Depreciation and Amortization by Segment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;For the three months ended March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Imaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;AVS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;PCS &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;PDx &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;The Company does not report total assets by segment as the Company&#x2019;s CODM does not assess performance, make strategic decisions, or allocate resources based on assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-50"
      decimals="INF"
      id="f-339"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-50"
      decimals="INF"
      id="f-340"
      unitRef="segment">4</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-341">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.929%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total Revenues by Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;For the three months ended March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total Imaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,140&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,062&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;AVS:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Procedural Guidance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Specialized Ultrasound&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total AVS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,239&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,227&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;PCS:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Monitoring Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Life Support Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total PCS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;753&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;747&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total PDx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;632&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;599&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,777&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,650&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Financial information not presented within the reportable segments, shown within the Other category, represents Hea&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;lthCar&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;e Financial Services (&#x201c;HFS&#x201d;) which does not meet the definition of an operating segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.929%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Significant Expenses by Segment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;For the three months ended March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Imaging:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other segment items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total Imaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,941&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,897&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;AVS:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other segment items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total AVS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;978&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;970&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;PCS:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other segment items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total PCS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;705&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;666&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;PDx:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cost of sales&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other segment items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total PDx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;428&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;421&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1) Other segment items for each segment includes selling, general, administrative, research, and development related expenses, as well as other segment income and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.929%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Segment EBIT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;For the three months ended March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Segment EBIT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Imaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;AVS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;PCS &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;PDx &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;715&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;681&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Acquisition and disposition-related benefits (charges)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Gain (loss) on business and asset dispositions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Spin-Off and separation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Amortization of acquisition-related intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Investment revaluation gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Interest and other financial charges &#x2013; net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Non-operating benefit income (costs)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Income before income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;692&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;512&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Financial information not presented within the reportable segments, shown within the Other category, primarily represents HFS which does not meet the definition of an operating segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;The following table represents the depreciation and amortization amounts reported within the Segment EBIT metric for our reportable segments. Depreciation and amortization expense related to shared property, plant, and equipment and intangibles, exclusive of acquisition-related intangible assets, has been fully allocated to our segments and those allocations are reflected in the amounts presented in the table below. These amounts are included within Cost of sales and Other segment items disclosed in the Significant Expenses by Segment table above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.929%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Depreciation and Amortization by Segment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;For the three months ended March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Imaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;AVS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;PCS &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;PDx &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-51" decimals="-6" id="f-342" unitRef="usd">2140000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-52" decimals="-6" id="f-343" unitRef="usd">2062000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-53" decimals="-6" id="f-344" unitRef="usd">641000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-54" decimals="-6" id="f-345" unitRef="usd">651000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-55" decimals="-6" id="f-346" unitRef="usd">598000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-56" decimals="-6" id="f-347" unitRef="usd">576000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-57" decimals="-6" id="f-348" unitRef="usd">1239000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-58" decimals="-6" id="f-349" unitRef="usd">1227000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-59" decimals="-6" id="f-350" unitRef="usd">556000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-60" decimals="-6" id="f-351" unitRef="usd">527000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-61" decimals="-6" id="f-352" unitRef="usd">197000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-62" decimals="-6" id="f-353" unitRef="usd">220000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-63" decimals="-6" id="f-354" unitRef="usd">753000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-64" decimals="-6" id="f-355" unitRef="usd">747000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-65" decimals="-6" id="f-356" unitRef="usd">632000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-66" decimals="-6" id="f-357" unitRef="usd">599000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-67" decimals="-6" id="f-358" unitRef="usd">13000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-68" decimals="-6" id="f-359" unitRef="usd">15000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-6" id="f-360" unitRef="usd">4777000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-6" id="f-361" unitRef="usd">4650000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue contextRef="c-51" decimals="-6" id="f-362" unitRef="usd">1353000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-52" decimals="-6" id="f-363" unitRef="usd">1338000000</us-gaap:CostOfRevenue>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-51" decimals="-6" id="f-364" unitRef="usd">588000000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-52" decimals="-6" id="f-365" unitRef="usd">559000000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:CostsAndExpenses contextRef="c-51" decimals="-6" id="f-366" unitRef="usd">1941000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-52" decimals="-6" id="f-367" unitRef="usd">1897000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostOfRevenue contextRef="c-57" decimals="-6" id="f-368" unitRef="usd">598000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-58" decimals="-6" id="f-369" unitRef="usd">599000000</us-gaap:CostOfRevenue>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-57" decimals="-6" id="f-370" unitRef="usd">380000000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-58" decimals="-6" id="f-371" unitRef="usd">371000000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:CostsAndExpenses contextRef="c-57" decimals="-6" id="f-372" unitRef="usd">978000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-58" decimals="-6" id="f-373" unitRef="usd">970000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostOfRevenue contextRef="c-63" decimals="-6" id="f-374" unitRef="usd">481000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-64" decimals="-6" id="f-375" unitRef="usd">460000000</us-gaap:CostOfRevenue>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-63" decimals="-6" id="f-376" unitRef="usd">224000000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-64" decimals="-6" id="f-377" unitRef="usd">206000000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:CostsAndExpenses contextRef="c-63" decimals="-6" id="f-378" unitRef="usd">705000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-64" decimals="-6" id="f-379" unitRef="usd">666000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostOfRevenue contextRef="c-65" decimals="-6" id="f-380" unitRef="usd">294000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-66" decimals="-6" id="f-381" unitRef="usd">295000000</us-gaap:CostOfRevenue>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-65" decimals="-6" id="f-382" unitRef="usd">133000000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-66" decimals="-6" id="f-383" unitRef="usd">126000000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:CostsAndExpenses contextRef="c-65" decimals="-6" id="f-384" unitRef="usd">428000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-66" decimals="-6" id="f-385" unitRef="usd">421000000</us-gaap:CostsAndExpenses>
    <gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges contextRef="c-51" decimals="-6" id="f-386" unitRef="usd">199000000</gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges>
    <gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges contextRef="c-52" decimals="-6" id="f-387" unitRef="usd">166000000</gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges>
    <gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges contextRef="c-57" decimals="-6" id="f-388" unitRef="usd">261000000</gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges>
    <gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges contextRef="c-58" decimals="-6" id="f-389" unitRef="usd">257000000</gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges>
    <gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges contextRef="c-63" decimals="-6" id="f-390" unitRef="usd">48000000</gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges>
    <gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges contextRef="c-64" decimals="-6" id="f-391" unitRef="usd">81000000</gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges>
    <gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges contextRef="c-65" decimals="-6" id="f-392" unitRef="usd">205000000</gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges>
    <gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges contextRef="c-66" decimals="-6" id="f-393" unitRef="usd">178000000</gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges>
    <gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges contextRef="c-67" decimals="-6" id="f-394" unitRef="usd">2000000</gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges>
    <gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges contextRef="c-68" decimals="-6" id="f-395" unitRef="usd">-1000000</gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges>
    <gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges contextRef="c-1" decimals="-6" id="f-396" unitRef="usd">715000000</gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges>
    <gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges contextRef="c-7" decimals="-6" id="f-397" unitRef="usd">681000000</gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges contextRef="c-1" decimals="-6" id="f-398" unitRef="usd">22000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges contextRef="c-7" decimals="-6" id="f-399" unitRef="usd">40000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <gehc:AcquisitionAndDispositionRelatedBenefitsCosts contextRef="c-1" decimals="-6" id="f-400" unitRef="usd">-8000000</gehc:AcquisitionAndDispositionRelatedBenefitsCosts>
    <gehc:AcquisitionAndDispositionRelatedBenefitsCosts contextRef="c-7" decimals="-6" id="f-401" unitRef="usd">0</gehc:AcquisitionAndDispositionRelatedBenefitsCosts>
    <us-gaap:GainLossOnDispositionOfAssets1 contextRef="c-1" decimals="-6" id="f-402" unitRef="usd">10000000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1 contextRef="c-7" decimals="-6" id="f-403" unitRef="usd">0</us-gaap:GainLossOnDispositionOfAssets1>
    <gehc:SpinOffAndSeparationCosts contextRef="c-1" decimals="-6" id="f-404" unitRef="usd">24000000</gehc:SpinOffAndSeparationCosts>
    <gehc:SpinOffAndSeparationCosts contextRef="c-7" decimals="-6" id="f-405" unitRef="usd">60000000</gehc:SpinOffAndSeparationCosts>
    <gehc:AmortizationOfIntangibleAssetsAcquired contextRef="c-1" decimals="-6" id="f-406" unitRef="usd">35000000</gehc:AmortizationOfIntangibleAssetsAcquired>
    <gehc:AmortizationOfIntangibleAssetsAcquired contextRef="c-7" decimals="-6" id="f-407" unitRef="usd">31000000</gehc:AmortizationOfIntangibleAssetsAcquired>
    <us-gaap:GainLossOnInvestments contextRef="c-1" decimals="-6" id="f-408" unitRef="usd">92000000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments contextRef="c-7" decimals="-6" id="f-409" unitRef="usd">-20000000</us-gaap:GainLossOnInvestments>
    <us-gaap:InterestAndDebtExpense contextRef="c-1" decimals="-6" id="f-410" unitRef="usd">110000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense contextRef="c-7" decimals="-6" id="f-411" unitRef="usd">122000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent contextRef="c-1" decimals="-6" id="f-412" unitRef="usd">-74000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent contextRef="c-7" decimals="-6" id="f-413" unitRef="usd">-102000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-414" unitRef="usd">692000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-7" decimals="-6" id="f-415" unitRef="usd">512000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-51" decimals="-6" id="f-416" unitRef="usd">57000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-52" decimals="-6" id="f-417" unitRef="usd">65000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-57" decimals="-6" id="f-418" unitRef="usd">18000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-58" decimals="-6" id="f-419" unitRef="usd">21000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-63" decimals="-6" id="f-420" unitRef="usd">13000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-64" decimals="-6" id="f-421" unitRef="usd">15000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-65" decimals="-6" id="f-422" unitRef="usd">12000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-66" decimals="-6" id="f-423" unitRef="usd">16000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="c-1" id="f-424">RECEIVABLES&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.983%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.985%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Current Receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Current customer receivables&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;3,379&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;3,382&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Non-income based tax receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other sundry receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Current sundry receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;299&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total current receivables &#x2013; net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;3,572&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;3,566&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Chargebacks, which are primarily related to our PDx business, are generally settled through issuance of credits, typically within one month of initial recognition, and are recorded as a reduction to current customer receivables. Balances related to chargebacks were $151 million and $153 million as of March 31, 2025 and December 31, 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.261%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.262%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Long-Term Receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Long-term customer receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Non-income based tax receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other sundry receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Long-term sundry receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;99&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;88&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total long-term receivables &#x2013; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;161&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&lt;br/&gt;Long-term receivables are recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position.&lt;/span&gt;&lt;/div&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="c-1" id="f-425">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.983%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.985%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Current Receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Current customer receivables&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;3,379&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;3,382&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Non-income based tax receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other sundry receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Current sundry receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;299&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total current receivables &#x2013; net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;3,572&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;3,566&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Chargebacks, which are primarily related to our PDx business, are generally settled through issuance of credits, typically within one month of initial recognition, and are recorded as a reduction to current customer receivables. Balances related to chargebacks were $151 million and $153 million as of March 31, 2025 and December 31, 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.261%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.262%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Long-Term Receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Long-term customer receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Non-income based tax receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other sundry receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Long-term sundry receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;99&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;88&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total long-term receivables &#x2013; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;161&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.261%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.262%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Loans receivable, at amortized cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Investment in finance leases, net of deferred income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Current financing receivables &#x2013; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;90&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;90&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Loans receivable, at amortized cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Investment in finance leases, net of deferred income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Non-current financing receivables &#x2013; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;186&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;183&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGrossCurrent contextRef="c-8" decimals="-6" id="f-426" unitRef="usd">3379000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent contextRef="c-9" decimals="-6" id="f-427" unitRef="usd">3382000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:ValueAddedTaxReceivableCurrent contextRef="c-8" decimals="-6" id="f-428" unitRef="usd">155000000</us-gaap:ValueAddedTaxReceivableCurrent>
    <us-gaap:ValueAddedTaxReceivableCurrent contextRef="c-9" decimals="-6" id="f-429" unitRef="usd">155000000</us-gaap:ValueAddedTaxReceivableCurrent>
    <gehc:OtherNontradeReceivablesCurrent contextRef="c-8" decimals="-6" id="f-430" unitRef="usd">144000000</gehc:OtherNontradeReceivablesCurrent>
    <gehc:OtherNontradeReceivablesCurrent contextRef="c-9" decimals="-6" id="f-431" unitRef="usd">133000000</gehc:OtherNontradeReceivablesCurrent>
    <us-gaap:NontradeReceivablesCurrent contextRef="c-8" decimals="-6" id="f-432" unitRef="usd">299000000</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:NontradeReceivablesCurrent contextRef="c-9" decimals="-6" id="f-433" unitRef="usd">287000000</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-8" decimals="-6" id="f-434" unitRef="usd">106000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-9" decimals="-6" id="f-435" unitRef="usd">103000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="c-8" decimals="-6" id="f-436" unitRef="usd">3572000000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="c-9" decimals="-6" id="f-437" unitRef="usd">3566000000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent contextRef="c-8" decimals="-6" id="f-438" unitRef="usd">151000000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent contextRef="c-9" decimals="-6" id="f-439" unitRef="usd">153000000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <us-gaap:AccountsReceivableGrossNoncurrent contextRef="c-8" decimals="-6" id="f-440" unitRef="usd">68000000</us-gaap:AccountsReceivableGrossNoncurrent>
    <us-gaap:AccountsReceivableGrossNoncurrent contextRef="c-9" decimals="-6" id="f-441" unitRef="usd">59000000</us-gaap:AccountsReceivableGrossNoncurrent>
    <us-gaap:ValueAddedTaxReceivableNoncurrent contextRef="c-8" decimals="-6" id="f-442" unitRef="usd">23000000</us-gaap:ValueAddedTaxReceivableNoncurrent>
    <us-gaap:ValueAddedTaxReceivableNoncurrent contextRef="c-9" decimals="-6" id="f-443" unitRef="usd">20000000</us-gaap:ValueAddedTaxReceivableNoncurrent>
    <gehc:OtherNontradeReceivablesNoncurrent contextRef="c-8" decimals="-6" id="f-444" unitRef="usd">76000000</gehc:OtherNontradeReceivablesNoncurrent>
    <gehc:OtherNontradeReceivablesNoncurrent contextRef="c-9" decimals="-6" id="f-445" unitRef="usd">68000000</gehc:OtherNontradeReceivablesNoncurrent>
    <us-gaap:NontradeReceivablesNoncurrent contextRef="c-8" decimals="-6" id="f-446" unitRef="usd">99000000</us-gaap:NontradeReceivablesNoncurrent>
    <us-gaap:NontradeReceivablesNoncurrent contextRef="c-9" decimals="-6" id="f-447" unitRef="usd">88000000</us-gaap:NontradeReceivablesNoncurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableNoncurrent contextRef="c-8" decimals="-6" id="f-448" unitRef="usd">6000000</us-gaap:AllowanceForDoubtfulAccountsReceivableNoncurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableNoncurrent contextRef="c-9" decimals="-6" id="f-449" unitRef="usd">5000000</us-gaap:AllowanceForDoubtfulAccountsReceivableNoncurrent>
    <gehc:ReceivablesNetNoncurrent contextRef="c-8" decimals="-6" id="f-450" unitRef="usd">161000000</gehc:ReceivablesNetNoncurrent>
    <gehc:ReceivablesNetNoncurrent contextRef="c-9" decimals="-6" id="f-451" unitRef="usd">142000000</gehc:ReceivablesNetNoncurrent>
    <us-gaap:FinancingReceivablesTextBlock contextRef="c-1" id="f-452">FINANCING RECEIVABLES&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&lt;br/&gt;Current financing receivables and non-current financing receivables are recognized within All other current assets and All other non-current assets, respectively, in the Condensed Consolidated Statements of Financial Position.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.261%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.262%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Loans receivable, at amortized cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Investment in finance leases, net of deferred income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Current financing receivables &#x2013; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;90&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;90&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Loans receivable, at amortized cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Investment in finance leases, net of deferred income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Non-current financing receivables &#x2013; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;186&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;183&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:0.36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;March 31, 2025&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3%, 3%, and 3% &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;of financing receivables were over 30 days past due, over 90 days past due, and on nonaccrual, respectively, with the majority of nonaccrual financing receivables secured by collateral. As of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;December 31, 2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4%, 4%, and 3% of financing receivables were over 30 days past due, over 90 days past due, and on nonaccrual, respectively, with the majority of nonaccrual financing receivables secured by collateral.&lt;/span&gt;&lt;/div&gt;</us-gaap:FinancingReceivablesTextBlock>
    <us-gaap:NotesAndLoansReceivableGrossCurrent contextRef="c-69" decimals="-6" id="f-453" unitRef="usd">23000000</us-gaap:NotesAndLoansReceivableGrossCurrent>
    <us-gaap:NotesAndLoansReceivableGrossCurrent contextRef="c-70" decimals="-6" id="f-454" unitRef="usd">23000000</us-gaap:NotesAndLoansReceivableGrossCurrent>
    <us-gaap:NotesAndLoansReceivableGrossCurrent contextRef="c-71" decimals="-6" id="f-455" unitRef="usd">69000000</us-gaap:NotesAndLoansReceivableGrossCurrent>
    <us-gaap:NotesAndLoansReceivableGrossCurrent contextRef="c-72" decimals="-6" id="f-456" unitRef="usd">69000000</us-gaap:NotesAndLoansReceivableGrossCurrent>
    <us-gaap:AllowanceForNotesAndLoansReceivableCurrent contextRef="c-8" decimals="-6" id="f-457" unitRef="usd">3000000</us-gaap:AllowanceForNotesAndLoansReceivableCurrent>
    <us-gaap:AllowanceForNotesAndLoansReceivableCurrent contextRef="c-9" decimals="-6" id="f-458" unitRef="usd">2000000</us-gaap:AllowanceForNotesAndLoansReceivableCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="c-8" decimals="-6" id="f-459" unitRef="usd">90000000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="c-9" decimals="-6" id="f-460" unitRef="usd">90000000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableGrossNoncurrent contextRef="c-69" decimals="-6" id="f-461" unitRef="usd">35000000</us-gaap:NotesAndLoansReceivableGrossNoncurrent>
    <us-gaap:NotesAndLoansReceivableGrossNoncurrent contextRef="c-70" decimals="-6" id="f-462" unitRef="usd">35000000</us-gaap:NotesAndLoansReceivableGrossNoncurrent>
    <us-gaap:NotesAndLoansReceivableGrossNoncurrent contextRef="c-71" decimals="-6" id="f-463" unitRef="usd">155000000</us-gaap:NotesAndLoansReceivableGrossNoncurrent>
    <us-gaap:NotesAndLoansReceivableGrossNoncurrent contextRef="c-72" decimals="-6" id="f-464" unitRef="usd">152000000</us-gaap:NotesAndLoansReceivableGrossNoncurrent>
    <us-gaap:AllowanceForNotesAndLoansReceivableNoncurrent contextRef="c-8" decimals="-6" id="f-465" unitRef="usd">4000000</us-gaap:AllowanceForNotesAndLoansReceivableNoncurrent>
    <us-gaap:AllowanceForNotesAndLoansReceivableNoncurrent contextRef="c-9" decimals="-6" id="f-466" unitRef="usd">4000000</us-gaap:AllowanceForNotesAndLoansReceivableNoncurrent>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent contextRef="c-8" decimals="-6" id="f-467" unitRef="usd">186000000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent contextRef="c-9" decimals="-6" id="f-468" unitRef="usd">183000000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:FinancingReceivablePercentPastDue1 contextRef="c-73" decimals="2" id="f-469" unitRef="number">0.03</us-gaap:FinancingReceivablePercentPastDue1>
    <us-gaap:FinancingReceivablePercentPastDue1 contextRef="c-74" decimals="2" id="f-470" unitRef="number">0.03</us-gaap:FinancingReceivablePercentPastDue1>
    <us-gaap:FinancingReceivableNonaccrualPercentPastDue1 contextRef="c-8" decimals="2" id="f-471" unitRef="number">0.03</us-gaap:FinancingReceivableNonaccrualPercentPastDue1>
    <us-gaap:FinancingReceivablePercentPastDue1 contextRef="c-75" decimals="2" id="f-472" unitRef="number">0.04</us-gaap:FinancingReceivablePercentPastDue1>
    <us-gaap:FinancingReceivablePercentPastDue1 contextRef="c-76" decimals="2" id="f-473" unitRef="number">0.04</us-gaap:FinancingReceivablePercentPastDue1>
    <us-gaap:FinancingReceivableNonaccrualPercentPastDue1 contextRef="c-9" decimals="2" id="f-474" unitRef="number">0.03</us-gaap:FinancingReceivableNonaccrualPercentPastDue1>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-475">LEASES&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities recognized within All other current liabilities and All other non-current liabilities in the Condensed Consolidated Statements of Financial Position were $386&#160;million and $385&#160;million as of March 31, 2025 and December 31, 2024, respectively. The total lease expense related to our operating lease portfolio was $62&#160;million and $60&#160;million for the three months ended March 31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseLiability contextRef="c-8" decimals="-6" id="f-476" unitRef="usd">386000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="c-9" decimals="-6" id="f-477" unitRef="usd">385000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-6" id="f-478" unitRef="usd">62000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-7" decimals="-6" id="f-479" unitRef="usd">60000000</us-gaap:OperatingLeaseCost>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="c-1" id="f-481">ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;ACQUISITIONS.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:118%"&gt;Nihon Medi-Physics&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;On March 31, 2025, the Company acquired the remaining 50% interest in Nihon Medi-Physics Co., Ltd (&#x201c;NMP&#x201d;) from joint venture partner Sumitomo Chemical for net cash consideration of $269 million. The acquisition was funded with cash on hand. NMP is a leading pharmaceutical manufacturer in Japan, focused on radiopharmaceuticals, which are used to enable clinical images across neurology, cardiology, and oncology procedures, as well as nonclinical and clinical development of radiotracers and theranostics research. Their product portfolio includes several GE HealthCare radiopharmaceuticals. NMP is included in the Company&#x2019;s PDx segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;On March 31, 2025, the fair value of the Company&#x2019;s existing 50% interest in NMP was determined to be $301 million based on the cash consideration exchanged for acquiring the remaining 50% equity interest. The carrying value of our 50% interest was $204 million. The Company recognized a net gain of $97 million resulting from this remeasurement to fair value. This gain included the reclassification of certain amounts related to the Company&#x2019;s 50% interest out of Accumulated other comprehensive income (loss) &#x2013; net (&#x201c;AOCI&#x201d;) including foreign currency translation gains of $63 million and losses related to a defined benefit pension plan of $8 million. The net gain from this remeasurement was recorded in Other (income) expense &#x2013; net in the Company&#x2019;s Condensed Consolidated Statements of Income for the three months ended March 31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;The following table provides a summary of the purchase price consideration transferred for the acquisition of NMP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.205%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cash consideration, net of cash acquired&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Fair value of previously held interest in NMP&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Fair value of contingent consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total allocable purchase price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;575&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&lt;br/&gt;&lt;br/&gt;The estimated fair values of the assets and liabilities assumed in connection with the acquisition of NMP are as follows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.205%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Initial allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Property, plant, and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;All other non-current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;All other non-current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total net assets post acquisition&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;575&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) All other non-current assets includes $12 million of indemnification assets, with the underlying indemnified liabilities recorded in All other non-current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2) Other includes Accounts payable, All other current liabilities, and Current compensation and benefits.&lt;br/&gt;&lt;br/&gt;The initial allocation of purchase price of NMP to the tangible and intangible assets acquired and liabilities assumed, as reflected in the table above, is based on the Company&#x2019;s preliminary allocations of their fair values. The valuation of assets acquired and liabilities assumed has not yet been finalized as of March 31, 2025. While all amounts remain subject to adjustments, the areas subject to the most significant potential adjustments are property, plant, and equipment, intangible assets, decommissioning liabilities, and deferred income taxes. The preliminary valuation required estimates and assumptions including, but not limited to, estimating future cash flows and direct costs in addition to developing the appropriate discount rates. Accordingly, the purchase price adjustments are preliminary and are subject to further adjustments as additional information becomes available and as additional analyses are performed, and such further adjustments may be material. The Company&#x2019;s management believes the fair values recognized for the assets acquired and the liabilities assumed are based on reasonable estimates and assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Property, plant, and equipment is mostly comprised of land, buildings, equipment (including machinery, furniture, and fixtures) and construction in process. The fair value of property, plant, and equipment was determined using a market participant approach.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other intangibles relate to $200 million of definite-lived intangible assets and $23 million of acquired in-process research and development. Definite-lived intangible assets consist primarily of developed product market authorization rights and customer relationships. The acquired definite-lived intangibles are being amortized over a weighted-average estimated useful life of approximately 12 years. The estimated fair value of intangibles was determined using the income approach, which is a valuation technique that provides an estimate of the fair value of an asset based on market participant expectations of cash flows an asset would generate over its useful life.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The goodwill associated with NMP, recorded within the PDx segment, is non-deductible for tax purposes and is attributed to expected synergies with NMP&#x2019;s existing assets and workforce that are expected to allow the Company greater access and growth in the Japan market.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Included in All other non-current liabilities are asset retirement obligations and decommissioning liabilities of $96 million, which were assumed in the transaction. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;NMP has a defined benefit pension plan which has pension assets of $73 million and pension liabilities of $34 million, a net asset of $39 million, which we acquired in the transaction and is included in All other non-current assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred income tax liabilities include the expected U.S. federal, state, and foreign tax consequences associated with temporary differences between the preliminary fair values of the assets acquired and liabilities assumed and the respective tax basis. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Due to the proximity of the acquisition date to the end of the Company&#x2019;s first quarter, the revenues and earnings of NMP are not significant to our consolidated results. If the acquisition of NMP had taken place as of the beginning of 2024, consolidated revenues and earnings would not have been significantly different than reported amounts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;MIM Software&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On April 1, 2024, the Company acquired 100% of the stock of MIM Software Inc. (&#x201c;MIM Software&#x201d;) for approximately $259 million, net of cash acquired of $11 million, and potential contingent payments valued at $13&#160;million pertaining to achievement of certain milestones, for a total preliminary purchase price of $283 million. The acquisition included up to $23&#160;million of other contingent payments based on service requirements. The acquisition was funded with cash on hand. This transaction was accounted for as a business combination. The final purchase price allocation resulted in goodwill of $189 million, customer-related intangible assets of $52&#160;million, developed technology intangible assets of $48&#160;million, net deferred tax liabilities of $13 million, and other net assets of $7 million. The goodwill associated with the acquired business, recorded within the Imaging segment, is non-deductible for tax purposes and is attributed to expected synergies and commercial benefits from use of the MIM Software technology in our existing GE HealthCare portfolio. MIM Software is a global provider of medical imaging analysis and artificial intelligence (&#x201c;AI&#x201d;) solutions for the practice of radiation oncology, molecular radiotherapy, diagnostic imaging, and urology at imaging centers, hospitals, specialty clinics, and research organizations worldwide. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue and earnings of MIM Software included in the Company&#x2019;s financial statements since the acquisition date are not material to our consolidated revenue and earnings. If the acquisition of MIM Software had taken place as of the beginning of 2023, consolidated revenues and earnings would not have been significantly different from reported amounts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;GOODWILL.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.261%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.431%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Imaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;AVS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;PCS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;PDx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;3,581&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,035&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,533&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;13,136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency exchange and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Balance at March 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;3,587&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,999&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,037&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,750&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;13,373&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We assess the possibility that a reporting unit&#x2019;s fair value has been reduced below its carrying amount due to the occurrence of events or circumstances between annual impairment testing dates. We did not identify any reporting units that required an interim impairment test since the last annual impairment testing date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;OTHER INTANGIBLE ASSETS.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.594%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.605%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.151%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of March 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Definite-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Patents and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(2,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1,987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Capitalized software &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1,479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1,437)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Trademarks and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total definite-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,696&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(3,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,141&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,481&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(3,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,004&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Indefinite-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,793&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(3,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,238&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,555&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(3,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,078&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Indefinite-lived intangible assets relate to acquired in-process research and development prior to project completion and are not amortized.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Amortization expense was $70 million and $80 million for the three months ended March 31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-480">ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;ACQUISITIONS.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:118%"&gt;Nihon Medi-Physics&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;On March 31, 2025, the Company acquired the remaining 50% interest in Nihon Medi-Physics Co., Ltd (&#x201c;NMP&#x201d;) from joint venture partner Sumitomo Chemical for net cash consideration of $269 million. The acquisition was funded with cash on hand. NMP is a leading pharmaceutical manufacturer in Japan, focused on radiopharmaceuticals, which are used to enable clinical images across neurology, cardiology, and oncology procedures, as well as nonclinical and clinical development of radiotracers and theranostics research. Their product portfolio includes several GE HealthCare radiopharmaceuticals. NMP is included in the Company&#x2019;s PDx segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;On March 31, 2025, the fair value of the Company&#x2019;s existing 50% interest in NMP was determined to be $301 million based on the cash consideration exchanged for acquiring the remaining 50% equity interest. The carrying value of our 50% interest was $204 million. The Company recognized a net gain of $97 million resulting from this remeasurement to fair value. This gain included the reclassification of certain amounts related to the Company&#x2019;s 50% interest out of Accumulated other comprehensive income (loss) &#x2013; net (&#x201c;AOCI&#x201d;) including foreign currency translation gains of $63 million and losses related to a defined benefit pension plan of $8 million. The net gain from this remeasurement was recorded in Other (income) expense &#x2013; net in the Company&#x2019;s Condensed Consolidated Statements of Income for the three months ended March 31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;The following table provides a summary of the purchase price consideration transferred for the acquisition of NMP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.205%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cash consideration, net of cash acquired&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Fair value of previously held interest in NMP&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Fair value of contingent consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total allocable purchase price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;575&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&lt;br/&gt;&lt;br/&gt;The estimated fair values of the assets and liabilities assumed in connection with the acquisition of NMP are as follows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.205%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Initial allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Property, plant, and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;All other non-current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;All other non-current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total net assets post acquisition&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;575&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) All other non-current assets includes $12 million of indemnification assets, with the underlying indemnified liabilities recorded in All other non-current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2) Other includes Accounts payable, All other current liabilities, and Current compensation and benefits.&lt;br/&gt;&lt;br/&gt;The initial allocation of purchase price of NMP to the tangible and intangible assets acquired and liabilities assumed, as reflected in the table above, is based on the Company&#x2019;s preliminary allocations of their fair values. The valuation of assets acquired and liabilities assumed has not yet been finalized as of March 31, 2025. While all amounts remain subject to adjustments, the areas subject to the most significant potential adjustments are property, plant, and equipment, intangible assets, decommissioning liabilities, and deferred income taxes. The preliminary valuation required estimates and assumptions including, but not limited to, estimating future cash flows and direct costs in addition to developing the appropriate discount rates. Accordingly, the purchase price adjustments are preliminary and are subject to further adjustments as additional information becomes available and as additional analyses are performed, and such further adjustments may be material. The Company&#x2019;s management believes the fair values recognized for the assets acquired and the liabilities assumed are based on reasonable estimates and assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Property, plant, and equipment is mostly comprised of land, buildings, equipment (including machinery, furniture, and fixtures) and construction in process. The fair value of property, plant, and equipment was determined using a market participant approach.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other intangibles relate to $200 million of definite-lived intangible assets and $23 million of acquired in-process research and development. Definite-lived intangible assets consist primarily of developed product market authorization rights and customer relationships. The acquired definite-lived intangibles are being amortized over a weighted-average estimated useful life of approximately 12 years. The estimated fair value of intangibles was determined using the income approach, which is a valuation technique that provides an estimate of the fair value of an asset based on market participant expectations of cash flows an asset would generate over its useful life.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The goodwill associated with NMP, recorded within the PDx segment, is non-deductible for tax purposes and is attributed to expected synergies with NMP&#x2019;s existing assets and workforce that are expected to allow the Company greater access and growth in the Japan market.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Included in All other non-current liabilities are asset retirement obligations and decommissioning liabilities of $96 million, which were assumed in the transaction. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;NMP has a defined benefit pension plan which has pension assets of $73 million and pension liabilities of $34 million, a net asset of $39 million, which we acquired in the transaction and is included in All other non-current assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred income tax liabilities include the expected U.S. federal, state, and foreign tax consequences associated with temporary differences between the preliminary fair values of the assets acquired and liabilities assumed and the respective tax basis. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Due to the proximity of the acquisition date to the end of the Company&#x2019;s first quarter, the revenues and earnings of NMP are not significant to our consolidated results. If the acquisition of NMP had taken place as of the beginning of 2024, consolidated revenues and earnings would not have been significantly different than reported amounts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;MIM Software&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On April 1, 2024, the Company acquired 100% of the stock of MIM Software Inc. (&#x201c;MIM Software&#x201d;) for approximately $259 million, net of cash acquired of $11 million, and potential contingent payments valued at $13&#160;million pertaining to achievement of certain milestones, for a total preliminary purchase price of $283 million. The acquisition included up to $23&#160;million of other contingent payments based on service requirements. The acquisition was funded with cash on hand. This transaction was accounted for as a business combination. The final purchase price allocation resulted in goodwill of $189 million, customer-related intangible assets of $52&#160;million, developed technology intangible assets of $48&#160;million, net deferred tax liabilities of $13 million, and other net assets of $7 million. The goodwill associated with the acquired business, recorded within the Imaging segment, is non-deductible for tax purposes and is attributed to expected synergies and commercial benefits from use of the MIM Software technology in our existing GE HealthCare portfolio. MIM Software is a global provider of medical imaging analysis and artificial intelligence (&#x201c;AI&#x201d;) solutions for the practice of radiation oncology, molecular radiotherapy, diagnostic imaging, and urology at imaging centers, hospitals, specialty clinics, and research organizations worldwide. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue and earnings of MIM Software included in the Company&#x2019;s financial statements since the acquisition date are not material to our consolidated revenue and earnings. If the acquisition of MIM Software had taken place as of the beginning of 2023, consolidated revenues and earnings would not have been significantly different from reported amounts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;GOODWILL.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.261%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.431%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Imaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;AVS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;PCS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;PDx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;3,581&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,035&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,533&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;13,136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency exchange and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Balance at March 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;3,587&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,999&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,037&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,750&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;13,373&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We assess the possibility that a reporting unit&#x2019;s fair value has been reduced below its carrying amount due to the occurrence of events or circumstances between annual impairment testing dates. We did not identify any reporting units that required an interim impairment test since the last annual impairment testing date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;OTHER INTANGIBLE ASSETS.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.594%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.605%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.151%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of March 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Definite-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Patents and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(2,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1,987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Capitalized software &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1,479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1,437)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Trademarks and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total definite-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,696&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(3,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,141&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,481&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(3,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,004&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Indefinite-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,793&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(3,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,238&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,555&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(3,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,078&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Indefinite-lived intangible assets relate to acquired in-process research and development prior to project completion and are not amortized.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Amortization expense was $70 million and $80 million for the three months ended March 31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c-77" decimals="2" id="f-482" unitRef="number">0.50</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-78" decimals="-6" id="f-483" unitRef="usd">269000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage contextRef="c-77" decimals="2" id="f-484" unitRef="number">0.50</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1 contextRef="c-78" decimals="-6" id="f-485" unitRef="usd">301000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c-77" decimals="2" id="f-486" unitRef="number">0.50</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage contextRef="c-77" decimals="2" id="f-487" unitRef="number">0.50</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <gehc:BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue contextRef="c-78" decimals="-6" id="f-488" unitRef="usd">204000000</gehc:BusinessCombinationStepAcquisitionEquityInterestInAcquireeCarryingValue>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain contextRef="c-78" decimals="-6" id="f-489" unitRef="usd">97000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage contextRef="c-77" decimals="2" id="f-490" unitRef="number">0.50</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <gehc:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax contextRef="c-78" decimals="-6" id="f-491" unitRef="usd">63000000</gehc:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax contextRef="c-78" decimals="-6" id="f-492" unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="c-1" id="f-493">&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;The following table provides a summary of the purchase price consideration transferred for the acquisition of NMP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.205%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cash consideration, net of cash acquired&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Fair value of previously held interest in NMP&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Fair value of contingent consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total allocable purchase price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;575&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&lt;br/&gt;&lt;br/&gt;The estimated fair values of the assets and liabilities assumed in connection with the acquisition of NMP are as follows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.205%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Initial allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Property, plant, and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;All other non-current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;All other non-current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total net assets post acquisition&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;575&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) All other non-current assets includes $12 million of indemnification assets, with the underlying indemnified liabilities recorded in All other non-current liabilities.&lt;/span&gt;&lt;/div&gt;(2) Other includes Accounts payable, All other current liabilities, and Current compensation and benefits.</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-78" decimals="-6" id="f-494" unitRef="usd">269000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1 contextRef="c-78" decimals="-6" id="f-495" unitRef="usd">301000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="c-78" decimals="-6" id="f-496" unitRef="usd">5000000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-78" decimals="-6" id="f-497" unitRef="usd">575000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables contextRef="c-77" decimals="-6" id="f-498" unitRef="usd">53000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory contextRef="c-77" decimals="-6" id="f-499" unitRef="usd">10000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="c-77" decimals="-6" id="f-500" unitRef="usd">243000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:Goodwill contextRef="c-77" decimals="-6" id="f-501" unitRef="usd">216000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-77" decimals="-6" id="f-502" unitRef="usd">223000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets contextRef="c-77" decimals="-6" id="f-503" unitRef="usd">52000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities contextRef="c-77" decimals="-6" id="f-504" unitRef="usd">87000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther contextRef="c-77" decimals="-6" id="f-505" unitRef="usd">107000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities contextRef="c-77" decimals="-6" id="f-506" unitRef="usd">28000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-77" decimals="-6" id="f-507" unitRef="usd">575000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <gehc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets contextRef="c-77" decimals="-6" id="f-508" unitRef="usd">12000000</gehc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndemnificationAssets>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="c-78" decimals="-6" id="f-509" unitRef="usd">200000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired contextRef="c-79" decimals="-6" id="f-510" unitRef="usd">23000000</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-78" id="f-511">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <gehc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities contextRef="c-77" decimals="-6" id="f-512" unitRef="usd">96000000</gehc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetRetirementObligationsAndDecommissioningLiabilities>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent contextRef="c-80" decimals="-6" id="f-513" unitRef="usd">73000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent contextRef="c-80" decimals="-6" id="f-514" unitRef="usd">34000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet contextRef="c-80" decimals="-6" id="f-515" unitRef="usd">39000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c-81"
      decimals="INF"
      id="f-516"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-82" decimals="-6" id="f-517" unitRef="usd">259000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:CashAcquiredFromAcquisition contextRef="c-82" decimals="-6" id="f-518" unitRef="usd">11000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-83" decimals="-6" id="f-519" unitRef="usd">13000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-82" decimals="-6" id="f-520" unitRef="usd">283000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-84" decimals="-6" id="f-521" unitRef="usd">23000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:Goodwill contextRef="c-81" decimals="-6" id="f-522" unitRef="usd">189000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-85" decimals="-6" id="f-523" unitRef="usd">52000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-86" decimals="-6" id="f-524" unitRef="usd">48000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities contextRef="c-81" decimals="-6" id="f-525" unitRef="usd">13000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <gehc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets contextRef="c-81" decimals="-6" id="f-526" unitRef="usd">7000000</gehc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="c-1" id="f-527">&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.261%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.431%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Imaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;AVS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;PCS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;PDx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;3,581&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,035&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,533&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;13,136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency exchange and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Balance at March 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;3,587&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,999&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,037&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,750&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;13,373&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill contextRef="c-87" decimals="-6" id="f-528" unitRef="usd">3581000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-88" decimals="-6" id="f-529" unitRef="usd">4987000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-89" decimals="-6" id="f-530" unitRef="usd">2035000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-90" decimals="-6" id="f-531" unitRef="usd">2533000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-9" decimals="-6" id="f-532" unitRef="usd">13136000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-91" decimals="-6" id="f-533" unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-92" decimals="-6" id="f-534" unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-93" decimals="-6" id="f-535" unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-94" decimals="-6" id="f-536" unitRef="usd">216000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-1" decimals="-6" id="f-537" unitRef="usd">216000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="c-91" decimals="-6" id="f-538" unitRef="usd">5000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="c-92" decimals="-6" id="f-539" unitRef="usd">12000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="c-93" decimals="-6" id="f-540" unitRef="usd">2000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="c-94" decimals="-6" id="f-541" unitRef="usd">1000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="c-1" decimals="-6" id="f-542" unitRef="usd">20000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill contextRef="c-95" decimals="-6" id="f-543" unitRef="usd">3587000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-96" decimals="-6" id="f-544" unitRef="usd">4999000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-97" decimals="-6" id="f-545" unitRef="usd">2037000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-98" decimals="-6" id="f-546" unitRef="usd">2750000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-8" decimals="-6" id="f-547" unitRef="usd">13373000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-549">&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.594%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.605%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.151%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of March 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Definite-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Patents and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(2,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1,987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Capitalized software &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1,479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1,437)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Trademarks and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total definite-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,696&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(3,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,141&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,481&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(3,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,004&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Indefinite-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,793&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(3,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,238&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,555&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(3,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,078&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Indefinite-lived intangible assets relate to acquired in-process research and development prior to project completion and are not amortized.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-548">&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.594%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.605%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.150%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.151%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of March 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Definite-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Patents and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(2,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1,987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Capitalized software &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1,479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1,437)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Trademarks and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total definite-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,696&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(3,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,141&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,481&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(3,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,004&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Indefinite-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,793&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(3,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,238&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,555&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(3,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,078&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Indefinite-lived intangible assets relate to acquired in-process research and development prior to project completion and are not amortized.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-99" decimals="-6" id="f-550" unitRef="usd">230000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-99" decimals="-6" id="f-551" unitRef="usd">26000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-99" decimals="-6" id="f-552" unitRef="usd">204000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-100" decimals="-6" id="f-553" unitRef="usd">112000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-100" decimals="-6" id="f-554" unitRef="usd">24000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-100" decimals="-6" id="f-555" unitRef="usd">88000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-101" decimals="-6" id="f-556" unitRef="usd">2668000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-101" decimals="-6" id="f-557" unitRef="usd">2021000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-101" decimals="-6" id="f-558" unitRef="usd">647000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-102" decimals="-6" id="f-559" unitRef="usd">2593000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-102" decimals="-6" id="f-560" unitRef="usd">1987000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-102" decimals="-6" id="f-561" unitRef="usd">606000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-103" decimals="-6" id="f-562" unitRef="usd">1751000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-103" decimals="-6" id="f-563" unitRef="usd">1479000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-103" decimals="-6" id="f-564" unitRef="usd">272000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-104" decimals="-6" id="f-565" unitRef="usd">1743000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-104" decimals="-6" id="f-566" unitRef="usd">1437000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-104" decimals="-6" id="f-567" unitRef="usd">306000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-105" decimals="-6" id="f-568" unitRef="usd">47000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-105" decimals="-6" id="f-569" unitRef="usd">29000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-105" decimals="-6" id="f-570" unitRef="usd">17000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-106" decimals="-6" id="f-571" unitRef="usd">33000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-106" decimals="-6" id="f-572" unitRef="usd">29000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-106" decimals="-6" id="f-573" unitRef="usd">4000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-8" decimals="-6" id="f-574" unitRef="usd">4696000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-8" decimals="-6" id="f-575" unitRef="usd">3555000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-8" decimals="-6" id="f-576" unitRef="usd">1141000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-9" decimals="-6" id="f-577" unitRef="usd">4481000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-9" decimals="-6" id="f-578" unitRef="usd">3477000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-9" decimals="-6" id="f-579" unitRef="usd">1004000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-8" decimals="-6" id="f-580" unitRef="usd">97000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-8" decimals="-6" id="f-581" unitRef="usd">97000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-9" decimals="-6" id="f-582" unitRef="usd">74000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-9" decimals="-6" id="f-583" unitRef="usd">74000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="c-8" decimals="-6" id="f-584" unitRef="usd">4793000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-8" decimals="-6" id="f-585" unitRef="usd">3555000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-8" decimals="-6" id="f-586" unitRef="usd">1238000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="c-9" decimals="-6" id="f-587" unitRef="usd">4555000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-9" decimals="-6" id="f-588" unitRef="usd">3477000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-9" decimals="-6" id="f-589" unitRef="usd">1078000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-6" id="f-590" unitRef="usd">70000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-7" decimals="-6" id="f-591" unitRef="usd">80000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-592">BORROWINGS&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s borrowings include the following senior unsecured notes and credit agreements:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Unsecured Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s borrowings include $8,250&#160;million aggregate principal amount of senior unsecured notes in six series with maturity dates ranging from 2025 through 2052 (collectively, the &#x201c;Notes&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:125%"&gt;Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2025, the Company terminated its existing five-year and 364-day senior unsecured revolving credit facilities. These were replaced with new five-year and 364-day senior unsecured revolving credit facilities in aggregate committed amounts of $3,000&#160;million and $500&#160;million, respectively. The terms of the new facilities are substantially similar to those of the terminated facilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;The Company has credit agreements providing for:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a five-year senior unsecured revolving credit facility in an aggregate committed amount of $3,000&#160;million, maturing on March 27, 2030; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a 364-day senior unsecured revolving credit facility in an aggregate committed amount of $500&#160;million, maturing on March 26, 2026; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a three-year senior unsecured term loan credit facility in an aggregate principal amount of $2,000&#160;million, maturing on January 2, 2026 (the &#x201c;Term Loan Facility&#x201d; and, together with the five-year revolving credit facility and the 364-day revolving credit facility, the &#x201c;Credit Facilities&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;There were no outstanding amounts under the five-year revolving credit facility and 364-day revolving credit facility, and there was $500&#160;million and $750&#160;million outstanding on the Term Loan Facility as of March 31, 2025 and December 31, 2024, respectively. In the first quarter of 2025, we repaid $250&#160;million of the Term Loan Facility.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.179%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Borrowings Composition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;5.600% senior notes due November 15, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;5.650% senior notes due November 15, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;4.800% senior notes due August 14, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;5.857% senior notes due March 15, 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;5.905% senior notes due November 22, 2032&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;6.377% senior notes due November 22, 2052&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Floating rate Term Loan Facility due January 2, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total principal debt issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;8,780&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;9,036&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Less: Unamortized debt issuance costs and discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Add: Cumulative basis adjustment for fair value hedges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;8,759&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;8,951&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Less: Short-term borrowings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Long-term borrowings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;6,757&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;7,449&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;(1) Short-term borrowings &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;as of March 31, 2025 &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;December 31, 2024 i&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;ncludes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$2,000&#160;million and $1,500&#160;million, respectively,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt; related to the current portion of our long-term borrowings, net of unamortized debt issuance costs and discounts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;See Note 12, &#x201c;Financial Instruments and Fair Value Measurements&#x201d; for further information about borrowings and associated derivatives contracts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;LETTERS OF CREDIT, GUARANTEES, AND OTHER COMMITMENTS.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of March 31, 2025 and December 31, 2024, the Company had bank guarantees and surety bonds of approximately $786&#160;million and $784&#160;million, respectively, related to certain commercial contracts. Additionally, we have issued approximately $24 million and $25 million of guarantees as of March 31, 2025 and December 31, 2024, respectively, primarily related to residual value and credit guarantees on equipment sold to third-party finance companies. Our Condensed Consolidated Statements of Financial Position reflect a liability of $2 million and $3 million as of March 31, 2025 and December 31, 2024, respectively, related to these guarantees. For credit-related guarantees, we estimate our expected credit losses related to off-balance sheet credit exposure consistent with the method used to estimate the allowance for credit losses on financial assets held at amortized cost.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-107" decimals="-6" id="f-593" unitRef="usd">8250000000</us-gaap:DebtInstrumentFaceAmount>
    <gehc:NumberOfDebtSeries
      contextRef="c-107"
      decimals="INF"
      id="f-594"
      unitRef="series">6</gehc:NumberOfDebtSeries>
    <us-gaap:DebtInstrumentTerm contextRef="c-108" id="f-595">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="c-109" id="f-596">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="c-108" id="f-597">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="c-109" id="f-598">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-110" decimals="-6" id="f-599" unitRef="usd">3000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-111" decimals="-6" id="f-600" unitRef="usd">500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm contextRef="c-108" id="f-601">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-110" decimals="-6" id="f-602" unitRef="usd">3000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm contextRef="c-109" id="f-603">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-111" decimals="-6" id="f-604" unitRef="usd">500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm contextRef="c-112" id="f-605">P3Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-113" decimals="-6" id="f-606" unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm contextRef="c-108" id="f-607">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="c-109" id="f-608">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCredit contextRef="c-114" decimals="INF" id="f-609" unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="c-115" decimals="INF" id="f-610" unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentTerm contextRef="c-108" id="f-611">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="c-116" id="f-612">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="c-109" id="f-613">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="c-117" id="f-614">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-118" decimals="-6" id="f-615" unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-119" decimals="-6" id="f-616" unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-120" decimals="-6" id="f-617" unitRef="usd">250000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="c-1" id="f-618">&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.179%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Borrowings Composition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;5.600% senior notes due November 15, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;5.650% senior notes due November 15, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;4.800% senior notes due August 14, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;5.857% senior notes due March 15, 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;5.905% senior notes due November 22, 2032&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;6.377% senior notes due November 22, 2052&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Floating rate Term Loan Facility due January 2, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total principal debt issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;8,780&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;9,036&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Less: Unamortized debt issuance costs and discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Add: Cumulative basis adjustment for fair value hedges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;8,759&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;8,951&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Less: Short-term borrowings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Long-term borrowings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;6,757&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;7,449&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;(1) Short-term borrowings &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;as of March 31, 2025 &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;December 31, 2024 i&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;ncludes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$2,000&#160;million and $1,500&#160;million, respectively,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt; related to the current portion of our long-term borrowings, net of unamortized debt issuance costs and discounts.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-121"
      decimals="INF"
      id="f-619"
      unitRef="number">0.05600</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-121" decimals="-6" id="f-620" unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-122" decimals="-6" id="f-621" unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-123"
      decimals="INF"
      id="f-622"
      unitRef="number">0.05650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-123" decimals="-6" id="f-623" unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-124" decimals="-6" id="f-624" unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-125"
      decimals="INF"
      id="f-625"
      unitRef="number">0.04800</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-125" decimals="-6" id="f-626" unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-126" decimals="-6" id="f-627" unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-127"
      decimals="INF"
      id="f-628"
      unitRef="number">0.05857</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-127" decimals="-6" id="f-629" unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-128" decimals="-6" id="f-630" unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-129"
      decimals="INF"
      id="f-631"
      unitRef="number">0.05905</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-129" decimals="-6" id="f-632" unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-130" decimals="-6" id="f-633" unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-131"
      decimals="INF"
      id="f-634"
      unitRef="number">0.06377</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-131" decimals="-6" id="f-635" unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-132" decimals="-6" id="f-636" unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-118" decimals="-6" id="f-637" unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-119" decimals="-6" id="f-638" unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-133" decimals="-6" id="f-639" unitRef="usd">30000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-134" decimals="-6" id="f-640" unitRef="usd">36000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-8" decimals="-6" id="f-641" unitRef="usd">8780000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-9" decimals="-6" id="f-642" unitRef="usd">9036000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-8" decimals="-6" id="f-643" unitRef="usd">30000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-9" decimals="-6" id="f-644" unitRef="usd">33000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease contextRef="c-8" decimals="-6" id="f-645" unitRef="usd">9000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease contextRef="c-9" decimals="-6" id="f-646" unitRef="usd">-51000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:LongTermDebt contextRef="c-8" decimals="-6" id="f-647" unitRef="usd">8759000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-9" decimals="-6" id="f-648" unitRef="usd">8951000000</us-gaap:LongTermDebt>
    <us-gaap:ShortTermBorrowings contextRef="c-8" decimals="-6" id="f-649" unitRef="usd">2002000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings contextRef="c-9" decimals="-6" id="f-650" unitRef="usd">1502000000</us-gaap:ShortTermBorrowings>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-8" decimals="-6" id="f-651" unitRef="usd">6757000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-9" decimals="-6" id="f-652" unitRef="usd">7449000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-8" decimals="-6" id="f-653" unitRef="usd">2000000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-9" decimals="-6" id="f-654" unitRef="usd">1500000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:GuaranteeObligationsMaximumExposure contextRef="c-135" decimals="-6" id="f-655" unitRef="usd">786000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <us-gaap:GuaranteeObligationsMaximumExposure contextRef="c-136" decimals="-6" id="f-656" unitRef="usd">784000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <us-gaap:GuaranteeObligationsMaximumExposure contextRef="c-137" decimals="-6" id="f-657" unitRef="usd">24000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <us-gaap:GuaranteeObligationsMaximumExposure contextRef="c-138" decimals="-6" id="f-658" unitRef="usd">25000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue contextRef="c-8" decimals="-6" id="f-659" unitRef="usd">2000000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue contextRef="c-9" decimals="-6" id="f-660" unitRef="usd">3000000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="c-1" id="f-661">POSTRETIREMENT BENEFIT PLANS&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We sponsor a number of pension and retiree health and life insurance benefit plans that we present in three categories: U.S. Plans, International Plans, and Other Postretirement Plans (&#x201c;OPEB Plans&#x201d;). Please refer to Note 10, &#x201c;Postretirement Benefit Plans&#x201d; in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 for further information. Pension plans with pension assets or obligations less than $50&#160;million are not included in the results below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.288%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.483%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.483%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.483%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.483%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.483%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.487%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Components of Expense (Income)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="24" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;U.S. Plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;International Plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;OPEB Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;For the three months ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Service cost &#x2013; Operating&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Amortization of net loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Amortization of prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Special termination cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Non-operating&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Net periodic expense (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;three months ended&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; March 31, 2025, the Company made cash payments totaling $43 million to its U.S. Plans, $10 million to its International Plans, and $45&#160;million to its OPEB Plans. In 2025, the Company expects to make total cash contributions of approximately $327&#160;million to these plans. The Company funds annually, at a minimum, the statutorily required minimum amount for our qualified plans. Non-qualified plans are unfunded and we pay benefits from our cash on hand.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defined Contribution Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;GE HealthCare sponsors a defined contribution plan for its eligible U.S. employees. Expenses associated with our employees&#x2019; participation in GE HealthCare&#x2019;s defined contribution plan were $45 million and $32 million for the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;three months ended&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; March 31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <gehc:DefinedBenefitPlanPlanAssetOrObligationReportingThreshold contextRef="c-139" decimals="-6" id="f-662" unitRef="usd">50000000</gehc:DefinedBenefitPlanPlanAssetOrObligationReportingThreshold>
    <gehc:DefinedBenefitPlanPlanAssetOrObligationReportingThreshold contextRef="c-1" decimals="-6" id="f-663" unitRef="usd">50000000</gehc:DefinedBenefitPlanPlanAssetOrObligationReportingThreshold>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock contextRef="c-1" id="f-664">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.288%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.483%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.483%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.483%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.483%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.483%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.487%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Components of Expense (Income)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="24" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;U.S. Plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;International Plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;OPEB Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;For the three months ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Service cost &#x2013; Operating&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Amortization of net loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Amortization of prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Special termination cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Non-operating&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Net periodic expense (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-140" decimals="-6" id="f-665" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-141" decimals="-6" id="f-666" unitRef="usd">8000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-142" decimals="-6" id="f-667" unitRef="usd">5000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-143" decimals="-6" id="f-668" unitRef="usd">5000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-144" decimals="-6" id="f-669" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="c-145" decimals="-6" id="f-670" unitRef="usd">2000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-140" decimals="-6" id="f-671" unitRef="usd">249000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-141" decimals="-6" id="f-672" unitRef="usd">242000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-142" decimals="-6" id="f-673" unitRef="usd">36000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-143" decimals="-6" id="f-674" unitRef="usd">35000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-144" decimals="-6" id="f-675" unitRef="usd">13000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-145" decimals="-6" id="f-676" unitRef="usd">13000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-140" decimals="-6" id="f-677" unitRef="usd">287000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-141" decimals="-6" id="f-678" unitRef="usd">298000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-142" decimals="-6" id="f-679" unitRef="usd">36000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-143" decimals="-6" id="f-680" unitRef="usd">48000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-144" decimals="-6" id="f-681" unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-145" decimals="-6" id="f-682" unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="c-140" decimals="-6" id="f-683" unitRef="usd">20000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="c-141" decimals="-6" id="f-684" unitRef="usd">17000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="c-142" decimals="-6" id="f-685" unitRef="usd">-5000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="c-143" decimals="-6" id="f-686" unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="c-144" decimals="-6" id="f-687" unitRef="usd">15000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="c-145" decimals="-6" id="f-688" unitRef="usd">15000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit contextRef="c-140" decimals="-6" id="f-689" unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit contextRef="c-141" decimals="-6" id="f-690" unitRef="usd">2000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit contextRef="c-142" decimals="-6" id="f-691" unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit contextRef="c-143" decimals="-6" id="f-692" unitRef="usd">0</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit contextRef="c-144" decimals="-6" id="f-693" unitRef="usd">-20000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit contextRef="c-145" decimals="-6" id="f-694" unitRef="usd">-22000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod contextRef="c-140" decimals="-6" id="f-695" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod>
    <us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod contextRef="c-141" decimals="-6" id="f-696" unitRef="usd">0</us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod>
    <us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod contextRef="c-142" decimals="-6" id="f-697" unitRef="usd">0</us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod>
    <us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod contextRef="c-143" decimals="-6" id="f-698" unitRef="usd">0</us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod>
    <us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod contextRef="c-144" decimals="-6" id="f-699" unitRef="usd">0</us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod>
    <us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod contextRef="c-145" decimals="-6" id="f-700" unitRef="usd">0</us-gaap:DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent contextRef="c-140" decimals="-6" id="f-701" unitRef="usd">-60000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent contextRef="c-141" decimals="-6" id="f-702" unitRef="usd">-71000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent contextRef="c-142" decimals="-6" id="f-703" unitRef="usd">4000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent contextRef="c-143" decimals="-6" id="f-704" unitRef="usd">-10000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent contextRef="c-144" decimals="-6" id="f-705" unitRef="usd">-21000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent contextRef="c-145" decimals="-6" id="f-706" unitRef="usd">-24000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-140" decimals="-6" id="f-707" unitRef="usd">-59000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-141" decimals="-6" id="f-708" unitRef="usd">-63000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-142" decimals="-6" id="f-709" unitRef="usd">9000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-143" decimals="-6" id="f-710" unitRef="usd">-5000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-144" decimals="-6" id="f-711" unitRef="usd">-20000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-145" decimals="-6" id="f-712" unitRef="usd">-22000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-146" decimals="-6" id="f-713" unitRef="usd">43000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-147" decimals="-6" id="f-714" unitRef="usd">10000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-144" decimals="-6" id="f-715" unitRef="usd">45000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear contextRef="c-8" decimals="-6" id="f-716" unitRef="usd">327000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c-1" decimals="-6" id="f-717" unitRef="usd">45000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c-7" decimals="-6" id="f-718" unitRef="usd">32000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-719">INCOME TAXES&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Our effective income tax rate was 15.0% and 24.2% for the three months ended March 31, 2025 and 2024, respectively. The tax rate for the three months ended March 31, 2025 is lower than the U.S. statutory rate primarily due to the release of income tax reserves in a foreign jurisdiction for tax years which are no longer subject to an assessment from the local taxing authorities, the remeasurement gain that was recorded due to the NMP acquisition which is not taxable, and research and development (&#x201c;R&amp;amp;D&#x201d;) benefits, partially offset by geographic earnings mix, withholding taxes, and state taxes. The tax rate for the three months ended March 31, 2024 is higher than the U.S. statutory rate primarily due to geographic earnings mix, withholding taxes, and state taxes, partially offset by R&amp;amp;D benefits.&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company is currently being audited in a number of jurisdictions for tax years 2004-2023, including China, France, Germany, India, Japan, Norway, the United Kingdom, and the United States.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-720" unitRef="number">0.150</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-7" decimals="3" id="f-721" unitRef="number">0.242</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="c-1" id="f-722">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) &#x2013; NET&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Changes in Accumulated other comprehensive income (loss) - net by component were as follows.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.02pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.235%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;For the three months ended March 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Currency translation adjustments&lt;/span&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-right:-1.31pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Pension and Other Postretirement  Plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total AOCI&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(1,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;576&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(1,379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other comprehensive income (loss) before reclassifications &#x2013; net of taxes of $15, $5, and $3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Reclassifications from AOCI &#x2013; net of taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt; of $&#x2014;, $16, and $&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;257&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;180&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Less: Other comprehensive income (loss) attributable to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(1,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;507&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(1,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.235%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;For the three months ended March 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Currency translation adjustments&lt;/span&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-right:-1.31pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Pension and Other Postretirement Plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total AOCI&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(1,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,033&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(691)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other comprehensive income (loss) before reclassifications &#x2013; net of taxes of $(7), $(1), and $(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Reclassifications from AOCI &#x2013; net of taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt; of $&#x2014;, $12, and $&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Less: Other comprehensive income (loss) attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(1,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;997&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(787)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) The amount of Currency translation adjustments recognized in Other comprehensive income (loss) (&#x201c;OCI&#x201d;) during the three months ended March 31, 2025 and 2024 included net gains (losses) relating to net investment hedges, as further discussed in Note 12, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Financial Instruments and Fair Value Measurements.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2) Reclassifications from AOCI into earnings for Pension and Other Postretirement Plans are recognized within Non-operating benefit (income) costs, while Cash flow hedges are recognized within Cost of products and Cost of services in our Condensed Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3) Includes net of tax impact of $63 million to Currency translation adjustments and $8 million to Pension and Other Postretirement Plans related to the derecognition of the prior NMP equity method investment. Refer to Note 7, &#x201c;Acquisitions, Goodwill, and Other Intangible Assets&#x201d; for additional information on the NMP acquisition.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-723">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Changes in Accumulated other comprehensive income (loss) - net by component were as follows.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.02pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.235%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;For the three months ended March 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Currency translation adjustments&lt;/span&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-right:-1.31pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Pension and Other Postretirement  Plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total AOCI&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(1,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;576&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(1,379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other comprehensive income (loss) before reclassifications &#x2013; net of taxes of $15, $5, and $3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Reclassifications from AOCI &#x2013; net of taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt; of $&#x2014;, $16, and $&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;257&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;180&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Less: Other comprehensive income (loss) attributable to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(1,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;507&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(1,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.235%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;For the three months ended March 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Currency translation adjustments&lt;/span&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-right:-1.31pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Pension and Other Postretirement Plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total AOCI&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(1,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,033&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(691)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other comprehensive income (loss) before reclassifications &#x2013; net of taxes of $(7), $(1), and $(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Reclassifications from AOCI &#x2013; net of taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt; of $&#x2014;, $12, and $&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Less: Other comprehensive income (loss) attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(1,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;997&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(787)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) The amount of Currency translation adjustments recognized in Other comprehensive income (loss) (&#x201c;OCI&#x201d;) during the three months ended March 31, 2025 and 2024 included net gains (losses) relating to net investment hedges, as further discussed in Note 12, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Financial Instruments and Fair Value Measurements.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2) Reclassifications from AOCI into earnings for Pension and Other Postretirement Plans are recognized within Non-operating benefit (income) costs, while Cash flow hedges are recognized within Cost of products and Cost of services in our Condensed Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3) Includes net of tax impact of $63 million to Currency translation adjustments and $8 million to Pension and Other Postretirement Plans related to the derecognition of the prior NMP equity method investment. Refer to Note 7, &#x201c;Acquisitions, Goodwill, and Other Intangible Assets&#x201d; for additional information on the NMP acquisition.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-148" decimals="-6" id="f-724" unitRef="usd">-1973000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-149" decimals="-6" id="f-725" unitRef="usd">576000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-150" decimals="-6" id="f-726" unitRef="usd">18000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-14" decimals="-6" id="f-727" unitRef="usd">-1379000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="c-151" decimals="-6" id="f-728" unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="c-152" decimals="-6" id="f-729" unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="c-153" decimals="-6" id="f-730" unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-151" decimals="-6" id="f-731" unitRef="usd">194000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-152" decimals="-6" id="f-732" unitRef="usd">-20000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-153" decimals="-6" id="f-733" unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-1" decimals="-6" id="f-734" unitRef="usd">163000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax contextRef="c-151" decimals="-6" id="f-735" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax contextRef="c-152" decimals="-6" id="f-736" unitRef="usd">-16000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax contextRef="c-153" decimals="-6" id="f-737" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="c-151" decimals="-6" id="f-738" unitRef="usd">-63000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="c-152" decimals="-6" id="f-739" unitRef="usd">49000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="c-153" decimals="-6" id="f-740" unitRef="usd">-3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="c-1" decimals="-6" id="f-741" unitRef="usd">-17000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-151" decimals="-6" id="f-742" unitRef="usd">257000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-152" decimals="-6" id="f-743" unitRef="usd">-69000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-153" decimals="-6" id="f-744" unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-1" decimals="-6" id="f-745" unitRef="usd">180000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest contextRef="c-151" decimals="-6" id="f-746" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest contextRef="c-152" decimals="-6" id="f-747" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest contextRef="c-153" decimals="-6" id="f-748" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-749" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-154" decimals="-6" id="f-750" unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-155" decimals="-6" id="f-751" unitRef="usd">507000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-156" decimals="-6" id="f-752" unitRef="usd">10000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-25" decimals="-6" id="f-753" unitRef="usd">-1199000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-157" decimals="-6" id="f-754" unitRef="usd">-1706000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-158" decimals="-6" id="f-755" unitRef="usd">1033000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-159" decimals="-6" id="f-756" unitRef="usd">-18000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-30" decimals="-6" id="f-757" unitRef="usd">-691000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="c-160" decimals="-6" id="f-758" unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="c-161" decimals="-6" id="f-759" unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="c-162" decimals="-6" id="f-760" unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-160" decimals="-6" id="f-761" unitRef="usd">-76000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-161" decimals="-6" id="f-762" unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-162" decimals="-6" id="f-763" unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-7" decimals="-6" id="f-764" unitRef="usd">-58000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax contextRef="c-160" decimals="-6" id="f-765" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax contextRef="c-161" decimals="-6" id="f-766" unitRef="usd">-12000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax contextRef="c-162" decimals="-6" id="f-767" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="c-160" decimals="-6" id="f-768" unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="c-161" decimals="-6" id="f-769" unitRef="usd">38000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="c-162" decimals="-6" id="f-770" unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="c-7" decimals="-6" id="f-771" unitRef="usd">37000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-160" decimals="-6" id="f-772" unitRef="usd">-76000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-161" decimals="-6" id="f-773" unitRef="usd">-35000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-162" decimals="-6" id="f-774" unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-7" decimals="-6" id="f-775" unitRef="usd">-95000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest contextRef="c-160" decimals="-6" id="f-776" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest contextRef="c-161" decimals="-6" id="f-777" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest contextRef="c-162" decimals="-6" id="f-778" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest contextRef="c-7" decimals="-6" id="f-779" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-163" decimals="-6" id="f-780" unitRef="usd">-1781000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-164" decimals="-6" id="f-781" unitRef="usd">997000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-165" decimals="-6" id="f-782" unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-41" decimals="-6" id="f-783" unitRef="usd">-787000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <gehc:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax contextRef="c-78" decimals="-6" id="f-784" unitRef="usd">63000000</gehc:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCINetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax contextRef="c-78" decimals="-6" id="f-785" unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:DerivativesAndFairValueTextBlock contextRef="c-1" id="f-786">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;DERIVATIVES AND HEDGING.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our primary objective in executing and holding derivative contracts is to reduce the volatility of earnings and cash flows associated with risks related to foreign currency exchange rates, interest rates, equity prices, and commodity prices. These derivative contracts reduce, but do not entirely eliminate, the aforementioned risks. Our policy is to use derivative contracts solely for managing risks and not for speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;For derivative instruments designated as cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;flow hedges, changes in the fair value of designated hedging instruments are initially recorded as a component of AOCI and subsequently reclassified to earnings in the period in which the hedged transaction affects earnings and to the same financial statement line item impacted by the hedged transaction. As of March 31, 2025, we expect to reclassify $14&#160;million of pre-tax net deferred gains associated with designated cash flow hedges to earnings in the next 12 months, contemporaneously with the impact on earnings of the related hedged transactions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The cash flows associated with derivatives designated as cash flow hedges are recorded in All other operating activities &#x2013; net in the Condensed Consolidated Statements of Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We use cross-currency interest rate swaps and foreign currency forward contracts in combination with foreign currency option contracts to hedge the foreign currency risk associated with our net investment in foreign operations. As of March 31, 2025, these contracts were designated as hedges of our net investment in foreign operations, primarily in Euro and Chinese Renminbi currencies.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The cash flows associated with derivatives designated as net investment hedges are recorded in All other investing activities &#x2013; net in the Condensed Consolidated Statements of Cash Flows. Cash flows from the periodic interest settlements on the cross-currency swaps are recorded in All other operating activities &#x2013; net in the Condensed Consolidated and Statements of Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Hedges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We use interest rate swaps to hedge the interest rate risk on our fixed rate borrowings. These derivatives are designated as fair value hedges to hedge the changes in fair value due to benchmark interest rate risk of specific designated cash flows of our senior unsecured notes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We record the changes in fair value on these swap contracts in Interest and other financial charges &#x2013; net in our Condensed Consolidated Statements of Income, the same line item where the offsetting change in the fair value of the designated cash flows of the senior unsecured note is recorded as a basis adjustment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash flows for the periodic interest settlements on the interest rate swaps are recorded in All other operating activities &#x2013; net in the Condensed Consolidated Statements of Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:125%"&gt;Derivatives Not Designated as Hedging Instrument&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;s&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We also execute derivative instruments, such as foreign currency forward contracts and equity-linked total return swaps, which are not designated as qualifying hedges. These derivatives serve as economic hedges of foreign currency exchange rate and equity price risks. We also identify and record foreign currency-related features in our purchase or sales contracts where the currency is not the local or functional currency of any substantive party to the contract as embedded derivatives.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The changes in fair value of derivatives not designated in qualifying hedge transactions are recorded in Cost of products, Cost of services, Selling, general, and administrative (&#x201c;SG&amp;amp;A&#x201d;), and Other (income) expense &#x2013; net in the Condensed Consolidated Statements of Income based on the nature of the underlying hedged transaction. Changes in fair value of embedded derivatives are recognized in Other (income) expense &#x2013; net in the Condensed Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The cash flows associated with derivatives not designated but used as economic hedges are recorded, based on the nature of the underlying hedged transaction, in All other operating activities &#x2013; net and All other investing activities &#x2013; net in the Condensed Consolidated Statements of Cash Flows. The cash flows related to embedded derivatives are included in All other operating activities &#x2013; net in the Condensed Consolidated Statements of Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents the gross fair values of our outstanding derivative instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.933%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Fair Value of Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Gross Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Fair Value &#x2013; Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Fair Value &#x2013; Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Gross Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Fair Value &#x2013; Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Fair Value &#x2013; Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Derivatives accounted for as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,474&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,210&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;43&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cross-currency swaps&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward and options contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Derivatives accounted for as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;3,835&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;3,726&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;45&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Interest rate swaps&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Derivatives accounted for as fair value hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;4,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;3,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other derivatives&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,779&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;53&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,294&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;57&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;12,788&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;160&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;11,930&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;145&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;155&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) As of March 31, 2025, accrued interest is included in the above fair value and is not considered material. As of December 31, 2024, accrued interest is excluded from the above fair value and is not considered material. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2) Other derivatives are comprised of embedded derivatives and derivatives related to equity contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents amounts recorded in Long-term borrowings in the Condensed Consolidated Statements of Financial Position related to cumulative basis adjustment for fair value hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.288%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.594%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.597%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;Carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;Cumulative basis adjustment included in the carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;Carrying amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;Cumulative basis adjustment included in the carrying amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&lt;span style="-sec-ix-hidden:f-857"&gt;&lt;span style="-sec-ix-hidden:f-858"&gt;Long-term borrowings designated in fair value hedges&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Under the master arrangements with the respective counterparties to our derivative contracts, in certain circumstances and subject to applicable requirements, we are allowed to net settle transactions with a single net amount payable by one party to the other. However, we have elected to present the derivative assets and derivative liabilities on a gross basis in our Condensed Consolidated Statements of Financial Position and in the table above. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of March 31, 2025 and December 31, 2024, the potential effect of rights of offset associated with the derivative contracts would be an offset to both assets and liabilities by $55&#160;million and $77&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The table below presents the pre-tax gains (losses) recognized in OCI associated with the Company&#x2019;s cash flow and net investment hedges.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.955%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.873%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Pre-tax Gains (Losses) Recognized in OCI Related to Cash Flow and Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;For the three months ended March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Amounts recognized in OCI for excluded components for the periods presented were immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The tables below present the gains (losses) on our derivative financial instruments and hedging activity in the Condensed Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.874%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Derivative Financial Instruments and Hedging Activity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;For the three months ended March 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Cost of products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Interest and other financial charges &lt;/span&gt;&lt;span style="color:#454545;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Other&lt;/span&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Effects of cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward and options contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Effects of net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Interest rate swaps&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Debt basis adjustment on Long-term borrowings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Effects of fair value hedges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other derivatives&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Effects of derivatives not designated as hedging instruments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.874%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;For the three months ended March 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Cost of products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Interest and other financial charges &lt;/span&gt;&lt;span style="color:#454545;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Other&lt;/span&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Effects of cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward and option contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Effects of net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Interest rate swaps&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Debt basis adjustment on Long-term borrowings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Effects of fair value hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other derivatives&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Effects of derivatives not designated as hedging instruments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Changes in fair value related to components other than the spot rate are excluded from effectiveness testing for the three months ended March 31, 2025 and 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2) Amount includes $(4)&#160;million and $(6)&#160;million of interest expense on interest rate derivatives for the three months ended March 31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3) Other derivatives are comprised of embedded derivatives and derivatives related to equity contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4) Amounts are inclusive of gains (losses) in Other (income) expense &#x2013; net in the Condensed Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;FAIR VALUE MEASUREMENTS.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table represents assets and liabilities that are recorded and measured at fair value on a recurring basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.094%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.094%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.094%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.094%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.094%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.094%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.094%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.099%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Fair Value of Assets and Liabilities Measured on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of March 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Money market funds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:118%"&gt;Cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;As of March 31, 2025 and December 31, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;, Cash, cash equivalents, and restricted cash of $2,473&#160;million and $2,889&#160;million, respectively, included money market funds of $230&#160;million and $312 million, and other cash equivalents of $1,229&#160;million and $1,573&#160;million, respectively. The carrying values of the other cash equivalents approximates the fair value due to their short maturities and are valued using Level 1 or Level 2 inputs. Refer to Note 16, &#x201c;Supplemental Financial Information&#x201d; for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:118%"&gt;Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;Derivatives are measured at fair value using a discounted cash flow method or option models using interest rates, foreign exchange spot and forward rates and yield curves observable at commonly quoted intervals, implied volatilities, and credit spreads as key inputs. Unobservable inputs relate to our own credit risk which is not significant to the overall measurement of fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:118%"&gt;Contingent consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;Contingent consideration is recorded at fair value based on estimates of future cash flows in connection with business acquisitions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;. As the valuation of these liabilities is based on inputs that are less observable or not observable in the market, the determination of fair value is classified within Level 3 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:118%"&gt;Non-recurring fair value measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;Changes in fair value measurements of assets and liabilities measured at fair value on a non-recurring basis, such as equity method investments, equity investments without readily determinable fair value, financing receivables, and long-lived assets, were not material for the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;three months ended&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt; March 31, 2025 and 2024, with the exception of the gain on fair value measurement of the NMP equity method investment as described in Note 7 &#x201c;Acquisitions, Goodwill, and Other Intangible Assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:118%"&gt;Fair value of other financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;The estimated fair value of borrowings as of March 31, 2025 and December 31, 2024 was $9,223&#160;million and $9,374&#160;million, respectively, compared to a carrying value (which only includes a reduction for unamortized debt issuance costs and discounts and cumulative basis adjustment) of $8,759&#160;million and $8,951&#160;million, respectively. The fair value of our borrowings includes accrued interest and is determined based on observable and quoted prices and spreads of comparable debt and benchmark securities and is considered Level 2 in the fair value hierarchy. See Note 8, &#x201c;Borrowings&#x201d; and Note 16, &#x201c;Supplemental Financial Information&#x201d; for further information.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesAndFairValueTextBlock>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths contextRef="c-1" decimals="-6" id="f-787" unitRef="usd">14000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock contextRef="c-1" id="f-789">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents the gross fair values of our outstanding derivative instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.933%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Fair Value of Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Gross Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Fair Value &#x2013; Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Fair Value &#x2013; Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Gross Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Fair Value &#x2013; Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Fair Value &#x2013; Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Derivatives accounted for as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,474&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,210&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;43&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cross-currency swaps&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward and options contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Derivatives accounted for as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;3,835&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;3,726&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;45&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Interest rate swaps&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Derivatives accounted for as fair value hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;4,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;3,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other derivatives&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,779&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;53&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,294&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;57&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;12,788&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;160&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;11,930&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;145&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;155&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) As of March 31, 2025, accrued interest is included in the above fair value and is not considered material. As of December 31, 2024, accrued interest is excluded from the above fair value and is not considered material. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2) Other derivatives are comprised of embedded derivatives and derivatives related to equity contracts.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock contextRef="c-1" id="f-788">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents the gross fair values of our outstanding derivative instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.933%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Fair Value of Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Gross Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Fair Value &#x2013; Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Fair Value &#x2013; Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Gross Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Fair Value &#x2013; Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Fair Value &#x2013; Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Derivatives accounted for as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,474&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,210&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;43&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cross-currency swaps&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward and options contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Derivatives accounted for as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;3,835&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;3,726&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;45&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Interest rate swaps&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Derivatives accounted for as fair value hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;4,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;3,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other derivatives&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,779&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;53&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4,294&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;57&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;12,788&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;160&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;11,930&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;145&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;155&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) As of March 31, 2025, accrued interest is included in the above fair value and is not considered material. As of December 31, 2024, accrued interest is excluded from the above fair value and is not considered material. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2) Other derivatives are comprised of embedded derivatives and derivatives related to equity contracts.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:DerivativeNotionalAmount contextRef="c-166" decimals="-6" id="f-790" unitRef="usd">1474000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-166" decimals="-6" id="f-791" unitRef="usd">25000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-166" decimals="-6" id="f-792" unitRef="usd">15000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-167" decimals="-6" id="f-793" unitRef="usd">1210000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-167" decimals="-6" id="f-794" unitRef="usd">43000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-167" decimals="-6" id="f-795" unitRef="usd">11000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-168" decimals="-6" id="f-796" unitRef="usd">1474000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-168" decimals="-6" id="f-797" unitRef="usd">25000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-168" decimals="-6" id="f-798" unitRef="usd">15000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-169" decimals="-6" id="f-799" unitRef="usd">1210000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-169" decimals="-6" id="f-800" unitRef="usd">43000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-169" decimals="-6" id="f-801" unitRef="usd">11000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-170" decimals="-6" id="f-802" unitRef="usd">2075000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-170" decimals="-6" id="f-803" unitRef="usd">12000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-170" decimals="-6" id="f-804" unitRef="usd">97000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-171" decimals="-6" id="f-805" unitRef="usd">1995000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-171" decimals="-6" id="f-806" unitRef="usd">15000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-171" decimals="-6" id="f-807" unitRef="usd">46000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-172" decimals="-6" id="f-808" unitRef="usd">1760000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-172" decimals="-6" id="f-809" unitRef="usd">29000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-172" decimals="-6" id="f-810" unitRef="usd">17000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-173" decimals="-6" id="f-811" unitRef="usd">1731000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-173" decimals="-6" id="f-812" unitRef="usd">30000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-173" decimals="-6" id="f-813" unitRef="usd">18000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-174" decimals="-6" id="f-814" unitRef="usd">3835000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-174" decimals="-6" id="f-815" unitRef="usd">41000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-174" decimals="-6" id="f-816" unitRef="usd">114000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-175" decimals="-6" id="f-817" unitRef="usd">3726000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-175" decimals="-6" id="f-818" unitRef="usd">45000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-175" decimals="-6" id="f-819" unitRef="usd">64000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-176" decimals="-6" id="f-820" unitRef="usd">2700000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-176" decimals="-6" id="f-821" unitRef="usd">17000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-176" decimals="-6" id="f-822" unitRef="usd">14000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-177" decimals="-6" id="f-823" unitRef="usd">2700000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-177" decimals="-6" id="f-824" unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-177" decimals="-6" id="f-825" unitRef="usd">51000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-178" decimals="-6" id="f-826" unitRef="usd">2700000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-178" decimals="-6" id="f-827" unitRef="usd">17000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-178" decimals="-6" id="f-828" unitRef="usd">14000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-179" decimals="-6" id="f-829" unitRef="usd">2700000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-179" decimals="-6" id="f-830" unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-179" decimals="-6" id="f-831" unitRef="usd">51000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-180" decimals="-6" id="f-832" unitRef="usd">4395000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-180" decimals="-6" id="f-833" unitRef="usd">22000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-180" decimals="-6" id="f-834" unitRef="usd">14000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-181" decimals="-6" id="f-835" unitRef="usd">3925000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-181" decimals="-6" id="f-836" unitRef="usd">11000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-181" decimals="-6" id="f-837" unitRef="usd">29000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-182" decimals="-6" id="f-838" unitRef="usd">384000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-182" decimals="-6" id="f-839" unitRef="usd">31000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-182" decimals="-6" id="f-840" unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-183" decimals="-6" id="f-841" unitRef="usd">370000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-183" decimals="-6" id="f-842" unitRef="usd">47000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-183" decimals="-6" id="f-843" unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-184" decimals="-6" id="f-844" unitRef="usd">4779000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-184" decimals="-6" id="f-845" unitRef="usd">53000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-184" decimals="-6" id="f-846" unitRef="usd">16000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-185" decimals="-6" id="f-847" unitRef="usd">4294000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-185" decimals="-6" id="f-848" unitRef="usd">57000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-185" decimals="-6" id="f-849" unitRef="usd">29000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-8" decimals="-6" id="f-850" unitRef="usd">12788000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-8" decimals="-6" id="f-851" unitRef="usd">136000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-8" decimals="-6" id="f-852" unitRef="usd">160000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount contextRef="c-9" decimals="-6" id="f-853" unitRef="usd">11930000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-9" decimals="-6" id="f-854" unitRef="usd">145000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-9" decimals="-6" id="f-855" unitRef="usd">155000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock contextRef="c-1" id="f-856">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents amounts recorded in Long-term borrowings in the Condensed Consolidated Statements of Financial Position related to cumulative basis adjustment for fair value hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.288%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.594%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.597%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;Carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;Cumulative basis adjustment included in the carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;Carrying amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;Cumulative basis adjustment included in the carrying amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&lt;span style="-sec-ix-hidden:f-857"&gt;&lt;span style="-sec-ix-hidden:f-858"&gt;Long-term borrowings designated in fair value hedges&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The tables below present the gains (losses) on our derivative financial instruments and hedging activity in the Condensed Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.874%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Derivative Financial Instruments and Hedging Activity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;For the three months ended March 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Cost of products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Interest and other financial charges &lt;/span&gt;&lt;span style="color:#454545;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Other&lt;/span&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Effects of cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward and options contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Effects of net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Interest rate swaps&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Debt basis adjustment on Long-term borrowings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Effects of fair value hedges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other derivatives&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Effects of derivatives not designated as hedging instruments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.874%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;For the three months ended March 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Cost of products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Interest and other financial charges &lt;/span&gt;&lt;span style="color:#454545;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #454545;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Other&lt;/span&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Effects of cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward and option contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Effects of net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Interest rate swaps&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Debt basis adjustment on Long-term borrowings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Effects of fair value hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Other derivatives&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Effects of derivatives not designated as hedging instruments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Changes in fair value related to components other than the spot rate are excluded from effectiveness testing for the three months ended March 31, 2025 and 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2) Amount includes $(4)&#160;million and $(6)&#160;million of interest expense on interest rate derivatives for the three months ended March 31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3) Other derivatives are comprised of embedded derivatives and derivatives related to equity contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4) Amounts are inclusive of gains (losses) in Other (income) expense &#x2013; net in the Condensed Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:HedgedLiabilityFairValueHedge contextRef="c-8" decimals="-6" id="f-859" unitRef="usd">2704000000</us-gaap:HedgedLiabilityFairValueHedge>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease contextRef="c-8" decimals="-6" id="f-860" unitRef="usd">9000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:HedgedLiabilityFairValueHedge contextRef="c-9" decimals="-6" id="f-861" unitRef="usd">2644000000</us-gaap:HedgedLiabilityFairValueHedge>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease contextRef="c-9" decimals="-6" id="f-862" unitRef="usd">-51000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <gehc:DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability contextRef="c-8" decimals="-6" id="f-863" unitRef="usd">55000000</gehc:DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability>
    <gehc:DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability contextRef="c-9" decimals="-6" id="f-864" unitRef="usd">77000000</gehc:DerivativeSubjectToMasterNettingArrangementPotentialOffsetToAssetLiability>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock contextRef="c-1" id="f-865">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The table below presents the pre-tax gains (losses) recognized in OCI associated with the Company&#x2019;s cash flow and net investment hedges.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.955%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.872%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.873%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Pre-tax Gains (Losses) Recognized in OCI Related to Cash Flow and Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;For the three months ended March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Amounts recognized in OCI for excluded components for the periods presented were immaterial.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-1" decimals="-6" id="f-866" unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-7" decimals="-6" id="f-867" unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-1" decimals="-6" id="f-868" unitRef="usd">-65000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-7" decimals="-6" id="f-869" unitRef="usd">32000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-186" decimals="-6" id="f-870" unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-187" decimals="-6" id="f-871" unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-188" decimals="-6" id="f-872" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-189" decimals="-6" id="f-873" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-190" decimals="-6" id="f-874" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-191" decimals="-6" id="f-875" unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-192" decimals="-6" id="f-876" unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-193" decimals="-6" id="f-877" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-194" decimals="-6" id="f-878" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-195" decimals="-6" id="f-879" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-196" decimals="-6" id="f-880" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-197" decimals="-6" id="f-881" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-198" decimals="-6" id="f-882" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-199" decimals="-6" id="f-883" unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-200" decimals="-6" id="f-884" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-201" decimals="-6" id="f-885" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-202" decimals="-6" id="f-886" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-203" decimals="-6" id="f-887" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-204" decimals="-6" id="f-888" unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-205" decimals="-6" id="f-889" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-191" decimals="-6" id="f-890" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-192" decimals="-6" id="f-891" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-193" decimals="-6" id="f-892" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-194" decimals="-6" id="f-893" unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-195" decimals="-6" id="f-894" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-206" decimals="-6" id="f-895" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-207" decimals="-6" id="f-896" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-208" decimals="-6" id="f-897" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-209" decimals="-6" id="f-898" unitRef="usd">57000000</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-210" decimals="-6" id="f-899" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-211" decimals="-6" id="f-900" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-212" decimals="-6" id="f-901" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-213" decimals="-6" id="f-902" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-214" decimals="-6" id="f-903" unitRef="usd">-61000000</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-215" decimals="-6" id="f-904" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-191" decimals="-6" id="f-905" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-192" decimals="-6" id="f-906" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-193" decimals="-6" id="f-907" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-194" decimals="-6" id="f-908" unitRef="usd">-4000000</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-195" decimals="-6" id="f-909" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-186" decimals="-6" id="f-910" unitRef="usd">15000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-187" decimals="-6" id="f-911" unitRef="usd">4000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-188" decimals="-6" id="f-912" unitRef="usd">0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-189" decimals="-6" id="f-913" unitRef="usd">0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-190" decimals="-6" id="f-914" unitRef="usd">-1000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-216" decimals="-6" id="f-915" unitRef="usd">0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-217" decimals="-6" id="f-916" unitRef="usd">0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-218" decimals="-6" id="f-917" unitRef="usd">-3000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-219" decimals="-6" id="f-918" unitRef="usd">0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-220" decimals="-6" id="f-919" unitRef="usd">-15000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-191" decimals="-6" id="f-920" unitRef="usd">15000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-192" decimals="-6" id="f-921" unitRef="usd">4000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-193" decimals="-6" id="f-922" unitRef="usd">-3000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-194" decimals="-6" id="f-923" unitRef="usd">0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-195" decimals="-6" id="f-924" unitRef="usd">-15000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-221" decimals="-6" id="f-925" unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-222" decimals="-6" id="f-926" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-223" decimals="-6" id="f-927" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-224" decimals="-6" id="f-928" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-225" decimals="-6" id="f-929" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-226" decimals="-6" id="f-930" unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-227" decimals="-6" id="f-931" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-228" decimals="-6" id="f-932" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-229" decimals="-6" id="f-933" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-230" decimals="-6" id="f-934" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-231" decimals="-6" id="f-935" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-232" decimals="-6" id="f-936" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-233" decimals="-6" id="f-937" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-234" decimals="-6" id="f-938" unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-235" decimals="-6" id="f-939" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-236" decimals="-6" id="f-940" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-237" decimals="-6" id="f-941" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-238" decimals="-6" id="f-942" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-239" decimals="-6" id="f-943" unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-240" decimals="-6" id="f-944" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-226" decimals="-6" id="f-945" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-227" decimals="-6" id="f-946" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-228" decimals="-6" id="f-947" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-229" decimals="-6" id="f-948" unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax contextRef="c-230" decimals="-6" id="f-949" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-241" decimals="-6" id="f-950" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-242" decimals="-6" id="f-951" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-243" decimals="-6" id="f-952" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-244" decimals="-6" id="f-953" unitRef="usd">-45000000</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-245" decimals="-6" id="f-954" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-246" decimals="-6" id="f-955" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-247" decimals="-6" id="f-956" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-248" decimals="-6" id="f-957" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-249" decimals="-6" id="f-958" unitRef="usd">38000000</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-250" decimals="-6" id="f-959" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-226" decimals="-6" id="f-960" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-227" decimals="-6" id="f-961" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-228" decimals="-6" id="f-962" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-229" decimals="-6" id="f-963" unitRef="usd">-6000000</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-230" decimals="-6" id="f-964" unitRef="usd">0</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-221" decimals="-6" id="f-965" unitRef="usd">-12000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-222" decimals="-6" id="f-966" unitRef="usd">-3000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-223" decimals="-6" id="f-967" unitRef="usd">0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-224" decimals="-6" id="f-968" unitRef="usd">0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-225" decimals="-6" id="f-969" unitRef="usd">0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-251" decimals="-6" id="f-970" unitRef="usd">0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-252" decimals="-6" id="f-971" unitRef="usd">0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-253" decimals="-6" id="f-972" unitRef="usd">5000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-254" decimals="-6" id="f-973" unitRef="usd">0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-255" decimals="-6" id="f-974" unitRef="usd">20000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-226" decimals="-6" id="f-975" unitRef="usd">-12000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-227" decimals="-6" id="f-976" unitRef="usd">-3000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-228" decimals="-6" id="f-977" unitRef="usd">5000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-229" decimals="-6" id="f-978" unitRef="usd">0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-230" decimals="-6" id="f-979" unitRef="usd">20000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-256" decimals="-6" id="f-980" unitRef="usd">-4000000</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax contextRef="c-257" decimals="-6" id="f-981" unitRef="usd">-6000000</gehc:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c-1" id="f-982">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table represents assets and liabilities that are recorded and measured at fair value on a recurring basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.094%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.094%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.094%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.094%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.094%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.094%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.094%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.099%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Fair Value of Assets and Liabilities Measured on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of March 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Money market funds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent contextRef="c-258" decimals="-6" id="f-983" unitRef="usd">0</gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent>
    <gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent contextRef="c-259" decimals="-6" id="f-984" unitRef="usd">230000000</gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent>
    <gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent contextRef="c-260" decimals="-6" id="f-985" unitRef="usd">0</gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent>
    <gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent contextRef="c-261" decimals="-6" id="f-986" unitRef="usd">230000000</gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent>
    <gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent contextRef="c-262" decimals="-6" id="f-987" unitRef="usd">0</gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent>
    <gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent contextRef="c-263" decimals="-6" id="f-988" unitRef="usd">312000000</gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent>
    <gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent contextRef="c-264" decimals="-6" id="f-989" unitRef="usd">0</gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent>
    <gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent contextRef="c-265" decimals="-6" id="f-990" unitRef="usd">312000000</gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-266" decimals="-6" id="f-991" unitRef="usd">27000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-267" decimals="-6" id="f-992" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-268" decimals="-6" id="f-993" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-269" decimals="-6" id="f-994" unitRef="usd">27000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-270" decimals="-6" id="f-995" unitRef="usd">32000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-271" decimals="-6" id="f-996" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-272" decimals="-6" id="f-997" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-273" decimals="-6" id="f-998" unitRef="usd">32000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeAssets contextRef="c-266" decimals="-6" id="f-999" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-267" decimals="-6" id="f-1000" unitRef="usd">136000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-268" decimals="-6" id="f-1001" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-269" decimals="-6" id="f-1002" unitRef="usd">136000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-270" decimals="-6" id="f-1003" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-271" decimals="-6" id="f-1004" unitRef="usd">145000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-272" decimals="-6" id="f-1005" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-273" decimals="-6" id="f-1006" unitRef="usd">145000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities contextRef="c-266" decimals="-6" id="f-1007" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-267" decimals="-6" id="f-1008" unitRef="usd">160000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-268" decimals="-6" id="f-1009" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-269" decimals="-6" id="f-1010" unitRef="usd">160000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-270" decimals="-6" id="f-1011" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-271" decimals="-6" id="f-1012" unitRef="usd">155000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-272" decimals="-6" id="f-1013" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-273" decimals="-6" id="f-1014" unitRef="usd">155000000</us-gaap:DerivativeLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-266" decimals="-6" id="f-1015" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-267" decimals="-6" id="f-1016" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-268" decimals="-6" id="f-1017" unitRef="usd">40000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-269" decimals="-6" id="f-1018" unitRef="usd">40000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-270" decimals="-6" id="f-1019" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-271" decimals="-6" id="f-1020" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-272" decimals="-6" id="f-1021" unitRef="usd">34000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-273" decimals="-6" id="f-1022" unitRef="usd">34000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent contextRef="c-8" decimals="-6" id="f-1023" unitRef="usd">2473000000</gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent>
    <gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent contextRef="c-9" decimals="-6" id="f-1024" unitRef="usd">2889000000</gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent>
    <gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent contextRef="c-261" decimals="-6" id="f-1025" unitRef="usd">230000000</gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent>
    <gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent contextRef="c-265" decimals="-6" id="f-1026" unitRef="usd">312000000</gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent>
    <gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent contextRef="c-274" decimals="-6" id="f-1027" unitRef="usd">1229000000</gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent>
    <gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent contextRef="c-275" decimals="-6" id="f-1028" unitRef="usd">1573000000</gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent>
    <us-gaap:LongTermDebtFairValue contextRef="c-276" decimals="-6" id="f-1029" unitRef="usd">9223000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-277" decimals="-6" id="f-1030" unitRef="usd">9374000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-278" decimals="-6" id="f-1031" unitRef="usd">8759000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-279" decimals="-6" id="f-1032" unitRef="usd">8951000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock contextRef="c-1" id="f-1033">COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES, AND OTHER LOSS CONTINGENCIES &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;GUARANTEES.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has off-balance sheet credit exposure through standby letters of credit, bank guarantees, bid bonds, and surety bonds. See Note 8, &#x201c;Borrowings&#x201d; for further information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;PRODUCT WARRANTIES.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We provide warranty coverage to our customers as part of customary practices in the market to provide assurance that the products we sell comply with agreed-upon specifications. We provide estimated product warranty expenses when we sell the related products. Warranty accruals are estimates that are based on the best available information, mostly historical claims experience, therefore claims costs may differ from amounts provided. An analysis of changes in the liability for product warranties follows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.733%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.983%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.984%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;For the three months ended March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;168&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;192&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Current-year provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency exchange and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;171&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;175&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Product warranties are recognized within All other current liabilities in the Condensed Consolidated Statements of Financial Position. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;LEGAL MATTERS. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In the normal course of our business, we are involved from time to time in various arbitrations; class actions; commercial, intellectual property, and product liability litigation; government investigations; investigations by competition/antitrust authorities; and other legal, regulatory, or governmental actions, including the significant matters described below that could have a material impact on our results of operations and cash flows. In many proceedings, including the specific matters described below, it is inherently difficult to determine whether any loss is probable or even reasonably possible or to estimate the size or range of the possible loss, and accruals for legal matters are not recorded until a loss for a particular matter is considered probable and reasonably estimable. Given the nature of legal matters and the complexities involved, it is often difficult to predict and determine a meaningful estimate of loss or range of loss until we know, among other factors, the particular claims involved, the likelihood of success of our defenses to those claims, the damages or other relief sought, how discovery or other procedural considerations will affect the outcome, the settlement posture of other parties, and other factors that may have a material effect on the outcome. For such matters, unless otherwise specified, we do not believe it is possible to provide a meaningful estimate of loss at this time. Moreover, it is not uncommon for legal matters to be resolved over many years, during which time relevant developments and new information must be continuously evaluated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contracts with Iraqi Ministry of Health&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In 2017, a number of U.S. Service members, civilians, and their families brought a complaint in the U.S. District Court for the District of Columbia (the &#x201c;District Court&#x201d;) against a number of pharmaceutical and medical device companies, including GE HealthCare and certain affiliates, alleging that the defendants violated the U.S. Anti-Terrorism Act. The complaint seeks monetary relief and alleges that the defendants provided funding for an Iraqi terrorist organization through their sales practices pursuant to pharmaceutical and medical device contracts with the Iraqi Ministry of Health. In July 2020, the District Court granted defendants&#x2019; motions to dismiss and dismissed all of the plaintiffs&#x2019; claims. In January 2022, a panel of the U.S. Court of Appeals for the District of Columbia Circuit reversed the District Court&#x2019;s decision. In February 2022, the defendants requested review of the decision by all of the judges on the U.S. Court of Appeals for the District of Columbia Circuit (the &#x201c;D.C. Circuit&#x201d;). In February 2023, the D.C. Circuit denied this request. In June 2023, defendants petitioned the Supreme Court to review the D.C. Circuit&#x2019;s decision. On June 24, 2024, the Supreme Court vacated the D.C. Circuit&#x2019;s decision and remanded the case to the D.C. Circuit for further consideration. On November 19, 2024, the D.C. Circuit heard oral argument from the parties, and the D.C. Circuit&#x2019;s decision is pending. The proceedings in the District Court are currently inactive.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Disclosures &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;From time to time, we make self-disclosures regarding our compliance with the Foreign Corrupt Practices Act (&#x201c;FCPA&#x201d;) and similar laws to relevant authorities who may pursue or decline to pursue enforcement proceedings against us. We, with the assistance of outside counsel, made voluntary self-disclosures to the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) and the U.S. Department of Justice (&#x201c;DOJ&#x201d;) beginning in 2018 regarding tender irregularities and other potential violations of the FCPA relating to our activities in certain provinces in China. We have been engaged in ongoing discussions with each of the SEC and the DOJ regarding these matters. We are fully cooperating with the reviews by these agencies and have implemented, and continue to implement, enhancements to our compliance policies and practices. At this time, we are unable to predict the duration, scope, result, or related costs associated with these disclosures to the SEC and the DOJ. We also are unable to predict what, if any, action may be taken by the SEC or the DOJ or what penalties or remedial actions they may seek. Any determination that our operations or activities are not in compliance with existing laws or regulations, including applicable foreign laws, could result in the imposition of fines, penalties, disgorgement, equitable relief, or other losses.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock contextRef="c-1" id="f-1034">An analysis of changes in the liability for product warranties follows.&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.733%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.983%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.984%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;For the three months ended March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;168&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;192&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Current-year provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Foreign currency exchange and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;171&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;175&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:ProductWarrantyAccrual contextRef="c-9" decimals="-6" id="f-1035" unitRef="usd">168000000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrual contextRef="c-32" decimals="-6" id="f-1036" unitRef="usd">192000000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued contextRef="c-1" decimals="-6" id="f-1037" unitRef="usd">59000000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued contextRef="c-7" decimals="-6" id="f-1038" unitRef="usd">41000000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualPayments contextRef="c-1" decimals="-6" id="f-1039" unitRef="usd">58000000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrualPayments contextRef="c-7" decimals="-6" id="f-1040" unitRef="usd">55000000</us-gaap:ProductWarrantyAccrualPayments>
    <gehc:StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease contextRef="c-1" decimals="-6" id="f-1041" unitRef="usd">2000000</gehc:StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease>
    <gehc:StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease contextRef="c-7" decimals="-6" id="f-1042" unitRef="usd">-2000000</gehc:StandardAndExtendedProductWarrantyAccrualOtherIncreaseDecrease>
    <us-gaap:ProductWarrantyAccrual contextRef="c-8" decimals="-6" id="f-1043" unitRef="usd">171000000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrual contextRef="c-43" decimals="-6" id="f-1044" unitRef="usd">175000000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock contextRef="c-1" id="f-1045">RESTRUCTURING ACTIVITIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Restructuring activities are essential to optimize the business operating model for GE HealthCare and mostly involve workforce reductions, organizational realignments, and revisions to our real estate footprint. Specifically, restructuring charges (gains) primarily include facility exit costs, employee-related termination benefits associated with workforce reductions, asset write-downs, and cease-use costs. For segment reporting, restructuring activities are not allocated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net expenses for restructuring initiatives committed to by management through March 31, 2025 are included in the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.511%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.594%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;For the three months ended March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Facility and other exit costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Asset write-downs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total restructuring activities &#x2013; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;22&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;These restructuring initiatives are expected to result in additional expenses of approximately $40&#160;million, to be incurred primarily over the next 12 months, substantially related to employee-related termination benefits and asset write-downs. Restructuring expenses (gains) are recognized within &lt;span style="-sec-ix-hidden:f-1056"&gt;&lt;span style="-sec-ix-hidden:f-1057"&gt;Cost of products, Cost of services, or SG&amp;amp;A, as appropriate, in the Condensed Consolidated Statements of Income.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liabilities related to restructuring are recognized within Current compensation and benefits, All other current liabilities, Non-current compensation and benefits, and All other non-current liabilities in the Condensed Consolidated Statements of Financial Position. The activity related to our restructuring liabilities follows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.791%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt;padding-right:-1.31pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Employee termination costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt;padding-right:-1.31pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Facility and other exit costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;67&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;86&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Charges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Payments and other adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Balance at March 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;89&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock contextRef="c-1" id="f-1046">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net expenses for restructuring initiatives committed to by management through March 31, 2025 are included in the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.511%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.594%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;For the three months ended March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Facility and other exit costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Asset write-downs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total restructuring activities &#x2013; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;22&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The activity related to our restructuring liabilities follows.&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.791%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt;padding-right:-1.31pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Employee termination costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt;padding-right:-1.31pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Facility and other exit costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;67&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;86&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Charges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Payments and other adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Balance at March 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;89&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:SeveranceCosts1 contextRef="c-1" decimals="-6" id="f-1047" unitRef="usd">21000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c-7" decimals="-6" id="f-1048" unitRef="usd">25000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1 contextRef="c-1" decimals="-6" id="f-1049" unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1 contextRef="c-7" decimals="-6" id="f-1050" unitRef="usd">8000000</us-gaap:BusinessExitCosts1>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="c-1" decimals="-6" id="f-1051" unitRef="usd">-1000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="c-7" decimals="-6" id="f-1052" unitRef="usd">-7000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges contextRef="c-1" decimals="-6" id="f-1053" unitRef="usd">22000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges contextRef="c-7" decimals="-6" id="f-1054" unitRef="usd">40000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1 contextRef="c-8" decimals="-6" id="f-1055" unitRef="usd">40000000</us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1>
    <us-gaap:RestructuringReserve contextRef="c-280" decimals="-6" id="f-1058" unitRef="usd">67000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-281" decimals="-6" id="f-1059" unitRef="usd">18000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-9" decimals="-6" id="f-1060" unitRef="usd">86000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges contextRef="c-282" decimals="-6" id="f-1061" unitRef="usd">19000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-283" decimals="-6" id="f-1062" unitRef="usd">1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-1" decimals="-6" id="f-1063" unitRef="usd">20000000</us-gaap:RestructuringCharges>
    <gehc:PaymentsForRestructuringAndOtherAdjustments contextRef="c-282" decimals="-6" id="f-1064" unitRef="usd">14000000</gehc:PaymentsForRestructuringAndOtherAdjustments>
    <gehc:PaymentsForRestructuringAndOtherAdjustments contextRef="c-283" decimals="-6" id="f-1065" unitRef="usd">3000000</gehc:PaymentsForRestructuringAndOtherAdjustments>
    <gehc:PaymentsForRestructuringAndOtherAdjustments contextRef="c-1" decimals="-6" id="f-1066" unitRef="usd">17000000</gehc:PaymentsForRestructuringAndOtherAdjustments>
    <us-gaap:RestructuringReserve contextRef="c-284" decimals="-6" id="f-1067" unitRef="usd">73000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-285" decimals="-6" id="f-1068" unitRef="usd">16000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-8" decimals="-6" id="f-1069" unitRef="usd">89000000</us-gaap:RestructuringReserve>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-1070">EARNINGS PER SHARE&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The numerator for both basic and diluted earnings per share (&#x201c;EPS&#x201d;) is Net income attributable to GE HealthCare. The denominator of basic EPS is the weighted-average number of shares outstanding during the period. The dilutive effect of outstanding stock options, restricted stock units, and performance share units is reflected in the denominator for diluted EPS using the treasury stock method.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.066%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.816%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.818%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Earnings Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;For the three months ended March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:125%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:125%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Net income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Net (income) loss attributable to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Net income attributable to GE HealthCare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:125%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Basic weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Dilutive effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Diluted weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Basic earnings per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;0.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;0.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Antidilutive securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(1) Diluted earnings per share excludes certain shares issuable under share-based compensation plans because the effect would have been antidilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-1071">&lt;div style="margin-bottom:0.08pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.066%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.816%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.818%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Earnings Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;For the three months ended March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:125%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:125%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Net income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Net (income) loss attributable to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Net income attributable to GE HealthCare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:125%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Basic weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Dilutive effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Diluted weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Basic earnings per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;0.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;0.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Antidilutive securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;(1) Diluted earnings per share excludes certain shares issuable under share-based compensation plans because the effect would have been antidilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-6" id="f-1072" unitRef="usd">588000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-6" id="f-1073" unitRef="usd">388000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-1074" unitRef="usd">24000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-7" decimals="-6" id="f-1075" unitRef="usd">14000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-6" id="f-1076" unitRef="usd">564000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-6" id="f-1077" unitRef="usd">374000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-6" id="f-1078" unitRef="shares">457000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-6" id="f-1079" unitRef="shares">456000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="c-1" decimals="-6" id="f-1080" unitRef="shares">2000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="c-7" decimals="-6" id="f-1081" unitRef="shares">3000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-6" id="f-1082" unitRef="shares">459000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="-6" id="f-1083" unitRef="shares">459000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-1084"
      unitRef="usdPerShare">1.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-1085"
      unitRef="usdPerShare">0.82</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-1086"
      unitRef="usdPerShare">1.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-1087"
      unitRef="usdPerShare">0.81</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="-6" id="f-1088" unitRef="shares">2000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-7" decimals="-6" id="f-1089" unitRef="shares">4000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock contextRef="c-1" id="f-1090">SUPPLEMENTAL FINANCIAL INFORMATION&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;CASH, CASH EQUIVALENTS, AND RESTRICTED CASH.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.02pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.985%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Short-term restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Financial Position&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,473&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,889&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:1.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Long-term restricted cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,476&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,893&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Long-term restricted cash is recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;INVENTORIES.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.985%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,158&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,939&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain inventory items are long-term in nature and therefore have been recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position and are not reflected in the table above. See the supplemental table &#x201c;All Other Non-Current Assets&#x201d; for further information. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;PROPERTY, PLANT, AND EQUIPMENT &#x2013; NET.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.985%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Land and improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Buildings, structures, and related equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;2,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;1,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Machinery and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;2,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;2,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Leasehold improvements and manufacturing plants under construction&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total property, plant, and equipment, at original cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;5,661&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;5,267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(3,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(3,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Right-of-use operating lease assets, net of amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Property, plant, and equipment &#x2013; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,851&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,550&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;ALL OTHER ASSETS AND ALL OTHER LIABILITIES. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.316%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.846%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;All Other Current Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Prepaid expenses and deferred costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Financing receivables &#x2013; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Derivative instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Tax receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;All other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;601&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;532&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.316%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.846%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;All Other Non-Current Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Prepaid pension asset&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Equity method and other investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Financing receivables &#x2013; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Long-term receivables &#x2013; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Contract and other deferred assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Capitalized cloud computing arrangement implementation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;All other non-current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;1,926&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;1,950&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.316%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.846%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;All Other Current Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Sales allowances and related liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Income and indirect tax liabilities including uncertain tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Product warranties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Accrued freight and utilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Derivative instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Interest payable on borrowings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Environmental and asset retirement obligations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;All other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;1,583&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;1,552&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.316%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.846%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;All Other Non-Current Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Contract liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Environmental and asset retirement obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Income and indirect tax liabilities including uncertain tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Derivative instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&lt;span style="-sec-ix-hidden:f-1193"&gt;&lt;span style="-sec-ix-hidden:f-1194"&gt;Finance lease obligations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Sales allowances and related liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;All other non-current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;1,840&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;1,796&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;(1) Derivative instruments include the related accrued interest. Refer to Note 12, &#x201c;Financial Instruments and Fair Value Measurements&#x201d; for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;(2) Current assets Other primarily represents indemnity assets associated with separation agreements with GE as of March 31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;(3) Non-current assets Other primarily consists of indemnity assets associated with separation agreements with GE, derivative instruments, and tax receivables.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;(4) Current liabilities Other primarily consists of miscellaneous accrued costs, contingent consideration liabilities, and dividends payable to stockholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;(5) Non-current liabilities Other primarily consists of miscellaneous accrued costs, indemnity liabilities associated with separation agreements with GE, and contingent consideration liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:118%"&gt;SUPPLY CHAIN FINANCE PROGRAMS. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;The Company participates in voluntary supply chain finance programs which provide participating suppliers the opportunity to sell their GE HealthCare receivables to third parties at the sole discretion of both the suppliers and the third parties. We evaluate supply chain finance programs to ensure the use of a third-party intermediary to settle our trade payables does not change the nature, existence, amount, or timing of our trade payables and does not provide the Company with any direct economic benefit. If any characteristics of the trade payables change or we receive a direct economic benefit, we reclassify the trade payables to borrowings. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;In connection with the supply chain finance programs, payment terms normally range from 30 to 180 days, depending on the underlying supplier agreements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;Included within &lt;span style="-sec-ix-hidden:f-1206"&gt;&lt;span style="-sec-ix-hidden:f-1207"&gt;Accounts payable&lt;/span&gt;&lt;/span&gt; in the Condensed Consolidated Statements of Financial Position as of March 31, 2025 and December 31, 2024 were $364 million and $394 million, respectively, of confirmed supplier invoices that are outstanding and subject to third-party programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:118%"&gt;REDEEMABLE NONCONTROLLING INTERESTS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:118%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;The Company has noncontrolling interests with redemption features. These redemption features, such as put options, could require the Company to purchase the noncontrolling interests upon the occurrence of certain events. All noncontrolling interests with redemption features that are not solely within our control are recognized within the Condensed Consolidated Statements of Financial Position between liabilities and equity. Redeemable noncontrolling interests are initially recorded at the issuance date fair value. Those that are currently redeemable, or probable of becoming redeemable, are subsequently adjusted to the greater of current redemption value or initial carrying value. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;Activity attributable to redeemable noncontrolling interests is presented below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;For the three months ended March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;188&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Net income attributable to redeemable noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Balance at end of period &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;211&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;177&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;OTHER INCOME (EXPENSE) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt; NET.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.040%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center;text-indent:5pt"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;For the three months ended March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Net financing income and investment income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Equity method income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Change in fair value of assumed obligations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Gain on remeasurement of NMP equity method investment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Other items, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;Total other income (expense) &#x2013; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;99&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;(1) Refer to Note 7, &#x201c;Acquisitions, Goodwill, and Other Intangible Assets&#x201d; for additional information on the NMP acquisition.&lt;/span&gt;&lt;/div&gt;(2) Other items, net primarily consists of licensing and royalty income, lease income, change in tax indemnities, and gains and losses related to derivatives. Additionally, for the three months ended March 31, 2025 it includes a realization of a gain contingency.</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock contextRef="c-1" id="f-1092">&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;CASH, CASH EQUIVALENTS, AND RESTRICTED CASH.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.02pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.985%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Short-term restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Financial Position&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,473&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,889&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:1.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Long-term restricted cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,476&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,893&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Long-term restricted cash is recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="c-1" id="f-1091">&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;CASH, CASH EQUIVALENTS, AND RESTRICTED CASH.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.02pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.985%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;2,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Short-term restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Financial Position&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,473&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,889&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;padding-left:1.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Long-term restricted cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total Cash, cash equivalents, and restricted cash as presented in the Condensed Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,476&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,893&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Long-term restricted cash is recognized within All other non-current assets in the Condensed Consolidated Statements of Financial Position.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-8" decimals="-6" id="f-1093" unitRef="usd">2454000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-9" decimals="-6" id="f-1094" unitRef="usd">2874000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c-8" decimals="-6" id="f-1095" unitRef="usd">19000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c-9" decimals="-6" id="f-1096" unitRef="usd">16000000</us-gaap:RestrictedCashCurrent>
    <gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent contextRef="c-8" decimals="-6" id="f-1097" unitRef="usd">2473000000</gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent>
    <gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent contextRef="c-9" decimals="-6" id="f-1098" unitRef="usd">2889000000</gehc:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-8" decimals="-6" id="f-1099" unitRef="usd">3000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-9" decimals="-6" id="f-1100" unitRef="usd">3000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-8" decimals="-6" id="f-1101" unitRef="usd">2476000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-9" decimals="-6" id="f-1102" unitRef="usd">2893000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c-1" id="f-1103">&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;INVENTORIES.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.985%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;1,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,158&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;1,939&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-8" decimals="-6" id="f-1104" unitRef="usd">991000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-9" decimals="-6" id="f-1105" unitRef="usd">921000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-8" decimals="-6" id="f-1106" unitRef="usd">99000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-9" decimals="-6" id="f-1107" unitRef="usd">92000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-8" decimals="-6" id="f-1108" unitRef="usd">1068000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-9" decimals="-6" id="f-1109" unitRef="usd">926000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet contextRef="c-8" decimals="-6" id="f-1110" unitRef="usd">2158000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-9" decimals="-6" id="f-1111" unitRef="usd">1939000000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-1112">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;PROPERTY, PLANT, AND EQUIPMENT &#x2013; NET.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.985%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Land and improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Buildings, structures, and related equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;2,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;1,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Machinery and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;2,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;2,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Leasehold improvements and manufacturing plants under construction&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Total property, plant, and equipment, at original cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;5,661&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;5,267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(3,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(3,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Right-of-use operating lease assets, net of amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Property, plant, and equipment &#x2013; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,851&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;2,550&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-286" decimals="-6" id="f-1113" unitRef="usd">146000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-287" decimals="-6" id="f-1114" unitRef="usd">66000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-288" decimals="-6" id="f-1115" unitRef="usd">2107000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-289" decimals="-6" id="f-1116" unitRef="usd">1943000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-290" decimals="-6" id="f-1117" unitRef="usd">2905000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-291" decimals="-6" id="f-1118" unitRef="usd">2705000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-292" decimals="-6" id="f-1119" unitRef="usd">503000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-293" decimals="-6" id="f-1120" unitRef="usd">553000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-8" decimals="-6" id="f-1121" unitRef="usd">5661000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-9" decimals="-6" id="f-1122" unitRef="usd">5267000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-8" decimals="-6" id="f-1123" unitRef="usd">3179000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-9" decimals="-6" id="f-1124" unitRef="usd">3080000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-8" decimals="-6" id="f-1125" unitRef="usd">369000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-9" decimals="-6" id="f-1126" unitRef="usd">364000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <gehc:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-8" decimals="-6" id="f-1127" unitRef="usd">2851000000</gehc:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <gehc:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-9" decimals="-6" id="f-1128" unitRef="usd">2550000000</gehc:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock contextRef="c-1" id="f-1129">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.316%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.846%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;All Other Current Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Prepaid expenses and deferred costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Financing receivables &#x2013; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Derivative instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Tax receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;All other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;601&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;532&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;(1) Derivative instruments include the related accrued interest. Refer to Note 12, &#x201c;Financial Instruments and Fair Value Measurements&#x201d; for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;(2) Current assets Other primarily represents indemnity assets associated with separation agreements with GE as of March 31, 2025.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <gehc:PrepaidExpensesAndDeferredCostsCurrent contextRef="c-8" decimals="-6" id="f-1130" unitRef="usd">249000000</gehc:PrepaidExpensesAndDeferredCostsCurrent>
    <gehc:PrepaidExpensesAndDeferredCostsCurrent contextRef="c-9" decimals="-6" id="f-1131" unitRef="usd">188000000</gehc:PrepaidExpensesAndDeferredCostsCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="c-8" decimals="-6" id="f-1132" unitRef="usd">90000000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="c-9" decimals="-6" id="f-1133" unitRef="usd">90000000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:DerivativeAssetsCurrent contextRef="c-8" decimals="-6" id="f-1134" unitRef="usd">100000000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent contextRef="c-9" decimals="-6" id="f-1135" unitRef="usd">123000000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:IncomeTaxesReceivable contextRef="c-8" decimals="-6" id="f-1136" unitRef="usd">116000000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable contextRef="c-9" decimals="-6" id="f-1137" unitRef="usd">115000000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OtherAssetsMiscellaneousCurrent contextRef="c-8" decimals="-6" id="f-1138" unitRef="usd">46000000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsMiscellaneousCurrent contextRef="c-9" decimals="-6" id="f-1139" unitRef="usd">16000000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-8" decimals="-6" id="f-1140" unitRef="usd">601000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-9" decimals="-6" id="f-1141" unitRef="usd">532000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock contextRef="c-1" id="f-1142">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.316%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.846%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;All Other Non-Current Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Prepaid pension asset&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Equity method and other investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Financing receivables &#x2013; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Long-term receivables &#x2013; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Contract and other deferred assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Capitalized cloud computing arrangement implementation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;All other non-current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;1,926&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;1,950&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;(3) Non-current assets Other primarily consists of indemnity assets associated with separation agreements with GE, derivative instruments, and tax receivables.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <us-gaap:PrepaidExpenseNoncurrent contextRef="c-8" decimals="-6" id="f-1143" unitRef="usd">723000000</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:PrepaidExpenseNoncurrent contextRef="c-9" decimals="-6" id="f-1144" unitRef="usd">657000000</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:LongTermInvestments contextRef="c-8" decimals="-6" id="f-1145" unitRef="usd">235000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments contextRef="c-9" decimals="-6" id="f-1146" unitRef="usd">373000000</us-gaap:LongTermInvestments>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent contextRef="c-8" decimals="-6" id="f-1147" unitRef="usd">186000000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent contextRef="c-9" decimals="-6" id="f-1148" unitRef="usd">183000000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:OtherReceivableAfterAllowanceForCreditLossNoncurrent contextRef="c-8" decimals="-6" id="f-1149" unitRef="usd">161000000</us-gaap:OtherReceivableAfterAllowanceForCreditLossNoncurrent>
    <us-gaap:OtherReceivableAfterAllowanceForCreditLossNoncurrent contextRef="c-9" decimals="-6" id="f-1150" unitRef="usd">142000000</us-gaap:OtherReceivableAfterAllowanceForCreditLossNoncurrent>
    <us-gaap:InventoryNoncurrent contextRef="c-8" decimals="-6" id="f-1151" unitRef="usd">143000000</us-gaap:InventoryNoncurrent>
    <us-gaap:InventoryNoncurrent contextRef="c-9" decimals="-6" id="f-1152" unitRef="usd">139000000</us-gaap:InventoryNoncurrent>
    <gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent contextRef="c-8" decimals="-6" id="f-1153" unitRef="usd">213000000</gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent>
    <gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent contextRef="c-9" decimals="-6" id="f-1154" unitRef="usd">208000000</gehc:ContractWithCustomerAssetAfterAllowanceForCreditLossAndDeferredCostsNoncurrent>
    <us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization contextRef="c-8" decimals="-6" id="f-1155" unitRef="usd">113000000</us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization>
    <us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization contextRef="c-9" decimals="-6" id="f-1156" unitRef="usd">84000000</us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent contextRef="c-8" decimals="-6" id="f-1157" unitRef="usd">152000000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent contextRef="c-9" decimals="-6" id="f-1158" unitRef="usd">164000000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-8" decimals="-6" id="f-1159" unitRef="usd">1926000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-9" decimals="-6" id="f-1160" unitRef="usd">1950000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock contextRef="c-1" id="f-1161">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.316%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.846%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;All Other Current Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Sales allowances and related liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6400a0;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Income and indirect tax liabilities including uncertain tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Product warranties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Accrued freight and utilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Derivative instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Interest payable on borrowings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Environmental and asset retirement obligations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;All other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;1,583&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;1,552&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;(1) Derivative instruments include the related accrued interest. Refer to Note 12, &#x201c;Financial Instruments and Fair Value Measurements&#x201d; for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;(4) Current liabilities Other primarily consists of miscellaneous accrued costs, contingent consideration liabilities, and dividends payable to stockholders.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <gehc:SalesAllowancesAndRelatedLiabilitiesCurrent contextRef="c-8" decimals="-6" id="f-1162" unitRef="usd">221000000</gehc:SalesAllowancesAndRelatedLiabilitiesCurrent>
    <gehc:SalesAllowancesAndRelatedLiabilitiesCurrent contextRef="c-9" decimals="-6" id="f-1163" unitRef="usd">242000000</gehc:SalesAllowancesAndRelatedLiabilitiesCurrent>
    <gehc:DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent contextRef="c-8" decimals="-6" id="f-1164" unitRef="usd">286000000</gehc:DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent>
    <gehc:DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent contextRef="c-9" decimals="-6" id="f-1165" unitRef="usd">279000000</gehc:DeferredIncomeTaxesAndOtherTaxLiabilitiesCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="c-8" decimals="-6" id="f-1166" unitRef="usd">171000000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="c-9" decimals="-6" id="f-1167" unitRef="usd">168000000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <gehc:AccruedFreightAndUtilitiesCurrent contextRef="c-8" decimals="-6" id="f-1168" unitRef="usd">154000000</gehc:AccruedFreightAndUtilitiesCurrent>
    <gehc:AccruedFreightAndUtilitiesCurrent contextRef="c-9" decimals="-6" id="f-1169" unitRef="usd">163000000</gehc:AccruedFreightAndUtilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-8" decimals="-6" id="f-1170" unitRef="usd">119000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-9" decimals="-6" id="f-1171" unitRef="usd">115000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="c-8" decimals="-6" id="f-1172" unitRef="usd">120000000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="c-9" decimals="-6" id="f-1173" unitRef="usd">90000000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:InterestPayableCurrent contextRef="c-8" decimals="-6" id="f-1174" unitRef="usd">141000000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent contextRef="c-9" decimals="-6" id="f-1175" unitRef="usd">92000000</us-gaap:InterestPayableCurrent>
    <gehc:AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent contextRef="c-8" decimals="-6" id="f-1176" unitRef="usd">17000000</gehc:AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent>
    <gehc:AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent contextRef="c-9" decimals="-6" id="f-1177" unitRef="usd">17000000</gehc:AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-8" decimals="-6" id="f-1178" unitRef="usd">355000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-9" decimals="-6" id="f-1179" unitRef="usd">386000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-8" decimals="-6" id="f-1180" unitRef="usd">1583000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-9" decimals="-6" id="f-1181" unitRef="usd">1552000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock contextRef="c-1" id="f-1182">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.316%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.846%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;All Other Non-Current Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;text-indent:-0.8pt;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Contract liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Environmental and asset retirement obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Income and indirect tax liabilities including uncertain tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Derivative instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&lt;span style="-sec-ix-hidden:f-1193"&gt;&lt;span style="-sec-ix-hidden:f-1194"&gt;Finance lease obligations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Sales allowances and related liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;All other non-current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;1,840&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;1,796&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;(1) Derivative instruments include the related accrued interest. Refer to Note 12, &#x201c;Financial Instruments and Fair Value Measurements&#x201d; for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;(5) Non-current liabilities Other primarily consists of miscellaneous accrued costs, indemnity liabilities associated with separation agreements with GE, and contingent consideration liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-8" decimals="-6" id="f-1183" unitRef="usd">724000000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-9" decimals="-6" id="f-1184" unitRef="usd">686000000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-8" decimals="-6" id="f-1185" unitRef="usd">266000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-9" decimals="-6" id="f-1186" unitRef="usd">270000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <gehc:AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent contextRef="c-8" decimals="-6" id="f-1187" unitRef="usd">395000000</gehc:AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent>
    <gehc:AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent contextRef="c-9" decimals="-6" id="f-1188" unitRef="usd">291000000</gehc:AssetRetirementObligationAndAccruedEnvironmentalLossContingenciesNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent contextRef="c-8" decimals="-6" id="f-1189" unitRef="usd">170000000</us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent contextRef="c-9" decimals="-6" id="f-1190" unitRef="usd">237000000</us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="c-8" decimals="-6" id="f-1191" unitRef="usd">39000000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="c-9" decimals="-6" id="f-1192" unitRef="usd">64000000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-8" decimals="-6" id="f-1195" unitRef="usd">40000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-9" decimals="-6" id="f-1196" unitRef="usd">40000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <gehc:SalesAllowancesAndRelatedLiabilitiesNoncurrent contextRef="c-8" decimals="-6" id="f-1197" unitRef="usd">24000000</gehc:SalesAllowancesAndRelatedLiabilitiesNoncurrent>
    <gehc:SalesAllowancesAndRelatedLiabilitiesNoncurrent contextRef="c-9" decimals="-6" id="f-1198" unitRef="usd">23000000</gehc:SalesAllowancesAndRelatedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="c-8" decimals="-6" id="f-1199" unitRef="usd">182000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="c-9" decimals="-6" id="f-1200" unitRef="usd">184000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-8" decimals="-6" id="f-1201" unitRef="usd">1840000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-9" decimals="-6" id="f-1202" unitRef="usd">1796000000</us-gaap:OtherLiabilitiesNoncurrent>
    <gehc:SupplierFinanceProgramPolicyPolicyTextBlock contextRef="c-1" id="f-1203">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;The Company participates in voluntary supply chain finance programs which provide participating suppliers the opportunity to sell their GE HealthCare receivables to third parties at the sole discretion of both the suppliers and the third parties. We evaluate supply chain finance programs to ensure the use of a third-party intermediary to settle our trade payables does not change the nature, existence, amount, or timing of our trade payables and does not provide the Company with any direct economic benefit. If any characteristics of the trade payables change or we receive a direct economic benefit, we reclassify the trade payables to borrowings. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;In connection with the supply chain finance programs, payment terms normally range from 30 to 180 days, depending on the underlying supplier agreements.&lt;/span&gt;&lt;/div&gt;</gehc:SupplierFinanceProgramPolicyPolicyTextBlock>
    <us-gaap:SupplierFinanceProgramPaymentTimingPeriod contextRef="c-294" id="f-1204">P30D</us-gaap:SupplierFinanceProgramPaymentTimingPeriod>
    <us-gaap:SupplierFinanceProgramPaymentTimingPeriod contextRef="c-295" id="f-1205">P180D</us-gaap:SupplierFinanceProgramPaymentTimingPeriod>
    <us-gaap:SupplierFinanceProgramObligationCurrent contextRef="c-8" decimals="-6" id="f-1208" unitRef="usd">364000000</us-gaap:SupplierFinanceProgramObligationCurrent>
    <us-gaap:SupplierFinanceProgramObligationCurrent contextRef="c-9" decimals="-6" id="f-1209" unitRef="usd">394000000</us-gaap:SupplierFinanceProgramObligationCurrent>
    <us-gaap:RedeemableNoncontrollingInterestTableTextBlock contextRef="c-1" id="f-1210">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;Activity attributable to redeemable noncontrolling interests is presented below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;For the three months ended March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;188&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;Net income attributable to redeemable noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;Balance at end of period &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;211&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;177&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RedeemableNoncontrollingInterestTableTextBlock>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount contextRef="c-9" decimals="-6" id="f-1211" unitRef="usd">188000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount contextRef="c-32" decimals="-6" id="f-1212" unitRef="usd">165000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-1213" unitRef="usd">24000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest contextRef="c-7" decimals="-6" id="f-1214" unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount contextRef="c-8" decimals="-6" id="f-1215" unitRef="usd">211000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount contextRef="c-43" decimals="-6" id="f-1216" unitRef="usd">177000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock contextRef="c-1" id="f-1217">&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;OTHER INCOME (EXPENSE) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt; NET.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.040%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt;text-align:center;text-indent:5pt"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;For the three months ended March 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #454545;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#454545;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Net financing income and investment income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;border-top:1pt solid #6022a6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Equity method income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Change in fair value of assumed obligations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Gain on remeasurement of NMP equity method investment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e4e4;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Other items, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e4e4;padding:2px 0 2px 1pt;text-align:right;text-indent:5pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e4e4;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:0.08pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;Total other income (expense) &#x2013; net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;99&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:125%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:118%"&gt;(1) Refer to Note 7, &#x201c;Acquisitions, Goodwill, and Other Intangible Assets&#x201d; for additional information on the NMP acquisition.&lt;/span&gt;&lt;/div&gt;(2) Other items, net primarily consists of licensing and royalty income, lease income, change in tax indemnities, and gains and losses related to derivatives. Additionally, for the three months ended March 31, 2025 it includes a realization of a gain contingency.</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:InvestmentIncomeNet contextRef="c-1" decimals="-6" id="f-1218" unitRef="usd">-1000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="c-7" decimals="-6" id="f-1219" unitRef="usd">-16000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-6" id="f-1220" unitRef="usd">3000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-7" decimals="-6" id="f-1221" unitRef="usd">1000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit contextRef="c-1" decimals="-6" id="f-1222" unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit contextRef="c-7" decimals="-6" id="f-1223" unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCredit>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain contextRef="c-1" decimals="-6" id="f-1224" unitRef="usd">97000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain contextRef="c-7" decimals="-6" id="f-1225" unitRef="usd">0</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <gehc:OtherItemsIncomeExpenseNet contextRef="c-1" decimals="-6" id="f-1226" unitRef="usd">8000000</gehc:OtherItemsIncomeExpenseNet>
    <gehc:OtherItemsIncomeExpenseNet contextRef="c-7" decimals="-6" id="f-1227" unitRef="usd">14000000</gehc:OtherItemsIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-6" id="f-1228" unitRef="usd">99000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-7" decimals="-6" id="f-1229" unitRef="usd">-8000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-1230">SUBSEQUENT EVENTSOn April 30, 2025, our Board of Directors authorized a share repurchase program for up to $1,000 million of our common stock. Repurchases may be made from time to time in the open market, in privately negotiated transactions, or in such other manner as determined by GE HealthCare. The repurchase program does not have an expiration date, does not obligate GE HealthCare to acquire any particular amount of common stock, and may be suspended or terminated at any time at the Company's discretion.</us-gaap:SubsequentEventsTextBlock>
    <srt:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-296" decimals="-6" id="f-1231" unitRef="usd">1000000000</srt:StockRepurchaseProgramAuthorizedAmount1>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-1" id="f-1232">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-1" id="f-1233">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-1" id="f-1234">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-1" id="f-1235">false</ecd:Rule10b51ArrTrmntdFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
